CHEMBL1201064
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  8 13  1  0
 13 14  2  0
 13 15  1  0
  8 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 30  2  1  0
 21  4  1  0
 16  5  1  0
 30 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1) 
675015

>  <SYNONYMS>  (1) 
Fluorometholone Acetate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1) 
4

>  <RESEARCH_CODES>  (1) 
U-17323

>  <APPLICANTS>  (1) 
Alcon Laboratories Inc

>  <USAN_STEM>  (1) 
-olone

>  <USAN_STEM_DEFINITION>  (1) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (1) 
-olone

>  <USAN_YEAR>  (1) 
1984.0

>  <FIRST_APPROVAL>  (1) 
1986.0

>  <ATC_CODE>  (1) 
D10AA01; S01CB05; C05AA06; S01BA07; D07XB04; D07AB06

>  <ATC_CODE_DESCRIPTION>  (1) 
D10AA01 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; S01CB05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; C05AA06 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; S01BA07 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; D07XB04 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; D07AB06 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (1) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (1) 
nan

>  <DRUG_TYPE>  (1) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1) 
Y

>  <FIRST_IN_CLASS>  (1) 
N

>  <CHIRALITY>  (1) 
Single Stereoisomer

>  <PRODRUG>  (1) 
Y

>  <ORAL>  (1) 
N

>  <PARENTERAL>  (1) 
N

>  <TOPICAL>  (1) 
Y

>  <BLACK_BOX>  (1) 
N

>  <AVAILABILITY_TYPE>  (1) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1) 
nan

>  <WITHDRAWN_COUNTRY>  (1) 
nan

>  <WITHDRAWN_REASON>  (1) 
nan

>  <CANONICAL_SMILES>  (1) 
C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(=O)C)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14

>  <name>  (1) 
Fluorometholone Acetate 

>  <MW>  (1) 
418.505

>  <logP>  (1) 
3.4941

$$$$
CHEMBL1009
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
  2 12  1  0
 12 13  2  0
 12 14  1  0
 11  4  1  0
M  END
>  <PARENT_MOLREGNO>  (2) 
112655

>  <SYNONYMS>  (2) 
Levodopa (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (2) 
4

>  <RESEARCH_CODES>  (2) 
nan

>  <APPLICANTS>  (2) 
Shire Development Inc; Orion Pharma; Merck Sharp And Dohme Corp; Hoffmann La Roche Inc; Valeant Pharmaceuticals International

>  <USAN_STEM>  (2) 
-dopa

>  <USAN_STEM_DEFINITION>  (2) 
dopamine receptor agonists

>  <USAN_STEM_SUBSTEM>  (2) 
-dopa

>  <USAN_YEAR>  (2) 
1969.0

>  <FIRST_APPROVAL>  (2) 
1970.0

>  <ATC_CODE>  (2) 
N04BA01

>  <ATC_CODE_DESCRIPTION>  (2) 
N04BA01 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopa and dopa derivatives]

>  <INDICATION_CLASS>  (2) 
Antiparkinsonian

>  <SC_PATENT_NO>  (2) 
US-6500867-B1

>  <DRUG_TYPE>  (2) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (2) 
Y

>  <FIRST_IN_CLASS>  (2) 
N

>  <CHIRALITY>  (2) 
Single Stereoisomer

>  <PRODRUG>  (2) 
N

>  <ORAL>  (2) 
Y

>  <PARENTERAL>  (2) 
N

>  <TOPICAL>  (2) 
N

>  <BLACK_BOX>  (2) 
N

>  <AVAILABILITY_TYPE>  (2) 
Prescription-only

>  <WITHDRAWN_YEAR>  (2) 
nan

>  <WITHDRAWN_COUNTRY>  (2) 
nan

>  <WITHDRAWN_REASON>  (2) 
nan

>  <CANONICAL_SMILES>  (2) 
N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O

>  <name>  (2) 
Levodopa 

>  <MW>  (2) 
197.19

>  <logP>  (2) 
0.0522

$$$$
CHEMBL270190
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
  4 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 23  2  1  0
 13  8  1  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (3) 
435293

>  <SYNONYMS>  (3) 
Alvimopan (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (3) 
4

>  <RESEARCH_CODES>  (3) 
ADL 8-2698

>  <APPLICANTS>  (3) 
Cubist Pharmaceuticals Inc

>  <USAN_STEM>  (3) 
nan

>  <USAN_STEM_DEFINITION>  (3) 
nan

>  <USAN_STEM_SUBSTEM>  (3) 
nan

>  <USAN_YEAR>  (3) 
2002.0

>  <FIRST_APPROVAL>  (3) 
2008.0

>  <ATC_CODE>  (3) 
A06AH02

>  <ATC_CODE_DESCRIPTION>  (3) 
A06AH02 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Peripheral opioid receptor antagonists]

>  <INDICATION_CLASS>  (3) 
nan

>  <SC_PATENT_NO>  (3) 
US-5250542-A

>  <DRUG_TYPE>  (3) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (3) 
Y

>  <FIRST_IN_CLASS>  (3) 
N

>  <CHIRALITY>  (3) 
Single Stereoisomer

>  <PRODRUG>  (3) 
N

>  <ORAL>  (3) 
Y

>  <PARENTERAL>  (3) 
N

>  <TOPICAL>  (3) 
N

>  <BLACK_BOX>  (3) 
Y

>  <AVAILABILITY_TYPE>  (3) 
Prescription-only

>  <WITHDRAWN_YEAR>  (3) 
nan

>  <WITHDRAWN_COUNTRY>  (3) 
nan

>  <WITHDRAWN_REASON>  (3) 
nan

>  <CANONICAL_SMILES>  (3) 
C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c3cccc(O)c3

>  <name>  (3) 
Alvimopan 

>  <MW>  (3) 
424.541

>  <logP>  (3) 
3.0514

$$$$
CHEMBL9
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 17  3  1  0
 17 11  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (4) 
246

>  <SYNONYMS>  (4) 
Norfloxacin (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (4) 
4

>  <RESEARCH_CODES>  (4) 
MK-366

>  <APPLICANTS>  (4) 
Merck Research Laboratories Div Merck Co Inc

>  <USAN_STEM>  (4) 
-oxacin

>  <USAN_STEM_DEFINITION>  (4) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (4) 
-oxacin

>  <USAN_YEAR>  (4) 
1984.0

>  <FIRST_APPROVAL>  (4) 
1986.0

>  <ATC_CODE>  (4) 
J01MA06; S01AE02

>  <ATC_CODE_DESCRIPTION>  (4) 
J01MA06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE02 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]

>  <INDICATION_CLASS>  (4) 
Antibacterial

>  <SC_PATENT_NO>  (4) 
nan

>  <DRUG_TYPE>  (4) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (4) 
Y

>  <FIRST_IN_CLASS>  (4) 
N

>  <CHIRALITY>  (4) 
Achiral Molecule

>  <PRODRUG>  (4) 
N

>  <ORAL>  (4) 
Y

>  <PARENTERAL>  (4) 
N

>  <TOPICAL>  (4) 
Y

>  <BLACK_BOX>  (4) 
Y

>  <AVAILABILITY_TYPE>  (4) 
Prescription-only

>  <WITHDRAWN_YEAR>  (4) 
nan

>  <WITHDRAWN_COUNTRY>  (4) 
nan

>  <WITHDRAWN_REASON>  (4) 
nan

>  <CANONICAL_SMILES>  (4) 
CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCNCC3

>  <name>  (4) 
Norfloxacin 

>  <MW>  (4) 
319.336

>  <logP>  (4) 
1.2683

$$$$
CHEMBL1068
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19  4  1  0
 10  5  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (5) 
139014

>  <SYNONYMS>  (5) 
Oxcarbazepine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (5) 
4

>  <RESEARCH_CODES>  (5) 
GP-47680; KIN-493

>  <APPLICANTS>  (5) 
Supernus Pharmaceuticals Inc; Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (5) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (5) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (5) 
-pin(e)

>  <USAN_YEAR>  (5) 
2002.0

>  <FIRST_APPROVAL>  (5) 
2000.0

>  <ATC_CODE>  (5) 
N03AF02

>  <ATC_CODE_DESCRIPTION>  (5) 
N03AF02 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives]

>  <INDICATION_CLASS>  (5) 
nan

>  <SC_PATENT_NO>  (5) 
US-7037525-B2

>  <DRUG_TYPE>  (5) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (5) 
Y

>  <FIRST_IN_CLASS>  (5) 
N

>  <CHIRALITY>  (5) 
Achiral Molecule

>  <PRODRUG>  (5) 
Y

>  <ORAL>  (5) 
Y

>  <PARENTERAL>  (5) 
N

>  <TOPICAL>  (5) 
N

>  <BLACK_BOX>  (5) 
Y

>  <AVAILABILITY_TYPE>  (5) 
Prescription-only

>  <WITHDRAWN_YEAR>  (5) 
nan

>  <WITHDRAWN_COUNTRY>  (5) 
nan

>  <WITHDRAWN_REASON>  (5) 
nan

>  <CANONICAL_SMILES>  (5) 
NC(=O)N1c2ccccc2CC(=O)c3ccccc13

>  <name>  (5) 
Oxcarbazepine 

>  <MW>  (5) 
252.273

>  <logP>  (5) 
2.6422

$$$$
CHEMBL61006
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (6) 
94091

>  <SYNONYMS>  (6) 
Phenylpropanolamine (BAN, INN); Phenylpropanolamine Polistirex (FDA, USAN); Phenylpropanolamine HCl (FDA, USP); Phenylpropanolamine Bitartrate (USP)

>  <DEVELOPMENT_PHASE>  (6) 
4

>  <RESEARCH_CODES>  (6) 
nan

>  <APPLICANTS>  (6) 
Endo Pharmaceuticals Inc; Dm Graham Laboratories Inc; Central Pharmaceuticals Inc; Ah Robins Co; Ucb Inc

>  <USAN_STEM>  (6) 
nan

>  <USAN_STEM_DEFINITION>  (6) 
nan

>  <USAN_STEM_SUBSTEM>  (6) 
nan

>  <USAN_YEAR>  (6) 
1987.0

>  <FIRST_APPROVAL>  (6) 
1958.0

>  <ATC_CODE>  (6) 
R01BA51; R01BA01

>  <ATC_CODE_DESCRIPTION>  (6) 
R01BA51 [Respiratory System:Nasal Preparations:Nasal Decongestants For Systemic Use:Sympathomimetics]; R01BA01 [Respiratory System:Nasal Preparations:Nasal Decongestants For Systemic Use:Sympathomimetics]

>  <INDICATION_CLASS>  (6) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (6) 
nan

>  <DRUG_TYPE>  (6) 
Polymer

>  <RULE_OF_FIVE>  (6) 
Y

>  <FIRST_IN_CLASS>  (6) 
N

>  <CHIRALITY>  (6) 
Single Stereoisomer

>  <PRODRUG>  (6) 
N

>  <ORAL>  (6) 
Y

>  <PARENTERAL>  (6) 
N

>  <TOPICAL>  (6) 
N

>  <BLACK_BOX>  (6) 
N

>  <AVAILABILITY_TYPE>  (6) 
Withdrawn

>  <WITHDRAWN_YEAR>  (6) 
2002.0

>  <WITHDRAWN_COUNTRY>  (6) 
United States; United States

>  <WITHDRAWN_REASON>  (6) 
Increased risk of hemorrhagic stroke; Increased risk of hemorrhagic stroke

>  <CANONICAL_SMILES>  (6) 
CC(N)C(O)c1ccccc1

>  <name>  (6) 
Phenylpropanolamine 

>  <MW>  (6) 
151.209

>  <logP>  (6) 
1.0672

$$$$
CHEMBL1229517
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 22 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 13 32  2  0
 32 33  1  0
 32  8  1  0
 24 16  1  0
 24 19  1  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (7) 
691867

>  <SYNONYMS>  (7) 
Vemurafenib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (7) 
4

>  <RESEARCH_CODES>  (7) 
PLX-4032; RG-7204; Ro-5185426

>  <APPLICANTS>  (7) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (7) 
-rafenib

>  <USAN_STEM_DEFINITION>  (7) 
raf kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (7) 
-rafenib

>  <USAN_YEAR>  (7) 
2010.0

>  <FIRST_APPROVAL>  (7) 
2011.0

>  <ATC_CODE>  (7) 
L01XE15

>  <ATC_CODE_DESCRIPTION>  (7) 
L01XE15 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (7) 
nan

>  <SC_PATENT_NO>  (7) 
US-7504509-B2

>  <DRUG_TYPE>  (7) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (7) 
Y

>  <FIRST_IN_CLASS>  (7) 
N

>  <CHIRALITY>  (7) 
Achiral Molecule

>  <PRODRUG>  (7) 
N

>  <ORAL>  (7) 
Y

>  <PARENTERAL>  (7) 
N

>  <TOPICAL>  (7) 
N

>  <BLACK_BOX>  (7) 
N

>  <AVAILABILITY_TYPE>  (7) 
Prescription-only

>  <WITHDRAWN_YEAR>  (7) 
nan

>  <WITHDRAWN_COUNTRY>  (7) 
nan

>  <WITHDRAWN_REASON>  (7) 
nan

>  <CANONICAL_SMILES>  (7) 
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)c4ccc(Cl)cc4)c1F

>  <name>  (7) 
Vemurafenib 

>  <MW>  (7) 
489.931

>  <logP>  (7) 
5.5442

$$$$
CHEMBL314854
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 15 19  1  0
 19 20  1  0
 12 21  1  0
 21 22  2  0
 22  9  1  0
M  END
>  <PARENT_MOLREGNO>  (8) 
144940

>  <SYNONYMS>  (8) 
Fingolimod (INN, FDA); Fingolimod HCl (USAN)

>  <DEVELOPMENT_PHASE>  (8) 
4

>  <RESEARCH_CODES>  (8) 
FTY-720

>  <APPLICANTS>  (8) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (8) 
-imod

>  <USAN_STEM_DEFINITION>  (8) 
immunomodulators

>  <USAN_STEM_SUBSTEM>  (8) 
-imod

>  <USAN_YEAR>  (8) 
2005.0

>  <FIRST_APPROVAL>  (8) 
2010.0

>  <ATC_CODE>  (8) 
L04AA27

>  <ATC_CODE_DESCRIPTION>  (8) 
L04AA27 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants]

>  <INDICATION_CLASS>  (8) 
nan

>  <SC_PATENT_NO>  (8) 
US-5604229-A

>  <DRUG_TYPE>  (8) 
Natural Product-derived

>  <RULE_OF_FIVE>  (8) 
Y

>  <FIRST_IN_CLASS>  (8) 
Y

>  <CHIRALITY>  (8) 
Achiral Molecule

>  <PRODRUG>  (8) 
Y

>  <ORAL>  (8) 
Y

>  <PARENTERAL>  (8) 
N

>  <TOPICAL>  (8) 
N

>  <BLACK_BOX>  (8) 
N

>  <AVAILABILITY_TYPE>  (8) 
Prescription-only

>  <WITHDRAWN_YEAR>  (8) 
nan

>  <WITHDRAWN_COUNTRY>  (8) 
nan

>  <WITHDRAWN_REASON>  (8) 
nan

>  <CANONICAL_SMILES>  (8) 
CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1

>  <name>  (8) 
Fingolimod 

>  <MW>  (8) 
307.478

>  <logP>  (8) 
3.2043

$$$$
CHEMBL553
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  3  0
 12 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 24  6  1  0
 22  8  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (9) 
14785

>  <SYNONYMS>  (9) 
Erlotinib (INN); Erlotinib HCl (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (9) 
4

>  <RESEARCH_CODES>  (9) 
CP-358774; OSI-774; R-1415; RG-1415; Ro-508231; CP-35877401; CP-358774-01

>  <APPLICANTS>  (9) 
Osi Pharmaceuticals Inc

>  <USAN_STEM>  (9) 
-tinib

>  <USAN_STEM_DEFINITION>  (9) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (9) 
-tinib

>  <USAN_YEAR>  (9) 
2001.0

>  <FIRST_APPROVAL>  (9) 
2004.0

>  <ATC_CODE>  (9) 
L01XE03

>  <ATC_CODE_DESCRIPTION>  (9) 
L01XE03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (9) 
nan

>  <SC_PATENT_NO>  (9) 
US-5747498-A

>  <DRUG_TYPE>  (9) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (9) 
Y

>  <FIRST_IN_CLASS>  (9) 
N

>  <CHIRALITY>  (9) 
Achiral Molecule

>  <PRODRUG>  (9) 
N

>  <ORAL>  (9) 
Y

>  <PARENTERAL>  (9) 
N

>  <TOPICAL>  (9) 
N

>  <BLACK_BOX>  (9) 
N

>  <AVAILABILITY_TYPE>  (9) 
Prescription-only

>  <WITHDRAWN_YEAR>  (9) 
nan

>  <WITHDRAWN_COUNTRY>  (9) 
nan

>  <WITHDRAWN_REASON>  (9) 
nan

>  <CANONICAL_SMILES>  (9) 
COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC

>  <name>  (9) 
Erlotinib 

>  <MW>  (9) 
393.443

>  <logP>  (9) 
3.4051

$$$$
CHEMBL469
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  8  4  1  0
 11  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (10) 
5080

>  <SYNONYMS>  (10) 
Ketorolac (BAN, INN); Ketorolac Tromethamine (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (10) 
4

>  <RESEARCH_CODES>  (10) 
nan

>  <APPLICANTS>  (10) 
Roche Palo Alto Llc; Luitpold Pharmaceuticals Inc; Allergan Inc; Allergan

>  <USAN_STEM>  (10) 
-ac

>  <USAN_STEM_DEFINITION>  (10) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (10) 
-ac

>  <USAN_YEAR>  (10) 
1984.0

>  <FIRST_APPROVAL>  (10) 
1989.0

>  <ATC_CODE>  (10) 
S01BC05; M01AB15

>  <ATC_CODE_DESCRIPTION>  (10) 
S01BC05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]; M01AB15 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (10) 
Analgesic

>  <SC_PATENT_NO>  (10) 
US-6333044-B1

>  <DRUG_TYPE>  (10) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (10) 
Y

>  <FIRST_IN_CLASS>  (10) 
N

>  <CHIRALITY>  (10) 
Racemic Mixture

>  <PRODRUG>  (10) 
N

>  <ORAL>  (10) 
Y

>  <PARENTERAL>  (10) 
Y

>  <TOPICAL>  (10) 
Y

>  <BLACK_BOX>  (10) 
Y

>  <AVAILABILITY_TYPE>  (10) 
Prescription-only

>  <WITHDRAWN_YEAR>  (10) 
nan

>  <WITHDRAWN_COUNTRY>  (10) 
nan

>  <WITHDRAWN_REASON>  (10) 
nan

>  <CANONICAL_SMILES>  (10) 
OC(=O)C1CCn2c1ccc2C(=O)c3ccccc3

>  <name>  (10) 
Ketorolac 

>  <MW>  (10) 
255.273

>  <logP>  (10) 
2.291

$$$$
CHEMBL566534
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 17  3  1  0
 19  5  1  0
 21  7  1  0
 19 11  1  0
M  END
>  <PARENT_MOLREGNO>  (11) 
573926

>  <SYNONYMS>  (11) 
Artemether (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (11) 
4

>  <RESEARCH_CODES>  (11) 
nan

>  <APPLICANTS>  (11) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (11) 
arte-

>  <USAN_STEM_DEFINITION>  (11) 
antimalarials (artemisin dervatives)

>  <USAN_STEM_SUBSTEM>  (11) 
arte-

>  <USAN_YEAR>  (11) 
2008.0

>  <FIRST_APPROVAL>  (11) 
2009.0

>  <ATC_CODE>  (11) 
P01BF01; P01BE02

>  <ATC_CODE_DESCRIPTION>  (11) 
P01BF01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Artemisinin and derivatives, combinations]; P01BE02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Artemisinin and derivatives, plain]

>  <INDICATION_CLASS>  (11) 
nan

>  <SC_PATENT_NO>  (11) 
nan

>  <DRUG_TYPE>  (11) 
Natural Product-derived

>  <RULE_OF_FIVE>  (11) 
Y

>  <FIRST_IN_CLASS>  (11) 
Y

>  <CHIRALITY>  (11) 
Single Stereoisomer

>  <PRODRUG>  (11) 
Y

>  <ORAL>  (11) 
Y

>  <PARENTERAL>  (11) 
N

>  <TOPICAL>  (11) 
N

>  <BLACK_BOX>  (11) 
N

>  <AVAILABILITY_TYPE>  (11) 
Prescription-only

>  <WITHDRAWN_YEAR>  (11) 
nan

>  <WITHDRAWN_COUNTRY>  (11) 
nan

>  <WITHDRAWN_REASON>  (11) 
nan

>  <CANONICAL_SMILES>  (11) 
CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3

>  <name>  (11) 
Artemether 

>  <MW>  (11) 
298.379

>  <logP>  (11) 
2.8408

$$$$
CHEMBL1201236
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
  2 12  1  0
 12 13  1  0
  2 14  1  0
 14 15  2  0
 14 16  1  0
 11  4  1  0
M  END
>  <PARENT_MOLREGNO>  (12) 
675187

>  <SYNONYMS>  (12) 
Carbidopa (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (12) 
4

>  <RESEARCH_CODES>  (12) 
nan

>  <APPLICANTS>  (12) 
Orion Pharma; Merck Sharp And Dohme Corp; Aton Pharma Inc

>  <USAN_STEM>  (12) 
-dopa

>  <USAN_STEM_DEFINITION>  (12) 
dopamine receptor agonists

>  <USAN_STEM_SUBSTEM>  (12) 
-dopa

>  <USAN_YEAR>  (12) 
1972.0

>  <FIRST_APPROVAL>  (12) 
1975.0

>  <ATC_CODE>  (12) 
nan

>  <ATC_CODE_DESCRIPTION>  (12) 
nan

>  <INDICATION_CLASS>  (12) 
Inhibitor (decarboxylase)

>  <SC_PATENT_NO>  (12) 
US-6500867-B1

>  <DRUG_TYPE>  (12) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (12) 
Y

>  <FIRST_IN_CLASS>  (12) 
N

>  <CHIRALITY>  (12) 
Single Stereoisomer

>  <PRODRUG>  (12) 
N

>  <ORAL>  (12) 
Y

>  <PARENTERAL>  (12) 
N

>  <TOPICAL>  (12) 
N

>  <BLACK_BOX>  (12) 
N

>  <AVAILABILITY_TYPE>  (12) 
Prescription-only

>  <WITHDRAWN_YEAR>  (12) 
nan

>  <WITHDRAWN_COUNTRY>  (12) 
nan

>  <WITHDRAWN_REASON>  (12) 
nan

>  <CANONICAL_SMILES>  (12) 
C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O

>  <name>  (12) 
Carbidopa 

>  <MW>  (12) 
226.232

>  <logP>  (12) 
-0.0531

$$$$
CHEMBL434
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15  8  1  0
M  END
>  <PARENT_MOLREGNO>  (13) 
1994

>  <SYNONYMS>  (13) 
Isoprenaline (INN, BAN); Isoproterenol HCl (FDA, USP); l-Isoprenaline HCl (JAN); Isoproterenol Sulfate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (13) 
4

>  <RESEARCH_CODES>  (13) 
nan

>  <APPLICANTS>  (13) 
Eli Lilly And Co; Abbvie Inc; Abbott Laboratories Pharmaceutical Products Div; 3m Pharmaceuticals Inc; Hospira Inc

>  <USAN_STEM>  (13) 
nan

>  <USAN_STEM_DEFINITION>  (13) 
nan

>  <USAN_STEM_SUBSTEM>  (13) 
nan

>  <USAN_YEAR>  (13) 
nan

>  <FIRST_APPROVAL>  (13) 
1956.0

>  <ATC_CODE>  (13) 
C01CA02; R03CB51; R03CB01; R03AB02

>  <ATC_CODE_DESCRIPTION>  (13) 
C01CA02 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]; R03CB51 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Non-selective beta-adrenoreceptor agonists]; R03CB01 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Non-selective beta-adrenoreceptor agonists]; R03AB02 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Non-selective beta-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (13) 
Bronchodilator

>  <SC_PATENT_NO>  (13) 
nan

>  <DRUG_TYPE>  (13) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (13) 
Y

>  <FIRST_IN_CLASS>  (13) 
N

>  <CHIRALITY>  (13) 
Racemic Mixture

>  <PRODRUG>  (13) 
N

>  <ORAL>  (13) 
N

>  <PARENTERAL>  (13) 
Y

>  <TOPICAL>  (13) 
Y

>  <BLACK_BOX>  (13) 
N

>  <AVAILABILITY_TYPE>  (13) 
Prescription-only

>  <WITHDRAWN_YEAR>  (13) 
nan

>  <WITHDRAWN_COUNTRY>  (13) 
nan

>  <WITHDRAWN_REASON>  (13) 
nan

>  <CANONICAL_SMILES>  (13) 
CC(C)NCC(O)c1ccc(O)c(O)c1

>  <name>  (13) 
Isoprenaline 

>  <MW>  (13) 
211.261

>  <logP>  (13) 
1.1292

$$$$
CHEMBL808
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
  5 23  1  0
 23 24  2  0
 24  2  1  0
 14 10  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (14) 
52874

>  <SYNONYMS>  (14) 
Econazole (BAN, INN, USAN); Econazole Nitrate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (14) 
4

>  <RESEARCH_CODES>  (14) 
R-14827; SQ-13050

>  <APPLICANTS>  (14) 
Ortho Dermatologics Div Janssen Pharmaceuticals Inc; Janssen Pharmaceutica, Belgium

>  <USAN_STEM>  (14) 
-conazole

>  <USAN_STEM_DEFINITION>  (14) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (14) 
-conazole

>  <USAN_YEAR>  (14) 
1972.0

>  <FIRST_APPROVAL>  (14) 
1982.0

>  <ATC_CODE>  (14) 
D01AC03; G01AF05

>  <ATC_CODE_DESCRIPTION>  (14) 
D01AC03 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Imidazole and triazole derivatives]; G01AF05 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Imidazole derivatives]

>  <INDICATION_CLASS>  (14) 
Antifungal

>  <SC_PATENT_NO>  (14) 
US-5993830-A

>  <DRUG_TYPE>  (14) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (14) 
Y

>  <FIRST_IN_CLASS>  (14) 
N

>  <CHIRALITY>  (14) 
Racemic Mixture

>  <PRODRUG>  (14) 
N

>  <ORAL>  (14) 
N

>  <PARENTERAL>  (14) 
N

>  <TOPICAL>  (14) 
Y

>  <BLACK_BOX>  (14) 
N

>  <AVAILABILITY_TYPE>  (14) 
Prescription-only

>  <WITHDRAWN_YEAR>  (14) 
nan

>  <WITHDRAWN_COUNTRY>  (14) 
nan

>  <WITHDRAWN_REASON>  (14) 
nan

>  <CANONICAL_SMILES>  (14) 
Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1

>  <name>  (14) 
Econazole 

>  <MW>  (14) 
381.69

>  <logP>  (14) 
5.8014

$$$$
CHEMBL1086
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
  8 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25  6  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (15) 
147956

>  <SYNONYMS>  (15) 
Cinchocaine (BAN, INN); Dibucaine (USP); Cinchocaine HCl (BAN); Dibucaine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (15) 
4

>  <RESEARCH_CODES>  (15) 
nan

>  <APPLICANTS>  (15) 
Novartis Pharmaceuticals Corp; Ciba-Geigy

>  <USAN_STEM>  (15) 
-caine

>  <USAN_STEM_DEFINITION>  (15) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (15) 
-caine

>  <USAN_YEAR>  (15) 
nan

>  <FIRST_APPROVAL>  (15) 
1982.0

>  <ATC_CODE>  (15) 
C05AD04; S01HA06; S02DA04; D04AB02; N01BB06

>  <ATC_CODE_DESCRIPTION>  (15) 
C05AD04 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; S01HA06 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]; S02DA04 [Sensory Organs:Otologicals:Other Otologicals:Analgesics and anesthetics]; D04AB02 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; N01BB06 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (15) 
Anesthetic (local)

>  <SC_PATENT_NO>  (15) 
nan

>  <DRUG_TYPE>  (15) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (15) 
Y

>  <FIRST_IN_CLASS>  (15) 
N

>  <CHIRALITY>  (15) 
Achiral Molecule

>  <PRODRUG>  (15) 
N

>  <ORAL>  (15) 
N

>  <PARENTERAL>  (15) 
Y

>  <TOPICAL>  (15) 
N

>  <BLACK_BOX>  (15) 
N

>  <AVAILABILITY_TYPE>  (15) 
Discontinued

>  <WITHDRAWN_YEAR>  (15) 
nan

>  <WITHDRAWN_COUNTRY>  (15) 
nan

>  <WITHDRAWN_REASON>  (15) 
nan

>  <CANONICAL_SMILES>  (15) 
CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1

>  <name>  (15) 
Cinchocaine 

>  <MW>  (15) 
343.471

>  <logP>  (15) 
3.4853

$$$$
CHEMBL1648
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 10 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
  9 27  1  0
 11  5  1  0
 20 12  1  0
 20 16  1  0
M  END
>  <PARENT_MOLREGNO>  (16) 
486789

>  <SYNONYMS>  (16) 
Isradipine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (16) 
4

>  <RESEARCH_CODES>  (16) 
PN-200-110

>  <APPLICANTS>  (16) 
SmithKline Beecham Corp Dba GlaxoSmithKline; GlaxoSmithKline Llc

>  <USAN_STEM>  (16) 
-dipine

>  <USAN_STEM_DEFINITION>  (16) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (16) 
-dipine

>  <USAN_YEAR>  (16) 
1987.0

>  <FIRST_APPROVAL>  (16) 
1990.0

>  <ATC_CODE>  (16) 
C08CA03

>  <ATC_CODE_DESCRIPTION>  (16) 
C08CA03 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (16) 
Antagonist (calcium channel)

>  <SC_PATENT_NO>  (16) 
nan

>  <DRUG_TYPE>  (16) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (16) 
Y

>  <FIRST_IN_CLASS>  (16) 
N

>  <CHIRALITY>  (16) 
Racemic Mixture

>  <PRODRUG>  (16) 
N

>  <ORAL>  (16) 
Y

>  <PARENTERAL>  (16) 
N

>  <TOPICAL>  (16) 
N

>  <BLACK_BOX>  (16) 
N

>  <AVAILABILITY_TYPE>  (16) 
Prescription-only

>  <WITHDRAWN_YEAR>  (16) 
nan

>  <WITHDRAWN_COUNTRY>  (16) 
nan

>  <WITHDRAWN_REASON>  (16) 
nan

>  <CANONICAL_SMILES>  (16) 
COC(=O)C1=C(C)NC(=C(C1c2cccc3nonc23)C(=O)OC(C)C)C

>  <name>  (16) 
Isradipine 

>  <MW>  (16) 
371.393

>  <logP>  (16) 
2.5822

$$$$
CHEMBL1651
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 23 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (17) 
487777

>  <SYNONYMS>  (17) 
Dexamethasone acetate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (17) 
4

>  <RESEARCH_CODES>  (17) 
nan

>  <APPLICANTS>  (17) 
Merck Research Laboratories Div Merck Co Inc

>  <USAN_STEM>  (17) 
nan

>  <USAN_STEM_DEFINITION>  (17) 
nan

>  <USAN_STEM_SUBSTEM>  (17) 
nan

>  <USAN_YEAR>  (17) 
1979.0

>  <FIRST_APPROVAL>  (17) 
1973.0

>  <ATC_CODE>  (17) 
D07XB05; R01AD03; D10AA03; H02AB02; C05AA09; A01AC02; S01BA01; S03BA01; S02BA06; D07AB19; S01CB01; R01AD53

>  <ATC_CODE_DESCRIPTION>  (17) 
D07XB05 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD03 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; D10AA03 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; H02AB02 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; C05AA09 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A01AC02 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S03BA01 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; S02BA06 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; D07AB19 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]; S01CB01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; R01AD53 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]

>  <INDICATION_CLASS>  (17) 
Adrenocortical Steroid

>  <SC_PATENT_NO>  (17) 
nan

>  <DRUG_TYPE>  (17) 
Natural Product-derived

>  <RULE_OF_FIVE>  (17) 
Y

>  <FIRST_IN_CLASS>  (17) 
N

>  <CHIRALITY>  (17) 
Single Stereoisomer

>  <PRODRUG>  (17) 
Y

>  <ORAL>  (17) 
N

>  <PARENTERAL>  (17) 
Y

>  <TOPICAL>  (17) 
N

>  <BLACK_BOX>  (17) 
N

>  <AVAILABILITY_TYPE>  (17) 
Discontinued

>  <WITHDRAWN_YEAR>  (17) 
nan

>  <WITHDRAWN_COUNTRY>  (17) 
nan

>  <WITHDRAWN_REASON>  (17) 
nan

>  <CANONICAL_SMILES>  (17) 
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C)C(=O)CO

>  <name>  (17) 
Dexamethasone acetate 

>  <MW>  (17) 
434.504

>  <logP>  (17) 
2.4665

$$$$
CHEMBL606
     RDKit          

 27 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (18) 
22391

>  <SYNONYMS>  (18) 
Misoprostol (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (18) 
4

>  <RESEARCH_CODES>  (18) 
SC-29333

>  <APPLICANTS>  (18) 
Gd Searle Llc

>  <USAN_STEM>  (18) 
-prost-

>  <USAN_STEM_DEFINITION>  (18) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (18) 
-prost-

>  <USAN_YEAR>  (18) 
1981.0

>  <FIRST_APPROVAL>  (18) 
1988.0

>  <ATC_CODE>  (18) 
G02AD06; A02BB01

>  <ATC_CODE_DESCRIPTION>  (18) 
G02AD06 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Uterotonics:Prostaglandins]; A02BB01 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Prostaglandins]

>  <INDICATION_CLASS>  (18) 
Anti-Ulcerative

>  <SC_PATENT_NO>  (18) 
nan

>  <DRUG_TYPE>  (18) 
Natural Product-derived

>  <RULE_OF_FIVE>  (18) 
Y

>  <FIRST_IN_CLASS>  (18) 
N

>  <CHIRALITY>  (18) 
Racemic Mixture

>  <PRODRUG>  (18) 
Y

>  <ORAL>  (18) 
Y

>  <PARENTERAL>  (18) 
N

>  <TOPICAL>  (18) 
N

>  <BLACK_BOX>  (18) 
Y

>  <AVAILABILITY_TYPE>  (18) 
Prescription-only

>  <WITHDRAWN_YEAR>  (18) 
nan

>  <WITHDRAWN_COUNTRY>  (18) 
nan

>  <WITHDRAWN_REASON>  (18) 
nan

>  <CANONICAL_SMILES>  (18) 
CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC

>  <name>  (18) 
Misoprostol 

>  <MW>  (18) 
382.541

>  <logP>  (18) 
3.9536

$$$$
CHEMBL32800
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 10  4  1  0
 22 15  1  0
M  END
>  <PARENT_MOLREGNO>  (19) 
49226

>  <SYNONYMS>  (19) 
Fenoterol (BAN, INN, USAN); Fenoterol Hydrobromide (JAN)

>  <DEVELOPMENT_PHASE>  (19) 
4

>  <RESEARCH_CODES>  (19) 
TH-1165A [As Hydrobromide Salt]

>  <APPLICANTS>  (19) 
Boehringer Ingelheim

>  <USAN_STEM>  (19) 
-terol

>  <USAN_STEM_DEFINITION>  (19) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (19) 
-terol

>  <USAN_YEAR>  (19) 
1971.0

>  <FIRST_APPROVAL>  (19) 
nan

>  <ATC_CODE>  (19) 
G02CA03; R03AC04; R03CC04

>  <ATC_CODE_DESCRIPTION>  (19) 
G02CA03 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Other Gynecologicals:Sympathomimetics, labour repressants]; R03AC04 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]; R03CC04 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (19) 
Bronchodilator

>  <SC_PATENT_NO>  (19) 
nan

>  <DRUG_TYPE>  (19) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (19) 
Y

>  <FIRST_IN_CLASS>  (19) 
N

>  <CHIRALITY>  (19) 
Racemic Mixture

>  <PRODRUG>  (19) 
N

>  <ORAL>  (19) 
N

>  <PARENTERAL>  (19) 
N

>  <TOPICAL>  (19) 
N

>  <BLACK_BOX>  (19) 
N

>  <AVAILABILITY_TYPE>  (19) 
Withdrawn

>  <WITHDRAWN_YEAR>  (19) 
1990.0

>  <WITHDRAWN_COUNTRY>  (19) 
New Zealand

>  <WITHDRAWN_REASON>  (19) 
Asthma Mortality

>  <CANONICAL_SMILES>  (19) 
CC(Cc1ccc(O)cc1)NCC(O)c2cc(O)cc(O)c2

>  <name>  (19) 
Fenoterol 

>  <MW>  (19) 
303.358

>  <logP>  (19) 
2.0576

$$$$
CHEMBL53418
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18  2  1  0
 18  6  2  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (20) 
82895

>  <SYNONYMS>  (20) 
Danthron (MI, USP); Dantron (BAN, INN)

>  <DEVELOPMENT_PHASE>  (20) 
4

>  <RESEARCH_CODES>  (20) 
nan

>  <APPLICANTS>  (20) 
Sterling Winthrop; 3m Pharmaceuticals

>  <USAN_STEM>  (20) 
nan

>  <USAN_STEM_DEFINITION>  (20) 
nan

>  <USAN_STEM_SUBSTEM>  (20) 
nan

>  <USAN_YEAR>  (20) 
nan

>  <FIRST_APPROVAL>  (20) 
nan

>  <ATC_CODE>  (20) 
A06AB03; A06AB53

>  <ATC_CODE_DESCRIPTION>  (20) 
A06AB03 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]; A06AB53 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]

>  <INDICATION_CLASS>  (20) 
nan

>  <SC_PATENT_NO>  (20) 
nan

>  <DRUG_TYPE>  (20) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (20) 
Y

>  <FIRST_IN_CLASS>  (20) 
N

>  <CHIRALITY>  (20) 
Achiral Molecule

>  <PRODRUG>  (20) 
N

>  <ORAL>  (20) 
N

>  <PARENTERAL>  (20) 
N

>  <TOPICAL>  (20) 
N

>  <BLACK_BOX>  (20) 
N

>  <AVAILABILITY_TYPE>  (20) 
Withdrawn

>  <WITHDRAWN_YEAR>  (20) 
nan

>  <WITHDRAWN_COUNTRY>  (20) 
United States

>  <WITHDRAWN_REASON>  (20) 
Carcinogenicity

>  <CANONICAL_SMILES>  (20) 
Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12

>  <name>  (20) 
Danthron 

>  <MW>  (20) 
240.214

>  <logP>  (20) 
1.8732

$$$$
CHEMBL62193
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  5 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  2  0
 21  3  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (21) 
93930

>  <SYNONYMS>  (21) 
Sulfadimethoxine (BAN, INN, JAN, MI, NF, USP); Sulfadimethoxine Sodium (USP)

>  <DEVELOPMENT_PHASE>  (21) 
4

>  <RESEARCH_CODES>  (21) 
nan

>  <APPLICANTS>  (21) 
Hoffmann-Laroche

>  <USAN_STEM>  (21) 
sulfa-

>  <USAN_STEM_DEFINITION>  (21) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (21) 
sulfa-

>  <USAN_YEAR>  (21) 
nan

>  <FIRST_APPROVAL>  (21) 
nan

>  <ATC_CODE>  (21) 
J01ED01

>  <ATC_CODE_DESCRIPTION>  (21) 
J01ED01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]

>  <INDICATION_CLASS>  (21) 
nan

>  <SC_PATENT_NO>  (21) 
nan

>  <DRUG_TYPE>  (21) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (21) 
Y

>  <FIRST_IN_CLASS>  (21) 
N

>  <CHIRALITY>  (21) 
Achiral Molecule

>  <PRODRUG>  (21) 
N

>  <ORAL>  (21) 
N

>  <PARENTERAL>  (21) 
N

>  <TOPICAL>  (21) 
N

>  <BLACK_BOX>  (21) 
N

>  <AVAILABILITY_TYPE>  (21) 
Withdrawn

>  <WITHDRAWN_YEAR>  (21) 
nan

>  <WITHDRAWN_COUNTRY>  (21) 
United States; United States

>  <WITHDRAWN_REASON>  (21) 
nan

>  <CANONICAL_SMILES>  (21) 
COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1

>  <name>  (21) 
Sulfadimethoxine 

>  <MW>  (21) 
310.335

>  <logP>  (21) 
0.8768

$$$$
CHEMBL1684
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
  8 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 23  5  1  0
 19  7  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (22) 
515239

>  <SYNONYMS>  (22) 
Bendrofluazide (BAN); Bendroflumethiazide (FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (22) 
4

>  <RESEARCH_CODES>  (22) 
nan

>  <APPLICANTS>  (22) 
King Pharmaceuticals Inc; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (22) 
-thiazide

>  <USAN_STEM_DEFINITION>  (22) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (22) 
-thiazide

>  <USAN_YEAR>  (22) 
nan

>  <FIRST_APPROVAL>  (22) 
1959.0

>  <ATC_CODE>  (22) 
C03AA01

>  <ATC_CODE_DESCRIPTION>  (22) 
C03AA01 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (22) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (22) 
nan

>  <DRUG_TYPE>  (22) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (22) 
Y

>  <FIRST_IN_CLASS>  (22) 
N

>  <CHIRALITY>  (22) 
Racemic Mixture

>  <PRODRUG>  (22) 
N

>  <ORAL>  (22) 
Y

>  <PARENTERAL>  (22) 
N

>  <TOPICAL>  (22) 
N

>  <BLACK_BOX>  (22) 
N

>  <AVAILABILITY_TYPE>  (22) 
Prescription-only

>  <WITHDRAWN_YEAR>  (22) 
nan

>  <WITHDRAWN_COUNTRY>  (22) 
nan

>  <WITHDRAWN_REASON>  (22) 
nan

>  <CANONICAL_SMILES>  (22) 
NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F

>  <name>  (22) 
Bendrofluazide 

>  <MW>  (22) 
421.422

>  <logP>  (22) 
1.6254

$$$$
CHEMBL1091
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28  8  1  0
 28 12  1  0
 24 13  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (23) 
150313

>  <SYNONYMS>  (23) 
Hydrocortisone acetate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (23) 
4

>  <RESEARCH_CODES>  (23) 
nan

>  <APPLICANTS>  (23) 
Merck And Co Inc; Meda Pharmaceuticals Inc; Jhp Pharmaceuticals Llc; Akorn Inc; Monarch Pharmaceuticals Inc

>  <USAN_STEM>  (23) 
-cort-

>  <USAN_STEM_DEFINITION>  (23) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (23) 
-cort-

>  <USAN_YEAR>  (23) 
nan

>  <FIRST_APPROVAL>  (23) 
1951.0

>  <ATC_CODE>  (23) 
D07AA02; S01CB03; D07XA01; C05AA01; A07EA02; A01AC03; H02AB09; S01BA02; S02BA01

>  <ATC_CODE_DESCRIPTION>  (23) 
D07AA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; S01CB03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; D07XA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; C05AA01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; A01AC03 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; H02AB09 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA01 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (23) 
Glucocorticoid

>  <SC_PATENT_NO>  (23) 
nan

>  <DRUG_TYPE>  (23) 
Natural Product-derived

>  <RULE_OF_FIVE>  (23) 
Y

>  <FIRST_IN_CLASS>  (23) 
N

>  <CHIRALITY>  (23) 
Single Stereoisomer

>  <PRODRUG>  (23) 
Y

>  <ORAL>  (23) 
N

>  <PARENTERAL>  (23) 
Y

>  <TOPICAL>  (23) 
Y

>  <BLACK_BOX>  (23) 
N

>  <AVAILABILITY_TYPE>  (23) 
Prescription-only

>  <WITHDRAWN_YEAR>  (23) 
nan

>  <WITHDRAWN_COUNTRY>  (23) 
nan

>  <WITHDRAWN_REASON>  (23) 
nan

>  <CANONICAL_SMILES>  (23) 
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

>  <name>  (23) 
Hydrocortisone acetate 

>  <MW>  (23) 
404.503

>  <logP>  (23) 
2.3524

$$$$
CHEMBL880
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  6 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 18  9  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (24) 
74284

>  <SYNONYMS>  (24) 
Famciclovir (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (24) 
4

>  <RESEARCH_CODES>  (24) 
BRL-42810

>  <APPLICANTS>  (24) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (24) 
-vir

>  <USAN_STEM_DEFINITION>  (24) 
antivirals: antivirals (acyclovir type)

>  <USAN_STEM_SUBSTEM>  (24) 
-vir (-ciclovir)

>  <USAN_YEAR>  (24) 
1992.0

>  <FIRST_APPROVAL>  (24) 
1994.0

>  <ATC_CODE>  (24) 
S01AD07; J05AB09

>  <ATC_CODE_DESCRIPTION>  (24) 
S01AD07 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]; J05AB09 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (24) 
Antiviral

>  <SC_PATENT_NO>  (24) 
US-5840763-A

>  <DRUG_TYPE>  (24) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (24) 
Y

>  <FIRST_IN_CLASS>  (24) 
N

>  <CHIRALITY>  (24) 
Achiral Molecule

>  <PRODRUG>  (24) 
N

>  <ORAL>  (24) 
Y

>  <PARENTERAL>  (24) 
N

>  <TOPICAL>  (24) 
N

>  <BLACK_BOX>  (24) 
N

>  <AVAILABILITY_TYPE>  (24) 
Prescription-only

>  <WITHDRAWN_YEAR>  (24) 
nan

>  <WITHDRAWN_COUNTRY>  (24) 
nan

>  <WITHDRAWN_REASON>  (24) 
nan

>  <CANONICAL_SMILES>  (24) 
CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(=O)C

>  <name>  (24) 
Famciclovir 

>  <MW>  (24) 
321.337

>  <logP>  (24) 
0.541

$$$$
CHEMBL435
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 16  5  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (25) 
2045

>  <SYNONYMS>  (25) 
Hydrochlorothiazide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (25) 
4

>  <RESEARCH_CODES>  (25) 
nan

>  <APPLICANTS>  (25) 
Astrazeneca Lp; Apothecon Inc Div Bristol Myers Squibb; Akrimax Pharmaceuticals Llc; Abbvie Inc; Astrazeneca Pharmaceuticals Lp

>  <USAN_STEM>  (25) 
-thiazide

>  <USAN_STEM_DEFINITION>  (25) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (25) 
-thiazide

>  <USAN_YEAR>  (25) 
nan

>  <FIRST_APPROVAL>  (25) 
1959.0

>  <ATC_CODE>  (25) 
C03AX01; C03AA03

>  <ATC_CODE_DESCRIPTION>  (25) 
C03AX01 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, combinations with other drugs]; C03AA03 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (25) 
Diuretic

>  <SC_PATENT_NO>  (25) 
US-5559111-A

>  <DRUG_TYPE>  (25) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (25) 
Y

>  <FIRST_IN_CLASS>  (25) 
N

>  <CHIRALITY>  (25) 
Achiral Molecule

>  <PRODRUG>  (25) 
N

>  <ORAL>  (25) 
Y

>  <PARENTERAL>  (25) 
N

>  <TOPICAL>  (25) 
N

>  <BLACK_BOX>  (25) 
N

>  <AVAILABILITY_TYPE>  (25) 
Prescription-only

>  <WITHDRAWN_YEAR>  (25) 
nan

>  <WITHDRAWN_COUNTRY>  (25) 
nan

>  <WITHDRAWN_REASON>  (25) 
nan

>  <CANONICAL_SMILES>  (25) 
NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl

>  <name>  (25) 
Hydrochlorothiazide 

>  <MW>  (25) 
297.745

>  <logP>  (25) 
-0.3513

$$$$
CHEMBL1434
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 25 28  1  0
 28 29  2  0
 28 30  1  0
 10 31  1  0
 31 32  1  0
 31 33  1  0
 26  4  1  0
 21  5  1  0
 18  7  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (26) 
371561

>  <SYNONYMS>  (26) 
Minocycline (BAN, INN, USAN); Minocycline HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (26) 
4

>  <RESEARCH_CODES>  (26) 
nan

>  <APPLICANTS>  (26) 
Ranbaxy Laboratories Ltd; Precision Dermatology Inc; Orapharma Inc; Medicis Pharmaceutical Corp; Rempex Pharmaceuticals Inc

>  <USAN_STEM>  (26) 
-cycline

>  <USAN_STEM_DEFINITION>  (26) 
antibiotics (tetracycline derivatives)

>  <USAN_STEM_SUBSTEM>  (26) 
-cycline

>  <USAN_YEAR>  (26) 
1966.0

>  <FIRST_APPROVAL>  (26) 
1971.0

>  <ATC_CODE>  (26) 
J01AA08; A01AB23

>  <ATC_CODE_DESCRIPTION>  (26) 
J01AA08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Tetracyclines:Tetracyclines]; A01AB23 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Antiinfectives and antiseptics for local oral treatment]

>  <INDICATION_CLASS>  (26) 
Antibacterial

>  <SC_PATENT_NO>  (26) 
US-5908838-A

>  <DRUG_TYPE>  (26) 
Natural Product-derived

>  <RULE_OF_FIVE>  (26) 
Y

>  <FIRST_IN_CLASS>  (26) 
N

>  <CHIRALITY>  (26) 
Single Stereoisomer

>  <PRODRUG>  (26) 
N

>  <ORAL>  (26) 
Y

>  <PARENTERAL>  (26) 
Y

>  <TOPICAL>  (26) 
Y

>  <BLACK_BOX>  (26) 
N

>  <AVAILABILITY_TYPE>  (26) 
Prescription-only

>  <WITHDRAWN_YEAR>  (26) 
nan

>  <WITHDRAWN_COUNTRY>  (26) 
nan

>  <WITHDRAWN_REASON>  (26) 
nan

>  <CANONICAL_SMILES>  (26) 
CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C

>  <name>  (26) 
Minocycline 

>  <MW>  (26) 
457.483

>  <logP>  (26) 
0.1866

$$$$
CHEMBL1095097
     RDKit          

 30 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 21 30  1  0
 30  5  1  0
 13  7  1  0
 17 15  1  0
 30 15  1  0
 24 19  1  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (27) 
626453

>  <SYNONYMS>  (27) 
Eplerenone (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (27) 
4

>  <RESEARCH_CODES>  (27) 
SC-66110; SC-6611O

>  <APPLICANTS>  (27) 
Gd Searle Llc

>  <USAN_STEM>  (27) 
-renone

>  <USAN_STEM_DEFINITION>  (27) 
aldosterone antagonists (spironolactone type)

>  <USAN_STEM_SUBSTEM>  (27) 
-renone

>  <USAN_YEAR>  (27) 
1997.0

>  <FIRST_APPROVAL>  (27) 
2002.0

>  <ATC_CODE>  (27) 
C03DA04

>  <ATC_CODE_DESCRIPTION>  (27) 
C03DA04 [Cardiovascular System:Diuretics:Potassium-Sparing Agents:Aldosterone antagonists]

>  <INDICATION_CLASS>  (27) 
Aldosterone Antagonist; Antihypertensive

>  <SC_PATENT_NO>  (27) 
US-6410054-B1; US-6410524-B1

>  <DRUG_TYPE>  (27) 
Natural Product-derived

>  <RULE_OF_FIVE>  (27) 
Y

>  <FIRST_IN_CLASS>  (27) 
N

>  <CHIRALITY>  (27) 
Single Stereoisomer

>  <PRODRUG>  (27) 
N

>  <ORAL>  (27) 
Y

>  <PARENTERAL>  (27) 
N

>  <TOPICAL>  (27) 
N

>  <BLACK_BOX>  (27) 
Y

>  <AVAILABILITY_TYPE>  (27) 
Prescription-only

>  <WITHDRAWN_YEAR>  (27) 
nan

>  <WITHDRAWN_COUNTRY>  (27) 
nan

>  <WITHDRAWN_REASON>  (27) 
nan

>  <CANONICAL_SMILES>  (27) 
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14

>  <name>  (27) 
Eplerenone 

>  <MW>  (27) 
414.498

>  <logP>  (27) 
3.1245

$$$$
CHEMBL1201766
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  8 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 16 19  1  0
 12  4  1  0
M  END
>  <PARENT_MOLREGNO>  (28) 
675717

>  <SYNONYMS>  (28) 
Fospropofol (INN); Fospropofol Disodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (28) 
4

>  <RESEARCH_CODES>  (28) 
nan

>  <APPLICANTS>  (28) 
Eisai Inc

>  <USAN_STEM>  (28) 
fos-

>  <USAN_STEM_DEFINITION>  (28) 
phosphoro-derivatives

>  <USAN_STEM_SUBSTEM>  (28) 
fos-

>  <USAN_YEAR>  (28) 
2005.0

>  <FIRST_APPROVAL>  (28) 
2008.0

>  <ATC_CODE>  (28) 
nan

>  <ATC_CODE_DESCRIPTION>  (28) 
nan

>  <INDICATION_CLASS>  (28) 
nan

>  <SC_PATENT_NO>  (28) 
US-6204257-B1

>  <DRUG_TYPE>  (28) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (28) 
Y

>  <FIRST_IN_CLASS>  (28) 
N

>  <CHIRALITY>  (28) 
Achiral Molecule

>  <PRODRUG>  (28) 
Y

>  <ORAL>  (28) 
N

>  <PARENTERAL>  (28) 
Y

>  <TOPICAL>  (28) 
N

>  <BLACK_BOX>  (28) 
N

>  <AVAILABILITY_TYPE>  (28) 
Discontinued

>  <WITHDRAWN_YEAR>  (28) 
nan

>  <WITHDRAWN_COUNTRY>  (28) 
nan

>  <WITHDRAWN_REASON>  (28) 
nan

>  <CANONICAL_SMILES>  (28) 
CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O

>  <name>  (28) 
Fospropofol 

>  <MW>  (28) 
288.28

>  <logP>  (28) 
3.379

$$$$
CHEMBL637
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
  9 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  8  3  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (29) 
27278

>  <SYNONYMS>  (29) 
Venlafaxine (BAN, INN); Venlafaxine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (29) 
4

>  <RESEARCH_CODES>  (29) 
WY-45030

>  <APPLICANTS>  (29) 
Wyeth Pharmaceuticals Inc; Osmotica Pharmaceutical Corp

>  <USAN_STEM>  (29) 
-axine

>  <USAN_STEM_DEFINITION>  (29) 
antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake

>  <USAN_STEM_SUBSTEM>  (29) 
-axine

>  <USAN_YEAR>  (29) 
1989.0

>  <FIRST_APPROVAL>  (29) 
1993.0

>  <ATC_CODE>  (29) 
N06AX16

>  <ATC_CODE_DESCRIPTION>  (29) 
N06AX16 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (29) 
Antidepressant

>  <SC_PATENT_NO>  (29) 
US-6274171-B1

>  <DRUG_TYPE>  (29) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (29) 
Y

>  <FIRST_IN_CLASS>  (29) 
N

>  <CHIRALITY>  (29) 
Racemic Mixture

>  <PRODRUG>  (29) 
N

>  <ORAL>  (29) 
Y

>  <PARENTERAL>  (29) 
N

>  <TOPICAL>  (29) 
N

>  <BLACK_BOX>  (29) 
Y

>  <AVAILABILITY_TYPE>  (29) 
Prescription-only

>  <WITHDRAWN_YEAR>  (29) 
nan

>  <WITHDRAWN_COUNTRY>  (29) 
nan

>  <WITHDRAWN_REASON>  (29) 
nan

>  <CANONICAL_SMILES>  (29) 
COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2

>  <name>  (29) 
Venlafaxine 

>  <MW>  (29) 
277.408

>  <logP>  (29) 
3.0356

$$$$
CHEMBL1201346
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 24 26  1  0
 14  9  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (30) 
675297

>  <SYNONYMS>  (30) 
Balsalazide (BAN, INN); Balsalazide Disodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (30) 
4

>  <RESEARCH_CODES>  (30) 
BX-661A

>  <APPLICANTS>  (30) 
Salix Pharmaceuticals Inc

>  <USAN_STEM>  (30) 
-sal-

>  <USAN_STEM_DEFINITION>  (30) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (30) 
-sal-

>  <USAN_YEAR>  (30) 
1994.0

>  <FIRST_APPROVAL>  (30) 
2000.0

>  <ATC_CODE>  (30) 
A07EC04

>  <ATC_CODE_DESCRIPTION>  (30) 
A07EC04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Aminosalicylic acid and similar agents]

>  <INDICATION_CLASS>  (30) 
Anti-Inflammatory (gastrointestinal)

>  <SC_PATENT_NO>  (30) 
US-6197341-B1

>  <DRUG_TYPE>  (30) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (30) 
Y

>  <FIRST_IN_CLASS>  (30) 
N

>  <CHIRALITY>  (30) 
Achiral Molecule

>  <PRODRUG>  (30) 
Y

>  <ORAL>  (30) 
Y

>  <PARENTERAL>  (30) 
N

>  <TOPICAL>  (30) 
N

>  <BLACK_BOX>  (30) 
N

>  <AVAILABILITY_TYPE>  (30) 
Prescription-only

>  <WITHDRAWN_YEAR>  (30) 
nan

>  <WITHDRAWN_COUNTRY>  (30) 
nan

>  <WITHDRAWN_REASON>  (30) 
nan

>  <CANONICAL_SMILES>  (30) 
OC(=O)CCNC(=O)c1ccc(cc1)N=Nc2ccc(O)c(c2)C(=O)O

>  <name>  (30) 
Balsalazide 

>  <MW>  (30) 
357.322

>  <logP>  (30) 
2.7103

$$$$
CHEMBL796
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  5 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 11  6  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (31) 
49842

>  <SYNONYMS>  (31) 
Methylphenidate (BAN, FDA, INN, USAN); Methylphenidate HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (31) 
4

>  <RESEARCH_CODES>  (31) 
nan

>  <APPLICANTS>  (31) 
Novartis Pharmaceuticals Corp; Nextwave Pharmaceuticals Inc; Mallinckrodt Inc; Janssen Pharmaceuticals Inc; Ucb Inc

>  <USAN_STEM>  (31) 
nan

>  <USAN_STEM_DEFINITION>  (31) 
nan

>  <USAN_STEM_SUBSTEM>  (31) 
nan

>  <USAN_YEAR>  (31) 
2003.0

>  <FIRST_APPROVAL>  (31) 
1955.0

>  <ATC_CODE>  (31) 
N06BA04

>  <ATC_CODE_DESCRIPTION>  (31) 
N06BA04 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (31) 
Stimulant (central)

>  <SC_PATENT_NO>  (31) 
US-5837284-A

>  <DRUG_TYPE>  (31) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (31) 
Y

>  <FIRST_IN_CLASS>  (31) 
N

>  <CHIRALITY>  (31) 
Racemic Mixture

>  <PRODRUG>  (31) 
N

>  <ORAL>  (31) 
Y

>  <PARENTERAL>  (31) 
N

>  <TOPICAL>  (31) 
Y

>  <BLACK_BOX>  (31) 
Y

>  <AVAILABILITY_TYPE>  (31) 
Prescription-only

>  <WITHDRAWN_YEAR>  (31) 
nan

>  <WITHDRAWN_COUNTRY>  (31) 
nan

>  <WITHDRAWN_REASON>  (31) 
nan

>  <CANONICAL_SMILES>  (31) 
COC(=O)C(C1CCCCN1)c2ccccc2

>  <name>  (31) 
Methylphenidate 

>  <MW>  (31) 
233.311

>  <logP>  (31) 
2.0853

$$$$
CHEMBL2110788
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
  9  3  1  0
 20 15  1  0
 26 21  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (32) 
1383228

>  <SYNONYMS>  (32) 
Benzilonium Bromide (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (32) 
4

>  <RESEARCH_CODES>  (32) 
CI-379; CN-20172-3; PU-239

>  <APPLICANTS>  (32) 
Parke-Davis

>  <USAN_STEM>  (32) 
-ium

>  <USAN_STEM_DEFINITION>  (32) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (32) 
-ium

>  <USAN_YEAR>  (32) 
1961.0

>  <FIRST_APPROVAL>  (32) 
nan

>  <ATC_CODE>  (32) 
A03AB01

>  <ATC_CODE_DESCRIPTION>  (32) 
A03AB01 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (32) 
Anticholinergic

>  <SC_PATENT_NO>  (32) 
nan

>  <DRUG_TYPE>  (32) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (32) 
Y

>  <FIRST_IN_CLASS>  (32) 
N

>  <CHIRALITY>  (32) 
Racemic Mixture

>  <PRODRUG>  (32) 
N

>  <ORAL>  (32) 
N

>  <PARENTERAL>  (32) 
N

>  <TOPICAL>  (32) 
N

>  <BLACK_BOX>  (32) 
N

>  <AVAILABILITY_TYPE>  (32) 
Unknown

>  <WITHDRAWN_YEAR>  (32) 
nan

>  <WITHDRAWN_COUNTRY>  (32) 
nan

>  <WITHDRAWN_REASON>  (32) 
nan

>  <CANONICAL_SMILES>  (32) 
CC[N+]1(CC)CCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3

>  <name>  (32) 
Benzilonium Bromide 

>  <MW>  (32) 
354.47

>  <logP>  (32) 
3.0946

$$$$
CHEMBL277100
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 11 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
  7  2  1  0
 21  8  1  0
 19 10  2  0
 29 23  1  0
M  END
>  <PARENT_MOLREGNO>  (33) 
15371

>  <SYNONYMS>  (33) 
Temafloxacin (BAN, INN); Temafloxacin HCl (USAN)

>  <DEVELOPMENT_PHASE>  (33) 
4

>  <RESEARCH_CODES>  (33) 
ABBOTT-62254

>  <APPLICANTS>  (33) 
Abbott

>  <USAN_STEM>  (33) 
-oxacin

>  <USAN_STEM_DEFINITION>  (33) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (33) 
-oxacin

>  <USAN_YEAR>  (33) 
1988.0

>  <FIRST_APPROVAL>  (33) 
1992.0

>  <ATC_CODE>  (33) 
J01MA05

>  <ATC_CODE_DESCRIPTION>  (33) 
J01MA05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]

>  <INDICATION_CLASS>  (33) 
Antibacterial (microbial DNA topoisomerase inhibitor)

>  <SC_PATENT_NO>  (33) 
nan

>  <DRUG_TYPE>  (33) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (33) 
Y

>  <FIRST_IN_CLASS>  (33) 
N

>  <CHIRALITY>  (33) 
Racemic Mixture

>  <PRODRUG>  (33) 
N

>  <ORAL>  (33) 
N

>  <PARENTERAL>  (33) 
N

>  <TOPICAL>  (33) 
N

>  <BLACK_BOX>  (33) 
N

>  <AVAILABILITY_TYPE>  (33) 
Withdrawn

>  <WITHDRAWN_YEAR>  (33) 
1992.0

>  <WITHDRAWN_COUNTRY>  (33) 
United States; United Kingdom; Germany

>  <WITHDRAWN_REASON>  (33) 
Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions

>  <CANONICAL_SMILES>  (33) 
CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4F

>  <name>  (33) 
Temafloxacin 

>  <MW>  (33) 
417.387

>  <logP>  (33) 
2.9043

$$$$
CHEMBL3304486
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 11 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 18 13  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (34) 
1766457

>  <SYNONYMS>  (34) 
Difemerine (INN); Difemerine HCl (MI)

>  <DEVELOPMENT_PHASE>  (34) 
4

>  <RESEARCH_CODES>  (34) 
nan

>  <APPLICANTS>  (34) 
nan

>  <USAN_STEM>  (34) 
nan

>  <USAN_STEM_DEFINITION>  (34) 
nan

>  <USAN_STEM_SUBSTEM>  (34) 
nan

>  <USAN_YEAR>  (34) 
nan

>  <FIRST_APPROVAL>  (34) 
nan

>  <ATC_CODE>  (34) 
A03AA09

>  <ATC_CODE_DESCRIPTION>  (34) 
A03AA09 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, esters with tertiary amino group]

>  <INDICATION_CLASS>  (34) 
nan

>  <SC_PATENT_NO>  (34) 
nan

>  <DRUG_TYPE>  (34) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (34) 
Y

>  <FIRST_IN_CLASS>  (34) 
N

>  <CHIRALITY>  (34) 
Achiral Molecule

>  <PRODRUG>  (34) 
N

>  <ORAL>  (34) 
N

>  <PARENTERAL>  (34) 
N

>  <TOPICAL>  (34) 
N

>  <BLACK_BOX>  (34) 
N

>  <AVAILABILITY_TYPE>  (34) 
Withdrawn

>  <WITHDRAWN_YEAR>  (34) 
1986.0

>  <WITHDRAWN_COUNTRY>  (34) 
Germany

>  <WITHDRAWN_REASON>  (34) 
Multi-Organ Toxicities

>  <CANONICAL_SMILES>  (34) 
CN(C)CC(C)(C)OC(=O)C(O)(c1ccccc1)c2ccccc2

>  <name>  (34) 
Difemerine 

>  <MW>  (34) 
327.424

>  <logP>  (34) 
2.8059

$$$$
CHEMBL1232903
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  7 10  1  0
M  END
>  <PARENT_MOLREGNO>  (35) 
695253

>  <SYNONYMS>  (35) 
Calcium Glycerylphosphate

>  <DEVELOPMENT_PHASE>  (35) 
4

>  <RESEARCH_CODES>  (35) 
nan

>  <APPLICANTS>  (35) 
nan

>  <USAN_STEM>  (35) 
nan

>  <USAN_STEM_DEFINITION>  (35) 
nan

>  <USAN_STEM_SUBSTEM>  (35) 
nan

>  <USAN_YEAR>  (35) 
nan

>  <FIRST_APPROVAL>  (35) 
nan

>  <ATC_CODE>  (35) 
A12AA08

>  <ATC_CODE_DESCRIPTION>  (35) 
A12AA08 [Alimentary Tract And Metabolism:Mineral Supplements:Calcium:Calcium]

>  <INDICATION_CLASS>  (35) 
nan

>  <SC_PATENT_NO>  (35) 
nan

>  <DRUG_TYPE>  (35) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (35) 
Y

>  <FIRST_IN_CLASS>  (35) 
N

>  <CHIRALITY>  (35) 
Achiral Molecule

>  <PRODRUG>  (35) 
N

>  <ORAL>  (35) 
N

>  <PARENTERAL>  (35) 
N

>  <TOPICAL>  (35) 
N

>  <BLACK_BOX>  (35) 
N

>  <AVAILABILITY_TYPE>  (35) 
Unknown

>  <WITHDRAWN_YEAR>  (35) 
nan

>  <WITHDRAWN_COUNTRY>  (35) 
nan

>  <WITHDRAWN_REASON>  (35) 
nan

>  <CANONICAL_SMILES>  (35) 
OCC(CO)OP(=O)(O)O

>  <name>  (35) 
Calcium Glycerylphosphate

>  <MW>  (35) 
172.073

>  <logP>  (35) 
-1.5511

$$$$
CHEMBL397976
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (36) 
386201

>  <SYNONYMS>  (36) 
Magnesium Pidolate

>  <DEVELOPMENT_PHASE>  (36) 
4

>  <RESEARCH_CODES>  (36) 
nan

>  <APPLICANTS>  (36) 
nan

>  <USAN_STEM>  (36) 
nan

>  <USAN_STEM_DEFINITION>  (36) 
nan

>  <USAN_STEM_SUBSTEM>  (36) 
nan

>  <USAN_YEAR>  (36) 
nan

>  <FIRST_APPROVAL>  (36) 
nan

>  <ATC_CODE>  (36) 
A12CC08

>  <ATC_CODE_DESCRIPTION>  (36) 
A12CC08 [Alimentary Tract And Metabolism:Mineral Supplements:Other Mineral Supplements:Magnesium]

>  <INDICATION_CLASS>  (36) 
nan

>  <SC_PATENT_NO>  (36) 
nan

>  <DRUG_TYPE>  (36) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (36) 
Y

>  <FIRST_IN_CLASS>  (36) 
N

>  <CHIRALITY>  (36) 
Single Stereoisomer

>  <PRODRUG>  (36) 
N

>  <ORAL>  (36) 
N

>  <PARENTERAL>  (36) 
N

>  <TOPICAL>  (36) 
N

>  <BLACK_BOX>  (36) 
N

>  <AVAILABILITY_TYPE>  (36) 
Unknown

>  <WITHDRAWN_YEAR>  (36) 
nan

>  <WITHDRAWN_COUNTRY>  (36) 
nan

>  <WITHDRAWN_REASON>  (36) 
nan

>  <CANONICAL_SMILES>  (36) 
OC(=O)[C@@H]1CCC(=O)N1

>  <name>  (36) 
Magnesium Pidolate

>  <MW>  (36) 
129.115

>  <logP>  (36) 
-0.6504

$$$$
CHEMBL1337
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
  6 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
  9  4  1  0
 18 12  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (37) 
281549

>  <SYNONYMS>  (37) 
Nitisinone (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (37) 
4

>  <RESEARCH_CODES>  (37) 
SC-0735

>  <APPLICANTS>  (37) 
Rare Disease Therapeutics Inc

>  <USAN_STEM>  (37) 
nan

>  <USAN_STEM_DEFINITION>  (37) 
nan

>  <USAN_STEM_SUBSTEM>  (37) 
nan

>  <USAN_YEAR>  (37) 
2002.0

>  <FIRST_APPROVAL>  (37) 
2002.0

>  <ATC_CODE>  (37) 
A16AX04

>  <ATC_CODE_DESCRIPTION>  (37) 
A16AX04 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Various alimentary tract and metabolism products]

>  <INDICATION_CLASS>  (37) 
nan

>  <SC_PATENT_NO>  (37) 
nan

>  <DRUG_TYPE>  (37) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (37) 
Y

>  <FIRST_IN_CLASS>  (37) 
Y

>  <CHIRALITY>  (37) 
Achiral Molecule

>  <PRODRUG>  (37) 
N

>  <ORAL>  (37) 
Y

>  <PARENTERAL>  (37) 
N

>  <TOPICAL>  (37) 
N

>  <BLACK_BOX>  (37) 
N

>  <AVAILABILITY_TYPE>  (37) 
Prescription-only

>  <WITHDRAWN_YEAR>  (37) 
nan

>  <WITHDRAWN_COUNTRY>  (37) 
nan

>  <WITHDRAWN_REASON>  (37) 
nan

>  <CANONICAL_SMILES>  (37) 
[O-][N+](=O)c1cc(ccc1C(=O)C2C(=O)CCCC2=O)C(F)(F)F

>  <name>  (37) 
Nitisinone 

>  <MW>  (37) 
329.23

>  <logP>  (37) 
2.7346

$$$$
CHEMBL106
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  2  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  2 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
  8  4  1  0
 14 10  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (38) 
13758

>  <SYNONYMS>  (38) 
Fluconazole (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (38) 
4

>  <RESEARCH_CODES>  (38) 
UK-49858

>  <APPLICANTS>  (38) 
Pfizer Inc.; Pfizer Chemicals Div Pfizer Inc; Pfizer Central Research

>  <USAN_STEM>  (38) 
-conazole

>  <USAN_STEM_DEFINITION>  (38) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (38) 
-conazole

>  <USAN_YEAR>  (38) 
1988.0

>  <FIRST_APPROVAL>  (38) 
1990.0

>  <ATC_CODE>  (38) 
D01AC15; J02AC01

>  <ATC_CODE_DESCRIPTION>  (38) 
D01AC15 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Imidazole and triazole derivatives]; J02AC01 [Antiinfectives For Systemic Use:Antimycotics For Systemic Use:Antimycotics For Systemic Use:Triazole derivatives]

>  <INDICATION_CLASS>  (38) 
Antifungal

>  <SC_PATENT_NO>  (38) 
nan

>  <DRUG_TYPE>  (38) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (38) 
Y

>  <FIRST_IN_CLASS>  (38) 
N

>  <CHIRALITY>  (38) 
Achiral Molecule

>  <PRODRUG>  (38) 
N

>  <ORAL>  (38) 
Y

>  <PARENTERAL>  (38) 
Y

>  <TOPICAL>  (38) 
N

>  <BLACK_BOX>  (38) 
N

>  <AVAILABILITY_TYPE>  (38) 
Prescription-only

>  <WITHDRAWN_YEAR>  (38) 
nan

>  <WITHDRAWN_COUNTRY>  (38) 
nan

>  <WITHDRAWN_REASON>  (38) 
nan

>  <CANONICAL_SMILES>  (38) 
OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F

>  <name>  (38) 
Fluconazole 

>  <MW>  (38) 
306.276

>  <logP>  (38) 
0.7358

$$$$
CHEMBL1200449
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 10 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 29  8  1  0
 29 12  1  0
 24 13  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (39) 
674400

>  <SYNONYMS>  (39) 
Triamcinolone Diacetate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (39) 
4

>  <RESEARCH_CODES>  (39) 
nan

>  <APPLICANTS>  (39) 
Sandoz Canada Inc; Bristol Myers Squibb Co; Astellas Pharma Us Inc

>  <USAN_STEM>  (39) 
-olone

>  <USAN_STEM_DEFINITION>  (39) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (39) 
-olone

>  <USAN_YEAR>  (39) 
nan

>  <FIRST_APPROVAL>  (39) 
1959.0

>  <ATC_CODE>  (39) 
D07XB02; R01AD11; A01AC01; S01BA05; C05AA12; R03BA06; H02AB08; D07AB09

>  <ATC_CODE_DESCRIPTION>  (39) 
D07XB02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD11 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; A01AC01 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; C05AA12 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R03BA06 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; H02AB08 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07AB09 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (39) 
Glucocorticoid

>  <SC_PATENT_NO>  (39) 
nan

>  <DRUG_TYPE>  (39) 
Natural Product-derived

>  <RULE_OF_FIVE>  (39) 
Y

>  <FIRST_IN_CLASS>  (39) 
N

>  <CHIRALITY>  (39) 
Single Stereoisomer

>  <PRODRUG>  (39) 
Y

>  <ORAL>  (39) 
Y

>  <PARENTERAL>  (39) 
Y

>  <TOPICAL>  (39) 
N

>  <BLACK_BOX>  (39) 
N

>  <AVAILABILITY_TYPE>  (39) 
Discontinued

>  <WITHDRAWN_YEAR>  (39) 
nan

>  <WITHDRAWN_COUNTRY>  (39) 
nan

>  <WITHDRAWN_REASON>  (39) 
nan

>  <CANONICAL_SMILES>  (39) 
CC(=O)OCC(=O)[C@@]1(O)[C@@H](C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)OC(=O)C

>  <name>  (39) 
Triamcinolone Diacetate 

>  <MW>  (39) 
478.513

>  <logP>  (39) 
1.7621

$$$$
CHEMBL16073
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  7 12  1  0
 12 13  2  0
 13  4  1  0
M  END
>  <PARENT_MOLREGNO>  (40) 
16498

>  <SYNONYMS>  (40) 
Phenacetin (INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (40) 
4

>  <RESEARCH_CODES>  (40) 
nan

>  <APPLICANTS>  (40) 
Marion Merrell Dow

>  <USAN_STEM>  (40) 
nan

>  <USAN_STEM_DEFINITION>  (40) 
nan

>  <USAN_STEM_SUBSTEM>  (40) 
nan

>  <USAN_YEAR>  (40) 
nan

>  <FIRST_APPROVAL>  (40) 
nan

>  <ATC_CODE>  (40) 
N02BE73; N02BE03; N02BE53

>  <ATC_CODE_DESCRIPTION>  (40) 
N02BE73 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]; N02BE03 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]; N02BE53 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]

>  <INDICATION_CLASS>  (40) 
nan

>  <SC_PATENT_NO>  (40) 
nan

>  <DRUG_TYPE>  (40) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (40) 
Y

>  <FIRST_IN_CLASS>  (40) 
N

>  <CHIRALITY>  (40) 
Achiral Molecule

>  <PRODRUG>  (40) 
N

>  <ORAL>  (40) 
N

>  <PARENTERAL>  (40) 
N

>  <TOPICAL>  (40) 
N

>  <BLACK_BOX>  (40) 
N

>  <AVAILABILITY_TYPE>  (40) 
Withdrawn

>  <WITHDRAWN_YEAR>  (40) 
1980.0

>  <WITHDRAWN_COUNTRY>  (40) 
United Kingdom; United States; Germany; Denmark

>  <WITHDRAWN_REASON>  (40) 
Nephropathy

>  <CANONICAL_SMILES>  (40) 
CCOc1ccc(NC(=O)C)cc1

>  <name>  (40) 
Phenacetin 

>  <MW>  (40) 
179.219

>  <logP>  (40) 
2.0437

$$$$
CHEMBL316561
     RDKit          

 24 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 10 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (41) 
153476

>  <SYNONYMS>  (41) 
Proglumide (BAN, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (41) 
4

>  <RESEARCH_CODES>  (41) 
W-5219

>  <APPLICANTS>  (41) 
Wallace

>  <USAN_STEM>  (41) 
-glumide

>  <USAN_STEM_DEFINITION>  (41) 
CCK antagonists, antiulcer, anxiolytic agent

>  <USAN_STEM_SUBSTEM>  (41) 
-glumide

>  <USAN_YEAR>  (41) 
1969.0

>  <FIRST_APPROVAL>  (41) 
nan

>  <ATC_CODE>  (41) 
A02BX06

>  <ATC_CODE_DESCRIPTION>  (41) 
A02BX06 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]

>  <INDICATION_CLASS>  (41) 
Anticholinergic

>  <SC_PATENT_NO>  (41) 
nan

>  <DRUG_TYPE>  (41) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (41) 
Y

>  <FIRST_IN_CLASS>  (41) 
N

>  <CHIRALITY>  (41) 
Racemic Mixture

>  <PRODRUG>  (41) 
N

>  <ORAL>  (41) 
N

>  <PARENTERAL>  (41) 
N

>  <TOPICAL>  (41) 
N

>  <BLACK_BOX>  (41) 
N

>  <AVAILABILITY_TYPE>  (41) 
Withdrawn

>  <WITHDRAWN_YEAR>  (41) 
1989.0

>  <WITHDRAWN_COUNTRY>  (41) 
Germany

>  <WITHDRAWN_REASON>  (41) 
Respiratory Reaction

>  <CANONICAL_SMILES>  (41) 
CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1

>  <name>  (41) 
Proglumide 

>  <MW>  (41) 
334.416

>  <logP>  (41) 
2.2984

$$$$
CHEMBL857
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16  8  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (42) 
65798

>  <SYNONYMS>  (42) 
Biotin (FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (42) 
4

>  <RESEARCH_CODES>  (42) 
nan

>  <APPLICANTS>  (42) 
Hospira Inc; Hoffmann La Roche Inc; Astrazeneca Lp; Abraxis Pharmaceutical Products; Sandoz Canada Inc

>  <USAN_STEM>  (42) 
nan

>  <USAN_STEM_DEFINITION>  (42) 
nan

>  <USAN_STEM_SUBSTEM>  (42) 
nan

>  <USAN_YEAR>  (42) 
nan

>  <FIRST_APPROVAL>  (42) 
1985.0

>  <ATC_CODE>  (42) 
A11HA05

>  <ATC_CODE_DESCRIPTION>  (42) 
A11HA05 [Alimentary Tract And Metabolism:Vitamins:Other Plain Vitamin Preparations:Other plain vitamin preparations]

>  <INDICATION_CLASS>  (42) 
Vitamin

>  <SC_PATENT_NO>  (42) 
nan

>  <DRUG_TYPE>  (42) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (42) 
Y

>  <FIRST_IN_CLASS>  (42) 
N

>  <CHIRALITY>  (42) 
Single Stereoisomer

>  <PRODRUG>  (42) 
N

>  <ORAL>  (42) 
N

>  <PARENTERAL>  (42) 
Y

>  <TOPICAL>  (42) 
N

>  <BLACK_BOX>  (42) 
N

>  <AVAILABILITY_TYPE>  (42) 
Prescription-only

>  <WITHDRAWN_YEAR>  (42) 
nan

>  <WITHDRAWN_COUNTRY>  (42) 
nan

>  <WITHDRAWN_REASON>  (42) 
nan

>  <CANONICAL_SMILES>  (42) 
OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12

>  <name>  (42) 
Biotin 

>  <MW>  (42) 
244.316

>  <logP>  (42) 
0.7968

$$$$
CHEMBL8
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 12 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23  4  1  0
  9  7  1  0
 22 10  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (43) 
241

>  <SYNONYMS>  (43) 
Ciprofloxacin (BAN, FDA, INN, USAN, USP); Ciprofloxacin HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (43) 
4

>  <RESEARCH_CODES>  (43) 
BAY-Q-3939; BAY-O-9867 Monohydrate; BAY-O-9867

>  <APPLICANTS>  (43) 
Depomed Inc; Bayer Pharmaceuticals Corp; Bayer Healthcare Pharmaceuticals Inc; Alcon Pharmaceuticals Ltd; Wraser Pharmaceuticals Llc

>  <USAN_STEM>  (43) 
-oxacin

>  <USAN_STEM_DEFINITION>  (43) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (43) 
-oxacin

>  <USAN_YEAR>  (43) 
1987.0

>  <FIRST_APPROVAL>  (43) 
1987.0

>  <ATC_CODE>  (43) 
S01AE03; J01MA02; S03AA07; S02AA15

>  <ATC_CODE_DESCRIPTION>  (43) 
S01AE03 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]; J01MA02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S03AA07 [Sensory Organs:Ophthalmological And Otological Preparations:Antiinfectives:Antiinfectives]; S02AA15 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]

>  <INDICATION_CLASS>  (43) 
Antibacterial

>  <SC_PATENT_NO>  (43) 
US-5972389-A

>  <DRUG_TYPE>  (43) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (43) 
Y

>  <FIRST_IN_CLASS>  (43) 
N

>  <CHIRALITY>  (43) 
Achiral Molecule

>  <PRODRUG>  (43) 
N

>  <ORAL>  (43) 
Y

>  <PARENTERAL>  (43) 
Y

>  <TOPICAL>  (43) 
Y

>  <BLACK_BOX>  (43) 
Y

>  <AVAILABILITY_TYPE>  (43) 
Prescription-only

>  <WITHDRAWN_YEAR>  (43) 
nan

>  <WITHDRAWN_COUNTRY>  (43) 
nan

>  <WITHDRAWN_REASON>  (43) 
nan

>  <CANONICAL_SMILES>  (43) 
OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

>  <name>  (43) 
Ciprofloxacin 

>  <MW>  (43) 
331.347

>  <logP>  (43) 
1.5833

$$$$
CHEMBL679
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  END
>  <PARENT_MOLREGNO>  (44) 
28976

>  <SYNONYMS>  (44) 
Adrenaline (BAN); Epinephrine (FDA, INN, JAN, USP); Epinephrine HCl (JAN, FDA); Epinephrine Bitartrate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (44) 
4

>  <RESEARCH_CODES>  (44) 
nan

>  <APPLICANTS>  (44) 
Belcher Pharmaceuticals Llc; Astrazeneca Lp; Forest Laboratories Inc; Amedra Pharmaceuticals Llc; 3m Pharmaceuticals Inc

>  <USAN_STEM>  (44) 
nan

>  <USAN_STEM_DEFINITION>  (44) 
nan

>  <USAN_STEM_SUBSTEM>  (44) 
nan

>  <USAN_YEAR>  (44) 
nan

>  <FIRST_APPROVAL>  (44) 
1965.0

>  <ATC_CODE>  (44) 
A01AD01; C01CA24; R01AA14; S01EA01; S01EA51; B02BC09; R03AA01; R03AK01

>  <ATC_CODE_DESCRIPTION>  (44) 
A01AD01 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Other agents for local oral treatment]; C01CA24 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]; R01AA14 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, plain]; S01EA01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Sympathomimetics in glaucoma therapy]; S01EA51 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Sympathomimetics in glaucoma therapy]; B02BC09 [Blood And Blood Forming Organs:Antihemorrhagics:Vitamin K And Other Hemostatics:Local hemostatics]; R03AA01 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Alpha- and beta-adrenoreceptor agonists]; R03AK01 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics]

>  <INDICATION_CLASS>  (44) 
Adrenergic (vasoconstrictor); Adrenergic (ophthalmic)

>  <SC_PATENT_NO>  (44) 
US-6629968-B1

>  <DRUG_TYPE>  (44) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (44) 
Y

>  <FIRST_IN_CLASS>  (44) 
N

>  <CHIRALITY>  (44) 
Single Stereoisomer

>  <PRODRUG>  (44) 
N

>  <ORAL>  (44) 
N

>  <PARENTERAL>  (44) 
Y

>  <TOPICAL>  (44) 
Y

>  <BLACK_BOX>  (44) 
N

>  <AVAILABILITY_TYPE>  (44) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (44) 
nan

>  <WITHDRAWN_COUNTRY>  (44) 
nan

>  <WITHDRAWN_REASON>  (44) 
nan

>  <CANONICAL_SMILES>  (44) 
CNC[C@H](O)c1ccc(O)c(O)c1

>  <name>  (44) 
Adrenaline 

>  <MW>  (44) 
183.207

>  <logP>  (44) 
0.3506

$$$$
CHEMBL601719
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  6 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
  2 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 29 30  1  0
  9  4  1  0
 15 11  2  0
 21 16  1  0
 29 22  1  0
M  END
>  <PARENT_MOLREGNO>  (45) 
602271

>  <SYNONYMS>  (45) 
Crizotinib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (45) 
4

>  <RESEARCH_CODES>  (45) 
PF-2341066

>  <APPLICANTS>  (45) 
Pfizer Inc.

>  <USAN_STEM>  (45) 
-tinib

>  <USAN_STEM_DEFINITION>  (45) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (45) 
-tinib

>  <USAN_YEAR>  (45) 
2009.0

>  <FIRST_APPROVAL>  (45) 
2011.0

>  <ATC_CODE>  (45) 
L01XE16

>  <ATC_CODE_DESCRIPTION>  (45) 
L01XE16 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (45) 
nan

>  <SC_PATENT_NO>  (45) 
US-7230098-B2

>  <DRUG_TYPE>  (45) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (45) 
Y

>  <FIRST_IN_CLASS>  (45) 
Y

>  <CHIRALITY>  (45) 
Single Stereoisomer

>  <PRODRUG>  (45) 
N

>  <ORAL>  (45) 
Y

>  <PARENTERAL>  (45) 
N

>  <TOPICAL>  (45) 
N

>  <BLACK_BOX>  (45) 
N

>  <AVAILABILITY_TYPE>  (45) 
Prescription-only

>  <WITHDRAWN_YEAR>  (45) 
nan

>  <WITHDRAWN_COUNTRY>  (45) 
nan

>  <WITHDRAWN_REASON>  (45) 
nan

>  <CANONICAL_SMILES>  (45) 
C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl

>  <name>  (45) 
Crizotinib 

>  <MW>  (45) 
450.345

>  <logP>  (45) 
5.0377

$$$$
CHEMBL923
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  2 10  1  0
 10 11  2  0
 10 12  1  0
 10 13  1  0
  2 14  1  0
 14 15  2  0
 14 16  1  0
 14 17  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (46) 
83772

>  <SYNONYMS>  (46) 
Risedronic Acid (BAN, INN); Risedronate sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (46) 
4

>  <RESEARCH_CODES>  (46) 
NE-58095

>  <APPLICANTS>  (46) 
Warner Chilcott Co Llc

>  <USAN_STEM>  (46) 
nan

>  <USAN_STEM_DEFINITION>  (46) 
nan

>  <USAN_STEM_SUBSTEM>  (46) 
nan

>  <USAN_YEAR>  (46) 
1990.0

>  <FIRST_APPROVAL>  (46) 
1998.0

>  <ATC_CODE>  (46) 
M05BA07

>  <ATC_CODE_DESCRIPTION>  (46) 
M05BA07 [Musculo-Skeletal System:Drugs For Treatment Of Bone Diseases:Drugs Affecting Bone Structure And Mineralization:Bisphosphonates]

>  <INDICATION_CLASS>  (46) 
Regulator (calcium)

>  <SC_PATENT_NO>  (46) 
US-5994329-A

>  <DRUG_TYPE>  (46) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (46) 
Y

>  <FIRST_IN_CLASS>  (46) 
N

>  <CHIRALITY>  (46) 
Achiral Molecule

>  <PRODRUG>  (46) 
N

>  <ORAL>  (46) 
Y

>  <PARENTERAL>  (46) 
N

>  <TOPICAL>  (46) 
N

>  <BLACK_BOX>  (46) 
N

>  <AVAILABILITY_TYPE>  (46) 
Prescription-only

>  <WITHDRAWN_YEAR>  (46) 
nan

>  <WITHDRAWN_COUNTRY>  (46) 
nan

>  <WITHDRAWN_REASON>  (46) 
nan

>  <CANONICAL_SMILES>  (46) 
OC(Cc1cccnc1)(P(=O)(O)O)P(=O)(O)O

>  <name>  (46) 
Risedronic Acid 

>  <MW>  (46) 
283.113

>  <logP>  (46) 
-0.3744

$$$$
CHEMBL1766
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (47) 
591037

>  <SYNONYMS>  (47) 
Desoximetasone (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (47) 
4

>  <RESEARCH_CODES>  (47) 
A-41-304; HOE-304; R-2113

>  <APPLICANTS>  (47) 
Taro Pharmaceuticals North America Inc

>  <USAN_STEM>  (47) 
nan

>  <USAN_STEM_DEFINITION>  (47) 
nan

>  <USAN_STEM_SUBSTEM>  (47) 
nan

>  <USAN_YEAR>  (47) 
1975.0

>  <FIRST_APPROVAL>  (47) 
1977.0

>  <ATC_CODE>  (47) 
D07XC02; D07AC03

>  <ATC_CODE_DESCRIPTION>  (47) 
D07XC02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, potent, other combinations]; D07AC03 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]

>  <INDICATION_CLASS>  (47) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (47) 
US-5990100-A

>  <DRUG_TYPE>  (47) 
Natural Product-derived

>  <RULE_OF_FIVE>  (47) 
Y

>  <FIRST_IN_CLASS>  (47) 
N

>  <CHIRALITY>  (47) 
Single Stereoisomer

>  <PRODRUG>  (47) 
N

>  <ORAL>  (47) 
N

>  <PARENTERAL>  (47) 
N

>  <TOPICAL>  (47) 
Y

>  <BLACK_BOX>  (47) 
N

>  <AVAILABILITY_TYPE>  (47) 
Prescription-only

>  <WITHDRAWN_YEAR>  (47) 
nan

>  <WITHDRAWN_COUNTRY>  (47) 
nan

>  <WITHDRAWN_REASON>  (47) 
nan

>  <CANONICAL_SMILES>  (47) 
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO

>  <name>  (47) 
Desoximetasone 

>  <MW>  (47) 
376.468

>  <logP>  (47) 
2.7808

$$$$
CHEMBL1200376
     RDKit          

 36 40  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 23 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
 32 27  1  0
M  END
>  <PARENT_MOLREGNO>  (48) 
674327

>  <SYNONYMS>  (48) 
Betamethasone Benzoate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (48) 
4

>  <RESEARCH_CODES>  (48) 
W-5975

>  <APPLICANTS>  (48) 
Parke Davis Pharmaceutical Research Div Warner Lambert Co; Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (48) 
nan

>  <USAN_STEM_DEFINITION>  (48) 
nan

>  <USAN_STEM_SUBSTEM>  (48) 
nan

>  <USAN_YEAR>  (48) 
1969.0

>  <FIRST_APPROVAL>  (48) 
1982.0

>  <ATC_CODE>  (48) 
S01CB04; H02AB01; A07EA04; D07AC01; D07XC01; S01BA06; R03BA04; S03BA03; C05AA05; R01AD06; S02BA07

>  <ATC_CODE_DESCRIPTION>  (48) 
S01CB04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; H02AB01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; A07EA04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; D07AC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; D07XC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, potent, other combinations]; S01BA06 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; R03BA04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; S03BA03 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; C05AA05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R01AD06 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S02BA07 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (48) 
Glucocorticoid

>  <SC_PATENT_NO>  (48) 
nan

>  <DRUG_TYPE>  (48) 
Natural Product-derived

>  <RULE_OF_FIVE>  (48) 
Y

>  <FIRST_IN_CLASS>  (48) 
N

>  <CHIRALITY>  (48) 
Single Stereoisomer

>  <PRODRUG>  (48) 
Y

>  <ORAL>  (48) 
N

>  <PARENTERAL>  (48) 
N

>  <TOPICAL>  (48) 
Y

>  <BLACK_BOX>  (48) 
N

>  <AVAILABILITY_TYPE>  (48) 
Discontinued

>  <WITHDRAWN_YEAR>  (48) 
nan

>  <WITHDRAWN_COUNTRY>  (48) 
nan

>  <WITHDRAWN_REASON>  (48) 
nan

>  <CANONICAL_SMILES>  (48) 
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5ccccc5)C(=O)CO

>  <name>  (48) 
Betamethasone Benzoate 

>  <MW>  (48) 
496.575

>  <logP>  (48) 
3.7604

$$$$
CHEMBL1201087
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
  6 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 18 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 29 33  1  0
 33 15  1  0
 27 17  1  0
 28 20  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (49) 
675038

>  <SYNONYMS>  (49) 
Cabergoline (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (49) 
4

>  <RESEARCH_CODES>  (49) 
FCE-21336

>  <APPLICANTS>  (49) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (49) 
-erg-

>  <USAN_STEM_DEFINITION>  (49) 
ergot alkaloid derivatives

>  <USAN_STEM_SUBSTEM>  (49) 
-erg-

>  <USAN_YEAR>  (49) 
1996.0

>  <FIRST_APPROVAL>  (49) 
1996.0

>  <ATC_CODE>  (49) 
N04BC06; G02CB03

>  <ATC_CODE_DESCRIPTION>  (49) 
N04BC06 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopamine agonists]; G02CB03 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Other Gynecologicals:Prolactine inhibitors]

>  <INDICATION_CLASS>  (49) 
Antidyskinetic; Antihyperprolactinemic; Dopamine Agonist

>  <SC_PATENT_NO>  (49) 
nan

>  <DRUG_TYPE>  (49) 
Natural Product-derived

>  <RULE_OF_FIVE>  (49) 
Y

>  <FIRST_IN_CLASS>  (49) 
N

>  <CHIRALITY>  (49) 
Single Stereoisomer

>  <PRODRUG>  (49) 
N

>  <ORAL>  (49) 
Y

>  <PARENTERAL>  (49) 
N

>  <TOPICAL>  (49) 
N

>  <BLACK_BOX>  (49) 
N

>  <AVAILABILITY_TYPE>  (49) 
Prescription-only

>  <WITHDRAWN_YEAR>  (49) 
nan

>  <WITHDRAWN_COUNTRY>  (49) 
nan

>  <WITHDRAWN_REASON>  (49) 
nan

>  <CANONICAL_SMILES>  (49) 
CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1

>  <name>  (49) 
Cabergoline 

>  <MW>  (49) 
451.615

>  <logP>  (49) 
3.1939

$$$$
CHEMBL650
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
  8 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27  2  1  0
 19  4  1  0
 14  5  1  0
 27 20  1  0
M  END
>  <PARENT_MOLREGNO>  (50) 
27575

>  <SYNONYMS>  (50) 
Methylprednisolone (BAN, FDA, INN, JAN, USP); Methylprednisolone Acetate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (50) 
4

>  <RESEARCH_CODES>  (50) 
U-67590A

>  <APPLICANTS>  (50) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (50) 
-pred-

>  <USAN_STEM_DEFINITION>  (50) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (50) 
-pred-

>  <USAN_YEAR>  (50) 
nan

>  <FIRST_APPROVAL>  (50) 
1957.0

>  <ATC_CODE>  (50) 
D07AA01; H02BX01; D10AA02; H02AB04

>  <ATC_CODE_DESCRIPTION>  (50) 
D07AA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; H02BX01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Combinations:Corticosteroids for systemic use, combinations]; D10AA02 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; H02AB04 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]

>  <INDICATION_CLASS>  (50) 
Glucocorticoid

>  <SC_PATENT_NO>  (50) 
nan

>  <DRUG_TYPE>  (50) 
Natural Product-derived

>  <RULE_OF_FIVE>  (50) 
Y

>  <FIRST_IN_CLASS>  (50) 
N

>  <CHIRALITY>  (50) 
Single Stereoisomer

>  <PRODRUG>  (50) 
N

>  <ORAL>  (50) 
Y

>  <PARENTERAL>  (50) 
Y

>  <TOPICAL>  (50) 
Y

>  <BLACK_BOX>  (50) 
N

>  <AVAILABILITY_TYPE>  (50) 
Prescription-only

>  <WITHDRAWN_YEAR>  (50) 
nan

>  <WITHDRAWN_COUNTRY>  (50) 
nan

>  <WITHDRAWN_REASON>  (50) 
nan

>  <CANONICAL_SMILES>  (50) 
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14

>  <name>  (50) 
Methylprednisolone 

>  <MW>  (50) 
374.477

>  <logP>  (50) 
1.8036

$$$$
CHEMBL728
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
  5 24  1  0
 24 25  1  0
 25  2  1  0
 23  9  1  0
 15 10  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (51) 
37266

>  <SYNONYMS>  (51) 
Prochlorperazine (BAN, FDA, INN, JAN, USP); Prochlorperazine Mesilate (JAN); Prochlorperazine edisylate (FDA, USP); Prochlorperazine Maleate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (51) 
4

>  <RESEARCH_CODES>  (51) 
nan

>  <APPLICANTS>  (51) 
GlaxoSmithKline

>  <USAN_STEM>  (51) 
nan

>  <USAN_STEM_DEFINITION>  (51) 
nan

>  <USAN_STEM_SUBSTEM>  (51) 
nan

>  <USAN_YEAR>  (51) 
nan

>  <FIRST_APPROVAL>  (51) 
1956.0

>  <ATC_CODE>  (51) 
N05AB04

>  <ATC_CODE_DESCRIPTION>  (51) 
N05AB04 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (51) 
Anti-Emetic; Antipsychotic

>  <SC_PATENT_NO>  (51) 
nan

>  <DRUG_TYPE>  (51) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (51) 
Y

>  <FIRST_IN_CLASS>  (51) 
N

>  <CHIRALITY>  (51) 
Achiral Molecule

>  <PRODRUG>  (51) 
N

>  <ORAL>  (51) 
Y

>  <PARENTERAL>  (51) 
Y

>  <TOPICAL>  (51) 
Y

>  <BLACK_BOX>  (51) 
Y

>  <AVAILABILITY_TYPE>  (51) 
Prescription-only

>  <WITHDRAWN_YEAR>  (51) 
nan

>  <WITHDRAWN_COUNTRY>  (51) 
nan

>  <WITHDRAWN_REASON>  (51) 
nan

>  <CANONICAL_SMILES>  (51) 
CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1

>  <name>  (51) 
Prochlorperazine 

>  <MW>  (51) 
373.953

>  <logP>  (51) 
4.5802

$$$$
CHEMBL1020
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 13 18  1  0
 18 19  1  0
  7  2  1  0
 18 10  1  0
M  END
>  <PARENT_MOLREGNO>  (52) 
118617

>  <SYNONYMS>  (52) 
Tolmetin (BAN, INN, USAN); Tolmetin Sodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (52) 
4

>  <RESEARCH_CODES>  (52) 
MCN-2559; McN-2559-21-98

>  <APPLICANTS>  (52) 
Ortho-Mcneil; Ortho Mcneil Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (52) 
nan

>  <USAN_STEM_DEFINITION>  (52) 
nan

>  <USAN_STEM_SUBSTEM>  (52) 
nan

>  <USAN_YEAR>  (52) 
1971.0

>  <FIRST_APPROVAL>  (52) 
1976.0

>  <ATC_CODE>  (52) 
M01AB03; M02AA21

>  <ATC_CODE_DESCRIPTION>  (52) 
M01AB03 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]; M02AA21 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]

>  <INDICATION_CLASS>  (52) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (52) 
nan

>  <DRUG_TYPE>  (52) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (52) 
Y

>  <FIRST_IN_CLASS>  (52) 
N

>  <CHIRALITY>  (52) 
Achiral Molecule

>  <PRODRUG>  (52) 
N

>  <ORAL>  (52) 
Y

>  <PARENTERAL>  (52) 
N

>  <TOPICAL>  (52) 
N

>  <BLACK_BOX>  (52) 
Y

>  <AVAILABILITY_TYPE>  (52) 
Prescription-only

>  <WITHDRAWN_YEAR>  (52) 
nan

>  <WITHDRAWN_COUNTRY>  (52) 
nan

>  <WITHDRAWN_REASON>  (52) 
nan

>  <CANONICAL_SMILES>  (52) 
Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C

>  <name>  (52) 
Tolmetin 

>  <MW>  (52) 
257.289

>  <logP>  (52) 
2.19162

$$$$
CHEMBL1200370
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  2 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12  7  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (53) 
674321

>  <SYNONYMS>  (53) 
Benzoyl Peroxide (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (53) 
4

>  <RESEARCH_CODES>  (53) 
nan

>  <APPLICANTS>  (53) 
Valeant International Barbados Srl; Stiefel Laboratories Inc; Galderma Laboratories Lp; Dow Pharmaceutical Sciences; Valeant International Srl

>  <USAN_STEM>  (53) 
nan

>  <USAN_STEM_DEFINITION>  (53) 
nan

>  <USAN_STEM_SUBSTEM>  (53) 
nan

>  <USAN_YEAR>  (53) 
1972.0

>  <FIRST_APPROVAL>  (53) 
1984.0

>  <ATC_CODE>  (53) 
D10AE01; D10AE51

>  <ATC_CODE_DESCRIPTION>  (53) 
D10AE01 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Peroxides]; D10AE51 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Peroxides]

>  <INDICATION_CLASS>  (53) 
Keratolytic

>  <SC_PATENT_NO>  (53) 
US-7820186-B2

>  <DRUG_TYPE>  (53) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (53) 
Y

>  <FIRST_IN_CLASS>  (53) 
N

>  <CHIRALITY>  (53) 
Achiral Molecule

>  <PRODRUG>  (53) 
N

>  <ORAL>  (53) 
N

>  <PARENTERAL>  (53) 
N

>  <TOPICAL>  (53) 
Y

>  <BLACK_BOX>  (53) 
N

>  <AVAILABILITY_TYPE>  (53) 
Prescription-only

>  <WITHDRAWN_YEAR>  (53) 
nan

>  <WITHDRAWN_COUNTRY>  (53) 
nan

>  <WITHDRAWN_REASON>  (53) 
nan

>  <CANONICAL_SMILES>  (53) 
O=C(OOC(=O)c1ccccc1)c2ccccc2

>  <name>  (53) 
Benzoyl Peroxide 

>  <MW>  (53) 
242.23

>  <logP>  (53) 
2.6154

$$$$
CHEMBL1443
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 23 27  1  0
 27 28  2  0
 27 29  1  0
 13  4  1  0
 12  7  1  0
 25 17  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (54) 
374064

>  <SYNONYMS>  (54) 
Nafcillin (BAN, INN); Nafcillin Sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (54) 
4

>  <RESEARCH_CODES>  (54) 
WY-3277

>  <APPLICANTS>  (54) 
Wyeth Ayerst Laboratories; Baxter Healthcare Corp

>  <USAN_STEM>  (54) 
-cillin

>  <USAN_STEM_DEFINITION>  (54) 
penicillins

>  <USAN_STEM_SUBSTEM>  (54) 
-cillin

>  <USAN_YEAR>  (54) 
1963.0

>  <FIRST_APPROVAL>  (54) 
1965.0

>  <ATC_CODE>  (54) 
J01CF06

>  <ATC_CODE_DESCRIPTION>  (54) 
J01CF06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]

>  <INDICATION_CLASS>  (54) 
Antibacterial

>  <SC_PATENT_NO>  (54) 
nan

>  <DRUG_TYPE>  (54) 
Natural Product-derived

>  <RULE_OF_FIVE>  (54) 
Y

>  <FIRST_IN_CLASS>  (54) 
N

>  <CHIRALITY>  (54) 
Single Stereoisomer

>  <PRODRUG>  (54) 
N

>  <ORAL>  (54) 
Y

>  <PARENTERAL>  (54) 
Y

>  <TOPICAL>  (54) 
N

>  <BLACK_BOX>  (54) 
N

>  <AVAILABILITY_TYPE>  (54) 
Prescription-only

>  <WITHDRAWN_YEAR>  (54) 
nan

>  <WITHDRAWN_COUNTRY>  (54) 
nan

>  <WITHDRAWN_REASON>  (54) 
nan

>  <CANONICAL_SMILES>  (54) 
CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O

>  <name>  (54) 
Nafcillin 

>  <MW>  (54) 
414.483

>  <logP>  (54) 
2.4838

$$$$
CHEMBL1090
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
  7  2  1  0
 10  6  1  0
 18 11  1  0
M  END
>  <PARENT_MOLREGNO>  (55) 
149095

>  <SYNONYMS>  (55) 
Vidarabine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (55) 
4

>  <RESEARCH_CODES>  (55) 
ARA-A; CI-673

>  <APPLICANTS>  (55) 
Parkedale Pharmaceuticals Inc

>  <USAN_STEM>  (55) 
-arabine

>  <USAN_STEM_DEFINITION>  (55) 
antineoplastics (arabinofuranosyl derivatives)

>  <USAN_STEM_SUBSTEM>  (55) 
-arabine

>  <USAN_YEAR>  (55) 
1974.0

>  <FIRST_APPROVAL>  (55) 
1976.0

>  <ATC_CODE>  (55) 
J05AB03; S01AD06

>  <ATC_CODE_DESCRIPTION>  (55) 
J05AB03 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD06 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]

>  <INDICATION_CLASS>  (55) 
Antiviral

>  <SC_PATENT_NO>  (55) 
nan

>  <DRUG_TYPE>  (55) 
Natural Product-derived

>  <RULE_OF_FIVE>  (55) 
Y

>  <FIRST_IN_CLASS>  (55) 
N

>  <CHIRALITY>  (55) 
Single Stereoisomer

>  <PRODRUG>  (55) 
N

>  <ORAL>  (55) 
N

>  <PARENTERAL>  (55) 
Y

>  <TOPICAL>  (55) 
Y

>  <BLACK_BOX>  (55) 
N

>  <AVAILABILITY_TYPE>  (55) 
Discontinued

>  <WITHDRAWN_YEAR>  (55) 
nan

>  <WITHDRAWN_COUNTRY>  (55) 
nan

>  <WITHDRAWN_REASON>  (55) 
nan

>  <CANONICAL_SMILES>  (55) 
Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O

>  <name>  (55) 
Vidarabine 

>  <MW>  (55) 
267.245

>  <logP>  (55) 
-1.98

$$$$
CHEMBL1643
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
  8  4  2  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (56) 
485738

>  <SYNONYMS>  (56) 
Ribavirin (FDA, INN, USAN, USP); Tribavirin (BAN)

>  <DEVELOPMENT_PHASE>  (56) 
4

>  <RESEARCH_CODES>  (56) 
nan

>  <APPLICANTS>  (56) 
Valeant Pharmaceuticals International; Schering Corp; Merck Sharp And Dohme Corp; Hoffmann La Roche Inc

>  <USAN_STEM>  (56) 
-vir-

>  <USAN_STEM_DEFINITION>  (56) 
antivirals

>  <USAN_STEM_SUBSTEM>  (56) 
-vir-

>  <USAN_YEAR>  (56) 
1974.0

>  <FIRST_APPROVAL>  (56) 
1985.0

>  <ATC_CODE>  (56) 
J05AB04

>  <ATC_CODE_DESCRIPTION>  (56) 
J05AB04 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (56) 
Antiviral

>  <SC_PATENT_NO>  (56) 
US-6150337-A

>  <DRUG_TYPE>  (56) 
Natural Product-derived

>  <RULE_OF_FIVE>  (56) 
Y

>  <FIRST_IN_CLASS>  (56) 
N

>  <CHIRALITY>  (56) 
Single Stereoisomer

>  <PRODRUG>  (56) 
N

>  <ORAL>  (56) 
Y

>  <PARENTERAL>  (56) 
N

>  <TOPICAL>  (56) 
Y

>  <BLACK_BOX>  (56) 
Y

>  <AVAILABILITY_TYPE>  (56) 
Prescription-only

>  <WITHDRAWN_YEAR>  (56) 
nan

>  <WITHDRAWN_COUNTRY>  (56) 
nan

>  <WITHDRAWN_REASON>  (56) 
nan

>  <CANONICAL_SMILES>  (56) 
NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O

>  <name>  (56) 
Ribavirin 

>  <MW>  (56) 
244.207

>  <logP>  (56) 
-3.0115

$$$$
CHEMBL1451
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
  8 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 19  2  1  0
 23  2  1  0
 17  6  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (57) 
381691

>  <SYNONYMS>  (57) 
Triamcinolone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (57) 
4

>  <RESEARCH_CODES>  (57) 
nan

>  <APPLICANTS>  (57) 
Bristol Myers Squibb Co; Astellas Pharma Us Inc

>  <USAN_STEM>  (57) 
-olone

>  <USAN_STEM_DEFINITION>  (57) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (57) 
-olone

>  <USAN_YEAR>  (57) 
nan

>  <FIRST_APPROVAL>  (57) 
1957.0

>  <ATC_CODE>  (57) 
D07XB02; R01AD11; A01AC01; S01BA05; C05AA12; R03BA06; H02AB08; D07AB09

>  <ATC_CODE_DESCRIPTION>  (57) 
D07XB02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD11 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; A01AC01 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; C05AA12 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R03BA06 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; H02AB08 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07AB09 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (57) 
Glucocorticoid

>  <SC_PATENT_NO>  (57) 
nan

>  <DRUG_TYPE>  (57) 
Natural Product-derived

>  <RULE_OF_FIVE>  (57) 
Y

>  <FIRST_IN_CLASS>  (57) 
N

>  <CHIRALITY>  (57) 
Single Stereoisomer

>  <PRODRUG>  (57) 
N

>  <ORAL>  (57) 
Y

>  <PARENTERAL>  (57) 
N

>  <TOPICAL>  (57) 
N

>  <BLACK_BOX>  (57) 
N

>  <AVAILABILITY_TYPE>  (57) 
Discontinued

>  <WITHDRAWN_YEAR>  (57) 
nan

>  <WITHDRAWN_COUNTRY>  (57) 
nan

>  <WITHDRAWN_REASON>  (57) 
nan

>  <CANONICAL_SMILES>  (57) 
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO

>  <name>  (57) 
Triamcinolone 

>  <MW>  (57) 
394.439

>  <logP>  (57) 
0.6205

$$$$
CHEMBL188952
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 15  1  0
 15 16  1  0
 15 17  2  0
 17  6  1  0
 14 10  1  0
M  END
>  <PARENT_MOLREGNO>  (58) 
314827

>  <SYNONYMS>  (58) 
Pirprofen (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (58) 
4

>  <RESEARCH_CODES>  (58) 
SU-21524

>  <APPLICANTS>  (58) 
nan

>  <USAN_STEM>  (58) 
-profen

>  <USAN_STEM_DEFINITION>  (58) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (58) 
-profen

>  <USAN_YEAR>  (58) 
1974.0

>  <FIRST_APPROVAL>  (58) 
1987.0

>  <ATC_CODE>  (58) 
M01AE08

>  <ATC_CODE_DESCRIPTION>  (58) 
M01AE08 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (58) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (58) 
nan

>  <DRUG_TYPE>  (58) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (58) 
Y

>  <FIRST_IN_CLASS>  (58) 
N

>  <CHIRALITY>  (58) 
Racemic Mixture

>  <PRODRUG>  (58) 
N

>  <ORAL>  (58) 
N

>  <PARENTERAL>  (58) 
N

>  <TOPICAL>  (58) 
N

>  <BLACK_BOX>  (58) 
N

>  <AVAILABILITY_TYPE>  (58) 
Withdrawn

>  <WITHDRAWN_YEAR>  (58) 
1990.0

>  <WITHDRAWN_COUNTRY>  (58) 
Spain; Germany; France

>  <WITHDRAWN_REASON>  (58) 
Gastrointestinal Toxicity; Hepatotoxicity

>  <CANONICAL_SMILES>  (58) 
CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1

>  <name>  (58) 
Pirprofen 

>  <MW>  (58) 
251.713

>  <logP>  (58) 
2.9043

$$$$
CHEMBL534
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  5 21  1  0
 21 22  1  0
 22  2  1  0
 20  6  1  0
 12  7  1  0
 20 16  2  0
M  END
>  <PARENT_MOLREGNO>  (59) 
12957

>  <SYNONYMS>  (59) 
Ketotifen (BAN, INN); Ketotifen fumarate (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (59) 
4

>  <RESEARCH_CODES>  (59) 
HC-20511; HC-20511 fumarate

>  <APPLICANTS>  (59) 
Bausch And Lomb Inc; Alcon Research Ltd

>  <USAN_STEM>  (59) 
-ifen(e)

>  <USAN_STEM_DEFINITION>  (59) 
antiestrogens of the clomifene and tamoxifen groups

>  <USAN_STEM_SUBSTEM>  (59) 
-ifen(e)

>  <USAN_YEAR>  (59) 
1979.0

>  <FIRST_APPROVAL>  (59) 
1999.0

>  <ATC_CODE>  (59) 
R06AX17; S01GX08

>  <ATC_CODE_DESCRIPTION>  (59) 
R06AX17 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]; S01GX08 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]

>  <INDICATION_CLASS>  (59) 
Anti-Asthmatic

>  <SC_PATENT_NO>  (59) 
nan

>  <DRUG_TYPE>  (59) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (59) 
Y

>  <FIRST_IN_CLASS>  (59) 
N

>  <CHIRALITY>  (59) 
Achiral Molecule

>  <PRODRUG>  (59) 
N

>  <ORAL>  (59) 
N

>  <PARENTERAL>  (59) 
N

>  <TOPICAL>  (59) 
Y

>  <BLACK_BOX>  (59) 
N

>  <AVAILABILITY_TYPE>  (59) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (59) 
nan

>  <WITHDRAWN_COUNTRY>  (59) 
nan

>  <WITHDRAWN_REASON>  (59) 
nan

>  <CANONICAL_SMILES>  (59) 
CN1CCC(=C2c3ccccc3CC(=O)c4sccc24)CC1

>  <name>  (59) 
Ketotifen 

>  <MW>  (59) 
309.434

>  <logP>  (59) 
4.0144

$$$$
CHEMBL819
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  5 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 22 26  1  0
 26 27  2  0
 26 28  1  0
 12  2  2  0
 11  6  1  0
 24 16  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (60) 
56432

>  <SYNONYMS>  (60) 
Oxacillin (BAN, INN); Oxacillin sodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (60) 
4

>  <RESEARCH_CODES>  (60) 
P-12; SO 16423; SQ-16423

>  <APPLICANTS>  (60) 
Baxter Healthcare Corp; Apothecon Sub Bristol Myers Squibb Co; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (60) 
-cillin

>  <USAN_STEM_DEFINITION>  (60) 
penicillins

>  <USAN_STEM_SUBSTEM>  (60) 
-cillin

>  <USAN_YEAR>  (60) 
1962.0

>  <FIRST_APPROVAL>  (60) 
1971.0

>  <ATC_CODE>  (60) 
J01CF04

>  <ATC_CODE_DESCRIPTION>  (60) 
J01CF04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]

>  <INDICATION_CLASS>  (60) 
Antibacterial

>  <SC_PATENT_NO>  (60) 
nan

>  <DRUG_TYPE>  (60) 
Natural Product-derived

>  <RULE_OF_FIVE>  (60) 
Y

>  <FIRST_IN_CLASS>  (60) 
N

>  <CHIRALITY>  (60) 
Single Stereoisomer

>  <PRODRUG>  (60) 
N

>  <ORAL>  (60) 
Y

>  <PARENTERAL>  (60) 
Y

>  <TOPICAL>  (60) 
N

>  <BLACK_BOX>  (60) 
N

>  <AVAILABILITY_TYPE>  (60) 
Prescription-only

>  <WITHDRAWN_YEAR>  (60) 
nan

>  <WITHDRAWN_COUNTRY>  (60) 
nan

>  <WITHDRAWN_REASON>  (60) 
nan

>  <CANONICAL_SMILES>  (60) 
Cc1onc(c2ccccc2)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O

>  <name>  (60) 
Oxacillin 

>  <MW>  (60) 
401.444

>  <logP>  (60) 
1.89532

$$$$
CHEMBL1229
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
  8 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 15 20  1  0
 20 21  1  0
 20 22  1  0
 22  6  1  0
M  END
>  <PARENT_MOLREGNO>  (61) 
228121

>  <SYNONYMS>  (61) 
Oseltamivir (BAN, INN); Oseltamivir Phosphate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (61) 
4

>  <RESEARCH_CODES>  (61) 
Ro-640796; Ro-640796002; Ro-64-0796-002

>  <APPLICANTS>  (61) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (61) 
-vir

>  <USAN_STEM_DEFINITION>  (61) 
antivirals: neuraminidase inhibitors

>  <USAN_STEM_SUBSTEM>  (61) 
-vir (-amivir)

>  <USAN_YEAR>  (61) 
1998.0

>  <FIRST_APPROVAL>  (61) 
1999.0

>  <ATC_CODE>  (61) 
J05AH02

>  <ATC_CODE_DESCRIPTION>  (61) 
J05AH02 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Neuraminidase inhibitors]

>  <INDICATION_CLASS>  (61) 
nan

>  <SC_PATENT_NO>  (61) 
US-5763483-A

>  <DRUG_TYPE>  (61) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (61) 
Y

>  <FIRST_IN_CLASS>  (61) 
N

>  <CHIRALITY>  (61) 
Single Stereoisomer

>  <PRODRUG>  (61) 
Y

>  <ORAL>  (61) 
Y

>  <PARENTERAL>  (61) 
N

>  <TOPICAL>  (61) 
N

>  <BLACK_BOX>  (61) 
N

>  <AVAILABILITY_TYPE>  (61) 
Prescription-only

>  <WITHDRAWN_YEAR>  (61) 
nan

>  <WITHDRAWN_COUNTRY>  (61) 
nan

>  <WITHDRAWN_REASON>  (61) 
nan

>  <CANONICAL_SMILES>  (61) 
CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1

>  <name>  (61) 
Oseltamivir 

>  <MW>  (61) 
312.41

>  <logP>  (61) 
1.2854

$$$$
CHEMBL647
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  6 13  1  0
 13 14  1  0
 13 15  2  0
 15  2  1  0
 12  8  1  0
M  END
>  <PARENT_MOLREGNO>  (62) 
27495

>  <SYNONYMS>  (62) 
Apraclonidine (BAN, INN); Apraclonidine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (62) 
4

>  <RESEARCH_CODES>  (62) 
AL-02145

>  <APPLICANTS>  (62) 
Alcon Laboratories Inc

>  <USAN_STEM>  (62) 
nan

>  <USAN_STEM_DEFINITION>  (62) 
nan

>  <USAN_STEM_SUBSTEM>  (62) 
nan

>  <USAN_YEAR>  (62) 
1988.0

>  <FIRST_APPROVAL>  (62) 
1987.0

>  <ATC_CODE>  (62) 
S01EA03

>  <ATC_CODE_DESCRIPTION>  (62) 
S01EA03 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Sympathomimetics in glaucoma therapy]

>  <INDICATION_CLASS>  (62) 
Adrenergic (alpha12-agonist)

>  <SC_PATENT_NO>  (62) 
nan

>  <DRUG_TYPE>  (62) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (62) 
Y

>  <FIRST_IN_CLASS>  (62) 
N

>  <CHIRALITY>  (62) 
Achiral Molecule

>  <PRODRUG>  (62) 
N

>  <ORAL>  (62) 
N

>  <PARENTERAL>  (62) 
N

>  <TOPICAL>  (62) 
Y

>  <BLACK_BOX>  (62) 
N

>  <AVAILABILITY_TYPE>  (62) 
Prescription-only

>  <WITHDRAWN_YEAR>  (62) 
nan

>  <WITHDRAWN_COUNTRY>  (62) 
nan

>  <WITHDRAWN_REASON>  (62) 
nan

>  <CANONICAL_SMILES>  (62) 
Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1

>  <name>  (62) 
Apraclonidine 

>  <MW>  (62) 
245.113

>  <logP>  (62) 
1.7559

$$$$
CHEMBL1201347
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  9 19  1  0
 19 20  1  0
  6 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 20  6  1  0
 18 12  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (63) 
675298

>  <SYNONYMS>  (63) 
Anileridine (BAN, INN, USP); Anileridine Phosphate (FDA); Anileridine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (63) 
4

>  <RESEARCH_CODES>  (63) 
nan

>  <APPLICANTS>  (63) 
Merck And Co Inc

>  <USAN_STEM>  (63) 
-eridine

>  <USAN_STEM_DEFINITION>  (63) 
analgesics (meperidine type)

>  <USAN_STEM_SUBSTEM>  (63) 
-eridine

>  <USAN_YEAR>  (63) 
nan

>  <FIRST_APPROVAL>  (63) 
1982.0

>  <ATC_CODE>  (63) 
N01AH05

>  <ATC_CODE_DESCRIPTION>  (63) 
N01AH05 [Nervous System:Anesthetics:Anesthetics, General:Opioid anesthetics]

>  <INDICATION_CLASS>  (63) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (63) 
nan

>  <DRUG_TYPE>  (63) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (63) 
Y

>  <FIRST_IN_CLASS>  (63) 
N

>  <CHIRALITY>  (63) 
Achiral Molecule

>  <PRODRUG>  (63) 
N

>  <ORAL>  (63) 
Y

>  <PARENTERAL>  (63) 
Y

>  <TOPICAL>  (63) 
N

>  <BLACK_BOX>  (63) 
N

>  <AVAILABILITY_TYPE>  (63) 
Discontinued

>  <WITHDRAWN_YEAR>  (63) 
nan

>  <WITHDRAWN_COUNTRY>  (63) 
nan

>  <WITHDRAWN_REASON>  (63) 
nan

>  <CANONICAL_SMILES>  (63) 
CCOC(=O)C1(CCN(CCc2ccc(N)cc2)CC1)c3ccccc3

>  <name>  (63) 
Anileridine 

>  <MW>  (63) 
352.478

>  <logP>  (63) 
3.4082

$$$$
CHEMBL1201222
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  2 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (64) 
675173

>  <SYNONYMS>  (64) 
Lisdexamfetamine (INN); Lisdexamfetamine Dimesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (64) 
4

>  <RESEARCH_CODES>  (64) 
NRP104

>  <APPLICANTS>  (64) 
Shire Development Inc

>  <USAN_STEM>  (64) 
-fetamin(e)

>  <USAN_STEM_DEFINITION>  (64) 
amfetamine derivatives

>  <USAN_STEM_SUBSTEM>  (64) 
-fetamin(e)

>  <USAN_YEAR>  (64) 
2005.0

>  <FIRST_APPROVAL>  (64) 
2007.0

>  <ATC_CODE>  (64) 
N06BA12

>  <ATC_CODE_DESCRIPTION>  (64) 
N06BA12 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (64) 
nan

>  <SC_PATENT_NO>  (64) 
US-7105486-B2

>  <DRUG_TYPE>  (64) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (64) 
Y

>  <FIRST_IN_CLASS>  (64) 
N

>  <CHIRALITY>  (64) 
Single Stereoisomer

>  <PRODRUG>  (64) 
Y

>  <ORAL>  (64) 
Y

>  <PARENTERAL>  (64) 
N

>  <TOPICAL>  (64) 
N

>  <BLACK_BOX>  (64) 
Y

>  <AVAILABILITY_TYPE>  (64) 
Prescription-only

>  <WITHDRAWN_YEAR>  (64) 
nan

>  <WITHDRAWN_COUNTRY>  (64) 
nan

>  <WITHDRAWN_REASON>  (64) 
nan

>  <CANONICAL_SMILES>  (64) 
C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN

>  <name>  (64) 
Lisdexamfetamine 

>  <MW>  (64) 
263.385

>  <logP>  (64) 
1.1901

$$$$
CHEMBL864
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 14  8  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (65) 
66273

>  <SYNONYMS>  (65) 
Carbinoxamine (BAN, INN); Carbinoxamine Maleate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (65) 
4

>  <RESEARCH_CODES>  (65) 
nan

>  <APPLICANTS>  (65) 
Ortho Mcneil Pharmaceutical Inc; Mcneil Pharmaceutical Co Div Mcneilab Inc

>  <USAN_STEM>  (65) 
nan

>  <USAN_STEM_DEFINITION>  (65) 
nan

>  <USAN_STEM_SUBSTEM>  (65) 
nan

>  <USAN_YEAR>  (65) 
nan

>  <FIRST_APPROVAL>  (65) 
2003.0

>  <ATC_CODE>  (65) 
R06AA08

>  <ATC_CODE_DESCRIPTION>  (65) 
R06AA08 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]

>  <INDICATION_CLASS>  (65) 
Antihistaminic

>  <SC_PATENT_NO>  (65) 
US-8062667-B2

>  <DRUG_TYPE>  (65) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (65) 
Y

>  <FIRST_IN_CLASS>  (65) 
N

>  <CHIRALITY>  (65) 
Racemic Mixture

>  <PRODRUG>  (65) 
N

>  <ORAL>  (65) 
Y

>  <PARENTERAL>  (65) 
N

>  <TOPICAL>  (65) 
N

>  <BLACK_BOX>  (65) 
N

>  <AVAILABILITY_TYPE>  (65) 
Prescription-only

>  <WITHDRAWN_YEAR>  (65) 
nan

>  <WITHDRAWN_COUNTRY>  (65) 
nan

>  <WITHDRAWN_REASON>  (65) 
nan

>  <CANONICAL_SMILES>  (65) 
CN(C)CCOC(c1ccc(Cl)cc1)c2ccccn2

>  <name>  (65) 
Carbinoxamine 

>  <MW>  (65) 
290.794

>  <logP>  (65) 
3.4026

$$$$
CHEMBL1628502
     RDKit          

 23 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 14 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 14  1  0
M  END
>  <PARENT_MOLREGNO>  (66) 
1051353

>  <SYNONYMS>  (66) 
Gabapentin Enacarbil (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (66) 
4

>  <RESEARCH_CODES>  (66) 
XP-13512

>  <APPLICANTS>  (66) 
Glaxo Group Ltd

>  <USAN_STEM>  (66) 
-gab-

>  <USAN_STEM_DEFINITION>  (66) 
gabamimetics

>  <USAN_STEM_SUBSTEM>  (66) 
-gab-

>  <USAN_YEAR>  (66) 
2008.0

>  <FIRST_APPROVAL>  (66) 
2011.0

>  <ATC_CODE>  (66) 
N03AX12

>  <ATC_CODE_DESCRIPTION>  (66) 
N03AX12 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (66) 
nan

>  <SC_PATENT_NO>  (66) 
US-6818787-B2

>  <DRUG_TYPE>  (66) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (66) 
Y

>  <FIRST_IN_CLASS>  (66) 
N

>  <CHIRALITY>  (66) 
Racemic Mixture

>  <PRODRUG>  (66) 
Y

>  <ORAL>  (66) 
Y

>  <PARENTERAL>  (66) 
N

>  <TOPICAL>  (66) 
N

>  <BLACK_BOX>  (66) 
N

>  <AVAILABILITY_TYPE>  (66) 
Prescription-only

>  <WITHDRAWN_YEAR>  (66) 
nan

>  <WITHDRAWN_COUNTRY>  (66) 
nan

>  <WITHDRAWN_REASON>  (66) 
nan

>  <CANONICAL_SMILES>  (66) 
CC(C)C(=O)OC(C)OC(=O)NCC1(CC(=O)O)CCCCC1

>  <name>  (66) 
Gabapentin Enacarbil 

>  <MW>  (66) 
329.393

>  <logP>  (66) 
2.683

$$$$
CHEMBL57
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20  2  1  0
 20  6  2  0
 10  8  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (67) 
4345

>  <SYNONYMS>  (67) 
Nevirapine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (67) 
4

>  <RESEARCH_CODES>  (67) 
BIRG-0587

>  <APPLICANTS>  (67) 
Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (67) 
-pin(e); -vir-

>  <USAN_STEM_DEFINITION>  (67) 
tricyclic compounds; antivirals

>  <USAN_STEM_SUBSTEM>  (67) 
-pin(e); -vir-

>  <USAN_YEAR>  (67) 
1991.0

>  <FIRST_APPROVAL>  (67) 
1996.0

>  <ATC_CODE>  (67) 
J05AG01

>  <ATC_CODE_DESCRIPTION>  (67) 
J05AG01 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Non-nucleoside reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (67) 
Antiviral

>  <SC_PATENT_NO>  (67) 
US-8460704-B2

>  <DRUG_TYPE>  (67) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (67) 
Y

>  <FIRST_IN_CLASS>  (67) 
N

>  <CHIRALITY>  (67) 
Achiral Molecule

>  <PRODRUG>  (67) 
N

>  <ORAL>  (67) 
Y

>  <PARENTERAL>  (67) 
N

>  <TOPICAL>  (67) 
N

>  <BLACK_BOX>  (67) 
Y

>  <AVAILABILITY_TYPE>  (67) 
Prescription-only

>  <WITHDRAWN_YEAR>  (67) 
nan

>  <WITHDRAWN_COUNTRY>  (67) 
nan

>  <WITHDRAWN_REASON>  (67) 
nan

>  <CANONICAL_SMILES>  (67) 
Cc1ccnc2N(C3CC3)c4ncccc4C(=O)Nc12

>  <name>  (67) 
Nevirapine 

>  <MW>  (67) 
266.304

>  <logP>  (67) 
2.65122

$$$$
CHEMBL600
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (68) 
20881

>  <SYNONYMS>  (68) 
Acetylcysteine (BAN, FDA, INN, JAN, USAN, USP); N-Acetyl-L-Cysteine (JAN)

>  <DEVELOPMENT_PHASE>  (68) 
4

>  <RESEARCH_CODES>  (68) 
5052

>  <APPLICANTS>  (68) 
Mead Johnson And Co Sub Bristol Myers Co; Cumberland Pharmaceuticals Inc; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (68) 
nan

>  <USAN_STEM_DEFINITION>  (68) 
nan

>  <USAN_STEM_SUBSTEM>  (68) 
nan

>  <USAN_YEAR>  (68) 
1963.0

>  <FIRST_APPROVAL>  (68) 
1963.0

>  <ATC_CODE>  (68) 
V03AB23; S01XA08; R05CB01

>  <ATC_CODE_DESCRIPTION>  (68) 
V03AB23 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]; S01XA08 [Sensory Organs:Ophthalmologicals:Other Ophthalmologicals:Other ophthalmologicals]; R05CB01 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Mucolytics]

>  <INDICATION_CLASS>  (68) 
Mucolytic

>  <SC_PATENT_NO>  (68) 
US-8148356-B2

>  <DRUG_TYPE>  (68) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (68) 
Y

>  <FIRST_IN_CLASS>  (68) 
N

>  <CHIRALITY>  (68) 
Single Stereoisomer

>  <PRODRUG>  (68) 
N

>  <ORAL>  (68) 
Y

>  <PARENTERAL>  (68) 
Y

>  <TOPICAL>  (68) 
Y

>  <BLACK_BOX>  (68) 
N

>  <AVAILABILITY_TYPE>  (68) 
Prescription-only

>  <WITHDRAWN_YEAR>  (68) 
nan

>  <WITHDRAWN_COUNTRY>  (68) 
nan

>  <WITHDRAWN_REASON>  (68) 
nan

>  <CANONICAL_SMILES>  (68) 
CC(=O)N[C@@H](CS)C(=O)O

>  <name>  (68) 
Acetylcysteine 

>  <MW>  (68) 
163.198

>  <logP>  (68) 
-0.4945

$$$$
CHEMBL1447
     RDKit          

 27 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  6 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
  9  4  1  0
 26 17  1  0
M  END
>  <PARENT_MOLREGNO>  (69) 
378207

>  <SYNONYMS>  (69) 
Lincomycin (BAN, INN, USAN); Lincomycin HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (69) 
4

>  <RESEARCH_CODES>  (69) 
U-10149

>  <APPLICANTS>  (69) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (69) 
-mycin

>  <USAN_STEM_DEFINITION>  (69) 
antibiotics (Streptomyces strains)

>  <USAN_STEM_SUBSTEM>  (69) 
-mycin

>  <USAN_YEAR>  (69) 
1962.0

>  <FIRST_APPROVAL>  (69) 
1964.0

>  <ATC_CODE>  (69) 
J01FF02

>  <ATC_CODE_DESCRIPTION>  (69) 
J01FF02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Macrolides, Lincosamides And Streptogramins:Lincosamides]

>  <INDICATION_CLASS>  (69) 
Antibacterial

>  <SC_PATENT_NO>  (69) 
nan

>  <DRUG_TYPE>  (69) 
Natural Product-derived

>  <RULE_OF_FIVE>  (69) 
Y

>  <FIRST_IN_CLASS>  (69) 
N

>  <CHIRALITY>  (69) 
Single Stereoisomer

>  <PRODRUG>  (69) 
N

>  <ORAL>  (69) 
Y

>  <PARENTERAL>  (69) 
Y

>  <TOPICAL>  (69) 
N

>  <BLACK_BOX>  (69) 
Y

>  <AVAILABILITY_TYPE>  (69) 
Prescription-only

>  <WITHDRAWN_YEAR>  (69) 
nan

>  <WITHDRAWN_COUNTRY>  (69) 
nan

>  <WITHDRAWN_REASON>  (69) 
nan

>  <CANONICAL_SMILES>  (69) 
CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O

>  <name>  (69) 
Lincomycin 

>  <MW>  (69) 
406.545

>  <logP>  (69) 
-0.857

$$$$
CHEMBL599
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
  3 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 12  2  1  0
 11  6  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (70) 
20496

>  <SYNONYMS>  (70) 
Meloxicam (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (70) 
4

>  <RESEARCH_CODES>  (70) 
UH-AC 62XX

>  <APPLICANTS>  (70) 
Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (70) 
-icam

>  <USAN_STEM_DEFINITION>  (70) 
anti-inflammatory agents (isoxicam type)

>  <USAN_STEM_SUBSTEM>  (70) 
-icam

>  <USAN_YEAR>  (70) 
1997.0

>  <FIRST_APPROVAL>  (70) 
2000.0

>  <ATC_CODE>  (70) 
M01AC56; M01AC06

>  <ATC_CODE_DESCRIPTION>  (70) 
M01AC56 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Oxicams]; M01AC06 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Oxicams]

>  <INDICATION_CLASS>  (70) 
Anti-Inflammatory (nonsteroidal)

>  <SC_PATENT_NO>  (70) 
nan

>  <DRUG_TYPE>  (70) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (70) 
Y

>  <FIRST_IN_CLASS>  (70) 
N

>  <CHIRALITY>  (70) 
Achiral Molecule

>  <PRODRUG>  (70) 
N

>  <ORAL>  (70) 
Y

>  <PARENTERAL>  (70) 
N

>  <TOPICAL>  (70) 
N

>  <BLACK_BOX>  (70) 
Y

>  <AVAILABILITY_TYPE>  (70) 
Prescription-only

>  <WITHDRAWN_YEAR>  (70) 
nan

>  <WITHDRAWN_COUNTRY>  (70) 
nan

>  <WITHDRAWN_REASON>  (70) 
nan

>  <CANONICAL_SMILES>  (70) 
CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3

>  <name>  (70) 
Meloxicam 

>  <MW>  (70) 
351.409

>  <logP>  (70) 
1.95092

$$$$
CHEMBL1139
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 16 24  1  0
 24 25  1  0
 25 10  1  0
 25 14  1  0
M  END
>  <PARENT_MOLREGNO>  (71) 
175331

>  <SYNONYMS>  (71) 
Epoprostenol (INN, USAN); Epoprostenol sodium (BAN, FDA, USAN)

>  <DEVELOPMENT_PHASE>  (71) 
4

>  <RESEARCH_CODES>  (71) 
U-53217; U-53217A

>  <APPLICANTS>  (71) 
GlaxoSmithKline Llc; Actelion Pharmaceuticals Ltd

>  <USAN_STEM>  (71) 
-prost-

>  <USAN_STEM_DEFINITION>  (71) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (71) 
-prost-

>  <USAN_YEAR>  (71) 
1979.0

>  <FIRST_APPROVAL>  (71) 
1995.0

>  <ATC_CODE>  (71) 
B01AC09

>  <ATC_CODE_DESCRIPTION>  (71) 
B01AC09 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (71) 
Inhibitor (platelet)

>  <SC_PATENT_NO>  (71) 
US-8318802-B2

>  <DRUG_TYPE>  (71) 
Natural Product-derived

>  <RULE_OF_FIVE>  (71) 
Y

>  <FIRST_IN_CLASS>  (71) 
N

>  <CHIRALITY>  (71) 
Single Stereoisomer

>  <PRODRUG>  (71) 
N

>  <ORAL>  (71) 
N

>  <PARENTERAL>  (71) 
Y

>  <TOPICAL>  (71) 
N

>  <BLACK_BOX>  (71) 
N

>  <AVAILABILITY_TYPE>  (71) 
Prescription-only

>  <WITHDRAWN_YEAR>  (71) 
nan

>  <WITHDRAWN_COUNTRY>  (71) 
nan

>  <WITHDRAWN_REASON>  (71) 
nan

>  <CANONICAL_SMILES>  (71) 
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(=C/CCCC(=O)O)\C[C@H]12

>  <name>  (71) 
Epoprostenol 

>  <MW>  (71) 
352.471

>  <logP>  (71) 
3.4085

$$$$
CHEMBL1200802
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15  5  1  0
M  END
>  <PARENT_MOLREGNO>  (72) 
674753

>  <SYNONYMS>  (72) 
Talbutal (FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (72) 
4

>  <RESEARCH_CODES>  (72) 
nan

>  <APPLICANTS>  (72) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (72) 
nan

>  <USAN_STEM_DEFINITION>  (72) 
nan

>  <USAN_STEM_SUBSTEM>  (72) 
nan

>  <USAN_YEAR>  (72) 
nan

>  <FIRST_APPROVAL>  (72) 
1982.0

>  <ATC_CODE>  (72) 
N05CA07

>  <ATC_CODE_DESCRIPTION>  (72) 
N05CA07 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (72) 
nan

>  <SC_PATENT_NO>  (72) 
nan

>  <DRUG_TYPE>  (72) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (72) 
Y

>  <FIRST_IN_CLASS>  (72) 
N

>  <CHIRALITY>  (72) 
Racemic Mixture

>  <PRODRUG>  (72) 
N

>  <ORAL>  (72) 
Y

>  <PARENTERAL>  (72) 
N

>  <TOPICAL>  (72) 
N

>  <BLACK_BOX>  (72) 
N

>  <AVAILABILITY_TYPE>  (72) 
Discontinued

>  <WITHDRAWN_YEAR>  (72) 
nan

>  <WITHDRAWN_COUNTRY>  (72) 
nan

>  <WITHDRAWN_REASON>  (72) 
nan

>  <CANONICAL_SMILES>  (72) 
CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O

>  <name>  (72) 
Talbutal 

>  <MW>  (72) 
224.26

>  <logP>  (72) 
0.961

$$$$
CHEMBL24171
     RDKit          

 16 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16  3  1  0
 10  4  1  0
 16 12  2  0
M  END
>  <PARENT_MOLREGNO>  (73) 
31196

>  <SYNONYMS>  (73) 
Bergapten

>  <DEVELOPMENT_PHASE>  (73) 
4

>  <RESEARCH_CODES>  (73) 
nan

>  <APPLICANTS>  (73) 
nan

>  <USAN_STEM>  (73) 
-erg-

>  <USAN_STEM_DEFINITION>  (73) 
ergot alkaloid derivatives

>  <USAN_STEM_SUBSTEM>  (73) 
-erg-

>  <USAN_YEAR>  (73) 
nan

>  <FIRST_APPROVAL>  (73) 
nan

>  <ATC_CODE>  (73) 
D05BA03

>  <ATC_CODE_DESCRIPTION>  (73) 
D05BA03 [Dermatologicals:Antipsoriatics:Antipsoriatics For Systemic Use:Psoralens for systemic use]

>  <INDICATION_CLASS>  (73) 
nan

>  <SC_PATENT_NO>  (73) 
nan

>  <DRUG_TYPE>  (73) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (73) 
Y

>  <FIRST_IN_CLASS>  (73) 
N

>  <CHIRALITY>  (73) 
Achiral Molecule

>  <PRODRUG>  (73) 
N

>  <ORAL>  (73) 
N

>  <PARENTERAL>  (73) 
N

>  <TOPICAL>  (73) 
N

>  <BLACK_BOX>  (73) 
N

>  <AVAILABILITY_TYPE>  (73) 
Unknown

>  <WITHDRAWN_YEAR>  (73) 
nan

>  <WITHDRAWN_COUNTRY>  (73) 
nan

>  <WITHDRAWN_REASON>  (73) 
nan

>  <CANONICAL_SMILES>  (73) 
COc1c2C=CC(=O)Oc2cc3occc13

>  <name>  (73) 
Bergapten

>  <MW>  (73) 
216.192

>  <logP>  (73) 
2.5478

$$$$
CHEMBL1201780
     RDKit          

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  5 11  1  0
 11 12  2  0
 11 13  1  0
M  END
>  <PARENT_MOLREGNO>  (74) 
675731

>  <SYNONYMS>  (74) 
Carglumic acid (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (74) 
4

>  <RESEARCH_CODES>  (74) 
OE-312 (Laboratory-Code-Designation)

>  <APPLICANTS>  (74) 
Orphan Europe

>  <USAN_STEM>  (74) 
nan

>  <USAN_STEM_DEFINITION>  (74) 
nan

>  <USAN_STEM_SUBSTEM>  (74) 
nan

>  <USAN_YEAR>  (74) 
2009.0

>  <FIRST_APPROVAL>  (74) 
2010.0

>  <ATC_CODE>  (74) 
A16AA05

>  <ATC_CODE_DESCRIPTION>  (74) 
A16AA05 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Amino acids and derivatives]

>  <INDICATION_CLASS>  (74) 
nan

>  <SC_PATENT_NO>  (74) 
nan

>  <DRUG_TYPE>  (74) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (74) 
Y

>  <FIRST_IN_CLASS>  (74) 
Y

>  <CHIRALITY>  (74) 
Single Stereoisomer

>  <PRODRUG>  (74) 
N

>  <ORAL>  (74) 
Y

>  <PARENTERAL>  (74) 
N

>  <TOPICAL>  (74) 
N

>  <BLACK_BOX>  (74) 
N

>  <AVAILABILITY_TYPE>  (74) 
Prescription-only

>  <WITHDRAWN_YEAR>  (74) 
nan

>  <WITHDRAWN_COUNTRY>  (74) 
nan

>  <WITHDRAWN_REASON>  (74) 
nan

>  <CANONICAL_SMILES>  (74) 
NC(=O)N[C@@H](CCC(=O)O)C(=O)O

>  <name>  (74) 
Carglumic acid 

>  <MW>  (74) 
190.155

>  <logP>  (74) 
-1.0273

$$$$
CHEMBL105
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 10 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 19 24  1  0
  8  3  1  0
 11  3  1  0
  6  4  1  0
 22  9  1  0
M  END
>  <PARENT_MOLREGNO>  (75) 
13590

>  <SYNONYMS>  (75) 
Mitomycin (BAN, FDA, INN, USAN, USP); Mitomycin C (JAN)

>  <DEVELOPMENT_PHASE>  (75) 
4

>  <RESEARCH_CODES>  (75) 
NSC-26980

>  <APPLICANTS>  (75) 
Supergen Inc; Mobius Therapeutics Llc; Bristol Laboratories Inc Div Bristol Myers Co

>  <USAN_STEM>  (75) 
-mycin

>  <USAN_STEM_DEFINITION>  (75) 
antibiotics (Streptomyces strains)

>  <USAN_STEM_SUBSTEM>  (75) 
-mycin

>  <USAN_YEAR>  (75) 
1972.0

>  <FIRST_APPROVAL>  (75) 
1981.0

>  <ATC_CODE>  (75) 
L01DC03

>  <ATC_CODE_DESCRIPTION>  (75) 
L01DC03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Cytotoxic Antibiotics And Related Substances:Other cytotoxic antibiotics]

>  <INDICATION_CLASS>  (75) 
Antineoplastic

>  <SC_PATENT_NO>  (75) 
US-7806265-B2

>  <DRUG_TYPE>  (75) 
Natural Product-derived

>  <RULE_OF_FIVE>  (75) 
Y

>  <FIRST_IN_CLASS>  (75) 
N

>  <CHIRALITY>  (75) 
Single Stereoisomer

>  <PRODRUG>  (75) 
N

>  <ORAL>  (75) 
N

>  <PARENTERAL>  (75) 
Y

>  <TOPICAL>  (75) 
Y

>  <BLACK_BOX>  (75) 
Y

>  <AVAILABILITY_TYPE>  (75) 
Prescription-only

>  <WITHDRAWN_YEAR>  (75) 
nan

>  <WITHDRAWN_COUNTRY>  (75) 
nan

>  <WITHDRAWN_REASON>  (75) 
nan

>  <CANONICAL_SMILES>  (75) 
CO[C@]12[C@H]3N[C@H]3CN1C4=C([C@H]2COC(=O)N)C(=O)C(=C(C)C4=O)N

>  <name>  (75) 
Mitomycin 

>  <MW>  (75) 
334.332

>  <logP>  (75) 
-1.6512

$$$$
CHEMBL1908906
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 12 23  1  0
 23 24  2  0
  6 25  1  0
 25 26  2  0
 26  3  1  0
 24  9  1  0
M  END
>  <PARENT_MOLREGNO>  (76) 
1248825

>  <SYNONYMS>  (76) 
Florbetaben F-18 (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (76) 
4

>  <RESEARCH_CODES>  (76) 
BAY-949172; UNII-TLA7312TOI

>  <APPLICANTS>  (76) 
Piramal Imaging Sa

>  <USAN_STEM>  (76) 
nan

>  <USAN_STEM_DEFINITION>  (76) 
nan

>  <USAN_STEM_SUBSTEM>  (76) 
nan

>  <USAN_YEAR>  (76) 
2013.0

>  <FIRST_APPROVAL>  (76) 
2014.0

>  <ATC_CODE>  (76) 
V09AX06

>  <ATC_CODE_DESCRIPTION>  (76) 
V09AX06 [Various:Diagnostic Radiopharmaceuticals:Central Nervous System:Other central nervous system diagnostic radiopharmaceuticals]

>  <INDICATION_CLASS>  (76) 
nan

>  <SC_PATENT_NO>  (76) 
US-7807135-B2

>  <DRUG_TYPE>  (76) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (76) 
Y

>  <FIRST_IN_CLASS>  (76) 
N

>  <CHIRALITY>  (76) 
Achiral Molecule

>  <PRODRUG>  (76) 
N

>  <ORAL>  (76) 
N

>  <PARENTERAL>  (76) 
Y

>  <TOPICAL>  (76) 
N

>  <BLACK_BOX>  (76) 
N

>  <AVAILABILITY_TYPE>  (76) 
Prescription-only

>  <WITHDRAWN_YEAR>  (76) 
nan

>  <WITHDRAWN_COUNTRY>  (76) 
nan

>  <WITHDRAWN_REASON>  (76) 
nan

>  <CANONICAL_SMILES>  (76) 
CNc1ccc(\C=C\c2ccc(OCCOCCOCCF)cc2)cc1

>  <name>  (76) 
Florbetaben F-18 

>  <MW>  (76) 
359.441

>  <logP>  (76) 
4.2802

$$$$
CHEMBL1070
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
  8 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  3  1  0
 16  6  1  0
M  END
>  <PARENT_MOLREGNO>  (77) 
139210

>  <SYNONYMS>  (77) 
Nabumetone (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (77) 
4

>  <RESEARCH_CODES>  (77) 
BRL-14777

>  <APPLICANTS>  (77) 
SmithKline Beecham Corp Dba GlaxoSmithKline

>  <USAN_STEM>  (77) 
nan

>  <USAN_STEM_DEFINITION>  (77) 
nan

>  <USAN_STEM_SUBSTEM>  (77) 
nan

>  <USAN_YEAR>  (77) 
1986.0

>  <FIRST_APPROVAL>  (77) 
1991.0

>  <ATC_CODE>  (77) 
M01AX01

>  <ATC_CODE_DESCRIPTION>  (77) 
M01AX01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Other antiinflammatory and antirheumatic agents, non-steroids]

>  <INDICATION_CLASS>  (77) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (77) 
nan

>  <DRUG_TYPE>  (77) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (77) 
Y

>  <FIRST_IN_CLASS>  (77) 
N

>  <CHIRALITY>  (77) 
Achiral Molecule

>  <PRODRUG>  (77) 
Y

>  <ORAL>  (77) 
Y

>  <PARENTERAL>  (77) 
N

>  <TOPICAL>  (77) 
N

>  <BLACK_BOX>  (77) 
Y

>  <AVAILABILITY_TYPE>  (77) 
Prescription-only

>  <WITHDRAWN_YEAR>  (77) 
nan

>  <WITHDRAWN_COUNTRY>  (77) 
nan

>  <WITHDRAWN_REASON>  (77) 
nan

>  <CANONICAL_SMILES>  (77) 
COc1ccc2cc(CCC(=O)C)ccc2c1

>  <name>  (77) 
Nabumetone 

>  <MW>  (77) 
228.291

>  <logP>  (77) 
3.37

$$$$
CHEMBL1200562
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
  8 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 27  8  1  0
 27 11  1  0
 23 12  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (78) 
674513

>  <SYNONYMS>  (78) 
Hydrocortisone Valerate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (78) 
4

>  <RESEARCH_CODES>  (78) 
nan

>  <APPLICANTS>  (78) 
Ranbaxy Laboratories Inc

>  <USAN_STEM>  (78) 
-cort-

>  <USAN_STEM_DEFINITION>  (78) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (78) 
-cort-

>  <USAN_YEAR>  (78) 
1977.0

>  <FIRST_APPROVAL>  (78) 
1978.0

>  <ATC_CODE>  (78) 
D07AA02; S01CB03; D07XA01; C05AA01; A07EA02; A01AC03; H02AB09; S01BA02; S02BA01

>  <ATC_CODE_DESCRIPTION>  (78) 
D07AA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; S01CB03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; D07XA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; C05AA01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; A01AC03 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; H02AB09 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA01 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (78) 
Glucocorticoid

>  <SC_PATENT_NO>  (78) 
nan

>  <DRUG_TYPE>  (78) 
Natural Product-derived

>  <RULE_OF_FIVE>  (78) 
Y

>  <FIRST_IN_CLASS>  (78) 
N

>  <CHIRALITY>  (78) 
Single Stereoisomer

>  <PRODRUG>  (78) 
Y

>  <ORAL>  (78) 
N

>  <PARENTERAL>  (78) 
N

>  <TOPICAL>  (78) 
Y

>  <BLACK_BOX>  (78) 
N

>  <AVAILABILITY_TYPE>  (78) 
Prescription-only

>  <WITHDRAWN_YEAR>  (78) 
nan

>  <WITHDRAWN_COUNTRY>  (78) 
nan

>  <WITHDRAWN_REASON>  (78) 
nan

>  <CANONICAL_SMILES>  (78) 
CCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO

>  <name>  (78) 
Hydrocortisone Valerate 

>  <MW>  (78) 
446.584

>  <logP>  (78) 
3.5227

$$$$
CHEMBL700
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  7  2  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (79) 
32842

>  <SYNONYMS>  (79) 
Sulfapyridine (BAN, FDA, INN, USP); Sulfapyridine Sodium (MI, NF)

>  <DEVELOPMENT_PHASE>  (79) 
4

>  <RESEARCH_CODES>  (79) 
nan

>  <APPLICANTS>  (79) 
Eli Lilly And Co

>  <USAN_STEM>  (79) 
sulfa-

>  <USAN_STEM_DEFINITION>  (79) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (79) 
sulfa-

>  <USAN_YEAR>  (79) 
nan

>  <FIRST_APPROVAL>  (79) 
1939.0

>  <ATC_CODE>  (79) 
J01EB04

>  <ATC_CODE_DESCRIPTION>  (79) 
J01EB04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]

>  <INDICATION_CLASS>  (79) 
Suppressant (dermatitis herpetiformis)

>  <SC_PATENT_NO>  (79) 
nan

>  <DRUG_TYPE>  (79) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (79) 
Y

>  <FIRST_IN_CLASS>  (79) 
N

>  <CHIRALITY>  (79) 
Achiral Molecule

>  <PRODRUG>  (79) 
N

>  <ORAL>  (79) 
Y

>  <PARENTERAL>  (79) 
N

>  <TOPICAL>  (79) 
N

>  <BLACK_BOX>  (79) 
N

>  <AVAILABILITY_TYPE>  (79) 
Discontinued

>  <WITHDRAWN_YEAR>  (79) 
nan

>  <WITHDRAWN_COUNTRY>  (79) 
nan

>  <WITHDRAWN_REASON>  (79) 
nan

>  <CANONICAL_SMILES>  (79) 
Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2

>  <name>  (79) 
Sulfapyridine 

>  <MW>  (79) 
249.295

>  <logP>  (79) 
1.4646

$$$$
CHEMBL1200438
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  6 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  5 21  1  0
 21 22  1  0
 21 23  2  0
 23  2  1  0
 12  8  1  0
 19 15  2  0
M  END
>  <PARENT_MOLREGNO>  (80) 
674389

>  <SYNONYMS>  (80) 
Tioconazole (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (80) 
4

>  <RESEARCH_CODES>  (80) 
UK-20349

>  <APPLICANTS>  (80) 
Pfizer Laboratories Div Pfizer Inc; Novartis Consumer Health Inc

>  <USAN_STEM>  (80) 
-conazole

>  <USAN_STEM_DEFINITION>  (80) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (80) 
-conazole

>  <USAN_YEAR>  (80) 
1978.0

>  <FIRST_APPROVAL>  (80) 
1983.0

>  <ATC_CODE>  (80) 
D01AC07; G01AF08

>  <ATC_CODE_DESCRIPTION>  (80) 
D01AC07 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Imidazole and triazole derivatives]; G01AF08 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Imidazole derivatives]

>  <INDICATION_CLASS>  (80) 
Antifungal

>  <SC_PATENT_NO>  (80) 
nan

>  <DRUG_TYPE>  (80) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (80) 
Y

>  <FIRST_IN_CLASS>  (80) 
N

>  <CHIRALITY>  (80) 
Racemic Mixture

>  <PRODRUG>  (80) 
N

>  <ORAL>  (80) 
N

>  <PARENTERAL>  (80) 
N

>  <TOPICAL>  (80) 
Y

>  <BLACK_BOX>  (80) 
N

>  <AVAILABILITY_TYPE>  (80) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (80) 
nan

>  <WITHDRAWN_COUNTRY>  (80) 
nan

>  <WITHDRAWN_REASON>  (80) 
nan

>  <CANONICAL_SMILES>  (80) 
Clc1ccc(C(Cn2ccnc2)OCc3ccsc3Cl)c(Cl)c1

>  <name>  (80) 
Tioconazole 

>  <MW>  (80) 
387.719

>  <logP>  (80) 
5.8629

$$$$
CHEMBL125
     RDKit          

 27 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 18 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  CHG  2  20  -1  24   1
M  END
>  <PARENT_MOLREGNO>  (81) 
25047

>  <SYNONYMS>  (81) 
Miltefosine (BAN, FDA, INN)

>  <DEVELOPMENT_PHASE>  (81) 
4

>  <RESEARCH_CODES>  (81) 
D-18506; HDPC

>  <APPLICANTS>  (81) 
Paladin Therapeutics Inc

>  <USAN_STEM>  (81) 
-fo-

>  <USAN_STEM_DEFINITION>  (81) 
phosphoro-derivatives

>  <USAN_STEM_SUBSTEM>  (81) 
-fo-

>  <USAN_YEAR>  (81) 
nan

>  <FIRST_APPROVAL>  (81) 
2014.0

>  <ATC_CODE>  (81) 
L01XX09

>  <ATC_CODE_DESCRIPTION>  (81) 
L01XX09 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (81) 
nan

>  <SC_PATENT_NO>  (81) 
nan

>  <DRUG_TYPE>  (81) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (81) 
Y

>  <FIRST_IN_CLASS>  (81) 
Y

>  <CHIRALITY>  (81) 
Racemic Mixture

>  <PRODRUG>  (81) 
N

>  <ORAL>  (81) 
Y

>  <PARENTERAL>  (81) 
N

>  <TOPICAL>  (81) 
N

>  <BLACK_BOX>  (81) 
N

>  <AVAILABILITY_TYPE>  (81) 
Prescription-only

>  <WITHDRAWN_YEAR>  (81) 
nan

>  <WITHDRAWN_COUNTRY>  (81) 
nan

>  <WITHDRAWN_REASON>  (81) 
nan

>  <CANONICAL_SMILES>  (81) 
CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C

>  <name>  (81) 
Miltefosine 

>  <MW>  (81) 
407.576

>  <logP>  (81) 
5.6755

$$$$
CHEMBL461522
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  2  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 14  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (82) 
453508

>  <SYNONYMS>  (82) 
Dipyrone (BAN, USAN); Metamizole Sodium (INN); Noramidopyrine Methanesulfonate Sodium (DCF); Sulpyrine (JAN)

>  <DEVELOPMENT_PHASE>  (82) 
4

>  <RESEARCH_CODES>  (82) 
nan

>  <APPLICANTS>  (82) 
Sterling Winthrop; Farmitalia, Societa Farmaceutici Italia, Italy

>  <USAN_STEM>  (82) 
nan

>  <USAN_STEM_DEFINITION>  (82) 
nan

>  <USAN_STEM_SUBSTEM>  (82) 
nan

>  <USAN_YEAR>  (82) 
1962.0

>  <FIRST_APPROVAL>  (82) 
nan

>  <ATC_CODE>  (82) 
N02BB52; N02BB72; N02BB02

>  <ATC_CODE_DESCRIPTION>  (82) 
N02BB52 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Pyrazolones]; N02BB72 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Pyrazolones]; N02BB02 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Pyrazolones]

>  <INDICATION_CLASS>  (82) 
Analgesic; Antipyretic

>  <SC_PATENT_NO>  (82) 
nan

>  <DRUG_TYPE>  (82) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (82) 
Y

>  <FIRST_IN_CLASS>  (82) 
N

>  <CHIRALITY>  (82) 
Achiral Molecule

>  <PRODRUG>  (82) 
N

>  <ORAL>  (82) 
N

>  <PARENTERAL>  (82) 
N

>  <TOPICAL>  (82) 
N

>  <BLACK_BOX>  (82) 
N

>  <AVAILABILITY_TYPE>  (82) 
Withdrawn

>  <WITHDRAWN_YEAR>  (82) 
1975.0

>  <WITHDRAWN_COUNTRY>  (82) 
United Kingdom; United States; Grecia; Suecia; Nepal; Zimbabwe; Yemen

>  <WITHDRAWN_REASON>  (82) 
Agranulocytosis; Anaphylactic Reaction

>  <CANONICAL_SMILES>  (82) 
CN(CS(=O)(=O)O)C1=C(C)N(C)N(C1=O)c2ccccc2

>  <name>  (82) 
Dipyrone 

>  <MW>  (82) 
311.363

>  <logP>  (82) 
0.76592

$$$$
CHEMBL19019
     RDKit          

 25 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 16 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 18  2  1  0
 19  5  1  0
 24  7  1  0
 12 10  1  0
 19 15  1  0
 24 15  1  0
M  END
>  <PARENT_MOLREGNO>  (83) 
21459

>  <SYNONYMS>  (83) 
Naltrexone (BAN, FDA, INN, USAN); Naltrexone HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (83) 
4

>  <RESEARCH_CODES>  (83) 
EN-1639A; EN-1639A [As Hydrochloride]

>  <APPLICANTS>  (83) 
Duramed Pharmaceuticals Inc; Alpharma Pharmaceuticals Llc King Pharmaceuticals; Alkermes Inc

>  <USAN_STEM>  (83) 
nal-

>  <USAN_STEM_DEFINITION>  (83) 
narcotic agonists/antagonists (normorphine type)

>  <USAN_STEM_SUBSTEM>  (83) 
nal-

>  <USAN_YEAR>  (83) 
1973.0

>  <FIRST_APPROVAL>  (83) 
1984.0

>  <ATC_CODE>  (83) 
N07BB04

>  <ATC_CODE_DESCRIPTION>  (83) 
N07BB04 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in alcohol dependence]

>  <INDICATION_CLASS>  (83) 
Antagonist (to narcotics)

>  <SC_PATENT_NO>  (83) 
US-5792477-A

>  <DRUG_TYPE>  (83) 
Natural Product-derived

>  <RULE_OF_FIVE>  (83) 
Y

>  <FIRST_IN_CLASS>  (83) 
N

>  <CHIRALITY>  (83) 
Single Stereoisomer

>  <PRODRUG>  (83) 
N

>  <ORAL>  (83) 
Y

>  <PARENTERAL>  (83) 
Y

>  <TOPICAL>  (83) 
N

>  <BLACK_BOX>  (83) 
Y

>  <AVAILABILITY_TYPE>  (83) 
Prescription-only

>  <WITHDRAWN_YEAR>  (83) 
nan

>  <WITHDRAWN_COUNTRY>  (83) 
nan

>  <WITHDRAWN_REASON>  (83) 
nan

>  <CANONICAL_SMILES>  (83) 
Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O

>  <name>  (83) 
Naltrexone 

>  <MW>  (83) 
341.407

>  <logP>  (83) 
1.5254

$$$$
CHEMBL641
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  5 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 12  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (84) 
27342

>  <SYNONYMS>  (84) 
Atomoxetine (BAN, INN); Atomoxetine HCl (FDA, USAN); Tomoxetine (INN)

>  <DEVELOPMENT_PHASE>  (84) 
4

>  <RESEARCH_CODES>  (84) 
LY-139603

>  <APPLICANTS>  (84) 
Eli Lilly And Co

>  <USAN_STEM>  (84) 
-oxetine

>  <USAN_STEM_DEFINITION>  (84) 
antidepressants (fluoxetine type)

>  <USAN_STEM_SUBSTEM>  (84) 
-oxetine

>  <USAN_YEAR>  (84) 
2001.0

>  <FIRST_APPROVAL>  (84) 
2002.0

>  <ATC_CODE>  (84) 
N06BA09

>  <ATC_CODE_DESCRIPTION>  (84) 
N06BA09 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (84) 
nan

>  <SC_PATENT_NO>  (84) 
US-5658590-A

>  <DRUG_TYPE>  (84) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (84) 
Y

>  <FIRST_IN_CLASS>  (84) 
N

>  <CHIRALITY>  (84) 
Single Stereoisomer

>  <PRODRUG>  (84) 
N

>  <ORAL>  (84) 
Y

>  <PARENTERAL>  (84) 
N

>  <TOPICAL>  (84) 
N

>  <BLACK_BOX>  (84) 
Y

>  <AVAILABILITY_TYPE>  (84) 
Prescription-only

>  <WITHDRAWN_YEAR>  (84) 
nan

>  <WITHDRAWN_COUNTRY>  (84) 
nan

>  <WITHDRAWN_REASON>  (84) 
nan

>  <CANONICAL_SMILES>  (84) 
CNCC[C@@H](Oc1ccccc1C)c2ccccc2

>  <name>  (84) 
Atomoxetine 

>  <MW>  (84) 
255.361

>  <logP>  (84) 
3.72462

$$$$
CHEMBL1201201
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (85) 
675152

>  <SYNONYMS>  (85) 
Metamfetamine (INN); Methamphetamine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (85) 
4

>  <RESEARCH_CODES>  (85) 
nan

>  <APPLICANTS>  (85) 
Lundbeck Inc

>  <USAN_STEM>  (85) 
nan

>  <USAN_STEM_DEFINITION>  (85) 
nan

>  <USAN_STEM_SUBSTEM>  (85) 
nan

>  <USAN_YEAR>  (85) 
nan

>  <FIRST_APPROVAL>  (85) 
1943.0

>  <ATC_CODE>  (85) 
N06BA03

>  <ATC_CODE_DESCRIPTION>  (85) 
N06BA03 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (85) 
Stimulant (central)

>  <SC_PATENT_NO>  (85) 
nan

>  <DRUG_TYPE>  (85) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (85) 
Y

>  <FIRST_IN_CLASS>  (85) 
N

>  <CHIRALITY>  (85) 
Single Stereoisomer

>  <PRODRUG>  (85) 
N

>  <ORAL>  (85) 
Y

>  <PARENTERAL>  (85) 
N

>  <TOPICAL>  (85) 
N

>  <BLACK_BOX>  (85) 
Y

>  <AVAILABILITY_TYPE>  (85) 
Prescription-only

>  <WITHDRAWN_YEAR>  (85) 
nan

>  <WITHDRAWN_COUNTRY>  (85) 
United States

>  <WITHDRAWN_REASON>  (85) 
nan

>  <CANONICAL_SMILES>  (85) 
CN[C@@H](C)Cc1ccccc1

>  <name>  (85) 
Metamfetamine 

>  <MW>  (85) 
149.237

>  <logP>  (85) 
1.837

$$$$
CHEMBL844
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  2  1  0
  9  5  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (86) 
62817

>  <SYNONYMS>  (86) 
Brimonidine (BAN, INN); Brimonidine Tartrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (86) 
4

>  <RESEARCH_CODES>  (86) 
UK-14304; AGN-190342-LF; UK-1430418

>  <APPLICANTS>  (86) 
Allergan Inc; Allergan; Alcon Pharmaceuticals Ltd

>  <USAN_STEM>  (86) 
nan

>  <USAN_STEM_DEFINITION>  (86) 
nan

>  <USAN_STEM_SUBSTEM>  (86) 
nan

>  <USAN_YEAR>  (86) 
1991.0

>  <FIRST_APPROVAL>  (86) 
1996.0

>  <ATC_CODE>  (86) 
D11AX21; S01EA05

>  <ATC_CODE_DESCRIPTION>  (86) 
D11AX21 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]; S01EA05 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Sympathomimetics in glaucoma therapy]

>  <INDICATION_CLASS>  (86) 
Adrenergic (ophthalmic)

>  <SC_PATENT_NO>  (86) 
US-6316441-B1

>  <DRUG_TYPE>  (86) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (86) 
Y

>  <FIRST_IN_CLASS>  (86) 
N

>  <CHIRALITY>  (86) 
Achiral Molecule

>  <PRODRUG>  (86) 
N

>  <ORAL>  (86) 
N

>  <PARENTERAL>  (86) 
N

>  <TOPICAL>  (86) 
Y

>  <BLACK_BOX>  (86) 
N

>  <AVAILABILITY_TYPE>  (86) 
Prescription-only

>  <WITHDRAWN_YEAR>  (86) 
nan

>  <WITHDRAWN_COUNTRY>  (86) 
nan

>  <WITHDRAWN_REASON>  (86) 
nan

>  <CANONICAL_SMILES>  (86) 
Brc1c(NC2=NCCN2)ccc3nccnc13

>  <name>  (86) 
Brimonidine 

>  <MW>  (86) 
292.14

>  <logP>  (86) 
1.7634

$$$$
CHEMBL1396
     RDKit          

 16 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  6  1  1  0
 16  4  1  0
 16  7  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (87) 
330452

>  <SYNONYMS>  (87) 
Varenicline (INN); Varenicline Tartrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (87) 
4

>  <RESEARCH_CODES>  (87) 
CP-526555-18

>  <APPLICANTS>  (87) 
Pfizer Inc.

>  <USAN_STEM>  (87) 
-nicline

>  <USAN_STEM_DEFINITION>  (87) 
nicotinic acetylcholine receptor partial agonists/agonists

>  <USAN_STEM_SUBSTEM>  (87) 
-nicline

>  <USAN_YEAR>  (87) 
2003.0

>  <FIRST_APPROVAL>  (87) 
2006.0

>  <ATC_CODE>  (87) 
N07BA03

>  <ATC_CODE_DESCRIPTION>  (87) 
N07BA03 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in nicotine dependence]

>  <INDICATION_CLASS>  (87) 
nan

>  <SC_PATENT_NO>  (87) 
US-6410550-B1

>  <DRUG_TYPE>  (87) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (87) 
Y

>  <FIRST_IN_CLASS>  (87) 
N

>  <CHIRALITY>  (87) 
Racemic Mixture

>  <PRODRUG>  (87) 
N

>  <ORAL>  (87) 
Y

>  <PARENTERAL>  (87) 
N

>  <TOPICAL>  (87) 
N

>  <BLACK_BOX>  (87) 
Y

>  <AVAILABILITY_TYPE>  (87) 
Prescription-only

>  <WITHDRAWN_YEAR>  (87) 
nan

>  <WITHDRAWN_COUNTRY>  (87) 
nan

>  <WITHDRAWN_REASON>  (87) 
nan

>  <CANONICAL_SMILES>  (87) 
C1NCC2CC1c3cc4nccnc4cc23

>  <name>  (87) 
Varenicline 

>  <MW>  (87) 
211.268

>  <logP>  (87) 
1.8039

$$$$
CHEMBL3707254
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
  6 18  2  0
 18 19  1  0
 19  4  2  0
 16 11  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (88) 
2039225

>  <SYNONYMS>  (88) 
Furazidin

>  <DEVELOPMENT_PHASE>  (88) 
4

>  <RESEARCH_CODES>  (88) 
nan

>  <APPLICANTS>  (88) 
nan

>  <USAN_STEM>  (88) 
nan

>  <USAN_STEM_DEFINITION>  (88) 
nan

>  <USAN_STEM_SUBSTEM>  (88) 
nan

>  <USAN_YEAR>  (88) 
nan

>  <FIRST_APPROVAL>  (88) 
nan

>  <ATC_CODE>  (88) 
J01XE03

>  <ATC_CODE_DESCRIPTION>  (88) 
J01XE03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Nitrofuran derivatives]

>  <INDICATION_CLASS>  (88) 
nan

>  <SC_PATENT_NO>  (88) 
nan

>  <DRUG_TYPE>  (88) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (88) 
Y

>  <FIRST_IN_CLASS>  (88) 
N

>  <CHIRALITY>  (88) 
Achiral Molecule

>  <PRODRUG>  (88) 
N

>  <ORAL>  (88) 
N

>  <PARENTERAL>  (88) 
N

>  <TOPICAL>  (88) 
N

>  <BLACK_BOX>  (88) 
N

>  <AVAILABILITY_TYPE>  (88) 
Unknown

>  <WITHDRAWN_YEAR>  (88) 
nan

>  <WITHDRAWN_COUNTRY>  (88) 
nan

>  <WITHDRAWN_REASON>  (88) 
nan

>  <CANONICAL_SMILES>  (88) 
[O-][N+](=O)c1oc(\C=C\C=N\N2CC(=O)NC2=O)cc1

>  <name>  (88) 
Furazidin

>  <MW>  (88) 
264.197

>  <logP>  (88) 
0.7386

$$$$
CHEMBL3707370
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11  3  1  0
M  END
>  <PARENT_MOLREGNO>  (89) 
2039341

>  <SYNONYMS>  (89) 
Piperidione

>  <DEVELOPMENT_PHASE>  (89) 
4

>  <RESEARCH_CODES>  (89) 
nan

>  <APPLICANTS>  (89) 
nan

>  <USAN_STEM>  (89) 
nan

>  <USAN_STEM_DEFINITION>  (89) 
nan

>  <USAN_STEM_SUBSTEM>  (89) 
nan

>  <USAN_YEAR>  (89) 
nan

>  <FIRST_APPROVAL>  (89) 
nan

>  <ATC_CODE>  (89) 
R05DB23

>  <ATC_CODE_DESCRIPTION>  (89) 
R05DB23 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Other cough suppressants]

>  <INDICATION_CLASS>  (89) 
nan

>  <SC_PATENT_NO>  (89) 
nan

>  <DRUG_TYPE>  (89) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (89) 
Y

>  <FIRST_IN_CLASS>  (89) 
N

>  <CHIRALITY>  (89) 
Achiral Molecule

>  <PRODRUG>  (89) 
N

>  <ORAL>  (89) 
N

>  <PARENTERAL>  (89) 
N

>  <TOPICAL>  (89) 
N

>  <BLACK_BOX>  (89) 
N

>  <AVAILABILITY_TYPE>  (89) 
Unknown

>  <WITHDRAWN_YEAR>  (89) 
nan

>  <WITHDRAWN_COUNTRY>  (89) 
nan

>  <WITHDRAWN_REASON>  (89) 
nan

>  <CANONICAL_SMILES>  (89) 
CCC1(CC)C(=O)CCNC1=O

>  <name>  (89) 
Piperidione

>  <MW>  (89) 
169.224

>  <logP>  (89) 
0.8818

$$$$
CHEMBL52440
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 14 19  1  0
 19 20  2  0
 20  3  1  0
 19  6  1  0
 17  8  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (90) 
77456

>  <SYNONYMS>  (90) 
Dextromethorphan (BAN, INN, USP); Dextromethorphan Polistirex (FDA, USAN); Dextromethorphan Hydrobromide (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (90) 
4

>  <RESEARCH_CODES>  (90) 
nan

>  <APPLICANTS>  (90) 
Reckitt Benckiser Llc; Avanir Pharmaceuticals Inc; Ani Pharmaceuticals Inc; Ah Robins Co

>  <USAN_STEM>  (90) 
-orphan

>  <USAN_STEM_DEFINITION>  (90) 
narcotic antagonists/agonists (morphinan derivatives)

>  <USAN_STEM_SUBSTEM>  (90) 
-orphan

>  <USAN_YEAR>  (90) 
1987.0

>  <FIRST_APPROVAL>  (90) 
1982.0

>  <ATC_CODE>  (90) 
R05DA09; N07XX59

>  <ATC_CODE_DESCRIPTION>  (90) 
R05DA09 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Opium alkaloids and derivatives]; N07XX59 [Nervous System:Other Nervous System Drugs:Other Nervous System Drugs:Other nervous system drugs]

>  <INDICATION_CLASS>  (90) 
Antitussive

>  <SC_PATENT_NO>  (90) 
US-5980882-A

>  <DRUG_TYPE>  (90) 
Polymer

>  <RULE_OF_FIVE>  (90) 
Y

>  <FIRST_IN_CLASS>  (90) 
N

>  <CHIRALITY>  (90) 
Single Stereoisomer

>  <PRODRUG>  (90) 
N

>  <ORAL>  (90) 
Y

>  <PARENTERAL>  (90) 
N

>  <TOPICAL>  (90) 
N

>  <BLACK_BOX>  (90) 
N

>  <AVAILABILITY_TYPE>  (90) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (90) 
nan

>  <WITHDRAWN_COUNTRY>  (90) 
nan

>  <WITHDRAWN_REASON>  (90) 
nan

>  <CANONICAL_SMILES>  (90) 
COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1

>  <name>  (90) 
Dextromethorphan 

>  <MW>  (90) 
271.404

>  <logP>  (90) 
3.3834

$$$$
CHEMBL1201210
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 16 23  1  0
 23 24  2  0
 24  5  1  0
 23  8  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (91) 
675161

>  <SYNONYMS>  (91) 
Propiomazine (BAN, INN, USAN); Propiomazine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (91) 
4

>  <RESEARCH_CODES>  (91) 
CB-1678; WY-1359

>  <APPLICANTS>  (91) 
Baxter Healthcare Corp Anesthesia Critical Care

>  <USAN_STEM>  (91) 
nan

>  <USAN_STEM_DEFINITION>  (91) 
nan

>  <USAN_STEM_SUBSTEM>  (91) 
nan

>  <USAN_YEAR>  (91) 
1962.0

>  <FIRST_APPROVAL>  (91) 
1960.0

>  <ATC_CODE>  (91) 
N05CM06

>  <ATC_CODE_DESCRIPTION>  (91) 
N05CM06 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]

>  <INDICATION_CLASS>  (91) 
Sedative (pre-anesthetic)

>  <SC_PATENT_NO>  (91) 
nan

>  <DRUG_TYPE>  (91) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (91) 
Y

>  <FIRST_IN_CLASS>  (91) 
N

>  <CHIRALITY>  (91) 
Racemic Mixture

>  <PRODRUG>  (91) 
N

>  <ORAL>  (91) 
N

>  <PARENTERAL>  (91) 
Y

>  <TOPICAL>  (91) 
N

>  <BLACK_BOX>  (91) 
N

>  <AVAILABILITY_TYPE>  (91) 
Discontinued

>  <WITHDRAWN_YEAR>  (91) 
nan

>  <WITHDRAWN_COUNTRY>  (91) 
nan

>  <WITHDRAWN_REASON>  (91) 
nan

>  <CANONICAL_SMILES>  (91) 
CCC(=O)c1ccc2Sc3ccccc3N(CC(C)N(C)C)c2c1

>  <name>  (91) 
Propiomazine 

>  <MW>  (91) 
340.492

>  <logP>  (91) 
4.8321

$$$$
CHEMBL109
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (92) 
15217

>  <SYNONYMS>  (92) 
Valproic acid (BAN, FDA, INN, USAN, USP); Sodium Valproate (JAN); Valproate Sodium (FDA, USAN); Divalproex Sodium (FDA, USAN, USP); Semisodium Valproate (BAN); Valproate Semisodium (INN)

>  <DEVELOPMENT_PHASE>  (92) 
4

>  <RESEARCH_CODES>  (92) 
44089; A-44090; ABBOTT 44090; ABBOTT-50711

>  <APPLICANTS>  (92) 
Banner Pharmacaps Inc; Abbvie Inc; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (92) 
nan

>  <USAN_STEM_DEFINITION>  (92) 
nan

>  <USAN_STEM_SUBSTEM>  (92) 
nan

>  <USAN_YEAR>  (92) 
1975.0

>  <FIRST_APPROVAL>  (92) 
1978.0

>  <ATC_CODE>  (92) 
N03AG01

>  <ATC_CODE_DESCRIPTION>  (92) 
N03AG01 [Nervous System:Antiepileptics:Antiepileptics:Fatty acid derivatives]

>  <INDICATION_CLASS>  (92) 
Anticonvulsant

>  <SC_PATENT_NO>  (92) 
US-6419953-B1

>  <DRUG_TYPE>  (92) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (92) 
Y

>  <FIRST_IN_CLASS>  (92) 
N

>  <CHIRALITY>  (92) 
Achiral Molecule

>  <PRODRUG>  (92) 
N

>  <ORAL>  (92) 
Y

>  <PARENTERAL>  (92) 
Y

>  <TOPICAL>  (92) 
N

>  <BLACK_BOX>  (92) 
Y

>  <AVAILABILITY_TYPE>  (92) 
Prescription-only

>  <WITHDRAWN_YEAR>  (92) 
nan

>  <WITHDRAWN_COUNTRY>  (92) 
nan

>  <WITHDRAWN_REASON>  (92) 
nan

>  <CANONICAL_SMILES>  (92) 
CCCC(CCC)C(=O)O

>  <name>  (92) 
Valproic acid 

>  <MW>  (92) 
144.214

>  <logP>  (92) 
2.2874

$$$$
CHEMBL545
     RDKit          

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
M  END
>  <PARENT_MOLREGNO>  (93) 
13618

>  <SYNONYMS>  (93) 
Alcohol (FDA, USP); Alcohol, Diluted (NF); Alcohol, Rubbing (INN); Ethanol (JAN)

>  <DEVELOPMENT_PHASE>  (93) 
4

>  <RESEARCH_CODES>  (93) 
nan

>  <APPLICANTS>  (93) 
B Braun Medical Inc; 3m Health Care Inc

>  <USAN_STEM>  (93) 
nan

>  <USAN_STEM_DEFINITION>  (93) 
nan

>  <USAN_STEM_SUBSTEM>  (93) 
nan

>  <USAN_YEAR>  (93) 
nan

>  <FIRST_APPROVAL>  (93) 
nan

>  <ATC_CODE>  (93) 
V03AB16; V03AZ01; D08AX08

>  <ATC_CODE_DESCRIPTION>  (93) 
V03AB16 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]; V03AZ01 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Nerve depressants]; D08AX08 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Other antiseptics and disinfectants]

>  <INDICATION_CLASS>  (93) 
Anti-Infective, Topical; Pharmaceutic Aid (solvent)

>  <SC_PATENT_NO>  (93) 
US-5897031-A

>  <DRUG_TYPE>  (93) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (93) 
Y

>  <FIRST_IN_CLASS>  (93) 
N

>  <CHIRALITY>  (93) 
Achiral Molecule

>  <PRODRUG>  (93) 
N

>  <ORAL>  (93) 
N

>  <PARENTERAL>  (93) 
Y

>  <TOPICAL>  (93) 
Y

>  <BLACK_BOX>  (93) 
N

>  <AVAILABILITY_TYPE>  (93) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (93) 
nan

>  <WITHDRAWN_COUNTRY>  (93) 
nan

>  <WITHDRAWN_REASON>  (93) 
nan

>  <CANONICAL_SMILES>  (93) 
CCO

>  <name>  (93) 
Alcohol 

>  <MW>  (93) 
46.069

>  <logP>  (93) 
-0.0014

$$$$
CHEMBL1341
     RDKit          

  8  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  1  0
  6  8  1  0
M  END
>  <PARENT_MOLREGNO>  (94) 
284208

>  <SYNONYMS>  (94) 
Methoxiflurane (FDA); Methoxyflurane (BAN, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (94) 
4

>  <RESEARCH_CODES>  (94) 
nan

>  <APPLICANTS>  (94) 
Abbott

>  <USAN_STEM>  (94) 
-flurane

>  <USAN_STEM_DEFINITION>  (94) 
general inhalation anesthetics (halogenated alkane derivatives)

>  <USAN_STEM_SUBSTEM>  (94) 
-flurane

>  <USAN_YEAR>  (94) 
1962.0

>  <FIRST_APPROVAL>  (94) 
nan

>  <ATC_CODE>  (94) 
N02BG09

>  <ATC_CODE_DESCRIPTION>  (94) 
N02BG09 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Other analgesics and antipyretics]

>  <INDICATION_CLASS>  (94) 
Anesthetic (inhalation)

>  <SC_PATENT_NO>  (94) 
nan

>  <DRUG_TYPE>  (94) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (94) 
Y

>  <FIRST_IN_CLASS>  (94) 
N

>  <CHIRALITY>  (94) 
Achiral Molecule

>  <PRODRUG>  (94) 
N

>  <ORAL>  (94) 
N

>  <PARENTERAL>  (94) 
N

>  <TOPICAL>  (94) 
Y

>  <BLACK_BOX>  (94) 
N

>  <AVAILABILITY_TYPE>  (94) 
Withdrawn

>  <WITHDRAWN_YEAR>  (94) 
2001.0

>  <WITHDRAWN_COUNTRY>  (94) 
United States

>  <WITHDRAWN_REASON>  (94) 
Serious, irreversible, and even fatal nephrotoxicity and hepatotoxicity

>  <CANONICAL_SMILES>  (94) 
COC(F)(F)C(Cl)Cl

>  <name>  (94) 
Methoxiflurane 

>  <MW>  (94) 
164.966

>  <logP>  (94) 
2.0293

$$$$
CHEMBL785
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
  2 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 12  6  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (95) 
47138

>  <SYNONYMS>  (95) 
Ritodrine (BAN, INN, USAN); Ritodrine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (95) 
4

>  <RESEARCH_CODES>  (95) 
DU-21220

>  <APPLICANTS>  (95) 
Astrazeneca Lp

>  <USAN_STEM>  (95) 
nan

>  <USAN_STEM_DEFINITION>  (95) 
nan

>  <USAN_STEM_SUBSTEM>  (95) 
nan

>  <USAN_YEAR>  (95) 
1969.0

>  <FIRST_APPROVAL>  (95) 
1991.0

>  <ATC_CODE>  (95) 
G02CA01

>  <ATC_CODE_DESCRIPTION>  (95) 
G02CA01 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Other Gynecologicals:Sympathomimetics, labour repressants]

>  <INDICATION_CLASS>  (95) 
Relaxant (smooth muscle)

>  <SC_PATENT_NO>  (95) 
nan

>  <DRUG_TYPE>  (95) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (95) 
Y

>  <FIRST_IN_CLASS>  (95) 
N

>  <CHIRALITY>  (95) 
Single Stereoisomer

>  <PRODRUG>  (95) 
N

>  <ORAL>  (95) 
Y

>  <PARENTERAL>  (95) 
Y

>  <TOPICAL>  (95) 
N

>  <BLACK_BOX>  (95) 
N

>  <AVAILABILITY_TYPE>  (95) 
Discontinued

>  <WITHDRAWN_YEAR>  (95) 
nan

>  <WITHDRAWN_COUNTRY>  (95) 
nan

>  <WITHDRAWN_REASON>  (95) 
nan

>  <CANONICAL_SMILES>  (95) 
C[C@H](NCCc1ccc(O)cc1)[C@H](O)c2ccc(O)cc2

>  <name>  (95) 
Ritodrine 

>  <MW>  (95) 
287.359

>  <logP>  (95) 
2.352

$$$$
CHEMBL871
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
  8 11  1  0
M  END
>  <PARENT_MOLREGNO>  (96) 
70675

>  <SYNONYMS>  (96) 
Etidronic Acid (BAN, INN, USAN); Etidronate Disodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (96) 
4

>  <RESEARCH_CODES>  (96) 
nan

>  <APPLICANTS>  (96) 
Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co; Mgi Pharma Inc

>  <USAN_STEM>  (96) 
nan

>  <USAN_STEM_DEFINITION>  (96) 
nan

>  <USAN_STEM_SUBSTEM>  (96) 
nan

>  <USAN_YEAR>  (96) 
1970.0

>  <FIRST_APPROVAL>  (96) 
1977.0

>  <ATC_CODE>  (96) 
M05BA01

>  <ATC_CODE_DESCRIPTION>  (96) 
M05BA01 [Musculo-Skeletal System:Drugs For Treatment Of Bone Diseases:Drugs Affecting Bone Structure And Mineralization:Bisphosphonates]

>  <INDICATION_CLASS>  (96) 
Regulator (calcium); Bone Resorption Inhibitor

>  <SC_PATENT_NO>  (96) 
nan

>  <DRUG_TYPE>  (96) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (96) 
Y

>  <FIRST_IN_CLASS>  (96) 
N

>  <CHIRALITY>  (96) 
Achiral Molecule

>  <PRODRUG>  (96) 
N

>  <ORAL>  (96) 
Y

>  <PARENTERAL>  (96) 
Y

>  <TOPICAL>  (96) 
N

>  <BLACK_BOX>  (96) 
N

>  <AVAILABILITY_TYPE>  (96) 
Prescription-only

>  <WITHDRAWN_YEAR>  (96) 
nan

>  <WITHDRAWN_COUNTRY>  (96) 
nan

>  <WITHDRAWN_REASON>  (96) 
nan

>  <CANONICAL_SMILES>  (96) 
CC(O)(P(=O)(O)O)P(=O)(O)O

>  <name>  (96) 
Etidronic Acid 

>  <MW>  (96) 
206.027

>  <logP>  (96) 
-0.9922

$$$$
CHEMBL1683
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
  7 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 26  7  1  0
 26 10  1  0
 22 11  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (97) 
515027

>  <SYNONYMS>  (97) 
Hydrocortisone butyrate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (97) 
4

>  <RESEARCH_CODES>  (97) 
nan

>  <APPLICANTS>  (97) 
Yamanouchi Europe Bv; Precision Dermatology Inc

>  <USAN_STEM>  (97) 
-cort-

>  <USAN_STEM_DEFINITION>  (97) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (97) 
-cort-

>  <USAN_YEAR>  (97) 
1980.0

>  <FIRST_APPROVAL>  (97) 
1982.0

>  <ATC_CODE>  (97) 
D07AB02

>  <ATC_CODE_DESCRIPTION>  (97) 
D07AB02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (97) 
Glucocorticoid

>  <SC_PATENT_NO>  (97) 
US-7378405-B2

>  <DRUG_TYPE>  (97) 
Natural Product-derived

>  <RULE_OF_FIVE>  (97) 
Y

>  <FIRST_IN_CLASS>  (97) 
N

>  <CHIRALITY>  (97) 
Single Stereoisomer

>  <PRODRUG>  (97) 
Y

>  <ORAL>  (97) 
N

>  <PARENTERAL>  (97) 
N

>  <TOPICAL>  (97) 
Y

>  <BLACK_BOX>  (97) 
N

>  <AVAILABILITY_TYPE>  (97) 
Prescription-only

>  <WITHDRAWN_YEAR>  (97) 
nan

>  <WITHDRAWN_COUNTRY>  (97) 
nan

>  <WITHDRAWN_REASON>  (97) 
nan

>  <CANONICAL_SMILES>  (97) 
CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)CO

>  <name>  (97) 
Hydrocortisone butyrate 

>  <MW>  (97) 
432.557

>  <logP>  (97) 
3.1326

$$$$
CHEMBL112
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (98) 
16450

>  <SYNONYMS>  (98) 
Acetaminophen (FDA, JAN, USP); Paracetamol (BAN, DCF, INN)

>  <DEVELOPMENT_PHASE>  (98) 
4

>  <RESEARCH_CODES>  (98) 
nan

>  <APPLICANTS>  (98) 
G And W Laboratories Inc; Cadence Pharmaceuticals Inc; Actavis Mid Atlantic Llc; Aaipharma Llc; Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (98) 
nan

>  <USAN_STEM_DEFINITION>  (98) 
nan

>  <USAN_STEM_SUBSTEM>  (98) 
nan

>  <USAN_YEAR>  (98) 
nan

>  <FIRST_APPROVAL>  (98) 
1968.0

>  <ATC_CODE>  (98) 
N02BE71; N02BE51; N02BE01

>  <ATC_CODE_DESCRIPTION>  (98) 
N02BE71 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]; N02BE51 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]; N02BE01 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]

>  <INDICATION_CLASS>  (98) 
Analgesic; Antipyretic

>  <SC_PATENT_NO>  (98) 
US-5972916-A

>  <DRUG_TYPE>  (98) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (98) 
Y

>  <FIRST_IN_CLASS>  (98) 
N

>  <CHIRALITY>  (98) 
Achiral Molecule

>  <PRODRUG>  (98) 
Y

>  <ORAL>  (98) 
Y

>  <PARENTERAL>  (98) 
Y

>  <TOPICAL>  (98) 
Y

>  <BLACK_BOX>  (98) 
N

>  <AVAILABILITY_TYPE>  (98) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (98) 
nan

>  <WITHDRAWN_COUNTRY>  (98) 
nan

>  <WITHDRAWN_REASON>  (98) 
nan

>  <CANONICAL_SMILES>  (98) 
CC(=O)Nc1ccc(O)cc1

>  <name>  (98) 
Acetaminophen 

>  <MW>  (98) 
151.165

>  <logP>  (98) 
1.3506

$$$$
CHEMBL562
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  2  0
 22 23  1  0
 23 24  2  0
 10  3  1  0
 23 10  1  0
 22 12  1  0
M  END
>  <PARENT_MOLREGNO>  (99) 
16303

>  <SYNONYMS>  (99) 
Griseofulvin (BAN, INN, JAN, USP); Griseofulvin, microcrystalline (FDA); Griseofulvin, Microsize (FDA); Griseofulvin, ultramicrocrystalline (FDA); Griseofulvin, Ultramicrosize (FDA)

>  <DEVELOPMENT_PHASE>  (99) 
4

>  <RESEARCH_CODES>  (99) 
nan

>  <APPLICANTS>  (99) 
Wyeth Ayerst Laboratories; Pedinol Pharmacal Inc; Johnson And Johnson Consumer Companies Inc

>  <USAN_STEM>  (99) 
-vin-

>  <USAN_STEM_DEFINITION>  (99) 
nan

>  <USAN_STEM_SUBSTEM>  (99) 
-vin-

>  <USAN_YEAR>  (99) 
nan

>  <FIRST_APPROVAL>  (99) 
1962.0

>  <ATC_CODE>  (99) 
D01BA01; D01AA08

>  <ATC_CODE_DESCRIPTION>  (99) 
D01BA01 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Systemic Use:Antifungals for systemic use]; D01AA08 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Antibiotics]

>  <INDICATION_CLASS>  (99) 
Antifungal

>  <SC_PATENT_NO>  (99) 
nan

>  <DRUG_TYPE>  (99) 
Natural Product-derived

>  <RULE_OF_FIVE>  (99) 
Y

>  <FIRST_IN_CLASS>  (99) 
N

>  <CHIRALITY>  (99) 
Single Stereoisomer

>  <PRODRUG>  (99) 
N

>  <ORAL>  (99) 
Y

>  <PARENTERAL>  (99) 
N

>  <TOPICAL>  (99) 
N

>  <BLACK_BOX>  (99) 
N

>  <AVAILABILITY_TYPE>  (99) 
Prescription-only

>  <WITHDRAWN_YEAR>  (99) 
nan

>  <WITHDRAWN_COUNTRY>  (99) 
nan

>  <WITHDRAWN_REASON>  (99) 
nan

>  <CANONICAL_SMILES>  (99) 
COC1=CC(=O)C[C@@H](C)[C@]12Oc3c(Cl)c(OC)cc(OC)c3C2=O

>  <name>  (99) 
Griseofulvin 

>  <MW>  (99) 
352.77

>  <logP>  (99) 
2.8103

$$$$
CHEMBL1551
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27  8  1  0
 27 11  1  0
 24 12  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (100) 
442013

>  <SYNONYMS>  (100) 
Ursodeoxycholic Acid (BAN, INN); Ursodesoxycholic Acid (JAN); Ursodiol (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (100) 
4

>  <RESEARCH_CODES>  (100) 
nan

>  <APPLICANTS>  (100) 
Watson Pharmaceuticals Inc; Aptalis Pharma Us Inc

>  <USAN_STEM>  (100) 
nan

>  <USAN_STEM_DEFINITION>  (100) 
nan

>  <USAN_STEM_SUBSTEM>  (100) 
nan

>  <USAN_YEAR>  (100) 
1988.0

>  <FIRST_APPROVAL>  (100) 
1987.0

>  <ATC_CODE>  (100) 
A05AA02

>  <ATC_CODE_DESCRIPTION>  (100) 
A05AA02 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Bile Therapy:Bile acid preparations]

>  <INDICATION_CLASS>  (100) 
Anticholelithogenic

>  <SC_PATENT_NO>  (100) 
nan

>  <DRUG_TYPE>  (100) 
Natural Product-derived

>  <RULE_OF_FIVE>  (100) 
Y

>  <FIRST_IN_CLASS>  (100) 
N

>  <CHIRALITY>  (100) 
Single Stereoisomer

>  <PRODRUG>  (100) 
N

>  <ORAL>  (100) 
Y

>  <PARENTERAL>  (100) 
N

>  <TOPICAL>  (100) 
N

>  <BLACK_BOX>  (100) 
N

>  <AVAILABILITY_TYPE>  (100) 
Prescription-only

>  <WITHDRAWN_YEAR>  (100) 
nan

>  <WITHDRAWN_COUNTRY>  (100) 
nan

>  <WITHDRAWN_REASON>  (100) 
nan

>  <CANONICAL_SMILES>  (100) 
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (100) 
Ursodeoxycholic Acid 

>  <MW>  (100) 
392.58

>  <logP>  (100) 
4.4779

$$$$
CHEMBL1614854
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11  3  1  0
M  END
>  <PARENT_MOLREGNO>  (101) 
1037865

>  <SYNONYMS>  (101) 
Dextrose (FDA, USP); Glucose (JAN)

>  <DEVELOPMENT_PHASE>  (101) 
4

>  <RESEARCH_CODES>  (101) 
nan

>  <APPLICANTS>  (101) 
Alcon Laboratories Inc; Akorn Inc; Abbott Laboratories Pharmaceutical Products Div; Abbott Laboratories Hosp Products Div; Alcon Pharmaceuticals Ltd

>  <USAN_STEM>  (101) 
nan

>  <USAN_STEM_DEFINITION>  (101) 
nan

>  <USAN_STEM_SUBSTEM>  (101) 
nan

>  <USAN_YEAR>  (101) 
nan

>  <FIRST_APPROVAL>  (101) 
nan

>  <ATC_CODE>  (101) 
C05BB56; V06DC01; B05CX01; V04CA02

>  <ATC_CODE_DESCRIPTION>  (101) 
C05BB56 [Cardiovascular System:Vasoprotectives:Antivaricose Therapy:Sclerosing agents for local injection]; V06DC01 [Various:General Nutrients:Other Nutrients:Carbohydrates]; B05CX01 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:Irrigating Solutions:Other irrigating solutions]; V04CA02 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for diabetes]

>  <INDICATION_CLASS>  (101) 
Replenisher (fluid and nutrient)

>  <SC_PATENT_NO>  (101) 
US-7084130-B2

>  <DRUG_TYPE>  (101) 
Natural Product-derived

>  <RULE_OF_FIVE>  (101) 
Y

>  <FIRST_IN_CLASS>  (101) 
N

>  <CHIRALITY>  (101) 
Single Stereoisomer

>  <PRODRUG>  (101) 
N

>  <ORAL>  (101) 
N

>  <PARENTERAL>  (101) 
Y

>  <TOPICAL>  (101) 
N

>  <BLACK_BOX>  (101) 
N

>  <AVAILABILITY_TYPE>  (101) 
Prescription-only

>  <WITHDRAWN_YEAR>  (101) 
nan

>  <WITHDRAWN_COUNTRY>  (101) 
nan

>  <WITHDRAWN_REASON>  (101) 
nan

>  <CANONICAL_SMILES>  (101) 
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O

>  <name>  (101) 
Dextrose 

>  <MW>  (101) 
180.156

>  <logP>  (101) 
-3.2214

$$$$
CHEMBL3
     RDKit          

 12 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  6  2  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (102) 
115

>  <SYNONYMS>  (102) 
Nicotine (FDA, MI, USP); Nicotine Polacrilex (FDA, USAN, USP); Nicotine Bitartrate (USAN)

>  <DEVELOPMENT_PHASE>  (102) 
4

>  <RESEARCH_CODES>  (102) 
nan

>  <APPLICANTS>  (102) 
Mcneil Consumer Healthcare; GlaxoSmithKline Consumer Healthcare; GlaxoSmithKline; Aveva Drug Delivery Systems Inc; Novartis Consumer Health Inc

>  <USAN_STEM>  (102) 
nan

>  <USAN_STEM_DEFINITION>  (102) 
nan

>  <USAN_STEM_SUBSTEM>  (102) 
nan

>  <USAN_YEAR>  (102) 
1985.0

>  <FIRST_APPROVAL>  (102) 
1984.0

>  <ATC_CODE>  (102) 
N07BA01

>  <ATC_CODE_DESCRIPTION>  (102) 
N07BA01 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in nicotine dependence]

>  <INDICATION_CLASS>  (102) 
Smoking Cessation Adjunct

>  <SC_PATENT_NO>  (102) 
US-8075911-B2

>  <DRUG_TYPE>  (102) 
Polymer

>  <RULE_OF_FIVE>  (102) 
Y

>  <FIRST_IN_CLASS>  (102) 
N

>  <CHIRALITY>  (102) 
Single Stereoisomer

>  <PRODRUG>  (102) 
N

>  <ORAL>  (102) 
Y

>  <PARENTERAL>  (102) 
N

>  <TOPICAL>  (102) 
Y

>  <BLACK_BOX>  (102) 
N

>  <AVAILABILITY_TYPE>  (102) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (102) 
nan

>  <WITHDRAWN_COUNTRY>  (102) 
nan

>  <WITHDRAWN_REASON>  (102) 
nan

>  <CANONICAL_SMILES>  (102) 
CN1CCC[C@H]1c2cccnc2

>  <name>  (102) 
Nicotine 

>  <MW>  (102) 
162.236

>  <logP>  (102) 
1.8483

$$$$
CHEMBL591
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  3  8  1  0
  8  9  3  0
M  END
>  <PARENT_MOLREGNO>  (103) 
19469

>  <SYNONYMS>  (103) 
Ethchlorvynol (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (103) 
4

>  <RESEARCH_CODES>  (103) 
nan

>  <APPLICANTS>  (103) 
Abbvie Inc

>  <USAN_STEM>  (103) 
nan

>  <USAN_STEM_DEFINITION>  (103) 
nan

>  <USAN_STEM_SUBSTEM>  (103) 
nan

>  <USAN_YEAR>  (103) 
nan

>  <FIRST_APPROVAL>  (103) 
1961.0

>  <ATC_CODE>  (103) 
N05CM08

>  <ATC_CODE_DESCRIPTION>  (103) 
N05CM08 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]

>  <INDICATION_CLASS>  (103) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (103) 
nan

>  <DRUG_TYPE>  (103) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (103) 
Y

>  <FIRST_IN_CLASS>  (103) 
N

>  <CHIRALITY>  (103) 
Racemic Mixture

>  <PRODRUG>  (103) 
N

>  <ORAL>  (103) 
Y

>  <PARENTERAL>  (103) 
N

>  <TOPICAL>  (103) 
N

>  <BLACK_BOX>  (103) 
N

>  <AVAILABILITY_TYPE>  (103) 
Discontinued

>  <WITHDRAWN_YEAR>  (103) 
nan

>  <WITHDRAWN_COUNTRY>  (103) 
nan

>  <WITHDRAWN_REASON>  (103) 
nan

>  <CANONICAL_SMILES>  (103) 
CCC(O)(\C=C\Cl)C#C

>  <name>  (103) 
Ethchlorvynol 

>  <MW>  (103) 
144.601

>  <logP>  (103) 
1.5132

$$$$
CHEMBL2079587
     RDKit          

 24 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23  2  1  0
 23  6  1  0
 20  7  1  0
 18 10  1  0
 16 12  1  0
M  END
>  <PARENT_MOLREGNO>  (104) 
1363818

>  <SYNONYMS>  (104) 
Stanozolol (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (104) 
4

>  <RESEARCH_CODES>  (104) 
WIN-14833

>  <APPLICANTS>  (104) 
Lundbeck Inc

>  <USAN_STEM>  (104) 
-olol

>  <USAN_STEM_DEFINITION>  (104) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (104) 
-olol

>  <USAN_YEAR>  (104) 
1962.0

>  <FIRST_APPROVAL>  (104) 
1962.0

>  <ATC_CODE>  (104) 
A14AA02

>  <ATC_CODE_DESCRIPTION>  (104) 
A14AA02 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives]

>  <INDICATION_CLASS>  (104) 
Androgen

>  <SC_PATENT_NO>  (104) 
nan

>  <DRUG_TYPE>  (104) 
Natural Product-derived

>  <RULE_OF_FIVE>  (104) 
Y

>  <FIRST_IN_CLASS>  (104) 
N

>  <CHIRALITY>  (104) 
Racemic Mixture

>  <PRODRUG>  (104) 
N

>  <ORAL>  (104) 
Y

>  <PARENTERAL>  (104) 
N

>  <TOPICAL>  (104) 
N

>  <BLACK_BOX>  (104) 
N

>  <AVAILABILITY_TYPE>  (104) 
Discontinued

>  <WITHDRAWN_YEAR>  (104) 
nan

>  <WITHDRAWN_COUNTRY>  (104) 
nan

>  <WITHDRAWN_REASON>  (104) 
nan

>  <CANONICAL_SMILES>  (104) 
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5n[nH]cc5C[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (104) 
Stanozolol 

>  <MW>  (104) 
328.5

>  <logP>  (104) 
4.1181

$$$$
CHEMBL121
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
  9 18  1  0
 18 19  2  0
  2 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 19  6  1  0
 16 11  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (105) 
20027

>  <SYNONYMS>  (105) 
Rosiglitazone (BAN, INN); Rosiglitazone maleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (105) 
4

>  <RESEARCH_CODES>  (105) 
BRL-49653; BRL-49653-C; BRL-49653C

>  <APPLICANTS>  (105) 
Sb Pharmco Puerto Rico Inc

>  <USAN_STEM>  (105) 
-glitazone

>  <USAN_STEM_DEFINITION>  (105) 
PPST agonists (thiazolidene derivatives)

>  <USAN_STEM_SUBSTEM>  (105) 
-glitazone

>  <USAN_YEAR>  (105) 
1997.0

>  <FIRST_APPROVAL>  (105) 
1999.0

>  <ATC_CODE>  (105) 
A10BG02

>  <ATC_CODE_DESCRIPTION>  (105) 
A10BG02 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Thiazolidinediones]

>  <INDICATION_CLASS>  (105) 
Antidiabetic

>  <SC_PATENT_NO>  (105) 
US-5965584-A

>  <DRUG_TYPE>  (105) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (105) 
Y

>  <FIRST_IN_CLASS>  (105) 
N

>  <CHIRALITY>  (105) 
Racemic Mixture

>  <PRODRUG>  (105) 
N

>  <ORAL>  (105) 
Y

>  <PARENTERAL>  (105) 
N

>  <TOPICAL>  (105) 
N

>  <BLACK_BOX>  (105) 
Y

>  <AVAILABILITY_TYPE>  (105) 
Prescription-only

>  <WITHDRAWN_YEAR>  (105) 
2010.0

>  <WITHDRAWN_COUNTRY>  (105) 
European Union

>  <WITHDRAWN_REASON>  (105) 
Increased risk of ischaemic heart disease

>  <CANONICAL_SMILES>  (105) 
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3

>  <name>  (105) 
Rosiglitazone 

>  <MW>  (105) 
357.435

>  <logP>  (105) 
2.4909

$$$$
CHEMBL1235932
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11  3  1  0
M  END
>  <PARENT_MOLREGNO>  (106) 
698282

>  <SYNONYMS>  (106) 
Fludeoxyglucose (18F) (INN); Fludeoxyglucose F-18 (USAN, USP, FDA)

>  <DEVELOPMENT_PHASE>  (106) 
4

>  <RESEARCH_CODES>  (106) 
18FDG

>  <APPLICANTS>  (106) 
Weill Medical College Cornell Univ; Feinstein Institute Medical Research; Downstate Clinical Pet Center

>  <USAN_STEM>  (106) 
nan

>  <USAN_STEM_DEFINITION>  (106) 
nan

>  <USAN_STEM_SUBSTEM>  (106) 
nan

>  <USAN_YEAR>  (106) 
1989.0

>  <FIRST_APPROVAL>  (106) 
1994.0

>  <ATC_CODE>  (106) 
V09IX04

>  <ATC_CODE_DESCRIPTION>  (106) 
V09IX04 [Various:Diagnostic Radiopharmaceuticals:Tumour Detection:Other diagnostic radiopharmaceuticals for tumour detection]

>  <INDICATION_CLASS>  (106) 
Diagnostic Aid; Radioactive Agent

>  <SC_PATENT_NO>  (106) 
nan

>  <DRUG_TYPE>  (106) 
Natural Product-derived

>  <RULE_OF_FIVE>  (106) 
Y

>  <FIRST_IN_CLASS>  (106) 
N

>  <CHIRALITY>  (106) 
Single Stereoisomer

>  <PRODRUG>  (106) 
N

>  <ORAL>  (106) 
N

>  <PARENTERAL>  (106) 
Y

>  <TOPICAL>  (106) 
N

>  <BLACK_BOX>  (106) 
N

>  <AVAILABILITY_TYPE>  (106) 
Prescription-only

>  <WITHDRAWN_YEAR>  (106) 
nan

>  <WITHDRAWN_COUNTRY>  (106) 
nan

>  <WITHDRAWN_REASON>  (106) 
nan

>  <CANONICAL_SMILES>  (106) 
OC[C@H]1O[C@@H](O)[C@H](F)[C@@H](O)[C@@H]1O

>  <name>  (106) 
Fludeoxyglucose 

>  <MW>  (106) 
182.147

>  <logP>  (106) 
-2.2442

$$$$
CHEMBL927
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 18 22  1  0
 22 23  2  0
 22 24  1  0
 17 25  1  0
 25 26  2  0
  6  2  1  0
 20 13  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (107) 
84624

>  <SYNONYMS>  (107) 
Cefdinir (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (107) 
4

>  <RESEARCH_CODES>  (107) 
CI-983; FK-482

>  <APPLICANTS>  (107) 
Abbvie Inc

>  <USAN_STEM>  (107) 
cef-

>  <USAN_STEM_DEFINITION>  (107) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (107) 
cef-

>  <USAN_YEAR>  (107) 
1991.0

>  <FIRST_APPROVAL>  (107) 
1997.0

>  <ATC_CODE>  (107) 
J01DD15

>  <ATC_CODE_DESCRIPTION>  (107) 
J01DD15 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Third-generation cephalosporins]

>  <INDICATION_CLASS>  (107) 
Antibacterial

>  <SC_PATENT_NO>  (107) 
nan

>  <DRUG_TYPE>  (107) 
Natural Product-derived

>  <RULE_OF_FIVE>  (107) 
Y

>  <FIRST_IN_CLASS>  (107) 
N

>  <CHIRALITY>  (107) 
Single Stereoisomer

>  <PRODRUG>  (107) 
N

>  <ORAL>  (107) 
Y

>  <PARENTERAL>  (107) 
N

>  <TOPICAL>  (107) 
N

>  <BLACK_BOX>  (107) 
N

>  <AVAILABILITY_TYPE>  (107) 
Prescription-only

>  <WITHDRAWN_YEAR>  (107) 
nan

>  <WITHDRAWN_COUNTRY>  (107) 
nan

>  <WITHDRAWN_REASON>  (107) 
nan

>  <CANONICAL_SMILES>  (107) 
Nc1nc(cs1)\C(=N\O)\C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)C=C

>  <name>  (107) 
Cefdinir 

>  <MW>  (107) 
395.422

>  <logP>  (107) 
-0.1718

$$$$
CHEMBL566315
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 10 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 30  3  1  0
 22  6  1  0
 18  7  1  0
 30 23  1  0
M  END
>  <PARENT_MOLREGNO>  (108) 
574221

>  <SYNONYMS>  (108) 
Obeticholic acid (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (108) 
4

>  <RESEARCH_CODES>  (108) 
DSP-1747; INT-747

>  <APPLICANTS>  (108) 
Intercept Pharmaceuticals

>  <USAN_STEM>  (108) 
nan

>  <USAN_STEM_DEFINITION>  (108) 
nan

>  <USAN_STEM_SUBSTEM>  (108) 
nan

>  <USAN_YEAR>  (108) 
2008.0

>  <FIRST_APPROVAL>  (108) 
2016.0

>  <ATC_CODE>  (108) 
A05AA04

>  <ATC_CODE_DESCRIPTION>  (108) 
A05AA04 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Bile Therapy:Bile acid preparations]

>  <INDICATION_CLASS>  (108) 
nan

>  <SC_PATENT_NO>  (108) 
nan

>  <DRUG_TYPE>  (108) 
Natural Product-derived

>  <RULE_OF_FIVE>  (108) 
Y

>  <FIRST_IN_CLASS>  (108) 
N

>  <CHIRALITY>  (108) 
Single Stereoisomer

>  <PRODRUG>  (108) 
N

>  <ORAL>  (108) 
Y

>  <PARENTERAL>  (108) 
N

>  <TOPICAL>  (108) 
N

>  <BLACK_BOX>  (108) 
N

>  <AVAILABILITY_TYPE>  (108) 
Prescription-only

>  <WITHDRAWN_YEAR>  (108) 
nan

>  <WITHDRAWN_COUNTRY>  (108) 
nan

>  <WITHDRAWN_REASON>  (108) 
nan

>  <CANONICAL_SMILES>  (108) 
CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(=O)O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14

>  <name>  (108) 
Obeticholic acid 

>  <MW>  (108) 
420.634

>  <logP>  (108) 
5.114

$$$$
CHEMBL1129
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 11 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
  7  3  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (109) 
169321

>  <SYNONYMS>  (109) 
Trifluridine (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (109) 
4

>  <RESEARCH_CODES>  (109) 
nan

>  <APPLICANTS>  (109) 
Monarch Pharmaceuticals Inc

>  <USAN_STEM>  (109) 
-uridine

>  <USAN_STEM_DEFINITION>  (109) 
antivirals,antineoplastics (uridine derivatives)

>  <USAN_STEM_SUBSTEM>  (109) 
-uridine

>  <USAN_YEAR>  (109) 
1977.0

>  <FIRST_APPROVAL>  (109) 
1980.0

>  <ATC_CODE>  (109) 
S01AD02; L01BC59

>  <ATC_CODE_DESCRIPTION>  (109) 
S01AD02 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]; L01BC59 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (109) 
Antiviral (ophthalmic)

>  <SC_PATENT_NO>  (109) 
US-5744475-A

>  <DRUG_TYPE>  (109) 
Natural Product-derived

>  <RULE_OF_FIVE>  (109) 
Y

>  <FIRST_IN_CLASS>  (109) 
N

>  <CHIRALITY>  (109) 
Single Stereoisomer

>  <PRODRUG>  (109) 
N

>  <ORAL>  (109) 
Y

>  <PARENTERAL>  (109) 
N

>  <TOPICAL>  (109) 
Y

>  <BLACK_BOX>  (109) 
N

>  <AVAILABILITY_TYPE>  (109) 
Prescription-only

>  <WITHDRAWN_YEAR>  (109) 
nan

>  <WITHDRAWN_COUNTRY>  (109) 
nan

>  <WITHDRAWN_REASON>  (109) 
nan

>  <CANONICAL_SMILES>  (109) 
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F

>  <name>  (109) 
Trifluridine 

>  <MW>  (109) 
296.201

>  <logP>  (109) 
-0.8039

$$$$
CHEMBL142438
     RDKit          

  2  1  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
M  END
>  <PARENT_MOLREGNO>  (110) 
238336

>  <SYNONYMS>  (110) 
Nitrogen (FDA, NF)

>  <DEVELOPMENT_PHASE>  (110) 
4

>  <RESEARCH_CODES>  (110) 
nan

>  <APPLICANTS>  (110) 
nan

>  <USAN_STEM>  (110) 
nan

>  <USAN_STEM_DEFINITION>  (110) 
nan

>  <USAN_STEM_SUBSTEM>  (110) 
nan

>  <USAN_YEAR>  (110) 
nan

>  <FIRST_APPROVAL>  (110) 
2015.0

>  <ATC_CODE>  (110) 
V03AN04

>  <ATC_CODE_DESCRIPTION>  (110) 
V03AN04 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Medical gases]

>  <INDICATION_CLASS>  (110) 
Pharmaceutic Aid (air displacement)

>  <SC_PATENT_NO>  (110) 
nan

>  <DRUG_TYPE>  (110) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (110) 
Y

>  <FIRST_IN_CLASS>  (110) 
N

>  <CHIRALITY>  (110) 
Achiral Molecule

>  <PRODRUG>  (110) 
N

>  <ORAL>  (110) 
N

>  <PARENTERAL>  (110) 
N

>  <TOPICAL>  (110) 
Y

>  <BLACK_BOX>  (110) 
N

>  <AVAILABILITY_TYPE>  (110) 
Prescription-only

>  <WITHDRAWN_YEAR>  (110) 
nan

>  <WITHDRAWN_COUNTRY>  (110) 
nan

>  <WITHDRAWN_REASON>  (110) 
nan

>  <CANONICAL_SMILES>  (110) 
N#N

>  <name>  (110) 
Nitrogen 

>  <MW>  (110) 
28.014

>  <logP>  (110) 
0.03016

$$$$
CHEMBL184
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  9 15  1  0
 15 16  2  0
 16  2  1  0
 15  6  1  0
M  END
>  <PARENT_MOLREGNO>  (111) 
365538

>  <SYNONYMS>  (111) 
Aciclovir (BAN, INN, JAN); Acyclovir (FDA, USAN, USP); Acyclovir sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (111) 
4

>  <RESEARCH_CODES>  (111) 
BW-248U Sodium

>  <APPLICANTS>  (111) 
Valeant International Barbados Srl; GlaxoSmithKline

>  <USAN_STEM>  (111) 
-vir

>  <USAN_STEM_DEFINITION>  (111) 
antivirals: antivirals (acyclovir type)

>  <USAN_STEM_SUBSTEM>  (111) 
-vir (-cyclovir)

>  <USAN_YEAR>  (111) 
1979.0

>  <FIRST_APPROVAL>  (111) 
1982.0

>  <ATC_CODE>  (111) 
D06BB53; D06BB03; J05AB01; S01AD03

>  <ATC_CODE_DESCRIPTION>  (111) 
D06BB53 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]; D06BB03 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]; J05AB01 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD03 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]

>  <INDICATION_CLASS>  (111) 
Antiviral

>  <SC_PATENT_NO>  (111) 
US-6514980-B1

>  <DRUG_TYPE>  (111) 
Natural Product-derived

>  <RULE_OF_FIVE>  (111) 
Y

>  <FIRST_IN_CLASS>  (111) 
N

>  <CHIRALITY>  (111) 
Achiral Molecule

>  <PRODRUG>  (111) 
Y

>  <ORAL>  (111) 
Y

>  <PARENTERAL>  (111) 
Y

>  <TOPICAL>  (111) 
Y

>  <BLACK_BOX>  (111) 
N

>  <AVAILABILITY_TYPE>  (111) 
Prescription-only

>  <WITHDRAWN_YEAR>  (111) 
nan

>  <WITHDRAWN_COUNTRY>  (111) 
nan

>  <WITHDRAWN_REASON>  (111) 
nan

>  <CANONICAL_SMILES>  (111) 
Nc1nc(O)c2ncn(COCCO)c2n1

>  <name>  (111) 
Aciclovir 

>  <MW>  (111) 
225.208

>  <logP>  (111) 
-0.9195

$$$$
CHEMBL646
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23  2  1  0
 23  5  1  0
 14  9  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (112) 
27419

>  <SYNONYMS>  (112) 
Triazolam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (112) 
4

>  <RESEARCH_CODES>  (112) 
U-33030

>  <APPLICANTS>  (112) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (112) 
nan

>  <USAN_STEM_DEFINITION>  (112) 
nan

>  <USAN_STEM_SUBSTEM>  (112) 
nan

>  <USAN_YEAR>  (112) 
1973.0

>  <FIRST_APPROVAL>  (112) 
1978.0

>  <ATC_CODE>  (112) 
N05CD05

>  <ATC_CODE_DESCRIPTION>  (112) 
N05CD05 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (112) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (112) 
nan

>  <DRUG_TYPE>  (112) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (112) 
Y

>  <FIRST_IN_CLASS>  (112) 
N

>  <CHIRALITY>  (112) 
Achiral Molecule

>  <PRODRUG>  (112) 
N

>  <ORAL>  (112) 
Y

>  <PARENTERAL>  (112) 
N

>  <TOPICAL>  (112) 
N

>  <BLACK_BOX>  (112) 
Y

>  <AVAILABILITY_TYPE>  (112) 
Prescription-only

>  <WITHDRAWN_YEAR>  (112) 
1992.0

>  <WITHDRAWN_COUNTRY>  (112) 
United Kingdom; France; Netherlands; Finland; Argentina

>  <WITHDRAWN_REASON>  (112) 
Psychiatric reaction and amnesia

>  <CANONICAL_SMILES>  (112) 
Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12

>  <name>  (112) 
Triazolam 

>  <MW>  (112) 
343.217

>  <logP>  (112) 
4.23352

$$$$
CHEMBL1109
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  7  2  1  0
 16 12  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (113) 
153330

>  <SYNONYMS>  (113) 
Sulfaphenazole (BAN, FDA, INN, JAN, MI)

>  <DEVELOPMENT_PHASE>  (113) 
4

>  <RESEARCH_CODES>  (113) 
nan

>  <APPLICANTS>  (113) 
Purdue Frederick Co; Pharmaceutical Research Assoc Inc

>  <USAN_STEM>  (113) 
sulfa-

>  <USAN_STEM_DEFINITION>  (113) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (113) 
sulfa-

>  <USAN_YEAR>  (113) 
nan

>  <FIRST_APPROVAL>  (113) 
1982.0

>  <ATC_CODE>  (113) 
S01AB05; J01ED08

>  <ATC_CODE_DESCRIPTION>  (113) 
S01AB05 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; J01ED08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]

>  <INDICATION_CLASS>  (113) 
nan

>  <SC_PATENT_NO>  (113) 
nan

>  <DRUG_TYPE>  (113) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (113) 
Y

>  <FIRST_IN_CLASS>  (113) 
N

>  <CHIRALITY>  (113) 
Achiral Molecule

>  <PRODRUG>  (113) 
N

>  <ORAL>  (113) 
Y

>  <PARENTERAL>  (113) 
N

>  <TOPICAL>  (113) 
N

>  <BLACK_BOX>  (113) 
N

>  <AVAILABILITY_TYPE>  (113) 
Discontinued

>  <WITHDRAWN_YEAR>  (113) 
nan

>  <WITHDRAWN_COUNTRY>  (113) 
nan

>  <WITHDRAWN_REASON>  (113) 
nan

>  <CANONICAL_SMILES>  (113) 
Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3

>  <name>  (113) 
Sulfaphenazole 

>  <MW>  (113) 
314.37

>  <logP>  (113) 
2.2553

$$$$
CHEMBL439849
     RDKit          

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  9 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 27 30  1  0
 30 31  3  0
 16 32  1  0
 32 33  1  0
 12  4  2  0
 11  6  1  0
 33 13  1  0
 29 21  1  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (114) 
312971

>  <SYNONYMS>  (114) 
Vilazodone (INN, USAN); Vilazodone HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (114) 
4

>  <RESEARCH_CODES>  (114) 
EMD-515259; EMD-68-843; SB-659746-A

>  <APPLICANTS>  (114) 
Pgxhealth; Forest Laboratories Inc

>  <USAN_STEM>  (114) 
nan

>  <USAN_STEM_DEFINITION>  (114) 
nan

>  <USAN_STEM_SUBSTEM>  (114) 
nan

>  <USAN_YEAR>  (114) 
2009.0

>  <FIRST_APPROVAL>  (114) 
2011.0

>  <ATC_CODE>  (114) 
N06AX24

>  <ATC_CODE_DESCRIPTION>  (114) 
N06AX24 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (114) 
nan

>  <SC_PATENT_NO>  (114) 
US-5532241-A

>  <DRUG_TYPE>  (114) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (114) 
Y

>  <FIRST_IN_CLASS>  (114) 
N

>  <CHIRALITY>  (114) 
Achiral Molecule

>  <PRODRUG>  (114) 
N

>  <ORAL>  (114) 
Y

>  <PARENTERAL>  (114) 
N

>  <TOPICAL>  (114) 
N

>  <BLACK_BOX>  (114) 
Y

>  <AVAILABILITY_TYPE>  (114) 
Prescription-only

>  <WITHDRAWN_YEAR>  (114) 
nan

>  <WITHDRAWN_COUNTRY>  (114) 
nan

>  <WITHDRAWN_REASON>  (114) 
nan

>  <CANONICAL_SMILES>  (114) 
NC(=O)c1oc2ccc(cc2c1)N3CCN(CCCCc4c[nH]c5ccc(cc45)C#N)CC3

>  <name>  (114) 
Vilazodone 

>  <MW>  (114) 
441.535

>  <logP>  (114) 
4.02958

$$$$
CHEMBL782
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (115) 
46726

>  <SYNONYMS>  (115) 
Tolbutamide (BAN, FDA, INN, JAN, USP); Tolbutamide Sodium (FDA); Tolbutamide Sodium, Sterile (USP)

>  <DEVELOPMENT_PHASE>  (115) 
4

>  <RESEARCH_CODES>  (115) 
nan

>  <APPLICANTS>  (115) 
Sandoz Inc; Pharmacia And Upjohn Co

>  <USAN_STEM>  (115) 
nan

>  <USAN_STEM_DEFINITION>  (115) 
nan

>  <USAN_STEM_SUBSTEM>  (115) 
nan

>  <USAN_YEAR>  (115) 
nan

>  <FIRST_APPROVAL>  (115) 
1961.0

>  <ATC_CODE>  (115) 
V04CA01; A10BB03

>  <ATC_CODE_DESCRIPTION>  (115) 
V04CA01 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for diabetes]; A10BB03 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (115) 
Antidiabetic; Diagnostic Aid (diabetes)

>  <SC_PATENT_NO>  (115) 
nan

>  <DRUG_TYPE>  (115) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (115) 
Y

>  <FIRST_IN_CLASS>  (115) 
N

>  <CHIRALITY>  (115) 
Achiral Molecule

>  <PRODRUG>  (115) 
N

>  <ORAL>  (115) 
Y

>  <PARENTERAL>  (115) 
Y

>  <TOPICAL>  (115) 
N

>  <BLACK_BOX>  (115) 
N

>  <AVAILABILITY_TYPE>  (115) 
Prescription-only

>  <WITHDRAWN_YEAR>  (115) 
nan

>  <WITHDRAWN_COUNTRY>  (115) 
nan

>  <WITHDRAWN_REASON>  (115) 
nan

>  <CANONICAL_SMILES>  (115) 
CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1

>  <name>  (115) 
Tolbutamide 

>  <MW>  (115) 
270.354

>  <logP>  (115) 
1.78302

$$$$
CHEMBL1477
     RDKit          

 33 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  7 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 11 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
  5 31  1  0
 31 32  1  0
 31 33  1  0
 23  4  1  0
 30 24  1  0
M  END
>  <PARENT_MOLREGNO>  (116) 
403465

>  <SYNONYMS>  (116) 
Cerivastatin (BAN, INN); Cerivastatin Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (116) 
4

>  <RESEARCH_CODES>  (116) 
BAY-w-6228

>  <APPLICANTS>  (116) 
Bayer Pharmaceuticals Corp

>  <USAN_STEM>  (116) 
-stat-

>  <USAN_STEM_DEFINITION>  (116) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (116) 
-stat- (-vastatin)

>  <USAN_YEAR>  (116) 
1996.0

>  <FIRST_APPROVAL>  (116) 
1997.0

>  <ATC_CODE>  (116) 
C10AA06

>  <ATC_CODE_DESCRIPTION>  (116) 
C10AA06 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (116) 
Antihyperlipidemic; Inhibitor (HMG-CoA reductase)

>  <SC_PATENT_NO>  (116) 
nan

>  <DRUG_TYPE>  (116) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (116) 
Y

>  <FIRST_IN_CLASS>  (116) 
N

>  <CHIRALITY>  (116) 
Single Stereoisomer

>  <PRODRUG>  (116) 
N

>  <ORAL>  (116) 
Y

>  <PARENTERAL>  (116) 
N

>  <TOPICAL>  (116) 
N

>  <BLACK_BOX>  (116) 
N

>  <AVAILABILITY_TYPE>  (116) 
Withdrawn

>  <WITHDRAWN_YEAR>  (116) 
2001.0

>  <WITHDRAWN_COUNTRY>  (116) 
United States

>  <WITHDRAWN_REASON>  (116) 
Rhabdomyolysis _ kidney failure and muscle damage

>  <CANONICAL_SMILES>  (116) 
COCc1c(nc(C(C)C)c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)c1c2ccc(F)cc2)C(C)C

>  <name>  (116) 
Cerivastatin 

>  <MW>  (116) 
459.558

>  <logP>  (116) 
4.8807

$$$$
CHEMBL441
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 12 16  1  0
 14  6  1  0
M  END
>  <PARENT_MOLREGNO>  (117) 
2166

>  <SYNONYMS>  (117) 
Thiopental (BAN); Thiopental sodium (FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (117) 
4

>  <RESEARCH_CODES>  (117) 
nan

>  <APPLICANTS>  (117) 
Abbott Laboratories Hosp Products Div

>  <USAN_STEM>  (117) 
nan

>  <USAN_STEM_DEFINITION>  (117) 
nan

>  <USAN_STEM_SUBSTEM>  (117) 
nan

>  <USAN_YEAR>  (117) 
nan

>  <FIRST_APPROVAL>  (117) 
1982.0

>  <ATC_CODE>  (117) 
N01AF03; N05CA19

>  <ATC_CODE_DESCRIPTION>  (117) 
N01AF03 [Nervous System:Anesthetics:Anesthetics, General:Barbiturates, plain]; N05CA19 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (117) 
Anesthetic (intravenous); Anticonvulsant

>  <SC_PATENT_NO>  (117) 
nan

>  <DRUG_TYPE>  (117) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (117) 
Y

>  <FIRST_IN_CLASS>  (117) 
N

>  <CHIRALITY>  (117) 
Racemic Mixture

>  <PRODRUG>  (117) 
N

>  <ORAL>  (117) 
N

>  <PARENTERAL>  (117) 
N

>  <TOPICAL>  (117) 
Y

>  <BLACK_BOX>  (117) 
N

>  <AVAILABILITY_TYPE>  (117) 
Discontinued

>  <WITHDRAWN_YEAR>  (117) 
nan

>  <WITHDRAWN_COUNTRY>  (117) 
nan

>  <WITHDRAWN_REASON>  (117) 
nan

>  <CANONICAL_SMILES>  (117) 
CCCC(C)C1(CC)C(=O)NC(=NC1=O)S

>  <name>  (117) 
Thiopental 

>  <MW>  (117) 
242.344

>  <logP>  (117) 
1.7612

$$$$
CHEMBL607
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
  6 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12  6  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (118) 
22528

>  <SYNONYMS>  (118) 
Pethidine (INN, BAN); Meperidine HCl (FDA, USP); Pethidine HCl (JAN)

>  <DEVELOPMENT_PHASE>  (118) 
4

>  <RESEARCH_CODES>  (118) 
nan

>  <APPLICANTS>  (118) 
Sanofi Aventis Us Llc; Hospira Inc; Baxter Healthcare Corp Anesthesia Critical Care

>  <USAN_STEM>  (118) 
-eridine

>  <USAN_STEM_DEFINITION>  (118) 
analgesics (meperidine type)

>  <USAN_STEM_SUBSTEM>  (118) 
-eridine

>  <USAN_YEAR>  (118) 
nan

>  <FIRST_APPROVAL>  (118) 
1942.0

>  <ATC_CODE>  (118) 
N02AB72; N02AB02; N02AB52

>  <ATC_CODE_DESCRIPTION>  (118) 
N02AB72 [Nervous System:Analgesics:Opioids:Phenylpiperidine derivatives]; N02AB02 [Nervous System:Analgesics:Opioids:Phenylpiperidine derivatives]; N02AB52 [Nervous System:Analgesics:Opioids:Phenylpiperidine derivatives]

>  <INDICATION_CLASS>  (118) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (118) 
nan

>  <DRUG_TYPE>  (118) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (118) 
Y

>  <FIRST_IN_CLASS>  (118) 
N

>  <CHIRALITY>  (118) 
Achiral Molecule

>  <PRODRUG>  (118) 
N

>  <ORAL>  (118) 
Y

>  <PARENTERAL>  (118) 
Y

>  <TOPICAL>  (118) 
N

>  <BLACK_BOX>  (118) 
N

>  <AVAILABILITY_TYPE>  (118) 
Prescription-only

>  <WITHDRAWN_YEAR>  (118) 
nan

>  <WITHDRAWN_COUNTRY>  (118) 
nan

>  <WITHDRAWN_REASON>  (118) 
nan

>  <CANONICAL_SMILES>  (118) 
CCOC(=O)C1(CCN(C)CC1)c2ccccc2

>  <name>  (118) 
Pethidine 

>  <MW>  (118) 
247.338

>  <logP>  (118) 
2.2131

$$$$
CHEMBL1215
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (119) 
219334

>  <SYNONYMS>  (119) 
Phenylephrine (BAN, INN); Phenylephrine HCl (FDA, JAN, USP); Phenylephrine Bitartrate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (119) 
4

>  <RESEARCH_CODES>  (119) 
nan

>  <APPLICANTS>  (119) 
Pfizer Inc.; Ani Pharmaceuticals Inc; Allergan Pharmaceutical; 3m Pharmaceuticals Inc; West Ward Pharmaceutical Corp

>  <USAN_STEM>  (119) 
nan

>  <USAN_STEM_DEFINITION>  (119) 
nan

>  <USAN_STEM_SUBSTEM>  (119) 
nan

>  <USAN_YEAR>  (119) 
nan

>  <FIRST_APPROVAL>  (119) 
1952.0

>  <ATC_CODE>  (119) 
R01AB01; S01GA55; S01FB01; R01BA03; C01CA06; R01AA04; S01GA05; R01BA53

>  <ATC_CODE_DESCRIPTION>  (119) 
R01AB01 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, combinations excl. corticosteroids]; S01GA55 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]; S01FB01 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Sympathomimetics excl. antiglaucoma preparations]; R01BA03 [Respiratory System:Nasal Preparations:Nasal Decongestants For Systemic Use:Sympathomimetics]; C01CA06 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]; R01AA04 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, plain]; S01GA05 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]; R01BA53 [Respiratory System:Nasal Preparations:Nasal Decongestants For Systemic Use:Sympathomimetics]

>  <INDICATION_CLASS>  (119) 
Adrenergic (ophthalmic)

>  <SC_PATENT_NO>  (119) 
US-8173707-B2

>  <DRUG_TYPE>  (119) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (119) 
Y

>  <FIRST_IN_CLASS>  (119) 
N

>  <CHIRALITY>  (119) 
Single Stereoisomer

>  <PRODRUG>  (119) 
N

>  <ORAL>  (119) 
Y

>  <PARENTERAL>  (119) 
Y

>  <TOPICAL>  (119) 
Y

>  <BLACK_BOX>  (119) 
N

>  <AVAILABILITY_TYPE>  (119) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (119) 
nan

>  <WITHDRAWN_COUNTRY>  (119) 
nan

>  <WITHDRAWN_REASON>  (119) 
nan

>  <CANONICAL_SMILES>  (119) 
CNC[C@H](O)c1cccc(O)c1

>  <name>  (119) 
Phenylephrine 

>  <MW>  (119) 
167.208

>  <logP>  (119) 
0.645

$$$$
CHEMBL524
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 10  3  1  0
M  END
>  <PARENT_MOLREGNO>  (120) 
11775

>  <SYNONYMS>  (120) 
Methoxamine (BAN, INN); Methoxamine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (120) 
4

>  <RESEARCH_CODES>  (120) 
nan

>  <APPLICANTS>  (120) 
GlaxoSmithKline

>  <USAN_STEM>  (120) 
nan

>  <USAN_STEM_DEFINITION>  (120) 
nan

>  <USAN_STEM_SUBSTEM>  (120) 
nan

>  <USAN_YEAR>  (120) 
nan

>  <FIRST_APPROVAL>  (120) 
1982.0

>  <ATC_CODE>  (120) 
C01CA10

>  <ATC_CODE_DESCRIPTION>  (120) 
C01CA10 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (120) 
nan

>  <SC_PATENT_NO>  (120) 
nan

>  <DRUG_TYPE>  (120) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (120) 
Y

>  <FIRST_IN_CLASS>  (120) 
N

>  <CHIRALITY>  (120) 
Racemic Mixture

>  <PRODRUG>  (120) 
N

>  <ORAL>  (120) 
N

>  <PARENTERAL>  (120) 
Y

>  <TOPICAL>  (120) 
N

>  <BLACK_BOX>  (120) 
N

>  <AVAILABILITY_TYPE>  (120) 
Discontinued

>  <WITHDRAWN_YEAR>  (120) 
nan

>  <WITHDRAWN_COUNTRY>  (120) 
nan

>  <WITHDRAWN_REASON>  (120) 
nan

>  <CANONICAL_SMILES>  (120) 
COc1ccc(OC)c(c1)C(O)C(C)N

>  <name>  (120) 
Methoxamine 

>  <MW>  (120) 
211.261

>  <logP>  (120) 
1.0844

$$$$
CHEMBL1201264
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 12  1  0
 18 13  1  0
 25 20  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (121) 
675215

>  <SYNONYMS>  (121) 
Methantheline Bromide (FDA, USP); Methanthelinium Bromide (BAN, DCF, INN)

>  <DEVELOPMENT_PHASE>  (121) 
4

>  <RESEARCH_CODES>  (121) 
nan

>  <APPLICANTS>  (121) 
Shire Development Inc

>  <USAN_STEM>  (121) 
nan

>  <USAN_STEM_DEFINITION>  (121) 
nan

>  <USAN_STEM_SUBSTEM>  (121) 
nan

>  <USAN_YEAR>  (121) 
nan

>  <FIRST_APPROVAL>  (121) 
1951.0

>  <ATC_CODE>  (121) 
A03AB07

>  <ATC_CODE_DESCRIPTION>  (121) 
A03AB07 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (121) 
nan

>  <SC_PATENT_NO>  (121) 
nan

>  <DRUG_TYPE>  (121) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (121) 
Y

>  <FIRST_IN_CLASS>  (121) 
N

>  <CHIRALITY>  (121) 
Achiral Molecule

>  <PRODRUG>  (121) 
N

>  <ORAL>  (121) 
Y

>  <PARENTERAL>  (121) 
N

>  <TOPICAL>  (121) 
N

>  <BLACK_BOX>  (121) 
N

>  <AVAILABILITY_TYPE>  (121) 
Discontinued

>  <WITHDRAWN_YEAR>  (121) 
nan

>  <WITHDRAWN_COUNTRY>  (121) 
nan

>  <WITHDRAWN_REASON>  (121) 
nan

>  <CANONICAL_SMILES>  (121) 
CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc3ccccc13

>  <name>  (121) 
Methantheline Bromide 

>  <MW>  (121) 
340.443

>  <logP>  (121) 
3.9538

$$$$
CHEMBL1997663
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  1  0
 18 28  1  0
 28 29  2  0
 29  7  1  0
 28 10  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (122) 
1318954

>  <SYNONYMS>  (122) 
Ethacizine

>  <DEVELOPMENT_PHASE>  (122) 
4

>  <RESEARCH_CODES>  (122) 
nan

>  <APPLICANTS>  (122) 
nan

>  <USAN_STEM>  (122) 
nan

>  <USAN_STEM_DEFINITION>  (122) 
nan

>  <USAN_STEM_SUBSTEM>  (122) 
nan

>  <USAN_YEAR>  (122) 
nan

>  <FIRST_APPROVAL>  (122) 
nan

>  <ATC_CODE>  (122) 
C01BC09

>  <ATC_CODE_DESCRIPTION>  (122) 
C01BC09 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ic]

>  <INDICATION_CLASS>  (122) 
nan

>  <SC_PATENT_NO>  (122) 
nan

>  <DRUG_TYPE>  (122) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (122) 
Y

>  <FIRST_IN_CLASS>  (122) 
N

>  <CHIRALITY>  (122) 
Achiral Molecule

>  <PRODRUG>  (122) 
N

>  <ORAL>  (122) 
N

>  <PARENTERAL>  (122) 
N

>  <TOPICAL>  (122) 
N

>  <BLACK_BOX>  (122) 
N

>  <AVAILABILITY_TYPE>  (122) 
Unknown

>  <WITHDRAWN_YEAR>  (122) 
nan

>  <WITHDRAWN_COUNTRY>  (122) 
nan

>  <WITHDRAWN_REASON>  (122) 
nan

>  <CANONICAL_SMILES>  (122) 
CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN(CC)CC)c2c1

>  <name>  (122) 
Ethacizine

>  <MW>  (122) 
413.543

>  <logP>  (122) 
5.1162

$$$$
CHEMBL2095212
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 12 25  1  0
 25 26  2  0
  4 27  2  0
 27 28  1  0
 28  2  1  0
 26  9  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (123) 
1369608

>  <SYNONYMS>  (123) 
Mirabegron (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (123) 
4

>  <RESEARCH_CODES>  (123) 
YM-178

>  <APPLICANTS>  (123) 
Astellas Pharma Global Development Inc

>  <USAN_STEM>  (123) 
-begron

>  <USAN_STEM_DEFINITION>  (123) 
beta 3 adrenoreceptor agonist

>  <USAN_STEM_SUBSTEM>  (123) 
-begron

>  <USAN_YEAR>  (123) 
2009.0

>  <FIRST_APPROVAL>  (123) 
2012.0

>  <ATC_CODE>  (123) 
G04BD12

>  <ATC_CODE_DESCRIPTION>  (123) 
G04BD12 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (123) 
nan

>  <SC_PATENT_NO>  (123) 
US-6346532-B1

>  <DRUG_TYPE>  (123) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (123) 
Y

>  <FIRST_IN_CLASS>  (123) 
Y

>  <CHIRALITY>  (123) 
Single Stereoisomer

>  <PRODRUG>  (123) 
N

>  <ORAL>  (123) 
Y

>  <PARENTERAL>  (123) 
N

>  <TOPICAL>  (123) 
N

>  <BLACK_BOX>  (123) 
N

>  <AVAILABILITY_TYPE>  (123) 
Prescription-only

>  <WITHDRAWN_YEAR>  (123) 
nan

>  <WITHDRAWN_COUNTRY>  (123) 
nan

>  <WITHDRAWN_REASON>  (123) 
nan

>  <CANONICAL_SMILES>  (123) 
Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1

>  <name>  (123) 
Mirabegron 

>  <MW>  (123) 
396.516

>  <logP>  (123) 
2.7722

$$$$
CHEMBL315838
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
  8  3  1  0
 17 12  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (124) 
139046

>  <SYNONYMS>  (124) 
Encainide (BAN, INN); Encainide HCl (USAN)

>  <DEVELOPMENT_PHASE>  (124) 
4

>  <RESEARCH_CODES>  (124) 
MJ-9067-1

>  <APPLICANTS>  (124) 
Bristol Labs

>  <USAN_STEM>  (124) 
nan

>  <USAN_STEM_DEFINITION>  (124) 
nan

>  <USAN_STEM_SUBSTEM>  (124) 
nan

>  <USAN_YEAR>  (124) 
1978.0

>  <FIRST_APPROVAL>  (124) 
1986.0

>  <ATC_CODE>  (124) 
C01BC08

>  <ATC_CODE_DESCRIPTION>  (124) 
C01BC08 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ic]

>  <INDICATION_CLASS>  (124) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (124) 
nan

>  <DRUG_TYPE>  (124) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (124) 
Y

>  <FIRST_IN_CLASS>  (124) 
N

>  <CHIRALITY>  (124) 
Racemic Mixture

>  <PRODRUG>  (124) 
N

>  <ORAL>  (124) 
N

>  <PARENTERAL>  (124) 
N

>  <TOPICAL>  (124) 
N

>  <BLACK_BOX>  (124) 
N

>  <AVAILABILITY_TYPE>  (124) 
Withdrawn

>  <WITHDRAWN_YEAR>  (124) 
1991.0

>  <WITHDRAWN_COUNTRY>  (124) 
United Kingdom; United States

>  <WITHDRAWN_REASON>  (124) 
Ventricular arrhythmias; Cardiotoxicity and Excess Mortality

>  <CANONICAL_SMILES>  (124) 
COc1ccc(cc1)C(=O)Nc2ccccc2CCC3CCCCN3C

>  <name>  (124) 
Encainide 

>  <MW>  (124) 
352.478

>  <logP>  (124) 
4.3644

$$$$
CHEMBL282724
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 10  2  1  0
  8  4  2  0
 18 14  2  0
 28 23  2  0
M  END
>  <PARENT_MOLREGNO>  (125) 
23417

>  <SYNONYMS>  (125) 
Sitaxentan (INN); Sitaxentan Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (125) 
4

>  <RESEARCH_CODES>  (125) 
TBC-11251NA; TBC-11251Z

>  <APPLICANTS>  (125) 
Pfizer Inc.

>  <USAN_STEM>  (125) 
-entan

>  <USAN_STEM_DEFINITION>  (125) 
endothelin receptor antagonists

>  <USAN_STEM_SUBSTEM>  (125) 
-entan

>  <USAN_YEAR>  (125) 
2011.0

>  <FIRST_APPROVAL>  (125) 
2006.0

>  <ATC_CODE>  (125) 
C02KX03

>  <ATC_CODE_DESCRIPTION>  (125) 
C02KX03 [Cardiovascular System:Antihypertensives:Other Antihypertensives:Other antihypertensives]

>  <INDICATION_CLASS>  (125) 
nan

>  <SC_PATENT_NO>  (125) 
nan

>  <DRUG_TYPE>  (125) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (125) 
Y

>  <FIRST_IN_CLASS>  (125) 
N

>  <CHIRALITY>  (125) 
Achiral Molecule

>  <PRODRUG>  (125) 
N

>  <ORAL>  (125) 
N

>  <PARENTERAL>  (125) 
N

>  <TOPICAL>  (125) 
N

>  <BLACK_BOX>  (125) 
N

>  <AVAILABILITY_TYPE>  (125) 
Withdrawn

>  <WITHDRAWN_YEAR>  (125) 
2010.0

>  <WITHDRAWN_COUNTRY>  (125) 
European Union; European Union

>  <WITHDRAWN_REASON>  (125) 
Liver toxicity; Liver toxicity

>  <CANONICAL_SMILES>  (125) 
Cc1cc2OCOc2cc1CC(=O)c3sccc3S(=O)(=O)Nc4onc(C)c4Cl

>  <name>  (125) 
Sitaxentan 

>  <MW>  (125) 
454.913

>  <logP>  (125) 
3.96124

$$$$
CHEMBL54976
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  2 13  1  0
 13 14  2  0
 13 15  1  0
 12  4  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (126) 
84633

>  <SYNONYMS>  (126) 
L-Tryptophan (JAN); Tryptophan (INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (126) 
4

>  <RESEARCH_CODES>  (126) 
nan

>  <APPLICANTS>  (126) 
nan

>  <USAN_STEM>  (126) 
nan

>  <USAN_STEM_DEFINITION>  (126) 
nan

>  <USAN_STEM_SUBSTEM>  (126) 
nan

>  <USAN_YEAR>  (126) 
1979.0

>  <FIRST_APPROVAL>  (126) 
nan

>  <ATC_CODE>  (126) 
N06AX02

>  <ATC_CODE_DESCRIPTION>  (126) 
N06AX02 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (126) 
Amino Acid

>  <SC_PATENT_NO>  (126) 
nan

>  <DRUG_TYPE>  (126) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (126) 
Y

>  <FIRST_IN_CLASS>  (126) 
N

>  <CHIRALITY>  (126) 
Single Stereoisomer

>  <PRODRUG>  (126) 
N

>  <ORAL>  (126) 
N

>  <PARENTERAL>  (126) 
N

>  <TOPICAL>  (126) 
N

>  <BLACK_BOX>  (126) 
N

>  <AVAILABILITY_TYPE>  (126) 
Withdrawn

>  <WITHDRAWN_YEAR>  (126) 
1989.0

>  <WITHDRAWN_COUNTRY>  (126) 
United Kingdom; Germany

>  <WITHDRAWN_REASON>  (126) 
Eosinophilic Myalgia Syndrome

>  <CANONICAL_SMILES>  (126) 
N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

>  <name>  (126) 
L-Tryptophan 

>  <MW>  (126) 
204.229

>  <logP>  (126) 
1.1223

$$$$
CHEMBL531
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 12  4  1  0
 21 11  1  0
 22 14  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (127) 
12494

>  <SYNONYMS>  (127) 
Pergolide (BAN, INN); Pergolide Mesylate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (127) 
4

>  <RESEARCH_CODES>  (127) 
LY-127809

>  <APPLICANTS>  (127) 
Valeant Pharmaceuticals International

>  <USAN_STEM>  (127) 
-erg-

>  <USAN_STEM_DEFINITION>  (127) 
ergot alkaloid derivatives

>  <USAN_STEM_SUBSTEM>  (127) 
-erg-

>  <USAN_YEAR>  (127) 
1979.0

>  <FIRST_APPROVAL>  (127) 
1988.0

>  <ATC_CODE>  (127) 
N04BC02

>  <ATC_CODE_DESCRIPTION>  (127) 
N04BC02 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopamine agonists]

>  <INDICATION_CLASS>  (127) 
Dopamine Agonist

>  <SC_PATENT_NO>  (127) 
nan

>  <DRUG_TYPE>  (127) 
Natural Product-derived

>  <RULE_OF_FIVE>  (127) 
Y

>  <FIRST_IN_CLASS>  (127) 
N

>  <CHIRALITY>  (127) 
Single Stereoisomer

>  <PRODRUG>  (127) 
N

>  <ORAL>  (127) 
Y

>  <PARENTERAL>  (127) 
N

>  <TOPICAL>  (127) 
N

>  <BLACK_BOX>  (127) 
N

>  <AVAILABILITY_TYPE>  (127) 
Withdrawn

>  <WITHDRAWN_YEAR>  (127) 
2007.0

>  <WITHDRAWN_COUNTRY>  (127) 
United States

>  <WITHDRAWN_REASON>  (127) 
Risk for heart valve damage

>  <CANONICAL_SMILES>  (127) 
CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34

>  <name>  (127) 
Pergolide 

>  <MW>  (127) 
314.498

>  <logP>  (127) 
4.2711

$$$$
CHEMBL400599
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
  2 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
  9  4  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (128) 
418415

>  <SYNONYMS>  (128) 
Benfluorex (BAN, DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (128) 
4

>  <RESEARCH_CODES>  (128) 
nan

>  <APPLICANTS>  (128) 
nan

>  <USAN_STEM>  (128) 
-orex

>  <USAN_STEM_DEFINITION>  (128) 
anorexiants

>  <USAN_STEM_SUBSTEM>  (128) 
-orex

>  <USAN_YEAR>  (128) 
nan

>  <FIRST_APPROVAL>  (128) 
1974.0

>  <ATC_CODE>  (128) 
A10BX06

>  <ATC_CODE_DESCRIPTION>  (128) 
A10BX06 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Other blood glucose lowering drugs, excl. insulins]

>  <INDICATION_CLASS>  (128) 
nan

>  <SC_PATENT_NO>  (128) 
nan

>  <DRUG_TYPE>  (128) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (128) 
Y

>  <FIRST_IN_CLASS>  (128) 
N

>  <CHIRALITY>  (128) 
Racemic Mixture

>  <PRODRUG>  (128) 
N

>  <ORAL>  (128) 
N

>  <PARENTERAL>  (128) 
N

>  <TOPICAL>  (128) 
N

>  <BLACK_BOX>  (128) 
N

>  <AVAILABILITY_TYPE>  (128) 
Withdrawn

>  <WITHDRAWN_YEAR>  (128) 
2009.0

>  <WITHDRAWN_COUNTRY>  (128) 
European Union

>  <WITHDRAWN_REASON>  (128) 
Cardiac valvulopathy; Pulmonary arterial hypertension

>  <CANONICAL_SMILES>  (128) 
CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c2ccccc2

>  <name>  (128) 
Benfluorex 

>  <MW>  (128) 
351.368

>  <logP>  (128) 
4.083

$$$$
CHEMBL2104537
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 16 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 10  3  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (129) 
1376807

>  <SYNONYMS>  (129) 
Amoproxan (DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (129) 
4

>  <RESEARCH_CODES>  (129) 
CERM-730

>  <APPLICANTS>  (129) 
nan

>  <USAN_STEM>  (129) 
nan

>  <USAN_STEM_DEFINITION>  (129) 
nan

>  <USAN_STEM_SUBSTEM>  (129) 
nan

>  <USAN_YEAR>  (129) 
nan

>  <FIRST_APPROVAL>  (129) 
nan

>  <ATC_CODE>  (129) 
nan

>  <ATC_CODE_DESCRIPTION>  (129) 
nan

>  <INDICATION_CLASS>  (129) 
nan

>  <SC_PATENT_NO>  (129) 
nan

>  <DRUG_TYPE>  (129) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (129) 
Y

>  <FIRST_IN_CLASS>  (129) 
N

>  <CHIRALITY>  (129) 
Racemic Mixture

>  <PRODRUG>  (129) 
N

>  <ORAL>  (129) 
N

>  <PARENTERAL>  (129) 
N

>  <TOPICAL>  (129) 
N

>  <BLACK_BOX>  (129) 
N

>  <AVAILABILITY_TYPE>  (129) 
Withdrawn

>  <WITHDRAWN_YEAR>  (129) 
1970.0

>  <WITHDRAWN_COUNTRY>  (129) 
France

>  <WITHDRAWN_REASON>  (129) 
Dermatologic and Ophthalmic Toxicity

>  <CANONICAL_SMILES>  (129) 
COc1cc(cc(OC)c1OC)C(=O)OC(COCCC(C)C)CN2CCOCC2

>  <name>  (129) 
Amoproxan 

>  <MW>  (129) 
425.522

>  <logP>  (129) 
2.6327

$$$$
CHEMBL21731
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  9 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 15  6  1  0
 21  6  1  0
 15 10  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (130) 
27713

>  <SYNONYMS>  (130) 
Maprotiline (BAN, INN, USAN); Maprotiline HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (130) 
4

>  <RESEARCH_CODES>  (130) 
BA-34276 [As Hydrochloride]

>  <APPLICANTS>  (130) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (130) 
nan

>  <USAN_STEM_DEFINITION>  (130) 
nan

>  <USAN_STEM_SUBSTEM>  (130) 
nan

>  <USAN_YEAR>  (130) 
1971.0

>  <FIRST_APPROVAL>  (130) 
1980.0

>  <ATC_CODE>  (130) 
N06AA21

>  <ATC_CODE_DESCRIPTION>  (130) 
N06AA21 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (130) 
Antidepressant

>  <SC_PATENT_NO>  (130) 
nan

>  <DRUG_TYPE>  (130) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (130) 
Y

>  <FIRST_IN_CLASS>  (130) 
N

>  <CHIRALITY>  (130) 
Achiral Molecule

>  <PRODRUG>  (130) 
N

>  <ORAL>  (130) 
Y

>  <PARENTERAL>  (130) 
N

>  <TOPICAL>  (130) 
N

>  <BLACK_BOX>  (130) 
Y

>  <AVAILABILITY_TYPE>  (130) 
Prescription-only

>  <WITHDRAWN_YEAR>  (130) 
nan

>  <WITHDRAWN_COUNTRY>  (130) 
nan

>  <WITHDRAWN_REASON>  (130) 
nan

>  <CANONICAL_SMILES>  (130) 
CNCCCC12CCC(c3ccccc13)c4ccccc24

>  <name>  (130) 
Maprotiline 

>  <MW>  (130) 
277.411

>  <logP>  (130) 
4.2114

$$$$
CHEMBL1266
     RDKit          

 15 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15  1  1  0
  8  4  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (131) 
245084

>  <SYNONYMS>  (131) 
Tetryzoline (INN, BAN, DCF); Tetrahydrozoline HCl (FDA, USP); Tetrahydrozoline Nitrate (JAN); Tetryzoline HCl (JAN)

>  <DEVELOPMENT_PHASE>  (131) 
4

>  <RESEARCH_CODES>  (131) 
nan

>  <APPLICANTS>  (131) 
Fougera Pharmaceuticals Inc

>  <USAN_STEM>  (131) 
nan

>  <USAN_STEM_DEFINITION>  (131) 
nan

>  <USAN_STEM_SUBSTEM>  (131) 
nan

>  <USAN_YEAR>  (131) 
nan

>  <FIRST_APPROVAL>  (131) 
1979.0

>  <ATC_CODE>  (131) 
R01AA06; S01GA02; S01GA52; R01AB03

>  <ATC_CODE_DESCRIPTION>  (131) 
R01AA06 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, plain]; S01GA02 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]; S01GA52 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]; R01AB03 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, combinations excl. corticosteroids]

>  <INDICATION_CLASS>  (131) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (131) 
nan

>  <DRUG_TYPE>  (131) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (131) 
Y

>  <FIRST_IN_CLASS>  (131) 
N

>  <CHIRALITY>  (131) 
Racemic Mixture

>  <PRODRUG>  (131) 
N

>  <ORAL>  (131) 
N

>  <PARENTERAL>  (131) 
N

>  <TOPICAL>  (131) 
Y

>  <BLACK_BOX>  (131) 
N

>  <AVAILABILITY_TYPE>  (131) 
Prescription-only

>  <WITHDRAWN_YEAR>  (131) 
nan

>  <WITHDRAWN_COUNTRY>  (131) 
nan

>  <WITHDRAWN_REASON>  (131) 
nan

>  <CANONICAL_SMILES>  (131) 
C1CC(C2=NCCN2)c3ccccc3C1

>  <name>  (131) 
Tetryzoline 

>  <MW>  (131) 
200.285

>  <logP>  (131) 
2.1082

$$$$
CHEMBL1380
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  2  0
 12 20  1  0
 20 21  2  0
 21  2  1  0
  8  6  1  0
 20  9  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (132) 
321707

>  <SYNONYMS>  (132) 
Abacavir (BAN, INN); Abacavir Sulfate (FDA, USAN); Abacavir Succinate (USAN)

>  <DEVELOPMENT_PHASE>  (132) 
4

>  <RESEARCH_CODES>  (132) 
1592U89

>  <APPLICANTS>  (132) 
Viiv Healthcare Co; Glaxo Wellcome

>  <USAN_STEM>  (132) 
-vir

>  <USAN_STEM_DEFINITION>  (132) 
antivirals: carbocyclic nucleosides

>  <USAN_STEM_SUBSTEM>  (132) 
-vir (-cavir)

>  <USAN_YEAR>  (132) 
1996.0

>  <FIRST_APPROVAL>  (132) 
1998.0

>  <ATC_CODE>  (132) 
J05AF06

>  <ATC_CODE_DESCRIPTION>  (132) 
J05AF06 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (132) 
Antiviral

>  <SC_PATENT_NO>  (132) 
US-5905082-A

>  <DRUG_TYPE>  (132) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (132) 
Y

>  <FIRST_IN_CLASS>  (132) 
N

>  <CHIRALITY>  (132) 
Single Stereoisomer

>  <PRODRUG>  (132) 
Y

>  <ORAL>  (132) 
Y

>  <PARENTERAL>  (132) 
N

>  <TOPICAL>  (132) 
N

>  <BLACK_BOX>  (132) 
Y

>  <AVAILABILITY_TYPE>  (132) 
Prescription-only

>  <WITHDRAWN_YEAR>  (132) 
nan

>  <WITHDRAWN_COUNTRY>  (132) 
nan

>  <WITHDRAWN_REASON>  (132) 
nan

>  <CANONICAL_SMILES>  (132) 
Nc1nc(NC2CC2)c3ncn([C@@H]4C[C@H](CO)C=C4)c3n1

>  <name>  (132) 
Abacavir 

>  <MW>  (132) 
286.339

>  <logP>  (132) 
1.0923

$$$$
CHEMBL1349
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 13  1  0
 23 16  2  0
M  END
>  <PARENT_MOLREGNO>  (133) 
297372

>  <SYNONYMS>  (133) 
Valaciclovir (INN, BAN); Valacyclovir HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (133) 
4

>  <RESEARCH_CODES>  (133) 
256U87 HCl

>  <APPLICANTS>  (133) 
GlaxoSmithKline

>  <USAN_STEM>  (133) 
-vir

>  <USAN_STEM_DEFINITION>  (133) 
antivirals: antivirals (acyclovir type)

>  <USAN_STEM_SUBSTEM>  (133) 
-vir (-cyclovir)

>  <USAN_YEAR>  (133) 
1993.0

>  <FIRST_APPROVAL>  (133) 
1995.0

>  <ATC_CODE>  (133) 
J05AB11

>  <ATC_CODE_DESCRIPTION>  (133) 
J05AB11 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (133) 
Antiviral

>  <SC_PATENT_NO>  (133) 
US-5879706-A

>  <DRUG_TYPE>  (133) 
Natural Product-derived

>  <RULE_OF_FIVE>  (133) 
Y

>  <FIRST_IN_CLASS>  (133) 
N

>  <CHIRALITY>  (133) 
Single Stereoisomer

>  <PRODRUG>  (133) 
Y

>  <ORAL>  (133) 
Y

>  <PARENTERAL>  (133) 
N

>  <TOPICAL>  (133) 
N

>  <BLACK_BOX>  (133) 
N

>  <AVAILABILITY_TYPE>  (133) 
Prescription-only

>  <WITHDRAWN_YEAR>  (133) 
nan

>  <WITHDRAWN_COUNTRY>  (133) 
nan

>  <WITHDRAWN_REASON>  (133) 
nan

>  <CANONICAL_SMILES>  (133) 
CC(C)[C@H](N)C(=O)OCCOCn1cnc2C(=O)N=C(N)Nc12

>  <name>  (133) 
Valaciclovir 

>  <MW>  (133) 
324.341

>  <logP>  (133) 
-0.7976

$$$$
CHEMBL1346
     RDKit          

 32 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
  8 20  1  0
  4 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
  4 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 20  5  1  0
 19 11  1  0
 18 14  1  0
 26 21  1  0
 32 27  1  0
M  END
>  <PARENT_MOLREGNO>  (134) 
291960

>  <SYNONYMS>  (134) 
Darifenacin (BAN, INN, USAN); Darifenacin Hydrobromide (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (134) 
4

>  <RESEARCH_CODES>  (134) 
UK-88525; UK-88525-04

>  <APPLICANTS>  (134) 
Warner Chilcott Co Llc

>  <USAN_STEM>  (134) 
nan

>  <USAN_STEM_DEFINITION>  (134) 
nan

>  <USAN_STEM_SUBSTEM>  (134) 
nan

>  <USAN_YEAR>  (134) 
2004.0

>  <FIRST_APPROVAL>  (134) 
2004.0

>  <ATC_CODE>  (134) 
G04BD10

>  <ATC_CODE_DESCRIPTION>  (134) 
G04BD10 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (134) 
nan

>  <SC_PATENT_NO>  (134) 
US-6106864-A

>  <DRUG_TYPE>  (134) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (134) 
Y

>  <FIRST_IN_CLASS>  (134) 
N

>  <CHIRALITY>  (134) 
Single Stereoisomer

>  <PRODRUG>  (134) 
N

>  <ORAL>  (134) 
Y

>  <PARENTERAL>  (134) 
N

>  <TOPICAL>  (134) 
N

>  <BLACK_BOX>  (134) 
N

>  <AVAILABILITY_TYPE>  (134) 
Prescription-only

>  <WITHDRAWN_YEAR>  (134) 
nan

>  <WITHDRAWN_COUNTRY>  (134) 
nan

>  <WITHDRAWN_REASON>  (134) 
nan

>  <CANONICAL_SMILES>  (134) 
NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5

>  <name>  (134) 
Darifenacin 

>  <MW>  (134) 
426.56

>  <logP>  (134) 
3.9575

$$$$
CHEMBL1096562
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
M  END
>  <PARENT_MOLREGNO>  (135) 
624125

>  <SYNONYMS>  (135) 
Methyl Aminolevulinate HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (135) 
4

>  <RESEARCH_CODES>  (135) 
P-1202

>  <APPLICANTS>  (135) 
Galderma Laboratories Lp

>  <USAN_STEM>  (135) 
nan

>  <USAN_STEM_DEFINITION>  (135) 
nan

>  <USAN_STEM_SUBSTEM>  (135) 
nan

>  <USAN_YEAR>  (135) 
2002.0

>  <FIRST_APPROVAL>  (135) 
2004.0

>  <ATC_CODE>  (135) 
L01XD03

>  <ATC_CODE_DESCRIPTION>  (135) 
L01XD03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Sensitizers used in photodynamic/radiation therapy]

>  <INDICATION_CLASS>  (135) 
nan

>  <SC_PATENT_NO>  (135) 
US-6034267-A

>  <DRUG_TYPE>  (135) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (135) 
Y

>  <FIRST_IN_CLASS>  (135) 
N

>  <CHIRALITY>  (135) 
Achiral Molecule

>  <PRODRUG>  (135) 
Y

>  <ORAL>  (135) 
N

>  <PARENTERAL>  (135) 
N

>  <TOPICAL>  (135) 
Y

>  <BLACK_BOX>  (135) 
N

>  <AVAILABILITY_TYPE>  (135) 
Prescription-only

>  <WITHDRAWN_YEAR>  (135) 
nan

>  <WITHDRAWN_COUNTRY>  (135) 
nan

>  <WITHDRAWN_REASON>  (135) 
nan

>  <CANONICAL_SMILES>  (135) 
COC(=O)CCC(=O)CN

>  <name>  (135) 
Methyl Aminolevulinate HCl 

>  <MW>  (135) 
145.158

>  <logP>  (135) 
-0.5326

$$$$
CHEMBL27
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 10  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (136) 
1370

>  <SYNONYMS>  (136) 
Propranolol (BAN, INN); Propranolol HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (136) 
4

>  <RESEARCH_CODES>  (136) 
AY-64043; ICI-45520

>  <APPLICANTS>  (136) 
Wyeth Ayerst Laboratories; GlaxoSmithKline Llc; Baxter Healthcare Corp Anesthesia Critical Care; Akrimax Pharmaceuticals Llc

>  <USAN_STEM>  (136) 
-olol

>  <USAN_STEM_DEFINITION>  (136) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (136) 
-olol

>  <USAN_YEAR>  (136) 
1965.0

>  <FIRST_APPROVAL>  (136) 
1967.0

>  <ATC_CODE>  (136) 
C07AA05

>  <ATC_CODE_DESCRIPTION>  (136) 
C07AA05 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (136) 
Anti-Adrenergic (beta-receptor); Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (136) 
US-6500454-B1

>  <DRUG_TYPE>  (136) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (136) 
Y

>  <FIRST_IN_CLASS>  (136) 
N

>  <CHIRALITY>  (136) 
Racemic Mixture

>  <PRODRUG>  (136) 
N

>  <ORAL>  (136) 
Y

>  <PARENTERAL>  (136) 
Y

>  <TOPICAL>  (136) 
N

>  <BLACK_BOX>  (136) 
Y

>  <AVAILABILITY_TYPE>  (136) 
Prescription-only

>  <WITHDRAWN_YEAR>  (136) 
nan

>  <WITHDRAWN_COUNTRY>  (136) 
nan

>  <WITHDRAWN_REASON>  (136) 
nan

>  <CANONICAL_SMILES>  (136) 
CC(C)NCC(O)COc1cccc2ccccc12

>  <name>  (136) 
Propranolol 

>  <MW>  (136) 
259.349

>  <logP>  (136) 
2.5775

$$$$
CHEMBL597
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
  7  2  1  0
 14 10  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (137) 
20131

>  <SYNONYMS>  (137) 
Phentolamine (BAN, INN); Phentolamine HCl (MI, USP); Phentolamine Mesilate (INN, JAN); Phentolamine Mesylate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (137) 
4

>  <RESEARCH_CODES>  (137) 
nan

>  <APPLICANTS>  (137) 
Septodont Holding Sas; Novartis Pharmaceuticals Corp; Ciba-Geigy

>  <USAN_STEM>  (137) 
nan

>  <USAN_STEM_DEFINITION>  (137) 
nan

>  <USAN_STEM_SUBSTEM>  (137) 
nan

>  <USAN_YEAR>  (137) 
nan

>  <FIRST_APPROVAL>  (137) 
1952.0

>  <ATC_CODE>  (137) 
V03AB36; C04AB01

>  <ATC_CODE_DESCRIPTION>  (137) 
V03AB36 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]; C04AB01 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Imidazoline derivatives]

>  <INDICATION_CLASS>  (137) 
Anti-Adrenergic

>  <SC_PATENT_NO>  (137) 
US-6764678-B2

>  <DRUG_TYPE>  (137) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (137) 
Y

>  <FIRST_IN_CLASS>  (137) 
N

>  <CHIRALITY>  (137) 
Achiral Molecule

>  <PRODRUG>  (137) 
N

>  <ORAL>  (137) 
N

>  <PARENTERAL>  (137) 
Y

>  <TOPICAL>  (137) 
N

>  <BLACK_BOX>  (137) 
N

>  <AVAILABILITY_TYPE>  (137) 
Prescription-only

>  <WITHDRAWN_YEAR>  (137) 
nan

>  <WITHDRAWN_COUNTRY>  (137) 
nan

>  <WITHDRAWN_REASON>  (137) 
nan

>  <CANONICAL_SMILES>  (137) 
Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3

>  <name>  (137) 
Phentolamine 

>  <MW>  (137) 
281.359

>  <logP>  (137) 
2.84042

$$$$
CHEMBL472
     RDKit          

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 18 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
  9  3  1  0
 20 15  1  0
 33 28  1  0
M  END
>  <PARENT_MOLREGNO>  (138) 
5582

>  <SYNONYMS>  (138) 
Glibenclamide (BAN, DCF, INN, JAN); Glyburide (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (138) 
4

>  <RESEARCH_CODES>  (138) 
HB 419; HB-419; U-26452

>  <APPLICANTS>  (138) 
Sanofi Aventis Us Llc; Pharmacia And Upjohn Co; Bristol Myers Squibb

>  <USAN_STEM>  (138) 
nan

>  <USAN_STEM_DEFINITION>  (138) 
nan

>  <USAN_STEM_SUBSTEM>  (138) 
nan

>  <USAN_YEAR>  (138) 
1969.0

>  <FIRST_APPROVAL>  (138) 
1984.0

>  <ATC_CODE>  (138) 
A10BB01

>  <ATC_CODE_DESCRIPTION>  (138) 
A10BB01 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (138) 
Antidiabetic

>  <SC_PATENT_NO>  (138) 
US-6303146-B1

>  <DRUG_TYPE>  (138) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (138) 
Y

>  <FIRST_IN_CLASS>  (138) 
N

>  <CHIRALITY>  (138) 
Achiral Molecule

>  <PRODRUG>  (138) 
N

>  <ORAL>  (138) 
Y

>  <PARENTERAL>  (138) 
N

>  <TOPICAL>  (138) 
N

>  <BLACK_BOX>  (138) 
N

>  <AVAILABILITY_TYPE>  (138) 
Prescription-only

>  <WITHDRAWN_YEAR>  (138) 
nan

>  <WITHDRAWN_COUNTRY>  (138) 
nan

>  <WITHDRAWN_REASON>  (138) 
nan

>  <CANONICAL_SMILES>  (138) 
COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3

>  <name>  (138) 
Glibenclamide 

>  <MW>  (138) 
494.013

>  <logP>  (138) 
3.6417

$$$$
CHEMBL15891
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11  2  1  0
M  END
>  <PARENT_MOLREGNO>  (139) 
16654

>  <SYNONYMS>  (139) 
Lindane (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (139) 
4

>  <RESEARCH_CODES>  (139) 
nan

>  <APPLICANTS>  (139) 
Reed And Carnrick Pharmaceuticals Div Block Drug Co Inc

>  <USAN_STEM>  (139) 
nan

>  <USAN_STEM_DEFINITION>  (139) 
nan

>  <USAN_STEM_SUBSTEM>  (139) 
nan

>  <USAN_YEAR>  (139) 
1980.0

>  <FIRST_APPROVAL>  (139) 
1974.0

>  <ATC_CODE>  (139) 
P03AB02

>  <ATC_CODE_DESCRIPTION>  (139) 
P03AB02 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides:Chlorine containing products]

>  <INDICATION_CLASS>  (139) 
Pediculicide; Scabicide

>  <SC_PATENT_NO>  (139) 
nan

>  <DRUG_TYPE>  (139) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (139) 
Y

>  <FIRST_IN_CLASS>  (139) 
N

>  <CHIRALITY>  (139) 
Single Stereoisomer

>  <PRODRUG>  (139) 
N

>  <ORAL>  (139) 
N

>  <PARENTERAL>  (139) 
N

>  <TOPICAL>  (139) 
Y

>  <BLACK_BOX>  (139) 
Y

>  <AVAILABILITY_TYPE>  (139) 
Prescription-only

>  <WITHDRAWN_YEAR>  (139) 
nan

>  <WITHDRAWN_COUNTRY>  (139) 
nan

>  <WITHDRAWN_REASON>  (139) 
nan

>  <CANONICAL_SMILES>  (139) 
Cl[C@@H]1[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl

>  <name>  (139) 
Lindane 

>  <MW>  (139) 
290.832

>  <logP>  (139) 
3.6444

$$$$
CHEMBL12713
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 14 23  1  0
 23 24  1  0
 10 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 29 30  1  0
 30 31  2  0
  7  2  1  0
 31  8  1  0
 24 11  1  0
 21 17  1  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (140) 
10813

>  <SYNONYMS>  (140) 
Sertindole (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (140) 
4

>  <RESEARCH_CODES>  (140) 
nan

>  <APPLICANTS>  (140) 
Lundbeck, Denmark; Abbott

>  <USAN_STEM>  (140) 
nan

>  <USAN_STEM_DEFINITION>  (140) 
nan

>  <USAN_STEM_SUBSTEM>  (140) 
nan

>  <USAN_YEAR>  (140) 
1992.0

>  <FIRST_APPROVAL>  (140) 
nan

>  <ATC_CODE>  (140) 
N05AE03

>  <ATC_CODE_DESCRIPTION>  (140) 
N05AE03 [Nervous System:Psycholeptics:Antipsychotics:Indole derivatives]

>  <INDICATION_CLASS>  (140) 
Antipsychotic; Neuroleptic

>  <SC_PATENT_NO>  (140) 
nan

>  <DRUG_TYPE>  (140) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (140) 
Y

>  <FIRST_IN_CLASS>  (140) 
N

>  <CHIRALITY>  (140) 
Achiral Molecule

>  <PRODRUG>  (140) 
N

>  <ORAL>  (140) 
N

>  <PARENTERAL>  (140) 
N

>  <TOPICAL>  (140) 
N

>  <BLACK_BOX>  (140) 
N

>  <AVAILABILITY_TYPE>  (140) 
Withdrawn

>  <WITHDRAWN_YEAR>  (140) 
1998.0

>  <WITHDRAWN_COUNTRY>  (140) 
United Kingdom; Germany; Italy; Ireland; Netherlands; European Union

>  <WITHDRAWN_REASON>  (140) 
Arrhythmias and Sudden Cardiac Death (Arrhythmias and Sudden)

>  <CANONICAL_SMILES>  (140) 
Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25

>  <name>  (140) 
Sertindole 

>  <MW>  (140) 
440.95

>  <logP>  (140) 
4.6276

$$$$
CHEMBL17
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (141) 
1085

>  <SYNONYMS>  (141) 
Dichlorphenamide (FDA, USP); Diclofenamide (BAN, DCF, INN, JAN)

>  <DEVELOPMENT_PHASE>  (141) 
4

>  <RESEARCH_CODES>  (141) 
nan

>  <APPLICANTS>  (141) 
Taro Pharmaceuticals Usa Inc

>  <USAN_STEM>  (141) 
nan

>  <USAN_STEM_DEFINITION>  (141) 
nan

>  <USAN_STEM_SUBSTEM>  (141) 
nan

>  <USAN_YEAR>  (141) 
nan

>  <FIRST_APPROVAL>  (141) 
1958.0

>  <ATC_CODE>  (141) 
S01EC02

>  <ATC_CODE_DESCRIPTION>  (141) 
S01EC02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Carbonic anhydrase inhibitors]

>  <INDICATION_CLASS>  (141) 
Carbonic Anhydrase Inhibitor

>  <SC_PATENT_NO>  (141) 
nan

>  <DRUG_TYPE>  (141) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (141) 
Y

>  <FIRST_IN_CLASS>  (141) 
N

>  <CHIRALITY>  (141) 
Achiral Molecule

>  <PRODRUG>  (141) 
N

>  <ORAL>  (141) 
Y

>  <PARENTERAL>  (141) 
N

>  <TOPICAL>  (141) 
N

>  <BLACK_BOX>  (141) 
N

>  <AVAILABILITY_TYPE>  (141) 
Prescription-only

>  <WITHDRAWN_YEAR>  (141) 
nan

>  <WITHDRAWN_COUNTRY>  (141) 
nan

>  <WITHDRAWN_REASON>  (141) 
nan

>  <CANONICAL_SMILES>  (141) 
NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N

>  <name>  (141) 
Dichlorphenamide 

>  <MW>  (141) 
305.164

>  <logP>  (141) 
0.2882

$$$$
CHEMBL956
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 11  6  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (142) 
93117

>  <SYNONYMS>  (142) 
Suprofen (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (142) 
4

>  <RESEARCH_CODES>  (142) 
R-25061

>  <APPLICANTS>  (142) 
Alcon Laboratories Inc

>  <USAN_STEM>  (142) 
-profen

>  <USAN_STEM_DEFINITION>  (142) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (142) 
-profen

>  <USAN_YEAR>  (142) 
1974.0

>  <FIRST_APPROVAL>  (142) 
1985.0

>  <ATC_CODE>  (142) 
M01AE07

>  <ATC_CODE_DESCRIPTION>  (142) 
M01AE07 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (142) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (142) 
nan

>  <DRUG_TYPE>  (142) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (142) 
Y

>  <FIRST_IN_CLASS>  (142) 
N

>  <CHIRALITY>  (142) 
Racemic Mixture

>  <PRODRUG>  (142) 
N

>  <ORAL>  (142) 
N

>  <PARENTERAL>  (142) 
N

>  <TOPICAL>  (142) 
Y

>  <BLACK_BOX>  (142) 
N

>  <AVAILABILITY_TYPE>  (142) 
Withdrawn

>  <WITHDRAWN_YEAR>  (142) 
1987.0

>  <WITHDRAWN_COUNTRY>  (142) 
United States; United Kingdom; Spain

>  <WITHDRAWN_REASON>  (142) 
Flank pain, decreased kidney function

>  <CANONICAL_SMILES>  (142) 
CC(C(=O)O)c1ccc(cc1)C(=O)c2cccs2

>  <name>  (142) 
Suprofen 

>  <MW>  (142) 
260.314

>  <logP>  (142) 
3.1672

$$$$
CHEMBL1200877
     RDKit          

 35 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
 24  2  1  0
 22  4  1  0
 17  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (143) 
674828

>  <SYNONYMS>  (143) 
Flumetasone Pivalate (BAN, JAN); Flumethasone Pivalate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (143) 
4

>  <RESEARCH_CODES>  (143) 
nan

>  <APPLICANTS>  (143) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (143) 
nan

>  <USAN_STEM_DEFINITION>  (143) 
nan

>  <USAN_STEM_SUBSTEM>  (143) 
nan

>  <USAN_YEAR>  (143) 
1963.0

>  <FIRST_APPROVAL>  (143) 
1982.0

>  <ATC_CODE>  (143) 
D07AB03; D07XB01

>  <ATC_CODE_DESCRIPTION>  (143) 
D07AB03 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]; D07XB01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]

>  <INDICATION_CLASS>  (143) 
Glucocorticoid

>  <SC_PATENT_NO>  (143) 
nan

>  <DRUG_TYPE>  (143) 
Natural Product-derived

>  <RULE_OF_FIVE>  (143) 
Y

>  <FIRST_IN_CLASS>  (143) 
N

>  <CHIRALITY>  (143) 
Single Stereoisomer

>  <PRODRUG>  (143) 
Y

>  <ORAL>  (143) 
N

>  <PARENTERAL>  (143) 
N

>  <TOPICAL>  (143) 
Y

>  <BLACK_BOX>  (143) 
N

>  <AVAILABILITY_TYPE>  (143) 
Discontinued

>  <WITHDRAWN_YEAR>  (143) 
nan

>  <WITHDRAWN_COUNTRY>  (143) 
nan

>  <WITHDRAWN_REASON>  (143) 
nan

>  <CANONICAL_SMILES>  (143) 
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C

>  <name>  (143) 
Flumetasone Pivalate 

>  <MW>  (143) 
494.575

>  <logP>  (143) 
3.4407

$$$$
CHEMBL1201213
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
M  END
>  <PARENT_MOLREGNO>  (144) 
675164

>  <SYNONYMS>  (144) 
Isoetarine (BAN, INN); Isoetharine (USAN, USP); Isoetharine HCl (FDA, USP); Isoetharine mesylate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (144) 
4

>  <RESEARCH_CODES>  (144) 
WIN-3406

>  <APPLICANTS>  (144) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (144) 
nan

>  <USAN_STEM_DEFINITION>  (144) 
nan

>  <USAN_STEM_SUBSTEM>  (144) 
nan

>  <USAN_YEAR>  (144) 
1962.0

>  <FIRST_APPROVAL>  (144) 
1979.0

>  <ATC_CODE>  (144) 
R03AC07; R03CC06

>  <ATC_CODE_DESCRIPTION>  (144) 
R03AC07 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]; R03CC06 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (144) 
Bronchodilator

>  <SC_PATENT_NO>  (144) 
nan

>  <DRUG_TYPE>  (144) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (144) 
Y

>  <FIRST_IN_CLASS>  (144) 
N

>  <CHIRALITY>  (144) 
Racemic Mixture

>  <PRODRUG>  (144) 
N

>  <ORAL>  (144) 
N

>  <PARENTERAL>  (144) 
N

>  <TOPICAL>  (144) 
Y

>  <BLACK_BOX>  (144) 
N

>  <AVAILABILITY_TYPE>  (144) 
Discontinued

>  <WITHDRAWN_YEAR>  (144) 
nan

>  <WITHDRAWN_COUNTRY>  (144) 
nan

>  <WITHDRAWN_REASON>  (144) 
nan

>  <CANONICAL_SMILES>  (144) 
CCC(NC(C)C)C(O)c1ccc(O)c(O)c1

>  <name>  (144) 
Isoetarine 

>  <MW>  (144) 
239.315

>  <logP>  (144) 
1.9078

$$$$
CHEMBL1013
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 11 15  1  0
 15 16  2  0
 15 17  1  0
 10 18  1  0
  2 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 13  6  1  0
 12  7  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (145) 
114480

>  <SYNONYMS>  (145) 
Loracarbef (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (145) 
4

>  <RESEARCH_CODES>  (145) 
LY-163892

>  <APPLICANTS>  (145) 
King Pharmaceuticals Inc

>  <USAN_STEM>  (145) 
-carbef

>  <USAN_STEM_DEFINITION>  (145) 
antibiotics (carbacephem derivatives)

>  <USAN_STEM_SUBSTEM>  (145) 
-carbef

>  <USAN_YEAR>  (145) 
1989.0

>  <FIRST_APPROVAL>  (145) 
1991.0

>  <ATC_CODE>  (145) 
J01DC08

>  <ATC_CODE_DESCRIPTION>  (145) 
J01DC08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Second-generation cephalosporins]

>  <INDICATION_CLASS>  (145) 
Antibacterial

>  <SC_PATENT_NO>  (145) 
nan

>  <DRUG_TYPE>  (145) 
Natural Product-derived

>  <RULE_OF_FIVE>  (145) 
Y

>  <FIRST_IN_CLASS>  (145) 
N

>  <CHIRALITY>  (145) 
Single Stereoisomer

>  <PRODRUG>  (145) 
N

>  <ORAL>  (145) 
Y

>  <PARENTERAL>  (145) 
N

>  <TOPICAL>  (145) 
N

>  <BLACK_BOX>  (145) 
N

>  <AVAILABILITY_TYPE>  (145) 
Discontinued

>  <WITHDRAWN_YEAR>  (145) 
nan

>  <WITHDRAWN_COUNTRY>  (145) 
nan

>  <WITHDRAWN_REASON>  (145) 
nan

>  <CANONICAL_SMILES>  (145) 
N[C@@H](C(=O)N[C@H]1[C@H]2CCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3

>  <name>  (145) 
Loracarbef 

>  <MW>  (145) 
349.774

>  <logP>  (145) 
0.7108

$$$$
CHEMBL3092041
     RDKit          

 25 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 12 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 19  3  1  0
 20  6  1  0
 24  8  1  0
 21  9  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (146) 
1606408

>  <SYNONYMS>  (146) 
Acetyldihydrocodeine

>  <DEVELOPMENT_PHASE>  (146) 
4

>  <RESEARCH_CODES>  (146) 
nan

>  <APPLICANTS>  (146) 
nan

>  <USAN_STEM>  (146) 
nan

>  <USAN_STEM_DEFINITION>  (146) 
nan

>  <USAN_STEM_SUBSTEM>  (146) 
nan

>  <USAN_YEAR>  (146) 
nan

>  <FIRST_APPROVAL>  (146) 
nan

>  <ATC_CODE>  (146) 
R05DA12

>  <ATC_CODE_DESCRIPTION>  (146) 
R05DA12 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Opium alkaloids and derivatives]

>  <INDICATION_CLASS>  (146) 
nan

>  <SC_PATENT_NO>  (146) 
nan

>  <DRUG_TYPE>  (146) 
Natural Product-derived

>  <RULE_OF_FIVE>  (146) 
Y

>  <FIRST_IN_CLASS>  (146) 
N

>  <CHIRALITY>  (146) 
Single Stereoisomer

>  <PRODRUG>  (146) 
N

>  <ORAL>  (146) 
N

>  <PARENTERAL>  (146) 
N

>  <TOPICAL>  (146) 
N

>  <BLACK_BOX>  (146) 
N

>  <AVAILABILITY_TYPE>  (146) 
Unknown

>  <WITHDRAWN_YEAR>  (146) 
nan

>  <WITHDRAWN_COUNTRY>  (146) 
nan

>  <WITHDRAWN_REASON>  (146) 
nan

>  <CANONICAL_SMILES>  (146) 
COc1ccc2C[C@@H]3[C@@H]4CC[C@H](OC(=O)C)[C@@H]5Oc1c2[C@]45CCN3C

>  <name>  (146) 
Acetyldihydrocodeine

>  <MW>  (146) 
343.423

>  <logP>  (146) 
2.2959

$$$$
CHEMBL3707449
     RDKit          

 19 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
M  END
>  <PARENT_MOLREGNO>  (147) 
2039420

>  <SYNONYMS>  (147) 
nan

>  <DEVELOPMENT_PHASE>  (147) 
4

>  <RESEARCH_CODES>  (147) 
nan

>  <APPLICANTS>  (147) 
nan

>  <USAN_STEM>  (147) 
nan

>  <USAN_STEM_DEFINITION>  (147) 
nan

>  <USAN_STEM_SUBSTEM>  (147) 
nan

>  <USAN_YEAR>  (147) 
nan

>  <FIRST_APPROVAL>  (147) 
nan

>  <ATC_CODE>  (147) 
A12AA11

>  <ATC_CODE_DESCRIPTION>  (147) 
A12AA11 [Alimentary Tract And Metabolism:Mineral Supplements:Calcium:Calcium]

>  <INDICATION_CLASS>  (147) 
nan

>  <SC_PATENT_NO>  (147) 
nan

>  <DRUG_TYPE>  (147) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (147) 
Y

>  <FIRST_IN_CLASS>  (147) 
N

>  <CHIRALITY>  (147) 
Single Stereoisomer

>  <PRODRUG>  (147) 
N

>  <ORAL>  (147) 
N

>  <PARENTERAL>  (147) 
N

>  <TOPICAL>  (147) 
N

>  <BLACK_BOX>  (147) 
N

>  <AVAILABILITY_TYPE>  (147) 
Unknown

>  <WITHDRAWN_YEAR>  (147) 
nan

>  <WITHDRAWN_COUNTRY>  (147) 
nan

>  <WITHDRAWN_REASON>  (147) 
nan

>  <CANONICAL_SMILES>  (147) 
CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O

>  <name>  (147) 
None

>  <MW>  (147) 
281.261

>  <logP>  (147) 
-3.3806

$$$$
CHEMBL139877
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (148) 
233553

>  <SYNONYMS>  (148) 
Sulfacarbamide (BAN, DCF, INN)

>  <DEVELOPMENT_PHASE>  (148) 
4

>  <RESEARCH_CODES>  (148) 
nan

>  <APPLICANTS>  (148) 
nan

>  <USAN_STEM>  (148) 
sulfa-

>  <USAN_STEM_DEFINITION>  (148) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (148) 
sulfa-

>  <USAN_YEAR>  (148) 
nan

>  <FIRST_APPROVAL>  (148) 
nan

>  <ATC_CODE>  (148) 
nan

>  <ATC_CODE_DESCRIPTION>  (148) 
nan

>  <INDICATION_CLASS>  (148) 
nan

>  <SC_PATENT_NO>  (148) 
nan

>  <DRUG_TYPE>  (148) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (148) 
Y

>  <FIRST_IN_CLASS>  (148) 
N

>  <CHIRALITY>  (148) 
Achiral Molecule

>  <PRODRUG>  (148) 
N

>  <ORAL>  (148) 
N

>  <PARENTERAL>  (148) 
N

>  <TOPICAL>  (148) 
N

>  <BLACK_BOX>  (148) 
N

>  <AVAILABILITY_TYPE>  (148) 
Withdrawn

>  <WITHDRAWN_YEAR>  (148) 
1988.0

>  <WITHDRAWN_COUNTRY>  (148) 
Germany

>  <WITHDRAWN_REASON>  (148) 
Dermatologic, Hematologic and Hepatic Reactions

>  <CANONICAL_SMILES>  (148) 
NC(=O)NS(=O)(=O)c1ccc(N)cc1

>  <name>  (148) 
Sulfacarbamide 

>  <MW>  (148) 
215.234

>  <logP>  (148) 
-0.3742

$$$$
CHEMBL1740513
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (149) 
1119564

>  <SYNONYMS>  (149) 
Isaxonine (INN, MI)

>  <DEVELOPMENT_PHASE>  (149) 
4

>  <RESEARCH_CODES>  (149) 
nan

>  <APPLICANTS>  (149) 
nan

>  <USAN_STEM>  (149) 
nan

>  <USAN_STEM_DEFINITION>  (149) 
nan

>  <USAN_STEM_SUBSTEM>  (149) 
nan

>  <USAN_YEAR>  (149) 
nan

>  <FIRST_APPROVAL>  (149) 
nan

>  <ATC_CODE>  (149) 
nan

>  <ATC_CODE_DESCRIPTION>  (149) 
nan

>  <INDICATION_CLASS>  (149) 
nan

>  <SC_PATENT_NO>  (149) 
nan

>  <DRUG_TYPE>  (149) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (149) 
Y

>  <FIRST_IN_CLASS>  (149) 
N

>  <CHIRALITY>  (149) 
Achiral Molecule

>  <PRODRUG>  (149) 
N

>  <ORAL>  (149) 
N

>  <PARENTERAL>  (149) 
N

>  <TOPICAL>  (149) 
N

>  <BLACK_BOX>  (149) 
N

>  <AVAILABILITY_TYPE>  (149) 
Withdrawn

>  <WITHDRAWN_YEAR>  (149) 
1984.0

>  <WITHDRAWN_COUNTRY>  (149) 
France

>  <WITHDRAWN_REASON>  (149) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (149) 
CC(C)Nc1ncccn1

>  <name>  (149) 
Isaxonine 

>  <MW>  (149) 
137.186

>  <logP>  (149) 
1.2969

$$$$
CHEMBL1909282
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  9  5  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (150) 
1249052

>  <SYNONYMS>  (150) 
Fenclozic Acid (BAN, INN, MI)

>  <DEVELOPMENT_PHASE>  (150) 
4

>  <RESEARCH_CODES>  (150) 
ICI-54450

>  <APPLICANTS>  (150) 
nan

>  <USAN_STEM>  (150) 
nan

>  <USAN_STEM_DEFINITION>  (150) 
nan

>  <USAN_STEM_SUBSTEM>  (150) 
nan

>  <USAN_YEAR>  (150) 
nan

>  <FIRST_APPROVAL>  (150) 
nan

>  <ATC_CODE>  (150) 
nan

>  <ATC_CODE_DESCRIPTION>  (150) 
nan

>  <INDICATION_CLASS>  (150) 
nan

>  <SC_PATENT_NO>  (150) 
nan

>  <DRUG_TYPE>  (150) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (150) 
Y

>  <FIRST_IN_CLASS>  (150) 
N

>  <CHIRALITY>  (150) 
Achiral Molecule

>  <PRODRUG>  (150) 
N

>  <ORAL>  (150) 
N

>  <PARENTERAL>  (150) 
N

>  <TOPICAL>  (150) 
N

>  <BLACK_BOX>  (150) 
N

>  <AVAILABILITY_TYPE>  (150) 
Withdrawn

>  <WITHDRAWN_YEAR>  (150) 
1970.0

>  <WITHDRAWN_COUNTRY>  (150) 
United Kingdom; United States

>  <WITHDRAWN_REASON>  (150) 
Jaundice; Elevated Hepatic Enzymes

>  <CANONICAL_SMILES>  (150) 
OC(=O)Cc1csc(n1)c2ccc(Cl)cc2

>  <name>  (150) 
Fenclozic Acid 

>  <MW>  (150) 
253.71

>  <logP>  (150) 
3.0906

$$$$
CHEMBL254857
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 13 24  1  0
 24 25  1  0
  5 26  1  0
 26 27  2  0
 27  2  1  0
 25 10  1  0
 23 15  1  0
 22 18  1  0
M  END
>  <PARENT_MOLREGNO>  (151) 
418438

>  <SYNONYMS>  (151) 
Fipexide (DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (151) 
4

>  <RESEARCH_CODES>  (151) 
nan

>  <APPLICANTS>  (151) 
nan

>  <USAN_STEM>  (151) 
nan

>  <USAN_STEM_DEFINITION>  (151) 
nan

>  <USAN_STEM_SUBSTEM>  (151) 
nan

>  <USAN_YEAR>  (151) 
nan

>  <FIRST_APPROVAL>  (151) 
nan

>  <ATC_CODE>  (151) 
N06BX05

>  <ATC_CODE_DESCRIPTION>  (151) 
N06BX05 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Other psychostimulants and nootropics]

>  <INDICATION_CLASS>  (151) 
nan

>  <SC_PATENT_NO>  (151) 
nan

>  <DRUG_TYPE>  (151) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (151) 
Y

>  <FIRST_IN_CLASS>  (151) 
N

>  <CHIRALITY>  (151) 
Achiral Molecule

>  <PRODRUG>  (151) 
N

>  <ORAL>  (151) 
N

>  <PARENTERAL>  (151) 
N

>  <TOPICAL>  (151) 
N

>  <BLACK_BOX>  (151) 
N

>  <AVAILABILITY_TYPE>  (151) 
Withdrawn

>  <WITHDRAWN_YEAR>  (151) 
1991.0

>  <WITHDRAWN_COUNTRY>  (151) 
France

>  <WITHDRAWN_REASON>  (151) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (151) 
Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1

>  <name>  (151) 
Fipexide 

>  <MW>  (151) 
388.851

>  <logP>  (151) 
2.7919

$$$$
CHEMBL2104607
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (152) 
1376877

>  <SYNONYMS>  (152) 
Nicethamide (BAN, DCF); Nikethamide (BAN, INN, MI, NF)

>  <DEVELOPMENT_PHASE>  (152) 
4

>  <RESEARCH_CODES>  (152) 
nan

>  <APPLICANTS>  (152) 
Ciba-Geigy; Abbott

>  <USAN_STEM>  (152) 
nan

>  <USAN_STEM_DEFINITION>  (152) 
nan

>  <USAN_STEM_SUBSTEM>  (152) 
nan

>  <USAN_YEAR>  (152) 
nan

>  <FIRST_APPROVAL>  (152) 
nan

>  <ATC_CODE>  (152) 
R07AB52; R07AB02

>  <ATC_CODE_DESCRIPTION>  (152) 
R07AB52 [Respiratory System:Other Respiratory System Products:Other Respiratory System Products:Respiratory stimulants]; R07AB02 [Respiratory System:Other Respiratory System Products:Other Respiratory System Products:Respiratory stimulants]

>  <INDICATION_CLASS>  (152) 
nan

>  <SC_PATENT_NO>  (152) 
nan

>  <DRUG_TYPE>  (152) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (152) 
Y

>  <FIRST_IN_CLASS>  (152) 
N

>  <CHIRALITY>  (152) 
Achiral Molecule

>  <PRODRUG>  (152) 
N

>  <ORAL>  (152) 
N

>  <PARENTERAL>  (152) 
N

>  <TOPICAL>  (152) 
N

>  <BLACK_BOX>  (152) 
N

>  <AVAILABILITY_TYPE>  (152) 
Withdrawn

>  <WITHDRAWN_YEAR>  (152) 
1988.0

>  <WITHDRAWN_COUNTRY>  (152) 
Multiple unspecified markets

>  <WITHDRAWN_REASON>  (152) 
CNS Stimulation

>  <CANONICAL_SMILES>  (152) 
CCN(CC)C(=O)c1cccnc1

>  <name>  (152) 
Nicethamide 

>  <MW>  (152) 
178.235

>  <logP>  (152) 
1.5636

$$$$
CHEMBL21869
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  8  2  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (153) 
27104

>  <SYNONYMS>  (153) 
Dibromsalan (INN, USAN)

>  <DEVELOPMENT_PHASE>  (153) 
4

>  <RESEARCH_CODES>  (153) 
nan

>  <APPLICANTS>  (153) 
nan

>  <USAN_STEM>  (153) 
-sal-

>  <USAN_STEM_DEFINITION>  (153) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (153) 
-sal-

>  <USAN_YEAR>  (153) 
1963.0

>  <FIRST_APPROVAL>  (153) 
nan

>  <ATC_CODE>  (153) 
nan

>  <ATC_CODE_DESCRIPTION>  (153) 
nan

>  <INDICATION_CLASS>  (153) 
Disinfectant

>  <SC_PATENT_NO>  (153) 
nan

>  <DRUG_TYPE>  (153) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (153) 
Y

>  <FIRST_IN_CLASS>  (153) 
N

>  <CHIRALITY>  (153) 
Achiral Molecule

>  <PRODRUG>  (153) 
N

>  <ORAL>  (153) 
N

>  <PARENTERAL>  (153) 
N

>  <TOPICAL>  (153) 
N

>  <BLACK_BOX>  (153) 
N

>  <AVAILABILITY_TYPE>  (153) 
Withdrawn

>  <WITHDRAWN_YEAR>  (153) 
nan

>  <WITHDRAWN_COUNTRY>  (153) 
United States

>  <WITHDRAWN_REASON>  (153) 
nan

>  <CANONICAL_SMILES>  (153) 
Oc1ccc(Br)cc1C(=O)Nc2ccc(Br)cc2

>  <name>  (153) 
Dibromsalan 

>  <MW>  (153) 
371.028

>  <logP>  (153) 
4.1695

$$$$
CHEMBL24944
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
  9  2  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (154) 
27105

>  <SYNONYMS>  (154) 
Tribromsalan (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (154) 
4

>  <RESEARCH_CODES>  (154) 
ET-394

>  <APPLICANTS>  (154) 
Marion Merrell Dow

>  <USAN_STEM>  (154) 
-sal-

>  <USAN_STEM_DEFINITION>  (154) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (154) 
-sal-

>  <USAN_YEAR>  (154) 
1963.0

>  <FIRST_APPROVAL>  (154) 
nan

>  <ATC_CODE>  (154) 
nan

>  <ATC_CODE_DESCRIPTION>  (154) 
nan

>  <INDICATION_CLASS>  (154) 
Disinfectant

>  <SC_PATENT_NO>  (154) 
nan

>  <DRUG_TYPE>  (154) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (154) 
Y

>  <FIRST_IN_CLASS>  (154) 
N

>  <CHIRALITY>  (154) 
Achiral Molecule

>  <PRODRUG>  (154) 
N

>  <ORAL>  (154) 
N

>  <PARENTERAL>  (154) 
N

>  <TOPICAL>  (154) 
N

>  <BLACK_BOX>  (154) 
N

>  <AVAILABILITY_TYPE>  (154) 
Withdrawn

>  <WITHDRAWN_YEAR>  (154) 
nan

>  <WITHDRAWN_COUNTRY>  (154) 
United States

>  <WITHDRAWN_REASON>  (154) 
nan

>  <CANONICAL_SMILES>  (154) 
Oc1c(Br)cc(Br)cc1C(=O)Nc2ccc(Br)cc2

>  <name>  (154) 
Tribromsalan 

>  <MW>  (154) 
449.924

>  <logP>  (154) 
4.932

$$$$
CHEMBL1452696
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  8 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  2 24  1  0
 10  5  1  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (155) 
876580

>  <SYNONYMS>  (155) 
Feprazone (BAN, INN, JAN, MI)

>  <DEVELOPMENT_PHASE>  (155) 
4

>  <RESEARCH_CODES>  (155) 
DA-2370

>  <APPLICANTS>  (155) 
nan

>  <USAN_STEM>  (155) 
nan

>  <USAN_STEM_DEFINITION>  (155) 
nan

>  <USAN_STEM_SUBSTEM>  (155) 
nan

>  <USAN_YEAR>  (155) 
nan

>  <FIRST_APPROVAL>  (155) 
1997.0

>  <ATC_CODE>  (155) 
M01AX68; M02AA16; M01AX18

>  <ATC_CODE_DESCRIPTION>  (155) 
M01AX68 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Other antiinflammatory and antirheumatic agents, non-steroids]; M02AA16 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; M01AX18 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Other antiinflammatory and antirheumatic agents, non-steroids]

>  <INDICATION_CLASS>  (155) 
nan

>  <SC_PATENT_NO>  (155) 
nan

>  <DRUG_TYPE>  (155) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (155) 
Y

>  <FIRST_IN_CLASS>  (155) 
N

>  <CHIRALITY>  (155) 
Achiral Molecule

>  <PRODRUG>  (155) 
N

>  <ORAL>  (155) 
N

>  <PARENTERAL>  (155) 
N

>  <TOPICAL>  (155) 
N

>  <BLACK_BOX>  (155) 
N

>  <AVAILABILITY_TYPE>  (155) 
Withdrawn

>  <WITHDRAWN_YEAR>  (155) 
1984.0

>  <WITHDRAWN_COUNTRY>  (155) 
Germany; United Kingdom

>  <WITHDRAWN_REASON>  (155) 
Cutaneous Reaction; Multi-Organ Toxicities

>  <CANONICAL_SMILES>  (155) 
CC(=CCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)C

>  <name>  (155) 
Feprazone 

>  <MW>  (155) 
320.392

>  <logP>  (155) 
3.9539

$$$$
CHEMBL583
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
 11 24  1  0
 24 25  1  0
 25 26  1  0
  7  2  1  0
 22  8  1  0
 19 10  2  0
 26 24  1  0
M  END
>  <PARENT_MOLREGNO>  (156) 
17136

>  <SYNONYMS>  (156) 
Grepafloxacin (INN); Grepafloxacin HCl (BAN, FDA, USAN)

>  <DEVELOPMENT_PHASE>  (156) 
4

>  <RESEARCH_CODES>  (156) 
OPC-17116

>  <APPLICANTS>  (156) 
Otsuka Pharmaceutical Co Ltd

>  <USAN_STEM>  (156) 
-oxacin

>  <USAN_STEM_DEFINITION>  (156) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (156) 
-oxacin

>  <USAN_YEAR>  (156) 
1995.0

>  <FIRST_APPROVAL>  (156) 
1997.0

>  <ATC_CODE>  (156) 
J01MA11

>  <ATC_CODE_DESCRIPTION>  (156) 
J01MA11 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]

>  <INDICATION_CLASS>  (156) 
Antibacterial

>  <SC_PATENT_NO>  (156) 
nan

>  <DRUG_TYPE>  (156) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (156) 
Y

>  <FIRST_IN_CLASS>  (156) 
N

>  <CHIRALITY>  (156) 
Racemic Mixture

>  <PRODRUG>  (156) 
N

>  <ORAL>  (156) 
Y

>  <PARENTERAL>  (156) 
N

>  <TOPICAL>  (156) 
N

>  <BLACK_BOX>  (156) 
N

>  <AVAILABILITY_TYPE>  (156) 
Withdrawn

>  <WITHDRAWN_YEAR>  (156) 
1999.0

>  <WITHDRAWN_COUNTRY>  (156) 
United States; United Kingdom; United States; Germany

>  <WITHDRAWN_REASON>  (156) 
Cardiac repolarization; QTc interval prolongation

>  <CANONICAL_SMILES>  (156) 
CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3c(C)c2F)C4CC4

>  <name>  (156) 
Grepafloxacin 

>  <MW>  (156) 
359.401

>  <logP>  (156) 
2.28022

$$$$
CHEMBL118
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 10 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
  7  2  1  0
 12  8  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (157) 
18694

>  <SYNONYMS>  (157) 
Celecoxib (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (157) 
4

>  <RESEARCH_CODES>  (157) 
SC-58635

>  <APPLICANTS>  (157) 
Gd Searle Llc

>  <USAN_STEM>  (157) 
-coxib

>  <USAN_STEM_DEFINITION>  (157) 
cyclooxygenase-2 inhibitors

>  <USAN_STEM_SUBSTEM>  (157) 
-coxib

>  <USAN_YEAR>  (157) 
1998.0

>  <FIRST_APPROVAL>  (157) 
1998.0

>  <ATC_CODE>  (157) 
L01XX33; M01AH01

>  <ATC_CODE_DESCRIPTION>  (157) 
L01XX33 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]; M01AH01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Coxibs]

>  <INDICATION_CLASS>  (157) 
nan

>  <SC_PATENT_NO>  (157) 
nan

>  <DRUG_TYPE>  (157) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (157) 
Y

>  <FIRST_IN_CLASS>  (157) 
N

>  <CHIRALITY>  (157) 
Achiral Molecule

>  <PRODRUG>  (157) 
N

>  <ORAL>  (157) 
Y

>  <PARENTERAL>  (157) 
N

>  <TOPICAL>  (157) 
N

>  <BLACK_BOX>  (157) 
Y

>  <AVAILABILITY_TYPE>  (157) 
Prescription-only

>  <WITHDRAWN_YEAR>  (157) 
2011.0

>  <WITHDRAWN_COUNTRY>  (157) 
European Union

>  <WITHDRAWN_REASON>  (157) 
nan

>  <CANONICAL_SMILES>  (157) 
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F

>  <name>  (157) 
Celecoxib 

>  <MW>  (157) 
381.379

>  <logP>  (157) 
3.51392

$$$$
CHEMBL1363
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 19 23  2  0
  6 24  1  0
 24 25  2  0
 25  3  1  0
 23 14  1  0
M  END
>  <PARENT_MOLREGNO>  (158) 
308174

>  <SYNONYMS>  (158) 
Arformoterol (INN); Arformoterol tartrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (158) 
4

>  <RESEARCH_CODES>  (158) 
nan

>  <APPLICANTS>  (158) 
Sunovion Pharmaceuticals Inc

>  <USAN_STEM>  (158) 
-terol

>  <USAN_STEM_DEFINITION>  (158) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (158) 
-terol

>  <USAN_YEAR>  (158) 
2003.0

>  <FIRST_APPROVAL>  (158) 
2006.0

>  <ATC_CODE>  (158) 
nan

>  <ATC_CODE_DESCRIPTION>  (158) 
nan

>  <INDICATION_CLASS>  (158) 
nan

>  <SC_PATENT_NO>  (158) 
US-6040344-A

>  <DRUG_TYPE>  (158) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (158) 
Y

>  <FIRST_IN_CLASS>  (158) 
N

>  <CHIRALITY>  (158) 
Single Stereoisomer

>  <PRODRUG>  (158) 
N

>  <ORAL>  (158) 
N

>  <PARENTERAL>  (158) 
N

>  <TOPICAL>  (158) 
Y

>  <BLACK_BOX>  (158) 
Y

>  <AVAILABILITY_TYPE>  (158) 
Prescription-only

>  <WITHDRAWN_YEAR>  (158) 
nan

>  <WITHDRAWN_COUNTRY>  (158) 
nan

>  <WITHDRAWN_REASON>  (158) 
nan

>  <CANONICAL_SMILES>  (158) 
COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1

>  <name>  (158) 
Arformoterol 

>  <MW>  (158) 
344.411

>  <logP>  (158) 
2.2233

$$$$
CHEMBL1200807
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
  7 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  3  0
 18  3  1  0
 21  3  1  0
 17  6  1  0
 17 10  1  0
M  END
>  <PARENT_MOLREGNO>  (159) 
674758

>  <SYNONYMS>  (159) 
Norelgestromin (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (159) 
4

>  <RESEARCH_CODES>  (159) 
RWJ-10553

>  <APPLICANTS>  (159) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (159) 
-gest-

>  <USAN_STEM_DEFINITION>  (159) 
progestins

>  <USAN_STEM_SUBSTEM>  (159) 
-gest-

>  <USAN_YEAR>  (159) 
2000.0

>  <FIRST_APPROVAL>  (159) 
2001.0

>  <ATC_CODE>  (159) 
nan

>  <ATC_CODE_DESCRIPTION>  (159) 
nan

>  <INDICATION_CLASS>  (159) 
nan

>  <SC_PATENT_NO>  (159) 
US-5876746-A

>  <DRUG_TYPE>  (159) 
Natural Product-derived

>  <RULE_OF_FIVE>  (159) 
Y

>  <FIRST_IN_CLASS>  (159) 
N

>  <CHIRALITY>  (159) 
Single Stereoisomer

>  <PRODRUG>  (159) 
N

>  <ORAL>  (159) 
N

>  <PARENTERAL>  (159) 
N

>  <TOPICAL>  (159) 
Y

>  <BLACK_BOX>  (159) 
Y

>  <AVAILABILITY_TYPE>  (159) 
Prescription-only

>  <WITHDRAWN_YEAR>  (159) 
nan

>  <WITHDRAWN_COUNTRY>  (159) 
nan

>  <WITHDRAWN_REASON>  (159) 
nan

>  <CANONICAL_SMILES>  (159) 
CC[C@]12CC[C@H]3[C@@H](CCC4=C\C(=N\O)\CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

>  <name>  (159) 
Norelgestromin 

>  <MW>  (159) 
327.468

>  <logP>  (159) 
4.1437

$$$$
CHEMBL430
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 16 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 14 26  1  0
 26 27  1  0
 27 28  1  0
  4  8  1  0
 24 11  1  0
 22 13  2  0
 28 26  1  0
M  END
>  <PARENT_MOLREGNO>  (160) 
1853

>  <SYNONYMS>  (160) 
Gemifloxacin (INN); Gemifloxacin Mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (160) 
4

>  <RESEARCH_CODES>  (160) 
LB-20304a; SB-265805-S

>  <APPLICANTS>  (160) 
Cornerstone Therapeutics Inc

>  <USAN_STEM>  (160) 
-oxacin

>  <USAN_STEM_DEFINITION>  (160) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (160) 
-oxacin

>  <USAN_YEAR>  (160) 
1998.0

>  <FIRST_APPROVAL>  (160) 
2003.0

>  <ATC_CODE>  (160) 
J01MA15

>  <ATC_CODE_DESCRIPTION>  (160) 
J01MA15 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]

>  <INDICATION_CLASS>  (160) 
nan

>  <SC_PATENT_NO>  (160) 
US-5776944-A

>  <DRUG_TYPE>  (160) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (160) 
Y

>  <FIRST_IN_CLASS>  (160) 
N

>  <CHIRALITY>  (160) 
Racemic Mixture

>  <PRODRUG>  (160) 
N

>  <ORAL>  (160) 
Y

>  <PARENTERAL>  (160) 
N

>  <TOPICAL>  (160) 
N

>  <BLACK_BOX>  (160) 
Y

>  <AVAILABILITY_TYPE>  (160) 
Prescription-only

>  <WITHDRAWN_YEAR>  (160) 
nan

>  <WITHDRAWN_COUNTRY>  (160) 
nan

>  <WITHDRAWN_REASON>  (160) 
nan

>  <CANONICAL_SMILES>  (160) 
CO\N=C\1/CN(CC1CN)c2nc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4

>  <name>  (160) 
Gemifloxacin 

>  <MW>  (160) 
389.387

>  <logP>  (160) 
0.966

$$$$
CHEMBL220491
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  6 12  1  0
 12 13  2  0
 12 14  2  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 20 22  2  0
 20 23  1  0
 19  4  1  0
 19 15  2  0
M  END
>  <PARENT_MOLREGNO>  (161) 
366278

>  <SYNONYMS>  (161) 
Brinzolamide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (161) 
4

>  <RESEARCH_CODES>  (161) 
AL-4862

>  <APPLICANTS>  (161) 
Alcon Pharmaceuticals Ltd

>  <USAN_STEM>  (161) 
-zolamide

>  <USAN_STEM_DEFINITION>  (161) 
carbonic anhydrase inhibitors

>  <USAN_STEM_SUBSTEM>  (161) 
-zolamide

>  <USAN_YEAR>  (161) 
1997.0

>  <FIRST_APPROVAL>  (161) 
1998.0

>  <ATC_CODE>  (161) 
S01EC54; S01EC04

>  <ATC_CODE_DESCRIPTION>  (161) 
S01EC54 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Carbonic anhydrase inhibitors]; S01EC04 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Carbonic anhydrase inhibitors]

>  <INDICATION_CLASS>  (161) 
Antiglaucoma Agent

>  <SC_PATENT_NO>  (161) 
US-6316441-B1

>  <DRUG_TYPE>  (161) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (161) 
Y

>  <FIRST_IN_CLASS>  (161) 
N

>  <CHIRALITY>  (161) 
Single Stereoisomer

>  <PRODRUG>  (161) 
N

>  <ORAL>  (161) 
N

>  <PARENTERAL>  (161) 
N

>  <TOPICAL>  (161) 
Y

>  <BLACK_BOX>  (161) 
N

>  <AVAILABILITY_TYPE>  (161) 
Prescription-only

>  <WITHDRAWN_YEAR>  (161) 
nan

>  <WITHDRAWN_COUNTRY>  (161) 
nan

>  <WITHDRAWN_REASON>  (161) 
nan

>  <CANONICAL_SMILES>  (161) 
CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(=O)(=O)N

>  <name>  (161) 
Brinzolamide 

>  <MW>  (161) 
383.517

>  <logP>  (161) 
0.0869

$$$$
CHEMBL1359
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
  8 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
 31 33  1  0
 11  4  1  0
 10  5  1  0
 21 17  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (162) 
304903

>  <SYNONYMS>  (162) 
Ertapenem (INN); Ertapenem sodium (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (162) 
4

>  <RESEARCH_CODES>  (162) 
MK-0826

>  <APPLICANTS>  (162) 
Merck And Co Inc

>  <USAN_STEM>  (162) 
-penem

>  <USAN_STEM_DEFINITION>  (162) 
antibacterial antibiotics, carbapenem derivatives

>  <USAN_STEM_SUBSTEM>  (162) 
-penem

>  <USAN_YEAR>  (162) 
2000.0

>  <FIRST_APPROVAL>  (162) 
2001.0

>  <ATC_CODE>  (162) 
J01DH03

>  <ATC_CODE_DESCRIPTION>  (162) 
J01DH03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Carbapenems]

>  <INDICATION_CLASS>  (162) 
nan

>  <SC_PATENT_NO>  (162) 
US-5478820-A

>  <DRUG_TYPE>  (162) 
Natural Product-derived

>  <RULE_OF_FIVE>  (162) 
Y

>  <FIRST_IN_CLASS>  (162) 
N

>  <CHIRALITY>  (162) 
Single Stereoisomer

>  <PRODRUG>  (162) 
N

>  <ORAL>  (162) 
N

>  <PARENTERAL>  (162) 
Y

>  <TOPICAL>  (162) 
N

>  <BLACK_BOX>  (162) 
N

>  <AVAILABILITY_TYPE>  (162) 
Prescription-only

>  <WITHDRAWN_YEAR>  (162) 
nan

>  <WITHDRAWN_COUNTRY>  (162) 
nan

>  <WITHDRAWN_REASON>  (162) 
nan

>  <CANONICAL_SMILES>  (162) 
C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O

>  <name>  (162) 
Ertapenem 

>  <MW>  (162) 
475.523

>  <logP>  (162) 
0.9407

$$$$
CHEMBL1261
     RDKit          

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  5 11  1  0
 11 12  2  0
 11 13  1  0
M  END
>  <PARENT_MOLREGNO>  (163) 
240769

>  <SYNONYMS>  (163) 
Citric Acid (FDA, JAN, USP); Citric Acid Monohydrate (USP)

>  <DEVELOPMENT_PHASE>  (163) 
4

>  <RESEARCH_CODES>  (163) 
nan

>  <APPLICANTS>  (163) 
Hospira Inc; Ferring Pharmaceuticals As; Exalenz Bioscience Ltd; Baxter Healthcare Corp; United Guardian Inc

>  <USAN_STEM>  (163) 
nan

>  <USAN_STEM_DEFINITION>  (163) 
nan

>  <USAN_STEM_SUBSTEM>  (163) 
nan

>  <USAN_YEAR>  (163) 
nan

>  <FIRST_APPROVAL>  (163) 
1982.0

>  <ATC_CODE>  (163) 
A09AB04

>  <ATC_CODE_DESCRIPTION>  (163) 
A09AB04 [Alimentary Tract And Metabolism:Digestives, Incl. Enzymes:Digestives, Incl. Enzymes:Acid preparations]

>  <INDICATION_CLASS>  (163) 
nan

>  <SC_PATENT_NO>  (163) 
US-8450338-B2

>  <DRUG_TYPE>  (163) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (163) 
Y

>  <FIRST_IN_CLASS>  (163) 
N

>  <CHIRALITY>  (163) 
Achiral Molecule

>  <PRODRUG>  (163) 
N

>  <ORAL>  (163) 
Y

>  <PARENTERAL>  (163) 
Y

>  <TOPICAL>  (163) 
N

>  <BLACK_BOX>  (163) 
N

>  <AVAILABILITY_TYPE>  (163) 
Prescription-only

>  <WITHDRAWN_YEAR>  (163) 
nan

>  <WITHDRAWN_COUNTRY>  (163) 
nan

>  <WITHDRAWN_REASON>  (163) 
nan

>  <CANONICAL_SMILES>  (163) 
OC(=O)CC(O)(CC(=O)O)C(=O)O

>  <name>  (163) 
Citric Acid 

>  <MW>  (163) 
192.123

>  <logP>  (163) 
-1.2485

$$$$
CHEMBL1946170
     RDKit          

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 12 28  1  0
 28 29  1  0
 28 30  2  0
  7 31  2  0
 31 32  1  0
 32 33  2  0
 33  5  1  0
 30  9  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (164) 
1277553

>  <SYNONYMS>  (164) 
Regorafenib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (164) 
4

>  <RESEARCH_CODES>  (164) 
BAY-73-4506; BAY-734506 monohydrate

>  <APPLICANTS>  (164) 
Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (164) 
-rafenib

>  <USAN_STEM_DEFINITION>  (164) 
raf kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (164) 
-rafenib

>  <USAN_YEAR>  (164) 
2011.0

>  <FIRST_APPROVAL>  (164) 
2012.0

>  <ATC_CODE>  (164) 
L01XE21

>  <ATC_CODE_DESCRIPTION>  (164) 
L01XE21 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (164) 
nan

>  <SC_PATENT_NO>  (164) 
US-7351834-B1

>  <DRUG_TYPE>  (164) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (164) 
Y

>  <FIRST_IN_CLASS>  (164) 
N

>  <CHIRALITY>  (164) 
Achiral Molecule

>  <PRODRUG>  (164) 
N

>  <ORAL>  (164) 
Y

>  <PARENTERAL>  (164) 
N

>  <TOPICAL>  (164) 
N

>  <BLACK_BOX>  (164) 
Y

>  <AVAILABILITY_TYPE>  (164) 
Prescription-only

>  <WITHDRAWN_YEAR>  (164) 
nan

>  <WITHDRAWN_COUNTRY>  (164) 
nan

>  <WITHDRAWN_REASON>  (164) 
nan

>  <CANONICAL_SMILES>  (164) 
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1

>  <name>  (164) 
Regorafenib 

>  <MW>  (164) 
482.821

>  <logP>  (164) 
5.6888

$$$$
CHEMBL1118
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
  5 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 12  6  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (165) 
161281

>  <SYNONYMS>  (165) 
Desvenlafaxine (FDA, INN); Desvenlafaxine Succinate (FDA, USAN); Desvenlafaxine Fumarate (FDA)

>  <DEVELOPMENT_PHASE>  (165) 
4

>  <RESEARCH_CODES>  (165) 
WY-45233

>  <APPLICANTS>  (165) 
Wyeth Pharmaceuticals Inc; Teva Pharmaceuticals Usa; Alembic Pharmaceuticals Ltd

>  <USAN_STEM>  (165) 
-axine

>  <USAN_STEM_DEFINITION>  (165) 
antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake

>  <USAN_STEM_SUBSTEM>  (165) 
-axine

>  <USAN_YEAR>  (165) 
2003.0

>  <FIRST_APPROVAL>  (165) 
2008.0

>  <ATC_CODE>  (165) 
N06AX23

>  <ATC_CODE_DESCRIPTION>  (165) 
N06AX23 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (165) 
nan

>  <SC_PATENT_NO>  (165) 
US-6673838-B2

>  <DRUG_TYPE>  (165) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (165) 
Y

>  <FIRST_IN_CLASS>  (165) 
N

>  <CHIRALITY>  (165) 
Racemic Mixture

>  <PRODRUG>  (165) 
N

>  <ORAL>  (165) 
Y

>  <PARENTERAL>  (165) 
N

>  <TOPICAL>  (165) 
N

>  <BLACK_BOX>  (165) 
Y

>  <AVAILABILITY_TYPE>  (165) 
Prescription-only

>  <WITHDRAWN_YEAR>  (165) 
nan

>  <WITHDRAWN_COUNTRY>  (165) 
nan

>  <WITHDRAWN_REASON>  (165) 
nan

>  <CANONICAL_SMILES>  (165) 
CN(C)CC(c1ccc(O)cc1)C2(O)CCCCC2

>  <name>  (165) 
Desvenlafaxine 

>  <MW>  (165) 
263.381

>  <logP>  (165) 
2.7326

$$$$
CHEMBL1194
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (166) 
208749

>  <SYNONYMS>  (166) 
Prilocaine (BAN, FDA, INN, USAN, USP); Prilocaine HCl (FDA, USAN, USP); Propitocaine HCl (JAN)

>  <DEVELOPMENT_PHASE>  (166) 
4

>  <RESEARCH_CODES>  (166) 
ASTRA 1512; L-67

>  <APPLICANTS>  (166) 
Oak Pharmaceuticals Inc; Dentsply Pharmaceutical Inc; Astrazeneca Lp

>  <USAN_STEM>  (166) 
-caine

>  <USAN_STEM_DEFINITION>  (166) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (166) 
-caine

>  <USAN_YEAR>  (166) 
1966.0

>  <FIRST_APPROVAL>  (166) 
1965.0

>  <ATC_CODE>  (166) 
N01BB54; N01BB04

>  <ATC_CODE_DESCRIPTION>  (166) 
N01BB54 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB04 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (166) 
Anesthetic (local)

>  <SC_PATENT_NO>  (166) 
US-6031007-A

>  <DRUG_TYPE>  (166) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (166) 
Y

>  <FIRST_IN_CLASS>  (166) 
N

>  <CHIRALITY>  (166) 
Racemic Mixture

>  <PRODRUG>  (166) 
N

>  <ORAL>  (166) 
N

>  <PARENTERAL>  (166) 
Y

>  <TOPICAL>  (166) 
Y

>  <BLACK_BOX>  (166) 
N

>  <AVAILABILITY_TYPE>  (166) 
Prescription-only

>  <WITHDRAWN_YEAR>  (166) 
nan

>  <WITHDRAWN_COUNTRY>  (166) 
nan

>  <WITHDRAWN_REASON>  (166) 
nan

>  <CANONICAL_SMILES>  (166) 
CCCNC(C)C(=O)Nc1ccccc1C

>  <name>  (166) 
Prilocaine 

>  <MW>  (166) 
220.316

>  <logP>  (166) 
2.32162

$$$$
CHEMBL655
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23  2  1  0
 23  5  1  0
 14  9  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (167) 
27611

>  <SYNONYMS>  (167) 
Midazolam (BAN, INN, JAN); Midazolam HCl (FDA, USAN); Midazolam Maleate (USAN)

>  <DEVELOPMENT_PHASE>  (167) 
4

>  <RESEARCH_CODES>  (167) 
Ro-213981003; Ro-213981-003; Ro-213981001

>  <APPLICANTS>  (167) 
Hoffmann-Laroche; Hoffmann La Roche Inc; Hlr Technology

>  <USAN_STEM>  (167) 
nan

>  <USAN_STEM_DEFINITION>  (167) 
nan

>  <USAN_STEM_SUBSTEM>  (167) 
nan

>  <USAN_YEAR>  (167) 
1978.0

>  <FIRST_APPROVAL>  (167) 
1985.0

>  <ATC_CODE>  (167) 
N05CD08

>  <ATC_CODE_DESCRIPTION>  (167) 
N05CD08 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (167) 
Anesthetic (injectable); Anesthetic (intravenous)

>  <SC_PATENT_NO>  (167) 
nan

>  <DRUG_TYPE>  (167) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (167) 
Y

>  <FIRST_IN_CLASS>  (167) 
N

>  <CHIRALITY>  (167) 
Achiral Molecule

>  <PRODRUG>  (167) 
N

>  <ORAL>  (167) 
Y

>  <PARENTERAL>  (167) 
Y

>  <TOPICAL>  (167) 
N

>  <BLACK_BOX>  (167) 
Y

>  <AVAILABILITY_TYPE>  (167) 
Prescription-only

>  <WITHDRAWN_YEAR>  (167) 
nan

>  <WITHDRAWN_COUNTRY>  (167) 
nan

>  <WITHDRAWN_REASON>  (167) 
nan

>  <CANONICAL_SMILES>  (167) 
Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12

>  <name>  (167) 
Midazolam 

>  <MW>  (167) 
325.774

>  <logP>  (167) 
4.32422

$$$$
CHEMBL285674
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  7  2  1  0
 15  5  1  0
 15 11  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (168) 
49847

>  <SYNONYMS>  (168) 
Estazolam (FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (168) 
4

>  <RESEARCH_CODES>  (168) 
ABBOTT-47631

>  <APPLICANTS>  (168) 
Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (168) 
nan

>  <USAN_STEM_DEFINITION>  (168) 
nan

>  <USAN_STEM_SUBSTEM>  (168) 
nan

>  <USAN_YEAR>  (168) 
1990.0

>  <FIRST_APPROVAL>  (168) 
1990.0

>  <ATC_CODE>  (168) 
N05CD04

>  <ATC_CODE_DESCRIPTION>  (168) 
N05CD04 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (168) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (168) 
nan

>  <DRUG_TYPE>  (168) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (168) 
Y

>  <FIRST_IN_CLASS>  (168) 
N

>  <CHIRALITY>  (168) 
Achiral Molecule

>  <PRODRUG>  (168) 
N

>  <ORAL>  (168) 
Y

>  <PARENTERAL>  (168) 
N

>  <TOPICAL>  (168) 
N

>  <BLACK_BOX>  (168) 
Y

>  <AVAILABILITY_TYPE>  (168) 
Prescription-only

>  <WITHDRAWN_YEAR>  (168) 
nan

>  <WITHDRAWN_COUNTRY>  (168) 
nan

>  <WITHDRAWN_REASON>  (168) 
nan

>  <CANONICAL_SMILES>  (168) 
Clc1ccc2c(c1)C(=NCc3nncn23)c4ccccc4

>  <name>  (168) 
Estazolam 

>  <MW>  (168) 
294.745

>  <logP>  (168) 
3.2717

$$$$
CHEMBL90
     RDKit          

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  4  1  0
M  END
>  <PARENT_MOLREGNO>  (169) 
8910

>  <SYNONYMS>  (169) 
Histamine Dihydrochloride (USAN); Histamine Phosphate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (169) 
4

>  <RESEARCH_CODES>  (169) 
nan

>  <APPLICANTS>  (169) 
Eli Lilly And Co

>  <USAN_STEM>  (169) 
nan

>  <USAN_STEM_DEFINITION>  (169) 
nan

>  <USAN_STEM_SUBSTEM>  (169) 
nan

>  <USAN_YEAR>  (169) 
1988.0

>  <FIRST_APPROVAL>  (169) 
1939.0

>  <ATC_CODE>  (169) 
L03AX14; V04CG03

>  <ATC_CODE_DESCRIPTION>  (169) 
L03AX14 [Antineoplastic And Immunomodulating Agents:Immunostimulants:Immunostimulants:Other immunostimulants]; V04CG03 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for gastric secretion]

>  <INDICATION_CLASS>  (169) 
Stimulant (gastric secretory)

>  <SC_PATENT_NO>  (169) 
nan

>  <DRUG_TYPE>  (169) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (169) 
Y

>  <FIRST_IN_CLASS>  (169) 
N

>  <CHIRALITY>  (169) 
Achiral Molecule

>  <PRODRUG>  (169) 
N

>  <ORAL>  (169) 
N

>  <PARENTERAL>  (169) 
Y

>  <TOPICAL>  (169) 
N

>  <BLACK_BOX>  (169) 
N

>  <AVAILABILITY_TYPE>  (169) 
Discontinued

>  <WITHDRAWN_YEAR>  (169) 
nan

>  <WITHDRAWN_COUNTRY>  (169) 
nan

>  <WITHDRAWN_REASON>  (169) 
nan

>  <CANONICAL_SMILES>  (169) 
NCCc1c[nH]cn1

>  <name>  (169) 
Histamine Dihydrochloride 

>  <MW>  (169) 
111.148

>  <logP>  (169) 
-0.0891

$$$$
CHEMBL1628227
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  7  1  0
 13  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (170) 
1051118

>  <SYNONYMS>  (170) 
Doxepin (BAN, INN); Doxepin HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (170) 
4

>  <RESEARCH_CODES>  (170) 
P-3693A

>  <APPLICANTS>  (170) 
Somaxon Pharmaceuticals Inc; Pfizer Laboratories Div Pfizer Inc; New River Pharmaceuticals Inc; Fougera Pharmaceuticals Inc

>  <USAN_STEM>  (170) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (170) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (170) 
-pin(e)

>  <USAN_YEAR>  (170) 
1964.0

>  <FIRST_APPROVAL>  (170) 
1969.0

>  <ATC_CODE>  (170) 
N06AA12

>  <ATC_CODE_DESCRIPTION>  (170) 
N06AA12 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (170) 
Antidepressant

>  <SC_PATENT_NO>  (170) 
US-6211229-B1

>  <DRUG_TYPE>  (170) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (170) 
Y

>  <FIRST_IN_CLASS>  (170) 
N

>  <CHIRALITY>  (170) 
Achiral Molecule

>  <PRODRUG>  (170) 
N

>  <ORAL>  (170) 
Y

>  <PARENTERAL>  (170) 
N

>  <TOPICAL>  (170) 
Y

>  <BLACK_BOX>  (170) 
Y

>  <AVAILABILITY_TYPE>  (170) 
Prescription-only

>  <WITHDRAWN_YEAR>  (170) 
nan

>  <WITHDRAWN_COUNTRY>  (170) 
nan

>  <WITHDRAWN_REASON>  (170) 
nan

>  <CANONICAL_SMILES>  (170) 
CN(C)CCC=C1c2ccccc2COc3ccccc13

>  <name>  (170) 
Doxepin 

>  <MW>  (170) 
279.383

>  <logP>  (170) 
3.9624

$$$$
CHEMBL76
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22 12  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (171) 
6579

>  <SYNONYMS>  (171) 
Chloroquine (BAN, INN, USP); Chloroquine HCl (FDA, USP); Chloroquine Phosphate (BAN, FDA, USP)

>  <DEVELOPMENT_PHASE>  (171) 
4

>  <RESEARCH_CODES>  (171) 
NSC-187208

>  <APPLICANTS>  (171) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (171) 
nan

>  <USAN_STEM_DEFINITION>  (171) 
nan

>  <USAN_STEM_SUBSTEM>  (171) 
nan

>  <USAN_YEAR>  (171) 
nan

>  <FIRST_APPROVAL>  (171) 
1949.0

>  <ATC_CODE>  (171) 
P01BA01

>  <ATC_CODE_DESCRIPTION>  (171) 
P01BA01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Aminoquinolines]

>  <INDICATION_CLASS>  (171) 
Anti-Amebic; Antimalarial; Suppressant (lupus erythematosus)

>  <SC_PATENT_NO>  (171) 
nan

>  <DRUG_TYPE>  (171) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (171) 
Y

>  <FIRST_IN_CLASS>  (171) 
N

>  <CHIRALITY>  (171) 
Racemic Mixture

>  <PRODRUG>  (171) 
N

>  <ORAL>  (171) 
Y

>  <PARENTERAL>  (171) 
Y

>  <TOPICAL>  (171) 
N

>  <BLACK_BOX>  (171) 
Y

>  <AVAILABILITY_TYPE>  (171) 
Prescription-only

>  <WITHDRAWN_YEAR>  (171) 
nan

>  <WITHDRAWN_COUNTRY>  (171) 
nan

>  <WITHDRAWN_REASON>  (171) 
nan

>  <CANONICAL_SMILES>  (171) 
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12

>  <name>  (171) 
Chloroquine 

>  <MW>  (171) 
319.88

>  <logP>  (171) 
4.8106

$$$$
CHEMBL817
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
  7  2  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (172) 
56131

>  <SYNONYMS>  (172) 
Tolazamide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (172) 
4

>  <RESEARCH_CODES>  (172) 
U-17835

>  <APPLICANTS>  (172) 
Pharmacia And Upjohn Co; Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa

>  <USAN_STEM>  (172) 
nan

>  <USAN_STEM_DEFINITION>  (172) 
nan

>  <USAN_STEM_SUBSTEM>  (172) 
nan

>  <USAN_YEAR>  (172) 
1964.0

>  <FIRST_APPROVAL>  (172) 
1966.0

>  <ATC_CODE>  (172) 
A10BB05

>  <ATC_CODE_DESCRIPTION>  (172) 
A10BB05 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (172) 
Antidiabetic

>  <SC_PATENT_NO>  (172) 
nan

>  <DRUG_TYPE>  (172) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (172) 
Y

>  <FIRST_IN_CLASS>  (172) 
N

>  <CHIRALITY>  (172) 
Achiral Molecule

>  <PRODRUG>  (172) 
N

>  <ORAL>  (172) 
Y

>  <PARENTERAL>  (172) 
N

>  <TOPICAL>  (172) 
N

>  <BLACK_BOX>  (172) 
N

>  <AVAILABILITY_TYPE>  (172) 
Prescription-only

>  <WITHDRAWN_YEAR>  (172) 
nan

>  <WITHDRAWN_COUNTRY>  (172) 
nan

>  <WITHDRAWN_REASON>  (172) 
nan

>  <CANONICAL_SMILES>  (172) 
Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2

>  <name>  (172) 
Tolazamide 

>  <MW>  (172) 
311.407

>  <logP>  (172) 
1.77392

$$$$
CHEMBL108
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  4  1  0
 10  5  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (173) 
15086

>  <SYNONYMS>  (173) 
Carbamazepine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (173) 
4

>  <RESEARCH_CODES>  (173) 
G-32883

>  <APPLICANTS>  (173) 
Validus Pharmaceuticals Inc; Shire Development Inc; Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (173) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (173) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (173) 
-pin(e)

>  <USAN_YEAR>  (173) 
1965.0

>  <FIRST_APPROVAL>  (173) 
1968.0

>  <ATC_CODE>  (173) 
N03AF01

>  <ATC_CODE_DESCRIPTION>  (173) 
N03AF01 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives]

>  <INDICATION_CLASS>  (173) 
Analgesic; Anticonvulsant

>  <SC_PATENT_NO>  (173) 
US-5912013-A

>  <DRUG_TYPE>  (173) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (173) 
Y

>  <FIRST_IN_CLASS>  (173) 
N

>  <CHIRALITY>  (173) 
Achiral Molecule

>  <PRODRUG>  (173) 
N

>  <ORAL>  (173) 
Y

>  <PARENTERAL>  (173) 
N

>  <TOPICAL>  (173) 
N

>  <BLACK_BOX>  (173) 
Y

>  <AVAILABILITY_TYPE>  (173) 
Prescription-only

>  <WITHDRAWN_YEAR>  (173) 
nan

>  <WITHDRAWN_COUNTRY>  (173) 
nan

>  <WITHDRAWN_REASON>  (173) 
nan

>  <CANONICAL_SMILES>  (173) 
NC(=O)N1c2ccccc2C=Cc3ccccc13

>  <name>  (173) 
Carbamazepine 

>  <MW>  (173) 
236.274

>  <logP>  (173) 
3.3872

$$$$
CHEMBL1201270
     RDKit          

 10 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  6 10  1  0
  8  1  1  0
 10  2  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (174) 
675221

>  <SYNONYMS>  (174) 
Hexamine (JAN); Methenamine (INN, USP); Methenamine Hippurate (BAN, FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (174) 
4

>  <RESEARCH_CODES>  (174) 
nan

>  <APPLICANTS>  (174) 
Sanofi Aventis Us Llc; Parke-Davis; Ecr; County Line Pharmaceuticals Llc

>  <USAN_STEM>  (174) 
nan

>  <USAN_STEM_DEFINITION>  (174) 
nan

>  <USAN_STEM_SUBSTEM>  (174) 
nan

>  <USAN_YEAR>  (174) 
1963.0

>  <FIRST_APPROVAL>  (174) 
1967.0

>  <ATC_CODE>  (174) 
J01XX05

>  <ATC_CODE_DESCRIPTION>  (174) 
J01XX05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Other antibacterials]

>  <INDICATION_CLASS>  (174) 
Antibacterial (urinary)

>  <SC_PATENT_NO>  (174) 
nan

>  <DRUG_TYPE>  (174) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (174) 
Y

>  <FIRST_IN_CLASS>  (174) 
N

>  <CHIRALITY>  (174) 
Achiral Molecule

>  <PRODRUG>  (174) 
Y

>  <ORAL>  (174) 
Y

>  <PARENTERAL>  (174) 
N

>  <TOPICAL>  (174) 
N

>  <BLACK_BOX>  (174) 
N

>  <AVAILABILITY_TYPE>  (174) 
Prescription-only

>  <WITHDRAWN_YEAR>  (174) 
nan

>  <WITHDRAWN_COUNTRY>  (174) 
nan

>  <WITHDRAWN_REASON>  (174) 
nan

>  <CANONICAL_SMILES>  (174) 
C1N2CN3CN(CN1C3)C2

>  <name>  (174) 
Hexamine 

>  <MW>  (174) 
140.19

>  <logP>  (174) 
-1.0198

$$$$
CHEMBL839
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 11  1  0
 21 15  2  0
M  END
>  <PARENT_MOLREGNO>  (175) 
62182

>  <SYNONYMS>  (175) 
Carteolol (BAN, INN); Carteolol HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (175) 
4

>  <RESEARCH_CODES>  (175) 
ABBOTT-43326; OPC-1085

>  <APPLICANTS>  (175) 
Novartis Pharmaceuticals Corp; Abbvie Inc

>  <USAN_STEM>  (175) 
-olol

>  <USAN_STEM_DEFINITION>  (175) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (175) 
-olol

>  <USAN_YEAR>  (175) 
1976.0

>  <FIRST_APPROVAL>  (175) 
1988.0

>  <ATC_CODE>  (175) 
S01ED55; S01ED05; C07AA15

>  <ATC_CODE_DESCRIPTION>  (175) 
S01ED55 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; S01ED05 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; C07AA15 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (175) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (175) 
nan

>  <DRUG_TYPE>  (175) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (175) 
Y

>  <FIRST_IN_CLASS>  (175) 
N

>  <CHIRALITY>  (175) 
Racemic Mixture

>  <PRODRUG>  (175) 
N

>  <ORAL>  (175) 
Y

>  <PARENTERAL>  (175) 
N

>  <TOPICAL>  (175) 
Y

>  <BLACK_BOX>  (175) 
N

>  <AVAILABILITY_TYPE>  (175) 
Prescription-only

>  <WITHDRAWN_YEAR>  (175) 
nan

>  <WITHDRAWN_COUNTRY>  (175) 
nan

>  <WITHDRAWN_REASON>  (175) 
nan

>  <CANONICAL_SMILES>  (175) 
CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12

>  <name>  (175) 
Carteolol 

>  <MW>  (175) 
292.379

>  <logP>  (175) 
1.6991

$$$$
CHEMBL1305
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  1 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
  9  4  1  0
 15 10  1  0
 20 16  1  0
M  END
>  <PARENT_MOLREGNO>  (176) 
258709

>  <SYNONYMS>  (176) 
Antazoline (BAN, INN); Antazoline HCl (MI, USP); Antazoline phosphate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (176) 
4

>  <RESEARCH_CODES>  (176) 
nan

>  <APPLICANTS>  (176) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (176) 
-azoline

>  <USAN_STEM_DEFINITION>  (176) 
antihistamines/local vasoconstrictors (antazoline type)

>  <USAN_STEM_SUBSTEM>  (176) 
-azoline

>  <USAN_YEAR>  (176) 
nan

>  <FIRST_APPROVAL>  (176) 
1994.0

>  <ATC_CODE>  (176) 
R01AC04; R06AX05

>  <ATC_CODE_DESCRIPTION>  (176) 
R01AC04 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Antiallergic agents, excl. corticosteroids]; R06AX05 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (176) 
Antihistaminic

>  <SC_PATENT_NO>  (176) 
nan

>  <DRUG_TYPE>  (176) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (176) 
Y

>  <FIRST_IN_CLASS>  (176) 
N

>  <CHIRALITY>  (176) 
Achiral Molecule

>  <PRODRUG>  (176) 
N

>  <ORAL>  (176) 
N

>  <PARENTERAL>  (176) 
N

>  <TOPICAL>  (176) 
Y

>  <BLACK_BOX>  (176) 
N

>  <AVAILABILITY_TYPE>  (176) 
Discontinued

>  <WITHDRAWN_YEAR>  (176) 
nan

>  <WITHDRAWN_COUNTRY>  (176) 
nan

>  <WITHDRAWN_REASON>  (176) 
nan

>  <CANONICAL_SMILES>  (176) 
C(N(Cc1ccccc1)c2ccccc2)C3=NCCN3

>  <name>  (176) 
Antazoline 

>  <MW>  (176) 
265.36

>  <logP>  (176) 
2.6949

$$$$
CHEMBL611
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 13  3  1  0
 11  5  1  0
 21 16  1  0
 28 24  1  0
M  END
>  <PARENT_MOLREGNO>  (177) 
23093

>  <SYNONYMS>  (177) 
Terazosin (BAN, INN); Terazosin HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (177) 
4

>  <RESEARCH_CODES>  (177) 
ABBOTT-45975

>  <APPLICANTS>  (177) 
Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (177) 
-azosin

>  <USAN_STEM_DEFINITION>  (177) 
antihypertensives (prazosin type)

>  <USAN_STEM_SUBSTEM>  (177) 
-azosin

>  <USAN_YEAR>  (177) 
1980.0

>  <FIRST_APPROVAL>  (177) 
1987.0

>  <ATC_CODE>  (177) 
G04CA03

>  <ATC_CODE_DESCRIPTION>  (177) 
G04CA03 [Genito Urinary System And Sex Hormones:Urologicals:Drugs Used In Benign Prostatic Hypertrophy:Alpha-adrenoreceptor antagonists]

>  <INDICATION_CLASS>  (177) 
Antihypertensive

>  <SC_PATENT_NO>  (177) 
nan

>  <DRUG_TYPE>  (177) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (177) 
Y

>  <FIRST_IN_CLASS>  (177) 
N

>  <CHIRALITY>  (177) 
Racemic Mixture

>  <PRODRUG>  (177) 
N

>  <ORAL>  (177) 
Y

>  <PARENTERAL>  (177) 
N

>  <TOPICAL>  (177) 
N

>  <BLACK_BOX>  (177) 
Y

>  <AVAILABILITY_TYPE>  (177) 
Prescription-only

>  <WITHDRAWN_YEAR>  (177) 
nan

>  <WITHDRAWN_COUNTRY>  (177) 
nan

>  <WITHDRAWN_REASON>  (177) 
nan

>  <CANONICAL_SMILES>  (177) 
COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

>  <name>  (177) 
Terazosin 

>  <MW>  (177) 
387.44

>  <logP>  (177) 
1.0568

$$$$
CHEMBL703
     RDKit          

 20 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
M  CHG  2   2   1  17   1
M  END
>  <PARENT_MOLREGNO>  (178) 
33060

>  <SYNONYMS>  (178) 
Succinylcholine chloride (FDA, USP); Suxamethonium Chloride (BAN, DCF, INN, JAN); Suxamethonium Bromide (BAN)

>  <DEVELOPMENT_PHASE>  (178) 
4

>  <RESEARCH_CODES>  (178) 
nan

>  <APPLICANTS>  (178) 
Sandoz Canada Inc; Hospira Inc; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (178) 
-ium

>  <USAN_STEM_DEFINITION>  (178) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (178) 
-ium

>  <USAN_YEAR>  (178) 
nan

>  <FIRST_APPROVAL>  (178) 
1952.0

>  <ATC_CODE>  (178) 
M03AB01

>  <ATC_CODE_DESCRIPTION>  (178) 
M03AB01 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Peripherally Acting Agents:Choline derivatives]

>  <INDICATION_CLASS>  (178) 
Neuromuscular Blocking Agent

>  <SC_PATENT_NO>  (178) 
nan

>  <DRUG_TYPE>  (178) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (178) 
Y

>  <FIRST_IN_CLASS>  (178) 
N

>  <CHIRALITY>  (178) 
Achiral Molecule

>  <PRODRUG>  (178) 
N

>  <ORAL>  (178) 
N

>  <PARENTERAL>  (178) 
Y

>  <TOPICAL>  (178) 
N

>  <BLACK_BOX>  (178) 
Y

>  <AVAILABILITY_TYPE>  (178) 
Prescription-only

>  <WITHDRAWN_YEAR>  (178) 
nan

>  <WITHDRAWN_COUNTRY>  (178) 
nan

>  <WITHDRAWN_REASON>  (178) 
nan

>  <CANONICAL_SMILES>  (178) 
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C

>  <name>  (178) 
Succinylcholine chloride 

>  <MW>  (178) 
290.404

>  <logP>  (178) 
0.2654

$$$$
CHEMBL1908370
     RDKit          

 29 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  3  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 14 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28  4  1  0
  9  7  1  0
 27 10  1  0
 23 15  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (179) 
1248741

>  <SYNONYMS>  (179) 
Finafloxacin (FDA, INN)

>  <DEVELOPMENT_PHASE>  (179) 
4

>  <RESEARCH_CODES>  (179) 
nan

>  <APPLICANTS>  (179) 
Alcon Research Ltd

>  <USAN_STEM>  (179) 
-oxacin

>  <USAN_STEM_DEFINITION>  (179) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (179) 
-oxacin

>  <USAN_YEAR>  (179) 
nan

>  <FIRST_APPROVAL>  (179) 
2014.0

>  <ATC_CODE>  (179) 
nan

>  <ATC_CODE_DESCRIPTION>  (179) 
nan

>  <INDICATION_CLASS>  (179) 
nan

>  <SC_PATENT_NO>  (179) 
US-6133260-A

>  <DRUG_TYPE>  (179) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (179) 
Y

>  <FIRST_IN_CLASS>  (179) 
N

>  <CHIRALITY>  (179) 
Single Stereoisomer

>  <PRODRUG>  (179) 
N

>  <ORAL>  (179) 
N

>  <PARENTERAL>  (179) 
N

>  <TOPICAL>  (179) 
Y

>  <BLACK_BOX>  (179) 
N

>  <AVAILABILITY_TYPE>  (179) 
Prescription-only

>  <WITHDRAWN_YEAR>  (179) 
nan

>  <WITHDRAWN_COUNTRY>  (179) 
nan

>  <WITHDRAWN_REASON>  (179) 
nan

>  <CANONICAL_SMILES>  (179) 
OC(=O)C1=CN(C2CC2)c3c(C#N)c(N4C[C@@H]5NCCO[C@H]5C4)c(F)cc3C1=O

>  <name>  (179) 
Finafloxacin 

>  <MW>  (179) 
398.394

>  <logP>  (179) 
1.22238

$$$$
CHEMBL1208
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19  3  1  0
 19 11  1  0
 17 13  2  0
M  END
>  <PARENT_MOLREGNO>  (180) 
214701

>  <SYNONYMS>  (180) 
Cinoxacin (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (180) 
4

>  <RESEARCH_CODES>  (180) 
64716

>  <APPLICANTS>  (180) 
Eli Lilly And Co

>  <USAN_STEM>  (180) 
-oxacin

>  <USAN_STEM_DEFINITION>  (180) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (180) 
-oxacin

>  <USAN_YEAR>  (180) 
1974.0

>  <FIRST_APPROVAL>  (180) 
1980.0

>  <ATC_CODE>  (180) 
J01MB06

>  <ATC_CODE_DESCRIPTION>  (180) 
J01MB06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Other quinolones]

>  <INDICATION_CLASS>  (180) 
Antibacterial

>  <SC_PATENT_NO>  (180) 
nan

>  <DRUG_TYPE>  (180) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (180) 
Y

>  <FIRST_IN_CLASS>  (180) 
N

>  <CHIRALITY>  (180) 
Achiral Molecule

>  <PRODRUG>  (180) 
N

>  <ORAL>  (180) 
Y

>  <PARENTERAL>  (180) 
N

>  <TOPICAL>  (180) 
N

>  <BLACK_BOX>  (180) 
N

>  <AVAILABILITY_TYPE>  (180) 
Discontinued

>  <WITHDRAWN_YEAR>  (180) 
nan

>  <WITHDRAWN_COUNTRY>  (180) 
nan

>  <WITHDRAWN_REASON>  (180) 
nan

>  <CANONICAL_SMILES>  (180) 
CCN1N=C(C(=O)O)C(=O)c2cc3OCOc3cc12

>  <name>  (180) 
Cinoxacin 

>  <MW>  (180) 
262.221

>  <logP>  (180) 
0.8433

$$$$
CHEMBL622
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 12 19  1  0
 19 20  1  0
 20 21  1  0
 21  3  1  0
 21  7  2  0
 19  8  2  0
M  END
>  <PARENT_MOLREGNO>  (181) 
26431

>  <SYNONYMS>  (181) 
Etodolac (BAN, FDA, INN, USAN, USP); Etodolic Acid (INN)

>  <DEVELOPMENT_PHASE>  (181) 
4

>  <RESEARCH_CODES>  (181) 
AY-24236

>  <APPLICANTS>  (181) 
Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (181) 
-ac

>  <USAN_STEM_DEFINITION>  (181) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (181) 
-ac

>  <USAN_YEAR>  (181) 
1975.0

>  <FIRST_APPROVAL>  (181) 
1991.0

>  <ATC_CODE>  (181) 
M01AB08

>  <ATC_CODE_DESCRIPTION>  (181) 
M01AB08 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (181) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (181) 
nan

>  <DRUG_TYPE>  (181) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (181) 
Y

>  <FIRST_IN_CLASS>  (181) 
N

>  <CHIRALITY>  (181) 
Racemic Mixture

>  <PRODRUG>  (181) 
N

>  <ORAL>  (181) 
Y

>  <PARENTERAL>  (181) 
N

>  <TOPICAL>  (181) 
N

>  <BLACK_BOX>  (181) 
Y

>  <AVAILABILITY_TYPE>  (181) 
Prescription-only

>  <WITHDRAWN_YEAR>  (181) 
nan

>  <WITHDRAWN_COUNTRY>  (181) 
nan

>  <WITHDRAWN_REASON>  (181) 
nan

>  <CANONICAL_SMILES>  (181) 
CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12

>  <name>  (181) 
Etodolac 

>  <MW>  (181) 
287.359

>  <logP>  (181) 
3.383

$$$$
CHEMBL468
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  5 17  1  0
 17 18  2  0
 17 19  1  0
 19  2  1  0
 15  6  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (182) 
5028

>  <SYNONYMS>  (182) 
Thalidomide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (182) 
4

>  <RESEARCH_CODES>  (182) 
K-17

>  <APPLICANTS>  (182) 
Celgene Corp

>  <USAN_STEM>  (182) 
-domide

>  <USAN_STEM_DEFINITION>  (182) 
thalidomide derivatives

>  <USAN_STEM_SUBSTEM>  (182) 
-domide

>  <USAN_YEAR>  (182) 
1961.0

>  <FIRST_APPROVAL>  (182) 
1998.0

>  <ATC_CODE>  (182) 
L04AX02

>  <ATC_CODE_DESCRIPTION>  (182) 
L04AX02 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Other immunosuppressants]

>  <INDICATION_CLASS>  (182) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (182) 
US-6045501-A

>  <DRUG_TYPE>  (182) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (182) 
Y

>  <FIRST_IN_CLASS>  (182) 
N

>  <CHIRALITY>  (182) 
Racemic Mixture

>  <PRODRUG>  (182) 
N

>  <ORAL>  (182) 
Y

>  <PARENTERAL>  (182) 
N

>  <TOPICAL>  (182) 
N

>  <BLACK_BOX>  (182) 
Y

>  <AVAILABILITY_TYPE>  (182) 
Prescription-only

>  <WITHDRAWN_YEAR>  (182) 
nan

>  <WITHDRAWN_COUNTRY>  (182) 
nan

>  <WITHDRAWN_REASON>  (182) 
nan

>  <CANONICAL_SMILES>  (182) 
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1

>  <name>  (182) 
Thalidomide 

>  <MW>  (182) 
258.233

>  <logP>  (182) 
0.0878

$$$$
CHEMBL996
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  3 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 17 21  1  0
 21 22  2  0
 21 23  1  0
 16 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 19  3  1  0
 12  8  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (183) 
109807

>  <SYNONYMS>  (183) 
Cefoxitin (BAN, INN, USAN); Cefoxitin Sodium (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (183) 
4

>  <RESEARCH_CODES>  (183) 
nan

>  <APPLICANTS>  (183) 
Mylan Institutional Llc; Merck And Co Inc

>  <USAN_STEM>  (183) 
cef-

>  <USAN_STEM_DEFINITION>  (183) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (183) 
cef-

>  <USAN_YEAR>  (183) 
1973.0

>  <FIRST_APPROVAL>  (183) 
1978.0

>  <ATC_CODE>  (183) 
J01DC01

>  <ATC_CODE_DESCRIPTION>  (183) 
J01DC01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Second-generation cephalosporins]

>  <INDICATION_CLASS>  (183) 
Antibacterial

>  <SC_PATENT_NO>  (183) 
nan

>  <DRUG_TYPE>  (183) 
Natural Product-derived

>  <RULE_OF_FIVE>  (183) 
Y

>  <FIRST_IN_CLASS>  (183) 
N

>  <CHIRALITY>  (183) 
Single Stereoisomer

>  <PRODRUG>  (183) 
N

>  <ORAL>  (183) 
N

>  <PARENTERAL>  (183) 
Y

>  <TOPICAL>  (183) 
N

>  <BLACK_BOX>  (183) 
Y

>  <AVAILABILITY_TYPE>  (183) 
Prescription-only

>  <WITHDRAWN_YEAR>  (183) 
nan

>  <WITHDRAWN_COUNTRY>  (183) 
nan

>  <WITHDRAWN_REASON>  (183) 
nan

>  <CANONICAL_SMILES>  (183) 
CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)O)COC(=O)N

>  <name>  (183) 
Cefoxitin 

>  <MW>  (183) 
427.46

>  <logP>  (183) 
0.0986

$$$$
CHEMBL1054
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
 10 15  1  0
 15 16  1  0
 15 17  1  0
  8 18  1  0
 18 19  2  0
 19 20  1  0
 19  5  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (184) 
134100

>  <SYNONYMS>  (184) 
Trichlormethiazide (FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (184) 
4

>  <RESEARCH_CODES>  (184) 
nan

>  <APPLICANTS>  (184) 
Schering Corp Sub Schering Plough Corp; Sanofi Aventis Us Llc

>  <USAN_STEM>  (184) 
-thiazide

>  <USAN_STEM_DEFINITION>  (184) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (184) 
-thiazide

>  <USAN_YEAR>  (184) 
nan

>  <FIRST_APPROVAL>  (184) 
1960.0

>  <ATC_CODE>  (184) 
C03AA06

>  <ATC_CODE_DESCRIPTION>  (184) 
C03AA06 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (184) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (184) 
nan

>  <DRUG_TYPE>  (184) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (184) 
Y

>  <FIRST_IN_CLASS>  (184) 
N

>  <CHIRALITY>  (184) 
Racemic Mixture

>  <PRODRUG>  (184) 
N

>  <ORAL>  (184) 
Y

>  <PARENTERAL>  (184) 
N

>  <TOPICAL>  (184) 
N

>  <BLACK_BOX>  (184) 
N

>  <AVAILABILITY_TYPE>  (184) 
Discontinued

>  <WITHDRAWN_YEAR>  (184) 
nan

>  <WITHDRAWN_COUNTRY>  (184) 
nan

>  <WITHDRAWN_REASON>  (184) 
nan

>  <CANONICAL_SMILES>  (184) 
NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl

>  <name>  (184) 
Trichlormethiazide 

>  <MW>  (184) 
380.662

>  <logP>  (184) 
0.821

$$$$
CHEMBL1231
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  3  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 20 15  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (185) 
229058

>  <SYNONYMS>  (185) 
Oxybutynin (BAN, FDA, INN, USAN); Oxybutynin Chloride (FDA, USAN, USP); Oxybutynin HCl (JAN)

>  <DEVELOPMENT_PHASE>  (185) 
4

>  <RESEARCH_CODES>  (185) 
5058; MJ-4309-1

>  <APPLICANTS>  (185) 
Watson Laboratories Inc; Ortho Mcneil Janssen Pharmaceuticals Inc; Msd Consumer Care Inc; Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (185) 
nan

>  <USAN_STEM_DEFINITION>  (185) 
nan

>  <USAN_STEM_SUBSTEM>  (185) 
nan

>  <USAN_YEAR>  (185) 
1962.0

>  <FIRST_APPROVAL>  (185) 
1975.0

>  <ATC_CODE>  (185) 
G04BD04

>  <ATC_CODE_DESCRIPTION>  (185) 
G04BD04 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (185) 
Anticholinergic

>  <SC_PATENT_NO>  (185) 
US-5674895-A

>  <DRUG_TYPE>  (185) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (185) 
Y

>  <FIRST_IN_CLASS>  (185) 
N

>  <CHIRALITY>  (185) 
Racemic Mixture

>  <PRODRUG>  (185) 
N

>  <ORAL>  (185) 
Y

>  <PARENTERAL>  (185) 
N

>  <TOPICAL>  (185) 
Y

>  <BLACK_BOX>  (185) 
N

>  <AVAILABILITY_TYPE>  (185) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (185) 
nan

>  <WITHDRAWN_COUNTRY>  (185) 
nan

>  <WITHDRAWN_REASON>  (185) 
nan

>  <CANONICAL_SMILES>  (185) 
CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2

>  <name>  (185) 
Oxybutynin 

>  <MW>  (185) 
357.494

>  <logP>  (185) 
3.3429

$$$$
CHEMBL503
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 18 29  1  0
 29  8  1  0
 29 13  1  0
 28 21  1  0
M  END
>  <PARENT_MOLREGNO>  (186) 
9495

>  <SYNONYMS>  (186) 
Lovastatin (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (186) 
4

>  <RESEARCH_CODES>  (186) 
MK-803

>  <APPLICANTS>  (186) 
Merck Research Laboratories Div Merck Co Inc; Andrx Labs Llc; Abbvie Inc

>  <USAN_STEM>  (186) 
-stat-

>  <USAN_STEM_DEFINITION>  (186) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (186) 
-stat- (-vastatin)

>  <USAN_YEAR>  (186) 
1987.0

>  <FIRST_APPROVAL>  (186) 
1987.0

>  <ATC_CODE>  (186) 
C10AA02

>  <ATC_CODE_DESCRIPTION>  (186) 
C10AA02 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (186) 
Antihyperlipidemic; Inhibitor (HMG-CoA reductase)

>  <SC_PATENT_NO>  (186) 
US-5916595-A

>  <DRUG_TYPE>  (186) 
Natural Product-derived

>  <RULE_OF_FIVE>  (186) 
Y

>  <FIRST_IN_CLASS>  (186) 
N

>  <CHIRALITY>  (186) 
Single Stereoisomer

>  <PRODRUG>  (186) 
Y

>  <ORAL>  (186) 
Y

>  <PARENTERAL>  (186) 
N

>  <TOPICAL>  (186) 
N

>  <BLACK_BOX>  (186) 
N

>  <AVAILABILITY_TYPE>  (186) 
Prescription-only

>  <WITHDRAWN_YEAR>  (186) 
nan

>  <WITHDRAWN_COUNTRY>  (186) 
nan

>  <WITHDRAWN_REASON>  (186) 
nan

>  <CANONICAL_SMILES>  (186) 
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12

>  <name>  (186) 
Lovastatin 

>  <MW>  (186) 
404.547

>  <logP>  (186) 
4.1955

$$$$
CHEMBL1072
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 10 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
  8 23  1  0
 23 24  2  0
 23 25  1  0
 11  6  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (187) 
139281

>  <SYNONYMS>  (187) 
Bumetanide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (187) 
4

>  <RESEARCH_CODES>  (187) 
Ro-106338

>  <APPLICANTS>  (187) 
Validus Pharmaceuticals Inc

>  <USAN_STEM>  (187) 
-etanide

>  <USAN_STEM_DEFINITION>  (187) 
diuretics (piretanide type)

>  <USAN_STEM_SUBSTEM>  (187) 
-etanide

>  <USAN_YEAR>  (187) 
1976.0

>  <FIRST_APPROVAL>  (187) 
1983.0

>  <ATC_CODE>  (187) 
C03CA02

>  <ATC_CODE_DESCRIPTION>  (187) 
C03CA02 [Cardiovascular System:Diuretics:High-Ceiling Diuretics:Sulfonamides, plain]

>  <INDICATION_CLASS>  (187) 
Diuretic

>  <SC_PATENT_NO>  (187) 
nan

>  <DRUG_TYPE>  (187) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (187) 
Y

>  <FIRST_IN_CLASS>  (187) 
N

>  <CHIRALITY>  (187) 
Achiral Molecule

>  <PRODRUG>  (187) 
N

>  <ORAL>  (187) 
Y

>  <PARENTERAL>  (187) 
Y

>  <TOPICAL>  (187) 
N

>  <BLACK_BOX>  (187) 
Y

>  <AVAILABILITY_TYPE>  (187) 
Prescription-only

>  <WITHDRAWN_YEAR>  (187) 
nan

>  <WITHDRAWN_COUNTRY>  (187) 
nan

>  <WITHDRAWN_REASON>  (187) 
nan

>  <CANONICAL_SMILES>  (187) 
CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O

>  <name>  (187) 
Bumetanide 

>  <MW>  (187) 
364.423

>  <logP>  (187) 
3.0365

$$$$
CHEMBL490
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
  7  2  1  0
 13  8  1  0
 24 16  1  0
 23 19  1  0
M  END
>  <PARENT_MOLREGNO>  (188) 
6643

>  <SYNONYMS>  (188) 
Paroxetine (BAN, INN, USAN, USP); Paroxetine HCl (FDA, USP); Paroxetine mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (188) 
4

>  <RESEARCH_CODES>  (188) 
BRL-29060; POT.MES

>  <APPLICANTS>  (188) 
SmithKline Beecham; Noven Therapeutics Llc; GlaxoSmithKline; Beecham Pharmaceuticals, England

>  <USAN_STEM>  (188) 
-oxetine

>  <USAN_STEM_DEFINITION>  (188) 
antidepressants (fluoxetine type)

>  <USAN_STEM_SUBSTEM>  (188) 
-oxetine

>  <USAN_YEAR>  (188) 
1989.0

>  <FIRST_APPROVAL>  (188) 
1992.0

>  <ATC_CODE>  (188) 
N06AB05

>  <ATC_CODE_DESCRIPTION>  (188) 
N06AB05 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (188) 
Antidepressant

>  <SC_PATENT_NO>  (188) 
US-5811436-A

>  <DRUG_TYPE>  (188) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (188) 
Y

>  <FIRST_IN_CLASS>  (188) 
N

>  <CHIRALITY>  (188) 
Single Stereoisomer

>  <PRODRUG>  (188) 
N

>  <ORAL>  (188) 
Y

>  <PARENTERAL>  (188) 
N

>  <TOPICAL>  (188) 
N

>  <BLACK_BOX>  (188) 
Y

>  <AVAILABILITY_TYPE>  (188) 
Prescription-only

>  <WITHDRAWN_YEAR>  (188) 
nan

>  <WITHDRAWN_COUNTRY>  (188) 
nan

>  <WITHDRAWN_REASON>  (188) 
nan

>  <CANONICAL_SMILES>  (188) 
Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3

>  <name>  (188) 
Paroxetine 

>  <MW>  (188) 
329.371

>  <logP>  (188) 
3.3265

$$$$
CHEMBL1282
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  5  1  0
 18  8  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (189) 
250908

>  <SYNONYMS>  (189) 
Imiquimod (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (189) 
4

>  <RESEARCH_CODES>  (189) 
R-837; S-26308

>  <APPLICANTS>  (189) 
Medicis Pharmaceutical Corp

>  <USAN_STEM>  (189) 
-imod

>  <USAN_STEM_DEFINITION>  (189) 
immunomodulators

>  <USAN_STEM_SUBSTEM>  (189) 
-imod

>  <USAN_YEAR>  (189) 
1991.0

>  <FIRST_APPROVAL>  (189) 
1997.0

>  <ATC_CODE>  (189) 
D06BB10

>  <ATC_CODE_DESCRIPTION>  (189) 
D06BB10 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]

>  <INDICATION_CLASS>  (189) 
Immunomodulator

>  <SC_PATENT_NO>  (189) 
US-7696159-B2

>  <DRUG_TYPE>  (189) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (189) 
Y

>  <FIRST_IN_CLASS>  (189) 
N

>  <CHIRALITY>  (189) 
Achiral Molecule

>  <PRODRUG>  (189) 
N

>  <ORAL>  (189) 
N

>  <PARENTERAL>  (189) 
N

>  <TOPICAL>  (189) 
Y

>  <BLACK_BOX>  (189) 
Y

>  <AVAILABILITY_TYPE>  (189) 
Prescription-only

>  <WITHDRAWN_YEAR>  (189) 
nan

>  <WITHDRAWN_COUNTRY>  (189) 
nan

>  <WITHDRAWN_REASON>  (189) 
nan

>  <CANONICAL_SMILES>  (189) 
CC(C)Cn1cnc2c(N)nc3ccccc3c12

>  <name>  (189) 
Imiquimod 

>  <MW>  (189) 
240.31

>  <logP>  (189) 
2.8227

$$$$
CHEMBL535
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 15 28  2  0
 28 29  1  0
 28 11  1  0
 17 27  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (190) 
13048

>  <SYNONYMS>  (190) 
Sunitinib (INN); Sunitinib Malate (FDA)

>  <DEVELOPMENT_PHASE>  (190) 
4

>  <RESEARCH_CODES>  (190) 
SU-11248

>  <APPLICANTS>  (190) 
Cp Pharmaceuticals International Cv

>  <USAN_STEM>  (190) 
-tinib

>  <USAN_STEM_DEFINITION>  (190) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (190) 
-tinib

>  <USAN_YEAR>  (190) 
nan

>  <FIRST_APPROVAL>  (190) 
2006.0

>  <ATC_CODE>  (190) 
L01XE04

>  <ATC_CODE_DESCRIPTION>  (190) 
L01XE04 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (190) 
nan

>  <SC_PATENT_NO>  (190) 
US-6573293-B2

>  <DRUG_TYPE>  (190) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (190) 
Y

>  <FIRST_IN_CLASS>  (190) 
N

>  <CHIRALITY>  (190) 
Achiral Molecule

>  <PRODRUG>  (190) 
N

>  <ORAL>  (190) 
Y

>  <PARENTERAL>  (190) 
N

>  <TOPICAL>  (190) 
N

>  <BLACK_BOX>  (190) 
Y

>  <AVAILABILITY_TYPE>  (190) 
Prescription-only

>  <WITHDRAWN_YEAR>  (190) 
nan

>  <WITHDRAWN_COUNTRY>  (190) 
nan

>  <WITHDRAWN_REASON>  (190) 
nan

>  <CANONICAL_SMILES>  (190) 
CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C

>  <name>  (190) 
Sunitinib 

>  <MW>  (190) 
398.482

>  <logP>  (190) 
3.33494

$$$$
CHEMBL1194325
     RDKit          

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  8 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
  2 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 21  6  1  0
 23  8  1  0
 18 13  1  0
 28 24  1  0
 33 29  1  0
M  CHG  1   8   1
M  END
>  <PARENT_MOLREGNO>  (191) 
668275

>  <SYNONYMS>  (191) 
Aclidinium Bromide (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (191) 
4

>  <RESEARCH_CODES>  (191) 
14115700; LAS-34273; LAS-34273 Micronized; LAS W-330

>  <APPLICANTS>  (191) 
Forest Laboratories Inc

>  <USAN_STEM>  (191) 
-clidinium; -ium

>  <USAN_STEM_DEFINITION>  (191) 
muscarinic receptor antagonists; quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (191) 
-clidinium; -ium

>  <USAN_YEAR>  (191) 
2007.0

>  <FIRST_APPROVAL>  (191) 
2012.0

>  <ATC_CODE>  (191) 
R03BB05

>  <ATC_CODE_DESCRIPTION>  (191) 
R03BB05 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Anticholinergics]

>  <INDICATION_CLASS>  (191) 
nan

>  <SC_PATENT_NO>  (191) 
US-5840279-A

>  <DRUG_TYPE>  (191) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (191) 
Y

>  <FIRST_IN_CLASS>  (191) 
N

>  <CHIRALITY>  (191) 
Single Stereoisomer

>  <PRODRUG>  (191) 
N

>  <ORAL>  (191) 
N

>  <PARENTERAL>  (191) 
N

>  <TOPICAL>  (191) 
Y

>  <BLACK_BOX>  (191) 
N

>  <AVAILABILITY_TYPE>  (191) 
Prescription-only

>  <WITHDRAWN_YEAR>  (191) 
nan

>  <WITHDRAWN_COUNTRY>  (191) 
nan

>  <WITHDRAWN_REASON>  (191) 
nan

>  <CANONICAL_SMILES>  (191) 
OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c4cccs4)c5cccs5

>  <name>  (191) 
Aclidinium Bromide 

>  <MW>  (191) 
484.663

>  <logP>  (191) 
4.6668

$$$$
CHEMBL23
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 17 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
  8  3  1  0
 25  9  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (192) 
1278

>  <SYNONYMS>  (192) 
Diltiazem (BAN, INN); Diltiazem Malate (FDA, USAN); Diltiazem HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (192) 
4

>  <RESEARCH_CODES>  (192) 
MK-793; RG-83606

>  <APPLICANTS>  (192) 
Valeant International Barbados Srl; Merck And Co Inc; Biovail Laboratories International Srl; Biovail Laboratories Inc; Watson Laboratories Inc

>  <USAN_STEM>  (192) 
dil-; -tiazem

>  <USAN_STEM_DEFINITION>  (192) 
vasodilators (undefined group); calcium channel blockers (diltiazem type)

>  <USAN_STEM_SUBSTEM>  (192) 
dil-; -tiazem

>  <USAN_YEAR>  (192) 
1977.0

>  <FIRST_APPROVAL>  (192) 
1982.0

>  <ATC_CODE>  (192) 
C05AE03; C08DB01

>  <ATC_CODE_DESCRIPTION>  (192) 
C05AE03 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Muscle relaxants]; C08DB01 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Direct Cardiac Effects:Benzothiazepine derivatives]

>  <INDICATION_CLASS>  (192) 
Antihypertensive; Vasodilator (coronary)

>  <SC_PATENT_NO>  (192) 
US-6923984-B1

>  <DRUG_TYPE>  (192) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (192) 
Y

>  <FIRST_IN_CLASS>  (192) 
N

>  <CHIRALITY>  (192) 
Single Stereoisomer

>  <PRODRUG>  (192) 
N

>  <ORAL>  (192) 
Y

>  <PARENTERAL>  (192) 
Y

>  <TOPICAL>  (192) 
N

>  <BLACK_BOX>  (192) 
N

>  <AVAILABILITY_TYPE>  (192) 
Prescription-only

>  <WITHDRAWN_YEAR>  (192) 
nan

>  <WITHDRAWN_COUNTRY>  (192) 
nan

>  <WITHDRAWN_REASON>  (192) 
nan

>  <CANONICAL_SMILES>  (192) 
COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(=O)C

>  <name>  (192) 
Diltiazem 

>  <MW>  (192) 
414.527

>  <logP>  (192) 
3.3685

$$$$
CHEMBL1590
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (193) 
454076

>  <SYNONYMS>  (193) 
Pseudoephedrine (BAN, INN); Pseudoephedrine Sulfate (FDA, USAN, USP); Pseudoephedrine Polistirex (FDA, USAN); Pseudoephedrine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (193) 
4

>  <RESEARCH_CODES>  (193) 
SCH-4855

>  <APPLICANTS>  (193) 
Central Pharmaceuticals Inc; Bayer Healthcare Llc; Ucb Inc; Alza Corp; Ah Robins Co

>  <USAN_STEM>  (193) 
nan

>  <USAN_STEM_DEFINITION>  (193) 
nan

>  <USAN_STEM_SUBSTEM>  (193) 
nan

>  <USAN_YEAR>  (193) 
1963.0

>  <FIRST_APPROVAL>  (193) 
1963.0

>  <ATC_CODE>  (193) 
R01BA02; R01BA52

>  <ATC_CODE_DESCRIPTION>  (193) 
R01BA02 [Respiratory System:Nasal Preparations:Nasal Decongestants For Systemic Use:Sympathomimetics]; R01BA52 [Respiratory System:Nasal Preparations:Nasal Decongestants For Systemic Use:Sympathomimetics]

>  <INDICATION_CLASS>  (193) 
Decongestant; Nasal Decongestant; Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (193) 
US-5855912-A

>  <DRUG_TYPE>  (193) 
Polymer

>  <RULE_OF_FIVE>  (193) 
Y

>  <FIRST_IN_CLASS>  (193) 
N

>  <CHIRALITY>  (193) 
Single Stereoisomer

>  <PRODRUG>  (193) 
N

>  <ORAL>  (193) 
Y

>  <PARENTERAL>  (193) 
N

>  <TOPICAL>  (193) 
N

>  <BLACK_BOX>  (193) 
N

>  <AVAILABILITY_TYPE>  (193) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (193) 
nan

>  <WITHDRAWN_COUNTRY>  (193) 
nan

>  <WITHDRAWN_REASON>  (193) 
nan

>  <CANONICAL_SMILES>  (193) 
CN[C@@H](C)[C@@H](O)c1ccccc1

>  <name>  (193) 
Pseudoephedrine 

>  <MW>  (193) 
165.236

>  <logP>  (193) 
1.3279

$$$$
CHEMBL590
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12  2  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (194) 
19344

>  <SYNONYMS>  (194) 
Menadione (BAN, FDA, USP)

>  <DEVELOPMENT_PHASE>  (194) 
4

>  <RESEARCH_CODES>  (194) 
nan

>  <APPLICANTS>  (194) 
Eli Lilly And Co

>  <USAN_STEM>  (194) 
nan

>  <USAN_STEM_DEFINITION>  (194) 
nan

>  <USAN_STEM_SUBSTEM>  (194) 
nan

>  <USAN_YEAR>  (194) 
nan

>  <FIRST_APPROVAL>  (194) 
nan

>  <ATC_CODE>  (194) 
B02BA02

>  <ATC_CODE_DESCRIPTION>  (194) 
B02BA02 [Blood And Blood Forming Organs:Antihemorrhagics:Vitamin K And Other Hemostatics:Vitamin K]

>  <INDICATION_CLASS>  (194) 
Vitamin (prothrombogenic)

>  <SC_PATENT_NO>  (194) 
nan

>  <DRUG_TYPE>  (194) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (194) 
Y

>  <FIRST_IN_CLASS>  (194) 
N

>  <CHIRALITY>  (194) 
Achiral Molecule

>  <PRODRUG>  (194) 
N

>  <ORAL>  (194) 
Y

>  <PARENTERAL>  (194) 
N

>  <TOPICAL>  (194) 
N

>  <BLACK_BOX>  (194) 
N

>  <AVAILABILITY_TYPE>  (194) 
Discontinued

>  <WITHDRAWN_YEAR>  (194) 
nan

>  <WITHDRAWN_COUNTRY>  (194) 
nan

>  <WITHDRAWN_REASON>  (194) 
nan

>  <CANONICAL_SMILES>  (194) 
CC1=CC(=O)c2ccccc2C1=O

>  <name>  (194) 
Menadione 

>  <MW>  (194) 
172.183

>  <logP>  (194) 
2.0119

$$$$
CHEMBL926
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  2  0
 11  5  1  0
 22 15  1  0
M  END
>  <PARENT_MOLREGNO>  (195) 
84505

>  <SYNONYMS>  (195) 
Dobutamine (BAN, INN, USAN, USP); Dobutamine HCl (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (195) 
4

>  <RESEARCH_CODES>  (195) 
Compound 81929; 46236

>  <APPLICANTS>  (195) 
Lilly; Hospira Inc; Eli Lilly And Co; Baxter Healthcare Corp

>  <USAN_STEM>  (195) 
nan

>  <USAN_STEM_DEFINITION>  (195) 
nan

>  <USAN_STEM_SUBSTEM>  (195) 
nan

>  <USAN_YEAR>  (195) 
1972.0

>  <FIRST_APPROVAL>  (195) 
1978.0

>  <ATC_CODE>  (195) 
C01CA07

>  <ATC_CODE_DESCRIPTION>  (195) 
C01CA07 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (195) 
Cardiotonic

>  <SC_PATENT_NO>  (195) 
nan

>  <DRUG_TYPE>  (195) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (195) 
Y

>  <FIRST_IN_CLASS>  (195) 
N

>  <CHIRALITY>  (195) 
Racemic Mixture

>  <PRODRUG>  (195) 
N

>  <ORAL>  (195) 
N

>  <PARENTERAL>  (195) 
Y

>  <TOPICAL>  (195) 
N

>  <BLACK_BOX>  (195) 
N

>  <AVAILABILITY_TYPE>  (195) 
Prescription-only

>  <WITHDRAWN_YEAR>  (195) 
nan

>  <WITHDRAWN_COUNTRY>  (195) 
nan

>  <WITHDRAWN_REASON>  (195) 
nan

>  <CANONICAL_SMILES>  (195) 
CC(CCc1ccc(O)cc1)NCCc2ccc(O)c(O)c2

>  <name>  (195) 
Dobutamine 

>  <MW>  (195) 
301.386

>  <logP>  (195) 
2.9568

$$$$
CHEMBL1561
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 12  4  1  0
M  END
>  <PARENT_MOLREGNO>  (196) 
445681

>  <SYNONYMS>  (196) 
Miglitol (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (196) 
4

>  <RESEARCH_CODES>  (196) 
BAY-M-1099

>  <APPLICANTS>  (196) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (196) 
nan

>  <USAN_STEM_DEFINITION>  (196) 
nan

>  <USAN_STEM_SUBSTEM>  (196) 
nan

>  <USAN_YEAR>  (196) 
1990.0

>  <FIRST_APPROVAL>  (196) 
1996.0

>  <ATC_CODE>  (196) 
A10BF02

>  <ATC_CODE_DESCRIPTION>  (196) 
A10BF02 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Alpha glucosidase inhibitors]

>  <INDICATION_CLASS>  (196) 
Inhibitor (alpha-glucosidase)

>  <SC_PATENT_NO>  (196) 
nan

>  <DRUG_TYPE>  (196) 
Natural Product-derived

>  <RULE_OF_FIVE>  (196) 
Y

>  <FIRST_IN_CLASS>  (196) 
N

>  <CHIRALITY>  (196) 
Single Stereoisomer

>  <PRODRUG>  (196) 
N

>  <ORAL>  (196) 
Y

>  <PARENTERAL>  (196) 
N

>  <TOPICAL>  (196) 
N

>  <BLACK_BOX>  (196) 
N

>  <AVAILABILITY_TYPE>  (196) 
Prescription-only

>  <WITHDRAWN_YEAR>  (196) 
nan

>  <WITHDRAWN_COUNTRY>  (196) 
nan

>  <WITHDRAWN_REASON>  (196) 
nan

>  <CANONICAL_SMILES>  (196) 
OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO

>  <name>  (196) 
Miglitol 

>  <MW>  (196) 
207.226

>  <logP>  (196) 
-3.2621

$$$$
CHEMBL1200868
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  5 15  1  0
 15 16  1  0
 15 17  2  0
 17  2  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (197) 
674819

>  <SYNONYMS>  (197) 
Fenamisal (BAN, INN); Phenyl Aminosalicylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (197) 
4

>  <RESEARCH_CODES>  (197) 
nan

>  <APPLICANTS>  (197) 
Pharmaceutical Research Assoc Inc

>  <USAN_STEM>  (197) 
nan

>  <USAN_STEM_DEFINITION>  (197) 
nan

>  <USAN_STEM_SUBSTEM>  (197) 
nan

>  <USAN_YEAR>  (197) 
1964.0

>  <FIRST_APPROVAL>  (197) 
1982.0

>  <ATC_CODE>  (197) 
nan

>  <ATC_CODE_DESCRIPTION>  (197) 
nan

>  <INDICATION_CLASS>  (197) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (197) 
nan

>  <DRUG_TYPE>  (197) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (197) 
Y

>  <FIRST_IN_CLASS>  (197) 
N

>  <CHIRALITY>  (197) 
Achiral Molecule

>  <PRODRUG>  (197) 
N

>  <ORAL>  (197) 
Y

>  <PARENTERAL>  (197) 
N

>  <TOPICAL>  (197) 
N

>  <BLACK_BOX>  (197) 
N

>  <AVAILABILITY_TYPE>  (197) 
Discontinued

>  <WITHDRAWN_YEAR>  (197) 
nan

>  <WITHDRAWN_COUNTRY>  (197) 
nan

>  <WITHDRAWN_REASON>  (197) 
nan

>  <CANONICAL_SMILES>  (197) 
Nc1ccc(C(=O)Oc2ccccc2)c(O)c1

>  <name>  (197) 
Fenamisal 

>  <MW>  (197) 
229.235

>  <logP>  (197) 
2.1936

$$$$
CHEMBL2368925
     RDKit          

 24 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 11  4  1  0
 12  6  1  0
 14  8  1  0
 24 16  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (198) 
1543376

>  <SYNONYMS>  (198) 
Dolasetron (BAN, INN); Dolasetron Mesylate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (198) 
4

>  <RESEARCH_CODES>  (198) 
MDL-73147EF

>  <APPLICANTS>  (198) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (198) 
-setron

>  <USAN_STEM_DEFINITION>  (198) 
serotonin 5-HT3 antagonists

>  <USAN_STEM_SUBSTEM>  (198) 
-setron

>  <USAN_YEAR>  (198) 
1991.0

>  <FIRST_APPROVAL>  (198) 
1997.0

>  <ATC_CODE>  (198) 
A04AA04

>  <ATC_CODE_DESCRIPTION>  (198) 
A04AA04 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Serotonin (5HT3) antagonists]

>  <INDICATION_CLASS>  (198) 
Anti-Emetic; Antimigraine

>  <SC_PATENT_NO>  (198) 
nan

>  <DRUG_TYPE>  (198) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (198) 
Y

>  <FIRST_IN_CLASS>  (198) 
N

>  <CHIRALITY>  (198) 
Single Stereoisomer

>  <PRODRUG>  (198) 
N

>  <ORAL>  (198) 
Y

>  <PARENTERAL>  (198) 
Y

>  <TOPICAL>  (198) 
N

>  <BLACK_BOX>  (198) 
N

>  <AVAILABILITY_TYPE>  (198) 
Prescription-only

>  <WITHDRAWN_YEAR>  (198) 
nan

>  <WITHDRAWN_COUNTRY>  (198) 
nan

>  <WITHDRAWN_REASON>  (198) 
nan

>  <CANONICAL_SMILES>  (198) 
O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c4c[nH]c5ccccc45

>  <name>  (198) 
Dolasetron 

>  <MW>  (198) 
324.38

>  <logP>  (198) 
2.519

$$$$
CHEMBL1592
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 14  9  1  0
 29 20  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (199) 
454141

>  <SYNONYMS>  (199) 
Quinapril (BAN, INN, USP); Quinapril HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (199) 
4

>  <RESEARCH_CODES>  (199) 
CI-906

>  <APPLICANTS>  (199) 
Pfizer Pharmaceuticals Ltd

>  <USAN_STEM>  (199) 
-pril

>  <USAN_STEM_DEFINITION>  (199) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (199) 
-pril

>  <USAN_YEAR>  (199) 
1985.0

>  <FIRST_APPROVAL>  (199) 
1991.0

>  <ATC_CODE>  (199) 
C09AA06

>  <ATC_CODE_DESCRIPTION>  (199) 
C09AA06 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (199) 
Antihypertensive; Enzyme Inhibitor (angiotensin-converting)

>  <SC_PATENT_NO>  (199) 
nan

>  <DRUG_TYPE>  (199) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (199) 
Y

>  <FIRST_IN_CLASS>  (199) 
N

>  <CHIRALITY>  (199) 
Single Stereoisomer

>  <PRODRUG>  (199) 
Y

>  <ORAL>  (199) 
Y

>  <PARENTERAL>  (199) 
N

>  <TOPICAL>  (199) 
N

>  <BLACK_BOX>  (199) 
Y

>  <AVAILABILITY_TYPE>  (199) 
Prescription-only

>  <WITHDRAWN_YEAR>  (199) 
nan

>  <WITHDRAWN_COUNTRY>  (199) 
nan

>  <WITHDRAWN_REASON>  (199) 
nan

>  <CANONICAL_SMILES>  (199) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O

>  <name>  (199) 
Quinapril 

>  <MW>  (199) 
438.524

>  <logP>  (199) 
2.5671

$$$$
CHEMBL439
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  7  2  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (200) 
2131

>  <SYNONYMS>  (200) 
Sulfadiazine (BAN, FDA, INN, JAN, USP); Sulfadiazine (Trisulfapyrimidines) (FDA); Silver Sulfadiazine (FDA); Sulfadiazine Silver (JAN); Sulfadiazine, Silver (USAN, USP); Sulfadiazine Sodium (FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (200) 
4

>  <RESEARCH_CODES>  (200) 
nan

>  <APPLICANTS>  (200) 
Eli Lilly And Co; Dr Reddys Laboratories Louisiana Llc; Bristol Myers Squibb Co; Abbvie Inc; King Pharmaceuticals Inc

>  <USAN_STEM>  (200) 
sulfa-

>  <USAN_STEM_DEFINITION>  (200) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (200) 
sulfa-

>  <USAN_YEAR>  (200) 
1975.0

>  <FIRST_APPROVAL>  (200) 
1941.0

>  <ATC_CODE>  (200) 
J01EC02; D06BA01; D06BA51

>  <ATC_CODE_DESCRIPTION>  (200) 
J01EC02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Intermediate-acting sulfonamides]; D06BA01 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]; D06BA51 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]

>  <INDICATION_CLASS>  (200) 
Anti-Infective, Topical; Antibacterial

>  <SC_PATENT_NO>  (200) 
nan

>  <DRUG_TYPE>  (200) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (200) 
Y

>  <FIRST_IN_CLASS>  (200) 
N

>  <CHIRALITY>  (200) 
Achiral Molecule

>  <PRODRUG>  (200) 
N

>  <ORAL>  (200) 
Y

>  <PARENTERAL>  (200) 
Y

>  <TOPICAL>  (200) 
Y

>  <BLACK_BOX>  (200) 
N

>  <AVAILABILITY_TYPE>  (200) 
Prescription-only

>  <WITHDRAWN_YEAR>  (200) 
nan

>  <WITHDRAWN_COUNTRY>  (200) 
nan

>  <WITHDRAWN_REASON>  (200) 
nan

>  <CANONICAL_SMILES>  (200) 
Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2

>  <name>  (200) 
Sulfadiazine 

>  <MW>  (200) 
250.283

>  <logP>  (200) 
0.8596

$$$$
CHEMBL1200394
     RDKit          

 23 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 17 21  1  0
 21 22  2  0
 21 23  1  0
M  END
>  <PARENT_MOLREGNO>  (201) 
674345

>  <SYNONYMS>  (201) 
Ethanolamine Oleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (201) 
4

>  <RESEARCH_CODES>  (201) 
nan

>  <APPLICANTS>  (201) 
Qol Medical Llc

>  <USAN_STEM>  (201) 
nan

>  <USAN_STEM_DEFINITION>  (201) 
nan

>  <USAN_STEM_SUBSTEM>  (201) 
nan

>  <USAN_YEAR>  (201) 
1987.0

>  <FIRST_APPROVAL>  (201) 
1988.0

>  <ATC_CODE>  (201) 
nan

>  <ATC_CODE_DESCRIPTION>  (201) 
nan

>  <INDICATION_CLASS>  (201) 
Sclerosing Agent

>  <SC_PATENT_NO>  (201) 
nan

>  <DRUG_TYPE>  (201) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (201) 
Y

>  <FIRST_IN_CLASS>  (201) 
N

>  <CHIRALITY>  (201) 
Racemic Mixture

>  <PRODRUG>  (201) 
N

>  <ORAL>  (201) 
N

>  <PARENTERAL>  (201) 
Y

>  <TOPICAL>  (201) 
N

>  <BLACK_BOX>  (201) 
N

>  <AVAILABILITY_TYPE>  (201) 
Prescription-only

>  <WITHDRAWN_YEAR>  (201) 
nan

>  <WITHDRAWN_COUNTRY>  (201) 
nan

>  <WITHDRAWN_REASON>  (201) 
nan

>  <CANONICAL_SMILES>  (201) 
CCCCCCCC\C=C/CCCCCCC(N)(CO)C(=O)O

>  <name>  (201) 
Ethanolamine Oleate 

>  <MW>  (201) 
327.509

>  <logP>  (201) 
4.4082

$$$$
CHEMBL1311
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
  9  2  1  0
  9  5  1  0
M  CHG  2  11   1  13  -1
M  END
>  <PARENT_MOLREGNO>  (202) 
263453

>  <SYNONYMS>  (202) 
Isosorbide Mononitrate (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (202) 
4

>  <RESEARCH_CODES>  (202) 
AHR-4698; BM 22.145; BM-22-145; IS-5-MN

>  <APPLICANTS>  (202) 
Schering Plough Corp; Promius Pharma Llc; Kremers Urban Pharmaceuticals Inc

>  <USAN_STEM>  (202) 
nan

>  <USAN_STEM_DEFINITION>  (202) 
nan

>  <USAN_STEM_SUBSTEM>  (202) 
nan

>  <USAN_YEAR>  (202) 
1988.0

>  <FIRST_APPROVAL>  (202) 
1991.0

>  <ATC_CODE>  (202) 
C01DA14

>  <ATC_CODE_DESCRIPTION>  (202) 
C01DA14 [Cardiovascular System:Cardiac Therapy:Vasodilators Used In Cardiac Diseases:Organic nitrates]

>  <INDICATION_CLASS>  (202) 
Vasodilator (coronary)

>  <SC_PATENT_NO>  (202) 
nan

>  <DRUG_TYPE>  (202) 
Natural Product-derived

>  <RULE_OF_FIVE>  (202) 
Y

>  <FIRST_IN_CLASS>  (202) 
N

>  <CHIRALITY>  (202) 
Single Stereoisomer

>  <PRODRUG>  (202) 
N

>  <ORAL>  (202) 
Y

>  <PARENTERAL>  (202) 
N

>  <TOPICAL>  (202) 
N

>  <BLACK_BOX>  (202) 
N

>  <AVAILABILITY_TYPE>  (202) 
Prescription-only

>  <WITHDRAWN_YEAR>  (202) 
nan

>  <WITHDRAWN_COUNTRY>  (202) 
nan

>  <WITHDRAWN_REASON>  (202) 
nan

>  <CANONICAL_SMILES>  (202) 
O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+](=O)[O-]

>  <name>  (202) 
Isosorbide Mononitrate 

>  <MW>  (202) 
191.139

>  <logP>  (202) 
-1.2782

$$$$
CHEMBL1201348
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  6  9  1  0
  4 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 18 21  1  0
 16  2  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (203) 
675299

>  <SYNONYMS>  (203) 
Menadiol (BAN); Menadiol Sodium Diphosphate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (203) 
4

>  <RESEARCH_CODES>  (203) 
nan

>  <APPLICANTS>  (203) 
Hoffmann La Roche Inc; Eli Lilly And Co

>  <USAN_STEM>  (203) 
nan

>  <USAN_STEM_DEFINITION>  (203) 
nan

>  <USAN_STEM_SUBSTEM>  (203) 
nan

>  <USAN_YEAR>  (203) 
nan

>  <FIRST_APPROVAL>  (203) 
nan

>  <ATC_CODE>  (203) 
nan

>  <ATC_CODE_DESCRIPTION>  (203) 
nan

>  <INDICATION_CLASS>  (203) 
Vitamin (prothrombogenic)

>  <SC_PATENT_NO>  (203) 
nan

>  <DRUG_TYPE>  (203) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (203) 
Y

>  <FIRST_IN_CLASS>  (203) 
N

>  <CHIRALITY>  (203) 
Achiral Molecule

>  <PRODRUG>  (203) 
N

>  <ORAL>  (203) 
Y

>  <PARENTERAL>  (203) 
Y

>  <TOPICAL>  (203) 
N

>  <BLACK_BOX>  (203) 
N

>  <AVAILABILITY_TYPE>  (203) 
Discontinued

>  <WITHDRAWN_YEAR>  (203) 
nan

>  <WITHDRAWN_COUNTRY>  (203) 
nan

>  <WITHDRAWN_REASON>  (203) 
nan

>  <CANONICAL_SMILES>  (203) 
Cc1cc(OP(=O)(O)O)c2ccccc2c1OP(=O)(O)O

>  <name>  (203) 
Menadiol 

>  <MW>  (203) 
334.157

>  <logP>  (203) 
2.09122

$$$$
CHEMBL778
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  2  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
  7  3  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (204) 
44905

>  <SYNONYMS>  (204) 
Dexmedetomidine (BAN, INN, USAN); Dexmedetomidine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (204) 
4

>  <RESEARCH_CODES>  (204) 
MPV-1440

>  <APPLICANTS>  (204) 
Hospira Inc; Farmos Group Ltd., Finland

>  <USAN_STEM>  (204) 
nan

>  <USAN_STEM_DEFINITION>  (204) 
nan

>  <USAN_STEM_SUBSTEM>  (204) 
nan

>  <USAN_YEAR>  (204) 
1989.0

>  <FIRST_APPROVAL>  (204) 
1999.0

>  <ATC_CODE>  (204) 
N05CM18

>  <ATC_CODE_DESCRIPTION>  (204) 
N05CM18 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]

>  <INDICATION_CLASS>  (204) 
Tranquilizer

>  <SC_PATENT_NO>  (204) 
US-6716867-B1

>  <DRUG_TYPE>  (204) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (204) 
Y

>  <FIRST_IN_CLASS>  (204) 
N

>  <CHIRALITY>  (204) 
Single Stereoisomer

>  <PRODRUG>  (204) 
N

>  <ORAL>  (204) 
N

>  <PARENTERAL>  (204) 
Y

>  <TOPICAL>  (204) 
N

>  <BLACK_BOX>  (204) 
N

>  <AVAILABILITY_TYPE>  (204) 
Prescription-only

>  <WITHDRAWN_YEAR>  (204) 
nan

>  <WITHDRAWN_COUNTRY>  (204) 
nan

>  <WITHDRAWN_REASON>  (204) 
nan

>  <CANONICAL_SMILES>  (204) 
C[C@H](c1c[nH]cn1)c2cccc(C)c2C

>  <name>  (204) 
Dexmedetomidine 

>  <MW>  (204) 
200.285

>  <logP>  (204) 
3.17834

$$$$
CHEMBL1024
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (205) 
119640

>  <SYNONYMS>  (205) 
Ifosfamide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (205) 
4

>  <RESEARCH_CODES>  (205) 
MJF-9325; Z-4942

>  <APPLICANTS>  (205) 
Baxter Healthcare Corp

>  <USAN_STEM>  (205) 
-fosfamide

>  <USAN_STEM_DEFINITION>  (205) 
isophosphoramide mustard derivatives

>  <USAN_STEM_SUBSTEM>  (205) 
-fosfamide

>  <USAN_YEAR>  (205) 
1978.0

>  <FIRST_APPROVAL>  (205) 
1988.0

>  <ATC_CODE>  (205) 
L01AA06

>  <ATC_CODE_DESCRIPTION>  (205) 
L01AA06 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrogen mustard analogues]

>  <INDICATION_CLASS>  (205) 
Antineoplastic

>  <SC_PATENT_NO>  (205) 
nan

>  <DRUG_TYPE>  (205) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (205) 
Y

>  <FIRST_IN_CLASS>  (205) 
N

>  <CHIRALITY>  (205) 
Racemic Mixture

>  <PRODRUG>  (205) 
Y

>  <ORAL>  (205) 
N

>  <PARENTERAL>  (205) 
Y

>  <TOPICAL>  (205) 
N

>  <BLACK_BOX>  (205) 
Y

>  <AVAILABILITY_TYPE>  (205) 
Prescription-only

>  <WITHDRAWN_YEAR>  (205) 
nan

>  <WITHDRAWN_COUNTRY>  (205) 
nan

>  <WITHDRAWN_REASON>  (205) 
nan

>  <CANONICAL_SMILES>  (205) 
ClCCNP1(=O)OCCCN1CCCl

>  <name>  (205) 
Ifosfamide 

>  <MW>  (205) 
261.089

>  <logP>  (205) 
1.884

$$$$
CHEMBL276832
     RDKit          

 12 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  3  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (206) 
8788

>  <SYNONYMS>  (206) 
Hydralazine (BAN, INN); Hydralazine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (206) 
4

>  <RESEARCH_CODES>  (206) 
nan

>  <APPLICANTS>  (206) 
Novartis Pharmaceuticals Corp; Arbor Pharmaceuticals Inc

>  <USAN_STEM>  (206) 
-dralazine

>  <USAN_STEM_DEFINITION>  (206) 
antihypertensives (hydrazine-phthalazines)

>  <USAN_STEM_SUBSTEM>  (206) 
-dralazine

>  <USAN_YEAR>  (206) 
nan

>  <FIRST_APPROVAL>  (206) 
1953.0

>  <ATC_CODE>  (206) 
C02DB02

>  <ATC_CODE_DESCRIPTION>  (206) 
C02DB02 [Cardiovascular System:Antihypertensives:Arteriolar Smooth Muscle, Agents Acting On:Hydrazinophthalazine derivatives]

>  <INDICATION_CLASS>  (206) 
Antihypertensive

>  <SC_PATENT_NO>  (206) 
US-6465463-B1

>  <DRUG_TYPE>  (206) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (206) 
Y

>  <FIRST_IN_CLASS>  (206) 
N

>  <CHIRALITY>  (206) 
Achiral Molecule

>  <PRODRUG>  (206) 
N

>  <ORAL>  (206) 
Y

>  <PARENTERAL>  (206) 
Y

>  <TOPICAL>  (206) 
N

>  <BLACK_BOX>  (206) 
N

>  <AVAILABILITY_TYPE>  (206) 
Prescription-only

>  <WITHDRAWN_YEAR>  (206) 
nan

>  <WITHDRAWN_COUNTRY>  (206) 
nan

>  <WITHDRAWN_REASON>  (206) 
nan

>  <CANONICAL_SMILES>  (206) 
NNc1nncc2ccccc12

>  <name>  (206) 
Hydralazine 

>  <MW>  (206) 
160.18

>  <logP>  (206) 
0.9154

$$$$
CHEMBL1200774
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
  7 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 19  2  1  0
 22  2  1  0
 17  6  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (207) 
674725

>  <SYNONYMS>  (207) 
Fluprednisolone (BAN, FDA, INN, NF, USAN)

>  <DEVELOPMENT_PHASE>  (207) 
4

>  <RESEARCH_CODES>  (207) 
U-7800

>  <APPLICANTS>  (207) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (207) 
-pred-

>  <USAN_STEM_DEFINITION>  (207) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (207) 
-pred-

>  <USAN_YEAR>  (207) 
1962.0

>  <FIRST_APPROVAL>  (207) 
1982.0

>  <ATC_CODE>  (207) 
nan

>  <ATC_CODE_DESCRIPTION>  (207) 
nan

>  <INDICATION_CLASS>  (207) 
Glucocorticoid

>  <SC_PATENT_NO>  (207) 
nan

>  <DRUG_TYPE>  (207) 
Natural Product-derived

>  <RULE_OF_FIVE>  (207) 
Y

>  <FIRST_IN_CLASS>  (207) 
N

>  <CHIRALITY>  (207) 
Single Stereoisomer

>  <PRODRUG>  (207) 
N

>  <ORAL>  (207) 
Y

>  <PARENTERAL>  (207) 
N

>  <TOPICAL>  (207) 
N

>  <BLACK_BOX>  (207) 
N

>  <AVAILABILITY_TYPE>  (207) 
Discontinued

>  <WITHDRAWN_YEAR>  (207) 
nan

>  <WITHDRAWN_COUNTRY>  (207) 
nan

>  <WITHDRAWN_REASON>  (207) 
nan

>  <CANONICAL_SMILES>  (207) 
C[C@]12C[C@H](O)[C@H]3[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO

>  <name>  (207) 
Fluprednisolone 

>  <MW>  (207) 
378.44

>  <logP>  (207) 
1.5056

$$$$
CHEMBL744
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15  2  1  0
 14  4  1  0
M  END
>  <PARENT_MOLREGNO>  (208) 
38898

>  <SYNONYMS>  (208) 
Riluzole (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (208) 
4

>  <RESEARCH_CODES>  (208) 
RP-54274

>  <APPLICANTS>  (208) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (208) 
nan

>  <USAN_STEM_DEFINITION>  (208) 
nan

>  <USAN_STEM_SUBSTEM>  (208) 
nan

>  <USAN_YEAR>  (208) 
1995.0

>  <FIRST_APPROVAL>  (208) 
1995.0

>  <ATC_CODE>  (208) 
N07XX02

>  <ATC_CODE_DESCRIPTION>  (208) 
N07XX02 [Nervous System:Other Nervous System Drugs:Other Nervous System Drugs:Other nervous system drugs]

>  <INDICATION_CLASS>  (208) 
Amyotrophic Lateral Sclerosis Treatment

>  <SC_PATENT_NO>  (208) 
nan

>  <DRUG_TYPE>  (208) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (208) 
Y

>  <FIRST_IN_CLASS>  (208) 
N

>  <CHIRALITY>  (208) 
Achiral Molecule

>  <PRODRUG>  (208) 
N

>  <ORAL>  (208) 
Y

>  <PARENTERAL>  (208) 
N

>  <TOPICAL>  (208) 
N

>  <BLACK_BOX>  (208) 
N

>  <AVAILABILITY_TYPE>  (208) 
Prescription-only

>  <WITHDRAWN_YEAR>  (208) 
nan

>  <WITHDRAWN_COUNTRY>  (208) 
nan

>  <WITHDRAWN_REASON>  (208) 
nan

>  <CANONICAL_SMILES>  (208) 
Nc1nc2ccc(OC(F)(F)F)cc2s1

>  <name>  (208) 
Riluzole 

>  <MW>  (208) 
234.202

>  <logP>  (208) 
2.7771

$$$$
CHEMBL480
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 13  2  1  0
 25 17  1  0
 24 19  1  0
M  CHG  2  15   1  16  -1
M  END
>  <PARENT_MOLREGNO>  (209) 
5975

>  <SYNONYMS>  (209) 
Lansoprazole (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (209) 
4

>  <RESEARCH_CODES>  (209) 
A-65006; AG-1749

>  <APPLICANTS>  (209) 
Takeda Pharmaceuticals Usa Inc; Takeda Pharmaceuticals North America Inc; Novartis Consumer Health Inc

>  <USAN_STEM>  (209) 
-prazole

>  <USAN_STEM_DEFINITION>  (209) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (209) 
-prazole

>  <USAN_YEAR>  (209) 
1989.0

>  <FIRST_APPROVAL>  (209) 
1995.0

>  <ATC_CODE>  (209) 
A02BC53; A02BC03

>  <ATC_CODE_DESCRIPTION>  (209) 
A02BC53 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]; A02BC03 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (209) 
Anti-Ulcerative

>  <SC_PATENT_NO>  (209) 
US-6328994-B1

>  <DRUG_TYPE>  (209) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (209) 
Y

>  <FIRST_IN_CLASS>  (209) 
N

>  <CHIRALITY>  (209) 
Racemic Mixture

>  <PRODRUG>  (209) 
N

>  <ORAL>  (209) 
Y

>  <PARENTERAL>  (209) 
Y

>  <TOPICAL>  (209) 
N

>  <BLACK_BOX>  (209) 
Y

>  <AVAILABILITY_TYPE>  (209) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (209) 
nan

>  <WITHDRAWN_COUNTRY>  (209) 
nan

>  <WITHDRAWN_REASON>  (209) 
nan

>  <CANONICAL_SMILES>  (209) 
Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2

>  <name>  (209) 
Lansoprazole 

>  <MW>  (209) 
369.368

>  <logP>  (209) 
3.51522

$$$$
CHEMBL1596
     RDKit          

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 10 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
  6 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 32  2  1  0
 31  5  1  0
 22 14  1  0
 21 17  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (210) 
454373

>  <SYNONYMS>  (210) 
Carindacillin (INN, BAN); Carbenicillin Indanyl Sodium (FDA, USAN, USP); Carindacillin Sodium (JAN)

>  <DEVELOPMENT_PHASE>  (210) 
4

>  <RESEARCH_CODES>  (210) 
CP-154642; CP-15464-2

>  <APPLICANTS>  (210) 
Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (210) 
-cillin

>  <USAN_STEM_DEFINITION>  (210) 
penicillins

>  <USAN_STEM_SUBSTEM>  (210) 
-cillin

>  <USAN_YEAR>  (210) 
1972.0

>  <FIRST_APPROVAL>  (210) 
1972.0

>  <ATC_CODE>  (210) 
J01CA05

>  <ATC_CODE_DESCRIPTION>  (210) 
J01CA05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (210) 
Antibacterial

>  <SC_PATENT_NO>  (210) 
nan

>  <DRUG_TYPE>  (210) 
Natural Product-derived

>  <RULE_OF_FIVE>  (210) 
Y

>  <FIRST_IN_CLASS>  (210) 
N

>  <CHIRALITY>  (210) 
Racemic Mixture

>  <PRODRUG>  (210) 
Y

>  <ORAL>  (210) 
Y

>  <PARENTERAL>  (210) 
N

>  <TOPICAL>  (210) 
N

>  <BLACK_BOX>  (210) 
N

>  <AVAILABILITY_TYPE>  (210) 
Discontinued

>  <WITHDRAWN_YEAR>  (210) 
nan

>  <WITHDRAWN_COUNTRY>  (210) 
nan

>  <WITHDRAWN_REASON>  (210) 
nan

>  <CANONICAL_SMILES>  (210) 
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4CCCc4c3)c5ccccc5)C(=O)N2[C@H]1C(=O)O

>  <name>  (210) 
Carindacillin 

>  <MW>  (210) 
494.569

>  <logP>  (210) 
2.4962

$$$$
CHEMBL1189432
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 19 24  1  0
 24 25  2  0
  7 25  1  0
 13  8  1  0
 25 16  1  0
M  END
>  <PARENT_MOLREGNO>  (211) 
663382

>  <SYNONYMS>  (211) 
Olopatadine (BAN, INN); Olopatadine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (211) 
4

>  <RESEARCH_CODES>  (211) 
ALO-4943A; KW-4679

>  <APPLICANTS>  (211) 
Alcon Pharmaceuticals Ltd; Alcon Laboratories Inc

>  <USAN_STEM>  (211) 
-(a)tadine; -atadine

>  <USAN_STEM_DEFINITION>  (211) 
tricyclic histaminic-H1 receptor antagonists, loratadine derivatives; tricyclic antiasthmatics

>  <USAN_STEM_SUBSTEM>  (211) 
-(a)tadine; -atadine

>  <USAN_YEAR>  (211) 
1995.0

>  <FIRST_APPROVAL>  (211) 
1996.0

>  <ATC_CODE>  (211) 
S01GX09; R01AC08

>  <ATC_CODE_DESCRIPTION>  (211) 
S01GX09 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]; R01AC08 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Antiallergic agents, excl. corticosteroids]

>  <INDICATION_CLASS>  (211) 
Anti-Allergic

>  <SC_PATENT_NO>  (211) 
US-5641805-A

>  <DRUG_TYPE>  (211) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (211) 
Y

>  <FIRST_IN_CLASS>  (211) 
N

>  <CHIRALITY>  (211) 
Achiral Molecule

>  <PRODRUG>  (211) 
N

>  <ORAL>  (211) 
N

>  <PARENTERAL>  (211) 
N

>  <TOPICAL>  (211) 
Y

>  <BLACK_BOX>  (211) 
N

>  <AVAILABILITY_TYPE>  (211) 
Prescription-only

>  <WITHDRAWN_YEAR>  (211) 
nan

>  <WITHDRAWN_COUNTRY>  (211) 
nan

>  <WITHDRAWN_REASON>  (211) 
nan

>  <CANONICAL_SMILES>  (211) 
CN(C)CC\C=C/1\c2ccccc2COc3ccc(CC(=O)O)cc13

>  <name>  (211) 
Olopatadine 

>  <MW>  (211) 
337.419

>  <logP>  (211) 
3.5895

$$$$
CHEMBL1167
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 13 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22  3  1  0
 21  9  1  0
 18 11  1  0
M  END
>  <PARENT_MOLREGNO>  (212) 
189099

>  <SYNONYMS>  (212) 
Spectinomycin (BAN, INN); Spectinomycin HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (212) 
4

>  <RESEARCH_CODES>  (212) 
M-141; U-18409AE

>  <APPLICANTS>  (212) 
Pfizer Inc.

>  <USAN_STEM>  (212) 
-mycin

>  <USAN_STEM_DEFINITION>  (212) 
antibiotics (Streptomyces strains)

>  <USAN_STEM_SUBSTEM>  (212) 
-mycin

>  <USAN_YEAR>  (212) 
1962.0

>  <FIRST_APPROVAL>  (212) 
1971.0

>  <ATC_CODE>  (212) 
J01XX04

>  <ATC_CODE_DESCRIPTION>  (212) 
J01XX04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Other antibacterials]

>  <INDICATION_CLASS>  (212) 
Antibacterial

>  <SC_PATENT_NO>  (212) 
nan

>  <DRUG_TYPE>  (212) 
Natural Product-derived

>  <RULE_OF_FIVE>  (212) 
Y

>  <FIRST_IN_CLASS>  (212) 
N

>  <CHIRALITY>  (212) 
Single Stereoisomer

>  <PRODRUG>  (212) 
N

>  <ORAL>  (212) 
N

>  <PARENTERAL>  (212) 
Y

>  <TOPICAL>  (212) 
N

>  <BLACK_BOX>  (212) 
N

>  <AVAILABILITY_TYPE>  (212) 
Discontinued

>  <WITHDRAWN_YEAR>  (212) 
nan

>  <WITHDRAWN_COUNTRY>  (212) 
nan

>  <WITHDRAWN_REASON>  (212) 
nan

>  <CANONICAL_SMILES>  (212) 
CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O

>  <name>  (212) 
Spectinomycin 

>  <MW>  (212) 
332.353

>  <logP>  (212) 
-2.9256

$$$$
CHEMBL1201056
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
  8  3  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (213) 
675007

>  <SYNONYMS>  (213) 
Sulfacitine (INN); Sulfacytine (BAN, FDA, USAN)

>  <DEVELOPMENT_PHASE>  (213) 
4

>  <RESEARCH_CODES>  (213) 
CI-636

>  <APPLICANTS>  (213) 
Glenwood Inc

>  <USAN_STEM>  (213) 
sulfa-

>  <USAN_STEM_DEFINITION>  (213) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (213) 
sulfa-

>  <USAN_YEAR>  (213) 
1972.0

>  <FIRST_APPROVAL>  (213) 
1975.0

>  <ATC_CODE>  (213) 
nan

>  <ATC_CODE_DESCRIPTION>  (213) 
nan

>  <INDICATION_CLASS>  (213) 
Antibacterial

>  <SC_PATENT_NO>  (213) 
nan

>  <DRUG_TYPE>  (213) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (213) 
Y

>  <FIRST_IN_CLASS>  (213) 
N

>  <CHIRALITY>  (213) 
Achiral Molecule

>  <PRODRUG>  (213) 
N

>  <ORAL>  (213) 
Y

>  <PARENTERAL>  (213) 
N

>  <TOPICAL>  (213) 
N

>  <BLACK_BOX>  (213) 
N

>  <AVAILABILITY_TYPE>  (213) 
Discontinued

>  <WITHDRAWN_YEAR>  (213) 
nan

>  <WITHDRAWN_COUNTRY>  (213) 
nan

>  <WITHDRAWN_REASON>  (213) 
nan

>  <CANONICAL_SMILES>  (213) 
CCN1C=CC(=NC1=O)NS(=O)(=O)c2ccc(N)cc2

>  <name>  (213) 
Sulfacitine 

>  <MW>  (213) 
294.336

>  <logP>  (213) 
0.6462

$$$$
CHEMBL515914
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
  9 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
  8 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 14  6  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (214) 
453649

>  <SYNONYMS>  (214) 
Azaribine (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (214) 
4

>  <RESEARCH_CODES>  (214) 
CB-304

>  <APPLICANTS>  (214) 
Parke-Davis

>  <USAN_STEM>  (214) 
-ribine

>  <USAN_STEM_DEFINITION>  (214) 
ribofuranil derivatives (pyrazofurin type)

>  <USAN_STEM_SUBSTEM>  (214) 
-ribine

>  <USAN_YEAR>  (214) 
1968.0

>  <FIRST_APPROVAL>  (214) 
nan

>  <ATC_CODE>  (214) 
nan

>  <ATC_CODE_DESCRIPTION>  (214) 
nan

>  <INDICATION_CLASS>  (214) 
Antipsoriatic

>  <SC_PATENT_NO>  (214) 
nan

>  <DRUG_TYPE>  (214) 
Natural Product-derived

>  <RULE_OF_FIVE>  (214) 
Y

>  <FIRST_IN_CLASS>  (214) 
N

>  <CHIRALITY>  (214) 
Single Stereoisomer

>  <PRODRUG>  (214) 
N

>  <ORAL>  (214) 
N

>  <PARENTERAL>  (214) 
N

>  <TOPICAL>  (214) 
N

>  <BLACK_BOX>  (214) 
N

>  <AVAILABILITY_TYPE>  (214) 
Withdrawn

>  <WITHDRAWN_YEAR>  (214) 
1976.0

>  <WITHDRAWN_COUNTRY>  (214) 
United States

>  <WITHDRAWN_REASON>  (214) 
Thromboembolism

>  <CANONICAL_SMILES>  (214) 
CC(=O)OC[C@H]1O[C@H]([C@H](OC(=O)C)[C@@H]1OC(=O)C)N2N=CC(=O)NC2=O

>  <name>  (214) 
Azaribine 

>  <MW>  (214) 
371.302

>  <logP>  (214) 
-1.7445

$$$$
CHEMBL1095
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  8  3  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (215) 
150452

>  <SYNONYMS>  (215) 
Ethotoin (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (215) 
4

>  <RESEARCH_CODES>  (215) 
nan

>  <APPLICANTS>  (215) 
Lundbeck Llc

>  <USAN_STEM>  (215) 
-toin

>  <USAN_STEM_DEFINITION>  (215) 
antiepileptics (hydantoin derivatives)

>  <USAN_STEM_SUBSTEM>  (215) 
-toin

>  <USAN_YEAR>  (215) 
nan

>  <FIRST_APPROVAL>  (215) 
1957.0

>  <ATC_CODE>  (215) 
N03AB01

>  <ATC_CODE_DESCRIPTION>  (215) 
N03AB01 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]

>  <INDICATION_CLASS>  (215) 
Anticonvulsant

>  <SC_PATENT_NO>  (215) 
nan

>  <DRUG_TYPE>  (215) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (215) 
Y

>  <FIRST_IN_CLASS>  (215) 
N

>  <CHIRALITY>  (215) 
Racemic Mixture

>  <PRODRUG>  (215) 
N

>  <ORAL>  (215) 
Y

>  <PARENTERAL>  (215) 
N

>  <TOPICAL>  (215) 
N

>  <BLACK_BOX>  (215) 
N

>  <AVAILABILITY_TYPE>  (215) 
Prescription-only

>  <WITHDRAWN_YEAR>  (215) 
nan

>  <WITHDRAWN_COUNTRY>  (215) 
nan

>  <WITHDRAWN_REASON>  (215) 
nan

>  <CANONICAL_SMILES>  (215) 
CCN1C(=O)NC(C1=O)c2ccccc2

>  <name>  (215) 
Ethotoin 

>  <MW>  (215) 
204.229

>  <logP>  (215) 
1.2994

$$$$
CHEMBL680
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 11 15  1  0
 15 16  2  0
 15 17  1  0
 10 18  1  0
  2 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 13  6  1  0
 12  7  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (216) 
29005

>  <SYNONYMS>  (216) 
Cefaclor (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (216) 
4

>  <RESEARCH_CODES>  (216) 
Compound 99638

>  <APPLICANTS>  (216) 
Eli Lilly And Co

>  <USAN_STEM>  (216) 
cef-

>  <USAN_STEM_DEFINITION>  (216) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (216) 
cef-

>  <USAN_YEAR>  (216) 
1976.0

>  <FIRST_APPROVAL>  (216) 
1979.0

>  <ATC_CODE>  (216) 
J01DC04

>  <ATC_CODE_DESCRIPTION>  (216) 
J01DC04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Second-generation cephalosporins]

>  <INDICATION_CLASS>  (216) 
Antibacterial

>  <SC_PATENT_NO>  (216) 
nan

>  <DRUG_TYPE>  (216) 
Natural Product-derived

>  <RULE_OF_FIVE>  (216) 
Y

>  <FIRST_IN_CLASS>  (216) 
N

>  <CHIRALITY>  (216) 
Single Stereoisomer

>  <PRODRUG>  (216) 
N

>  <ORAL>  (216) 
Y

>  <PARENTERAL>  (216) 
N

>  <TOPICAL>  (216) 
N

>  <BLACK_BOX>  (216) 
N

>  <AVAILABILITY_TYPE>  (216) 
Prescription-only

>  <WITHDRAWN_YEAR>  (216) 
nan

>  <WITHDRAWN_COUNTRY>  (216) 
nan

>  <WITHDRAWN_REASON>  (216) 
nan

>  <CANONICAL_SMILES>  (216) 
N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3

>  <name>  (216) 
Cefaclor 

>  <MW>  (216) 
367.814

>  <logP>  (216) 
0.6213

$$$$
CHEMBL16
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  7  2  1  0
 13  8  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (217) 
921

>  <SYNONYMS>  (217) 
Phenytoin (BAN, FDA, INN, JAN, USAN, USP); Phenytoin Sodium (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (217) 
4

>  <RESEARCH_CODES>  (217) 
nan

>  <APPLICANTS>  (217) 
Parke Davis Pharmaceutical Research Div Warner Lambert Co; Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (217) 
-toin

>  <USAN_STEM_DEFINITION>  (217) 
antiepileptics (hydantoin derivatives)

>  <USAN_STEM_SUBSTEM>  (217) 
-toin

>  <USAN_YEAR>  (217) 
1975.0

>  <FIRST_APPROVAL>  (217) 
1953.0

>  <ATC_CODE>  (217) 
N03AB02; N03AB52

>  <ATC_CODE_DESCRIPTION>  (217) 
N03AB02 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]; N03AB52 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]

>  <INDICATION_CLASS>  (217) 
Anticonvulsant

>  <SC_PATENT_NO>  (217) 
nan

>  <DRUG_TYPE>  (217) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (217) 
Y

>  <FIRST_IN_CLASS>  (217) 
N

>  <CHIRALITY>  (217) 
Achiral Molecule

>  <PRODRUG>  (217) 
N

>  <ORAL>  (217) 
Y

>  <PARENTERAL>  (217) 
Y

>  <TOPICAL>  (217) 
N

>  <BLACK_BOX>  (217) 
Y

>  <AVAILABILITY_TYPE>  (217) 
Prescription-only

>  <WITHDRAWN_YEAR>  (217) 
nan

>  <WITHDRAWN_COUNTRY>  (217) 
nan

>  <WITHDRAWN_REASON>  (217) 
nan

>  <CANONICAL_SMILES>  (217) 
OC1=NC(=O)C(N1)(c2ccccc2)c3ccccc3

>  <name>  (217) 
Phenytoin 

>  <MW>  (217) 
252.273

>  <logP>  (217) 
1.974

$$$$
CHEMBL969
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 15 22  1  0
 22 23  2  0
 23  2  1  0
 22  5  1  0
 10  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (218) 
95969

>  <SYNONYMS>  (218) 
Prazepam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (218) 
4

>  <RESEARCH_CODES>  (218) 
W-4020

>  <APPLICANTS>  (218) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (218) 
-azepam

>  <USAN_STEM_DEFINITION>  (218) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (218) 
-azepam

>  <USAN_YEAR>  (218) 
1968.0

>  <FIRST_APPROVAL>  (218) 
1982.0

>  <ATC_CODE>  (218) 
N05BA11

>  <ATC_CODE_DESCRIPTION>  (218) 
N05BA11 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (218) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (218) 
nan

>  <DRUG_TYPE>  (218) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (218) 
Y

>  <FIRST_IN_CLASS>  (218) 
N

>  <CHIRALITY>  (218) 
Achiral Molecule

>  <PRODRUG>  (218) 
N

>  <ORAL>  (218) 
Y

>  <PARENTERAL>  (218) 
N

>  <TOPICAL>  (218) 
N

>  <BLACK_BOX>  (218) 
N

>  <AVAILABILITY_TYPE>  (218) 
Discontinued

>  <WITHDRAWN_YEAR>  (218) 
nan

>  <WITHDRAWN_COUNTRY>  (218) 
nan

>  <WITHDRAWN_REASON>  (218) 
nan

>  <CANONICAL_SMILES>  (218) 
Clc1ccc2N(CC3CC3)C(=O)CN=C(c4ccccc4)c2c1

>  <name>  (218) 
Prazepam 

>  <MW>  (218) 
324.811

>  <logP>  (218) 
3.934

$$$$
CHEMBL1177
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (219) 
193096

>  <SYNONYMS>  (219) 
Pemoline (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (219) 
4

>  <RESEARCH_CODES>  (219) 
nan

>  <APPLICANTS>  (219) 
Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (219) 
nan

>  <USAN_STEM_DEFINITION>  (219) 
nan

>  <USAN_STEM_SUBSTEM>  (219) 
nan

>  <USAN_YEAR>  (219) 
1966.0

>  <FIRST_APPROVAL>  (219) 
1975.0

>  <ATC_CODE>  (219) 
N06BA05

>  <ATC_CODE_DESCRIPTION>  (219) 
N06BA05 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (219) 
Stimulant (central)

>  <SC_PATENT_NO>  (219) 
nan

>  <DRUG_TYPE>  (219) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (219) 
Y

>  <FIRST_IN_CLASS>  (219) 
N

>  <CHIRALITY>  (219) 
Racemic Mixture

>  <PRODRUG>  (219) 
N

>  <ORAL>  (219) 
Y

>  <PARENTERAL>  (219) 
N

>  <TOPICAL>  (219) 
N

>  <BLACK_BOX>  (219) 
Y

>  <AVAILABILITY_TYPE>  (219) 
Withdrawn

>  <WITHDRAWN_YEAR>  (219) 
1997.0

>  <WITHDRAWN_COUNTRY>  (219) 
Canada; United Kingdom

>  <WITHDRAWN_REASON>  (219) 
Hepatic toxicity

>  <CANONICAL_SMILES>  (219) 
NC1=NC(=O)C(O1)c2ccccc2

>  <name>  (219) 
Pemoline 

>  <MW>  (219) 
176.175

>  <logP>  (219) 
0.5992

$$$$
CHEMBL1754
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  5 14  1  0
 14 15  1  0
 15 16  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 14 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 15  3  1  0
 13  8  1  0
 22 17  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (220) 
581848

>  <SYNONYMS>  (220) 
Doxapram (BAN, INN); Doxapram HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (220) 
4

>  <RESEARCH_CODES>  (220) 
AHR-619

>  <APPLICANTS>  (220) 
Baxter Healthcare Corp Anesthesia And Critical Care

>  <USAN_STEM>  (220) 
nan

>  <USAN_STEM_DEFINITION>  (220) 
nan

>  <USAN_STEM_SUBSTEM>  (220) 
nan

>  <USAN_YEAR>  (220) 
1962.0

>  <FIRST_APPROVAL>  (220) 
1965.0

>  <ATC_CODE>  (220) 
R07AB01

>  <ATC_CODE_DESCRIPTION>  (220) 
R07AB01 [Respiratory System:Other Respiratory System Products:Other Respiratory System Products:Respiratory stimulants]

>  <INDICATION_CLASS>  (220) 
Stimulant (respiratory)

>  <SC_PATENT_NO>  (220) 
nan

>  <DRUG_TYPE>  (220) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (220) 
Y

>  <FIRST_IN_CLASS>  (220) 
N

>  <CHIRALITY>  (220) 
Racemic Mixture

>  <PRODRUG>  (220) 
N

>  <ORAL>  (220) 
N

>  <PARENTERAL>  (220) 
Y

>  <TOPICAL>  (220) 
N

>  <BLACK_BOX>  (220) 
N

>  <AVAILABILITY_TYPE>  (220) 
Prescription-only

>  <WITHDRAWN_YEAR>  (220) 
nan

>  <WITHDRAWN_COUNTRY>  (220) 
nan

>  <WITHDRAWN_REASON>  (220) 
nan

>  <CANONICAL_SMILES>  (220) 
CCN1CC(CCN2CCOCC2)C(C1=O)(c3ccccc3)c4ccccc4

>  <name>  (220) 
Doxapram 

>  <MW>  (220) 
378.516

>  <logP>  (220) 
3.1733

$$$$
CHEMBL905
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12 19  1  0
 19 20  2  0
 20  6  1  0
 20  9  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (221) 
79047

>  <SYNONYMS>  (221) 
Rizatriptan (BAN, INN); Rizatriptan Benzoate (FDA, USAN); Rizatriptan Sulfate (USAN)

>  <DEVELOPMENT_PHASE>  (221) 
4

>  <RESEARCH_CODES>  (221) 
MK-462; MK-0462; MK-A462

>  <APPLICANTS>  (221) 
Merck And Co Inc; Merck

>  <USAN_STEM>  (221) 
-triptan

>  <USAN_STEM_DEFINITION>  (221) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (221) 
-triptan

>  <USAN_YEAR>  (221) 
1996.0

>  <FIRST_APPROVAL>  (221) 
1998.0

>  <ATC_CODE>  (221) 
N02CC04

>  <ATC_CODE_DESCRIPTION>  (221) 
N02CC04 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (221) 
Antimigraine

>  <SC_PATENT_NO>  (221) 
nan

>  <DRUG_TYPE>  (221) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (221) 
Y

>  <FIRST_IN_CLASS>  (221) 
N

>  <CHIRALITY>  (221) 
Achiral Molecule

>  <PRODRUG>  (221) 
N

>  <ORAL>  (221) 
Y

>  <PARENTERAL>  (221) 
N

>  <TOPICAL>  (221) 
N

>  <BLACK_BOX>  (221) 
N

>  <AVAILABILITY_TYPE>  (221) 
Prescription-only

>  <WITHDRAWN_YEAR>  (221) 
nan

>  <WITHDRAWN_COUNTRY>  (221) 
nan

>  <WITHDRAWN_REASON>  (221) 
nan

>  <CANONICAL_SMILES>  (221) 
CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12

>  <name>  (221) 
Rizatriptan 

>  <MW>  (221) 
269.352

>  <logP>  (221) 
1.9118

$$$$
CHEMBL629
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  7  1  0
 13  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (222) 
27072

>  <SYNONYMS>  (222) 
Amitriptyline (BAN, INN); Amitriptyline HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (222) 
4

>  <RESEARCH_CODES>  (222) 
nan

>  <APPLICANTS>  (222) 
Valeant Pharmaceuticals International; Schering Corp Sub Schering Plough Corp; New River Pharmaceuticals Inc; Astrazeneca Pharmaceuticals Lp

>  <USAN_STEM>  (222) 
-triptyline

>  <USAN_STEM_DEFINITION>  (222) 
antidepressants (dibenzo[a,d]cycloheptane derivatives)

>  <USAN_STEM_SUBSTEM>  (222) 
-triptyline

>  <USAN_YEAR>  (222) 
nan

>  <FIRST_APPROVAL>  (222) 
1961.0

>  <ATC_CODE>  (222) 
N06AA09

>  <ATC_CODE_DESCRIPTION>  (222) 
N06AA09 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (222) 
Antidepressant

>  <SC_PATENT_NO>  (222) 
nan

>  <DRUG_TYPE>  (222) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (222) 
Y

>  <FIRST_IN_CLASS>  (222) 
N

>  <CHIRALITY>  (222) 
Achiral Molecule

>  <PRODRUG>  (222) 
N

>  <ORAL>  (222) 
Y

>  <PARENTERAL>  (222) 
Y

>  <TOPICAL>  (222) 
N

>  <BLACK_BOX>  (222) 
Y

>  <AVAILABILITY_TYPE>  (222) 
Prescription-only

>  <WITHDRAWN_YEAR>  (222) 
nan

>  <WITHDRAWN_COUNTRY>  (222) 
nan

>  <WITHDRAWN_REASON>  (222) 
nan

>  <CANONICAL_SMILES>  (222) 
CN(C)CCC=C1c2ccccc2CCc3ccccc13

>  <name>  (222) 
Amitriptyline 

>  <MW>  (222) 
277.411

>  <logP>  (222) 
4.1686

$$$$
CHEMBL1201232
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  8 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  4 24  1  0
 24 25  1  0
 24 26  1  0
 17 12  1  0
 23 18  1  0
M  CHG  1   4   1
M  END
>  <PARENT_MOLREGNO>  (223) 
675183

>  <SYNONYMS>  (223) 
Isopropamide Iodide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (223) 
4

>  <RESEARCH_CODES>  (223) 
nan

>  <APPLICANTS>  (223) 
GlaxoSmithKline

>  <USAN_STEM>  (223) 
-pamide

>  <USAN_STEM_DEFINITION>  (223) 
diuretics (sulfamoylbenzoic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (223) 
-pamide

>  <USAN_YEAR>  (223) 
nan

>  <FIRST_APPROVAL>  (223) 
1957.0

>  <ATC_CODE>  (223) 
A03AB09

>  <ATC_CODE_DESCRIPTION>  (223) 
A03AB09 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (223) 
Anticholinergic

>  <SC_PATENT_NO>  (223) 
nan

>  <DRUG_TYPE>  (223) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (223) 
Y

>  <FIRST_IN_CLASS>  (223) 
N

>  <CHIRALITY>  (223) 
Achiral Molecule

>  <PRODRUG>  (223) 
N

>  <ORAL>  (223) 
Y

>  <PARENTERAL>  (223) 
N

>  <TOPICAL>  (223) 
N

>  <BLACK_BOX>  (223) 
N

>  <AVAILABILITY_TYPE>  (223) 
Discontinued

>  <WITHDRAWN_YEAR>  (223) 
nan

>  <WITHDRAWN_COUNTRY>  (223) 
nan

>  <WITHDRAWN_REASON>  (223) 
nan

>  <CANONICAL_SMILES>  (223) 
CC(C)[N+](C)(CCC(C(=O)N)(c1ccccc1)c2ccccc2)C(C)C

>  <name>  (223) 
Isopropamide Iodide 

>  <MW>  (223) 
353.53

>  <logP>  (223) 
4.1115

$$$$
CHEMBL1263
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  5 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
  8  3  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (224) 
242716

>  <SYNONYMS>  (224) 
Salmeterol (BAN, INN, USAN); Salmeterol Xinafoate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (224) 
4

>  <RESEARCH_CODES>  (224) 
GR-33343-X; GR-33343X; GR-33343-G; GR-33343 G

>  <APPLICANTS>  (224) 
GlaxoSmithKline; Glaxo, England; Glaxo Group Ltd Dba GlaxoSmithKline

>  <USAN_STEM>  (224) 
sal-; -terol

>  <USAN_STEM_DEFINITION>  (224) 
anti-inflammatory agents (salicylic acid derivatives); bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (224) 
sal-; -terol

>  <USAN_YEAR>  (224) 
1985.0

>  <FIRST_APPROVAL>  (224) 
1994.0

>  <ATC_CODE>  (224) 
R03AC12

>  <ATC_CODE_DESCRIPTION>  (224) 
R03AC12 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (224) 
Bronchodilator

>  <SC_PATENT_NO>  (224) 
US-5873360-A

>  <DRUG_TYPE>  (224) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (224) 
Y

>  <FIRST_IN_CLASS>  (224) 
N

>  <CHIRALITY>  (224) 
Racemic Mixture

>  <PRODRUG>  (224) 
N

>  <ORAL>  (224) 
N

>  <PARENTERAL>  (224) 
N

>  <TOPICAL>  (224) 
Y

>  <BLACK_BOX>  (224) 
N

>  <AVAILABILITY_TYPE>  (224) 
Prescription-only

>  <WITHDRAWN_YEAR>  (224) 
nan

>  <WITHDRAWN_COUNTRY>  (224) 
nan

>  <WITHDRAWN_REASON>  (224) 
nan

>  <CANONICAL_SMILES>  (224) 
OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2

>  <name>  (224) 
Salmeterol 

>  <MW>  (224) 
415.574

>  <logP>  (224) 
4.1074

$$$$
CHEMBL1518
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11  4  1  0
M  END
>  <PARENT_MOLREGNO>  (225) 
421208

>  <SYNONYMS>  (225) 
Propylthiouracil (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (225) 
4

>  <RESEARCH_CODES>  (225) 
nan

>  <APPLICANTS>  (225) 
Eli Lilly And Co; Dava Pharmaceuticals Inc

>  <USAN_STEM>  (225) 
-uracil

>  <USAN_STEM_DEFINITION>  (225) 
uracil derivatives used as thyroid antagonists and as antineoplastics

>  <USAN_STEM_SUBSTEM>  (225) 
-uracil

>  <USAN_YEAR>  (225) 
nan

>  <FIRST_APPROVAL>  (225) 
1947.0

>  <ATC_CODE>  (225) 
H03BA02

>  <ATC_CODE_DESCRIPTION>  (225) 
H03BA02 [Systemic Hormonal Preparations, Excl. :Thyroid Therapy:Antithyroid Preparations:Thiouracils]

>  <INDICATION_CLASS>  (225) 
Thyroid Inhibitor

>  <SC_PATENT_NO>  (225) 
nan

>  <DRUG_TYPE>  (225) 
Natural Product-derived

>  <RULE_OF_FIVE>  (225) 
Y

>  <FIRST_IN_CLASS>  (225) 
N

>  <CHIRALITY>  (225) 
Achiral Molecule

>  <PRODRUG>  (225) 
N

>  <ORAL>  (225) 
Y

>  <PARENTERAL>  (225) 
N

>  <TOPICAL>  (225) 
N

>  <BLACK_BOX>  (225) 
Y

>  <AVAILABILITY_TYPE>  (225) 
Prescription-only

>  <WITHDRAWN_YEAR>  (225) 
nan

>  <WITHDRAWN_COUNTRY>  (225) 
nan

>  <WITHDRAWN_REASON>  (225) 
nan

>  <CANONICAL_SMILES>  (225) 
CCCC1=CC(=O)NC(=S)N1

>  <name>  (225) 
Propylthiouracil 

>  <MW>  (225) 
170.237

>  <logP>  (225) 
1.38499

$$$$
CHEMBL1219
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 11 24  2  0
 24 25  1  0
 24  7  1  0
 23 15  1  0
 22 17  1  0
M  CHG  2  13   1  14  -1
M  END
>  <PARENT_MOLREGNO>  (226) 
222203

>  <SYNONYMS>  (226) 
Rabeprazole (BAN, INN); Rabeprazole Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (226) 
4

>  <RESEARCH_CODES>  (226) 
LY-307640; E-3810

>  <APPLICANTS>  (226) 
Eisai Inc

>  <USAN_STEM>  (226) 
-prazole

>  <USAN_STEM_DEFINITION>  (226) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (226) 
-prazole

>  <USAN_YEAR>  (226) 
1995.0

>  <FIRST_APPROVAL>  (226) 
1999.0

>  <ATC_CODE>  (226) 
A02BC04; A02BC54

>  <ATC_CODE_DESCRIPTION>  (226) 
A02BC04 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]; A02BC54 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (226) 
Anti-Ulcerative; Gastric Acid Pump Inhibitor

>  <SC_PATENT_NO>  (226) 
nan

>  <DRUG_TYPE>  (226) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (226) 
Y

>  <FIRST_IN_CLASS>  (226) 
N

>  <CHIRALITY>  (226) 
Racemic Mixture

>  <PRODRUG>  (226) 
N

>  <ORAL>  (226) 
Y

>  <PARENTERAL>  (226) 
N

>  <TOPICAL>  (226) 
N

>  <BLACK_BOX>  (226) 
N

>  <AVAILABILITY_TYPE>  (226) 
Prescription-only

>  <WITHDRAWN_YEAR>  (226) 
nan

>  <WITHDRAWN_COUNTRY>  (226) 
nan

>  <WITHDRAWN_REASON>  (226) 
nan

>  <CANONICAL_SMILES>  (226) 
COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C

>  <name>  (226) 
Rabeprazole 

>  <MW>  (226) 
359.451

>  <logP>  (226) 
2.98942

$$$$
CHEMBL1201863
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 13  2  1  0
 25 17  1  0
 24 19  1  0
M  CHG  2  15   1  16  -1
M  END
>  <PARENT_MOLREGNO>  (227) 
675812

>  <SYNONYMS>  (227) 
Dexlansoprazole (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (227) 
4

>  <RESEARCH_CODES>  (227) 
T-168390; TAK-390

>  <APPLICANTS>  (227) 
Takeda Pharmaceuticals North America Inc

>  <USAN_STEM>  (227) 
-prazole

>  <USAN_STEM_DEFINITION>  (227) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (227) 
-prazole

>  <USAN_YEAR>  (227) 
2006.0

>  <FIRST_APPROVAL>  (227) 
2009.0

>  <ATC_CODE>  (227) 
A02BC06

>  <ATC_CODE_DESCRIPTION>  (227) 
A02BC06 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (227) 
nan

>  <SC_PATENT_NO>  (227) 
US-6238994-B1

>  <DRUG_TYPE>  (227) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (227) 
Y

>  <FIRST_IN_CLASS>  (227) 
N

>  <CHIRALITY>  (227) 
Single Stereoisomer

>  <PRODRUG>  (227) 
N

>  <ORAL>  (227) 
Y

>  <PARENTERAL>  (227) 
N

>  <TOPICAL>  (227) 
N

>  <BLACK_BOX>  (227) 
Y

>  <AVAILABILITY_TYPE>  (227) 
Prescription-only

>  <WITHDRAWN_YEAR>  (227) 
nan

>  <WITHDRAWN_COUNTRY>  (227) 
nan

>  <WITHDRAWN_REASON>  (227) 
nan

>  <CANONICAL_SMILES>  (227) 
Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2

>  <name>  (227) 
Dexlansoprazole 

>  <MW>  (227) 
369.368

>  <logP>  (227) 
3.51522

$$$$
CHEMBL546
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (228) 
13756

>  <SYNONYMS>  (228) 
Oxprenolol (BAN, INN); Oxprenolol HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (228) 
4

>  <RESEARCH_CODES>  (228) 
BA-39089

>  <APPLICANTS>  (228) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (228) 
-olol

>  <USAN_STEM_DEFINITION>  (228) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (228) 
-olol

>  <USAN_YEAR>  (228) 
1968.0

>  <FIRST_APPROVAL>  (228) 
1983.0

>  <ATC_CODE>  (228) 
C07AA02

>  <ATC_CODE_DESCRIPTION>  (228) 
C07AA02 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (228) 
Vasodilator (coronary)

>  <SC_PATENT_NO>  (228) 
nan

>  <DRUG_TYPE>  (228) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (228) 
Y

>  <FIRST_IN_CLASS>  (228) 
N

>  <CHIRALITY>  (228) 
Racemic Mixture

>  <PRODRUG>  (228) 
N

>  <ORAL>  (228) 
Y

>  <PARENTERAL>  (228) 
N

>  <TOPICAL>  (228) 
N

>  <BLACK_BOX>  (228) 
N

>  <AVAILABILITY_TYPE>  (228) 
Discontinued

>  <WITHDRAWN_YEAR>  (228) 
nan

>  <WITHDRAWN_COUNTRY>  (228) 
nan

>  <WITHDRAWN_REASON>  (228) 
nan

>  <CANONICAL_SMILES>  (228) 
CC(C)NCC(O)COc1ccccc1OCC=C

>  <name>  (228) 
Oxprenolol 

>  <MW>  (228) 
265.353

>  <logP>  (228) 
1.9891

$$$$
CHEMBL1254682
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 13 20  1  0
 20 21  2  0
 21  2  1  0
 20  5  1  0
 16  7  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (229) 
704148

>  <SYNONYMS>  (229) 
Levallorphan (BAN, INN); Levallorphan Tartrate (FDA, JAN, MI, USP)

>  <DEVELOPMENT_PHASE>  (229) 
4

>  <RESEARCH_CODES>  (229) 
nan

>  <APPLICANTS>  (229) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (229) 
-orphan

>  <USAN_STEM_DEFINITION>  (229) 
narcotic antagonists/agonists (morphinan derivatives)

>  <USAN_STEM_SUBSTEM>  (229) 
-orphan

>  <USAN_YEAR>  (229) 
nan

>  <FIRST_APPROVAL>  (229) 
1982.0

>  <ATC_CODE>  (229) 
nan

>  <ATC_CODE_DESCRIPTION>  (229) 
nan

>  <INDICATION_CLASS>  (229) 
nan

>  <SC_PATENT_NO>  (229) 
nan

>  <DRUG_TYPE>  (229) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (229) 
Y

>  <FIRST_IN_CLASS>  (229) 
N

>  <CHIRALITY>  (229) 
Single Stereoisomer

>  <PRODRUG>  (229) 
N

>  <ORAL>  (229) 
N

>  <PARENTERAL>  (229) 
Y

>  <TOPICAL>  (229) 
N

>  <BLACK_BOX>  (229) 
N

>  <AVAILABILITY_TYPE>  (229) 
Discontinued

>  <WITHDRAWN_YEAR>  (229) 
nan

>  <WITHDRAWN_COUNTRY>  (229) 
nan

>  <WITHDRAWN_REASON>  (229) 
nan

>  <CANONICAL_SMILES>  (229) 
Oc1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC=C)c2c1

>  <name>  (229) 
Levallorphan 

>  <MW>  (229) 
283.415

>  <logP>  (229) 
3.6366

$$$$
CHEMBL3707268
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
  7  2  1  0
M  END
>  <PARENT_MOLREGNO>  (230) 
2039239

>  <SYNONYMS>  (230) 
Fluciclovine F 18 (FDA); Fluciclovine F18 (USAN)

>  <DEVELOPMENT_PHASE>  (230) 
4

>  <RESEARCH_CODES>  (230) 
FACBC; GE-148; NMK-36

>  <APPLICANTS>  (230) 
Blue Earth Diagnostics Ltd.

>  <USAN_STEM>  (230) 
-vin-

>  <USAN_STEM_DEFINITION>  (230) 
vinca alkaloids

>  <USAN_STEM_SUBSTEM>  (230) 
-vin-

>  <USAN_YEAR>  (230) 
2015.0

>  <FIRST_APPROVAL>  (230) 
2016.0

>  <ATC_CODE>  (230) 
nan

>  <ATC_CODE_DESCRIPTION>  (230) 
nan

>  <INDICATION_CLASS>  (230) 
nan

>  <SC_PATENT_NO>  (230) 
nan

>  <DRUG_TYPE>  (230) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (230) 
Y

>  <FIRST_IN_CLASS>  (230) 
N

>  <CHIRALITY>  (230) 
Single Stereoisomer

>  <PRODRUG>  (230) 
N

>  <ORAL>  (230) 
N

>  <PARENTERAL>  (230) 
Y

>  <TOPICAL>  (230) 
N

>  <BLACK_BOX>  (230) 
N

>  <AVAILABILITY_TYPE>  (230) 
Prescription-only

>  <WITHDRAWN_YEAR>  (230) 
nan

>  <WITHDRAWN_COUNTRY>  (230) 
nan

>  <WITHDRAWN_REASON>  (230) 
nan

>  <CANONICAL_SMILES>  (230) 
C[C@@]1(F)C[C@@](N)(C1)C(=O)O

>  <name>  (230) 
Fluciclovine F 18 

>  <MW>  (230) 
147.149

>  <logP>  (230) 
0.2905

$$$$
CHEMBL3707235
     RDKit          

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  2 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 23 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
 11  4  1  0
 21 16  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (231) 
2039206

>  <SYNONYMS>  (231) 
Gemigliptin

>  <DEVELOPMENT_PHASE>  (231) 
4

>  <RESEARCH_CODES>  (231) 
nan

>  <APPLICANTS>  (231) 
nan

>  <USAN_STEM>  (231) 
-gliptin

>  <USAN_STEM_DEFINITION>  (231) 
dipeptidyl aminopeptidase-IV inhibitors

>  <USAN_STEM_SUBSTEM>  (231) 
-gliptin

>  <USAN_YEAR>  (231) 
nan

>  <FIRST_APPROVAL>  (231) 
nan

>  <ATC_CODE>  (231) 
A10BH06

>  <ATC_CODE_DESCRIPTION>  (231) 
A10BH06 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Dipeptidyl peptidase 4 (DPP-4) inhibitors]

>  <INDICATION_CLASS>  (231) 
nan

>  <SC_PATENT_NO>  (231) 
nan

>  <DRUG_TYPE>  (231) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (231) 
Y

>  <FIRST_IN_CLASS>  (231) 
N

>  <CHIRALITY>  (231) 
Single Stereoisomer

>  <PRODRUG>  (231) 
N

>  <ORAL>  (231) 
N

>  <PARENTERAL>  (231) 
N

>  <TOPICAL>  (231) 
N

>  <BLACK_BOX>  (231) 
N

>  <AVAILABILITY_TYPE>  (231) 
Unknown

>  <WITHDRAWN_YEAR>  (231) 
nan

>  <WITHDRAWN_COUNTRY>  (231) 
nan

>  <WITHDRAWN_REASON>  (231) 
nan

>  <CANONICAL_SMILES>  (231) 
N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N2CCc3c(C2)nc(nc3C(F)(F)F)C(F)(F)F

>  <name>  (231) 
Gemigliptin

>  <MW>  (231) 
489.367

>  <logP>  (231) 
2.374

$$$$
CHEMBL1201321
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  3  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 10 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
  7 25  1  0
 25 26  1  0
  4 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 26  4  1  0
 18 13  1  0
 24 19  1  0
 32 27  1  0
M  END
>  <PARENT_MOLREGNO>  (232) 
675272

>  <SYNONYMS>  (232) 
Difenoxin (BAN, INN, USAN); Difenoxin HCl (FDA)

>  <DEVELOPMENT_PHASE>  (232) 
4

>  <RESEARCH_CODES>  (232) 
MCN-JR-15,403-11; R-15403 [as hydrochloride]; R-15403

>  <APPLICANTS>  (232) 
Valeant Pharmaceuticals International; Janssen Pharmaceutica, Belgium

>  <USAN_STEM>  (232) 
-oxin

>  <USAN_STEM_DEFINITION>  (232) 
fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)

>  <USAN_STEM_SUBSTEM>  (232) 
-oxin

>  <USAN_YEAR>  (232) 
1971.0

>  <FIRST_APPROVAL>  (232) 
1978.0

>  <ATC_CODE>  (232) 
A07DA04

>  <ATC_CODE_DESCRIPTION>  (232) 
A07DA04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Antipropulsives:Antipropulsives]

>  <INDICATION_CLASS>  (232) 
Antiperistaltic

>  <SC_PATENT_NO>  (232) 
nan

>  <DRUG_TYPE>  (232) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (232) 
Y

>  <FIRST_IN_CLASS>  (232) 
N

>  <CHIRALITY>  (232) 
Achiral Molecule

>  <PRODRUG>  (232) 
N

>  <ORAL>  (232) 
Y

>  <PARENTERAL>  (232) 
N

>  <TOPICAL>  (232) 
N

>  <BLACK_BOX>  (232) 
N

>  <AVAILABILITY_TYPE>  (232) 
Prescription-only

>  <WITHDRAWN_YEAR>  (232) 
nan

>  <WITHDRAWN_COUNTRY>  (232) 
nan

>  <WITHDRAWN_REASON>  (232) 
nan

>  <CANONICAL_SMILES>  (232) 
OC(=O)C1(CCN(CCC(C#N)(c2ccccc2)c3ccccc3)CC1)c4ccccc4

>  <name>  (232) 
Difenoxin 

>  <MW>  (232) 
424.544

>  <logP>  (232) 
5.00478

$$$$
CHEMBL27193
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 10  5  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (233) 
37260

>  <SYNONYMS>  (233) 
Dilevalol (BAN, INN); Dilevalol HCl (JAN, USAN)

>  <DEVELOPMENT_PHASE>  (233) 
4

>  <RESEARCH_CODES>  (233) 
SCH-19927

>  <APPLICANTS>  (233) 
Schering

>  <USAN_STEM>  (233) 
-alol; dil-

>  <USAN_STEM_DEFINITION>  (233) 
combined alpha and beta receptors; vasodilators (undefined group)

>  <USAN_STEM_SUBSTEM>  (233) 
-alol; dil-

>  <USAN_YEAR>  (233) 
1984.0

>  <FIRST_APPROVAL>  (233) 
1990.0

>  <ATC_CODE>  (233) 
nan

>  <ATC_CODE_DESCRIPTION>  (233) 
nan

>  <INDICATION_CLASS>  (233) 
Anti-Adrenergic (beta-receptor); Antihypertensive

>  <SC_PATENT_NO>  (233) 
nan

>  <DRUG_TYPE>  (233) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (233) 
Y

>  <FIRST_IN_CLASS>  (233) 
N

>  <CHIRALITY>  (233) 
Single Stereoisomer

>  <PRODRUG>  (233) 
N

>  <ORAL>  (233) 
N

>  <PARENTERAL>  (233) 
N

>  <TOPICAL>  (233) 
N

>  <BLACK_BOX>  (233) 
N

>  <AVAILABILITY_TYPE>  (233) 
Withdrawn

>  <WITHDRAWN_YEAR>  (233) 
1990.0

>  <WITHDRAWN_COUNTRY>  (233) 
United Kingdom

>  <WITHDRAWN_REASON>  (233) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (233) 
C[C@H](CCc1ccccc1)NC[C@H](O)c2ccc(O)c(c2)C(=O)N

>  <name>  (233) 
Dilevalol 

>  <MW>  (233) 
328.412

>  <logP>  (233) 
2.1354

$$$$
CHEMBL585
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
  8 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  2  1  0
 12  6  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (234) 
17411

>  <SYNONYMS>  (234) 
Triamterene (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (234) 
4

>  <RESEARCH_CODES>  (234) 
SK&F-8542; SK-8542

>  <APPLICANTS>  (234) 
Wellspring Pharmaceutical Corp; Mylan Bertek Pharmaceuticals Inc; GlaxoSmithKline Llc

>  <USAN_STEM>  (234) 
nan

>  <USAN_STEM_DEFINITION>  (234) 
nan

>  <USAN_STEM_SUBSTEM>  (234) 
nan

>  <USAN_YEAR>  (234) 
1963.0

>  <FIRST_APPROVAL>  (234) 
1964.0

>  <ATC_CODE>  (234) 
C03DB02

>  <ATC_CODE_DESCRIPTION>  (234) 
C03DB02 [Cardiovascular System:Diuretics:Potassium-Sparing Agents:Other potassium-sparing agents]

>  <INDICATION_CLASS>  (234) 
Diuretic

>  <SC_PATENT_NO>  (234) 
nan

>  <DRUG_TYPE>  (234) 
Natural Product-derived

>  <RULE_OF_FIVE>  (234) 
Y

>  <FIRST_IN_CLASS>  (234) 
N

>  <CHIRALITY>  (234) 
Achiral Molecule

>  <PRODRUG>  (234) 
N

>  <ORAL>  (234) 
Y

>  <PARENTERAL>  (234) 
N

>  <TOPICAL>  (234) 
N

>  <BLACK_BOX>  (234) 
Y

>  <AVAILABILITY_TYPE>  (234) 
Prescription-only

>  <WITHDRAWN_YEAR>  (234) 
nan

>  <WITHDRAWN_COUNTRY>  (234) 
nan

>  <WITHDRAWN_REASON>  (234) 
nan

>  <CANONICAL_SMILES>  (234) 
Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3

>  <name>  (234) 
Triamterene 

>  <MW>  (234) 
253.269

>  <logP>  (234) 
0.8334

$$$$
CHEMBL704
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
  9 11  1  0
  8  2  1  0
M  END
>  <PARENT_MOLREGNO>  (235) 
33202

>  <SYNONYMS>  (235) 
Mesalamine (FDA, USAN, USP); Mesalazine (BAN, INN)

>  <DEVELOPMENT_PHASE>  (235) 
4

>  <RESEARCH_CODES>  (235) 
nan

>  <APPLICANTS>  (235) 
Shire Development Inc; Salix Pharmaceuticals Inc; Meda Pharmaceuticals Inc; Aptalis Pharma Us Inc; Warner Chilcott Co Llc

>  <USAN_STEM>  (235) 
-sal-

>  <USAN_STEM_DEFINITION>  (235) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (235) 
-sal-

>  <USAN_YEAR>  (235) 
1986.0

>  <FIRST_APPROVAL>  (235) 
1987.0

>  <ATC_CODE>  (235) 
A07EC02

>  <ATC_CODE_DESCRIPTION>  (235) 
A07EC02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Aminosalicylic acid and similar agents]

>  <INDICATION_CLASS>  (235) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (235) 
US-6551620-B2

>  <DRUG_TYPE>  (235) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (235) 
Y

>  <FIRST_IN_CLASS>  (235) 
N

>  <CHIRALITY>  (235) 
Achiral Molecule

>  <PRODRUG>  (235) 
N

>  <ORAL>  (235) 
Y

>  <PARENTERAL>  (235) 
N

>  <TOPICAL>  (235) 
Y

>  <BLACK_BOX>  (235) 
N

>  <AVAILABILITY_TYPE>  (235) 
Prescription-only

>  <WITHDRAWN_YEAR>  (235) 
nan

>  <WITHDRAWN_COUNTRY>  (235) 
nan

>  <WITHDRAWN_REASON>  (235) 
nan

>  <CANONICAL_SMILES>  (235) 
Nc1ccc(O)c(c1)C(=O)O

>  <name>  (235) 
Mesalamine 

>  <MW>  (235) 
153.137

>  <logP>  (235) 
0.6726

$$$$
CHEMBL1504
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 27  2  1  0
 26  5  1  0
 24  7  1  0
 19  8  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (236) 
419622

>  <SYNONYMS>  (236) 
Triamcinolone Acetonide (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (236) 
4

>  <RESEARCH_CODES>  (236) 
nan

>  <APPLICANTS>  (236) 
Apothecon Inc Div Bristol Myers Squibb; Allergan Inc; Alcon Inc; Abbvie Inc; Bristol Myers Squibb Co Pharmaceutical Research Institute

>  <USAN_STEM>  (236) 
-olone

>  <USAN_STEM_DEFINITION>  (236) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (236) 
-olone

>  <USAN_YEAR>  (236) 
nan

>  <FIRST_APPROVAL>  (236) 
1960.0

>  <ATC_CODE>  (236) 
nan

>  <ATC_CODE_DESCRIPTION>  (236) 
nan

>  <INDICATION_CLASS>  (236) 
Glucocorticoid

>  <SC_PATENT_NO>  (236) 
US-5976573-A

>  <DRUG_TYPE>  (236) 
Natural Product-derived

>  <RULE_OF_FIVE>  (236) 
Y

>  <FIRST_IN_CLASS>  (236) 
N

>  <CHIRALITY>  (236) 
Single Stereoisomer

>  <PRODRUG>  (236) 
N

>  <ORAL>  (236) 
N

>  <PARENTERAL>  (236) 
Y

>  <TOPICAL>  (236) 
Y

>  <BLACK_BOX>  (236) 
Y

>  <AVAILABILITY_TYPE>  (236) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (236) 
nan

>  <WITHDRAWN_COUNTRY>  (236) 
nan

>  <WITHDRAWN_REASON>  (236) 
nan

>  <CANONICAL_SMILES>  (236) 
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

>  <name>  (236) 
Triamcinolone Acetonide 

>  <MW>  (236) 
434.504

>  <logP>  (236) 
2.4188

$$$$
CHEMBL1294
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 10 23  1  0
 23 24  2  0
 24  3  1  0
 23  6  1  0
 18 13  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (237) 
255477

>  <SYNONYMS>  (237) 
Quinidine (MI, NF); Quinidine Sulfate (FDA, JAN, USP); Quinidine Gluconate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (237) 
4

>  <RESEARCH_CODES>  (237) 
nan

>  <APPLICANTS>  (237) 
Warner Chilcott Div Warner Lambert Co; Eli Lilly And Co; Bayer Healthcare Pharmaceuticals Inc; Avanir Pharmaceuticals Inc; Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (237) 
nan

>  <USAN_STEM_DEFINITION>  (237) 
nan

>  <USAN_STEM_SUBSTEM>  (237) 
nan

>  <USAN_YEAR>  (237) 
nan

>  <FIRST_APPROVAL>  (237) 
1950.0

>  <ATC_CODE>  (237) 
C01BA51; C01BA01; C01BA71

>  <ATC_CODE_DESCRIPTION>  (237) 
C01BA51 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ia]; C01BA01 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ia]; C01BA71 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ia]

>  <INDICATION_CLASS>  (237) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (237) 
US-RE38115-E1

>  <DRUG_TYPE>  (237) 
Natural Product-derived

>  <RULE_OF_FIVE>  (237) 
Y

>  <FIRST_IN_CLASS>  (237) 
N

>  <CHIRALITY>  (237) 
Single Stereoisomer

>  <PRODRUG>  (237) 
N

>  <ORAL>  (237) 
Y

>  <PARENTERAL>  (237) 
Y

>  <TOPICAL>  (237) 
N

>  <BLACK_BOX>  (237) 
Y

>  <AVAILABILITY_TYPE>  (237) 
Prescription-only

>  <WITHDRAWN_YEAR>  (237) 
nan

>  <WITHDRAWN_COUNTRY>  (237) 
nan

>  <WITHDRAWN_REASON>  (237) 
nan

>  <CANONICAL_SMILES>  (237) 
COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1

>  <name>  (237) 
Quinidine 

>  <MW>  (237) 
324.424

>  <logP>  (237) 
3.1732

$$$$
CHEMBL177756
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
  9  4  1  0
 25 10  1  0
 17 11  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (238) 
294107

>  <SYNONYMS>  (238) 
Fluorescein (BAN, JAN, USP); Fluorescein Sodium (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (238) 
4

>  <RESEARCH_CODES>  (238) 
nan

>  <APPLICANTS>  (238) 
Novartis Pharmaceuticals Corp; Alcon Pharmaceuticals Ltd; Alcon; Akorn Inc

>  <USAN_STEM>  (238) 
nan

>  <USAN_STEM_DEFINITION>  (238) 
nan

>  <USAN_STEM_SUBSTEM>  (238) 
nan

>  <USAN_YEAR>  (238) 
nan

>  <FIRST_APPROVAL>  (238) 
1976.0

>  <ATC_CODE>  (238) 
S01JA51; S01JA01

>  <ATC_CODE_DESCRIPTION>  (238) 
S01JA51 [Sensory Organs:Ophthalmologicals:Diagnostic Agents:Colouring agents]; S01JA01 [Sensory Organs:Ophthalmologicals:Diagnostic Agents:Colouring agents]

>  <INDICATION_CLASS>  (238) 
Diagnostic Aid (corneal trauma indicator)

>  <SC_PATENT_NO>  (238) 
nan

>  <DRUG_TYPE>  (238) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (238) 
Y

>  <FIRST_IN_CLASS>  (238) 
N

>  <CHIRALITY>  (238) 
Achiral Molecule

>  <PRODRUG>  (238) 
N

>  <ORAL>  (238) 
N

>  <PARENTERAL>  (238) 
Y

>  <TOPICAL>  (238) 
N

>  <BLACK_BOX>  (238) 
N

>  <AVAILABILITY_TYPE>  (238) 
Prescription-only

>  <WITHDRAWN_YEAR>  (238) 
nan

>  <WITHDRAWN_COUNTRY>  (238) 
nan

>  <WITHDRAWN_REASON>  (238) 
nan

>  <CANONICAL_SMILES>  (238) 
OC(=O)c1ccccc1C2=C3C=CC(=O)C=C3Oc4cc(O)ccc24

>  <name>  (238) 
Fluorescein 

>  <MW>  (238) 
332.311

>  <logP>  (238) 
3.9686

$$$$
CHEMBL771
     RDKit          

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  2  1  0
M  END
>  <PARENT_MOLREGNO>  (239) 
43740

>  <SYNONYMS>  (239) 
Cycloserine (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (239) 
4

>  <RESEARCH_CODES>  (239) 
nan

>  <APPLICANTS>  (239) 
Purdue Gmp Center Llc Dba The Chao Center Industrial Pharmacy

>  <USAN_STEM>  (239) 
nan

>  <USAN_STEM_DEFINITION>  (239) 
nan

>  <USAN_STEM_SUBSTEM>  (239) 
nan

>  <USAN_YEAR>  (239) 
nan

>  <FIRST_APPROVAL>  (239) 
1964.0

>  <ATC_CODE>  (239) 
J04AB01

>  <ATC_CODE_DESCRIPTION>  (239) 
J04AB01 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Antibiotics]

>  <INDICATION_CLASS>  (239) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (239) 
nan

>  <DRUG_TYPE>  (239) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (239) 
Y

>  <FIRST_IN_CLASS>  (239) 
N

>  <CHIRALITY>  (239) 
Single Stereoisomer

>  <PRODRUG>  (239) 
N

>  <ORAL>  (239) 
Y

>  <PARENTERAL>  (239) 
N

>  <TOPICAL>  (239) 
N

>  <BLACK_BOX>  (239) 
N

>  <AVAILABILITY_TYPE>  (239) 
Prescription-only

>  <WITHDRAWN_YEAR>  (239) 
nan

>  <WITHDRAWN_COUNTRY>  (239) 
nan

>  <WITHDRAWN_REASON>  (239) 
nan

>  <CANONICAL_SMILES>  (239) 
N[C@@H]1CONC1=O

>  <name>  (239) 
Cycloserine 

>  <MW>  (239) 
102.093

>  <logP>  (239) 
-1.6249

$$$$
CHEMBL80
     RDKit          

 24 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 15 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 17  2  1  0
 18  5  1  0
 23  7  1  0
 18 14  1  0
 23 14  1  0
M  END
>  <PARENT_MOLREGNO>  (240) 
6902

>  <SYNONYMS>  (240) 
Naloxone (BAN, INN); Naloxone HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (240) 
4

>  <RESEARCH_CODES>  (240) 
EN-15304

>  <APPLICANTS>  (240) 
Sanofi Aventis Us Llc; Reckitt Benckiser Pharmaceuticals Inc; Endo Pharmaceuticals Inc

>  <USAN_STEM>  (240) 
nal-

>  <USAN_STEM_DEFINITION>  (240) 
narcotic agonists/antagonists (normorphine type)

>  <USAN_STEM_SUBSTEM>  (240) 
nal-

>  <USAN_YEAR>  (240) 
1963.0

>  <FIRST_APPROVAL>  (240) 
1971.0

>  <ATC_CODE>  (240) 
V03AB15

>  <ATC_CODE_DESCRIPTION>  (240) 
V03AB15 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (240) 
Antagonist (to narcotics)

>  <SC_PATENT_NO>  (240) 
US-6159498-A

>  <DRUG_TYPE>  (240) 
Natural Product-derived

>  <RULE_OF_FIVE>  (240) 
Y

>  <FIRST_IN_CLASS>  (240) 
N

>  <CHIRALITY>  (240) 
Single Stereoisomer

>  <PRODRUG>  (240) 
N

>  <ORAL>  (240) 
Y

>  <PARENTERAL>  (240) 
Y

>  <TOPICAL>  (240) 
Y

>  <BLACK_BOX>  (240) 
N

>  <AVAILABILITY_TYPE>  (240) 
Prescription-only

>  <WITHDRAWN_YEAR>  (240) 
nan

>  <WITHDRAWN_COUNTRY>  (240) 
nan

>  <WITHDRAWN_REASON>  (240) 
nan

>  <CANONICAL_SMILES>  (240) 
Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O

>  <name>  (240) 
Naloxone 

>  <MW>  (240) 
327.38

>  <logP>  (240) 
1.3014

$$$$
CHEMBL1256391
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  4  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8  2  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (241) 
705377

>  <SYNONYMS>  (241) 
Pirfenidone (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (241) 
4

>  <RESEARCH_CODES>  (241) 
AMR-69

>  <APPLICANTS>  (241) 
Intermune IncINC; Genentech Inc

>  <USAN_STEM>  (241) 
nan

>  <USAN_STEM_DEFINITION>  (241) 
nan

>  <USAN_STEM_SUBSTEM>  (241) 
nan

>  <USAN_YEAR>  (241) 
1975.0

>  <FIRST_APPROVAL>  (241) 
2011.0

>  <ATC_CODE>  (241) 
L04AX05

>  <ATC_CODE_DESCRIPTION>  (241) 
L04AX05 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Other immunosuppressants]

>  <INDICATION_CLASS>  (241) 
Analgesic; Anti-Inflammatory; Antipyretic

>  <SC_PATENT_NO>  (241) 
US-7566729-B1

>  <DRUG_TYPE>  (241) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (241) 
Y

>  <FIRST_IN_CLASS>  (241) 
N

>  <CHIRALITY>  (241) 
Achiral Molecule

>  <PRODRUG>  (241) 
N

>  <ORAL>  (241) 
Y

>  <PARENTERAL>  (241) 
N

>  <TOPICAL>  (241) 
N

>  <BLACK_BOX>  (241) 
N

>  <AVAILABILITY_TYPE>  (241) 
Prescription-only

>  <WITHDRAWN_YEAR>  (241) 
nan

>  <WITHDRAWN_COUNTRY>  (241) 
nan

>  <WITHDRAWN_REASON>  (241) 
nan

>  <CANONICAL_SMILES>  (241) 
CC1=CN(C(=O)C=C1)c2ccccc2

>  <name>  (241) 
Pirfenidone 

>  <MW>  (241) 
185.226

>  <logP>  (241) 
2.14592

$$$$
CHEMBL841
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 12 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
  6 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
  6 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 15  9  1  0
 22 16  1  0
 28 23  1  0
 34 29  1  0
M  END
>  <PARENT_MOLREGNO>  (242) 
62259

>  <SYNONYMS>  (242) 
Loperamide (BAN, INN); Loperamide HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (242) 
4

>  <RESEARCH_CODES>  (242) 
R-18553

>  <APPLICANTS>  (242) 
Mcneil Consumer Products Co Div Mcneilab Inc; Mcneil Consumer Healthcare; Janssen Pharmaceutica Products Lp; Banner Pharmacaps Inc; Mcneil Pediatrics

>  <USAN_STEM>  (242) 
nan

>  <USAN_STEM_DEFINITION>  (242) 
nan

>  <USAN_STEM_SUBSTEM>  (242) 
nan

>  <USAN_YEAR>  (242) 
1975.0

>  <FIRST_APPROVAL>  (242) 
1976.0

>  <ATC_CODE>  (242) 
A07DA03; A07DA53

>  <ATC_CODE_DESCRIPTION>  (242) 
A07DA03 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Antipropulsives:Antipropulsives]; A07DA53 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Antipropulsives:Antipropulsives]

>  <INDICATION_CLASS>  (242) 
Antiperistaltic

>  <SC_PATENT_NO>  (242) 
US-6103260-A

>  <DRUG_TYPE>  (242) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (242) 
Y

>  <FIRST_IN_CLASS>  (242) 
N

>  <CHIRALITY>  (242) 
Achiral Molecule

>  <PRODRUG>  (242) 
N

>  <ORAL>  (242) 
Y

>  <PARENTERAL>  (242) 
N

>  <TOPICAL>  (242) 
N

>  <BLACK_BOX>  (242) 
Y

>  <AVAILABILITY_TYPE>  (242) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (242) 
nan

>  <WITHDRAWN_COUNTRY>  (242) 
nan

>  <WITHDRAWN_REASON>  (242) 
nan

>  <CANONICAL_SMILES>  (242) 
CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4

>  <name>  (242) 
Loperamide 

>  <MW>  (242) 
477.048

>  <logP>  (242) 
5.088

$$$$
CHEMBL1201353
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (243) 
675304

>  <SYNONYMS>  (243) 
Dexchlorpheniramine (BAN, INN); d-Chlorpheniramine Maleate (JAN); Dexchlorpheniramine Maleate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (243) 
4

>  <RESEARCH_CODES>  (243) 
nan

>  <APPLICANTS>  (243) 
Wockhardt Eu Operations (Swiss) Ag; Schering Corp Sub Schering Plough Corp; Pliva Inc

>  <USAN_STEM>  (243) 
nan

>  <USAN_STEM_DEFINITION>  (243) 
nan

>  <USAN_STEM_SUBSTEM>  (243) 
nan

>  <USAN_YEAR>  (243) 
nan

>  <FIRST_APPROVAL>  (243) 
1981.0

>  <ATC_CODE>  (243) 
R06AB02; R06AB52

>  <ATC_CODE_DESCRIPTION>  (243) 
R06AB02 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]; R06AB52 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]

>  <INDICATION_CLASS>  (243) 
Antihistaminic

>  <SC_PATENT_NO>  (243) 
nan

>  <DRUG_TYPE>  (243) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (243) 
Y

>  <FIRST_IN_CLASS>  (243) 
N

>  <CHIRALITY>  (243) 
Single Stereoisomer

>  <PRODRUG>  (243) 
N

>  <ORAL>  (243) 
Y

>  <PARENTERAL>  (243) 
N

>  <TOPICAL>  (243) 
N

>  <BLACK_BOX>  (243) 
N

>  <AVAILABILITY_TYPE>  (243) 
Prescription-only

>  <WITHDRAWN_YEAR>  (243) 
nan

>  <WITHDRAWN_COUNTRY>  (243) 
nan

>  <WITHDRAWN_REASON>  (243) 
nan

>  <CANONICAL_SMILES>  (243) 
CN(C)CC[C@@H](c1ccc(Cl)cc1)c2ccccn2

>  <name>  (243) 
Dexchlorpheniramine 

>  <MW>  (243) 
274.795

>  <logP>  (243) 
3.8186

$$$$
CHEMBL1535
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
 22 23  2  0
 23 13  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (244) 
429737

>  <SYNONYMS>  (244) 
Hydroxychloroquine (BAN, INN); Hydroxychloroquine sulfate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (244) 
4

>  <RESEARCH_CODES>  (244) 
TCMDC-123987

>  <APPLICANTS>  (244) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (244) 
nan

>  <USAN_STEM_DEFINITION>  (244) 
nan

>  <USAN_STEM_SUBSTEM>  (244) 
nan

>  <USAN_YEAR>  (244) 
nan

>  <FIRST_APPROVAL>  (244) 
1955.0

>  <ATC_CODE>  (244) 
P01BA02

>  <ATC_CODE_DESCRIPTION>  (244) 
P01BA02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Aminoquinolines]

>  <INDICATION_CLASS>  (244) 
Antimalarial; Suppressant (lupus erythematosus)

>  <SC_PATENT_NO>  (244) 
nan

>  <DRUG_TYPE>  (244) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (244) 
Y

>  <FIRST_IN_CLASS>  (244) 
N

>  <CHIRALITY>  (244) 
Racemic Mixture

>  <PRODRUG>  (244) 
N

>  <ORAL>  (244) 
Y

>  <PARENTERAL>  (244) 
N

>  <TOPICAL>  (244) 
N

>  <BLACK_BOX>  (244) 
Y

>  <AVAILABILITY_TYPE>  (244) 
Prescription-only

>  <WITHDRAWN_YEAR>  (244) 
nan

>  <WITHDRAWN_COUNTRY>  (244) 
nan

>  <WITHDRAWN_REASON>  (244) 
nan

>  <CANONICAL_SMILES>  (244) 
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12

>  <name>  (244) 
Hydroxychloroquine 

>  <MW>  (244) 
335.879

>  <logP>  (244) 
3.783

$$$$
CHEMBL970
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
 23 24  2  0
 24  6  1  0
 17 12  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (245) 
95970

>  <SYNONYMS>  (245) 
Halazepam (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (245) 
4

>  <RESEARCH_CODES>  (245) 
SCH-12041

>  <APPLICANTS>  (245) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (245) 
-azepam

>  <USAN_STEM_DEFINITION>  (245) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (245) 
-azepam

>  <USAN_YEAR>  (245) 
1972.0

>  <FIRST_APPROVAL>  (245) 
1981.0

>  <ATC_CODE>  (245) 
N05BA13

>  <ATC_CODE_DESCRIPTION>  (245) 
N05BA13 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (245) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (245) 
nan

>  <DRUG_TYPE>  (245) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (245) 
Y

>  <FIRST_IN_CLASS>  (245) 
N

>  <CHIRALITY>  (245) 
Achiral Molecule

>  <PRODRUG>  (245) 
N

>  <ORAL>  (245) 
Y

>  <PARENTERAL>  (245) 
N

>  <TOPICAL>  (245) 
N

>  <BLACK_BOX>  (245) 
N

>  <AVAILABILITY_TYPE>  (245) 
Discontinued

>  <WITHDRAWN_YEAR>  (245) 
nan

>  <WITHDRAWN_COUNTRY>  (245) 
nan

>  <WITHDRAWN_REASON>  (245) 
nan

>  <CANONICAL_SMILES>  (245) 
FC(F)(F)CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13

>  <name>  (245) 
Halazepam 

>  <MW>  (245) 
352.743

>  <logP>  (245) 
4.0863

$$$$
CHEMBL866
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 14  3  1  0
 11  6  2  0
M  END
>  <PARENT_MOLREGNO>  (246) 
68396

>  <SYNONYMS>  (246) 
Mycophenolic acid (BAN, FDA, INN, USAN); Mycophenolate Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (246) 
4

>  <RESEARCH_CODES>  (246) 
68618; RS-61443 [as mofetil]; ERL-080

>  <APPLICANTS>  (246) 
Novartis Pharmaceuticals Corp; Novartis Pharma

>  <USAN_STEM>  (246) 
nan

>  <USAN_STEM_DEFINITION>  (246) 
nan

>  <USAN_STEM_SUBSTEM>  (246) 
nan

>  <USAN_YEAR>  (246) 
1970.0

>  <FIRST_APPROVAL>  (246) 
2004.0

>  <ATC_CODE>  (246) 
L04AA06

>  <ATC_CODE_DESCRIPTION>  (246) 
L04AA06 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants]

>  <INDICATION_CLASS>  (246) 
Antineoplastic

>  <SC_PATENT_NO>  (246) 
US-6025391-A

>  <DRUG_TYPE>  (246) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (246) 
Y

>  <FIRST_IN_CLASS>  (246) 
N

>  <CHIRALITY>  (246) 
Achiral Molecule

>  <PRODRUG>  (246) 
N

>  <ORAL>  (246) 
Y

>  <PARENTERAL>  (246) 
N

>  <TOPICAL>  (246) 
N

>  <BLACK_BOX>  (246) 
Y

>  <AVAILABILITY_TYPE>  (246) 
Prescription-only

>  <WITHDRAWN_YEAR>  (246) 
nan

>  <WITHDRAWN_COUNTRY>  (246) 
nan

>  <WITHDRAWN_REASON>  (246) 
nan

>  <CANONICAL_SMILES>  (246) 
COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O

>  <name>  (246) 
Mycophenolic acid 

>  <MW>  (246) 
320.341

>  <logP>  (246) 
2.73322

$$$$
CHEMBL282052
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 12  2  1  0
  9  4  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (247) 
22572

>  <SYNONYMS>  (247) 
Methaqualone (BAN, INN, USAN, USP); Methaqualone HCl (MI, USP)

>  <DEVELOPMENT_PHASE>  (247) 
4

>  <RESEARCH_CODES>  (247) 
CI-705; CN-38703; QZ-2; R-148; TR-495

>  <APPLICANTS>  (247) 
Wallace; Parke-Davis

>  <USAN_STEM>  (247) 
nan

>  <USAN_STEM_DEFINITION>  (247) 
nan

>  <USAN_STEM_SUBSTEM>  (247) 
nan

>  <USAN_YEAR>  (247) 
1962.0

>  <FIRST_APPROVAL>  (247) 
nan

>  <ATC_CODE>  (247) 
N05CX02; N05CM01

>  <ATC_CODE_DESCRIPTION>  (247) 
N05CX02 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Hypnotics and sedatives in combination, excl. barbiturates]; N05CM01 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]

>  <INDICATION_CLASS>  (247) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (247) 
nan

>  <DRUG_TYPE>  (247) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (247) 
Y

>  <FIRST_IN_CLASS>  (247) 
N

>  <CHIRALITY>  (247) 
Achiral Molecule

>  <PRODRUG>  (247) 
N

>  <ORAL>  (247) 
N

>  <PARENTERAL>  (247) 
N

>  <TOPICAL>  (247) 
N

>  <BLACK_BOX>  (247) 
N

>  <AVAILABILITY_TYPE>  (247) 
Withdrawn

>  <WITHDRAWN_YEAR>  (247) 
1984.0

>  <WITHDRAWN_COUNTRY>  (247) 
United States; United States

>  <WITHDRAWN_REASON>  (247) 
Overdose; Overdose

>  <CANONICAL_SMILES>  (247) 
CC1=Nc2ccccc2C(=O)N1c3ccccc3C

>  <name>  (247) 
Methaqualone 

>  <MW>  (247) 
250.301

>  <logP>  (247) 
3.00254

$$$$
CHEMBL895
     RDKit          

 26 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 17 26  1  0
 16  2  1  0
 17  5  1  0
 20  7  1  0
 26  9  1  0
 26 14  2  0
 25 22  1  0
M  END
>  <PARENT_MOLREGNO>  (248) 
77207

>  <SYNONYMS>  (248) 
Nalbuphine (BAN, INN); Nalbuphine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (248) 
4

>  <RESEARCH_CODES>  (248) 
EN-2234A

>  <APPLICANTS>  (248) 
Endo Pharmaceuticals Inc; Abbvie Inc

>  <USAN_STEM>  (248) 
nal-

>  <USAN_STEM_DEFINITION>  (248) 
narcotic agonists/antagonists (normorphine type)

>  <USAN_STEM_SUBSTEM>  (248) 
nal-

>  <USAN_YEAR>  (248) 
1968.0

>  <FIRST_APPROVAL>  (248) 
1979.0

>  <ATC_CODE>  (248) 
N02AF02

>  <ATC_CODE_DESCRIPTION>  (248) 
N02AF02 [Nervous System:Analgesics:Opioids:Morphinan derivatives]

>  <INDICATION_CLASS>  (248) 
Analgesic; Antagonist (to narcotics)

>  <SC_PATENT_NO>  (248) 
nan

>  <DRUG_TYPE>  (248) 
Natural Product-derived

>  <RULE_OF_FIVE>  (248) 
Y

>  <FIRST_IN_CLASS>  (248) 
N

>  <CHIRALITY>  (248) 
Single Stereoisomer

>  <PRODRUG>  (248) 
N

>  <ORAL>  (248) 
N

>  <PARENTERAL>  (248) 
Y

>  <TOPICAL>  (248) 
N

>  <BLACK_BOX>  (248) 
Y

>  <AVAILABILITY_TYPE>  (248) 
Prescription-only

>  <WITHDRAWN_YEAR>  (248) 
nan

>  <WITHDRAWN_COUNTRY>  (248) 
nan

>  <WITHDRAWN_REASON>  (248) 
nan

>  <CANONICAL_SMILES>  (248) 
O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c45

>  <name>  (248) 
Nalbuphine 

>  <MW>  (248) 
357.45

>  <logP>  (248) 
1.7073

$$$$
CHEMBL768
     RDKit          

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 10 20  1  0
 20 21  2  0
 21  7  1  0
M  END
>  <PARENT_MOLREGNO>  (249) 
43354

>  <SYNONYMS>  (249) 
Esmolol (BAN, INN); Esmolol HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (249) 
4

>  <RESEARCH_CODES>  (249) 
ASL-8052

>  <APPLICANTS>  (249) 
Baxter Healthcare Corp

>  <USAN_STEM>  (249) 
-olol

>  <USAN_STEM_DEFINITION>  (249) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (249) 
-olol

>  <USAN_YEAR>  (249) 
1983.0

>  <FIRST_APPROVAL>  (249) 
1986.0

>  <ATC_CODE>  (249) 
C07AB09

>  <ATC_CODE_DESCRIPTION>  (249) 
C07AB09 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]

>  <INDICATION_CLASS>  (249) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (249) 
US-6310094-B1

>  <DRUG_TYPE>  (249) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (249) 
Y

>  <FIRST_IN_CLASS>  (249) 
N

>  <CHIRALITY>  (249) 
Racemic Mixture

>  <PRODRUG>  (249) 
N

>  <ORAL>  (249) 
N

>  <PARENTERAL>  (249) 
Y

>  <TOPICAL>  (249) 
N

>  <BLACK_BOX>  (249) 
Y

>  <AVAILABILITY_TYPE>  (249) 
Prescription-only

>  <WITHDRAWN_YEAR>  (249) 
2007.0

>  <WITHDRAWN_COUNTRY>  (249) 
United States

>  <WITHDRAWN_REASON>  (249) 
Increased risk of medication errors resulting in serious adverse events, including deaths

>  <CANONICAL_SMILES>  (249) 
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1

>  <name>  (249) 
Esmolol 

>  <MW>  (249) 
295.379

>  <logP>  (249) 
1.5299

$$$$
CHEMBL1963683
     RDKit          

 32 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 19 13  1  0
 32 27  1  0
M  END
>  <PARENT_MOLREGNO>  (250) 
1285394

>  <SYNONYMS>  (250) 
Tafluprost (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (250) 
4

>  <RESEARCH_CODES>  (250) 
AFP-168; MK-2452

>  <APPLICANTS>  (250) 
Merck Sharp And Dohme Corp

>  <USAN_STEM>  (250) 
-prost

>  <USAN_STEM_DEFINITION>  (250) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (250) 
-prost

>  <USAN_YEAR>  (250) 
2010.0

>  <FIRST_APPROVAL>  (250) 
2012.0

>  <ATC_CODE>  (250) 
S01EE05

>  <ATC_CODE_DESCRIPTION>  (250) 
S01EE05 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Prostaglandin analogues1)]

>  <INDICATION_CLASS>  (250) 
nan

>  <SC_PATENT_NO>  (250) 
US-5886035-A

>  <DRUG_TYPE>  (250) 
Natural Product-derived

>  <RULE_OF_FIVE>  (250) 
Y

>  <FIRST_IN_CLASS>  (250) 
N

>  <CHIRALITY>  (250) 
Single Stereoisomer

>  <PRODRUG>  (250) 
Y

>  <ORAL>  (250) 
N

>  <PARENTERAL>  (250) 
N

>  <TOPICAL>  (250) 
Y

>  <BLACK_BOX>  (250) 
N

>  <AVAILABILITY_TYPE>  (250) 
Prescription-only

>  <WITHDRAWN_YEAR>  (250) 
nan

>  <WITHDRAWN_COUNTRY>  (250) 
nan

>  <WITHDRAWN_REASON>  (250) 
nan

>  <CANONICAL_SMILES>  (250) 
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COc2ccccc2

>  <name>  (250) 
Tafluprost 

>  <MW>  (250) 
452.538

>  <logP>  (250) 
4.683

$$$$
CHEMBL1753
     RDKit          

 27 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  6 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
  9  4  1  0
 26 17  1  0
M  END
>  <PARENT_MOLREGNO>  (251) 
581843

>  <SYNONYMS>  (251) 
Clindamycin (BAN, INN, USAN); Clindamycin HCl (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (251) 
4

>  <RESEARCH_CODES>  (251) 
U-21251; U-25179E

>  <APPLICANTS>  (251) 
Pharmacia And Upjohn Co; Pharmacia & Upjohn

>  <USAN_STEM>  (251) 
-mycin

>  <USAN_STEM_DEFINITION>  (251) 
antibiotics (Streptomyces strains)

>  <USAN_STEM_SUBSTEM>  (251) 
-mycin

>  <USAN_YEAR>  (251) 
1968.0

>  <FIRST_APPROVAL>  (251) 
1970.0

>  <ATC_CODE>  (251) 
D10AF01; G01AA10; J01FF01; D10AF51

>  <ATC_CODE_DESCRIPTION>  (251) 
D10AF01 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Antiinfectives for treatment of acne]; G01AA10 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Antibiotics]; J01FF01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Macrolides, Lincosamides And Streptogramins:Lincosamides]; D10AF51 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Antiinfectives for treatment of acne]

>  <INDICATION_CLASS>  (251) 
Antibacterial

>  <SC_PATENT_NO>  (251) 
nan

>  <DRUG_TYPE>  (251) 
Natural Product-derived

>  <RULE_OF_FIVE>  (251) 
Y

>  <FIRST_IN_CLASS>  (251) 
N

>  <CHIRALITY>  (251) 
Single Stereoisomer

>  <PRODRUG>  (251) 
N

>  <ORAL>  (251) 
Y

>  <PARENTERAL>  (251) 
N

>  <TOPICAL>  (251) 
N

>  <BLACK_BOX>  (251) 
Y

>  <AVAILABILITY_TYPE>  (251) 
Prescription-only

>  <WITHDRAWN_YEAR>  (251) 
nan

>  <WITHDRAWN_COUNTRY>  (251) 
nan

>  <WITHDRAWN_REASON>  (251) 
nan

>  <CANONICAL_SMILES>  (251) 
CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O

>  <name>  (251) 
Clindamycin 

>  <MW>  (251) 
424.991

>  <logP>  (251) 
0.3895

$$$$
CHEMBL193240
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 10  5  1  0
 15 13  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (252) 
321696

>  <SYNONYMS>  (252) 
Roflumilast (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (252) 
4

>  <RESEARCH_CODES>  (252) 
B9302-107; BY-217; BYK-20869

>  <APPLICANTS>  (252) 
Forest Research Institute Inc

>  <USAN_STEM>  (252) 
-ast

>  <USAN_STEM_DEFINITION>  (252) 
antiasthmatics/antiallergics: type IV phosphodiesterase inbibitors

>  <USAN_STEM_SUBSTEM>  (252) 
-ast (-milast)

>  <USAN_YEAR>  (252) 
2002.0

>  <FIRST_APPROVAL>  (252) 
2011.0

>  <ATC_CODE>  (252) 
R03DX07

>  <ATC_CODE_DESCRIPTION>  (252) 
R03DX07 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Other systemic drugs for obstructive airway diseases]

>  <INDICATION_CLASS>  (252) 
nan

>  <SC_PATENT_NO>  (252) 
US-5712298-A

>  <DRUG_TYPE>  (252) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (252) 
Y

>  <FIRST_IN_CLASS>  (252) 
N

>  <CHIRALITY>  (252) 
Achiral Molecule

>  <PRODRUG>  (252) 
N

>  <ORAL>  (252) 
Y

>  <PARENTERAL>  (252) 
N

>  <TOPICAL>  (252) 
N

>  <BLACK_BOX>  (252) 
N

>  <AVAILABILITY_TYPE>  (252) 
Prescription-only

>  <WITHDRAWN_YEAR>  (252) 
nan

>  <WITHDRAWN_COUNTRY>  (252) 
nan

>  <WITHDRAWN_REASON>  (252) 
nan

>  <CANONICAL_SMILES>  (252) 
FC(F)Oc1ccc(cc1OCC2CC2)C(=O)Nc3c(Cl)cncc3Cl

>  <name>  (252) 
Roflumilast 

>  <MW>  (252) 
403.212

>  <logP>  (252) 
5.0309

$$$$
CHEMBL560
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  3
 19 20  1  0
 19 21  1  0
 12  2  1  0
 16  3  1  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (253) 
16117

>  <SYNONYMS>  (253) 
Pentazocine (BAN, INN, JAN, USAN, USP); Pentazocine HCl (FDA, USAN, USP); Pentazocine lactate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (253) 
4

>  <RESEARCH_CODES>  (253) 
WIN-20228

>  <APPLICANTS>  (253) 
Sterling Winthrop; Sanofi Aventis Us Llc; Hospira Inc

>  <USAN_STEM>  (253) 
-azocine

>  <USAN_STEM_DEFINITION>  (253) 
narcotic antagonists/agonists (6,7-benzomorphan derivatives)

>  <USAN_STEM_SUBSTEM>  (253) 
-azocine

>  <USAN_YEAR>  (253) 
1963.0

>  <FIRST_APPROVAL>  (253) 
1967.0

>  <ATC_CODE>  (253) 
N02AD01

>  <ATC_CODE_DESCRIPTION>  (253) 
N02AD01 [Nervous System:Analgesics:Opioids:Benzomorphan derivatives]

>  <INDICATION_CLASS>  (253) 
Analgesic

>  <SC_PATENT_NO>  (253) 
nan

>  <DRUG_TYPE>  (253) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (253) 
Y

>  <FIRST_IN_CLASS>  (253) 
N

>  <CHIRALITY>  (253) 
Single Stereoisomer

>  <PRODRUG>  (253) 
N

>  <ORAL>  (253) 
Y

>  <PARENTERAL>  (253) 
Y

>  <TOPICAL>  (253) 
N

>  <BLACK_BOX>  (253) 
N

>  <AVAILABILITY_TYPE>  (253) 
Prescription-only

>  <WITHDRAWN_YEAR>  (253) 
nan

>  <WITHDRAWN_COUNTRY>  (253) 
nan

>  <WITHDRAWN_REASON>  (253) 
nan

>  <CANONICAL_SMILES>  (253) 
C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CC=C(C)C

>  <name>  (253) 
Pentazocine 

>  <MW>  (253) 
285.431

>  <logP>  (253) 
3.8826

$$$$
CHEMBL92963
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  4  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 16  4  1  0
M  END
>  <PARENT_MOLREGNO>  (254) 
150999

>  <SYNONYMS>  (254) 
Narcobarbital

>  <DEVELOPMENT_PHASE>  (254) 
4

>  <RESEARCH_CODES>  (254) 
nan

>  <APPLICANTS>  (254) 
nan

>  <USAN_STEM>  (254) 
-barb-

>  <USAN_STEM_DEFINITION>  (254) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (254) 
-barb-

>  <USAN_YEAR>  (254) 
nan

>  <FIRST_APPROVAL>  (254) 
nan

>  <ATC_CODE>  (254) 
N01AG01

>  <ATC_CODE_DESCRIPTION>  (254) 
N01AG01 [Nervous System:Anesthetics:Anesthetics, General:Barbiturates in combination with other drugs]

>  <INDICATION_CLASS>  (254) 
nan

>  <SC_PATENT_NO>  (254) 
nan

>  <DRUG_TYPE>  (254) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (254) 
Y

>  <FIRST_IN_CLASS>  (254) 
N

>  <CHIRALITY>  (254) 
Racemic Mixture

>  <PRODRUG>  (254) 
N

>  <ORAL>  (254) 
N

>  <PARENTERAL>  (254) 
N

>  <TOPICAL>  (254) 
N

>  <BLACK_BOX>  (254) 
N

>  <AVAILABILITY_TYPE>  (254) 
Unknown

>  <WITHDRAWN_YEAR>  (254) 
nan

>  <WITHDRAWN_COUNTRY>  (254) 
nan

>  <WITHDRAWN_REASON>  (254) 
nan

>  <CANONICAL_SMILES>  (254) 
CC(C)C1(CC(=C)Br)C(=O)NC(=O)N(C)C1=O

>  <name>  (254) 
Narcobarbital

>  <MW>  (254) 
303.156

>  <logP>  (254) 
1.6357

$$$$
CHEMBL1069
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
  7 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 26 30  1  0
 30 31  2  0
 30 32  1  0
 14  9  1  0
 20 15  1  0
 25 21  1  0
M  END
>  <PARENT_MOLREGNO>  (255) 
139045

>  <SYNONYMS>  (255) 
Valsartan (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (255) 
4

>  <RESEARCH_CODES>  (255) 
CGP-48933

>  <APPLICANTS>  (255) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (255) 
-sartan

>  <USAN_STEM_DEFINITION>  (255) 
angiotensin II receptor antagonists

>  <USAN_STEM_SUBSTEM>  (255) 
-sartan

>  <USAN_YEAR>  (255) 
1995.0

>  <FIRST_APPROVAL>  (255) 
1996.0

>  <ATC_CODE>  (255) 
C09CA03

>  <ATC_CODE_DESCRIPTION>  (255) 
C09CA03 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Angiotensin Ii Antagonists, Plain:Angiotensin II antagonists, plain]

>  <INDICATION_CLASS>  (255) 
Antihypertensive

>  <SC_PATENT_NO>  (255) 
US-5559111-A

>  <DRUG_TYPE>  (255) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (255) 
Y

>  <FIRST_IN_CLASS>  (255) 
N

>  <CHIRALITY>  (255) 
Single Stereoisomer

>  <PRODRUG>  (255) 
N

>  <ORAL>  (255) 
Y

>  <PARENTERAL>  (255) 
N

>  <TOPICAL>  (255) 
N

>  <BLACK_BOX>  (255) 
Y

>  <AVAILABILITY_TYPE>  (255) 
Prescription-only

>  <WITHDRAWN_YEAR>  (255) 
nan

>  <WITHDRAWN_COUNTRY>  (255) 
nan

>  <WITHDRAWN_REASON>  (255) 
nan

>  <CANONICAL_SMILES>  (255) 
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3nnn[nH]3)[C@@H](C(C)C)C(=O)O

>  <name>  (255) 
Valsartan 

>  <MW>  (255) 
435.528

>  <logP>  (255) 
4.1617

$$$$
CHEMBL1200386
     RDKit          

 35 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
  7 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
 26  7  1  0
 26 10  1  0
 22 11  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (256) 
674337

>  <SYNONYMS>  (256) 
Prednicarbate (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (256) 
4

>  <RESEARCH_CODES>  (256) 
HOE-777; S-770777; S-77 0777

>  <APPLICANTS>  (256) 
Valeant International Bermuda

>  <USAN_STEM>  (256) 
pred-

>  <USAN_STEM_DEFINITION>  (256) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (256) 
pred-

>  <USAN_YEAR>  (256) 
1983.0

>  <FIRST_APPROVAL>  (256) 
1991.0

>  <ATC_CODE>  (256) 
D07AC18

>  <ATC_CODE_DESCRIPTION>  (256) 
D07AC18 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]

>  <INDICATION_CLASS>  (256) 
Glucocorticoid

>  <SC_PATENT_NO>  (256) 
nan

>  <DRUG_TYPE>  (256) 
Natural Product-derived

>  <RULE_OF_FIVE>  (256) 
Y

>  <FIRST_IN_CLASS>  (256) 
N

>  <CHIRALITY>  (256) 
Single Stereoisomer

>  <PRODRUG>  (256) 
Y

>  <ORAL>  (256) 
N

>  <PARENTERAL>  (256) 
N

>  <TOPICAL>  (256) 
Y

>  <BLACK_BOX>  (256) 
N

>  <AVAILABILITY_TYPE>  (256) 
Prescription-only

>  <WITHDRAWN_YEAR>  (256) 
nan

>  <WITHDRAWN_COUNTRY>  (256) 
nan

>  <WITHDRAWN_REASON>  (256) 
nan

>  <CANONICAL_SMILES>  (256) 
CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC

>  <name>  (256) 
Prednicarbate 

>  <MW>  (256) 
488.577

>  <logP>  (256) 
3.6993

$$$$
CHEMBL514800
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
 12 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 25 30  2  0
 30 31  1  0
 31 32  2  0
  9  4  1  0
 31 18  1  0
 30 21  1  0
M  END
>  <PARENT_MOLREGNO>  (257) 
458773

>  <SYNONYMS>  (257) 
Apremilast (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (257) 
4

>  <RESEARCH_CODES>  (257) 
CC-10004

>  <APPLICANTS>  (257) 
Celgene Corp

>  <USAN_STEM>  (257) 
-ast

>  <USAN_STEM_DEFINITION>  (257) 
antiasthmatics/antiallergics: type IV phosphodiesterase inbibitors

>  <USAN_STEM_SUBSTEM>  (257) 
-ast (-milast)

>  <USAN_YEAR>  (257) 
2005.0

>  <FIRST_APPROVAL>  (257) 
2014.0

>  <ATC_CODE>  (257) 
L04AA32

>  <ATC_CODE_DESCRIPTION>  (257) 
L04AA32 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants]

>  <INDICATION_CLASS>  (257) 
nan

>  <SC_PATENT_NO>  (257) 
US-6020358-A

>  <DRUG_TYPE>  (257) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (257) 
Y

>  <FIRST_IN_CLASS>  (257) 
N

>  <CHIRALITY>  (257) 
Single Stereoisomer

>  <PRODRUG>  (257) 
N

>  <ORAL>  (257) 
Y

>  <PARENTERAL>  (257) 
N

>  <TOPICAL>  (257) 
N

>  <BLACK_BOX>  (257) 
N

>  <AVAILABILITY_TYPE>  (257) 
Prescription-only

>  <WITHDRAWN_YEAR>  (257) 
nan

>  <WITHDRAWN_COUNTRY>  (257) 
nan

>  <WITHDRAWN_REASON>  (257) 
nan

>  <CANONICAL_SMILES>  (257) 
CCOc1cc(ccc1OC)[C@@H](CS(=O)(=O)C)N2C(=O)c3cccc(NC(=O)C)c3C2=O

>  <name>  (257) 
Apremilast 

>  <MW>  (257) 
460.508

>  <logP>  (257) 
2.4342

$$$$
CHEMBL567597
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 17  2  1  0
 18  5  1  0
 18 11  1  0
 20 13  1  0
M  END
>  <PARENT_MOLREGNO>  (258) 
575613

>  <SYNONYMS>  (258) 
Artemisinin (INN, MI)

>  <DEVELOPMENT_PHASE>  (258) 
4

>  <RESEARCH_CODES>  (258) 
GNF-Pf-5341

>  <APPLICANTS>  (258) 
nan

>  <USAN_STEM>  (258) 
arte-

>  <USAN_STEM_DEFINITION>  (258) 
antimalarials (artemisin dervatives)

>  <USAN_STEM_SUBSTEM>  (258) 
arte-

>  <USAN_YEAR>  (258) 
nan

>  <FIRST_APPROVAL>  (258) 
nan

>  <ATC_CODE>  (258) 
P01BE01

>  <ATC_CODE_DESCRIPTION>  (258) 
P01BE01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Artemisinin and derivatives, plain]

>  <INDICATION_CLASS>  (258) 
nan

>  <SC_PATENT_NO>  (258) 
nan

>  <DRUG_TYPE>  (258) 
Natural Product-derived

>  <RULE_OF_FIVE>  (258) 
Y

>  <FIRST_IN_CLASS>  (258) 
Y

>  <CHIRALITY>  (258) 
Single Stereoisomer

>  <PRODRUG>  (258) 
Y

>  <ORAL>  (258) 
Y

>  <PARENTERAL>  (258) 
N

>  <TOPICAL>  (258) 
N

>  <BLACK_BOX>  (258) 
N

>  <AVAILABILITY_TYPE>  (258) 
Discontinued

>  <WITHDRAWN_YEAR>  (258) 
nan

>  <WITHDRAWN_COUNTRY>  (258) 
nan

>  <WITHDRAWN_REASON>  (258) 
nan

>  <CANONICAL_SMILES>  (258) 
C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4

>  <name>  (258) 
Artemisinin 

>  <MW>  (258) 
282.336

>  <logP>  (258) 
2.3949

$$$$
CHEMBL1214
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 10 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  6 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 23  2  1  0
 22  5  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (259) 
218758

>  <SYNONYMS>  (259) 
Carbenicillin (BAN, INN); Carbenicillin Disodium (FDA, USAN, USP); Carbenicillin Sodium (JAN); Carbenicillin Potassium (USAN)

>  <DEVELOPMENT_PHASE>  (259) 
4

>  <RESEARCH_CODES>  (259) 
BRL-2064; CP-15-639-2; GS-3159

>  <APPLICANTS>  (259) 
Roerig Div Pfizer Inc; GlaxoSmithKline

>  <USAN_STEM>  (259) 
-cillin

>  <USAN_STEM_DEFINITION>  (259) 
penicillins

>  <USAN_STEM_SUBSTEM>  (259) 
-cillin

>  <USAN_YEAR>  (259) 
1968.0

>  <FIRST_APPROVAL>  (259) 
1982.0

>  <ATC_CODE>  (259) 
J01CA03

>  <ATC_CODE_DESCRIPTION>  (259) 
J01CA03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (259) 
Antibacterial

>  <SC_PATENT_NO>  (259) 
nan

>  <DRUG_TYPE>  (259) 
Natural Product-derived

>  <RULE_OF_FIVE>  (259) 
Y

>  <FIRST_IN_CLASS>  (259) 
N

>  <CHIRALITY>  (259) 
Racemic Mixture

>  <PRODRUG>  (259) 
N

>  <ORAL>  (259) 
N

>  <PARENTERAL>  (259) 
Y

>  <TOPICAL>  (259) 
N

>  <BLACK_BOX>  (259) 
N

>  <AVAILABILITY_TYPE>  (259) 
Discontinued

>  <WITHDRAWN_YEAR>  (259) 
nan

>  <WITHDRAWN_COUNTRY>  (259) 
nan

>  <WITHDRAWN_REASON>  (259) 
nan

>  <CANONICAL_SMILES>  (259) 
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O

>  <name>  (259) 
Carbenicillin 

>  <MW>  (259) 
378.406

>  <logP>  (259) 
0.4865

$$$$
CHEMBL431
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 22 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 14  9  1  0
 24 20  1  0
 31 22  1  0
M  END
>  <PARENT_MOLREGNO>  (260) 
1967

>  <SYNONYMS>  (260) 
Spirapril (BAN, INN); Spirapril HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (260) 
4

>  <RESEARCH_CODES>  (260) 
SCH-33844

>  <APPLICANTS>  (260) 
Schering Corp

>  <USAN_STEM>  (260) 
-pril

>  <USAN_STEM_DEFINITION>  (260) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (260) 
-pril

>  <USAN_YEAR>  (260) 
1987.0

>  <FIRST_APPROVAL>  (260) 
1994.0

>  <ATC_CODE>  (260) 
C09AA11

>  <ATC_CODE_DESCRIPTION>  (260) 
C09AA11 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (260) 
Enzyme Inhibitor (angiotensin-converting)

>  <SC_PATENT_NO>  (260) 
nan

>  <DRUG_TYPE>  (260) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (260) 
Y

>  <FIRST_IN_CLASS>  (260) 
N

>  <CHIRALITY>  (260) 
Single Stereoisomer

>  <PRODRUG>  (260) 
Y

>  <ORAL>  (260) 
Y

>  <PARENTERAL>  (260) 
N

>  <TOPICAL>  (260) 
N

>  <BLACK_BOX>  (260) 
N

>  <AVAILABILITY_TYPE>  (260) 
Discontinued

>  <WITHDRAWN_YEAR>  (260) 
nan

>  <WITHDRAWN_COUNTRY>  (260) 
nan

>  <WITHDRAWN_REASON>  (260) 
nan

>  <CANONICAL_SMILES>  (260) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3

>  <name>  (260) 
Spirapril 

>  <MW>  (260) 
466.625

>  <logP>  (260) 
2.3908

$$$$
CHEMBL607400
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
  6 13  1  0
 13 14  2  0
 13 15  1  0
 15  4  1  0
M  END
>  <PARENT_MOLREGNO>  (261) 
609761

>  <SYNONYMS>  (261) 
Brivaracetam (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (261) 
4

>  <RESEARCH_CODES>  (261) 
UCB-34714

>  <APPLICANTS>  (261) 
Ucb Inc; Ubc Inc

>  <USAN_STEM>  (261) 
-racetam

>  <USAN_STEM_DEFINITION>  (261) 
nootropes (piracetam type)

>  <USAN_STEM_SUBSTEM>  (261) 
-racetam

>  <USAN_YEAR>  (261) 
2005.0

>  <FIRST_APPROVAL>  (261) 
2016.0

>  <ATC_CODE>  (261) 
N03AX23

>  <ATC_CODE_DESCRIPTION>  (261) 
N03AX23 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (261) 
nan

>  <SC_PATENT_NO>  (261) 
US-6784197-B2

>  <DRUG_TYPE>  (261) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (261) 
Y

>  <FIRST_IN_CLASS>  (261) 
N

>  <CHIRALITY>  (261) 
Single Stereoisomer

>  <PRODRUG>  (261) 
N

>  <ORAL>  (261) 
Y

>  <PARENTERAL>  (261) 
Y

>  <TOPICAL>  (261) 
N

>  <BLACK_BOX>  (261) 
N

>  <AVAILABILITY_TYPE>  (261) 
Prescription-only

>  <WITHDRAWN_YEAR>  (261) 
nan

>  <WITHDRAWN_COUNTRY>  (261) 
nan

>  <WITHDRAWN_REASON>  (261) 
nan

>  <CANONICAL_SMILES>  (261) 
CCC[C@H]1CN([C@@H](CC)C(=O)N)C(=O)C1

>  <name>  (261) 
Brivaracetam 

>  <MW>  (261) 
212.293

>  <logP>  (261) 
0.8989

$$$$
CHEMBL1301
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
  7 20  1  0
 20 21  2  0
 21  4  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (262) 
257016

>  <SYNONYMS>  (262) 
Hydroxystilbamidine (BAN, INN); Hydroxystilbamidine Isethionate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (262) 
4

>  <RESEARCH_CODES>  (262) 
nan

>  <APPLICANTS>  (262) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (262) 
-(ur)amidine

>  <USAN_STEM_DEFINITION>  (262) 
pentamidine derivatives/analogues

>  <USAN_STEM_SUBSTEM>  (262) 
-(ur)amidine

>  <USAN_YEAR>  (262) 
nan

>  <FIRST_APPROVAL>  (262) 
1953.0

>  <ATC_CODE>  (262) 
nan

>  <ATC_CODE_DESCRIPTION>  (262) 
nan

>  <INDICATION_CLASS>  (262) 
nan

>  <SC_PATENT_NO>  (262) 
nan

>  <DRUG_TYPE>  (262) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (262) 
Y

>  <FIRST_IN_CLASS>  (262) 
N

>  <CHIRALITY>  (262) 
Achiral Molecule

>  <PRODRUG>  (262) 
N

>  <ORAL>  (262) 
N

>  <PARENTERAL>  (262) 
Y

>  <TOPICAL>  (262) 
N

>  <BLACK_BOX>  (262) 
N

>  <AVAILABILITY_TYPE>  (262) 
Discontinued

>  <WITHDRAWN_YEAR>  (262) 
nan

>  <WITHDRAWN_COUNTRY>  (262) 
nan

>  <WITHDRAWN_REASON>  (262) 
nan

>  <CANONICAL_SMILES>  (262) 
NC(=N)c1ccc(\C=C\c2ccc(cc2O)C(=N)N)cc1

>  <name>  (262) 
Hydroxystilbamidine 

>  <MW>  (262) 
280.331

>  <logP>  (262) 
2.13074

$$$$
CHEMBL1082
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  6 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 22  2  1  0
 21  5  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (263) 
143284

>  <SYNONYMS>  (263) 
Amoxicillin (BAN, FDA, INN, JAN, USAN, USP); Amoxicilline (INN); Amoxicillin Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (263) 
4

>  <RESEARCH_CODES>  (263) 
BRL-2333; BRL-2333AB-B

>  <APPLICANTS>  (263) 
Shionogi Inc; GlaxoSmithKline; Gastroentero Logic Llc; Dr Reddys Laboratories Inc; Takeda Pharmaceuticals Usa Inc

>  <USAN_STEM>  (263) 
-cillin

>  <USAN_STEM_DEFINITION>  (263) 
penicillins

>  <USAN_STEM_SUBSTEM>  (263) 
-cillin

>  <USAN_YEAR>  (263) 
1972.0

>  <FIRST_APPROVAL>  (263) 
1974.0

>  <ATC_CODE>  (263) 
J01CA04

>  <ATC_CODE_DESCRIPTION>  (263) 
J01CA04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (263) 
Antibacterial

>  <SC_PATENT_NO>  (263) 
US-6544555-B2

>  <DRUG_TYPE>  (263) 
Natural Product-derived

>  <RULE_OF_FIVE>  (263) 
Y

>  <FIRST_IN_CLASS>  (263) 
N

>  <CHIRALITY>  (263) 
Single Stereoisomer

>  <PRODRUG>  (263) 
N

>  <ORAL>  (263) 
Y

>  <PARENTERAL>  (263) 
N

>  <TOPICAL>  (263) 
N

>  <BLACK_BOX>  (263) 
N

>  <AVAILABILITY_TYPE>  (263) 
Prescription-only

>  <WITHDRAWN_YEAR>  (263) 
nan

>  <WITHDRAWN_COUNTRY>  (263) 
nan

>  <WITHDRAWN_REASON>  (263) 
nan

>  <CANONICAL_SMILES>  (263) 
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O

>  <name>  (263) 
Amoxicillin 

>  <MW>  (263) 
365.411

>  <logP>  (263) 
0.0237

$$$$
CHEMBL1200391
     RDKit          

  8  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  1  0
  2  7  1  0
  7  8  1  0
M  END
>  <PARENT_MOLREGNO>  (264) 
674342

>  <SYNONYMS>  (264) 
Trometamol (BAN, INN); Tromethamine (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (264) 
4

>  <RESEARCH_CODES>  (264) 
nan

>  <APPLICANTS>  (264) 
Hospira Inc

>  <USAN_STEM>  (264) 
nan

>  <USAN_STEM_DEFINITION>  (264) 
nan

>  <USAN_STEM_SUBSTEM>  (264) 
nan

>  <USAN_YEAR>  (264) 
1962.0

>  <FIRST_APPROVAL>  (264) 
1965.0

>  <ATC_CODE>  (264) 
B05XX02; B05BB03

>  <ATC_CODE_DESCRIPTION>  (264) 
B05XX02 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:I.V. Solution Additives:Other i.v. solution additives]; B05BB03 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:I.V. Solutions:Solutions affecting the electrolyte balance]

>  <INDICATION_CLASS>  (264) 
Alkalizer

>  <SC_PATENT_NO>  (264) 
nan

>  <DRUG_TYPE>  (264) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (264) 
Y

>  <FIRST_IN_CLASS>  (264) 
N

>  <CHIRALITY>  (264) 
Achiral Molecule

>  <PRODRUG>  (264) 
N

>  <ORAL>  (264) 
N

>  <PARENTERAL>  (264) 
Y

>  <TOPICAL>  (264) 
N

>  <BLACK_BOX>  (264) 
N

>  <AVAILABILITY_TYPE>  (264) 
Prescription-only

>  <WITHDRAWN_YEAR>  (264) 
nan

>  <WITHDRAWN_COUNTRY>  (264) 
nan

>  <WITHDRAWN_REASON>  (264) 
nan

>  <CANONICAL_SMILES>  (264) 
NC(CO)(CO)CO

>  <name>  (264) 
Trometamol 

>  <MW>  (264) 
121.136

>  <logP>  (264) 
-2.3392

$$$$
CHEMBL1531
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
  8 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  3  0
 18  3  1  0
 21  3  1  0
 17  7  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (265) 
428747

>  <SYNONYMS>  (265) 
Etonogestrel (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (265) 
4

>  <RESEARCH_CODES>  (265) 
ORG-3236

>  <APPLICANTS>  (265) 
Organon Usa Inc

>  <USAN_STEM>  (265) 
-gest-

>  <USAN_STEM_DEFINITION>  (265) 
progestins

>  <USAN_STEM_SUBSTEM>  (265) 
-gest-

>  <USAN_YEAR>  (265) 
1993.0

>  <FIRST_APPROVAL>  (265) 
2001.0

>  <ATC_CODE>  (265) 
G03AC08

>  <ATC_CODE_DESCRIPTION>  (265) 
G03AC08 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Hormonal Contraceptives For Systemic Use:Progestogens]

>  <INDICATION_CLASS>  (265) 
Progestin

>  <SC_PATENT_NO>  (265) 
US-5989581-A

>  <DRUG_TYPE>  (265) 
Natural Product-derived

>  <RULE_OF_FIVE>  (265) 
Y

>  <FIRST_IN_CLASS>  (265) 
N

>  <CHIRALITY>  (265) 
Single Stereoisomer

>  <PRODRUG>  (265) 
N

>  <ORAL>  (265) 
N

>  <PARENTERAL>  (265) 
Y

>  <TOPICAL>  (265) 
Y

>  <BLACK_BOX>  (265) 
Y

>  <AVAILABILITY_TYPE>  (265) 
Prescription-only

>  <WITHDRAWN_YEAR>  (265) 
nan

>  <WITHDRAWN_COUNTRY>  (265) 
nan

>  <WITHDRAWN_REASON>  (265) 
nan

>  <CANONICAL_SMILES>  (265) 
CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

>  <name>  (265) 
Etonogestrel 

>  <MW>  (265) 
324.464

>  <logP>  (265) 
4.0487

$$$$
CHEMBL500
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 10  1  0
 18 14  2  0
M  END
>  <PARENT_MOLREGNO>  (266) 
8543

>  <SYNONYMS>  (266) 
Pindolol (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (266) 
4

>  <RESEARCH_CODES>  (266) 
LB-46

>  <APPLICANTS>  (266) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (266) 
-olol

>  <USAN_STEM_DEFINITION>  (266) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (266) 
-olol

>  <USAN_YEAR>  (266) 
1970.0

>  <FIRST_APPROVAL>  (266) 
1982.0

>  <ATC_CODE>  (266) 
C07AA03

>  <ATC_CODE_DESCRIPTION>  (266) 
C07AA03 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (266) 
Vasodilator

>  <SC_PATENT_NO>  (266) 
nan

>  <DRUG_TYPE>  (266) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (266) 
Y

>  <FIRST_IN_CLASS>  (266) 
N

>  <CHIRALITY>  (266) 
Racemic Mixture

>  <PRODRUG>  (266) 
N

>  <ORAL>  (266) 
Y

>  <PARENTERAL>  (266) 
N

>  <TOPICAL>  (266) 
N

>  <BLACK_BOX>  (266) 
N

>  <AVAILABILITY_TYPE>  (266) 
Prescription-only

>  <WITHDRAWN_YEAR>  (266) 
nan

>  <WITHDRAWN_COUNTRY>  (266) 
nan

>  <WITHDRAWN_REASON>  (266) 
nan

>  <CANONICAL_SMILES>  (266) 
CC(C)NCC(O)COc1cccc2[nH]ccc12

>  <name>  (266) 
Pindolol 

>  <MW>  (266) 
248.326

>  <logP>  (266) 
1.9056

$$$$
CHEMBL1200585
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23  2  1  0
 23  6  1  0
 20  7  1  0
 18 10  1  0
M  END
>  <PARENT_MOLREGNO>  (267) 
674536

>  <SYNONYMS>  (267) 
Oxymetholone (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (267) 
4

>  <RESEARCH_CODES>  (267) 
CI-406

>  <APPLICANTS>  (267) 
Meda Pharmaceuticals Inc

>  <USAN_STEM>  (267) 
-olone

>  <USAN_STEM_DEFINITION>  (267) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (267) 
-olone

>  <USAN_YEAR>  (267) 
1963.0

>  <FIRST_APPROVAL>  (267) 
1972.0

>  <ATC_CODE>  (267) 
A14AA05

>  <ATC_CODE_DESCRIPTION>  (267) 
A14AA05 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives]

>  <INDICATION_CLASS>  (267) 
Androgen

>  <SC_PATENT_NO>  (267) 
nan

>  <DRUG_TYPE>  (267) 
Natural Product-derived

>  <RULE_OF_FIVE>  (267) 
Y

>  <FIRST_IN_CLASS>  (267) 
N

>  <CHIRALITY>  (267) 
Single Stereoisomer

>  <PRODRUG>  (267) 
N

>  <ORAL>  (267) 
Y

>  <PARENTERAL>  (267) 
N

>  <TOPICAL>  (267) 
N

>  <BLACK_BOX>  (267) 
Y

>  <AVAILABILITY_TYPE>  (267) 
Prescription-only

>  <WITHDRAWN_YEAR>  (267) 
nan

>  <WITHDRAWN_COUNTRY>  (267) 
nan

>  <WITHDRAWN_REASON>  (267) 
nan

>  <CANONICAL_SMILES>  (267) 
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C(=C/O)\C[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (267) 
Oxymetholone 

>  <MW>  (267) 
332.484

>  <logP>  (267) 
4.401

$$$$
CHEMBL1021
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  9 18  2  0
 18 19  1  0
 18  5  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (268) 
119162

>  <SYNONYMS>  (268) 
Nepafenac (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (268) 
4

>  <RESEARCH_CODES>  (268) 
AHR-9434; AL-6515

>  <APPLICANTS>  (268) 
Alcon Research Ltd; Alcon Pharmaceuticals Ltd

>  <USAN_STEM>  (268) 
-ac

>  <USAN_STEM_DEFINITION>  (268) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (268) 
-ac

>  <USAN_YEAR>  (268) 
1997.0

>  <FIRST_APPROVAL>  (268) 
2005.0

>  <ATC_CODE>  (268) 
S01BC10

>  <ATC_CODE_DESCRIPTION>  (268) 
S01BC10 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]

>  <INDICATION_CLASS>  (268) 
nan

>  <SC_PATENT_NO>  (268) 
US-6403609-B1

>  <DRUG_TYPE>  (268) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (268) 
Y

>  <FIRST_IN_CLASS>  (268) 
N

>  <CHIRALITY>  (268) 
Achiral Molecule

>  <PRODRUG>  (268) 
Y

>  <ORAL>  (268) 
N

>  <PARENTERAL>  (268) 
N

>  <TOPICAL>  (268) 
Y

>  <BLACK_BOX>  (268) 
N

>  <AVAILABILITY_TYPE>  (268) 
Prescription-only

>  <WITHDRAWN_YEAR>  (268) 
nan

>  <WITHDRAWN_COUNTRY>  (268) 
nan

>  <WITHDRAWN_REASON>  (268) 
nan

>  <CANONICAL_SMILES>  (268) 
NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N

>  <name>  (268) 
Nepafenac 

>  <MW>  (268) 
254.289

>  <logP>  (268) 
1.5276

$$$$
CHEMBL1201193
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 10  5  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (269) 
675144

>  <SYNONYMS>  (269) 
Levobupivacaine (BAN, INN); Levobupivacaine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (269) 
4

>  <RESEARCH_CODES>  (269) 
nan

>  <APPLICANTS>  (269) 
Purdue Pharma Lp

>  <USAN_STEM>  (269) 
-caine

>  <USAN_STEM_DEFINITION>  (269) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (269) 
-caine

>  <USAN_YEAR>  (269) 
1998.0

>  <FIRST_APPROVAL>  (269) 
1999.0

>  <ATC_CODE>  (269) 
N01BB10

>  <ATC_CODE_DESCRIPTION>  (269) 
N01BB10 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (269) 
nan

>  <SC_PATENT_NO>  (269) 
nan

>  <DRUG_TYPE>  (269) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (269) 
Y

>  <FIRST_IN_CLASS>  (269) 
N

>  <CHIRALITY>  (269) 
Single Stereoisomer

>  <PRODRUG>  (269) 
N

>  <ORAL>  (269) 
N

>  <PARENTERAL>  (269) 
Y

>  <TOPICAL>  (269) 
N

>  <BLACK_BOX>  (269) 
N

>  <AVAILABILITY_TYPE>  (269) 
Discontinued

>  <WITHDRAWN_YEAR>  (269) 
nan

>  <WITHDRAWN_COUNTRY>  (269) 
nan

>  <WITHDRAWN_REASON>  (269) 
nan

>  <CANONICAL_SMILES>  (269) 
CCCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C

>  <name>  (269) 
Levobupivacaine 

>  <MW>  (269) 
288.435

>  <logP>  (269) 
3.89654

$$$$
CHEMBL1314
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (270) 
264400

>  <SYNONYMS>  (270) 
Tiopronin (DCF, FDA, INN, JAN, MI)

>  <DEVELOPMENT_PHASE>  (270) 
4

>  <RESEARCH_CODES>  (270) 
nan

>  <APPLICANTS>  (270) 
Mission Pharmacal Co

>  <USAN_STEM>  (270) 
nan

>  <USAN_STEM_DEFINITION>  (270) 
nan

>  <USAN_STEM_SUBSTEM>  (270) 
nan

>  <USAN_YEAR>  (270) 
nan

>  <FIRST_APPROVAL>  (270) 
1988.0

>  <ATC_CODE>  (270) 
R05CB12

>  <ATC_CODE_DESCRIPTION>  (270) 
R05CB12 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Mucolytics]

>  <INDICATION_CLASS>  (270) 
nan

>  <SC_PATENT_NO>  (270) 
nan

>  <DRUG_TYPE>  (270) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (270) 
Y

>  <FIRST_IN_CLASS>  (270) 
N

>  <CHIRALITY>  (270) 
Racemic Mixture

>  <PRODRUG>  (270) 
N

>  <ORAL>  (270) 
Y

>  <PARENTERAL>  (270) 
N

>  <TOPICAL>  (270) 
N

>  <BLACK_BOX>  (270) 
N

>  <AVAILABILITY_TYPE>  (270) 
Prescription-only

>  <WITHDRAWN_YEAR>  (270) 
nan

>  <WITHDRAWN_COUNTRY>  (270) 
nan

>  <WITHDRAWN_REASON>  (270) 
nan

>  <CANONICAL_SMILES>  (270) 
CC(S)C(=O)NCC(=O)O

>  <name>  (270) 
Tiopronin 

>  <MW>  (270) 
163.198

>  <logP>  (270) 
-0.4945

$$$$
CHEMBL1512
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 27  2  1  0
 26  5  1  0
 24  7  1  0
 20  8  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (271) 
421058

>  <SYNONYMS>  (271) 
Flunisolide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (271) 
4

>  <RESEARCH_CODES>  (271) 
RS-3999

>  <APPLICANTS>  (271) 
Teva Branded Pharmaceutical Products R And D Inc; Roche Palo Alto Llc; Ivax Research Inc; Acton Pharmaceuticals Inc

>  <USAN_STEM>  (271) 
nan

>  <USAN_STEM_DEFINITION>  (271) 
nan

>  <USAN_STEM_SUBSTEM>  (271) 
nan

>  <USAN_YEAR>  (271) 
1974.0

>  <FIRST_APPROVAL>  (271) 
1981.0

>  <ATC_CODE>  (271) 
R03BA03; R01AD04

>  <ATC_CODE_DESCRIPTION>  (271) 
R03BA03 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; R01AD04 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]

>  <INDICATION_CLASS>  (271) 
Glucocorticoid

>  <SC_PATENT_NO>  (271) 
US-5776433-A

>  <DRUG_TYPE>  (271) 
Natural Product-derived

>  <RULE_OF_FIVE>  (271) 
Y

>  <FIRST_IN_CLASS>  (271) 
N

>  <CHIRALITY>  (271) 
Single Stereoisomer

>  <PRODRUG>  (271) 
N

>  <ORAL>  (271) 
N

>  <PARENTERAL>  (271) 
N

>  <TOPICAL>  (271) 
Y

>  <BLACK_BOX>  (271) 
N

>  <AVAILABILITY_TYPE>  (271) 
Prescription-only

>  <WITHDRAWN_YEAR>  (271) 
nan

>  <WITHDRAWN_COUNTRY>  (271) 
nan

>  <WITHDRAWN_REASON>  (271) 
nan

>  <CANONICAL_SMILES>  (271) 
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

>  <name>  (271) 
Flunisolide 

>  <MW>  (271) 
434.504

>  <logP>  (271) 
2.2747

$$$$
CHEMBL838
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 25 30  1  0
 30 31  2  0
 14  9  1  0
 30 16  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (272) 
61706

>  <SYNONYMS>  (272) 
Benazepril (BAN, INN); Benazepril HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (272) 
4

>  <RESEARCH_CODES>  (272) 
CGS-14824A HCl; CGS-14824A

>  <APPLICANTS>  (272) 
Us Pharmaceuticals Holdings I Llc; Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (272) 
-pril

>  <USAN_STEM_DEFINITION>  (272) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (272) 
-pril

>  <USAN_YEAR>  (272) 
1987.0

>  <FIRST_APPROVAL>  (272) 
1991.0

>  <ATC_CODE>  (272) 
C09AA07

>  <ATC_CODE_DESCRIPTION>  (272) 
C09AA07 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (272) 
Enzyme Inhibitor (angiotensin-converting)

>  <SC_PATENT_NO>  (272) 
US-6162802-A

>  <DRUG_TYPE>  (272) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (272) 
Y

>  <FIRST_IN_CLASS>  (272) 
N

>  <CHIRALITY>  (272) 
Single Stereoisomer

>  <PRODRUG>  (272) 
Y

>  <ORAL>  (272) 
Y

>  <PARENTERAL>  (272) 
N

>  <TOPICAL>  (272) 
N

>  <BLACK_BOX>  (272) 
Y

>  <AVAILABILITY_TYPE>  (272) 
Prescription-only

>  <WITHDRAWN_YEAR>  (272) 
nan

>  <WITHDRAWN_COUNTRY>  (272) 
nan

>  <WITHDRAWN_REASON>  (272) 
nan

>  <CANONICAL_SMILES>  (272) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O

>  <name>  (272) 
Benazepril 

>  <MW>  (272) 
424.497

>  <logP>  (272) 
2.5731

$$$$
CHEMBL460
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 10 18  1  0
 18 19  2  0
 18 20  1  0
 20  3  1  0
 20  7  2  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (273) 
3799

>  <SYNONYMS>  (273) 
Molindone (BAN, INN); Molindone HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (273) 
4

>  <RESEARCH_CODES>  (273) 
EN-1733A

>  <APPLICANTS>  (273) 
Endo Pharmaceuticals Inc

>  <USAN_STEM>  (273) 
nan

>  <USAN_STEM_DEFINITION>  (273) 
nan

>  <USAN_STEM_SUBSTEM>  (273) 
nan

>  <USAN_YEAR>  (273) 
1967.0

>  <FIRST_APPROVAL>  (273) 
1974.0

>  <ATC_CODE>  (273) 
N05AE02

>  <ATC_CODE_DESCRIPTION>  (273) 
N05AE02 [Nervous System:Psycholeptics:Antipsychotics:Indole derivatives]

>  <INDICATION_CLASS>  (273) 
Antipsychotic

>  <SC_PATENT_NO>  (273) 
nan

>  <DRUG_TYPE>  (273) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (273) 
Y

>  <FIRST_IN_CLASS>  (273) 
N

>  <CHIRALITY>  (273) 
Racemic Mixture

>  <PRODRUG>  (273) 
N

>  <ORAL>  (273) 
Y

>  <PARENTERAL>  (273) 
N

>  <TOPICAL>  (273) 
N

>  <BLACK_BOX>  (273) 
N

>  <AVAILABILITY_TYPE>  (273) 
Prescription-only

>  <WITHDRAWN_YEAR>  (273) 
nan

>  <WITHDRAWN_COUNTRY>  (273) 
nan

>  <WITHDRAWN_REASON>  (273) 
nan

>  <CANONICAL_SMILES>  (273) 
CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12

>  <name>  (273) 
Molindone 

>  <MW>  (273) 
276.38

>  <logP>  (273) 
1.96282

$$$$
CHEMBL1493
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  6 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  3 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 11  2  1  0
 10  5  1  0
 23 18  1  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (274) 
418484

>  <SYNONYMS>  (274) 
Flavoxate (BAN, INN); Flavoxate HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (274) 
4

>  <RESEARCH_CODES>  (274) 
DW-61

>  <APPLICANTS>  (274) 
Ortho Mcneil Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (274) 
nan

>  <USAN_STEM_DEFINITION>  (274) 
nan

>  <USAN_STEM_SUBSTEM>  (274) 
nan

>  <USAN_YEAR>  (274) 
1968.0

>  <FIRST_APPROVAL>  (274) 
1970.0

>  <ATC_CODE>  (274) 
G04BD02

>  <ATC_CODE_DESCRIPTION>  (274) 
G04BD02 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (274) 
Relaxant (smooth muscle)

>  <SC_PATENT_NO>  (274) 
nan

>  <DRUG_TYPE>  (274) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (274) 
Y

>  <FIRST_IN_CLASS>  (274) 
N

>  <CHIRALITY>  (274) 
Achiral Molecule

>  <PRODRUG>  (274) 
N

>  <ORAL>  (274) 
Y

>  <PARENTERAL>  (274) 
N

>  <TOPICAL>  (274) 
N

>  <BLACK_BOX>  (274) 
N

>  <AVAILABILITY_TYPE>  (274) 
Prescription-only

>  <WITHDRAWN_YEAR>  (274) 
nan

>  <WITHDRAWN_COUNTRY>  (274) 
nan

>  <WITHDRAWN_REASON>  (274) 
nan

>  <CANONICAL_SMILES>  (274) 
CC1=C(Oc2c(cccc2C1=O)C(=O)OCCN3CCCCC3)c4ccccc4

>  <name>  (274) 
Flavoxate 

>  <MW>  (274) 
391.467

>  <logP>  (274) 
4.41112

$$$$
CHEMBL1625
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 15 17  2  0
 17  3  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (275) 
469732

>  <SYNONYMS>  (275) 
Oxybenzone (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (275) 
4

>  <RESEARCH_CODES>  (275) 
nan

>  <APPLICANTS>  (275) 
Schering Plough Healthcare Products Inc

>  <USAN_STEM>  (275) 
nan

>  <USAN_STEM_DEFINITION>  (275) 
nan

>  <USAN_STEM_SUBSTEM>  (275) 
nan

>  <USAN_YEAR>  (275) 
1965.0

>  <FIRST_APPROVAL>  (275) 
1992.0

>  <ATC_CODE>  (275) 
nan

>  <ATC_CODE_DESCRIPTION>  (275) 
nan

>  <INDICATION_CLASS>  (275) 
Ultraviolet Screen

>  <SC_PATENT_NO>  (275) 
nan

>  <DRUG_TYPE>  (275) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (275) 
Y

>  <FIRST_IN_CLASS>  (275) 
N

>  <CHIRALITY>  (275) 
Achiral Molecule

>  <PRODRUG>  (275) 
N

>  <ORAL>  (275) 
N

>  <PARENTERAL>  (275) 
N

>  <TOPICAL>  (275) 
Y

>  <BLACK_BOX>  (275) 
N

>  <AVAILABILITY_TYPE>  (275) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (275) 
nan

>  <WITHDRAWN_COUNTRY>  (275) 
nan

>  <WITHDRAWN_REASON>  (275) 
nan

>  <CANONICAL_SMILES>  (275) 
COc1ccc(C(=O)c2ccccc2)c(O)c1

>  <name>  (275) 
Oxybenzone 

>  <MW>  (275) 
228.247

>  <logP>  (275) 
2.6318

$$$$
CHEMBL671
     RDKit          

 11 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  1  0
 10 11  1  0
  5  3  1  0
  8  6  1  0
 11  9  1  0
M  END
>  <PARENT_MOLREGNO>  (276) 
28310

>  <SYNONYMS>  (276) 
Thiotepa (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (276) 
4

>  <RESEARCH_CODES>  (276) 
nan

>  <APPLICANTS>  (276) 
Immunex Corp

>  <USAN_STEM>  (276) 
-tepa

>  <USAN_STEM_DEFINITION>  (276) 
antineoplastics (thiotepa derivatives)

>  <USAN_STEM_SUBSTEM>  (276) 
-tepa

>  <USAN_YEAR>  (276) 
nan

>  <FIRST_APPROVAL>  (276) 
1959.0

>  <ATC_CODE>  (276) 
L01AC01

>  <ATC_CODE_DESCRIPTION>  (276) 
L01AC01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Ethylene imines]

>  <INDICATION_CLASS>  (276) 
Antineoplastic

>  <SC_PATENT_NO>  (276) 
nan

>  <DRUG_TYPE>  (276) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (276) 
Y

>  <FIRST_IN_CLASS>  (276) 
N

>  <CHIRALITY>  (276) 
Achiral Molecule

>  <PRODRUG>  (276) 
N

>  <ORAL>  (276) 
N

>  <PARENTERAL>  (276) 
Y

>  <TOPICAL>  (276) 
N

>  <BLACK_BOX>  (276) 
N

>  <AVAILABILITY_TYPE>  (276) 
Prescription-only

>  <WITHDRAWN_YEAR>  (276) 
nan

>  <WITHDRAWN_COUNTRY>  (276) 
nan

>  <WITHDRAWN_REASON>  (276) 
nan

>  <CANONICAL_SMILES>  (276) 
S=P(N1CC1)(N2CC2)N3CC3

>  <name>  (276) 
Thiotepa 

>  <MW>  (276) 
189.224

>  <logP>  (276) 
0.1577

$$$$
CHEMBL416
     RDKit          

 16 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16  3  1  0
 10  4  1  0
 16 12  2  0
M  END
>  <PARENT_MOLREGNO>  (277) 
1063

>  <SYNONYMS>  (277) 
Methoxsalen (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (277) 
4

>  <RESEARCH_CODES>  (277) 
nan

>  <APPLICANTS>  (277) 
Valeant Pharmaceuticals International; Therakos Inc

>  <USAN_STEM>  (277) 
-sal-

>  <USAN_STEM_DEFINITION>  (277) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (277) 
-sal-

>  <USAN_YEAR>  (277) 
nan

>  <FIRST_APPROVAL>  (277) 
1954.0

>  <ATC_CODE>  (277) 
D05BA02; D05AD02

>  <ATC_CODE_DESCRIPTION>  (277) 
D05BA02 [Dermatologicals:Antipsoriatics:Antipsoriatics For Systemic Use:Psoralens for systemic use]; D05AD02 [Dermatologicals:Antipsoriatics:Antipsoriatics For Topical Use:Psoralens for topical use]

>  <INDICATION_CLASS>  (277) 
Pigmentation Agent

>  <SC_PATENT_NO>  (277) 
nan

>  <DRUG_TYPE>  (277) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (277) 
Y

>  <FIRST_IN_CLASS>  (277) 
N

>  <CHIRALITY>  (277) 
Achiral Molecule

>  <PRODRUG>  (277) 
N

>  <ORAL>  (277) 
Y

>  <PARENTERAL>  (277) 
Y

>  <TOPICAL>  (277) 
Y

>  <BLACK_BOX>  (277) 
Y

>  <AVAILABILITY_TYPE>  (277) 
Prescription-only

>  <WITHDRAWN_YEAR>  (277) 
nan

>  <WITHDRAWN_COUNTRY>  (277) 
nan

>  <WITHDRAWN_REASON>  (277) 
nan

>  <CANONICAL_SMILES>  (277) 
COc1c2OC(=O)C=Cc2cc3ccoc13

>  <name>  (277) 
Methoxsalen 

>  <MW>  (277) 
216.192

>  <logP>  (277) 
2.5478

$$$$
CHEMBL16476
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (278) 
18271

>  <SYNONYMS>  (278) 
Pronetalol (BAN, INN)

>  <DEVELOPMENT_PHASE>  (278) 
4

>  <RESEARCH_CODES>  (278) 
AY-6204 HCl; GNF-Pf-2670; ICI-38174 [As Hydrochloride]

>  <APPLICANTS>  (278) 
nan

>  <USAN_STEM>  (278) 
-alol

>  <USAN_STEM_DEFINITION>  (278) 
combined alpha and beta receptors

>  <USAN_STEM_SUBSTEM>  (278) 
-alol

>  <USAN_YEAR>  (278) 
nan

>  <FIRST_APPROVAL>  (278) 
nan

>  <ATC_CODE>  (278) 
nan

>  <ATC_CODE_DESCRIPTION>  (278) 
nan

>  <INDICATION_CLASS>  (278) 
nan

>  <SC_PATENT_NO>  (278) 
nan

>  <DRUG_TYPE>  (278) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (278) 
Y

>  <FIRST_IN_CLASS>  (278) 
N

>  <CHIRALITY>  (278) 
Racemic Mixture

>  <PRODRUG>  (278) 
N

>  <ORAL>  (278) 
N

>  <PARENTERAL>  (278) 
N

>  <TOPICAL>  (278) 
N

>  <BLACK_BOX>  (278) 
N

>  <AVAILABILITY_TYPE>  (278) 
Withdrawn

>  <WITHDRAWN_YEAR>  (278) 
1965.0

>  <WITHDRAWN_COUNTRY>  (278) 
United Kingdom

>  <WITHDRAWN_REASON>  (278) 
Animal carcinogenicity (rodent)

>  <CANONICAL_SMILES>  (278) 
CC(C)NCC(O)c1ccc2ccccc2c1

>  <name>  (278) 
Pronetalol 

>  <MW>  (278) 
229.323

>  <logP>  (278) 
2.8712

$$$$
CHEMBL408513
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 12  7  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (279) 
435188

>  <SYNONYMS>  (279) 
Belinostat (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (279) 
4

>  <RESEARCH_CODES>  (279) 
PXD-101

>  <APPLICANTS>  (279) 
Spectrum Pharmaceuticals Inc

>  <USAN_STEM>  (279) 
-stat

>  <USAN_STEM_DEFINITION>  (279) 
enzyme inhibitors: inhibitors of histone deacetylase

>  <USAN_STEM_SUBSTEM>  (279) 
-stat (-inostat)

>  <USAN_YEAR>  (279) 
2006.0

>  <FIRST_APPROVAL>  (279) 
2014.0

>  <ATC_CODE>  (279) 
L01XX49

>  <ATC_CODE_DESCRIPTION>  (279) 
L01XX49 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (279) 
nan

>  <SC_PATENT_NO>  (279) 
US-6888027-B2

>  <DRUG_TYPE>  (279) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (279) 
Y

>  <FIRST_IN_CLASS>  (279) 
N

>  <CHIRALITY>  (279) 
Achiral Molecule

>  <PRODRUG>  (279) 
N

>  <ORAL>  (279) 
N

>  <PARENTERAL>  (279) 
Y

>  <TOPICAL>  (279) 
N

>  <BLACK_BOX>  (279) 
N

>  <AVAILABILITY_TYPE>  (279) 
Prescription-only

>  <WITHDRAWN_YEAR>  (279) 
nan

>  <WITHDRAWN_COUNTRY>  (279) 
nan

>  <WITHDRAWN_REASON>  (279) 
nan

>  <CANONICAL_SMILES>  (279) 
ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc2ccccc2

>  <name>  (279) 
Belinostat 

>  <MW>  (279) 
318.354

>  <logP>  (279) 
2.006

$$$$
CHEMBL1466
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
  3 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25  2  1  0
 15  5  1  0
 13  8  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (280) 
394231

>  <SYNONYMS>  (280) 
Dicoumarol (DCF, INN); Dicumarol (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (280) 
4

>  <RESEARCH_CODES>  (280) 
nan

>  <APPLICANTS>  (280) 
Eli Lilly And Co; Abbvie Inc

>  <USAN_STEM>  (280) 
-arol

>  <USAN_STEM_DEFINITION>  (280) 
anticoagulants (dicumarol type)

>  <USAN_STEM_SUBSTEM>  (280) 
-arol

>  <USAN_YEAR>  (280) 
1971.0

>  <FIRST_APPROVAL>  (280) 
1944.0

>  <ATC_CODE>  (280) 
B01AA01

>  <ATC_CODE_DESCRIPTION>  (280) 
B01AA01 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Vitamin K antagonists]

>  <INDICATION_CLASS>  (280) 
Anticoagulant

>  <SC_PATENT_NO>  (280) 
nan

>  <DRUG_TYPE>  (280) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (280) 
Y

>  <FIRST_IN_CLASS>  (280) 
N

>  <CHIRALITY>  (280) 
Achiral Molecule

>  <PRODRUG>  (280) 
N

>  <ORAL>  (280) 
Y

>  <PARENTERAL>  (280) 
N

>  <TOPICAL>  (280) 
N

>  <BLACK_BOX>  (280) 
N

>  <AVAILABILITY_TYPE>  (280) 
Discontinued

>  <WITHDRAWN_YEAR>  (280) 
nan

>  <WITHDRAWN_COUNTRY>  (280) 
nan

>  <WITHDRAWN_REASON>  (280) 
nan

>  <CANONICAL_SMILES>  (280) 
OC1=C(CC2=C(O)c3ccccc3OC2=O)C(=O)Oc4ccccc14

>  <name>  (280) 
Dicoumarol 

>  <MW>  (280) 
336.299

>  <logP>  (280) 
2.9014

$$$$
CHEMBL12856
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  4  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  7  2  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (281) 
11066

>  <SYNONYMS>  (281) 
Amrinone (BAN, INN, JAN); Inamrinone (USAN, USP); Inamrinone Lactate (FDA)

>  <DEVELOPMENT_PHASE>  (281) 
4

>  <RESEARCH_CODES>  (281) 
WIN-40680

>  <APPLICANTS>  (281) 
Sterling Winthrop; Sanofi Aventis Us Llc

>  <USAN_STEM>  (281) 
-rinone

>  <USAN_STEM_DEFINITION>  (281) 
cardiotonics (amrinone type)

>  <USAN_STEM_SUBSTEM>  (281) 
-rinone

>  <USAN_YEAR>  (281) 
1999.0

>  <FIRST_APPROVAL>  (281) 
1984.0

>  <ATC_CODE>  (281) 
C01CE01

>  <ATC_CODE_DESCRIPTION>  (281) 
C01CE01 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Phosphodiesterase inhibitors]

>  <INDICATION_CLASS>  (281) 
Cardiotonic

>  <SC_PATENT_NO>  (281) 
nan

>  <DRUG_TYPE>  (281) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (281) 
Y

>  <FIRST_IN_CLASS>  (281) 
N

>  <CHIRALITY>  (281) 
Achiral Molecule

>  <PRODRUG>  (281) 
N

>  <ORAL>  (281) 
N

>  <PARENTERAL>  (281) 
Y

>  <TOPICAL>  (281) 
N

>  <BLACK_BOX>  (281) 
N

>  <AVAILABILITY_TYPE>  (281) 
Prescription-only

>  <WITHDRAWN_YEAR>  (281) 
nan

>  <WITHDRAWN_COUNTRY>  (281) 
nan

>  <WITHDRAWN_REASON>  (281) 
nan

>  <CANONICAL_SMILES>  (281) 
NC1=CC(=CNC1=O)c2ccncc2

>  <name>  (281) 
Amrinone 

>  <MW>  (281) 
187.202

>  <logP>  (281) 
1.0191

$$$$
CHEMBL70046
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  5 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 12 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
  8  3  1  0
 19 10  1  0
M  END
>  <PARENT_MOLREGNO>  (282) 
110103

>  <SYNONYMS>  (282) 
Sorivudine (BAN, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (282) 
4

>  <RESEARCH_CODES>  (282) 
SO-32756; YN-72

>  <APPLICANTS>  (282) 
Bristol-Myers Squibb

>  <USAN_STEM>  (282) 
-vudine

>  <USAN_STEM_DEFINITION>  (282) 
antineoplastics,antivirals (zidovudine group) (exception: edoxudine)

>  <USAN_STEM_SUBSTEM>  (282) 
-vudine

>  <USAN_YEAR>  (282) 
1992.0

>  <FIRST_APPROVAL>  (282) 
nan

>  <ATC_CODE>  (282) 
nan

>  <ATC_CODE_DESCRIPTION>  (282) 
nan

>  <INDICATION_CLASS>  (282) 
Antiviral

>  <SC_PATENT_NO>  (282) 
nan

>  <DRUG_TYPE>  (282) 
Natural Product-derived

>  <RULE_OF_FIVE>  (282) 
Y

>  <FIRST_IN_CLASS>  (282) 
N

>  <CHIRALITY>  (282) 
Single Stereoisomer

>  <PRODRUG>  (282) 
N

>  <ORAL>  (282) 
N

>  <PARENTERAL>  (282) 
N

>  <TOPICAL>  (282) 
N

>  <BLACK_BOX>  (282) 
N

>  <AVAILABILITY_TYPE>  (282) 
Withdrawn

>  <WITHDRAWN_YEAR>  (282) 
1993.0

>  <WITHDRAWN_COUNTRY>  (282) 
Japan

>  <WITHDRAWN_REASON>  (282) 
Drug Interactionwith 5-FU and Deaths

>  <CANONICAL_SMILES>  (282) 
OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=C(\C=C\Br)C(=O)NC2=O

>  <name>  (282) 
Sorivudine 

>  <MW>  (282) 
349.137

>  <logP>  (282) 
-1.4863

$$$$
CHEMBL516
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  1  0
 22  2  1  0
 20  6  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (283) 
11005

>  <SYNONYMS>  (283) 
Cyproheptadine (BAN, INN); Cyproheptadine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (283) 
4

>  <RESEARCH_CODES>  (283) 
nan

>  <APPLICANTS>  (283) 
Merck And Co Inc

>  <USAN_STEM>  (283) 
-(a)tadine

>  <USAN_STEM_DEFINITION>  (283) 
tricyclic histaminic-H1 receptor antagonists, loratadine derivatives

>  <USAN_STEM_SUBSTEM>  (283) 
-(a)tadine

>  <USAN_YEAR>  (283) 
nan

>  <FIRST_APPROVAL>  (283) 
1961.0

>  <ATC_CODE>  (283) 
R06AX02

>  <ATC_CODE_DESCRIPTION>  (283) 
R06AX02 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (283) 
Antihistaminic; Antipruritic

>  <SC_PATENT_NO>  (283) 
nan

>  <DRUG_TYPE>  (283) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (283) 
Y

>  <FIRST_IN_CLASS>  (283) 
N

>  <CHIRALITY>  (283) 
Achiral Molecule

>  <PRODRUG>  (283) 
N

>  <ORAL>  (283) 
Y

>  <PARENTERAL>  (283) 
N

>  <TOPICAL>  (283) 
N

>  <BLACK_BOX>  (283) 
N

>  <AVAILABILITY_TYPE>  (283) 
Prescription-only

>  <WITHDRAWN_YEAR>  (283) 
nan

>  <WITHDRAWN_COUNTRY>  (283) 
nan

>  <WITHDRAWN_REASON>  (283) 
nan

>  <CANONICAL_SMILES>  (283) 
CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1

>  <name>  (283) 
Cyproheptadine 

>  <MW>  (283) 
287.406

>  <logP>  (283) 
4.6979

$$$$
CHEMBL113
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13  2  1  0
 12  7  2  0
M  END
>  <PARENT_MOLREGNO>  (284) 
16485

>  <SYNONYMS>  (284) 
Caffeine (BAN, FDA, JAN, USP); Caffeine Citrate (FDA); Caffeine, Citrated (MI, NF)

>  <DEVELOPMENT_PHASE>  (284) 
4

>  <RESEARCH_CODES>  (284) 
nan

>  <APPLICANTS>  (284) 
Novartis Consumer Health Inc; Medicis Pharmaceutical Corp; Caraco Pharmaceutical Laboratories Ltd; Bedford Laboratories; Watson Laboratories Inc

>  <USAN_STEM>  (284) 
nan

>  <USAN_STEM_DEFINITION>  (284) 
nan

>  <USAN_STEM_SUBSTEM>  (284) 
nan

>  <USAN_YEAR>  (284) 
nan

>  <FIRST_APPROVAL>  (284) 
1948.0

>  <ATC_CODE>  (284) 
N06BC01

>  <ATC_CODE_DESCRIPTION>  (284) 
N06BC01 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Xanthine derivatives]

>  <INDICATION_CLASS>  (284) 
Stimulant (central)

>  <SC_PATENT_NO>  (284) 
US-5972916-A

>  <DRUG_TYPE>  (284) 
Natural Product-derived

>  <RULE_OF_FIVE>  (284) 
Y

>  <FIRST_IN_CLASS>  (284) 
N

>  <CHIRALITY>  (284) 
Achiral Molecule

>  <PRODRUG>  (284) 
N

>  <ORAL>  (284) 
Y

>  <PARENTERAL>  (284) 
Y

>  <TOPICAL>  (284) 
Y

>  <BLACK_BOX>  (284) 
N

>  <AVAILABILITY_TYPE>  (284) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (284) 
nan

>  <WITHDRAWN_COUNTRY>  (284) 
nan

>  <WITHDRAWN_REASON>  (284) 
nan

>  <CANONICAL_SMILES>  (284) 
CN1C(=O)N(C)c2ncn(C)c2C1=O

>  <name>  (284) 
Caffeine 

>  <MW>  (284) 
194.194

>  <logP>  (284) 
-1.0293

$$$$
CHEMBL3353410
     RDKit          

 37 40  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
  5 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 13 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 20  3  1  0
 27 22  1  0
 37 28  1  0
 37 32  1  0
M  END
>  <PARENT_MOLREGNO>  (285) 
1817518

>  <SYNONYMS>  (285) 
Osimertinib (USAN); Osimertinib mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (285) 
4

>  <RESEARCH_CODES>  (285) 
AZD-9291; AZD-9291 mesylate

>  <APPLICANTS>  (285) 
Astrazeneca Pharmaceuticals Lp; Astrazeneca

>  <USAN_STEM>  (285) 
-tinib

>  <USAN_STEM_DEFINITION>  (285) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (285) 
-tinib

>  <USAN_YEAR>  (285) 
2015.0

>  <FIRST_APPROVAL>  (285) 
2015.0

>  <ATC_CODE>  (285) 
nan

>  <ATC_CODE_DESCRIPTION>  (285) 
nan

>  <INDICATION_CLASS>  (285) 
nan

>  <SC_PATENT_NO>  (285) 
US-8946235-B2

>  <DRUG_TYPE>  (285) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (285) 
Y

>  <FIRST_IN_CLASS>  (285) 
N

>  <CHIRALITY>  (285) 
Achiral Molecule

>  <PRODRUG>  (285) 
N

>  <ORAL>  (285) 
Y

>  <PARENTERAL>  (285) 
N

>  <TOPICAL>  (285) 
N

>  <BLACK_BOX>  (285) 
N

>  <AVAILABILITY_TYPE>  (285) 
Prescription-only

>  <WITHDRAWN_YEAR>  (285) 
nan

>  <WITHDRAWN_COUNTRY>  (285) 
nan

>  <WITHDRAWN_REASON>  (285) 
nan

>  <CANONICAL_SMILES>  (285) 
COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34

>  <name>  (285) 
Osimertinib 

>  <MW>  (285) 
499.619

>  <logP>  (285) 
4.5098

$$$$
CHEMBL522038
     RDKit          

 34 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  8 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 28 31  1  0
 31 32  2  0
 32 33  1  0
 31 34  1  0
 14  9  1  0
 20 17  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (286) 
478003

>  <SYNONYMS>  (286) 
Ximelagatran (INN, USAN)

>  <DEVELOPMENT_PHASE>  (286) 
4

>  <RESEARCH_CODES>  (286) 
H 376/95

>  <APPLICANTS>  (286) 
Astrazeneca

>  <USAN_STEM>  (286) 
-gatran

>  <USAN_STEM_DEFINITION>  (286) 
thrombin inhibitors (argatroban type)

>  <USAN_STEM_SUBSTEM>  (286) 
-gatran

>  <USAN_YEAR>  (286) 
2002.0

>  <FIRST_APPROVAL>  (286) 
nan

>  <ATC_CODE>  (286) 
B01AE05

>  <ATC_CODE_DESCRIPTION>  (286) 
B01AE05 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Direct thrombin inhibitors]

>  <INDICATION_CLASS>  (286) 
nan

>  <SC_PATENT_NO>  (286) 
nan

>  <DRUG_TYPE>  (286) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (286) 
Y

>  <FIRST_IN_CLASS>  (286) 
N

>  <CHIRALITY>  (286) 
Single Stereoisomer

>  <PRODRUG>  (286) 
N

>  <ORAL>  (286) 
N

>  <PARENTERAL>  (286) 
N

>  <TOPICAL>  (286) 
N

>  <BLACK_BOX>  (286) 
N

>  <AVAILABILITY_TYPE>  (286) 
Withdrawn

>  <WITHDRAWN_YEAR>  (286) 
2006.0

>  <WITHDRAWN_COUNTRY>  (286) 
Worldwide

>  <WITHDRAWN_REASON>  (286) 
nan

>  <CANONICAL_SMILES>  (286) 
CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCc3ccc(cc3)\C(=N/O)\N

>  <name>  (286) 
Ximelagatran 

>  <MW>  (286) 
473.574

>  <logP>  (286) 
1.0998

$$$$
CHEMBL457
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 15 16  2  0
 15 17  1  0
  7 18  2  0
 18  2  1  0
M  END
>  <PARENT_MOLREGNO>  (287) 
2994

>  <SYNONYMS>  (287) 
Gemfibrozil (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (287) 
4

>  <RESEARCH_CODES>  (287) 
CI-719

>  <APPLICANTS>  (287) 
Pfizer Pharmaceuticals Ltd

>  <USAN_STEM>  (287) 
nan

>  <USAN_STEM_DEFINITION>  (287) 
nan

>  <USAN_STEM_SUBSTEM>  (287) 
nan

>  <USAN_YEAR>  (287) 
1980.0

>  <FIRST_APPROVAL>  (287) 
1981.0

>  <ATC_CODE>  (287) 
C10AB04

>  <ATC_CODE_DESCRIPTION>  (287) 
C10AB04 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:Fibrates]

>  <INDICATION_CLASS>  (287) 
Antihyperlipidemic

>  <SC_PATENT_NO>  (287) 
nan

>  <DRUG_TYPE>  (287) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (287) 
Y

>  <FIRST_IN_CLASS>  (287) 
N

>  <CHIRALITY>  (287) 
Achiral Molecule

>  <PRODRUG>  (287) 
N

>  <ORAL>  (287) 
Y

>  <PARENTERAL>  (287) 
N

>  <TOPICAL>  (287) 
N

>  <BLACK_BOX>  (287) 
N

>  <AVAILABILITY_TYPE>  (287) 
Prescription-only

>  <WITHDRAWN_YEAR>  (287) 
nan

>  <WITHDRAWN_COUNTRY>  (287) 
nan

>  <WITHDRAWN_REASON>  (287) 
nan

>  <CANONICAL_SMILES>  (287) 
Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1

>  <name>  (287) 
Gemfibrozil 

>  <MW>  (287) 
250.338

>  <logP>  (287) 
3.57324

$$$$
CHEMBL3545256
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
  7 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  2  0
 25 28  1  0
 24  2  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (288) 
1927105

>  <SYNONYMS>  (288) 
Aztreonam (BAN, FDA, INN, JAN, USAN, USP); Aztreonam lysine (USAN)

>  <DEVELOPMENT_PHASE>  (288) 
4

>  <RESEARCH_CODES>  (288) 
SO-26776; SQ-26776; Corus 1020

>  <APPLICANTS>  (288) 
Gilead Sciences Inc; Corus Pharma, Inc.; Bristol Myers Squibb Co; Bristol Myers Squibb

>  <USAN_STEM>  (288) 
nan

>  <USAN_STEM_DEFINITION>  (288) 
nan

>  <USAN_STEM_SUBSTEM>  (288) 
nan

>  <USAN_YEAR>  (288) 
1983.0

>  <FIRST_APPROVAL>  (288) 
1986.0

>  <ATC_CODE>  (288) 
J01DF01

>  <ATC_CODE_DESCRIPTION>  (288) 
J01DF01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Monobactams]

>  <INDICATION_CLASS>  (288) 
Antimicrobial

>  <SC_PATENT_NO>  (288) 
nan

>  <DRUG_TYPE>  (288) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (288) 
Y

>  <FIRST_IN_CLASS>  (288) 
N

>  <CHIRALITY>  (288) 
Single Stereoisomer

>  <PRODRUG>  (288) 
N

>  <ORAL>  (288) 
nan

>  <PARENTERAL>  (288) 
nan

>  <TOPICAL>  (288) 
nan

>  <BLACK_BOX>  (288) 
nan

>  <AVAILABILITY_TYPE>  (288) 
nan

>  <WITHDRAWN_YEAR>  (288) 
nan

>  <WITHDRAWN_COUNTRY>  (288) 
nan

>  <WITHDRAWN_REASON>  (288) 
nan

>  <CANONICAL_SMILES>  (288) 
C[C@H]1[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)O)\c2csc(C)n2)C(=O)N1S(=O)(=O)O

>  <name>  (288) 
Aztreonam 

>  <MW>  (288) 
434.452

>  <logP>  (288) 
-0.44628

$$$$
CHEMBL691
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  3  0
 16  2  1  0
 19  2  1  0
 15  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (289) 
31241

>  <SYNONYMS>  (289) 
Ethinylestradiol (FDA, USP, BAN, INN, JAN)

>  <DEVELOPMENT_PHASE>  (289) 
4

>  <RESEARCH_CODES>  (289) 
nan

>  <APPLICANTS>  (289) 
Organon Usa Inc; Janssen Pharmaceuticals Inc; Gd Searle Llc; Bayer Healthcare Pharmaceuticals Inc; Ortho Mcneil Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (289) 
nan

>  <USAN_STEM_DEFINITION>  (289) 
nan

>  <USAN_STEM_SUBSTEM>  (289) 
nan

>  <USAN_YEAR>  (289) 
nan

>  <FIRST_APPROVAL>  (289) 
2001.0

>  <ATC_CODE>  (289) 
L02AA03; G03CA01

>  <ATC_CODE_DESCRIPTION>  (289) 
L02AA03 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormones And Related Agents:Estrogens]; G03CA01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Natural and semisynthetic estrogens, plain]

>  <INDICATION_CLASS>  (289) 
Estrogen

>  <SC_PATENT_NO>  (289) 
US-5798338-A

>  <DRUG_TYPE>  (289) 
Natural Product-derived

>  <RULE_OF_FIVE>  (289) 
Y

>  <FIRST_IN_CLASS>  (289) 
N

>  <CHIRALITY>  (289) 
Single Stereoisomer

>  <PRODRUG>  (289) 
N

>  <ORAL>  (289) 
Y

>  <PARENTERAL>  (289) 
N

>  <TOPICAL>  (289) 
Y

>  <BLACK_BOX>  (289) 
N

>  <AVAILABILITY_TYPE>  (289) 
Prescription-only

>  <WITHDRAWN_YEAR>  (289) 
nan

>  <WITHDRAWN_COUNTRY>  (289) 
nan

>  <WITHDRAWN_REASON>  (289) 
nan

>  <CANONICAL_SMILES>  (289) 
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C

>  <name>  (289) 
Ethinylestradiol 

>  <MW>  (289) 
296.41

>  <logP>  (289) 
3.6126

$$$$
CHEMBL891
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  5 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 23 27  1  0
 27 28  2  0
 27 29  1  0
 13  2  2  0
 11  6  1  0
 25 17  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (290) 
76766

>  <SYNONYMS>  (290) 
Cloxacillin (BAN, INN); Cloxacillin Sodium (FDA, JAN, USAN, USP); Cloxacillin Benzathine (USP)

>  <DEVELOPMENT_PHASE>  (290) 
4

>  <RESEARCH_CODES>  (290) 
BRL-1621; P-25

>  <APPLICANTS>  (290) 
Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (290) 
-cillin

>  <USAN_STEM_DEFINITION>  (290) 
penicillins

>  <USAN_STEM_SUBSTEM>  (290) 
-cillin

>  <USAN_YEAR>  (290) 
1963.0

>  <FIRST_APPROVAL>  (290) 
1974.0

>  <ATC_CODE>  (290) 
J01CF02

>  <ATC_CODE_DESCRIPTION>  (290) 
J01CF02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]

>  <INDICATION_CLASS>  (290) 
Antibacterial

>  <SC_PATENT_NO>  (290) 
nan

>  <DRUG_TYPE>  (290) 
Natural Product-derived

>  <RULE_OF_FIVE>  (290) 
Y

>  <FIRST_IN_CLASS>  (290) 
N

>  <CHIRALITY>  (290) 
Single Stereoisomer

>  <PRODRUG>  (290) 
N

>  <ORAL>  (290) 
Y

>  <PARENTERAL>  (290) 
N

>  <TOPICAL>  (290) 
N

>  <BLACK_BOX>  (290) 
N

>  <AVAILABILITY_TYPE>  (290) 
Discontinued

>  <WITHDRAWN_YEAR>  (290) 
nan

>  <WITHDRAWN_COUNTRY>  (290) 
nan

>  <WITHDRAWN_REASON>  (290) 
nan

>  <CANONICAL_SMILES>  (290) 
Cc1onc(c2ccccc2Cl)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O

>  <name>  (290) 
Cloxacillin 

>  <MW>  (290) 
435.889

>  <logP>  (290) 
2.54872

$$$$
CHEMBL12
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20  2  1  0
 13  8  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (291) 
721

>  <SYNONYMS>  (291) 
Diazepam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (291) 
4

>  <RESEARCH_CODES>  (291) 
LA-III; Ro-52807; WY-3467

>  <APPLICANTS>  (291) 
Valeant Pharmaceuticals International; Us Army Medical Research Materiel Command; Pharmacia And Upjohn Co; Hoffmann La Roche Inc

>  <USAN_STEM>  (291) 
-azepam

>  <USAN_STEM_DEFINITION>  (291) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (291) 
-azepam

>  <USAN_YEAR>  (291) 
1963.0

>  <FIRST_APPROVAL>  (291) 
1963.0

>  <ATC_CODE>  (291) 
N05BA01

>  <ATC_CODE_DESCRIPTION>  (291) 
N05BA01 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (291) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (291) 
nan

>  <DRUG_TYPE>  (291) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (291) 
Y

>  <FIRST_IN_CLASS>  (291) 
N

>  <CHIRALITY>  (291) 
Achiral Molecule

>  <PRODRUG>  (291) 
N

>  <ORAL>  (291) 
Y

>  <PARENTERAL>  (291) 
Y

>  <TOPICAL>  (291) 
Y

>  <BLACK_BOX>  (291) 
N

>  <AVAILABILITY_TYPE>  (291) 
Prescription-only

>  <WITHDRAWN_YEAR>  (291) 
nan

>  <WITHDRAWN_COUNTRY>  (291) 
nan

>  <WITHDRAWN_REASON>  (291) 
nan

>  <CANONICAL_SMILES>  (291) 
CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13

>  <name>  (291) 
Diazepam 

>  <MW>  (291) 
284.746

>  <logP>  (291) 
3.1538

$$$$
CHEMBL1420
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
  7  2  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (292) 
359778

>  <SYNONYMS>  (292) 
Pralidoxime (BAN, INN); Pralidoxime Iodide (INN, JAN, USAN); Pralidoxime chloride (FDA, USAN, USP); Pralidoxime Mesylate (USAN)

>  <DEVELOPMENT_PHASE>  (292) 
4

>  <RESEARCH_CODES>  (292) 
2-PAM; 2-PAM Chloride

>  <APPLICANTS>  (292) 
Us Army Medical Research Materiel Command; Meridian Medical Technologies Inc; Baxter Healthcare Corp Anesthesia Critical Care; Baxter Healthcare Corp Anesthesia And Critical Care; Wyeth Ayerst Laboratories

>  <USAN_STEM>  (292) 
nan

>  <USAN_STEM_DEFINITION>  (292) 
nan

>  <USAN_STEM_SUBSTEM>  (292) 
nan

>  <USAN_YEAR>  (292) 
1962.0

>  <FIRST_APPROVAL>  (292) 
1964.0

>  <ATC_CODE>  (292) 
V03AB04

>  <ATC_CODE_DESCRIPTION>  (292) 
V03AB04 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (292) 
Cholinesterase Reactivator

>  <SC_PATENT_NO>  (292) 
nan

>  <DRUG_TYPE>  (292) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (292) 
Y

>  <FIRST_IN_CLASS>  (292) 
N

>  <CHIRALITY>  (292) 
Achiral Molecule

>  <PRODRUG>  (292) 
N

>  <ORAL>  (292) 
Y

>  <PARENTERAL>  (292) 
Y

>  <TOPICAL>  (292) 
N

>  <BLACK_BOX>  (292) 
N

>  <AVAILABILITY_TYPE>  (292) 
Prescription-only

>  <WITHDRAWN_YEAR>  (292) 
nan

>  <WITHDRAWN_COUNTRY>  (292) 
nan

>  <WITHDRAWN_REASON>  (292) 
nan

>  <CANONICAL_SMILES>  (292) 
C[n+]1ccccc1C=NO

>  <name>  (292) 
Pralidoxime 

>  <MW>  (292) 
137.162

>  <logP>  (292) 
0.3192

$$$$
CHEMBL1115
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
M  CHG  1  11   1
M  END
>  <PARENT_MOLREGNO>  (293) 
157330

>  <SYNONYMS>  (293) 
Pyridostigmine Bromide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (293) 
4

>  <RESEARCH_CODES>  (293) 
nan

>  <APPLICANTS>  (293) 
Valeant Pharmaceuticals North America Llc; Valeant Pharmaceuticals International; United States Army Office Surgeon General; Sandoz Canada Inc

>  <USAN_STEM>  (293) 
-stigmine

>  <USAN_STEM_DEFINITION>  (293) 
cholinesterase inhibitors (physostigmine type)

>  <USAN_STEM_SUBSTEM>  (293) 
-stigmine

>  <USAN_YEAR>  (293) 
nan

>  <FIRST_APPROVAL>  (293) 
1955.0

>  <ATC_CODE>  (293) 
N07AA02

>  <ATC_CODE_DESCRIPTION>  (293) 
N07AA02 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Anticholinesterases]

>  <INDICATION_CLASS>  (293) 
Cholinergic

>  <SC_PATENT_NO>  (293) 
nan

>  <DRUG_TYPE>  (293) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (293) 
Y

>  <FIRST_IN_CLASS>  (293) 
N

>  <CHIRALITY>  (293) 
Achiral Molecule

>  <PRODRUG>  (293) 
N

>  <ORAL>  (293) 
Y

>  <PARENTERAL>  (293) 
Y

>  <TOPICAL>  (293) 
N

>  <BLACK_BOX>  (293) 
N

>  <AVAILABILITY_TYPE>  (293) 
Prescription-only

>  <WITHDRAWN_YEAR>  (293) 
nan

>  <WITHDRAWN_COUNTRY>  (293) 
nan

>  <WITHDRAWN_REASON>  (293) 
nan

>  <CANONICAL_SMILES>  (293) 
CN(C)C(=O)Oc1ccc[n+](C)c1

>  <name>  (293) 
Pyridostigmine Bromide 

>  <MW>  (293) 
181.215

>  <logP>  (293) 
0.5715

$$$$
CHEMBL1241
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  8  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (294) 
231013

>  <SYNONYMS>  (294) 
Tripelennamine (BAN, INN); Tripelennamine Citrate (FDA, USP); Tripelennamine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (294) 
4

>  <RESEARCH_CODES>  (294) 
nan

>  <APPLICANTS>  (294) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (294) 
nan

>  <USAN_STEM_DEFINITION>  (294) 
nan

>  <USAN_STEM_SUBSTEM>  (294) 
nan

>  <USAN_YEAR>  (294) 
nan

>  <FIRST_APPROVAL>  (294) 
1948.0

>  <ATC_CODE>  (294) 
D04AA04; R06AC04

>  <ATC_CODE_DESCRIPTION>  (294) 
D04AA04 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]; R06AC04 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted ethylene diamines]

>  <INDICATION_CLASS>  (294) 
Antihistaminic

>  <SC_PATENT_NO>  (294) 
nan

>  <DRUG_TYPE>  (294) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (294) 
Y

>  <FIRST_IN_CLASS>  (294) 
N

>  <CHIRALITY>  (294) 
Achiral Molecule

>  <PRODRUG>  (294) 
N

>  <ORAL>  (294) 
Y

>  <PARENTERAL>  (294) 
N

>  <TOPICAL>  (294) 
N

>  <BLACK_BOX>  (294) 
N

>  <AVAILABILITY_TYPE>  (294) 
Discontinued

>  <WITHDRAWN_YEAR>  (294) 
nan

>  <WITHDRAWN_COUNTRY>  (294) 
nan

>  <WITHDRAWN_REASON>  (294) 
nan

>  <CANONICAL_SMILES>  (294) 
CN(C)CCN(Cc1ccccc1)c2ccccn2

>  <name>  (294) 
Tripelennamine 

>  <MW>  (294) 
255.365

>  <logP>  (294) 
2.6498

$$$$
CHEMBL856
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  9  3  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (295) 
65728

>  <SYNONYMS>  (295) 
Primidone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (295) 
4

>  <RESEARCH_CODES>  (295) 
nan

>  <APPLICANTS>  (295) 
Valeant Pharmaceuticals International; Nuro Pharma Llc

>  <USAN_STEM>  (295) 
nan

>  <USAN_STEM_DEFINITION>  (295) 
nan

>  <USAN_STEM_SUBSTEM>  (295) 
nan

>  <USAN_YEAR>  (295) 
nan

>  <FIRST_APPROVAL>  (295) 
1954.0

>  <ATC_CODE>  (295) 
N03AA03

>  <ATC_CODE_DESCRIPTION>  (295) 
N03AA03 [Nervous System:Antiepileptics:Antiepileptics:Barbiturates and derivatives]

>  <INDICATION_CLASS>  (295) 
Anticonvulsant

>  <SC_PATENT_NO>  (295) 
nan

>  <DRUG_TYPE>  (295) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (295) 
Y

>  <FIRST_IN_CLASS>  (295) 
N

>  <CHIRALITY>  (295) 
Achiral Molecule

>  <PRODRUG>  (295) 
N

>  <ORAL>  (295) 
Y

>  <PARENTERAL>  (295) 
N

>  <TOPICAL>  (295) 
N

>  <BLACK_BOX>  (295) 
N

>  <AVAILABILITY_TYPE>  (295) 
Prescription-only

>  <WITHDRAWN_YEAR>  (295) 
nan

>  <WITHDRAWN_COUNTRY>  (295) 
nan

>  <WITHDRAWN_REASON>  (295) 
nan

>  <CANONICAL_SMILES>  (295) 
CCC1(C(=O)NCNC1=O)c2ccccc2

>  <name>  (295) 
Primidone 

>  <MW>  (295) 
218.256

>  <logP>  (295) 
0.5379

$$$$
CHEMBL504760
     RDKit          

 11 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  9 11  1  0
  7  2  1  0
 11  4  1  0
M  END
>  <PARENT_MOLREGNO>  (296) 
445067

>  <SYNONYMS>  (296) 
Camphor (USP); D-CAMPHOR (JAN); DL-Camphor (JAN); Trans-Pi-Oxocamphor (JAN)

>  <DEVELOPMENT_PHASE>  (296) 
4

>  <RESEARCH_CODES>  (296) 
nan

>  <APPLICANTS>  (296) 
Stiefel; Sterling Health U.S.A; Bristol-Myers Products; Ascher; Whitehall-Robins

>  <USAN_STEM>  (296) 
nan

>  <USAN_STEM_DEFINITION>  (296) 
nan

>  <USAN_STEM_SUBSTEM>  (296) 
nan

>  <USAN_YEAR>  (296) 
nan

>  <FIRST_APPROVAL>  (296) 
nan

>  <ATC_CODE>  (296) 
C01EB02

>  <ATC_CODE_DESCRIPTION>  (296) 
C01EB02 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (296) 
Antipruritic

>  <SC_PATENT_NO>  (296) 
nan

>  <DRUG_TYPE>  (296) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (296) 
Y

>  <FIRST_IN_CLASS>  (296) 
N

>  <CHIRALITY>  (296) 
Single Stereoisomer

>  <PRODRUG>  (296) 
N

>  <ORAL>  (296) 
N

>  <PARENTERAL>  (296) 
N

>  <TOPICAL>  (296) 
N

>  <BLACK_BOX>  (296) 
N

>  <AVAILABILITY_TYPE>  (296) 
Unknown

>  <WITHDRAWN_YEAR>  (296) 
nan

>  <WITHDRAWN_COUNTRY>  (296) 
nan

>  <WITHDRAWN_REASON>  (296) 
nan

>  <CANONICAL_SMILES>  (296) 
CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2

>  <name>  (296) 
Camphor 

>  <MW>  (296) 
152.237

>  <logP>  (296) 
2.4017

$$$$
CHEMBL1401
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 19 21  1  0
 10  5  1  0
 18 14  1  0
M  CHG  2  19   1  21  -1
M  END
>  <PARENT_MOLREGNO>  (297) 
338934

>  <SYNONYMS>  (297) 
Nitazoxanide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (297) 
4

>  <RESEARCH_CODES>  (297) 
PH-5776

>  <APPLICANTS>  (297) 
Romark Laboratories

>  <USAN_STEM>  (297) 
-oxanide

>  <USAN_STEM_DEFINITION>  (297) 
antiparasitics (salicylanilide derivatives)

>  <USAN_STEM_SUBSTEM>  (297) 
-oxanide

>  <USAN_YEAR>  (297) 
2003.0

>  <FIRST_APPROVAL>  (297) 
2002.0

>  <ATC_CODE>  (297) 
P01AX11

>  <ATC_CODE_DESCRIPTION>  (297) 
P01AX11 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Other agents against amoebiasis and other protozoal diseases]

>  <INDICATION_CLASS>  (297) 
nan

>  <SC_PATENT_NO>  (297) 
US-5965590-A

>  <DRUG_TYPE>  (297) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (297) 
Y

>  <FIRST_IN_CLASS>  (297) 
N

>  <CHIRALITY>  (297) 
Achiral Molecule

>  <PRODRUG>  (297) 
Y

>  <ORAL>  (297) 
Y

>  <PARENTERAL>  (297) 
N

>  <TOPICAL>  (297) 
N

>  <BLACK_BOX>  (297) 
N

>  <AVAILABILITY_TYPE>  (297) 
Prescription-only

>  <WITHDRAWN_YEAR>  (297) 
nan

>  <WITHDRAWN_COUNTRY>  (297) 
nan

>  <WITHDRAWN_REASON>  (297) 
nan

>  <CANONICAL_SMILES>  (297) 
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-]

>  <name>  (297) 
Nitazoxanide 

>  <MW>  (297) 
307.287

>  <logP>  (297) 
2.2289

$$$$
CHEMBL1138
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  6 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
  8  5  1  0
 16 10  1  0
 23 17  1  0
 30 24  1  0
M  END
>  <PARENT_MOLREGNO>  (298) 
175106

>  <SYNONYMS>  (298) 
Ezetimibe (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (298) 
4

>  <RESEARCH_CODES>  (298) 
SCH-58235

>  <APPLICANTS>  (298) 
Msd International Gmbh

>  <USAN_STEM>  (298) 
-imibe

>  <USAN_STEM_DEFINITION>  (298) 
antihyperlipidaemics, acyl CoA: cholesterol acyltransferase (ACAT)inhibitors

>  <USAN_STEM_SUBSTEM>  (298) 
-imibe

>  <USAN_YEAR>  (298) 
1999.0

>  <FIRST_APPROVAL>  (298) 
2002.0

>  <ATC_CODE>  (298) 
C10AX09

>  <ATC_CODE_DESCRIPTION>  (298) 
C10AX09 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:Other lipid modifying agents]

>  <INDICATION_CLASS>  (298) 
nan

>  <SC_PATENT_NO>  (298) 
US-5969156-A

>  <DRUG_TYPE>  (298) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (298) 
Y

>  <FIRST_IN_CLASS>  (298) 
N

>  <CHIRALITY>  (298) 
Single Stereoisomer

>  <PRODRUG>  (298) 
N

>  <ORAL>  (298) 
Y

>  <PARENTERAL>  (298) 
N

>  <TOPICAL>  (298) 
N

>  <BLACK_BOX>  (298) 
N

>  <AVAILABILITY_TYPE>  (298) 
Prescription-only

>  <WITHDRAWN_YEAR>  (298) 
nan

>  <WITHDRAWN_COUNTRY>  (298) 
nan

>  <WITHDRAWN_REASON>  (298) 
nan

>  <CANONICAL_SMILES>  (298) 
O[C@@H](CC[C@@H]1[C@H](N(C1=O)c2ccc(F)cc2)c3ccc(O)cc3)c4ccc(F)cc4

>  <name>  (298) 
Ezetimibe 

>  <MW>  (298) 
409.432

>  <logP>  (298) 
4.8883

$$$$
CHEMBL1214124
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  3  0
  5 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  3 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
  7  2  1  0
 13  8  1  0
 21 16  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (299) 
685974

>  <SYNONYMS>  (299) 
Perampanel (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (299) 
4

>  <RESEARCH_CODES>  (299) 
E-2007; E2007; ER-155055-90

>  <APPLICANTS>  (299) 
Eisai Inc

>  <USAN_STEM>  (299) 
-ampanel

>  <USAN_STEM_DEFINITION>  (299) 
ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors): antagonists

>  <USAN_STEM_SUBSTEM>  (299) 
-ampanel

>  <USAN_YEAR>  (299) 
2006.0

>  <FIRST_APPROVAL>  (299) 
2012.0

>  <ATC_CODE>  (299) 
N03AX22

>  <ATC_CODE_DESCRIPTION>  (299) 
N03AX22 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (299) 
nan

>  <SC_PATENT_NO>  (299) 
US-6949571-B2

>  <DRUG_TYPE>  (299) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (299) 
Y

>  <FIRST_IN_CLASS>  (299) 
N

>  <CHIRALITY>  (299) 
Achiral Molecule

>  <PRODRUG>  (299) 
N

>  <ORAL>  (299) 
Y

>  <PARENTERAL>  (299) 
N

>  <TOPICAL>  (299) 
N

>  <BLACK_BOX>  (299) 
Y

>  <AVAILABILITY_TYPE>  (299) 
Prescription-only

>  <WITHDRAWN_YEAR>  (299) 
nan

>  <WITHDRAWN_COUNTRY>  (299) 
nan

>  <WITHDRAWN_REASON>  (299) 
nan

>  <CANONICAL_SMILES>  (299) 
O=C1N(C=C(C=C1c2ccccc2C#N)c3ccccn3)c4ccccc4

>  <name>  (299) 
Perampanel 

>  <MW>  (299) 
349.393

>  <logP>  (299) 
4.43818

$$$$
CHEMBL1237132
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 24 25  1  0
 16 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 15 30  1  0
 17 11  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (300) 
699483

>  <SYNONYMS>  (300) 
Clevidipine (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (300) 
4

>  <RESEARCH_CODES>  (300) 
nan

>  <APPLICANTS>  (300) 
The Medicines Co

>  <USAN_STEM>  (300) 
-dipine

>  <USAN_STEM_DEFINITION>  (300) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (300) 
-dipine

>  <USAN_YEAR>  (300) 
2009.0

>  <FIRST_APPROVAL>  (300) 
2008.0

>  <ATC_CODE>  (300) 
C08CA16

>  <ATC_CODE_DESCRIPTION>  (300) 
C08CA16 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (300) 
nan

>  <SC_PATENT_NO>  (300) 
US-5856346-A

>  <DRUG_TYPE>  (300) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (300) 
Y

>  <FIRST_IN_CLASS>  (300) 
N

>  <CHIRALITY>  (300) 
Racemic Mixture

>  <PRODRUG>  (300) 
N

>  <ORAL>  (300) 
N

>  <PARENTERAL>  (300) 
Y

>  <TOPICAL>  (300) 
N

>  <BLACK_BOX>  (300) 
N

>  <AVAILABILITY_TYPE>  (300) 
Prescription-only

>  <WITHDRAWN_YEAR>  (300) 
nan

>  <WITHDRAWN_COUNTRY>  (300) 
nan

>  <WITHDRAWN_REASON>  (300) 
nan

>  <CANONICAL_SMILES>  (300) 
CCCC(=O)OCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C

>  <name>  (300) 
Clevidipine 

>  <MW>  (300) 
456.322

>  <logP>  (300) 
4.2452

$$$$
CHEMBL2107797
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
  7 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  3  0
 17  3  1  0
 20  3  1  0
 16  6  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (301) 
1380067

>  <SYNONYMS>  (301) 
Norgestrel (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (301) 
4

>  <RESEARCH_CODES>  (301) 
WY-3707

>  <APPLICANTS>  (301) 
Wyeth Pharmaceuticals Inc Sub Pfizer Inc; Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (301) 
-gest-

>  <USAN_STEM_DEFINITION>  (301) 
progestins

>  <USAN_STEM_SUBSTEM>  (301) 
-gest-

>  <USAN_YEAR>  (301) 
1966.0

>  <FIRST_APPROVAL>  (301) 
1968.0

>  <ATC_CODE>  (301) 
nan

>  <ATC_CODE_DESCRIPTION>  (301) 
nan

>  <INDICATION_CLASS>  (301) 
Progestin

>  <SC_PATENT_NO>  (301) 
nan

>  <DRUG_TYPE>  (301) 
Natural Product-derived

>  <RULE_OF_FIVE>  (301) 
Y

>  <FIRST_IN_CLASS>  (301) 
N

>  <CHIRALITY>  (301) 
Racemic Mixture

>  <PRODRUG>  (301) 
N

>  <ORAL>  (301) 
Y

>  <PARENTERAL>  (301) 
N

>  <TOPICAL>  (301) 
N

>  <BLACK_BOX>  (301) 
N

>  <AVAILABILITY_TYPE>  (301) 
Prescription-only

>  <WITHDRAWN_YEAR>  (301) 
nan

>  <WITHDRAWN_COUNTRY>  (301) 
nan

>  <WITHDRAWN_REASON>  (301) 
nan

>  <CANONICAL_SMILES>  (301) 
CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CCC2(O)C#C

>  <name>  (301) 
Norgestrel 

>  <MW>  (301) 
312.453

>  <logP>  (301) 
3.8826

$$$$
CHEMBL256087
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 10  4  1  0
M  END
>  <PARENT_MOLREGNO>  (302) 
425650

>  <SYNONYMS>  (302) 
DL-Menthol (JAN); Menthol (FDA, USP)

>  <DEVELOPMENT_PHASE>  (302) 
4

>  <RESEARCH_CODES>  (302) 
nan

>  <APPLICANTS>  (302) 
Hisamitsu Pharmaceutical Co Inc

>  <USAN_STEM>  (302) 
nan

>  <USAN_STEM_DEFINITION>  (302) 
nan

>  <USAN_STEM_SUBSTEM>  (302) 
nan

>  <USAN_YEAR>  (302) 
nan

>  <FIRST_APPROVAL>  (302) 
2008.0

>  <ATC_CODE>  (302) 
nan

>  <ATC_CODE_DESCRIPTION>  (302) 
nan

>  <INDICATION_CLASS>  (302) 
Antipruritic (topical)

>  <SC_PATENT_NO>  (302) 
US-8809615-B2

>  <DRUG_TYPE>  (302) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (302) 
Y

>  <FIRST_IN_CLASS>  (302) 
N

>  <CHIRALITY>  (302) 
Racemic Mixture

>  <PRODRUG>  (302) 
N

>  <ORAL>  (302) 
N

>  <PARENTERAL>  (302) 
N

>  <TOPICAL>  (302) 
Y

>  <BLACK_BOX>  (302) 
N

>  <AVAILABILITY_TYPE>  (302) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (302) 
nan

>  <WITHDRAWN_COUNTRY>  (302) 
nan

>  <WITHDRAWN_REASON>  (302) 
nan

>  <CANONICAL_SMILES>  (302) 
CC(C)C1CCC(C)CC1O

>  <name>  (302) 
DL-Menthol 

>  <MW>  (302) 
156.269

>  <logP>  (302) 
2.4395

$$$$
CHEMBL1444
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  3  0
  9 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  8  3  1  0
 15 10  1  0
 22 18  1  0
M  END
>  <PARENT_MOLREGNO>  (303) 
374548

>  <SYNONYMS>  (303) 
Letrozole (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (303) 
4

>  <RESEARCH_CODES>  (303) 
CGS-20267

>  <APPLICANTS>  (303) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (303) 
-rozole

>  <USAN_STEM_DEFINITION>  (303) 
aromatase inhibitors (imidazole/triazole derivatives)

>  <USAN_STEM_SUBSTEM>  (303) 
-rozole

>  <USAN_YEAR>  (303) 
1993.0

>  <FIRST_APPROVAL>  (303) 
1997.0

>  <ATC_CODE>  (303) 
L02BG04

>  <ATC_CODE_DESCRIPTION>  (303) 
L02BG04 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Aromatase inhibitors]

>  <INDICATION_CLASS>  (303) 
Antineoplastic

>  <SC_PATENT_NO>  (303) 
nan

>  <DRUG_TYPE>  (303) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (303) 
Y

>  <FIRST_IN_CLASS>  (303) 
N

>  <CHIRALITY>  (303) 
Achiral Molecule

>  <PRODRUG>  (303) 
N

>  <ORAL>  (303) 
Y

>  <PARENTERAL>  (303) 
N

>  <TOPICAL>  (303) 
N

>  <BLACK_BOX>  (303) 
N

>  <AVAILABILITY_TYPE>  (303) 
Prescription-only

>  <WITHDRAWN_YEAR>  (303) 
nan

>  <WITHDRAWN_COUNTRY>  (303) 
nan

>  <WITHDRAWN_REASON>  (303) 
nan

>  <CANONICAL_SMILES>  (303) 
N#Cc1ccc(cc1)C(c2ccc(cc2)C#N)n3cncn3

>  <name>  (303) 
Letrozole 

>  <MW>  (303) 
285.31

>  <logP>  (303) 
2.65916

$$$$
CHEMBL1475
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17  2  1  0
 17  7  1  0
 15 10  2  0
M  END
>  <PARENT_MOLREGNO>  (304) 
402531

>  <SYNONYMS>  (304) 
Trioxsalen (FDA, USAN, USP); Trioxysalen (INN, JAN)

>  <DEVELOPMENT_PHASE>  (304) 
4

>  <RESEARCH_CODES>  (304) 
nan

>  <APPLICANTS>  (304) 
Valeant Pharmaceuticals International

>  <USAN_STEM>  (304) 
-sal-

>  <USAN_STEM_DEFINITION>  (304) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (304) 
-sal-

>  <USAN_YEAR>  (304) 
1965.0

>  <FIRST_APPROVAL>  (304) 
1964.0

>  <ATC_CODE>  (304) 
D05BA01; D05AD01

>  <ATC_CODE_DESCRIPTION>  (304) 
D05BA01 [Dermatologicals:Antipsoriatics:Antipsoriatics For Systemic Use:Psoralens for systemic use]; D05AD01 [Dermatologicals:Antipsoriatics:Antipsoriatics For Topical Use:Psoralens for topical use]

>  <INDICATION_CLASS>  (304) 
Pigmentation Agent

>  <SC_PATENT_NO>  (304) 
nan

>  <DRUG_TYPE>  (304) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (304) 
Y

>  <FIRST_IN_CLASS>  (304) 
N

>  <CHIRALITY>  (304) 
Achiral Molecule

>  <PRODRUG>  (304) 
N

>  <ORAL>  (304) 
Y

>  <PARENTERAL>  (304) 
N

>  <TOPICAL>  (304) 
N

>  <BLACK_BOX>  (304) 
N

>  <AVAILABILITY_TYPE>  (304) 
Discontinued

>  <WITHDRAWN_YEAR>  (304) 
nan

>  <WITHDRAWN_COUNTRY>  (304) 
nan

>  <WITHDRAWN_REASON>  (304) 
nan

>  <CANONICAL_SMILES>  (304) 
CC1=CC(=O)Oc2c(C)c3oc(C)cc3cc12

>  <name>  (304) 
Trioxsalen 

>  <MW>  (304) 
228.247

>  <logP>  (304) 
3.46446

$$$$
CHEMBL1200971
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 12 24  1  0
 24 25  2  0
  7 26  1  0
 26 27  2  0
 26 28  1  0
 11  6  1  0
 24  8  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (305) 
674922

>  <SYNONYMS>  (305) 
Cefaloglycin (BAN, INN, JAN); Cephaloglycin (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (305) 
4

>  <RESEARCH_CODES>  (305) 
39435

>  <APPLICANTS>  (305) 
Eli Lilly And Co

>  <USAN_STEM>  (305) 
nan

>  <USAN_STEM_DEFINITION>  (305) 
nan

>  <USAN_STEM_SUBSTEM>  (305) 
nan

>  <USAN_YEAR>  (305) 
1965.0

>  <FIRST_APPROVAL>  (305) 
1970.0

>  <ATC_CODE>  (305) 
nan

>  <ATC_CODE_DESCRIPTION>  (305) 
nan

>  <INDICATION_CLASS>  (305) 
Antibacterial

>  <SC_PATENT_NO>  (305) 
nan

>  <DRUG_TYPE>  (305) 
Natural Product-derived

>  <RULE_OF_FIVE>  (305) 
Y

>  <FIRST_IN_CLASS>  (305) 
N

>  <CHIRALITY>  (305) 
Single Stereoisomer

>  <PRODRUG>  (305) 
N

>  <ORAL>  (305) 
Y

>  <PARENTERAL>  (305) 
N

>  <TOPICAL>  (305) 
N

>  <BLACK_BOX>  (305) 
N

>  <AVAILABILITY_TYPE>  (305) 
Discontinued

>  <WITHDRAWN_YEAR>  (305) 
nan

>  <WITHDRAWN_COUNTRY>  (305) 
nan

>  <WITHDRAWN_REASON>  (305) 
nan

>  <CANONICAL_SMILES>  (305) 
CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)C(=O)O

>  <name>  (305) 
Cefaloglycin 

>  <MW>  (305) 
405.432

>  <logP>  (305) 
-0.0119

$$$$
CHEMBL918
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (306) 
83000

>  <SYNONYMS>  (306) 
Phenacemide (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (306) 
4

>  <RESEARCH_CODES>  (306) 
nan

>  <APPLICANTS>  (306) 
Abbvie Inc

>  <USAN_STEM>  (306) 
nan

>  <USAN_STEM_DEFINITION>  (306) 
nan

>  <USAN_STEM_SUBSTEM>  (306) 
nan

>  <USAN_YEAR>  (306) 
nan

>  <FIRST_APPROVAL>  (306) 
1951.0

>  <ATC_CODE>  (306) 
N03AX07

>  <ATC_CODE_DESCRIPTION>  (306) 
N03AX07 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (306) 
Anticonvulsant

>  <SC_PATENT_NO>  (306) 
nan

>  <DRUG_TYPE>  (306) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (306) 
Y

>  <FIRST_IN_CLASS>  (306) 
N

>  <CHIRALITY>  (306) 
Achiral Molecule

>  <PRODRUG>  (306) 
N

>  <ORAL>  (306) 
Y

>  <PARENTERAL>  (306) 
N

>  <TOPICAL>  (306) 
N

>  <BLACK_BOX>  (306) 
N

>  <AVAILABILITY_TYPE>  (306) 
Discontinued

>  <WITHDRAWN_YEAR>  (306) 
nan

>  <WITHDRAWN_COUNTRY>  (306) 
nan

>  <WITHDRAWN_REASON>  (306) 
nan

>  <CANONICAL_SMILES>  (306) 
NC(=O)NC(=O)Cc1ccccc1

>  <name>  (306) 
Phenacemide 

>  <MW>  (306) 
178.191

>  <logP>  (306) 
0.424

$$$$
CHEMBL963
     RDKit          

 22 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 13 22  2  0
 15  2  1  0
 16  5  1  0
 22  5  1  0
 20  6  1  0
 22  8  1  0
M  END
>  <PARENT_MOLREGNO>  (307) 
94484

>  <SYNONYMS>  (307) 
Oxymorphone (BAN, INN); Oxymorphone HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (307) 
4

>  <RESEARCH_CODES>  (307) 
nan

>  <APPLICANTS>  (307) 
Endo Pharmaceuticals Inc

>  <USAN_STEM>  (307) 
nan

>  <USAN_STEM_DEFINITION>  (307) 
nan

>  <USAN_STEM_SUBSTEM>  (307) 
nan

>  <USAN_YEAR>  (307) 
nan

>  <FIRST_APPROVAL>  (307) 
1959.0

>  <ATC_CODE>  (307) 
nan

>  <ATC_CODE_DESCRIPTION>  (307) 
nan

>  <INDICATION_CLASS>  (307) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (307) 
US-7276250-B2

>  <DRUG_TYPE>  (307) 
Natural Product-derived

>  <RULE_OF_FIVE>  (307) 
Y

>  <FIRST_IN_CLASS>  (307) 
N

>  <CHIRALITY>  (307) 
Single Stereoisomer

>  <PRODRUG>  (307) 
N

>  <ORAL>  (307) 
Y

>  <PARENTERAL>  (307) 
Y

>  <TOPICAL>  (307) 
Y

>  <BLACK_BOX>  (307) 
Y

>  <AVAILABILITY_TYPE>  (307) 
Prescription-only

>  <WITHDRAWN_YEAR>  (307) 
nan

>  <WITHDRAWN_COUNTRY>  (307) 
nan

>  <WITHDRAWN_REASON>  (307) 
nan

>  <CANONICAL_SMILES>  (307) 
CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35

>  <name>  (307) 
Oxymorphone 

>  <MW>  (307) 
301.342

>  <logP>  (307) 
0.7452

$$$$
CHEMBL1479
     RDKit          

 25 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  3  0
 10  2  1  0
 14  2  1  0
  8  4  2  0
 19 13  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (308) 
405364

>  <SYNONYMS>  (308) 
Danazol (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (308) 
4

>  <RESEARCH_CODES>  (308) 
WIN-17757

>  <APPLICANTS>  (308) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (308) 
nan

>  <USAN_STEM_DEFINITION>  (308) 
nan

>  <USAN_STEM_SUBSTEM>  (308) 
nan

>  <USAN_YEAR>  (308) 
1968.0

>  <FIRST_APPROVAL>  (308) 
1976.0

>  <ATC_CODE>  (308) 
G03XA01

>  <ATC_CODE_DESCRIPTION>  (308) 
G03XA01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Other Sex Hormones And Modulators Of The Genital System:Antigonadotropins and similar agents]

>  <INDICATION_CLASS>  (308) 
Anterior Pituitary Suppressant

>  <SC_PATENT_NO>  (308) 
nan

>  <DRUG_TYPE>  (308) 
Natural Product-derived

>  <RULE_OF_FIVE>  (308) 
Y

>  <FIRST_IN_CLASS>  (308) 
N

>  <CHIRALITY>  (308) 
Single Stereoisomer

>  <PRODRUG>  (308) 
N

>  <ORAL>  (308) 
Y

>  <PARENTERAL>  (308) 
N

>  <TOPICAL>  (308) 
N

>  <BLACK_BOX>  (308) 
Y

>  <AVAILABILITY_TYPE>  (308) 
Prescription-only

>  <WITHDRAWN_YEAR>  (308) 
nan

>  <WITHDRAWN_COUNTRY>  (308) 
nan

>  <WITHDRAWN_REASON>  (308) 
nan

>  <CANONICAL_SMILES>  (308) 
C[C@]12Cc3cnoc3C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C

>  <name>  (308) 
Danazol 

>  <MW>  (308) 
337.463

>  <logP>  (308) 
4.221

$$$$
CHEMBL1200624
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 17 22  1  0
 22 23  3  0
 14 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28  5  1  0
 27  8  1  0
 24  9  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (309) 
674575

>  <SYNONYMS>  (309) 
Ethynodiol Diacetate (FDA, USAN, USP); Etynodiol (BAN, INN); Etynodiol Acetate (JAN)

>  <DEVELOPMENT_PHASE>  (309) 
4

>  <RESEARCH_CODES>  (309) 
SC-11800

>  <APPLICANTS>  (309) 
Gd Searle Llc

>  <USAN_STEM>  (309) 
nan

>  <USAN_STEM_DEFINITION>  (309) 
nan

>  <USAN_STEM_SUBSTEM>  (309) 
nan

>  <USAN_YEAR>  (309) 
1962.0

>  <FIRST_APPROVAL>  (309) 
1966.0

>  <ATC_CODE>  (309) 
G03DC06

>  <ATC_CODE_DESCRIPTION>  (309) 
G03DC06 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Estren derivatives]

>  <INDICATION_CLASS>  (309) 
Progestin

>  <SC_PATENT_NO>  (309) 
nan

>  <DRUG_TYPE>  (309) 
Natural Product-derived

>  <RULE_OF_FIVE>  (309) 
Y

>  <FIRST_IN_CLASS>  (309) 
N

>  <CHIRALITY>  (309) 
Single Stereoisomer

>  <PRODRUG>  (309) 
Y

>  <ORAL>  (309) 
Y

>  <PARENTERAL>  (309) 
N

>  <TOPICAL>  (309) 
N

>  <BLACK_BOX>  (309) 
N

>  <AVAILABILITY_TYPE>  (309) 
Prescription-only

>  <WITHDRAWN_YEAR>  (309) 
nan

>  <WITHDRAWN_COUNTRY>  (309) 
nan

>  <WITHDRAWN_REASON>  (309) 
nan

>  <CANONICAL_SMILES>  (309) 
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(=O)C)C#C)[C@@H]3CCC2=C1

>  <name>  (309) 
Ethynodiol Diacetate 

>  <MW>  (309) 
384.516

>  <logP>  (309) 
4.4259

$$$$
CHEMBL1201237
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 11  1  0
 21 15  2  0
M  END
>  <PARENT_MOLREGNO>  (310) 
675188

>  <SYNONYMS>  (310) 
Levobunolol (BAN, INN); Levobunolol HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (310) 
4

>  <RESEARCH_CODES>  (310) 
W-7000A

>  <APPLICANTS>  (310) 
Allergan Pharmaceutical

>  <USAN_STEM>  (310) 
-olol

>  <USAN_STEM_DEFINITION>  (310) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (310) 
-olol

>  <USAN_YEAR>  (310) 
1979.0

>  <FIRST_APPROVAL>  (310) 
1985.0

>  <ATC_CODE>  (310) 
S01ED03

>  <ATC_CODE_DESCRIPTION>  (310) 
S01ED03 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]

>  <INDICATION_CLASS>  (310) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (310) 
nan

>  <DRUG_TYPE>  (310) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (310) 
Y

>  <FIRST_IN_CLASS>  (310) 
N

>  <CHIRALITY>  (310) 
Single Stereoisomer

>  <PRODRUG>  (310) 
N

>  <ORAL>  (310) 
N

>  <PARENTERAL>  (310) 
N

>  <TOPICAL>  (310) 
Y

>  <BLACK_BOX>  (310) 
N

>  <AVAILABILITY_TYPE>  (310) 
Prescription-only

>  <WITHDRAWN_YEAR>  (310) 
nan

>  <WITHDRAWN_COUNTRY>  (310) 
nan

>  <WITHDRAWN_REASON>  (310) 
nan

>  <CANONICAL_SMILES>  (310) 
CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12

>  <name>  (310) 
Levobunolol 

>  <MW>  (310) 
291.391

>  <logP>  (310) 
2.3334

$$$$
CHEMBL1201288
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 12 22  2  0
 22 23  1  0
  9  4  1  0
 23 10  2  0
 20 15  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (311) 
675239

>  <SYNONYMS>  (311) 
Dantrolene (BAN, INN, USAN); Dantrolene sodium (BAN, FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (311) 
4

>  <RESEARCH_CODES>  (311) 
F-368; F-440

>  <APPLICANTS>  (311) 
Jhp Pharmaceuticals Llc

>  <USAN_STEM>  (311) 
nan

>  <USAN_STEM_DEFINITION>  (311) 
nan

>  <USAN_STEM_SUBSTEM>  (311) 
nan

>  <USAN_YEAR>  (311) 
1966.0

>  <FIRST_APPROVAL>  (311) 
1974.0

>  <ATC_CODE>  (311) 
M03CA01

>  <ATC_CODE_DESCRIPTION>  (311) 
M03CA01 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Directly Acting Agents:Dantrolene and derivatives]

>  <INDICATION_CLASS>  (311) 
Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (311) 
US-7758890-B2

>  <DRUG_TYPE>  (311) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (311) 
Y

>  <FIRST_IN_CLASS>  (311) 
N

>  <CHIRALITY>  (311) 
Achiral Molecule

>  <PRODRUG>  (311) 
N

>  <ORAL>  (311) 
Y

>  <PARENTERAL>  (311) 
Y

>  <TOPICAL>  (311) 
N

>  <BLACK_BOX>  (311) 
Y

>  <AVAILABILITY_TYPE>  (311) 
Prescription-only

>  <WITHDRAWN_YEAR>  (311) 
nan

>  <WITHDRAWN_COUNTRY>  (311) 
nan

>  <WITHDRAWN_REASON>  (311) 
nan

>  <CANONICAL_SMILES>  (311) 
[O-][N+](=O)c1ccc(cc1)c2oc(\C=N\N3CC(=O)NC3=O)cc2

>  <name>  (311) 
Dantrolene 

>  <MW>  (311) 
314.257

>  <logP>  (311) 
1.7405

$$$$
CHEMBL467
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
M  END
>  <PARENT_MOLREGNO>  (312) 
4730

>  <SYNONYMS>  (312) 
Hydroxycarbamide (INN); Hydroxyurea (BAN, FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (312) 
4

>  <RESEARCH_CODES>  (312) 
SQ-1089

>  <APPLICANTS>  (312) 
Bristol Myers Squibb Co

>  <USAN_STEM>  (312) 
nan

>  <USAN_STEM_DEFINITION>  (312) 
nan

>  <USAN_STEM_SUBSTEM>  (312) 
nan

>  <USAN_YEAR>  (312) 
1965.0

>  <FIRST_APPROVAL>  (312) 
1967.0

>  <ATC_CODE>  (312) 
L01XX05

>  <ATC_CODE_DESCRIPTION>  (312) 
L01XX05 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (312) 
Antineoplastic

>  <SC_PATENT_NO>  (312) 
nan

>  <DRUG_TYPE>  (312) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (312) 
Y

>  <FIRST_IN_CLASS>  (312) 
N

>  <CHIRALITY>  (312) 
Achiral Molecule

>  <PRODRUG>  (312) 
N

>  <ORAL>  (312) 
Y

>  <PARENTERAL>  (312) 
N

>  <TOPICAL>  (312) 
N

>  <BLACK_BOX>  (312) 
Y

>  <AVAILABILITY_TYPE>  (312) 
Prescription-only

>  <WITHDRAWN_YEAR>  (312) 
nan

>  <WITHDRAWN_COUNTRY>  (312) 
nan

>  <WITHDRAWN_REASON>  (312) 
nan

>  <CANONICAL_SMILES>  (312) 
NC(=O)NO

>  <name>  (312) 
Hydroxycarbamide 

>  <MW>  (312) 
76.055

>  <logP>  (312) 
-0.9561

$$$$
CHEMBL103
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22  4  1  0
 22  7  1  0
 19  8  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (313) 
12825

>  <SYNONYMS>  (313) 
Progesterone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (313) 
4

>  <RESEARCH_CODES>  (313) 
nan

>  <APPLICANTS>  (313) 
Ferring Pharmaceuticals Inc; Eli Lilly And Co; Alza Corp; Abbott Laboratories; Watson Laboratories Inc

>  <USAN_STEM>  (313) 
-gest-

>  <USAN_STEM_DEFINITION>  (313) 
progestins

>  <USAN_STEM_SUBSTEM>  (313) 
-gest-

>  <USAN_YEAR>  (313) 
nan

>  <FIRST_APPROVAL>  (313) 
1976.0

>  <ATC_CODE>  (313) 
G03DA04

>  <ATC_CODE_DESCRIPTION>  (313) 
G03DA04 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnen (4) derivatives]

>  <INDICATION_CLASS>  (313) 
Progestin

>  <SC_PATENT_NO>  (313) 
US-7300664-B1

>  <DRUG_TYPE>  (313) 
Natural Product-derived

>  <RULE_OF_FIVE>  (313) 
Y

>  <FIRST_IN_CLASS>  (313) 
N

>  <CHIRALITY>  (313) 
Single Stereoisomer

>  <PRODRUG>  (313) 
N

>  <ORAL>  (313) 
Y

>  <PARENTERAL>  (313) 
Y

>  <TOPICAL>  (313) 
Y

>  <BLACK_BOX>  (313) 
Y

>  <AVAILABILITY_TYPE>  (313) 
Prescription-only

>  <WITHDRAWN_YEAR>  (313) 
nan

>  <WITHDRAWN_COUNTRY>  (313) 
nan

>  <WITHDRAWN_REASON>  (313) 
nan

>  <CANONICAL_SMILES>  (313) 
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (313) 
Progesterone 

>  <MW>  (313) 
314.469

>  <logP>  (313) 
4.7235

$$$$
CHEMBL601
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
M  END
>  <PARENT_MOLREGNO>  (314) 
20917

>  <SYNONYMS>  (314) 
Aminolevulinic Acid HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (314) 
4

>  <RESEARCH_CODES>  (314) 
nan

>  <APPLICANTS>  (314) 
Dusa Pharmaceuticals Inc

>  <USAN_STEM>  (314) 
nan

>  <USAN_STEM_DEFINITION>  (314) 
nan

>  <USAN_STEM_SUBSTEM>  (314) 
nan

>  <USAN_YEAR>  (314) 
1997.0

>  <FIRST_APPROVAL>  (314) 
1999.0

>  <ATC_CODE>  (314) 
L01XD04

>  <ATC_CODE_DESCRIPTION>  (314) 
L01XD04 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Sensitizers used in photodynamic/radiation therapy]

>  <INDICATION_CLASS>  (314) 
Antineoplastic

>  <SC_PATENT_NO>  (314) 
US-5954703-A

>  <DRUG_TYPE>  (314) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (314) 
Y

>  <FIRST_IN_CLASS>  (314) 
N

>  <CHIRALITY>  (314) 
Achiral Molecule

>  <PRODRUG>  (314) 
N

>  <ORAL>  (314) 
N

>  <PARENTERAL>  (314) 
N

>  <TOPICAL>  (314) 
Y

>  <BLACK_BOX>  (314) 
N

>  <AVAILABILITY_TYPE>  (314) 
Prescription-only

>  <WITHDRAWN_YEAR>  (314) 
nan

>  <WITHDRAWN_COUNTRY>  (314) 
nan

>  <WITHDRAWN_REASON>  (314) 
nan

>  <CANONICAL_SMILES>  (314) 
NCC(=O)CCC(=O)O

>  <name>  (314) 
Aminolevulinic Acid HCl 

>  <MW>  (314) 
131.131

>  <logP>  (314) 
-0.621

$$$$
CHEMBL248702
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (315) 
421350

>  <SYNONYMS>  (315) 
Dexfenfluramine (BAN, INN); Dexfenfluramine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (315) 
4

>  <RESEARCH_CODES>  (315) 
S-5614 HCl

>  <APPLICANTS>  (315) 
Interneuron

>  <USAN_STEM>  (315) 
nan

>  <USAN_STEM_DEFINITION>  (315) 
nan

>  <USAN_STEM_SUBSTEM>  (315) 
nan

>  <USAN_YEAR>  (315) 
1991.0

>  <FIRST_APPROVAL>  (315) 
nan

>  <ATC_CODE>  (315) 
A08AA04

>  <ATC_CODE_DESCRIPTION>  (315) 
A08AA04 [Alimentary Tract And Metabolism:Antiobesity Preparations, Excl. Diet Products:Antiobesity Preparations, Excl. Diet Products:Centrally acting antiobesity products]

>  <INDICATION_CLASS>  (315) 
Appetite Suppressant (systemic)

>  <SC_PATENT_NO>  (315) 
nan

>  <DRUG_TYPE>  (315) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (315) 
Y

>  <FIRST_IN_CLASS>  (315) 
N

>  <CHIRALITY>  (315) 
Single Stereoisomer

>  <PRODRUG>  (315) 
N

>  <ORAL>  (315) 
N

>  <PARENTERAL>  (315) 
N

>  <TOPICAL>  (315) 
N

>  <BLACK_BOX>  (315) 
N

>  <AVAILABILITY_TYPE>  (315) 
Withdrawn

>  <WITHDRAWN_YEAR>  (315) 
1997.0

>  <WITHDRAWN_COUNTRY>  (315) 
United Kingdom; United States; European Union; Canada; Malasia; India; Saudi Arabia

>  <WITHDRAWN_REASON>  (315) 
Cardiac valvular disease

>  <CANONICAL_SMILES>  (315) 
CCN[C@@H](C)Cc1cccc(c1)C(F)(F)F

>  <name>  (315) 
Dexfenfluramine 

>  <MW>  (315) 
231.261

>  <logP>  (315) 
3.2459

$$$$
CHEMBL3137312
     RDKit          

 35 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  6 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
  4 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  2  0
 28 31  1  0
 26 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
  8  3  1  0
 19 13  1  0
 35 21  1  0
 34 24  1  0
M  END
>  <PARENT_MOLREGNO>  (316) 
1626743

>  <SYNONYMS>  (316) 
Dasabuvir (INN, USAN); Dasabuvir sodium (FDA)

>  <DEVELOPMENT_PHASE>  (316) 
4

>  <RESEARCH_CODES>  (316) 
ABT-333

>  <APPLICANTS>  (316) 
Abbvie Inc.; Abbvie Inc

>  <USAN_STEM>  (316) 
-vir

>  <USAN_STEM_DEFINITION>  (316) 
antivirals: RNA polymerase (NS5B) inhibitor

>  <USAN_STEM_SUBSTEM>  (316) 
-vir (-buvir)

>  <USAN_YEAR>  (316) 
2013.0

>  <FIRST_APPROVAL>  (316) 
2014.0

>  <ATC_CODE>  (316) 
J05AX16

>  <ATC_CODE_DESCRIPTION>  (316) 
J05AX16 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals]

>  <INDICATION_CLASS>  (316) 
nan

>  <SC_PATENT_NO>  (316) 
US-6037157-A

>  <DRUG_TYPE>  (316) 
Natural Product-derived

>  <RULE_OF_FIVE>  (316) 
Y

>  <FIRST_IN_CLASS>  (316) 
N

>  <CHIRALITY>  (316) 
Achiral Molecule

>  <PRODRUG>  (316) 
N

>  <ORAL>  (316) 
Y

>  <PARENTERAL>  (316) 
N

>  <TOPICAL>  (316) 
N

>  <BLACK_BOX>  (316) 
N

>  <AVAILABILITY_TYPE>  (316) 
Prescription-only

>  <WITHDRAWN_YEAR>  (316) 
nan

>  <WITHDRAWN_COUNTRY>  (316) 
nan

>  <WITHDRAWN_REASON>  (316) 
nan

>  <CANONICAL_SMILES>  (316) 
COc1c(cc(cc1C(C)(C)C)N2C=CC(=O)NC2=O)c3ccc4cc(NS(=O)(=O)C)ccc4c3

>  <name>  (316) 
Dasabuvir 

>  <MW>  (316) 
493.585

>  <logP>  (316) 
4.0236

$$$$
CHEMBL1585
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (317) 
453722

>  <SYNONYMS>  (317) 
Pipobroman (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (317) 
4

>  <RESEARCH_CODES>  (317) 
A-8103

>  <APPLICANTS>  (317) 
Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (317) 
nan

>  <USAN_STEM_DEFINITION>  (317) 
nan

>  <USAN_STEM_SUBSTEM>  (317) 
nan

>  <USAN_YEAR>  (317) 
1965.0

>  <FIRST_APPROVAL>  (317) 
1966.0

>  <ATC_CODE>  (317) 
L01AX02

>  <ATC_CODE_DESCRIPTION>  (317) 
L01AX02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Other alkylating agents]

>  <INDICATION_CLASS>  (317) 
Antineoplastic

>  <SC_PATENT_NO>  (317) 
nan

>  <DRUG_TYPE>  (317) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (317) 
Y

>  <FIRST_IN_CLASS>  (317) 
N

>  <CHIRALITY>  (317) 
Achiral Molecule

>  <PRODRUG>  (317) 
N

>  <ORAL>  (317) 
Y

>  <PARENTERAL>  (317) 
N

>  <TOPICAL>  (317) 
N

>  <BLACK_BOX>  (317) 
N

>  <AVAILABILITY_TYPE>  (317) 
Discontinued

>  <WITHDRAWN_YEAR>  (317) 
nan

>  <WITHDRAWN_COUNTRY>  (317) 
nan

>  <WITHDRAWN_REASON>  (317) 
nan

>  <CANONICAL_SMILES>  (317) 
BrCCC(=O)N1CCN(CC1)C(=O)CCBr

>  <name>  (317) 
Pipobroman 

>  <MW>  (317) 
356.058

>  <logP>  (317) 
1.2272

$$$$
CHEMBL1233
     RDKit          

 18 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
M  END
>  <PARENT_MOLREGNO>  (318) 
230249

>  <SYNONYMS>  (318) 
Carisoprodol (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (318) 
4

>  <RESEARCH_CODES>  (318) 
nan

>  <APPLICANTS>  (318) 
Schering Corp Sub Schering Plough Corp; Meda Pharmaceuticals Meda Pharmaceuticals Inc

>  <USAN_STEM>  (318) 
nan

>  <USAN_STEM_DEFINITION>  (318) 
nan

>  <USAN_STEM_SUBSTEM>  (318) 
nan

>  <USAN_YEAR>  (318) 
nan

>  <FIRST_APPROVAL>  (318) 
1959.0

>  <ATC_CODE>  (318) 
M03BA52; M03BA72; M03BA02

>  <ATC_CODE_DESCRIPTION>  (318) 
M03BA52 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Carbamic acid esters]; M03BA72 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Carbamic acid esters]; M03BA02 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Carbamic acid esters]

>  <INDICATION_CLASS>  (318) 
Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (318) 
nan

>  <DRUG_TYPE>  (318) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (318) 
Y

>  <FIRST_IN_CLASS>  (318) 
N

>  <CHIRALITY>  (318) 
Racemic Mixture

>  <PRODRUG>  (318) 
N

>  <ORAL>  (318) 
Y

>  <PARENTERAL>  (318) 
N

>  <TOPICAL>  (318) 
N

>  <BLACK_BOX>  (318) 
N

>  <AVAILABILITY_TYPE>  (318) 
Prescription-only

>  <WITHDRAWN_YEAR>  (318) 
2007.0

>  <WITHDRAWN_COUNTRY>  (318) 
European Union

>  <WITHDRAWN_REASON>  (318) 
Increased risk of abuse or addiction, intoxication and events related to psychomotor impairment

>  <CANONICAL_SMILES>  (318) 
CCCC(C)(COC(=O)N)COC(=O)NC(C)C

>  <name>  (318) 
Carisoprodol 

>  <MW>  (318) 
260.334

>  <logP>  (318) 
2.0227

$$$$
CHEMBL1170
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24  6  1  0
 24  9  1  0
 21 10  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (319) 
190629

>  <SYNONYMS>  (319) 
Testosterone propionate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (319) 
4

>  <RESEARCH_CODES>  (319) 
nan

>  <APPLICANTS>  (319) 
Watson Laboratories Inc; Elkins Sinn Div Ah Robins Co Inc; Eli Lilly And Co; Bel Mar Laboratories Inc

>  <USAN_STEM>  (319) 
-ster-

>  <USAN_STEM_DEFINITION>  (319) 
steroids (androgens, anabolics)

>  <USAN_STEM_SUBSTEM>  (319) 
-ster-

>  <USAN_YEAR>  (319) 
nan

>  <FIRST_APPROVAL>  (319) 
1974.0

>  <ATC_CODE>  (319) 
G03BA03

>  <ATC_CODE_DESCRIPTION>  (319) 
G03BA03 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Androgens:3-oxoandrosten (4) derivatives]

>  <INDICATION_CLASS>  (319) 
Androgen

>  <SC_PATENT_NO>  (319) 
nan

>  <DRUG_TYPE>  (319) 
Natural Product-derived

>  <RULE_OF_FIVE>  (319) 
Y

>  <FIRST_IN_CLASS>  (319) 
N

>  <CHIRALITY>  (319) 
Single Stereoisomer

>  <PRODRUG>  (319) 
Y

>  <ORAL>  (319) 
N

>  <PARENTERAL>  (319) 
Y

>  <TOPICAL>  (319) 
N

>  <BLACK_BOX>  (319) 
N

>  <AVAILABILITY_TYPE>  (319) 
Discontinued

>  <WITHDRAWN_YEAR>  (319) 
nan

>  <WITHDRAWN_COUNTRY>  (319) 
nan

>  <WITHDRAWN_REASON>  (319) 
nan

>  <CANONICAL_SMILES>  (319) 
CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (319) 
Testosterone propionate 

>  <MW>  (319) 
344.495

>  <logP>  (319) 
4.8401

$$$$
CHEMBL135
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 16  2  1  0
 19  2  1  0
 15  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (320) 
27626

>  <SYNONYMS>  (320) 
Estradiol (BAN, FDA, INN, USP); Estradiol Hemihydrate (FDA)

>  <DEVELOPMENT_PHASE>  (320) 
4

>  <RESEARCH_CODES>  (320) 
nan

>  <APPLICANTS>  (320) 
Meda Pharmaceuticals Inc; Kv Pharmaceutical Co; Bayer Healthcare Pharmaceuticals Inc; Ascend Therapeutics Inc; Medicis Pharmaceutical Corp

>  <USAN_STEM>  (320) 
estr-

>  <USAN_STEM_DEFINITION>  (320) 
estrogens

>  <USAN_STEM_SUBSTEM>  (320) 
estr-

>  <USAN_YEAR>  (320) 
nan

>  <FIRST_APPROVAL>  (320) 
1975.0

>  <ATC_CODE>  (320) 
G03CA03; G03CA53

>  <ATC_CODE_DESCRIPTION>  (320) 
G03CA03 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Natural and semisynthetic estrogens, plain]; G03CA53 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Natural and semisynthetic estrogens, plain]

>  <INDICATION_CLASS>  (320) 
Estrogen

>  <SC_PATENT_NO>  (320) 
US-5860946-A

>  <DRUG_TYPE>  (320) 
Natural Product-derived

>  <RULE_OF_FIVE>  (320) 
Y

>  <FIRST_IN_CLASS>  (320) 
N

>  <CHIRALITY>  (320) 
Single Stereoisomer

>  <PRODRUG>  (320) 
N

>  <ORAL>  (320) 
Y

>  <PARENTERAL>  (320) 
N

>  <TOPICAL>  (320) 
Y

>  <BLACK_BOX>  (320) 
Y

>  <AVAILABILITY_TYPE>  (320) 
Prescription-only

>  <WITHDRAWN_YEAR>  (320) 
nan

>  <WITHDRAWN_COUNTRY>  (320) 
nan

>  <WITHDRAWN_REASON>  (320) 
nan

>  <CANONICAL_SMILES>  (320) 
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O

>  <name>  (320) 
Estradiol 

>  <MW>  (320) 
272.388

>  <logP>  (320) 
3.6092

$$$$
CHEMBL1201760
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 18 22  1  0
 22 23  2  0
 23 24  1  0
 16 25  1  0
 25 26  2  0
 25 27  1  0
  8  2  1  0
 23  9  1  0
 22 13  1  0
 21 19  1  0
M  END
>  <PARENT_MOLREGNO>  (321) 
675711

>  <SYNONYMS>  (321) 
Besifloxacin (INN); Besifloxacin HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (321) 
4

>  <RESEARCH_CODES>  (321) 
BOL-303224-A; SS-734

>  <APPLICANTS>  (321) 
Bausch And Lomb Inc

>  <USAN_STEM>  (321) 
-oxacin

>  <USAN_STEM_DEFINITION>  (321) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (321) 
-oxacin

>  <USAN_YEAR>  (321) 
2007.0

>  <FIRST_APPROVAL>  (321) 
2009.0

>  <ATC_CODE>  (321) 
S01AE08

>  <ATC_CODE_DESCRIPTION>  (321) 
S01AE08 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]

>  <INDICATION_CLASS>  (321) 
nan

>  <SC_PATENT_NO>  (321) 
US-5447926-A

>  <DRUG_TYPE>  (321) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (321) 
Y

>  <FIRST_IN_CLASS>  (321) 
N

>  <CHIRALITY>  (321) 
Single Stereoisomer

>  <PRODRUG>  (321) 
N

>  <ORAL>  (321) 
N

>  <PARENTERAL>  (321) 
N

>  <TOPICAL>  (321) 
Y

>  <BLACK_BOX>  (321) 
N

>  <AVAILABILITY_TYPE>  (321) 
Prescription-only

>  <WITHDRAWN_YEAR>  (321) 
nan

>  <WITHDRAWN_COUNTRY>  (321) 
nan

>  <WITHDRAWN_REASON>  (321) 
nan

>  <CANONICAL_SMILES>  (321) 
N[C@@H]1CCCCN(C1)c2c(F)cc3C(=O)C(=CN(C4CC4)c3c2Cl)C(=O)O

>  <name>  (321) 
Besifloxacin 

>  <MW>  (321) 
393.846

>  <logP>  (321) 
3.1447

$$$$
CHEMBL15677
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 10  5  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (322) 
16521

>  <SYNONYMS>  (322) 
Fenclofenac (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (322) 
4

>  <RESEARCH_CODES>  (322) 
R-67408; RX-67408

>  <APPLICANTS>  (322) 
nan

>  <USAN_STEM>  (322) 
-ac

>  <USAN_STEM_DEFINITION>  (322) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (322) 
-ac

>  <USAN_YEAR>  (322) 
1978.0

>  <FIRST_APPROVAL>  (322) 
1978.0

>  <ATC_CODE>  (322) 
nan

>  <ATC_CODE_DESCRIPTION>  (322) 
nan

>  <INDICATION_CLASS>  (322) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (322) 
nan

>  <DRUG_TYPE>  (322) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (322) 
Y

>  <FIRST_IN_CLASS>  (322) 
N

>  <CHIRALITY>  (322) 
Achiral Molecule

>  <PRODRUG>  (322) 
N

>  <ORAL>  (322) 
N

>  <PARENTERAL>  (322) 
N

>  <TOPICAL>  (322) 
N

>  <BLACK_BOX>  (322) 
N

>  <AVAILABILITY_TYPE>  (322) 
Withdrawn

>  <WITHDRAWN_YEAR>  (322) 
1984.0

>  <WITHDRAWN_COUNTRY>  (322) 
United Kingdom

>  <WITHDRAWN_REASON>  (322) 
Cutaneous Reactions; Animal Carcinogenicity

>  <CANONICAL_SMILES>  (322) 
OC(=O)Cc1ccccc1Oc2ccc(Cl)cc2Cl

>  <name>  (322) 
Fenclofenac 

>  <MW>  (322) 
297.137

>  <logP>  (322) 
4.4128

$$$$
CHEMBL806
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 10 17  1  0
 17 18  2  0
 17 19  1  0
 12  7  1  0
M  CHG  2  17   1  19  -1
M  END
>  <PARENT_MOLREGNO>  (323) 
52087

>  <SYNONYMS>  (323) 
Flutamide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (323) 
4

>  <RESEARCH_CODES>  (323) 
SCH-13521

>  <APPLICANTS>  (323) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (323) 
-lutamide

>  <USAN_STEM_DEFINITION>  (323) 
non-steroid antiandrogens

>  <USAN_STEM_SUBSTEM>  (323) 
-lutamide

>  <USAN_YEAR>  (323) 
1975.0

>  <FIRST_APPROVAL>  (323) 
1989.0

>  <ATC_CODE>  (323) 
L02BB01

>  <ATC_CODE_DESCRIPTION>  (323) 
L02BB01 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Anti-androgens]

>  <INDICATION_CLASS>  (323) 
nan

>  <SC_PATENT_NO>  (323) 
nan

>  <DRUG_TYPE>  (323) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (323) 
Y

>  <FIRST_IN_CLASS>  (323) 
N

>  <CHIRALITY>  (323) 
Achiral Molecule

>  <PRODRUG>  (323) 
Y

>  <ORAL>  (323) 
Y

>  <PARENTERAL>  (323) 
N

>  <TOPICAL>  (323) 
N

>  <BLACK_BOX>  (323) 
Y

>  <AVAILABILITY_TYPE>  (323) 
Prescription-only

>  <WITHDRAWN_YEAR>  (323) 
nan

>  <WITHDRAWN_COUNTRY>  (323) 
nan

>  <WITHDRAWN_REASON>  (323) 
nan

>  <CANONICAL_SMILES>  (323) 
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-]

>  <name>  (323) 
Flutamide 

>  <MW>  (323) 
276.214

>  <logP>  (323) 
3.2081

$$$$
CHEMBL1491306
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  4 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  2  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (324) 
915190

>  <SYNONYMS>  (324) 
Benzylthiouracil

>  <DEVELOPMENT_PHASE>  (324) 
4

>  <RESEARCH_CODES>  (324) 
nan

>  <APPLICANTS>  (324) 
nan

>  <USAN_STEM>  (324) 
-uracil

>  <USAN_STEM_DEFINITION>  (324) 
uracil derivatives used as thyroid antagonists and as antineoplastics

>  <USAN_STEM_SUBSTEM>  (324) 
-uracil

>  <USAN_YEAR>  (324) 
nan

>  <FIRST_APPROVAL>  (324) 
nan

>  <ATC_CODE>  (324) 
H03BA03

>  <ATC_CODE_DESCRIPTION>  (324) 
H03BA03 [Systemic Hormonal Preparations, Excl. :Thyroid Therapy:Antithyroid Preparations:Thiouracils]

>  <INDICATION_CLASS>  (324) 
nan

>  <SC_PATENT_NO>  (324) 
nan

>  <DRUG_TYPE>  (324) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (324) 
Y

>  <FIRST_IN_CLASS>  (324) 
N

>  <CHIRALITY>  (324) 
Achiral Molecule

>  <PRODRUG>  (324) 
N

>  <ORAL>  (324) 
N

>  <PARENTERAL>  (324) 
N

>  <TOPICAL>  (324) 
N

>  <BLACK_BOX>  (324) 
N

>  <AVAILABILITY_TYPE>  (324) 
Unknown

>  <WITHDRAWN_YEAR>  (324) 
nan

>  <WITHDRAWN_COUNTRY>  (324) 
nan

>  <WITHDRAWN_REASON>  (324) 
nan

>  <CANONICAL_SMILES>  (324) 
Oc1cc(Cc2ccccc2)nc(S)n1

>  <name>  (324) 
Benzylthiouracil

>  <MW>  (324) 
218.281

>  <logP>  (324) 
2.0617

$$$$
CHEMBL1463345
     RDKit          

 25 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
  8  2  1  0
 12  2  1  0
 17 11  1  0
 20 15  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (325) 
887229

>  <SYNONYMS>  (325) 
Canrenone (INN, USAN)

>  <DEVELOPMENT_PHASE>  (325) 
4

>  <RESEARCH_CODES>  (325) 
SC-9376

>  <APPLICANTS>  (325) 
nan

>  <USAN_STEM>  (325) 
-renone

>  <USAN_STEM_DEFINITION>  (325) 
aldosterone antagonists (spironolactone type)

>  <USAN_STEM_SUBSTEM>  (325) 
-renone

>  <USAN_YEAR>  (325) 
1967.0

>  <FIRST_APPROVAL>  (325) 
nan

>  <ATC_CODE>  (325) 
C03DA03

>  <ATC_CODE_DESCRIPTION>  (325) 
C03DA03 [Cardiovascular System:Diuretics:Potassium-Sparing Agents:Aldosterone antagonists]

>  <INDICATION_CLASS>  (325) 
Aldosterone Antagonist

>  <SC_PATENT_NO>  (325) 
nan

>  <DRUG_TYPE>  (325) 
Natural Product-derived

>  <RULE_OF_FIVE>  (325) 
Y

>  <FIRST_IN_CLASS>  (325) 
N

>  <CHIRALITY>  (325) 
Single Stereoisomer

>  <PRODRUG>  (325) 
N

>  <ORAL>  (325) 
N

>  <PARENTERAL>  (325) 
N

>  <TOPICAL>  (325) 
N

>  <BLACK_BOX>  (325) 
N

>  <AVAILABILITY_TYPE>  (325) 
Withdrawn

>  <WITHDRAWN_YEAR>  (325) 
1986.0

>  <WITHDRAWN_COUNTRY>  (325) 
Germany

>  <WITHDRAWN_REASON>  (325) 
Animal carcinogenicity

>  <CANONICAL_SMILES>  (325) 
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5

>  <name>  (325) 
Canrenone 

>  <MW>  (325) 
340.463

>  <logP>  (325) 
4.3701

$$$$
CHEMBL1198857
     RDKit          

 32 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  5 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
  8  3  1  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (326) 
672807

>  <SYNONYMS>  (326) 
Vilanterol (INN, USAN); Vilanterol Trifenatate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (326) 
4

>  <RESEARCH_CODES>  (326) 
GW642444X; GW642444M

>  <APPLICANTS>  (326) 
GlaxoSmithKline Intellectual Property Development Ltd England; GlaxoSmithKline; Glaxo Group Ltd England Dba GlaxoSmithKline

>  <USAN_STEM>  (326) 
-terol

>  <USAN_STEM_DEFINITION>  (326) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (326) 
-terol

>  <USAN_YEAR>  (326) 
2009.0

>  <FIRST_APPROVAL>  (326) 
2013.0

>  <ATC_CODE>  (326) 
nan

>  <ATC_CODE_DESCRIPTION>  (326) 
nan

>  <INDICATION_CLASS>  (326) 
nan

>  <SC_PATENT_NO>  (326) 
US-5873360-A

>  <DRUG_TYPE>  (326) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (326) 
Y

>  <FIRST_IN_CLASS>  (326) 
N

>  <CHIRALITY>  (326) 
Single Stereoisomer

>  <PRODRUG>  (326) 
N

>  <ORAL>  (326) 
N

>  <PARENTERAL>  (326) 
N

>  <TOPICAL>  (326) 
Y

>  <BLACK_BOX>  (326) 
Y

>  <AVAILABILITY_TYPE>  (326) 
Prescription-only

>  <WITHDRAWN_YEAR>  (326) 
nan

>  <WITHDRAWN_COUNTRY>  (326) 
nan

>  <WITHDRAWN_REASON>  (326) 
nan

>  <CANONICAL_SMILES>  (326) 
OCc1cc(ccc1O)[C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl

>  <name>  (326) 
Vilanterol 

>  <MW>  (326) 
486.436

>  <logP>  (326) 
4.6081

$$$$
CHEMBL1037
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  9 15  1  0
 15  6  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (327) 
123976

>  <SYNONYMS>  (327) 
Guanadrel (INN); Guanadrel Sulfate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (327) 
4

>  <RESEARCH_CODES>  (327) 
CL-1388R; U-28288D

>  <APPLICANTS>  (327) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (327) 
guan-

>  <USAN_STEM_DEFINITION>  (327) 
antihypertensives (guanidine derivatives)

>  <USAN_STEM_SUBSTEM>  (327) 
guan-

>  <USAN_YEAR>  (327) 
1968.0

>  <FIRST_APPROVAL>  (327) 
1982.0

>  <ATC_CODE>  (327) 
nan

>  <ATC_CODE_DESCRIPTION>  (327) 
nan

>  <INDICATION_CLASS>  (327) 
Antihypertensive

>  <SC_PATENT_NO>  (327) 
nan

>  <DRUG_TYPE>  (327) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (327) 
Y

>  <FIRST_IN_CLASS>  (327) 
N

>  <CHIRALITY>  (327) 
Racemic Mixture

>  <PRODRUG>  (327) 
N

>  <ORAL>  (327) 
Y

>  <PARENTERAL>  (327) 
N

>  <TOPICAL>  (327) 
N

>  <BLACK_BOX>  (327) 
N

>  <AVAILABILITY_TYPE>  (327) 
Discontinued

>  <WITHDRAWN_YEAR>  (327) 
nan

>  <WITHDRAWN_COUNTRY>  (327) 
nan

>  <WITHDRAWN_REASON>  (327) 
nan

>  <CANONICAL_SMILES>  (327) 
NC(=N)NCC1COC2(CCCCC2)O1

>  <name>  (327) 
Guanadrel 

>  <MW>  (327) 
213.281

>  <logP>  (327) 
0.54527

$$$$
CHEMBL1454
     RDKit          

 14 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  5  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8  1  1  0
  7  3  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (328) 
384948

>  <SYNONYMS>  (328) 
Levamisole (BAN, INN); Levamisole HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (328) 
4

>  <RESEARCH_CODES>  (328) 
TCMDC-125847; R-12564

>  <APPLICANTS>  (328) 
Janssen Pharmaceutica Products Lp

>  <USAN_STEM>  (328) 
nan

>  <USAN_STEM_DEFINITION>  (328) 
nan

>  <USAN_STEM_SUBSTEM>  (328) 
nan

>  <USAN_YEAR>  (328) 
1970.0

>  <FIRST_APPROVAL>  (328) 
1990.0

>  <ATC_CODE>  (328) 
P02CE01

>  <ATC_CODE_DESCRIPTION>  (328) 
P02CE01 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Imidazothiazole derivatives]

>  <INDICATION_CLASS>  (328) 
Biological Response Modifier

>  <SC_PATENT_NO>  (328) 
nan

>  <DRUG_TYPE>  (328) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (328) 
Y

>  <FIRST_IN_CLASS>  (328) 
N

>  <CHIRALITY>  (328) 
Single Stereoisomer

>  <PRODRUG>  (328) 
N

>  <ORAL>  (328) 
Y

>  <PARENTERAL>  (328) 
N

>  <TOPICAL>  (328) 
N

>  <BLACK_BOX>  (328) 
N

>  <AVAILABILITY_TYPE>  (328) 
Discontinued

>  <WITHDRAWN_YEAR>  (328) 
nan

>  <WITHDRAWN_COUNTRY>  (328) 
nan

>  <WITHDRAWN_REASON>  (328) 
nan

>  <CANONICAL_SMILES>  (328) 
C1CN2C[C@@H](N=C2S1)c3ccccc3

>  <name>  (328) 
Levamisole 

>  <MW>  (328) 
204.298

>  <logP>  (328) 
2.1461

$$$$
CHEMBL1510
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  2  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 14 26  1  0
 26 27  2  0
  6  2  1  0
 27  8  1  0
 27 11  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (329) 
421034

>  <SYNONYMS>  (329) 
Eletriptan (BAN, INN); Eletriptan Hydrobromide (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (329) 
4

>  <RESEARCH_CODES>  (329) 
UK-116044; UK-116044-04 [As Hydrobromide); UK-116044-04; UK-11604404

>  <APPLICANTS>  (329) 
Pfizer Ireland Pharmaceuticals

>  <USAN_STEM>  (329) 
-triptan

>  <USAN_STEM_DEFINITION>  (329) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (329) 
-triptan

>  <USAN_YEAR>  (329) 
1997.0

>  <FIRST_APPROVAL>  (329) 
2002.0

>  <ATC_CODE>  (329) 
N02CC06

>  <ATC_CODE_DESCRIPTION>  (329) 
N02CC06 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (329) 
nan

>  <SC_PATENT_NO>  (329) 
US-5545644-A

>  <DRUG_TYPE>  (329) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (329) 
Y

>  <FIRST_IN_CLASS>  (329) 
N

>  <CHIRALITY>  (329) 
Single Stereoisomer

>  <PRODRUG>  (329) 
N

>  <ORAL>  (329) 
Y

>  <PARENTERAL>  (329) 
N

>  <TOPICAL>  (329) 
N

>  <BLACK_BOX>  (329) 
N

>  <AVAILABILITY_TYPE>  (329) 
Prescription-only

>  <WITHDRAWN_YEAR>  (329) 
nan

>  <WITHDRAWN_COUNTRY>  (329) 
nan

>  <WITHDRAWN_REASON>  (329) 
nan

>  <CANONICAL_SMILES>  (329) 
CN1CCC[C@@H]1Cc2c[nH]c3ccc(CCS(=O)(=O)c4ccccc4)cc23

>  <name>  (329) 
Eletriptan 

>  <MW>  (329) 
382.529

>  <logP>  (329) 
3.821

$$$$
CHEMBL1201338
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  9 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 15 10  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (330) 
675289

>  <SYNONYMS>  (330) 
Cyclopentolate (BAN, INN); Cyclopentolate HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (330) 
4

>  <RESEARCH_CODES>  (330) 
nan

>  <APPLICANTS>  (330) 
Bausch And Lomb Pharmaceuticals Inc; Alcon Pharmaceuticals Ltd; Alcon Laboratories Inc; Akorn Inc; Pharmafair Inc

>  <USAN_STEM>  (330) 
nan

>  <USAN_STEM_DEFINITION>  (330) 
nan

>  <USAN_STEM_SUBSTEM>  (330) 
nan

>  <USAN_YEAR>  (330) 
nan

>  <FIRST_APPROVAL>  (330) 
1974.0

>  <ATC_CODE>  (330) 
S01FA04; S01FA54

>  <ATC_CODE_DESCRIPTION>  (330) 
S01FA04 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]; S01FA54 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]

>  <INDICATION_CLASS>  (330) 
Anticholinergic (ophthalmic)

>  <SC_PATENT_NO>  (330) 
nan

>  <DRUG_TYPE>  (330) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (330) 
Y

>  <FIRST_IN_CLASS>  (330) 
N

>  <CHIRALITY>  (330) 
Racemic Mixture

>  <PRODRUG>  (330) 
N

>  <ORAL>  (330) 
N

>  <PARENTERAL>  (330) 
N

>  <TOPICAL>  (330) 
Y

>  <BLACK_BOX>  (330) 
N

>  <AVAILABILITY_TYPE>  (330) 
Prescription-only

>  <WITHDRAWN_YEAR>  (330) 
nan

>  <WITHDRAWN_COUNTRY>  (330) 
nan

>  <WITHDRAWN_REASON>  (330) 
nan

>  <CANONICAL_SMILES>  (330) 
CN(C)CCOC(=O)C(c1ccccc1)C2(O)CCCC2

>  <name>  (330) 
Cyclopentolate 

>  <MW>  (330) 
291.391

>  <logP>  (330) 
2.1801

$$$$
CHEMBL1597
     RDKit          

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
M  END
>  <PARENT_MOLREGNO>  (331) 
454382

>  <SYNONYMS>  (331) 
Dimercaprol (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (331) 
4

>  <RESEARCH_CODES>  (331) 
nan

>  <APPLICANTS>  (331) 
Akorn Inc

>  <USAN_STEM>  (331) 
nan

>  <USAN_STEM_DEFINITION>  (331) 
nan

>  <USAN_STEM_SUBSTEM>  (331) 
nan

>  <USAN_YEAR>  (331) 
nan

>  <FIRST_APPROVAL>  (331) 
1946.0

>  <ATC_CODE>  (331) 
V03AB09

>  <ATC_CODE_DESCRIPTION>  (331) 
V03AB09 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (331) 
Antidote (to arsenic and gold and mercury poisoning)

>  <SC_PATENT_NO>  (331) 
nan

>  <DRUG_TYPE>  (331) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (331) 
Y

>  <FIRST_IN_CLASS>  (331) 
N

>  <CHIRALITY>  (331) 
Racemic Mixture

>  <PRODRUG>  (331) 
N

>  <ORAL>  (331) 
N

>  <PARENTERAL>  (331) 
Y

>  <TOPICAL>  (331) 
N

>  <BLACK_BOX>  (331) 
N

>  <AVAILABILITY_TYPE>  (331) 
Prescription-only

>  <WITHDRAWN_YEAR>  (331) 
nan

>  <WITHDRAWN_COUNTRY>  (331) 
nan

>  <WITHDRAWN_REASON>  (331) 
nan

>  <CANONICAL_SMILES>  (331) 
OCC(S)CS

>  <name>  (331) 
Dimercaprol 

>  <MW>  (331) 
124.23

>  <logP>  (331) 
0.2069

$$$$
CHEMBL341812
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  8 13  1  0
 13 14  2  0
 14  5  1  0
M  END
>  <PARENT_MOLREGNO>  (332) 
228897

>  <SYNONYMS>  (332) 
Ibufenac (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (332) 
4

>  <RESEARCH_CODES>  (332) 
RD-11654

>  <APPLICANTS>  (332) 
Boots, England

>  <USAN_STEM>  (332) 
-ac

>  <USAN_STEM_DEFINITION>  (332) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (332) 
-ac

>  <USAN_YEAR>  (332) 
1966.0

>  <FIRST_APPROVAL>  (332) 
nan

>  <ATC_CODE>  (332) 
nan

>  <ATC_CODE_DESCRIPTION>  (332) 
nan

>  <INDICATION_CLASS>  (332) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (332) 
nan

>  <DRUG_TYPE>  (332) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (332) 
Y

>  <FIRST_IN_CLASS>  (332) 
N

>  <CHIRALITY>  (332) 
Achiral Molecule

>  <PRODRUG>  (332) 
N

>  <ORAL>  (332) 
N

>  <PARENTERAL>  (332) 
N

>  <TOPICAL>  (332) 
N

>  <BLACK_BOX>  (332) 
N

>  <AVAILABILITY_TYPE>  (332) 
Withdrawn

>  <WITHDRAWN_YEAR>  (332) 
1968.0

>  <WITHDRAWN_COUNTRY>  (332) 
United Kingdom

>  <WITHDRAWN_REASON>  (332) 
Hepatotoxicity; Jaundice

>  <CANONICAL_SMILES>  (332) 
CC(C)Cc1ccc(CC(=O)O)cc1

>  <name>  (332) 
Ibufenac 

>  <MW>  (332) 
192.258

>  <logP>  (332) 
2.5122

$$$$
CHEMBL499
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 15 11  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (333) 
8531

>  <SYNONYMS>  (333) 
Timolol (BAN, FDA, INN, USAN); Timolol Maleate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (333) 
4

>  <RESEARCH_CODES>  (333) 
nan

>  <APPLICANTS>  (333) 
Ista Pharmaceuticals; Falcon Pharmaceuticals Ltd; Aton Pharma Inc; Allergan Inc; Santen Oy

>  <USAN_STEM>  (333) 
-olol

>  <USAN_STEM_DEFINITION>  (333) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (333) 
-olol

>  <USAN_YEAR>  (333) 
1973.0

>  <FIRST_APPROVAL>  (333) 
1978.0

>  <ATC_CODE>  (333) 
C07AA06; S01ED51; S01ED01

>  <ATC_CODE_DESCRIPTION>  (333) 
C07AA06 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]; S01ED51 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; S01ED01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]

>  <INDICATION_CLASS>  (333) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (333) 
US-6174524-B1

>  <DRUG_TYPE>  (333) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (333) 
Y

>  <FIRST_IN_CLASS>  (333) 
N

>  <CHIRALITY>  (333) 
Single Stereoisomer

>  <PRODRUG>  (333) 
N

>  <ORAL>  (333) 
Y

>  <PARENTERAL>  (333) 
N

>  <TOPICAL>  (333) 
Y

>  <BLACK_BOX>  (333) 
Y

>  <AVAILABILITY_TYPE>  (333) 
Prescription-only

>  <WITHDRAWN_YEAR>  (333) 
nan

>  <WITHDRAWN_COUNTRY>  (333) 
nan

>  <WITHDRAWN_REASON>  (333) 
nan

>  <CANONICAL_SMILES>  (333) 
CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2

>  <name>  (333) 
Timolol 

>  <MW>  (333) 
316.427

>  <logP>  (333) 
0.5025

$$$$
CHEMBL1771
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
  5 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 14  6  1  0
 13  9  2  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (334) 
598402

>  <SYNONYMS>  (334) 
Clopidogrel (BAN, INN); Clopidogrel Bisulfate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (334) 
4

>  <RESEARCH_CODES>  (334) 
SR-25990C

>  <APPLICANTS>  (334) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (334) 
-grel

>  <USAN_STEM_DEFINITION>  (334) 
platelet aggregation inhibitors

>  <USAN_STEM_SUBSTEM>  (334) 
-grel

>  <USAN_YEAR>  (334) 
1997.0

>  <FIRST_APPROVAL>  (334) 
1997.0

>  <ATC_CODE>  (334) 
B01AC04

>  <ATC_CODE_DESCRIPTION>  (334) 
B01AC04 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (334) 
Inhibitor (platelet)

>  <SC_PATENT_NO>  (334) 
US-6429210-B1

>  <DRUG_TYPE>  (334) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (334) 
Y

>  <FIRST_IN_CLASS>  (334) 
N

>  <CHIRALITY>  (334) 
Single Stereoisomer

>  <PRODRUG>  (334) 
Y

>  <ORAL>  (334) 
Y

>  <PARENTERAL>  (334) 
N

>  <TOPICAL>  (334) 
N

>  <BLACK_BOX>  (334) 
Y

>  <AVAILABILITY_TYPE>  (334) 
Prescription-only

>  <WITHDRAWN_YEAR>  (334) 
nan

>  <WITHDRAWN_COUNTRY>  (334) 
nan

>  <WITHDRAWN_REASON>  (334) 
nan

>  <CANONICAL_SMILES>  (334) 
COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl

>  <name>  (334) 
Clopidogrel 

>  <MW>  (334) 
321.829

>  <logP>  (334) 
3.6739

$$$$
CHEMBL49
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 12  2  1  0
  8  4  1  0
 22 17  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (335) 
3599

>  <SYNONYMS>  (335) 
Buspirone (BAN, INN); Buspirone HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (335) 
4

>  <RESEARCH_CODES>  (335) 
MJ-9022-1

>  <APPLICANTS>  (335) 
Bristol Myers Squibb Co Pharmaceutical Research Institute

>  <USAN_STEM>  (335) 
-spirone

>  <USAN_STEM_DEFINITION>  (335) 
anxiolytics (buspirone type)

>  <USAN_STEM_SUBSTEM>  (335) 
-spirone

>  <USAN_YEAR>  (335) 
1973.0

>  <FIRST_APPROVAL>  (335) 
1986.0

>  <ATC_CODE>  (335) 
N05BE01

>  <ATC_CODE_DESCRIPTION>  (335) 
N05BE01 [Nervous System:Psycholeptics:Anxiolytics:Azaspirodecanedione derivatives]

>  <INDICATION_CLASS>  (335) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (335) 
nan

>  <DRUG_TYPE>  (335) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (335) 
Y

>  <FIRST_IN_CLASS>  (335) 
N

>  <CHIRALITY>  (335) 
Achiral Molecule

>  <PRODRUG>  (335) 
N

>  <ORAL>  (335) 
Y

>  <PARENTERAL>  (335) 
N

>  <TOPICAL>  (335) 
N

>  <BLACK_BOX>  (335) 
N

>  <AVAILABILITY_TYPE>  (335) 
Prescription-only

>  <WITHDRAWN_YEAR>  (335) 
nan

>  <WITHDRAWN_COUNTRY>  (335) 
nan

>  <WITHDRAWN_REASON>  (335) 
nan

>  <CANONICAL_SMILES>  (335) 
O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4

>  <name>  (335) 
Buspirone 

>  <MW>  (335) 
385.512

>  <logP>  (335) 
2.0882

$$$$
CHEMBL1278
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 14 22  1  0
 22 23  2  0
 23  8  1  0
 22 11  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (336) 
250297

>  <SYNONYMS>  (336) 
Naratriptan (BAN, INN); Naratriptan HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (336) 
4

>  <RESEARCH_CODES>  (336) 
GR-85548A

>  <APPLICANTS>  (336) 
Sun Pharmaceutical Industries Ltd; GlaxoSmithKline; Apotex Corp

>  <USAN_STEM>  (336) 
-triptan

>  <USAN_STEM_DEFINITION>  (336) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (336) 
-triptan

>  <USAN_YEAR>  (336) 
1993.0

>  <FIRST_APPROVAL>  (336) 
1998.0

>  <ATC_CODE>  (336) 
N02CC02

>  <ATC_CODE_DESCRIPTION>  (336) 
N02CC02 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (336) 
Antimigraine

>  <SC_PATENT_NO>  (336) 
nan

>  <DRUG_TYPE>  (336) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (336) 
Y

>  <FIRST_IN_CLASS>  (336) 
N

>  <CHIRALITY>  (336) 
Achiral Molecule

>  <PRODRUG>  (336) 
N

>  <ORAL>  (336) 
Y

>  <PARENTERAL>  (336) 
N

>  <TOPICAL>  (336) 
N

>  <BLACK_BOX>  (336) 
N

>  <AVAILABILITY_TYPE>  (336) 
Prescription-only

>  <WITHDRAWN_YEAR>  (336) 
nan

>  <WITHDRAWN_COUNTRY>  (336) 
nan

>  <WITHDRAWN_REASON>  (336) 
nan

>  <CANONICAL_SMILES>  (336) 
CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1

>  <name>  (336) 
Naratriptan 

>  <MW>  (336) 
335.473

>  <logP>  (336) 
2.0688

$$$$
CHEMBL267744
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
  9 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 19  6  1  0
 16 12  1  0
M  END
>  <PARENT_MOLREGNO>  (337) 
2819

>  <SYNONYMS>  (337) 
Ticrynafen (USAN); Tienilic Acid (BAN, DCF, INN)

>  <DEVELOPMENT_PHASE>  (337) 
4

>  <RESEARCH_CODES>  (337) 
SK&F-62698

>  <APPLICANTS>  (337) 
SmithKline Beecham

>  <USAN_STEM>  (337) 
nan

>  <USAN_STEM_DEFINITION>  (337) 
nan

>  <USAN_STEM_SUBSTEM>  (337) 
nan

>  <USAN_YEAR>  (337) 
1975.0

>  <FIRST_APPROVAL>  (337) 
1979.0

>  <ATC_CODE>  (337) 
C03CC02

>  <ATC_CODE_DESCRIPTION>  (337) 
C03CC02 [Cardiovascular System:Diuretics:High-Ceiling Diuretics:Aryloxyacetic acid derivatives]

>  <INDICATION_CLASS>  (337) 
Antihypertensive; Diuretic; Uricosuric

>  <SC_PATENT_NO>  (337) 
nan

>  <DRUG_TYPE>  (337) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (337) 
Y

>  <FIRST_IN_CLASS>  (337) 
N

>  <CHIRALITY>  (337) 
Achiral Molecule

>  <PRODRUG>  (337) 
N

>  <ORAL>  (337) 
N

>  <PARENTERAL>  (337) 
N

>  <TOPICAL>  (337) 
N

>  <BLACK_BOX>  (337) 
N

>  <AVAILABILITY_TYPE>  (337) 
Withdrawn

>  <WITHDRAWN_YEAR>  (337) 
1980.0

>  <WITHDRAWN_COUNTRY>  (337) 
United Kingdom; United States; Germany; France

>  <WITHDRAWN_REASON>  (337) 
Liver Toxicity and Death

>  <CANONICAL_SMILES>  (337) 
OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl

>  <name>  (337) 
Ticrynafen 

>  <MW>  (337) 
331.176

>  <logP>  (337) 
3.7493

$$$$
CHEMBL1501
     RDKit          

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 14  8  1  0
 34  8  1  0
 34 16  1  0
 29 17  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (338) 
419542

>  <SYNONYMS>  (338) 
Fluocinonide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (338) 
4

>  <RESEARCH_CODES>  (338) 
nan

>  <APPLICANTS>  (338) 
Taro Pharmaceuticals Usa Inc; Medicis Pharmaceutical Corp; County Line Pharmaceuticals Llc

>  <USAN_STEM>  (338) 
-onide

>  <USAN_STEM_DEFINITION>  (338) 
topical steroids (acetal derivatives)

>  <USAN_STEM_SUBSTEM>  (338) 
-onide

>  <USAN_YEAR>  (338) 
1970.0

>  <FIRST_APPROVAL>  (338) 
1971.0

>  <ATC_CODE>  (338) 
D07AC08; C05AA11

>  <ATC_CODE_DESCRIPTION>  (338) 
D07AC08 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; C05AA11 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]

>  <INDICATION_CLASS>  (338) 
Glucocorticoid

>  <SC_PATENT_NO>  (338) 
US-6765001-B2

>  <DRUG_TYPE>  (338) 
Natural Product-derived

>  <RULE_OF_FIVE>  (338) 
Y

>  <FIRST_IN_CLASS>  (338) 
N

>  <CHIRALITY>  (338) 
Single Stereoisomer

>  <PRODRUG>  (338) 
N

>  <ORAL>  (338) 
N

>  <PARENTERAL>  (338) 
N

>  <TOPICAL>  (338) 
Y

>  <BLACK_BOX>  (338) 
Y

>  <AVAILABILITY_TYPE>  (338) 
Prescription-only

>  <WITHDRAWN_YEAR>  (338) 
nan

>  <WITHDRAWN_COUNTRY>  (338) 
nan

>  <WITHDRAWN_REASON>  (338) 
nan

>  <CANONICAL_SMILES>  (338) 
CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]23C

>  <name>  (338) 
Fluocinonide 

>  <MW>  (338) 
494.531

>  <logP>  (338) 
2.9376

$$$$
CHEMBL940
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  3  1  0
M  END
>  <PARENT_MOLREGNO>  (339) 
88316

>  <SYNONYMS>  (339) 
Gabapentin (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (339) 
4

>  <RESEARCH_CODES>  (339) 
CI-945; GOE-3450

>  <APPLICANTS>  (339) 
Pfizer Pharmaceuticals Ltd; Parke Davis Div Warner Lambert Co; Depomed Inc

>  <USAN_STEM>  (339) 
-gab-

>  <USAN_STEM_DEFINITION>  (339) 
gabamimetics

>  <USAN_STEM_SUBSTEM>  (339) 
-gab-

>  <USAN_YEAR>  (339) 
1989.0

>  <FIRST_APPROVAL>  (339) 
1993.0

>  <ATC_CODE>  (339) 
N03AX12

>  <ATC_CODE_DESCRIPTION>  (339) 
N03AX12 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (339) 
Anticonvulsant

>  <SC_PATENT_NO>  (339) 
US-6054482-A

>  <DRUG_TYPE>  (339) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (339) 
Y

>  <FIRST_IN_CLASS>  (339) 
N

>  <CHIRALITY>  (339) 
Achiral Molecule

>  <PRODRUG>  (339) 
N

>  <ORAL>  (339) 
Y

>  <PARENTERAL>  (339) 
N

>  <TOPICAL>  (339) 
N

>  <BLACK_BOX>  (339) 
N

>  <AVAILABILITY_TYPE>  (339) 
Prescription-only

>  <WITHDRAWN_YEAR>  (339) 
nan

>  <WITHDRAWN_COUNTRY>  (339) 
nan

>  <WITHDRAWN_REASON>  (339) 
nan

>  <CANONICAL_SMILES>  (339) 
NCC1(CC(=O)O)CCCCC1

>  <name>  (339) 
Gabapentin 

>  <MW>  (339) 
171.24

>  <logP>  (339) 
1.3703

$$$$
CHEMBL1289926
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 16 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 10  5  1  0
 28 12  1  0
 27 15  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (340) 
716337

>  <SYNONYMS>  (340) 
Axitinib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (340) 
4

>  <RESEARCH_CODES>  (340) 
AG-013736; AG-13736

>  <APPLICANTS>  (340) 
Pfizer Inc.

>  <USAN_STEM>  (340) 
-tinib

>  <USAN_STEM_DEFINITION>  (340) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (340) 
-tinib

>  <USAN_YEAR>  (340) 
2005.0

>  <FIRST_APPROVAL>  (340) 
2012.0

>  <ATC_CODE>  (340) 
L01XE17

>  <ATC_CODE_DESCRIPTION>  (340) 
L01XE17 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (340) 
nan

>  <SC_PATENT_NO>  (340) 
US-6534524-B1

>  <DRUG_TYPE>  (340) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (340) 
Y

>  <FIRST_IN_CLASS>  (340) 
N

>  <CHIRALITY>  (340) 
Achiral Molecule

>  <PRODRUG>  (340) 
N

>  <ORAL>  (340) 
Y

>  <PARENTERAL>  (340) 
N

>  <TOPICAL>  (340) 
N

>  <BLACK_BOX>  (340) 
N

>  <AVAILABILITY_TYPE>  (340) 
Prescription-only

>  <WITHDRAWN_YEAR>  (340) 
nan

>  <WITHDRAWN_COUNTRY>  (340) 
nan

>  <WITHDRAWN_REASON>  (340) 
nan

>  <CANONICAL_SMILES>  (340) 
CNC(=O)c1ccccc1Sc2ccc3c(\C=C\c4ccccn4)n[nH]c3c2

>  <name>  (340) 
Axitinib 

>  <MW>  (340) 
386.48

>  <logP>  (340) 
4.6391

$$$$
CHEMBL1744
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  7  2  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (341) 
574499

>  <SYNONYMS>  (341) 
Phendimetrazine (BAN, INN); Phendimetrazine Tartrate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (341) 
4

>  <RESEARCH_CODES>  (341) 
nan

>  <APPLICANTS>  (341) 
Wyeth Ayerst Laboratories; Sandoz Inc

>  <USAN_STEM>  (341) 
nan

>  <USAN_STEM_DEFINITION>  (341) 
nan

>  <USAN_STEM_SUBSTEM>  (341) 
nan

>  <USAN_YEAR>  (341) 
nan

>  <FIRST_APPROVAL>  (341) 
1976.0

>  <ATC_CODE>  (341) 
nan

>  <ATC_CODE_DESCRIPTION>  (341) 
nan

>  <INDICATION_CLASS>  (341) 
Appetite Suppressant (systemic)

>  <SC_PATENT_NO>  (341) 
nan

>  <DRUG_TYPE>  (341) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (341) 
Y

>  <FIRST_IN_CLASS>  (341) 
N

>  <CHIRALITY>  (341) 
Racemic Mixture

>  <PRODRUG>  (341) 
N

>  <ORAL>  (341) 
Y

>  <PARENTERAL>  (341) 
N

>  <TOPICAL>  (341) 
N

>  <BLACK_BOX>  (341) 
N

>  <AVAILABILITY_TYPE>  (341) 
Prescription-only

>  <WITHDRAWN_YEAR>  (341) 
nan

>  <WITHDRAWN_COUNTRY>  (341) 
nan

>  <WITHDRAWN_REASON>  (341) 
nan

>  <CANONICAL_SMILES>  (341) 
CC1C(OCCN1C)c2ccccc2

>  <name>  (341) 
Phendimetrazine 

>  <MW>  (341) 
191.274

>  <logP>  (341) 
2.0782

$$$$
CHEMBL70927
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  7 10  1  0
  8  2  1  0
M  END
>  <PARENT_MOLREGNO>  (342) 
112090

>  <SYNONYMS>  (342) 
Deferiprone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (342) 
4

>  <RESEARCH_CODES>  (342) 
APO-066; APO-66; CP20; DN-180-01-AF

>  <APPLICANTS>  (342) 
Apopharma Inc

>  <USAN_STEM>  (342) 
nan

>  <USAN_STEM_DEFINITION>  (342) 
nan

>  <USAN_STEM_SUBSTEM>  (342) 
nan

>  <USAN_YEAR>  (342) 
2008.0

>  <FIRST_APPROVAL>  (342) 
1999.0

>  <ATC_CODE>  (342) 
V03AC02

>  <ATC_CODE_DESCRIPTION>  (342) 
V03AC02 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Iron chelating agents]

>  <INDICATION_CLASS>  (342) 
nan

>  <SC_PATENT_NO>  (342) 
US-7049328-B2

>  <DRUG_TYPE>  (342) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (342) 
Y

>  <FIRST_IN_CLASS>  (342) 
N

>  <CHIRALITY>  (342) 
Achiral Molecule

>  <PRODRUG>  (342) 
N

>  <ORAL>  (342) 
Y

>  <PARENTERAL>  (342) 
N

>  <TOPICAL>  (342) 
N

>  <BLACK_BOX>  (342) 
Y

>  <AVAILABILITY_TYPE>  (342) 
Prescription-only

>  <WITHDRAWN_YEAR>  (342) 
nan

>  <WITHDRAWN_COUNTRY>  (342) 
nan

>  <WITHDRAWN_REASON>  (342) 
nan

>  <CANONICAL_SMILES>  (342) 
CN1C=CC(=O)C(=C1C)O

>  <name>  (342) 
Deferiprone 

>  <MW>  (342) 
139.154

>  <logP>  (342) 
0.39932

$$$$
CHEMBL934
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  2 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 11  6  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (343) 
86284

>  <SYNONYMS>  (343) 
Metyrapone (BAN, FDA, INN, JAN, USAN, USP); Metyrapone Tartrate (USAN)

>  <DEVELOPMENT_PHASE>  (343) 
4

>  <RESEARCH_CODES>  (343) 
SU-4885

>  <APPLICANTS>  (343) 
Hra Pharma Llc; Ciba-Geigy

>  <USAN_STEM>  (343) 
nan

>  <USAN_STEM_DEFINITION>  (343) 
nan

>  <USAN_STEM_SUBSTEM>  (343) 
nan

>  <USAN_YEAR>  (343) 
1963.0

>  <FIRST_APPROVAL>  (343) 
1961.0

>  <ATC_CODE>  (343) 
V04CD01

>  <ATC_CODE_DESCRIPTION>  (343) 
V04CD01 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for pituitary function]

>  <INDICATION_CLASS>  (343) 
Diagnostic Aid (pituitary function determination)

>  <SC_PATENT_NO>  (343) 
nan

>  <DRUG_TYPE>  (343) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (343) 
Y

>  <FIRST_IN_CLASS>  (343) 
N

>  <CHIRALITY>  (343) 
Achiral Molecule

>  <PRODRUG>  (343) 
N

>  <ORAL>  (343) 
Y

>  <PARENTERAL>  (343) 
N

>  <TOPICAL>  (343) 
N

>  <BLACK_BOX>  (343) 
N

>  <AVAILABILITY_TYPE>  (343) 
Prescription-only

>  <WITHDRAWN_YEAR>  (343) 
nan

>  <WITHDRAWN_COUNTRY>  (343) 
nan

>  <WITHDRAWN_REASON>  (343) 
nan

>  <CANONICAL_SMILES>  (343) 
CC(C)(C(=O)c1cccnc1)c2cccnc2

>  <name>  (343) 
Metyrapone 

>  <MW>  (343) 
226.279

>  <logP>  (343) 
2.6371

$$$$
CHEMBL186
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 12 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
  4 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
 15  8  1  0
 14  9  1  0
 26 21  1  0
 32 27  1  0
M  CHG  2  19  -1  21   1
M  END
>  <PARENT_MOLREGNO>  (344) 
372385

>  <SYNONYMS>  (344) 
Cefepime (BAN, INN, USAN); Cefepime HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (344) 
4

>  <RESEARCH_CODES>  (344) 
BMY-28142

>  <APPLICANTS>  (344) 
Squibb; Hospira Inc; Baxter Healthcare Corp; B Braun Medical Inc

>  <USAN_STEM>  (344) 
cef-

>  <USAN_STEM_DEFINITION>  (344) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (344) 
cef-

>  <USAN_YEAR>  (344) 
1987.0

>  <FIRST_APPROVAL>  (344) 
1996.0

>  <ATC_CODE>  (344) 
J01DE01

>  <ATC_CODE_DESCRIPTION>  (344) 
J01DE01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Fourth-generation cephalosporins]

>  <INDICATION_CLASS>  (344) 
Antibacterial

>  <SC_PATENT_NO>  (344) 
nan

>  <DRUG_TYPE>  (344) 
Natural Product-derived

>  <RULE_OF_FIVE>  (344) 
Y

>  <FIRST_IN_CLASS>  (344) 
N

>  <CHIRALITY>  (344) 
Single Stereoisomer

>  <PRODRUG>  (344) 
N

>  <ORAL>  (344) 
N

>  <PARENTERAL>  (344) 
Y

>  <TOPICAL>  (344) 
N

>  <BLACK_BOX>  (344) 
N

>  <AVAILABILITY_TYPE>  (344) 
Prescription-only

>  <WITHDRAWN_YEAR>  (344) 
nan

>  <WITHDRAWN_COUNTRY>  (344) 
nan

>  <WITHDRAWN_REASON>  (344) 
nan

>  <CANONICAL_SMILES>  (344) 
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)[O-])C[N+]3(C)CCCC3)\c4csc(N)n4

>  <name>  (344) 
Cefepime 

>  <MW>  (344) 
480.572

>  <logP>  (344) 
-1.2799

$$$$
CHEMBL1483
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 10 16  1  0
 16 17  1  0
 17 18  2  0
 18  5  1  0
 17  8  1  0
M  END
>  <PARENT_MOLREGNO>  (345) 
406787

>  <SYNONYMS>  (345) 
Albendazole (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (345) 
4

>  <RESEARCH_CODES>  (345) 
SK&F 62979; SK&F-62979

>  <APPLICANTS>  (345) 
Corepharma Llc

>  <USAN_STEM>  (345) 
-bendazole

>  <USAN_STEM_DEFINITION>  (345) 
anthelmintics (tibendazole type)

>  <USAN_STEM_SUBSTEM>  (345) 
-bendazole

>  <USAN_YEAR>  (345) 
1976.0

>  <FIRST_APPROVAL>  (345) 
1996.0

>  <ATC_CODE>  (345) 
P02CA03

>  <ATC_CODE_DESCRIPTION>  (345) 
P02CA03 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Benzimidazole derivatives]

>  <INDICATION_CLASS>  (345) 
Anthelmintic

>  <SC_PATENT_NO>  (345) 
nan

>  <DRUG_TYPE>  (345) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (345) 
Y

>  <FIRST_IN_CLASS>  (345) 
N

>  <CHIRALITY>  (345) 
Achiral Molecule

>  <PRODRUG>  (345) 
N

>  <ORAL>  (345) 
Y

>  <PARENTERAL>  (345) 
N

>  <TOPICAL>  (345) 
N

>  <BLACK_BOX>  (345) 
N

>  <AVAILABILITY_TYPE>  (345) 
Prescription-only

>  <WITHDRAWN_YEAR>  (345) 
nan

>  <WITHDRAWN_COUNTRY>  (345) 
nan

>  <WITHDRAWN_REASON>  (345) 
nan

>  <CANONICAL_SMILES>  (345) 
CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1

>  <name>  (345) 
Albendazole 

>  <MW>  (345) 
265.338

>  <logP>  (345) 
3.2433

$$$$
CHEMBL1005
     RDKit          

 27 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  5 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 15 22  1  0
 22 23  1  0
 12 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 11  6  1  0
 23 12  1  0
M  END
>  <PARENT_MOLREGNO>  (346) 
111871

>  <SYNONYMS>  (346) 
Remifentanil (BAN, INN); Remifentanil HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (346) 
4

>  <RESEARCH_CODES>  (346) 
GI-87084B

>  <APPLICANTS>  (346) 
Mylan Institutional Llc

>  <USAN_STEM>  (346) 
-fentanil

>  <USAN_STEM_DEFINITION>  (346) 
narcotic analgesics (fentanyl derivatives)

>  <USAN_STEM_SUBSTEM>  (346) 
-fentanil

>  <USAN_YEAR>  (346) 
1992.0

>  <FIRST_APPROVAL>  (346) 
1996.0

>  <ATC_CODE>  (346) 
N01AH06

>  <ATC_CODE_DESCRIPTION>  (346) 
N01AH06 [Nervous System:Anesthetics:Anesthetics, General:Opioid anesthetics]

>  <INDICATION_CLASS>  (346) 
Analgesic

>  <SC_PATENT_NO>  (346) 
US-5866591-A

>  <DRUG_TYPE>  (346) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (346) 
Y

>  <FIRST_IN_CLASS>  (346) 
N

>  <CHIRALITY>  (346) 
Achiral Molecule

>  <PRODRUG>  (346) 
N

>  <ORAL>  (346) 
N

>  <PARENTERAL>  (346) 
Y

>  <TOPICAL>  (346) 
N

>  <BLACK_BOX>  (346) 
N

>  <AVAILABILITY_TYPE>  (346) 
Prescription-only

>  <WITHDRAWN_YEAR>  (346) 
nan

>  <WITHDRAWN_COUNTRY>  (346) 
nan

>  <WITHDRAWN_REASON>  (346) 
nan

>  <CANONICAL_SMILES>  (346) 
CCC(=O)N(c1ccccc1)C2(CCN(CCC(=O)OC)CC2)C(=O)OC

>  <name>  (346) 
Remifentanil 

>  <MW>  (346) 
376.453

>  <logP>  (346) 
2.0003

$$$$
CHEMBL1256
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
M  END
>  <PARENT_MOLREGNO>  (347) 
238127

>  <SYNONYMS>  (347) 
Isoflurane (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (347) 
4

>  <RESEARCH_CODES>  (347) 
Compound 469

>  <APPLICANTS>  (347) 
Baxter Healthcare Corp

>  <USAN_STEM>  (347) 
-flurane

>  <USAN_STEM_DEFINITION>  (347) 
general inhalation anesthetics (halogenated alkane derivatives)

>  <USAN_STEM_SUBSTEM>  (347) 
-flurane

>  <USAN_YEAR>  (347) 
1972.0

>  <FIRST_APPROVAL>  (347) 
1979.0

>  <ATC_CODE>  (347) 
N01AB06

>  <ATC_CODE_DESCRIPTION>  (347) 
N01AB06 [Nervous System:Anesthetics:Anesthetics, General:Halogenated hydrocarbons]

>  <INDICATION_CLASS>  (347) 
Anesthetic (inhalation)

>  <SC_PATENT_NO>  (347) 
nan

>  <DRUG_TYPE>  (347) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (347) 
Y

>  <FIRST_IN_CLASS>  (347) 
N

>  <CHIRALITY>  (347) 
Racemic Mixture

>  <PRODRUG>  (347) 
N

>  <ORAL>  (347) 
N

>  <PARENTERAL>  (347) 
N

>  <TOPICAL>  (347) 
Y

>  <BLACK_BOX>  (347) 
N

>  <AVAILABILITY_TYPE>  (347) 
Prescription-only

>  <WITHDRAWN_YEAR>  (347) 
nan

>  <WITHDRAWN_COUNTRY>  (347) 
nan

>  <WITHDRAWN_REASON>  (347) 
nan

>  <CANONICAL_SMILES>  (347) 
FC(F)OC(Cl)C(F)(F)F

>  <name>  (347) 
Isoflurane 

>  <MW>  (347) 
184.491

>  <logP>  (347) 
2.3528

$$$$
CHEMBL1619
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
  8  2  1  0
 11  7  1  0
 19 12  1  0
M  END
>  <PARENT_MOLREGNO>  (348) 
467361

>  <SYNONYMS>  (348) 
Cladribine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (348) 
4

>  <RESEARCH_CODES>  (348) 
RWJ-26251

>  <APPLICANTS>  (348) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (348) 
-ribine

>  <USAN_STEM_DEFINITION>  (348) 
ribofuranil derivatives (pyrazofurin type)

>  <USAN_STEM_SUBSTEM>  (348) 
-ribine

>  <USAN_YEAR>  (348) 
1992.0

>  <FIRST_APPROVAL>  (348) 
1993.0

>  <ATC_CODE>  (348) 
L01BB04

>  <ATC_CODE_DESCRIPTION>  (348) 
L01BB04 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Purine analogues]

>  <INDICATION_CLASS>  (348) 
Antineoplastic

>  <SC_PATENT_NO>  (348) 
nan

>  <DRUG_TYPE>  (348) 
Natural Product-derived

>  <RULE_OF_FIVE>  (348) 
Y

>  <FIRST_IN_CLASS>  (348) 
N

>  <CHIRALITY>  (348) 
Single Stereoisomer

>  <PRODRUG>  (348) 
N

>  <ORAL>  (348) 
N

>  <PARENTERAL>  (348) 
Y

>  <TOPICAL>  (348) 
N

>  <BLACK_BOX>  (348) 
Y

>  <AVAILABILITY_TYPE>  (348) 
Prescription-only

>  <WITHDRAWN_YEAR>  (348) 
nan

>  <WITHDRAWN_COUNTRY>  (348) 
nan

>  <WITHDRAWN_REASON>  (348) 
nan

>  <CANONICAL_SMILES>  (348) 
Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3

>  <name>  (348) 
Cladribine 

>  <MW>  (348) 
285.691

>  <logP>  (348) 
-0.2974

$$$$
CHEMBL1279
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 11 16  1  0
 16 17  2  0
 16 18  1  0
 15  3  1  0
 14  6  2  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (349) 
250328

>  <SYNONYMS>  (349) 
Frovatriptan (BAN, INN); Frovatriptan Succinate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (349) 
4

>  <RESEARCH_CODES>  (349) 
SB-209509AX; SB-209509-AX; VML-251

>  <APPLICANTS>  (349) 
Endo Pharmaceuticals Inc

>  <USAN_STEM>  (349) 
-triptan

>  <USAN_STEM_DEFINITION>  (349) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (349) 
-triptan

>  <USAN_YEAR>  (349) 
1997.0

>  <FIRST_APPROVAL>  (349) 
2001.0

>  <ATC_CODE>  (349) 
N02CC07

>  <ATC_CODE_DESCRIPTION>  (349) 
N02CC07 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (349) 
nan

>  <SC_PATENT_NO>  (349) 
US-5464864-A

>  <DRUG_TYPE>  (349) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (349) 
Y

>  <FIRST_IN_CLASS>  (349) 
N

>  <CHIRALITY>  (349) 
Single Stereoisomer

>  <PRODRUG>  (349) 
N

>  <ORAL>  (349) 
Y

>  <PARENTERAL>  (349) 
N

>  <TOPICAL>  (349) 
N

>  <BLACK_BOX>  (349) 
N

>  <AVAILABILITY_TYPE>  (349) 
Prescription-only

>  <WITHDRAWN_YEAR>  (349) 
nan

>  <WITHDRAWN_COUNTRY>  (349) 
nan

>  <WITHDRAWN_REASON>  (349) 
nan

>  <CANONICAL_SMILES>  (349) 
CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(=O)N

>  <name>  (349) 
Frovatriptan 

>  <MW>  (349) 
243.31

>  <logP>  (349) 
1.3435

$$$$
CHEMBL231068
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 14 27  1  0
 27 28  1  0
 10  5  1  0
 28 11  1  0
 26 17  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (350) 
388819

>  <SYNONYMS>  (350) 
Flibanserin (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (350) 
4

>  <RESEARCH_CODES>  (350) 
BIMT-17; BIMT-17-BS

>  <APPLICANTS>  (350) 
Sprout Pharmaceuticals Inc; Boehringer Ingelheim, Italy

>  <USAN_STEM>  (350) 
-anserin

>  <USAN_STEM_DEFINITION>  (350) 
serotonin 5-HT2 receptor antagonists

>  <USAN_STEM_SUBSTEM>  (350) 
-anserin

>  <USAN_YEAR>  (350) 
1997.0

>  <FIRST_APPROVAL>  (350) 
2015.0

>  <ATC_CODE>  (350) 
G02CX02

>  <ATC_CODE_DESCRIPTION>  (350) 
G02CX02 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Other Gynecologicals:Other gynecologicals]

>  <INDICATION_CLASS>  (350) 
nan

>  <SC_PATENT_NO>  (350) 
US-7151103-B2

>  <DRUG_TYPE>  (350) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (350) 
Y

>  <FIRST_IN_CLASS>  (350) 
N

>  <CHIRALITY>  (350) 
Achiral Molecule

>  <PRODRUG>  (350) 
N

>  <ORAL>  (350) 
Y

>  <PARENTERAL>  (350) 
N

>  <TOPICAL>  (350) 
N

>  <BLACK_BOX>  (350) 
Y

>  <AVAILABILITY_TYPE>  (350) 
Prescription-only

>  <WITHDRAWN_YEAR>  (350) 
nan

>  <WITHDRAWN_COUNTRY>  (350) 
nan

>  <WITHDRAWN_REASON>  (350) 
nan

>  <CANONICAL_SMILES>  (350) 
FC(F)(F)c1cccc(c1)N2CCN(CCN3C(=O)Nc4ccccc34)CC2

>  <name>  (350) 
Flibanserin 

>  <MW>  (350) 
390.409

>  <logP>  (350) 
3.1706

$$$$
CHEMBL887
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  5  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (351) 
75752

>  <SYNONYMS>  (351) 
Rasagiline (INN, USAN); Rasagiline mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (351) 
4

>  <RESEARCH_CODES>  (351) 
TVP-1012

>  <APPLICANTS>  (351) 
Teva Neuroscience Inc

>  <USAN_STEM>  (351) 
-giline

>  <USAN_STEM_DEFINITION>  (351) 
MAO inhibitors, type B

>  <USAN_STEM_SUBSTEM>  (351) 
-giline

>  <USAN_YEAR>  (351) 
1995.0

>  <FIRST_APPROVAL>  (351) 
2006.0

>  <ATC_CODE>  (351) 
N04BD02

>  <ATC_CODE_DESCRIPTION>  (351) 
N04BD02 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Monoamine oxidase B inhibitors]

>  <INDICATION_CLASS>  (351) 
Antiparkinsonian

>  <SC_PATENT_NO>  (351) 
US-5453446-A

>  <DRUG_TYPE>  (351) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (351) 
Y

>  <FIRST_IN_CLASS>  (351) 
N

>  <CHIRALITY>  (351) 
Single Stereoisomer

>  <PRODRUG>  (351) 
N

>  <ORAL>  (351) 
Y

>  <PARENTERAL>  (351) 
N

>  <TOPICAL>  (351) 
N

>  <BLACK_BOX>  (351) 
N

>  <AVAILABILITY_TYPE>  (351) 
Prescription-only

>  <WITHDRAWN_YEAR>  (351) 
nan

>  <WITHDRAWN_COUNTRY>  (351) 
nan

>  <WITHDRAWN_REASON>  (351) 
nan

>  <CANONICAL_SMILES>  (351) 
C#CCN[C@@H]1CCc2ccccc12

>  <name>  (351) 
Rasagiline 

>  <MW>  (351) 
171.243

>  <logP>  (351) 
1.8967

$$$$
CHEMBL1389
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
  7 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  3  0
 17  3  1  0
 20  3  1  0
 16  6  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (352) 
328164

>  <SYNONYMS>  (352) 
Levonorgestrel (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (352) 
4

>  <RESEARCH_CODES>  (352) 
WY-5104

>  <APPLICANTS>  (352) 
Population Council Center For Biomedical Research; Population Council; Duramed Pharmaceuticals Inc; Bayer Healthcare Pharmaceuticals Inc; Teva Branded Pharmaceutical Products R And D Inc

>  <USAN_STEM>  (352) 
-gest-

>  <USAN_STEM_DEFINITION>  (352) 
progestins

>  <USAN_STEM_SUBSTEM>  (352) 
-gest-

>  <USAN_YEAR>  (352) 
1980.0

>  <FIRST_APPROVAL>  (352) 
1982.0

>  <ATC_CODE>  (352) 
G03AD01

>  <ATC_CODE_DESCRIPTION>  (352) 
G03AD01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Hormonal Contraceptives For Systemic Use:Emergency contraceptives]

>  <INDICATION_CLASS>  (352) 
Progestin

>  <SC_PATENT_NO>  (352) 
US-5785053-A

>  <DRUG_TYPE>  (352) 
Natural Product-derived

>  <RULE_OF_FIVE>  (352) 
Y

>  <FIRST_IN_CLASS>  (352) 
N

>  <CHIRALITY>  (352) 
Single Stereoisomer

>  <PRODRUG>  (352) 
N

>  <ORAL>  (352) 
Y

>  <PARENTERAL>  (352) 
Y

>  <TOPICAL>  (352) 
Y

>  <BLACK_BOX>  (352) 
N

>  <AVAILABILITY_TYPE>  (352) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (352) 
nan

>  <WITHDRAWN_COUNTRY>  (352) 
nan

>  <WITHDRAWN_REASON>  (352) 
nan

>  <CANONICAL_SMILES>  (352) 
CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

>  <name>  (352) 
Levonorgestrel 

>  <MW>  (352) 
312.453

>  <logP>  (352) 
3.8826

$$$$
CHEMBL3187365
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  6  2  1  0
 20  4  1  0
 13  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (353) 
1676656

>  <SYNONYMS>  (353) 
Asenapine (INN); Asenapine maleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (353) 
4

>  <RESEARCH_CODES>  (353) 
ORG-5222

>  <APPLICANTS>  (353) 
Organon Usa Inc Sub Merck And Co Inc

>  <USAN_STEM>  (353) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (353) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (353) 
-pin(e)

>  <USAN_YEAR>  (353) 
2002.0

>  <FIRST_APPROVAL>  (353) 
2009.0

>  <ATC_CODE>  (353) 
N05AH05

>  <ATC_CODE_DESCRIPTION>  (353) 
N05AH05 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]

>  <INDICATION_CLASS>  (353) 
nan

>  <SC_PATENT_NO>  (353) 
US-5763476-A

>  <DRUG_TYPE>  (353) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (353) 
Y

>  <FIRST_IN_CLASS>  (353) 
N

>  <CHIRALITY>  (353) 
Racemic Mixture

>  <PRODRUG>  (353) 
N

>  <ORAL>  (353) 
N

>  <PARENTERAL>  (353) 
N

>  <TOPICAL>  (353) 
Y

>  <BLACK_BOX>  (353) 
Y

>  <AVAILABILITY_TYPE>  (353) 
Prescription-only

>  <WITHDRAWN_YEAR>  (353) 
nan

>  <WITHDRAWN_COUNTRY>  (353) 
nan

>  <WITHDRAWN_REASON>  (353) 
nan

>  <CANONICAL_SMILES>  (353) 
CN1CC2C(C1)c3cc(Cl)ccc3Oc4ccccc24

>  <name>  (353) 
Asenapine 

>  <MW>  (353) 
285.774

>  <logP>  (353) 
4.2585

$$$$
CHEMBL1472
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 11 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
  8  4  1  0
 17 13  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (354) 
400344

>  <SYNONYMS>  (354) 
Protirelin (BAN, FDA, INN, JAN, USAN); Protirelin Tartrate (JAN)

>  <DEVELOPMENT_PHASE>  (354) 
4

>  <RESEARCH_CODES>  (354) 
A-38579; ABBOTT-38579; Synthetic Trh

>  <APPLICANTS>  (354) 
Ferring Pharmaceuticals Inc; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (354) 
-relin

>  <USAN_STEM_DEFINITION>  (354) 
prehormones or hormone-release stimulating peptides: thyrotropin releasing hormone analogues

>  <USAN_STEM_SUBSTEM>  (354) 
-relin (-tirelin)

>  <USAN_YEAR>  (354) 
1974.0

>  <FIRST_APPROVAL>  (354) 
1976.0

>  <ATC_CODE>  (354) 
V04CJ02

>  <ATC_CODE_DESCRIPTION>  (354) 
V04CJ02 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for thyreoidea function]

>  <INDICATION_CLASS>  (354) 
Prothyrotropin

>  <SC_PATENT_NO>  (354) 
nan

>  <DRUG_TYPE>  (354) 
Oligopeptide

>  <RULE_OF_FIVE>  (354) 
Y

>  <FIRST_IN_CLASS>  (354) 
N

>  <CHIRALITY>  (354) 
Single Stereoisomer

>  <PRODRUG>  (354) 
N

>  <ORAL>  (354) 
N

>  <PARENTERAL>  (354) 
Y

>  <TOPICAL>  (354) 
N

>  <BLACK_BOX>  (354) 
N

>  <AVAILABILITY_TYPE>  (354) 
Discontinued

>  <WITHDRAWN_YEAR>  (354) 
nan

>  <WITHDRAWN_COUNTRY>  (354) 
nan

>  <WITHDRAWN_REASON>  (354) 
nan

>  <CANONICAL_SMILES>  (354) 
NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]3CCC(=O)N3

>  <name>  (354) 
Protirelin 

>  <MW>  (354) 
362.39

>  <logP>  (354) 
-1.8081

$$$$
CHEMBL1172
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  6 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22  2  1  0
 21  5  1  0
 12  7  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (355) 
191342

>  <SYNONYMS>  (355) 
Desloratadine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (355) 
4

>  <RESEARCH_CODES>  (355) 
SCH-34117

>  <APPLICANTS>  (355) 
Merck Sharp And Dohme Corp

>  <USAN_STEM>  (355) 
-(a)tadine; -atadine

>  <USAN_STEM_DEFINITION>  (355) 
tricyclic histaminic-H1 receptor antagonists, loratadine derivatives; tricyclic antiasthmatics

>  <USAN_STEM_SUBSTEM>  (355) 
-(a)tadine; -atadine

>  <USAN_YEAR>  (355) 
1998.0

>  <FIRST_APPROVAL>  (355) 
2001.0

>  <ATC_CODE>  (355) 
R06AX27

>  <ATC_CODE_DESCRIPTION>  (355) 
R06AX27 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (355) 
nan

>  <SC_PATENT_NO>  (355) 
US-5607697-A

>  <DRUG_TYPE>  (355) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (355) 
Y

>  <FIRST_IN_CLASS>  (355) 
N

>  <CHIRALITY>  (355) 
Achiral Molecule

>  <PRODRUG>  (355) 
N

>  <ORAL>  (355) 
Y

>  <PARENTERAL>  (355) 
N

>  <TOPICAL>  (355) 
N

>  <BLACK_BOX>  (355) 
N

>  <AVAILABILITY_TYPE>  (355) 
Prescription-only

>  <WITHDRAWN_YEAR>  (355) 
nan

>  <WITHDRAWN_COUNTRY>  (355) 
nan

>  <WITHDRAWN_REASON>  (355) 
nan

>  <CANONICAL_SMILES>  (355) 
Clc1ccc2C(=C3CCNCC3)c4ncccc4CCc2c1

>  <name>  (355) 
Desloratadine 

>  <MW>  (355) 
310.828

>  <logP>  (355) 
4.0189

$$$$
CHEMBL1418176
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21  2  1  0
 21  6  1  0
 18  7  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (356) 
842060

>  <SYNONYMS>  (356) 
Metandienone (INN); Methandienone (BAN); Methandrostenolone (MI, USP)

>  <DEVELOPMENT_PHASE>  (356) 
4

>  <RESEARCH_CODES>  (356) 
nan

>  <APPLICANTS>  (356) 
nan

>  <USAN_STEM>  (356) 
-andr-; -olone

>  <USAN_STEM_DEFINITION>  (356) 
androgens; steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (356) 
-andr-; -olone

>  <USAN_YEAR>  (356) 
nan

>  <FIRST_APPROVAL>  (356) 
nan

>  <ATC_CODE>  (356) 
A14AA03; D11AE01

>  <ATC_CODE_DESCRIPTION>  (356) 
A14AA03 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives]; D11AE01 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Androgens for topical use]

>  <INDICATION_CLASS>  (356) 
nan

>  <SC_PATENT_NO>  (356) 
nan

>  <DRUG_TYPE>  (356) 
Natural Product-derived

>  <RULE_OF_FIVE>  (356) 
Y

>  <FIRST_IN_CLASS>  (356) 
N

>  <CHIRALITY>  (356) 
Single Stereoisomer

>  <PRODRUG>  (356) 
N

>  <ORAL>  (356) 
N

>  <PARENTERAL>  (356) 
N

>  <TOPICAL>  (356) 
N

>  <BLACK_BOX>  (356) 
N

>  <AVAILABILITY_TYPE>  (356) 
Withdrawn

>  <WITHDRAWN_YEAR>  (356) 
1982.0

>  <WITHDRAWN_COUNTRY>  (356) 
United Kingdom; United States; Germany; France

>  <WITHDRAWN_REASON>  (356) 
Off-label abuse

>  <CANONICAL_SMILES>  (356) 
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (356) 
Metandienone 

>  <MW>  (356) 
300.442

>  <logP>  (356) 
4.0453

$$$$
CHEMBL1218
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19  8  1  0
 19 11  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (357) 
221962

>  <SYNONYMS>  (357) 
Ramelteon (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (357) 
4

>  <RESEARCH_CODES>  (357) 
TAK-375

>  <APPLICANTS>  (357) 
Takeda Pharmaceuticals Usa Inc

>  <USAN_STEM>  (357) 
-melteon

>  <USAN_STEM_DEFINITION>  (357) 
selective melatonin receptor agonist

>  <USAN_STEM_SUBSTEM>  (357) 
-melteon

>  <USAN_YEAR>  (357) 
2004.0

>  <FIRST_APPROVAL>  (357) 
2005.0

>  <ATC_CODE>  (357) 
N05CH02

>  <ATC_CODE_DESCRIPTION>  (357) 
N05CH02 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Melatonin receptor agonists]

>  <INDICATION_CLASS>  (357) 
nan

>  <SC_PATENT_NO>  (357) 
US-6034239-A

>  <DRUG_TYPE>  (357) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (357) 
Y

>  <FIRST_IN_CLASS>  (357) 
Y

>  <CHIRALITY>  (357) 
Single Stereoisomer

>  <PRODRUG>  (357) 
N

>  <ORAL>  (357) 
Y

>  <PARENTERAL>  (357) 
N

>  <TOPICAL>  (357) 
N

>  <BLACK_BOX>  (357) 
N

>  <AVAILABILITY_TYPE>  (357) 
Prescription-only

>  <WITHDRAWN_YEAR>  (357) 
nan

>  <WITHDRAWN_COUNTRY>  (357) 
nan

>  <WITHDRAWN_REASON>  (357) 
nan

>  <CANONICAL_SMILES>  (357) 
CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12

>  <name>  (357) 
Ramelteon 

>  <MW>  (357) 
259.349

>  <logP>  (357) 
2.5676

$$$$
CHEMBL1539
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  7 19  2  0
 19 20  1  0
 20 21  1  0
 19  3  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (358) 
430546

>  <SYNONYMS>  (358) 
Sulfadoxine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (358) 
4

>  <RESEARCH_CODES>  (358) 
Ro-44393

>  <APPLICANTS>  (358) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (358) 
sulfa-

>  <USAN_STEM_DEFINITION>  (358) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (358) 
sulfa-

>  <USAN_YEAR>  (358) 
1968.0

>  <FIRST_APPROVAL>  (358) 
1981.0

>  <ATC_CODE>  (358) 
nan

>  <ATC_CODE_DESCRIPTION>  (358) 
nan

>  <INDICATION_CLASS>  (358) 
Antibacterial

>  <SC_PATENT_NO>  (358) 
nan

>  <DRUG_TYPE>  (358) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (358) 
Y

>  <FIRST_IN_CLASS>  (358) 
N

>  <CHIRALITY>  (358) 
Achiral Molecule

>  <PRODRUG>  (358) 
N

>  <ORAL>  (358) 
Y

>  <PARENTERAL>  (358) 
N

>  <TOPICAL>  (358) 
N

>  <BLACK_BOX>  (358) 
N

>  <AVAILABILITY_TYPE>  (358) 
Discontinued

>  <WITHDRAWN_YEAR>  (358) 
nan

>  <WITHDRAWN_COUNTRY>  (358) 
nan

>  <WITHDRAWN_REASON>  (358) 
nan

>  <CANONICAL_SMILES>  (358) 
COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC

>  <name>  (358) 
Sulfadoxine 

>  <MW>  (358) 
310.335

>  <logP>  (358) 
0.8768

$$$$
CHEMBL660
     RDKit          

 11 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  6 11  1  0
 10  2  1  0
 11  2  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (359) 
27647

>  <SYNONYMS>  (359) 
Amantadine (BAN, INN); Amantadine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (359) 
4

>  <RESEARCH_CODES>  (359) 
TCMDC-125869; EXP-105-1

>  <APPLICANTS>  (359) 
Endo Pharmaceuticals Inc

>  <USAN_STEM>  (359) 
-mantadine

>  <USAN_STEM_DEFINITION>  (359) 
antivirals/antiparkinsonians (adamantane derivatives)

>  <USAN_STEM_SUBSTEM>  (359) 
-mantadine

>  <USAN_YEAR>  (359) 
1964.0

>  <FIRST_APPROVAL>  (359) 
1968.0

>  <ATC_CODE>  (359) 
N04BB01

>  <ATC_CODE_DESCRIPTION>  (359) 
N04BB01 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Adamantane derivatives]

>  <INDICATION_CLASS>  (359) 
Antiviral

>  <SC_PATENT_NO>  (359) 
nan

>  <DRUG_TYPE>  (359) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (359) 
Y

>  <FIRST_IN_CLASS>  (359) 
N

>  <CHIRALITY>  (359) 
Achiral Molecule

>  <PRODRUG>  (359) 
N

>  <ORAL>  (359) 
Y

>  <PARENTERAL>  (359) 
N

>  <TOPICAL>  (359) 
N

>  <BLACK_BOX>  (359) 
N

>  <AVAILABILITY_TYPE>  (359) 
Prescription-only

>  <WITHDRAWN_YEAR>  (359) 
nan

>  <WITHDRAWN_COUNTRY>  (359) 
nan

>  <WITHDRAWN_REASON>  (359) 
nan

>  <CANONICAL_SMILES>  (359) 
NC12CC3CC(CC(C3)C1)C2

>  <name>  (359) 
Amantadine 

>  <MW>  (359) 
151.253

>  <logP>  (359) 
1.9139

$$$$
CHEMBL445
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  6  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (360) 
2262

>  <SYNONYMS>  (360) 
Nortriptyline (BAN, INN); Nortriptyline HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (360) 
4

>  <RESEARCH_CODES>  (360) 
38489

>  <APPLICANTS>  (360) 
Ranbaxy Pharmaceuticals Inc; Mallinckrodt Llc; Mallinckrodt Inc; Eli Lilly And Co

>  <USAN_STEM>  (360) 
-triptyline

>  <USAN_STEM_DEFINITION>  (360) 
antidepressants (dibenzo[a,d]cycloheptane derivatives)

>  <USAN_STEM_SUBSTEM>  (360) 
-triptyline

>  <USAN_YEAR>  (360) 
1963.0

>  <FIRST_APPROVAL>  (360) 
1964.0

>  <ATC_CODE>  (360) 
N06AA10

>  <ATC_CODE_DESCRIPTION>  (360) 
N06AA10 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (360) 
Antidepressant

>  <SC_PATENT_NO>  (360) 
nan

>  <DRUG_TYPE>  (360) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (360) 
Y

>  <FIRST_IN_CLASS>  (360) 
N

>  <CHIRALITY>  (360) 
Achiral Molecule

>  <PRODRUG>  (360) 
N

>  <ORAL>  (360) 
Y

>  <PARENTERAL>  (360) 
N

>  <TOPICAL>  (360) 
N

>  <BLACK_BOX>  (360) 
Y

>  <AVAILABILITY_TYPE>  (360) 
Prescription-only

>  <WITHDRAWN_YEAR>  (360) 
nan

>  <WITHDRAWN_COUNTRY>  (360) 
nan

>  <WITHDRAWN_REASON>  (360) 
nan

>  <CANONICAL_SMILES>  (360) 
CNCCC=C1c2ccccc2CCc3ccccc13

>  <name>  (360) 
Nortriptyline 

>  <MW>  (360) 
263.384

>  <logP>  (360) 
3.8264

$$$$
CHEMBL1763
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 16  5  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (361) 
583522

>  <SYNONYMS>  (361) 
Hydroflumethiazide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (361) 
4

>  <RESEARCH_CODES>  (361) 
nan

>  <APPLICANTS>  (361) 
Shire Development Llc; Shire Development Inc

>  <USAN_STEM>  (361) 
-thiazide

>  <USAN_STEM_DEFINITION>  (361) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (361) 
-thiazide

>  <USAN_YEAR>  (361) 
nan

>  <FIRST_APPROVAL>  (361) 
1959.0

>  <ATC_CODE>  (361) 
C03AH02; C03AA02

>  <ATC_CODE_DESCRIPTION>  (361) 
C03AH02 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, combinations with psycholeptics and/or analgesics]; C03AA02 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (361) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (361) 
nan

>  <DRUG_TYPE>  (361) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (361) 
Y

>  <FIRST_IN_CLASS>  (361) 
N

>  <CHIRALITY>  (361) 
Achiral Molecule

>  <PRODRUG>  (361) 
N

>  <ORAL>  (361) 
Y

>  <PARENTERAL>  (361) 
N

>  <TOPICAL>  (361) 
N

>  <BLACK_BOX>  (361) 
N

>  <AVAILABILITY_TYPE>  (361) 
Prescription-only

>  <WITHDRAWN_YEAR>  (361) 
nan

>  <WITHDRAWN_COUNTRY>  (361) 
nan

>  <WITHDRAWN_REASON>  (361) 
nan

>  <CANONICAL_SMILES>  (361) 
NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F

>  <name>  (361) 
Hydroflumethiazide 

>  <MW>  (361) 
331.297

>  <logP>  (361) 
0.0141

$$$$
CHEMBL941
     RDKit          

 37 41  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 21 35  2  0
  5 36  1  0
 36 37  1  0
 37  2  1  0
 12  7  1  0
 35 16  1  0
 28 23  1  0
 34 29  1  0
M  END
>  <PARENT_MOLREGNO>  (362) 
88797

>  <SYNONYMS>  (362) 
Imatinib (BAN, INN); Imatinib mesylate (FDA)

>  <DEVELOPMENT_PHASE>  (362) 
4

>  <RESEARCH_CODES>  (362) 
STI-571

>  <APPLICANTS>  (362) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (362) 
-tinib

>  <USAN_STEM_DEFINITION>  (362) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (362) 
-tinib

>  <USAN_YEAR>  (362) 
nan

>  <FIRST_APPROVAL>  (362) 
2001.0

>  <ATC_CODE>  (362) 
L01XE01

>  <ATC_CODE_DESCRIPTION>  (362) 
L01XE01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (362) 
nan

>  <SC_PATENT_NO>  (362) 
US-5521184-A

>  <DRUG_TYPE>  (362) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (362) 
Y

>  <FIRST_IN_CLASS>  (362) 
N

>  <CHIRALITY>  (362) 
Achiral Molecule

>  <PRODRUG>  (362) 
N

>  <ORAL>  (362) 
Y

>  <PARENTERAL>  (362) 
N

>  <TOPICAL>  (362) 
N

>  <BLACK_BOX>  (362) 
N

>  <AVAILABILITY_TYPE>  (362) 
Prescription-only

>  <WITHDRAWN_YEAR>  (362) 
nan

>  <WITHDRAWN_COUNTRY>  (362) 
nan

>  <WITHDRAWN_REASON>  (362) 
nan

>  <CANONICAL_SMILES>  (362) 
CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1

>  <name>  (362) 
Imatinib 

>  <MW>  (362) 
493.615

>  <logP>  (362) 
4.59032

$$$$
CHEMBL945
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 14  7  1  0
M  END
>  <PARENT_MOLREGNO>  (363) 
89526

>  <SYNONYMS>  (363) 
Amiloride (BAN, INN); Amiloride HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (363) 
4

>  <RESEARCH_CODES>  (363) 
nan

>  <APPLICANTS>  (363) 
Paddock Laboratories Llc; Merck Research Laboratories Div Merck Co Inc

>  <USAN_STEM>  (363) 
nan

>  <USAN_STEM_DEFINITION>  (363) 
nan

>  <USAN_STEM_SUBSTEM>  (363) 
nan

>  <USAN_YEAR>  (363) 
1967.0

>  <FIRST_APPROVAL>  (363) 
1981.0

>  <ATC_CODE>  (363) 
C03DB01

>  <ATC_CODE_DESCRIPTION>  (363) 
C03DB01 [Cardiovascular System:Diuretics:Potassium-Sparing Agents:Other potassium-sparing agents]

>  <INDICATION_CLASS>  (363) 
Diuretic

>  <SC_PATENT_NO>  (363) 
nan

>  <DRUG_TYPE>  (363) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (363) 
Y

>  <FIRST_IN_CLASS>  (363) 
N

>  <CHIRALITY>  (363) 
Achiral Molecule

>  <PRODRUG>  (363) 
N

>  <ORAL>  (363) 
Y

>  <PARENTERAL>  (363) 
N

>  <TOPICAL>  (363) 
N

>  <BLACK_BOX>  (363) 
Y

>  <AVAILABILITY_TYPE>  (363) 
Prescription-only

>  <WITHDRAWN_YEAR>  (363) 
nan

>  <WITHDRAWN_COUNTRY>  (363) 
nan

>  <WITHDRAWN_REASON>  (363) 
nan

>  <CANONICAL_SMILES>  (363) 
NC(=N)NC(=O)c1nc(Cl)c(N)nc1N

>  <name>  (363) 
Amiloride 

>  <MW>  (363) 
229.631

>  <logP>  (363) 
-1.08233

$$$$
CHEMBL925
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  2  0
 11 13  1  0
 10  4  1  0
M  END
>  <PARENT_MOLREGNO>  (364) 
84482

>  <SYNONYMS>  (364) 
Tyrosine (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (364) 
4

>  <RESEARCH_CODES>  (364) 
nan

>  <APPLICANTS>  (364) 
International Minerals Chemical Corp

>  <USAN_STEM>  (364) 
nan

>  <USAN_STEM_DEFINITION>  (364) 
nan

>  <USAN_STEM_SUBSTEM>  (364) 
nan

>  <USAN_YEAR>  (364) 
1979.0

>  <FIRST_APPROVAL>  (364) 
nan

>  <ATC_CODE>  (364) 
nan

>  <ATC_CODE_DESCRIPTION>  (364) 
nan

>  <INDICATION_CLASS>  (364) 
Amino Acid

>  <SC_PATENT_NO>  (364) 
nan

>  <DRUG_TYPE>  (364) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (364) 
Y

>  <FIRST_IN_CLASS>  (364) 
N

>  <CHIRALITY>  (364) 
Single Stereoisomer

>  <PRODRUG>  (364) 
N

>  <ORAL>  (364) 
Y

>  <PARENTERAL>  (364) 
N

>  <TOPICAL>  (364) 
N

>  <BLACK_BOX>  (364) 
N

>  <AVAILABILITY_TYPE>  (364) 
Discontinued

>  <WITHDRAWN_YEAR>  (364) 
nan

>  <WITHDRAWN_COUNTRY>  (364) 
nan

>  <WITHDRAWN_REASON>  (364) 
nan

>  <CANONICAL_SMILES>  (364) 
N[C@@H](Cc1ccc(O)cc1)C(=O)O

>  <name>  (364) 
Tyrosine 

>  <MW>  (364) 
181.191

>  <logP>  (364) 
0.3466

$$$$
CHEMBL1200953
     RDKit          

 35 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
  7 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
 26  7  1  0
 26 10  1  0
 22 11  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (365) 
674904

>  <SYNONYMS>  (365) 
Hydrocortisone Butyrate Propionate (JAN); Hydrocortisone Probutate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (365) 
4

>  <RESEARCH_CODES>  (365) 
TS-408

>  <APPLICANTS>  (365) 
Fougera Pharmaceuticals Inc

>  <USAN_STEM>  (365) 
-cort-

>  <USAN_STEM_DEFINITION>  (365) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (365) 
-cort-

>  <USAN_YEAR>  (365) 
1997.0

>  <FIRST_APPROVAL>  (365) 
1997.0

>  <ATC_CODE>  (365) 
D07AB11

>  <ATC_CODE_DESCRIPTION>  (365) 
D07AB11 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (365) 
Glucocorticoid

>  <SC_PATENT_NO>  (365) 
nan

>  <DRUG_TYPE>  (365) 
Natural Product-derived

>  <RULE_OF_FIVE>  (365) 
Y

>  <FIRST_IN_CLASS>  (365) 
N

>  <CHIRALITY>  (365) 
Single Stereoisomer

>  <PRODRUG>  (365) 
Y

>  <ORAL>  (365) 
N

>  <PARENTERAL>  (365) 
N

>  <TOPICAL>  (365) 
Y

>  <BLACK_BOX>  (365) 
N

>  <AVAILABILITY_TYPE>  (365) 
Prescription-only

>  <WITHDRAWN_YEAR>  (365) 
nan

>  <WITHDRAWN_COUNTRY>  (365) 
nan

>  <WITHDRAWN_REASON>  (365) 
nan

>  <CANONICAL_SMILES>  (365) 
CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC

>  <name>  (365) 
Hydrocortisone Butyrate Propionate 

>  <MW>  (365) 
488.621

>  <logP>  (365) 
4.0935

$$$$
CHEMBL1988479
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  3  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13  3  1  0
M  END
>  <PARENT_MOLREGNO>  (366) 
1309770

>  <SYNONYMS>  (366) 
Etallobarbital

>  <DEVELOPMENT_PHASE>  (366) 
4

>  <RESEARCH_CODES>  (366) 
nan

>  <APPLICANTS>  (366) 
nan

>  <USAN_STEM>  (366) 
-barb-

>  <USAN_STEM_DEFINITION>  (366) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (366) 
-barb-

>  <USAN_YEAR>  (366) 
nan

>  <FIRST_APPROVAL>  (366) 
nan

>  <ATC_CODE>  (366) 
N05CA20

>  <ATC_CODE_DESCRIPTION>  (366) 
N05CA20 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (366) 
nan

>  <SC_PATENT_NO>  (366) 
nan

>  <DRUG_TYPE>  (366) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (366) 
Y

>  <FIRST_IN_CLASS>  (366) 
N

>  <CHIRALITY>  (366) 
Achiral Molecule

>  <PRODRUG>  (366) 
N

>  <ORAL>  (366) 
N

>  <PARENTERAL>  (366) 
N

>  <TOPICAL>  (366) 
N

>  <BLACK_BOX>  (366) 
N

>  <AVAILABILITY_TYPE>  (366) 
Unknown

>  <WITHDRAWN_YEAR>  (366) 
nan

>  <WITHDRAWN_COUNTRY>  (366) 
nan

>  <WITHDRAWN_REASON>  (366) 
nan

>  <CANONICAL_SMILES>  (366) 
CCC1(CC=C)C(=O)NC(=O)NC1=O

>  <name>  (366) 
Etallobarbital

>  <MW>  (366) 
196.206

>  <logP>  (366) 
0.3249

$$$$
CHEMBL2105689
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  3  0
 10 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  9 18  1  0
  5 19  1  0
 19 20  1  0
 19 21  2  0
 21  2  1  0
 18  6  1  0
 17 13  1  0
M  END
>  <PARENT_MOLREGNO>  (367) 
1377959

>  <SYNONYMS>  (367) 
Luliconazole (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (367) 
4

>  <RESEARCH_CODES>  (367) 
NND-502; PR-2699

>  <APPLICANTS>  (367) 
Medicis Pharmaceutical Corp

>  <USAN_STEM>  (367) 
-conazole

>  <USAN_STEM_DEFINITION>  (367) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (367) 
-conazole

>  <USAN_YEAR>  (367) 
2010.0

>  <FIRST_APPROVAL>  (367) 
2013.0

>  <ATC_CODE>  (367) 
D01AC18

>  <ATC_CODE_DESCRIPTION>  (367) 
D01AC18 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Imidazole and triazole derivatives]

>  <INDICATION_CLASS>  (367) 
nan

>  <SC_PATENT_NO>  (367) 
US-5900488-A

>  <DRUG_TYPE>  (367) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (367) 
Y

>  <FIRST_IN_CLASS>  (367) 
N

>  <CHIRALITY>  (367) 
Single Stereoisomer

>  <PRODRUG>  (367) 
N

>  <ORAL>  (367) 
N

>  <PARENTERAL>  (367) 
N

>  <TOPICAL>  (367) 
Y

>  <BLACK_BOX>  (367) 
N

>  <AVAILABILITY_TYPE>  (367) 
Prescription-only

>  <WITHDRAWN_YEAR>  (367) 
nan

>  <WITHDRAWN_COUNTRY>  (367) 
nan

>  <WITHDRAWN_REASON>  (367) 
nan

>  <CANONICAL_SMILES>  (367) 
Clc1ccc([C@@H]2CS\C(=C(\C#N)/n3ccnc3)\S2)c(Cl)c1

>  <name>  (367) 
Luliconazole 

>  <MW>  (367) 
354.287

>  <logP>  (367) 
5.06088

$$$$
CHEMBL1186610
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 17 11  1  0
 18 13  1  0
M  CHG  1  18   1
M  END
>  <PARENT_MOLREGNO>  (368) 
660560

>  <SYNONYMS>  (368) 
Anisotropine Methylbromide (FDA, JAN, USAN); Octatropine Methylbromide (BAN, INN)

>  <DEVELOPMENT_PHASE>  (368) 
4

>  <RESEARCH_CODES>  (368) 
nan

>  <APPLICANTS>  (368) 
Endo Pharmaceuticals Inc

>  <USAN_STEM>  (368) 
-trop-

>  <USAN_STEM_DEFINITION>  (368) 
atropine derivatives

>  <USAN_STEM_SUBSTEM>  (368) 
-trop-

>  <USAN_YEAR>  (368) 
1963.0

>  <FIRST_APPROVAL>  (368) 
1962.0

>  <ATC_CODE>  (368) 
nan

>  <ATC_CODE_DESCRIPTION>  (368) 
nan

>  <INDICATION_CLASS>  (368) 
Anticholinergic

>  <SC_PATENT_NO>  (368) 
nan

>  <DRUG_TYPE>  (368) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (368) 
Y

>  <FIRST_IN_CLASS>  (368) 
N

>  <CHIRALITY>  (368) 
Single Stereoisomer

>  <PRODRUG>  (368) 
N

>  <ORAL>  (368) 
Y

>  <PARENTERAL>  (368) 
N

>  <TOPICAL>  (368) 
N

>  <BLACK_BOX>  (368) 
N

>  <AVAILABILITY_TYPE>  (368) 
Discontinued

>  <WITHDRAWN_YEAR>  (368) 
nan

>  <WITHDRAWN_COUNTRY>  (368) 
nan

>  <WITHDRAWN_REASON>  (368) 
nan

>  <CANONICAL_SMILES>  (368) 
CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C

>  <name>  (368) 
Anisotropine Methylbromide 

>  <MW>  (368) 
282.448

>  <logP>  (368) 
3.5158

$$$$
CHEMBL642
     RDKit          

 24 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 10 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 21  7  1  0
M  END
>  <PARENT_MOLREGNO>  (369) 
27347

>  <SYNONYMS>  (369) 
Acebutolol (BAN, INN, USAN); Acebutolol HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (369) 
4

>  <RESEARCH_CODES>  (369) 
IL-17803A; M&B-17803A

>  <APPLICANTS>  (369) 
Promius Pharma Llc

>  <USAN_STEM>  (369) 
-olol

>  <USAN_STEM_DEFINITION>  (369) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (369) 
-olol

>  <USAN_YEAR>  (369) 
1973.0

>  <FIRST_APPROVAL>  (369) 
1984.0

>  <ATC_CODE>  (369) 
C07AB04

>  <ATC_CODE_DESCRIPTION>  (369) 
C07AB04 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]

>  <INDICATION_CLASS>  (369) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (369) 
nan

>  <DRUG_TYPE>  (369) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (369) 
Y

>  <FIRST_IN_CLASS>  (369) 
N

>  <CHIRALITY>  (369) 
Racemic Mixture

>  <PRODRUG>  (369) 
N

>  <ORAL>  (369) 
Y

>  <PARENTERAL>  (369) 
N

>  <TOPICAL>  (369) 
N

>  <BLACK_BOX>  (369) 
N

>  <AVAILABILITY_TYPE>  (369) 
Prescription-only

>  <WITHDRAWN_YEAR>  (369) 
nan

>  <WITHDRAWN_COUNTRY>  (369) 
nan

>  <WITHDRAWN_REASON>  (369) 
nan

>  <CANONICAL_SMILES>  (369) 
CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C

>  <name>  (369) 
Acebutolol 

>  <MW>  (369) 
336.432

>  <logP>  (369) 
2.3655

$$$$
CHEMBL634
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 12 16  1  0
 16 17  1  0
 12 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 18 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
  6 29  1  0
 29 30  2  0
 29  3  1  0
 17  9  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (370) 
27190

>  <SYNONYMS>  (370) 
Alfentanil (BAN, INN); Alfentanil HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (370) 
4

>  <RESEARCH_CODES>  (370) 
R-39209

>  <APPLICANTS>  (370) 
Akorn Inc

>  <USAN_STEM>  (370) 
-fentanil

>  <USAN_STEM_DEFINITION>  (370) 
narcotic analgesics (fentanyl derivatives)

>  <USAN_STEM_SUBSTEM>  (370) 
-fentanil

>  <USAN_YEAR>  (370) 
1980.0

>  <FIRST_APPROVAL>  (370) 
1986.0

>  <ATC_CODE>  (370) 
N01AH02

>  <ATC_CODE_DESCRIPTION>  (370) 
N01AH02 [Nervous System:Anesthetics:Anesthetics, General:Opioid anesthetics]

>  <INDICATION_CLASS>  (370) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (370) 
nan

>  <DRUG_TYPE>  (370) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (370) 
Y

>  <FIRST_IN_CLASS>  (370) 
N

>  <CHIRALITY>  (370) 
Achiral Molecule

>  <PRODRUG>  (370) 
N

>  <ORAL>  (370) 
N

>  <PARENTERAL>  (370) 
Y

>  <TOPICAL>  (370) 
N

>  <BLACK_BOX>  (370) 
N

>  <AVAILABILITY_TYPE>  (370) 
Prescription-only

>  <WITHDRAWN_YEAR>  (370) 
nan

>  <WITHDRAWN_COUNTRY>  (370) 
nan

>  <WITHDRAWN_REASON>  (370) 
nan

>  <CANONICAL_SMILES>  (370) 
CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)c3ccccc3)C1=O

>  <name>  (370) 
Alfentanil 

>  <MW>  (370) 
416.526

>  <logP>  (370) 
1.3839

$$$$
CHEMBL569
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (371) 
16581

>  <SYNONYMS>  (371) 
Procaine (BAN, INN); Procaine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (371) 
4

>  <RESEARCH_CODES>  (371) 
nan

>  <APPLICANTS>  (371) 
Lederle Laboratories Div American Cyanamid Co; Eastman Kodak Co

>  <USAN_STEM>  (371) 
-caine

>  <USAN_STEM_DEFINITION>  (371) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (371) 
-caine

>  <USAN_YEAR>  (371) 
nan

>  <FIRST_APPROVAL>  (371) 
1954.0

>  <ATC_CODE>  (371) 
N01BA02; C05AD05; N01BA52; S01HA05

>  <ATC_CODE_DESCRIPTION>  (371) 
N01BA02 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]; C05AD05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; N01BA52 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]; S01HA05 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]

>  <INDICATION_CLASS>  (371) 
Anesthetic (local)

>  <SC_PATENT_NO>  (371) 
nan

>  <DRUG_TYPE>  (371) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (371) 
Y

>  <FIRST_IN_CLASS>  (371) 
N

>  <CHIRALITY>  (371) 
Achiral Molecule

>  <PRODRUG>  (371) 
N

>  <ORAL>  (371) 
N

>  <PARENTERAL>  (371) 
Y

>  <TOPICAL>  (371) 
N

>  <BLACK_BOX>  (371) 
N

>  <AVAILABILITY_TYPE>  (371) 
Discontinued

>  <WITHDRAWN_YEAR>  (371) 
nan

>  <WITHDRAWN_COUNTRY>  (371) 
nan

>  <WITHDRAWN_REASON>  (371) 
nan

>  <CANONICAL_SMILES>  (371) 
CCN(CC)CCOC(=O)c1ccc(N)cc1

>  <name>  (371) 
Procaine 

>  <MW>  (371) 
236.315

>  <logP>  (371) 
1.7674

$$$$
CHEMBL1621
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31  2  1  0
 11  6  1  0
 21 12  1  0
 21 15  1  0
 30 24  1  0
M  END
>  <PARENT_MOLREGNO>  (372) 
468656

>  <SYNONYMS>  (372) 
Paliperidone (FDA, INN, USAN); Paliperidone Palmitate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (372) 
4

>  <RESEARCH_CODES>  (372) 
Ro-76477; Ro-92670

>  <APPLICANTS>  (372) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (372) 
-peridone

>  <USAN_STEM_DEFINITION>  (372) 
antipsychotics (risperidone type)

>  <USAN_STEM_SUBSTEM>  (372) 
-peridone

>  <USAN_YEAR>  (372) 
2004.0

>  <FIRST_APPROVAL>  (372) 
2006.0

>  <ATC_CODE>  (372) 
N05AX13

>  <ATC_CODE_DESCRIPTION>  (372) 
N05AX13 [Nervous System:Psycholeptics:Antipsychotics:Other antipsychotics]

>  <INDICATION_CLASS>  (372) 
nan

>  <SC_PATENT_NO>  (372) 
US-6077843-A

>  <DRUG_TYPE>  (372) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (372) 
Y

>  <FIRST_IN_CLASS>  (372) 
N

>  <CHIRALITY>  (372) 
Racemic Mixture

>  <PRODRUG>  (372) 
N

>  <ORAL>  (372) 
Y

>  <PARENTERAL>  (372) 
Y

>  <TOPICAL>  (372) 
N

>  <BLACK_BOX>  (372) 
Y

>  <AVAILABILITY_TYPE>  (372) 
Prescription-only

>  <WITHDRAWN_YEAR>  (372) 
nan

>  <WITHDRAWN_COUNTRY>  (372) 
nan

>  <WITHDRAWN_REASON>  (372) 
nan

>  <CANONICAL_SMILES>  (372) 
CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCC(O)C5=N1

>  <name>  (372) 
Paliperidone 

>  <MW>  (372) 
426.492

>  <logP>  (372) 
3.08132

$$$$
CHEMBL1077896
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  9  4  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (373) 
618203

>  <SYNONYMS>  (373) 
Ropivacaine (BAN, INN); Ropivacaine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (373) 
4

>  <RESEARCH_CODES>  (373) 
nan

>  <APPLICANTS>  (373) 
Fresenius Kabi Usa Llc; Astra

>  <USAN_STEM>  (373) 
-caine

>  <USAN_STEM_DEFINITION>  (373) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (373) 
-caine

>  <USAN_YEAR>  (373) 
nan

>  <FIRST_APPROVAL>  (373) 
1996.0

>  <ATC_CODE>  (373) 
N01BB09

>  <ATC_CODE_DESCRIPTION>  (373) 
N01BB09 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (373) 
nan

>  <SC_PATENT_NO>  (373) 
US-7828787-B2

>  <DRUG_TYPE>  (373) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (373) 
Y

>  <FIRST_IN_CLASS>  (373) 
N

>  <CHIRALITY>  (373) 
Single Stereoisomer

>  <PRODRUG>  (373) 
N

>  <ORAL>  (373) 
N

>  <PARENTERAL>  (373) 
Y

>  <TOPICAL>  (373) 
N

>  <BLACK_BOX>  (373) 
N

>  <AVAILABILITY_TYPE>  (373) 
Prescription-only

>  <WITHDRAWN_YEAR>  (373) 
nan

>  <WITHDRAWN_COUNTRY>  (373) 
nan

>  <WITHDRAWN_REASON>  (373) 
nan

>  <CANONICAL_SMILES>  (373) 
CCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C

>  <name>  (373) 
Ropivacaine 

>  <MW>  (373) 
274.408

>  <logP>  (373) 
3.50644

$$$$
CHEMBL191
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 12  5  1  0
 19 14  1  0
 25 20  1  0
 30 26  2  0
M  END
>  <PARENT_MOLREGNO>  (374) 
408842

>  <SYNONYMS>  (374) 
Losartan (BAN, INN); Losartan potassium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (374) 
4

>  <RESEARCH_CODES>  (374) 
DuP-753

>  <APPLICANTS>  (374) 
Merck Research Laboratories Div Merck Co Inc; Merck And Co Inc

>  <USAN_STEM>  (374) 
-sartan

>  <USAN_STEM_DEFINITION>  (374) 
angiotensin II receptor antagonists

>  <USAN_STEM_SUBSTEM>  (374) 
-sartan

>  <USAN_YEAR>  (374) 
1992.0

>  <FIRST_APPROVAL>  (374) 
1995.0

>  <ATC_CODE>  (374) 
C09CA01

>  <ATC_CODE_DESCRIPTION>  (374) 
C09CA01 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Angiotensin Ii Antagonists, Plain:Angiotensin II antagonists, plain]

>  <INDICATION_CLASS>  (374) 
Antihypertensive

>  <SC_PATENT_NO>  (374) 
nan

>  <DRUG_TYPE>  (374) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (374) 
Y

>  <FIRST_IN_CLASS>  (374) 
N

>  <CHIRALITY>  (374) 
Achiral Molecule

>  <PRODRUG>  (374) 
N

>  <ORAL>  (374) 
Y

>  <PARENTERAL>  (374) 
N

>  <TOPICAL>  (374) 
N

>  <BLACK_BOX>  (374) 
Y

>  <AVAILABILITY_TYPE>  (374) 
Prescription-only

>  <WITHDRAWN_YEAR>  (374) 
nan

>  <WITHDRAWN_COUNTRY>  (374) 
nan

>  <WITHDRAWN_REASON>  (374) 
nan

>  <CANONICAL_SMILES>  (374) 
CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4nn[nH]n4

>  <name>  (374) 
Losartan 

>  <MW>  (374) 
422.92

>  <logP>  (374) 
4.2668

$$$$
CHEMBL684
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (375) 
29569

>  <SYNONYMS>  (375) 
Diethylcarbamazine (BAN, INN); Diethylcarbamazine citrate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (375) 
4

>  <RESEARCH_CODES>  (375) 
nan

>  <APPLICANTS>  (375) 
Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (375) 
nan

>  <USAN_STEM_DEFINITION>  (375) 
nan

>  <USAN_STEM_SUBSTEM>  (375) 
nan

>  <USAN_YEAR>  (375) 
nan

>  <FIRST_APPROVAL>  (375) 
1950.0

>  <ATC_CODE>  (375) 
P02CB02

>  <ATC_CODE_DESCRIPTION>  (375) 
P02CB02 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Piperazine and derivatives]

>  <INDICATION_CLASS>  (375) 
Anthelmintic

>  <SC_PATENT_NO>  (375) 
nan

>  <DRUG_TYPE>  (375) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (375) 
Y

>  <FIRST_IN_CLASS>  (375) 
N

>  <CHIRALITY>  (375) 
Achiral Molecule

>  <PRODRUG>  (375) 
N

>  <ORAL>  (375) 
Y

>  <PARENTERAL>  (375) 
N

>  <TOPICAL>  (375) 
N

>  <BLACK_BOX>  (375) 
N

>  <AVAILABILITY_TYPE>  (375) 
Discontinued

>  <WITHDRAWN_YEAR>  (375) 
nan

>  <WITHDRAWN_COUNTRY>  (375) 
nan

>  <WITHDRAWN_REASON>  (375) 
nan

>  <CANONICAL_SMILES>  (375) 
CCN(CC)C(=O)N1CCN(C)CC1

>  <name>  (375) 
Diethylcarbamazine 

>  <MW>  (375) 
199.298

>  <logP>  (375) 
0.6956

$$$$
CHEMBL84
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 18 23  1  0
 23 24  1  0
 23 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 13 30  1  0
 30 31  2  0
 10  3  1  0
 30  9  1  0
 29 12  1  0
 29 15  1  0
 27 17  1  0
M  END
>  <PARENT_MOLREGNO>  (376) 
7501

>  <SYNONYMS>  (376) 
Topotecan (BAN, INN); Topotecan HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (376) 
4

>  <RESEARCH_CODES>  (376) 
SK&F-S-104864A; SK-S-104864-A

>  <APPLICANTS>  (376) 
SmithKline Beecham Corp Dba GlaxoSmithKline; Sandoz Inc; Hospira Inc; GlaxoSmithKline; Teva Pharmaceuticals Usa

>  <USAN_STEM>  (376) 
-tecan

>  <USAN_STEM_DEFINITION>  (376) 
antineoplastics (camptothecine derivatives)

>  <USAN_STEM_SUBSTEM>  (376) 
-tecan

>  <USAN_YEAR>  (376) 
1990.0

>  <FIRST_APPROVAL>  (376) 
1996.0

>  <ATC_CODE>  (376) 
L01XX17

>  <ATC_CODE_DESCRIPTION>  (376) 
L01XX17 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (376) 
Antineoplastic (DNA topoisomerase I Inhibitor)

>  <SC_PATENT_NO>  (376) 
US-8158645-B2

>  <DRUG_TYPE>  (376) 
Natural Product-derived

>  <RULE_OF_FIVE>  (376) 
Y

>  <FIRST_IN_CLASS>  (376) 
N

>  <CHIRALITY>  (376) 
Single Stereoisomer

>  <PRODRUG>  (376) 
N

>  <ORAL>  (376) 
Y

>  <PARENTERAL>  (376) 
Y

>  <TOPICAL>  (376) 
N

>  <BLACK_BOX>  (376) 
Y

>  <AVAILABILITY_TYPE>  (376) 
Prescription-only

>  <WITHDRAWN_YEAR>  (376) 
nan

>  <WITHDRAWN_COUNTRY>  (376) 
nan

>  <WITHDRAWN_REASON>  (376) 
nan

>  <CANONICAL_SMILES>  (376) 
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(CN(C)C)c(O)ccc5nc34)C2=O

>  <name>  (376) 
Topotecan 

>  <MW>  (376) 
421.453

>  <logP>  (376) 
1.8468

$$$$
CHEMBL1790041
     RDKit          

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 15 20  2  0
 20 21  1  0
 21 13  2  0
M  CHG  2   5   1   7  -1
M  END
>  <PARENT_MOLREGNO>  (377) 
1153672

>  <SYNONYMS>  (377) 
Ranitidine (BAN, INN, USAN); Ranitidine Bismuth Citrate (BAN, FDA, USAN); Ranitidine Bismutrex (BAN); Ranitidine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (377) 
4

>  <RESEARCH_CODES>  (377) 
GR-122311X; AH-19065

>  <APPLICANTS>  (377) 
Glaxo, England; Covis Pharma Sarl; Boehringer Ingelheim Pharmaceuticals Inc; Boehringer Ingelheim; GlaxoSmithKline

>  <USAN_STEM>  (377) 
-tidine

>  <USAN_STEM_DEFINITION>  (377) 
H2-receptor antagonists (cimetidine type)

>  <USAN_STEM_SUBSTEM>  (377) 
-tidine

>  <USAN_YEAR>  (377) 
1979.0

>  <FIRST_APPROVAL>  (377) 
1983.0

>  <ATC_CODE>  (377) 
A02BA02; A02BA07

>  <ATC_CODE_DESCRIPTION>  (377) 
A02BA02 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):H2-receptor antagonists]; A02BA07 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):H2-receptor antagonists]

>  <INDICATION_CLASS>  (377) 
Antagonist (to histamine-H2 receptors)

>  <SC_PATENT_NO>  (377) 
nan

>  <DRUG_TYPE>  (377) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (377) 
Y

>  <FIRST_IN_CLASS>  (377) 
N

>  <CHIRALITY>  (377) 
Achiral Molecule

>  <PRODRUG>  (377) 
N

>  <ORAL>  (377) 
Y

>  <PARENTERAL>  (377) 
Y

>  <TOPICAL>  (377) 
N

>  <BLACK_BOX>  (377) 
N

>  <AVAILABILITY_TYPE>  (377) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (377) 
nan

>  <WITHDRAWN_COUNTRY>  (377) 
nan

>  <WITHDRAWN_REASON>  (377) 
nan

>  <CANONICAL_SMILES>  (377) 
CNC(=C[N+](=O)[O-])NCCSCc1oc(CN(C)C)cc1

>  <name>  (377) 
Ranitidine 

>  <MW>  (377) 
314.411

>  <logP>  (377) 
1.459

$$$$
CHEMBL609
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
M  END
>  <PARENT_MOLREGNO>  (378) 
22956

>  <SYNONYMS>  (378) 
Trientine (INN); Trientine Dihydrochloride (BAN); Trientine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (378) 
4

>  <RESEARCH_CODES>  (378) 
MK-0681

>  <APPLICANTS>  (378) 
Aton Pharma Inc

>  <USAN_STEM>  (378) 
nan

>  <USAN_STEM_DEFINITION>  (378) 
nan

>  <USAN_STEM_SUBSTEM>  (378) 
nan

>  <USAN_YEAR>  (378) 
1984.0

>  <FIRST_APPROVAL>  (378) 
1985.0

>  <ATC_CODE>  (378) 
nan

>  <ATC_CODE_DESCRIPTION>  (378) 
nan

>  <INDICATION_CLASS>  (378) 
Chelating Agent

>  <SC_PATENT_NO>  (378) 
nan

>  <DRUG_TYPE>  (378) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (378) 
Y

>  <FIRST_IN_CLASS>  (378) 
N

>  <CHIRALITY>  (378) 
Achiral Molecule

>  <PRODRUG>  (378) 
N

>  <ORAL>  (378) 
Y

>  <PARENTERAL>  (378) 
N

>  <TOPICAL>  (378) 
N

>  <BLACK_BOX>  (378) 
N

>  <AVAILABILITY_TYPE>  (378) 
Prescription-only

>  <WITHDRAWN_YEAR>  (378) 
nan

>  <WITHDRAWN_COUNTRY>  (378) 
nan

>  <WITHDRAWN_REASON>  (378) 
nan

>  <CANONICAL_SMILES>  (378) 
NCCNCCNCCN

>  <name>  (378) 
Trientine 

>  <MW>  (378) 
146.238

>  <logP>  (378) 
-1.917

$$$$
CHEMBL1201356
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 22 25  2  0
 24  9  1  0
 23 13  1  0
 25 15  1  0
 25 18  1  0
M  END
>  <PARENT_MOLREGNO>  (379) 
675307

>  <SYNONYMS>  (379) 
Methylergometrine (INN, BAN); Methylergometrine Maleate (JAN); Methylergonovine Maleate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (379) 
4

>  <RESEARCH_CODES>  (379) 
nan

>  <APPLICANTS>  (379) 
Us Pharmaceuticals Holdings I Llc

>  <USAN_STEM>  (379) 
-erg-; -vin-

>  <USAN_STEM_DEFINITION>  (379) 
ergot alkaloid derivatives; vinca alkaloids

>  <USAN_STEM_SUBSTEM>  (379) 
-erg-; -vin-

>  <USAN_YEAR>  (379) 
nan

>  <FIRST_APPROVAL>  (379) 
1946.0

>  <ATC_CODE>  (379) 
G02AB01

>  <ATC_CODE_DESCRIPTION>  (379) 
G02AB01 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Uterotonics:Ergot alkaloids]

>  <INDICATION_CLASS>  (379) 
Oxytocic

>  <SC_PATENT_NO>  (379) 
nan

>  <DRUG_TYPE>  (379) 
Natural Product-derived

>  <RULE_OF_FIVE>  (379) 
Y

>  <FIRST_IN_CLASS>  (379) 
N

>  <CHIRALITY>  (379) 
Single Stereoisomer

>  <PRODRUG>  (379) 
N

>  <ORAL>  (379) 
Y

>  <PARENTERAL>  (379) 
Y

>  <TOPICAL>  (379) 
N

>  <BLACK_BOX>  (379) 
N

>  <AVAILABILITY_TYPE>  (379) 
Prescription-only

>  <WITHDRAWN_YEAR>  (379) 
nan

>  <WITHDRAWN_COUNTRY>  (379) 
nan

>  <WITHDRAWN_REASON>  (379) 
nan

>  <CANONICAL_SMILES>  (379) 
CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34

>  <name>  (379) 
Methylergometrine 

>  <MW>  (379) 
339.439

>  <logP>  (379) 
1.9247

$$$$
CHEMBL1865134
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 10 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  9 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 14  5  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (380) 
1205705

>  <SYNONYMS>  (380) 
Sodium Dibunate (BAN, INN)

>  <DEVELOPMENT_PHASE>  (380) 
4

>  <RESEARCH_CODES>  (380) 
L-1633

>  <APPLICANTS>  (380) 
nan

>  <USAN_STEM>  (380) 
nan

>  <USAN_STEM_DEFINITION>  (380) 
nan

>  <USAN_STEM_SUBSTEM>  (380) 
nan

>  <USAN_YEAR>  (380) 
nan

>  <FIRST_APPROVAL>  (380) 
nan

>  <ATC_CODE>  (380) 
R05DB16

>  <ATC_CODE_DESCRIPTION>  (380) 
R05DB16 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Other cough suppressants]

>  <INDICATION_CLASS>  (380) 
nan

>  <SC_PATENT_NO>  (380) 
nan

>  <DRUG_TYPE>  (380) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (380) 
Y

>  <FIRST_IN_CLASS>  (380) 
N

>  <CHIRALITY>  (380) 
Achiral Molecule

>  <PRODRUG>  (380) 
N

>  <ORAL>  (380) 
N

>  <PARENTERAL>  (380) 
N

>  <TOPICAL>  (380) 
N

>  <BLACK_BOX>  (380) 
N

>  <AVAILABILITY_TYPE>  (380) 
Unknown

>  <WITHDRAWN_YEAR>  (380) 
nan

>  <WITHDRAWN_COUNTRY>  (380) 
nan

>  <WITHDRAWN_REASON>  (380) 
nan

>  <CANONICAL_SMILES>  (380) 
CC(C)(C)c1ccc2c(c(ccc2c1)C(C)(C)C)S(=O)(=O)O

>  <name>  (380) 
Sodium Dibunate 

>  <MW>  (380) 
320.454

>  <logP>  (380) 
4.6815

$$$$
CHEMBL2010601
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  8 23  1  0
 23 24  2  0
 24 25  1  0
  7 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 24  5  1  0
 21 12  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (381) 
1331852

>  <SYNONYMS>  (381) 
Ivacaftor (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (381) 
4

>  <RESEARCH_CODES>  (381) 
VX-770

>  <APPLICANTS>  (381) 
Vertex Pharmaceuticals Inc

>  <USAN_STEM>  (381) 
nan

>  <USAN_STEM_DEFINITION>  (381) 
nan

>  <USAN_STEM_SUBSTEM>  (381) 
nan

>  <USAN_YEAR>  (381) 
2010.0

>  <FIRST_APPROVAL>  (381) 
2012.0

>  <ATC_CODE>  (381) 
R07AX02

>  <ATC_CODE_DESCRIPTION>  (381) 
R07AX02 [Respiratory System:Other Respiratory System Products:Other Respiratory System Products:Other respiratory system products]

>  <INDICATION_CLASS>  (381) 
nan

>  <SC_PATENT_NO>  (381) 
US-7495103-B2

>  <DRUG_TYPE>  (381) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (381) 
Y

>  <FIRST_IN_CLASS>  (381) 
Y

>  <CHIRALITY>  (381) 
Achiral Molecule

>  <PRODRUG>  (381) 
N

>  <ORAL>  (381) 
Y

>  <PARENTERAL>  (381) 
N

>  <TOPICAL>  (381) 
N

>  <BLACK_BOX>  (381) 
N

>  <AVAILABILITY_TYPE>  (381) 
Prescription-only

>  <WITHDRAWN_YEAR>  (381) 
nan

>  <WITHDRAWN_COUNTRY>  (381) 
nan

>  <WITHDRAWN_REASON>  (381) 
nan

>  <CANONICAL_SMILES>  (381) 
CC(C)(C)c1cc(c(NC(=O)C2=CNc3ccccc3C2=O)cc1O)C(C)(C)C

>  <name>  (381) 
Ivacaftor 

>  <MW>  (381) 
392.499

>  <logP>  (381) 
5.081

$$$$
CHEMBL579205
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  6 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
  8  3  1  0
 19 10  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (382) 
577065

>  <SYNONYMS>  (382) 
Flutemetamol F-18 (USAN, FDA)

>  <DEVELOPMENT_PHASE>  (382) 
4

>  <RESEARCH_CODES>  (382) 
[18F]AH110690

>  <APPLICANTS>  (382) 
Ge Healthcare

>  <USAN_STEM>  (382) 
nan

>  <USAN_STEM_DEFINITION>  (382) 
nan

>  <USAN_STEM_SUBSTEM>  (382) 
nan

>  <USAN_YEAR>  (382) 
2012.0

>  <FIRST_APPROVAL>  (382) 
2013.0

>  <ATC_CODE>  (382) 
V09AX04

>  <ATC_CODE_DESCRIPTION>  (382) 
V09AX04 [Various:Diagnostic Radiopharmaceuticals:Central Nervous System:Other central nervous system diagnostic radiopharmaceuticals]

>  <INDICATION_CLASS>  (382) 
nan

>  <SC_PATENT_NO>  (382) 
US-7270800-B2

>  <DRUG_TYPE>  (382) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (382) 
Y

>  <FIRST_IN_CLASS>  (382) 
N

>  <CHIRALITY>  (382) 
Achiral Molecule

>  <PRODRUG>  (382) 
N

>  <ORAL>  (382) 
N

>  <PARENTERAL>  (382) 
Y

>  <TOPICAL>  (382) 
N

>  <BLACK_BOX>  (382) 
N

>  <AVAILABILITY_TYPE>  (382) 
Prescription-only

>  <WITHDRAWN_YEAR>  (382) 
nan

>  <WITHDRAWN_COUNTRY>  (382) 
nan

>  <WITHDRAWN_REASON>  (382) 
nan

>  <CANONICAL_SMILES>  (382) 
CNc1ccc(cc1F)c2nc3ccc(O)cc3s2

>  <name>  (382) 
Flutemetamol F-18 

>  <MW>  (382) 
274.32

>  <logP>  (382) 
3.8497

$$$$
CHEMBL592
     RDKit          

 19 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 11  2  1  0
 10  5  1  0
 19  5  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (383) 
19572

>  <SYNONYMS>  (383) 
Levorphanol (BAN, INN); Levorphanol Tartrate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (383) 
4

>  <RESEARCH_CODES>  (383) 
nan

>  <APPLICANTS>  (383) 
Valeant Pharmaceuticals International

>  <USAN_STEM>  (383) 
nan

>  <USAN_STEM_DEFINITION>  (383) 
nan

>  <USAN_STEM_SUBSTEM>  (383) 
nan

>  <USAN_YEAR>  (383) 
nan

>  <FIRST_APPROVAL>  (383) 
1991.0

>  <ATC_CODE>  (383) 
nan

>  <ATC_CODE_DESCRIPTION>  (383) 
nan

>  <INDICATION_CLASS>  (383) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (383) 
nan

>  <DRUG_TYPE>  (383) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (383) 
Y

>  <FIRST_IN_CLASS>  (383) 
N

>  <CHIRALITY>  (383) 
Single Stereoisomer

>  <PRODRUG>  (383) 
N

>  <ORAL>  (383) 
Y

>  <PARENTERAL>  (383) 
Y

>  <TOPICAL>  (383) 
N

>  <BLACK_BOX>  (383) 
N

>  <AVAILABILITY_TYPE>  (383) 
Prescription-only

>  <WITHDRAWN_YEAR>  (383) 
nan

>  <WITHDRAWN_COUNTRY>  (383) 
nan

>  <WITHDRAWN_REASON>  (383) 
nan

>  <CANONICAL_SMILES>  (383) 
CN1CC[C@]23CCCC[C@H]2[C@H]1Cc4ccc(O)cc34

>  <name>  (383) 
Levorphanol 

>  <MW>  (383) 
257.377

>  <logP>  (383) 
3.0804

$$$$
CHEMBL2105527
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20  2  1  0
 13  8  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (384) 
1377797

>  <SYNONYMS>  (384) 
Tetrazepam (BAN, DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (384) 
4

>  <RESEARCH_CODES>  (384) 
CB-4261

>  <APPLICANTS>  (384) 
nan

>  <USAN_STEM>  (384) 
-azepam

>  <USAN_STEM_DEFINITION>  (384) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (384) 
-azepam

>  <USAN_YEAR>  (384) 
nan

>  <FIRST_APPROVAL>  (384) 
nan

>  <ATC_CODE>  (384) 
M03BX07

>  <ATC_CODE_DESCRIPTION>  (384) 
M03BX07 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Other centrally acting agents]

>  <INDICATION_CLASS>  (384) 
nan

>  <SC_PATENT_NO>  (384) 
nan

>  <DRUG_TYPE>  (384) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (384) 
Y

>  <FIRST_IN_CLASS>  (384) 
N

>  <CHIRALITY>  (384) 
Achiral Molecule

>  <PRODRUG>  (384) 
N

>  <ORAL>  (384) 
N

>  <PARENTERAL>  (384) 
N

>  <TOPICAL>  (384) 
N

>  <BLACK_BOX>  (384) 
N

>  <AVAILABILITY_TYPE>  (384) 
Withdrawn

>  <WITHDRAWN_YEAR>  (384) 
2013.0

>  <WITHDRAWN_COUNTRY>  (384) 
European Union

>  <WITHDRAWN_REASON>  (384) 
nan

>  <CANONICAL_SMILES>  (384) 
CN1C(=O)CN=C(C2=CCCCC2)c3cc(Cl)ccc13

>  <name>  (384) 
Tetrazepam 

>  <MW>  (384) 
288.778

>  <logP>  (384) 
3.6059

$$$$
CHEMBL3707340
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 10  2  1  0
M  END
>  <PARENT_MOLREGNO>  (385) 
2039311

>  <SYNONYMS>  (385) 
Tribromometacresol

>  <DEVELOPMENT_PHASE>  (385) 
4

>  <RESEARCH_CODES>  (385) 
nan

>  <APPLICANTS>  (385) 
nan

>  <USAN_STEM>  (385) 
nan

>  <USAN_STEM_DEFINITION>  (385) 
nan

>  <USAN_STEM_SUBSTEM>  (385) 
nan

>  <USAN_YEAR>  (385) 
nan

>  <FIRST_APPROVAL>  (385) 
nan

>  <ATC_CODE>  (385) 
D01AE03

>  <ATC_CODE_DESCRIPTION>  (385) 
D01AE03 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (385) 
nan

>  <SC_PATENT_NO>  (385) 
nan

>  <DRUG_TYPE>  (385) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (385) 
Y

>  <FIRST_IN_CLASS>  (385) 
N

>  <CHIRALITY>  (385) 
Achiral Molecule

>  <PRODRUG>  (385) 
N

>  <ORAL>  (385) 
N

>  <PARENTERAL>  (385) 
N

>  <TOPICAL>  (385) 
N

>  <BLACK_BOX>  (385) 
N

>  <AVAILABILITY_TYPE>  (385) 
Unknown

>  <WITHDRAWN_YEAR>  (385) 
nan

>  <WITHDRAWN_COUNTRY>  (385) 
nan

>  <WITHDRAWN_REASON>  (385) 
nan

>  <CANONICAL_SMILES>  (385) 
Cc1c(Br)cc(Br)c(O)c1Br

>  <name>  (385) 
Tribromometacresol

>  <MW>  (385) 
344.828

>  <logP>  (385) 
3.98812

$$$$
CHEMBL3707366
     RDKit          

 15 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  7 13  1  0
 13 14  2  0
 13 15  1  0
M  END
>  <PARENT_MOLREGNO>  (386) 
2039337

>  <SYNONYMS>  (386) 
Alanyl Glutamine

>  <DEVELOPMENT_PHASE>  (386) 
4

>  <RESEARCH_CODES>  (386) 
nan

>  <APPLICANTS>  (386) 
nan

>  <USAN_STEM>  (386) 
nan

>  <USAN_STEM_DEFINITION>  (386) 
nan

>  <USAN_STEM_SUBSTEM>  (386) 
nan

>  <USAN_YEAR>  (386) 
nan

>  <FIRST_APPROVAL>  (386) 
nan

>  <ATC_CODE>  (386) 
B05XB02

>  <ATC_CODE_DESCRIPTION>  (386) 
B05XB02 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:I.V. Solution Additives:Amino acids]

>  <INDICATION_CLASS>  (386) 
nan

>  <SC_PATENT_NO>  (386) 
nan

>  <DRUG_TYPE>  (386) 
Oligopeptide

>  <RULE_OF_FIVE>  (386) 
Y

>  <FIRST_IN_CLASS>  (386) 
N

>  <CHIRALITY>  (386) 
Single Stereoisomer

>  <PRODRUG>  (386) 
N

>  <ORAL>  (386) 
N

>  <PARENTERAL>  (386) 
N

>  <TOPICAL>  (386) 
N

>  <BLACK_BOX>  (386) 
N

>  <AVAILABILITY_TYPE>  (386) 
Unknown

>  <WITHDRAWN_YEAR>  (386) 
nan

>  <WITHDRAWN_COUNTRY>  (386) 
nan

>  <WITHDRAWN_REASON>  (386) 
nan

>  <CANONICAL_SMILES>  (386) 
C[C@H](N)C(=O)N[C@@H](CCC(=O)N)C(=O)O

>  <name>  (386) 
Alanyl Glutamine

>  <MW>  (386) 
217.225

>  <logP>  (386) 
-1.8315

$$$$
CHEMBL13376
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  7 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 19 24  1  0
 24 25  2  0
 25  3  1  0
 24  6  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (387) 
11685

>  <SYNONYMS>  (387) 
Clometacin (DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (387) 
4

>  <RESEARCH_CODES>  (387) 
C-1656; R-3959

>  <APPLICANTS>  (387) 
nan

>  <USAN_STEM>  (387) 
-metacin

>  <USAN_STEM_DEFINITION>  (387) 
anti-inflammatory agents (indomethacin type)

>  <USAN_STEM_SUBSTEM>  (387) 
-metacin

>  <USAN_YEAR>  (387) 
nan

>  <FIRST_APPROVAL>  (387) 
nan

>  <ATC_CODE>  (387) 
nan

>  <ATC_CODE_DESCRIPTION>  (387) 
nan

>  <INDICATION_CLASS>  (387) 
nan

>  <SC_PATENT_NO>  (387) 
nan

>  <DRUG_TYPE>  (387) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (387) 
Y

>  <FIRST_IN_CLASS>  (387) 
N

>  <CHIRALITY>  (387) 
Achiral Molecule

>  <PRODRUG>  (387) 
N

>  <ORAL>  (387) 
N

>  <PARENTERAL>  (387) 
N

>  <TOPICAL>  (387) 
N

>  <BLACK_BOX>  (387) 
N

>  <AVAILABILITY_TYPE>  (387) 
Withdrawn

>  <WITHDRAWN_YEAR>  (387) 
1987.0

>  <WITHDRAWN_COUNTRY>  (387) 
France

>  <WITHDRAWN_REASON>  (387) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (387) 
COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1

>  <name>  (387) 
Clometacin 

>  <MW>  (387) 
357.793

>  <logP>  (387) 
3.92732

$$$$
CHEMBL1474889
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  2  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (388) 
898773

>  <SYNONYMS>  (388) 
Clobutinol (INN, MI); Clobutinol HCl (JAN)

>  <DEVELOPMENT_PHASE>  (388) 
4

>  <RESEARCH_CODES>  (388) 
KAT-256 [As Hydrochloride]

>  <APPLICANTS>  (388) 
nan

>  <USAN_STEM>  (388) 
nan

>  <USAN_STEM_DEFINITION>  (388) 
nan

>  <USAN_STEM_SUBSTEM>  (388) 
nan

>  <USAN_YEAR>  (388) 
nan

>  <FIRST_APPROVAL>  (388) 
1961.0

>  <ATC_CODE>  (388) 
R05DB03

>  <ATC_CODE_DESCRIPTION>  (388) 
R05DB03 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Other cough suppressants]

>  <INDICATION_CLASS>  (388) 
nan

>  <SC_PATENT_NO>  (388) 
nan

>  <DRUG_TYPE>  (388) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (388) 
Y

>  <FIRST_IN_CLASS>  (388) 
N

>  <CHIRALITY>  (388) 
Racemic Mixture

>  <PRODRUG>  (388) 
N

>  <ORAL>  (388) 
N

>  <PARENTERAL>  (388) 
N

>  <TOPICAL>  (388) 
N

>  <BLACK_BOX>  (388) 
N

>  <AVAILABILITY_TYPE>  (388) 
Withdrawn

>  <WITHDRAWN_YEAR>  (388) 
2007.0

>  <WITHDRAWN_COUNTRY>  (388) 
European Union

>  <WITHDRAWN_REASON>  (388) 
Cardiovascular

>  <CANONICAL_SMILES>  (388) 
CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1

>  <name>  (388) 
Clobutinol 

>  <MW>  (388) 
255.789

>  <logP>  (388) 
2.8312

$$$$
CHEMBL1140
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (389) 
175447

>  <SYNONYMS>  (389) 
Niacinamide (FDA, USP); Nicotinamide (INN, JAN)

>  <DEVELOPMENT_PHASE>  (389) 
4

>  <RESEARCH_CODES>  (389) 
nan

>  <APPLICANTS>  (389) 
Hospira Inc; Hoffmann La Roche Inc; Astrazeneca Lp; Abraxis Pharmaceutical Products; International Minerals Chemical Corp

>  <USAN_STEM>  (389) 
nan

>  <USAN_STEM_DEFINITION>  (389) 
nan

>  <USAN_STEM_SUBSTEM>  (389) 
nan

>  <USAN_YEAR>  (389) 
nan

>  <FIRST_APPROVAL>  (389) 
nan

>  <ATC_CODE>  (389) 
A11HA01

>  <ATC_CODE_DESCRIPTION>  (389) 
A11HA01 [Alimentary Tract And Metabolism:Vitamins:Other Plain Vitamin Preparations:Other plain vitamin preparations]

>  <INDICATION_CLASS>  (389) 
Vitamin (enzyme co-factor)

>  <SC_PATENT_NO>  (389) 
nan

>  <DRUG_TYPE>  (389) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (389) 
Y

>  <FIRST_IN_CLASS>  (389) 
N

>  <CHIRALITY>  (389) 
Achiral Molecule

>  <PRODRUG>  (389) 
N

>  <ORAL>  (389) 
Y

>  <PARENTERAL>  (389) 
Y

>  <TOPICAL>  (389) 
N

>  <BLACK_BOX>  (389) 
N

>  <AVAILABILITY_TYPE>  (389) 
Prescription-only

>  <WITHDRAWN_YEAR>  (389) 
nan

>  <WITHDRAWN_COUNTRY>  (389) 
nan

>  <WITHDRAWN_REASON>  (389) 
nan

>  <CANONICAL_SMILES>  (389) 
NC(=O)c1cccnc1

>  <name>  (389) 
Niacinamide 

>  <MW>  (389) 
122.127

>  <logP>  (389) 
0.1805

$$$$
CHEMBL374731
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
  4 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 16  2  1  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (390) 
366271

>  <SYNONYMS>  (390) 
Telbivudine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (390) 
4

>  <RESEARCH_CODES>  (390) 
NV-02B

>  <APPLICANTS>  (390) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (390) 
-vudine

>  <USAN_STEM_DEFINITION>  (390) 
antineoplastics,antivirals (zidovudine group) (exception: edoxudine)

>  <USAN_STEM_SUBSTEM>  (390) 
-vudine

>  <USAN_YEAR>  (390) 
2002.0

>  <FIRST_APPROVAL>  (390) 
2006.0

>  <ATC_CODE>  (390) 
J05AF11

>  <ATC_CODE_DESCRIPTION>  (390) 
J05AF11 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (390) 
nan

>  <SC_PATENT_NO>  (390) 
US-6395716-B1

>  <DRUG_TYPE>  (390) 
Natural Product-derived

>  <RULE_OF_FIVE>  (390) 
Y

>  <FIRST_IN_CLASS>  (390) 
N

>  <CHIRALITY>  (390) 
Single Stereoisomer

>  <PRODRUG>  (390) 
Y

>  <ORAL>  (390) 
Y

>  <PARENTERAL>  (390) 
N

>  <TOPICAL>  (390) 
N

>  <BLACK_BOX>  (390) 
Y

>  <AVAILABILITY_TYPE>  (390) 
Prescription-only

>  <WITHDRAWN_YEAR>  (390) 
nan

>  <WITHDRAWN_COUNTRY>  (390) 
nan

>  <WITHDRAWN_REASON>  (390) 
nan

>  <CANONICAL_SMILES>  (390) 
CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O

>  <name>  (390) 
Telbivudine 

>  <MW>  (390) 
242.231

>  <logP>  (390) 
-1.51428

$$$$
CHEMBL455
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (391) 
2525

>  <SYNONYMS>  (391) 
Sulfacetamide (BAN, INN, USP); Sulfacetamide (Triple Sulfa) (FDA); Sulfacetamide sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (391) 
4

>  <RESEARCH_CODES>  (391) 
nan

>  <APPLICANTS>  (391) 
Sanofi Aventis Us Llc; Ortho Mcneil Pharmaceutical Inc; Novartis Pharmaceuticals Corp; Allergan Pharmaceutical; Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (391) 
sulfa-

>  <USAN_STEM_DEFINITION>  (391) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (391) 
sulfa-

>  <USAN_YEAR>  (391) 
nan

>  <FIRST_APPROVAL>  (391) 
1945.0

>  <ATC_CODE>  (391) 
S01AB04; D10AF06

>  <ATC_CODE_DESCRIPTION>  (391) 
S01AB04 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; D10AF06 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Antiinfectives for treatment of acne]

>  <INDICATION_CLASS>  (391) 
Antibacterial

>  <SC_PATENT_NO>  (391) 
nan

>  <DRUG_TYPE>  (391) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (391) 
Y

>  <FIRST_IN_CLASS>  (391) 
N

>  <CHIRALITY>  (391) 
Achiral Molecule

>  <PRODRUG>  (391) 
N

>  <ORAL>  (391) 
N

>  <PARENTERAL>  (391) 
N

>  <TOPICAL>  (391) 
Y

>  <BLACK_BOX>  (391) 
N

>  <AVAILABILITY_TYPE>  (391) 
Prescription-only

>  <WITHDRAWN_YEAR>  (391) 
nan

>  <WITHDRAWN_COUNTRY>  (391) 
nan

>  <WITHDRAWN_REASON>  (391) 
nan

>  <CANONICAL_SMILES>  (391) 
CC(=O)NS(=O)(=O)c1ccc(N)cc1

>  <name>  (391) 
Sulfacetamide 

>  <MW>  (391) 
214.246

>  <logP>  (391) 
0.0936

$$$$
CHEMBL425
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  6 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 20 22  1  0
  9  4  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (392) 
1369

>  <SYNONYMS>  (392) 
Olsalazine (BAN, INN); Olsalazine Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (392) 
4

>  <RESEARCH_CODES>  (392) 
CJ-91B

>  <APPLICANTS>  (392) 
Meda Pharmaceuticals Inc

>  <USAN_STEM>  (392) 
-sal-

>  <USAN_STEM_DEFINITION>  (392) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (392) 
-sal-

>  <USAN_YEAR>  (392) 
1987.0

>  <FIRST_APPROVAL>  (392) 
1990.0

>  <ATC_CODE>  (392) 
A07EC03

>  <ATC_CODE_DESCRIPTION>  (392) 
A07EC03 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Aminosalicylic acid and similar agents]

>  <INDICATION_CLASS>  (392) 
Anti-Inflammatory (gastrointestinal)

>  <SC_PATENT_NO>  (392) 
nan

>  <DRUG_TYPE>  (392) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (392) 
Y

>  <FIRST_IN_CLASS>  (392) 
N

>  <CHIRALITY>  (392) 
Achiral Molecule

>  <PRODRUG>  (392) 
Y

>  <ORAL>  (392) 
Y

>  <PARENTERAL>  (392) 
N

>  <TOPICAL>  (392) 
N

>  <BLACK_BOX>  (392) 
N

>  <AVAILABILITY_TYPE>  (392) 
Prescription-only

>  <WITHDRAWN_YEAR>  (392) 
nan

>  <WITHDRAWN_COUNTRY>  (392) 
nan

>  <WITHDRAWN_REASON>  (392) 
nan

>  <CANONICAL_SMILES>  (392) 
OC(=O)c1cc(ccc1O)N=Nc2ccc(O)c(c2)C(=O)O

>  <name>  (392) 
Olsalazine 

>  <MW>  (392) 
302.242

>  <logP>  (392) 
2.9096

$$$$
CHEMBL494753
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 11 17  2  0
 17 18  1  0
 18 19  2  0
  6 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 20  2  1  0
 23  2  1  0
 19  5  1  0
 19  9  1  0
M  END
>  <PARENT_MOLREGNO>  (393) 
485955

>  <SYNONYMS>  (393) 
Estropipate (BAN, FDA, USP)

>  <DEVELOPMENT_PHASE>  (393) 
4

>  <RESEARCH_CODES>  (393) 
nan

>  <APPLICANTS>  (393) 
Pharmacia And Upjohn Co; Mylan Pharmaceuticals Inc; Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc; Barr Laboratories Inc; Sun Pharmaceutical Industries Ltd

>  <USAN_STEM>  (393) 
estr-

>  <USAN_STEM_DEFINITION>  (393) 
estrogens

>  <USAN_STEM_SUBSTEM>  (393) 
estr-

>  <USAN_YEAR>  (393) 
nan

>  <FIRST_APPROVAL>  (393) 
1977.0

>  <ATC_CODE>  (393) 
nan

>  <ATC_CODE_DESCRIPTION>  (393) 
nan

>  <INDICATION_CLASS>  (393) 
Estrogen

>  <SC_PATENT_NO>  (393) 
nan

>  <DRUG_TYPE>  (393) 
Natural Product-derived

>  <RULE_OF_FIVE>  (393) 
Y

>  <FIRST_IN_CLASS>  (393) 
N

>  <CHIRALITY>  (393) 
Single Stereoisomer

>  <PRODRUG>  (393) 
N

>  <ORAL>  (393) 
Y

>  <PARENTERAL>  (393) 
N

>  <TOPICAL>  (393) 
Y

>  <BLACK_BOX>  (393) 
Y

>  <AVAILABILITY_TYPE>  (393) 
Prescription-only

>  <WITHDRAWN_YEAR>  (393) 
nan

>  <WITHDRAWN_COUNTRY>  (393) 
nan

>  <WITHDRAWN_REASON>  (393) 
nan

>  <CANONICAL_SMILES>  (393) 
C[C@]12CC[C@H]3[C@@H](CCc4cc(OS(=O)(=O)O)ccc34)[C@@H]1CCC2=O

>  <name>  (393) 
Estropipate 

>  <MW>  (393) 
350.436

>  <logP>  (393) 
3.2934

$$$$
CHEMBL240597
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27  8  1  0
 27 11  1  0
 24 12  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (394) 
404691

>  <SYNONYMS>  (394) 
Chenodeoxycholic Acid (BAN, INN, JAN); Chenodiol (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (394) 
4

>  <RESEARCH_CODES>  (394) 
nan

>  <APPLICANTS>  (394) 
Sigma Tau Pharmaceuticals Inc

>  <USAN_STEM>  (394) 
nan

>  <USAN_STEM_DEFINITION>  (394) 
nan

>  <USAN_STEM_SUBSTEM>  (394) 
nan

>  <USAN_YEAR>  (394) 
1978.0

>  <FIRST_APPROVAL>  (394) 
1983.0

>  <ATC_CODE>  (394) 
A05AA01

>  <ATC_CODE_DESCRIPTION>  (394) 
A05AA01 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Bile Therapy:Bile acid preparations]

>  <INDICATION_CLASS>  (394) 
Anticholelithogenic

>  <SC_PATENT_NO>  (394) 
nan

>  <DRUG_TYPE>  (394) 
Natural Product-derived

>  <RULE_OF_FIVE>  (394) 
Y

>  <FIRST_IN_CLASS>  (394) 
N

>  <CHIRALITY>  (394) 
Single Stereoisomer

>  <PRODRUG>  (394) 
N

>  <ORAL>  (394) 
Y

>  <PARENTERAL>  (394) 
N

>  <TOPICAL>  (394) 
N

>  <BLACK_BOX>  (394) 
N

>  <AVAILABILITY_TYPE>  (394) 
Prescription-only

>  <WITHDRAWN_YEAR>  (394) 
nan

>  <WITHDRAWN_COUNTRY>  (394) 
nan

>  <WITHDRAWN_REASON>  (394) 
nan

>  <CANONICAL_SMILES>  (394) 
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (394) 
Chenodeoxycholic Acid 

>  <MW>  (394) 
392.58

>  <logP>  (394) 
4.4779

$$$$
CHEMBL1055
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  7 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 10  5  1  0
 22 12  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (395) 
134333

>  <SYNONYMS>  (395) 
Chlortalidone (BAN, INN, JAN); Chlorthalidone (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (395) 
4

>  <RESEARCH_CODES>  (395) 
G-33182

>  <APPLICANTS>  (395) 
Novartis Pharmaceuticals Corp; Monarch Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc; Astrazeneca Pharmaceuticals Lp; Sanofi Aventis Us Llc

>  <USAN_STEM>  (395) 
nan

>  <USAN_STEM_DEFINITION>  (395) 
nan

>  <USAN_STEM_SUBSTEM>  (395) 
nan

>  <USAN_YEAR>  (395) 
1961.0

>  <FIRST_APPROVAL>  (395) 
1960.0

>  <ATC_CODE>  (395) 
C03BA04

>  <ATC_CODE_DESCRIPTION>  (395) 
C03BA04 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Excl. Thiazides:Sulfonamides, plain]

>  <INDICATION_CLASS>  (395) 
Diuretic

>  <SC_PATENT_NO>  (395) 
US-7157584-B2

>  <DRUG_TYPE>  (395) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (395) 
Y

>  <FIRST_IN_CLASS>  (395) 
N

>  <CHIRALITY>  (395) 
Racemic Mixture

>  <PRODRUG>  (395) 
N

>  <ORAL>  (395) 
Y

>  <PARENTERAL>  (395) 
N

>  <TOPICAL>  (395) 
N

>  <BLACK_BOX>  (395) 
N

>  <AVAILABILITY_TYPE>  (395) 
Prescription-only

>  <WITHDRAWN_YEAR>  (395) 
nan

>  <WITHDRAWN_COUNTRY>  (395) 
nan

>  <WITHDRAWN_REASON>  (395) 
nan

>  <CANONICAL_SMILES>  (395) 
NS(=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc23

>  <name>  (395) 
Chlortalidone 

>  <MW>  (395) 
338.772

>  <logP>  (395) 
0.9242

$$$$
CHEMBL1079604
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
  7 16  2  0
 16  2  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (396) 
611679

>  <SYNONYMS>  (396) 
Metaxalone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (396) 
4

>  <RESEARCH_CODES>  (396) 
AHR-438

>  <APPLICANTS>  (396) 
King Pharmaceuticals Inc

>  <USAN_STEM>  (396) 
nan

>  <USAN_STEM_DEFINITION>  (396) 
nan

>  <USAN_STEM_SUBSTEM>  (396) 
nan

>  <USAN_YEAR>  (396) 
1962.0

>  <FIRST_APPROVAL>  (396) 
1962.0

>  <ATC_CODE>  (396) 
nan

>  <ATC_CODE_DESCRIPTION>  (396) 
nan

>  <INDICATION_CLASS>  (396) 
Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (396) 
US-7122566-B1

>  <DRUG_TYPE>  (396) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (396) 
Y

>  <FIRST_IN_CLASS>  (396) 
N

>  <CHIRALITY>  (396) 
Racemic Mixture

>  <PRODRUG>  (396) 
N

>  <ORAL>  (396) 
Y

>  <PARENTERAL>  (396) 
N

>  <TOPICAL>  (396) 
N

>  <BLACK_BOX>  (396) 
N

>  <AVAILABILITY_TYPE>  (396) 
Prescription-only

>  <WITHDRAWN_YEAR>  (396) 
nan

>  <WITHDRAWN_COUNTRY>  (396) 
nan

>  <WITHDRAWN_REASON>  (396) 
nan

>  <CANONICAL_SMILES>  (396) 
Cc1cc(C)cc(OCC2CNC(=O)O2)c1

>  <name>  (396) 
Metaxalone 

>  <MW>  (396) 
221.256

>  <logP>  (396) 
1.79064

$$$$
CHEMBL1788404
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  2 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 12  7  1  0
 19 14  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (397) 
1152068

>  <SYNONYMS>  (397) 
Bephenium

>  <DEVELOPMENT_PHASE>  (397) 
4

>  <RESEARCH_CODES>  (397) 
nan

>  <APPLICANTS>  (397) 
nan

>  <USAN_STEM>  (397) 
-ium

>  <USAN_STEM_DEFINITION>  (397) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (397) 
-ium

>  <USAN_YEAR>  (397) 
nan

>  <FIRST_APPROVAL>  (397) 
nan

>  <ATC_CODE>  (397) 
P02CX02

>  <ATC_CODE_DESCRIPTION>  (397) 
P02CX02 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Other antinematodals]

>  <INDICATION_CLASS>  (397) 
nan

>  <SC_PATENT_NO>  (397) 
nan

>  <DRUG_TYPE>  (397) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (397) 
Y

>  <FIRST_IN_CLASS>  (397) 
N

>  <CHIRALITY>  (397) 
Achiral Molecule

>  <PRODRUG>  (397) 
N

>  <ORAL>  (397) 
N

>  <PARENTERAL>  (397) 
N

>  <TOPICAL>  (397) 
N

>  <BLACK_BOX>  (397) 
N

>  <AVAILABILITY_TYPE>  (397) 
Unknown

>  <WITHDRAWN_YEAR>  (397) 
nan

>  <WITHDRAWN_COUNTRY>  (397) 
nan

>  <WITHDRAWN_REASON>  (397) 
nan

>  <CANONICAL_SMILES>  (397) 
C[N+](C)(CCOc1ccccc1)Cc2ccccc2

>  <name>  (397) 
Bephenium

>  <MW>  (397) 
256.369

>  <logP>  (397) 
3.342

$$$$
CHEMBL1200694
     RDKit          

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  4  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
M  END
>  <PARENT_MOLREGNO>  (398) 
674645

>  <SYNONYMS>  (398) 
Sevoflurane (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (398) 
4

>  <RESEARCH_CODES>  (398) 
MR6S4; MR-6S4

>  <APPLICANTS>  (398) 
Abbvie Inc

>  <USAN_STEM>  (398) 
-flurane

>  <USAN_STEM_DEFINITION>  (398) 
general inhalation anesthetics (halogenated alkane derivatives)

>  <USAN_STEM_SUBSTEM>  (398) 
-flurane

>  <USAN_YEAR>  (398) 
1971.0

>  <FIRST_APPROVAL>  (398) 
1995.0

>  <ATC_CODE>  (398) 
N01AB08

>  <ATC_CODE_DESCRIPTION>  (398) 
N01AB08 [Nervous System:Anesthetics:Anesthetics, General:Halogenated hydrocarbons]

>  <INDICATION_CLASS>  (398) 
Anesthetic (inhalation)

>  <SC_PATENT_NO>  (398) 
US-5990176-A

>  <DRUG_TYPE>  (398) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (398) 
Y

>  <FIRST_IN_CLASS>  (398) 
N

>  <CHIRALITY>  (398) 
Achiral Molecule

>  <PRODRUG>  (398) 
N

>  <ORAL>  (398) 
N

>  <PARENTERAL>  (398) 
N

>  <TOPICAL>  (398) 
Y

>  <BLACK_BOX>  (398) 
N

>  <AVAILABILITY_TYPE>  (398) 
Prescription-only

>  <WITHDRAWN_YEAR>  (398) 
nan

>  <WITHDRAWN_COUNTRY>  (398) 
nan

>  <WITHDRAWN_REASON>  (398) 
nan

>  <CANONICAL_SMILES>  (398) 
FCOC(C(F)(F)F)C(F)(F)F

>  <name>  (398) 
Sevoflurane 

>  <MW>  (398) 
200.053

>  <logP>  (398) 
2.4232

$$$$
CHEMBL594
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  7 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 14  6  1  0
 14  9  1  0
 22 15  1  0
M  END
>  <PARENT_MOLREGNO>  (399) 
19712

>  <SYNONYMS>  (399) 
Emedastine (BAN, INN); Emedastine Difumarate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (399) 
4

>  <RESEARCH_CODES>  (399) 
AL-3432A

>  <APPLICANTS>  (399) 
Alcon Laboratories Inc

>  <USAN_STEM>  (399) 
-astine

>  <USAN_STEM_DEFINITION>  (399) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (399) 
-astine

>  <USAN_YEAR>  (399) 
1996.0

>  <FIRST_APPROVAL>  (399) 
1997.0

>  <ATC_CODE>  (399) 
S01GX06

>  <ATC_CODE_DESCRIPTION>  (399) 
S01GX06 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]

>  <INDICATION_CLASS>  (399) 
Anti-Allergic; Antihistaminic, H1-Receptor; Asthma Prophylactic

>  <SC_PATENT_NO>  (399) 
nan

>  <DRUG_TYPE>  (399) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (399) 
Y

>  <FIRST_IN_CLASS>  (399) 
N

>  <CHIRALITY>  (399) 
Achiral Molecule

>  <PRODRUG>  (399) 
N

>  <ORAL>  (399) 
N

>  <PARENTERAL>  (399) 
N

>  <TOPICAL>  (399) 
Y

>  <BLACK_BOX>  (399) 
N

>  <AVAILABILITY_TYPE>  (399) 
Prescription-only

>  <WITHDRAWN_YEAR>  (399) 
nan

>  <WITHDRAWN_COUNTRY>  (399) 
nan

>  <WITHDRAWN_REASON>  (399) 
nan

>  <CANONICAL_SMILES>  (399) 
CCOCCn1c(nc2ccccc12)N3CCCN(C)CC3

>  <name>  (399) 
Emedastine 

>  <MW>  (399) 
302.422

>  <logP>  (399) 
2.2147

$$$$
CHEMBL710
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26  8  1  0
 26 11  1  0
 23 12  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (400) 
33679

>  <SYNONYMS>  (400) 
Finasteride (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (400) 
4

>  <RESEARCH_CODES>  (400) 
MK-906

>  <APPLICANTS>  (400) 
Merck Research Laboratories Div Merck Co Inc; Merck And Co Inc

>  <USAN_STEM>  (400) 
-steride

>  <USAN_STEM_DEFINITION>  (400) 
testosterone reductase inhibitors

>  <USAN_STEM_SUBSTEM>  (400) 
-steride

>  <USAN_YEAR>  (400) 
1989.0

>  <FIRST_APPROVAL>  (400) 
1992.0

>  <ATC_CODE>  (400) 
G04CB01; D11AX10

>  <ATC_CODE_DESCRIPTION>  (400) 
G04CB01 [Genito Urinary System And Sex Hormones:Urologicals:Drugs Used In Benign Prostatic Hypertrophy:Testosterone-5-alpha reductase inhibitors]; D11AX10 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (400) 
Inhibitor (alpha reductase)

>  <SC_PATENT_NO>  (400) 
US-5942519-A

>  <DRUG_TYPE>  (400) 
Natural Product-derived

>  <RULE_OF_FIVE>  (400) 
Y

>  <FIRST_IN_CLASS>  (400) 
N

>  <CHIRALITY>  (400) 
Single Stereoisomer

>  <PRODRUG>  (400) 
N

>  <ORAL>  (400) 
Y

>  <PARENTERAL>  (400) 
N

>  <TOPICAL>  (400) 
N

>  <BLACK_BOX>  (400) 
Y

>  <AVAILABILITY_TYPE>  (400) 
Prescription-only

>  <WITHDRAWN_YEAR>  (400) 
nan

>  <WITHDRAWN_COUNTRY>  (400) 
nan

>  <WITHDRAWN_REASON>  (400) 
nan

>  <CANONICAL_SMILES>  (400) 
CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (400) 
Finasteride 

>  <MW>  (400) 
372.553

>  <logP>  (400) 
3.8145

$$$$
CHEMBL1456
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 14  3  1  0
 11  6  2  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (401) 
386457

>  <SYNONYMS>  (401) 
Mycophenolate mofetil (FDA, USAN); Mycophenolate Mofetil HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (401) 
4

>  <RESEARCH_CODES>  (401) 
RS-61443; RS-61443-190

>  <APPLICANTS>  (401) 
Roche Palo Alto Llc

>  <USAN_STEM>  (401) 
nan

>  <USAN_STEM_DEFINITION>  (401) 
nan

>  <USAN_STEM_SUBSTEM>  (401) 
nan

>  <USAN_YEAR>  (401) 
1990.0

>  <FIRST_APPROVAL>  (401) 
1995.0

>  <ATC_CODE>  (401) 
nan

>  <ATC_CODE_DESCRIPTION>  (401) 
nan

>  <INDICATION_CLASS>  (401) 
Immunomodulator

>  <SC_PATENT_NO>  (401) 
nan

>  <DRUG_TYPE>  (401) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (401) 
Y

>  <FIRST_IN_CLASS>  (401) 
N

>  <CHIRALITY>  (401) 
Achiral Molecule

>  <PRODRUG>  (401) 
Y

>  <ORAL>  (401) 
Y

>  <PARENTERAL>  (401) 
Y

>  <TOPICAL>  (401) 
N

>  <BLACK_BOX>  (401) 
Y

>  <AVAILABILITY_TYPE>  (401) 
Prescription-only

>  <WITHDRAWN_YEAR>  (401) 
nan

>  <WITHDRAWN_COUNTRY>  (401) 
nan

>  <WITHDRAWN_REASON>  (401) 
nan

>  <CANONICAL_SMILES>  (401) 
COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)OCCN3CCOCC3

>  <name>  (401) 
Mycophenolate mofetil 

>  <MW>  (401) 
433.501

>  <logP>  (401) 
2.52402

$$$$
CHEMBL406
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 10  2  1  0
  9  4  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (402) 
619

>  <SYNONYMS>  (402) 
Indapamide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (402) 
4

>  <RESEARCH_CODES>  (402) 
nan

>  <APPLICANTS>  (402) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (402) 
-pamide

>  <USAN_STEM_DEFINITION>  (402) 
diuretics (sulfamoylbenzoic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (402) 
-pamide

>  <USAN_YEAR>  (402) 
1979.0

>  <FIRST_APPROVAL>  (402) 
1983.0

>  <ATC_CODE>  (402) 
C03BA11

>  <ATC_CODE_DESCRIPTION>  (402) 
C03BA11 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Excl. Thiazides:Sulfonamides, plain]

>  <INDICATION_CLASS>  (402) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (402) 
nan

>  <DRUG_TYPE>  (402) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (402) 
Y

>  <FIRST_IN_CLASS>  (402) 
N

>  <CHIRALITY>  (402) 
Racemic Mixture

>  <PRODRUG>  (402) 
N

>  <ORAL>  (402) 
Y

>  <PARENTERAL>  (402) 
N

>  <TOPICAL>  (402) 
N

>  <BLACK_BOX>  (402) 
N

>  <AVAILABILITY_TYPE>  (402) 
Prescription-only

>  <WITHDRAWN_YEAR>  (402) 
nan

>  <WITHDRAWN_COUNTRY>  (402) 
nan

>  <WITHDRAWN_REASON>  (402) 
nan

>  <CANONICAL_SMILES>  (402) 
CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N

>  <name>  (402) 
Indapamide 

>  <MW>  (402) 
365.842

>  <logP>  (402) 
2.0834

$$$$
CHEMBL1571
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
  6 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 17  2  1  0
 22  2  1  0
 15  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (403) 
453121

>  <SYNONYMS>  (403) 
Testolactone (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (403) 
4

>  <RESEARCH_CODES>  (403) 
SQ-9538

>  <APPLICANTS>  (403) 
Bristol Myers Squibb Co; Bristol Myers Squibb

>  <USAN_STEM>  (403) 
nan

>  <USAN_STEM_DEFINITION>  (403) 
nan

>  <USAN_STEM_SUBSTEM>  (403) 
nan

>  <USAN_YEAR>  (403) 
1964.0

>  <FIRST_APPROVAL>  (403) 
1969.0

>  <ATC_CODE>  (403) 
nan

>  <ATC_CODE_DESCRIPTION>  (403) 
nan

>  <INDICATION_CLASS>  (403) 
Antineoplastic

>  <SC_PATENT_NO>  (403) 
nan

>  <DRUG_TYPE>  (403) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (403) 
Y

>  <FIRST_IN_CLASS>  (403) 
N

>  <CHIRALITY>  (403) 
Single Stereoisomer

>  <PRODRUG>  (403) 
N

>  <ORAL>  (403) 
Y

>  <PARENTERAL>  (403) 
Y

>  <TOPICAL>  (403) 
N

>  <BLACK_BOX>  (403) 
N

>  <AVAILABILITY_TYPE>  (403) 
Discontinued

>  <WITHDRAWN_YEAR>  (403) 
nan

>  <WITHDRAWN_COUNTRY>  (403) 
nan

>  <WITHDRAWN_REASON>  (403) 
nan

>  <CANONICAL_SMILES>  (403) 
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC(=O)O2

>  <name>  (403) 
Testolactone 

>  <MW>  (403) 
300.398

>  <logP>  (403) 
3.5899

$$$$
CHEMBL621
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 11 25  1  0
 25 26  1  0
  7  2  1  0
 26  8  1  0
 23 15  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (404) 
26401

>  <SYNONYMS>  (404) 
Trazodone (BAN, INN); Trazodone HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (404) 
4

>  <RESEARCH_CODES>  (404) 
AF-1161

>  <APPLICANTS>  (404) 
Apothecon Inc Div Bristol Myers Squibb; Angelini Labopharm Llc

>  <USAN_STEM>  (404) 
nan

>  <USAN_STEM_DEFINITION>  (404) 
nan

>  <USAN_STEM_SUBSTEM>  (404) 
nan

>  <USAN_YEAR>  (404) 
1970.0

>  <FIRST_APPROVAL>  (404) 
1981.0

>  <ATC_CODE>  (404) 
N06AX05

>  <ATC_CODE_DESCRIPTION>  (404) 
N06AX05 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (404) 
Antidepressant

>  <SC_PATENT_NO>  (404) 
US-6607748-B1

>  <DRUG_TYPE>  (404) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (404) 
Y

>  <FIRST_IN_CLASS>  (404) 
N

>  <CHIRALITY>  (404) 
Achiral Molecule

>  <PRODRUG>  (404) 
N

>  <ORAL>  (404) 
Y

>  <PARENTERAL>  (404) 
N

>  <TOPICAL>  (404) 
N

>  <BLACK_BOX>  (404) 
Y

>  <AVAILABILITY_TYPE>  (404) 
Prescription-only

>  <WITHDRAWN_YEAR>  (404) 
nan

>  <WITHDRAWN_COUNTRY>  (404) 
nan

>  <WITHDRAWN_REASON>  (404) 
nan

>  <CANONICAL_SMILES>  (404) 
Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2

>  <name>  (404) 
Trazodone 

>  <MW>  (404) 
371.872

>  <logP>  (404) 
2.3617

$$$$
CHEMBL692
     RDKit          

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
M  END
>  <PARENT_MOLREGNO>  (405) 
31422

>  <SYNONYMS>  (405) 
Glycerin (FDA, JAN, USP); Glycerol (INN)

>  <DEVELOPMENT_PHASE>  (405) 
4

>  <RESEARCH_CODES>  (405) 
nan

>  <APPLICANTS>  (405) 
B Braun Medical Inc

>  <USAN_STEM>  (405) 
nan

>  <USAN_STEM_DEFINITION>  (405) 
nan

>  <USAN_STEM_SUBSTEM>  (405) 
nan

>  <USAN_YEAR>  (405) 
nan

>  <FIRST_APPROVAL>  (405) 
1982.0

>  <ATC_CODE>  (405) 
A06AX01; A06AG04

>  <ATC_CODE_DESCRIPTION>  (405) 
A06AX01 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Other drugs for constipation]; A06AG04 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Enemas]

>  <INDICATION_CLASS>  (405) 
Pharmaceutic Aid (humectant); Pharmaceutic Aid (solvent)

>  <SC_PATENT_NO>  (405) 
nan

>  <DRUG_TYPE>  (405) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (405) 
Y

>  <FIRST_IN_CLASS>  (405) 
N

>  <CHIRALITY>  (405) 
Achiral Molecule

>  <PRODRUG>  (405) 
N

>  <ORAL>  (405) 
N

>  <PARENTERAL>  (405) 
Y

>  <TOPICAL>  (405) 
N

>  <BLACK_BOX>  (405) 
N

>  <AVAILABILITY_TYPE>  (405) 
Prescription-only

>  <WITHDRAWN_YEAR>  (405) 
nan

>  <WITHDRAWN_COUNTRY>  (405) 
nan

>  <WITHDRAWN_REASON>  (405) 
nan

>  <CANONICAL_SMILES>  (405) 
OCC(O)CO

>  <name>  (405) 
Glycerin 

>  <MW>  (405) 
92.094

>  <logP>  (405) 
-1.6681

$$$$
CHEMBL72
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  6  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (406) 
6243

>  <SYNONYMS>  (406) 
Desipramine (BAN, INN); Desipramine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (406) 
4

>  <RESEARCH_CODES>  (406) 
18-8181; EX 4355; EX-4355; G-35020; JB-8181; RMI-9384A

>  <APPLICANTS>  (406) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (406) 
-pramine

>  <USAN_STEM_DEFINITION>  (406) 
antidepressants (imipramine type)

>  <USAN_STEM_SUBSTEM>  (406) 
-pramine

>  <USAN_YEAR>  (406) 
1962.0

>  <FIRST_APPROVAL>  (406) 
1964.0

>  <ATC_CODE>  (406) 
N06AA01

>  <ATC_CODE_DESCRIPTION>  (406) 
N06AA01 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (406) 
Antidepressant

>  <SC_PATENT_NO>  (406) 
nan

>  <DRUG_TYPE>  (406) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (406) 
Y

>  <FIRST_IN_CLASS>  (406) 
N

>  <CHIRALITY>  (406) 
Achiral Molecule

>  <PRODRUG>  (406) 
N

>  <ORAL>  (406) 
Y

>  <PARENTERAL>  (406) 
N

>  <TOPICAL>  (406) 
N

>  <BLACK_BOX>  (406) 
Y

>  <AVAILABILITY_TYPE>  (406) 
Prescription-only

>  <WITHDRAWN_YEAR>  (406) 
nan

>  <WITHDRAWN_COUNTRY>  (406) 
nan

>  <WITHDRAWN_REASON>  (406) 
nan

>  <CANONICAL_SMILES>  (406) 
CNCCCN1c2ccccc2CCc3ccccc13

>  <name>  (406) 
Desipramine 

>  <MW>  (406) 
266.388

>  <logP>  (406) 
3.5328

$$$$
CHEMBL87493
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (407) 
139434

>  <SYNONYMS>  (407) 
Fenfluramine (BAN, INN); Fenfluramine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (407) 
4

>  <RESEARCH_CODES>  (407) 
AHR-3002

>  <APPLICANTS>  (407) 
Robins

>  <USAN_STEM>  (407) 
nan

>  <USAN_STEM_DEFINITION>  (407) 
nan

>  <USAN_STEM_SUBSTEM>  (407) 
nan

>  <USAN_YEAR>  (407) 
1965.0

>  <FIRST_APPROVAL>  (407) 
nan

>  <ATC_CODE>  (407) 
A08AA02

>  <ATC_CODE_DESCRIPTION>  (407) 
A08AA02 [Alimentary Tract And Metabolism:Antiobesity Preparations, Excl. Diet Products:Antiobesity Preparations, Excl. Diet Products:Centrally acting antiobesity products]

>  <INDICATION_CLASS>  (407) 
Anorexic

>  <SC_PATENT_NO>  (407) 
nan

>  <DRUG_TYPE>  (407) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (407) 
Y

>  <FIRST_IN_CLASS>  (407) 
N

>  <CHIRALITY>  (407) 
Racemic Mixture

>  <PRODRUG>  (407) 
N

>  <ORAL>  (407) 
N

>  <PARENTERAL>  (407) 
N

>  <TOPICAL>  (407) 
N

>  <BLACK_BOX>  (407) 
N

>  <AVAILABILITY_TYPE>  (407) 
Withdrawn

>  <WITHDRAWN_YEAR>  (407) 
nan

>  <WITHDRAWN_COUNTRY>  (407) 
United States

>  <WITHDRAWN_REASON>  (407) 
Valvulopathy

>  <CANONICAL_SMILES>  (407) 
CCNC(C)Cc1cccc(c1)C(F)(F)F

>  <name>  (407) 
Fenfluramine 

>  <MW>  (407) 
231.261

>  <logP>  (407) 
3.2459

$$$$
CHEMBL42
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  7  2  1  0
 23  8  1  0
 16 10  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (408) 
2261

>  <SYNONYMS>  (408) 
Clozapine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (408) 
4

>  <RESEARCH_CODES>  (408) 
HF-1854

>  <APPLICANTS>  (408) 
Novartis Pharmaceuticals Corp; Jazz Pharmaceuticals Iii International Ltd

>  <USAN_STEM>  (408) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (408) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (408) 
-pin(e)

>  <USAN_YEAR>  (408) 
1969.0

>  <FIRST_APPROVAL>  (408) 
1989.0

>  <ATC_CODE>  (408) 
N05AH02

>  <ATC_CODE_DESCRIPTION>  (408) 
N05AH02 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]

>  <INDICATION_CLASS>  (408) 
Antipsychotic

>  <SC_PATENT_NO>  (408) 
US-6024981-A

>  <DRUG_TYPE>  (408) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (408) 
Y

>  <FIRST_IN_CLASS>  (408) 
N

>  <CHIRALITY>  (408) 
Achiral Molecule

>  <PRODRUG>  (408) 
N

>  <ORAL>  (408) 
Y

>  <PARENTERAL>  (408) 
N

>  <TOPICAL>  (408) 
N

>  <BLACK_BOX>  (408) 
Y

>  <AVAILABILITY_TYPE>  (408) 
Prescription-only

>  <WITHDRAWN_YEAR>  (408) 
nan

>  <WITHDRAWN_COUNTRY>  (408) 
nan

>  <WITHDRAWN_REASON>  (408) 
nan

>  <CANONICAL_SMILES>  (408) 
CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24

>  <name>  (408) 
Clozapine 

>  <MW>  (408) 
326.831

>  <logP>  (408) 
3.7227

$$$$
CHEMBL1773
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 14 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 16 10  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (409) 
598447

>  <SYNONYMS>  (409) 
Capecitabine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (409) 
4

>  <RESEARCH_CODES>  (409) 
Ro-091978000

>  <APPLICANTS>  (409) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (409) 
-citabine

>  <USAN_STEM_DEFINITION>  (409) 
nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

>  <USAN_STEM_SUBSTEM>  (409) 
-citabine

>  <USAN_YEAR>  (409) 
1995.0

>  <FIRST_APPROVAL>  (409) 
1998.0

>  <ATC_CODE>  (409) 
L01BC06

>  <ATC_CODE_DESCRIPTION>  (409) 
L01BC06 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (409) 
Antineoplastic

>  <SC_PATENT_NO>  (409) 
nan

>  <DRUG_TYPE>  (409) 
Natural Product-derived

>  <RULE_OF_FIVE>  (409) 
Y

>  <FIRST_IN_CLASS>  (409) 
N

>  <CHIRALITY>  (409) 
Single Stereoisomer

>  <PRODRUG>  (409) 
N

>  <ORAL>  (409) 
Y

>  <PARENTERAL>  (409) 
N

>  <TOPICAL>  (409) 
N

>  <BLACK_BOX>  (409) 
Y

>  <AVAILABILITY_TYPE>  (409) 
Prescription-only

>  <WITHDRAWN_YEAR>  (409) 
nan

>  <WITHDRAWN_COUNTRY>  (409) 
nan

>  <WITHDRAWN_REASON>  (409) 
nan

>  <CANONICAL_SMILES>  (409) 
CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O

>  <name>  (409) 
Capecitabine 

>  <MW>  (409) 
359.354

>  <logP>  (409) 
0.7602

$$$$
CHEMBL223228
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  5 17  1  0
 17 18  3  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16  5  1  0
 16 10  1  0
 21 19  1  0
M  END
>  <PARENT_MOLREGNO>  (410) 
374719

>  <SYNONYMS>  (410) 
Efavirenz (BAN, FDA, INN)

>  <DEVELOPMENT_PHASE>  (410) 
4

>  <RESEARCH_CODES>  (410) 
nan

>  <APPLICANTS>  (410) 
Gilead Sciences Inc; Bristol Myers Squibb Pharma Co; Bristol Myers Squibb Co

>  <USAN_STEM>  (410) 
-vir-

>  <USAN_STEM_DEFINITION>  (410) 
antivirals: antivirals (non-nucleoside reverse transcriptase inhibitors,benzoxazinone derivatives)

>  <USAN_STEM_SUBSTEM>  (410) 
-vir- (-virenz)

>  <USAN_YEAR>  (410) 
nan

>  <FIRST_APPROVAL>  (410) 
1998.0

>  <ATC_CODE>  (410) 
J05AG03

>  <ATC_CODE_DESCRIPTION>  (410) 
J05AG03 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Non-nucleoside reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (410) 
nan

>  <SC_PATENT_NO>  (410) 
US-5814639-A

>  <DRUG_TYPE>  (410) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (410) 
Y

>  <FIRST_IN_CLASS>  (410) 
N

>  <CHIRALITY>  (410) 
Single Stereoisomer

>  <PRODRUG>  (410) 
N

>  <ORAL>  (410) 
Y

>  <PARENTERAL>  (410) 
N

>  <TOPICAL>  (410) 
N

>  <BLACK_BOX>  (410) 
N

>  <AVAILABILITY_TYPE>  (410) 
Prescription-only

>  <WITHDRAWN_YEAR>  (410) 
nan

>  <WITHDRAWN_COUNTRY>  (410) 
nan

>  <WITHDRAWN_REASON>  (410) 
nan

>  <CANONICAL_SMILES>  (410) 
FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC3CC3

>  <name>  (410) 
Efavirenz 

>  <MW>  (410) 
315.678

>  <logP>  (410) 
4.0731

$$$$
CHEMBL20
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  2  0
 10 13  1  0
  9  5  1  0
M  END
>  <PARENT_MOLREGNO>  (411) 
1125

>  <SYNONYMS>  (411) 
Acetazolamide (BAN, FDA, INN, JAN, USP); Acetazolamide Sodium (FDA, JAN)

>  <DEVELOPMENT_PHASE>  (411) 
4

>  <RESEARCH_CODES>  (411) 
nan

>  <APPLICANTS>  (411) 
Teva Womens Health Inc; Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc

>  <USAN_STEM>  (411) 
-zolamide

>  <USAN_STEM_DEFINITION>  (411) 
carbonic anhydrase inhibitors

>  <USAN_STEM_SUBSTEM>  (411) 
-zolamide

>  <USAN_YEAR>  (411) 
nan

>  <FIRST_APPROVAL>  (411) 
1953.0

>  <ATC_CODE>  (411) 
S01EC01

>  <ATC_CODE_DESCRIPTION>  (411) 
S01EC01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Carbonic anhydrase inhibitors]

>  <INDICATION_CLASS>  (411) 
Carbonic Anhydrase Inhibitor

>  <SC_PATENT_NO>  (411) 
nan

>  <DRUG_TYPE>  (411) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (411) 
Y

>  <FIRST_IN_CLASS>  (411) 
N

>  <CHIRALITY>  (411) 
Achiral Molecule

>  <PRODRUG>  (411) 
N

>  <ORAL>  (411) 
Y

>  <PARENTERAL>  (411) 
Y

>  <TOPICAL>  (411) 
N

>  <BLACK_BOX>  (411) 
Y

>  <AVAILABILITY_TYPE>  (411) 
Prescription-only

>  <WITHDRAWN_YEAR>  (411) 
nan

>  <WITHDRAWN_COUNTRY>  (411) 
nan

>  <WITHDRAWN_REASON>  (411) 
nan

>  <CANONICAL_SMILES>  (411) 
CC(=O)Nc1nnc(s1)S(=O)(=O)N

>  <name>  (411) 
Acetazolamide 

>  <MW>  (411) 
222.251

>  <logP>  (411) 
-0.8561

$$$$
CHEMBL513
     RDKit          

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  0
 11 12  2  0
M  END
>  <PARENT_MOLREGNO>  (412) 
10840

>  <SYNONYMS>  (412) 
Carmustine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (412) 
4

>  <RESEARCH_CODES>  (412) 
BCNU

>  <APPLICANTS>  (412) 
Emcure Pharmaceuticals Ltd; Arbor Pharmaceuticals Inc

>  <USAN_STEM>  (412) 
-mustine

>  <USAN_STEM_DEFINITION>  (412) 
antineoplastics (chloroethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (412) 
-mustine

>  <USAN_YEAR>  (412) 
1970.0

>  <FIRST_APPROVAL>  (412) 
1977.0

>  <ATC_CODE>  (412) 
L01AD01

>  <ATC_CODE_DESCRIPTION>  (412) 
L01AD01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrosoureas]

>  <INDICATION_CLASS>  (412) 
Antineoplastic

>  <SC_PATENT_NO>  (412) 
nan

>  <DRUG_TYPE>  (412) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (412) 
Y

>  <FIRST_IN_CLASS>  (412) 
N

>  <CHIRALITY>  (412) 
Achiral Molecule

>  <PRODRUG>  (412) 
N

>  <ORAL>  (412) 
N

>  <PARENTERAL>  (412) 
Y

>  <TOPICAL>  (412) 
N

>  <BLACK_BOX>  (412) 
Y

>  <AVAILABILITY_TYPE>  (412) 
Prescription-only

>  <WITHDRAWN_YEAR>  (412) 
nan

>  <WITHDRAWN_COUNTRY>  (412) 
nan

>  <WITHDRAWN_REASON>  (412) 
nan

>  <CANONICAL_SMILES>  (412) 
ClCCNC(=O)N(CCCl)N=O

>  <name>  (412) 
Carmustine 

>  <MW>  (412) 
214.052

>  <logP>  (412) 
1.157

$$$$
CHEMBL723
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
  8  3  1  0
 30 18  1  0
 30 22  2  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (413) 
36662

>  <SYNONYMS>  (413) 
Carvedilol (BAN, FDA, INN, JAN, USAN); Carvedilol Phosphate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (413) 
4

>  <RESEARCH_CODES>  (413) 
BM 14.190; BM-14-190; BM-14.190; SK&F-105517-D

>  <APPLICANTS>  (413) 
SmithKline Beecham Corp Dba GlaxoSmithKline; Sb Pharmco Puerto Rico Inc

>  <USAN_STEM>  (413) 
-dil-

>  <USAN_STEM_DEFINITION>  (413) 
vasodilators (undefined group)

>  <USAN_STEM_SUBSTEM>  (413) 
-dil-

>  <USAN_YEAR>  (413) 
1988.0

>  <FIRST_APPROVAL>  (413) 
1995.0

>  <ATC_CODE>  (413) 
C07AG02

>  <ATC_CODE_DESCRIPTION>  (413) 
C07AG02 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Alpha and beta blocking agents]

>  <INDICATION_CLASS>  (413) 
Anti-Anginal; Antihypertensive

>  <SC_PATENT_NO>  (413) 
US-6022562-A

>  <DRUG_TYPE>  (413) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (413) 
Y

>  <FIRST_IN_CLASS>  (413) 
N

>  <CHIRALITY>  (413) 
Racemic Mixture

>  <PRODRUG>  (413) 
N

>  <ORAL>  (413) 
Y

>  <PARENTERAL>  (413) 
N

>  <TOPICAL>  (413) 
N

>  <BLACK_BOX>  (413) 
N

>  <AVAILABILITY_TYPE>  (413) 
Prescription-only

>  <WITHDRAWN_YEAR>  (413) 
nan

>  <WITHDRAWN_COUNTRY>  (413) 
nan

>  <WITHDRAWN_REASON>  (413) 
nan

>  <CANONICAL_SMILES>  (413) 
COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23

>  <name>  (413) 
Carvedilol 

>  <MW>  (413) 
406.482

>  <logP>  (413) 
3.738

$$$$
CHEMBL278020
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 12  7  1  0
M  CHG  1  13   1
M  END
>  <PARENT_MOLREGNO>  (414) 
14126

>  <SYNONYMS>  (414) 
Neostigmine (BAN); Neostigmine Methylsulfate (FDA, JAN, USP); Neostigmine Bromide (BAN, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (414) 
4

>  <RESEARCH_CODES>  (414) 
nan

>  <APPLICANTS>  (414) 
Elkins-Sinn; Eclat Pharmaceuticals Llc; Astra; Apothecon; Icn

>  <USAN_STEM>  (414) 
-stigmine

>  <USAN_STEM_DEFINITION>  (414) 
cholinesterase inhibitors (physostigmine type)

>  <USAN_STEM_SUBSTEM>  (414) 
-stigmine

>  <USAN_YEAR>  (414) 
nan

>  <FIRST_APPROVAL>  (414) 
2013.0

>  <ATC_CODE>  (414) 
S01EB06; N07AA51; N07AA01

>  <ATC_CODE_DESCRIPTION>  (414) 
S01EB06 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]; N07AA51 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Anticholinesterases]; N07AA01 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Anticholinesterases]

>  <INDICATION_CLASS>  (414) 
Cholinergic

>  <SC_PATENT_NO>  (414) 
nan

>  <DRUG_TYPE>  (414) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (414) 
Y

>  <FIRST_IN_CLASS>  (414) 
N

>  <CHIRALITY>  (414) 
Achiral Molecule

>  <PRODRUG>  (414) 
N

>  <ORAL>  (414) 
N

>  <PARENTERAL>  (414) 
Y

>  <TOPICAL>  (414) 
N

>  <BLACK_BOX>  (414) 
N

>  <AVAILABILITY_TYPE>  (414) 
Prescription-only

>  <WITHDRAWN_YEAR>  (414) 
nan

>  <WITHDRAWN_COUNTRY>  (414) 
nan

>  <WITHDRAWN_REASON>  (414) 
nan

>  <CANONICAL_SMILES>  (414) 
CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C

>  <name>  (414) 
Neostigmine 

>  <MW>  (414) 
223.296

>  <logP>  (414) 
1.9437

$$$$
CHEMBL1274
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
 13 20  1  0
 20 21  2  0
 20 22  1  0
  8  2  1  0
 15 10  1  0
M  CHG  2  20   1  22  -1
M  END
>  <PARENT_MOLREGNO>  (415) 
249414

>  <SYNONYMS>  (415) 
Nilutamide (BAN, FDA, INN, MI, USAN)

>  <DEVELOPMENT_PHASE>  (415) 
4

>  <RESEARCH_CODES>  (415) 
RU-23908

>  <APPLICANTS>  (415) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (415) 
-lutamide

>  <USAN_STEM_DEFINITION>  (415) 
non-steroid antiandrogens

>  <USAN_STEM_SUBSTEM>  (415) 
-lutamide

>  <USAN_YEAR>  (415) 
1995.0

>  <FIRST_APPROVAL>  (415) 
1996.0

>  <ATC_CODE>  (415) 
L02BB02

>  <ATC_CODE_DESCRIPTION>  (415) 
L02BB02 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Anti-androgens]

>  <INDICATION_CLASS>  (415) 
Antineoplastic

>  <SC_PATENT_NO>  (415) 
nan

>  <DRUG_TYPE>  (415) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (415) 
Y

>  <FIRST_IN_CLASS>  (415) 
N

>  <CHIRALITY>  (415) 
Achiral Molecule

>  <PRODRUG>  (415) 
N

>  <ORAL>  (415) 
Y

>  <PARENTERAL>  (415) 
N

>  <TOPICAL>  (415) 
N

>  <BLACK_BOX>  (415) 
Y

>  <AVAILABILITY_TYPE>  (415) 
Prescription-only

>  <WITHDRAWN_YEAR>  (415) 
nan

>  <WITHDRAWN_COUNTRY>  (415) 
nan

>  <WITHDRAWN_REASON>  (415) 
nan

>  <CANONICAL_SMILES>  (415) 
CC1(C)NC(=O)N(C1=O)c2ccc(c(c2)C(F)(F)F)[N+](=O)[O-]

>  <name>  (415) 
Nilutamide 

>  <MW>  (415) 
317.223

>  <logP>  (415) 
2.4484

$$$$
CHEMBL1308
     RDKit          

  6  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  2  2  0
M  END
>  <PARENT_MOLREGNO>  (416) 
261343

>  <SYNONYMS>  (416) 
Fomepizole (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (416) 
4

>  <RESEARCH_CODES>  (416) 
4-MP

>  <APPLICANTS>  (416) 
Paladin Labs Usa Inc

>  <USAN_STEM>  (416) 
nan

>  <USAN_STEM_DEFINITION>  (416) 
nan

>  <USAN_STEM_SUBSTEM>  (416) 
nan

>  <USAN_YEAR>  (416) 
1990.0

>  <FIRST_APPROVAL>  (416) 
1997.0

>  <ATC_CODE>  (416) 
V03AB34

>  <ATC_CODE_DESCRIPTION>  (416) 
V03AB34 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (416) 
Antidote (alcohol dehydrogenase inhibitor)

>  <SC_PATENT_NO>  (416) 
US-7553863-B2

>  <DRUG_TYPE>  (416) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (416) 
Y

>  <FIRST_IN_CLASS>  (416) 
N

>  <CHIRALITY>  (416) 
Achiral Molecule

>  <PRODRUG>  (416) 
N

>  <ORAL>  (416) 
N

>  <PARENTERAL>  (416) 
Y

>  <TOPICAL>  (416) 
N

>  <BLACK_BOX>  (416) 
N

>  <AVAILABILITY_TYPE>  (416) 
Prescription-only

>  <WITHDRAWN_YEAR>  (416) 
nan

>  <WITHDRAWN_COUNTRY>  (416) 
nan

>  <WITHDRAWN_REASON>  (416) 
nan

>  <CANONICAL_SMILES>  (416) 
Cc1cn[nH]c1

>  <name>  (416) 
Fomepizole 

>  <MW>  (416) 
82.106

>  <logP>  (416) 
0.71812

$$$$
CHEMBL1542
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
  5 17  1  0
 17 18  2  0
 17 19  1  0
  6  2  1  0
 16  8  1  0
 16 12  2  0
M  CHG  2  17   1  19  -1
M  END
>  <PARENT_MOLREGNO>  (417) 
431141

>  <SYNONYMS>  (417) 
Azathioprine (BAN, FDA, INN, JAN, USAN, USP); Azathioprine sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (417) 
4

>  <RESEARCH_CODES>  (417) 
BW-57-322

>  <APPLICANTS>  (417) 
Prometheus Laboratories Inc

>  <USAN_STEM>  (417) 
nan

>  <USAN_STEM_DEFINITION>  (417) 
nan

>  <USAN_STEM_SUBSTEM>  (417) 
nan

>  <USAN_YEAR>  (417) 
1962.0

>  <FIRST_APPROVAL>  (417) 
1968.0

>  <ATC_CODE>  (417) 
L04AX01

>  <ATC_CODE_DESCRIPTION>  (417) 
L04AX01 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Other immunosuppressants]

>  <INDICATION_CLASS>  (417) 
Immunosuppressant

>  <SC_PATENT_NO>  (417) 
nan

>  <DRUG_TYPE>  (417) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (417) 
Y

>  <FIRST_IN_CLASS>  (417) 
N

>  <CHIRALITY>  (417) 
Achiral Molecule

>  <PRODRUG>  (417) 
Y

>  <ORAL>  (417) 
Y

>  <PARENTERAL>  (417) 
Y

>  <TOPICAL>  (417) 
N

>  <BLACK_BOX>  (417) 
Y

>  <AVAILABILITY_TYPE>  (417) 
Prescription-only

>  <WITHDRAWN_YEAR>  (417) 
nan

>  <WITHDRAWN_COUNTRY>  (417) 
nan

>  <WITHDRAWN_REASON>  (417) 
nan

>  <CANONICAL_SMILES>  (417) 
Cn1cnc(c1Sc2ncnc3nc[nH]c23)[N+](=O)[O-]

>  <name>  (417) 
Azathioprine 

>  <MW>  (417) 
277.269

>  <logP>  (417) 
1.1458

$$$$
CHEMBL667
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
M  CHG  1   7   1
M  END
>  <PARENT_MOLREGNO>  (418) 
27812

>  <SYNONYMS>  (418) 
Acetylcholine chloride (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (418) 
4

>  <RESEARCH_CODES>  (418) 
nan

>  <APPLICANTS>  (418) 
Novartis Pharmaceuticals Corp; Bausch And Lomb Inc

>  <USAN_STEM>  (418) 
nan

>  <USAN_STEM_DEFINITION>  (418) 
nan

>  <USAN_STEM_SUBSTEM>  (418) 
nan

>  <USAN_YEAR>  (418) 
nan

>  <FIRST_APPROVAL>  (418) 
1973.0

>  <ATC_CODE>  (418) 
S01EB09

>  <ATC_CODE_DESCRIPTION>  (418) 
S01EB09 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]

>  <INDICATION_CLASS>  (418) 
Cardiac Depressant; Cholinergic; Miotic; Vasodilator (peripheral)

>  <SC_PATENT_NO>  (418) 
nan

>  <DRUG_TYPE>  (418) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (418) 
Y

>  <FIRST_IN_CLASS>  (418) 
N

>  <CHIRALITY>  (418) 
Achiral Molecule

>  <PRODRUG>  (418) 
N

>  <ORAL>  (418) 
N

>  <PARENTERAL>  (418) 
N

>  <TOPICAL>  (418) 
Y

>  <BLACK_BOX>  (418) 
N

>  <AVAILABILITY_TYPE>  (418) 
Prescription-only

>  <WITHDRAWN_YEAR>  (418) 
nan

>  <WITHDRAWN_COUNTRY>  (418) 
nan

>  <WITHDRAWN_REASON>  (418) 
nan

>  <CANONICAL_SMILES>  (418) 
CC(=O)OCC[N+](C)(C)C

>  <name>  (418) 
Acetylcholine chloride 

>  <MW>  (418) 
146.21

>  <logP>  (418) 
0.2557

$$$$
CHEMBL86715
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  9  5  1  0
 15 10  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (419) 
139241

>  <SYNONYMS>  (419) 
Procyclidine (BAN, INN); Procyclidine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (419) 
4

>  <RESEARCH_CODES>  (419) 
nan

>  <APPLICANTS>  (419) 
Monarch Pharmaceuticals Inc

>  <USAN_STEM>  (419) 
-clidine

>  <USAN_STEM_DEFINITION>  (419) 
muscarinic agonists (various indications)

>  <USAN_STEM_SUBSTEM>  (419) 
-clidine

>  <USAN_YEAR>  (419) 
nan

>  <FIRST_APPROVAL>  (419) 
1955.0

>  <ATC_CODE>  (419) 
N04AA04

>  <ATC_CODE_DESCRIPTION>  (419) 
N04AA04 [Nervous System:Anti-Parkinson Drugs:Anticholinergic Agents:Tertiary amines]

>  <INDICATION_CLASS>  (419) 
Antiparkinsonian; Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (419) 
nan

>  <DRUG_TYPE>  (419) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (419) 
Y

>  <FIRST_IN_CLASS>  (419) 
N

>  <CHIRALITY>  (419) 
Racemic Mixture

>  <PRODRUG>  (419) 
N

>  <ORAL>  (419) 
Y

>  <PARENTERAL>  (419) 
N

>  <TOPICAL>  (419) 
N

>  <BLACK_BOX>  (419) 
N

>  <AVAILABILITY_TYPE>  (419) 
Discontinued

>  <WITHDRAWN_YEAR>  (419) 
nan

>  <WITHDRAWN_COUNTRY>  (419) 
nan

>  <WITHDRAWN_REASON>  (419) 
nan

>  <CANONICAL_SMILES>  (419) 
OC(CCN1CCCC1)(C2CCCCC2)c3ccccc3

>  <name>  (419) 
Procyclidine 

>  <MW>  (419) 
287.447

>  <logP>  (419) 
3.9404

$$$$
CHEMBL1201269
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (420) 
675220

>  <SYNONYMS>  (420) 
Chlorphentermine (BAN, INN); Chlorphentermine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (420) 
4

>  <RESEARCH_CODES>  (420) 
S-62; W-2426

>  <APPLICANTS>  (420) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (420) 
nan

>  <USAN_STEM_DEFINITION>  (420) 
nan

>  <USAN_STEM_SUBSTEM>  (420) 
nan

>  <USAN_YEAR>  (420) 
1963.0

>  <FIRST_APPROVAL>  (420) 
1982.0

>  <ATC_CODE>  (420) 
nan

>  <ATC_CODE_DESCRIPTION>  (420) 
nan

>  <INDICATION_CLASS>  (420) 
Anorexic

>  <SC_PATENT_NO>  (420) 
nan

>  <DRUG_TYPE>  (420) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (420) 
Y

>  <FIRST_IN_CLASS>  (420) 
N

>  <CHIRALITY>  (420) 
Achiral Molecule

>  <PRODRUG>  (420) 
N

>  <ORAL>  (420) 
Y

>  <PARENTERAL>  (420) 
N

>  <TOPICAL>  (420) 
N

>  <BLACK_BOX>  (420) 
N

>  <AVAILABILITY_TYPE>  (420) 
Withdrawn

>  <WITHDRAWN_YEAR>  (420) 
1969.0

>  <WITHDRAWN_COUNTRY>  (420) 
Germany

>  <WITHDRAWN_REASON>  (420) 
Cardiovascular

>  <CANONICAL_SMILES>  (420) 
CC(C)(N)Cc1ccc(Cl)cc1

>  <name>  (420) 
Chlorphentermine 

>  <MW>  (420) 
183.682

>  <logP>  (420) 
2.6198

$$$$
CHEMBL301265
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14  5  1  0
 13  8  2  0
M  END
>  <PARENT_MOLREGNO>  (421) 
88815

>  <SYNONYMS>  (421) 
Pramipexole (BAN, INN, USAN); Pramipexole Dihydrochloride (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (421) 
4

>  <RESEARCH_CODES>  (421) 
SUD-919CL2Y; U-98528E; PNU-98528E; SND-919CL2Y; SND919CL2Y

>  <APPLICANTS>  (421) 
Boehringer Ingelheim Pharmaceuticals Inc; Boehringer Ingelheim

>  <USAN_STEM>  (421) 
nan

>  <USAN_STEM_DEFINITION>  (421) 
nan

>  <USAN_STEM_SUBSTEM>  (421) 
nan

>  <USAN_YEAR>  (421) 
1995.0

>  <FIRST_APPROVAL>  (421) 
1997.0

>  <ATC_CODE>  (421) 
N04BC05

>  <ATC_CODE_DESCRIPTION>  (421) 
N04BC05 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopamine agonists]

>  <INDICATION_CLASS>  (421) 
Antidepressant; Antiparkinsonian; Antischizophrenic; Dopamine Agonist

>  <SC_PATENT_NO>  (421) 
US-6001861-A

>  <DRUG_TYPE>  (421) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (421) 
Y

>  <FIRST_IN_CLASS>  (421) 
N

>  <CHIRALITY>  (421) 
Single Stereoisomer

>  <PRODRUG>  (421) 
N

>  <ORAL>  (421) 
Y

>  <PARENTERAL>  (421) 
N

>  <TOPICAL>  (421) 
N

>  <BLACK_BOX>  (421) 
N

>  <AVAILABILITY_TYPE>  (421) 
Prescription-only

>  <WITHDRAWN_YEAR>  (421) 
nan

>  <WITHDRAWN_COUNTRY>  (421) 
nan

>  <WITHDRAWN_REASON>  (421) 
nan

>  <CANONICAL_SMILES>  (421) 
CCCN[C@H]1CCc2nc(N)sc2C1

>  <name>  (421) 
Pramipexole 

>  <MW>  (421) 
211.334

>  <logP>  (421) 
1.5822

$$$$
CHEMBL1697760
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  2 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
  8  3  1  0
 17 10  1  0
M  END
>  <PARENT_MOLREGNO>  (422) 
1078524

>  <SYNONYMS>  (422) 
Muzolimine (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (422) 
4

>  <RESEARCH_CODES>  (422) 
BAY-G-2821

>  <APPLICANTS>  (422) 
Bayer

>  <USAN_STEM>  (422) 
nan

>  <USAN_STEM_DEFINITION>  (422) 
nan

>  <USAN_STEM_SUBSTEM>  (422) 
nan

>  <USAN_YEAR>  (422) 
1977.0

>  <FIRST_APPROVAL>  (422) 
nan

>  <ATC_CODE>  (422) 
C03CD01

>  <ATC_CODE_DESCRIPTION>  (422) 
C03CD01 [Cardiovascular System:Diuretics:High-Ceiling Diuretics:Pyrazolone derivatives]

>  <INDICATION_CLASS>  (422) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (422) 
nan

>  <DRUG_TYPE>  (422) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (422) 
Y

>  <FIRST_IN_CLASS>  (422) 
N

>  <CHIRALITY>  (422) 
Racemic Mixture

>  <PRODRUG>  (422) 
N

>  <ORAL>  (422) 
N

>  <PARENTERAL>  (422) 
N

>  <TOPICAL>  (422) 
N

>  <BLACK_BOX>  (422) 
N

>  <AVAILABILITY_TYPE>  (422) 
Withdrawn

>  <WITHDRAWN_YEAR>  (422) 
1987.0

>  <WITHDRAWN_COUNTRY>  (422) 
European Union; Germany; France

>  <WITHDRAWN_REASON>  (422) 
Polyneuropathy

>  <CANONICAL_SMILES>  (422) 
CC(N1N=C(N)CC1=O)c2ccc(Cl)c(Cl)c2

>  <name>  (422) 
Muzolimine 

>  <MW>  (422) 
272.135

>  <logP>  (422) 
2.5589

$$$$
CHEMBL526
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  8 12  2  0
 12 13  1  0
 12  4  1  0
M  END
>  <PARENT_MOLREGNO>  (423) 
11819

>  <SYNONYMS>  (423) 
Propofol (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (423) 
4

>  <RESEARCH_CODES>  (423) 
ICI-35868

>  <APPLICANTS>  (423) 
Fresenius Kabi Usa Llc

>  <USAN_STEM>  (423) 
nan

>  <USAN_STEM_DEFINITION>  (423) 
nan

>  <USAN_STEM_SUBSTEM>  (423) 
nan

>  <USAN_YEAR>  (423) 
1984.0

>  <FIRST_APPROVAL>  (423) 
1989.0

>  <ATC_CODE>  (423) 
N01AX10

>  <ATC_CODE_DESCRIPTION>  (423) 
N01AX10 [Nervous System:Anesthetics:Anesthetics, General:Other general anesthetics]

>  <INDICATION_CLASS>  (423) 
Anesthetic (intravenous)

>  <SC_PATENT_NO>  (423) 
US-5714520-A

>  <DRUG_TYPE>  (423) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (423) 
Y

>  <FIRST_IN_CLASS>  (423) 
N

>  <CHIRALITY>  (423) 
Achiral Molecule

>  <PRODRUG>  (423) 
N

>  <ORAL>  (423) 
N

>  <PARENTERAL>  (423) 
Y

>  <TOPICAL>  (423) 
N

>  <BLACK_BOX>  (423) 
N

>  <AVAILABILITY_TYPE>  (423) 
Prescription-only

>  <WITHDRAWN_YEAR>  (423) 
nan

>  <WITHDRAWN_COUNTRY>  (423) 
nan

>  <WITHDRAWN_REASON>  (423) 
nan

>  <CANONICAL_SMILES>  (423) 
CC(C)c1cccc(C(C)C)c1O

>  <name>  (423) 
Propofol 

>  <MW>  (423) 
178.275

>  <logP>  (423) 
3.639

$$$$
CHEMBL533
     RDKit          

 26 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 19 25  1  0
 25 26  2  0
 26 16  1  0
M  END
>  <PARENT_MOLREGNO>  (424) 
12608

>  <SYNONYMS>  (424) 
Ibutilide (BAN, INN); Ibutilide Fumarate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (424) 
4

>  <RESEARCH_CODES>  (424) 
U-70226E

>  <APPLICANTS>  (424) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (424) 
-ilide

>  <USAN_STEM_DEFINITION>  (424) 
class III antiarrhythmic agents

>  <USAN_STEM_SUBSTEM>  (424) 
-ilide

>  <USAN_YEAR>  (424) 
1990.0

>  <FIRST_APPROVAL>  (424) 
1995.0

>  <ATC_CODE>  (424) 
C01BD05

>  <ATC_CODE_DESCRIPTION>  (424) 
C01BD05 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class III]

>  <INDICATION_CLASS>  (424) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (424) 
nan

>  <DRUG_TYPE>  (424) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (424) 
Y

>  <FIRST_IN_CLASS>  (424) 
N

>  <CHIRALITY>  (424) 
Racemic Mixture

>  <PRODRUG>  (424) 
N

>  <ORAL>  (424) 
N

>  <PARENTERAL>  (424) 
Y

>  <TOPICAL>  (424) 
N

>  <BLACK_BOX>  (424) 
Y

>  <AVAILABILITY_TYPE>  (424) 
Prescription-only

>  <WITHDRAWN_YEAR>  (424) 
nan

>  <WITHDRAWN_COUNTRY>  (424) 
nan

>  <WITHDRAWN_REASON>  (424) 
nan

>  <CANONICAL_SMILES>  (424) 
CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1

>  <name>  (424) 
Ibutilide 

>  <MW>  (424) 
384.586

>  <logP>  (424) 
4.164

$$$$
CHEMBL1208642
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
M  END
>  <PARENT_MOLREGNO>  (425) 
682593

>  <SYNONYMS>  (425) 
Sodium Thiosulfate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (425) 
4

>  <RESEARCH_CODES>  (425) 
nan

>  <APPLICANTS>  (425) 
United States Army Office Surgeon General; Hope Pharmaceuticals

>  <USAN_STEM>  (425) 
nan

>  <USAN_STEM_DEFINITION>  (425) 
nan

>  <USAN_STEM_SUBSTEM>  (425) 
nan

>  <USAN_YEAR>  (425) 
nan

>  <FIRST_APPROVAL>  (425) 
1992.0

>  <ATC_CODE>  (425) 
V03AB06

>  <ATC_CODE_DESCRIPTION>  (425) 
V03AB06 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (425) 
Antidote (to cyanide poisoning)

>  <SC_PATENT_NO>  (425) 
US-8496973-B2

>  <DRUG_TYPE>  (425) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (425) 
Y

>  <FIRST_IN_CLASS>  (425) 
N

>  <CHIRALITY>  (425) 
Achiral Molecule

>  <PRODRUG>  (425) 
N

>  <ORAL>  (425) 
N

>  <PARENTERAL>  (425) 
Y

>  <TOPICAL>  (425) 
N

>  <BLACK_BOX>  (425) 
Y

>  <AVAILABILITY_TYPE>  (425) 
Prescription-only

>  <WITHDRAWN_YEAR>  (425) 
nan

>  <WITHDRAWN_COUNTRY>  (425) 
nan

>  <WITHDRAWN_REASON>  (425) 
nan

>  <CANONICAL_SMILES>  (425) 
OS(=O)(=S)O

>  <name>  (425) 
Sodium Thiosulfate 

>  <MW>  (425) 
114.147

>  <logP>  (425) 
-0.3213

$$$$
CHEMBL1243
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  7  2  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (426) 
233590

>  <SYNONYMS>  (426) 
Sulfabenzamide (BAN, INN, USAN, USP); Sulfabenzamide (Triple Sulfa) (FDA)

>  <DEVELOPMENT_PHASE>  (426) 
4

>  <RESEARCH_CODES>  (426) 
nan

>  <APPLICANTS>  (426) 
Ortho Mcneil Pharmaceutical Inc

>  <USAN_STEM>  (426) 
sulfa-

>  <USAN_STEM_DEFINITION>  (426) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (426) 
sulfa-

>  <USAN_YEAR>  (426) 
1971.0

>  <FIRST_APPROVAL>  (426) 
1945.0

>  <ATC_CODE>  (426) 
nan

>  <ATC_CODE_DESCRIPTION>  (426) 
nan

>  <INDICATION_CLASS>  (426) 
Antibacterial

>  <SC_PATENT_NO>  (426) 
nan

>  <DRUG_TYPE>  (426) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (426) 
Y

>  <FIRST_IN_CLASS>  (426) 
N

>  <CHIRALITY>  (426) 
Achiral Molecule

>  <PRODRUG>  (426) 
N

>  <ORAL>  (426) 
N

>  <PARENTERAL>  (426) 
N

>  <TOPICAL>  (426) 
Y

>  <BLACK_BOX>  (426) 
N

>  <AVAILABILITY_TYPE>  (426) 
Discontinued

>  <WITHDRAWN_YEAR>  (426) 
nan

>  <WITHDRAWN_COUNTRY>  (426) 
nan

>  <WITHDRAWN_REASON>  (426) 
nan

>  <CANONICAL_SMILES>  (426) 
Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2

>  <name>  (426) 
Sulfabenzamide 

>  <MW>  (426) 
276.317

>  <logP>  (426) 
1.3875

$$$$
CHEMBL407
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 10  6  2  0
 22  9  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (427) 
635

>  <SYNONYMS>  (427) 
Flumazenil (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (427) 
4

>  <RESEARCH_CODES>  (427) 
Ro-151788000; Ro-151788

>  <APPLICANTS>  (427) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (427) 
-azenil

>  <USAN_STEM_DEFINITION>  (427) 
benzodiazepine receptor agonists/antagonists (benzodiazepine derivatives)

>  <USAN_STEM_SUBSTEM>  (427) 
-azenil

>  <USAN_YEAR>  (427) 
1987.0

>  <FIRST_APPROVAL>  (427) 
1991.0

>  <ATC_CODE>  (427) 
V03AB25

>  <ATC_CODE_DESCRIPTION>  (427) 
V03AB25 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (427) 
Antagonist (to benzodiazepine)

>  <SC_PATENT_NO>  (427) 
nan

>  <DRUG_TYPE>  (427) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (427) 
Y

>  <FIRST_IN_CLASS>  (427) 
N

>  <CHIRALITY>  (427) 
Achiral Molecule

>  <PRODRUG>  (427) 
N

>  <ORAL>  (427) 
N

>  <PARENTERAL>  (427) 
Y

>  <TOPICAL>  (427) 
N

>  <BLACK_BOX>  (427) 
Y

>  <AVAILABILITY_TYPE>  (427) 
Prescription-only

>  <WITHDRAWN_YEAR>  (427) 
nan

>  <WITHDRAWN_COUNTRY>  (427) 
nan

>  <WITHDRAWN_REASON>  (427) 
nan

>  <CANONICAL_SMILES>  (427) 
CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23

>  <name>  (427) 
Flumazenil 

>  <MW>  (427) 
303.293

>  <logP>  (427) 
1.7737

$$$$
CHEMBL1200622
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 15 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 11  1  0
 29 14  1  0
 25 18  1  0
M  END
>  <PARENT_MOLREGNO>  (428) 
674573

>  <SYNONYMS>  (428) 
Paricalcitol (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (428) 
4

>  <RESEARCH_CODES>  (428) 
Compound 49510

>  <APPLICANTS>  (428) 
Abbvie Inc

>  <USAN_STEM>  (428) 
-calci-

>  <USAN_STEM_DEFINITION>  (428) 
vitamin D analogues

>  <USAN_STEM_SUBSTEM>  (428) 
-calci-

>  <USAN_YEAR>  (428) 
1997.0

>  <FIRST_APPROVAL>  (428) 
1998.0

>  <ATC_CODE>  (428) 
H05BX02

>  <ATC_CODE_DESCRIPTION>  (428) 
H05BX02 [Systemic Hormonal Preparations, Excl. :Calcium Homeostasis:Anti-Parathyroid Agents:Other anti-parathyroid agents]

>  <INDICATION_CLASS>  (428) 
nan

>  <SC_PATENT_NO>  (428) 
US-5597815-A

>  <DRUG_TYPE>  (428) 
Natural Product-derived

>  <RULE_OF_FIVE>  (428) 
Y

>  <FIRST_IN_CLASS>  (428) 
N

>  <CHIRALITY>  (428) 
Single Stereoisomer

>  <PRODRUG>  (428) 
N

>  <ORAL>  (428) 
Y

>  <PARENTERAL>  (428) 
Y

>  <TOPICAL>  (428) 
N

>  <BLACK_BOX>  (428) 
N

>  <AVAILABILITY_TYPE>  (428) 
Prescription-only

>  <WITHDRAWN_YEAR>  (428) 
nan

>  <WITHDRAWN_COUNTRY>  (428) 
nan

>  <WITHDRAWN_REASON>  (428) 
nan

>  <CANONICAL_SMILES>  (428) 
C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(=C\C=C3C[C@@H](O)C[C@H](O)C3)\CCC[C@]12C

>  <name>  (428) 
Paricalcitol 

>  <MW>  (428) 
416.646

>  <logP>  (428) 
5.5606

$$$$
CHEMBL443
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  5 17  1  0
 17  2  2  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (429) 
2247

>  <SYNONYMS>  (429) 
Acetylsulfamethoxazole (JAN); Sulfamethoxazole (BAN, FDA, INN, JAN, USAN, USP); Sulfamethoxazole Sodium (JAN)

>  <DEVELOPMENT_PHASE>  (429) 
4

>  <RESEARCH_CODES>  (429) 
Ro-42130

>  <APPLICANTS>  (429) 
Monarch Pharmaceuticals Inc; Hoffmann La Roche Inc; Heather Drug Co Inc; Able Laboratories Inc; Mutual Pharmaceutical Co Inc

>  <USAN_STEM>  (429) 
sulfa-

>  <USAN_STEM_DEFINITION>  (429) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (429) 
sulfa-

>  <USAN_YEAR>  (429) 
1962.0

>  <FIRST_APPROVAL>  (429) 
1973.0

>  <ATC_CODE>  (429) 
J01EC01

>  <ATC_CODE_DESCRIPTION>  (429) 
J01EC01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Intermediate-acting sulfonamides]

>  <INDICATION_CLASS>  (429) 
Antibacterial

>  <SC_PATENT_NO>  (429) 
nan

>  <DRUG_TYPE>  (429) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (429) 
Y

>  <FIRST_IN_CLASS>  (429) 
N

>  <CHIRALITY>  (429) 
Achiral Molecule

>  <PRODRUG>  (429) 
N

>  <ORAL>  (429) 
Y

>  <PARENTERAL>  (429) 
Y

>  <TOPICAL>  (429) 
N

>  <BLACK_BOX>  (429) 
N

>  <AVAILABILITY_TYPE>  (429) 
Prescription-only

>  <WITHDRAWN_YEAR>  (429) 
nan

>  <WITHDRAWN_COUNTRY>  (429) 
nan

>  <WITHDRAWN_REASON>  (429) 
nan

>  <CANONICAL_SMILES>  (429) 
Cc1onc(NS(=O)(=O)c2ccc(N)cc2)c1

>  <name>  (429) 
Acetylsulfamethoxazole 

>  <MW>  (429) 
253.283

>  <logP>  (429) 
1.36602

$$$$
CHEMBL1201134
     RDKit          

 27 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 13 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27  8  1  0
 26 12  1  0
M  END
>  <PARENT_MOLREGNO>  (430) 
675085

>  <SYNONYMS>  (430) 
Lubiprostone (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (430) 
4

>  <RESEARCH_CODES>  (430) 
RU-0211

>  <APPLICANTS>  (430) 
Sucampo Pharmaceuticals Inc

>  <USAN_STEM>  (430) 
-prost-

>  <USAN_STEM_DEFINITION>  (430) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (430) 
-prost-

>  <USAN_YEAR>  (430) 
2002.0

>  <FIRST_APPROVAL>  (430) 
2006.0

>  <ATC_CODE>  (430) 
A06AX03

>  <ATC_CODE_DESCRIPTION>  (430) 
A06AX03 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Other drugs for constipation]

>  <INDICATION_CLASS>  (430) 
nan

>  <SC_PATENT_NO>  (430) 
US-6414016-B1

>  <DRUG_TYPE>  (430) 
Natural Product-derived

>  <RULE_OF_FIVE>  (430) 
Y

>  <FIRST_IN_CLASS>  (430) 
N

>  <CHIRALITY>  (430) 
Single Stereoisomer

>  <PRODRUG>  (430) 
N

>  <ORAL>  (430) 
Y

>  <PARENTERAL>  (430) 
N

>  <TOPICAL>  (430) 
N

>  <BLACK_BOX>  (430) 
N

>  <AVAILABILITY_TYPE>  (430) 
Prescription-only

>  <WITHDRAWN_YEAR>  (430) 
nan

>  <WITHDRAWN_COUNTRY>  (430) 
nan

>  <WITHDRAWN_REASON>  (430) 
nan

>  <CANONICAL_SMILES>  (430) 
CCCCC(F)(F)[C@@]1(O)CC[C@@H]2[C@@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1

>  <name>  (430) 
Lubiprostone 

>  <MW>  (430) 
390.467

>  <logP>  (430) 
4.3099

$$$$
CHEMBL1201286
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 12 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 19 14  1  0
 25 20  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (431) 
675237

>  <SYNONYMS>  (431) 
Oxyphenonium Bromide (BAN, FDA, INN, MI)

>  <DEVELOPMENT_PHASE>  (431) 
4

>  <RESEARCH_CODES>  (431) 
nan

>  <APPLICANTS>  (431) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (431) 
-ium

>  <USAN_STEM_DEFINITION>  (431) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (431) 
-ium

>  <USAN_YEAR>  (431) 
nan

>  <FIRST_APPROVAL>  (431) 
1982.0

>  <ATC_CODE>  (431) 
A03AB53; A03AB03

>  <ATC_CODE_DESCRIPTION>  (431) 
A03AB53 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]; A03AB03 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (431) 
nan

>  <SC_PATENT_NO>  (431) 
nan

>  <DRUG_TYPE>  (431) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (431) 
Y

>  <FIRST_IN_CLASS>  (431) 
N

>  <CHIRALITY>  (431) 
Racemic Mixture

>  <PRODRUG>  (431) 
N

>  <ORAL>  (431) 
Y

>  <PARENTERAL>  (431) 
N

>  <TOPICAL>  (431) 
N

>  <BLACK_BOX>  (431) 
N

>  <AVAILABILITY_TYPE>  (431) 
Discontinued

>  <WITHDRAWN_YEAR>  (431) 
nan

>  <WITHDRAWN_COUNTRY>  (431) 
nan

>  <WITHDRAWN_REASON>  (431) 
nan

>  <CANONICAL_SMILES>  (431) 
CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c2ccccc2

>  <name>  (431) 
Oxyphenonium Bromide 

>  <MW>  (431) 
348.507

>  <logP>  (431) 
3.4841

$$$$
CHEMBL760
     RDKit          

 16 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15  2  1  0
 14  5  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (432) 
42290

>  <SYNONYMS>  (432) 
Anagrelide (BAN, INN); Anagrelide HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (432) 
4

>  <RESEARCH_CODES>  (432) 
BL-4162a

>  <APPLICANTS>  (432) 
Shire Development Llc

>  <USAN_STEM>  (432) 
-grel-

>  <USAN_STEM_DEFINITION>  (432) 
platelet aggregation inhibitors

>  <USAN_STEM_SUBSTEM>  (432) 
-grel-

>  <USAN_YEAR>  (432) 
1979.0

>  <FIRST_APPROVAL>  (432) 
1997.0

>  <ATC_CODE>  (432) 
L01XX35

>  <ATC_CODE_DESCRIPTION>  (432) 
L01XX35 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (432) 
Antithrombotic

>  <SC_PATENT_NO>  (432) 
nan

>  <DRUG_TYPE>  (432) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (432) 
Y

>  <FIRST_IN_CLASS>  (432) 
N

>  <CHIRALITY>  (432) 
Achiral Molecule

>  <PRODRUG>  (432) 
N

>  <ORAL>  (432) 
Y

>  <PARENTERAL>  (432) 
N

>  <TOPICAL>  (432) 
N

>  <BLACK_BOX>  (432) 
N

>  <AVAILABILITY_TYPE>  (432) 
Prescription-only

>  <WITHDRAWN_YEAR>  (432) 
nan

>  <WITHDRAWN_COUNTRY>  (432) 
nan

>  <WITHDRAWN_REASON>  (432) 
nan

>  <CANONICAL_SMILES>  (432) 
Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl

>  <name>  (432) 
Anagrelide 

>  <MW>  (432) 
256.092

>  <logP>  (432) 
1.9263

$$$$
CHEMBL2048484
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  1  0
  7  2  1  0
 13  9  1  0
 20 14  1  0
 30 21  1  0
M  END
>  <PARENT_MOLREGNO>  (433) 
1351917

>  <SYNONYMS>  (433) 
Canagliflozin (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (433) 
4

>  <RESEARCH_CODES>  (433) 
JNJ-24831754-ZAE; JNJ-28431754; JNJ-28431754-AAA; TA-7284

>  <APPLICANTS>  (433) 
Johnson & Johnson; Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (433) 
-gliflozin

>  <USAN_STEM_DEFINITION>  (433) 
phlorozin derivatives, phenolic glycosides

>  <USAN_STEM_SUBSTEM>  (433) 
-gliflozin

>  <USAN_YEAR>  (433) 
2009.0

>  <FIRST_APPROVAL>  (433) 
2011.0

>  <ATC_CODE>  (433) 
A10BX11

>  <ATC_CODE_DESCRIPTION>  (433) 
A10BX11 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Other blood glucose lowering drugs, excl. insulins]

>  <INDICATION_CLASS>  (433) 
nan

>  <SC_PATENT_NO>  (433) 
US-7943582-B2; US-7943788-B2

>  <DRUG_TYPE>  (433) 
Natural Product-derived

>  <RULE_OF_FIVE>  (433) 
Y

>  <FIRST_IN_CLASS>  (433) 
Y

>  <CHIRALITY>  (433) 
Single Stereoisomer

>  <PRODRUG>  (433) 
N

>  <ORAL>  (433) 
Y

>  <PARENTERAL>  (433) 
N

>  <TOPICAL>  (433) 
N

>  <BLACK_BOX>  (433) 
N

>  <AVAILABILITY_TYPE>  (433) 
Prescription-only

>  <WITHDRAWN_YEAR>  (433) 
nan

>  <WITHDRAWN_COUNTRY>  (433) 
nan

>  <WITHDRAWN_REASON>  (433) 
nan

>  <CANONICAL_SMILES>  (433) 
Cc1ccc(cc1Cc2ccc(s2)c3ccc(F)cc3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O

>  <name>  (433) 
Canagliflozin 

>  <MW>  (433) 
444.524

>  <logP>  (433) 
2.96832

$$$$
CHEMBL1651906
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  2  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 17  8  1  0
M  END
>  <PARENT_MOLREGNO>  (434) 
1064511

>  <SYNONYMS>  (434) 
Streptozocin (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (434) 
4

>  <RESEARCH_CODES>  (434) 
U-9889

>  <APPLICANTS>  (434) 
Teva Parenteral Medicines Inc

>  <USAN_STEM>  (434) 
nan

>  <USAN_STEM_DEFINITION>  (434) 
nan

>  <USAN_STEM_SUBSTEM>  (434) 
nan

>  <USAN_YEAR>  (434) 
1975.0

>  <FIRST_APPROVAL>  (434) 
1982.0

>  <ATC_CODE>  (434) 
L01AD04

>  <ATC_CODE_DESCRIPTION>  (434) 
L01AD04 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrosoureas]

>  <INDICATION_CLASS>  (434) 
Antineoplastic

>  <SC_PATENT_NO>  (434) 
nan

>  <DRUG_TYPE>  (434) 
Natural Product-derived

>  <RULE_OF_FIVE>  (434) 
Y

>  <FIRST_IN_CLASS>  (434) 
N

>  <CHIRALITY>  (434) 
Racemic Mixture

>  <PRODRUG>  (434) 
N

>  <ORAL>  (434) 
N

>  <PARENTERAL>  (434) 
Y

>  <TOPICAL>  (434) 
N

>  <BLACK_BOX>  (434) 
Y

>  <AVAILABILITY_TYPE>  (434) 
Prescription-only

>  <WITHDRAWN_YEAR>  (434) 
nan

>  <WITHDRAWN_COUNTRY>  (434) 
nan

>  <WITHDRAWN_REASON>  (434) 
nan

>  <CANONICAL_SMILES>  (434) 
CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O

>  <name>  (434) 
Streptozocin 

>  <MW>  (434) 
265.222

>  <logP>  (434) 
-2.8909

$$$$
CHEMBL3707216
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10  4  1  0
M  END
>  <PARENT_MOLREGNO>  (435) 
2039187

>  <SYNONYMS>  (435) 
4-Dimethylaminophenol

>  <DEVELOPMENT_PHASE>  (435) 
4

>  <RESEARCH_CODES>  (435) 
nan

>  <APPLICANTS>  (435) 
nan

>  <USAN_STEM>  (435) 
nan

>  <USAN_STEM_DEFINITION>  (435) 
nan

>  <USAN_STEM_SUBSTEM>  (435) 
nan

>  <USAN_YEAR>  (435) 
nan

>  <FIRST_APPROVAL>  (435) 
nan

>  <ATC_CODE>  (435) 
V03AB27

>  <ATC_CODE_DESCRIPTION>  (435) 
V03AB27 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (435) 
nan

>  <SC_PATENT_NO>  (435) 
nan

>  <DRUG_TYPE>  (435) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (435) 
Y

>  <FIRST_IN_CLASS>  (435) 
N

>  <CHIRALITY>  (435) 
Achiral Molecule

>  <PRODRUG>  (435) 
N

>  <ORAL>  (435) 
N

>  <PARENTERAL>  (435) 
N

>  <TOPICAL>  (435) 
N

>  <BLACK_BOX>  (435) 
N

>  <AVAILABILITY_TYPE>  (435) 
Unknown

>  <WITHDRAWN_YEAR>  (435) 
nan

>  <WITHDRAWN_COUNTRY>  (435) 
nan

>  <WITHDRAWN_REASON>  (435) 
nan

>  <CANONICAL_SMILES>  (435) 
CN(C)c1ccc(O)cc1

>  <name>  (435) 
4-Dimethylaminophenol

>  <MW>  (435) 
137.182

>  <logP>  (435) 
1.4582

$$$$
CHEMBL268869
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
  6 18  1  0
 18 19  2  0
 19  3  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (436) 
2516

>  <SYNONYMS>  (436) 
Sulfamethoxypyridazine (BAN, INN, MI, USP)

>  <DEVELOPMENT_PHASE>  (436) 
4

>  <RESEARCH_CODES>  (436) 
nan

>  <APPLICANTS>  (436) 
Parke-Davis

>  <USAN_STEM>  (436) 
sulfa-

>  <USAN_STEM_DEFINITION>  (436) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (436) 
sulfa-

>  <USAN_YEAR>  (436) 
nan

>  <FIRST_APPROVAL>  (436) 
nan

>  <ATC_CODE>  (436) 
J01ED05

>  <ATC_CODE_DESCRIPTION>  (436) 
J01ED05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]

>  <INDICATION_CLASS>  (436) 
nan

>  <SC_PATENT_NO>  (436) 
nan

>  <DRUG_TYPE>  (436) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (436) 
Y

>  <FIRST_IN_CLASS>  (436) 
N

>  <CHIRALITY>  (436) 
Achiral Molecule

>  <PRODRUG>  (436) 
N

>  <ORAL>  (436) 
N

>  <PARENTERAL>  (436) 
N

>  <TOPICAL>  (436) 
N

>  <BLACK_BOX>  (436) 
N

>  <AVAILABILITY_TYPE>  (436) 
Withdrawn

>  <WITHDRAWN_YEAR>  (436) 
1986.0

>  <WITHDRAWN_COUNTRY>  (436) 
United Kingdom

>  <WITHDRAWN_REASON>  (436) 
nan

>  <CANONICAL_SMILES>  (436) 
COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1

>  <name>  (436) 
Sulfamethoxypyridazine 

>  <MW>  (436) 
280.309

>  <logP>  (436) 
0.8682

$$$$
CHEMBL1200617
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 26  5  1  0
 26 10  1  0
 22 11  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (437) 
674568

>  <SYNONYMS>  (437) 
Rimexolone (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (437) 
4

>  <RESEARCH_CODES>  (437) 
ORG-6216

>  <APPLICANTS>  (437) 
Alcon Laboratories Inc

>  <USAN_STEM>  (437) 
-olone

>  <USAN_STEM_DEFINITION>  (437) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (437) 
-olone

>  <USAN_YEAR>  (437) 
1990.0

>  <FIRST_APPROVAL>  (437) 
1994.0

>  <ATC_CODE>  (437) 
H02AB12; S01BA13

>  <ATC_CODE_DESCRIPTION>  (437) 
H02AB12 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA13 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]

>  <INDICATION_CLASS>  (437) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (437) 
nan

>  <DRUG_TYPE>  (437) 
Natural Product-derived

>  <RULE_OF_FIVE>  (437) 
Y

>  <FIRST_IN_CLASS>  (437) 
N

>  <CHIRALITY>  (437) 
Single Stereoisomer

>  <PRODRUG>  (437) 
N

>  <ORAL>  (437) 
N

>  <PARENTERAL>  (437) 
N

>  <TOPICAL>  (437) 
Y

>  <BLACK_BOX>  (437) 
N

>  <AVAILABILITY_TYPE>  (437) 
Prescription-only

>  <WITHDRAWN_YEAR>  (437) 
nan

>  <WITHDRAWN_COUNTRY>  (437) 
nan

>  <WITHDRAWN_REASON>  (437) 
nan

>  <CANONICAL_SMILES>  (437) 
CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

>  <name>  (437) 
Rimexolone 

>  <MW>  (437) 
370.533

>  <logP>  (437) 
4.4965

$$$$
CHEMBL272485
     RDKit          

 20 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (438) 
435597

>  <SYNONYMS>  (438) 
Dibutyl Phthalate (NF)

>  <DEVELOPMENT_PHASE>  (438) 
4

>  <RESEARCH_CODES>  (438) 
nan

>  <APPLICANTS>  (438) 
nan

>  <USAN_STEM>  (438) 
nan

>  <USAN_STEM_DEFINITION>  (438) 
nan

>  <USAN_STEM_SUBSTEM>  (438) 
nan

>  <USAN_YEAR>  (438) 
nan

>  <FIRST_APPROVAL>  (438) 
nan

>  <ATC_CODE>  (438) 
P03BX03

>  <ATC_CODE_DESCRIPTION>  (438) 
P03BX03 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Insecticides And Repellents:Other insecticides and repellents]

>  <INDICATION_CLASS>  (438) 
nan

>  <SC_PATENT_NO>  (438) 
nan

>  <DRUG_TYPE>  (438) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (438) 
Y

>  <FIRST_IN_CLASS>  (438) 
N

>  <CHIRALITY>  (438) 
Achiral Molecule

>  <PRODRUG>  (438) 
N

>  <ORAL>  (438) 
N

>  <PARENTERAL>  (438) 
N

>  <TOPICAL>  (438) 
N

>  <BLACK_BOX>  (438) 
N

>  <AVAILABILITY_TYPE>  (438) 
Unknown

>  <WITHDRAWN_YEAR>  (438) 
nan

>  <WITHDRAWN_COUNTRY>  (438) 
nan

>  <WITHDRAWN_REASON>  (438) 
nan

>  <CANONICAL_SMILES>  (438) 
CCCCOC(=O)c1ccccc1C(=O)OCCCC

>  <name>  (438) 
Dibutyl Phthalate 

>  <MW>  (438) 
278.348

>  <logP>  (438) 
3.6004

$$$$
CHEMBL1594
     RDKit          

 15 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
M  END
>  <PARENT_MOLREGNO>  (439) 
454250

>  <SYNONYMS>  (439) 
Pantothenic acid (FDA, BAN); Calcium Pantothenate (INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (439) 
4

>  <RESEARCH_CODES>  (439) 
nan

>  <APPLICANTS>  (439) 
Lilly; Johnson & Johnson-Merck Consumer; Hospira Inc; Basf

>  <USAN_STEM>  (439) 
nan

>  <USAN_STEM_DEFINITION>  (439) 
nan

>  <USAN_STEM_SUBSTEM>  (439) 
nan

>  <USAN_YEAR>  (439) 
nan

>  <FIRST_APPROVAL>  (439) 
1993.0

>  <ATC_CODE>  (439) 
A11HA31; D03AX04

>  <ATC_CODE_DESCRIPTION>  (439) 
A11HA31 [Alimentary Tract And Metabolism:Vitamins:Other Plain Vitamin Preparations:Other plain vitamin preparations]; D03AX04 [Dermatologicals:Preparations For Treatment Of Wounds And Ulcers:Cicatrizants:Other cicatrizants]

>  <INDICATION_CLASS>  (439) 
Vitamin (enzyme co-factor)

>  <SC_PATENT_NO>  (439) 
nan

>  <DRUG_TYPE>  (439) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (439) 
Y

>  <FIRST_IN_CLASS>  (439) 
N

>  <CHIRALITY>  (439) 
Single Stereoisomer

>  <PRODRUG>  (439) 
N

>  <ORAL>  (439) 
N

>  <PARENTERAL>  (439) 
Y

>  <TOPICAL>  (439) 
N

>  <BLACK_BOX>  (439) 
N

>  <AVAILABILITY_TYPE>  (439) 
Discontinued

>  <WITHDRAWN_YEAR>  (439) 
nan

>  <WITHDRAWN_COUNTRY>  (439) 
nan

>  <WITHDRAWN_REASON>  (439) 
nan

>  <CANONICAL_SMILES>  (439) 
CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O

>  <name>  (439) 
Pantothenic acid 

>  <MW>  (439) 
219.237

>  <logP>  (439) 
-1.0433

$$$$
CHEMBL495
     RDKit          

 25 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (440) 
8130

>  <SYNONYMS>  (440) 
Alprostadil (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (440) 
4

>  <RESEARCH_CODES>  (440) 
U-10136

>  <APPLICANTS>  (440) 
Pharmacia And Upjohn Co; Pfizer Inc.; Meda Pharmaceuticals Inc; Actient Pharmaceuticals Llc

>  <USAN_STEM>  (440) 
-dil; -prost-

>  <USAN_STEM_DEFINITION>  (440) 
vasodilators (undefined group); prostaglandins

>  <USAN_STEM_SUBSTEM>  (440) 
-dil; -prost-

>  <USAN_YEAR>  (440) 
1977.0

>  <FIRST_APPROVAL>  (440) 
1981.0

>  <ATC_CODE>  (440) 
G04BE01; C01EA01

>  <ATC_CODE_DESCRIPTION>  (440) 
G04BE01 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]; C01EA01 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Prostaglandins]

>  <INDICATION_CLASS>  (440) 
Vasodilator

>  <SC_PATENT_NO>  (440) 
US-5886039-A

>  <DRUG_TYPE>  (440) 
Natural Product-derived

>  <RULE_OF_FIVE>  (440) 
Y

>  <FIRST_IN_CLASS>  (440) 
N

>  <CHIRALITY>  (440) 
Single Stereoisomer

>  <PRODRUG>  (440) 
N

>  <ORAL>  (440) 
N

>  <PARENTERAL>  (440) 
Y

>  <TOPICAL>  (440) 
Y

>  <BLACK_BOX>  (440) 
Y

>  <AVAILABILITY_TYPE>  (440) 
Prescription-only

>  <WITHDRAWN_YEAR>  (440) 
nan

>  <WITHDRAWN_COUNTRY>  (440) 
nan

>  <WITHDRAWN_REASON>  (440) 
nan

>  <CANONICAL_SMILES>  (440) 
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O

>  <name>  (440) 
Alprostadil 

>  <MW>  (440) 
354.487

>  <logP>  (440) 
3.4751

$$$$
CHEMBL485259
     RDKit          

 11 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
  7  2  1  0
 11  2  1  0
M  END
>  <PARENT_MOLREGNO>  (441) 
484235

>  <SYNONYMS>  (441) 
Eucalyptol (USAN, USP)

>  <DEVELOPMENT_PHASE>  (441) 
4

>  <RESEARCH_CODES>  (441) 
nan

>  <APPLICANTS>  (441) 
nan

>  <USAN_STEM>  (441) 
nan

>  <USAN_STEM_DEFINITION>  (441) 
nan

>  <USAN_STEM_SUBSTEM>  (441) 
nan

>  <USAN_YEAR>  (441) 
1988.0

>  <FIRST_APPROVAL>  (441) 
nan

>  <ATC_CODE>  (441) 
R05CA13

>  <ATC_CODE_DESCRIPTION>  (441) 
R05CA13 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Expectorants]

>  <INDICATION_CLASS>  (441) 
nan

>  <SC_PATENT_NO>  (441) 
nan

>  <DRUG_TYPE>  (441) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (441) 
Y

>  <FIRST_IN_CLASS>  (441) 
N

>  <CHIRALITY>  (441) 
Achiral Molecule

>  <PRODRUG>  (441) 
N

>  <ORAL>  (441) 
N

>  <PARENTERAL>  (441) 
N

>  <TOPICAL>  (441) 
N

>  <BLACK_BOX>  (441) 
N

>  <AVAILABILITY_TYPE>  (441) 
Unknown

>  <WITHDRAWN_YEAR>  (441) 
nan

>  <WITHDRAWN_COUNTRY>  (441) 
nan

>  <WITHDRAWN_REASON>  (441) 
nan

>  <CANONICAL_SMILES>  (441) 
CC12CCC(CC1)C(C)(C)O2

>  <name>  (441) 
Eucalyptol 

>  <MW>  (441) 
154.253

>  <logP>  (441) 
2.7441

$$$$
CHEMBL1201012
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 27  2  1  0
 26  5  1  0
 24  7  1  0
 20  8  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (442) 
674963

>  <SYNONYMS>  (442) 
Fludroxycortide (BAN, DCF, INN, JAN); Flurandrenolide (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (442) 
4

>  <RESEARCH_CODES>  (442) 
33379

>  <APPLICANTS>  (442) 
Watson Pharmaceuticals Inc; Eli Lilly And Co; Aqua Pharmaceuticals

>  <USAN_STEM>  (442) 
-andr-

>  <USAN_STEM_DEFINITION>  (442) 
androgens

>  <USAN_STEM_SUBSTEM>  (442) 
-andr-

>  <USAN_YEAR>  (442) 
1969.0

>  <FIRST_APPROVAL>  (442) 
1965.0

>  <ATC_CODE>  (442) 
D07AC07

>  <ATC_CODE_DESCRIPTION>  (442) 
D07AC07 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]

>  <INDICATION_CLASS>  (442) 
Glucocorticoid

>  <SC_PATENT_NO>  (442) 
nan

>  <DRUG_TYPE>  (442) 
Natural Product-derived

>  <RULE_OF_FIVE>  (442) 
Y

>  <FIRST_IN_CLASS>  (442) 
N

>  <CHIRALITY>  (442) 
Single Stereoisomer

>  <PRODRUG>  (442) 
N

>  <ORAL>  (442) 
N

>  <PARENTERAL>  (442) 
N

>  <TOPICAL>  (442) 
Y

>  <BLACK_BOX>  (442) 
N

>  <AVAILABILITY_TYPE>  (442) 
Prescription-only

>  <WITHDRAWN_YEAR>  (442) 
nan

>  <WITHDRAWN_COUNTRY>  (442) 
nan

>  <WITHDRAWN_REASON>  (442) 
nan

>  <CANONICAL_SMILES>  (442) 
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

>  <name>  (442) 
Fludroxycortide 

>  <MW>  (442) 
436.52

>  <logP>  (442) 
2.4987

$$$$
CHEMBL1356238
     RDKit          

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  2  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (443) 
780122

>  <SYNONYMS>  (443) 
Pyrithione Zinc (BAN, FDA, INN, USAN); Pyrithione Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (443) 
4

>  <RESEARCH_CODES>  (443) 
AL02725

>  <APPLICANTS>  (443) 
Warner Chilcott Co Llc; Olin

>  <USAN_STEM>  (443) 
nan

>  <USAN_STEM_DEFINITION>  (443) 
nan

>  <USAN_STEM_SUBSTEM>  (443) 
nan

>  <USAN_YEAR>  (443) 
1966.0

>  <FIRST_APPROVAL>  (443) 
1986.0

>  <ATC_CODE>  (443) 
D11AX12

>  <ATC_CODE_DESCRIPTION>  (443) 
D11AX12 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (443) 
Antibacterial; Antifungal; Antiseborrheic; Antimicrobial (topical)

>  <SC_PATENT_NO>  (443) 
nan

>  <DRUG_TYPE>  (443) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (443) 
Y

>  <FIRST_IN_CLASS>  (443) 
N

>  <CHIRALITY>  (443) 
Achiral Molecule

>  <PRODRUG>  (443) 
N

>  <ORAL>  (443) 
N

>  <PARENTERAL>  (443) 
N

>  <TOPICAL>  (443) 
Y

>  <BLACK_BOX>  (443) 
N

>  <AVAILABILITY_TYPE>  (443) 
Discontinued

>  <WITHDRAWN_YEAR>  (443) 
nan

>  <WITHDRAWN_COUNTRY>  (443) 
nan

>  <WITHDRAWN_REASON>  (443) 
nan

>  <CANONICAL_SMILES>  (443) 
[O-][n+]1ccccc1S

>  <name>  (443) 
Pyrithione Zinc 

>  <MW>  (443) 
127.168

>  <logP>  (443) 
0.6087

$$$$
CHEMBL1165342
     RDKit          

 26 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 12  3  1  0
 22  3  1  0
 12  7  1  0
 19 10  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (444) 
644928

>  <SYNONYMS>  (444) 
Vincamine (BAN, DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (444) 
4

>  <RESEARCH_CODES>  (444) 
nan

>  <APPLICANTS>  (444) 
nan

>  <USAN_STEM>  (444) 
vin-

>  <USAN_STEM_DEFINITION>  (444) 
vinca alkaloids

>  <USAN_STEM_SUBSTEM>  (444) 
vin-

>  <USAN_YEAR>  (444) 
nan

>  <FIRST_APPROVAL>  (444) 
nan

>  <ATC_CODE>  (444) 
C04AX07

>  <ATC_CODE_DESCRIPTION>  (444) 
C04AX07 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Other peripheral vasodilators]

>  <INDICATION_CLASS>  (444) 
nan

>  <SC_PATENT_NO>  (444) 
nan

>  <DRUG_TYPE>  (444) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (444) 
Y

>  <FIRST_IN_CLASS>  (444) 
N

>  <CHIRALITY>  (444) 
Single Stereoisomer

>  <PRODRUG>  (444) 
N

>  <ORAL>  (444) 
N

>  <PARENTERAL>  (444) 
N

>  <TOPICAL>  (444) 
N

>  <BLACK_BOX>  (444) 
N

>  <AVAILABILITY_TYPE>  (444) 
Withdrawn

>  <WITHDRAWN_YEAR>  (444) 
1987.0

>  <WITHDRAWN_COUNTRY>  (444) 
Germany

>  <WITHDRAWN_REASON>  (444) 
Hematological

>  <CANONICAL_SMILES>  (444) 
CC[C@@]12CCCN3CCc4c([C@H]13)n(c5ccccc45)[C@](O)(C2)C(=O)OC

>  <name>  (444) 
Vincamine 

>  <MW>  (444) 
354.45

>  <logP>  (444) 
2.9525

$$$$
CHEMBL1200623
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20  3  1  0
 20  7  1  0
 17  8  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (445) 
674574

>  <SYNONYMS>  (445) 
Ethylestrenol (BAN, FDA, INN, USAN); Ethylnandrol (JAN)

>  <DEVELOPMENT_PHASE>  (445) 
4

>  <RESEARCH_CODES>  (445) 
nan

>  <APPLICANTS>  (445) 
Organon Usa Inc

>  <USAN_STEM>  (445) 
nan

>  <USAN_STEM_DEFINITION>  (445) 
nan

>  <USAN_STEM_SUBSTEM>  (445) 
nan

>  <USAN_YEAR>  (445) 
1962.0

>  <FIRST_APPROVAL>  (445) 
1964.0

>  <ATC_CODE>  (445) 
A14AB02

>  <ATC_CODE_DESCRIPTION>  (445) 
A14AB02 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Estren derivatives]

>  <INDICATION_CLASS>  (445) 
Anabolic

>  <SC_PATENT_NO>  (445) 
nan

>  <DRUG_TYPE>  (445) 
Natural Product-derived

>  <RULE_OF_FIVE>  (445) 
Y

>  <FIRST_IN_CLASS>  (445) 
N

>  <CHIRALITY>  (445) 
Single Stereoisomer

>  <PRODRUG>  (445) 
N

>  <ORAL>  (445) 
Y

>  <PARENTERAL>  (445) 
N

>  <TOPICAL>  (445) 
N

>  <BLACK_BOX>  (445) 
N

>  <AVAILABILITY_TYPE>  (445) 
Discontinued

>  <WITHDRAWN_YEAR>  (445) 
nan

>  <WITHDRAWN_COUNTRY>  (445) 
nan

>  <WITHDRAWN_REASON>  (445) 
nan

>  <CANONICAL_SMILES>  (445) 
CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C

>  <name>  (445) 
Ethylestrenol 

>  <MW>  (445) 
288.475

>  <logP>  (445) 
5.0903

$$$$
CHEMBL1614644
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  8  1  0
 14  9  1  0
 22 17  1  0
M  CHG  2   2   1   4  -1
M  END
>  <PARENT_MOLREGNO>  (446) 
1037650

>  <SYNONYMS>  (446) 
Imipraminoxide (INN)

>  <DEVELOPMENT_PHASE>  (446) 
4

>  <RESEARCH_CODES>  (446) 
nan

>  <APPLICANTS>  (446) 
nan

>  <USAN_STEM>  (446) 
nan

>  <USAN_STEM_DEFINITION>  (446) 
nan

>  <USAN_STEM_SUBSTEM>  (446) 
nan

>  <USAN_YEAR>  (446) 
nan

>  <FIRST_APPROVAL>  (446) 
nan

>  <ATC_CODE>  (446) 
N06AA03

>  <ATC_CODE_DESCRIPTION>  (446) 
N06AA03 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (446) 
nan

>  <SC_PATENT_NO>  (446) 
nan

>  <DRUG_TYPE>  (446) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (446) 
Y

>  <FIRST_IN_CLASS>  (446) 
N

>  <CHIRALITY>  (446) 
Achiral Molecule

>  <PRODRUG>  (446) 
N

>  <ORAL>  (446) 
N

>  <PARENTERAL>  (446) 
N

>  <TOPICAL>  (446) 
N

>  <BLACK_BOX>  (446) 
N

>  <AVAILABILITY_TYPE>  (446) 
Unknown

>  <WITHDRAWN_YEAR>  (446) 
nan

>  <WITHDRAWN_COUNTRY>  (446) 
nan

>  <WITHDRAWN_REASON>  (446) 
nan

>  <CANONICAL_SMILES>  (446) 
C[N+](C)([O-])CCCN1c2ccccc2CCc3ccccc13

>  <name>  (446) 
Imipraminoxide 

>  <MW>  (446) 
296.414

>  <logP>  (446) 
3.8876

$$$$
CHEMBL1159650
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
  6 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 27  6  1  0
 27 10  1  0
 22 11  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (447) 
641189

>  <SYNONYMS>  (447) 
Clobetasol (BAN, INN); Clobetasol Propionate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (447) 
4

>  <RESEARCH_CODES>  (447) 
CCI-4725; GR 2/925

>  <APPLICANTS>  (447) 
Galderma Laboratories Lp; Galderma Laboratories L P; Galderma Laboratories Inc; Fougera Pharmaceuticals Inc; Stiefel Laboratories Inc

>  <USAN_STEM>  (447) 
nan

>  <USAN_STEM_DEFINITION>  (447) 
nan

>  <USAN_STEM_SUBSTEM>  (447) 
nan

>  <USAN_YEAR>  (447) 
1983.0

>  <FIRST_APPROVAL>  (447) 
1985.0

>  <ATC_CODE>  (447) 
D07AD01

>  <ATC_CODE_DESCRIPTION>  (447) 
D07AD01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, very potent (group IV)]

>  <INDICATION_CLASS>  (447) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (447) 
US-5972920-A

>  <DRUG_TYPE>  (447) 
Natural Product-derived

>  <RULE_OF_FIVE>  (447) 
Y

>  <FIRST_IN_CLASS>  (447) 
N

>  <CHIRALITY>  (447) 
Single Stereoisomer

>  <PRODRUG>  (447) 
N

>  <ORAL>  (447) 
N

>  <PARENTERAL>  (447) 
N

>  <TOPICAL>  (447) 
Y

>  <BLACK_BOX>  (447) 
Y

>  <AVAILABILITY_TYPE>  (447) 
Prescription-only

>  <WITHDRAWN_YEAR>  (447) 
nan

>  <WITHDRAWN_COUNTRY>  (447) 
nan

>  <WITHDRAWN_REASON>  (447) 
nan

>  <CANONICAL_SMILES>  (447) 
CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl

>  <name>  (447) 
Clobetasol 

>  <MW>  (447) 
466.977

>  <logP>  (447) 
4.1031

$$$$
CHEMBL1324
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
  7  2  1  0
 17 10  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (448) 
267825

>  <SYNONYMS>  (448) 
Tolcapone (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (448) 
4

>  <RESEARCH_CODES>  (448) 
Ro-407592; Ro-40-7592

>  <APPLICANTS>  (448) 
Valeant Pharmaceuticals North America Llc

>  <USAN_STEM>  (448) 
nan

>  <USAN_STEM_DEFINITION>  (448) 
nan

>  <USAN_STEM_SUBSTEM>  (448) 
nan

>  <USAN_YEAR>  (448) 
1993.0

>  <FIRST_APPROVAL>  (448) 
1998.0

>  <ATC_CODE>  (448) 
N04BX01

>  <ATC_CODE_DESCRIPTION>  (448) 
N04BX01 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Other dopaminergic agents]

>  <INDICATION_CLASS>  (448) 
Antiparkinsonian

>  <SC_PATENT_NO>  (448) 
nan

>  <DRUG_TYPE>  (448) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (448) 
Y

>  <FIRST_IN_CLASS>  (448) 
N

>  <CHIRALITY>  (448) 
Achiral Molecule

>  <PRODRUG>  (448) 
N

>  <ORAL>  (448) 
Y

>  <PARENTERAL>  (448) 
N

>  <TOPICAL>  (448) 
N

>  <BLACK_BOX>  (448) 
Y

>  <AVAILABILITY_TYPE>  (448) 
Prescription-only

>  <WITHDRAWN_YEAR>  (448) 
1998.0

>  <WITHDRAWN_COUNTRY>  (448) 
European Union; Canada; Ireland; Portugal; Australia

>  <WITHDRAWN_REASON>  (448) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (448) 
Cc1ccc(cc1)C(=O)c2cc(O)c(O)c(c2)[N+](=O)[O-]

>  <name>  (448) 
Tolcapone 

>  <MW>  (448) 
273.244

>  <logP>  (448) 
2.54542

$$$$
CHEMBL220492
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
  8 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22  2  1  0
 21  5  1  0
 20  8  1  0
M  END
>  <PARENT_MOLREGNO>  (449) 
366279

>  <SYNONYMS>  (449) 
Topiramate (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (449) 
4

>  <RESEARCH_CODES>  (449) 
MCN-4853; RWJ-17021

>  <APPLICANTS>  (449) 
Vivus Inc; Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (449) 
nan

>  <USAN_STEM_DEFINITION>  (449) 
nan

>  <USAN_STEM_SUBSTEM>  (449) 
nan

>  <USAN_YEAR>  (449) 
1987.0

>  <FIRST_APPROVAL>  (449) 
1996.0

>  <ATC_CODE>  (449) 
N03AX11

>  <ATC_CODE_DESCRIPTION>  (449) 
N03AX11 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (449) 
Anticonvulsant

>  <SC_PATENT_NO>  (449) 
US-5998380-A

>  <DRUG_TYPE>  (449) 
Natural Product-derived

>  <RULE_OF_FIVE>  (449) 
Y

>  <FIRST_IN_CLASS>  (449) 
N

>  <CHIRALITY>  (449) 
Single Stereoisomer

>  <PRODRUG>  (449) 
N

>  <ORAL>  (449) 
Y

>  <PARENTERAL>  (449) 
N

>  <TOPICAL>  (449) 
N

>  <BLACK_BOX>  (449) 
Y

>  <AVAILABILITY_TYPE>  (449) 
Prescription-only

>  <WITHDRAWN_YEAR>  (449) 
nan

>  <WITHDRAWN_COUNTRY>  (449) 
nan

>  <WITHDRAWN_REASON>  (449) 
nan

>  <CANONICAL_SMILES>  (449) 
CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1

>  <name>  (449) 
Topiramate 

>  <MW>  (449) 
339.366

>  <logP>  (449) 
-0.3954

$$$$
CHEMBL803
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
  8  2  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (450) 
51182

>  <SYNONYMS>  (450) 
Cytarabine (BAN, FDA, INN, JAN, USAN, USP); Cytarabine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (450) 
4

>  <RESEARCH_CODES>  (450) 
U-19920; U-19920A

>  <APPLICANTS>  (450) 
Teva Parenteral Medicines Inc; Pacira Pharmaceuticals Inc

>  <USAN_STEM>  (450) 
-arabine

>  <USAN_STEM_DEFINITION>  (450) 
antineoplastics (arabinofuranosyl derivatives)

>  <USAN_STEM_SUBSTEM>  (450) 
-arabine

>  <USAN_YEAR>  (450) 
1964.0

>  <FIRST_APPROVAL>  (450) 
1969.0

>  <ATC_CODE>  (450) 
L01BC01

>  <ATC_CODE_DESCRIPTION>  (450) 
L01BC01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (450) 
Antineoplastic; Antiviral

>  <SC_PATENT_NO>  (450) 
nan

>  <DRUG_TYPE>  (450) 
Natural Product-derived

>  <RULE_OF_FIVE>  (450) 
Y

>  <FIRST_IN_CLASS>  (450) 
N

>  <CHIRALITY>  (450) 
Single Stereoisomer

>  <PRODRUG>  (450) 
N

>  <ORAL>  (450) 
N

>  <PARENTERAL>  (450) 
Y

>  <TOPICAL>  (450) 
N

>  <BLACK_BOX>  (450) 
Y

>  <AVAILABILITY_TYPE>  (450) 
Prescription-only

>  <WITHDRAWN_YEAR>  (450) 
nan

>  <WITHDRAWN_COUNTRY>  (450) 
nan

>  <WITHDRAWN_REASON>  (450) 
nan

>  <CANONICAL_SMILES>  (450) 
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O

>  <name>  (450) 
Cytarabine 

>  <MW>  (450) 
243.219

>  <logP>  (450) 
-2.563

$$$$
CHEMBL766
     RDKit          

 24 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 19 21  1  0
  9 22  1  0
 22 23  2  0
 22 24  1  0
  5  2  1  0
M  END
>  <PARENT_MOLREGNO>  (451) 
43261

>  <SYNONYMS>  (451) 
Cilastatin (BAN, INN); Cilastatin Sodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (451) 
4

>  <RESEARCH_CODES>  (451) 
MK-791

>  <APPLICANTS>  (451) 
Merck And Co Inc

>  <USAN_STEM>  (451) 
-stat-

>  <USAN_STEM_DEFINITION>  (451) 
enzyme inhibitors

>  <USAN_STEM_SUBSTEM>  (451) 
-stat-

>  <USAN_YEAR>  (451) 
1984.0

>  <FIRST_APPROVAL>  (451) 
1985.0

>  <ATC_CODE>  (451) 
nan

>  <ATC_CODE_DESCRIPTION>  (451) 
nan

>  <INDICATION_CLASS>  (451) 
Enzyme Inhibitor

>  <SC_PATENT_NO>  (451) 
nan

>  <DRUG_TYPE>  (451) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (451) 
Y

>  <FIRST_IN_CLASS>  (451) 
N

>  <CHIRALITY>  (451) 
Single Stereoisomer

>  <PRODRUG>  (451) 
N

>  <ORAL>  (451) 
N

>  <PARENTERAL>  (451) 
Y

>  <TOPICAL>  (451) 
N

>  <BLACK_BOX>  (451) 
N

>  <AVAILABILITY_TYPE>  (451) 
Prescription-only

>  <WITHDRAWN_YEAR>  (451) 
nan

>  <WITHDRAWN_COUNTRY>  (451) 
nan

>  <WITHDRAWN_REASON>  (451) 
nan

>  <CANONICAL_SMILES>  (451) 
CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(=O)O)\C(=O)O

>  <name>  (451) 
Cilastatin 

>  <MW>  (451) 
358.46

>  <logP>  (451) 
1.4326

$$$$
CHEMBL1201216
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 11 23  1  0
 23 24  1  0
  7  2  1  0
 24  8  1  0
 22 14  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (452) 
675167

>  <SYNONYMS>  (452) 
Dapiprazole (INN); Dapiprazole HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (452) 
4

>  <RESEARCH_CODES>  (452) 
AF-2139

>  <APPLICANTS>  (452) 
Fera Pharmaceuticals Llc

>  <USAN_STEM>  (452) 
-prazole

>  <USAN_STEM_DEFINITION>  (452) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (452) 
-prazole

>  <USAN_YEAR>  (452) 
1989.0

>  <FIRST_APPROVAL>  (452) 
1990.0

>  <ATC_CODE>  (452) 
S01EX02

>  <ATC_CODE_DESCRIPTION>  (452) 
S01EX02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Other antiglaucoma preparations]

>  <INDICATION_CLASS>  (452) 
Adrenergic (alpha-blocking); Antiglaucoma Agent; Neuroleptic; Psychotropic

>  <SC_PATENT_NO>  (452) 
nan

>  <DRUG_TYPE>  (452) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (452) 
Y

>  <FIRST_IN_CLASS>  (452) 
N

>  <CHIRALITY>  (452) 
Achiral Molecule

>  <PRODRUG>  (452) 
N

>  <ORAL>  (452) 
N

>  <PARENTERAL>  (452) 
N

>  <TOPICAL>  (452) 
Y

>  <BLACK_BOX>  (452) 
N

>  <AVAILABILITY_TYPE>  (452) 
Discontinued

>  <WITHDRAWN_YEAR>  (452) 
nan

>  <WITHDRAWN_COUNTRY>  (452) 
nan

>  <WITHDRAWN_REASON>  (452) 
nan

>  <CANONICAL_SMILES>  (452) 
Cc1ccccc1N2CCN(CCc3nnc4CCCCn34)CC2

>  <name>  (452) 
Dapiprazole 

>  <MW>  (452) 
325.46

>  <logP>  (452) 
2.28752

$$$$
CHEMBL2
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 13  3  1  0
 11  5  1  0
 21 16  1  0
 28 24  2  0
M  END
>  <PARENT_MOLREGNO>  (453) 
97

>  <SYNONYMS>  (453) 
Prazosin (BAN, INN); Prazosin HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (453) 
4

>  <RESEARCH_CODES>  (453) 
CP-12299; CP-122991; CP-12299-1

>  <APPLICANTS>  (453) 
Pfizer Laboratories Div Pfizer Inc; Pfizer Inc.

>  <USAN_STEM>  (453) 
-azosin

>  <USAN_STEM_DEFINITION>  (453) 
antihypertensives (prazosin type)

>  <USAN_STEM_SUBSTEM>  (453) 
-azosin

>  <USAN_YEAR>  (453) 
1968.0

>  <FIRST_APPROVAL>  (453) 
1976.0

>  <ATC_CODE>  (453) 
C02CA01

>  <ATC_CODE_DESCRIPTION>  (453) 
C02CA01 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Peripherally Acting:Alpha-adrenoreceptor antagonists]

>  <INDICATION_CLASS>  (453) 
Antihypertensive

>  <SC_PATENT_NO>  (453) 
nan

>  <DRUG_TYPE>  (453) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (453) 
Y

>  <FIRST_IN_CLASS>  (453) 
N

>  <CHIRALITY>  (453) 
Achiral Molecule

>  <PRODRUG>  (453) 
N

>  <ORAL>  (453) 
Y

>  <PARENTERAL>  (453) 
N

>  <TOPICAL>  (453) 
N

>  <BLACK_BOX>  (453) 
N

>  <AVAILABILITY_TYPE>  (453) 
Prescription-only

>  <WITHDRAWN_YEAR>  (453) 
nan

>  <WITHDRAWN_COUNTRY>  (453) 
nan

>  <WITHDRAWN_REASON>  (453) 
nan

>  <CANONICAL_SMILES>  (453) 
COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4

>  <name>  (453) 
Prazosin 

>  <MW>  (453) 
383.408

>  <logP>  (453) 
1.7846

$$$$
CHEMBL1495
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 12 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
  7  2  1  0
 19 14  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (454) 
418489

>  <SYNONYMS>  (454) 
Oxyphencyclimine (BAN, INN); Oxyphencyclimine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (454) 
4

>  <RESEARCH_CODES>  (454) 
nan

>  <APPLICANTS>  (454) 
Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (454) 
nan

>  <USAN_STEM_DEFINITION>  (454) 
nan

>  <USAN_STEM_SUBSTEM>  (454) 
nan

>  <USAN_YEAR>  (454) 
nan

>  <FIRST_APPROVAL>  (454) 
1982.0

>  <ATC_CODE>  (454) 
A03AA01

>  <ATC_CODE_DESCRIPTION>  (454) 
A03AA01 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, esters with tertiary amino group]

>  <INDICATION_CLASS>  (454) 
nan

>  <SC_PATENT_NO>  (454) 
nan

>  <DRUG_TYPE>  (454) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (454) 
Y

>  <FIRST_IN_CLASS>  (454) 
N

>  <CHIRALITY>  (454) 
Racemic Mixture

>  <PRODRUG>  (454) 
N

>  <ORAL>  (454) 
Y

>  <PARENTERAL>  (454) 
N

>  <TOPICAL>  (454) 
N

>  <BLACK_BOX>  (454) 
N

>  <AVAILABILITY_TYPE>  (454) 
Discontinued

>  <WITHDRAWN_YEAR>  (454) 
nan

>  <WITHDRAWN_COUNTRY>  (454) 
nan

>  <WITHDRAWN_REASON>  (454) 
nan

>  <CANONICAL_SMILES>  (454) 
CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3

>  <name>  (454) 
Oxyphencyclimine 

>  <MW>  (454) 
344.455

>  <logP>  (454) 
2.7317

$$$$
CHEMBL1079
     RDKit          

 16 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 10  2  2  0
  9  5  1  0
 16 12  1  0
M  END
>  <PARENT_MOLREGNO>  (455) 
140117

>  <SYNONYMS>  (455) 
Tizanidine (BAN, INN); Tizanidine HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (455) 
4

>  <RESEARCH_CODES>  (455) 
AN-021; DS-103-282

>  <APPLICANTS>  (455) 
Acorda Therapeutics Inc

>  <USAN_STEM>  (455) 
nan

>  <USAN_STEM_DEFINITION>  (455) 
nan

>  <USAN_STEM_SUBSTEM>  (455) 
nan

>  <USAN_YEAR>  (455) 
1993.0

>  <FIRST_APPROVAL>  (455) 
1996.0

>  <ATC_CODE>  (455) 
M03BX02

>  <ATC_CODE_DESCRIPTION>  (455) 
M03BX02 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Other centrally acting agents]

>  <INDICATION_CLASS>  (455) 
Antispasmodic

>  <SC_PATENT_NO>  (455) 
nan

>  <DRUG_TYPE>  (455) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (455) 
Y

>  <FIRST_IN_CLASS>  (455) 
N

>  <CHIRALITY>  (455) 
Achiral Molecule

>  <PRODRUG>  (455) 
N

>  <ORAL>  (455) 
Y

>  <PARENTERAL>  (455) 
N

>  <TOPICAL>  (455) 
N

>  <BLACK_BOX>  (455) 
N

>  <AVAILABILITY_TYPE>  (455) 
Prescription-only

>  <WITHDRAWN_YEAR>  (455) 
nan

>  <WITHDRAWN_COUNTRY>  (455) 
nan

>  <WITHDRAWN_REASON>  (455) 
nan

>  <CANONICAL_SMILES>  (455) 
Clc1ccc2nsnc2c1NC3=NCCN3

>  <name>  (455) 
Tizanidine 

>  <MW>  (455) 
253.718

>  <logP>  (455) 
1.7158

$$$$
CHEMBL765
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  7  1  0
M  END
>  <PARENT_MOLREGNO>  (456) 
43086

>  <SYNONYMS>  (456) 
Guanethidine (BAN, INN); Guanethidine monosulfate (FDA, USAN, USP); Guanethidine Sulfate (JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (456) 
4

>  <RESEARCH_CODES>  (456) 
SU-5864

>  <APPLICANTS>  (456) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (456) 
guan-

>  <USAN_STEM_DEFINITION>  (456) 
antihypertensives (guanidine derivatives)

>  <USAN_STEM_SUBSTEM>  (456) 
guan-

>  <USAN_YEAR>  (456) 
1963.0

>  <FIRST_APPROVAL>  (456) 
1960.0

>  <ATC_CODE>  (456) 
C02CC02; S01EX01

>  <ATC_CODE_DESCRIPTION>  (456) 
C02CC02 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Peripherally Acting:Guanidine derivatives]; S01EX01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Other antiglaucoma preparations]

>  <INDICATION_CLASS>  (456) 
Antihypertensive

>  <SC_PATENT_NO>  (456) 
nan

>  <DRUG_TYPE>  (456) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (456) 
Y

>  <FIRST_IN_CLASS>  (456) 
N

>  <CHIRALITY>  (456) 
Achiral Molecule

>  <PRODRUG>  (456) 
N

>  <ORAL>  (456) 
Y

>  <PARENTERAL>  (456) 
N

>  <TOPICAL>  (456) 
N

>  <BLACK_BOX>  (456) 
N

>  <AVAILABILITY_TYPE>  (456) 
Discontinued

>  <WITHDRAWN_YEAR>  (456) 
nan

>  <WITHDRAWN_COUNTRY>  (456) 
nan

>  <WITHDRAWN_REASON>  (456) 
nan

>  <CANONICAL_SMILES>  (456) 
NC(=N)NCCN1CCCCCCC1

>  <name>  (456) 
Guanethidine 

>  <MW>  (456) 
198.314

>  <logP>  (456) 
0.73557

$$$$
CHEMBL446
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  7 19  2  0
 19  2  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (457) 
2265

>  <SYNONYMS>  (457) 
Sulfadimidine (BAN, INN); Sulfamethazine (USP); Sulfamethazine (Trisulfapyrimidines) (FDA)

>  <DEVELOPMENT_PHASE>  (457) 
4

>  <RESEARCH_CODES>  (457) 
nan

>  <APPLICANTS>  (457) 
Lederle Laboratories Div American Cyanamid Co; Eli Lilly And Co; Bristol Myers Squibb Co

>  <USAN_STEM>  (457) 
sulfa-

>  <USAN_STEM_DEFINITION>  (457) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (457) 
sulfa-

>  <USAN_YEAR>  (457) 
nan

>  <FIRST_APPROVAL>  (457) 
1949.0

>  <ATC_CODE>  (457) 
J01EB03

>  <ATC_CODE_DESCRIPTION>  (457) 
J01EB03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]

>  <INDICATION_CLASS>  (457) 
Antibacterial

>  <SC_PATENT_NO>  (457) 
nan

>  <DRUG_TYPE>  (457) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (457) 
Y

>  <FIRST_IN_CLASS>  (457) 
N

>  <CHIRALITY>  (457) 
Achiral Molecule

>  <PRODRUG>  (457) 
N

>  <ORAL>  (457) 
Y

>  <PARENTERAL>  (457) 
N

>  <TOPICAL>  (457) 
N

>  <BLACK_BOX>  (457) 
N

>  <AVAILABILITY_TYPE>  (457) 
Discontinued

>  <WITHDRAWN_YEAR>  (457) 
nan

>  <WITHDRAWN_COUNTRY>  (457) 
nan

>  <WITHDRAWN_REASON>  (457) 
nan

>  <CANONICAL_SMILES>  (457) 
Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1

>  <name>  (457) 
Sulfadimidine 

>  <MW>  (457) 
278.337

>  <logP>  (457) 
1.47644

$$$$
CHEMBL6
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
  9 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
  8  3  1  0
 16  6  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (458) 
173

>  <SYNONYMS>  (458) 
Indometacin (BAN, DCF, INN, JAN); Indometacin Farnesil (JAN); Indomethacin (FDA, USAN, USP); Indomethacin Sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (458) 
4

>  <RESEARCH_CODES>  (458) 
nan

>  <APPLICANTS>  (458) 
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa; Iroko Pharmaceuticals Llc; Heritage Pharmaceuticals Inc; Fresenius Kabi Usa Llc; Mylan Pharmaceuticals Inc

>  <USAN_STEM>  (458) 
nan

>  <USAN_STEM_DEFINITION>  (458) 
nan

>  <USAN_STEM_SUBSTEM>  (458) 
nan

>  <USAN_YEAR>  (458) 
1963.0

>  <FIRST_APPROVAL>  (458) 
1965.0

>  <ATC_CODE>  (458) 
M01AB51; M02AA23; M01AB01; S01BC01; C01EB03

>  <ATC_CODE_DESCRIPTION>  (458) 
M01AB51 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]; M02AA23 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; M01AB01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]; S01BC01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]; C01EB03 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (458) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (458) 
US-8734847-B2

>  <DRUG_TYPE>  (458) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (458) 
Y

>  <FIRST_IN_CLASS>  (458) 
N

>  <CHIRALITY>  (458) 
Achiral Molecule

>  <PRODRUG>  (458) 
N

>  <ORAL>  (458) 
Y

>  <PARENTERAL>  (458) 
Y

>  <TOPICAL>  (458) 
Y

>  <BLACK_BOX>  (458) 
Y

>  <AVAILABILITY_TYPE>  (458) 
Prescription-only

>  <WITHDRAWN_YEAR>  (458) 
nan

>  <WITHDRAWN_COUNTRY>  (458) 
nan

>  <WITHDRAWN_REASON>  (458) 
nan

>  <CANONICAL_SMILES>  (458) 
COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3

>  <name>  (458) 
Indometacin 

>  <MW>  (458) 
357.793

>  <logP>  (458) 
3.92732

$$$$
CHEMBL53
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 11  2  1  0
 10  5  1  0
 20  9  1  0
 20 13  1  0
M  END
>  <PARENT_MOLREGNO>  (459) 
3854

>  <SYNONYMS>  (459) 
Apomorphine (BAN); Apomorphine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (459) 
4

>  <RESEARCH_CODES>  (459) 
nan

>  <APPLICANTS>  (459) 
Us Worldmeds Llc

>  <USAN_STEM>  (459) 
nan

>  <USAN_STEM_DEFINITION>  (459) 
nan

>  <USAN_STEM_SUBSTEM>  (459) 
nan

>  <USAN_YEAR>  (459) 
nan

>  <FIRST_APPROVAL>  (459) 
2004.0

>  <ATC_CODE>  (459) 
G04BE07; N04BC07

>  <ATC_CODE_DESCRIPTION>  (459) 
G04BE07 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]; N04BC07 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopamine agonists]

>  <INDICATION_CLASS>  (459) 
Emetic

>  <SC_PATENT_NO>  (459) 
nan

>  <DRUG_TYPE>  (459) 
Natural Product-derived

>  <RULE_OF_FIVE>  (459) 
Y

>  <FIRST_IN_CLASS>  (459) 
N

>  <CHIRALITY>  (459) 
Single Stereoisomer

>  <PRODRUG>  (459) 
N

>  <ORAL>  (459) 
N

>  <PARENTERAL>  (459) 
Y

>  <TOPICAL>  (459) 
N

>  <BLACK_BOX>  (459) 
N

>  <AVAILABILITY_TYPE>  (459) 
Prescription-only

>  <WITHDRAWN_YEAR>  (459) 
nan

>  <WITHDRAWN_COUNTRY>  (459) 
nan

>  <WITHDRAWN_REASON>  (459) 
nan

>  <CANONICAL_SMILES>  (459) 
CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34

>  <name>  (459) 
Apomorphine 

>  <MW>  (459) 
267.328

>  <logP>  (459) 
2.8499

$$$$
CHEMBL502
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 12 20  1  0
 20 21  1  0
  7 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 26  3  1  0
 24  5  2  0
 21  9  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (460) 
9372

>  <SYNONYMS>  (460) 
Donepezil (BAN, INN); Donepezil HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (460) 
4

>  <RESEARCH_CODES>  (460) 
E-2020; BNAG; E2020

>  <APPLICANTS>  (460) 
Eisai Inc

>  <USAN_STEM>  (460) 
-pezil

>  <USAN_STEM_DEFINITION>  (460) 
acetylcholinesterase inhibitors used in the treatment of Alzheimers disease

>  <USAN_STEM_SUBSTEM>  (460) 
-pezil

>  <USAN_YEAR>  (460) 
1997.0

>  <FIRST_APPROVAL>  (460) 
1996.0

>  <ATC_CODE>  (460) 
N06DA02

>  <ATC_CODE_DESCRIPTION>  (460) 
N06DA02 [Nervous System:Psychoanaleptics:Anti-Dementia Drugs:Anticholinesterases]

>  <INDICATION_CLASS>  (460) 
Alzheimer's Disease Treatment (adjunct); Cognition Adjuvant; Dementia Symptoms Treatment Adjunct; Inhibitor (acetylcholinesterase)

>  <SC_PATENT_NO>  (460) 
US-8039009-B2

>  <DRUG_TYPE>  (460) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (460) 
Y

>  <FIRST_IN_CLASS>  (460) 
N

>  <CHIRALITY>  (460) 
Racemic Mixture

>  <PRODRUG>  (460) 
N

>  <ORAL>  (460) 
Y

>  <PARENTERAL>  (460) 
N

>  <TOPICAL>  (460) 
N

>  <BLACK_BOX>  (460) 
N

>  <AVAILABILITY_TYPE>  (460) 
Prescription-only

>  <WITHDRAWN_YEAR>  (460) 
nan

>  <WITHDRAWN_COUNTRY>  (460) 
nan

>  <WITHDRAWN_REASON>  (460) 
nan

>  <CANONICAL_SMILES>  (460) 
COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC

>  <name>  (460) 
Donepezil 

>  <MW>  (460) 
379.5

>  <logP>  (460) 
4.3611

$$$$
CHEMBL1460
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
  7  3  1  0
 17  8  1  0
 17 11  2  0
M  END
>  <PARENT_MOLREGNO>  (461) 
390877

>  <SYNONYMS>  (461) 
Didanosine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (461) 
4

>  <RESEARCH_CODES>  (461) 
BMY-40900

>  <APPLICANTS>  (461) 
Bristol Myers Squibb Co Pharmaceutical Research Institute; Bristol Myers Squibb Co

>  <USAN_STEM>  (461) 
nan

>  <USAN_STEM_DEFINITION>  (461) 
nan

>  <USAN_STEM_SUBSTEM>  (461) 
nan

>  <USAN_YEAR>  (461) 
1990.0

>  <FIRST_APPROVAL>  (461) 
1991.0

>  <ATC_CODE>  (461) 
J05AF02

>  <ATC_CODE_DESCRIPTION>  (461) 
J05AF02 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (461) 
Antiviral

>  <SC_PATENT_NO>  (461) 
nan

>  <DRUG_TYPE>  (461) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (461) 
Y

>  <FIRST_IN_CLASS>  (461) 
N

>  <CHIRALITY>  (461) 
Single Stereoisomer

>  <PRODRUG>  (461) 
N

>  <ORAL>  (461) 
Y

>  <PARENTERAL>  (461) 
N

>  <TOPICAL>  (461) 
N

>  <BLACK_BOX>  (461) 
Y

>  <AVAILABILITY_TYPE>  (461) 
Prescription-only

>  <WITHDRAWN_YEAR>  (461) 
nan

>  <WITHDRAWN_COUNTRY>  (461) 
nan

>  <WITHDRAWN_REASON>  (461) 
nan

>  <CANONICAL_SMILES>  (461) 
OC[C@@H]1CC[C@@H](O1)n2cnc3C(=O)NC=Nc23

>  <name>  (461) 
Didanosine 

>  <MW>  (461) 
236.231

>  <logP>  (461) 
-0.2105

$$$$
CHEMBL1098319
     RDKit          

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
M  END
>  <PARENT_MOLREGNO>  (462) 
624467

>  <SYNONYMS>  (462) 
Mesna (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (462) 
4

>  <RESEARCH_CODES>  (462) 
D-7093

>  <APPLICANTS>  (462) 
Baxter Healthcare Corp

>  <USAN_STEM>  (462) 
nan

>  <USAN_STEM_DEFINITION>  (462) 
nan

>  <USAN_STEM_SUBSTEM>  (462) 
nan

>  <USAN_YEAR>  (462) 
1990.0

>  <FIRST_APPROVAL>  (462) 
1988.0

>  <ATC_CODE>  (462) 
R05CB05; V03AF01

>  <ATC_CODE_DESCRIPTION>  (462) 
R05CB05 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Mucolytics]; V03AF01 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Detoxifying agents for antineoplastic treatment]

>  <INDICATION_CLASS>  (462) 
Detoxifying Agent

>  <SC_PATENT_NO>  (462) 
nan

>  <DRUG_TYPE>  (462) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (462) 
Y

>  <FIRST_IN_CLASS>  (462) 
N

>  <CHIRALITY>  (462) 
Achiral Molecule

>  <PRODRUG>  (462) 
N

>  <ORAL>  (462) 
Y

>  <PARENTERAL>  (462) 
Y

>  <TOPICAL>  (462) 
N

>  <BLACK_BOX>  (462) 
Y

>  <AVAILABILITY_TYPE>  (462) 
Prescription-only

>  <WITHDRAWN_YEAR>  (462) 
nan

>  <WITHDRAWN_COUNTRY>  (462) 
nan

>  <WITHDRAWN_REASON>  (462) 
nan

>  <CANONICAL_SMILES>  (462) 
OS(=O)(=O)CCS

>  <name>  (462) 
Mesna 

>  <MW>  (462) 
142.201

>  <logP>  (462) 
-0.196

$$$$
CHEMBL61
     RDKit          

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 15 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 10  3  1  0
 30 13  1  0
 18 14  1  0
 30 22  1  0
 28 24  2  0
M  END
>  <PARENT_MOLREGNO>  (463) 
4775

>  <SYNONYMS>  (463) 
Podofilox (FDA, USAN); Podophyllotoxin (BAN)

>  <DEVELOPMENT_PHASE>  (463) 
4

>  <RESEARCH_CODES>  (463) 
nan

>  <APPLICANTS>  (463) 
Watson Pharmaceuticals Inc

>  <USAN_STEM>  (463) 
nan

>  <USAN_STEM_DEFINITION>  (463) 
nan

>  <USAN_STEM_SUBSTEM>  (463) 
nan

>  <USAN_YEAR>  (463) 
1989.0

>  <FIRST_APPROVAL>  (463) 
1990.0

>  <ATC_CODE>  (463) 
D06BB04

>  <ATC_CODE_DESCRIPTION>  (463) 
D06BB04 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]

>  <INDICATION_CLASS>  (463) 
Antimitotic

>  <SC_PATENT_NO>  (463) 
nan

>  <DRUG_TYPE>  (463) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (463) 
Y

>  <FIRST_IN_CLASS>  (463) 
N

>  <CHIRALITY>  (463) 
Single Stereoisomer

>  <PRODRUG>  (463) 
N

>  <ORAL>  (463) 
N

>  <PARENTERAL>  (463) 
N

>  <TOPICAL>  (463) 
Y

>  <BLACK_BOX>  (463) 
N

>  <AVAILABILITY_TYPE>  (463) 
Prescription-only

>  <WITHDRAWN_YEAR>  (463) 
nan

>  <WITHDRAWN_COUNTRY>  (463) 
nan

>  <WITHDRAWN_REASON>  (463) 
nan

>  <CANONICAL_SMILES>  (463) 
COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24

>  <name>  (463) 
Podofilox 

>  <MW>  (463) 
414.41

>  <logP>  (463) 
2.4092

$$$$
CHEMBL1200666
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 14 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
  9  7  1  0
 29 10  1  0
 29 13  1  0
 17 24  1  0
M  END
>  <PARENT_MOLREGNO>  (464) 
674617

>  <SYNONYMS>  (464) 
Calcipotriene (FDA, USAN); Calcipotriene Hydrate (FDA); Calcipotriol (BAN, INN)

>  <DEVELOPMENT_PHASE>  (464) 
4

>  <RESEARCH_CODES>  (464) 
MC-903

>  <APPLICANTS>  (464) 
Stiefel Laboratories Inc; Leo Pharmaceutical Products Ltd; Leo Pharma As

>  <USAN_STEM>  (464) 
calci-

>  <USAN_STEM_DEFINITION>  (464) 
vitamin D analogues

>  <USAN_STEM_SUBSTEM>  (464) 
calci-

>  <USAN_YEAR>  (464) 
1992.0

>  <FIRST_APPROVAL>  (464) 
1993.0

>  <ATC_CODE>  (464) 
D05AX02; D05AX52

>  <ATC_CODE_DESCRIPTION>  (464) 
D05AX02 [Dermatologicals:Antipsoriatics:Antipsoriatics For Topical Use:Other antipsoriatics for topical use]; D05AX52 [Dermatologicals:Antipsoriatics:Antipsoriatics For Topical Use:Other antipsoriatics for topical use]

>  <INDICATION_CLASS>  (464) 
Antipsoriatic

>  <SC_PATENT_NO>  (464) 
US-6753013-B1

>  <DRUG_TYPE>  (464) 
Natural Product-derived

>  <RULE_OF_FIVE>  (464) 
Y

>  <FIRST_IN_CLASS>  (464) 
N

>  <CHIRALITY>  (464) 
Single Stereoisomer

>  <PRODRUG>  (464) 
N

>  <ORAL>  (464) 
N

>  <PARENTERAL>  (464) 
N

>  <TOPICAL>  (464) 
Y

>  <BLACK_BOX>  (464) 
N

>  <AVAILABILITY_TYPE>  (464) 
Prescription-only

>  <WITHDRAWN_YEAR>  (464) 
nan

>  <WITHDRAWN_COUNTRY>  (464) 
nan

>  <WITHDRAWN_REASON>  (464) 
nan

>  <CANONICAL_SMILES>  (464) 
C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(=C\C=C/4\C[C@@H](O)C[C@H](O)C4=C)\CCC[C@]23C

>  <name>  (464) 
Calcipotriene 

>  <MW>  (464) 
412.614

>  <logP>  (464) 
5.0906

$$$$
CHEMBL497
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (465) 
8193

>  <SYNONYMS>  (465) 
Clioquinol (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (465) 
4

>  <RESEARCH_CODES>  (465) 
nan

>  <APPLICANTS>  (465) 
Bayer Pharmaceuticals Corp

>  <USAN_STEM>  (465) 
nan

>  <USAN_STEM_DEFINITION>  (465) 
nan

>  <USAN_STEM_SUBSTEM>  (465) 
nan

>  <USAN_YEAR>  (465) 
nan

>  <FIRST_APPROVAL>  (465) 
1982.0

>  <ATC_CODE>  (465) 
P01AA02; S02AA05; G01AC02; D09AA10; D08AH30; P01AA52

>  <ATC_CODE_DESCRIPTION>  (465) 
P01AA02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Hydroxyquinoline derivatives]; S02AA05 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]; G01AC02 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Quinoline derivatives]; D09AA10 [Dermatologicals:Medicated Dressings:Medicated Dressings:Medicated dressings with antiinfectives]; D08AH30 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Quinoline derivatives]; P01AA52 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Hydroxyquinoline derivatives]

>  <INDICATION_CLASS>  (465) 
Anti-Amebic; Anti-Infective, Topical

>  <SC_PATENT_NO>  (465) 
nan

>  <DRUG_TYPE>  (465) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (465) 
Y

>  <FIRST_IN_CLASS>  (465) 
N

>  <CHIRALITY>  (465) 
Achiral Molecule

>  <PRODRUG>  (465) 
N

>  <ORAL>  (465) 
N

>  <PARENTERAL>  (465) 
N

>  <TOPICAL>  (465) 
Y

>  <BLACK_BOX>  (465) 
N

>  <AVAILABILITY_TYPE>  (465) 
Withdrawn

>  <WITHDRAWN_YEAR>  (465) 
1973.0

>  <WITHDRAWN_COUNTRY>  (465) 
United Kingdom; United States; Germany; France; Japan

>  <WITHDRAWN_REASON>  (465) 
Neurotoxicity

>  <CANONICAL_SMILES>  (465) 
Oc1c(I)cc(Cl)c2cccnc12

>  <name>  (465) 
Clioquinol 

>  <MW>  (465) 
305.502

>  <logP>  (465) 
3.1984

$$$$
CHEMBL1200821
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 14 16  1  0
 15  8  1  0
M  END
>  <PARENT_MOLREGNO>  (466) 
674772

>  <SYNONYMS>  (466) 
Propyliodone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (466) 
4

>  <RESEARCH_CODES>  (466) 
nan

>  <APPLICANTS>  (466) 
GlaxoSmithKline

>  <USAN_STEM>  (466) 
nan

>  <USAN_STEM_DEFINITION>  (466) 
nan

>  <USAN_STEM_SUBSTEM>  (466) 
nan

>  <USAN_YEAR>  (466) 
nan

>  <FIRST_APPROVAL>  (466) 
nan

>  <ATC_CODE>  (466) 
V08AD03

>  <ATC_CODE_DESCRIPTION>  (466) 
V08AD03 [Various:Contrast Media:X-Ray Contrast Media, Iodinated:Non-watersoluble X-ray contrast media]

>  <INDICATION_CLASS>  (466) 
Diagnostic Aid (radiopaque medium)

>  <SC_PATENT_NO>  (466) 
nan

>  <DRUG_TYPE>  (466) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (466) 
Y

>  <FIRST_IN_CLASS>  (466) 
N

>  <CHIRALITY>  (466) 
Achiral Molecule

>  <PRODRUG>  (466) 
N

>  <ORAL>  (466) 
N

>  <PARENTERAL>  (466) 
Y

>  <TOPICAL>  (466) 
N

>  <BLACK_BOX>  (466) 
N

>  <AVAILABILITY_TYPE>  (466) 
Discontinued

>  <WITHDRAWN_YEAR>  (466) 
nan

>  <WITHDRAWN_COUNTRY>  (466) 
nan

>  <WITHDRAWN_REASON>  (466) 
nan

>  <CANONICAL_SMILES>  (466) 
CCCOC(=O)CN1C=C(I)C(=O)C(=C1)I

>  <name>  (466) 
Propyliodone 

>  <MW>  (466) 
447.01

>  <logP>  (466) 
2.0107

$$$$
CHEMBL1200600
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
  8 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27  2  1  0
 18  4  1  0
 13  5  1  0
 27 20  1  0
M  END
>  <PARENT_MOLREGNO>  (467) 
674551

>  <SYNONYMS>  (467) 
Fluorometholone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (467) 
4

>  <RESEARCH_CODES>  (467) 
nan

>  <APPLICANTS>  (467) 
Pharmacia And Upjohn Co; Allergan Pharmaceutical

>  <USAN_STEM>  (467) 
-olone

>  <USAN_STEM_DEFINITION>  (467) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (467) 
-olone

>  <USAN_YEAR>  (467) 
nan

>  <FIRST_APPROVAL>  (467) 
1972.0

>  <ATC_CODE>  (467) 
D10AA01; S01CB05; C05AA06; S01BA07; D07XB04; D07AB06

>  <ATC_CODE_DESCRIPTION>  (467) 
D10AA01 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; S01CB05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; C05AA06 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; S01BA07 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; D07XB04 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; D07AB06 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (467) 
Glucocorticoid

>  <SC_PATENT_NO>  (467) 
nan

>  <DRUG_TYPE>  (467) 
Natural Product-derived

>  <RULE_OF_FIVE>  (467) 
Y

>  <FIRST_IN_CLASS>  (467) 
N

>  <CHIRALITY>  (467) 
Single Stereoisomer

>  <PRODRUG>  (467) 
N

>  <ORAL>  (467) 
N

>  <PARENTERAL>  (467) 
N

>  <TOPICAL>  (467) 
Y

>  <BLACK_BOX>  (467) 
N

>  <AVAILABILITY_TYPE>  (467) 
Prescription-only

>  <WITHDRAWN_YEAR>  (467) 
nan

>  <WITHDRAWN_COUNTRY>  (467) 
nan

>  <WITHDRAWN_REASON>  (467) 
nan

>  <CANONICAL_SMILES>  (467) 
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14

>  <name>  (467) 
Fluorometholone 

>  <MW>  (467) 
376.468

>  <logP>  (467) 
2.9233

$$$$
CHEMBL1201864
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  3  0
 16  2  1  0
 19  2  1  0
 15  5  1  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (468) 
675813

>  <SYNONYMS>  (468) 
Dienogest (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (468) 
4

>  <RESEARCH_CODES>  (468) 
MJR-35; STS-557; ZK-37659

>  <APPLICANTS>  (468) 
Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (468) 
-gest-

>  <USAN_STEM_DEFINITION>  (468) 
progestins

>  <USAN_STEM_SUBSTEM>  (468) 
-gest-

>  <USAN_YEAR>  (468) 
1999.0

>  <FIRST_APPROVAL>  (468) 
2010.0

>  <ATC_CODE>  (468) 
G03DB08

>  <ATC_CODE_DESCRIPTION>  (468) 
G03DB08 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnadien derivatives]

>  <INDICATION_CLASS>  (468) 
nan

>  <SC_PATENT_NO>  (468) 
US-6133251-A

>  <DRUG_TYPE>  (468) 
Natural Product-derived

>  <RULE_OF_FIVE>  (468) 
Y

>  <FIRST_IN_CLASS>  (468) 
N

>  <CHIRALITY>  (468) 
Single Stereoisomer

>  <PRODRUG>  (468) 
N

>  <ORAL>  (468) 
Y

>  <PARENTERAL>  (468) 
N

>  <TOPICAL>  (468) 
N

>  <BLACK_BOX>  (468) 
Y

>  <AVAILABILITY_TYPE>  (468) 
Prescription-only

>  <WITHDRAWN_YEAR>  (468) 
nan

>  <WITHDRAWN_COUNTRY>  (468) 
nan

>  <WITHDRAWN_REASON>  (468) 
nan

>  <CANONICAL_SMILES>  (468) 
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N

>  <name>  (468) 
Dienogest 

>  <MW>  (468) 
311.425

>  <logP>  (468) 
3.83718

$$$$
CHEMBL152
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 13 16  1  0
  6 17  1  0
 17 18  2  0
 18  2  1  0
M  END
>  <PARENT_MOLREGNO>  (469) 
48701

>  <SYNONYMS>  (469) 
Cidofovir (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (469) 
4

>  <RESEARCH_CODES>  (469) 
GS-0504

>  <APPLICANTS>  (469) 
Gilead Sciences Inc

>  <USAN_STEM>  (469) 
-vir

>  <USAN_STEM_DEFINITION>  (469) 
antivirals

>  <USAN_STEM_SUBSTEM>  (469) 
-vir

>  <USAN_YEAR>  (469) 
1994.0

>  <FIRST_APPROVAL>  (469) 
1996.0

>  <ATC_CODE>  (469) 
J05AB12

>  <ATC_CODE_DESCRIPTION>  (469) 
J05AB12 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (469) 
Antiviral

>  <SC_PATENT_NO>  (469) 
nan

>  <DRUG_TYPE>  (469) 
Natural Product-derived

>  <RULE_OF_FIVE>  (469) 
Y

>  <FIRST_IN_CLASS>  (469) 
N

>  <CHIRALITY>  (469) 
Single Stereoisomer

>  <PRODRUG>  (469) 
N

>  <ORAL>  (469) 
N

>  <PARENTERAL>  (469) 
Y

>  <TOPICAL>  (469) 
N

>  <BLACK_BOX>  (469) 
Y

>  <AVAILABILITY_TYPE>  (469) 
Prescription-only

>  <WITHDRAWN_YEAR>  (469) 
nan

>  <WITHDRAWN_COUNTRY>  (469) 
nan

>  <WITHDRAWN_REASON>  (469) 
nan

>  <CANONICAL_SMILES>  (469) 
NC1=NC(=O)N(C[C@@H](CO)OCP(=O)(O)O)C=C1

>  <name>  (469) 
Cidofovir 

>  <MW>  (469) 
279.189

>  <logP>  (469) 
-1.6618

$$$$
CHEMBL98
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (470) 
11305

>  <SYNONYMS>  (470) 
Vorinostat (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (470) 
4

>  <RESEARCH_CODES>  (470) 
nan

>  <APPLICANTS>  (470) 
Merck And Co Inc

>  <USAN_STEM>  (470) 
-stat

>  <USAN_STEM_DEFINITION>  (470) 
enzyme inhibitors: inhibitors of histone deacetylase

>  <USAN_STEM_SUBSTEM>  (470) 
-stat (-inostat)

>  <USAN_YEAR>  (470) 
2005.0

>  <FIRST_APPROVAL>  (470) 
2006.0

>  <ATC_CODE>  (470) 
L01XX38

>  <ATC_CODE_DESCRIPTION>  (470) 
L01XX38 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (470) 
nan

>  <SC_PATENT_NO>  (470) 
US-RE38506-E1

>  <DRUG_TYPE>  (470) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (470) 
Y

>  <FIRST_IN_CLASS>  (470) 
N

>  <CHIRALITY>  (470) 
Achiral Molecule

>  <PRODRUG>  (470) 
N

>  <ORAL>  (470) 
Y

>  <PARENTERAL>  (470) 
N

>  <TOPICAL>  (470) 
N

>  <BLACK_BOX>  (470) 
N

>  <AVAILABILITY_TYPE>  (470) 
Prescription-only

>  <WITHDRAWN_YEAR>  (470) 
nan

>  <WITHDRAWN_COUNTRY>  (470) 
nan

>  <WITHDRAWN_REASON>  (470) 
nan

>  <CANONICAL_SMILES>  (470) 
ONC(=O)CCCCCCC(=O)Nc1ccccc1

>  <name>  (470) 
Vorinostat 

>  <MW>  (470) 
264.325

>  <logP>  (470) 
2.4711

$$$$
CHEMBL409
     RDKit          

 29 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
  2 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  3  0
 21 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 14  8  1  0
 25 18  1  0
M  END
>  <PARENT_MOLREGNO>  (471) 
717

>  <SYNONYMS>  (471) 
Bicalutamide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (471) 
4

>  <RESEARCH_CODES>  (471) 
ICI-176334

>  <APPLICANTS>  (471) 
Astrazeneca Uk Ltd

>  <USAN_STEM>  (471) 
-lutamide

>  <USAN_STEM_DEFINITION>  (471) 
non-steroid antiandrogens

>  <USAN_STEM_SUBSTEM>  (471) 
-lutamide

>  <USAN_YEAR>  (471) 
1994.0

>  <FIRST_APPROVAL>  (471) 
1995.0

>  <ATC_CODE>  (471) 
L02BB03

>  <ATC_CODE_DESCRIPTION>  (471) 
L02BB03 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Anti-androgens]

>  <INDICATION_CLASS>  (471) 
Antineoplastic

>  <SC_PATENT_NO>  (471) 
nan

>  <DRUG_TYPE>  (471) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (471) 
Y

>  <FIRST_IN_CLASS>  (471) 
N

>  <CHIRALITY>  (471) 
Racemic Mixture

>  <PRODRUG>  (471) 
N

>  <ORAL>  (471) 
Y

>  <PARENTERAL>  (471) 
N

>  <TOPICAL>  (471) 
N

>  <BLACK_BOX>  (471) 
N

>  <AVAILABILITY_TYPE>  (471) 
Prescription-only

>  <WITHDRAWN_YEAR>  (471) 
nan

>  <WITHDRAWN_COUNTRY>  (471) 
nan

>  <WITHDRAWN_REASON>  (471) 
nan

>  <CANONICAL_SMILES>  (471) 
CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F

>  <name>  (471) 
Bicalutamide 

>  <MW>  (471) 
430.379

>  <logP>  (471) 
2.87958

$$$$
CHEMBL720
     RDKit          

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (472) 
35486

>  <SYNONYMS>  (472) 
Benzyl alcohol (FDA, INN, JAN, NF)

>  <DEVELOPMENT_PHASE>  (472) 
4

>  <RESEARCH_CODES>  (472) 
nan

>  <APPLICANTS>  (472) 
Shionogi Inc

>  <USAN_STEM>  (472) 
nan

>  <USAN_STEM_DEFINITION>  (472) 
nan

>  <USAN_STEM_SUBSTEM>  (472) 
nan

>  <USAN_YEAR>  (472) 
nan

>  <FIRST_APPROVAL>  (472) 
2009.0

>  <ATC_CODE>  (472) 
P03AX06

>  <ATC_CODE_DESCRIPTION>  (472) 
P03AX06 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides:Other ectoparasiticides, incl. scabicides]

>  <INDICATION_CLASS>  (472) 
Pharmaceutic Aid (antimicrobial agent)

>  <SC_PATENT_NO>  (472) 
US-5858383-A

>  <DRUG_TYPE>  (472) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (472) 
Y

>  <FIRST_IN_CLASS>  (472) 
N

>  <CHIRALITY>  (472) 
Achiral Molecule

>  <PRODRUG>  (472) 
N

>  <ORAL>  (472) 
N

>  <PARENTERAL>  (472) 
N

>  <TOPICAL>  (472) 
Y

>  <BLACK_BOX>  (472) 
N

>  <AVAILABILITY_TYPE>  (472) 
Prescription-only

>  <WITHDRAWN_YEAR>  (472) 
nan

>  <WITHDRAWN_COUNTRY>  (472) 
nan

>  <WITHDRAWN_REASON>  (472) 
nan

>  <CANONICAL_SMILES>  (472) 
OCc1ccccc1

>  <name>  (472) 
Benzyl alcohol 

>  <MW>  (472) 
108.14

>  <logP>  (472) 
1.1789

$$$$
CHEMBL196
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (473) 
443348

>  <SYNONYMS>  (473) 
Ascorbic Acid (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (473) 
4

>  <RESEARCH_CODES>  (473) 
nan

>  <APPLICANTS>  (473) 
Hospira Inc; Hoffmann La Roche Inc; Astrazeneca Lp; Abraxis Pharmaceutical Products; Salix Pharmaceuticals Inc

>  <USAN_STEM>  (473) 
nan

>  <USAN_STEM_DEFINITION>  (473) 
nan

>  <USAN_STEM_SUBSTEM>  (473) 
nan

>  <USAN_YEAR>  (473) 
nan

>  <FIRST_APPROVAL>  (473) 
1985.0

>  <ATC_CODE>  (473) 
S01XA15; G01AD03; A11GA01

>  <ATC_CODE_DESCRIPTION>  (473) 
S01XA15 [Sensory Organs:Ophthalmologicals:Other Ophthalmologicals:Other ophthalmologicals]; G01AD03 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Organic acids]; A11GA01 [Alimentary Tract And Metabolism:Vitamins:Ascorbic Acid (Vitamin C), Incl. Combinations:Ascorbic acid (vitamin C), plain]

>  <INDICATION_CLASS>  (473) 
Acidifier (urlnary); Vitamin (antiscorbutic)

>  <SC_PATENT_NO>  (473) 
US-7169381-B2

>  <DRUG_TYPE>  (473) 
Natural Product-derived

>  <RULE_OF_FIVE>  (473) 
Y

>  <FIRST_IN_CLASS>  (473) 
N

>  <CHIRALITY>  (473) 
Single Stereoisomer

>  <PRODRUG>  (473) 
N

>  <ORAL>  (473) 
Y

>  <PARENTERAL>  (473) 
Y

>  <TOPICAL>  (473) 
N

>  <BLACK_BOX>  (473) 
N

>  <AVAILABILITY_TYPE>  (473) 
Prescription-only

>  <WITHDRAWN_YEAR>  (473) 
nan

>  <WITHDRAWN_COUNTRY>  (473) 
nan

>  <WITHDRAWN_REASON>  (473) 
nan

>  <CANONICAL_SMILES>  (473) 
OC[C@H](O)[C@H]1OC(=O)C(=C1O)O

>  <name>  (473) 
Ascorbic Acid 

>  <MW>  (473) 
176.124

>  <logP>  (473) 
-1.4074

$$$$
CHEMBL1549
     RDKit          

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 15 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
  8  2  1  0
 35  2  1  0
 35 11  1  0
 30 12  1  0
 29 25  1  0
M  END
>  <PARENT_MOLREGNO>  (474) 
439720

>  <SYNONYMS>  (474) 
Hydrocortisone cypionate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (474) 
4

>  <RESEARCH_CODES>  (474) 
nan

>  <APPLICANTS>  (474) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (474) 
-cort-

>  <USAN_STEM_DEFINITION>  (474) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (474) 
-cort-

>  <USAN_YEAR>  (474) 
nan

>  <FIRST_APPROVAL>  (474) 
1955.0

>  <ATC_CODE>  (474) 
D07AA02; S01CB03; D07XA01; C05AA01; A07EA02; A01AC03; H02AB09; S01BA02; S02BA01

>  <ATC_CODE_DESCRIPTION>  (474) 
D07AA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; S01CB03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; D07XA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; C05AA01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; A01AC03 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; H02AB09 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA01 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (474) 
nan

>  <SC_PATENT_NO>  (474) 
nan

>  <DRUG_TYPE>  (474) 
Natural Product-derived

>  <RULE_OF_FIVE>  (474) 
Y

>  <FIRST_IN_CLASS>  (474) 
N

>  <CHIRALITY>  (474) 
Single Stereoisomer

>  <PRODRUG>  (474) 
Y

>  <ORAL>  (474) 
Y

>  <PARENTERAL>  (474) 
N

>  <TOPICAL>  (474) 
N

>  <BLACK_BOX>  (474) 
N

>  <AVAILABILITY_TYPE>  (474) 
Discontinued

>  <WITHDRAWN_YEAR>  (474) 
nan

>  <WITHDRAWN_COUNTRY>  (474) 
nan

>  <WITHDRAWN_REASON>  (474) 
nan

>  <CANONICAL_SMILES>  (474) 
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COC(=O)CCC5CCCC5)[C@@]4(C)C[C@H](O)[C@H]23

>  <name>  (474) 
Hydrocortisone cypionate 

>  <MW>  (474) 
486.649

>  <logP>  (474) 
4.3029

$$$$
CHEMBL982
     RDKit          

 25 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 16 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 18  2  1  0
 19  5  1  0
 24  7  1  0
 12 10  1  0
 19 15  1  0
 24 15  1  0
M  END
>  <PARENT_MOLREGNO>  (475) 
100696

>  <SYNONYMS>  (475) 
Nalmefene (BAN, INN, USAN); Nalmefene HCl (FDA)

>  <DEVELOPMENT_PHASE>  (475) 
4

>  <RESEARCH_CODES>  (475) 
JF-1; ORF-11676

>  <APPLICANTS>  (475) 
Key Pharmaceuticals; Baxter Healthcare Corp Anesthesia Critical Care

>  <USAN_STEM>  (475) 
nal-

>  <USAN_STEM_DEFINITION>  (475) 
narcotic agonists/antagonists (normorphine type)

>  <USAN_STEM_SUBSTEM>  (475) 
nal-

>  <USAN_YEAR>  (475) 
1981.0

>  <FIRST_APPROVAL>  (475) 
1995.0

>  <ATC_CODE>  (475) 
N07BB05

>  <ATC_CODE_DESCRIPTION>  (475) 
N07BB05 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in alcohol dependence]

>  <INDICATION_CLASS>  (475) 
Antagonist (to narcotics)

>  <SC_PATENT_NO>  (475) 
nan

>  <DRUG_TYPE>  (475) 
Natural Product-derived

>  <RULE_OF_FIVE>  (475) 
Y

>  <FIRST_IN_CLASS>  (475) 
N

>  <CHIRALITY>  (475) 
Single Stereoisomer

>  <PRODRUG>  (475) 
N

>  <ORAL>  (475) 
N

>  <PARENTERAL>  (475) 
Y

>  <TOPICAL>  (475) 
N

>  <BLACK_BOX>  (475) 
N

>  <AVAILABILITY_TYPE>  (475) 
Discontinued

>  <WITHDRAWN_YEAR>  (475) 
nan

>  <WITHDRAWN_COUNTRY>  (475) 
nan

>  <WITHDRAWN_REASON>  (475) 
nan

>  <CANONICAL_SMILES>  (475) 
Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=C)CC[C@@]36O

>  <name>  (475) 
Nalmefene 

>  <MW>  (475) 
339.435

>  <logP>  (475) 
2.5125

$$$$
CHEMBL1200359
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
  6 18  1  0
 18 19  2  0
 19  3  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (476) 
674310

>  <SYNONYMS>  (476) 
Sulfameter (FDA, USAN); Sulfametoxydiazine (BAN, DCF, INN)

>  <DEVELOPMENT_PHASE>  (476) 
4

>  <RESEARCH_CODES>  (476) 
AHR-857

>  <APPLICANTS>  (476) 
Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (476) 
sulfa-

>  <USAN_STEM_DEFINITION>  (476) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (476) 
sulfa-

>  <USAN_YEAR>  (476) 
1967.0

>  <FIRST_APPROVAL>  (476) 
1966.0

>  <ATC_CODE>  (476) 
J01ED04

>  <ATC_CODE_DESCRIPTION>  (476) 
J01ED04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]

>  <INDICATION_CLASS>  (476) 
Antibacterial

>  <SC_PATENT_NO>  (476) 
nan

>  <DRUG_TYPE>  (476) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (476) 
Y

>  <FIRST_IN_CLASS>  (476) 
N

>  <CHIRALITY>  (476) 
Achiral Molecule

>  <PRODRUG>  (476) 
N

>  <ORAL>  (476) 
Y

>  <PARENTERAL>  (476) 
N

>  <TOPICAL>  (476) 
N

>  <BLACK_BOX>  (476) 
N

>  <AVAILABILITY_TYPE>  (476) 
Withdrawn

>  <WITHDRAWN_YEAR>  (476) 
1988.0

>  <WITHDRAWN_COUNTRY>  (476) 
Germany

>  <WITHDRAWN_REASON>  (476) 
nan

>  <CANONICAL_SMILES>  (476) 
COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1

>  <name>  (476) 
Sulfameter 

>  <MW>  (476) 
280.309

>  <logP>  (476) 
0.8682

$$$$
CHEMBL1065
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 23 26  2  0
 25  9  1  0
 24 13  1  0
 26 15  1  0
 26 19  1  0
M  END
>  <PARENT_MOLREGNO>  (477) 
138605

>  <SYNONYMS>  (477) 
Methysergide (BAN, INN, USAN); Methysergide maleate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (477) 
4

>  <RESEARCH_CODES>  (477) 
nan

>  <APPLICANTS>  (477) 
Novartis Pharmaceuticals Corp; Novartis

>  <USAN_STEM>  (477) 
-erg-

>  <USAN_STEM_DEFINITION>  (477) 
ergot alkaloid derivatives

>  <USAN_STEM_SUBSTEM>  (477) 
-erg-

>  <USAN_YEAR>  (477) 
1970.0

>  <FIRST_APPROVAL>  (477) 
1962.0

>  <ATC_CODE>  (477) 
N02CA04

>  <ATC_CODE_DESCRIPTION>  (477) 
N02CA04 [Nervous System:Analgesics:Antimigraine Preparations:Ergot alkaloids]

>  <INDICATION_CLASS>  (477) 
Vasoconstrictor (specific in migraine)

>  <SC_PATENT_NO>  (477) 
nan

>  <DRUG_TYPE>  (477) 
Natural Product-derived

>  <RULE_OF_FIVE>  (477) 
Y

>  <FIRST_IN_CLASS>  (477) 
N

>  <CHIRALITY>  (477) 
Single Stereoisomer

>  <PRODRUG>  (477) 
N

>  <ORAL>  (477) 
Y

>  <PARENTERAL>  (477) 
N

>  <TOPICAL>  (477) 
N

>  <BLACK_BOX>  (477) 
N

>  <AVAILABILITY_TYPE>  (477) 
Discontinued

>  <WITHDRAWN_YEAR>  (477) 
nan

>  <WITHDRAWN_COUNTRY>  (477) 
nan

>  <WITHDRAWN_REASON>  (477) 
nan

>  <CANONICAL_SMILES>  (477) 
CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34

>  <name>  (477) 
Methysergide 

>  <MW>  (477) 
353.466

>  <logP>  (477) 
1.9351

$$$$
CHEMBL89598
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  2  0
M  END
>  <PARENT_MOLREGNO>  (478) 
141484

>  <SYNONYMS>  (478) 
Vigabatrin (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (478) 
4

>  <RESEARCH_CODES>  (478) 
MDL-71754

>  <APPLICANTS>  (478) 
Lundbeck Llc

>  <USAN_STEM>  (478) 
-gab-

>  <USAN_STEM_DEFINITION>  (478) 
gabamimetics

>  <USAN_STEM_SUBSTEM>  (478) 
-gab-

>  <USAN_YEAR>  (478) 
1985.0

>  <FIRST_APPROVAL>  (478) 
2009.0

>  <ATC_CODE>  (478) 
N03AG04

>  <ATC_CODE_DESCRIPTION>  (478) 
N03AG04 [Nervous System:Antiepileptics:Antiepileptics:Fatty acid derivatives]

>  <INDICATION_CLASS>  (478) 
Anticonvulsant (tardive dyskinesia)

>  <SC_PATENT_NO>  (478) 
nan

>  <DRUG_TYPE>  (478) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (478) 
Y

>  <FIRST_IN_CLASS>  (478) 
N

>  <CHIRALITY>  (478) 
Racemic Mixture

>  <PRODRUG>  (478) 
N

>  <ORAL>  (478) 
Y

>  <PARENTERAL>  (478) 
N

>  <TOPICAL>  (478) 
N

>  <BLACK_BOX>  (478) 
Y

>  <AVAILABILITY_TYPE>  (478) 
Prescription-only

>  <WITHDRAWN_YEAR>  (478) 
nan

>  <WITHDRAWN_COUNTRY>  (478) 
nan

>  <WITHDRAWN_REASON>  (478) 
nan

>  <CANONICAL_SMILES>  (478) 
NC(CCC(=O)O)C=C

>  <name>  (478) 
Vigabatrin 

>  <MW>  (478) 
129.159

>  <logP>  (478) 
0.3645

$$$$
CHEMBL127
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
  8 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 11  4  1  0
 10  5  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (479) 
26386

>  <SYNONYMS>  (479) 
Meropenem (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (479) 
4

>  <RESEARCH_CODES>  (479) 
ICI-194660; SM-7338

>  <APPLICANTS>  (479) 
Astrazeneca Uk Ltd

>  <USAN_STEM>  (479) 
-penem

>  <USAN_STEM_DEFINITION>  (479) 
antibacterial antibiotics, carbapenem derivatives

>  <USAN_STEM_SUBSTEM>  (479) 
-penem

>  <USAN_YEAR>  (479) 
1992.0

>  <FIRST_APPROVAL>  (479) 
1996.0

>  <ATC_CODE>  (479) 
J01DH02

>  <ATC_CODE_DESCRIPTION>  (479) 
J01DH02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Carbapenems]

>  <INDICATION_CLASS>  (479) 
Antibacterial

>  <SC_PATENT_NO>  (479) 
nan

>  <DRUG_TYPE>  (479) 
Natural Product-derived

>  <RULE_OF_FIVE>  (479) 
Y

>  <FIRST_IN_CLASS>  (479) 
N

>  <CHIRALITY>  (479) 
Single Stereoisomer

>  <PRODRUG>  (479) 
N

>  <ORAL>  (479) 
N

>  <PARENTERAL>  (479) 
Y

>  <TOPICAL>  (479) 
N

>  <BLACK_BOX>  (479) 
Y

>  <AVAILABILITY_TYPE>  (479) 
Prescription-only

>  <WITHDRAWN_YEAR>  (479) 
nan

>  <WITHDRAWN_COUNTRY>  (479) 
nan

>  <WITHDRAWN_REASON>  (479) 
nan

>  <CANONICAL_SMILES>  (479) 
C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)N(C)C

>  <name>  (479) 
Meropenem 

>  <MW>  (479) 
383.47

>  <logP>  (479) 
-0.308

$$$$
CHEMBL1201336
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 11 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 12  7  1  0
 19 14  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (480) 
675287

>  <SYNONYMS>  (480) 
Fosphenytoin (BAN, INN); Fosphenytoin sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (480) 
4

>  <RESEARCH_CODES>  (480) 
ACC-9653-010; CI-982

>  <APPLICANTS>  (480) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (480) 
fos-; -toin

>  <USAN_STEM_DEFINITION>  (480) 
phosphoro-derivatives; antiepileptics (hydantoin derivatives)

>  <USAN_STEM_SUBSTEM>  (480) 
fos-; -toin

>  <USAN_YEAR>  (480) 
1993.0

>  <FIRST_APPROVAL>  (480) 
1996.0

>  <ATC_CODE>  (480) 
N03AB05

>  <ATC_CODE_DESCRIPTION>  (480) 
N03AB05 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]

>  <INDICATION_CLASS>  (480) 
Anticonvulsant

>  <SC_PATENT_NO>  (480) 
nan

>  <DRUG_TYPE>  (480) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (480) 
Y

>  <FIRST_IN_CLASS>  (480) 
N

>  <CHIRALITY>  (480) 
Achiral Molecule

>  <PRODRUG>  (480) 
Y

>  <ORAL>  (480) 
N

>  <PARENTERAL>  (480) 
Y

>  <TOPICAL>  (480) 
N

>  <BLACK_BOX>  (480) 
Y

>  <AVAILABILITY_TYPE>  (480) 
Prescription-only

>  <WITHDRAWN_YEAR>  (480) 
nan

>  <WITHDRAWN_COUNTRY>  (480) 
nan

>  <WITHDRAWN_REASON>  (480) 
nan

>  <CANONICAL_SMILES>  (480) 
OP(=O)(O)OCN1C(=O)NC(C1=O)(c2ccccc2)c3ccccc3

>  <name>  (480) 
Fosphenytoin 

>  <MW>  (480) 
362.278

>  <logP>  (480) 
1.5488

$$$$
CHEMBL1185
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 12 20  1  0
 20 21  2  0
 21  6  1  0
 21  9  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (481) 
196215

>  <SYNONYMS>  (481) 
Zolmitriptan (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (481) 
4

>  <RESEARCH_CODES>  (481) 
311C90

>  <APPLICANTS>  (481) 
Ipr Pharmaceuticals Inc; Astrazeneca Pharmaceuticals Lp

>  <USAN_STEM>  (481) 
-triptan

>  <USAN_STEM_DEFINITION>  (481) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (481) 
-triptan

>  <USAN_YEAR>  (481) 
1997.0

>  <FIRST_APPROVAL>  (481) 
1997.0

>  <ATC_CODE>  (481) 
N02CC03

>  <ATC_CODE_DESCRIPTION>  (481) 
N02CC03 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (481) 
Antimigraine

>  <SC_PATENT_NO>  (481) 
US-6750237-B1

>  <DRUG_TYPE>  (481) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (481) 
Y

>  <FIRST_IN_CLASS>  (481) 
N

>  <CHIRALITY>  (481) 
Single Stereoisomer

>  <PRODRUG>  (481) 
N

>  <ORAL>  (481) 
Y

>  <PARENTERAL>  (481) 
N

>  <TOPICAL>  (481) 
Y

>  <BLACK_BOX>  (481) 
N

>  <AVAILABILITY_TYPE>  (481) 
Prescription-only

>  <WITHDRAWN_YEAR>  (481) 
nan

>  <WITHDRAWN_COUNTRY>  (481) 
nan

>  <WITHDRAWN_REASON>  (481) 
nan

>  <CANONICAL_SMILES>  (481) 
CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12

>  <name>  (481) 
Zolmitriptan 

>  <MW>  (481) 
287.363

>  <logP>  (481) 
1.9229

$$$$
CHEMBL376359
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
  6 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  3  0
 14 24  1  0
 24 25  2  0
 24  2  1  0
 13  7  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (482) 
377721

>  <SYNONYMS>  (482) 
Alogliptin (INN); Alogliptin Benzoate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (482) 
4

>  <RESEARCH_CODES>  (482) 
SYR-322

>  <APPLICANTS>  (482) 
Takeda Pharmaceuticals Usa Inc

>  <USAN_STEM>  (482) 
-gliptin

>  <USAN_STEM_DEFINITION>  (482) 
dipeptidyl aminopeptidase-IV inhibitors

>  <USAN_STEM_SUBSTEM>  (482) 
-gliptin

>  <USAN_YEAR>  (482) 
2008.0

>  <FIRST_APPROVAL>  (482) 
2013.0

>  <ATC_CODE>  (482) 
A10BH04

>  <ATC_CODE_DESCRIPTION>  (482) 
A10BH04 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Dipeptidyl peptidase 4 (DPP-4) inhibitors]

>  <INDICATION_CLASS>  (482) 
nan

>  <SC_PATENT_NO>  (482) 
US-5965584-A

>  <DRUG_TYPE>  (482) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (482) 
Y

>  <FIRST_IN_CLASS>  (482) 
N

>  <CHIRALITY>  (482) 
Single Stereoisomer

>  <PRODRUG>  (482) 
N

>  <ORAL>  (482) 
Y

>  <PARENTERAL>  (482) 
N

>  <TOPICAL>  (482) 
N

>  <BLACK_BOX>  (482) 
N

>  <AVAILABILITY_TYPE>  (482) 
Prescription-only

>  <WITHDRAWN_YEAR>  (482) 
nan

>  <WITHDRAWN_COUNTRY>  (482) 
nan

>  <WITHDRAWN_REASON>  (482) 
nan

>  <CANONICAL_SMILES>  (482) 
CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(Cc3ccccc3C#N)C1=O

>  <name>  (482) 
Alogliptin 

>  <MW>  (482) 
339.399

>  <logP>  (482) 
0.39448

$$$$
CHEMBL644
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  8  1  0
 14  9  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (483) 
27385

>  <SYNONYMS>  (483) 
Trimipramine (BAN, INN, USAN); Trimipramine Maleate (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (483) 
4

>  <RESEARCH_CODES>  (483) 
7162 RP; IL-6001

>  <APPLICANTS>  (483) 
Wyeth-Ayerst; Odyssey Pharmaceuticals Inc

>  <USAN_STEM>  (483) 
-pramine

>  <USAN_STEM_DEFINITION>  (483) 
antidepressants (imipramine type)

>  <USAN_STEM_SUBSTEM>  (483) 
-pramine

>  <USAN_YEAR>  (483) 
1966.0

>  <FIRST_APPROVAL>  (483) 
1979.0

>  <ATC_CODE>  (483) 
N06AA06

>  <ATC_CODE_DESCRIPTION>  (483) 
N06AA06 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (483) 
Antidepressant

>  <SC_PATENT_NO>  (483) 
nan

>  <DRUG_TYPE>  (483) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (483) 
Y

>  <FIRST_IN_CLASS>  (483) 
N

>  <CHIRALITY>  (483) 
Racemic Mixture

>  <PRODRUG>  (483) 
N

>  <ORAL>  (483) 
Y

>  <PARENTERAL>  (483) 
N

>  <TOPICAL>  (483) 
N

>  <BLACK_BOX>  (483) 
Y

>  <AVAILABILITY_TYPE>  (483) 
Prescription-only

>  <WITHDRAWN_YEAR>  (483) 
nan

>  <WITHDRAWN_COUNTRY>  (483) 
nan

>  <WITHDRAWN_REASON>  (483) 
nan

>  <CANONICAL_SMILES>  (483) 
CC(CN(C)C)CN1c2ccccc2CCc3ccccc13

>  <name>  (483) 
Trimipramine 

>  <MW>  (483) 
294.442

>  <logP>  (483) 
4.121

$$$$
CHEMBL631
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 15 10  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (484) 
27112

>  <SYNONYMS>  (484) 
Propafenone (BAN, INN); Propafenone HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (484) 
4

>  <RESEARCH_CODES>  (484) 
GNF-Pf-4594

>  <APPLICANTS>  (484) 
GlaxoSmithKline Llc

>  <USAN_STEM>  (484) 
-afenone

>  <USAN_STEM_DEFINITION>  (484) 
antiarrhythmics (propafenone derivatives)

>  <USAN_STEM_SUBSTEM>  (484) 
-afenone

>  <USAN_YEAR>  (484) 
1988.0

>  <FIRST_APPROVAL>  (484) 
1989.0

>  <ATC_CODE>  (484) 
C01BC03

>  <ATC_CODE_DESCRIPTION>  (484) 
C01BC03 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ic]

>  <INDICATION_CLASS>  (484) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (484) 
nan

>  <DRUG_TYPE>  (484) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (484) 
Y

>  <FIRST_IN_CLASS>  (484) 
N

>  <CHIRALITY>  (484) 
Racemic Mixture

>  <PRODRUG>  (484) 
N

>  <ORAL>  (484) 
Y

>  <PARENTERAL>  (484) 
N

>  <TOPICAL>  (484) 
N

>  <BLACK_BOX>  (484) 
Y

>  <AVAILABILITY_TYPE>  (484) 
Prescription-only

>  <WITHDRAWN_YEAR>  (484) 
nan

>  <WITHDRAWN_COUNTRY>  (484) 
nan

>  <WITHDRAWN_REASON>  (484) 
nan

>  <CANONICAL_SMILES>  (484) 
CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2

>  <name>  (484) 
Propafenone 

>  <MW>  (484) 
341.451

>  <logP>  (484) 
3.2414

$$$$
CHEMBL1413
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  9  2  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (485) 
353011

>  <SYNONYMS>  (485) 
Ciclopirox (BAN, FDA, INN, USAN, USP); Ciclopirox Olamine (JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (485) 
4

>  <RESEARCH_CODES>  (485) 
HOE-296b; HOE-296

>  <APPLICANTS>  (485) 
Sanofi Aventis Us Llc; Medicis Pharmaceutical Corp; Hoechst-Roussel

>  <USAN_STEM>  (485) 
-pirox

>  <USAN_STEM_DEFINITION>  (485) 
antimycotics (pyridone derivatives)

>  <USAN_STEM_SUBSTEM>  (485) 
-pirox

>  <USAN_YEAR>  (485) 
1975.0

>  <FIRST_APPROVAL>  (485) 
1982.0

>  <ATC_CODE>  (485) 
D01AE14; G01AX12

>  <ATC_CODE_DESCRIPTION>  (485) 
D01AE14 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]; G01AX12 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Other antiinfectives and antiseptics]

>  <INDICATION_CLASS>  (485) 
Antifungal

>  <SC_PATENT_NO>  (485) 
US-7018656-B2

>  <DRUG_TYPE>  (485) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (485) 
Y

>  <FIRST_IN_CLASS>  (485) 
N

>  <CHIRALITY>  (485) 
Achiral Molecule

>  <PRODRUG>  (485) 
N

>  <ORAL>  (485) 
N

>  <PARENTERAL>  (485) 
N

>  <TOPICAL>  (485) 
Y

>  <BLACK_BOX>  (485) 
Y

>  <AVAILABILITY_TYPE>  (485) 
Prescription-only

>  <WITHDRAWN_YEAR>  (485) 
nan

>  <WITHDRAWN_COUNTRY>  (485) 
nan

>  <WITHDRAWN_REASON>  (485) 
nan

>  <CANONICAL_SMILES>  (485) 
CC1=CC(=O)N(O)C(=C1)C2CCCCC2

>  <name>  (485) 
Ciclopirox 

>  <MW>  (485) 
207.273

>  <logP>  (485) 
2.44172

$$$$
CHEMBL15770
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 11 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 10 23  1  0
  7 24  1  0
 24 25  2  0
 25  4  1  0
  9 22  1  0
 22 16  1  0
M  CHG  2   2   1   3  -1
M  END
>  <PARENT_MOLREGNO>  (486) 
16510

>  <SYNONYMS>  (486) 
Sulindac (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (486) 
4

>  <RESEARCH_CODES>  (486) 
nan

>  <APPLICANTS>  (486) 
Merck Research Laboratories Div Merck Co Inc

>  <USAN_STEM>  (486) 
-ac

>  <USAN_STEM_DEFINITION>  (486) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (486) 
-ac

>  <USAN_YEAR>  (486) 
1975.0

>  <FIRST_APPROVAL>  (486) 
1978.0

>  <ATC_CODE>  (486) 
M01AB02

>  <ATC_CODE_DESCRIPTION>  (486) 
M01AB02 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (486) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (486) 
nan

>  <DRUG_TYPE>  (486) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (486) 
Y

>  <FIRST_IN_CLASS>  (486) 
N

>  <CHIRALITY>  (486) 
Single Stereoisomer

>  <PRODRUG>  (486) 
Y

>  <ORAL>  (486) 
Y

>  <PARENTERAL>  (486) 
N

>  <TOPICAL>  (486) 
N

>  <BLACK_BOX>  (486) 
Y

>  <AVAILABILITY_TYPE>  (486) 
Prescription-only

>  <WITHDRAWN_YEAR>  (486) 
nan

>  <WITHDRAWN_COUNTRY>  (486) 
nan

>  <WITHDRAWN_REASON>  (486) 
nan

>  <CANONICAL_SMILES>  (486) 
C[S+]([O-])c1ccc(\C=C/2\C(=C(CC(=O)O)c3cc(F)ccc23)C)cc1

>  <name>  (486) 
Sulindac 

>  <MW>  (486) 
356.418

>  <logP>  (486) 
4.3655

$$$$
CHEMBL134
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  8  2  1  0
 14 10  1  0
M  END
>  <PARENT_MOLREGNO>  (487) 
27609

>  <SYNONYMS>  (487) 
Clonidine (BAN, FDA, INN, USAN, USP); Clonidine HCl (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (487) 
4

>  <RESEARCH_CODES>  (487) 
ST-155-BS; ST-155BS; ST-155

>  <APPLICANTS>  (487) 
Shionogi Inc; Mylan Institutional Llc; Boehringer Ingelheim Pharmaceuticals Inc; Boehringer Ingelheim; Tris Pharma Inc

>  <USAN_STEM>  (487) 
nan

>  <USAN_STEM_DEFINITION>  (487) 
nan

>  <USAN_STEM_SUBSTEM>  (487) 
nan

>  <USAN_YEAR>  (487) 
1969.0

>  <FIRST_APPROVAL>  (487) 
1974.0

>  <ATC_CODE>  (487) 
N02CX02; C02AC01; S01EA04

>  <ATC_CODE_DESCRIPTION>  (487) 
N02CX02 [Nervous System:Analgesics:Antimigraine Preparations:Other antimigraine preparations]; C02AC01 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Centrally Acting:Imidazoline receptor agonists]; S01EA04 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Sympathomimetics in glaucoma therapy]

>  <INDICATION_CLASS>  (487) 
Antihypertensive

>  <SC_PATENT_NO>  (487) 
nan

>  <DRUG_TYPE>  (487) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (487) 
Y

>  <FIRST_IN_CLASS>  (487) 
N

>  <CHIRALITY>  (487) 
Achiral Molecule

>  <PRODRUG>  (487) 
N

>  <ORAL>  (487) 
Y

>  <PARENTERAL>  (487) 
Y

>  <TOPICAL>  (487) 
Y

>  <BLACK_BOX>  (487) 
Y

>  <AVAILABILITY_TYPE>  (487) 
Prescription-only

>  <WITHDRAWN_YEAR>  (487) 
nan

>  <WITHDRAWN_COUNTRY>  (487) 
nan

>  <WITHDRAWN_REASON>  (487) 
nan

>  <CANONICAL_SMILES>  (487) 
Clc1cccc(Cl)c1NC2=NCCN2

>  <name>  (487) 
Clonidine 

>  <MW>  (487) 
230.098

>  <logP>  (487) 
2.3645

$$$$
CHEMBL1228
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  8 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 10  5  1  0
 18 12  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (488) 
227917

>  <SYNONYMS>  (488) 
Oxyphenbutazone (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (488) 
4

>  <RESEARCH_CODES>  (488) 
nan

>  <APPLICANTS>  (488) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (488) 
-butazone

>  <USAN_STEM_DEFINITION>  (488) 
anti-inflammatory analgesics (phenylbutazone type)

>  <USAN_STEM_SUBSTEM>  (488) 
-butazone

>  <USAN_YEAR>  (488) 
nan

>  <FIRST_APPROVAL>  (488) 
1960.0

>  <ATC_CODE>  (488) 
M01AA03; S01BC02; M02AA04

>  <ATC_CODE_DESCRIPTION>  (488) 
M01AA03 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Butylpyrazolidines]; S01BC02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]; M02AA04 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]

>  <INDICATION_CLASS>  (488) 
Anti-Inflammatory; Antirheumatic

>  <SC_PATENT_NO>  (488) 
nan

>  <DRUG_TYPE>  (488) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (488) 
Y

>  <FIRST_IN_CLASS>  (488) 
N

>  <CHIRALITY>  (488) 
Racemic Mixture

>  <PRODRUG>  (488) 
N

>  <ORAL>  (488) 
Y

>  <PARENTERAL>  (488) 
N

>  <TOPICAL>  (488) 
N

>  <BLACK_BOX>  (488) 
N

>  <AVAILABILITY_TYPE>  (488) 
Withdrawn

>  <WITHDRAWN_YEAR>  (488) 
1984.0

>  <WITHDRAWN_COUNTRY>  (488) 
United Kingdom; United States; Germany; France

>  <WITHDRAWN_REASON>  (488) 
Blood Dyscrasis; Steven Johnson Syndrome

>  <CANONICAL_SMILES>  (488) 
CCCCC1C(=O)N(N(C1=O)c2ccc(O)cc2)c3ccccc3

>  <name>  (488) 
Oxyphenbutazone 

>  <MW>  (488) 
324.38

>  <logP>  (488) 
3.4934

$$$$
CHEMBL31
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  4 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 20 24  1  0
 18 25  1  0
 25 26  2  0
 25 27  1  0
 24  3  1  0
 11  5  1  0
 24 15  2  0
 23 21  1  0
M  END
>  <PARENT_MOLREGNO>  (489) 
1712

>  <SYNONYMS>  (489) 
Gatifloxacin (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (489) 
4

>  <RESEARCH_CODES>  (489) 
AM-1155; BMS-206584-01

>  <APPLICANTS>  (489) 
Allergan Inc; Allergan

>  <USAN_STEM>  (489) 
-oxacin

>  <USAN_STEM_DEFINITION>  (489) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (489) 
-oxacin

>  <USAN_YEAR>  (489) 
1997.0

>  <FIRST_APPROVAL>  (489) 
1999.0

>  <ATC_CODE>  (489) 
J01MA16; S01AE06

>  <ATC_CODE_DESCRIPTION>  (489) 
J01MA16 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE06 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]

>  <INDICATION_CLASS>  (489) 
Antibacterial

>  <SC_PATENT_NO>  (489) 
US-5880283-A

>  <DRUG_TYPE>  (489) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (489) 
Y

>  <FIRST_IN_CLASS>  (489) 
N

>  <CHIRALITY>  (489) 
Racemic Mixture

>  <PRODRUG>  (489) 
N

>  <ORAL>  (489) 
Y

>  <PARENTERAL>  (489) 
Y

>  <TOPICAL>  (489) 
Y

>  <BLACK_BOX>  (489) 
N

>  <AVAILABILITY_TYPE>  (489) 
Prescription-only

>  <WITHDRAWN_YEAR>  (489) 
2006.0

>  <WITHDRAWN_COUNTRY>  (489) 
United States

>  <WITHDRAWN_REASON>  (489) 
Increased risk of dysglycemia

>  <CANONICAL_SMILES>  (489) 
COc1c(N2CCNC(C)C2)c(F)cc3C(=O)C(=CN(C4CC4)c13)C(=O)O

>  <name>  (489) 
Gatifloxacin 

>  <MW>  (489) 
375.4

>  <logP>  (489) 
1.9804

$$$$
CHEMBL14687
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
M  END
>  <PARENT_MOLREGNO>  (490) 
13616

>  <SYNONYMS>  (490) 
Propanol

>  <DEVELOPMENT_PHASE>  (490) 
4

>  <RESEARCH_CODES>  (490) 
nan

>  <APPLICANTS>  (490) 
nan

>  <USAN_STEM>  (490) 
nan

>  <USAN_STEM_DEFINITION>  (490) 
nan

>  <USAN_STEM_SUBSTEM>  (490) 
nan

>  <USAN_YEAR>  (490) 
nan

>  <FIRST_APPROVAL>  (490) 
nan

>  <ATC_CODE>  (490) 
D08AX03; D08AX53

>  <ATC_CODE_DESCRIPTION>  (490) 
D08AX03 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Other antiseptics and disinfectants]; D08AX53 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Other antiseptics and disinfectants]

>  <INDICATION_CLASS>  (490) 
nan

>  <SC_PATENT_NO>  (490) 
nan

>  <DRUG_TYPE>  (490) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (490) 
Y

>  <FIRST_IN_CLASS>  (490) 
N

>  <CHIRALITY>  (490) 
Achiral Molecule

>  <PRODRUG>  (490) 
N

>  <ORAL>  (490) 
N

>  <PARENTERAL>  (490) 
N

>  <TOPICAL>  (490) 
N

>  <BLACK_BOX>  (490) 
N

>  <AVAILABILITY_TYPE>  (490) 
Unknown

>  <WITHDRAWN_YEAR>  (490) 
nan

>  <WITHDRAWN_COUNTRY>  (490) 
nan

>  <WITHDRAWN_REASON>  (490) 
nan

>  <CANONICAL_SMILES>  (490) 
CCCO

>  <name>  (490) 
Propanol

>  <MW>  (490) 
60.096

>  <logP>  (490) 
0.3887

$$$$
CHEMBL52
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
  2 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  2  0
 11  4  1  0
 22 15  1  0
M  END
>  <PARENT_MOLREGNO>  (491) 
3784

>  <SYNONYMS>  (491) 
Masoprocol (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (491) 
4

>  <RESEARCH_CODES>  (491) 
CHX-100; MESO-NDGA

>  <APPLICANTS>  (491) 
Univ Arizona Cancer Center

>  <USAN_STEM>  (491) 
nan

>  <USAN_STEM_DEFINITION>  (491) 
nan

>  <USAN_STEM_SUBSTEM>  (491) 
nan

>  <USAN_YEAR>  (491) 
1990.0

>  <FIRST_APPROVAL>  (491) 
1992.0

>  <ATC_CODE>  (491) 
L01XX10

>  <ATC_CODE_DESCRIPTION>  (491) 
L01XX10 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (491) 
Antineoplastic

>  <SC_PATENT_NO>  (491) 
nan

>  <DRUG_TYPE>  (491) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (491) 
Y

>  <FIRST_IN_CLASS>  (491) 
N

>  <CHIRALITY>  (491) 
Racemic Mixture

>  <PRODRUG>  (491) 
N

>  <ORAL>  (491) 
N

>  <PARENTERAL>  (491) 
N

>  <TOPICAL>  (491) 
Y

>  <BLACK_BOX>  (491) 
N

>  <AVAILABILITY_TYPE>  (491) 
Discontinued

>  <WITHDRAWN_YEAR>  (491) 
nan

>  <WITHDRAWN_COUNTRY>  (491) 
nan

>  <WITHDRAWN_REASON>  (491) 
nan

>  <CANONICAL_SMILES>  (491) 
CC(Cc1ccc(O)c(O)c1)C(C)Cc2ccc(O)c(O)c2

>  <name>  (491) 
Masoprocol 

>  <MW>  (491) 
302.37

>  <logP>  (491) 
3.5664

$$$$
CHEMBL416956
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 14 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 11 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
  8  3  1  0
 18  9  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (492) 
51162

>  <SYNONYMS>  (492) 
Mefloquine (BAN, INN, USAN); Mefloquine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (492) 
4

>  <RESEARCH_CODES>  (492) 
GNF-Pf-5544; Ro-215998; WR-142490; Ro-215998001

>  <APPLICANTS>  (492) 
United States Army Walter Reed Army Institute Research; U. S. Dept. Of The Army; Hoffmann La Roche Inc

>  <USAN_STEM>  (492) 
nan

>  <USAN_STEM_DEFINITION>  (492) 
nan

>  <USAN_STEM_SUBSTEM>  (492) 
nan

>  <USAN_YEAR>  (492) 
1975.0

>  <FIRST_APPROVAL>  (492) 
1989.0

>  <ATC_CODE>  (492) 
P01BC02

>  <ATC_CODE_DESCRIPTION>  (492) 
P01BC02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Methanolquinolines]

>  <INDICATION_CLASS>  (492) 
Antimalarial

>  <SC_PATENT_NO>  (492) 
nan

>  <DRUG_TYPE>  (492) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (492) 
Y

>  <FIRST_IN_CLASS>  (492) 
N

>  <CHIRALITY>  (492) 
Racemic Mixture

>  <PRODRUG>  (492) 
N

>  <ORAL>  (492) 
Y

>  <PARENTERAL>  (492) 
N

>  <TOPICAL>  (492) 
N

>  <BLACK_BOX>  (492) 
Y

>  <AVAILABILITY_TYPE>  (492) 
Prescription-only

>  <WITHDRAWN_YEAR>  (492) 
nan

>  <WITHDRAWN_COUNTRY>  (492) 
nan

>  <WITHDRAWN_REASON>  (492) 
nan

>  <CANONICAL_SMILES>  (492) 
OC(C1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F

>  <name>  (492) 
Mefloquine 

>  <MW>  (492) 
378.316

>  <logP>  (492) 
4.4479

$$$$
CHEMBL985
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
M  END
>  <PARENT_MOLREGNO>  (493) 
102073

>  <SYNONYMS>  (493) 
Urea (FDA, JAN, USP); Urea (14C) (USP, FDA); Urea (13C) (USP, FDA)

>  <DEVELOPMENT_PHASE>  (493) 
4

>  <RESEARCH_CODES>  (493) 
nan

>  <APPLICANTS>  (493) 
Hospira Inc; Exalenz Bioscience Ltd; Diagnostics And Devices Inc; Avent Inc; Otsuka America Pharmaceuticals Inc

>  <USAN_STEM>  (493) 
nan

>  <USAN_STEM_DEFINITION>  (493) 
nan

>  <USAN_STEM_SUBSTEM>  (493) 
nan

>  <USAN_YEAR>  (493) 
nan

>  <FIRST_APPROVAL>  (493) 
1996.0

>  <ATC_CODE>  (493) 
B05BC02; D02AE01; D02AE51

>  <ATC_CODE_DESCRIPTION>  (493) 
B05BC02 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:I.V. Solutions:Solutions producing osmotic diuresis]; D02AE01 [Dermatologicals:Emollients And Protectives:Emollients And Protectives:Carbamide products]; D02AE51 [Dermatologicals:Emollients And Protectives:Emollients And Protectives:Carbamide products]

>  <INDICATION_CLASS>  (493) 
Diuretic

>  <SC_PATENT_NO>  (493) 
nan

>  <DRUG_TYPE>  (493) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (493) 
Y

>  <FIRST_IN_CLASS>  (493) 
N

>  <CHIRALITY>  (493) 
Achiral Molecule

>  <PRODRUG>  (493) 
N

>  <ORAL>  (493) 
Y

>  <PARENTERAL>  (493) 
Y

>  <TOPICAL>  (493) 
Y

>  <BLACK_BOX>  (493) 
N

>  <AVAILABILITY_TYPE>  (493) 
Prescription-only

>  <WITHDRAWN_YEAR>  (493) 
nan

>  <WITHDRAWN_COUNTRY>  (493) 
nan

>  <WITHDRAWN_REASON>  (493) 
nan

>  <CANONICAL_SMILES>  (493) 
NC(=O)N

>  <name>  (493) 
Urea 

>  <MW>  (493) 
60.056

>  <logP>  (493) 
-0.9762

$$$$
CHEMBL130
     RDKit          

 20 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  3 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  2  0
 18 20  1  0
 17 12  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (494) 
27340

>  <SYNONYMS>  (494) 
Chloramphenicol (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (494) 
4

>  <RESEARCH_CODES>  (494) 
nan

>  <APPLICANTS>  (494) 
Parkedale Pharmaceuticals Inc; Parke Davis Pharmaceutical Research Div Warner Lambert Co; Allergan Pharmaceutical

>  <USAN_STEM>  (494) 
nan

>  <USAN_STEM_DEFINITION>  (494) 
nan

>  <USAN_STEM_SUBSTEM>  (494) 
nan

>  <USAN_YEAR>  (494) 
nan

>  <FIRST_APPROVAL>  (494) 
1950.0

>  <ATC_CODE>  (494) 
J01BA01; S02AA01; S03AA08; D10AF03; G01AA05; D06AX02; S01AA01

>  <ATC_CODE_DESCRIPTION>  (494) 
J01BA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Amphenicols:Amphenicols]; S02AA01 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]; S03AA08 [Sensory Organs:Ophthalmological And Otological Preparations:Antiinfectives:Antiinfectives]; D10AF03 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Antiinfectives for treatment of acne]; G01AA05 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Antibiotics]; D06AX02 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Antibiotics For Topical Use:Other antibiotics for topical use]; S01AA01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]

>  <INDICATION_CLASS>  (494) 
Antibacterial; Antirickettsial

>  <SC_PATENT_NO>  (494) 
nan

>  <DRUG_TYPE>  (494) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (494) 
Y

>  <FIRST_IN_CLASS>  (494) 
N

>  <CHIRALITY>  (494) 
Single Stereoisomer

>  <PRODRUG>  (494) 
N

>  <ORAL>  (494) 
Y

>  <PARENTERAL>  (494) 
Y

>  <TOPICAL>  (494) 
Y

>  <BLACK_BOX>  (494) 
Y

>  <AVAILABILITY_TYPE>  (494) 
Withdrawn

>  <WITHDRAWN_YEAR>  (494) 
2012.0

>  <WITHDRAWN_COUNTRY>  (494) 
United States

>  <WITHDRAWN_REASON>  (494) 
Bone marrow depression (anemia, thrombocytopenia, and granulocytopenia temporally associated with treatment). Bone marrow toxicities may present as either reversible bone marrow depression, which was dose-related and responsive to drug withdrawal, or as aplastic anemia, which was not dose-related, irreversible, and associated with a high mortality

>  <CANONICAL_SMILES>  (494) 
OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-]

>  <name>  (494) 
Chloramphenicol 

>  <MW>  (494) 
323.132

>  <logP>  (494) 
0.909

$$$$
CHEMBL1752
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 10 16  1  0
 16 17  1  0
 17 18  2  0
 17  2  1  0
 16  7  2  0
M  END
>  <PARENT_MOLREGNO>  (495) 
581819

>  <SYNONYMS>  (495) 
Diprophylline (BAN, DCF, INN, JAN); Dyphylline (FDA, USP)

>  <DEVELOPMENT_PHASE>  (495) 
4

>  <RESEARCH_CODES>  (495) 
nan

>  <APPLICANTS>  (495) 
Teva Pharmaceuticals Usa Inc

>  <USAN_STEM>  (495) 
nan

>  <USAN_STEM_DEFINITION>  (495) 
nan

>  <USAN_STEM_SUBSTEM>  (495) 
nan

>  <USAN_YEAR>  (495) 
nan

>  <FIRST_APPROVAL>  (495) 
1951.0

>  <ATC_CODE>  (495) 
R03DA01; R03DA51

>  <ATC_CODE_DESCRIPTION>  (495) 
R03DA01 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA51 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]

>  <INDICATION_CLASS>  (495) 
Bronchodilator

>  <SC_PATENT_NO>  (495) 
nan

>  <DRUG_TYPE>  (495) 
Natural Product-derived

>  <RULE_OF_FIVE>  (495) 
Y

>  <FIRST_IN_CLASS>  (495) 
N

>  <CHIRALITY>  (495) 
Racemic Mixture

>  <PRODRUG>  (495) 
N

>  <ORAL>  (495) 
Y

>  <PARENTERAL>  (495) 
Y

>  <TOPICAL>  (495) 
N

>  <BLACK_BOX>  (495) 
N

>  <AVAILABILITY_TYPE>  (495) 
Prescription-only

>  <WITHDRAWN_YEAR>  (495) 
nan

>  <WITHDRAWN_COUNTRY>  (495) 
nan

>  <WITHDRAWN_REASON>  (495) 
nan

>  <CANONICAL_SMILES>  (495) 
CN1C(=O)N(C)c2ncn(CC(O)CO)c2C1=O

>  <name>  (495) 
Diprophylline 

>  <MW>  (495) 
254.246

>  <logP>  (495) 
-2.2131

$$$$
CHEMBL1405
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 16  2  1  0
 19  2  1  0
 15  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (496) 
342897

>  <SYNONYMS>  (496) 
Estrone (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (496) 
4

>  <RESEARCH_CODES>  (496) 
nan

>  <APPLICANTS>  (496) 
Parkedale Pharmaceuticals Inc

>  <USAN_STEM>  (496) 
estr-

>  <USAN_STEM_DEFINITION>  (496) 
estrogens

>  <USAN_STEM_SUBSTEM>  (496) 
estr-

>  <USAN_YEAR>  (496) 
nan

>  <FIRST_APPROVAL>  (496) 
1979.0

>  <ATC_CODE>  (496) 
G03CA07; G03CC04

>  <ATC_CODE_DESCRIPTION>  (496) 
G03CA07 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Natural and semisynthetic estrogens, plain]; G03CC04 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Estrogens, combinations with other drugs]

>  <INDICATION_CLASS>  (496) 
Estrogen

>  <SC_PATENT_NO>  (496) 
nan

>  <DRUG_TYPE>  (496) 
Natural Product-derived

>  <RULE_OF_FIVE>  (496) 
Y

>  <FIRST_IN_CLASS>  (496) 
N

>  <CHIRALITY>  (496) 
Single Stereoisomer

>  <PRODRUG>  (496) 
N

>  <ORAL>  (496) 
N

>  <PARENTERAL>  (496) 
Y

>  <TOPICAL>  (496) 
N

>  <BLACK_BOX>  (496) 
N

>  <AVAILABILITY_TYPE>  (496) 
Prescription-only

>  <WITHDRAWN_YEAR>  (496) 
nan

>  <WITHDRAWN_COUNTRY>  (496) 
nan

>  <WITHDRAWN_REASON>  (496) 
nan

>  <CANONICAL_SMILES>  (496) 
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O

>  <name>  (496) 
Estrone 

>  <MW>  (496) 
270.372

>  <logP>  (496) 
3.8174

$$$$
CHEMBL1463
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9  2  1  0
M  END
>  <PARENT_MOLREGNO>  (497) 
393942

>  <SYNONYMS>  (497) 
Flucytosine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (497) 
4

>  <RESEARCH_CODES>  (497) 
Ro-29915

>  <APPLICANTS>  (497) 
Valeant Pharmaceuticals International

>  <USAN_STEM>  (497) 
nan

>  <USAN_STEM_DEFINITION>  (497) 
nan

>  <USAN_STEM_SUBSTEM>  (497) 
nan

>  <USAN_YEAR>  (497) 
1969.0

>  <FIRST_APPROVAL>  (497) 
1971.0

>  <ATC_CODE>  (497) 
J02AX01; D01AE21

>  <ATC_CODE_DESCRIPTION>  (497) 
J02AX01 [Antiinfectives For Systemic Use:Antimycotics For Systemic Use:Antimycotics For Systemic Use:Other antimycotics for systemic use]; D01AE21 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (497) 
Antifungal

>  <SC_PATENT_NO>  (497) 
nan

>  <DRUG_TYPE>  (497) 
Natural Product-derived

>  <RULE_OF_FIVE>  (497) 
Y

>  <FIRST_IN_CLASS>  (497) 
N

>  <CHIRALITY>  (497) 
Achiral Molecule

>  <PRODRUG>  (497) 
Y

>  <ORAL>  (497) 
Y

>  <PARENTERAL>  (497) 
N

>  <TOPICAL>  (497) 
N

>  <BLACK_BOX>  (497) 
Y

>  <AVAILABILITY_TYPE>  (497) 
Prescription-only

>  <WITHDRAWN_YEAR>  (497) 
nan

>  <WITHDRAWN_COUNTRY>  (497) 
nan

>  <WITHDRAWN_REASON>  (497) 
nan

>  <CANONICAL_SMILES>  (497) 
NC1=C(F)C=NC(=O)N1

>  <name>  (497) 
Flucytosine 

>  <MW>  (497) 
129.094

>  <logP>  (497) 
-0.5088

$$$$
CHEMBL1238
     RDKit          

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
M  END
>  <PARENT_MOLREGNO>  (498) 
230691

>  <SYNONYMS>  (498) 
Azelaic Acid (FDA, INN, MI, USAN)

>  <DEVELOPMENT_PHASE>  (498) 
4

>  <RESEARCH_CODES>  (498) 
ZK-62498

>  <APPLICANTS>  (498) 
Bayer Healthcare Pharmaceuticals Inc Dermatology; Allergan Inc

>  <USAN_STEM>  (498) 
nan

>  <USAN_STEM_DEFINITION>  (498) 
nan

>  <USAN_STEM_SUBSTEM>  (498) 
nan

>  <USAN_YEAR>  (498) 
1996.0

>  <FIRST_APPROVAL>  (498) 
1995.0

>  <ATC_CODE>  (498) 
D10AX03

>  <ATC_CODE_DESCRIPTION>  (498) 
D10AX03 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Other anti-acne preparations for topical use]

>  <INDICATION_CLASS>  (498) 
Anti-Acne

>  <SC_PATENT_NO>  (498) 
US-6534070-B1

>  <DRUG_TYPE>  (498) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (498) 
Y

>  <FIRST_IN_CLASS>  (498) 
N

>  <CHIRALITY>  (498) 
Achiral Molecule

>  <PRODRUG>  (498) 
N

>  <ORAL>  (498) 
N

>  <PARENTERAL>  (498) 
N

>  <TOPICAL>  (498) 
Y

>  <BLACK_BOX>  (498) 
N

>  <AVAILABILITY_TYPE>  (498) 
Prescription-only

>  <WITHDRAWN_YEAR>  (498) 
nan

>  <WITHDRAWN_COUNTRY>  (498) 
nan

>  <WITHDRAWN_REASON>  (498) 
nan

>  <CANONICAL_SMILES>  (498) 
OC(=O)CCCCCCCC(=O)O

>  <name>  (498) 
Azelaic Acid 

>  <MW>  (498) 
188.223

>  <logP>  (498) 
1.8863

$$$$
CHEMBL193
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 10 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
  9 25  1  0
 11  5  1  0
 17 12  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (499) 
419596

>  <SYNONYMS>  (499) 
Nifedipine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (499) 
4

>  <RESEARCH_CODES>  (499) 
BAY-A-1040

>  <APPLICANTS>  (499) 
Pfizer Laboratories Div Pfizer Inc; Pfizer Inc.; Bayer Pharmaceuticals Corp; Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (499) 
-dipine

>  <USAN_STEM_DEFINITION>  (499) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (499) 
-dipine

>  <USAN_YEAR>  (499) 
1973.0

>  <FIRST_APPROVAL>  (499) 
1981.0

>  <ATC_CODE>  (499) 
C08CA55; C08CA05

>  <ATC_CODE_DESCRIPTION>  (499) 
C08CA55 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]; C08CA05 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (499) 
Vasodilator (coronary)

>  <SC_PATENT_NO>  (499) 
nan

>  <DRUG_TYPE>  (499) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (499) 
Y

>  <FIRST_IN_CLASS>  (499) 
N

>  <CHIRALITY>  (499) 
Achiral Molecule

>  <PRODRUG>  (499) 
N

>  <ORAL>  (499) 
Y

>  <PARENTERAL>  (499) 
N

>  <TOPICAL>  (499) 
N

>  <BLACK_BOX>  (499) 
Y

>  <AVAILABILITY_TYPE>  (499) 
Prescription-only

>  <WITHDRAWN_YEAR>  (499) 
nan

>  <WITHDRAWN_COUNTRY>  (499) 
nan

>  <WITHDRAWN_REASON>  (499) 
nan

>  <CANONICAL_SMILES>  (499) 
COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C

>  <name>  (499) 
Nifedipine 

>  <MW>  (499) 
346.339

>  <logP>  (499) 
2.1756

$$$$
CHEMBL917
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
  7  3  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (500) 
82983

>  <SYNONYMS>  (500) 
Floxuridine (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (500) 
4

>  <RESEARCH_CODES>  (500) 
FUDR

>  <APPLICANTS>  (500) 
Hospira Inc

>  <USAN_STEM>  (500) 
-uridine

>  <USAN_STEM_DEFINITION>  (500) 
antivirals,antineoplastics (uridine derivatives)

>  <USAN_STEM_SUBSTEM>  (500) 
-uridine

>  <USAN_YEAR>  (500) 
1965.0

>  <FIRST_APPROVAL>  (500) 
1970.0

>  <ATC_CODE>  (500) 
nan

>  <ATC_CODE_DESCRIPTION>  (500) 
nan

>  <INDICATION_CLASS>  (500) 
Antineoplastic; Antiviral

>  <SC_PATENT_NO>  (500) 
nan

>  <DRUG_TYPE>  (500) 
Natural Product-derived

>  <RULE_OF_FIVE>  (500) 
Y

>  <FIRST_IN_CLASS>  (500) 
N

>  <CHIRALITY>  (500) 
Single Stereoisomer

>  <PRODRUG>  (500) 
N

>  <ORAL>  (500) 
N

>  <PARENTERAL>  (500) 
Y

>  <TOPICAL>  (500) 
N

>  <BLACK_BOX>  (500) 
Y

>  <AVAILABILITY_TYPE>  (500) 
Prescription-only

>  <WITHDRAWN_YEAR>  (500) 
nan

>  <WITHDRAWN_COUNTRY>  (500) 
nan

>  <WITHDRAWN_REASON>  (500) 
nan

>  <CANONICAL_SMILES>  (500) 
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(F)C(=O)NC2=O

>  <name>  (500) 
Floxuridine 

>  <MW>  (500) 
246.194

>  <logP>  (500) 
-1.6836

$$$$
CHEMBL1187
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  2  5  1  0
M  END
>  <PARENT_MOLREGNO>  (501) 
199357

>  <SYNONYMS>  (501) 
Phosphoric acid (FDA, NF)

>  <DEVELOPMENT_PHASE>  (501) 
4

>  <RESEARCH_CODES>  (501) 
nan

>  <APPLICANTS>  (501) 
Hospira Inc; B Braun Medical Inc; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (501) 
nan

>  <USAN_STEM_DEFINITION>  (501) 
nan

>  <USAN_STEM_SUBSTEM>  (501) 
nan

>  <USAN_YEAR>  (501) 
nan

>  <FIRST_APPROVAL>  (501) 
nan

>  <ATC_CODE>  (501) 
nan

>  <ATC_CODE_DESCRIPTION>  (501) 
nan

>  <INDICATION_CLASS>  (501) 
Pharmaceutic Aid (solvent)

>  <SC_PATENT_NO>  (501) 
nan

>  <DRUG_TYPE>  (501) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (501) 
Y

>  <FIRST_IN_CLASS>  (501) 
N

>  <CHIRALITY>  (501) 
Achiral Molecule

>  <PRODRUG>  (501) 
N

>  <ORAL>  (501) 
N

>  <PARENTERAL>  (501) 
Y

>  <TOPICAL>  (501) 
N

>  <BLACK_BOX>  (501) 
N

>  <AVAILABILITY_TYPE>  (501) 
Prescription-only

>  <WITHDRAWN_YEAR>  (501) 
nan

>  <WITHDRAWN_COUNTRY>  (501) 
nan

>  <WITHDRAWN_REASON>  (501) 
nan

>  <CANONICAL_SMILES>  (501) 
OP(=O)(O)O

>  <name>  (501) 
Phosphoric acid 

>  <MW>  (501) 
97.994

>  <logP>  (501) 
-0.9286

$$$$
CHEMBL1201217
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 11  6  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (502) 
675168

>  <SYNONYMS>  (502) 
Dyclonine (BAN, INN); Dyclocaine (BAN); Dyclonine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (502) 
4

>  <RESEARCH_CODES>  (502) 
nan

>  <APPLICANTS>  (502) 
Astrazeneca Lp

>  <USAN_STEM>  (502) 
nan

>  <USAN_STEM_DEFINITION>  (502) 
nan

>  <USAN_STEM_SUBSTEM>  (502) 
nan

>  <USAN_YEAR>  (502) 
nan

>  <FIRST_APPROVAL>  (502) 
1982.0

>  <ATC_CODE>  (502) 
N01BX02; R02AD04

>  <ATC_CODE_DESCRIPTION>  (502) 
N01BX02 [Nervous System:Anesthetics:Anesthetics, Local:Other local anesthetics]; R02AD04 [Respiratory System:Throat Preparations:Throat Preparations:Anesthetics, local]

>  <INDICATION_CLASS>  (502) 
Anesthetic (topical)

>  <SC_PATENT_NO>  (502) 
nan

>  <DRUG_TYPE>  (502) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (502) 
Y

>  <FIRST_IN_CLASS>  (502) 
N

>  <CHIRALITY>  (502) 
Achiral Molecule

>  <PRODRUG>  (502) 
N

>  <ORAL>  (502) 
N

>  <PARENTERAL>  (502) 
N

>  <TOPICAL>  (502) 
Y

>  <BLACK_BOX>  (502) 
N

>  <AVAILABILITY_TYPE>  (502) 
Discontinued

>  <WITHDRAWN_YEAR>  (502) 
nan

>  <WITHDRAWN_COUNTRY>  (502) 
nan

>  <WITHDRAWN_REASON>  (502) 
nan

>  <CANONICAL_SMILES>  (502) 
CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2

>  <name>  (502) 
Dyclonine 

>  <MW>  (502) 
289.419

>  <logP>  (502) 
3.9242

$$$$
CHEMBL959
     RDKit          

 13 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
  8 13  1  0
 12  4  1  0
 13  4  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (503) 
93858

>  <SYNONYMS>  (503) 
Rimantadine (BAN, INN); Rimantadine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (503) 
4

>  <RESEARCH_CODES>  (503) 
EXP-126

>  <APPLICANTS>  (503) 
Forest Laboratories Inc; Caraco Pharmaceutical Laboratories Ltd

>  <USAN_STEM>  (503) 
-mantadine

>  <USAN_STEM_DEFINITION>  (503) 
antivirals/antiparkinsonians (adamantane derivatives)

>  <USAN_STEM_SUBSTEM>  (503) 
-mantadine

>  <USAN_YEAR>  (503) 
1966.0

>  <FIRST_APPROVAL>  (503) 
1993.0

>  <ATC_CODE>  (503) 
J05AC02

>  <ATC_CODE_DESCRIPTION>  (503) 
J05AC02 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Cyclic amines]

>  <INDICATION_CLASS>  (503) 
Antiviral

>  <SC_PATENT_NO>  (503) 
nan

>  <DRUG_TYPE>  (503) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (503) 
Y

>  <FIRST_IN_CLASS>  (503) 
N

>  <CHIRALITY>  (503) 
Racemic Mixture

>  <PRODRUG>  (503) 
N

>  <ORAL>  (503) 
Y

>  <PARENTERAL>  (503) 
N

>  <TOPICAL>  (503) 
N

>  <BLACK_BOX>  (503) 
N

>  <AVAILABILITY_TYPE>  (503) 
Prescription-only

>  <WITHDRAWN_YEAR>  (503) 
nan

>  <WITHDRAWN_COUNTRY>  (503) 
nan

>  <WITHDRAWN_REASON>  (503) 
nan

>  <CANONICAL_SMILES>  (503) 
CC(N)C12CC3CC(CC(C3)C1)C2

>  <name>  (503) 
Rimantadine 

>  <MW>  (503) 
179.307

>  <logP>  (503) 
2.55

$$$$
CHEMBL461101
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
  4 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
 31 33  2  0
  7  2  1  0
 15 10  1  0
 22 17  1  0
 33 26  1  0
M  END
>  <PARENT_MOLREGNO>  (504) 
457398

>  <SYNONYMS>  (504) 
Eltrombopag (INN); Eltrombopag olamine (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (504) 
4

>  <RESEARCH_CODES>  (504) 
SB-497115-GR

>  <APPLICANTS>  (504) 
GlaxoSmithKline

>  <USAN_STEM>  (504) 
-trombopag

>  <USAN_STEM_DEFINITION>  (504) 
thrombopoetin agonists

>  <USAN_STEM_SUBSTEM>  (504) 
-trombopag

>  <USAN_YEAR>  (504) 
2005.0

>  <FIRST_APPROVAL>  (504) 
2008.0

>  <ATC_CODE>  (504) 
B02BX05

>  <ATC_CODE_DESCRIPTION>  (504) 
B02BX05 [Blood And Blood Forming Organs:Antihemorrhagics:Vitamin K And Other Hemostatics:Other systemic hemostatics]

>  <INDICATION_CLASS>  (504) 
nan

>  <SC_PATENT_NO>  (504) 
US-6280959-B1

>  <DRUG_TYPE>  (504) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (504) 
Y

>  <FIRST_IN_CLASS>  (504) 
N

>  <CHIRALITY>  (504) 
Achiral Molecule

>  <PRODRUG>  (504) 
N

>  <ORAL>  (504) 
Y

>  <PARENTERAL>  (504) 
N

>  <TOPICAL>  (504) 
N

>  <BLACK_BOX>  (504) 
Y

>  <AVAILABILITY_TYPE>  (504) 
Prescription-only

>  <WITHDRAWN_YEAR>  (504) 
nan

>  <WITHDRAWN_COUNTRY>  (504) 
nan

>  <WITHDRAWN_REASON>  (504) 
nan

>  <CANONICAL_SMILES>  (504) 
CC1=NN(C(=O)/C/1=N\Nc2cccc(c2O)c3cccc(c3)C(=O)O)c4ccc(C)c(C)c4

>  <name>  (504) 
Eltrombopag 

>  <MW>  (504) 
442.475

>  <logP>  (504) 
4.56484

$$$$
CHEMBL1201212
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 10  3  1  0
M  END
>  <PARENT_MOLREGNO>  (505) 
675163

>  <SYNONYMS>  (505) 
Midodrine (BAN, INN); Midodrine HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (505) 
4

>  <RESEARCH_CODES>  (505) 
A-4020 Linz; ST-1085 [As The Base]; ST-1085; St. Peter 224

>  <APPLICANTS>  (505) 
Shire Development Llc

>  <USAN_STEM>  (505) 
nan

>  <USAN_STEM_DEFINITION>  (505) 
nan

>  <USAN_STEM_SUBSTEM>  (505) 
nan

>  <USAN_YEAR>  (505) 
1983.0

>  <FIRST_APPROVAL>  (505) 
1996.0

>  <ATC_CODE>  (505) 
C01CA17

>  <ATC_CODE_DESCRIPTION>  (505) 
C01CA17 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (505) 
Antihypotensive

>  <SC_PATENT_NO>  (505) 
nan

>  <DRUG_TYPE>  (505) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (505) 
Y

>  <FIRST_IN_CLASS>  (505) 
N

>  <CHIRALITY>  (505) 
Racemic Mixture

>  <PRODRUG>  (505) 
Y

>  <ORAL>  (505) 
Y

>  <PARENTERAL>  (505) 
N

>  <TOPICAL>  (505) 
N

>  <BLACK_BOX>  (505) 
Y

>  <AVAILABILITY_TYPE>  (505) 
Prescription-only

>  <WITHDRAWN_YEAR>  (505) 
nan

>  <WITHDRAWN_COUNTRY>  (505) 
nan

>  <WITHDRAWN_REASON>  (505) 
nan

>  <CANONICAL_SMILES>  (505) 
COc1ccc(OC)c(c1)C(O)CNC(=O)CN

>  <name>  (505) 
Midodrine 

>  <MW>  (505) 
254.286

>  <logP>  (505) 
-0.1879

$$$$
CHEMBL1196
     RDKit          

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (506) 
209007

>  <SYNONYMS>  (506) 
Proxymetacaine (INN, BAN, DCF); Proparacaine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (506) 
4

>  <RESEARCH_CODES>  (506) 
nan

>  <APPLICANTS>  (506) 
Apothecon Inc Div Bristol Myers Squibb; Allergan Pharmaceutical

>  <USAN_STEM>  (506) 
-caine

>  <USAN_STEM_DEFINITION>  (506) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (506) 
-caine

>  <USAN_YEAR>  (506) 
nan

>  <FIRST_APPROVAL>  (506) 
1953.0

>  <ATC_CODE>  (506) 
S01HA04

>  <ATC_CODE_DESCRIPTION>  (506) 
S01HA04 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]

>  <INDICATION_CLASS>  (506) 
Anesthetic (topical, ophthalmic)

>  <SC_PATENT_NO>  (506) 
nan

>  <DRUG_TYPE>  (506) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (506) 
Y

>  <FIRST_IN_CLASS>  (506) 
N

>  <CHIRALITY>  (506) 
Achiral Molecule

>  <PRODRUG>  (506) 
N

>  <ORAL>  (506) 
N

>  <PARENTERAL>  (506) 
N

>  <TOPICAL>  (506) 
Y

>  <BLACK_BOX>  (506) 
N

>  <AVAILABILITY_TYPE>  (506) 
Prescription-only

>  <WITHDRAWN_YEAR>  (506) 
nan

>  <WITHDRAWN_COUNTRY>  (506) 
nan

>  <WITHDRAWN_REASON>  (506) 
nan

>  <CANONICAL_SMILES>  (506) 
CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC

>  <name>  (506) 
Proxymetacaine 

>  <MW>  (506) 
294.395

>  <logP>  (506) 
2.5562

$$$$
CHEMBL1201250
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  2  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 25  8  1  0
 23 10  1  0
 22 13  1  0
M  END
>  <PARENT_MOLREGNO>  (507) 
675201

>  <SYNONYMS>  (507) 
Benzquinamide (BAN, INN, USAN); Benzquinamide HCl (FDA)

>  <DEVELOPMENT_PHASE>  (507) 
4

>  <RESEARCH_CODES>  (507) 
P-2647

>  <APPLICANTS>  (507) 
Roerig Div Pfizer Inc; Roerig; Pfizer Inc.

>  <USAN_STEM>  (507) 
nan

>  <USAN_STEM_DEFINITION>  (507) 
nan

>  <USAN_STEM_SUBSTEM>  (507) 
nan

>  <USAN_YEAR>  (507) 
1962.0

>  <FIRST_APPROVAL>  (507) 
1974.0

>  <ATC_CODE>  (507) 
nan

>  <ATC_CODE_DESCRIPTION>  (507) 
nan

>  <INDICATION_CLASS>  (507) 
Anti-Emetic

>  <SC_PATENT_NO>  (507) 
nan

>  <DRUG_TYPE>  (507) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (507) 
Y

>  <FIRST_IN_CLASS>  (507) 
N

>  <CHIRALITY>  (507) 
Racemic Mixture

>  <PRODRUG>  (507) 
N

>  <ORAL>  (507) 
N

>  <PARENTERAL>  (507) 
Y

>  <TOPICAL>  (507) 
Y

>  <BLACK_BOX>  (507) 
N

>  <AVAILABILITY_TYPE>  (507) 
Discontinued

>  <WITHDRAWN_YEAR>  (507) 
nan

>  <WITHDRAWN_COUNTRY>  (507) 
nan

>  <WITHDRAWN_REASON>  (507) 
nan

>  <CANONICAL_SMILES>  (507) 
CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C

>  <name>  (507) 
Benzquinamide 

>  <MW>  (507) 
404.507

>  <logP>  (507) 
2.423

$$$$
CHEMBL1201772
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  9 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 14 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 13  5  1  0
 12  7  2  0
 19 17  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (508) 
675723

>  <SYNONYMS>  (508) 
Prasugrel (INN); Prasugrel HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (508) 
4

>  <RESEARCH_CODES>  (508) 
nan

>  <APPLICANTS>  (508) 
Eli Lilly And Co

>  <USAN_STEM>  (508) 
-grel

>  <USAN_STEM_DEFINITION>  (508) 
platelet aggregation inhibitors

>  <USAN_STEM_SUBSTEM>  (508) 
-grel

>  <USAN_YEAR>  (508) 
2004.0

>  <FIRST_APPROVAL>  (508) 
2009.0

>  <ATC_CODE>  (508) 
B01AC22

>  <ATC_CODE_DESCRIPTION>  (508) 
B01AC22 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (508) 
nan

>  <SC_PATENT_NO>  (508) 
US-5288726-A

>  <DRUG_TYPE>  (508) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (508) 
Y

>  <FIRST_IN_CLASS>  (508) 
N

>  <CHIRALITY>  (508) 
Racemic Mixture

>  <PRODRUG>  (508) 
Y

>  <ORAL>  (508) 
Y

>  <PARENTERAL>  (508) 
N

>  <TOPICAL>  (508) 
N

>  <BLACK_BOX>  (508) 
Y

>  <AVAILABILITY_TYPE>  (508) 
Prescription-only

>  <WITHDRAWN_YEAR>  (508) 
nan

>  <WITHDRAWN_COUNTRY>  (508) 
nan

>  <WITHDRAWN_REASON>  (508) 
nan

>  <CANONICAL_SMILES>  (508) 
CC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C3CC3)c4ccccc4F

>  <name>  (508) 
Prasugrel 

>  <MW>  (508) 
373.449

>  <logP>  (508) 
3.891

$$$$
CHEMBL1377
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (509) 
320522

>  <SYNONYMS>  (509) 
Proguanil (INN, BAN, DCF); Chloroguanide HCl (USP); Proguanil HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (509) 
4

>  <RESEARCH_CODES>  (509) 
336U50; GWAH7673A

>  <APPLICANTS>  (509) 
GlaxoSmithKline

>  <USAN_STEM>  (509) 
nan

>  <USAN_STEM_DEFINITION>  (509) 
nan

>  <USAN_STEM_SUBSTEM>  (509) 
nan

>  <USAN_YEAR>  (509) 
nan

>  <FIRST_APPROVAL>  (509) 
2000.0

>  <ATC_CODE>  (509) 
P01BB01; P01BB51

>  <ATC_CODE_DESCRIPTION>  (509) 
P01BB01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Biguanides]; P01BB51 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Biguanides]

>  <INDICATION_CLASS>  (509) 
nan

>  <SC_PATENT_NO>  (509) 
nan

>  <DRUG_TYPE>  (509) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (509) 
Y

>  <FIRST_IN_CLASS>  (509) 
N

>  <CHIRALITY>  (509) 
Achiral Molecule

>  <PRODRUG>  (509) 
Y

>  <ORAL>  (509) 
Y

>  <PARENTERAL>  (509) 
N

>  <TOPICAL>  (509) 
N

>  <BLACK_BOX>  (509) 
N

>  <AVAILABILITY_TYPE>  (509) 
Prescription-only

>  <WITHDRAWN_YEAR>  (509) 
nan

>  <WITHDRAWN_COUNTRY>  (509) 
nan

>  <WITHDRAWN_REASON>  (509) 
nan

>  <CANONICAL_SMILES>  (509) 
CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1

>  <name>  (509) 
Proguanil 

>  <MW>  (509) 
253.737

>  <logP>  (509) 
2.20904

$$$$
CHEMBL238804
     RDKit          

 35 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
  4 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 21 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 29 18  1  0
 27 22  1  0
 35 30  1  0
M  END
>  <PARENT_MOLREGNO>  (510) 
406189

>  <SYNONYMS>  (510) 
Selexipag (INN, USAN)

>  <DEVELOPMENT_PHASE>  (510) 
4

>  <RESEARCH_CODES>  (510) 
ACT-293987; NS-304

>  <APPLICANTS>  (510) 
Actelion Pharmaceuticals Ltd

>  <USAN_STEM>  (510) 
nan

>  <USAN_STEM_DEFINITION>  (510) 
nan

>  <USAN_STEM_SUBSTEM>  (510) 
nan

>  <USAN_YEAR>  (510) 
2011.0

>  <FIRST_APPROVAL>  (510) 
2015.0

>  <ATC_CODE>  (510) 
B01AC27

>  <ATC_CODE_DESCRIPTION>  (510) 
B01AC27 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (510) 
nan

>  <SC_PATENT_NO>  (510) 
US-7205302-B2

>  <DRUG_TYPE>  (510) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (510) 
Y

>  <FIRST_IN_CLASS>  (510) 
N

>  <CHIRALITY>  (510) 
Achiral Molecule

>  <PRODRUG>  (510) 
N

>  <ORAL>  (510) 
Y

>  <PARENTERAL>  (510) 
N

>  <TOPICAL>  (510) 
N

>  <BLACK_BOX>  (510) 
N

>  <AVAILABILITY_TYPE>  (510) 
Prescription-only

>  <WITHDRAWN_YEAR>  (510) 
nan

>  <WITHDRAWN_COUNTRY>  (510) 
nan

>  <WITHDRAWN_REASON>  (510) 
nan

>  <CANONICAL_SMILES>  (510) 
CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c2ccccc2)c(n1)c3ccccc3

>  <name>  (510) 
Selexipag 

>  <MW>  (510) 
496.633

>  <logP>  (510) 
3.898

$$$$
CHEMBL198362
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 13 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
  6  2  1  0
 16 11  1  0
 22 17  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (511) 
328601

>  <SYNONYMS>  (511) 
Rivaroxaban (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (511) 
4

>  <RESEARCH_CODES>  (511) 
BAY-59-7939

>  <APPLICANTS>  (511) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (511) 
-xaban

>  <USAN_STEM_DEFINITION>  (511) 
antithrombotic: blood coagulation factor XA inhibitors

>  <USAN_STEM_SUBSTEM>  (511) 
-xaban

>  <USAN_YEAR>  (511) 
2006.0

>  <FIRST_APPROVAL>  (511) 
2011.0

>  <ATC_CODE>  (511) 
B01AF01

>  <ATC_CODE_DESCRIPTION>  (511) 
B01AF01 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Direct factor Xa inhibitors]

>  <INDICATION_CLASS>  (511) 
nan

>  <SC_PATENT_NO>  (511) 
US-7157456-B2

>  <DRUG_TYPE>  (511) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (511) 
Y

>  <FIRST_IN_CLASS>  (511) 
Y

>  <CHIRALITY>  (511) 
Single Stereoisomer

>  <PRODRUG>  (511) 
N

>  <ORAL>  (511) 
Y

>  <PARENTERAL>  (511) 
N

>  <TOPICAL>  (511) 
N

>  <BLACK_BOX>  (511) 
Y

>  <AVAILABILITY_TYPE>  (511) 
Prescription-only

>  <WITHDRAWN_YEAR>  (511) 
nan

>  <WITHDRAWN_COUNTRY>  (511) 
nan

>  <WITHDRAWN_REASON>  (511) 
nan

>  <CANONICAL_SMILES>  (511) 
Clc1ccc(s1)C(=O)NC[C@H]2CN(C(=O)O2)c3ccc(cc3)N4CCOCC4=O

>  <name>  (511) 
Rivaroxaban 

>  <MW>  (511) 
435.889

>  <logP>  (511) 
2.5199

$$$$
CHEMBL898
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  6 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
  9  4  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (512) 
77652

>  <SYNONYMS>  (512) 
Diflunisal (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (512) 
4

>  <RESEARCH_CODES>  (512) 
nan

>  <APPLICANTS>  (512) 
Merck And Co Inc

>  <USAN_STEM>  (512) 
-sal

>  <USAN_STEM_DEFINITION>  (512) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (512) 
-sal

>  <USAN_YEAR>  (512) 
1975.0

>  <FIRST_APPROVAL>  (512) 
1982.0

>  <ATC_CODE>  (512) 
N02BA11

>  <ATC_CODE_DESCRIPTION>  (512) 
N02BA11 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Salicylic acid and derivatives]

>  <INDICATION_CLASS>  (512) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (512) 
nan

>  <DRUG_TYPE>  (512) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (512) 
Y

>  <FIRST_IN_CLASS>  (512) 
N

>  <CHIRALITY>  (512) 
Achiral Molecule

>  <PRODRUG>  (512) 
N

>  <ORAL>  (512) 
Y

>  <PARENTERAL>  (512) 
N

>  <TOPICAL>  (512) 
N

>  <BLACK_BOX>  (512) 
Y

>  <AVAILABILITY_TYPE>  (512) 
Prescription-only

>  <WITHDRAWN_YEAR>  (512) 
nan

>  <WITHDRAWN_COUNTRY>  (512) 
nan

>  <WITHDRAWN_REASON>  (512) 
nan

>  <CANONICAL_SMILES>  (512) 
OC(=O)c1cc(ccc1O)c2ccc(F)cc2F

>  <name>  (512) 
Diflunisal 

>  <MW>  (512) 
250.2

>  <logP>  (512) 
3.0356

$$$$
CHEMBL1441
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (513) 
374005

>  <SYNONYMS>  (513) 
Ethionamide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (513) 
4

>  <RESEARCH_CODES>  (513) 
1314 TH

>  <APPLICANTS>  (513) 
Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (513) 
nan

>  <USAN_STEM_DEFINITION>  (513) 
nan

>  <USAN_STEM_SUBSTEM>  (513) 
nan

>  <USAN_YEAR>  (513) 
1961.0

>  <FIRST_APPROVAL>  (513) 
1965.0

>  <ATC_CODE>  (513) 
J04AD03

>  <ATC_CODE_DESCRIPTION>  (513) 
J04AD03 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Thiocarbamide derivatives]

>  <INDICATION_CLASS>  (513) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (513) 
nan

>  <DRUG_TYPE>  (513) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (513) 
Y

>  <FIRST_IN_CLASS>  (513) 
N

>  <CHIRALITY>  (513) 
Achiral Molecule

>  <PRODRUG>  (513) 
Y

>  <ORAL>  (513) 
Y

>  <PARENTERAL>  (513) 
N

>  <TOPICAL>  (513) 
N

>  <BLACK_BOX>  (513) 
N

>  <AVAILABILITY_TYPE>  (513) 
Prescription-only

>  <WITHDRAWN_YEAR>  (513) 
nan

>  <WITHDRAWN_COUNTRY>  (513) 
nan

>  <WITHDRAWN_REASON>  (513) 
nan

>  <CANONICAL_SMILES>  (513) 
CCc1cc(ccn1)C(=S)N

>  <name>  (513) 
Ethionamide 

>  <MW>  (513) 
166.249

>  <logP>  (513) 
1.2782

$$$$
CHEMBL1200522
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 17 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
  8  3  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (514) 
674473

>  <SYNONYMS>  (514) 
Avobenzone (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (514) 
4

>  <RESEARCH_CODES>  (514) 
nan

>  <APPLICANTS>  (514) 
Schering Plough Healthcare Products Inc; Loreal Usa Products Inc

>  <USAN_STEM>  (514) 
nan

>  <USAN_STEM_DEFINITION>  (514) 
nan

>  <USAN_STEM_SUBSTEM>  (514) 
nan

>  <USAN_YEAR>  (514) 
1989.0

>  <FIRST_APPROVAL>  (514) 
1992.0

>  <ATC_CODE>  (514) 
nan

>  <ATC_CODE_DESCRIPTION>  (514) 
nan

>  <INDICATION_CLASS>  (514) 
Sunscreen

>  <SC_PATENT_NO>  (514) 
nan

>  <DRUG_TYPE>  (514) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (514) 
Y

>  <FIRST_IN_CLASS>  (514) 
N

>  <CHIRALITY>  (514) 
Achiral Molecule

>  <PRODRUG>  (514) 
N

>  <ORAL>  (514) 
N

>  <PARENTERAL>  (514) 
N

>  <TOPICAL>  (514) 
Y

>  <BLACK_BOX>  (514) 
N

>  <AVAILABILITY_TYPE>  (514) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (514) 
nan

>  <WITHDRAWN_COUNTRY>  (514) 
nan

>  <WITHDRAWN_REASON>  (514) 
nan

>  <CANONICAL_SMILES>  (514) 
COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C

>  <name>  (514) 
Avobenzone 

>  <MW>  (514) 
310.393

>  <logP>  (514) 
4.4484

$$$$
CHEMBL1043
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
  7  2  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (515) 
126356

>  <SYNONYMS>  (515) 
Dapsone (BAN, FDA, INN, USAN, USP); Diaphenylsulfone (DCF)

>  <DEVELOPMENT_PHASE>  (515) 
4

>  <RESEARCH_CODES>  (515) 
nan

>  <APPLICANTS>  (515) 
Allergan Inc

>  <USAN_STEM>  (515) 
-dapsone

>  <USAN_STEM_DEFINITION>  (515) 
antimycobacterials (diaminodiphenylsulfone derivatives)

>  <USAN_STEM_SUBSTEM>  (515) 
-dapsone

>  <USAN_YEAR>  (515) 
1963.0

>  <FIRST_APPROVAL>  (515) 
1979.0

>  <ATC_CODE>  (515) 
D10AX05; J04BA02

>  <ATC_CODE_DESCRIPTION>  (515) 
D10AX05 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Other anti-acne preparations for topical use]; J04BA02 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Lepra:Drugs for treatment of lepra]

>  <INDICATION_CLASS>  (515) 
Antibacterial (leprostatic); Suppressant (dermatitis herpetiformis)

>  <SC_PATENT_NO>  (515) 
US-5863560-A

>  <DRUG_TYPE>  (515) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (515) 
Y

>  <FIRST_IN_CLASS>  (515) 
N

>  <CHIRALITY>  (515) 
Achiral Molecule

>  <PRODRUG>  (515) 
N

>  <ORAL>  (515) 
Y

>  <PARENTERAL>  (515) 
N

>  <TOPICAL>  (515) 
Y

>  <BLACK_BOX>  (515) 
N

>  <AVAILABILITY_TYPE>  (515) 
Prescription-only

>  <WITHDRAWN_YEAR>  (515) 
nan

>  <WITHDRAWN_COUNTRY>  (515) 
nan

>  <WITHDRAWN_REASON>  (515) 
nan

>  <CANONICAL_SMILES>  (515) 
Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2

>  <name>  (515) 
Dapsone 

>  <MW>  (515) 
248.307

>  <logP>  (515) 
1.6838

$$$$
CHEMBL483254
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 18 25  1  0
 25 26  2  0
 10  2  2  0
  9  4  1  0
 26 15  1  0
M  END
>  <PARENT_MOLREGNO>  (516) 
499179

>  <SYNONYMS>  (516) 
Panobinostat (INN, USAN); Panobinostat lactate (FDA)

>  <DEVELOPMENT_PHASE>  (516) 
4

>  <RESEARCH_CODES>  (516) 
LBH589

>  <APPLICANTS>  (516) 
Novartis Pharmaceuticals Corp; Novartis Ag

>  <USAN_STEM>  (516) 
-stat

>  <USAN_STEM_DEFINITION>  (516) 
enzyme inhibitors: inhibitors of histone deacetylase

>  <USAN_STEM_SUBSTEM>  (516) 
-stat (-inostat)

>  <USAN_YEAR>  (516) 
2011.0

>  <FIRST_APPROVAL>  (516) 
2015.0

>  <ATC_CODE>  (516) 
L01XX42

>  <ATC_CODE_DESCRIPTION>  (516) 
L01XX42 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (516) 
nan

>  <SC_PATENT_NO>  (516) 
US-6552065-B2

>  <DRUG_TYPE>  (516) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (516) 
Y

>  <FIRST_IN_CLASS>  (516) 
N

>  <CHIRALITY>  (516) 
Achiral Molecule

>  <PRODRUG>  (516) 
N

>  <ORAL>  (516) 
Y

>  <PARENTERAL>  (516) 
N

>  <TOPICAL>  (516) 
N

>  <BLACK_BOX>  (516) 
Y

>  <AVAILABILITY_TYPE>  (516) 
Prescription-only

>  <WITHDRAWN_YEAR>  (516) 
nan

>  <WITHDRAWN_COUNTRY>  (516) 
nan

>  <WITHDRAWN_REASON>  (516) 
nan

>  <CANONICAL_SMILES>  (516) 
Cc1[nH]c2ccccc2c1CCNCc3ccc(\C=C\C(=O)NO)cc3

>  <name>  (516) 
Panobinostat 

>  <MW>  (516) 
349.434

>  <logP>  (516) 
3.32722

$$$$
CHEMBL1738990
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
  6 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 13  8  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (517) 
1118041

>  <SYNONYMS>  (517) 
Levopropoxyphene (BAN, INN); Levopropoxyphene Napsylate (USAN, USP); Levopropoxyphene Napsylate Anhydrous (FDA)

>  <DEVELOPMENT_PHASE>  (517) 
4

>  <RESEARCH_CODES>  (517) 
29866

>  <APPLICANTS>  (517) 
Eli Lilly Industries Inc

>  <USAN_STEM>  (517) 
nan

>  <USAN_STEM_DEFINITION>  (517) 
nan

>  <USAN_STEM_SUBSTEM>  (517) 
nan

>  <USAN_YEAR>  (517) 
1962.0

>  <FIRST_APPROVAL>  (517) 
1962.0

>  <ATC_CODE>  (517) 
nan

>  <ATC_CODE_DESCRIPTION>  (517) 
nan

>  <INDICATION_CLASS>  (517) 
Antitussive

>  <SC_PATENT_NO>  (517) 
nan

>  <DRUG_TYPE>  (517) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (517) 
Y

>  <FIRST_IN_CLASS>  (517) 
N

>  <CHIRALITY>  (517) 
Single Stereoisomer

>  <PRODRUG>  (517) 
N

>  <ORAL>  (517) 
Y

>  <PARENTERAL>  (517) 
N

>  <TOPICAL>  (517) 
N

>  <BLACK_BOX>  (517) 
N

>  <AVAILABILITY_TYPE>  (517) 
Discontinued

>  <WITHDRAWN_YEAR>  (517) 
nan

>  <WITHDRAWN_COUNTRY>  (517) 
nan

>  <WITHDRAWN_REASON>  (517) 
nan

>  <CANONICAL_SMILES>  (517) 
CCC(=O)O[C@](Cc1ccccc1)([C@@H](C)CN(C)C)c2ccccc2

>  <name>  (517) 
Levopropoxyphene 

>  <MW>  (517) 
339.479

>  <logP>  (517) 
4.2755

$$$$
CHEMBL505
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (518) 
10358

>  <SYNONYMS>  (518) 
Chlorphenamine (INN); Chlorpheniramine (BAN); Chlorpheniramine Polistirex (FDA, USAN); Chlorpheniramine maleate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (518) 
4

>  <RESEARCH_CODES>  (518) 
nan

>  <APPLICANTS>  (518) 
Dm Graham Laboratories Inc; Cypress Pharmaceutical Inc; Central Pharmaceuticals Inc; Alza Corp; Ucb Inc

>  <USAN_STEM>  (518) 
nan

>  <USAN_STEM_DEFINITION>  (518) 
nan

>  <USAN_STEM_SUBSTEM>  (518) 
nan

>  <USAN_YEAR>  (518) 
1987.0

>  <FIRST_APPROVAL>  (518) 
1950.0

>  <ATC_CODE>  (518) 
R06AB54; R06AB04

>  <ATC_CODE_DESCRIPTION>  (518) 
R06AB54 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]; R06AB04 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]

>  <INDICATION_CLASS>  (518) 
Antihistaminic

>  <SC_PATENT_NO>  (518) 
US-6248363-B1

>  <DRUG_TYPE>  (518) 
Polymer

>  <RULE_OF_FIVE>  (518) 
Y

>  <FIRST_IN_CLASS>  (518) 
N

>  <CHIRALITY>  (518) 
Single Stereoisomer

>  <PRODRUG>  (518) 
N

>  <ORAL>  (518) 
Y

>  <PARENTERAL>  (518) 
Y

>  <TOPICAL>  (518) 
N

>  <BLACK_BOX>  (518) 
N

>  <AVAILABILITY_TYPE>  (518) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (518) 
nan

>  <WITHDRAWN_COUNTRY>  (518) 
nan

>  <WITHDRAWN_REASON>  (518) 
nan

>  <CANONICAL_SMILES>  (518) 
CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2

>  <name>  (518) 
Chlorphenamine 

>  <MW>  (518) 
274.795

>  <logP>  (518) 
3.8186

$$$$
CHEMBL1108
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
  7  2  1  0
 18 13  1  0
 28 19  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (519) 
152751

>  <SYNONYMS>  (519) 
Droperidol (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (519) 
4

>  <RESEARCH_CODES>  (519) 
McN-JR-4749; R-4749

>  <APPLICANTS>  (519) 
Akorn Manufacturing Inc; Akorn Inc

>  <USAN_STEM>  (519) 
-peridol

>  <USAN_STEM_DEFINITION>  (519) 
antipsychotics (haloperidol type)

>  <USAN_STEM_SUBSTEM>  (519) 
-peridol

>  <USAN_YEAR>  (519) 
1963.0

>  <FIRST_APPROVAL>  (519) 
1970.0

>  <ATC_CODE>  (519) 
N05AD08

>  <ATC_CODE_DESCRIPTION>  (519) 
N05AD08 [Nervous System:Psycholeptics:Antipsychotics:Butyrophenone derivatives]

>  <INDICATION_CLASS>  (519) 
Antipsychotic

>  <SC_PATENT_NO>  (519) 
nan

>  <DRUG_TYPE>  (519) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (519) 
Y

>  <FIRST_IN_CLASS>  (519) 
N

>  <CHIRALITY>  (519) 
Achiral Molecule

>  <PRODRUG>  (519) 
N

>  <ORAL>  (519) 
N

>  <PARENTERAL>  (519) 
Y

>  <TOPICAL>  (519) 
N

>  <BLACK_BOX>  (519) 
Y

>  <AVAILABILITY_TYPE>  (519) 
Prescription-only

>  <WITHDRAWN_YEAR>  (519) 
nan

>  <WITHDRAWN_COUNTRY>  (519) 
nan

>  <WITHDRAWN_REASON>  (519) 
nan

>  <CANONICAL_SMILES>  (519) 
Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34

>  <name>  (519) 
Droperidol 

>  <MW>  (519) 
379.435

>  <logP>  (519) 
3.6784

$$$$
CHEMBL658
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  5 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 12 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 18 26  1  0
 26 27  1  0
 11  6  1  0
 27 12  1  0
 25 21  1  0
M  END
>  <PARENT_MOLREGNO>  (520) 
27638

>  <SYNONYMS>  (520) 
Sufentanil (BAN, INN, USAN); Sufentanil Citrate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (520) 
4

>  <RESEARCH_CODES>  (520) 
R-30730; R-33800

>  <APPLICANTS>  (520) 
Janssen Pharmaceutica, Belgium; Akorn Inc

>  <USAN_STEM>  (520) 
-fentanil

>  <USAN_STEM_DEFINITION>  (520) 
narcotic analgesics (fentanyl derivatives)

>  <USAN_STEM_SUBSTEM>  (520) 
-fentanil

>  <USAN_YEAR>  (520) 
1976.0

>  <FIRST_APPROVAL>  (520) 
1984.0

>  <ATC_CODE>  (520) 
N01AH03

>  <ATC_CODE_DESCRIPTION>  (520) 
N01AH03 [Nervous System:Anesthetics:Anesthetics, General:Opioid anesthetics]

>  <INDICATION_CLASS>  (520) 
Analgesic; Analgesic (narcotic)

>  <SC_PATENT_NO>  (520) 
nan

>  <DRUG_TYPE>  (520) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (520) 
Y

>  <FIRST_IN_CLASS>  (520) 
N

>  <CHIRALITY>  (520) 
Achiral Molecule

>  <PRODRUG>  (520) 
N

>  <ORAL>  (520) 
N

>  <PARENTERAL>  (520) 
Y

>  <TOPICAL>  (520) 
N

>  <BLACK_BOX>  (520) 
N

>  <AVAILABILITY_TYPE>  (520) 
Prescription-only

>  <WITHDRAWN_YEAR>  (520) 
nan

>  <WITHDRAWN_COUNTRY>  (520) 
nan

>  <WITHDRAWN_REASON>  (520) 
nan

>  <CANONICAL_SMILES>  (520) 
CCC(=O)N(c1ccccc1)C2(COC)CCN(CCc3cccs3)CC2

>  <name>  (520) 
Sufentanil 

>  <MW>  (520) 
386.561

>  <logP>  (520) 
4.2148

$$$$
CHEMBL438
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
  6 18  2  0
 18  2  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (521) 
2130

>  <SYNONYMS>  (521) 
Sulfamerazine (BAN, FDA, INN, USP); Sulfamerazine (Trisulfapyrimidines) (FDA); Sulfamerazine Sodium [Injection] (INN, NF)

>  <DEVELOPMENT_PHASE>  (521) 
4

>  <RESEARCH_CODES>  (521) 
nan

>  <APPLICANTS>  (521) 
Lederle Laboratories Div American Cyanamid Co; Eli Lilly And Co; Bristol Myers Squibb Co

>  <USAN_STEM>  (521) 
sulfa-

>  <USAN_STEM_DEFINITION>  (521) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (521) 
sulfa-

>  <USAN_YEAR>  (521) 
nan

>  <FIRST_APPROVAL>  (521) 
1982.0

>  <ATC_CODE>  (521) 
J01ED07; D06BA06

>  <ATC_CODE_DESCRIPTION>  (521) 
J01ED07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]; D06BA06 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]

>  <INDICATION_CLASS>  (521) 
Antibacterial

>  <SC_PATENT_NO>  (521) 
nan

>  <DRUG_TYPE>  (521) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (521) 
Y

>  <FIRST_IN_CLASS>  (521) 
N

>  <CHIRALITY>  (521) 
Achiral Molecule

>  <PRODRUG>  (521) 
N

>  <ORAL>  (521) 
Y

>  <PARENTERAL>  (521) 
N

>  <TOPICAL>  (521) 
N

>  <BLACK_BOX>  (521) 
N

>  <AVAILABILITY_TYPE>  (521) 
Discontinued

>  <WITHDRAWN_YEAR>  (521) 
nan

>  <WITHDRAWN_COUNTRY>  (521) 
nan

>  <WITHDRAWN_REASON>  (521) 
nan

>  <CANONICAL_SMILES>  (521) 
Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1

>  <name>  (521) 
Sulfamerazine 

>  <MW>  (521) 
264.31

>  <logP>  (521) 
1.16802

$$$$
CHEMBL783
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 13 21  1  0
 21 22  2  0
 21 23  1  0
  9  4  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (522) 
46727

>  <SYNONYMS>  (522) 
Nateglinide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (522) 
4

>  <RESEARCH_CODES>  (522) 
A-4166; AY-4166; DJN-608; SDZ DJN 608; SDZ-DJN-608

>  <APPLICANTS>  (522) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (522) 
-glinide

>  <USAN_STEM_DEFINITION>  (522) 
antidiabetic, SGLT2 inhibitors, not phlorozin derivatives

>  <USAN_STEM_SUBSTEM>  (522) 
-glinide

>  <USAN_YEAR>  (522) 
2000.0

>  <FIRST_APPROVAL>  (522) 
2000.0

>  <ATC_CODE>  (522) 
A10BX03

>  <ATC_CODE_DESCRIPTION>  (522) 
A10BX03 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Other blood glucose lowering drugs, excl. insulins]

>  <INDICATION_CLASS>  (522) 
nan

>  <SC_PATENT_NO>  (522) 
US-6559188-B1

>  <DRUG_TYPE>  (522) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (522) 
Y

>  <FIRST_IN_CLASS>  (522) 
N

>  <CHIRALITY>  (522) 
Single Stereoisomer

>  <PRODRUG>  (522) 
N

>  <ORAL>  (522) 
Y

>  <PARENTERAL>  (522) 
N

>  <TOPICAL>  (522) 
N

>  <BLACK_BOX>  (522) 
N

>  <AVAILABILITY_TYPE>  (522) 
Prescription-only

>  <WITHDRAWN_YEAR>  (522) 
nan

>  <WITHDRAWN_COUNTRY>  (522) 
nan

>  <WITHDRAWN_REASON>  (522) 
nan

>  <CANONICAL_SMILES>  (522) 
CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@H](Cc2ccccc2)C(=O)O

>  <name>  (522) 
Nateglinide 

>  <MW>  (522) 
317.429

>  <logP>  (522) 
3.2609

$$$$
CHEMBL1482
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  CHG  1   4   1
M  END
>  <PARENT_MOLREGNO>  (523) 
406520

>  <SYNONYMS>  (523) 
Bethanechol chloride (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (523) 
4

>  <RESEARCH_CODES>  (523) 
nan

>  <APPLICANTS>  (523) 
Odyssey Pharmaceuticals Inc

>  <USAN_STEM>  (523) 
nan

>  <USAN_STEM_DEFINITION>  (523) 
nan

>  <USAN_STEM_SUBSTEM>  (523) 
nan

>  <USAN_YEAR>  (523) 
nan

>  <FIRST_APPROVAL>  (523) 
1948.0

>  <ATC_CODE>  (523) 
N07AB02

>  <ATC_CODE_DESCRIPTION>  (523) 
N07AB02 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Choline esters]

>  <INDICATION_CLASS>  (523) 
Cholinergic

>  <SC_PATENT_NO>  (523) 
nan

>  <DRUG_TYPE>  (523) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (523) 
Y

>  <FIRST_IN_CLASS>  (523) 
N

>  <CHIRALITY>  (523) 
Racemic Mixture

>  <PRODRUG>  (523) 
N

>  <ORAL>  (523) 
Y

>  <PARENTERAL>  (523) 
Y

>  <TOPICAL>  (523) 
N

>  <BLACK_BOX>  (523) 
N

>  <AVAILABILITY_TYPE>  (523) 
Prescription-only

>  <WITHDRAWN_YEAR>  (523) 
nan

>  <WITHDRAWN_COUNTRY>  (523) 
nan

>  <WITHDRAWN_REASON>  (523) 
nan

>  <CANONICAL_SMILES>  (523) 
CC(C[N+](C)(C)C)OC(=O)N

>  <name>  (523) 
Bethanechol chloride 

>  <MW>  (523) 
161.225

>  <logP>  (523) 
0.1764

$$$$
CHEMBL1200975
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
 24  2  1  0
 22  4  1  0
 17  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (524) 
674926

>  <SYNONYMS>  (524) 
Clocortolone Pivalate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (524) 
4

>  <RESEARCH_CODES>  (524) 
SH-863

>  <APPLICANTS>  (524) 
Promius Pharma Llc

>  <USAN_STEM>  (524) 
-olone

>  <USAN_STEM_DEFINITION>  (524) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (524) 
-olone

>  <USAN_YEAR>  (524) 
1972.0

>  <FIRST_APPROVAL>  (524) 
1977.0

>  <ATC_CODE>  (524) 
D07AB21

>  <ATC_CODE_DESCRIPTION>  (524) 
D07AB21 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]

>  <INDICATION_CLASS>  (524) 
Glucocorticoid

>  <SC_PATENT_NO>  (524) 
nan

>  <DRUG_TYPE>  (524) 
Natural Product-derived

>  <RULE_OF_FIVE>  (524) 
Y

>  <FIRST_IN_CLASS>  (524) 
N

>  <CHIRALITY>  (524) 
Single Stereoisomer

>  <PRODRUG>  (524) 
N

>  <ORAL>  (524) 
N

>  <PARENTERAL>  (524) 
N

>  <TOPICAL>  (524) 
Y

>  <BLACK_BOX>  (524) 
N

>  <AVAILABILITY_TYPE>  (524) 
Prescription-only

>  <WITHDRAWN_YEAR>  (524) 
nan

>  <WITHDRAWN_COUNTRY>  (524) 
nan

>  <WITHDRAWN_REASON>  (524) 
nan

>  <CANONICAL_SMILES>  (524) 
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C

>  <name>  (524) 
Clocortolone Pivalate 

>  <MW>  (524) 
495.031

>  <logP>  (524) 
4.5951

$$$$
CHEMBL53292
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
  3 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 12  2  1  0
 11  6  1  0
 23 18  2  0
M  END
>  <PARENT_MOLREGNO>  (525) 
78364

>  <SYNONYMS>  (525) 
Isoxicam (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (525) 
4

>  <RESEARCH_CODES>  (525) 
W-8495

>  <APPLICANTS>  (525) 
Parke-Davis

>  <USAN_STEM>  (525) 
-icam

>  <USAN_STEM_DEFINITION>  (525) 
anti-inflammatory agents (isoxicam type)

>  <USAN_STEM_SUBSTEM>  (525) 
-icam

>  <USAN_YEAR>  (525) 
1974.0

>  <FIRST_APPROVAL>  (525) 
nan

>  <ATC_CODE>  (525) 
nan

>  <ATC_CODE_DESCRIPTION>  (525) 
nan

>  <INDICATION_CLASS>  (525) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (525) 
nan

>  <DRUG_TYPE>  (525) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (525) 
Y

>  <FIRST_IN_CLASS>  (525) 
N

>  <CHIRALITY>  (525) 
Achiral Molecule

>  <PRODRUG>  (525) 
N

>  <ORAL>  (525) 
N

>  <PARENTERAL>  (525) 
N

>  <TOPICAL>  (525) 
N

>  <BLACK_BOX>  (525) 
N

>  <AVAILABILITY_TYPE>  (525) 
Withdrawn

>  <WITHDRAWN_YEAR>  (525) 
1983.0

>  <WITHDRAWN_COUNTRY>  (525) 
Spain; Germany; France

>  <WITHDRAWN_REASON>  (525) 
Stevens Johnson Syndrome; Toxic Epidermal Necrolysis

>  <CANONICAL_SMILES>  (525) 
CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3cc(C)on3

>  <name>  (525) 
Isoxicam 

>  <MW>  (525) 
335.341

>  <logP>  (525) 
1.48242

$$$$
CHEMBL1580
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
  7  3  1  0
 19  9  1  0
 19 12  2  0
M  END
>  <PARENT_MOLREGNO>  (526) 
453578

>  <SYNONYMS>  (526) 
Pentostatin (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (526) 
4

>  <RESEARCH_CODES>  (526) 
CI-825; PD-81565

>  <APPLICANTS>  (526) 
Hospira Inc

>  <USAN_STEM>  (526) 
-stat-

>  <USAN_STEM_DEFINITION>  (526) 
enzyme inhibitors

>  <USAN_STEM_SUBSTEM>  (526) 
-stat-

>  <USAN_YEAR>  (526) 
1977.0

>  <FIRST_APPROVAL>  (526) 
1991.0

>  <ATC_CODE>  (526) 
L01XX08

>  <ATC_CODE_DESCRIPTION>  (526) 
L01XX08 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (526) 
Potentiator

>  <SC_PATENT_NO>  (526) 
nan

>  <DRUG_TYPE>  (526) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (526) 
Y

>  <FIRST_IN_CLASS>  (526) 
N

>  <CHIRALITY>  (526) 
Single Stereoisomer

>  <PRODRUG>  (526) 
N

>  <ORAL>  (526) 
N

>  <PARENTERAL>  (526) 
Y

>  <TOPICAL>  (526) 
N

>  <BLACK_BOX>  (526) 
Y

>  <AVAILABILITY_TYPE>  (526) 
Prescription-only

>  <WITHDRAWN_YEAR>  (526) 
nan

>  <WITHDRAWN_COUNTRY>  (526) 
nan

>  <WITHDRAWN_REASON>  (526) 
nan

>  <CANONICAL_SMILES>  (526) 
OC[C@H]1O[C@H](C[C@@H]1O)n2cnc3[C@H](O)CNC=Nc23

>  <name>  (526) 
Pentostatin 

>  <MW>  (526) 
268.273

>  <logP>  (526) 
-1.1798

$$$$
CHEMBL1201302
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 29 32  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (527) 
675253

>  <SYNONYMS>  (527) 
Dexamethasone Sodium Phosphate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (527) 
4

>  <RESEARCH_CODES>  (527) 
nan

>  <APPLICANTS>  (527) 
Ucb Inc; Organon Usa Inc; Merck And Co Inc

>  <USAN_STEM>  (527) 
nan

>  <USAN_STEM_DEFINITION>  (527) 
nan

>  <USAN_STEM_SUBSTEM>  (527) 
nan

>  <USAN_YEAR>  (527) 
nan

>  <FIRST_APPROVAL>  (527) 
1959.0

>  <ATC_CODE>  (527) 
D07XB05; R01AD03; D10AA03; H02AB02; C05AA09; A01AC02; S01BA01; S03BA01; S02BA06; D07AB19; S01CB01; R01AD53

>  <ATC_CODE_DESCRIPTION>  (527) 
D07XB05 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD03 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; D10AA03 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; H02AB02 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; C05AA09 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A01AC02 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S03BA01 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; S02BA06 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; D07AB19 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]; S01CB01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; R01AD53 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]

>  <INDICATION_CLASS>  (527) 
Glucocorticoid

>  <SC_PATENT_NO>  (527) 
nan

>  <DRUG_TYPE>  (527) 
Natural Product-derived

>  <RULE_OF_FIVE>  (527) 
Y

>  <FIRST_IN_CLASS>  (527) 
N

>  <CHIRALITY>  (527) 
Single Stereoisomer

>  <PRODRUG>  (527) 
Y

>  <ORAL>  (527) 
N

>  <PARENTERAL>  (527) 
Y

>  <TOPICAL>  (527) 
Y

>  <BLACK_BOX>  (527) 
N

>  <AVAILABILITY_TYPE>  (527) 
Prescription-only

>  <WITHDRAWN_YEAR>  (527) 
nan

>  <WITHDRAWN_COUNTRY>  (527) 
nan

>  <WITHDRAWN_REASON>  (527) 
nan

>  <CANONICAL_SMILES>  (527) 
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O

>  <name>  (527) 
Dexamethasone Sodium Phosphate 

>  <MW>  (527) 
472.446

>  <logP>  (527) 
2.0127

$$$$
CHEMBL1437
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (528) 
372912

>  <SYNONYMS>  (528) 
Norepinephrine (INN, JAN); Noradrenaline (BAN); Norepinephrine Bitartrate (FDA, USAN, USP); Norepinephrine HCl (JAN)

>  <DEVELOPMENT_PHASE>  (528) 
4

>  <RESEARCH_CODES>  (528) 
nan

>  <APPLICANTS>  (528) 
Hospira Inc; Eastman Kodak Co

>  <USAN_STEM>  (528) 
nan

>  <USAN_STEM_DEFINITION>  (528) 
nan

>  <USAN_STEM_SUBSTEM>  (528) 
nan

>  <USAN_YEAR>  (528) 
1980.0

>  <FIRST_APPROVAL>  (528) 
1950.0

>  <ATC_CODE>  (528) 
C01CA03

>  <ATC_CODE_DESCRIPTION>  (528) 
C01CA03 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (528) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (528) 
nan

>  <DRUG_TYPE>  (528) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (528) 
Y

>  <FIRST_IN_CLASS>  (528) 
N

>  <CHIRALITY>  (528) 
Single Stereoisomer

>  <PRODRUG>  (528) 
N

>  <ORAL>  (528) 
N

>  <PARENTERAL>  (528) 
Y

>  <TOPICAL>  (528) 
N

>  <BLACK_BOX>  (528) 
Y

>  <AVAILABILITY_TYPE>  (528) 
Prescription-only

>  <WITHDRAWN_YEAR>  (528) 
nan

>  <WITHDRAWN_COUNTRY>  (528) 
nan

>  <WITHDRAWN_REASON>  (528) 
nan

>  <CANONICAL_SMILES>  (528) 
NC[C@H](O)c1ccc(O)c(O)c1

>  <name>  (528) 
Norepinephrine 

>  <MW>  (528) 
169.18

>  <logP>  (528) 
0.0899

$$$$
CHEMBL682
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
  9 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24  7  1  0
 21 11  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (529) 
29097

>  <SYNONYMS>  (529) 
Amodiaquine (BAN, INN, USP); Amodiaquine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (529) 
4

>  <RESEARCH_CODES>  (529) 
GNF-Pf-5648; SJ000110703; TCMDC-123932

>  <APPLICANTS>  (529) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (529) 
nan

>  <USAN_STEM_DEFINITION>  (529) 
nan

>  <USAN_STEM_SUBSTEM>  (529) 
nan

>  <USAN_YEAR>  (529) 
nan

>  <FIRST_APPROVAL>  (529) 
1982.0

>  <ATC_CODE>  (529) 
P01BA06

>  <ATC_CODE_DESCRIPTION>  (529) 
P01BA06 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Aminoquinolines]

>  <INDICATION_CLASS>  (529) 
Antimalarial; Antiprotozoal

>  <SC_PATENT_NO>  (529) 
nan

>  <DRUG_TYPE>  (529) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (529) 
Y

>  <FIRST_IN_CLASS>  (529) 
N

>  <CHIRALITY>  (529) 
Achiral Molecule

>  <PRODRUG>  (529) 
N

>  <ORAL>  (529) 
Y

>  <PARENTERAL>  (529) 
N

>  <TOPICAL>  (529) 
N

>  <BLACK_BOX>  (529) 
N

>  <AVAILABILITY_TYPE>  (529) 
Discontinued

>  <WITHDRAWN_YEAR>  (529) 
nan

>  <WITHDRAWN_COUNTRY>  (529) 
nan

>  <WITHDRAWN_REASON>  (529) 
nan

>  <CANONICAL_SMILES>  (529) 
CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O

>  <name>  (529) 
Amodiaquine 

>  <MW>  (529) 
355.869

>  <logP>  (529) 
5.1792

$$$$
CHEMBL95889
     RDKit          

  8  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (530) 
160056

>  <SYNONYMS>  (530) 
Betaine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (530) 
4

>  <RESEARCH_CODES>  (530) 
nan

>  <APPLICANTS>  (530) 
Rare Disease Therapeutics Inc

>  <USAN_STEM>  (530) 
nan

>  <USAN_STEM_DEFINITION>  (530) 
nan

>  <USAN_STEM_SUBSTEM>  (530) 
nan

>  <USAN_YEAR>  (530) 
nan

>  <FIRST_APPROVAL>  (530) 
1996.0

>  <ATC_CODE>  (530) 
A16AA06; A09AB02

>  <ATC_CODE_DESCRIPTION>  (530) 
A16AA06 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Amino acids and derivatives]; A09AB02 [Alimentary Tract And Metabolism:Digestives, Incl. Enzymes:Digestives, Incl. Enzymes:Acid preparations]

>  <INDICATION_CLASS>  (530) 
Replenisher Adjunct (electrolyte)

>  <SC_PATENT_NO>  (530) 
nan

>  <DRUG_TYPE>  (530) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (530) 
Y

>  <FIRST_IN_CLASS>  (530) 
N

>  <CHIRALITY>  (530) 
Achiral Molecule

>  <PRODRUG>  (530) 
N

>  <ORAL>  (530) 
Y

>  <PARENTERAL>  (530) 
N

>  <TOPICAL>  (530) 
N

>  <BLACK_BOX>  (530) 
N

>  <AVAILABILITY_TYPE>  (530) 
Prescription-only

>  <WITHDRAWN_YEAR>  (530) 
nan

>  <WITHDRAWN_COUNTRY>  (530) 
nan

>  <WITHDRAWN_REASON>  (530) 
nan

>  <CANONICAL_SMILES>  (530) 
C[N+](C)(C)CC(=O)O

>  <name>  (530) 
Betaine HCl 

>  <MW>  (530) 
118.156

>  <logP>  (530) 
-0.2228

$$$$
CHEMBL6622
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  9 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 12  5  1  0
 12  8  1  0
M  CHG  4   1  -1   2   1  14   1  16  -1
M  END
>  <PARENT_MOLREGNO>  (531) 
556

>  <SYNONYMS>  (531) 
Isosorbide Dinitrate (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (531) 
4

>  <RESEARCH_CODES>  (531) 
nan

>  <APPLICANTS>  (531) 
Schwarz Pharma Inc; Biovail Laboratories Inc; Astrazeneca Pharmaceuticals Lp; Arbor Pharmaceuticals Inc; Valeant International Barbados Srl

>  <USAN_STEM>  (531) 
nan

>  <USAN_STEM_DEFINITION>  (531) 
nan

>  <USAN_STEM_SUBSTEM>  (531) 
nan

>  <USAN_YEAR>  (531) 
1966.0

>  <FIRST_APPROVAL>  (531) 
1986.0

>  <ATC_CODE>  (531) 
C05AE02; C01DA08; C01DA58

>  <ATC_CODE_DESCRIPTION>  (531) 
C05AE02 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Muscle relaxants]; C01DA08 [Cardiovascular System:Cardiac Therapy:Vasodilators Used In Cardiac Diseases:Organic nitrates]; C01DA58 [Cardiovascular System:Cardiac Therapy:Vasodilators Used In Cardiac Diseases:Organic nitrates]

>  <INDICATION_CLASS>  (531) 
Vasodilator (coronary)

>  <SC_PATENT_NO>  (531) 
US-6465463-B1

>  <DRUG_TYPE>  (531) 
Natural Product-derived

>  <RULE_OF_FIVE>  (531) 
Y

>  <FIRST_IN_CLASS>  (531) 
N

>  <CHIRALITY>  (531) 
Single Stereoisomer

>  <PRODRUG>  (531) 
Y

>  <ORAL>  (531) 
Y

>  <PARENTERAL>  (531) 
N

>  <TOPICAL>  (531) 
Y

>  <BLACK_BOX>  (531) 
N

>  <AVAILABILITY_TYPE>  (531) 
Prescription-only

>  <WITHDRAWN_YEAR>  (531) 
nan

>  <WITHDRAWN_COUNTRY>  (531) 
nan

>  <WITHDRAWN_REASON>  (531) 
nan

>  <CANONICAL_SMILES>  (531) 
[O-][N+](=O)O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+](=O)[O-]

>  <name>  (531) 
Isosorbide Dinitrate 

>  <MW>  (531) 
236.136

>  <logP>  (531) 
-1.0622

$$$$
CHEMBL1200559
     RDKit          

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
M  END
>  <PARENT_MOLREGNO>  (532) 
674510

>  <SYNONYMS>  (532) 
Lactic Acid (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (532) 
4

>  <RESEARCH_CODES>  (532) 
nan

>  <APPLICANTS>  (532) 
Gambro Renal Products

>  <USAN_STEM>  (532) 
nan

>  <USAN_STEM_DEFINITION>  (532) 
nan

>  <USAN_STEM_SUBSTEM>  (532) 
nan

>  <USAN_YEAR>  (532) 
nan

>  <FIRST_APPROVAL>  (532) 
2006.0

>  <ATC_CODE>  (532) 
G01AD01

>  <ATC_CODE_DESCRIPTION>  (532) 
G01AD01 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Organic acids]

>  <INDICATION_CLASS>  (532) 
nan

>  <SC_PATENT_NO>  (532) 
nan

>  <DRUG_TYPE>  (532) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (532) 
Y

>  <FIRST_IN_CLASS>  (532) 
N

>  <CHIRALITY>  (532) 
Racemic Mixture

>  <PRODRUG>  (532) 
N

>  <ORAL>  (532) 
N

>  <PARENTERAL>  (532) 
Y

>  <TOPICAL>  (532) 
N

>  <BLACK_BOX>  (532) 
N

>  <AVAILABILITY_TYPE>  (532) 
Prescription-only

>  <WITHDRAWN_YEAR>  (532) 
nan

>  <WITHDRAWN_COUNTRY>  (532) 
nan

>  <WITHDRAWN_REASON>  (532) 
nan

>  <CANONICAL_SMILES>  (532) 
CC(O)C(=O)O

>  <name>  (532) 
Lactic Acid 

>  <MW>  (532) 
90.078

>  <logP>  (532) 
-0.5482

$$$$
CHEMBL181
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14  2  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (533) 
364859

>  <SYNONYMS>  (533) 
Diazoxide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (533) 
4

>  <RESEARCH_CODES>  (533) 
SCH-6783; SRG-95213

>  <APPLICANTS>  (533) 
Teva Global Respiratory Research Llc; Teva Branded Pharmaceutical Products R And D Inc; Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (533) 
nan

>  <USAN_STEM_DEFINITION>  (533) 
nan

>  <USAN_STEM_SUBSTEM>  (533) 
nan

>  <USAN_YEAR>  (533) 
1962.0

>  <FIRST_APPROVAL>  (533) 
1973.0

>  <ATC_CODE>  (533) 
V03AH01; C02DA01

>  <ATC_CODE_DESCRIPTION>  (533) 
V03AH01 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Drugs for treatment of hypoglycemia]; C02DA01 [Cardiovascular System:Antihypertensives:Arteriolar Smooth Muscle, Agents Acting On:Thiazide derivatives]

>  <INDICATION_CLASS>  (533) 
Antihypertensive

>  <SC_PATENT_NO>  (533) 
nan

>  <DRUG_TYPE>  (533) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (533) 
Y

>  <FIRST_IN_CLASS>  (533) 
N

>  <CHIRALITY>  (533) 
Achiral Molecule

>  <PRODRUG>  (533) 
N

>  <ORAL>  (533) 
Y

>  <PARENTERAL>  (533) 
Y

>  <TOPICAL>  (533) 
N

>  <BLACK_BOX>  (533) 
N

>  <AVAILABILITY_TYPE>  (533) 
Prescription-only

>  <WITHDRAWN_YEAR>  (533) 
nan

>  <WITHDRAWN_COUNTRY>  (533) 
nan

>  <WITHDRAWN_REASON>  (533) 
nan

>  <CANONICAL_SMILES>  (533) 
CC1=NS(=O)(=O)c2cc(Cl)ccc2N1

>  <name>  (533) 
Diazoxide 

>  <MW>  (533) 
230.676

>  <logP>  (533) 
1.8726

$$$$
CHEMBL94081
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  8 13  1  0
 13 14  1  0
 13 15  2  0
 15  5  1  0
M  END
>  <PARENT_MOLREGNO>  (534) 
150722

>  <SYNONYMS>  (534) 
Alclofenac (BAN, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (534) 
4

>  <RESEARCH_CODES>  (534) 
W-7320

>  <APPLICANTS>  (534) 
Continental Pharma, Belgium

>  <USAN_STEM>  (534) 
-ac

>  <USAN_STEM_DEFINITION>  (534) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (534) 
-ac

>  <USAN_YEAR>  (534) 
1971.0

>  <FIRST_APPROVAL>  (534) 
nan

>  <ATC_CODE>  (534) 
M01AB06

>  <ATC_CODE_DESCRIPTION>  (534) 
M01AB06 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (534) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (534) 
nan

>  <DRUG_TYPE>  (534) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (534) 
Y

>  <FIRST_IN_CLASS>  (534) 
N

>  <CHIRALITY>  (534) 
Achiral Molecule

>  <PRODRUG>  (534) 
N

>  <ORAL>  (534) 
N

>  <PARENTERAL>  (534) 
N

>  <TOPICAL>  (534) 
N

>  <BLACK_BOX>  (534) 
N

>  <AVAILABILITY_TYPE>  (534) 
Withdrawn

>  <WITHDRAWN_YEAR>  (534) 
1979.0

>  <WITHDRAWN_COUNTRY>  (534) 
United Kingdom

>  <WITHDRAWN_REASON>  (534) 
Vasculitis; Rash

>  <CANONICAL_SMILES>  (534) 
OC(=O)Cc1ccc(OCC=C)c(Cl)c1

>  <name>  (534) 
Alclofenac 

>  <MW>  (534) 
226.659

>  <logP>  (534) 
2.5319

$$$$
CHEMBL1201109
     RDKit          

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 26  2  1  0
 25  5  1  0
 23  7  1  0
 19  8  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (535) 
675060

>  <SYNONYMS>  (535) 
Desonide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (535) 
4

>  <RESEARCH_CODES>  (535) 
D-2083; D2083

>  <APPLICANTS>  (535) 
Perrigo New York Inc; Galderma Laboratories Lp; Bayer Pharmaceuticals Corp; Bayer Healthcare Pharmaceuticals Inc Dermatology; Stiefel Laboratories Inc

>  <USAN_STEM>  (535) 
-onide

>  <USAN_STEM_DEFINITION>  (535) 
topical steroids (acetal derivatives)

>  <USAN_STEM_SUBSTEM>  (535) 
-onide

>  <USAN_YEAR>  (535) 
1970.0

>  <FIRST_APPROVAL>  (535) 
1972.0

>  <ATC_CODE>  (535) 
D07AB08; S01BA11

>  <ATC_CODE_DESCRIPTION>  (535) 
D07AB08 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]; S01BA11 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]

>  <INDICATION_CLASS>  (535) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (535) 
US-6387383-B1

>  <DRUG_TYPE>  (535) 
Natural Product-derived

>  <RULE_OF_FIVE>  (535) 
Y

>  <FIRST_IN_CLASS>  (535) 
N

>  <CHIRALITY>  (535) 
Single Stereoisomer

>  <PRODRUG>  (535) 
Y

>  <ORAL>  (535) 
N

>  <PARENTERAL>  (535) 
N

>  <TOPICAL>  (535) 
Y

>  <BLACK_BOX>  (535) 
N

>  <AVAILABILITY_TYPE>  (535) 
Prescription-only

>  <WITHDRAWN_YEAR>  (535) 
nan

>  <WITHDRAWN_COUNTRY>  (535) 
nan

>  <WITHDRAWN_REASON>  (535) 
nan

>  <CANONICAL_SMILES>  (535) 
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

>  <name>  (535) 
Desonide 

>  <MW>  (535) 
416.514

>  <logP>  (535) 
2.3267

$$$$
CHEMBL781
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  2 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 13  2  1  0
  7  3  1  0
 13  8  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (536) 
46385

>  <SYNONYMS>  (536) 
Mazindol (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (536) 
4

>  <RESEARCH_CODES>  (536) 
42-548

>  <APPLICANTS>  (536) 
Wyeth Ayerst Laboratories; Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (536) 
nan

>  <USAN_STEM_DEFINITION>  (536) 
nan

>  <USAN_STEM_SUBSTEM>  (536) 
nan

>  <USAN_YEAR>  (536) 
1970.0

>  <FIRST_APPROVAL>  (536) 
1973.0

>  <ATC_CODE>  (536) 
A08AA05

>  <ATC_CODE_DESCRIPTION>  (536) 
A08AA05 [Alimentary Tract And Metabolism:Antiobesity Preparations, Excl. Diet Products:Antiobesity Preparations, Excl. Diet Products:Centrally acting antiobesity products]

>  <INDICATION_CLASS>  (536) 
Anorexic

>  <SC_PATENT_NO>  (536) 
nan

>  <DRUG_TYPE>  (536) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (536) 
Y

>  <FIRST_IN_CLASS>  (536) 
N

>  <CHIRALITY>  (536) 
Racemic Mixture

>  <PRODRUG>  (536) 
N

>  <ORAL>  (536) 
Y

>  <PARENTERAL>  (536) 
N

>  <TOPICAL>  (536) 
N

>  <BLACK_BOX>  (536) 
N

>  <AVAILABILITY_TYPE>  (536) 
Discontinued

>  <WITHDRAWN_YEAR>  (536) 
nan

>  <WITHDRAWN_COUNTRY>  (536) 
nan

>  <WITHDRAWN_REASON>  (536) 
nan

>  <CANONICAL_SMILES>  (536) 
OC1(N2CCN=C2c3ccccc13)c4ccc(Cl)cc4

>  <name>  (536) 
Mazindol 

>  <MW>  (536) 
284.746

>  <logP>  (536) 
2.6092

$$$$
CHEMBL850
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  4  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 19 23  1  0
 23 24  2  0
 24 25  1  0
 17 26  1  0
 26 27  2  0
 26 28  1  0
  8  2  1  0
 24  9  1  0
 23 14  1  0
 22 20  1  0
M  END
>  <PARENT_MOLREGNO>  (537) 
65351

>  <SYNONYMS>  (537) 
Sparfloxacin (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (537) 
4

>  <RESEARCH_CODES>  (537) 
AT-4140; CI-978

>  <APPLICANTS>  (537) 
Mylan Pharmaceuticals Inc

>  <USAN_STEM>  (537) 
-oxacin

>  <USAN_STEM_DEFINITION>  (537) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (537) 
-oxacin

>  <USAN_YEAR>  (537) 
1991.0

>  <FIRST_APPROVAL>  (537) 
1996.0

>  <ATC_CODE>  (537) 
J01MA09

>  <ATC_CODE_DESCRIPTION>  (537) 
J01MA09 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]

>  <INDICATION_CLASS>  (537) 
Antibacterial

>  <SC_PATENT_NO>  (537) 
nan

>  <DRUG_TYPE>  (537) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (537) 
Y

>  <FIRST_IN_CLASS>  (537) 
N

>  <CHIRALITY>  (537) 
Single Stereoisomer

>  <PRODRUG>  (537) 
N

>  <ORAL>  (537) 
Y

>  <PARENTERAL>  (537) 
N

>  <TOPICAL>  (537) 
N

>  <BLACK_BOX>  (537) 
N

>  <AVAILABILITY_TYPE>  (537) 
Withdrawn

>  <WITHDRAWN_YEAR>  (537) 
2001.0

>  <WITHDRAWN_COUNTRY>  (537) 
United States

>  <WITHDRAWN_REASON>  (537) 
QT prolongation and phototoxicity

>  <CANONICAL_SMILES>  (537) 
C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3C(=O)C(=CN(C4CC4)c3c2F)C(=O)O

>  <name>  (537) 
Sparfloxacin 

>  <MW>  (537) 
392.406

>  <logP>  (537) 
2.0816

$$$$
CHEMBL1098
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 10  5  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (538) 
150882

>  <SYNONYMS>  (538) 
Bupivacaine (BAN, FDA, INN, USAN); Bupivacaine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (538) 
4

>  <RESEARCH_CODES>  (538) 
SKY-0402; LAC-43; WIN-11318

>  <APPLICANTS>  (538) 
Pacira Pharmaceuticals Inc; Hospira Inc; Fresenius Kabi Usa Llc; Amphastar Pharmaceuticals Inc

>  <USAN_STEM>  (538) 
-caine

>  <USAN_STEM_DEFINITION>  (538) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (538) 
-caine

>  <USAN_YEAR>  (538) 
1967.0

>  <FIRST_APPROVAL>  (538) 
1972.0

>  <ATC_CODE>  (538) 
N01BB01; N01BB51

>  <ATC_CODE_DESCRIPTION>  (538) 
N01BB01 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB51 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (538) 
Anesthetic (local)

>  <SC_PATENT_NO>  (538) 
US-8182835-B2

>  <DRUG_TYPE>  (538) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (538) 
Y

>  <FIRST_IN_CLASS>  (538) 
N

>  <CHIRALITY>  (538) 
Racemic Mixture

>  <PRODRUG>  (538) 
N

>  <ORAL>  (538) 
N

>  <PARENTERAL>  (538) 
Y

>  <TOPICAL>  (538) 
N

>  <BLACK_BOX>  (538) 
Y

>  <AVAILABILITY_TYPE>  (538) 
Prescription-only

>  <WITHDRAWN_YEAR>  (538) 
nan

>  <WITHDRAWN_COUNTRY>  (538) 
nan

>  <WITHDRAWN_REASON>  (538) 
nan

>  <CANONICAL_SMILES>  (538) 
CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C

>  <name>  (538) 
Bupivacaine 

>  <MW>  (538) 
288.435

>  <logP>  (538) 
3.89654

$$$$
CHEMBL1581
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
  4 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 18 10  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (539) 
453579

>  <SYNONYMS>  (539) 
Perindopril (BAN, INN, USAN); Perindopril arginine (FDA); Perindopril Erbumine (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (539) 
4

>  <RESEARCH_CODES>  (539) 
McN-A-2833; S-9490; McN-A-2833-109; S-9490-3

>  <APPLICANTS>  (539) 
Xoma (Us) Llc; Symplmed Pharmaceuticals Llc; Ortho-Mcneil

>  <USAN_STEM>  (539) 
-pril

>  <USAN_STEM_DEFINITION>  (539) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (539) 
-pril

>  <USAN_YEAR>  (539) 
1988.0

>  <FIRST_APPROVAL>  (539) 
1993.0

>  <ATC_CODE>  (539) 
C09AA04

>  <ATC_CODE_DESCRIPTION>  (539) 
C09AA04 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (539) 
Enzyme Inhibitor (angiotensin-converting); Antihypertensive

>  <SC_PATENT_NO>  (539) 
US-6696481-B2

>  <DRUG_TYPE>  (539) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (539) 
Y

>  <FIRST_IN_CLASS>  (539) 
N

>  <CHIRALITY>  (539) 
Single Stereoisomer

>  <PRODRUG>  (539) 
Y

>  <ORAL>  (539) 
Y

>  <PARENTERAL>  (539) 
N

>  <TOPICAL>  (539) 
N

>  <BLACK_BOX>  (539) 
Y

>  <AVAILABILITY_TYPE>  (539) 
Prescription-only

>  <WITHDRAWN_YEAR>  (539) 
nan

>  <WITHDRAWN_COUNTRY>  (539) 
nan

>  <WITHDRAWN_REASON>  (539) 
nan

>  <CANONICAL_SMILES>  (539) 
CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C(=O)OCC

>  <name>  (539) 
Perindopril 

>  <MW>  (539) 
368.474

>  <logP>  (539) 
1.9406

$$$$
CHEMBL1738
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 11  4  1  0
 19 12  1  0
M  END
>  <PARENT_MOLREGNO>  (540) 
567195

>  <SYNONYMS>  (540) 
Dexrazoxane (BAN, INN, USAN); Dexrazoxane HCl (FDA)

>  <DEVELOPMENT_PHASE>  (540) 
4

>  <RESEARCH_CODES>  (540) 
ADR-529; ICRF-187

>  <APPLICANTS>  (540) 
Pharmacia And Upjohn Co; Pharmacia & Upjohn; Apricus Pharmaceuticals Usa Inc

>  <USAN_STEM>  (540) 
nan

>  <USAN_STEM_DEFINITION>  (540) 
nan

>  <USAN_STEM_SUBSTEM>  (540) 
nan

>  <USAN_YEAR>  (540) 
1990.0

>  <FIRST_APPROVAL>  (540) 
1995.0

>  <ATC_CODE>  (540) 
V03AF02

>  <ATC_CODE_DESCRIPTION>  (540) 
V03AF02 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Detoxifying agents for antineoplastic treatment]

>  <INDICATION_CLASS>  (540) 
Cardioprotectant

>  <SC_PATENT_NO>  (540) 
US-6727253-B2

>  <DRUG_TYPE>  (540) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (540) 
Y

>  <FIRST_IN_CLASS>  (540) 
N

>  <CHIRALITY>  (540) 
Single Stereoisomer

>  <PRODRUG>  (540) 
N

>  <ORAL>  (540) 
N

>  <PARENTERAL>  (540) 
Y

>  <TOPICAL>  (540) 
N

>  <BLACK_BOX>  (540) 
N

>  <AVAILABILITY_TYPE>  (540) 
Prescription-only

>  <WITHDRAWN_YEAR>  (540) 
nan

>  <WITHDRAWN_COUNTRY>  (540) 
nan

>  <WITHDRAWN_REASON>  (540) 
nan

>  <CANONICAL_SMILES>  (540) 
C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2

>  <name>  (540) 
Dexrazoxane 

>  <MW>  (540) 
268.273

>  <logP>  (540) 
-2.7083

$$$$
CHEMBL707
     RDKit          

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 13  3  1  0
 11  5  1  0
 21 16  1  0
 33 24  1  0
 32 27  1  0
M  END
>  <PARENT_MOLREGNO>  (541) 
33373

>  <SYNONYMS>  (541) 
Doxazosin (BAN, INN); Doxazosin Mesilate (JAN); Doxazosin Mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (541) 
4

>  <RESEARCH_CODES>  (541) 
UK-3327427; UK-33274-27

>  <APPLICANTS>  (541) 
Pfizer Laboratories Div Pfizer Inc; Pfizer Inc.

>  <USAN_STEM>  (541) 
-azosin

>  <USAN_STEM_DEFINITION>  (541) 
antihypertensives (prazosin type)

>  <USAN_STEM_SUBSTEM>  (541) 
-azosin

>  <USAN_YEAR>  (541) 
1981.0

>  <FIRST_APPROVAL>  (541) 
1990.0

>  <ATC_CODE>  (541) 
C02CA04

>  <ATC_CODE_DESCRIPTION>  (541) 
C02CA04 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Peripherally Acting:Alpha-adrenoreceptor antagonists]

>  <INDICATION_CLASS>  (541) 
Antihypertensive

>  <SC_PATENT_NO>  (541) 
nan

>  <DRUG_TYPE>  (541) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (541) 
Y

>  <FIRST_IN_CLASS>  (541) 
N

>  <CHIRALITY>  (541) 
Racemic Mixture

>  <PRODRUG>  (541) 
N

>  <ORAL>  (541) 
Y

>  <PARENTERAL>  (541) 
N

>  <TOPICAL>  (541) 
N

>  <BLACK_BOX>  (541) 
N

>  <AVAILABILITY_TYPE>  (541) 
Prescription-only

>  <WITHDRAWN_YEAR>  (541) 
nan

>  <WITHDRAWN_COUNTRY>  (541) 
nan

>  <WITHDRAWN_REASON>  (541) 
nan

>  <CANONICAL_SMILES>  (541) 
COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4

>  <name>  (541) 
Doxazosin 

>  <MW>  (541) 
451.483

>  <logP>  (541) 
1.7178

$$$$
CHEMBL45024
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (542) 
67198

>  <SYNONYMS>  (542) 
Vitamin U

>  <DEVELOPMENT_PHASE>  (542) 
4

>  <RESEARCH_CODES>  (542) 
nan

>  <APPLICANTS>  (542) 
nan

>  <USAN_STEM>  (542) 
nan

>  <USAN_STEM_DEFINITION>  (542) 
nan

>  <USAN_STEM_SUBSTEM>  (542) 
nan

>  <USAN_YEAR>  (542) 
nan

>  <FIRST_APPROVAL>  (542) 
nan

>  <ATC_CODE>  (542) 
A02BX04

>  <ATC_CODE_DESCRIPTION>  (542) 
A02BX04 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]

>  <INDICATION_CLASS>  (542) 
nan

>  <SC_PATENT_NO>  (542) 
nan

>  <DRUG_TYPE>  (542) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (542) 
Y

>  <FIRST_IN_CLASS>  (542) 
N

>  <CHIRALITY>  (542) 
Single Stereoisomer

>  <PRODRUG>  (542) 
N

>  <ORAL>  (542) 
N

>  <PARENTERAL>  (542) 
N

>  <TOPICAL>  (542) 
N

>  <BLACK_BOX>  (542) 
N

>  <AVAILABILITY_TYPE>  (542) 
Unknown

>  <WITHDRAWN_YEAR>  (542) 
nan

>  <WITHDRAWN_COUNTRY>  (542) 
nan

>  <WITHDRAWN_REASON>  (542) 
nan

>  <CANONICAL_SMILES>  (542) 
C[S+](C)CC[C@H](N)C(=O)O

>  <name>  (542) 
Vitamin U

>  <MW>  (542) 
164.25

>  <logP>  (542) 
-0.3337

$$$$
CHEMBL504
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
M  CHG  2   2   1   4  -1
M  END
>  <PARENT_MOLREGNO>  (543) 
10009

>  <SYNONYMS>  (543) 
Dimethyl Sulfoxide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (543) 
4

>  <RESEARCH_CODES>  (543) 
DMSO; SQ-9453

>  <APPLICANTS>  (543) 
Bioniche Pharma Usa Llc

>  <USAN_STEM>  (543) 
nan

>  <USAN_STEM_DEFINITION>  (543) 
nan

>  <USAN_STEM_SUBSTEM>  (543) 
nan

>  <USAN_YEAR>  (543) 
1965.0

>  <FIRST_APPROVAL>  (543) 
1978.0

>  <ATC_CODE>  (543) 
M02AX03; G04BX13

>  <ATC_CODE_DESCRIPTION>  (543) 
M02AX03 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Other topical products for joint and muscular pain]; G04BX13 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Other urologicals]

>  <INDICATION_CLASS>  (543) 
Anti-Inflammatory (topical)

>  <SC_PATENT_NO>  (543) 
nan

>  <DRUG_TYPE>  (543) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (543) 
Y

>  <FIRST_IN_CLASS>  (543) 
N

>  <CHIRALITY>  (543) 
Achiral Molecule

>  <PRODRUG>  (543) 
N

>  <ORAL>  (543) 
N

>  <PARENTERAL>  (543) 
Y

>  <TOPICAL>  (543) 
N

>  <BLACK_BOX>  (543) 
N

>  <AVAILABILITY_TYPE>  (543) 
Prescription-only

>  <WITHDRAWN_YEAR>  (543) 
nan

>  <WITHDRAWN_COUNTRY>  (543) 
nan

>  <WITHDRAWN_REASON>  (543) 
nan

>  <CANONICAL_SMILES>  (543) 
C[S+](C)[O-]

>  <name>  (543) 
Dimethyl Sulfoxide 

>  <MW>  (543) 
78.136

>  <logP>  (543) 
-0.0053

$$$$
CHEMBL1455
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
  6 13  1  0
 13 14  1  0
 13 15  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (544) 
386327

>  <SYNONYMS>  (544) 
Altretamine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (544) 
4

>  <RESEARCH_CODES>  (544) 
nan

>  <APPLICANTS>  (544) 
Eisai Inc

>  <USAN_STEM>  (544) 
nan

>  <USAN_STEM_DEFINITION>  (544) 
nan

>  <USAN_STEM_SUBSTEM>  (544) 
nan

>  <USAN_YEAR>  (544) 
1990.0

>  <FIRST_APPROVAL>  (544) 
1990.0

>  <ATC_CODE>  (544) 
L01XX03

>  <ATC_CODE_DESCRIPTION>  (544) 
L01XX03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (544) 
Antineoplastic

>  <SC_PATENT_NO>  (544) 
nan

>  <DRUG_TYPE>  (544) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (544) 
Y

>  <FIRST_IN_CLASS>  (544) 
N

>  <CHIRALITY>  (544) 
Achiral Molecule

>  <PRODRUG>  (544) 
N

>  <ORAL>  (544) 
Y

>  <PARENTERAL>  (544) 
N

>  <TOPICAL>  (544) 
N

>  <BLACK_BOX>  (544) 
Y

>  <AVAILABILITY_TYPE>  (544) 
Prescription-only

>  <WITHDRAWN_YEAR>  (544) 
nan

>  <WITHDRAWN_COUNTRY>  (544) 
nan

>  <WITHDRAWN_REASON>  (544) 
nan

>  <CANONICAL_SMILES>  (544) 
CN(C)c1nc(nc(n1)N(C)C)N(C)C

>  <name>  (544) 
Altretamine 

>  <MW>  (544) 
210.285

>  <logP>  (544) 
0.0696

$$$$
CHEMBL1789941
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  3  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
  9  5  1  0
 14 10  1  0
 23 15  1  0
 23 19  2  0
M  END
>  <PARENT_MOLREGNO>  (545) 
1153572

>  <SYNONYMS>  (545) 
Ruxolitinib (INN, USAN); Ruxolitinib Phosphate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (545) 
4

>  <RESEARCH_CODES>  (545) 
INCB-018424; INCB-018424 Salt

>  <APPLICANTS>  (545) 
Incyte Corp

>  <USAN_STEM>  (545) 
-tinib

>  <USAN_STEM_DEFINITION>  (545) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (545) 
-tinib

>  <USAN_YEAR>  (545) 
2009.0

>  <FIRST_APPROVAL>  (545) 
2011.0

>  <ATC_CODE>  (545) 
L01XE18

>  <ATC_CODE_DESCRIPTION>  (545) 
L01XE18 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (545) 
nan

>  <SC_PATENT_NO>  (545) 
US-7598257-B2

>  <DRUG_TYPE>  (545) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (545) 
Y

>  <FIRST_IN_CLASS>  (545) 
Y

>  <CHIRALITY>  (545) 
Single Stereoisomer

>  <PRODRUG>  (545) 
N

>  <ORAL>  (545) 
Y

>  <PARENTERAL>  (545) 
N

>  <TOPICAL>  (545) 
N

>  <BLACK_BOX>  (545) 
N

>  <AVAILABILITY_TYPE>  (545) 
Prescription-only

>  <WITHDRAWN_YEAR>  (545) 
nan

>  <WITHDRAWN_COUNTRY>  (545) 
nan

>  <WITHDRAWN_REASON>  (545) 
nan

>  <CANONICAL_SMILES>  (545) 
N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34

>  <name>  (545) 
Ruxolitinib 

>  <MW>  (545) 
306.373

>  <logP>  (545) 
3.46638

$$$$
CHEMBL1106
     RDKit          

 19 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  6  2  1  0
 19  5  1  0
 12  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (546) 
152610

>  <SYNONYMS>  (546) 
Epinastine (INN); Epinastine HCl (FDA, JAN)

>  <DEVELOPMENT_PHASE>  (546) 
4

>  <RESEARCH_CODES>  (546) 
nan

>  <APPLICANTS>  (546) 
Allergan Inc

>  <USAN_STEM>  (546) 
-astine

>  <USAN_STEM_DEFINITION>  (546) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (546) 
-astine

>  <USAN_YEAR>  (546) 
nan

>  <FIRST_APPROVAL>  (546) 
2003.0

>  <ATC_CODE>  (546) 
R06AX24; S01GX10

>  <ATC_CODE_DESCRIPTION>  (546) 
R06AX24 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]; S01GX10 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]

>  <INDICATION_CLASS>  (546) 
nan

>  <SC_PATENT_NO>  (546) 
nan

>  <DRUG_TYPE>  (546) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (546) 
Y

>  <FIRST_IN_CLASS>  (546) 
N

>  <CHIRALITY>  (546) 
Racemic Mixture

>  <PRODRUG>  (546) 
N

>  <ORAL>  (546) 
N

>  <PARENTERAL>  (546) 
N

>  <TOPICAL>  (546) 
Y

>  <BLACK_BOX>  (546) 
N

>  <AVAILABILITY_TYPE>  (546) 
Prescription-only

>  <WITHDRAWN_YEAR>  (546) 
nan

>  <WITHDRAWN_COUNTRY>  (546) 
nan

>  <WITHDRAWN_REASON>  (546) 
nan

>  <CANONICAL_SMILES>  (546) 
NC1=NCC2N1c3ccccc3Cc4ccccc24

>  <name>  (546) 
Epinastine 

>  <MW>  (546) 
249.317

>  <logP>  (546) 
2.4668

$$$$
CHEMBL2107175
     RDKit          

 23 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 12 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 16 21  1  0
 21 22  1  0
 22 23  3  0
 21 10  2  0
M  END
>  <PARENT_MOLREGNO>  (547) 
1379445

>  <SYNONYMS>  (547) 
Ranelic Acid (INN)

>  <DEVELOPMENT_PHASE>  (547) 
4

>  <RESEARCH_CODES>  (547) 
nan

>  <APPLICANTS>  (547) 
nan

>  <USAN_STEM>  (547) 
nan

>  <USAN_STEM_DEFINITION>  (547) 
nan

>  <USAN_STEM_SUBSTEM>  (547) 
nan

>  <USAN_YEAR>  (547) 
nan

>  <FIRST_APPROVAL>  (547) 
nan

>  <ATC_CODE>  (547) 
M05BX03

>  <ATC_CODE_DESCRIPTION>  (547) 
M05BX03 [Musculo-Skeletal System:Drugs For Treatment Of Bone Diseases:Drugs Affecting Bone Structure And Mineralization:Other drugs affecting bone structure and mineralization]

>  <INDICATION_CLASS>  (547) 
nan

>  <SC_PATENT_NO>  (547) 
nan

>  <DRUG_TYPE>  (547) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (547) 
Y

>  <FIRST_IN_CLASS>  (547) 
N

>  <CHIRALITY>  (547) 
Achiral Molecule

>  <PRODRUG>  (547) 
N

>  <ORAL>  (547) 
N

>  <PARENTERAL>  (547) 
N

>  <TOPICAL>  (547) 
N

>  <BLACK_BOX>  (547) 
N

>  <AVAILABILITY_TYPE>  (547) 
Unknown

>  <WITHDRAWN_YEAR>  (547) 
nan

>  <WITHDRAWN_COUNTRY>  (547) 
nan

>  <WITHDRAWN_REASON>  (547) 
nan

>  <CANONICAL_SMILES>  (547) 
OC(=O)CN(CC(=O)O)c1sc(C(=O)O)c(CC(=O)O)c1C#N

>  <name>  (547) 
Ranelic Acid 

>  <MW>  (547) 
342.285

>  <logP>  (547) 
-0.07932

$$$$
CHEMBL86
     RDKit          

 20 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 18 11  1  0
M  END
>  <PARENT_MOLREGNO>  (548) 
7736

>  <SYNONYMS>  (548) 
Metoclopramide (BAN, INN, JAN); Metoclopramide HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (548) 
4

>  <RESEARCH_CODES>  (548) 
AHR-3070-C

>  <APPLICANTS>  (548) 
Meda Pharmaceuticals Inc; Baxter Healthcare Corp Anesthesia Critical Care; Ani Pharmaceuticals Inc; Ah Robins Co; Salix Pharmaceuticals Inc

>  <USAN_STEM>  (548) 
nan

>  <USAN_STEM_DEFINITION>  (548) 
nan

>  <USAN_STEM_SUBSTEM>  (548) 
nan

>  <USAN_YEAR>  (548) 
1964.0

>  <FIRST_APPROVAL>  (548) 
1979.0

>  <ATC_CODE>  (548) 
A03FA01

>  <ATC_CODE_DESCRIPTION>  (548) 
A03FA01 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Propulsives:Propulsives]

>  <INDICATION_CLASS>  (548) 
Anti-Emetic

>  <SC_PATENT_NO>  (548) 
US-6024981-A

>  <DRUG_TYPE>  (548) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (548) 
Y

>  <FIRST_IN_CLASS>  (548) 
N

>  <CHIRALITY>  (548) 
Achiral Molecule

>  <PRODRUG>  (548) 
N

>  <ORAL>  (548) 
Y

>  <PARENTERAL>  (548) 
Y

>  <TOPICAL>  (548) 
N

>  <BLACK_BOX>  (548) 
Y

>  <AVAILABILITY_TYPE>  (548) 
Prescription-only

>  <WITHDRAWN_YEAR>  (548) 
nan

>  <WITHDRAWN_COUNTRY>  (548) 
nan

>  <WITHDRAWN_REASON>  (548) 
nan

>  <CANONICAL_SMILES>  (548) 
CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC

>  <name>  (548) 
Metoclopramide 

>  <MW>  (548) 
299.802

>  <logP>  (548) 
2.0024

$$$$
CHEMBL201960
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  9  5  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (549) 
339024

>  <SYNONYMS>  (549) 
Pyrovalerone (INN); Pyrovalerone HCl (USAN)

>  <DEVELOPMENT_PHASE>  (549) 
4

>  <RESEARCH_CODES>  (549) 
F-1983

>  <APPLICANTS>  (549) 
Novartis

>  <USAN_STEM>  (549) 
nan

>  <USAN_STEM_DEFINITION>  (549) 
nan

>  <USAN_STEM_SUBSTEM>  (549) 
nan

>  <USAN_YEAR>  (549) 
1964.0

>  <FIRST_APPROVAL>  (549) 
nan

>  <ATC_CODE>  (549) 
nan

>  <ATC_CODE_DESCRIPTION>  (549) 
nan

>  <INDICATION_CLASS>  (549) 
Stimulant (central)

>  <SC_PATENT_NO>  (549) 
nan

>  <DRUG_TYPE>  (549) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (549) 
Y

>  <FIRST_IN_CLASS>  (549) 
N

>  <CHIRALITY>  (549) 
Racemic Mixture

>  <PRODRUG>  (549) 
N

>  <ORAL>  (549) 
N

>  <PARENTERAL>  (549) 
N

>  <TOPICAL>  (549) 
N

>  <BLACK_BOX>  (549) 
N

>  <AVAILABILITY_TYPE>  (549) 
Withdrawn

>  <WITHDRAWN_YEAR>  (549) 
1979.0

>  <WITHDRAWN_COUNTRY>  (549) 
France

>  <WITHDRAWN_REASON>  (549) 
Misuse and abuse

>  <CANONICAL_SMILES>  (549) 
CCCC(N1CCCC1)C(=O)c2ccc(C)cc2

>  <name>  (549) 
Pyrovalerone 

>  <MW>  (549) 
245.366

>  <logP>  (549) 
3.44222

$$$$
CHEMBL2426701
     RDKit          

 11 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  8  2  1  0
  9  6  1  0
M  END
>  <PARENT_MOLREGNO>  (550) 
1581828

>  <SYNONYMS>  (550) 
(1s)-(-)-Verbenone

>  <DEVELOPMENT_PHASE>  (550) 
4

>  <RESEARCH_CODES>  (550) 
nan

>  <APPLICANTS>  (550) 
nan

>  <USAN_STEM>  (550) 
nan

>  <USAN_STEM_DEFINITION>  (550) 
nan

>  <USAN_STEM_SUBSTEM>  (550) 
nan

>  <USAN_YEAR>  (550) 
nan

>  <FIRST_APPROVAL>  (550) 
nan

>  <ATC_CODE>  (550) 
R05CA11

>  <ATC_CODE_DESCRIPTION>  (550) 
R05CA11 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Expectorants]

>  <INDICATION_CLASS>  (550) 
nan

>  <SC_PATENT_NO>  (550) 
nan

>  <DRUG_TYPE>  (550) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (550) 
Y

>  <FIRST_IN_CLASS>  (550) 
N

>  <CHIRALITY>  (550) 
Single Stereoisomer

>  <PRODRUG>  (550) 
N

>  <ORAL>  (550) 
N

>  <PARENTERAL>  (550) 
N

>  <TOPICAL>  (550) 
N

>  <BLACK_BOX>  (550) 
N

>  <AVAILABILITY_TYPE>  (550) 
Unknown

>  <WITHDRAWN_YEAR>  (550) 
nan

>  <WITHDRAWN_COUNTRY>  (550) 
nan

>  <WITHDRAWN_REASON>  (550) 
nan

>  <CANONICAL_SMILES>  (550) 
CC1=CC(=O)[C@H]2C[C@@H]1C2(C)C

>  <name>  (550) 


>  <MW>  (550) 
150.221

>  <logP>  (550) 
2.1777

$$$$
CHEMBL1204644
     RDKit          

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  2  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 10 13  1  0
M  END
>  <PARENT_MOLREGNO>  (551) 
678595

>  <SYNONYMS>  (551) 
Fosfocreatine

>  <DEVELOPMENT_PHASE>  (551) 
4

>  <RESEARCH_CODES>  (551) 
nan

>  <APPLICANTS>  (551) 
nan

>  <USAN_STEM>  (551) 
fos-

>  <USAN_STEM_DEFINITION>  (551) 
phosphoro-derivatives

>  <USAN_STEM_SUBSTEM>  (551) 
fos-

>  <USAN_YEAR>  (551) 
nan

>  <FIRST_APPROVAL>  (551) 
nan

>  <ATC_CODE>  (551) 
C01EB06

>  <ATC_CODE_DESCRIPTION>  (551) 
C01EB06 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (551) 
nan

>  <SC_PATENT_NO>  (551) 
nan

>  <DRUG_TYPE>  (551) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (551) 
Y

>  <FIRST_IN_CLASS>  (551) 
N

>  <CHIRALITY>  (551) 
Achiral Molecule

>  <PRODRUG>  (551) 
N

>  <ORAL>  (551) 
N

>  <PARENTERAL>  (551) 
N

>  <TOPICAL>  (551) 
N

>  <BLACK_BOX>  (551) 
N

>  <AVAILABILITY_TYPE>  (551) 
Unknown

>  <WITHDRAWN_YEAR>  (551) 
nan

>  <WITHDRAWN_COUNTRY>  (551) 
nan

>  <WITHDRAWN_REASON>  (551) 
nan

>  <CANONICAL_SMILES>  (551) 
CN(CC(=O)O)C(=N)NP(=O)(O)O

>  <name>  (551) 
Fosfocreatine

>  <MW>  (551) 
211.114

>  <logP>  (551) 
-1.38013

$$$$
CHEMBL1560
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 11  7  1  0
M  END
>  <PARENT_MOLREGNO>  (552) 
444750

>  <SYNONYMS>  (552) 
Captopril (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (552) 
4

>  <RESEARCH_CODES>  (552) 
SQ-14225

>  <APPLICANTS>  (552) 
Par Pharmaceutical Inc; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (552) 
-pril

>  <USAN_STEM_DEFINITION>  (552) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (552) 
-pril

>  <USAN_YEAR>  (552) 
1978.0

>  <FIRST_APPROVAL>  (552) 
1981.0

>  <ATC_CODE>  (552) 
C09AA01

>  <ATC_CODE_DESCRIPTION>  (552) 
C09AA01 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (552) 
Antihypertensive; Enzyme Inhibitor (angiotensin-converting)

>  <SC_PATENT_NO>  (552) 
nan

>  <DRUG_TYPE>  (552) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (552) 
Y

>  <FIRST_IN_CLASS>  (552) 
N

>  <CHIRALITY>  (552) 
Single Stereoisomer

>  <PRODRUG>  (552) 
N

>  <ORAL>  (552) 
Y

>  <PARENTERAL>  (552) 
N

>  <TOPICAL>  (552) 
N

>  <BLACK_BOX>  (552) 
Y

>  <AVAILABILITY_TYPE>  (552) 
Prescription-only

>  <WITHDRAWN_YEAR>  (552) 
nan

>  <WITHDRAWN_COUNTRY>  (552) 
nan

>  <WITHDRAWN_REASON>  (552) 
nan

>  <CANONICAL_SMILES>  (552) 
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O

>  <name>  (552) 
Captopril 

>  <MW>  (552) 
217.29

>  <logP>  (552) 
0.6279

$$$$
CHEMBL1200436
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21  2  1  0
 21  6  1  0
 18  7  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (553) 
674387

>  <SYNONYMS>  (553) 
Oxandrolone (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (553) 
4

>  <RESEARCH_CODES>  (553) 
SC-11585

>  <APPLICANTS>  (553) 
Savient Pharmaceuticals Inc

>  <USAN_STEM>  (553) 
-olone

>  <USAN_STEM_DEFINITION>  (553) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (553) 
-olone

>  <USAN_YEAR>  (553) 
1962.0

>  <FIRST_APPROVAL>  (553) 
1964.0

>  <ATC_CODE>  (553) 
A14AA08

>  <ATC_CODE_DESCRIPTION>  (553) 
A14AA08 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives]

>  <INDICATION_CLASS>  (553) 
Androgen

>  <SC_PATENT_NO>  (553) 
US-5872147-A

>  <DRUG_TYPE>  (553) 
Natural Product-derived

>  <RULE_OF_FIVE>  (553) 
Y

>  <FIRST_IN_CLASS>  (553) 
N

>  <CHIRALITY>  (553) 
Single Stereoisomer

>  <PRODRUG>  (553) 
N

>  <ORAL>  (553) 
Y

>  <PARENTERAL>  (553) 
N

>  <TOPICAL>  (553) 
N

>  <BLACK_BOX>  (553) 
Y

>  <AVAILABILITY_TYPE>  (553) 
Prescription-only

>  <WITHDRAWN_YEAR>  (553) 
nan

>  <WITHDRAWN_COUNTRY>  (553) 
nan

>  <WITHDRAWN_REASON>  (553) 
nan

>  <CANONICAL_SMILES>  (553) 
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (553) 
Oxandrolone 

>  <MW>  (553) 
306.446

>  <logP>  (553) 
3.5431

$$$$
CHEMBL1200660
     RDKit          

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10  2  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (554) 
674611

>  <SYNONYMS>  (554) 
Isosorbide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (554) 
4

>  <RESEARCH_CODES>  (554) 
AT-101

>  <APPLICANTS>  (554) 
Alcon Laboratories Inc

>  <USAN_STEM>  (554) 
nan

>  <USAN_STEM_DEFINITION>  (554) 
nan

>  <USAN_STEM_SUBSTEM>  (554) 
nan

>  <USAN_YEAR>  (554) 
1966.0

>  <FIRST_APPROVAL>  (554) 
1974.0

>  <ATC_CODE>  (554) 
nan

>  <ATC_CODE_DESCRIPTION>  (554) 
nan

>  <INDICATION_CLASS>  (554) 
Diuretic

>  <SC_PATENT_NO>  (554) 
nan

>  <DRUG_TYPE>  (554) 
Natural Product-derived

>  <RULE_OF_FIVE>  (554) 
Y

>  <FIRST_IN_CLASS>  (554) 
N

>  <CHIRALITY>  (554) 
Single Stereoisomer

>  <PRODRUG>  (554) 
N

>  <ORAL>  (554) 
Y

>  <PARENTERAL>  (554) 
N

>  <TOPICAL>  (554) 
N

>  <BLACK_BOX>  (554) 
N

>  <AVAILABILITY_TYPE>  (554) 
Discontinued

>  <WITHDRAWN_YEAR>  (554) 
nan

>  <WITHDRAWN_COUNTRY>  (554) 
nan

>  <WITHDRAWN_REASON>  (554) 
nan

>  <CANONICAL_SMILES>  (554) 
O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12

>  <name>  (554) 
Isosorbide 

>  <MW>  (554) 
146.142

>  <logP>  (554) 
-1.4942

$$$$
CHEMBL877
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (555) 
73547

>  <SYNONYMS>  (555) 
Tranexamic acid (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (555) 
4

>  <RESEARCH_CODES>  (555) 
CL-65336; Trans Amcha

>  <APPLICANTS>  (555) 
Pharmacia And Upjohn Co; Ferring Pharmaceuticals As

>  <USAN_STEM>  (555) 
nan

>  <USAN_STEM_DEFINITION>  (555) 
nan

>  <USAN_STEM_SUBSTEM>  (555) 
nan

>  <USAN_YEAR>  (555) 
1967.0

>  <FIRST_APPROVAL>  (555) 
1986.0

>  <ATC_CODE>  (555) 
B02AA02

>  <ATC_CODE_DESCRIPTION>  (555) 
B02AA02 [Blood And Blood Forming Organs:Antihemorrhagics:Antifibrinolytics:Amino acids]

>  <INDICATION_CLASS>  (555) 
Hemostatic

>  <SC_PATENT_NO>  (555) 
US-7947739-B2

>  <DRUG_TYPE>  (555) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (555) 
Y

>  <FIRST_IN_CLASS>  (555) 
N

>  <CHIRALITY>  (555) 
Single Stereoisomer

>  <PRODRUG>  (555) 
N

>  <ORAL>  (555) 
Y

>  <PARENTERAL>  (555) 
Y

>  <TOPICAL>  (555) 
N

>  <BLACK_BOX>  (555) 
N

>  <AVAILABILITY_TYPE>  (555) 
Prescription-only

>  <WITHDRAWN_YEAR>  (555) 
nan

>  <WITHDRAWN_COUNTRY>  (555) 
nan

>  <WITHDRAWN_REASON>  (555) 
nan

>  <CANONICAL_SMILES>  (555) 
NC[C@@H]1CC[C@H](CC1)C(=O)O

>  <name>  (555) 
Tranexamic acid 

>  <MW>  (555) 
157.213

>  <logP>  (555) 
0.8361

$$$$
CHEMBL189963
     RDKit          

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 10 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 26 32  1  0
 32 33  2  0
 32  4  1  0
 25  7  1  0
 17 12  1  0
 23 18  1  0
 31 27  1  0
M  END
>  <PARENT_MOLREGNO>  (556) 
319858

>  <SYNONYMS>  (556) 
Palbociclib (FDA, INN, USAN); Palbociclib Isethionate (USAN)

>  <DEVELOPMENT_PHASE>  (556) 
4

>  <RESEARCH_CODES>  (556) 
PD-0332991; PD-03329910054; PF-0008066573

>  <APPLICANTS>  (556) 
Pfizer Inc.

>  <USAN_STEM>  (556) 
-ciclib

>  <USAN_STEM_DEFINITION>  (556) 
cyclin dependent kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (556) 
-ciclib

>  <USAN_YEAR>  (556) 
2012.0

>  <FIRST_APPROVAL>  (556) 
2015.0

>  <ATC_CODE>  (556) 
L01XE33

>  <ATC_CODE_DESCRIPTION>  (556) 
L01XE33 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (556) 
nan

>  <SC_PATENT_NO>  (556) 
US-6936612-B2

>  <DRUG_TYPE>  (556) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (556) 
Y

>  <FIRST_IN_CLASS>  (556) 
Y

>  <CHIRALITY>  (556) 
Achiral Molecule

>  <PRODRUG>  (556) 
N

>  <ORAL>  (556) 
Y

>  <PARENTERAL>  (556) 
N

>  <TOPICAL>  (556) 
N

>  <BLACK_BOX>  (556) 
N

>  <AVAILABILITY_TYPE>  (556) 
Prescription-only

>  <WITHDRAWN_YEAR>  (556) 
nan

>  <WITHDRAWN_COUNTRY>  (556) 
nan

>  <WITHDRAWN_REASON>  (556) 
nan

>  <CANONICAL_SMILES>  (556) 
CC(=O)C1=C(C)c2cnc(Nc3ccc(cn3)N4CCNCC4)nc2N(C5CCCC5)C1=O

>  <name>  (556) 
Palbociclib 

>  <MW>  (556) 
447.543

>  <logP>  (556) 
2.96582

$$$$
CHEMBL189
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  3  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 10  2  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (557) 
380567

>  <SYNONYMS>  (557) 
Milrinone (BAN, INN, USAN, USP); Milrinone Lactate (FDA)

>  <DEVELOPMENT_PHASE>  (557) 
4

>  <RESEARCH_CODES>  (557) 
WIN-472032; WIN-47203-2

>  <APPLICANTS>  (557) 
Sterling Winthrop; Sanofi Aventis Us Llc

>  <USAN_STEM>  (557) 
-rinone

>  <USAN_STEM_DEFINITION>  (557) 
cardiotonics (amrinone type)

>  <USAN_STEM_SUBSTEM>  (557) 
-rinone

>  <USAN_YEAR>  (557) 
1983.0

>  <FIRST_APPROVAL>  (557) 
1987.0

>  <ATC_CODE>  (557) 
C01CE02

>  <ATC_CODE_DESCRIPTION>  (557) 
C01CE02 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Phosphodiesterase inhibitors]

>  <INDICATION_CLASS>  (557) 
Cardiotonic

>  <SC_PATENT_NO>  (557) 
nan

>  <DRUG_TYPE>  (557) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (557) 
Y

>  <FIRST_IN_CLASS>  (557) 
N

>  <CHIRALITY>  (557) 
Achiral Molecule

>  <PRODRUG>  (557) 
N

>  <ORAL>  (557) 
N

>  <PARENTERAL>  (557) 
Y

>  <TOPICAL>  (557) 
N

>  <BLACK_BOX>  (557) 
N

>  <AVAILABILITY_TYPE>  (557) 
Prescription-only

>  <WITHDRAWN_YEAR>  (557) 
nan

>  <WITHDRAWN_COUNTRY>  (557) 
nan

>  <WITHDRAWN_REASON>  (557) 
nan

>  <CANONICAL_SMILES>  (557) 
CC1=C(C=C(C#N)C(=O)N1)c2ccncc2

>  <name>  (557) 
Milrinone 

>  <MW>  (557) 
211.224

>  <logP>  (557) 
1.617

$$$$
CHEMBL517712
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  6  2  1  0
  9  3  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (558) 
445395

>  <SYNONYMS>  (558) 
Atropine (BAN, FDA, USP); Atropine Sulfate (FDA, JAN, USP); Atropine Sulphate (BAN)

>  <DEVELOPMENT_PHASE>  (558) 
4

>  <RESEARCH_CODES>  (558) 
nan

>  <APPLICANTS>  (558) 
Mylan Institutional Llc; Meridian Medical Technologies Inc; Hospira Inc; Gd Searle Llc; Us Army Medical Research Materiel Command

>  <USAN_STEM>  (558) 
-trop-

>  <USAN_STEM_DEFINITION>  (558) 
atropine derivatives

>  <USAN_STEM_SUBSTEM>  (558) 
-trop-

>  <USAN_YEAR>  (558) 
nan

>  <FIRST_APPROVAL>  (558) 
1960.0

>  <ATC_CODE>  (558) 
S01FA01; A03BA01

>  <ATC_CODE_DESCRIPTION>  (558) 
S01FA01 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]; A03BA01 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Belladonna And Derivatives, Plain:Belladonna alkaloids, tertiary amines]

>  <INDICATION_CLASS>  (558) 
Anticholinergic; Anticholinergic (ophthalmic)

>  <SC_PATENT_NO>  (558) 
nan

>  <DRUG_TYPE>  (558) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (558) 
Y

>  <FIRST_IN_CLASS>  (558) 
N

>  <CHIRALITY>  (558) 
Racemic Mixture

>  <PRODRUG>  (558) 
N

>  <ORAL>  (558) 
Y

>  <PARENTERAL>  (558) 
Y

>  <TOPICAL>  (558) 
Y

>  <BLACK_BOX>  (558) 
N

>  <AVAILABILITY_TYPE>  (558) 
Prescription-only

>  <WITHDRAWN_YEAR>  (558) 
nan

>  <WITHDRAWN_COUNTRY>  (558) 
nan

>  <WITHDRAWN_REASON>  (558) 
nan

>  <CANONICAL_SMILES>  (558) 
CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3

>  <name>  (558) 
Atropine 

>  <MW>  (558) 
289.375

>  <logP>  (558) 
1.9309

$$$$
CHEMBL580
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  4 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20  2  1  0
 10  5  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (559) 
16959

>  <SYNONYMS>  (559) 
Lorazepam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (559) 
4

>  <RESEARCH_CODES>  (559) 
WY-4036

>  <APPLICANTS>  (559) 
Valeant International Barbados Srl; Baxter Healthcare Corp Anesthesia Critical Care

>  <USAN_STEM>  (559) 
-azepam

>  <USAN_STEM_DEFINITION>  (559) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (559) 
-azepam

>  <USAN_YEAR>  (559) 
1969.0

>  <FIRST_APPROVAL>  (559) 
1977.0

>  <ATC_CODE>  (559) 
N05BA06; N05BA56

>  <ATC_CODE_DESCRIPTION>  (559) 
N05BA06 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]; N05BA56 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (559) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (559) 
nan

>  <DRUG_TYPE>  (559) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (559) 
Y

>  <FIRST_IN_CLASS>  (559) 
N

>  <CHIRALITY>  (559) 
Racemic Mixture

>  <PRODRUG>  (559) 
N

>  <ORAL>  (559) 
Y

>  <PARENTERAL>  (559) 
Y

>  <TOPICAL>  (559) 
N

>  <BLACK_BOX>  (559) 
Y

>  <AVAILABILITY_TYPE>  (559) 
Prescription-only

>  <WITHDRAWN_YEAR>  (559) 
nan

>  <WITHDRAWN_COUNTRY>  (559) 
nan

>  <WITHDRAWN_REASON>  (559) 
nan

>  <CANONICAL_SMILES>  (559) 
OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O

>  <name>  (559) 
Lorazepam 

>  <MW>  (559) 
321.163

>  <logP>  (559) 
3.1013

$$$$
CHEMBL1200853
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22  4  1  0
 22  7  1  0
 19  8  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (560) 
674804

>  <SYNONYMS>  (560) 
Dydrogesterone (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (560) 
4

>  <RESEARCH_CODES>  (560) 
nan

>  <APPLICANTS>  (560) 
Solvay Pharmaceuticals

>  <USAN_STEM>  (560) 
-gest-

>  <USAN_STEM_DEFINITION>  (560) 
progestins

>  <USAN_STEM_SUBSTEM>  (560) 
-gest-

>  <USAN_YEAR>  (560) 
1962.0

>  <FIRST_APPROVAL>  (560) 
1982.0

>  <ATC_CODE>  (560) 
G03DB01

>  <ATC_CODE_DESCRIPTION>  (560) 
G03DB01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnadien derivatives]

>  <INDICATION_CLASS>  (560) 
Progestin

>  <SC_PATENT_NO>  (560) 
nan

>  <DRUG_TYPE>  (560) 
Natural Product-derived

>  <RULE_OF_FIVE>  (560) 
Y

>  <FIRST_IN_CLASS>  (560) 
N

>  <CHIRALITY>  (560) 
Single Stereoisomer

>  <PRODRUG>  (560) 
N

>  <ORAL>  (560) 
Y

>  <PARENTERAL>  (560) 
N

>  <TOPICAL>  (560) 
N

>  <BLACK_BOX>  (560) 
N

>  <AVAILABILITY_TYPE>  (560) 
Discontinued

>  <WITHDRAWN_YEAR>  (560) 
nan

>  <WITHDRAWN_COUNTRY>  (560) 
nan

>  <WITHDRAWN_REASON>  (560) 
nan

>  <CANONICAL_SMILES>  (560) 
CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C

>  <name>  (560) 
Dydrogesterone 

>  <MW>  (560) 
312.453

>  <logP>  (560) 
4.4995

$$$$
CHEMBL1201207
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 29 32  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (561) 
675158

>  <SYNONYMS>  (561) 
Betamethasone Sodium Phosphate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (561) 
4

>  <RESEARCH_CODES>  (561) 
nan

>  <APPLICANTS>  (561) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (561) 
nan

>  <USAN_STEM_DEFINITION>  (561) 
nan

>  <USAN_STEM_SUBSTEM>  (561) 
nan

>  <USAN_YEAR>  (561) 
nan

>  <FIRST_APPROVAL>  (561) 
1965.0

>  <ATC_CODE>  (561) 
S01CB04; H02AB01; A07EA04; D07AC01; D07XC01; S01BA06; R03BA04; S03BA03; C05AA05; R01AD06; S02BA07

>  <ATC_CODE_DESCRIPTION>  (561) 
S01CB04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; H02AB01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; A07EA04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; D07AC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; D07XC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, potent, other combinations]; S01BA06 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; R03BA04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; S03BA03 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; C05AA05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R01AD06 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S02BA07 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (561) 
Glucocorticoid

>  <SC_PATENT_NO>  (561) 
nan

>  <DRUG_TYPE>  (561) 
Natural Product-derived

>  <RULE_OF_FIVE>  (561) 
Y

>  <FIRST_IN_CLASS>  (561) 
N

>  <CHIRALITY>  (561) 
Single Stereoisomer

>  <PRODRUG>  (561) 
Y

>  <ORAL>  (561) 
N

>  <PARENTERAL>  (561) 
Y

>  <TOPICAL>  (561) 
N

>  <BLACK_BOX>  (561) 
N

>  <AVAILABILITY_TYPE>  (561) 
Prescription-only

>  <WITHDRAWN_YEAR>  (561) 
nan

>  <WITHDRAWN_COUNTRY>  (561) 
nan

>  <WITHDRAWN_REASON>  (561) 
nan

>  <CANONICAL_SMILES>  (561) 
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O

>  <name>  (561) 
Betamethasone Sodium Phosphate 

>  <MW>  (561) 
472.446

>  <logP>  (561) 
2.0127

$$$$
CHEMBL973
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  3  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  2 19  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (562) 
96107

>  <SYNONYMS>  (562) 
Teriflunomide (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (562) 
4

>  <RESEARCH_CODES>  (562) 
HMR-1726

>  <APPLICANTS>  (562) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (562) 
nan

>  <USAN_STEM_DEFINITION>  (562) 
nan

>  <USAN_STEM_SUBSTEM>  (562) 
nan

>  <USAN_YEAR>  (562) 
2011.0

>  <FIRST_APPROVAL>  (562) 
2012.0

>  <ATC_CODE>  (562) 
L04AA31

>  <ATC_CODE_DESCRIPTION>  (562) 
L04AA31 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants]

>  <INDICATION_CLASS>  (562) 
nan

>  <SC_PATENT_NO>  (562) 
US-6794410-B2

>  <DRUG_TYPE>  (562) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (562) 
Y

>  <FIRST_IN_CLASS>  (562) 
N

>  <CHIRALITY>  (562) 
Achiral Molecule

>  <PRODRUG>  (562) 
N

>  <ORAL>  (562) 
Y

>  <PARENTERAL>  (562) 
N

>  <TOPICAL>  (562) 
N

>  <BLACK_BOX>  (562) 
Y

>  <AVAILABILITY_TYPE>  (562) 
Prescription-only

>  <WITHDRAWN_YEAR>  (562) 
nan

>  <WITHDRAWN_COUNTRY>  (562) 
nan

>  <WITHDRAWN_REASON>  (562) 
nan

>  <CANONICAL_SMILES>  (562) 
C\C(=C(/C#N)\C(=O)Nc1ccc(cc1)C(F)(F)F)\O

>  <name>  (562) 
Teriflunomide 

>  <MW>  (562) 
270.21

>  <logP>  (562) 
2.99948

$$$$
CHEMBL1201341
     RDKit          

 15 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
M  CHG  1  12   1
M  END
>  <PARENT_MOLREGNO>  (563) 
675292

>  <SYNONYMS>  (563) 
Echothiophate Iodide (FDA, USP); Ecothiopate Iodide (BAN, INN, JAN)

>  <DEVELOPMENT_PHASE>  (563) 
4

>  <RESEARCH_CODES>  (563) 
nan

>  <APPLICANTS>  (563) 
Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (563) 
nan

>  <USAN_STEM_DEFINITION>  (563) 
nan

>  <USAN_STEM_SUBSTEM>  (563) 
nan

>  <USAN_YEAR>  (563) 
nan

>  <FIRST_APPROVAL>  (563) 
1960.0

>  <ATC_CODE>  (563) 
S01EB03

>  <ATC_CODE_DESCRIPTION>  (563) 
S01EB03 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]

>  <INDICATION_CLASS>  (563) 
Cholinergic (ophthalmic)

>  <SC_PATENT_NO>  (563) 
nan

>  <DRUG_TYPE>  (563) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (563) 
Y

>  <FIRST_IN_CLASS>  (563) 
N

>  <CHIRALITY>  (563) 
Achiral Molecule

>  <PRODRUG>  (563) 
N

>  <ORAL>  (563) 
N

>  <PARENTERAL>  (563) 
N

>  <TOPICAL>  (563) 
Y

>  <BLACK_BOX>  (563) 
N

>  <AVAILABILITY_TYPE>  (563) 
Prescription-only

>  <WITHDRAWN_YEAR>  (563) 
nan

>  <WITHDRAWN_COUNTRY>  (563) 
nan

>  <WITHDRAWN_REASON>  (563) 
nan

>  <CANONICAL_SMILES>  (563) 
CCOP(=O)(OCC)SCC[N+](C)(C)C

>  <name>  (563) 
Echothiophate Iodide 

>  <MW>  (563) 
256.328

>  <logP>  (563) 
2.6069

$$$$
CHEMBL1734
     RDKit          

 27 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
  9  4  1  0
 11  6  1  0
 21 12  1  0
 20 15  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (564) 
561914

>  <SYNONYMS>  (564) 
Solifenacin (INN); Solifenacin Succinate (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (564) 
4

>  <RESEARCH_CODES>  (564) 
YM-67905; YM-905

>  <APPLICANTS>  (564) 
Astellas Pharma Us Inc

>  <USAN_STEM>  (564) 
nan

>  <USAN_STEM_DEFINITION>  (564) 
nan

>  <USAN_STEM_SUBSTEM>  (564) 
nan

>  <USAN_YEAR>  (564) 
2001.0

>  <FIRST_APPROVAL>  (564) 
2004.0

>  <ATC_CODE>  (564) 
G04BD08

>  <ATC_CODE_DESCRIPTION>  (564) 
G04BD08 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (564) 
nan

>  <SC_PATENT_NO>  (564) 
US-6017927-A

>  <DRUG_TYPE>  (564) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (564) 
Y

>  <FIRST_IN_CLASS>  (564) 
N

>  <CHIRALITY>  (564) 
Single Stereoisomer

>  <PRODRUG>  (564) 
N

>  <ORAL>  (564) 
Y

>  <PARENTERAL>  (564) 
N

>  <TOPICAL>  (564) 
N

>  <BLACK_BOX>  (564) 
N

>  <AVAILABILITY_TYPE>  (564) 
Prescription-only

>  <WITHDRAWN_YEAR>  (564) 
nan

>  <WITHDRAWN_COUNTRY>  (564) 
nan

>  <WITHDRAWN_REASON>  (564) 
nan

>  <CANONICAL_SMILES>  (564) 
O=C(O[C@H]1CN2CCC1CC2)N3CCc4ccccc4[C@@H]3c5ccccc5

>  <name>  (564) 
Solifenacin 

>  <MW>  (564) 
362.473

>  <logP>  (564) 
3.8649

$$$$
CHEMBL41
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
  5 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 12  7  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (565) 
2223

>  <SYNONYMS>  (565) 
Fluoxetine (BAN, INN, USAN); Fluoxetine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (565) 
4

>  <RESEARCH_CODES>  (565) 
LY-110140

>  <APPLICANTS>  (565) 
Warner Chilcott Co Llc; Eli Lilly And Co; Edgemont Pharmaceuticals Llc

>  <USAN_STEM>  (565) 
-oxetine

>  <USAN_STEM_DEFINITION>  (565) 
antidepressants (fluoxetine type)

>  <USAN_STEM_SUBSTEM>  (565) 
-oxetine

>  <USAN_YEAR>  (565) 
1975.0

>  <FIRST_APPROVAL>  (565) 
1987.0

>  <ATC_CODE>  (565) 
N06AB03

>  <ATC_CODE_DESCRIPTION>  (565) 
N06AB03 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (565) 
Antidepressant

>  <SC_PATENT_NO>  (565) 
US-5910319-A

>  <DRUG_TYPE>  (565) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (565) 
Y

>  <FIRST_IN_CLASS>  (565) 
N

>  <CHIRALITY>  (565) 
Racemic Mixture

>  <PRODRUG>  (565) 
N

>  <ORAL>  (565) 
Y

>  <PARENTERAL>  (565) 
N

>  <TOPICAL>  (565) 
N

>  <BLACK_BOX>  (565) 
Y

>  <AVAILABILITY_TYPE>  (565) 
Prescription-only

>  <WITHDRAWN_YEAR>  (565) 
nan

>  <WITHDRAWN_COUNTRY>  (565) 
nan

>  <WITHDRAWN_REASON>  (565) 
nan

>  <CANONICAL_SMILES>  (565) 
CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2

>  <name>  (565) 
Fluoxetine 

>  <MW>  (565) 
309.331

>  <logP>  (565) 
4.435

$$$$
CHEMBL668
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  6  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (566) 
28112

>  <SYNONYMS>  (566) 
Protriptyline (BAN, INN); Protriptyline HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (566) 
4

>  <RESEARCH_CODES>  (566) 
MK-240

>  <APPLICANTS>  (566) 
Teva Womens Health R And D

>  <USAN_STEM>  (566) 
-triptyline

>  <USAN_STEM_DEFINITION>  (566) 
antidepressants (dibenzo[a,d]cycloheptane derivatives)

>  <USAN_STEM_SUBSTEM>  (566) 
-triptyline

>  <USAN_YEAR>  (566) 
1963.0

>  <FIRST_APPROVAL>  (566) 
1967.0

>  <ATC_CODE>  (566) 
N06AA11

>  <ATC_CODE_DESCRIPTION>  (566) 
N06AA11 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (566) 
Antidepressant

>  <SC_PATENT_NO>  (566) 
nan

>  <DRUG_TYPE>  (566) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (566) 
Y

>  <FIRST_IN_CLASS>  (566) 
N

>  <CHIRALITY>  (566) 
Achiral Molecule

>  <PRODRUG>  (566) 
N

>  <ORAL>  (566) 
Y

>  <PARENTERAL>  (566) 
N

>  <TOPICAL>  (566) 
N

>  <BLACK_BOX>  (566) 
Y

>  <AVAILABILITY_TYPE>  (566) 
Prescription-only

>  <WITHDRAWN_YEAR>  (566) 
nan

>  <WITHDRAWN_COUNTRY>  (566) 
nan

>  <WITHDRAWN_REASON>  (566) 
nan

>  <CANONICAL_SMILES>  (566) 
CNCCCC1c2ccccc2C=Cc3ccccc13

>  <name>  (566) 
Protriptyline 

>  <MW>  (566) 
263.384

>  <logP>  (566) 
4.3019

$$$$
CHEMBL779
     RDKit          

 29 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
  7 28  1  0
 28 29  2  0
 28  2  1  0
 18  6  1  0
 17  9  1  0
 17 12  1  0
 27 19  1  0
 26 22  1  0
M  END
>  <PARENT_MOLREGNO>  (567) 
44920

>  <SYNONYMS>  (567) 
Tadalafil (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (567) 
4

>  <RESEARCH_CODES>  (567) 
IC-351; IC351

>  <APPLICANTS>  (567) 
Eli Lilly Co; Eli Lilly And Co

>  <USAN_STEM>  (567) 
-afil

>  <USAN_STEM_DEFINITION>  (567) 
PDE5 inhibitors

>  <USAN_STEM_SUBSTEM>  (567) 
-afil

>  <USAN_YEAR>  (567) 
2001.0

>  <FIRST_APPROVAL>  (567) 
2003.0

>  <ATC_CODE>  (567) 
G04BE08

>  <ATC_CODE_DESCRIPTION>  (567) 
G04BE08 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]

>  <INDICATION_CLASS>  (567) 
nan

>  <SC_PATENT_NO>  (567) 
US-5859006-A

>  <DRUG_TYPE>  (567) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (567) 
Y

>  <FIRST_IN_CLASS>  (567) 
N

>  <CHIRALITY>  (567) 
Single Stereoisomer

>  <PRODRUG>  (567) 
N

>  <ORAL>  (567) 
Y

>  <PARENTERAL>  (567) 
N

>  <TOPICAL>  (567) 
N

>  <BLACK_BOX>  (567) 
N

>  <AVAILABILITY_TYPE>  (567) 
Prescription-only

>  <WITHDRAWN_YEAR>  (567) 
nan

>  <WITHDRAWN_COUNTRY>  (567) 
nan

>  <WITHDRAWN_REASON>  (567) 
nan

>  <CANONICAL_SMILES>  (567) 
CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c5ccc6OCOc6c5)C1=O

>  <name>  (567) 
Tadalafil 

>  <MW>  (567) 
389.411

>  <logP>  (567) 
2.2113

$$$$
CHEMBL734
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
M  END
>  <PARENT_MOLREGNO>  (568) 
37820

>  <SYNONYMS>  (568) 
Acetohydroxamic acid (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (568) 
4

>  <RESEARCH_CODES>  (568) 
nan

>  <APPLICANTS>  (568) 
Mission Pharmacal Co

>  <USAN_STEM>  (568) 
nan

>  <USAN_STEM_DEFINITION>  (568) 
nan

>  <USAN_STEM_SUBSTEM>  (568) 
nan

>  <USAN_YEAR>  (568) 
1984.0

>  <FIRST_APPROVAL>  (568) 
1983.0

>  <ATC_CODE>  (568) 
G04BX03

>  <ATC_CODE_DESCRIPTION>  (568) 
G04BX03 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Other urologicals]

>  <INDICATION_CLASS>  (568) 
Enzyme Inhibitor (urease)

>  <SC_PATENT_NO>  (568) 
nan

>  <DRUG_TYPE>  (568) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (568) 
Y

>  <FIRST_IN_CLASS>  (568) 
N

>  <CHIRALITY>  (568) 
Achiral Molecule

>  <PRODRUG>  (568) 
N

>  <ORAL>  (568) 
Y

>  <PARENTERAL>  (568) 
N

>  <TOPICAL>  (568) 
N

>  <BLACK_BOX>  (568) 
N

>  <AVAILABILITY_TYPE>  (568) 
Prescription-only

>  <WITHDRAWN_YEAR>  (568) 
nan

>  <WITHDRAWN_COUNTRY>  (568) 
nan

>  <WITHDRAWN_REASON>  (568) 
nan

>  <CANONICAL_SMILES>  (568) 
CC(=O)NO

>  <name>  (568) 
Acetohydroxamic acid 

>  <MW>  (568) 
75.067

>  <logP>  (568) 
-0.4883

$$$$
CHEMBL99946
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 10  8  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (569) 
164035

>  <SYNONYMS>  (569) 
Levomilnacipran (INN, USAN); Levomilnacipran HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (569) 
4

>  <RESEARCH_CODES>  (569) 
F-2695

>  <APPLICANTS>  (569) 
Forest Laboratories

>  <USAN_STEM>  (569) 
nan

>  <USAN_STEM_DEFINITION>  (569) 
nan

>  <USAN_STEM_SUBSTEM>  (569) 
nan

>  <USAN_YEAR>  (569) 
2010.0

>  <FIRST_APPROVAL>  (569) 
2013.0

>  <ATC_CODE>  (569) 
nan

>  <ATC_CODE_DESCRIPTION>  (569) 
nan

>  <INDICATION_CLASS>  (569) 
nan

>  <SC_PATENT_NO>  (569) 
US-RE43879-E1

>  <DRUG_TYPE>  (569) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (569) 
Y

>  <FIRST_IN_CLASS>  (569) 
N

>  <CHIRALITY>  (569) 
Single Stereoisomer

>  <PRODRUG>  (569) 
N

>  <ORAL>  (569) 
Y

>  <PARENTERAL>  (569) 
N

>  <TOPICAL>  (569) 
N

>  <BLACK_BOX>  (569) 
Y

>  <AVAILABILITY_TYPE>  (569) 
Prescription-only

>  <WITHDRAWN_YEAR>  (569) 
nan

>  <WITHDRAWN_COUNTRY>  (569) 
nan

>  <WITHDRAWN_REASON>  (569) 
nan

>  <CANONICAL_SMILES>  (569) 
CCN(CC)C(=O)[C@]1(C[C@H]1CN)c2ccccc2

>  <name>  (569) 
Levomilnacipran 

>  <MW>  (569) 
246.354

>  <logP>  (569) 
1.7714

$$$$
CHEMBL55
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 18 21  1  0
 21 22  2  0
 21 23  1  0
  7 24  1  0
 24 25  2  0
 25  4  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (570) 
3965

>  <SYNONYMS>  (570) 
Pentamidine (BAN, DCF, INN, MI); Pentamidine Isetionate (JAN); Pentamidine Isethionate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (570) 
4

>  <RESEARCH_CODES>  (570) 
GNF-Pf-3680; MB-800 [as isethionate]; MB-800; RP-2512 [as isethionate]; RP-2512

>  <APPLICANTS>  (570) 
Rhone-Poulenc Rorer; Fujisawa; Fresenius Kabi Usa Llc

>  <USAN_STEM>  (570) 
-(ur)amidine

>  <USAN_STEM_DEFINITION>  (570) 
pentamidine derivatives/analogues

>  <USAN_STEM_SUBSTEM>  (570) 
-(ur)amidine

>  <USAN_YEAR>  (570) 
2007.0

>  <FIRST_APPROVAL>  (570) 
1984.0

>  <ATC_CODE>  (570) 
P01CX01

>  <ATC_CODE_DESCRIPTION>  (570) 
P01CX01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Leishmaniasis And Trypanosomiasis:Other agents against leishmaniasis and trypanosomiasis]

>  <INDICATION_CLASS>  (570) 
nan

>  <SC_PATENT_NO>  (570) 
nan

>  <DRUG_TYPE>  (570) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (570) 
Y

>  <FIRST_IN_CLASS>  (570) 
N

>  <CHIRALITY>  (570) 
Achiral Molecule

>  <PRODRUG>  (570) 
N

>  <ORAL>  (570) 
N

>  <PARENTERAL>  (570) 
Y

>  <TOPICAL>  (570) 
Y

>  <BLACK_BOX>  (570) 
N

>  <AVAILABILITY_TYPE>  (570) 
Prescription-only

>  <WITHDRAWN_YEAR>  (570) 
nan

>  <WITHDRAWN_COUNTRY>  (570) 
nan

>  <WITHDRAWN_REASON>  (570) 
nan

>  <CANONICAL_SMILES>  (570) 
NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1

>  <name>  (570) 
Pentamidine 

>  <MW>  (570) 
340.427

>  <logP>  (570) 
2.88284

$$$$
CHEMBL1909285
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
  4 16  1  0
 16 17  2  0
 16 18  1  0
  6  2  1  0
 12  7  1  0
M  CHG  4  13   1  15  -1  16   1  18  -1
M  END
>  <PARENT_MOLREGNO>  (571) 
1249055

>  <SYNONYMS>  (571) 
Nitrefazole (BAN, INN, MI)

>  <DEVELOPMENT_PHASE>  (571) 
4

>  <RESEARCH_CODES>  (571) 
EMD-15-700

>  <APPLICANTS>  (571) 
nan

>  <USAN_STEM>  (571) 
nan

>  <USAN_STEM_DEFINITION>  (571) 
nan

>  <USAN_STEM_SUBSTEM>  (571) 
nan

>  <USAN_YEAR>  (571) 
nan

>  <FIRST_APPROVAL>  (571) 
nan

>  <ATC_CODE>  (571) 
nan

>  <ATC_CODE_DESCRIPTION>  (571) 
nan

>  <INDICATION_CLASS>  (571) 
nan

>  <SC_PATENT_NO>  (571) 
nan

>  <DRUG_TYPE>  (571) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (571) 
Y

>  <FIRST_IN_CLASS>  (571) 
N

>  <CHIRALITY>  (571) 
Achiral Molecule

>  <PRODRUG>  (571) 
N

>  <ORAL>  (571) 
N

>  <PARENTERAL>  (571) 
N

>  <TOPICAL>  (571) 
N

>  <BLACK_BOX>  (571) 
N

>  <AVAILABILITY_TYPE>  (571) 
Withdrawn

>  <WITHDRAWN_YEAR>  (571) 
1984.0

>  <WITHDRAWN_COUNTRY>  (571) 
Germany

>  <WITHDRAWN_REASON>  (571) 
Hepatic and Hematologic Toxicity

>  <CANONICAL_SMILES>  (571) 
Cc1nc(cn1c2ccc(cc2)[N+](=O)[O-])[N+](=O)[O-]

>  <name>  (571) 
Nitrefazole 

>  <MW>  (571) 
248.198

>  <logP>  (571) 
1.99712

$$$$
CHEMBL1234886
     RDKit          

  2  1  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
M  END
>  <PARENT_MOLREGNO>  (572) 
697236

>  <SYNONYMS>  (572) 
Oxygen (FDA, USP)

>  <DEVELOPMENT_PHASE>  (572) 
4

>  <RESEARCH_CODES>  (572) 
nan

>  <APPLICANTS>  (572) 
nan

>  <USAN_STEM>  (572) 
nan

>  <USAN_STEM_DEFINITION>  (572) 
nan

>  <USAN_STEM_SUBSTEM>  (572) 
nan

>  <USAN_YEAR>  (572) 
nan

>  <FIRST_APPROVAL>  (572) 
2015.0

>  <ATC_CODE>  (572) 
V03AN01

>  <ATC_CODE_DESCRIPTION>  (572) 
V03AN01 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Medical gases]

>  <INDICATION_CLASS>  (572) 
Gas, Medicinal

>  <SC_PATENT_NO>  (572) 
nan

>  <DRUG_TYPE>  (572) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (572) 
Y

>  <FIRST_IN_CLASS>  (572) 
N

>  <CHIRALITY>  (572) 
Achiral Molecule

>  <PRODRUG>  (572) 
N

>  <ORAL>  (572) 
N

>  <PARENTERAL>  (572) 
N

>  <TOPICAL>  (572) 
Y

>  <BLACK_BOX>  (572) 
N

>  <AVAILABILITY_TYPE>  (572) 
Prescription-only

>  <WITHDRAWN_YEAR>  (572) 
nan

>  <WITHDRAWN_COUNTRY>  (572) 
nan

>  <WITHDRAWN_REASON>  (572) 
nan

>  <CANONICAL_SMILES>  (572) 
O=O

>  <name>  (572) 
Oxygen 

>  <MW>  (572) 
31.998

>  <logP>  (572) 
0.067

$$$$
CHEMBL1509
     RDKit          

 27 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
  8  2  1  0
 13  2  1  0
 11  9  1  0
 18 12  1  0
 22 16  1  0
 21 19  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (573) 
421032

>  <SYNONYMS>  (573) 
Drospirenone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (573) 
4

>  <RESEARCH_CODES>  (573) 
ZK-30595

>  <APPLICANTS>  (573) 
Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (573) 
-renone

>  <USAN_STEM_DEFINITION>  (573) 
aldosterone antagonists (spironolactone type)

>  <USAN_STEM_SUBSTEM>  (573) 
-renone

>  <USAN_YEAR>  (573) 
1997.0

>  <FIRST_APPROVAL>  (573) 
2001.0

>  <ATC_CODE>  (573) 
G03AC10

>  <ATC_CODE_DESCRIPTION>  (573) 
G03AC10 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Hormonal Contraceptives For Systemic Use:Progestogens]

>  <INDICATION_CLASS>  (573) 
Aldosterone Antagonist

>  <SC_PATENT_NO>  (573) 
US-5798338-A

>  <DRUG_TYPE>  (573) 
Natural Product-derived

>  <RULE_OF_FIVE>  (573) 
Y

>  <FIRST_IN_CLASS>  (573) 
N

>  <CHIRALITY>  (573) 
Single Stereoisomer

>  <PRODRUG>  (573) 
N

>  <ORAL>  (573) 
Y

>  <PARENTERAL>  (573) 
N

>  <TOPICAL>  (573) 
N

>  <BLACK_BOX>  (573) 
Y

>  <AVAILABILITY_TYPE>  (573) 
Prescription-only

>  <WITHDRAWN_YEAR>  (573) 
nan

>  <WITHDRAWN_COUNTRY>  (573) 
nan

>  <WITHDRAWN_REASON>  (573) 
nan

>  <CANONICAL_SMILES>  (573) 
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7

>  <name>  (573) 
Drospirenone 

>  <MW>  (573) 
366.501

>  <logP>  (573) 
4.3059

$$$$
CHEMBL1448
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 15 19  1  0
 19 20  2  0
 19 21  1  0
  8  2  1  0
 17 12  1  0
M  CHG  2  19   1  21  -1
M  END
>  <PARENT_MOLREGNO>  (574) 
378218

>  <SYNONYMS>  (574) 
Niclosamide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (574) 
4

>  <RESEARCH_CODES>  (574) 
BAY-2353

>  <APPLICANTS>  (574) 
Bayer Pharmaceuticals Corp

>  <USAN_STEM>  (574) 
nan

>  <USAN_STEM_DEFINITION>  (574) 
nan

>  <USAN_STEM_SUBSTEM>  (574) 
nan

>  <USAN_YEAR>  (574) 
1966.0

>  <FIRST_APPROVAL>  (574) 
1982.0

>  <ATC_CODE>  (574) 
P02DA01

>  <ATC_CODE_DESCRIPTION>  (574) 
P02DA01 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Anticestodals:Salicylic acid derivatives]

>  <INDICATION_CLASS>  (574) 
Anthelmintic

>  <SC_PATENT_NO>  (574) 
nan

>  <DRUG_TYPE>  (574) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (574) 
Y

>  <FIRST_IN_CLASS>  (574) 
N

>  <CHIRALITY>  (574) 
Achiral Molecule

>  <PRODRUG>  (574) 
N

>  <ORAL>  (574) 
Y

>  <PARENTERAL>  (574) 
N

>  <TOPICAL>  (574) 
N

>  <BLACK_BOX>  (574) 
N

>  <AVAILABILITY_TYPE>  (574) 
Discontinued

>  <WITHDRAWN_YEAR>  (574) 
nan

>  <WITHDRAWN_COUNTRY>  (574) 
nan

>  <WITHDRAWN_REASON>  (574) 
nan

>  <CANONICAL_SMILES>  (574) 
Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-]

>  <name>  (574) 
Niclosamide 

>  <MW>  (574) 
327.123

>  <logP>  (574) 
3.8595

$$$$
CHEMBL711
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  3 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 11  2  1  0
 11  6  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (575) 
33727

>  <SYNONYMS>  (575) 
Phenindione (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (575) 
4

>  <RESEARCH_CODES>  (575) 
nan

>  <APPLICANTS>  (575) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (575) 
nan

>  <USAN_STEM_DEFINITION>  (575) 
nan

>  <USAN_STEM_SUBSTEM>  (575) 
nan

>  <USAN_YEAR>  (575) 
nan

>  <FIRST_APPROVAL>  (575) 
1982.0

>  <ATC_CODE>  (575) 
B01AA02

>  <ATC_CODE_DESCRIPTION>  (575) 
B01AA02 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Vitamin K antagonists]

>  <INDICATION_CLASS>  (575) 
nan

>  <SC_PATENT_NO>  (575) 
nan

>  <DRUG_TYPE>  (575) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (575) 
Y

>  <FIRST_IN_CLASS>  (575) 
N

>  <CHIRALITY>  (575) 
Achiral Molecule

>  <PRODRUG>  (575) 
N

>  <ORAL>  (575) 
Y

>  <PARENTERAL>  (575) 
N

>  <TOPICAL>  (575) 
N

>  <BLACK_BOX>  (575) 
N

>  <AVAILABILITY_TYPE>  (575) 
Discontinued

>  <WITHDRAWN_YEAR>  (575) 
nan

>  <WITHDRAWN_COUNTRY>  (575) 
nan

>  <WITHDRAWN_REASON>  (575) 
nan

>  <CANONICAL_SMILES>  (575) 
O=C1C(C(=O)c2ccccc12)c3ccccc3

>  <name>  (575) 
Phenindione 

>  <MW>  (575) 
222.243

>  <logP>  (575) 
2.8494

$$$$
CHEMBL1540
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
  9 17  1  0
 17 18  2  0
 18  2  1  0
 17  6  1  0
M  END
>  <PARENT_MOLREGNO>  (576) 
430597

>  <SYNONYMS>  (576) 
Penciclovir (BAN, INN, USAN); Penciclovir sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (576) 
4

>  <RESEARCH_CODES>  (576) 
BRL-39123; BRL-39123-D

>  <APPLICANTS>  (576) 
SmithKline Beecham; Denco Asset Llc

>  <USAN_STEM>  (576) 
-vir

>  <USAN_STEM_DEFINITION>  (576) 
antivirals: antivirals (acyclovir type)

>  <USAN_STEM_SUBSTEM>  (576) 
-vir (-ciclovir)

>  <USAN_YEAR>  (576) 
1992.0

>  <FIRST_APPROVAL>  (576) 
1996.0

>  <ATC_CODE>  (576) 
J05AB13; D06BB06

>  <ATC_CODE_DESCRIPTION>  (576) 
J05AB13 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; D06BB06 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]

>  <INDICATION_CLASS>  (576) 
Antiviral

>  <SC_PATENT_NO>  (576) 
US-5840763-A

>  <DRUG_TYPE>  (576) 
Natural Product-derived

>  <RULE_OF_FIVE>  (576) 
Y

>  <FIRST_IN_CLASS>  (576) 
N

>  <CHIRALITY>  (576) 
Achiral Molecule

>  <PRODRUG>  (576) 
N

>  <ORAL>  (576) 
N

>  <PARENTERAL>  (576) 
N

>  <TOPICAL>  (576) 
Y

>  <BLACK_BOX>  (576) 
N

>  <AVAILABILITY_TYPE>  (576) 
Prescription-only

>  <WITHDRAWN_YEAR>  (576) 
nan

>  <WITHDRAWN_COUNTRY>  (576) 
nan

>  <WITHDRAWN_REASON>  (576) 
nan

>  <CANONICAL_SMILES>  (576) 
Nc1nc(O)c2ncn(CCC(CO)CO)c2n1

>  <name>  (576) 
Penciclovir 

>  <MW>  (576) 
253.262

>  <logP>  (576) 
-0.895

$$$$
CHEMBL1316
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 11  6  1  0
 19  9  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (577) 
264453

>  <SYNONYMS>  (577) 
Carprofen (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (577) 
4

>  <RESEARCH_CODES>  (577) 
Ro-205720000

>  <APPLICANTS>  (577) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (577) 
-profen

>  <USAN_STEM_DEFINITION>  (577) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (577) 
-profen

>  <USAN_YEAR>  (577) 
1976.0

>  <FIRST_APPROVAL>  (577) 
1987.0

>  <ATC_CODE>  (577) 
nan

>  <ATC_CODE_DESCRIPTION>  (577) 
nan

>  <INDICATION_CLASS>  (577) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (577) 
nan

>  <DRUG_TYPE>  (577) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (577) 
Y

>  <FIRST_IN_CLASS>  (577) 
N

>  <CHIRALITY>  (577) 
Racemic Mixture

>  <PRODRUG>  (577) 
N

>  <ORAL>  (577) 
Y

>  <PARENTERAL>  (577) 
N

>  <TOPICAL>  (577) 
N

>  <BLACK_BOX>  (577) 
N

>  <AVAILABILITY_TYPE>  (577) 
Discontinued

>  <WITHDRAWN_YEAR>  (577) 
nan

>  <WITHDRAWN_COUNTRY>  (577) 
nan

>  <WITHDRAWN_REASON>  (577) 
nan

>  <CANONICAL_SMILES>  (577) 
CC(C(=O)O)c1ccc2c(c1)[nH]c3ccc(Cl)cc23

>  <name>  (577) 
Carprofen 

>  <MW>  (577) 
273.719

>  <logP>  (577) 
4.1626

$$$$
CHEMBL939
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
  9 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 21  3  1  0
 19  5  1  0
 18 11  1  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (578) 
88232

>  <SYNONYMS>  (578) 
Gefitinib (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (578) 
4

>  <RESEARCH_CODES>  (578) 
ZD-1839

>  <APPLICANTS>  (578) 
Astrazeneca Uk Ltd

>  <USAN_STEM>  (578) 
-tinib

>  <USAN_STEM_DEFINITION>  (578) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (578) 
-tinib

>  <USAN_YEAR>  (578) 
2002.0

>  <FIRST_APPROVAL>  (578) 
2003.0

>  <ATC_CODE>  (578) 
L01XE02

>  <ATC_CODE_DESCRIPTION>  (578) 
L01XE02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (578) 
nan

>  <SC_PATENT_NO>  (578) 
US-5770599-A

>  <DRUG_TYPE>  (578) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (578) 
Y

>  <FIRST_IN_CLASS>  (578) 
N

>  <CHIRALITY>  (578) 
Achiral Molecule

>  <PRODRUG>  (578) 
N

>  <ORAL>  (578) 
Y

>  <PARENTERAL>  (578) 
N

>  <TOPICAL>  (578) 
N

>  <BLACK_BOX>  (578) 
N

>  <AVAILABILITY_TYPE>  (578) 
Prescription-only

>  <WITHDRAWN_YEAR>  (578) 
nan

>  <WITHDRAWN_COUNTRY>  (578) 
nan

>  <WITHDRAWN_REASON>  (578) 
nan

>  <CANONICAL_SMILES>  (578) 
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN4CCOCC4

>  <name>  (578) 
Gefitinib 

>  <MW>  (578) 
446.91

>  <logP>  (578) 
4.2756

$$$$
CHEMBL476
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 10  6  2  0
M  END
>  <PARENT_MOLREGNO>  (579) 
5772

>  <SYNONYMS>  (579) 
Dacarbazine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (579) 
4

>  <RESEARCH_CODES>  (579) 
DTIC

>  <APPLICANTS>  (579) 
Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (579) 
nan

>  <USAN_STEM_DEFINITION>  (579) 
nan

>  <USAN_STEM_SUBSTEM>  (579) 
nan

>  <USAN_YEAR>  (579) 
1972.0

>  <FIRST_APPROVAL>  (579) 
1975.0

>  <ATC_CODE>  (579) 
L01AX04

>  <ATC_CODE_DESCRIPTION>  (579) 
L01AX04 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Other alkylating agents]

>  <INDICATION_CLASS>  (579) 
Antineoplastic

>  <SC_PATENT_NO>  (579) 
nan

>  <DRUG_TYPE>  (579) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (579) 
Y

>  <FIRST_IN_CLASS>  (579) 
N

>  <CHIRALITY>  (579) 
Achiral Molecule

>  <PRODRUG>  (579) 
N

>  <ORAL>  (579) 
N

>  <PARENTERAL>  (579) 
Y

>  <TOPICAL>  (579) 
N

>  <BLACK_BOX>  (579) 
Y

>  <AVAILABILITY_TYPE>  (579) 
Prescription-only

>  <WITHDRAWN_YEAR>  (579) 
nan

>  <WITHDRAWN_COUNTRY>  (579) 
nan

>  <WITHDRAWN_REASON>  (579) 
nan

>  <CANONICAL_SMILES>  (579) 
CN(C)N=Nc1[nH]cnc1C(=O)N

>  <name>  (579) 
Dacarbazine 

>  <MW>  (579) 
182.187

>  <logP>  (579) 
0.0689

$$$$
CHEMBL936
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  2 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  2 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 11  6  1  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (580) 
86466

>  <SYNONYMS>  (580) 
Difenidol (BAN, INN); Difenidol HCl (JAN); Diphenidol (USAN); Diphenidol HCl (FDA, USAN); Diphenidol Pamoate (USAN)

>  <DEVELOPMENT_PHASE>  (580) 
4

>  <RESEARCH_CODES>  (580) 
SK&F-478; SK-478; SK&F-478A; SK-478-A; SK&F-478-J

>  <APPLICANTS>  (580) 
SmithKline Beecham; GlaxoSmithKline

>  <USAN_STEM>  (580) 
nan

>  <USAN_STEM_DEFINITION>  (580) 
nan

>  <USAN_STEM_SUBSTEM>  (580) 
nan

>  <USAN_YEAR>  (580) 
1963.0

>  <FIRST_APPROVAL>  (580) 
1967.0

>  <ATC_CODE>  (580) 
nan

>  <ATC_CODE_DESCRIPTION>  (580) 
nan

>  <INDICATION_CLASS>  (580) 
Anti-Emetic

>  <SC_PATENT_NO>  (580) 
nan

>  <DRUG_TYPE>  (580) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (580) 
Y

>  <FIRST_IN_CLASS>  (580) 
N

>  <CHIRALITY>  (580) 
Achiral Molecule

>  <PRODRUG>  (580) 
N

>  <ORAL>  (580) 
Y

>  <PARENTERAL>  (580) 
N

>  <TOPICAL>  (580) 
N

>  <BLACK_BOX>  (580) 
N

>  <AVAILABILITY_TYPE>  (580) 
Discontinued

>  <WITHDRAWN_YEAR>  (580) 
nan

>  <WITHDRAWN_COUNTRY>  (580) 
nan

>  <WITHDRAWN_REASON>  (580) 
nan

>  <CANONICAL_SMILES>  (580) 
OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3

>  <name>  (580) 
Difenidol 

>  <MW>  (580) 
309.453

>  <logP>  (580) 
4.1886

$$$$
CHEMBL1522
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 12 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
  7  2  1  0
 20 11  1  0
 20 15  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (581) 
421334

>  <SYNONYMS>  (581) 
Eszopiclone (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (581) 
4

>  <RESEARCH_CODES>  (581) 
(S)-Zopiclone

>  <APPLICANTS>  (581) 
Sunovion Pharmaceuticals Inc

>  <USAN_STEM>  (581) 
-clone

>  <USAN_STEM_DEFINITION>  (581) 
hypnotics/tranquilizers (zopiclone type)

>  <USAN_STEM_SUBSTEM>  (581) 
-clone

>  <USAN_YEAR>  (581) 
2002.0

>  <FIRST_APPROVAL>  (581) 
2004.0

>  <ATC_CODE>  (581) 
N05CF04

>  <ATC_CODE_DESCRIPTION>  (581) 
N05CF04 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine related drugs]

>  <INDICATION_CLASS>  (581) 
nan

>  <SC_PATENT_NO>  (581) 
nan

>  <DRUG_TYPE>  (581) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (581) 
Y

>  <FIRST_IN_CLASS>  (581) 
N

>  <CHIRALITY>  (581) 
Single Stereoisomer

>  <PRODRUG>  (581) 
N

>  <ORAL>  (581) 
Y

>  <PARENTERAL>  (581) 
N

>  <TOPICAL>  (581) 
N

>  <BLACK_BOX>  (581) 
Y

>  <AVAILABILITY_TYPE>  (581) 
Prescription-only

>  <WITHDRAWN_YEAR>  (581) 
nan

>  <WITHDRAWN_COUNTRY>  (581) 
nan

>  <WITHDRAWN_REASON>  (581) 
nan

>  <CANONICAL_SMILES>  (581) 
CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4

>  <name>  (581) 
Eszopiclone 

>  <MW>  (581) 
388.815

>  <logP>  (581) 
1.568

$$$$
CHEMBL1190
     RDKit          

 18 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
M  CHG  2   2   1  15   1
M  END
>  <PARENT_MOLREGNO>  (582) 
203048

>  <SYNONYMS>  (582) 
Decamethonium Bromide (FDA, INN, MI, USP); Decamethonium Iodide (BAN)

>  <DEVELOPMENT_PHASE>  (582) 
4

>  <RESEARCH_CODES>  (582) 
nan

>  <APPLICANTS>  (582) 
GlaxoSmithKline

>  <USAN_STEM>  (582) 
-ium

>  <USAN_STEM_DEFINITION>  (582) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (582) 
-ium

>  <USAN_YEAR>  (582) 
nan

>  <FIRST_APPROVAL>  (582) 
1982.0

>  <ATC_CODE>  (582) 
nan

>  <ATC_CODE_DESCRIPTION>  (582) 
nan

>  <INDICATION_CLASS>  (582) 
nan

>  <SC_PATENT_NO>  (582) 
nan

>  <DRUG_TYPE>  (582) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (582) 
Y

>  <FIRST_IN_CLASS>  (582) 
N

>  <CHIRALITY>  (582) 
Achiral Molecule

>  <PRODRUG>  (582) 
N

>  <ORAL>  (582) 
N

>  <PARENTERAL>  (582) 
Y

>  <TOPICAL>  (582) 
N

>  <BLACK_BOX>  (582) 
N

>  <AVAILABILITY_TYPE>  (582) 
Discontinued

>  <WITHDRAWN_YEAR>  (582) 
nan

>  <WITHDRAWN_COUNTRY>  (582) 
nan

>  <WITHDRAWN_REASON>  (582) 
nan

>  <CANONICAL_SMILES>  (582) 
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C

>  <name>  (582) 
Decamethonium Bromide 

>  <MW>  (582) 
258.494

>  <logP>  (582) 
3.5196

$$$$
CHEMBL70
     RDKit          

 21 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 13 21  2  0
 15  2  1  0
 16  5  1  0
 21  5  1  0
 19  6  1  0
 21  8  1  0
M  END
>  <PARENT_MOLREGNO>  (583) 
6005

>  <SYNONYMS>  (583) 
Morphine (BAN); Morphine HCl (JAN, MI, USP); Morphine Sulfate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (583) 
4

>  <RESEARCH_CODES>  (583) 
nan

>  <APPLICANTS>  (583) 
Hospira Inc; Hikma Maple Ltd; Alpharma Pharmaceuticals Llc King Pharmaceuticals; Actavis Elizabeth Llc; King Pharmaceuticals Inc Sub Pfizer Inc

>  <USAN_STEM>  (583) 
nan

>  <USAN_STEM_DEFINITION>  (583) 
nan

>  <USAN_STEM_SUBSTEM>  (583) 
nan

>  <USAN_YEAR>  (583) 
nan

>  <FIRST_APPROVAL>  (583) 
1984.0

>  <ATC_CODE>  (583) 
N02AA01; A07DA52; N02AA51

>  <ATC_CODE_DESCRIPTION>  (583) 
N02AA01 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]; A07DA52 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Antipropulsives:Antipropulsives]; N02AA51 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]

>  <INDICATION_CLASS>  (583) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (583) 
US-5807572-A

>  <DRUG_TYPE>  (583) 
Natural Product-derived

>  <RULE_OF_FIVE>  (583) 
Y

>  <FIRST_IN_CLASS>  (583) 
N

>  <CHIRALITY>  (583) 
Single Stereoisomer

>  <PRODRUG>  (583) 
N

>  <ORAL>  (583) 
Y

>  <PARENTERAL>  (583) 
Y

>  <TOPICAL>  (583) 
N

>  <BLACK_BOX>  (583) 
Y

>  <AVAILABILITY_TYPE>  (583) 
Prescription-only

>  <WITHDRAWN_YEAR>  (583) 
nan

>  <WITHDRAWN_COUNTRY>  (583) 
nan

>  <WITHDRAWN_REASON>  (583) 
nan

>  <CANONICAL_SMILES>  (583) 
CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35

>  <name>  (583) 
Morphine 

>  <MW>  (583) 
285.343

>  <logP>  (583) 
1.1981

$$$$
CHEMBL288470
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10  4  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (584) 
60246

>  <SYNONYMS>  (584) 
Aminophenazone (INN); Aminopyrine (JAN, MI, NF); Aminophenazone Cyclamate (INN)

>  <DEVELOPMENT_PHASE>  (584) 
4

>  <RESEARCH_CODES>  (584) 
nan

>  <APPLICANTS>  (584) 
nan

>  <USAN_STEM>  (584) 
nan

>  <USAN_STEM_DEFINITION>  (584) 
nan

>  <USAN_STEM_SUBSTEM>  (584) 
nan

>  <USAN_YEAR>  (584) 
nan

>  <FIRST_APPROVAL>  (584) 
nan

>  <ATC_CODE>  (584) 
N02BB53; N02BB73; N02BB03

>  <ATC_CODE_DESCRIPTION>  (584) 
N02BB53 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Pyrazolones]; N02BB73 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Pyrazolones]; N02BB03 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Pyrazolones]

>  <INDICATION_CLASS>  (584) 
nan

>  <SC_PATENT_NO>  (584) 
nan

>  <DRUG_TYPE>  (584) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (584) 
Y

>  <FIRST_IN_CLASS>  (584) 
N

>  <CHIRALITY>  (584) 
Achiral Molecule

>  <PRODRUG>  (584) 
N

>  <ORAL>  (584) 
N

>  <PARENTERAL>  (584) 
N

>  <TOPICAL>  (584) 
N

>  <BLACK_BOX>  (584) 
N

>  <AVAILABILITY_TYPE>  (584) 
Withdrawn

>  <WITHDRAWN_YEAR>  (584) 
1970.0

>  <WITHDRAWN_COUNTRY>  (584) 
United Kingdom; United States; Germany; France; United Kingdom; United States; Germany; France

>  <WITHDRAWN_REASON>  (584) 
Agranulocytosis; Agranulocytosis

>  <CANONICAL_SMILES>  (584) 
CN(C)C1=C(C)N(C)N(C1=O)c2ccccc2

>  <name>  (584) 
Aminophenazone 

>  <MW>  (584) 
231.299

>  <logP>  (584) 
1.55042

$$$$
CHEMBL571
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 11  6  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (585) 
16591

>  <SYNONYMS>  (585) 
Ketoprofen (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (585) 
4

>  <RESEARCH_CODES>  (585) 
R.P. 19583; RP-19583

>  <APPLICANTS>  (585) 
Wyeth Consumer Healthcare; Wyeth Ayerst Laboratories; Novartis Consumer Health Inc; Bayer Healthcare Llc; Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (585) 
-profen

>  <USAN_STEM_DEFINITION>  (585) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (585) 
-profen

>  <USAN_YEAR>  (585) 
1972.0

>  <FIRST_APPROVAL>  (585) 
1986.0

>  <ATC_CODE>  (585) 
M01AE03; M02AA10; M01AE53

>  <ATC_CODE_DESCRIPTION>  (585) 
M01AE03 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]; M02AA10 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; M01AE53 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (585) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (585) 
nan

>  <DRUG_TYPE>  (585) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (585) 
Y

>  <FIRST_IN_CLASS>  (585) 
N

>  <CHIRALITY>  (585) 
Racemic Mixture

>  <PRODRUG>  (585) 
N

>  <ORAL>  (585) 
Y

>  <PARENTERAL>  (585) 
N

>  <TOPICAL>  (585) 
N

>  <BLACK_BOX>  (585) 
Y

>  <AVAILABILITY_TYPE>  (585) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (585) 
nan

>  <WITHDRAWN_COUNTRY>  (585) 
nan

>  <WITHDRAWN_REASON>  (585) 
nan

>  <CANONICAL_SMILES>  (585) 
CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2

>  <name>  (585) 
Ketoprofen 

>  <MW>  (585) 
254.285

>  <logP>  (585) 
3.1057

$$$$
CHEMBL1027
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
  7 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
  6  2  2  0
 16 11  1  0
 24 20  2  0
M  END
>  <PARENT_MOLREGNO>  (586) 
122170

>  <SYNONYMS>  (586) 
Tiagabine (BAN, INN); Tiagabine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (586) 
4

>  <RESEARCH_CODES>  (586) 
A-70569-1; ABT-569; NNC-05-0328; NO-05-0328; ABBOTT-70569.1; ABBOTT-70569.HCl

>  <APPLICANTS>  (586) 
Cephalon Inc

>  <USAN_STEM>  (586) 
-gab-

>  <USAN_STEM_DEFINITION>  (586) 
gabamimetics

>  <USAN_STEM_SUBSTEM>  (586) 
-gab-

>  <USAN_YEAR>  (586) 
1996.0

>  <FIRST_APPROVAL>  (586) 
1997.0

>  <ATC_CODE>  (586) 
N03AG06

>  <ATC_CODE_DESCRIPTION>  (586) 
N03AG06 [Nervous System:Antiepileptics:Antiepileptics:Fatty acid derivatives]

>  <INDICATION_CLASS>  (586) 
Anticonvulsant

>  <SC_PATENT_NO>  (586) 
US-5866590-A

>  <DRUG_TYPE>  (586) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (586) 
Y

>  <FIRST_IN_CLASS>  (586) 
N

>  <CHIRALITY>  (586) 
Single Stereoisomer

>  <PRODRUG>  (586) 
N

>  <ORAL>  (586) 
Y

>  <PARENTERAL>  (586) 
N

>  <TOPICAL>  (586) 
N

>  <BLACK_BOX>  (586) 
N

>  <AVAILABILITY_TYPE>  (586) 
Prescription-only

>  <WITHDRAWN_YEAR>  (586) 
nan

>  <WITHDRAWN_COUNTRY>  (586) 
nan

>  <WITHDRAWN_REASON>  (586) 
nan

>  <CANONICAL_SMILES>  (586) 
Cc1ccsc1C(=CCCN2CCC[C@H](C2)C(=O)O)c3sccc3C

>  <name>  (586) 
Tiagabine 

>  <MW>  (586) 
375.559

>  <logP>  (586) 
5.04484

$$$$
CHEMBL911
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
  8 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 16  7  1  0
 16 10  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (587) 
80965

>  <SYNONYMS>  (587) 
Zolpidem (BAN, INN); Zolpidem Tartrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (587) 
4

>  <RESEARCH_CODES>  (587) 
SL-800750-23N; SL-80.0750-23N

>  <APPLICANTS>  (587) 
Purdue Pharma Products Lp; Novadel Pharma Inc; Meda Pharmaceuticals; Biovail Laboratories International Srl; Sanofi Aventis Us Llc

>  <USAN_STEM>  (587) 
-pidem

>  <USAN_STEM_DEFINITION>  (587) 
hypnotics/sedatives (zolpidem type)

>  <USAN_STEM_SUBSTEM>  (587) 
-pidem

>  <USAN_YEAR>  (587) 
1987.0

>  <FIRST_APPROVAL>  (587) 
1992.0

>  <ATC_CODE>  (587) 
N05CF02

>  <ATC_CODE_DESCRIPTION>  (587) 
N05CF02 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine related drugs]

>  <INDICATION_CLASS>  (587) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (587) 
US-6514531-B1

>  <DRUG_TYPE>  (587) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (587) 
Y

>  <FIRST_IN_CLASS>  (587) 
N

>  <CHIRALITY>  (587) 
Achiral Molecule

>  <PRODRUG>  (587) 
N

>  <ORAL>  (587) 
Y

>  <PARENTERAL>  (587) 
N

>  <TOPICAL>  (587) 
Y

>  <BLACK_BOX>  (587) 
Y

>  <AVAILABILITY_TYPE>  (587) 
Prescription-only

>  <WITHDRAWN_YEAR>  (587) 
nan

>  <WITHDRAWN_COUNTRY>  (587) 
nan

>  <WITHDRAWN_REASON>  (587) 
nan

>  <CANONICAL_SMILES>  (587) 
CN(C)C(=O)Cc1c(nc2ccc(C)cn12)c3ccc(C)cc3

>  <name>  (587) 
Zolpidem 

>  <MW>  (587) 
307.397

>  <logP>  (587) 
3.24884

$$$$
CHEMBL1101
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
  2 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 10  5  1  0
 15 11  1  0
 17 13  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (588) 
151063

>  <SYNONYMS>  (588) 
Biperiden (BAN, INN, JAN, USP); Biperiden HCl (BAN, FDA, JAN, USP); Biperiden Lactate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (588) 
4

>  <RESEARCH_CODES>  (588) 
nan

>  <APPLICANTS>  (588) 
Knoll; Abbvie Inc

>  <USAN_STEM>  (588) 
nan

>  <USAN_STEM_DEFINITION>  (588) 
nan

>  <USAN_STEM_SUBSTEM>  (588) 
nan

>  <USAN_YEAR>  (588) 
nan

>  <FIRST_APPROVAL>  (588) 
1959.0

>  <ATC_CODE>  (588) 
N04AA02

>  <ATC_CODE_DESCRIPTION>  (588) 
N04AA02 [Nervous System:Anti-Parkinson Drugs:Anticholinergic Agents:Tertiary amines]

>  <INDICATION_CLASS>  (588) 
Anticholinergic; Antiparkinsonian

>  <SC_PATENT_NO>  (588) 
nan

>  <DRUG_TYPE>  (588) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (588) 
Y

>  <FIRST_IN_CLASS>  (588) 
N

>  <CHIRALITY>  (588) 
Racemic Mixture

>  <PRODRUG>  (588) 
N

>  <ORAL>  (588) 
Y

>  <PARENTERAL>  (588) 
Y

>  <TOPICAL>  (588) 
N

>  <BLACK_BOX>  (588) 
N

>  <AVAILABILITY_TYPE>  (588) 
Prescription-only

>  <WITHDRAWN_YEAR>  (588) 
nan

>  <WITHDRAWN_COUNTRY>  (588) 
nan

>  <WITHDRAWN_REASON>  (588) 
nan

>  <CANONICAL_SMILES>  (588) 
OC(CCN1CCCCC1)(C2CC3CC2C=C3)c4ccccc4

>  <name>  (588) 
Biperiden 

>  <MW>  (588) 
311.469

>  <logP>  (588) 
3.9624

$$$$
CHEMBL428
     RDKit          

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 11 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
  7  2  1  0
  7  3  1  0
 21  8  1  0
 19 10  2  0
 29 23  1  0
M  END
>  <PARENT_MOLREGNO>  (589) 
1616

>  <SYNONYMS>  (589) 
Trovafloxacin (INN); Trovafloxacin Mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (589) 
4

>  <RESEARCH_CODES>  (589) 
CP-9921927; CP-99219-27

>  <APPLICANTS>  (589) 
Pfizer Pharmaceuticals Inc; Pfizer Central Research

>  <USAN_STEM>  (589) 
-oxacin

>  <USAN_STEM_DEFINITION>  (589) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (589) 
-oxacin

>  <USAN_YEAR>  (589) 
1995.0

>  <FIRST_APPROVAL>  (589) 
1997.0

>  <ATC_CODE>  (589) 
J01MA13

>  <ATC_CODE_DESCRIPTION>  (589) 
J01MA13 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]

>  <INDICATION_CLASS>  (589) 
Antibacterial

>  <SC_PATENT_NO>  (589) 
nan

>  <DRUG_TYPE>  (589) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (589) 
Y

>  <FIRST_IN_CLASS>  (589) 
N

>  <CHIRALITY>  (589) 
Single Stereoisomer

>  <PRODRUG>  (589) 
N

>  <ORAL>  (589) 
Y

>  <PARENTERAL>  (589) 
N

>  <TOPICAL>  (589) 
N

>  <BLACK_BOX>  (589) 
Y

>  <AVAILABILITY_TYPE>  (589) 
Withdrawn

>  <WITHDRAWN_YEAR>  (589) 
1999.0

>  <WITHDRAWN_COUNTRY>  (589) 
European Union; United States

>  <WITHDRAWN_REASON>  (589) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (589) 
N[C@@H]1[C@H]2CN(C[C@@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F

>  <name>  (589) 
Trovafloxacin 

>  <MW>  (589) 
416.359

>  <logP>  (589) 
1.8945

$$$$
CHEMBL1089
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (590) 
148018

>  <SYNONYMS>  (590) 
Phenelzine (BAN, INN); Phenelzine sulfate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (590) 
4

>  <RESEARCH_CODES>  (590) 
nan

>  <APPLICANTS>  (590) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (590) 
nan

>  <USAN_STEM_DEFINITION>  (590) 
nan

>  <USAN_STEM_SUBSTEM>  (590) 
nan

>  <USAN_YEAR>  (590) 
nan

>  <FIRST_APPROVAL>  (590) 
1961.0

>  <ATC_CODE>  (590) 
N06AF03

>  <ATC_CODE_DESCRIPTION>  (590) 
N06AF03 [Nervous System:Psychoanaleptics:Antidepressants:Monoamine oxidase inhibitors, non-selective]

>  <INDICATION_CLASS>  (590) 
Antidepressant

>  <SC_PATENT_NO>  (590) 
nan

>  <DRUG_TYPE>  (590) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (590) 
Y

>  <FIRST_IN_CLASS>  (590) 
N

>  <CHIRALITY>  (590) 
Achiral Molecule

>  <PRODRUG>  (590) 
N

>  <ORAL>  (590) 
Y

>  <PARENTERAL>  (590) 
N

>  <TOPICAL>  (590) 
N

>  <BLACK_BOX>  (590) 
Y

>  <AVAILABILITY_TYPE>  (590) 
Prescription-only

>  <WITHDRAWN_YEAR>  (590) 
nan

>  <WITHDRAWN_COUNTRY>  (590) 
nan

>  <WITHDRAWN_REASON>  (590) 
nan

>  <CANONICAL_SMILES>  (590) 
NNCCc1ccccc1

>  <name>  (590) 
Phenelzine 

>  <MW>  (590) 
136.198

>  <logP>  (590) 
0.6924

$$$$
CHEMBL2105760
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
  6 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31  2  1  0
 29  4  1  0
 17 12  1  0
 26 18  1  0
 26 22  2  0
M  END
>  <PARENT_MOLREGNO>  (591) 
1378030

>  <SYNONYMS>  (591) 
Brexpiprazole (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (591) 
4

>  <RESEARCH_CODES>  (591) 
OPC-34712

>  <APPLICANTS>  (591) 
Otsuka Pharmaceutical Development & Commercialization; Otsuka Pharmaceutical Co Ltd

>  <USAN_STEM>  (591) 
-prazole

>  <USAN_STEM_DEFINITION>  (591) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (591) 
-prazole

>  <USAN_YEAR>  (591) 
2011.0

>  <FIRST_APPROVAL>  (591) 
2015.0

>  <ATC_CODE>  (591) 
N05AX16

>  <ATC_CODE_DESCRIPTION>  (591) 
N05AX16 [Nervous System:Psycholeptics:Antipsychotics:Other antipsychotics]

>  <INDICATION_CLASS>  (591) 
nan

>  <SC_PATENT_NO>  (591) 
US-7888362-B2

>  <DRUG_TYPE>  (591) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (591) 
Y

>  <FIRST_IN_CLASS>  (591) 
N

>  <CHIRALITY>  (591) 
Achiral Molecule

>  <PRODRUG>  (591) 
N

>  <ORAL>  (591) 
Y

>  <PARENTERAL>  (591) 
N

>  <TOPICAL>  (591) 
N

>  <BLACK_BOX>  (591) 
Y

>  <AVAILABILITY_TYPE>  (591) 
Prescription-only

>  <WITHDRAWN_YEAR>  (591) 
nan

>  <WITHDRAWN_COUNTRY>  (591) 
nan

>  <WITHDRAWN_REASON>  (591) 
nan

>  <CANONICAL_SMILES>  (591) 
O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1

>  <name>  (591) 
Brexpiprazole 

>  <MW>  (591) 
433.577

>  <logP>  (591) 
4.724

$$$$
CHEMBL741
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  5  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
  8  2  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (592) 
38727

>  <SYNONYMS>  (592) 
Lamotrigine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (592) 
4

>  <RESEARCH_CODES>  (592) 
BW-430C

>  <APPLICANTS>  (592) 
SmithKline Beecham Corp Dba GlaxoSmithKline; SmithKline Beecham Corp; GlaxoSmithKline

>  <USAN_STEM>  (592) 
nan

>  <USAN_STEM_DEFINITION>  (592) 
nan

>  <USAN_STEM_SUBSTEM>  (592) 
nan

>  <USAN_YEAR>  (592) 
1985.0

>  <FIRST_APPROVAL>  (592) 
1994.0

>  <ATC_CODE>  (592) 
N03AX09

>  <ATC_CODE_DESCRIPTION>  (592) 
N03AX09 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (592) 
Anticonvulsant

>  <SC_PATENT_NO>  (592) 
US-7919115-B2

>  <DRUG_TYPE>  (592) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (592) 
Y

>  <FIRST_IN_CLASS>  (592) 
N

>  <CHIRALITY>  (592) 
Achiral Molecule

>  <PRODRUG>  (592) 
N

>  <ORAL>  (592) 
Y

>  <PARENTERAL>  (592) 
N

>  <TOPICAL>  (592) 
N

>  <BLACK_BOX>  (592) 
Y

>  <AVAILABILITY_TYPE>  (592) 
Prescription-only

>  <WITHDRAWN_YEAR>  (592) 
nan

>  <WITHDRAWN_COUNTRY>  (592) 
nan

>  <WITHDRAWN_REASON>  (592) 
nan

>  <CANONICAL_SMILES>  (592) 
Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl

>  <name>  (592) 
Lamotrigine 

>  <MW>  (592) 
256.096

>  <logP>  (592) 
2.0098

$$$$
CHEMBL1168
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 14  9  1  0
 27 20  1  0
 25 21  1  0
M  END
>  <PARENT_MOLREGNO>  (593) 
189203

>  <SYNONYMS>  (593) 
Ramipril (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (593) 
4

>  <RESEARCH_CODES>  (593) 
HOE-498

>  <APPLICANTS>  (593) 
King Pharmaceuticals Inc Sub Pfizer Inc; King Pharmaceuticals Inc

>  <USAN_STEM>  (593) 
-pril

>  <USAN_STEM_DEFINITION>  (593) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (593) 
-pril

>  <USAN_YEAR>  (593) 
1986.0

>  <FIRST_APPROVAL>  (593) 
1991.0

>  <ATC_CODE>  (593) 
C09AA05

>  <ATC_CODE_DESCRIPTION>  (593) 
C09AA05 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (593) 
Antihypertensive; Enzyme Inhibitor (angiotensin-converting)

>  <SC_PATENT_NO>  (593) 
US-7368469-B2

>  <DRUG_TYPE>  (593) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (593) 
Y

>  <FIRST_IN_CLASS>  (593) 
N

>  <CHIRALITY>  (593) 
Single Stereoisomer

>  <PRODRUG>  (593) 
Y

>  <ORAL>  (593) 
Y

>  <PARENTERAL>  (593) 
N

>  <TOPICAL>  (593) 
N

>  <BLACK_BOX>  (593) 
Y

>  <AVAILABILITY_TYPE>  (593) 
Prescription-only

>  <WITHDRAWN_YEAR>  (593) 
nan

>  <WITHDRAWN_COUNTRY>  (593) 
nan

>  <WITHDRAWN_REASON>  (593) 
nan

>  <CANONICAL_SMILES>  (593) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O

>  <name>  (593) 
Ramipril 

>  <MW>  (593) 
416.518

>  <logP>  (593) 
2.3832

$$$$
CHEMBL814
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (594) 
54722

>  <SYNONYMS>  (594) 
Fluvoxamine (BAN, INN); Fluvoxamine Maleate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (594) 
4

>  <RESEARCH_CODES>  (594) 
DU-23000

>  <APPLICANTS>  (594) 
Solvay Pharmaceuticals; Jazz Pharmaceuticals Inc; Ani Pharmaceuticals Inc

>  <USAN_STEM>  (594) 
nan

>  <USAN_STEM_DEFINITION>  (594) 
nan

>  <USAN_STEM_SUBSTEM>  (594) 
nan

>  <USAN_YEAR>  (594) 
1995.0

>  <FIRST_APPROVAL>  (594) 
1994.0

>  <ATC_CODE>  (594) 
N06AB08

>  <ATC_CODE_DESCRIPTION>  (594) 
N06AB08 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (594) 
Antiobsessional Agent

>  <SC_PATENT_NO>  (594) 
US-7465462-B1

>  <DRUG_TYPE>  (594) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (594) 
Y

>  <FIRST_IN_CLASS>  (594) 
N

>  <CHIRALITY>  (594) 
Achiral Molecule

>  <PRODRUG>  (594) 
N

>  <ORAL>  (594) 
Y

>  <PARENTERAL>  (594) 
N

>  <TOPICAL>  (594) 
N

>  <BLACK_BOX>  (594) 
Y

>  <AVAILABILITY_TYPE>  (594) 
Prescription-only

>  <WITHDRAWN_YEAR>  (594) 
nan

>  <WITHDRAWN_COUNTRY>  (594) 
nan

>  <WITHDRAWN_REASON>  (594) 
nan

>  <CANONICAL_SMILES>  (594) 
COCCCC\C(=N/OCCN)\c1ccc(cc1)C(F)(F)F

>  <name>  (594) 
Fluvoxamine 

>  <MW>  (594) 
318.339

>  <logP>  (594) 
3.2015

$$$$
CHEMBL1200907
     RDKit          

 24 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  3  0
 12 19  1  0
  6 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 20  2  1  0
 23  2  1  0
 15  5  1  0
 11  9  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (595) 
674858

>  <SYNONYMS>  (595) 
Trilostane (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (595) 
4

>  <RESEARCH_CODES>  (595) 
WIN-24540

>  <APPLICANTS>  (595) 
Bioenvision Inc

>  <USAN_STEM>  (595) 
nan

>  <USAN_STEM_DEFINITION>  (595) 
nan

>  <USAN_STEM_SUBSTEM>  (595) 
nan

>  <USAN_YEAR>  (595) 
1976.0

>  <FIRST_APPROVAL>  (595) 
1984.0

>  <ATC_CODE>  (595) 
H02CA01

>  <ATC_CODE_DESCRIPTION>  (595) 
H02CA01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Antiadrenal Preparations:Anticorticosteroids]

>  <INDICATION_CLASS>  (595) 
Adrenocortical Suppressant

>  <SC_PATENT_NO>  (595) 
nan

>  <DRUG_TYPE>  (595) 
Natural Product-derived

>  <RULE_OF_FIVE>  (595) 
Y

>  <FIRST_IN_CLASS>  (595) 
N

>  <CHIRALITY>  (595) 
Single Stereoisomer

>  <PRODRUG>  (595) 
N

>  <ORAL>  (595) 
Y

>  <PARENTERAL>  (595) 
N

>  <TOPICAL>  (595) 
N

>  <BLACK_BOX>  (595) 
N

>  <AVAILABILITY_TYPE>  (595) 
Discontinued

>  <WITHDRAWN_YEAR>  (595) 
nan

>  <WITHDRAWN_COUNTRY>  (595) 
nan

>  <WITHDRAWN_REASON>  (595) 
nan

>  <CANONICAL_SMILES>  (595) 
C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=C(C[C@]35C)C#N)O)[C@@H]1CC[C@@H]2O

>  <name>  (595) 
Trilostane 

>  <MW>  (595) 
329.44

>  <logP>  (595) 
3.46688

$$$$
CHEMBL177591
     RDKit          

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
M  END
>  <PARENT_MOLREGNO>  (596) 
295525

>  <SYNONYMS>  (596) 
Dimethylcarbate

>  <DEVELOPMENT_PHASE>  (596) 
4

>  <RESEARCH_CODES>  (596) 
nan

>  <APPLICANTS>  (596) 
nan

>  <USAN_STEM>  (596) 
nan

>  <USAN_STEM_DEFINITION>  (596) 
nan

>  <USAN_STEM_SUBSTEM>  (596) 
nan

>  <USAN_YEAR>  (596) 
nan

>  <FIRST_APPROVAL>  (596) 
nan

>  <ATC_CODE>  (596) 
P03BX05

>  <ATC_CODE_DESCRIPTION>  (596) 
P03BX05 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Insecticides And Repellents:Other insecticides and repellents]

>  <INDICATION_CLASS>  (596) 
nan

>  <SC_PATENT_NO>  (596) 
nan

>  <DRUG_TYPE>  (596) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (596) 
Y

>  <FIRST_IN_CLASS>  (596) 
N

>  <CHIRALITY>  (596) 
Achiral Molecule

>  <PRODRUG>  (596) 
N

>  <ORAL>  (596) 
N

>  <PARENTERAL>  (596) 
N

>  <TOPICAL>  (596) 
N

>  <BLACK_BOX>  (596) 
N

>  <AVAILABILITY_TYPE>  (596) 
Unknown

>  <WITHDRAWN_YEAR>  (596) 
nan

>  <WITHDRAWN_COUNTRY>  (596) 
nan

>  <WITHDRAWN_REASON>  (596) 
nan

>  <CANONICAL_SMILES>  (596) 
CN(C)C(=O)O

>  <name>  (596) 
Dimethylcarbate

>  <MW>  (596) 
89.094

>  <logP>  (596) 
0.226

$$$$
CHEMBL953
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
  8 21  1  0
 21 22  3  0
 17 10  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (597) 
92412

>  <SYNONYMS>  (597) 
Entacapone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (597) 
4

>  <RESEARCH_CODES>  (597) 
OR-611

>  <APPLICANTS>  (597) 
Orion Pharma

>  <USAN_STEM>  (597) 
nan

>  <USAN_STEM_DEFINITION>  (597) 
nan

>  <USAN_STEM_SUBSTEM>  (597) 
nan

>  <USAN_YEAR>  (597) 
1997.0

>  <FIRST_APPROVAL>  (597) 
1999.0

>  <ATC_CODE>  (597) 
N04BX02

>  <ATC_CODE_DESCRIPTION>  (597) 
N04BX02 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Other dopaminergic agents]

>  <INDICATION_CLASS>  (597) 
Antidyskinetic

>  <SC_PATENT_NO>  (597) 
US-6500867-B1

>  <DRUG_TYPE>  (597) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (597) 
Y

>  <FIRST_IN_CLASS>  (597) 
N

>  <CHIRALITY>  (597) 
Achiral Molecule

>  <PRODRUG>  (597) 
N

>  <ORAL>  (597) 
Y

>  <PARENTERAL>  (597) 
N

>  <TOPICAL>  (597) 
N

>  <BLACK_BOX>  (597) 
N

>  <AVAILABILITY_TYPE>  (597) 
Prescription-only

>  <WITHDRAWN_YEAR>  (597) 
nan

>  <WITHDRAWN_COUNTRY>  (597) 
nan

>  <WITHDRAWN_REASON>  (597) 
nan

>  <CANONICAL_SMILES>  (597) 
CCN(CC)C(=O)\C(=C\c1cc(O)c(O)c(c1)[N+](=O)[O-])\C#N

>  <name>  (597) 
Entacapone 

>  <MW>  (597) 
305.29

>  <logP>  (597) 
1.78138

$$$$
CHEMBL931
     RDKit          

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
M  END
>  <PARENT_MOLREGNO>  (598) 
85649

>  <SYNONYMS>  (598) 
Halothane (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (598) 
4

>  <RESEARCH_CODES>  (598) 
nan

>  <APPLICANTS>  (598) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (598) 
nan

>  <USAN_STEM_DEFINITION>  (598) 
nan

>  <USAN_STEM_SUBSTEM>  (598) 
nan

>  <USAN_YEAR>  (598) 
nan

>  <FIRST_APPROVAL>  (598) 
1958.0

>  <ATC_CODE>  (598) 
N01AB01

>  <ATC_CODE_DESCRIPTION>  (598) 
N01AB01 [Nervous System:Anesthetics:Anesthetics, General:Halogenated hydrocarbons]

>  <INDICATION_CLASS>  (598) 
Anesthetic (inhalation)

>  <SC_PATENT_NO>  (598) 
nan

>  <DRUG_TYPE>  (598) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (598) 
Y

>  <FIRST_IN_CLASS>  (598) 
N

>  <CHIRALITY>  (598) 
Racemic Mixture

>  <PRODRUG>  (598) 
N

>  <ORAL>  (598) 
N

>  <PARENTERAL>  (598) 
N

>  <TOPICAL>  (598) 
Y

>  <BLACK_BOX>  (598) 
N

>  <AVAILABILITY_TYPE>  (598) 
Discontinued

>  <WITHDRAWN_YEAR>  (598) 
nan

>  <WITHDRAWN_COUNTRY>  (598) 
nan

>  <WITHDRAWN_REASON>  (598) 
nan

>  <CANONICAL_SMILES>  (598) 
FC(F)(F)C(Cl)Br

>  <name>  (598) 
Halothane 

>  <MW>  (598) 
197.381

>  <logP>  (598) 
2.5085

$$$$
CHEMBL661
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22  2  1  0
 22  5  1  0
 14  9  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (599) 
27648

>  <SYNONYMS>  (599) 
Alprazolam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (599) 
4

>  <RESEARCH_CODES>  (599) 
U-31889

>  <APPLICANTS>  (599) 
Ucb Inc; Pharmacia And Upjohn Co; Pharmacia And Upjohn

>  <USAN_STEM>  (599) 
nan

>  <USAN_STEM_DEFINITION>  (599) 
nan

>  <USAN_STEM_SUBSTEM>  (599) 
nan

>  <USAN_YEAR>  (599) 
1973.0

>  <FIRST_APPROVAL>  (599) 
1981.0

>  <ATC_CODE>  (599) 
N05BA12

>  <ATC_CODE_DESCRIPTION>  (599) 
N05BA12 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (599) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (599) 
US-6024981-A

>  <DRUG_TYPE>  (599) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (599) 
Y

>  <FIRST_IN_CLASS>  (599) 
N

>  <CHIRALITY>  (599) 
Achiral Molecule

>  <PRODRUG>  (599) 
N

>  <ORAL>  (599) 
Y

>  <PARENTERAL>  (599) 
N

>  <TOPICAL>  (599) 
N

>  <BLACK_BOX>  (599) 
N

>  <AVAILABILITY_TYPE>  (599) 
Prescription-only

>  <WITHDRAWN_YEAR>  (599) 
nan

>  <WITHDRAWN_COUNTRY>  (599) 
nan

>  <WITHDRAWN_REASON>  (599) 
nan

>  <CANONICAL_SMILES>  (599) 
Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12

>  <name>  (599) 
Alprazolam 

>  <MW>  (599) 
308.772

>  <logP>  (599) 
3.58012

$$$$
CHEMBL1373
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  8  1  0
 19 14  1  0
M  CHG  2   5   1   6  -1
M  END
>  <PARENT_MOLREGNO>  (600) 
317124

>  <SYNONYMS>  (600) 
Modafinil (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (600) 
4

>  <RESEARCH_CODES>  (600) 
CEP-1538; CRL-40476

>  <APPLICANTS>  (600) 
Cephalon Inc

>  <USAN_STEM>  (600) 
-nil

>  <USAN_STEM_DEFINITION>  (600) 
benzodiazepine receptor antagonists/agonists

>  <USAN_STEM_SUBSTEM>  (600) 
-nil

>  <USAN_YEAR>  (600) 
1994.0

>  <FIRST_APPROVAL>  (600) 
1998.0

>  <ATC_CODE>  (600) 
N06BA07

>  <ATC_CODE_DESCRIPTION>  (600) 
N06BA07 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (600) 
Analeptic (treatment of narcolepsy hypersomnia)

>  <SC_PATENT_NO>  (600) 
US-7297346-B2

>  <DRUG_TYPE>  (600) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (600) 
Y

>  <FIRST_IN_CLASS>  (600) 
N

>  <CHIRALITY>  (600) 
Racemic Mixture

>  <PRODRUG>  (600) 
N

>  <ORAL>  (600) 
Y

>  <PARENTERAL>  (600) 
N

>  <TOPICAL>  (600) 
N

>  <BLACK_BOX>  (600) 
Y

>  <AVAILABILITY_TYPE>  (600) 
Prescription-only

>  <WITHDRAWN_YEAR>  (600) 
nan

>  <WITHDRAWN_COUNTRY>  (600) 
nan

>  <WITHDRAWN_REASON>  (600) 
nan

>  <CANONICAL_SMILES>  (600) 
NC(=O)C[S+]([O-])C(c1ccccc1)c2ccccc2

>  <name>  (600) 
Modafinil 

>  <MW>  (600) 
273.357

>  <logP>  (600) 
2.01

$$$$
CHEMBL2104993
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  5 19  1  0
 19 20  1  0
 19 21  2  0
 21  2  1  0
 12  7  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (601) 
1377263

>  <SYNONYMS>  (601) 
Vortioxetine (INN, USAN); Vortioxetine Hydrobromide (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (601) 
4

>  <RESEARCH_CODES>  (601) 
Lu-AA21004-(HBr)

>  <APPLICANTS>  (601) 
Takeda Pharms USA; Takeda Pharmaceuticals Usa Inc

>  <USAN_STEM>  (601) 
-oxetine

>  <USAN_STEM_DEFINITION>  (601) 
antidepressants (fluoxetine type)

>  <USAN_STEM_SUBSTEM>  (601) 
-oxetine

>  <USAN_YEAR>  (601) 
2011.0

>  <FIRST_APPROVAL>  (601) 
2013.0

>  <ATC_CODE>  (601) 
N06AX26

>  <ATC_CODE_DESCRIPTION>  (601) 
N06AX26 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (601) 
nan

>  <SC_PATENT_NO>  (601) 
US-7144884-B2

>  <DRUG_TYPE>  (601) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (601) 
Y

>  <FIRST_IN_CLASS>  (601) 
Y

>  <CHIRALITY>  (601) 
Achiral Molecule

>  <PRODRUG>  (601) 
N

>  <ORAL>  (601) 
Y

>  <PARENTERAL>  (601) 
N

>  <TOPICAL>  (601) 
N

>  <BLACK_BOX>  (601) 
Y

>  <AVAILABILITY_TYPE>  (601) 
Prescription-only

>  <WITHDRAWN_YEAR>  (601) 
nan

>  <WITHDRAWN_COUNTRY>  (601) 
nan

>  <WITHDRAWN_REASON>  (601) 
nan

>  <CANONICAL_SMILES>  (601) 
Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1

>  <name>  (601) 
Vortioxetine 

>  <MW>  (601) 
298.455

>  <logP>  (601) 
3.86424

$$$$
CHEMBL1051
     RDKit          

 31 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 19 13  1  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (602) 
132003

>  <SYNONYMS>  (602) 
Latanoprost (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (602) 
4

>  <RESEARCH_CODES>  (602) 
PHXA-41; XA-41

>  <APPLICANTS>  (602) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (602) 
-prost

>  <USAN_STEM_DEFINITION>  (602) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (602) 
-prost

>  <USAN_YEAR>  (602) 
1996.0

>  <FIRST_APPROVAL>  (602) 
1996.0

>  <ATC_CODE>  (602) 
S01EE01

>  <ATC_CODE_DESCRIPTION>  (602) 
S01EE01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Prostaglandin analogues1)]

>  <INDICATION_CLASS>  (602) 
Antiglaucoma Agent

>  <SC_PATENT_NO>  (602) 
nan

>  <DRUG_TYPE>  (602) 
Natural Product-derived

>  <RULE_OF_FIVE>  (602) 
Y

>  <FIRST_IN_CLASS>  (602) 
N

>  <CHIRALITY>  (602) 
Single Stereoisomer

>  <PRODRUG>  (602) 
Y

>  <ORAL>  (602) 
N

>  <PARENTERAL>  (602) 
N

>  <TOPICAL>  (602) 
Y

>  <BLACK_BOX>  (602) 
N

>  <AVAILABILITY_TYPE>  (602) 
Prescription-only

>  <WITHDRAWN_YEAR>  (602) 
nan

>  <WITHDRAWN_COUNTRY>  (602) 
nan

>  <WITHDRAWN_REASON>  (602) 
nan

>  <CANONICAL_SMILES>  (602) 
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2

>  <name>  (602) 
Latanoprost 

>  <MW>  (602) 
432.601

>  <logP>  (602) 
4.1864

$$$$
CHEMBL1685
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  8 17  1  0
 17 18  1  0
 16  2  1  0
 17  2  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (603) 
518361

>  <SYNONYMS>  (603) 
Dezocine (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (603) 
4

>  <RESEARCH_CODES>  (603) 
WY-16225

>  <APPLICANTS>  (603) 
Astrazeneca Lp

>  <USAN_STEM>  (603) 
nan

>  <USAN_STEM_DEFINITION>  (603) 
nan

>  <USAN_STEM_SUBSTEM>  (603) 
nan

>  <USAN_YEAR>  (603) 
1976.0

>  <FIRST_APPROVAL>  (603) 
1989.0

>  <ATC_CODE>  (603) 
N02AX03

>  <ATC_CODE_DESCRIPTION>  (603) 
N02AX03 [Nervous System:Analgesics:Opioids:Other opioids]

>  <INDICATION_CLASS>  (603) 
Analgesic

>  <SC_PATENT_NO>  (603) 
nan

>  <DRUG_TYPE>  (603) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (603) 
Y

>  <FIRST_IN_CLASS>  (603) 
N

>  <CHIRALITY>  (603) 
Single Stereoisomer

>  <PRODRUG>  (603) 
N

>  <ORAL>  (603) 
N

>  <PARENTERAL>  (603) 
Y

>  <TOPICAL>  (603) 
N

>  <BLACK_BOX>  (603) 
N

>  <AVAILABILITY_TYPE>  (603) 
Discontinued

>  <WITHDRAWN_YEAR>  (603) 
nan

>  <WITHDRAWN_COUNTRY>  (603) 
nan

>  <WITHDRAWN_REASON>  (603) 
nan

>  <CANONICAL_SMILES>  (603) 
C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc13)[C@@H]2N

>  <name>  (603) 
Dezocine 

>  <MW>  (603) 
245.366

>  <logP>  (603) 
3.1136

$$$$
CHEMBL421
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  6 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
  9  4  1  0
 18 13  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (604) 
1223

>  <SYNONYMS>  (604) 
Salazosulfapyridine (JAN); Sulfasalazine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (604) 
4

>  <RESEARCH_CODES>  (604) 
SAS-500

>  <APPLICANTS>  (604) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (604) 
-sal-; sulfa-

>  <USAN_STEM_DEFINITION>  (604) 
anti-inflammatory agents (salicylic acid derivatives); antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (604) 
-sal-; sulfa-

>  <USAN_YEAR>  (604) 
1975.0

>  <FIRST_APPROVAL>  (604) 
1950.0

>  <ATC_CODE>  (604) 
A07EC01

>  <ATC_CODE_DESCRIPTION>  (604) 
A07EC01 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Aminosalicylic acid and similar agents]

>  <INDICATION_CLASS>  (604) 
Antibacterial

>  <SC_PATENT_NO>  (604) 
nan

>  <DRUG_TYPE>  (604) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (604) 
Y

>  <FIRST_IN_CLASS>  (604) 
N

>  <CHIRALITY>  (604) 
Achiral Molecule

>  <PRODRUG>  (604) 
Y

>  <ORAL>  (604) 
Y

>  <PARENTERAL>  (604) 
N

>  <TOPICAL>  (604) 
N

>  <BLACK_BOX>  (604) 
N

>  <AVAILABILITY_TYPE>  (604) 
Prescription-only

>  <WITHDRAWN_YEAR>  (604) 
nan

>  <WITHDRAWN_COUNTRY>  (604) 
nan

>  <WITHDRAWN_REASON>  (604) 
nan

>  <CANONICAL_SMILES>  (604) 
OC(=O)c1cc(ccc1O)N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3

>  <name>  (604) 
Salazosulfapyridine 

>  <MW>  (604) 
398.4

>  <logP>  (604) 
3.7016

$$$$
CHEMBL1117
     RDKit          

 36 40  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
 13 34  1  0
 34 35  2  0
 34 36  1  0
  8  2  1  0
 33 11  1  0
 33 16  1  0
 30 19  2  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (605) 
158277

>  <SYNONYMS>  (605) 
Idarubicin (BAN, INN); Idarubicin HCl (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (605) 
4

>  <RESEARCH_CODES>  (605) 
IMI-30

>  <APPLICANTS>  (605) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (605) 
-rubicin

>  <USAN_STEM_DEFINITION>  (605) 
antineoplastic antibiotics (daunorubicin type)

>  <USAN_STEM_SUBSTEM>  (605) 
-rubicin

>  <USAN_YEAR>  (605) 
1987.0

>  <FIRST_APPROVAL>  (605) 
1990.0

>  <ATC_CODE>  (605) 
L01DB06

>  <ATC_CODE_DESCRIPTION>  (605) 
L01DB06 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Cytotoxic Antibiotics And Related Substances:Anthracyclines and related substances]

>  <INDICATION_CLASS>  (605) 
Antineoplastic

>  <SC_PATENT_NO>  (605) 
nan

>  <DRUG_TYPE>  (605) 
Natural Product-derived

>  <RULE_OF_FIVE>  (605) 
Y

>  <FIRST_IN_CLASS>  (605) 
N

>  <CHIRALITY>  (605) 
Single Stereoisomer

>  <PRODRUG>  (605) 
N

>  <ORAL>  (605) 
N

>  <PARENTERAL>  (605) 
Y

>  <TOPICAL>  (605) 
N

>  <BLACK_BOX>  (605) 
Y

>  <AVAILABILITY_TYPE>  (605) 
Prescription-only

>  <WITHDRAWN_YEAR>  (605) 
nan

>  <WITHDRAWN_COUNTRY>  (605) 
nan

>  <WITHDRAWN_REASON>  (605) 
nan

>  <CANONICAL_SMILES>  (605) 
C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(=O)C

>  <name>  (605) 
Idarubicin 

>  <MW>  (605) 
497.5

>  <logP>  (605) 
1.0203

$$$$
CHEMBL385517
     RDKit          

 23 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  3  0
  2 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 17 23  1  0
 10  5  1  0
 10  8  1  0
 22 13  1  0
 23 13  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (606) 
360723

>  <SYNONYMS>  (606) 
Saxagliptin (INN, USAN); Saxagliptin HCl (FDA)

>  <DEVELOPMENT_PHASE>  (606) 
4

>  <RESEARCH_CODES>  (606) 
BMS-477118; BMS-477118-11

>  <APPLICANTS>  (606) 
Bristol-Myers Squibb; Bristol Myers Squibb Co; Bristol Myers Squibb

>  <USAN_STEM>  (606) 
-gliptin

>  <USAN_STEM_DEFINITION>  (606) 
dipeptidyl aminopeptidase-IV inhibitors; 

>  <USAN_STEM_SUBSTEM>  (606) 
-gliptin

>  <USAN_YEAR>  (606) 
2007.0

>  <FIRST_APPROVAL>  (606) 
2009.0

>  <ATC_CODE>  (606) 
A10BH03

>  <ATC_CODE_DESCRIPTION>  (606) 
A10BH03 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Dipeptidyl peptidase 4 (DPP-4) inhibitors]

>  <INDICATION_CLASS>  (606) 
nan

>  <SC_PATENT_NO>  (606) 
US-7951400-B2

>  <DRUG_TYPE>  (606) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (606) 
Y

>  <FIRST_IN_CLASS>  (606) 
N

>  <CHIRALITY>  (606) 
Racemic Mixture

>  <PRODRUG>  (606) 
N

>  <ORAL>  (606) 
Y

>  <PARENTERAL>  (606) 
N

>  <TOPICAL>  (606) 
N

>  <BLACK_BOX>  (606) 
N

>  <AVAILABILITY_TYPE>  (606) 
Prescription-only

>  <WITHDRAWN_YEAR>  (606) 
nan

>  <WITHDRAWN_COUNTRY>  (606) 
nan

>  <WITHDRAWN_REASON>  (606) 
nan

>  <CANONICAL_SMILES>  (606) 
N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4

>  <name>  (606) 
Saxagliptin 

>  <MW>  (606) 
315.417

>  <logP>  (606) 
1.15798

$$$$
CHEMBL1908307
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16  2  1  0
 16 10  1  0
M  CHG  2   5   1   7  -1
M  END
>  <PARENT_MOLREGNO>  (607) 
1248678

>  <SYNONYMS>  (607) 
Flosequinan (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (607) 
4

>  <RESEARCH_CODES>  (607) 
BTS-49465

>  <APPLICANTS>  (607) 
Boots, England

>  <USAN_STEM>  (607) 
nan

>  <USAN_STEM_DEFINITION>  (607) 
nan

>  <USAN_STEM_SUBSTEM>  (607) 
nan

>  <USAN_YEAR>  (607) 
1989.0

>  <FIRST_APPROVAL>  (607) 
1992.0

>  <ATC_CODE>  (607) 
C01DB01

>  <ATC_CODE_DESCRIPTION>  (607) 
C01DB01 [Cardiovascular System:Cardiac Therapy:Vasodilators Used In Cardiac Diseases:Quinolone vasodilators]

>  <INDICATION_CLASS>  (607) 
Antihypertensive (vasodilator)

>  <SC_PATENT_NO>  (607) 
nan

>  <DRUG_TYPE>  (607) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (607) 
Y

>  <FIRST_IN_CLASS>  (607) 
N

>  <CHIRALITY>  (607) 
Achiral Molecule

>  <PRODRUG>  (607) 
N

>  <ORAL>  (607) 
N

>  <PARENTERAL>  (607) 
N

>  <TOPICAL>  (607) 
N

>  <BLACK_BOX>  (607) 
N

>  <AVAILABILITY_TYPE>  (607) 
Withdrawn

>  <WITHDRAWN_YEAR>  (607) 
1993.0

>  <WITHDRAWN_COUNTRY>  (607) 
United Kingdom; United States

>  <WITHDRAWN_REASON>  (607) 
Increased mortality at higher doses; increased hospitalizations

>  <CANONICAL_SMILES>  (607) 
CN1C=C([S+](C)[O-])C(=O)c2ccc(F)cc12

>  <name>  (607) 
Flosequinan 

>  <MW>  (607) 
239.271

>  <logP>  (607) 
1.415

$$$$
CHEMBL2105233
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15  5  1  0
M  END
>  <PARENT_MOLREGNO>  (608) 
1377503

>  <SYNONYMS>  (608) 
Proxibarbal (INN, MI)

>  <DEVELOPMENT_PHASE>  (608) 
4

>  <RESEARCH_CODES>  (608) 
nan

>  <APPLICANTS>  (608) 
nan

>  <USAN_STEM>  (608) 
-barb-

>  <USAN_STEM_DEFINITION>  (608) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (608) 
-barb-

>  <USAN_YEAR>  (608) 
nan

>  <FIRST_APPROVAL>  (608) 
nan

>  <ATC_CODE>  (608) 
N05CA22

>  <ATC_CODE_DESCRIPTION>  (608) 
N05CA22 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (608) 
nan

>  <SC_PATENT_NO>  (608) 
nan

>  <DRUG_TYPE>  (608) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (608) 
Y

>  <FIRST_IN_CLASS>  (608) 
N

>  <CHIRALITY>  (608) 
Racemic Mixture

>  <PRODRUG>  (608) 
N

>  <ORAL>  (608) 
N

>  <PARENTERAL>  (608) 
N

>  <TOPICAL>  (608) 
N

>  <BLACK_BOX>  (608) 
N

>  <AVAILABILITY_TYPE>  (608) 
Withdrawn

>  <WITHDRAWN_YEAR>  (608) 
1998.0

>  <WITHDRAWN_COUNTRY>  (608) 
Spain; France; Italy; Portugal; Turkey

>  <WITHDRAWN_REASON>  (608) 
lmmunoallergic Thrombocytopenia

>  <CANONICAL_SMILES>  (608) 
CC(O)CC1(CC=C)C(=O)NC(=O)NC1=O

>  <name>  (608) 
Proxibarbal 

>  <MW>  (608) 
226.232

>  <logP>  (608) 
-0.3142

$$$$
CHEMBL2103822
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  9  7  1  0
 18 10  1  0
 18 14  2  0
M  END
>  <PARENT_MOLREGNO>  (609) 
1376092

>  <SYNONYMS>  (609) 
Tasimelteon (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (609) 
4

>  <RESEARCH_CODES>  (609) 
BMS-214778; VEC-162

>  <APPLICANTS>  (609) 
Vanda Pharmaceuticals Inc

>  <USAN_STEM>  (609) 
-melteon

>  <USAN_STEM_DEFINITION>  (609) 
selective melatonin receptor agonist

>  <USAN_STEM_SUBSTEM>  (609) 
-melteon

>  <USAN_YEAR>  (609) 
2007.0

>  <FIRST_APPROVAL>  (609) 
2014.0

>  <ATC_CODE>  (609) 
N05CH03

>  <ATC_CODE_DESCRIPTION>  (609) 
N05CH03 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Melatonin receptor agonists]

>  <INDICATION_CLASS>  (609) 
nan

>  <SC_PATENT_NO>  (609) 
US-5856529-A

>  <DRUG_TYPE>  (609) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (609) 
Y

>  <FIRST_IN_CLASS>  (609) 
N

>  <CHIRALITY>  (609) 
Single Stereoisomer

>  <PRODRUG>  (609) 
N

>  <ORAL>  (609) 
Y

>  <PARENTERAL>  (609) 
N

>  <TOPICAL>  (609) 
N

>  <BLACK_BOX>  (609) 
N

>  <AVAILABILITY_TYPE>  (609) 
Prescription-only

>  <WITHDRAWN_YEAR>  (609) 
nan

>  <WITHDRAWN_COUNTRY>  (609) 
nan

>  <WITHDRAWN_REASON>  (609) 
nan

>  <CANONICAL_SMILES>  (609) 
CCC(=O)NC[C@@H]1C[C@H]1c2cccc3OCCc23

>  <name>  (609) 
Tasimelteon 

>  <MW>  (609) 
245.322

>  <logP>  (609) 
2.2512

$$$$
CHEMBL2110588
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 11 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 17 13  1  0
 29 20  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (610) 
1383028

>  <SYNONYMS>  (610) 
Eliglustat (INN, USAN); Eliglustat Tartrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (610) 
4

>  <RESEARCH_CODES>  (610) 
GENZ-112638

>  <APPLICANTS>  (610) 
Genzyme Corp

>  <USAN_STEM>  (610) 
-stat

>  <USAN_STEM_DEFINITION>  (610) 
enzyme inhibitors: glucosyltransferase inhibitors

>  <USAN_STEM_SUBSTEM>  (610) 
-stat (-glustat)

>  <USAN_YEAR>  (610) 
2009.0

>  <FIRST_APPROVAL>  (610) 
2014.0

>  <ATC_CODE>  (610) 
A16AX10

>  <ATC_CODE_DESCRIPTION>  (610) 
A16AX10 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Various alimentary tract and metabolism products]

>  <INDICATION_CLASS>  (610) 
nan

>  <SC_PATENT_NO>  (610) 
US-6916802-B2

>  <DRUG_TYPE>  (610) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (610) 
Y

>  <FIRST_IN_CLASS>  (610) 
N

>  <CHIRALITY>  (610) 
Single Stereoisomer

>  <PRODRUG>  (610) 
N

>  <ORAL>  (610) 
Y

>  <PARENTERAL>  (610) 
N

>  <TOPICAL>  (610) 
N

>  <BLACK_BOX>  (610) 
N

>  <AVAILABILITY_TYPE>  (610) 
Prescription-only

>  <WITHDRAWN_YEAR>  (610) 
nan

>  <WITHDRAWN_COUNTRY>  (610) 
nan

>  <WITHDRAWN_REASON>  (610) 
nan

>  <CANONICAL_SMILES>  (610) 
CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c2ccc3OCCOc3c2

>  <name>  (610) 
Eliglustat 

>  <MW>  (610) 
404.551

>  <logP>  (610) 
3.4323

$$$$
CHEMBL1621597
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
  9  4  1  0
 12  6  1  0
 24 19  1  0
M  CHG  1   4   1
M  END
>  <PARENT_MOLREGNO>  (611) 
1044548

>  <SYNONYMS>  (611) 
Ipratropium Bromide (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (611) 
4

>  <RESEARCH_CODES>  (611) 
SCH-1000-BR Monohydrate; SCH-1000-Br-

>  <APPLICANTS>  (611) 
Dey Lp; Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (611) 
-ium; -trop-

>  <USAN_STEM_DEFINITION>  (611) 
quaternary ammonium derivatives; atropine derivatives

>  <USAN_STEM_SUBSTEM>  (611) 
-ium; -trop-

>  <USAN_YEAR>  (611) 
1977.0

>  <FIRST_APPROVAL>  (611) 
1986.0

>  <ATC_CODE>  (611) 
R03BB01; R01AX03

>  <ATC_CODE_DESCRIPTION>  (611) 
R03BB01 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Anticholinergics]; R01AX03 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Other nasal preparations]

>  <INDICATION_CLASS>  (611) 
Bronchodilator

>  <SC_PATENT_NO>  (611) 
US-5964416-A

>  <DRUG_TYPE>  (611) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (611) 
Y

>  <FIRST_IN_CLASS>  (611) 
N

>  <CHIRALITY>  (611) 
Racemic Mixture

>  <PRODRUG>  (611) 
N

>  <ORAL>  (611) 
N

>  <PARENTERAL>  (611) 
N

>  <TOPICAL>  (611) 
Y

>  <BLACK_BOX>  (611) 
Y

>  <AVAILABILITY_TYPE>  (611) 
Prescription-only

>  <WITHDRAWN_YEAR>  (611) 
nan

>  <WITHDRAWN_COUNTRY>  (611) 
nan

>  <WITHDRAWN_REASON>  (611) 
nan

>  <CANONICAL_SMILES>  (611) 
CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3

>  <name>  (611) 
Ipratropium Bromide 

>  <MW>  (611) 
332.464

>  <logP>  (611) 
2.8541

$$$$
CHEMBL1235931
     RDKit          

  8  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
M  END
>  <PARENT_MOLREGNO>  (612) 
698281

>  <SYNONYMS>  (612) 
Calcium Levulinate (BAN, USP)

>  <DEVELOPMENT_PHASE>  (612) 
4

>  <RESEARCH_CODES>  (612) 
nan

>  <APPLICANTS>  (612) 
nan

>  <USAN_STEM>  (612) 
nan

>  <USAN_STEM_DEFINITION>  (612) 
nan

>  <USAN_STEM_SUBSTEM>  (612) 
nan

>  <USAN_YEAR>  (612) 
nan

>  <FIRST_APPROVAL>  (612) 
nan

>  <ATC_CODE>  (612) 
A12CC07; A12AA30

>  <ATC_CODE_DESCRIPTION>  (612) 
A12CC07 [Alimentary Tract And Metabolism:Mineral Supplements:Other Mineral Supplements:Magnesium]; A12AA30 [Alimentary Tract And Metabolism:Mineral Supplements:Calcium:Calcium]

>  <INDICATION_CLASS>  (612) 
Replenisher (calcium)

>  <SC_PATENT_NO>  (612) 
nan

>  <DRUG_TYPE>  (612) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (612) 
Y

>  <FIRST_IN_CLASS>  (612) 
N

>  <CHIRALITY>  (612) 
Achiral Molecule

>  <PRODRUG>  (612) 
N

>  <ORAL>  (612) 
N

>  <PARENTERAL>  (612) 
N

>  <TOPICAL>  (612) 
N

>  <BLACK_BOX>  (612) 
N

>  <AVAILABILITY_TYPE>  (612) 
Unknown

>  <WITHDRAWN_YEAR>  (612) 
nan

>  <WITHDRAWN_COUNTRY>  (612) 
nan

>  <WITHDRAWN_REASON>  (612) 
nan

>  <CANONICAL_SMILES>  (612) 
CC(=O)CCC(=O)O

>  <name>  (612) 
Calcium Levulinate 

>  <MW>  (612) 
116.116

>  <logP>  (612) 
0.4402

$$$$
CHEMBL1230762
     RDKit          

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
M  END
>  <PARENT_MOLREGNO>  (613) 
693112

>  <SYNONYMS>  (613) 
Aluminium Acetoacetate

>  <DEVELOPMENT_PHASE>  (613) 
4

>  <RESEARCH_CODES>  (613) 
nan

>  <APPLICANTS>  (613) 
nan

>  <USAN_STEM>  (613) 
-ium

>  <USAN_STEM_DEFINITION>  (613) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (613) 
-ium

>  <USAN_YEAR>  (613) 
nan

>  <FIRST_APPROVAL>  (613) 
nan

>  <ATC_CODE>  (613) 
A02AB05

>  <ATC_CODE_DESCRIPTION>  (613) 
A02AB05 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Antacids:Aluminium compounds]

>  <INDICATION_CLASS>  (613) 
nan

>  <SC_PATENT_NO>  (613) 
nan

>  <DRUG_TYPE>  (613) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (613) 
Y

>  <FIRST_IN_CLASS>  (613) 
N

>  <CHIRALITY>  (613) 
Achiral Molecule

>  <PRODRUG>  (613) 
N

>  <ORAL>  (613) 
N

>  <PARENTERAL>  (613) 
N

>  <TOPICAL>  (613) 
N

>  <BLACK_BOX>  (613) 
N

>  <AVAILABILITY_TYPE>  (613) 
Unknown

>  <WITHDRAWN_YEAR>  (613) 
nan

>  <WITHDRAWN_COUNTRY>  (613) 
nan

>  <WITHDRAWN_REASON>  (613) 
nan

>  <CANONICAL_SMILES>  (613) 
CC(=O)CC(=O)O

>  <name>  (613) 
Aluminium Acetoacetate

>  <MW>  (613) 
102.089

>  <logP>  (613) 
0.0501

$$$$
CHEMBL434394
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  2 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 18  8  1  0
 17 11  1  0
 29 19  1  0
 28 22  1  0
M  END
>  <PARENT_MOLREGNO>  (614) 
27569

>  <SYNONYMS>  (614) 
Nebivolol (BAN, INN, USAN); Nebivolol HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (614) 
4

>  <RESEARCH_CODES>  (614) 
R-65824; Ro-67555

>  <APPLICANTS>  (614) 
Janssen; Forest Laboratories Inc

>  <USAN_STEM>  (614) 
-olol

>  <USAN_STEM_DEFINITION>  (614) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (614) 
-olol

>  <USAN_YEAR>  (614) 
1988.0

>  <FIRST_APPROVAL>  (614) 
2007.0

>  <ATC_CODE>  (614) 
C07AB12

>  <ATC_CODE_DESCRIPTION>  (614) 
C07AB12 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]

>  <INDICATION_CLASS>  (614) 
Antihypertensive (beta-blocker)

>  <SC_PATENT_NO>  (614) 
US-6545040-B1

>  <DRUG_TYPE>  (614) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (614) 
Y

>  <FIRST_IN_CLASS>  (614) 
N

>  <CHIRALITY>  (614) 
Racemic Mixture

>  <PRODRUG>  (614) 
N

>  <ORAL>  (614) 
Y

>  <PARENTERAL>  (614) 
N

>  <TOPICAL>  (614) 
N

>  <BLACK_BOX>  (614) 
N

>  <AVAILABILITY_TYPE>  (614) 
Prescription-only

>  <WITHDRAWN_YEAR>  (614) 
nan

>  <WITHDRAWN_COUNTRY>  (614) 
nan

>  <WITHDRAWN_REASON>  (614) 
nan

>  <CANONICAL_SMILES>  (614) 
OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3

>  <name>  (614) 
Nebivolol 

>  <MW>  (614) 
405.441

>  <logP>  (614) 
2.3636

$$$$
CHEMBL498
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (615) 
8516

>  <SYNONYMS>  (615) 
Chlorpropamide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (615) 
4

>  <RESEARCH_CODES>  (615) 
nan

>  <APPLICANTS>  (615) 
Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (615) 
nan

>  <USAN_STEM_DEFINITION>  (615) 
nan

>  <USAN_STEM_SUBSTEM>  (615) 
nan

>  <USAN_YEAR>  (615) 
nan

>  <FIRST_APPROVAL>  (615) 
1958.0

>  <ATC_CODE>  (615) 
A10BB02

>  <ATC_CODE_DESCRIPTION>  (615) 
A10BB02 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (615) 
Antidiabetic

>  <SC_PATENT_NO>  (615) 
nan

>  <DRUG_TYPE>  (615) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (615) 
Y

>  <FIRST_IN_CLASS>  (615) 
N

>  <CHIRALITY>  (615) 
Achiral Molecule

>  <PRODRUG>  (615) 
N

>  <ORAL>  (615) 
Y

>  <PARENTERAL>  (615) 
N

>  <TOPICAL>  (615) 
N

>  <BLACK_BOX>  (615) 
N

>  <AVAILABILITY_TYPE>  (615) 
Prescription-only

>  <WITHDRAWN_YEAR>  (615) 
nan

>  <WITHDRAWN_COUNTRY>  (615) 
nan

>  <WITHDRAWN_REASON>  (615) 
nan

>  <CANONICAL_SMILES>  (615) 
CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1

>  <name>  (615) 
Chlorpropamide 

>  <MW>  (615) 
276.745

>  <logP>  (615) 
1.7379

$$$$
CHEMBL1201231
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
  7 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 27 30  1  0
 18  2  1  0
 21  2  1  0
 16  6  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (616) 
675182

>  <SYNONYMS>  (616) 
Prednisolone Sodium Phosphate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (616) 
4

>  <RESEARCH_CODES>  (616) 
nan

>  <APPLICANTS>  (616) 
Shionogi Inc; Seton Pharmaceutical Llc; Novartis Pharmaceuticals Corp; Merck And Co Inc

>  <USAN_STEM>  (616) 
pred-

>  <USAN_STEM_DEFINITION>  (616) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (616) 
pred-

>  <USAN_YEAR>  (616) 
nan

>  <FIRST_APPROVAL>  (616) 
1973.0

>  <ATC_CODE>  (616) 
nan

>  <ATC_CODE_DESCRIPTION>  (616) 
nan

>  <INDICATION_CLASS>  (616) 
Glucocorticoid

>  <SC_PATENT_NO>  (616) 
US-6740341-B1

>  <DRUG_TYPE>  (616) 
Natural Product-derived

>  <RULE_OF_FIVE>  (616) 
Y

>  <FIRST_IN_CLASS>  (616) 
N

>  <CHIRALITY>  (616) 
Single Stereoisomer

>  <PRODRUG>  (616) 
N

>  <ORAL>  (616) 
Y

>  <PARENTERAL>  (616) 
Y

>  <TOPICAL>  (616) 
Y

>  <BLACK_BOX>  (616) 
N

>  <AVAILABILITY_TYPE>  (616) 
Prescription-only

>  <WITHDRAWN_YEAR>  (616) 
nan

>  <WITHDRAWN_COUNTRY>  (616) 
nan

>  <WITHDRAWN_REASON>  (616) 
nan

>  <CANONICAL_SMILES>  (616) 
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)(O)O

>  <name>  (616) 
Prednisolone Sodium Phosphate 

>  <MW>  (616) 
440.429

>  <logP>  (616) 
1.6746

$$$$
CHEMBL1200865
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
  7 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 26  7  1  0
 26 10  1  0
 22 11  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (617) 
674816

>  <SYNONYMS>  (617) 
Loteprednol (BAN, INN); Loteprednol Etabonate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (617) 
4

>  <RESEARCH_CODES>  (617) 
CDDD-5604; HGP-1; P-5604

>  <APPLICANTS>  (617) 
Pharmos Corp; Bausch And Lomb Inc

>  <USAN_STEM>  (617) 
-pred-

>  <USAN_STEM_DEFINITION>  (617) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (617) 
-pred-

>  <USAN_YEAR>  (617) 
1990.0

>  <FIRST_APPROVAL>  (617) 
1998.0

>  <ATC_CODE>  (617) 
S01BA14

>  <ATC_CODE_DESCRIPTION>  (617) 
S01BA14 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]

>  <INDICATION_CLASS>  (617) 
Anti-Inflammatory (topical)

>  <SC_PATENT_NO>  (617) 
US-5800807-A

>  <DRUG_TYPE>  (617) 
Natural Product-derived

>  <RULE_OF_FIVE>  (617) 
Y

>  <FIRST_IN_CLASS>  (617) 
N

>  <CHIRALITY>  (617) 
Single Stereoisomer

>  <PRODRUG>  (617) 
Y

>  <ORAL>  (617) 
N

>  <PARENTERAL>  (617) 
N

>  <TOPICAL>  (617) 
Y

>  <BLACK_BOX>  (617) 
N

>  <AVAILABILITY_TYPE>  (617) 
Prescription-only

>  <WITHDRAWN_YEAR>  (617) 
nan

>  <WITHDRAWN_COUNTRY>  (617) 
nan

>  <WITHDRAWN_REASON>  (617) 
nan

>  <CANONICAL_SMILES>  (617) 
CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl

>  <name>  (617) 
Loteprednol 

>  <MW>  (617) 
466.958

>  <logP>  (617) 
3.9165

$$$$
CHEMBL1201268
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  8  2  1  0
 11  4  1  0
 11  9  1  0
 23 18  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (618) 
675219

>  <SYNONYMS>  (618) 
Hyoscine Methobromide (BAN); Methscopolamine Bromide (FDA, USP); N-Methylscopolamine Methylsulfate (JAN)

>  <DEVELOPMENT_PHASE>  (618) 
4

>  <RESEARCH_CODES>  (618) 
nan

>  <APPLICANTS>  (618) 
Fougera Pharmaceuticals Inc

>  <USAN_STEM>  (618) 
nan

>  <USAN_STEM_DEFINITION>  (618) 
nan

>  <USAN_STEM_SUBSTEM>  (618) 
nan

>  <USAN_YEAR>  (618) 
nan

>  <FIRST_APPROVAL>  (618) 
1953.0

>  <ATC_CODE>  (618) 
S01FA03; A03BB03

>  <ATC_CODE_DESCRIPTION>  (618) 
S01FA03 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]; A03BB03 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Belladonna And Derivatives, Plain:Belladonna alkaloids, semisynthetic, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (618) 
nan

>  <SC_PATENT_NO>  (618) 
nan

>  <DRUG_TYPE>  (618) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (618) 
Y

>  <FIRST_IN_CLASS>  (618) 
N

>  <CHIRALITY>  (618) 
Single Stereoisomer

>  <PRODRUG>  (618) 
N

>  <ORAL>  (618) 
Y

>  <PARENTERAL>  (618) 
N

>  <TOPICAL>  (618) 
N

>  <BLACK_BOX>  (618) 
N

>  <AVAILABILITY_TYPE>  (618) 
Prescription-only

>  <WITHDRAWN_YEAR>  (618) 
nan

>  <WITHDRAWN_COUNTRY>  (618) 
nan

>  <WITHDRAWN_REASON>  (618) 
nan

>  <CANONICAL_SMILES>  (618) 
C[N+]1(C)[C@H]2C[C@@H](C[C@H]1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)c4ccccc4

>  <name>  (618) 
Hyoscine Methobromide 

>  <MW>  (618) 
318.393

>  <logP>  (618) 
1.0627

$$$$
CHEMBL1201313
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 13  8  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (619) 
675264

>  <SYNONYMS>  (619) 
Clofedanol (INN, BAN); Chlophedianol HCl (FDA, USAN); Clofedanol HCl (JAN)

>  <DEVELOPMENT_PHASE>  (619) 
4

>  <RESEARCH_CODES>  (619) 
SL-501

>  <APPLICANTS>  (619) 
3m Pharmaceuticals Inc

>  <USAN_STEM>  (619) 
nan

>  <USAN_STEM_DEFINITION>  (619) 
nan

>  <USAN_STEM_SUBSTEM>  (619) 
nan

>  <USAN_YEAR>  (619) 
1961.0

>  <FIRST_APPROVAL>  (619) 
1982.0

>  <ATC_CODE>  (619) 
R05DB10

>  <ATC_CODE_DESCRIPTION>  (619) 
R05DB10 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Other cough suppressants]

>  <INDICATION_CLASS>  (619) 
Antitussive

>  <SC_PATENT_NO>  (619) 
nan

>  <DRUG_TYPE>  (619) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (619) 
Y

>  <FIRST_IN_CLASS>  (619) 
N

>  <CHIRALITY>  (619) 
Racemic Mixture

>  <PRODRUG>  (619) 
N

>  <ORAL>  (619) 
Y

>  <PARENTERAL>  (619) 
N

>  <TOPICAL>  (619) 
N

>  <BLACK_BOX>  (619) 
N

>  <AVAILABILITY_TYPE>  (619) 
Discontinued

>  <WITHDRAWN_YEAR>  (619) 
nan

>  <WITHDRAWN_COUNTRY>  (619) 
nan

>  <WITHDRAWN_REASON>  (619) 
nan

>  <CANONICAL_SMILES>  (619) 
CN(C)CCC(O)(c1ccccc1)c2ccccc2Cl

>  <name>  (619) 
Clofedanol 

>  <MW>  (619) 
289.806

>  <logP>  (619) 
3.5276

$$$$
CHEMBL1998966
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  8 19  1  0
 19 20  2  0
 20  5  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (620) 
1320257

>  <SYNONYMS>  (620) 
Pifoxime (INN, MI)

>  <DEVELOPMENT_PHASE>  (620) 
4

>  <RESEARCH_CODES>  (620) 
nan

>  <APPLICANTS>  (620) 
nan

>  <USAN_STEM>  (620) 
nan

>  <USAN_STEM_DEFINITION>  (620) 
nan

>  <USAN_STEM_SUBSTEM>  (620) 
nan

>  <USAN_YEAR>  (620) 
nan

>  <FIRST_APPROVAL>  (620) 
nan

>  <ATC_CODE>  (620) 
nan

>  <ATC_CODE_DESCRIPTION>  (620) 
nan

>  <INDICATION_CLASS>  (620) 
nan

>  <SC_PATENT_NO>  (620) 
nan

>  <DRUG_TYPE>  (620) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (620) 
Y

>  <FIRST_IN_CLASS>  (620) 
N

>  <CHIRALITY>  (620) 
Achiral Molecule

>  <PRODRUG>  (620) 
N

>  <ORAL>  (620) 
N

>  <PARENTERAL>  (620) 
N

>  <TOPICAL>  (620) 
N

>  <BLACK_BOX>  (620) 
N

>  <AVAILABILITY_TYPE>  (620) 
Withdrawn

>  <WITHDRAWN_YEAR>  (620) 
1976.0

>  <WITHDRAWN_COUNTRY>  (620) 
France

>  <WITHDRAWN_REASON>  (620) 
Neuropsychiatric Reaction

>  <CANONICAL_SMILES>  (620) 
C\C(=N/O)\c1ccc(OCC(=O)N2CCCCC2)cc1

>  <name>  (620) 
Pifoxime 

>  <MW>  (620) 
276.336

>  <logP>  (620) 
2.2761

$$$$
CHEMBL2064047
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  9 11  1  0
  8  4  1  0
M  END
>  <PARENT_MOLREGNO>  (621) 
1357451

>  <SYNONYMS>  (621) 
Tidiacic (DCF, INN)

>  <DEVELOPMENT_PHASE>  (621) 
4

>  <RESEARCH_CODES>  (621) 
nan

>  <APPLICANTS>  (621) 
nan

>  <USAN_STEM>  (621) 
-cic

>  <USAN_STEM_DEFINITION>  (621) 
hepatoprotectives (timonacic type)

>  <USAN_STEM_SUBSTEM>  (621) 
-cic

>  <USAN_YEAR>  (621) 
nan

>  <FIRST_APPROVAL>  (621) 
nan

>  <ATC_CODE>  (621) 
A05BA07

>  <ATC_CODE_DESCRIPTION>  (621) 
A05BA07 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Liver Therapy, Lipotropics:Liver therapy]

>  <INDICATION_CLASS>  (621) 
nan

>  <SC_PATENT_NO>  (621) 
nan

>  <DRUG_TYPE>  (621) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (621) 
Y

>  <FIRST_IN_CLASS>  (621) 
N

>  <CHIRALITY>  (621) 
Racemic Mixture

>  <PRODRUG>  (621) 
N

>  <ORAL>  (621) 
N

>  <PARENTERAL>  (621) 
N

>  <TOPICAL>  (621) 
N

>  <BLACK_BOX>  (621) 
N

>  <AVAILABILITY_TYPE>  (621) 
Unknown

>  <WITHDRAWN_YEAR>  (621) 
nan

>  <WITHDRAWN_COUNTRY>  (621) 
nan

>  <WITHDRAWN_REASON>  (621) 
nan

>  <CANONICAL_SMILES>  (621) 
OC(=O)C1CSC(N1)C(=O)O

>  <name>  (621) 
Tidiacic 

>  <MW>  (621) 
177.181

>  <logP>  (621) 
-0.8133

$$$$
CHEMBL511142
     RDKit          

 34 40  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 26 34  1  0
  8  3  1  0
 25  3  1  0
 26  6  1  0
 29 16  1  0
 34 18  2  0
 34 23  1  0
 33 31  1  0
M  END
>  <PARENT_MOLREGNO>  (622) 
446784

>  <SYNONYMS>  (622) 
Buprenorphine (BAN, FDA, INN); Buprenorphine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (622) 
4

>  <RESEARCH_CODES>  (622) 
CL-112302; NIH-8805; RX-6029M HCl; U- 952

>  <APPLICANTS>  (622) 
Reckitt Benckiser Pharmaceuticals Inc; Purdue Pharma Lp

>  <USAN_STEM>  (622) 
nan

>  <USAN_STEM_DEFINITION>  (622) 
nan

>  <USAN_STEM_SUBSTEM>  (622) 
nan

>  <USAN_YEAR>  (622) 
1976.0

>  <FIRST_APPROVAL>  (622) 
1981.0

>  <ATC_CODE>  (622) 
N07BC01; N07BC51; N02AE01

>  <ATC_CODE_DESCRIPTION>  (622) 
N07BC01 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in opioid dependence]; N07BC51 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in opioid dependence]; N02AE01 [Nervous System:Analgesics:Opioids:Oripavine derivatives]

>  <INDICATION_CLASS>  (622) 
Analgesic

>  <SC_PATENT_NO>  (622) 
US-6159498-A

>  <DRUG_TYPE>  (622) 
Natural Product-derived

>  <RULE_OF_FIVE>  (622) 
Y

>  <FIRST_IN_CLASS>  (622) 
N

>  <CHIRALITY>  (622) 
Single Stereoisomer

>  <PRODRUG>  (622) 
N

>  <ORAL>  (622) 
N

>  <PARENTERAL>  (622) 
Y

>  <TOPICAL>  (622) 
Y

>  <BLACK_BOX>  (622) 
Y

>  <AVAILABILITY_TYPE>  (622) 
Prescription-only

>  <WITHDRAWN_YEAR>  (622) 
nan

>  <WITHDRAWN_COUNTRY>  (622) 
nan

>  <WITHDRAWN_REASON>  (622) 
nan

>  <CANONICAL_SMILES>  (622) 
CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56

>  <name>  (622) 
Buprenorphine 

>  <MW>  (622) 
467.65

>  <logP>  (622) 
4.4138

$$$$
CHEMBL2111101
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 14 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
  9 30  1  0
 30 31  2  0
 31  6  1  0
 22 16  1  0
 29 23  1  0
M  END
>  <PARENT_MOLREGNO>  (623) 
1383541

>  <SYNONYMS>  (623) 
Pimavanserin (INN); Pimavanserin tartrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (623) 
4

>  <RESEARCH_CODES>  (623) 
ACP-103

>  <APPLICANTS>  (623) 
nan

>  <USAN_STEM>  (623) 
-anserin

>  <USAN_STEM_DEFINITION>  (623) 
serotonin 5-HT2 receptor antagonists

>  <USAN_STEM_SUBSTEM>  (623) 
-anserin

>  <USAN_YEAR>  (623) 
2005.0

>  <FIRST_APPROVAL>  (623) 
2016.0

>  <ATC_CODE>  (623) 
nan

>  <ATC_CODE_DESCRIPTION>  (623) 
nan

>  <INDICATION_CLASS>  (623) 
nan

>  <SC_PATENT_NO>  (623) 
nan

>  <DRUG_TYPE>  (623) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (623) 
Y

>  <FIRST_IN_CLASS>  (623) 
N

>  <CHIRALITY>  (623) 
Achiral Molecule

>  <PRODRUG>  (623) 
N

>  <ORAL>  (623) 
Y

>  <PARENTERAL>  (623) 
N

>  <TOPICAL>  (623) 
N

>  <BLACK_BOX>  (623) 
Y

>  <AVAILABILITY_TYPE>  (623) 
Prescription-only

>  <WITHDRAWN_YEAR>  (623) 
nan

>  <WITHDRAWN_COUNTRY>  (623) 
nan

>  <WITHDRAWN_REASON>  (623) 
nan

>  <CANONICAL_SMILES>  (623) 
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C3CCN(C)CC3)cc1

>  <name>  (623) 
Pimavanserin 

>  <MW>  (623) 
427.564

>  <logP>  (623) 
4.6665

$$$$
CHEMBL3707367
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (624) 
2039338

>  <SYNONYMS>  (624) 
2-(4-Chlorphenoxy)-Ethanol

>  <DEVELOPMENT_PHASE>  (624) 
4

>  <RESEARCH_CODES>  (624) 
nan

>  <APPLICANTS>  (624) 
nan

>  <USAN_STEM>  (624) 
nan

>  <USAN_STEM_DEFINITION>  (624) 
nan

>  <USAN_STEM_SUBSTEM>  (624) 
nan

>  <USAN_YEAR>  (624) 
nan

>  <FIRST_APPROVAL>  (624) 
nan

>  <ATC_CODE>  (624) 
D01AE06

>  <ATC_CODE_DESCRIPTION>  (624) 
D01AE06 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (624) 
nan

>  <SC_PATENT_NO>  (624) 
nan

>  <DRUG_TYPE>  (624) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (624) 
Y

>  <FIRST_IN_CLASS>  (624) 
N

>  <CHIRALITY>  (624) 
Achiral Molecule

>  <PRODRUG>  (624) 
N

>  <ORAL>  (624) 
N

>  <PARENTERAL>  (624) 
N

>  <TOPICAL>  (624) 
N

>  <BLACK_BOX>  (624) 
N

>  <AVAILABILITY_TYPE>  (624) 
Unknown

>  <WITHDRAWN_YEAR>  (624) 
nan

>  <WITHDRAWN_COUNTRY>  (624) 
nan

>  <WITHDRAWN_REASON>  (624) 
nan

>  <CANONICAL_SMILES>  (624) 
OCCOc1ccc(Cl)cc1

>  <name>  (624) 
2-

>  <MW>  (624) 
172.611

>  <logP>  (624) 
1.7111

$$$$
CHEMBL3707389
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 10 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
  2 25  1  0
 25 26  2  0
 25 27  1  0
 11  6  1  0
 18 13  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (625) 
2039360

>  <SYNONYMS>  (625) 
Amino(Diphenylhydantoin) Valeric Acid

>  <DEVELOPMENT_PHASE>  (625) 
4

>  <RESEARCH_CODES>  (625) 
nan

>  <APPLICANTS>  (625) 
nan

>  <USAN_STEM>  (625) 
nan

>  <USAN_STEM_DEFINITION>  (625) 
nan

>  <USAN_STEM_SUBSTEM>  (625) 
nan

>  <USAN_YEAR>  (625) 
nan

>  <FIRST_APPROVAL>  (625) 
nan

>  <ATC_CODE>  (625) 
N03AB03

>  <ATC_CODE_DESCRIPTION>  (625) 
N03AB03 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]

>  <INDICATION_CLASS>  (625) 
nan

>  <SC_PATENT_NO>  (625) 
nan

>  <DRUG_TYPE>  (625) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (625) 
Y

>  <FIRST_IN_CLASS>  (625) 
N

>  <CHIRALITY>  (625) 
Racemic Mixture

>  <PRODRUG>  (625) 
N

>  <ORAL>  (625) 
N

>  <PARENTERAL>  (625) 
N

>  <TOPICAL>  (625) 
N

>  <BLACK_BOX>  (625) 
N

>  <AVAILABILITY_TYPE>  (625) 
Unknown

>  <WITHDRAWN_YEAR>  (625) 
nan

>  <WITHDRAWN_COUNTRY>  (625) 
nan

>  <WITHDRAWN_REASON>  (625) 
nan

>  <CANONICAL_SMILES>  (625) 
NC(CCCN1C(=O)NC(C1=O)(c2ccccc2)c3ccccc3)C(=O)O

>  <name>  (625) 
Amino

>  <MW>  (625) 
367.405

>  <logP>  (625) 
1.6741

$$$$
CHEMBL1175
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  5 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 16  7  1  0
 16 11  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (626) 
192908

>  <SYNONYMS>  (626) 
Duloxetine (BAN, INN); Duloxetine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (626) 
4

>  <RESEARCH_CODES>  (626) 
LY-248686

>  <APPLICANTS>  (626) 
Eli Lilly And Co

>  <USAN_STEM>  (626) 
-oxetine

>  <USAN_STEM_DEFINITION>  (626) 
antidepressants (fluoxetine type)

>  <USAN_STEM_SUBSTEM>  (626) 
-oxetine

>  <USAN_YEAR>  (626) 
1992.0

>  <FIRST_APPROVAL>  (626) 
2004.0

>  <ATC_CODE>  (626) 
N06AX21

>  <ATC_CODE_DESCRIPTION>  (626) 
N06AX21 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (626) 
Antidepressant

>  <SC_PATENT_NO>  (626) 
US-6596756-B1

>  <DRUG_TYPE>  (626) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (626) 
Y

>  <FIRST_IN_CLASS>  (626) 
N

>  <CHIRALITY>  (626) 
Single Stereoisomer

>  <PRODRUG>  (626) 
N

>  <ORAL>  (626) 
Y

>  <PARENTERAL>  (626) 
N

>  <TOPICAL>  (626) 
N

>  <BLACK_BOX>  (626) 
Y

>  <AVAILABILITY_TYPE>  (626) 
Prescription-only

>  <WITHDRAWN_YEAR>  (626) 
nan

>  <WITHDRAWN_COUNTRY>  (626) 
nan

>  <WITHDRAWN_REASON>  (626) 
nan

>  <CANONICAL_SMILES>  (626) 
CNCC[C@H](Oc1cccc2ccccc12)c3cccs3

>  <name>  (626) 
Duloxetine 

>  <MW>  (626) 
297.423

>  <logP>  (626) 
4.6309

$$$$
CHEMBL423
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 13 21  1  0
 21 22  2  0
 22 10  1  0
 20 18  1  0
M  END
>  <PARENT_MOLREGNO>  (627) 
1354

>  <SYNONYMS>  (627) 
Betaxolol (BAN, INN); Betaxolol HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (627) 
4

>  <RESEARCH_CODES>  (627) 
ALO-1401-02; SL 75.212-10; SL-75212-10

>  <APPLICANTS>  (627) 
Sanofi Aventis Us Llc; Alcon Laboratories Inc

>  <USAN_STEM>  (627) 
-olol

>  <USAN_STEM_DEFINITION>  (627) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (627) 
-olol

>  <USAN_YEAR>  (627) 
1983.0

>  <FIRST_APPROVAL>  (627) 
1985.0

>  <ATC_CODE>  (627) 
S01ED02; C07AB05; S01ED52

>  <ATC_CODE_DESCRIPTION>  (627) 
S01ED02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; C07AB05 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]; S01ED52 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]

>  <INDICATION_CLASS>  (627) 
Anti-Anginal; Antihypertensive

>  <SC_PATENT_NO>  (627) 
nan

>  <DRUG_TYPE>  (627) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (627) 
Y

>  <FIRST_IN_CLASS>  (627) 
N

>  <CHIRALITY>  (627) 
Racemic Mixture

>  <PRODRUG>  (627) 
N

>  <ORAL>  (627) 
Y

>  <PARENTERAL>  (627) 
N

>  <TOPICAL>  (627) 
Y

>  <BLACK_BOX>  (627) 
N

>  <AVAILABILITY_TYPE>  (627) 
Prescription-only

>  <WITHDRAWN_YEAR>  (627) 
nan

>  <WITHDRAWN_COUNTRY>  (627) 
nan

>  <WITHDRAWN_REASON>  (627) 
nan

>  <CANONICAL_SMILES>  (627) 
CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1

>  <name>  (627) 
Betaxolol 

>  <MW>  (627) 
307.434

>  <logP>  (627) 
2.3934

$$$$
CHEMBL1189679
     RDKit          

 22 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  3 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 13  2  1  0
 14  5  1  0
 14  9  2  0
 20 15  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (628) 
663629

>  <SYNONYMS>  (628) 
Palonosetron (INN); Palonosetron HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (628) 
4

>  <RESEARCH_CODES>  (628) 
RS-25259-197

>  <APPLICANTS>  (628) 
Helsinn Healthcare Sa

>  <USAN_STEM>  (628) 
-setron

>  <USAN_STEM_DEFINITION>  (628) 
serotonin 5-HT3 antagonists

>  <USAN_STEM_SUBSTEM>  (628) 
-setron

>  <USAN_YEAR>  (628) 
1995.0

>  <FIRST_APPROVAL>  (628) 
2003.0

>  <ATC_CODE>  (628) 
A04AA55; A04AA05

>  <ATC_CODE_DESCRIPTION>  (628) 
A04AA55 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Serotonin (5HT3) antagonists]; A04AA05 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Serotonin (5HT3) antagonists]

>  <INDICATION_CLASS>  (628) 
Anti-Emetic; Antinauseant

>  <SC_PATENT_NO>  (628) 
US-6297375-B1

>  <DRUG_TYPE>  (628) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (628) 
Y

>  <FIRST_IN_CLASS>  (628) 
N

>  <CHIRALITY>  (628) 
Single Stereoisomer

>  <PRODRUG>  (628) 
N

>  <ORAL>  (628) 
Y

>  <PARENTERAL>  (628) 
Y

>  <TOPICAL>  (628) 
N

>  <BLACK_BOX>  (628) 
N

>  <AVAILABILITY_TYPE>  (628) 
Prescription-only

>  <WITHDRAWN_YEAR>  (628) 
nan

>  <WITHDRAWN_COUNTRY>  (628) 
nan

>  <WITHDRAWN_REASON>  (628) 
nan

>  <CANONICAL_SMILES>  (628) 
O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]4CN5CCC4CC5

>  <name>  (628) 
Palonosetron 

>  <MW>  (628) 
296.414

>  <logP>  (628) 
2.6565

$$$$
CHEMBL2079611
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  2  0
  8  3  1  0
 10  5  1  0
 24 13  1  0
 24 17  1  0
M  END
>  <PARENT_MOLREGNO>  (629) 
1363842

>  <SYNONYMS>  (629) 
Hydroquinine

>  <DEVELOPMENT_PHASE>  (629) 
4

>  <RESEARCH_CODES>  (629) 
nan

>  <APPLICANTS>  (629) 
nan

>  <USAN_STEM>  (629) 
nan

>  <USAN_STEM_DEFINITION>  (629) 
nan

>  <USAN_STEM_SUBSTEM>  (629) 
nan

>  <USAN_YEAR>  (629) 
nan

>  <FIRST_APPROVAL>  (629) 
nan

>  <ATC_CODE>  (629) 
M09AA01

>  <ATC_CODE_DESCRIPTION>  (629) 
M09AA01 [Musculo-Skeletal System:Other Drugs For Disorders Of The Musculo-Skeletal System:Other Drugs For Disorders Of The Musculo-Skeletal System:Quinine and derivatives]

>  <INDICATION_CLASS>  (629) 
nan

>  <SC_PATENT_NO>  (629) 
nan

>  <DRUG_TYPE>  (629) 
Natural Product-derived

>  <RULE_OF_FIVE>  (629) 
Y

>  <FIRST_IN_CLASS>  (629) 
N

>  <CHIRALITY>  (629) 
Racemic Mixture

>  <PRODRUG>  (629) 
N

>  <ORAL>  (629) 
N

>  <PARENTERAL>  (629) 
N

>  <TOPICAL>  (629) 
N

>  <BLACK_BOX>  (629) 
N

>  <AVAILABILITY_TYPE>  (629) 
Unknown

>  <WITHDRAWN_YEAR>  (629) 
nan

>  <WITHDRAWN_COUNTRY>  (629) 
nan

>  <WITHDRAWN_REASON>  (629) 
nan

>  <CANONICAL_SMILES>  (629) 
CCC1CN2CCC1CC2[C@H](O)c3ccnc4ccc(OC)cc34

>  <name>  (629) 
Hydroquinine

>  <MW>  (629) 
326.44

>  <logP>  (629) 
3.3972

$$$$
CHEMBL1201235
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  7  2  1  0
 10  4  1  0
 21 16  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (630) 
675186

>  <SYNONYMS>  (630) 
Homatropine Methylbromide (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (630) 
4

>  <RESEARCH_CODES>  (630) 
nan

>  <APPLICANTS>  (630) 
Endo Pharmaceuticals Inc

>  <USAN_STEM>  (630) 
-trop-

>  <USAN_STEM_DEFINITION>  (630) 
atropine derivatives

>  <USAN_STEM_SUBSTEM>  (630) 
-trop-

>  <USAN_YEAR>  (630) 
nan

>  <FIRST_APPROVAL>  (630) 
1943.0

>  <ATC_CODE>  (630) 
A03CB04

>  <ATC_CODE_DESCRIPTION>  (630) 
A03CB04 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Antispasmodics In Combination With Psycholeptics:Belladonna and derivatives in combination with psycholeptics]

>  <INDICATION_CLASS>  (630) 
Anticholinergic

>  <SC_PATENT_NO>  (630) 
nan

>  <DRUG_TYPE>  (630) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (630) 
Y

>  <FIRST_IN_CLASS>  (630) 
N

>  <CHIRALITY>  (630) 
Racemic Mixture

>  <PRODRUG>  (630) 
N

>  <ORAL>  (630) 
Y

>  <PARENTERAL>  (630) 
N

>  <TOPICAL>  (630) 
N

>  <BLACK_BOX>  (630) 
N

>  <AVAILABILITY_TYPE>  (630) 
Prescription-only

>  <WITHDRAWN_YEAR>  (630) 
nan

>  <WITHDRAWN_COUNTRY>  (630) 
nan

>  <WITHDRAWN_REASON>  (630) 
nan

>  <CANONICAL_SMILES>  (630) 
C[N+]1(C)[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)C(O)c3ccccc3

>  <name>  (630) 
Homatropine Methylbromide 

>  <MW>  (630) 
290.383

>  <logP>  (630) 
2.033

$$$$
CHEMBL360328
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  2  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (631) 
301194

>  <SYNONYMS>  (631) 
Lorcaserin (INN); Lorcaserin HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (631) 
4

>  <RESEARCH_CODES>  (631) 
APD-356

>  <APPLICANTS>  (631) 
Eisai Inc

>  <USAN_STEM>  (631) 
-caserin

>  <USAN_STEM_DEFINITION>  (631) 
serotonin receptor agonists, primarily 5-HT2

>  <USAN_STEM_SUBSTEM>  (631) 
-caserin

>  <USAN_YEAR>  (631) 
2005.0

>  <FIRST_APPROVAL>  (631) 
2012.0

>  <ATC_CODE>  (631) 
A08AA11

>  <ATC_CODE_DESCRIPTION>  (631) 
A08AA11 [Alimentary Tract And Metabolism:Antiobesity Preparations, Excl. Diet Products:Antiobesity Preparations, Excl. Diet Products:Centrally acting antiobesity products]

>  <INDICATION_CLASS>  (631) 
nan

>  <SC_PATENT_NO>  (631) 
US-6953787-B2

>  <DRUG_TYPE>  (631) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (631) 
Y

>  <FIRST_IN_CLASS>  (631) 
N

>  <CHIRALITY>  (631) 
Single Stereoisomer

>  <PRODRUG>  (631) 
N

>  <ORAL>  (631) 
Y

>  <PARENTERAL>  (631) 
N

>  <TOPICAL>  (631) 
N

>  <BLACK_BOX>  (631) 
N

>  <AVAILABILITY_TYPE>  (631) 
Prescription-only

>  <WITHDRAWN_YEAR>  (631) 
nan

>  <WITHDRAWN_COUNTRY>  (631) 
nan

>  <WITHDRAWN_REASON>  (631) 
nan

>  <CANONICAL_SMILES>  (631) 
C[C@H]1CNCCc2ccc(Cl)cc12

>  <name>  (631) 
Lorcaserin 

>  <MW>  (631) 
195.693

>  <logP>  (631) 
2.5892

$$$$
CHEMBL2311071
     RDKit          

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
M  END
>  <PARENT_MOLREGNO>  (632) 
1510482

>  <SYNONYMS>  (632) 
Vinyl chloride

>  <DEVELOPMENT_PHASE>  (632) 
4

>  <RESEARCH_CODES>  (632) 
nan

>  <APPLICANTS>  (632) 
nan

>  <USAN_STEM>  (632) 
nan

>  <USAN_STEM_DEFINITION>  (632) 
nan

>  <USAN_STEM_SUBSTEM>  (632) 
nan

>  <USAN_YEAR>  (632) 
nan

>  <FIRST_APPROVAL>  (632) 
nan

>  <ATC_CODE>  (632) 
nan

>  <ATC_CODE_DESCRIPTION>  (632) 
nan

>  <INDICATION_CLASS>  (632) 
nan

>  <SC_PATENT_NO>  (632) 
nan

>  <DRUG_TYPE>  (632) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (632) 
Y

>  <FIRST_IN_CLASS>  (632) 
N

>  <CHIRALITY>  (632) 
Achiral Molecule

>  <PRODRUG>  (632) 
N

>  <ORAL>  (632) 
N

>  <PARENTERAL>  (632) 
N

>  <TOPICAL>  (632) 
N

>  <BLACK_BOX>  (632) 
N

>  <AVAILABILITY_TYPE>  (632) 
Withdrawn

>  <WITHDRAWN_YEAR>  (632) 
nan

>  <WITHDRAWN_COUNTRY>  (632) 
United States

>  <WITHDRAWN_REASON>  (632) 
nan

>  <CANONICAL_SMILES>  (632) 
ClC=C

>  <name>  (632) 
Vinyl chloride

>  <MW>  (632) 
62.499

>  <logP>  (632) 
1.3687

$$$$
CHEMBL313833
     RDKit          

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4  2  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (633) 
131607

>  <SYNONYMS>  (633) 
Tranylcypromine (BAN, INN); Tranylcypromine Sulfate (FDA, MI, USP)

>  <DEVELOPMENT_PHASE>  (633) 
4

>  <RESEARCH_CODES>  (633) 
nan

>  <APPLICANTS>  (633) 
Covis Pharma Sarl

>  <USAN_STEM>  (633) 
nan

>  <USAN_STEM_DEFINITION>  (633) 
nan

>  <USAN_STEM_SUBSTEM>  (633) 
nan

>  <USAN_YEAR>  (633) 
nan

>  <FIRST_APPROVAL>  (633) 
1961.0

>  <ATC_CODE>  (633) 
N06AF04

>  <ATC_CODE_DESCRIPTION>  (633) 
N06AF04 [Nervous System:Psychoanaleptics:Antidepressants:Monoamine oxidase inhibitors, non-selective]

>  <INDICATION_CLASS>  (633) 
nan

>  <SC_PATENT_NO>  (633) 
nan

>  <DRUG_TYPE>  (633) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (633) 
Y

>  <FIRST_IN_CLASS>  (633) 
N

>  <CHIRALITY>  (633) 
Racemic Mixture

>  <PRODRUG>  (633) 
N

>  <ORAL>  (633) 
Y

>  <PARENTERAL>  (633) 
N

>  <TOPICAL>  (633) 
N

>  <BLACK_BOX>  (633) 
Y

>  <AVAILABILITY_TYPE>  (633) 
Prescription-only

>  <WITHDRAWN_YEAR>  (633) 
nan

>  <WITHDRAWN_COUNTRY>  (633) 
nan

>  <WITHDRAWN_REASON>  (633) 
nan

>  <CANONICAL_SMILES>  (633) 
NC1CC1c2ccccc2

>  <name>  (633) 
Tranylcypromine 

>  <MW>  (633) 
133.194

>  <logP>  (633) 
1.5012

$$$$
CHEMBL1173655
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  2  0
 13 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 28 10  1  0
 26 12  1  0
 22 15  1  0
 34 30  1  0
M  END
>  <PARENT_MOLREGNO>  (634) 
650126

>  <SYNONYMS>  (634) 
Afatinib (INN, USAN); Afatinib Dimaleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (634) 
4

>  <RESEARCH_CODES>  (634) 
BIBW-2992; BIBW2992-MA2

>  <APPLICANTS>  (634) 
Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim

>  <USAN_STEM>  (634) 
-tinib

>  <USAN_STEM_DEFINITION>  (634) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (634) 
-tinib

>  <USAN_YEAR>  (634) 
2010.0

>  <FIRST_APPROVAL>  (634) 
2013.0

>  <ATC_CODE>  (634) 
L01XE13

>  <ATC_CODE_DESCRIPTION>  (634) 
L01XE13 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (634) 
nan

>  <SC_PATENT_NO>  (634) 
US-6251912-B1

>  <DRUG_TYPE>  (634) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (634) 
Y

>  <FIRST_IN_CLASS>  (634) 
N

>  <CHIRALITY>  (634) 
Single Stereoisomer

>  <PRODRUG>  (634) 
N

>  <ORAL>  (634) 
Y

>  <PARENTERAL>  (634) 
N

>  <TOPICAL>  (634) 
N

>  <BLACK_BOX>  (634) 
N

>  <AVAILABILITY_TYPE>  (634) 
Prescription-only

>  <WITHDRAWN_YEAR>  (634) 
nan

>  <WITHDRAWN_COUNTRY>  (634) 
nan

>  <WITHDRAWN_REASON>  (634) 
nan

>  <CANONICAL_SMILES>  (634) 
CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4

>  <name>  (634) 
Afatinib 

>  <MW>  (634) 
485.947

>  <logP>  (634) 
4.3899

$$$$
CHEMBL977
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 15 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
  8  2  1  0
 33  2  1  0
 33 11  1  0
 28 12  1  0
M  END
>  <PARENT_MOLREGNO>  (635) 
99284

>  <SYNONYMS>  (635) 
Hydrocortisone Hemisuccinate (USP); Hydrocortisone Succinate (JAN); Hydrocortisone Sodium Succinate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (635) 
4

>  <RESEARCH_CODES>  (635) 
NSC-7576

>  <APPLICANTS>  (635) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (635) 
-cort-

>  <USAN_STEM_DEFINITION>  (635) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (635) 
-cort-

>  <USAN_YEAR>  (635) 
nan

>  <FIRST_APPROVAL>  (635) 
1955.0

>  <ATC_CODE>  (635) 
D07AA02; S01CB03; D07XA01; C05AA01; A07EA02; A01AC03; H02AB09; S01BA02; S02BA01

>  <ATC_CODE_DESCRIPTION>  (635) 
D07AA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; S01CB03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; D07XA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; C05AA01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; A01AC03 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; H02AB09 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA01 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (635) 
Adrenocortical Steroid; Glucocorticoid

>  <SC_PATENT_NO>  (635) 
nan

>  <DRUG_TYPE>  (635) 
Natural Product-derived

>  <RULE_OF_FIVE>  (635) 
Y

>  <FIRST_IN_CLASS>  (635) 
N

>  <CHIRALITY>  (635) 
Single Stereoisomer

>  <PRODRUG>  (635) 
Y

>  <ORAL>  (635) 
N

>  <PARENTERAL>  (635) 
Y

>  <TOPICAL>  (635) 
N

>  <BLACK_BOX>  (635) 
N

>  <AVAILABILITY_TYPE>  (635) 
Prescription-only

>  <WITHDRAWN_YEAR>  (635) 
nan

>  <WITHDRAWN_COUNTRY>  (635) 
nan

>  <WITHDRAWN_REASON>  (635) 
nan

>  <CANONICAL_SMILES>  (635) 
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]4(C)C[C@H](O)[C@H]23

>  <name>  (635) 
Hydrocortisone Hemisuccinate 

>  <MW>  (635) 
462.539

>  <logP>  (635) 
2.1973

$$$$
CHEMBL1201335
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  7  2  1  0
 17 13  1  0
 23 18  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (636) 
675286

>  <SYNONYMS>  (636) 
Glycopyrronium (USAN); Glycopyrronium tosylate (USAN); Glycopyrrolate (FDA, USAN, USP); Glycopyrronium Bromide (BAN, INN, JAN); Ritropirronium Bromide (INN)

>  <DEVELOPMENT_PHASE>  (636) 
4

>  <RESEARCH_CODES>  (636) 
DRM04; AHR-504

>  <APPLICANTS>  (636) 
Merz Pharmaceuticals Llc; Dermira, Inc.; Baxter Healthcare Corp Anesthesia And Critical Care; Ah Robins Co; Shionogi Inc

>  <USAN_STEM>  (636) 
nan

>  <USAN_STEM_DEFINITION>  (636) 
nan

>  <USAN_STEM_SUBSTEM>  (636) 
nan

>  <USAN_YEAR>  (636) 
1963.0

>  <FIRST_APPROVAL>  (636) 
1961.0

>  <ATC_CODE>  (636) 
R03BB06; A03AB02

>  <ATC_CODE_DESCRIPTION>  (636) 
R03BB06 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Anticholinergics]; A03AB02 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (636) 
Anticholinergic

>  <SC_PATENT_NO>  (636) 
US-6521260-B1

>  <DRUG_TYPE>  (636) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (636) 
Y

>  <FIRST_IN_CLASS>  (636) 
N

>  <CHIRALITY>  (636) 
Racemic Mixture

>  <PRODRUG>  (636) 
N

>  <ORAL>  (636) 
Y

>  <PARENTERAL>  (636) 
Y

>  <TOPICAL>  (636) 
Y

>  <BLACK_BOX>  (636) 
N

>  <AVAILABILITY_TYPE>  (636) 
Prescription-only

>  <WITHDRAWN_YEAR>  (636) 
nan

>  <WITHDRAWN_COUNTRY>  (636) 
nan

>  <WITHDRAWN_REASON>  (636) 
nan

>  <CANONICAL_SMILES>  (636) 
C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3

>  <name>  (636) 
Glycopyrronium 

>  <MW>  (636) 
318.437

>  <logP>  (636) 
2.4563

$$$$
CHEMBL154
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  8 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 15 17  1  0
 12  3  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (637) 
51056

>  <SYNONYMS>  (637) 
Naproxen (BAN, FDA, INN, JAN, USAN, USP); Naproxen Sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (637) 
4

>  <RESEARCH_CODES>  (637) 
RS-3540; RS-3650

>  <APPLICANTS>  (637) 
Hoffmann La Roche Inc; Bayer Healthcare Llc; Banner Pharmacaps Inc; Astrazeneca Lp; SmithKline Beecham Corp Dba GlaxoSmithKline

>  <USAN_STEM>  (637) 
nan

>  <USAN_STEM_DEFINITION>  (637) 
nan

>  <USAN_STEM_SUBSTEM>  (637) 
nan

>  <USAN_YEAR>  (637) 
1970.0

>  <FIRST_APPROVAL>  (637) 
1976.0

>  <ATC_CODE>  (637) 
M01AE02; G02CC02; M02AA12

>  <ATC_CODE_DESCRIPTION>  (637) 
M01AE02 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]; G02CC02 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Other Gynecologicals:Antiinflammatory products for vaginal administration]; M02AA12 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]

>  <INDICATION_CLASS>  (637) 
Analgesic; Anti-Inflammatory; Antipyretic

>  <SC_PATENT_NO>  (637) 
US-5714504-A

>  <DRUG_TYPE>  (637) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (637) 
Y

>  <FIRST_IN_CLASS>  (637) 
N

>  <CHIRALITY>  (637) 
Single Stereoisomer

>  <PRODRUG>  (637) 
N

>  <ORAL>  (637) 
Y

>  <PARENTERAL>  (637) 
N

>  <TOPICAL>  (637) 
N

>  <BLACK_BOX>  (637) 
Y

>  <AVAILABILITY_TYPE>  (637) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (637) 
nan

>  <WITHDRAWN_COUNTRY>  (637) 
nan

>  <WITHDRAWN_REASON>  (637) 
nan

>  <CANONICAL_SMILES>  (637) 
COc1ccc2cc(ccc2c1)[C@H](C)C(=O)O

>  <name>  (637) 
Naproxen 

>  <MW>  (637) 
230.263

>  <logP>  (637) 
3.0365

$$$$
CHEMBL853
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
  8  2  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (638) 
65494

>  <SYNONYMS>  (638) 
Zalcitabine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (638) 
4

>  <RESEARCH_CODES>  (638) 
Ro-242027000; Ro-24-2027000

>  <APPLICANTS>  (638) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (638) 
-citabine

>  <USAN_STEM_DEFINITION>  (638) 
nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

>  <USAN_STEM_SUBSTEM>  (638) 
-citabine

>  <USAN_YEAR>  (638) 
1991.0

>  <FIRST_APPROVAL>  (638) 
1992.0

>  <ATC_CODE>  (638) 
J05AF03

>  <ATC_CODE_DESCRIPTION>  (638) 
J05AF03 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (638) 
Antiviral

>  <SC_PATENT_NO>  (638) 
nan

>  <DRUG_TYPE>  (638) 
Natural Product-derived

>  <RULE_OF_FIVE>  (638) 
Y

>  <FIRST_IN_CLASS>  (638) 
N

>  <CHIRALITY>  (638) 
Single Stereoisomer

>  <PRODRUG>  (638) 
N

>  <ORAL>  (638) 
Y

>  <PARENTERAL>  (638) 
N

>  <TOPICAL>  (638) 
N

>  <BLACK_BOX>  (638) 
Y

>  <AVAILABILITY_TYPE>  (638) 
Discontinued

>  <WITHDRAWN_YEAR>  (638) 
nan

>  <WITHDRAWN_COUNTRY>  (638) 
nan

>  <WITHDRAWN_REASON>  (638) 
nan

>  <CANONICAL_SMILES>  (638) 
NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2

>  <name>  (638) 
Zalcitabine 

>  <MW>  (638) 
211.221

>  <logP>  (638) 
-0.5046

$$$$
CHEMBL643
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  2 18  1  0
 18 19  1  0
 18 20  1  0
 17  4  1  0
 10  5  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (639) 
27368

>  <SYNONYMS>  (639) 
Promethazine (BAN, INN); Promethazine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (639) 
4

>  <RESEARCH_CODES>  (639) 
nan

>  <APPLICANTS>  (639) 
Wyeth Ayerst Laboratories; Shionogi Inc; Baxter Healthcare Corp Anesthesia Critical Care; Ani Pharmaceuticals Inc; Wyeth Pharmaceuticals Inc

>  <USAN_STEM>  (639) 
nan

>  <USAN_STEM_DEFINITION>  (639) 
nan

>  <USAN_STEM_SUBSTEM>  (639) 
nan

>  <USAN_YEAR>  (639) 
nan

>  <FIRST_APPROVAL>  (639) 
1951.0

>  <ATC_CODE>  (639) 
R06AD02; D04AA10; R06AD52

>  <ATC_CODE_DESCRIPTION>  (639) 
R06AD02 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]; D04AA10 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]; R06AD52 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]

>  <INDICATION_CLASS>  (639) 
Anti-Emetic; Antihistaminic

>  <SC_PATENT_NO>  (639) 
nan

>  <DRUG_TYPE>  (639) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (639) 
Y

>  <FIRST_IN_CLASS>  (639) 
N

>  <CHIRALITY>  (639) 
Racemic Mixture

>  <PRODRUG>  (639) 
N

>  <ORAL>  (639) 
Y

>  <PARENTERAL>  (639) 
Y

>  <TOPICAL>  (639) 
Y

>  <BLACK_BOX>  (639) 
Y

>  <AVAILABILITY_TYPE>  (639) 
Prescription-only

>  <WITHDRAWN_YEAR>  (639) 
nan

>  <WITHDRAWN_COUNTRY>  (639) 
nan

>  <WITHDRAWN_REASON>  (639) 
nan

>  <CANONICAL_SMILES>  (639) 
CC(CN1c2ccccc2Sc3ccccc13)N(C)C

>  <name>  (639) 
Promethazine 

>  <MW>  (639) 
284.428

>  <logP>  (639) 
4.2394

$$$$
CHEMBL726
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 22 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
  7 29  1  0
 29 30  1  0
 30  4  1  0
 24 11  1  0
 17 12  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (640) 
36842

>  <SYNONYMS>  (640) 
Fluphenazine (BAN, INN); Fluphenazine HCl (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (640) 
4

>  <RESEARCH_CODES>  (640) 
nan

>  <APPLICANTS>  (640) 
Schering Corp Sub Schering Plough Corp; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (640) 
nan

>  <USAN_STEM_DEFINITION>  (640) 
nan

>  <USAN_STEM_SUBSTEM>  (640) 
nan

>  <USAN_YEAR>  (640) 
nan

>  <FIRST_APPROVAL>  (640) 
1959.0

>  <ATC_CODE>  (640) 
N05AB02

>  <ATC_CODE_DESCRIPTION>  (640) 
N05AB02 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (640) 
Antipsychotic

>  <SC_PATENT_NO>  (640) 
nan

>  <DRUG_TYPE>  (640) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (640) 
Y

>  <FIRST_IN_CLASS>  (640) 
N

>  <CHIRALITY>  (640) 
Achiral Molecule

>  <PRODRUG>  (640) 
N

>  <ORAL>  (640) 
Y

>  <PARENTERAL>  (640) 
Y

>  <TOPICAL>  (640) 
N

>  <BLACK_BOX>  (640) 
Y

>  <AVAILABILITY_TYPE>  (640) 
Prescription-only

>  <WITHDRAWN_YEAR>  (640) 
nan

>  <WITHDRAWN_COUNTRY>  (640) 
nan

>  <WITHDRAWN_REASON>  (640) 
nan

>  <CANONICAL_SMILES>  (640) 
OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1

>  <name>  (640) 
Fluphenazine 

>  <MW>  (640) 
437.531

>  <logP>  (640) 
4.3081

$$$$
CHEMBL205596
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 28  8  1  0
 28 11  1  0
 24 12  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (641) 
343964

>  <SYNONYMS>  (641) 
Cholic acid (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (641) 
4

>  <RESEARCH_CODES>  (641) 
nan

>  <APPLICANTS>  (641) 
Retrophin Inc; Asklepion Pharmaceuticals, Llc

>  <USAN_STEM>  (641) 
nan

>  <USAN_STEM_DEFINITION>  (641) 
nan

>  <USAN_STEM_SUBSTEM>  (641) 
nan

>  <USAN_YEAR>  (641) 
2014.0

>  <FIRST_APPROVAL>  (641) 
2015.0

>  <ATC_CODE>  (641) 
A05AA03

>  <ATC_CODE_DESCRIPTION>  (641) 
A05AA03 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Bile Therapy:Bile acid preparations]

>  <INDICATION_CLASS>  (641) 
nan

>  <SC_PATENT_NO>  (641) 
nan

>  <DRUG_TYPE>  (641) 
Natural Product-derived

>  <RULE_OF_FIVE>  (641) 
Y

>  <FIRST_IN_CLASS>  (641) 
N

>  <CHIRALITY>  (641) 
Single Stereoisomer

>  <PRODRUG>  (641) 
N

>  <ORAL>  (641) 
Y

>  <PARENTERAL>  (641) 
N

>  <TOPICAL>  (641) 
N

>  <BLACK_BOX>  (641) 
N

>  <AVAILABILITY_TYPE>  (641) 
Prescription-only

>  <WITHDRAWN_YEAR>  (641) 
nan

>  <WITHDRAWN_COUNTRY>  (641) 
nan

>  <WITHDRAWN_REASON>  (641) 
nan

>  <CANONICAL_SMILES>  (641) 
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

>  <name>  (641) 
Cholic acid 

>  <MW>  (641) 
408.579

>  <logP>  (641) 
3.4487

$$$$
CHEMBL328875
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (642) 
148501

>  <SYNONYMS>  (642) 
Aminomethylbenzoic Acid

>  <DEVELOPMENT_PHASE>  (642) 
4

>  <RESEARCH_CODES>  (642) 
nan

>  <APPLICANTS>  (642) 
nan

>  <USAN_STEM>  (642) 
nan

>  <USAN_STEM_DEFINITION>  (642) 
nan

>  <USAN_STEM_SUBSTEM>  (642) 
nan

>  <USAN_YEAR>  (642) 
nan

>  <FIRST_APPROVAL>  (642) 
nan

>  <ATC_CODE>  (642) 
B02AA03

>  <ATC_CODE_DESCRIPTION>  (642) 
B02AA03 [Blood And Blood Forming Organs:Antihemorrhagics:Antifibrinolytics:Amino acids]

>  <INDICATION_CLASS>  (642) 
nan

>  <SC_PATENT_NO>  (642) 
nan

>  <DRUG_TYPE>  (642) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (642) 
Y

>  <FIRST_IN_CLASS>  (642) 
N

>  <CHIRALITY>  (642) 
Achiral Molecule

>  <PRODRUG>  (642) 
N

>  <ORAL>  (642) 
N

>  <PARENTERAL>  (642) 
N

>  <TOPICAL>  (642) 
N

>  <BLACK_BOX>  (642) 
N

>  <AVAILABILITY_TYPE>  (642) 
Unknown

>  <WITHDRAWN_YEAR>  (642) 
nan

>  <WITHDRAWN_COUNTRY>  (642) 
nan

>  <WITHDRAWN_REASON>  (642) 
nan

>  <CANONICAL_SMILES>  (642) 
NCc1ccc(cc1)C(=O)O

>  <name>  (642) 
Aminomethylbenzoic Acid

>  <MW>  (642) 
151.165

>  <logP>  (642) 
0.8435

$$$$
CHEMBL1201266
     RDKit          

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 15 17  1  0
 11 18  2  0
 18 19  1  0
  9 20  1  0
 20 21  3  0
 18  7  1  0
M  END
>  <PARENT_MOLREGNO>  (643) 
675217

>  <SYNONYMS>  (643) 
Lodoxamide (BAN, INN); Lodoxamide Trometamol (BAN); Lodoxamide Tromethamine (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (643) 
4

>  <RESEARCH_CODES>  (643) 
U-42585E

>  <APPLICANTS>  (643) 
Alcon Laboratories Inc

>  <USAN_STEM>  (643) 
nan

>  <USAN_STEM_DEFINITION>  (643) 
nan

>  <USAN_STEM_SUBSTEM>  (643) 
nan

>  <USAN_YEAR>  (643) 
1978.0

>  <FIRST_APPROVAL>  (643) 
1993.0

>  <ATC_CODE>  (643) 
S01GX05

>  <ATC_CODE_DESCRIPTION>  (643) 
S01GX05 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]

>  <INDICATION_CLASS>  (643) 
Anti-Allergic; Anti-Asthmatic

>  <SC_PATENT_NO>  (643) 
nan

>  <DRUG_TYPE>  (643) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (643) 
Y

>  <FIRST_IN_CLASS>  (643) 
N

>  <CHIRALITY>  (643) 
Achiral Molecule

>  <PRODRUG>  (643) 
N

>  <ORAL>  (643) 
N

>  <PARENTERAL>  (643) 
N

>  <TOPICAL>  (643) 
Y

>  <BLACK_BOX>  (643) 
N

>  <AVAILABILITY_TYPE>  (643) 
Prescription-only

>  <WITHDRAWN_YEAR>  (643) 
nan

>  <WITHDRAWN_COUNTRY>  (643) 
nan

>  <WITHDRAWN_REASON>  (643) 
nan

>  <CANONICAL_SMILES>  (643) 
OC(=O)C(=O)Nc1cc(cc(NC(=O)C(=O)O)c1Cl)C#N

>  <name>  (643) 
Lodoxamide 

>  <MW>  (643) 
311.637

>  <logP>  (643) 
0.25788

$$$$
CHEMBL716
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 12  7  1  0
 27 13  1  0
 20 15  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (644) 
34234

>  <SYNONYMS>  (644) 
Quetiapine (BAN, INN); Quetiapine Fumarate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (644) 
4

>  <RESEARCH_CODES>  (644) 
ICI-204636; ZD-5077; ZM-204636

>  <APPLICANTS>  (644) 
Astrazeneca Pharmaceuticals Lp; Astrazeneca Lp

>  <USAN_STEM>  (644) 
-tiapine

>  <USAN_STEM_DEFINITION>  (644) 
antipsychotics (dibenzothiazepine derivatives)

>  <USAN_STEM_SUBSTEM>  (644) 
-tiapine

>  <USAN_YEAR>  (644) 
1996.0

>  <FIRST_APPROVAL>  (644) 
1997.0

>  <ATC_CODE>  (644) 
N05AH04

>  <ATC_CODE_DESCRIPTION>  (644) 
N05AH04 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]

>  <INDICATION_CLASS>  (644) 
Antipsychotic

>  <SC_PATENT_NO>  (644) 
US-5948437-A

>  <DRUG_TYPE>  (644) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (644) 
Y

>  <FIRST_IN_CLASS>  (644) 
N

>  <CHIRALITY>  (644) 
Achiral Molecule

>  <PRODRUG>  (644) 
N

>  <ORAL>  (644) 
Y

>  <PARENTERAL>  (644) 
N

>  <TOPICAL>  (644) 
N

>  <BLACK_BOX>  (644) 
Y

>  <AVAILABILITY_TYPE>  (644) 
Prescription-only

>  <WITHDRAWN_YEAR>  (644) 
nan

>  <WITHDRAWN_COUNTRY>  (644) 
nan

>  <WITHDRAWN_REASON>  (644) 
nan

>  <CANONICAL_SMILES>  (644) 
OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24

>  <name>  (644) 
Quetiapine 

>  <MW>  (644) 
383.517

>  <logP>  (644) 
2.856

$$$$
CHEMBL623
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
  5 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 24  3  1  0
 14  9  1  0
 21 15  1  0
 33 28  1  0
M  END
>  <PARENT_MOLREGNO>  (645) 
26465

>  <SYNONYMS>  (645) 
Nefazodone (BAN, INN); Nefazodone HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (645) 
4

>  <RESEARCH_CODES>  (645) 
BMY-13754; MJ-13754-1

>  <APPLICANTS>  (645) 
Bristol Myers Squibb Co Pharmaceutical Research Institute

>  <USAN_STEM>  (645) 
nan

>  <USAN_STEM_DEFINITION>  (645) 
nan

>  <USAN_STEM_SUBSTEM>  (645) 
nan

>  <USAN_YEAR>  (645) 
1984.0

>  <FIRST_APPROVAL>  (645) 
1994.0

>  <ATC_CODE>  (645) 
N06AX06

>  <ATC_CODE_DESCRIPTION>  (645) 
N06AX06 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (645) 
Antidepressant

>  <SC_PATENT_NO>  (645) 
nan

>  <DRUG_TYPE>  (645) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (645) 
Y

>  <FIRST_IN_CLASS>  (645) 
N

>  <CHIRALITY>  (645) 
Achiral Molecule

>  <PRODRUG>  (645) 
N

>  <ORAL>  (645) 
Y

>  <PARENTERAL>  (645) 
N

>  <TOPICAL>  (645) 
N

>  <BLACK_BOX>  (645) 
Y

>  <AVAILABILITY_TYPE>  (645) 
Prescription-only

>  <WITHDRAWN_YEAR>  (645) 
nan

>  <WITHDRAWN_COUNTRY>  (645) 
nan

>  <WITHDRAWN_REASON>  (645) 
nan

>  <CANONICAL_SMILES>  (645) 
CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4

>  <name>  (645) 
Nefazodone 

>  <MW>  (645) 
470.017

>  <logP>  (645) 
3.5519

$$$$
CHEMBL2105581
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
  7 20  2  0
 20 21  1  0
 21 22  1  0
  5 23  1  0
 23 24  2  0
 23 25  2  0
 23 26  1  0
 20  3  1  0
 16 12  1  0
M  END
>  <PARENT_MOLREGNO>  (646) 
1377851

>  <SYNONYMS>  (646) 
Veralipride (INN, MI)

>  <DEVELOPMENT_PHASE>  (646) 
4

>  <RESEARCH_CODES>  (646) 
nan

>  <APPLICANTS>  (646) 
nan

>  <USAN_STEM>  (646) 
-pride

>  <USAN_STEM_DEFINITION>  (646) 
sulpiride derivatives

>  <USAN_STEM_SUBSTEM>  (646) 
-pride

>  <USAN_YEAR>  (646) 
nan

>  <FIRST_APPROVAL>  (646) 
1979.0

>  <ATC_CODE>  (646) 
N05AL06

>  <ATC_CODE_DESCRIPTION>  (646) 
N05AL06 [Nervous System:Psycholeptics:Antipsychotics:Benzamides]

>  <INDICATION_CLASS>  (646) 
nan

>  <SC_PATENT_NO>  (646) 
nan

>  <DRUG_TYPE>  (646) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (646) 
Y

>  <FIRST_IN_CLASS>  (646) 
N

>  <CHIRALITY>  (646) 
Racemic Mixture

>  <PRODRUG>  (646) 
N

>  <ORAL>  (646) 
N

>  <PARENTERAL>  (646) 
N

>  <TOPICAL>  (646) 
N

>  <BLACK_BOX>  (646) 
N

>  <AVAILABILITY_TYPE>  (646) 
Withdrawn

>  <WITHDRAWN_YEAR>  (646) 
2005.0

>  <WITHDRAWN_COUNTRY>  (646) 
Spain

>  <WITHDRAWN_REASON>  (646) 
Depression, anxiety, sleep disorders, tremor (shaking) and tardive dyskinesia

>  <CANONICAL_SMILES>  (646) 
COc1cc(cc(C(=O)NCC2CCCN2CC=C)c1OC)S(=O)(=O)N

>  <name>  (646) 
Veralipride 

>  <MW>  (646) 
383.47

>  <logP>  (646) 
0.7314

$$$$
CHEMBL1200542
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26  8  1  0
 26 11  1  0
 23 12  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (647) 
674493

>  <SYNONYMS>  (647) 
Desoxycorticosterone Acetate (FDA, USP); Desoxycortone (BAN, INN)

>  <DEVELOPMENT_PHASE>  (647) 
4

>  <RESEARCH_CODES>  (647) 
nan

>  <APPLICANTS>  (647) 
Organon Usa Inc; Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (647) 
-cort-; -ster-

>  <USAN_STEM_DEFINITION>  (647) 
cortisone derivatives; steroids (androgens, anabolics)

>  <USAN_STEM_SUBSTEM>  (647) 
-cort-; -ster-

>  <USAN_YEAR>  (647) 
nan

>  <FIRST_APPROVAL>  (647) 
1939.0

>  <ATC_CODE>  (647) 
H02AA03

>  <ATC_CODE_DESCRIPTION>  (647) 
H02AA03 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Mineralocorticoids]

>  <INDICATION_CLASS>  (647) 
Adrenocortical Steroid (salt-regulating)

>  <SC_PATENT_NO>  (647) 
nan

>  <DRUG_TYPE>  (647) 
Natural Product-derived

>  <RULE_OF_FIVE>  (647) 
Y

>  <FIRST_IN_CLASS>  (647) 
N

>  <CHIRALITY>  (647) 
Single Stereoisomer

>  <PRODRUG>  (647) 
Y

>  <ORAL>  (647) 
N

>  <PARENTERAL>  (647) 
Y

>  <TOPICAL>  (647) 
N

>  <BLACK_BOX>  (647) 
N

>  <AVAILABILITY_TYPE>  (647) 
Discontinued

>  <WITHDRAWN_YEAR>  (647) 
nan

>  <WITHDRAWN_COUNTRY>  (647) 
nan

>  <WITHDRAWN_REASON>  (647) 
nan

>  <CANONICAL_SMILES>  (647) 
CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (647) 
Desoxycorticosterone Acetate 

>  <MW>  (647) 
372.505

>  <logP>  (647) 
4.2667

$$$$
CHEMBL653
     RDKit          

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 16 21  2  0
 21 13  1  0
M  CHG  2   5   1   7  -1
M  END
>  <PARENT_MOLREGNO>  (648) 
27604

>  <SYNONYMS>  (648) 
Nizatidine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (648) 
4

>  <RESEARCH_CODES>  (648) 
LY-139037

>  <APPLICANTS>  (648) 
SmithKline Beecham Corp Dba GlaxoSmithKline; Pfizer Inc.; Braintree Laboratories Inc

>  <USAN_STEM>  (648) 
-tidine

>  <USAN_STEM_DEFINITION>  (648) 
H2-receptor antagonists (cimetidine type)

>  <USAN_STEM_SUBSTEM>  (648) 
-tidine

>  <USAN_YEAR>  (648) 
1983.0

>  <FIRST_APPROVAL>  (648) 
1988.0

>  <ATC_CODE>  (648) 
A02BA04

>  <ATC_CODE_DESCRIPTION>  (648) 
A02BA04 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):H2-receptor antagonists]

>  <INDICATION_CLASS>  (648) 
Anti-Ulcerative

>  <SC_PATENT_NO>  (648) 
US-6930119-B2

>  <DRUG_TYPE>  (648) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (648) 
Y

>  <FIRST_IN_CLASS>  (648) 
N

>  <CHIRALITY>  (648) 
Achiral Molecule

>  <PRODRUG>  (648) 
N

>  <ORAL>  (648) 
Y

>  <PARENTERAL>  (648) 
N

>  <TOPICAL>  (648) 
N

>  <BLACK_BOX>  (648) 
N

>  <AVAILABILITY_TYPE>  (648) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (648) 
nan

>  <WITHDRAWN_COUNTRY>  (648) 
nan

>  <WITHDRAWN_REASON>  (648) 
nan

>  <CANONICAL_SMILES>  (648) 
CN\C(=C/[N+](=O)[O-])\NCCSCc1csc(CN(C)C)n1

>  <name>  (648) 
Nizatidine 

>  <MW>  (648) 
331.467

>  <logP>  (648) 
1.3225

$$$$
CHEMBL317052
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 17 27  1  0
 27 28  2  0
  9  5  2  0
 28 10  1  0
 27 14  1  0
 25 18  1  0
M  END
>  <PARENT_MOLREGNO>  (649) 
162546

>  <SYNONYMS>  (649) 
Regadenoson (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (649) 
4

>  <RESEARCH_CODES>  (649) 
CVT-3146

>  <APPLICANTS>  (649) 
Astellas Pharma Us Inc

>  <USAN_STEM>  (649) 
-denoson

>  <USAN_STEM_DEFINITION>  (649) 
adenosine A receptor agonists

>  <USAN_STEM_SUBSTEM>  (649) 
-denoson

>  <USAN_YEAR>  (649) 
2004.0

>  <FIRST_APPROVAL>  (649) 
2008.0

>  <ATC_CODE>  (649) 
C01EB21

>  <ATC_CODE_DESCRIPTION>  (649) 
C01EB21 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (649) 
nan

>  <SC_PATENT_NO>  (649) 
US-6403567-B1

>  <DRUG_TYPE>  (649) 
Natural Product-derived

>  <RULE_OF_FIVE>  (649) 
Y

>  <FIRST_IN_CLASS>  (649) 
N

>  <CHIRALITY>  (649) 
Single Stereoisomer

>  <PRODRUG>  (649) 
N

>  <ORAL>  (649) 
N

>  <PARENTERAL>  (649) 
Y

>  <TOPICAL>  (649) 
N

>  <BLACK_BOX>  (649) 
N

>  <AVAILABILITY_TYPE>  (649) 
Prescription-only

>  <WITHDRAWN_YEAR>  (649) 
nan

>  <WITHDRAWN_COUNTRY>  (649) 
nan

>  <WITHDRAWN_REASON>  (649) 
nan

>  <CANONICAL_SMILES>  (649) 
CNC(=O)c1cnn(c1)c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2

>  <name>  (649) 
Regadenoson 

>  <MW>  (649) 
390.36

>  <logP>  (649) 
-2.4347

$$$$
CHEMBL1018
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  3 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 13  7  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (650) 
117108

>  <SYNONYMS>  (650) 
Dienestrol (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (650) 
4

>  <RESEARCH_CODES>  (650) 
nan

>  <APPLICANTS>  (650) 
Ortho Mcneil Pharmaceutical Inc

>  <USAN_STEM>  (650) 
-estr-

>  <USAN_STEM_DEFINITION>  (650) 
estrogens

>  <USAN_STEM_SUBSTEM>  (650) 
-estr-

>  <USAN_YEAR>  (650) 
nan

>  <FIRST_APPROVAL>  (650) 
1947.0

>  <ATC_CODE>  (650) 
G03CC02; G03CB01

>  <ATC_CODE_DESCRIPTION>  (650) 
G03CC02 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Estrogens, combinations with other drugs]; G03CB01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Synthetic estrogens, plain]

>  <INDICATION_CLASS>  (650) 
Estrogen

>  <SC_PATENT_NO>  (650) 
nan

>  <DRUG_TYPE>  (650) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (650) 
Y

>  <FIRST_IN_CLASS>  (650) 
N

>  <CHIRALITY>  (650) 
Achiral Molecule

>  <PRODRUG>  (650) 
N

>  <ORAL>  (650) 
N

>  <PARENTERAL>  (650) 
N

>  <TOPICAL>  (650) 
Y

>  <BLACK_BOX>  (650) 
N

>  <AVAILABILITY_TYPE>  (650) 
Discontinued

>  <WITHDRAWN_YEAR>  (650) 
nan

>  <WITHDRAWN_COUNTRY>  (650) 
nan

>  <WITHDRAWN_REASON>  (650) 
nan

>  <CANONICAL_SMILES>  (650) 
C\C=C(\C(=C\C)\c1ccc(O)cc1)/c2ccc(O)cc2

>  <name>  (650) 
Dienestrol 

>  <MW>  (650) 
266.34

>  <logP>  (650) 
4.6046

$$$$
CHEMBL2105345
     RDKit          

 24 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 11 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  2  0
 24  8  1  0
M  END
>  <PARENT_MOLREGNO>  (651) 
1377615

>  <SYNONYMS>  (651) 
Propanidid (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (651) 
4

>  <RESEARCH_CODES>  (651) 
BAYER-1420; FBA-1420; TH-2180; WH-5668

>  <APPLICANTS>  (651) 
Farbenfabriken Bayer A.G., Germany; 3m Pharmaceuticals

>  <USAN_STEM>  (651) 
nan

>  <USAN_STEM_DEFINITION>  (651) 
nan

>  <USAN_STEM_SUBSTEM>  (651) 
nan

>  <USAN_YEAR>  (651) 
1963.0

>  <FIRST_APPROVAL>  (651) 
nan

>  <ATC_CODE>  (651) 
N01AX04

>  <ATC_CODE_DESCRIPTION>  (651) 
N01AX04 [Nervous System:Anesthetics:Anesthetics, General:Other general anesthetics]

>  <INDICATION_CLASS>  (651) 
Anesthetic (intravenous)

>  <SC_PATENT_NO>  (651) 
nan

>  <DRUG_TYPE>  (651) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (651) 
Y

>  <FIRST_IN_CLASS>  (651) 
N

>  <CHIRALITY>  (651) 
Achiral Molecule

>  <PRODRUG>  (651) 
N

>  <ORAL>  (651) 
N

>  <PARENTERAL>  (651) 
N

>  <TOPICAL>  (651) 
N

>  <BLACK_BOX>  (651) 
N

>  <AVAILABILITY_TYPE>  (651) 
Withdrawn

>  <WITHDRAWN_YEAR>  (651) 
1983.0

>  <WITHDRAWN_COUNTRY>  (651) 
United Kingdom

>  <WITHDRAWN_REASON>  (651) 
Allergy

>  <CANONICAL_SMILES>  (651) 
CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1

>  <name>  (651) 
Propanidid 

>  <MW>  (651) 
337.416

>  <logP>  (651) 
2.4381

$$$$
CHEMBL1085
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 22 26  1  0
 26 27  1  0
 15 28  1  0
 28 29  2  0
 29  4  1  0
 28  7  1  0
 14  9  1  0
 27 19  1  0
M  END
>  <PARENT_MOLREGNO>  (652) 
147927

>  <SYNONYMS>  (652) 
Acetophenazine (INN); Acetophenazine maleate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (652) 
4

>  <RESEARCH_CODES>  (652) 
SCH-6673

>  <APPLICANTS>  (652) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (652) 
nan

>  <USAN_STEM_DEFINITION>  (652) 
nan

>  <USAN_STEM_SUBSTEM>  (652) 
nan

>  <USAN_YEAR>  (652) 
1963.0

>  <FIRST_APPROVAL>  (652) 
1961.0

>  <ATC_CODE>  (652) 
N05AB07

>  <ATC_CODE_DESCRIPTION>  (652) 
N05AB07 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (652) 
Antipsychotic

>  <SC_PATENT_NO>  (652) 
nan

>  <DRUG_TYPE>  (652) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (652) 
Y

>  <FIRST_IN_CLASS>  (652) 
N

>  <CHIRALITY>  (652) 
Achiral Molecule

>  <PRODRUG>  (652) 
N

>  <ORAL>  (652) 
Y

>  <PARENTERAL>  (652) 
N

>  <TOPICAL>  (652) 
N

>  <BLACK_BOX>  (652) 
N

>  <AVAILABILITY_TYPE>  (652) 
Discontinued

>  <WITHDRAWN_YEAR>  (652) 
nan

>  <WITHDRAWN_COUNTRY>  (652) 
nan

>  <WITHDRAWN_REASON>  (652) 
nan

>  <CANONICAL_SMILES>  (652) 
CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1

>  <name>  (652) 
Acetophenazine 

>  <MW>  (652) 
411.571

>  <logP>  (652) 
3.4919

$$$$
CHEMBL129
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
  4 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 18  2  1  0
 14  5  1  0
M  CHG  2   9   1  10  -1
M  END
>  <PARENT_MOLREGNO>  (653) 
27307

>  <SYNONYMS>  (653) 
Zidovudine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (653) 
4

>  <RESEARCH_CODES>  (653) 
AZT; BW-A509U; BW-A-509U; Compound S

>  <APPLICANTS>  (653) 
Viiv Healthcare Co; Matrix Laboratories Ltd; Aurobindo Pharma Ltd

>  <USAN_STEM>  (653) 
-vudine

>  <USAN_STEM_DEFINITION>  (653) 
antineoplastics,antivirals (zidovudine group) (exception: edoxudine)

>  <USAN_STEM_SUBSTEM>  (653) 
-vudine

>  <USAN_YEAR>  (653) 
1987.0

>  <FIRST_APPROVAL>  (653) 
1987.0

>  <ATC_CODE>  (653) 
J05AF01

>  <ATC_CODE_DESCRIPTION>  (653) 
J05AF01 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (653) 
Antiviral

>  <SC_PATENT_NO>  (653) 
US-5905082-A

>  <DRUG_TYPE>  (653) 
Natural Product-derived

>  <RULE_OF_FIVE>  (653) 
Y

>  <FIRST_IN_CLASS>  (653) 
N

>  <CHIRALITY>  (653) 
Single Stereoisomer

>  <PRODRUG>  (653) 
Y

>  <ORAL>  (653) 
Y

>  <PARENTERAL>  (653) 
Y

>  <TOPICAL>  (653) 
N

>  <BLACK_BOX>  (653) 
Y

>  <AVAILABILITY_TYPE>  (653) 
Prescription-only

>  <WITHDRAWN_YEAR>  (653) 
nan

>  <WITHDRAWN_COUNTRY>  (653) 
nan

>  <WITHDRAWN_REASON>  (653) 
nan

>  <CANONICAL_SMILES>  (653) 
CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O

>  <name>  (653) 
Zidovudine 

>  <MW>  (653) 
267.245

>  <logP>  (653) 
-0.19628

$$$$
CHEMBL1350
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  5 14  1  0
 14 15  2  0
 14 16  1  0
 14 17  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (654) 
299299

>  <SYNONYMS>  (654) 
Tiludronic Acid (BAN, INN); Tiludronate Disodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (654) 
4

>  <RESEARCH_CODES>  (654) 
SR-41319; SR-41319B

>  <APPLICANTS>  (654) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (654) 
nan

>  <USAN_STEM_DEFINITION>  (654) 
nan

>  <USAN_STEM_SUBSTEM>  (654) 
nan

>  <USAN_YEAR>  (654) 
1994.0

>  <FIRST_APPROVAL>  (654) 
1997.0

>  <ATC_CODE>  (654) 
M05BA05

>  <ATC_CODE_DESCRIPTION>  (654) 
M05BA05 [Musculo-Skeletal System:Drugs For Treatment Of Bone Diseases:Drugs Affecting Bone Structure And Mineralization:Bisphosphonates]

>  <INDICATION_CLASS>  (654) 
Osteoporosis Treatment And Prevention; Paget's Disease Treatment

>  <SC_PATENT_NO>  (654) 
nan

>  <DRUG_TYPE>  (654) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (654) 
Y

>  <FIRST_IN_CLASS>  (654) 
N

>  <CHIRALITY>  (654) 
Achiral Molecule

>  <PRODRUG>  (654) 
N

>  <ORAL>  (654) 
Y

>  <PARENTERAL>  (654) 
N

>  <TOPICAL>  (654) 
N

>  <BLACK_BOX>  (654) 
N

>  <AVAILABILITY_TYPE>  (654) 
Prescription-only

>  <WITHDRAWN_YEAR>  (654) 
nan

>  <WITHDRAWN_COUNTRY>  (654) 
nan

>  <WITHDRAWN_REASON>  (654) 
nan

>  <CANONICAL_SMILES>  (654) 
OP(=O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O

>  <name>  (654) 
Tiludronic Acid 

>  <MW>  (654) 
318.611

>  <logP>  (654) 
2.0711

$$$$
CHEMBL572
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
  6 16  2  0
 16 17  1  0
 17  4  2  0
 14  9  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (655) 
16592

>  <SYNONYMS>  (655) 
Nitrofurantoin (BAN, FDA, INN, JAN, USP); Nitrofurantoin Macrocrystalline (FDA); Nitrofurantoin sodium (FDA)

>  <DEVELOPMENT_PHASE>  (655) 
4

>  <RESEARCH_CODES>  (655) 
nan

>  <APPLICANTS>  (655) 
Shionogi Inc; Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co; Almatica Pharma Inc

>  <USAN_STEM>  (655) 
nan

>  <USAN_STEM_DEFINITION>  (655) 
nan

>  <USAN_STEM_SUBSTEM>  (655) 
nan

>  <USAN_YEAR>  (655) 
nan

>  <FIRST_APPROVAL>  (655) 
1953.0

>  <ATC_CODE>  (655) 
J01XE01; J01XE51

>  <ATC_CODE_DESCRIPTION>  (655) 
J01XE01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Nitrofuran derivatives]; J01XE51 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Nitrofuran derivatives]

>  <INDICATION_CLASS>  (655) 
Antibacterial (urinary)

>  <SC_PATENT_NO>  (655) 
nan

>  <DRUG_TYPE>  (655) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (655) 
Y

>  <FIRST_IN_CLASS>  (655) 
N

>  <CHIRALITY>  (655) 
Achiral Molecule

>  <PRODRUG>  (655) 
N

>  <ORAL>  (655) 
Y

>  <PARENTERAL>  (655) 
Y

>  <TOPICAL>  (655) 
N

>  <BLACK_BOX>  (655) 
N

>  <AVAILABILITY_TYPE>  (655) 
Prescription-only

>  <WITHDRAWN_YEAR>  (655) 
nan

>  <WITHDRAWN_COUNTRY>  (655) 
nan

>  <WITHDRAWN_REASON>  (655) 
nan

>  <CANONICAL_SMILES>  (655) 
[O-][N+](=O)c1oc(\C=N\N2CC(=O)NC2=O)cc1

>  <name>  (655) 
Nitrofurantoin 

>  <MW>  (655) 
238.159

>  <logP>  (655) 
0.0735

$$$$
CHEMBL1474963
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 11  3  2  0
 10  5  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (656) 
898847

>  <SYNONYMS>  (656) 
Benzarone (DCF, INN, MI)

>  <DEVELOPMENT_PHASE>  (656) 
4

>  <RESEARCH_CODES>  (656) 
L-2197

>  <APPLICANTS>  (656) 
nan

>  <USAN_STEM>  (656) 
-arone

>  <USAN_STEM_DEFINITION>  (656) 
antirrhythmics

>  <USAN_STEM_SUBSTEM>  (656) 
-arone

>  <USAN_YEAR>  (656) 
nan

>  <FIRST_APPROVAL>  (656) 
nan

>  <ATC_CODE>  (656) 
nan

>  <ATC_CODE_DESCRIPTION>  (656) 
nan

>  <INDICATION_CLASS>  (656) 
nan

>  <SC_PATENT_NO>  (656) 
nan

>  <DRUG_TYPE>  (656) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (656) 
Y

>  <FIRST_IN_CLASS>  (656) 
N

>  <CHIRALITY>  (656) 
Achiral Molecule

>  <PRODRUG>  (656) 
N

>  <ORAL>  (656) 
N

>  <PARENTERAL>  (656) 
N

>  <TOPICAL>  (656) 
N

>  <BLACK_BOX>  (656) 
N

>  <AVAILABILITY_TYPE>  (656) 
Withdrawn

>  <WITHDRAWN_YEAR>  (656) 
1992.0

>  <WITHDRAWN_COUNTRY>  (656) 
Germany

>  <WITHDRAWN_REASON>  (656) 
Hepatitis

>  <CANONICAL_SMILES>  (656) 
CCc1oc2ccccc2c1C(=O)c3ccc(O)cc3

>  <name>  (656) 
Benzarone 

>  <MW>  (656) 
266.296

>  <logP>  (656) 
3.9318

$$$$
CHEMBL1200545
     RDKit          

 35 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 24 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 24  2  1  0
 22  4  1  0
 17  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (657) 
674496

>  <SYNONYMS>  (657) 
Diflorasone (BAN, INN); Diflorasone Diacetate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (657) 
4

>  <RESEARCH_CODES>  (657) 
U-34865

>  <APPLICANTS>  (657) 
Taro Pharmaceuticals Usa Inc; Pharmacia And Upjohn Co

>  <USAN_STEM>  (657) 
nan

>  <USAN_STEM_DEFINITION>  (657) 
nan

>  <USAN_STEM_SUBSTEM>  (657) 
nan

>  <USAN_YEAR>  (657) 
1973.0

>  <FIRST_APPROVAL>  (657) 
1977.0

>  <ATC_CODE>  (657) 
D07AC10

>  <ATC_CODE_DESCRIPTION>  (657) 
D07AC10 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]

>  <INDICATION_CLASS>  (657) 
Anti-Inflammatory (topical)

>  <SC_PATENT_NO>  (657) 
nan

>  <DRUG_TYPE>  (657) 
Natural Product-derived

>  <RULE_OF_FIVE>  (657) 
Y

>  <FIRST_IN_CLASS>  (657) 
N

>  <CHIRALITY>  (657) 
Single Stereoisomer

>  <PRODRUG>  (657) 
Y

>  <ORAL>  (657) 
N

>  <PARENTERAL>  (657) 
N

>  <TOPICAL>  (657) 
Y

>  <BLACK_BOX>  (657) 
N

>  <AVAILABILITY_TYPE>  (657) 
Prescription-only

>  <WITHDRAWN_YEAR>  (657) 
nan

>  <WITHDRAWN_COUNTRY>  (657) 
nan

>  <WITHDRAWN_REASON>  (657) 
nan

>  <CANONICAL_SMILES>  (657) 
C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C)C(=O)COC(=O)C

>  <name>  (657) 
Diflorasone 

>  <MW>  (657) 
494.531

>  <logP>  (657) 
2.9853

$$$$
CHEMBL802
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8  2  1  0
 15 10  1  0
M  CHG  2   8   1   9  -1
M  END
>  <PARENT_MOLREGNO>  (658) 
51042

>  <SYNONYMS>  (658) 
Minoxidil (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (658) 
4

>  <RESEARCH_CODES>  (658) 
U-10858

>  <APPLICANTS>  (658) 
Pharmacia And Upjohn Co; Johnson And Johnson Group Consumer Companies

>  <USAN_STEM>  (658) 
-dil

>  <USAN_STEM_DEFINITION>  (658) 
vasodilators (undefined group)

>  <USAN_STEM_SUBSTEM>  (658) 
-dil

>  <USAN_YEAR>  (658) 
1970.0

>  <FIRST_APPROVAL>  (658) 
1979.0

>  <ATC_CODE>  (658) 
C02DC01; D11AX01

>  <ATC_CODE_DESCRIPTION>  (658) 
C02DC01 [Cardiovascular System:Antihypertensives:Arteriolar Smooth Muscle, Agents Acting On:Pyrimidine derivatives]; D11AX01 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (658) 
Antihypertensive; Hair Growth Stimulant (topical)

>  <SC_PATENT_NO>  (658) 
US-6946120-B2

>  <DRUG_TYPE>  (658) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (658) 
Y

>  <FIRST_IN_CLASS>  (658) 
N

>  <CHIRALITY>  (658) 
Achiral Molecule

>  <PRODRUG>  (658) 
Y

>  <ORAL>  (658) 
Y

>  <PARENTERAL>  (658) 
N

>  <TOPICAL>  (658) 
Y

>  <BLACK_BOX>  (658) 
Y

>  <AVAILABILITY_TYPE>  (658) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (658) 
nan

>  <WITHDRAWN_COUNTRY>  (658) 
nan

>  <WITHDRAWN_REASON>  (658) 
nan

>  <CANONICAL_SMILES>  (658) 
Nc1cc(nc(N)[n+]1[O-])N2CCCCC2

>  <name>  (658) 
Minoxidil 

>  <MW>  (658) 
209.253

>  <logP>  (658) 
-0.1303

$$$$
CHEMBL863
     RDKit          

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  2  0
  5  7  1  0
M  END
>  <PARENT_MOLREGNO>  (659) 
66213

>  <SYNONYMS>  (659) 
Cysteine (INN); Cysteine HCl (FDA, USP); L-Cysteine (JAN); L-Cysteine Ethylester HCl (JAN); L-Cysteinemethyl HCl (JAN)

>  <DEVELOPMENT_PHASE>  (659) 
4

>  <RESEARCH_CODES>  (659) 
nan

>  <APPLICANTS>  (659) 
Hospira Inc

>  <USAN_STEM>  (659) 
nan

>  <USAN_STEM_DEFINITION>  (659) 
nan

>  <USAN_STEM_SUBSTEM>  (659) 
nan

>  <USAN_YEAR>  (659) 
nan

>  <FIRST_APPROVAL>  (659) 
1986.0

>  <ATC_CODE>  (659) 
nan

>  <ATC_CODE_DESCRIPTION>  (659) 
nan

>  <INDICATION_CLASS>  (659) 
Amino Acid

>  <SC_PATENT_NO>  (659) 
nan

>  <DRUG_TYPE>  (659) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (659) 
Y

>  <FIRST_IN_CLASS>  (659) 
N

>  <CHIRALITY>  (659) 
Single Stereoisomer

>  <PRODRUG>  (659) 
N

>  <ORAL>  (659) 
N

>  <PARENTERAL>  (659) 
Y

>  <TOPICAL>  (659) 
N

>  <BLACK_BOX>  (659) 
N

>  <AVAILABILITY_TYPE>  (659) 
Discontinued

>  <WITHDRAWN_YEAR>  (659) 
nan

>  <WITHDRAWN_COUNTRY>  (659) 
nan

>  <WITHDRAWN_REASON>  (659) 
nan

>  <CANONICAL_SMILES>  (659) 
N[C@@H](CS)C(=O)O

>  <name>  (659) 
Cysteine 

>  <MW>  (659) 
121.161

>  <logP>  (659) 
-0.6719

$$$$
CHEMBL204656
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 24 25  1  0
  6 26  1  0
 26 27  1  0
 27 28  1  0
 26 29  1  0
 29 30  1  0
 29 31  1  0
 16  3  1  0
 14  5  2  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (660) 
340684

>  <SYNONYMS>  (660) 
Elvitegravir (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (660) 
4

>  <RESEARCH_CODES>  (660) 
GS-9137; JTK-303

>  <APPLICANTS>  (660) 
Gilead Sciences Inc

>  <USAN_STEM>  (660) 
-vir

>  <USAN_STEM_DEFINITION>  (660) 
antivirals: integrase inhibitors

>  <USAN_STEM_SUBSTEM>  (660) 
-vir (-tegravir)

>  <USAN_YEAR>  (660) 
2007.0

>  <FIRST_APPROVAL>  (660) 
2012.0

>  <ATC_CODE>  (660) 
J05AX11

>  <ATC_CODE_DESCRIPTION>  (660) 
J05AX11 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals]

>  <INDICATION_CLASS>  (660) 
nan

>  <SC_PATENT_NO>  (660) 
US-5814639-A

>  <DRUG_TYPE>  (660) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (660) 
Y

>  <FIRST_IN_CLASS>  (660) 
N

>  <CHIRALITY>  (660) 
Single Stereoisomer

>  <PRODRUG>  (660) 
N

>  <ORAL>  (660) 
Y

>  <PARENTERAL>  (660) 
N

>  <TOPICAL>  (660) 
N

>  <BLACK_BOX>  (660) 
N

>  <AVAILABILITY_TYPE>  (660) 
Prescription-only

>  <WITHDRAWN_YEAR>  (660) 
nan

>  <WITHDRAWN_COUNTRY>  (660) 
nan

>  <WITHDRAWN_REASON>  (660) 
nan

>  <CANONICAL_SMILES>  (660) 
COc1cc2N(C=C(C(=O)O)C(=O)c2cc1Cc3cccc(Cl)c3F)[C@H](CO)C(C)C

>  <name>  (660) 
Elvitegravir 

>  <MW>  (660) 
447.89

>  <logP>  (660) 
4.281

$$$$
CHEMBL485
     RDKit          

 22 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 16  3  1  0
 17  6  1  0
 21  8  1  0
 18  9  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (661) 
6167

>  <SYNONYMS>  (661) 
Codeine (BAN, USP); Codeine sulfate (FDA, USP); Codeine Phosphate (BAN, FDA, JAN, USP); Codeine Polistirex (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (661) 
4

>  <RESEARCH_CODES>  (661) 
nan

>  <APPLICANTS>  (661) 
Forest Laboratories Inc; Fisons Corp; Ani Pharmaceuticals Inc; Ah Robins Co; Meda Pharmaceuticals Meda Pharmaceuticals Inc

>  <USAN_STEM>  (661) 
nan

>  <USAN_STEM_DEFINITION>  (661) 
nan

>  <USAN_STEM_SUBSTEM>  (661) 
nan

>  <USAN_YEAR>  (661) 
1987.0

>  <FIRST_APPROVAL>  (661) 
1952.0

>  <ATC_CODE>  (661) 
R05DA04; N02AA79; N02AA59

>  <ATC_CODE_DESCRIPTION>  (661) 
R05DA04 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Opium alkaloids and derivatives]; N02AA79 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]; N02AA59 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]

>  <INDICATION_CLASS>  (661) 
Analgesic (narcotic); Antitussive

>  <SC_PATENT_NO>  (661) 
US-6248363-B1

>  <DRUG_TYPE>  (661) 
Polymer

>  <RULE_OF_FIVE>  (661) 
Y

>  <FIRST_IN_CLASS>  (661) 
N

>  <CHIRALITY>  (661) 
Single Stereoisomer

>  <PRODRUG>  (661) 
N

>  <ORAL>  (661) 
Y

>  <PARENTERAL>  (661) 
N

>  <TOPICAL>  (661) 
N

>  <BLACK_BOX>  (661) 
Y

>  <AVAILABILITY_TYPE>  (661) 
Prescription-only

>  <WITHDRAWN_YEAR>  (661) 
nan

>  <WITHDRAWN_COUNTRY>  (661) 
nan

>  <WITHDRAWN_REASON>  (661) 
nan

>  <CANONICAL_SMILES>  (661) 
COc1ccc2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C

>  <name>  (661) 
Codeine 

>  <MW>  (661) 
299.37

>  <logP>  (661) 
1.5011

$$$$
CHEMBL1577
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 11 17  1  0
 17 18  2  0
 17 19  2  0
 17 20  1  0
 14  2  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (662) 
453564

>  <SYNONYMS>  (662) 
Methyclothiazide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (662) 
4

>  <RESEARCH_CODES>  (662) 
nan

>  <APPLICANTS>  (662) 
Medpointe Pharmaceuticals Medpointe Healthcare Inc; Abbvie Inc; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (662) 
-thiazide

>  <USAN_STEM_DEFINITION>  (662) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (662) 
-thiazide

>  <USAN_YEAR>  (662) 
1963.0

>  <FIRST_APPROVAL>  (662) 
1960.0

>  <ATC_CODE>  (662) 
C03AA08

>  <ATC_CODE_DESCRIPTION>  (662) 
C03AA08 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (662) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (662) 
nan

>  <DRUG_TYPE>  (662) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (662) 
Y

>  <FIRST_IN_CLASS>  (662) 
N

>  <CHIRALITY>  (662) 
Racemic Mixture

>  <PRODRUG>  (662) 
N

>  <ORAL>  (662) 
Y

>  <PARENTERAL>  (662) 
N

>  <TOPICAL>  (662) 
N

>  <BLACK_BOX>  (662) 
N

>  <AVAILABILITY_TYPE>  (662) 
Prescription-only

>  <WITHDRAWN_YEAR>  (662) 
nan

>  <WITHDRAWN_COUNTRY>  (662) 
nan

>  <WITHDRAWN_REASON>  (662) 
nan

>  <CANONICAL_SMILES>  (662) 
CN1C(CCl)Nc2cc(Cl)c(cc2S1(=O)=O)S(=O)(=O)N

>  <name>  (662) 
Methyclothiazide 

>  <MW>  (662) 
360.244

>  <logP>  (662) 
0.5983

$$$$
CHEMBL861
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  9  3  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (663) 
66016

>  <SYNONYMS>  (663) 
Mephenytoin (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (663) 
4

>  <RESEARCH_CODES>  (663) 
nan

>  <APPLICANTS>  (663) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (663) 
-toin

>  <USAN_STEM_DEFINITION>  (663) 
antiepileptics (hydantoin derivatives)

>  <USAN_STEM_SUBSTEM>  (663) 
-toin

>  <USAN_YEAR>  (663) 
1962.0

>  <FIRST_APPROVAL>  (663) 
1946.0

>  <ATC_CODE>  (663) 
N03AB04; N03AB54

>  <ATC_CODE_DESCRIPTION>  (663) 
N03AB04 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]; N03AB54 [Nervous System:Antiepileptics:Antiepileptics:Hydantoin derivatives]

>  <INDICATION_CLASS>  (663) 
Anticonvulsant

>  <SC_PATENT_NO>  (663) 
nan

>  <DRUG_TYPE>  (663) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (663) 
Y

>  <FIRST_IN_CLASS>  (663) 
N

>  <CHIRALITY>  (663) 
Racemic Mixture

>  <PRODRUG>  (663) 
N

>  <ORAL>  (663) 
Y

>  <PARENTERAL>  (663) 
N

>  <TOPICAL>  (663) 
N

>  <BLACK_BOX>  (663) 
N

>  <AVAILABILITY_TYPE>  (663) 
Discontinued

>  <WITHDRAWN_YEAR>  (663) 
nan

>  <WITHDRAWN_COUNTRY>  (663) 
nan

>  <WITHDRAWN_REASON>  (663) 
nan

>  <CANONICAL_SMILES>  (663) 
CCC1(NC(=O)N(C)C1=O)c2ccccc2

>  <name>  (663) 
Mephenytoin 

>  <MW>  (663) 
218.256

>  <logP>  (663) 
1.4735

$$$$
CHEMBL1399
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  3  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 21 22  3  0
 17  6  1  0
 14 10  1  0
M  END
>  <PARENT_MOLREGNO>  (664) 
337366

>  <SYNONYMS>  (664) 
Anastrozole (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (664) 
4

>  <RESEARCH_CODES>  (664) 
ICI-D1033; ZD-1033

>  <APPLICANTS>  (664) 
Astrazeneca Uk Ltd

>  <USAN_STEM>  (664) 
-rozole

>  <USAN_STEM_DEFINITION>  (664) 
aromatase inhibitors (imidazole/triazole derivatives)

>  <USAN_STEM_SUBSTEM>  (664) 
-rozole

>  <USAN_YEAR>  (664) 
1995.0

>  <FIRST_APPROVAL>  (664) 
1995.0

>  <ATC_CODE>  (664) 
L02BG03

>  <ATC_CODE_DESCRIPTION>  (664) 
L02BG03 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Aromatase inhibitors]

>  <INDICATION_CLASS>  (664) 
Antineoplastic

>  <SC_PATENT_NO>  (664) 
nan

>  <DRUG_TYPE>  (664) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (664) 
Y

>  <FIRST_IN_CLASS>  (664) 
N

>  <CHIRALITY>  (664) 
Achiral Molecule

>  <PRODRUG>  (664) 
N

>  <ORAL>  (664) 
Y

>  <PARENTERAL>  (664) 
N

>  <TOPICAL>  (664) 
N

>  <BLACK_BOX>  (664) 
N

>  <AVAILABILITY_TYPE>  (664) 
Prescription-only

>  <WITHDRAWN_YEAR>  (664) 
nan

>  <WITHDRAWN_COUNTRY>  (664) 
nan

>  <WITHDRAWN_REASON>  (664) 
nan

>  <CANONICAL_SMILES>  (664) 
CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N

>  <name>  (664) 
Anastrozole 

>  <MW>  (664) 
293.374

>  <logP>  (664) 
2.92876

$$$$
CHEMBL1532
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
  9 15  1  0
 15 16  2  0
 15 17  2  0
 15 18  1  0
 14  3  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (665) 
428791

>  <SYNONYMS>  (665) 
Quinethazone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (665) 
4

>  <RESEARCH_CODES>  (665) 
nan

>  <APPLICANTS>  (665) 
Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (665) 
nan

>  <USAN_STEM_DEFINITION>  (665) 
nan

>  <USAN_STEM_SUBSTEM>  (665) 
nan

>  <USAN_YEAR>  (665) 
nan

>  <FIRST_APPROVAL>  (665) 
1963.0

>  <ATC_CODE>  (665) 
C03BA02

>  <ATC_CODE_DESCRIPTION>  (665) 
C03BA02 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Excl. Thiazides:Sulfonamides, plain]

>  <INDICATION_CLASS>  (665) 
nan

>  <SC_PATENT_NO>  (665) 
nan

>  <DRUG_TYPE>  (665) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (665) 
Y

>  <FIRST_IN_CLASS>  (665) 
N

>  <CHIRALITY>  (665) 
Racemic Mixture

>  <PRODRUG>  (665) 
N

>  <ORAL>  (665) 
Y

>  <PARENTERAL>  (665) 
N

>  <TOPICAL>  (665) 
N

>  <BLACK_BOX>  (665) 
N

>  <AVAILABILITY_TYPE>  (665) 
Discontinued

>  <WITHDRAWN_YEAR>  (665) 
nan

>  <WITHDRAWN_COUNTRY>  (665) 
nan

>  <WITHDRAWN_REASON>  (665) 
nan

>  <CANONICAL_SMILES>  (665) 
CCC1NC(=O)c2cc(c(Cl)cc2N1)S(=O)(=O)N

>  <name>  (665) 
Quinethazone 

>  <MW>  (665) 
289.744

>  <logP>  (665) 
0.8788

$$$$
CHEMBL1229211
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 10 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 25 30  1  0
 29  2  1  0
 29  6  1  0
 26  8  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (666) 
691562

>  <SYNONYMS>  (666) 
Dolutegravir (INN, USAN); Dolutegravir Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (666) 
4

>  <RESEARCH_CODES>  (666) 
GSK1349572; S-349572; GSK1349572A

>  <APPLICANTS>  (666) 
Viiv Hlthcare; Viiv Healthcare Co; GlaxoSmithKline

>  <USAN_STEM>  (666) 
-vir

>  <USAN_STEM_DEFINITION>  (666) 
antivirals: integrase inhibitors

>  <USAN_STEM_SUBSTEM>  (666) 
-vir (-tegravir)

>  <USAN_YEAR>  (666) 
2010.0

>  <FIRST_APPROVAL>  (666) 
2013.0

>  <ATC_CODE>  (666) 
J05AX12

>  <ATC_CODE_DESCRIPTION>  (666) 
J05AX12 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals]

>  <INDICATION_CLASS>  (666) 
nan

>  <SC_PATENT_NO>  (666) 
US-5905082-A

>  <DRUG_TYPE>  (666) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (666) 
Y

>  <FIRST_IN_CLASS>  (666) 
N

>  <CHIRALITY>  (666) 
Single Stereoisomer

>  <PRODRUG>  (666) 
N

>  <ORAL>  (666) 
Y

>  <PARENTERAL>  (666) 
N

>  <TOPICAL>  (666) 
N

>  <BLACK_BOX>  (666) 
N

>  <AVAILABILITY_TYPE>  (666) 
Prescription-only

>  <WITHDRAWN_YEAR>  (666) 
nan

>  <WITHDRAWN_COUNTRY>  (666) 
nan

>  <WITHDRAWN_REASON>  (666) 
nan

>  <CANONICAL_SMILES>  (666) 
C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O

>  <name>  (666) 
Dolutegravir 

>  <MW>  (666) 
419.384

>  <logP>  (666) 
1.3528

$$$$
CHEMBL1144
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 18 30  1  0
 30  8  1  0
 30 13  1  0
M  END
>  <PARENT_MOLREGNO>  (667) 
178796

>  <SYNONYMS>  (667) 
Pravastatin (BAN, INN); Pravastatin sodium (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (667) 
4

>  <RESEARCH_CODES>  (667) 
CS-514; SQ-31000

>  <APPLICANTS>  (667) 
Bristol Myers Squibb Co; Bristol Myers Squibb

>  <USAN_STEM>  (667) 
-stat-

>  <USAN_STEM_DEFINITION>  (667) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (667) 
-stat- (-vastatin)

>  <USAN_YEAR>  (667) 
1988.0

>  <FIRST_APPROVAL>  (667) 
1991.0

>  <ATC_CODE>  (667) 
C10AA03

>  <ATC_CODE_DESCRIPTION>  (667) 
C10AA03 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (667) 
Antihyperlipidemic

>  <SC_PATENT_NO>  (667) 
nan

>  <DRUG_TYPE>  (667) 
Natural Product-derived

>  <RULE_OF_FIVE>  (667) 
Y

>  <FIRST_IN_CLASS>  (667) 
N

>  <CHIRALITY>  (667) 
Single Stereoisomer

>  <PRODRUG>  (667) 
N

>  <ORAL>  (667) 
Y

>  <PARENTERAL>  (667) 
N

>  <TOPICAL>  (667) 
N

>  <BLACK_BOX>  (667) 
N

>  <AVAILABILITY_TYPE>  (667) 
Prescription-only

>  <WITHDRAWN_YEAR>  (667) 
nan

>  <WITHDRAWN_COUNTRY>  (667) 
nan

>  <WITHDRAWN_REASON>  (667) 
nan

>  <CANONICAL_SMILES>  (667) 
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@@H]12

>  <name>  (667) 
Pravastatin 

>  <MW>  (667) 
424.534

>  <logP>  (667) 
2.4404

$$$$
CHEMBL58323
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  4  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (668) 
88739

>  <SYNONYMS>  (668) 
Erlosamide (INN); Lacosamide (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (668) 
4

>  <RESEARCH_CODES>  (668) 
ADD-243037; SPM-927

>  <APPLICANTS>  (668) 
Ucb Inc

>  <USAN_STEM>  (668) 
nan

>  <USAN_STEM_DEFINITION>  (668) 
nan

>  <USAN_STEM_SUBSTEM>  (668) 
nan

>  <USAN_YEAR>  (668) 
nan

>  <FIRST_APPROVAL>  (668) 
2008.0

>  <ATC_CODE>  (668) 
N03AX18

>  <ATC_CODE_DESCRIPTION>  (668) 
N03AX18 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (668) 
nan

>  <SC_PATENT_NO>  (668) 
US-RE38551-E1

>  <DRUG_TYPE>  (668) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (668) 
Y

>  <FIRST_IN_CLASS>  (668) 
N

>  <CHIRALITY>  (668) 
Single Stereoisomer

>  <PRODRUG>  (668) 
N

>  <ORAL>  (668) 
Y

>  <PARENTERAL>  (668) 
Y

>  <TOPICAL>  (668) 
N

>  <BLACK_BOX>  (668) 
N

>  <AVAILABILITY_TYPE>  (668) 
Prescription-only

>  <WITHDRAWN_YEAR>  (668) 
nan

>  <WITHDRAWN_COUNTRY>  (668) 
nan

>  <WITHDRAWN_REASON>  (668) 
nan

>  <CANONICAL_SMILES>  (668) 
COC[C@@H](NC(=O)C)C(=O)NCc1ccccc1

>  <name>  (668) 
Erlosamide 

>  <MW>  (668) 
250.298

>  <logP>  (668) 
0.4539

$$$$
CHEMBL830
     RDKit          

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  5 10  1  0
 10 11  2  0
 10 12  1  0
M  END
>  <PARENT_MOLREGNO>  (669) 
58841

>  <SYNONYMS>  (669) 
Eflornithine (BAN, INN); Eflornithine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (669) 
4

>  <RESEARCH_CODES>  (669) 
MDL-71782A

>  <APPLICANTS>  (669) 
Skinmedica Inc; Sanofi Aventis Us Llc

>  <USAN_STEM>  (669) 
nan

>  <USAN_STEM_DEFINITION>  (669) 
nan

>  <USAN_STEM_SUBSTEM>  (669) 
nan

>  <USAN_YEAR>  (669) 
1986.0

>  <FIRST_APPROVAL>  (669) 
1990.0

>  <ATC_CODE>  (669) 
P01CX03; D11AX16

>  <ATC_CODE_DESCRIPTION>  (669) 
P01CX03 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Leishmaniasis And Trypanosomiasis:Other agents against leishmaniasis and trypanosomiasis]; D11AX16 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (669) 
Antineoplastic; Antiprotozoal

>  <SC_PATENT_NO>  (669) 
nan

>  <DRUG_TYPE>  (669) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (669) 
Y

>  <FIRST_IN_CLASS>  (669) 
N

>  <CHIRALITY>  (669) 
Racemic Mixture

>  <PRODRUG>  (669) 
N

>  <ORAL>  (669) 
N

>  <PARENTERAL>  (669) 
Y

>  <TOPICAL>  (669) 
Y

>  <BLACK_BOX>  (669) 
N

>  <AVAILABILITY_TYPE>  (669) 
Prescription-only

>  <WITHDRAWN_YEAR>  (669) 
nan

>  <WITHDRAWN_COUNTRY>  (669) 
nan

>  <WITHDRAWN_REASON>  (669) 
nan

>  <CANONICAL_SMILES>  (669) 
NCCCC(N)(C(F)F)C(=O)O

>  <name>  (669) 
Eflornithine 

>  <MW>  (669) 
182.17

>  <logP>  (669) 
-0.2275

$$$$
CHEMBL427
     RDKit          

  8  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  7  8  1  0
M  END
>  <PARENT_MOLREGNO>  (670) 
1470

>  <SYNONYMS>  (670) 
Chlormethine (INN, BAN); Mechlorethamine HCl (FDA, USP); Nitrogen Mustard N-Oxide HCl (JAN)

>  <DEVELOPMENT_PHASE>  (670) 
4

>  <RESEARCH_CODES>  (670) 
nan

>  <APPLICANTS>  (670) 
Lundbeck Inc

>  <USAN_STEM>  (670) 
nan

>  <USAN_STEM_DEFINITION>  (670) 
nan

>  <USAN_STEM_SUBSTEM>  (670) 
nan

>  <USAN_YEAR>  (670) 
nan

>  <FIRST_APPROVAL>  (670) 
1949.0

>  <ATC_CODE>  (670) 
L01AA05

>  <ATC_CODE_DESCRIPTION>  (670) 
L01AA05 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrogen mustard analogues]

>  <INDICATION_CLASS>  (670) 
Antineoplastic

>  <SC_PATENT_NO>  (670) 
US-7838564-B2

>  <DRUG_TYPE>  (670) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (670) 
Y

>  <FIRST_IN_CLASS>  (670) 
N

>  <CHIRALITY>  (670) 
Achiral Molecule

>  <PRODRUG>  (670) 
N

>  <ORAL>  (670) 
N

>  <PARENTERAL>  (670) 
Y

>  <TOPICAL>  (670) 
Y

>  <BLACK_BOX>  (670) 
Y

>  <AVAILABILITY_TYPE>  (670) 
Prescription-only

>  <WITHDRAWN_YEAR>  (670) 
nan

>  <WITHDRAWN_COUNTRY>  (670) 
nan

>  <WITHDRAWN_REASON>  (670) 
nan

>  <CANONICAL_SMILES>  (670) 
CN(CCCl)CCCl

>  <name>  (670) 
Chlormethine 

>  <MW>  (670) 
156.056

>  <logP>  (670) 
1.3958

$$$$
CHEMBL1193
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  6 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12  7  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (671) 
208661

>  <SYNONYMS>  (671) 
Pheniramine (BAN, INN); Pheniramine maleate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (671) 
4

>  <RESEARCH_CODES>  (671) 
nan

>  <APPLICANTS>  (671) 
Johnson And Johnson Group Consumer Companies; Bausch And Lomb Inc; Alcon Laboratories Inc

>  <USAN_STEM>  (671) 
nan

>  <USAN_STEM_DEFINITION>  (671) 
nan

>  <USAN_STEM_SUBSTEM>  (671) 
nan

>  <USAN_YEAR>  (671) 
1988.0

>  <FIRST_APPROVAL>  (671) 
1994.0

>  <ATC_CODE>  (671) 
R06AB05; D04AA16

>  <ATC_CODE_DESCRIPTION>  (671) 
R06AB05 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]; D04AA16 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]

>  <INDICATION_CLASS>  (671) 
nan

>  <SC_PATENT_NO>  (671) 
nan

>  <DRUG_TYPE>  (671) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (671) 
Y

>  <FIRST_IN_CLASS>  (671) 
N

>  <CHIRALITY>  (671) 
Racemic Mixture

>  <PRODRUG>  (671) 
N

>  <ORAL>  (671) 
N

>  <PARENTERAL>  (671) 
N

>  <TOPICAL>  (671) 
Y

>  <BLACK_BOX>  (671) 
N

>  <AVAILABILITY_TYPE>  (671) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (671) 
nan

>  <WITHDRAWN_COUNTRY>  (671) 
nan

>  <WITHDRAWN_REASON>  (671) 
nan

>  <CANONICAL_SMILES>  (671) 
CN(C)CCC(c1ccccc1)c2ccccn2

>  <name>  (671) 
Pheniramine 

>  <MW>  (671) 
240.35

>  <logP>  (671) 
3.1652

$$$$
CHEMBL1201203
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  6  2  1  0
  9  3  1  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (672) 
675154

>  <SYNONYMS>  (672) 
Benzatropine (INN, BAN); Benztropine (BAN); Benztropine Mesilate (JAN); Benztropine Mesylate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (672) 
4

>  <RESEARCH_CODES>  (672) 
nan

>  <APPLICANTS>  (672) 
Oak Pharmaceuticals Inc Sub Akorn Inc; Merck And Co Inc

>  <USAN_STEM>  (672) 
-trop-

>  <USAN_STEM_DEFINITION>  (672) 
atropine derivatives

>  <USAN_STEM_SUBSTEM>  (672) 
-trop-

>  <USAN_YEAR>  (672) 
nan

>  <FIRST_APPROVAL>  (672) 
1954.0

>  <ATC_CODE>  (672) 
N04AC01

>  <ATC_CODE_DESCRIPTION>  (672) 
N04AC01 [Nervous System:Anti-Parkinson Drugs:Anticholinergic Agents:Ethers of tropine or tropine derivatives]

>  <INDICATION_CLASS>  (672) 
Antiparkinsonian

>  <SC_PATENT_NO>  (672) 
nan

>  <DRUG_TYPE>  (672) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (672) 
Y

>  <FIRST_IN_CLASS>  (672) 
N

>  <CHIRALITY>  (672) 
Single Stereoisomer

>  <PRODRUG>  (672) 
N

>  <ORAL>  (672) 
Y

>  <PARENTERAL>  (672) 
Y

>  <TOPICAL>  (672) 
N

>  <BLACK_BOX>  (672) 
N

>  <AVAILABILITY_TYPE>  (672) 
Prescription-only

>  <WITHDRAWN_YEAR>  (672) 
nan

>  <WITHDRAWN_COUNTRY>  (672) 
nan

>  <WITHDRAWN_REASON>  (672) 
nan

>  <CANONICAL_SMILES>  (672) 
CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c3ccccc3)c4ccccc4

>  <name>  (672) 
Benzatropine 

>  <MW>  (672) 
307.437

>  <logP>  (672) 
4.4178

$$$$
CHEMBL1110
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
  6  2  2  0
 13  8  1  0
 21 11  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (673) 
153342

>  <SYNONYMS>  (673) 
Alosetron (BAN, INN); Alosetron HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (673) 
4

>  <RESEARCH_CODES>  (673) 
GR-68755C

>  <APPLICANTS>  (673) 
Prometheus Laboratories Inc

>  <USAN_STEM>  (673) 
-setron

>  <USAN_STEM_DEFINITION>  (673) 
serotonin 5-HT3 antagonists

>  <USAN_STEM_SUBSTEM>  (673) 
-setron

>  <USAN_YEAR>  (673) 
1992.0

>  <FIRST_APPROVAL>  (673) 
2000.0

>  <ATC_CODE>  (673) 
A03AE01

>  <ATC_CODE_DESCRIPTION>  (673) 
A03AE01 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Serotonin receptor antagonists]

>  <INDICATION_CLASS>  (673) 
Anti-Emetic

>  <SC_PATENT_NO>  (673) 
US-6284770-B1

>  <DRUG_TYPE>  (673) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (673) 
Y

>  <FIRST_IN_CLASS>  (673) 
N

>  <CHIRALITY>  (673) 
Achiral Molecule

>  <PRODRUG>  (673) 
N

>  <ORAL>  (673) 
Y

>  <PARENTERAL>  (673) 
N

>  <TOPICAL>  (673) 
N

>  <BLACK_BOX>  (673) 
Y

>  <AVAILABILITY_TYPE>  (673) 
Prescription-only

>  <WITHDRAWN_YEAR>  (673) 
nan

>  <WITHDRAWN_COUNTRY>  (673) 
nan

>  <WITHDRAWN_REASON>  (673) 
nan

>  <CANONICAL_SMILES>  (673) 
Cc1[nH]cnc1CN2CCc3c(C2=O)c4ccccc4n3C

>  <name>  (673) 
Alosetron 

>  <MW>  (673) 
294.358

>  <logP>  (673) 
2.40832

$$$$
CHEMBL626
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  2 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 11  6  1  0
 22 13  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (674) 
26722

>  <SYNONYMS>  (674) 
Naftifine (BAN, INN); Naftifine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (674) 
4

>  <RESEARCH_CODES>  (674) 
AW-105843; AW-105-843

>  <APPLICANTS>  (674) 
Merz Pharmaceuticals Llc

>  <USAN_STEM>  (674) 
nan

>  <USAN_STEM_DEFINITION>  (674) 
nan

>  <USAN_STEM_SUBSTEM>  (674) 
nan

>  <USAN_YEAR>  (674) 
1981.0

>  <FIRST_APPROVAL>  (674) 
1988.0

>  <ATC_CODE>  (674) 
D01AE22

>  <ATC_CODE_DESCRIPTION>  (674) 
D01AE22 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (674) 
Antifungal

>  <SC_PATENT_NO>  (674) 
US-8778365-B1

>  <DRUG_TYPE>  (674) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (674) 
Y

>  <FIRST_IN_CLASS>  (674) 
N

>  <CHIRALITY>  (674) 
Achiral Molecule

>  <PRODRUG>  (674) 
N

>  <ORAL>  (674) 
N

>  <PARENTERAL>  (674) 
N

>  <TOPICAL>  (674) 
Y

>  <BLACK_BOX>  (674) 
N

>  <AVAILABILITY_TYPE>  (674) 
Prescription-only

>  <WITHDRAWN_YEAR>  (674) 
nan

>  <WITHDRAWN_COUNTRY>  (674) 
nan

>  <WITHDRAWN_REASON>  (674) 
nan

>  <CANONICAL_SMILES>  (674) 
CN(C\C=C\c1ccccc1)Cc2cccc3ccccc23

>  <name>  (674) 
Naftifine 

>  <MW>  (674) 
287.406

>  <logP>  (674) 
4.985

$$$$
CHEMBL979
     RDKit          

 15 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
M  END
>  <PARENT_MOLREGNO>  (675) 
99389

>  <SYNONYMS>  (675) 
Meprobamate (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (675) 
4

>  <RESEARCH_CODES>  (675) 
nan

>  <APPLICANTS>  (675) 
Heather Drug Co Inc; Halsey Drug Co Inc; Elkins Sinn Div Ah Robins Co Inc; Caraco Pharmaceutical Laboratories Ltd; Impax Laboratories Inc

>  <USAN_STEM>  (675) 
-bamate

>  <USAN_STEM_DEFINITION>  (675) 
tranquilizers/antiepileptics (propanediol and pentanediol groups

>  <USAN_STEM_SUBSTEM>  (675) 
-bamate

>  <USAN_YEAR>  (675) 
nan

>  <FIRST_APPROVAL>  (675) 
1955.0

>  <ATC_CODE>  (675) 
N05CX01; N05BC01; N05BC51

>  <ATC_CODE_DESCRIPTION>  (675) 
N05CX01 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Hypnotics and sedatives in combination, excl. barbiturates]; N05BC01 [Nervous System:Psycholeptics:Anxiolytics:Carbamates]; N05BC51 [Nervous System:Psycholeptics:Anxiolytics:Carbamates]

>  <INDICATION_CLASS>  (675) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (675) 
nan

>  <DRUG_TYPE>  (675) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (675) 
Y

>  <FIRST_IN_CLASS>  (675) 
N

>  <CHIRALITY>  (675) 
Achiral Molecule

>  <PRODRUG>  (675) 
N

>  <ORAL>  (675) 
Y

>  <PARENTERAL>  (675) 
N

>  <TOPICAL>  (675) 
N

>  <BLACK_BOX>  (675) 
N

>  <AVAILABILITY_TYPE>  (675) 
Prescription-only

>  <WITHDRAWN_YEAR>  (675) 
nan

>  <WITHDRAWN_COUNTRY>  (675) 
nan

>  <WITHDRAWN_REASON>  (675) 
nan

>  <CANONICAL_SMILES>  (675) 
CCCC(C)(COC(=O)N)COC(=O)N

>  <name>  (675) 
Meprobamate 

>  <MW>  (675) 
218.253

>  <logP>  (675) 
0.9834

$$$$
CHEMBL1184360
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 14 18  1  0
 18 19  1  0
 18 20  1  0
 17  9  1  0
 16 12  1  0
M  END
>  <PARENT_MOLREGNO>  (676) 
658310

>  <SYNONYMS>  (676) 
Diamthazole (BAN, MI); Dimazole (INN)

>  <DEVELOPMENT_PHASE>  (676) 
4

>  <RESEARCH_CODES>  (676) 
nan

>  <APPLICANTS>  (676) 
Hoffmann-Laroche

>  <USAN_STEM>  (676) 
nan

>  <USAN_STEM_DEFINITION>  (676) 
nan

>  <USAN_STEM_SUBSTEM>  (676) 
nan

>  <USAN_YEAR>  (676) 
nan

>  <FIRST_APPROVAL>  (676) 
nan

>  <ATC_CODE>  (676) 
D01AE17

>  <ATC_CODE_DESCRIPTION>  (676) 
D01AE17 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (676) 
nan

>  <SC_PATENT_NO>  (676) 
nan

>  <DRUG_TYPE>  (676) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (676) 
Y

>  <FIRST_IN_CLASS>  (676) 
N

>  <CHIRALITY>  (676) 
Achiral Molecule

>  <PRODRUG>  (676) 
N

>  <ORAL>  (676) 
N

>  <PARENTERAL>  (676) 
N

>  <TOPICAL>  (676) 
N

>  <BLACK_BOX>  (676) 
N

>  <AVAILABILITY_TYPE>  (676) 
Withdrawn

>  <WITHDRAWN_YEAR>  (676) 
1972.0

>  <WITHDRAWN_COUNTRY>  (676) 
France; United States

>  <WITHDRAWN_REASON>  (676) 
Neuropsychiatric Reaction

>  <CANONICAL_SMILES>  (676) 
CCN(CC)CCOc1ccc2nc(sc2c1)N(C)C

>  <name>  (676) 
Diamthazole 

>  <MW>  (676) 
293.436

>  <logP>  (676) 
3.0829

$$$$
CHEMBL539
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
M  END
>  <PARENT_MOLREGNO>  (677) 
13342

>  <SYNONYMS>  (677) 
Acetic Acid (JAN, NF); Acetic acid, glacial (FDA, JAN)

>  <DEVELOPMENT_PHASE>  (677) 
4

>  <RESEARCH_CODES>  (677) 
nan

>  <APPLICANTS>  (677) 
Hi Tech Pharmacal Co Inc; Bayer Pharmaceuticals Corp; Baxter Healthcare Corp; B Braun Medical Inc; Hospira Inc

>  <USAN_STEM>  (677) 
nan

>  <USAN_STEM_DEFINITION>  (677) 
nan

>  <USAN_STEM_SUBSTEM>  (677) 
nan

>  <USAN_YEAR>  (677) 
nan

>  <FIRST_APPROVAL>  (677) 
nan

>  <ATC_CODE>  (677) 
S02AA10; G01AD02

>  <ATC_CODE_DESCRIPTION>  (677) 
S02AA10 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]; G01AD02 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Organic acids]

>  <INDICATION_CLASS>  (677) 
Pharmaceutic Aid (acidifying agent)

>  <SC_PATENT_NO>  (677) 
nan

>  <DRUG_TYPE>  (677) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (677) 
Y

>  <FIRST_IN_CLASS>  (677) 
N

>  <CHIRALITY>  (677) 
Achiral Molecule

>  <PRODRUG>  (677) 
N

>  <ORAL>  (677) 
N

>  <PARENTERAL>  (677) 
N

>  <TOPICAL>  (677) 
Y

>  <BLACK_BOX>  (677) 
N

>  <AVAILABILITY_TYPE>  (677) 
Prescription-only

>  <WITHDRAWN_YEAR>  (677) 
nan

>  <WITHDRAWN_COUNTRY>  (677) 
nan

>  <WITHDRAWN_REASON>  (677) 
nan

>  <CANONICAL_SMILES>  (677) 
CC(=O)O

>  <name>  (677) 
Acetic Acid 

>  <MW>  (677) 
60.052

>  <logP>  (677) 
0.0909

$$$$
CHEMBL1239
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 10  5  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (678) 
230966

>  <SYNONYMS>  (678) 
Benzyl benzoate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (678) 
4

>  <RESEARCH_CODES>  (678) 
nan

>  <APPLICANTS>  (678) 
Lannett Co Inc

>  <USAN_STEM>  (678) 
nan

>  <USAN_STEM_DEFINITION>  (678) 
nan

>  <USAN_STEM_SUBSTEM>  (678) 
nan

>  <USAN_YEAR>  (678) 
nan

>  <FIRST_APPROVAL>  (678) 
1976.0

>  <ATC_CODE>  (678) 
P03AX01

>  <ATC_CODE_DESCRIPTION>  (678) 
P03AX01 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides:Other ectoparasiticides, incl. scabicides]

>  <INDICATION_CLASS>  (678) 
nan

>  <SC_PATENT_NO>  (678) 
nan

>  <DRUG_TYPE>  (678) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (678) 
Y

>  <FIRST_IN_CLASS>  (678) 
N

>  <CHIRALITY>  (678) 
Achiral Molecule

>  <PRODRUG>  (678) 
N

>  <ORAL>  (678) 
N

>  <PARENTERAL>  (678) 
N

>  <TOPICAL>  (678) 
Y

>  <BLACK_BOX>  (678) 
N

>  <AVAILABILITY_TYPE>  (678) 
Discontinued

>  <WITHDRAWN_YEAR>  (678) 
nan

>  <WITHDRAWN_COUNTRY>  (678) 
nan

>  <WITHDRAWN_REASON>  (678) 
nan

>  <CANONICAL_SMILES>  (678) 
O=C(OCc1ccccc1)c2ccccc2

>  <name>  (678) 
Benzyl benzoate 

>  <MW>  (678) 
212.248

>  <logP>  (678) 
3.0436

$$$$
CHEMBL420
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (679) 
1202

>  <SYNONYMS>  (679) 
Guanabenz (INN, USAN); Guanabenz Acetate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (679) 
4

>  <RESEARCH_CODES>  (679) 
WY-8678; WY-8678 Acetate

>  <APPLICANTS>  (679) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (679) 
guan-

>  <USAN_STEM_DEFINITION>  (679) 
antihypertensives (guanidine derivatives)

>  <USAN_STEM_SUBSTEM>  (679) 
guan-

>  <USAN_YEAR>  (679) 
1971.0

>  <FIRST_APPROVAL>  (679) 
1982.0

>  <ATC_CODE>  (679) 
nan

>  <ATC_CODE_DESCRIPTION>  (679) 
nan

>  <INDICATION_CLASS>  (679) 
Antihypertensive

>  <SC_PATENT_NO>  (679) 
nan

>  <DRUG_TYPE>  (679) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (679) 
Y

>  <FIRST_IN_CLASS>  (679) 
N

>  <CHIRALITY>  (679) 
Achiral Molecule

>  <PRODRUG>  (679) 
N

>  <ORAL>  (679) 
Y

>  <PARENTERAL>  (679) 
N

>  <TOPICAL>  (679) 
N

>  <BLACK_BOX>  (679) 
N

>  <AVAILABILITY_TYPE>  (679) 
Prescription-only

>  <WITHDRAWN_YEAR>  (679) 
nan

>  <WITHDRAWN_COUNTRY>  (679) 
nan

>  <WITHDRAWN_REASON>  (679) 
nan

>  <CANONICAL_SMILES>  (679) 
NC(=N)N\N=C\c1c(Cl)cccc1Cl

>  <name>  (679) 
Guanabenz 

>  <MW>  (679) 
231.086

>  <logP>  (679) 
1.81037

$$$$
CHEMBL1064
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 19 30  1  0
 30  9  1  0
 30 14  1  0
 29 22  1  0
M  END
>  <PARENT_MOLREGNO>  (680) 
138562

>  <SYNONYMS>  (680) 
Simvastatin (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (680) 
4

>  <RESEARCH_CODES>  (680) 
MK-733

>  <APPLICANTS>  (680) 
Msd International Gmbh; Merck Sharp And Dohme Corp; Merck Research Laboratories Div Merck Co Inc; Abbvie Inc; Synthon Pharmaceuticals Ltd

>  <USAN_STEM>  (680) 
-stat-

>  <USAN_STEM_DEFINITION>  (680) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (680) 
-stat- (-vastatin)

>  <USAN_YEAR>  (680) 
1987.0

>  <FIRST_APPROVAL>  (680) 
1991.0

>  <ATC_CODE>  (680) 
C10AA01

>  <ATC_CODE_DESCRIPTION>  (680) 
C10AA01 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (680) 
Antihyperlipidemic

>  <SC_PATENT_NO>  (680) 
US-6080428-A

>  <DRUG_TYPE>  (680) 
Natural Product-derived

>  <RULE_OF_FIVE>  (680) 
Y

>  <FIRST_IN_CLASS>  (680) 
N

>  <CHIRALITY>  (680) 
Single Stereoisomer

>  <PRODRUG>  (680) 
Y

>  <ORAL>  (680) 
Y

>  <PARENTERAL>  (680) 
N

>  <TOPICAL>  (680) 
N

>  <BLACK_BOX>  (680) 
Y

>  <AVAILABILITY_TYPE>  (680) 
Prescription-only

>  <WITHDRAWN_YEAR>  (680) 
nan

>  <WITHDRAWN_COUNTRY>  (680) 
nan

>  <WITHDRAWN_REASON>  (680) 
nan

>  <CANONICAL_SMILES>  (680) 
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12

>  <name>  (680) 
Simvastatin 

>  <MW>  (680) 
418.574

>  <logP>  (680) 
4.5856

$$$$
CHEMBL1505
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 12 22  1  0
 22 23  2  0
 23  6  1  0
 23  9  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (681) 
420985

>  <SYNONYMS>  (681) 
Almotriptan (BAN, INN, USAN); Almotriptan Malate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (681) 
4

>  <RESEARCH_CODES>  (681) 
LAS-31416; LAS-31416 D,L-Malate acid; PNU-180638E

>  <APPLICANTS>  (681) 
Janssen Pharmaceuticals Inc; Grupo Farmacutico Almirall S.A., Spain

>  <USAN_STEM>  (681) 
-triptan

>  <USAN_STEM_DEFINITION>  (681) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (681) 
-triptan

>  <USAN_YEAR>  (681) 
1997.0

>  <FIRST_APPROVAL>  (681) 
2001.0

>  <ATC_CODE>  (681) 
N02CC05

>  <ATC_CODE_DESCRIPTION>  (681) 
N02CC05 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (681) 
Antimigraine

>  <SC_PATENT_NO>  (681) 
US-5565447-A

>  <DRUG_TYPE>  (681) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (681) 
Y

>  <FIRST_IN_CLASS>  (681) 
N

>  <CHIRALITY>  (681) 
Achiral Molecule

>  <PRODRUG>  (681) 
N

>  <ORAL>  (681) 
Y

>  <PARENTERAL>  (681) 
N

>  <TOPICAL>  (681) 
N

>  <BLACK_BOX>  (681) 
N

>  <AVAILABILITY_TYPE>  (681) 
Prescription-only

>  <WITHDRAWN_YEAR>  (681) 
nan

>  <WITHDRAWN_COUNTRY>  (681) 
nan

>  <WITHDRAWN_REASON>  (681) 
nan

>  <CANONICAL_SMILES>  (681) 
CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12

>  <name>  (681) 
Almotriptan 

>  <MW>  (681) 
335.473

>  <logP>  (681) 
2.1976

$$$$
CHEMBL1576
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5 11  1  0
 11 12  3  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (682) 
453538

>  <SYNONYMS>  (682) 
Ethinamate (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (682) 
4

>  <RESEARCH_CODES>  (682) 
nan

>  <APPLICANTS>  (682) 
Dista Products Co Div Eli Lilly And Co

>  <USAN_STEM>  (682) 
nan

>  <USAN_STEM_DEFINITION>  (682) 
nan

>  <USAN_STEM_SUBSTEM>  (682) 
nan

>  <USAN_YEAR>  (682) 
nan

>  <FIRST_APPROVAL>  (682) 
1982.0

>  <ATC_CODE>  (682) 
nan

>  <ATC_CODE_DESCRIPTION>  (682) 
nan

>  <INDICATION_CLASS>  (682) 
nan

>  <SC_PATENT_NO>  (682) 
nan

>  <DRUG_TYPE>  (682) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (682) 
Y

>  <FIRST_IN_CLASS>  (682) 
N

>  <CHIRALITY>  (682) 
Achiral Molecule

>  <PRODRUG>  (682) 
N

>  <ORAL>  (682) 
Y

>  <PARENTERAL>  (682) 
N

>  <TOPICAL>  (682) 
N

>  <BLACK_BOX>  (682) 
N

>  <AVAILABILITY_TYPE>  (682) 
Discontinued

>  <WITHDRAWN_YEAR>  (682) 
nan

>  <WITHDRAWN_COUNTRY>  (682) 
nan

>  <WITHDRAWN_REASON>  (682) 
nan

>  <CANONICAL_SMILES>  (682) 
NC(=O)OC1(CCCCC1)C#C

>  <name>  (682) 
Ethinamate 

>  <MW>  (682) 
167.208

>  <logP>  (682) 
1.4178

$$$$
CHEMBL117785
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 10 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 21  3  1  0
 19  5  2  0
 18  8  1  0
M  END
>  <PARENT_MOLREGNO>  (683) 
193281

>  <SYNONYMS>  (683) 
Tetrabenazine (BAN, FDA, INN, MI); Dutetrabenazine (USAN)

>  <DEVELOPMENT_PHASE>  (683) 
4

>  <RESEARCH_CODES>  (683) 
Ro-19569; SD-809

>  <APPLICANTS>  (683) 
Valeant International Bermuda; Auspex Pharmaceuticals, Inc.

>  <USAN_STEM>  (683) 
nan

>  <USAN_STEM_DEFINITION>  (683) 
nan

>  <USAN_STEM_SUBSTEM>  (683) 
nan

>  <USAN_YEAR>  (683) 
2014.0

>  <FIRST_APPROVAL>  (683) 
2008.0

>  <ATC_CODE>  (683) 
N07XX06

>  <ATC_CODE_DESCRIPTION>  (683) 
N07XX06 [Nervous System:Other Nervous System Drugs:Other Nervous System Drugs:Other nervous system drugs]

>  <INDICATION_CLASS>  (683) 
nan

>  <SC_PATENT_NO>  (683) 
nan

>  <DRUG_TYPE>  (683) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (683) 
Y

>  <FIRST_IN_CLASS>  (683) 
N

>  <CHIRALITY>  (683) 
Racemic Mixture

>  <PRODRUG>  (683) 
N

>  <ORAL>  (683) 
Y

>  <PARENTERAL>  (683) 
N

>  <TOPICAL>  (683) 
N

>  <BLACK_BOX>  (683) 
Y

>  <AVAILABILITY_TYPE>  (683) 
Prescription-only

>  <WITHDRAWN_YEAR>  (683) 
nan

>  <WITHDRAWN_COUNTRY>  (683) 
nan

>  <WITHDRAWN_REASON>  (683) 
nan

>  <CANONICAL_SMILES>  (683) 
COc1cc2CCN3CC(CC(C)C)C(=O)CC3c2cc1OC

>  <name>  (683) 
Tetrabenazine 

>  <MW>  (683) 
317.429

>  <logP>  (683) 
3.2381

$$$$
CHEMBL777
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
  4 11  1  0
 10  6  1  0
M  END
>  <PARENT_MOLREGNO>  (684) 
44876

>  <SYNONYMS>  (684) 
Clavulanic Acid (BAN, INN, MI); Clavulanate potassium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (684) 
4

>  <RESEARCH_CODES>  (684) 
BRL-14151; BRL-14151K

>  <APPLICANTS>  (684) 
GlaxoSmithKline; Dr Reddys Laboratories Inc

>  <USAN_STEM>  (684) 
nan

>  <USAN_STEM_DEFINITION>  (684) 
nan

>  <USAN_STEM_SUBSTEM>  (684) 
nan

>  <USAN_YEAR>  (684) 
1986.0

>  <FIRST_APPROVAL>  (684) 
1984.0

>  <ATC_CODE>  (684) 
nan

>  <ATC_CODE_DESCRIPTION>  (684) 
nan

>  <INDICATION_CLASS>  (684) 
Inhibitor (beta-lactamase)

>  <SC_PATENT_NO>  (684) 
US-6746692-B2

>  <DRUG_TYPE>  (684) 
Natural Product-derived

>  <RULE_OF_FIVE>  (684) 
Y

>  <FIRST_IN_CLASS>  (684) 
N

>  <CHIRALITY>  (684) 
Single Stereoisomer

>  <PRODRUG>  (684) 
N

>  <ORAL>  (684) 
Y

>  <PARENTERAL>  (684) 
Y

>  <TOPICAL>  (684) 
N

>  <BLACK_BOX>  (684) 
N

>  <AVAILABILITY_TYPE>  (684) 
Prescription-only

>  <WITHDRAWN_YEAR>  (684) 
nan

>  <WITHDRAWN_COUNTRY>  (684) 
nan

>  <WITHDRAWN_REASON>  (684) 
nan

>  <CANONICAL_SMILES>  (684) 
OC\C=C\1/O[C@@H]2CC(=O)N2[C@H]1C(=O)O

>  <name>  (684) 
Clavulanic Acid 

>  <MW>  (684) 
199.162

>  <logP>  (684) 
-1.0956

$$$$
CHEMBL477
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
  7  2  1  0
 10  6  1  0
 18 11  1  0
M  END
>  <PARENT_MOLREGNO>  (685) 
5797

>  <SYNONYMS>  (685) 
Adenosine (BAN, FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (685) 
4

>  <RESEARCH_CODES>  (685) 
SR-96225

>  <APPLICANTS>  (685) 
Astellas Pharma Us Inc

>  <USAN_STEM>  (685) 
nan

>  <USAN_STEM_DEFINITION>  (685) 
nan

>  <USAN_STEM_SUBSTEM>  (685) 
nan

>  <USAN_YEAR>  (685) 
1988.0

>  <FIRST_APPROVAL>  (685) 
1989.0

>  <ATC_CODE>  (685) 
C01EB10

>  <ATC_CODE_DESCRIPTION>  (685) 
C01EB10 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (685) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (685) 
nan

>  <DRUG_TYPE>  (685) 
Natural Product-derived

>  <RULE_OF_FIVE>  (685) 
Y

>  <FIRST_IN_CLASS>  (685) 
N

>  <CHIRALITY>  (685) 
Single Stereoisomer

>  <PRODRUG>  (685) 
N

>  <ORAL>  (685) 
N

>  <PARENTERAL>  (685) 
Y

>  <TOPICAL>  (685) 
N

>  <BLACK_BOX>  (685) 
N

>  <AVAILABILITY_TYPE>  (685) 
Prescription-only

>  <WITHDRAWN_YEAR>  (685) 
nan

>  <WITHDRAWN_COUNTRY>  (685) 
nan

>  <WITHDRAWN_REASON>  (685) 
nan

>  <CANONICAL_SMILES>  (685) 
Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O

>  <name>  (685) 
Adenosine 

>  <MW>  (685) 
267.245

>  <logP>  (685) 
-1.98

$$$$
CHEMBL252518
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 17  2  1  0
 18  5  1  0
 18 11  1  0
 20 13  1  0
M  END
>  <PARENT_MOLREGNO>  (686) 
420212

>  <SYNONYMS>  (686) 
Artenimol (INN)

>  <DEVELOPMENT_PHASE>  (686) 
4

>  <RESEARCH_CODES>  (686) 
GNF-Pf-5634

>  <APPLICANTS>  (686) 
nan

>  <USAN_STEM>  (686) 
arte-

>  <USAN_STEM_DEFINITION>  (686) 
antimalarials (artemisin dervatives)

>  <USAN_STEM_SUBSTEM>  (686) 
arte-

>  <USAN_YEAR>  (686) 
nan

>  <FIRST_APPROVAL>  (686) 
nan

>  <ATC_CODE>  (686) 
P01BE05

>  <ATC_CODE_DESCRIPTION>  (686) 
P01BE05 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Artemisinin and derivatives, plain]

>  <INDICATION_CLASS>  (686) 
nan

>  <SC_PATENT_NO>  (686) 
nan

>  <DRUG_TYPE>  (686) 
Natural Product-derived

>  <RULE_OF_FIVE>  (686) 
Y

>  <FIRST_IN_CLASS>  (686) 
N

>  <CHIRALITY>  (686) 
Single Stereoisomer

>  <PRODRUG>  (686) 
N

>  <ORAL>  (686) 
Y

>  <PARENTERAL>  (686) 
N

>  <TOPICAL>  (686) 
N

>  <BLACK_BOX>  (686) 
N

>  <AVAILABILITY_TYPE>  (686) 
Discontinued

>  <WITHDRAWN_YEAR>  (686) 
nan

>  <WITHDRAWN_COUNTRY>  (686) 
nan

>  <WITHDRAWN_REASON>  (686) 
nan

>  <CANONICAL_SMILES>  (686) 
C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4

>  <name>  (686) 
Artenimol 

>  <MW>  (686) 
284.352

>  <logP>  (686) 
2.1867

$$$$
CHEMBL3707255
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10  2  1  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (687) 
2039226

>  <SYNONYMS>  (687) 
Epomediol

>  <DEVELOPMENT_PHASE>  (687) 
4

>  <RESEARCH_CODES>  (687) 
nan

>  <APPLICANTS>  (687) 
nan

>  <USAN_STEM>  (687) 
nan

>  <USAN_STEM_DEFINITION>  (687) 
nan

>  <USAN_STEM_SUBSTEM>  (687) 
nan

>  <USAN_YEAR>  (687) 
nan

>  <FIRST_APPROVAL>  (687) 
nan

>  <ATC_CODE>  (687) 
A05BA05

>  <ATC_CODE_DESCRIPTION>  (687) 
A05BA05 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Liver Therapy, Lipotropics:Liver therapy]

>  <INDICATION_CLASS>  (687) 
nan

>  <SC_PATENT_NO>  (687) 
nan

>  <DRUG_TYPE>  (687) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (687) 
Y

>  <FIRST_IN_CLASS>  (687) 
N

>  <CHIRALITY>  (687) 
Racemic Mixture

>  <PRODRUG>  (687) 
N

>  <ORAL>  (687) 
N

>  <PARENTERAL>  (687) 
N

>  <TOPICAL>  (687) 
N

>  <BLACK_BOX>  (687) 
N

>  <AVAILABILITY_TYPE>  (687) 
Unknown

>  <WITHDRAWN_YEAR>  (687) 
nan

>  <WITHDRAWN_COUNTRY>  (687) 
nan

>  <WITHDRAWN_REASON>  (687) 
nan

>  <CANONICAL_SMILES>  (687) 
CC1(C)OC2(C)C(O)CC1CC2O

>  <name>  (687) 
Epomediol

>  <MW>  (687) 
186.251

>  <logP>  (687) 
0.6857

$$$$
CHEMBL3707258
     RDKit          

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  1  0
M  END
>  <PARENT_MOLREGNO>  (688) 
2039229

>  <SYNONYMS>  (688) 
Diiodohydroxypropane

>  <DEVELOPMENT_PHASE>  (688) 
4

>  <RESEARCH_CODES>  (688) 
nan

>  <APPLICANTS>  (688) 
nan

>  <USAN_STEM>  (688) 
nan

>  <USAN_STEM_DEFINITION>  (688) 
nan

>  <USAN_STEM_SUBSTEM>  (688) 
nan

>  <USAN_YEAR>  (688) 
nan

>  <FIRST_APPROVAL>  (688) 
nan

>  <ATC_CODE>  (688) 
D08AG04

>  <ATC_CODE_DESCRIPTION>  (688) 
D08AG04 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Iodine products]

>  <INDICATION_CLASS>  (688) 
nan

>  <SC_PATENT_NO>  (688) 
nan

>  <DRUG_TYPE>  (688) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (688) 
Y

>  <FIRST_IN_CLASS>  (688) 
N

>  <CHIRALITY>  (688) 
Achiral Molecule

>  <PRODRUG>  (688) 
N

>  <ORAL>  (688) 
N

>  <PARENTERAL>  (688) 
N

>  <TOPICAL>  (688) 
N

>  <BLACK_BOX>  (688) 
N

>  <AVAILABILITY_TYPE>  (688) 
Unknown

>  <WITHDRAWN_YEAR>  (688) 
nan

>  <WITHDRAWN_COUNTRY>  (688) 
nan

>  <WITHDRAWN_REASON>  (688) 
nan

>  <CANONICAL_SMILES>  (688) 
OC(CI)CI

>  <name>  (688) 
Diiodohydroxypropane

>  <MW>  (688) 
311.888

>  <logP>  (688) 
1.2173

$$$$
CHEMBL110691
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  5 26  1  0
 26 27  2  0
 26 28  1  0
 24  5  1  0
 24  8  1  0
 21  9  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (689) 
182928

>  <SYNONYMS>  (689) 
Chlormadinone (BAN, INN); Chlormadinone Acetate (JAN, NF, USAN)

>  <DEVELOPMENT_PHASE>  (689) 
4

>  <RESEARCH_CODES>  (689) 
nan

>  <APPLICANTS>  (689) 
Syntex

>  <USAN_STEM>  (689) 
nan

>  <USAN_STEM_DEFINITION>  (689) 
nan

>  <USAN_STEM_SUBSTEM>  (689) 
nan

>  <USAN_YEAR>  (689) 
1964.0

>  <FIRST_APPROVAL>  (689) 
nan

>  <ATC_CODE>  (689) 
G03DB06

>  <ATC_CODE_DESCRIPTION>  (689) 
G03DB06 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnadien derivatives]

>  <INDICATION_CLASS>  (689) 
Progestin

>  <SC_PATENT_NO>  (689) 
nan

>  <DRUG_TYPE>  (689) 
Natural Product-derived

>  <RULE_OF_FIVE>  (689) 
Y

>  <FIRST_IN_CLASS>  (689) 
N

>  <CHIRALITY>  (689) 
Single Stereoisomer

>  <PRODRUG>  (689) 
N

>  <ORAL>  (689) 
N

>  <PARENTERAL>  (689) 
N

>  <TOPICAL>  (689) 
N

>  <BLACK_BOX>  (689) 
N

>  <AVAILABILITY_TYPE>  (689) 
Withdrawn

>  <WITHDRAWN_YEAR>  (689) 
1970.0

>  <WITHDRAWN_COUNTRY>  (689) 
United Kingdom; United States

>  <WITHDRAWN_REASON>  (689) 
Animal carcinogenicity (dogs)

>  <CANONICAL_SMILES>  (689) 
CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)C

>  <name>  (689) 
Chlormadinone 

>  <MW>  (689) 
404.934

>  <logP>  (689) 
4.7517

$$$$
CHEMBL1111
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
  4 14  1  0
 14 15  2  0
 14 16  1  0
  3 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  3 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 13  6  1  0
 22 17  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (690) 
154051

>  <SYNONYMS>  (690) 
Ambrisentan (BAN, FDA, INN)

>  <DEVELOPMENT_PHASE>  (690) 
4

>  <RESEARCH_CODES>  (690) 
nan

>  <APPLICANTS>  (690) 
Gilead Sciences Inc

>  <USAN_STEM>  (690) 
-entan

>  <USAN_STEM_DEFINITION>  (690) 
endothelin receptor antagonists

>  <USAN_STEM_SUBSTEM>  (690) 
-entan

>  <USAN_YEAR>  (690) 
nan

>  <FIRST_APPROVAL>  (690) 
2007.0

>  <ATC_CODE>  (690) 
C02KX02

>  <ATC_CODE_DESCRIPTION>  (690) 
C02KX02 [Cardiovascular System:Antihypertensives:Other Antihypertensives:Other antihypertensives]

>  <INDICATION_CLASS>  (690) 
nan

>  <SC_PATENT_NO>  (690) 
US-5840722-A

>  <DRUG_TYPE>  (690) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (690) 
Y

>  <FIRST_IN_CLASS>  (690) 
N

>  <CHIRALITY>  (690) 
Single Stereoisomer

>  <PRODRUG>  (690) 
N

>  <ORAL>  (690) 
Y

>  <PARENTERAL>  (690) 
N

>  <TOPICAL>  (690) 
N

>  <BLACK_BOX>  (690) 
Y

>  <AVAILABILITY_TYPE>  (690) 
Prescription-only

>  <WITHDRAWN_YEAR>  (690) 
nan

>  <WITHDRAWN_COUNTRY>  (690) 
nan

>  <WITHDRAWN_REASON>  (690) 
nan

>  <CANONICAL_SMILES>  (690) 
COC([C@H](Oc1nc(C)cc(C)n1)C(=O)O)(c2ccccc2)c3ccccc3

>  <name>  (690) 
Ambrisentan 

>  <MW>  (690) 
378.428

>  <logP>  (690) 
3.51564

$$$$
CHEMBL2220442
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
  5 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 17 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30  4  1  0
 24 18  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (691) 
1450253

>  <SYNONYMS>  (691) 
Fluvastatin (BAN, INN); Fluvastatin Sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (691) 
4

>  <RESEARCH_CODES>  (691) 
XU-62320

>  <APPLICANTS>  (691) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (691) 
-stat-

>  <USAN_STEM_DEFINITION>  (691) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (691) 
-stat- (-vastatin)

>  <USAN_YEAR>  (691) 
1989.0

>  <FIRST_APPROVAL>  (691) 
1993.0

>  <ATC_CODE>  (691) 
C10AA04

>  <ATC_CODE_DESCRIPTION>  (691) 
C10AA04 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (691) 
Antihyperlipidemic; Inhibitor (HMG-CoA reductase)

>  <SC_PATENT_NO>  (691) 
nan

>  <DRUG_TYPE>  (691) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (691) 
Y

>  <FIRST_IN_CLASS>  (691) 
N

>  <CHIRALITY>  (691) 
Racemic Mixture

>  <PRODRUG>  (691) 
N

>  <ORAL>  (691) 
Y

>  <PARENTERAL>  (691) 
N

>  <TOPICAL>  (691) 
N

>  <BLACK_BOX>  (691) 
N

>  <AVAILABILITY_TYPE>  (691) 
Prescription-only

>  <WITHDRAWN_YEAR>  (691) 
nan

>  <WITHDRAWN_COUNTRY>  (691) 
nan

>  <WITHDRAWN_REASON>  (691) 
nan

>  <CANONICAL_SMILES>  (691) 
CC(C)n1c(\C=C\C(O)CC(O)CC(=O)O)c(c2ccc(F)cc2)c3ccccc13

>  <name>  (691) 
Fluvastatin 

>  <MW>  (691) 
411.473

>  <logP>  (691) 
4.6281

$$$$
CHEMBL1900528
     RDKit          

 26 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 15 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
  8  2  1  0
 11  4  1  0
 11  9  1  0
 21 17  1  0
 26 22  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (692) 
1241099

>  <SYNONYMS>  (692) 
Tiotropium Bromide (INN); Tiotropium Bromide Monohydrate (FDA)

>  <DEVELOPMENT_PHASE>  (692) 
4

>  <RESEARCH_CODES>  (692) 
BA-679-BR

>  <APPLICANTS>  (692) 
Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (692) 
-ium; -trop-

>  <USAN_STEM_DEFINITION>  (692) 
quaternary ammonium derivatives; atropine derivatives

>  <USAN_STEM_SUBSTEM>  (692) 
-ium; -trop-

>  <USAN_YEAR>  (692) 
nan

>  <FIRST_APPROVAL>  (692) 
2004.0

>  <ATC_CODE>  (692) 
R03BB04; R03BB54

>  <ATC_CODE_DESCRIPTION>  (692) 
R03BB04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Anticholinergics]; R03BB54 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Anticholinergics]

>  <INDICATION_CLASS>  (692) 
nan

>  <SC_PATENT_NO>  (692) 
US-5964416-A

>  <DRUG_TYPE>  (692) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (692) 
Y

>  <FIRST_IN_CLASS>  (692) 
N

>  <CHIRALITY>  (692) 
Single Stereoisomer

>  <PRODRUG>  (692) 
N

>  <ORAL>  (692) 
N

>  <PARENTERAL>  (692) 
N

>  <TOPICAL>  (692) 
Y

>  <BLACK_BOX>  (692) 
N

>  <AVAILABILITY_TYPE>  (692) 
Prescription-only

>  <WITHDRAWN_YEAR>  (692) 
nan

>  <WITHDRAWN_COUNTRY>  (692) 
nan

>  <WITHDRAWN_REASON>  (692) 
nan

>  <CANONICAL_SMILES>  (692) 
C[N+]1(C)[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)C(O)(c4cccs4)c5cccs5

>  <name>  (692) 
Tiotropium Bromide 

>  <MW>  (692) 
392.522

>  <logP>  (692) 
2.3457

$$$$
CHEMBL686
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
  6 17  2  0
 17 18  1  0
 17  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (693) 
29989

>  <SYNONYMS>  (693) 
Mefenamic acid (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (693) 
4

>  <RESEARCH_CODES>  (693) 
CI-473; CN-35355; INF-3355

>  <APPLICANTS>  (693) 
Shionogi Inc

>  <USAN_STEM>  (693) 
nan

>  <USAN_STEM_DEFINITION>  (693) 
nan

>  <USAN_STEM_SUBSTEM>  (693) 
nan

>  <USAN_YEAR>  (693) 
1962.0

>  <FIRST_APPROVAL>  (693) 
1967.0

>  <ATC_CODE>  (693) 
M01AG01

>  <ATC_CODE_DESCRIPTION>  (693) 
M01AG01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Fenamates]

>  <INDICATION_CLASS>  (693) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (693) 
nan

>  <DRUG_TYPE>  (693) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (693) 
Y

>  <FIRST_IN_CLASS>  (693) 
N

>  <CHIRALITY>  (693) 
Achiral Molecule

>  <PRODRUG>  (693) 
N

>  <ORAL>  (693) 
Y

>  <PARENTERAL>  (693) 
N

>  <TOPICAL>  (693) 
N

>  <BLACK_BOX>  (693) 
Y

>  <AVAILABILITY_TYPE>  (693) 
Prescription-only

>  <WITHDRAWN_YEAR>  (693) 
nan

>  <WITHDRAWN_COUNTRY>  (693) 
nan

>  <WITHDRAWN_REASON>  (693) 
nan

>  <CANONICAL_SMILES>  (693) 
Cc1cccc(Nc2ccccc2C(=O)O)c1C

>  <name>  (693) 
Mefenamic acid 

>  <MW>  (693) 
241.29

>  <logP>  (693) 
3.74524

$$$$
CHEMBL64
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (694) 
4941

>  <SYNONYMS>  (694) 
Isoniazid (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (694) 
4

>  <RESEARCH_CODES>  (694) 
nan

>  <APPLICANTS>  (694) 
Panray Corp Sub Ormont Drug And Chemical Co Inc; Hoffmann La Roche Inc; Eli Lilly And Co; Bristol Myers Squibb Co; Sandoz Inc

>  <USAN_STEM>  (694) 
nan

>  <USAN_STEM_DEFINITION>  (694) 
nan

>  <USAN_STEM_SUBSTEM>  (694) 
nan

>  <USAN_YEAR>  (694) 
nan

>  <FIRST_APPROVAL>  (694) 
1952.0

>  <ATC_CODE>  (694) 
J04AC51; J04AC01

>  <ATC_CODE_DESCRIPTION>  (694) 
J04AC51 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Hydrazides]; J04AC01 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Hydrazides]

>  <INDICATION_CLASS>  (694) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (694) 
nan

>  <DRUG_TYPE>  (694) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (694) 
Y

>  <FIRST_IN_CLASS>  (694) 
N

>  <CHIRALITY>  (694) 
Achiral Molecule

>  <PRODRUG>  (694) 
Y

>  <ORAL>  (694) 
Y

>  <PARENTERAL>  (694) 
Y

>  <TOPICAL>  (694) 
N

>  <BLACK_BOX>  (694) 
Y

>  <AVAILABILITY_TYPE>  (694) 
Prescription-only

>  <WITHDRAWN_YEAR>  (694) 
nan

>  <WITHDRAWN_COUNTRY>  (694) 
nan

>  <WITHDRAWN_REASON>  (694) 
nan

>  <CANONICAL_SMILES>  (694) 
NNC(=O)c1ccncc1

>  <name>  (694) 
Isoniazid 

>  <MW>  (694) 
137.142

>  <logP>  (694) 
-0.3149

$$$$
CHEMBL1071
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 16  6  2  0
 14  9  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (695) 
139225

>  <SYNONYMS>  (695) 
Oxaprozin (BAN, FDA, INN, JAN, USAN, USP); Oxaprozin Potassium (FDA)

>  <DEVELOPMENT_PHASE>  (695) 
4

>  <RESEARCH_CODES>  (695) 
WY-21743

>  <APPLICANTS>  (695) 
Gd Searle Llc

>  <USAN_STEM>  (695) 
nan

>  <USAN_STEM_DEFINITION>  (695) 
nan

>  <USAN_STEM_SUBSTEM>  (695) 
nan

>  <USAN_YEAR>  (695) 
1973.0

>  <FIRST_APPROVAL>  (695) 
1992.0

>  <ATC_CODE>  (695) 
M01AE12

>  <ATC_CODE_DESCRIPTION>  (695) 
M01AE12 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (695) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (695) 
nan

>  <DRUG_TYPE>  (695) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (695) 
Y

>  <FIRST_IN_CLASS>  (695) 
N

>  <CHIRALITY>  (695) 
Achiral Molecule

>  <PRODRUG>  (695) 
N

>  <ORAL>  (695) 
Y

>  <PARENTERAL>  (695) 
N

>  <TOPICAL>  (695) 
N

>  <BLACK_BOX>  (695) 
Y

>  <AVAILABILITY_TYPE>  (695) 
Prescription-only

>  <WITHDRAWN_YEAR>  (695) 
nan

>  <WITHDRAWN_COUNTRY>  (695) 
nan

>  <WITHDRAWN_REASON>  (695) 
nan

>  <CANONICAL_SMILES>  (695) 
OC(=O)CCc1oc(c2ccccc2)c(n1)c3ccccc3

>  <name>  (695) 
Oxaprozin 

>  <MW>  (695) 
293.322

>  <logP>  (695) 
4.0258

$$$$
CHEMBL3707346
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (696) 
2039317

>  <SYNONYMS>  (696) 
Fluoromethylcholine (18f)

>  <DEVELOPMENT_PHASE>  (696) 
4

>  <RESEARCH_CODES>  (696) 
nan

>  <APPLICANTS>  (696) 
nan

>  <USAN_STEM>  (696) 
nan

>  <USAN_STEM_DEFINITION>  (696) 
nan

>  <USAN_STEM_SUBSTEM>  (696) 
nan

>  <USAN_YEAR>  (696) 
nan

>  <FIRST_APPROVAL>  (696) 
nan

>  <ATC_CODE>  (696) 
V09IX07

>  <ATC_CODE_DESCRIPTION>  (696) 
V09IX07 [Various:Diagnostic Radiopharmaceuticals:Tumour Detection:Other diagnostic radiopharmaceuticals for tumour detection]

>  <INDICATION_CLASS>  (696) 
nan

>  <SC_PATENT_NO>  (696) 
nan

>  <DRUG_TYPE>  (696) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (696) 
Y

>  <FIRST_IN_CLASS>  (696) 
N

>  <CHIRALITY>  (696) 
Achiral Molecule

>  <PRODRUG>  (696) 
N

>  <ORAL>  (696) 
N

>  <PARENTERAL>  (696) 
N

>  <TOPICAL>  (696) 
N

>  <BLACK_BOX>  (696) 
N

>  <AVAILABILITY_TYPE>  (696) 
Unknown

>  <WITHDRAWN_YEAR>  (696) 
nan

>  <WITHDRAWN_COUNTRY>  (696) 
nan

>  <WITHDRAWN_REASON>  (696) 
nan

>  <CANONICAL_SMILES>  (696) 
C[N+](C)(C)CCOCF

>  <name>  (696) 
Fluoromethylcholine 

>  <MW>  (696) 
136.19

>  <logP>  (696) 
0.6362

$$$$
CHEMBL3707212
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22  4  1  0
 22  8  1  0
 19  9  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (697) 
2039183

>  <SYNONYMS>  (697) 
Gestonorone

>  <DEVELOPMENT_PHASE>  (697) 
4

>  <RESEARCH_CODES>  (697) 
nan

>  <APPLICANTS>  (697) 
nan

>  <USAN_STEM>  (697) 
nan

>  <USAN_STEM_DEFINITION>  (697) 
nan

>  <USAN_STEM_SUBSTEM>  (697) 
nan

>  <USAN_YEAR>  (697) 
nan

>  <FIRST_APPROVAL>  (697) 
nan

>  <ATC_CODE>  (697) 
G03DA01; L02AB03

>  <ATC_CODE_DESCRIPTION>  (697) 
G03DA01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnen (4) derivatives]; L02AB03 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormones And Related Agents:Progestogens]

>  <INDICATION_CLASS>  (697) 
nan

>  <SC_PATENT_NO>  (697) 
nan

>  <DRUG_TYPE>  (697) 
Natural Product-derived

>  <RULE_OF_FIVE>  (697) 
Y

>  <FIRST_IN_CLASS>  (697) 
N

>  <CHIRALITY>  (697) 
Single Stereoisomer

>  <PRODRUG>  (697) 
N

>  <ORAL>  (697) 
N

>  <PARENTERAL>  (697) 
N

>  <TOPICAL>  (697) 
N

>  <BLACK_BOX>  (697) 
N

>  <AVAILABILITY_TYPE>  (697) 
Unknown

>  <WITHDRAWN_YEAR>  (697) 
nan

>  <WITHDRAWN_COUNTRY>  (697) 
nan

>  <WITHDRAWN_REASON>  (697) 
nan

>  <CANONICAL_SMILES>  (697) 
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C

>  <name>  (697) 
Gestonorone

>  <MW>  (697) 
316.441

>  <logP>  (697) 
3.4483

$$$$
CHEMBL405
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (698) 
543

>  <SYNONYMS>  (698) 
Amfetamine (INN, BAN); Amphetamine (FDA); Amphetamine resin complex (FDA); Amphetamine Aspartate (FDA); Amphetamine sulfate (FDA, USP); Amphetamine Adipate (FDA)

>  <DEVELOPMENT_PHASE>  (698) 
4

>  <RESEARCH_CODES>  (698) 
nan

>  <APPLICANTS>  (698) 
Ucb Inc; Teva Womens Health Inc; Teva Pharmaceuticals Usa Inc; Shire Development Inc

>  <USAN_STEM>  (698) 
nan

>  <USAN_STEM_DEFINITION>  (698) 
nan

>  <USAN_STEM_SUBSTEM>  (698) 
nan

>  <USAN_YEAR>  (698) 
nan

>  <FIRST_APPROVAL>  (698) 
1955.0

>  <ATC_CODE>  (698) 
N06BA01

>  <ATC_CODE_DESCRIPTION>  (698) 
N06BA01 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (698) 
Stimulant (central)

>  <SC_PATENT_NO>  (698) 
US-6322819-B1

>  <DRUG_TYPE>  (698) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (698) 
Y

>  <FIRST_IN_CLASS>  (698) 
N

>  <CHIRALITY>  (698) 
Racemic Mixture

>  <PRODRUG>  (698) 
N

>  <ORAL>  (698) 
Y

>  <PARENTERAL>  (698) 
N

>  <TOPICAL>  (698) 
N

>  <BLACK_BOX>  (698) 
Y

>  <AVAILABILITY_TYPE>  (698) 
Prescription-only

>  <WITHDRAWN_YEAR>  (698) 
nan

>  <WITHDRAWN_COUNTRY>  (698) 
nan

>  <WITHDRAWN_REASON>  (698) 
nan

>  <CANONICAL_SMILES>  (698) 
CC(N)Cc1ccccc1

>  <name>  (698) 
Amfetamine 

>  <MW>  (698) 
135.21

>  <logP>  (698) 
1.5763

$$$$
CHEMBL1200909
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
 32 12  1  0
 32 16  1  0
 28 17  1  0
 26 20  1  0
M  END
>  <PARENT_MOLREGNO>  (699) 
674860

>  <SYNONYMS>  (699) 
Prednisolone Butylacetate (JAN); Prednisolone Tebutate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (699) 
4

>  <RESEARCH_CODES>  (699) 
nan

>  <APPLICANTS>  (699) 
Merck And Co Inc

>  <USAN_STEM>  (699) 
pred-

>  <USAN_STEM_DEFINITION>  (699) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (699) 
pred-

>  <USAN_YEAR>  (699) 
nan

>  <FIRST_APPROVAL>  (699) 
1956.0

>  <ATC_CODE>  (699) 
C05AA04; A07EA01; S01BA04; S02BA03; D07AA03; H02AB06; D07XA02; R01AD02; S01CB02; S03BA02

>  <ATC_CODE_DESCRIPTION>  (699) 
C05AA04 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA01 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; S01BA04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA03 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; D07AA03 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; H02AB06 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07XA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; R01AD02 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S01CB02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; S03BA02 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (699) 
Glucocorticoid

>  <SC_PATENT_NO>  (699) 
nan

>  <DRUG_TYPE>  (699) 
Natural Product-derived

>  <RULE_OF_FIVE>  (699) 
Y

>  <FIRST_IN_CLASS>  (699) 
N

>  <CHIRALITY>  (699) 
Single Stereoisomer

>  <PRODRUG>  (699) 
Y

>  <ORAL>  (699) 
N

>  <PARENTERAL>  (699) 
Y

>  <TOPICAL>  (699) 
N

>  <BLACK_BOX>  (699) 
N

>  <AVAILABILITY_TYPE>  (699) 
Discontinued

>  <WITHDRAWN_YEAR>  (699) 
nan

>  <WITHDRAWN_COUNTRY>  (699) 
nan

>  <WITHDRAWN_REASON>  (699) 
nan

>  <CANONICAL_SMILES>  (699) 
CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

>  <name>  (699) 
Prednisolone Butylacetate 

>  <MW>  (699) 
458.595

>  <logP>  (699) 
3.5447

$$$$
CHEMBL1395
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21  2  1  0
 21  6  1  0
 18  7  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (700) 
328400

>  <SYNONYMS>  (700) 
Methyltestosterone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (700) 
4

>  <RESEARCH_CODES>  (700) 
nan

>  <APPLICANTS>  (700) 
Schering Corp Sub Schering Plough Corp; Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (700) 
-ster-

>  <USAN_STEM_DEFINITION>  (700) 
steroids (androgens, anabolics)

>  <USAN_STEM_SUBSTEM>  (700) 
-ster-

>  <USAN_YEAR>  (700) 
nan

>  <FIRST_APPROVAL>  (700) 
1973.0

>  <ATC_CODE>  (700) 
G03BA02; G03EK01

>  <ATC_CODE_DESCRIPTION>  (700) 
G03BA02 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Androgens:3-oxoandrosten (4) derivatives]; G03EK01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Androgens And Female Sex Hormones In Combination:Androgens and female sex hormones in combination with other drugs]

>  <INDICATION_CLASS>  (700) 
Androgen

>  <SC_PATENT_NO>  (700) 
nan

>  <DRUG_TYPE>  (700) 
Natural Product-derived

>  <RULE_OF_FIVE>  (700) 
Y

>  <FIRST_IN_CLASS>  (700) 
N

>  <CHIRALITY>  (700) 
Single Stereoisomer

>  <PRODRUG>  (700) 
N

>  <ORAL>  (700) 
Y

>  <PARENTERAL>  (700) 
N

>  <TOPICAL>  (700) 
Y

>  <BLACK_BOX>  (700) 
N

>  <AVAILABILITY_TYPE>  (700) 
Prescription-only

>  <WITHDRAWN_YEAR>  (700) 
nan

>  <WITHDRAWN_COUNTRY>  (700) 
nan

>  <WITHDRAWN_REASON>  (700) 
nan

>  <CANONICAL_SMILES>  (700) 
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (700) 
Methyltestosterone 

>  <MW>  (700) 
302.458

>  <logP>  (700) 
4.2693

$$$$
CHEMBL459
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
  2 13  1  0
 13 14  2  0
 13 15  1  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (701) 
3730

>  <SYNONYMS>  (701) 
Methyldopa (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (701) 
4

>  <RESEARCH_CODES>  (701) 
MK-351

>  <APPLICANTS>  (701) 
Sandoz Inc; Merck Research Laboratories Div Merck Co Inc; Merck And Co Inc

>  <USAN_STEM>  (701) 
-dopa

>  <USAN_STEM_DEFINITION>  (701) 
dopamine receptor agonists

>  <USAN_STEM_SUBSTEM>  (701) 
-dopa

>  <USAN_YEAR>  (701) 
1962.0

>  <FIRST_APPROVAL>  (701) 
1962.0

>  <ATC_CODE>  (701) 
C02AB01

>  <ATC_CODE_DESCRIPTION>  (701) 
C02AB01 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Centrally Acting:Methyldopa]

>  <INDICATION_CLASS>  (701) 
Antihypertensive

>  <SC_PATENT_NO>  (701) 
nan

>  <DRUG_TYPE>  (701) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (701) 
Y

>  <FIRST_IN_CLASS>  (701) 
N

>  <CHIRALITY>  (701) 
Single Stereoisomer

>  <PRODRUG>  (701) 
N

>  <ORAL>  (701) 
Y

>  <PARENTERAL>  (701) 
N

>  <TOPICAL>  (701) 
N

>  <BLACK_BOX>  (701) 
N

>  <AVAILABILITY_TYPE>  (701) 
Prescription-only

>  <WITHDRAWN_YEAR>  (701) 
nan

>  <WITHDRAWN_COUNTRY>  (701) 
nan

>  <WITHDRAWN_REASON>  (701) 
nan

>  <CANONICAL_SMILES>  (701) 
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O

>  <name>  (701) 
Methyldopa 

>  <MW>  (701) 
211.217

>  <logP>  (701) 
0.4423

$$$$
CHEMBL43452
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
  9 18  1  0
 18 19  2  0
 18 20  1  0
 20  2  1  0
 20  6  2  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (702) 
63100

>  <SYNONYMS>  (702) 
Pomalidomide (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (702) 
4

>  <RESEARCH_CODES>  (702) 
CC-4047; IMID-3

>  <APPLICANTS>  (702) 
Celgene Corp

>  <USAN_STEM>  (702) 
-domide

>  <USAN_STEM_DEFINITION>  (702) 
thalidomide derivatives

>  <USAN_STEM_SUBSTEM>  (702) 
-domide

>  <USAN_YEAR>  (702) 
2006.0

>  <FIRST_APPROVAL>  (702) 
2013.0

>  <ATC_CODE>  (702) 
L04AX06

>  <ATC_CODE_DESCRIPTION>  (702) 
L04AX06 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Other immunosuppressants]

>  <INDICATION_CLASS>  (702) 
nan

>  <SC_PATENT_NO>  (702) 
US-5635517-A

>  <DRUG_TYPE>  (702) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (702) 
Y

>  <FIRST_IN_CLASS>  (702) 
N

>  <CHIRALITY>  (702) 
Racemic Mixture

>  <PRODRUG>  (702) 
N

>  <ORAL>  (702) 
Y

>  <PARENTERAL>  (702) 
N

>  <TOPICAL>  (702) 
N

>  <BLACK_BOX>  (702) 
Y

>  <AVAILABILITY_TYPE>  (702) 
Prescription-only

>  <WITHDRAWN_YEAR>  (702) 
nan

>  <WITHDRAWN_COUNTRY>  (702) 
nan

>  <WITHDRAWN_REASON>  (702) 
nan

>  <CANONICAL_SMILES>  (702) 
Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12

>  <name>  (702) 
Pomalidomide 

>  <MW>  (702) 
273.248

>  <logP>  (702) 
-0.33

$$$$
CHEMBL389621
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 15 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
  8  2  1  0
 26  2  1  0
 26 11  1  0
 21 12  1  0
M  END
>  <PARENT_MOLREGNO>  (703) 
374052

>  <SYNONYMS>  (703) 
Hydrocortisone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (703) 
4

>  <RESEARCH_CODES>  (703) 
nan

>  <APPLICANTS>  (703) 
Hi Tech Pharmacal Co Inc; Bayer Pharmaceuticals Corp; Ani Pharmaceuticals Inc; Alcon Pharmaceuticals Ltd; Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (703) 
-cort-

>  <USAN_STEM_DEFINITION>  (703) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (703) 
-cort-

>  <USAN_YEAR>  (703) 
nan

>  <FIRST_APPROVAL>  (703) 
1952.0

>  <ATC_CODE>  (703) 
D07AA02; S01CB03; R01AD60; D07XA01; C05AA01; A07EA02; A01AC03; H02AB09; S01BA02; S02BA01

>  <ATC_CODE_DESCRIPTION>  (703) 
D07AA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; S01CB03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; R01AD60 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; D07XA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; C05AA01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; A01AC03 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; H02AB09 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA01 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (703) 
Glucocorticoid

>  <SC_PATENT_NO>  (703) 
US-6514980-B1

>  <DRUG_TYPE>  (703) 
Natural Product-derived

>  <RULE_OF_FIVE>  (703) 
Y

>  <FIRST_IN_CLASS>  (703) 
N

>  <CHIRALITY>  (703) 
Single Stereoisomer

>  <PRODRUG>  (703) 
N

>  <ORAL>  (703) 
Y

>  <PARENTERAL>  (703) 
Y

>  <TOPICAL>  (703) 
Y

>  <BLACK_BOX>  (703) 
N

>  <AVAILABILITY_TYPE>  (703) 
Prescription-only

>  <WITHDRAWN_YEAR>  (703) 
nan

>  <WITHDRAWN_COUNTRY>  (703) 
nan

>  <WITHDRAWN_REASON>  (703) 
nan

>  <CANONICAL_SMILES>  (703) 
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23

>  <name>  (703) 
Hydrocortisone 

>  <MW>  (703) 
362.466

>  <logP>  (703) 
1.7816

$$$$
CHEMBL1519
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 14  9  1  0
 28 20  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (704) 
421317

>  <SYNONYMS>  (704) 
Indolapril (INN); Trandolapril (BAN, FDA, INN)

>  <DEVELOPMENT_PHASE>  (704) 
4

>  <RESEARCH_CODES>  (704) 
RU-44570

>  <APPLICANTS>  (704) 
Abbvie Inc

>  <USAN_STEM>  (704) 
-pril

>  <USAN_STEM_DEFINITION>  (704) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (704) 
-pril

>  <USAN_YEAR>  (704) 
nan

>  <FIRST_APPROVAL>  (704) 
1996.0

>  <ATC_CODE>  (704) 
C09AA10

>  <ATC_CODE_DESCRIPTION>  (704) 
C09AA10 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (704) 
nan

>  <SC_PATENT_NO>  (704) 
nan

>  <DRUG_TYPE>  (704) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (704) 
Y

>  <FIRST_IN_CLASS>  (704) 
N

>  <CHIRALITY>  (704) 
Single Stereoisomer

>  <PRODRUG>  (704) 
Y

>  <ORAL>  (704) 
Y

>  <PARENTERAL>  (704) 
N

>  <TOPICAL>  (704) 
N

>  <BLACK_BOX>  (704) 
Y

>  <AVAILABILITY_TYPE>  (704) 
Prescription-only

>  <WITHDRAWN_YEAR>  (704) 
nan

>  <WITHDRAWN_COUNTRY>  (704) 
nan

>  <WITHDRAWN_REASON>  (704) 
nan

>  <CANONICAL_SMILES>  (704) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O

>  <name>  (704) 
Indolapril 

>  <MW>  (704) 
430.545

>  <logP>  (704) 
2.7733

$$$$
CHEMBL3707239
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 10 22  1  0
 22 23  1  0
 23 24  2  0
 23  2  1  0
 22  7  2  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (705) 
2039210

>  <SYNONYMS>  (705) 
Etofylline Nicotinate

>  <DEVELOPMENT_PHASE>  (705) 
4

>  <RESEARCH_CODES>  (705) 
nan

>  <APPLICANTS>  (705) 
nan

>  <USAN_STEM>  (705) 
-fylline

>  <USAN_STEM_DEFINITION>  (705) 
theophylline derivatives

>  <USAN_STEM_SUBSTEM>  (705) 
-fylline

>  <USAN_YEAR>  (705) 
nan

>  <FIRST_APPROVAL>  (705) 
nan

>  <ATC_CODE>  (705) 
C04AD04

>  <ATC_CODE_DESCRIPTION>  (705) 
C04AD04 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Purine derivatives]

>  <INDICATION_CLASS>  (705) 
nan

>  <SC_PATENT_NO>  (705) 
nan

>  <DRUG_TYPE>  (705) 
Natural Product-derived

>  <RULE_OF_FIVE>  (705) 
Y

>  <FIRST_IN_CLASS>  (705) 
N

>  <CHIRALITY>  (705) 
Achiral Molecule

>  <PRODRUG>  (705) 
N

>  <ORAL>  (705) 
N

>  <PARENTERAL>  (705) 
N

>  <TOPICAL>  (705) 
N

>  <BLACK_BOX>  (705) 
N

>  <AVAILABILITY_TYPE>  (705) 
Unknown

>  <WITHDRAWN_YEAR>  (705) 
nan

>  <WITHDRAWN_COUNTRY>  (705) 
nan

>  <WITHDRAWN_REASON>  (705) 
nan

>  <CANONICAL_SMILES>  (705) 
CN1C(=O)N(C)c2ncn(CCOC(=O)c3cccnc3)c2C1=O

>  <name>  (705) 
Etofylline Nicotinate

>  <MW>  (705) 
329.316

>  <logP>  (705) 
-0.3143

$$$$
CHEMBL1467
     RDKit          

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  2  1  0
 10  6  2  0
M  END
>  <PARENT_MOLREGNO>  (706) 
395607

>  <SYNONYMS>  (706) 
Allopurinol (BAN, FDA, INN, JAN, USAN, USP); Allopurinol Sodium (FDA)

>  <DEVELOPMENT_PHASE>  (706) 
4

>  <RESEARCH_CODES>  (706) 
BW-56158; BW-56-158

>  <APPLICANTS>  (706) 
Watson Laboratories Inc; Prometheus Laboratories Inc; Mylan Institutional Llc; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (706) 
nan

>  <USAN_STEM_DEFINITION>  (706) 
nan

>  <USAN_STEM_SUBSTEM>  (706) 
nan

>  <USAN_YEAR>  (706) 
1964.0

>  <FIRST_APPROVAL>  (706) 
1966.0

>  <ATC_CODE>  (706) 
M04AA01; M04AA51

>  <ATC_CODE_DESCRIPTION>  (706) 
M04AA01 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations inhibiting uric acid production]; M04AA51 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations inhibiting uric acid production]

>  <INDICATION_CLASS>  (706) 
Xanthine Oxidase Inhibitor

>  <SC_PATENT_NO>  (706) 
nan

>  <DRUG_TYPE>  (706) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (706) 
Y

>  <FIRST_IN_CLASS>  (706) 
N

>  <CHIRALITY>  (706) 
Achiral Molecule

>  <PRODRUG>  (706) 
N

>  <ORAL>  (706) 
Y

>  <PARENTERAL>  (706) 
Y

>  <TOPICAL>  (706) 
N

>  <BLACK_BOX>  (706) 
N

>  <AVAILABILITY_TYPE>  (706) 
Prescription-only

>  <WITHDRAWN_YEAR>  (706) 
nan

>  <WITHDRAWN_COUNTRY>  (706) 
nan

>  <WITHDRAWN_REASON>  (706) 
nan

>  <CANONICAL_SMILES>  (706) 
O=C1NC=Nc2[nH]ncc12

>  <name>  (706) 
Allopurinol 

>  <MW>  (706) 
136.114

>  <logP>  (706) 
-0.3538

$$$$
CHEMBL972
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  2 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  3  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (707) 
96021

>  <SYNONYMS>  (707) 
Selegiline (BAN, FDA, INN, USAN); Selegiline HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (707) 
4

>  <RESEARCH_CODES>  (707) 
nan

>  <APPLICANTS>  (707) 
Valeant Pharmaceuticals International; Somerset Pharmaceuticals Inc

>  <USAN_STEM>  (707) 
-giline

>  <USAN_STEM_DEFINITION>  (707) 
MAO inhibitors, type B

>  <USAN_STEM_SUBSTEM>  (707) 
-giline

>  <USAN_YEAR>  (707) 
1992.0

>  <FIRST_APPROVAL>  (707) 
1989.0

>  <ATC_CODE>  (707) 
N04BD01

>  <ATC_CODE_DESCRIPTION>  (707) 
N04BD01 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Monoamine oxidase B inhibitors]

>  <INDICATION_CLASS>  (707) 
Antidyskinetic; Antiparkinsonian (in combination with levodopa/carbidopa)

>  <SC_PATENT_NO>  (707) 
US-6423342-B1

>  <DRUG_TYPE>  (707) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (707) 
Y

>  <FIRST_IN_CLASS>  (707) 
N

>  <CHIRALITY>  (707) 
Single Stereoisomer

>  <PRODRUG>  (707) 
N

>  <ORAL>  (707) 
Y

>  <PARENTERAL>  (707) 
N

>  <TOPICAL>  (707) 
Y

>  <BLACK_BOX>  (707) 
Y

>  <AVAILABILITY_TYPE>  (707) 
Prescription-only

>  <WITHDRAWN_YEAR>  (707) 
nan

>  <WITHDRAWN_COUNTRY>  (707) 
nan

>  <WITHDRAWN_REASON>  (707) 
nan

>  <CANONICAL_SMILES>  (707) 
C[C@H](Cc1ccccc1)N(C)CC#C

>  <name>  (707) 
Selegiline 

>  <MW>  (707) 
187.286

>  <logP>  (707) 
2.1826

$$$$
CHEMBL1201192
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  8  1  0
 19 14  1  0
M  CHG  2   5   1   6  -1
M  END
>  <PARENT_MOLREGNO>  (708) 
675143

>  <SYNONYMS>  (708) 
Armodafinil (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (708) 
4

>  <RESEARCH_CODES>  (708) 
CEP-10953

>  <APPLICANTS>  (708) 
Cephalon Inc

>  <USAN_STEM>  (708) 
-nil

>  <USAN_STEM_DEFINITION>  (708) 
benzodiazepine receptor antagonists/agonists

>  <USAN_STEM_SUBSTEM>  (708) 
-nil

>  <USAN_YEAR>  (708) 
2004.0

>  <FIRST_APPROVAL>  (708) 
2007.0

>  <ATC_CODE>  (708) 
N06BA13

>  <ATC_CODE_DESCRIPTION>  (708) 
N06BA13 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (708) 
nan

>  <SC_PATENT_NO>  (708) 
US-7132570-B2

>  <DRUG_TYPE>  (708) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (708) 
Y

>  <FIRST_IN_CLASS>  (708) 
N

>  <CHIRALITY>  (708) 
Single Stereoisomer

>  <PRODRUG>  (708) 
N

>  <ORAL>  (708) 
Y

>  <PARENTERAL>  (708) 
N

>  <TOPICAL>  (708) 
N

>  <BLACK_BOX>  (708) 
N

>  <AVAILABILITY_TYPE>  (708) 
Prescription-only

>  <WITHDRAWN_YEAR>  (708) 
nan

>  <WITHDRAWN_COUNTRY>  (708) 
nan

>  <WITHDRAWN_REASON>  (708) 
nan

>  <CANONICAL_SMILES>  (708) 
NC(=O)C[S+]([O-])C(c1ccccc1)c2ccccc2

>  <name>  (708) 
Armodafinil 

>  <MW>  (708) 
273.357

>  <logP>  (708) 
2.01

$$$$
CHEMBL568
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19  2  1  0
 10  5  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (709) 
16506

>  <SYNONYMS>  (709) 
Oxazepam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (709) 
4

>  <RESEARCH_CODES>  (709) 
WY-3498

>  <APPLICANTS>  (709) 
Alpharma Us Pharmaceuticals Division

>  <USAN_STEM>  (709) 
-azepam

>  <USAN_STEM_DEFINITION>  (709) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (709) 
-azepam

>  <USAN_YEAR>  (709) 
1965.0

>  <FIRST_APPROVAL>  (709) 
1965.0

>  <ATC_CODE>  (709) 
N05BA04

>  <ATC_CODE_DESCRIPTION>  (709) 
N05BA04 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (709) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (709) 
nan

>  <DRUG_TYPE>  (709) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (709) 
Y

>  <FIRST_IN_CLASS>  (709) 
N

>  <CHIRALITY>  (709) 
Racemic Mixture

>  <PRODRUG>  (709) 
N

>  <ORAL>  (709) 
Y

>  <PARENTERAL>  (709) 
N

>  <TOPICAL>  (709) 
N

>  <BLACK_BOX>  (709) 
N

>  <AVAILABILITY_TYPE>  (709) 
Prescription-only

>  <WITHDRAWN_YEAR>  (709) 
nan

>  <WITHDRAWN_COUNTRY>  (709) 
nan

>  <WITHDRAWN_REASON>  (709) 
nan

>  <CANONICAL_SMILES>  (709) 
OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O

>  <name>  (709) 
Oxazepam 

>  <MW>  (709) 
286.718

>  <logP>  (709) 
2.4479

$$$$
CHEMBL1200468
     RDKit          

 19 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
  9 13  1  0
 13 14  1  0
  7 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
M  END
>  <PARENT_MOLREGNO>  (710) 
674419

>  <SYNONYMS>  (710) 
Malathion (BAN, FDA, USP)

>  <DEVELOPMENT_PHASE>  (710) 
4

>  <RESEARCH_CODES>  (710) 
nan

>  <APPLICANTS>  (710) 
Taro Pharmaceuticals North America Inc

>  <USAN_STEM>  (710) 
nan

>  <USAN_STEM_DEFINITION>  (710) 
nan

>  <USAN_STEM_SUBSTEM>  (710) 
nan

>  <USAN_YEAR>  (710) 
nan

>  <FIRST_APPROVAL>  (710) 
1982.0

>  <ATC_CODE>  (710) 
P03AX03

>  <ATC_CODE_DESCRIPTION>  (710) 
P03AX03 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides:Other ectoparasiticides, incl. scabicides]

>  <INDICATION_CLASS>  (710) 
Pediculicide

>  <SC_PATENT_NO>  (710) 
US-7977324-B2

>  <DRUG_TYPE>  (710) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (710) 
Y

>  <FIRST_IN_CLASS>  (710) 
N

>  <CHIRALITY>  (710) 
Racemic Mixture

>  <PRODRUG>  (710) 
N

>  <ORAL>  (710) 
N

>  <PARENTERAL>  (710) 
N

>  <TOPICAL>  (710) 
Y

>  <BLACK_BOX>  (710) 
N

>  <AVAILABILITY_TYPE>  (710) 
Prescription-only

>  <WITHDRAWN_YEAR>  (710) 
nan

>  <WITHDRAWN_COUNTRY>  (710) 
nan

>  <WITHDRAWN_REASON>  (710) 
nan

>  <CANONICAL_SMILES>  (710) 
CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC

>  <name>  (710) 
Malathion 

>  <MW>  (710) 
330.364

>  <logP>  (710) 
2.1218

$$$$
CHEMBL85
     RDKit          

 30 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30  2  1  0
 11  6  1  0
 21 12  1  0
 21 15  1  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (711) 
7714

>  <SYNONYMS>  (711) 
Risperidone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (711) 
4

>  <RESEARCH_CODES>  (711) 
R-64766; R-64-766

>  <APPLICANTS>  (711) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (711) 
-peridone

>  <USAN_STEM_DEFINITION>  (711) 
antipsychotics (risperidone type)

>  <USAN_STEM_SUBSTEM>  (711) 
-peridone

>  <USAN_YEAR>  (711) 
1989.0

>  <FIRST_APPROVAL>  (711) 
1993.0

>  <ATC_CODE>  (711) 
N05AX08

>  <ATC_CODE_DESCRIPTION>  (711) 
N05AX08 [Nervous System:Psycholeptics:Antipsychotics:Other antipsychotics]

>  <INDICATION_CLASS>  (711) 
Neuroleptic

>  <SC_PATENT_NO>  (711) 
US-5792477-A

>  <DRUG_TYPE>  (711) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (711) 
Y

>  <FIRST_IN_CLASS>  (711) 
N

>  <CHIRALITY>  (711) 
Achiral Molecule

>  <PRODRUG>  (711) 
N

>  <ORAL>  (711) 
Y

>  <PARENTERAL>  (711) 
Y

>  <TOPICAL>  (711) 
N

>  <BLACK_BOX>  (711) 
Y

>  <AVAILABILITY_TYPE>  (711) 
Prescription-only

>  <WITHDRAWN_YEAR>  (711) 
nan

>  <WITHDRAWN_COUNTRY>  (711) 
nan

>  <WITHDRAWN_REASON>  (711) 
nan

>  <CANONICAL_SMILES>  (711) 
CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1

>  <name>  (711) 
Risperidone 

>  <MW>  (711) 
410.493

>  <logP>  (711) 
3.59042

$$$$
CHEMBL13
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
  8 18  1  0
 18 19  2  0
 19  5  1  0
M  END
>  <PARENT_MOLREGNO>  (712) 
789

>  <SYNONYMS>  (712) 
Metoprolol (BAN, INN, USAN); Metoprolol Tartrate (FDA, JAN, USAN, USP); Metoprolol Succinate (FDA, USAN, USP); Metoprolol Fumarate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (712) 
4

>  <RESEARCH_CODES>  (712) 
CGP-2175E; H 93/26 Succinate; H-93/26; CGP-2175C

>  <APPLICANTS>  (712) 
Us Pharmaceuticals Holdings I Llc; Novartis Pharmaceuticals Corp; Astrazeneca Lp

>  <USAN_STEM>  (712) 
-olol

>  <USAN_STEM_DEFINITION>  (712) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (712) 
-olol

>  <USAN_YEAR>  (712) 
1976.0

>  <FIRST_APPROVAL>  (712) 
1978.0

>  <ATC_CODE>  (712) 
C07AB02; C07AB52

>  <ATC_CODE_DESCRIPTION>  (712) 
C07AB02 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]; C07AB52 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]

>  <INDICATION_CLASS>  (712) 
Anti-Adrenergic (beta-receptor); Anti-Anginal; Antihypertensive

>  <SC_PATENT_NO>  (712) 
nan

>  <DRUG_TYPE>  (712) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (712) 
Y

>  <FIRST_IN_CLASS>  (712) 
N

>  <CHIRALITY>  (712) 
Racemic Mixture

>  <PRODRUG>  (712) 
N

>  <ORAL>  (712) 
Y

>  <PARENTERAL>  (712) 
Y

>  <TOPICAL>  (712) 
N

>  <BLACK_BOX>  (712) 
Y

>  <AVAILABILITY_TYPE>  (712) 
Prescription-only

>  <WITHDRAWN_YEAR>  (712) 
nan

>  <WITHDRAWN_COUNTRY>  (712) 
nan

>  <WITHDRAWN_REASON>  (712) 
nan

>  <CANONICAL_SMILES>  (712) 
COCCc1ccc(OCC(O)CNC(C)C)cc1

>  <name>  (712) 
Metoprolol 

>  <MW>  (712) 
267.369

>  <logP>  (712) 
1.6132

$$$$
CHEMBL137
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  9  2  1  0
M  CHG  2   6   1   8  -1
M  END
>  <PARENT_MOLREGNO>  (713) 
27912

>  <SYNONYMS>  (713) 
Metronidazole (BAN, FDA, INN, JAN, USAN, USP); Metronidazole HCl (FDA, USAN); Metronidazole Benzoate (BAN, USP)

>  <DEVELOPMENT_PHASE>  (713) 
4

>  <RESEARCH_CODES>  (713) 
BAY-5360; BAYER-5360; RP-8823; SC-32642

>  <APPLICANTS>  (713) 
Baxter Healthcare Corp; B Braun Medical Inc; Aptalis Pharma Us Inc; Abbott Laboratories Pharmaceutical Products Div; Pfizer Inc.

>  <USAN_STEM>  (713) 
-nidazole

>  <USAN_STEM_DEFINITION>  (713) 
antiprotozoal substances (metronidazole type)

>  <USAN_STEM_SUBSTEM>  (713) 
-nidazole

>  <USAN_YEAR>  (713) 
1962.0

>  <FIRST_APPROVAL>  (713) 
1963.0

>  <ATC_CODE>  (713) 
J01XD01; A01AB17; P01AB51; P01AB01; D06BX01; G01AF01

>  <ATC_CODE_DESCRIPTION>  (713) 
J01XD01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Imidazole derivatives]; A01AB17 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Antiinfectives and antiseptics for local oral treatment]; P01AB51 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Nitroimidazole derivatives]; P01AB01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Nitroimidazole derivatives]; D06BX01 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Other chemotherapeutics]; G01AF01 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Imidazole derivatives]

>  <INDICATION_CLASS>  (713) 
Antiprotozoal (trichomonas); Antibacterial

>  <SC_PATENT_NO>  (713) 
US-6350468-B1

>  <DRUG_TYPE>  (713) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (713) 
Y

>  <FIRST_IN_CLASS>  (713) 
N

>  <CHIRALITY>  (713) 
Achiral Molecule

>  <PRODRUG>  (713) 
N

>  <ORAL>  (713) 
Y

>  <PARENTERAL>  (713) 
Y

>  <TOPICAL>  (713) 
Y

>  <BLACK_BOX>  (713) 
Y

>  <AVAILABILITY_TYPE>  (713) 
Prescription-only

>  <WITHDRAWN_YEAR>  (713) 
nan

>  <WITHDRAWN_COUNTRY>  (713) 
nan

>  <WITHDRAWN_REASON>  (713) 
nan

>  <CANONICAL_SMILES>  (713) 
Cc1ncc([N+](=O)[O-])n1CCO

>  <name>  (713) 
Metronidazole 

>  <MW>  (713) 
171.156

>  <logP>  (713) 
0.09202

$$$$
CHEMBL15841
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (714) 
16457

>  <SYNONYMS>  (714) 
Ethyl Parahydroxybenzoate (JAN); Ethylparaben (NF)

>  <DEVELOPMENT_PHASE>  (714) 
4

>  <RESEARCH_CODES>  (714) 
nan

>  <APPLICANTS>  (714) 
nan

>  <USAN_STEM>  (714) 
nan

>  <USAN_STEM_DEFINITION>  (714) 
nan

>  <USAN_STEM_SUBSTEM>  (714) 
nan

>  <USAN_YEAR>  (714) 
nan

>  <FIRST_APPROVAL>  (714) 
nan

>  <ATC_CODE>  (714) 
D01AE10

>  <ATC_CODE_DESCRIPTION>  (714) 
D01AE10 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (714) 
Pharmaceutic Aid (antifungal agent)

>  <SC_PATENT_NO>  (714) 
nan

>  <DRUG_TYPE>  (714) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (714) 
Y

>  <FIRST_IN_CLASS>  (714) 
N

>  <CHIRALITY>  (714) 
Achiral Molecule

>  <PRODRUG>  (714) 
N

>  <ORAL>  (714) 
N

>  <PARENTERAL>  (714) 
N

>  <TOPICAL>  (714) 
N

>  <BLACK_BOX>  (714) 
N

>  <AVAILABILITY_TYPE>  (714) 
Unknown

>  <WITHDRAWN_YEAR>  (714) 
nan

>  <WITHDRAWN_COUNTRY>  (714) 
nan

>  <WITHDRAWN_REASON>  (714) 
nan

>  <CANONICAL_SMILES>  (714) 
CCOC(=O)c1ccc(O)cc1

>  <name>  (714) 
Ethyl Parahydroxybenzoate 

>  <MW>  (714) 
166.176

>  <logP>  (714) 
1.5689

$$$$
CHEMBL1201139
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  5 26  1  0
 26 27  2  0
 26 28  1  0
 24  5  1  0
 24  8  1  0
 21  9  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (715) 
675090

>  <SYNONYMS>  (715) 
Megestrol (BAN, INN); Megestrol Acetate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (715) 
4

>  <RESEARCH_CODES>  (715) 
5071; BDH-1298; SC-10363

>  <APPLICANTS>  (715) 
Par Pharmaceutical Inc; Bristol Myers Squibb

>  <USAN_STEM>  (715) 
-gest-

>  <USAN_STEM_DEFINITION>  (715) 
progestins

>  <USAN_STEM_SUBSTEM>  (715) 
-gest-

>  <USAN_YEAR>  (715) 
1963.0

>  <FIRST_APPROVAL>  (715) 
1971.0

>  <ATC_CODE>  (715) 
G03DB02; G03AC05; L02AB01

>  <ATC_CODE_DESCRIPTION>  (715) 
G03DB02 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnadien derivatives]; G03AC05 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Hormonal Contraceptives For Systemic Use:Progestogens]; L02AB01 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormones And Related Agents:Progestogens]

>  <INDICATION_CLASS>  (715) 
Antineoplastic

>  <SC_PATENT_NO>  (715) 
US-6592903-B2

>  <DRUG_TYPE>  (715) 
Natural Product-derived

>  <RULE_OF_FIVE>  (715) 
Y

>  <FIRST_IN_CLASS>  (715) 
N

>  <CHIRALITY>  (715) 
Single Stereoisomer

>  <PRODRUG>  (715) 
N

>  <ORAL>  (715) 
Y

>  <PARENTERAL>  (715) 
N

>  <TOPICAL>  (715) 
N

>  <BLACK_BOX>  (715) 
N

>  <AVAILABILITY_TYPE>  (715) 
Prescription-only

>  <WITHDRAWN_YEAR>  (715) 
nan

>  <WITHDRAWN_COUNTRY>  (715) 
nan

>  <WITHDRAWN_REASON>  (715) 
nan

>  <CANONICAL_SMILES>  (715) 
CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)C

>  <name>  (715) 
Megestrol 

>  <MW>  (715) 
384.516

>  <logP>  (715) 
4.5753

$$$$
CHEMBL698
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (716) 
32027

>  <SYNONYMS>  (716) 
Amethocaine (BAN); Tetracaine (BAN, FDA, INN, USP); Amethocaine HCl (BAN); Tetracaine HCl (BAN, JAN, USP); Tetracaine hydrochloride (FDA)

>  <DEVELOPMENT_PHASE>  (716) 
4

>  <RESEARCH_CODES>  (716) 
nan

>  <APPLICANTS>  (716) 
Galderma Laboratories Lp; Ciba Vision, Us Ophthalmics; Alcon Research Ltd; Alcon; Sterling Winthrop

>  <USAN_STEM>  (716) 
-caine

>  <USAN_STEM_DEFINITION>  (716) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (716) 
-caine

>  <USAN_YEAR>  (716) 
nan

>  <FIRST_APPROVAL>  (716) 
2005.0

>  <ATC_CODE>  (716) 
N01BA03; C05AD02; D04AB06; S01HA03

>  <ATC_CODE_DESCRIPTION>  (716) 
N01BA03 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]; C05AD02 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; D04AB06 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; S01HA03 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]

>  <INDICATION_CLASS>  (716) 
Anesthetic (local); Anesthetic (topical)

>  <SC_PATENT_NO>  (716) 
US-5658583-A

>  <DRUG_TYPE>  (716) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (716) 
Y

>  <FIRST_IN_CLASS>  (716) 
Y

>  <CHIRALITY>  (716) 
Achiral Molecule

>  <PRODRUG>  (716) 
N

>  <ORAL>  (716) 
N

>  <PARENTERAL>  (716) 
N

>  <TOPICAL>  (716) 
Y

>  <BLACK_BOX>  (716) 
N

>  <AVAILABILITY_TYPE>  (716) 
Prescription-only

>  <WITHDRAWN_YEAR>  (716) 
nan

>  <WITHDRAWN_COUNTRY>  (716) 
nan

>  <WITHDRAWN_REASON>  (716) 
nan

>  <CANONICAL_SMILES>  (716) 
CCCCNc1ccc(cc1)C(=O)OCCN(C)C

>  <name>  (716) 
Amethocaine 

>  <MW>  (716) 
264.369

>  <logP>  (716) 
2.617

$$$$
CHEMBL1073
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  7  2  1  0
 18 13  1  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (717) 
139286

>  <SYNONYMS>  (717) 
Glipizide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (717) 
4

>  <RESEARCH_CODES>  (717) 
CP-28720; K-4024

>  <APPLICANTS>  (717) 
Pfizer Inc.; Bristol Myers Squibb Co

>  <USAN_STEM>  (717) 
gli-

>  <USAN_STEM_DEFINITION>  (717) 
antihyperglycemics

>  <USAN_STEM_SUBSTEM>  (717) 
gli-

>  <USAN_YEAR>  (717) 
1974.0

>  <FIRST_APPROVAL>  (717) 
1984.0

>  <ATC_CODE>  (717) 
A10BB07

>  <ATC_CODE_DESCRIPTION>  (717) 
A10BB07 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (717) 
Antidiabetic

>  <SC_PATENT_NO>  (717) 
US-RE44459-E1

>  <DRUG_TYPE>  (717) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (717) 
Y

>  <FIRST_IN_CLASS>  (717) 
N

>  <CHIRALITY>  (717) 
Achiral Molecule

>  <PRODRUG>  (717) 
N

>  <ORAL>  (717) 
Y

>  <PARENTERAL>  (717) 
N

>  <TOPICAL>  (717) 
N

>  <BLACK_BOX>  (717) 
N

>  <AVAILABILITY_TYPE>  (717) 
Prescription-only

>  <WITHDRAWN_YEAR>  (717) 
nan

>  <WITHDRAWN_COUNTRY>  (717) 
nan

>  <WITHDRAWN_REASON>  (717) 
nan

>  <CANONICAL_SMILES>  (717) 
Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3

>  <name>  (717) 
Glipizide 

>  <MW>  (717) 
445.545

>  <logP>  (717) 
2.07812

$$$$
CHEMBL1201129
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
  8  2  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (718) 
675080

>  <SYNONYMS>  (718) 
Decitabine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (718) 
4

>  <RESEARCH_CODES>  (718) 
nan

>  <APPLICANTS>  (718) 
Eisai Inc

>  <USAN_STEM>  (718) 
-citabine

>  <USAN_STEM_DEFINITION>  (718) 
nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

>  <USAN_STEM_SUBSTEM>  (718) 
-citabine

>  <USAN_YEAR>  (718) 
1989.0

>  <FIRST_APPROVAL>  (718) 
2006.0

>  <ATC_CODE>  (718) 
L01BC08

>  <ATC_CODE_DESCRIPTION>  (718) 
L01BC08 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (718) 
Antineoplastic

>  <SC_PATENT_NO>  (718) 
nan

>  <DRUG_TYPE>  (718) 
Natural Product-derived

>  <RULE_OF_FIVE>  (718) 
Y

>  <FIRST_IN_CLASS>  (718) 
N

>  <CHIRALITY>  (718) 
Single Stereoisomer

>  <PRODRUG>  (718) 
Y

>  <ORAL>  (718) 
N

>  <PARENTERAL>  (718) 
Y

>  <TOPICAL>  (718) 
N

>  <BLACK_BOX>  (718) 
N

>  <AVAILABILITY_TYPE>  (718) 
Prescription-only

>  <WITHDRAWN_YEAR>  (718) 
nan

>  <WITHDRAWN_COUNTRY>  (718) 
nan

>  <WITHDRAWN_REASON>  (718) 
nan

>  <CANONICAL_SMILES>  (718) 
NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2

>  <name>  (718) 
Decitabine 

>  <MW>  (718) 
228.208

>  <logP>  (718) 
-2.1388

$$$$
CHEMBL636
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (719) 
27251

>  <SYNONYMS>  (719) 
Rivastigmine (BAN, FDA, INN, USAN); Rivastigmine Tartrate (FDA)

>  <DEVELOPMENT_PHASE>  (719) 
4

>  <RESEARCH_CODES>  (719) 
ENA-713; SDZ-212-713; SDZ-ENA-713

>  <APPLICANTS>  (719) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (719) 
-stigmine

>  <USAN_STEM_DEFINITION>  (719) 
cholinesterase inhibitors (physostigmine type)

>  <USAN_STEM_SUBSTEM>  (719) 
-stigmine

>  <USAN_YEAR>  (719) 
1997.0

>  <FIRST_APPROVAL>  (719) 
2000.0

>  <ATC_CODE>  (719) 
N06DA03

>  <ATC_CODE_DESCRIPTION>  (719) 
N06DA03 [Nervous System:Psychoanaleptics:Anti-Dementia Drugs:Anticholinesterases]

>  <INDICATION_CLASS>  (719) 
nan

>  <SC_PATENT_NO>  (719) 
US-6316023-B1

>  <DRUG_TYPE>  (719) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (719) 
Y

>  <FIRST_IN_CLASS>  (719) 
N

>  <CHIRALITY>  (719) 
Single Stereoisomer

>  <PRODRUG>  (719) 
N

>  <ORAL>  (719) 
Y

>  <PARENTERAL>  (719) 
N

>  <TOPICAL>  (719) 
Y

>  <BLACK_BOX>  (719) 
N

>  <AVAILABILITY_TYPE>  (719) 
Prescription-only

>  <WITHDRAWN_YEAR>  (719) 
nan

>  <WITHDRAWN_COUNTRY>  (719) 
nan

>  <WITHDRAWN_REASON>  (719) 
nan

>  <CANONICAL_SMILES>  (719) 
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C

>  <name>  (719) 
Rivastigmine 

>  <MW>  (719) 
250.342

>  <logP>  (719) 
2.7597

$$$$
CHEMBL271227
     RDKit          

 29 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 15 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29  5  1  0
 28  8  1  0
 25 10  1  0
 18 13  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (720) 
438435

>  <SYNONYMS>  (720) 
Abiraterone Acetate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (720) 
4

>  <RESEARCH_CODES>  (720) 
CB-7630

>  <APPLICANTS>  (720) 
Janssen Biotech Inc

>  <USAN_STEM>  (720) 
nan

>  <USAN_STEM_DEFINITION>  (720) 
nan

>  <USAN_STEM_SUBSTEM>  (720) 
nan

>  <USAN_YEAR>  (720) 
2009.0

>  <FIRST_APPROVAL>  (720) 
2011.0

>  <ATC_CODE>  (720) 
L02BX03

>  <ATC_CODE_DESCRIPTION>  (720) 
L02BX03 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Other hormone antagonists and related agents]

>  <INDICATION_CLASS>  (720) 
nan

>  <SC_PATENT_NO>  (720) 
US-5604213-A

>  <DRUG_TYPE>  (720) 
Natural Product-derived

>  <RULE_OF_FIVE>  (720) 
Y

>  <FIRST_IN_CLASS>  (720) 
Y

>  <CHIRALITY>  (720) 
Single Stereoisomer

>  <PRODRUG>  (720) 
Y

>  <ORAL>  (720) 
Y

>  <PARENTERAL>  (720) 
N

>  <TOPICAL>  (720) 
N

>  <BLACK_BOX>  (720) 
N

>  <AVAILABILITY_TYPE>  (720) 
Prescription-only

>  <WITHDRAWN_YEAR>  (720) 
nan

>  <WITHDRAWN_COUNTRY>  (720) 
nan

>  <WITHDRAWN_REASON>  (720) 
nan

>  <CANONICAL_SMILES>  (720) 
CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4c5cccnc5)[C@@H]3CC=C2C1

>  <name>  (720) 
Abiraterone Acetate 

>  <MW>  (720) 
391.555

>  <logP>  (720) 
5.9694

$$$$
CHEMBL174
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  6 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 21  2  1  0
 20  5  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (721) 
305519

>  <SYNONYMS>  (721) 
Ampicillin (BAN, INN, JAN, USAN, USP); Ampicillin/Ampicillin Trihydrate (FDA); Ampicillin Sodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (721) 
4

>  <RESEARCH_CODES>  (721) 
AY-6108; BRL-1341; P-50

>  <APPLICANTS>  (721) 
Wyeth Ayerst Laboratories; Pfizer Inc.; Bristol Laboratories Inc Div Bristol Myers Co; Apothecon Sub Bristol Myers Squibb Co

>  <USAN_STEM>  (721) 
-cillin

>  <USAN_STEM_DEFINITION>  (721) 
penicillins

>  <USAN_STEM_SUBSTEM>  (721) 
-cillin

>  <USAN_YEAR>  (721) 
1962.0

>  <FIRST_APPROVAL>  (721) 
1965.0

>  <ATC_CODE>  (721) 
J01CA51; J01CA01; S01AA19

>  <ATC_CODE_DESCRIPTION>  (721) 
J01CA51 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]; J01CA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]; S01AA19 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]

>  <INDICATION_CLASS>  (721) 
Antibacterial

>  <SC_PATENT_NO>  (721) 
nan

>  <DRUG_TYPE>  (721) 
Natural Product-derived

>  <RULE_OF_FIVE>  (721) 
Y

>  <FIRST_IN_CLASS>  (721) 
N

>  <CHIRALITY>  (721) 
Single Stereoisomer

>  <PRODRUG>  (721) 
N

>  <ORAL>  (721) 
Y

>  <PARENTERAL>  (721) 
Y

>  <TOPICAL>  (721) 
N

>  <BLACK_BOX>  (721) 
N

>  <AVAILABILITY_TYPE>  (721) 
Prescription-only

>  <WITHDRAWN_YEAR>  (721) 
nan

>  <WITHDRAWN_COUNTRY>  (721) 
nan

>  <WITHDRAWN_REASON>  (721) 
nan

>  <CANONICAL_SMILES>  (721) 
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O

>  <name>  (721) 
Ampicillin 

>  <MW>  (721) 
349.412

>  <logP>  (721) 
0.3181

$$$$
CHEMBL946
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21 22  1  0
 22  2  1  0
 20  6  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (722) 
89672

>  <SYNONYMS>  (722) 
Azatadine (BAN, INN); Azatadine Maleate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (722) 
4

>  <RESEARCH_CODES>  (722) 
SCH-10649

>  <APPLICANTS>  (722) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (722) 
-(a)tadine

>  <USAN_STEM_DEFINITION>  (722) 
tricyclic histaminic-H1 receptor antagonists, loratadine derivatives

>  <USAN_STEM_SUBSTEM>  (722) 
-(a)tadine

>  <USAN_YEAR>  (722) 
1967.0

>  <FIRST_APPROVAL>  (722) 
1977.0

>  <ATC_CODE>  (722) 
R06AX09

>  <ATC_CODE_DESCRIPTION>  (722) 
R06AX09 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (722) 
Antihistaminic

>  <SC_PATENT_NO>  (722) 
nan

>  <DRUG_TYPE>  (722) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (722) 
Y

>  <FIRST_IN_CLASS>  (722) 
N

>  <CHIRALITY>  (722) 
Achiral Molecule

>  <PRODRUG>  (722) 
N

>  <ORAL>  (722) 
Y

>  <PARENTERAL>  (722) 
N

>  <TOPICAL>  (722) 
N

>  <BLACK_BOX>  (722) 
N

>  <AVAILABILITY_TYPE>  (722) 
Discontinued

>  <WITHDRAWN_YEAR>  (722) 
nan

>  <WITHDRAWN_COUNTRY>  (722) 
nan

>  <WITHDRAWN_REASON>  (722) 
nan

>  <CANONICAL_SMILES>  (722) 
CN1CCC(=C2c3ccccc3CCc4cccnc24)CC1

>  <name>  (722) 
Azatadine 

>  <MW>  (722) 
290.41

>  <logP>  (722) 
3.7077

$$$$
CHEMBL3707205
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 10 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 16 11  1  0
 22 17  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (723) 
2039176

>  <SYNONYMS>  (723) 
(2-Benzhydryloxyethyl)Diethyl-Methylammonium Iodide

>  <DEVELOPMENT_PHASE>  (723) 
4

>  <RESEARCH_CODES>  (723) 
nan

>  <APPLICANTS>  (723) 
nan

>  <USAN_STEM>  (723) 
-ium

>  <USAN_STEM_DEFINITION>  (723) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (723) 
-ium

>  <USAN_YEAR>  (723) 
nan

>  <FIRST_APPROVAL>  (723) 
nan

>  <ATC_CODE>  (723) 
A03AB16

>  <ATC_CODE_DESCRIPTION>  (723) 
A03AB16 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (723) 
nan

>  <SC_PATENT_NO>  (723) 
nan

>  <DRUG_TYPE>  (723) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (723) 
Y

>  <FIRST_IN_CLASS>  (723) 
N

>  <CHIRALITY>  (723) 
Achiral Molecule

>  <PRODRUG>  (723) 
N

>  <ORAL>  (723) 
N

>  <PARENTERAL>  (723) 
N

>  <TOPICAL>  (723) 
N

>  <BLACK_BOX>  (723) 
N

>  <AVAILABILITY_TYPE>  (723) 
Unknown

>  <WITHDRAWN_YEAR>  (723) 
nan

>  <WITHDRAWN_COUNTRY>  (723) 
nan

>  <WITHDRAWN_REASON>  (723) 
nan

>  <CANONICAL_SMILES>  (723) 
CC[N+](C)(CC)CCOC(c1ccccc1)c2ccccc2

>  <name>  (723) 


>  <MW>  (723) 
298.45

>  <logP>  (723) 
4.279

$$$$
CHEMBL1200689
     RDKit          

  2  1  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  2  0  0  0  0  0  0
  1  2  2  0
M  RAD  1   2   2
M  END
>  <PARENT_MOLREGNO>  (724) 
674640

>  <SYNONYMS>  (724) 
Nitric Oxide (FDA)

>  <DEVELOPMENT_PHASE>  (724) 
4

>  <RESEARCH_CODES>  (724) 
nan

>  <APPLICANTS>  (724) 
Ino Therapeutics Inc

>  <USAN_STEM>  (724) 
nan

>  <USAN_STEM_DEFINITION>  (724) 
nan

>  <USAN_STEM_SUBSTEM>  (724) 
nan

>  <USAN_YEAR>  (724) 
nan

>  <FIRST_APPROVAL>  (724) 
1999.0

>  <ATC_CODE>  (724) 
R07AX01

>  <ATC_CODE_DESCRIPTION>  (724) 
R07AX01 [Respiratory System:Other Respiratory System Products:Other Respiratory System Products:Other respiratory system products]

>  <INDICATION_CLASS>  (724) 
nan

>  <SC_PATENT_NO>  (724) 
US-5732693-A

>  <DRUG_TYPE>  (724) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (724) 
Y

>  <FIRST_IN_CLASS>  (724) 
N

>  <CHIRALITY>  (724) 
Achiral Molecule

>  <PRODRUG>  (724) 
N

>  <ORAL>  (724) 
N

>  <PARENTERAL>  (724) 
N

>  <TOPICAL>  (724) 
Y

>  <BLACK_BOX>  (724) 
N

>  <AVAILABILITY_TYPE>  (724) 
Prescription-only

>  <WITHDRAWN_YEAR>  (724) 
nan

>  <WITHDRAWN_COUNTRY>  (724) 
nan

>  <WITHDRAWN_REASON>  (724) 
nan

>  <CANONICAL_SMILES>  (724) 
O=[N]

>  <name>  (724) 
Nitric Oxide 

>  <MW>  (724) 
30.006

>  <logP>  (724) 
-0.4471

$$$$
CHEMBL473159
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9  2  1  0
M  END
>  <PARENT_MOLREGNO>  (725) 
459125

>  <SYNONYMS>  (725) 
Phloroglucinol

>  <DEVELOPMENT_PHASE>  (725) 
4

>  <RESEARCH_CODES>  (725) 
nan

>  <APPLICANTS>  (725) 
nan

>  <USAN_STEM>  (725) 
nan

>  <USAN_STEM_DEFINITION>  (725) 
nan

>  <USAN_STEM_SUBSTEM>  (725) 
nan

>  <USAN_YEAR>  (725) 
nan

>  <FIRST_APPROVAL>  (725) 
nan

>  <ATC_CODE>  (725) 
A03AX12

>  <ATC_CODE_DESCRIPTION>  (725) 
A03AX12 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Other drugs for functional gastrointestinal disorders]

>  <INDICATION_CLASS>  (725) 
nan

>  <SC_PATENT_NO>  (725) 
nan

>  <DRUG_TYPE>  (725) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (725) 
Y

>  <FIRST_IN_CLASS>  (725) 
N

>  <CHIRALITY>  (725) 
Achiral Molecule

>  <PRODRUG>  (725) 
N

>  <ORAL>  (725) 
N

>  <PARENTERAL>  (725) 
N

>  <TOPICAL>  (725) 
N

>  <BLACK_BOX>  (725) 
N

>  <AVAILABILITY_TYPE>  (725) 
Unknown

>  <WITHDRAWN_YEAR>  (725) 
nan

>  <WITHDRAWN_COUNTRY>  (725) 
nan

>  <WITHDRAWN_REASON>  (725) 
nan

>  <CANONICAL_SMILES>  (725) 
Oc1cc(O)cc(O)c1

>  <name>  (725) 
Phloroglucinol

>  <MW>  (725) 
126.111

>  <logP>  (725) 
0.8034

$$$$
CHEMBL727
     RDKit          

 11 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11  2  1  0
  8  4  2  0
M  END
>  <PARENT_MOLREGNO>  (726) 
36864

>  <SYNONYMS>  (726) 
Thioguanine (FDA, USAN, USP); Tioguanine (BAN, INN)

>  <DEVELOPMENT_PHASE>  (726) 
4

>  <RESEARCH_CODES>  (726) 
nan

>  <APPLICANTS>  (726) 
GlaxoSmithKline

>  <USAN_STEM>  (726) 
nan

>  <USAN_STEM_DEFINITION>  (726) 
nan

>  <USAN_STEM_SUBSTEM>  (726) 
nan

>  <USAN_YEAR>  (726) 
1965.0

>  <FIRST_APPROVAL>  (726) 
1966.0

>  <ATC_CODE>  (726) 
L01BB03

>  <ATC_CODE_DESCRIPTION>  (726) 
L01BB03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Purine analogues]

>  <INDICATION_CLASS>  (726) 
Antineoplastic

>  <SC_PATENT_NO>  (726) 
nan

>  <DRUG_TYPE>  (726) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (726) 
Y

>  <FIRST_IN_CLASS>  (726) 
N

>  <CHIRALITY>  (726) 
Achiral Molecule

>  <PRODRUG>  (726) 
N

>  <ORAL>  (726) 
Y

>  <PARENTERAL>  (726) 
N

>  <TOPICAL>  (726) 
N

>  <BLACK_BOX>  (726) 
N

>  <AVAILABILITY_TYPE>  (726) 
Prescription-only

>  <WITHDRAWN_YEAR>  (726) 
nan

>  <WITHDRAWN_COUNTRY>  (726) 
nan

>  <WITHDRAWN_REASON>  (726) 
nan

>  <CANONICAL_SMILES>  (726) 
NC1=Nc2[nH]cnc2C(=S)N1

>  <name>  (726) 
Thioguanine 

>  <MW>  (726) 
167.197

>  <logP>  (726) 
0.59769

$$$$
CHEMBL24778
     RDKit          

 35 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  9 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
  2 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
 16  4  1  0
 14  6  2  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (727) 
33307

>  <SYNONYMS>  (727) 
Silodosin (FDA, INN)

>  <DEVELOPMENT_PHASE>  (727) 
4

>  <RESEARCH_CODES>  (727) 
nan

>  <APPLICANTS>  (727) 
Watson Laboratories Inc

>  <USAN_STEM>  (727) 
nan

>  <USAN_STEM_DEFINITION>  (727) 
nan

>  <USAN_STEM_SUBSTEM>  (727) 
nan

>  <USAN_YEAR>  (727) 
nan

>  <FIRST_APPROVAL>  (727) 
2008.0

>  <ATC_CODE>  (727) 
G04CA04

>  <ATC_CODE_DESCRIPTION>  (727) 
G04CA04 [Genito Urinary System And Sex Hormones:Urologicals:Drugs Used In Benign Prostatic Hypertrophy:Alpha-adrenoreceptor antagonists]

>  <INDICATION_CLASS>  (727) 
nan

>  <SC_PATENT_NO>  (727) 
US-5387603-A

>  <DRUG_TYPE>  (727) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (727) 
Y

>  <FIRST_IN_CLASS>  (727) 
N

>  <CHIRALITY>  (727) 
Single Stereoisomer

>  <PRODRUG>  (727) 
N

>  <ORAL>  (727) 
Y

>  <PARENTERAL>  (727) 
N

>  <TOPICAL>  (727) 
N

>  <BLACK_BOX>  (727) 
N

>  <AVAILABILITY_TYPE>  (727) 
Prescription-only

>  <WITHDRAWN_YEAR>  (727) 
nan

>  <WITHDRAWN_COUNTRY>  (727) 
nan

>  <WITHDRAWN_REASON>  (727) 
nan

>  <CANONICAL_SMILES>  (727) 
C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(=O)N)NCCOc3ccccc3OCC(F)(F)F

>  <name>  (727) 
Silodosin 

>  <MW>  (727) 
495.542

>  <logP>  (727) 
3.0711

$$$$
CHEMBL1200714
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16  2  1  0
 10  4  1  0
M  END
>  <PARENT_MOLREGNO>  (728) 
674665

>  <SYNONYMS>  (728) 
Chlormezanone (BAN, FDA, INN, JAN, MI)

>  <DEVELOPMENT_PHASE>  (728) 
4

>  <RESEARCH_CODES>  (728) 
nan

>  <APPLICANTS>  (728) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (728) 
nan

>  <USAN_STEM_DEFINITION>  (728) 
nan

>  <USAN_STEM_SUBSTEM>  (728) 
nan

>  <USAN_YEAR>  (728) 
nan

>  <FIRST_APPROVAL>  (728) 
1960.0

>  <ATC_CODE>  (728) 
M03BB52; M03BB02; M03BB72

>  <ATC_CODE_DESCRIPTION>  (728) 
M03BB52 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Oxazol, thiazine, and triazine derivatives]; M03BB02 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Oxazol, thiazine, and triazine derivatives]; M03BB72 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Oxazol, thiazine, and triazine derivatives]

>  <INDICATION_CLASS>  (728) 
nan

>  <SC_PATENT_NO>  (728) 
nan

>  <DRUG_TYPE>  (728) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (728) 
Y

>  <FIRST_IN_CLASS>  (728) 
N

>  <CHIRALITY>  (728) 
Racemic Mixture

>  <PRODRUG>  (728) 
N

>  <ORAL>  (728) 
Y

>  <PARENTERAL>  (728) 
N

>  <TOPICAL>  (728) 
N

>  <BLACK_BOX>  (728) 
N

>  <AVAILABILITY_TYPE>  (728) 
Withdrawn

>  <WITHDRAWN_YEAR>  (728) 
1996.0

>  <WITHDRAWN_COUNTRY>  (728) 
United States; European Union; Germany; France; Japan; Pakistan; Portugal; United Arab Emirates; Zimbabwe; Saudi Arabia

>  <WITHDRAWN_REASON>  (728) 
Hepatotoxicity; Steven-Johnson Syndrome; Toxic Epidermal Necrolysis

>  <CANONICAL_SMILES>  (728) 
CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O

>  <name>  (728) 
Chlormezanone 

>  <MW>  (728) 
273.741

>  <logP>  (728) 
1.6155

$$$$
CHEMBL746
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 17 22  1  0
 22 23  2  0
 22 24  1  0
  7 25  1  0
 25 26  2  0
 25 27  1  0
 21  4  1  0
 11  5  1  0
 21 13  2  0
M  END
>  <PARENT_MOLREGNO>  (729) 
39540

>  <SYNONYMS>  (729) 
Nedocromil (BAN, INN, USAN); Nedocromil sodium (FDA, USAN); Nedocromil Calcium (USAN)

>  <DEVELOPMENT_PHASE>  (729) 
4

>  <RESEARCH_CODES>  (729) 
FPL-59002; FPL-59002KP; FPL-59002KC

>  <APPLICANTS>  (729) 
Sanofi Aventis Us Llc; King Pharmaceuticals Inc; Fisons; Allergan Inc

>  <USAN_STEM>  (729) 
-cromil

>  <USAN_STEM_DEFINITION>  (729) 
antiallergics (cromoglicic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (729) 
-cromil

>  <USAN_YEAR>  (729) 
1985.0

>  <FIRST_APPROVAL>  (729) 
1992.0

>  <ATC_CODE>  (729) 
S01GX04; R01AC07; R03BC03

>  <ATC_CODE_DESCRIPTION>  (729) 
S01GX04 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]; R01AC07 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Antiallergic agents, excl. corticosteroids]; R03BC03 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Antiallergic agents, excl. corticosteroids]

>  <INDICATION_CLASS>  (729) 
Anti-Allergic (prophylactic)

>  <SC_PATENT_NO>  (729) 
nan

>  <DRUG_TYPE>  (729) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (729) 
Y

>  <FIRST_IN_CLASS>  (729) 
N

>  <CHIRALITY>  (729) 
Achiral Molecule

>  <PRODRUG>  (729) 
N

>  <ORAL>  (729) 
N

>  <PARENTERAL>  (729) 
N

>  <TOPICAL>  (729) 
Y

>  <BLACK_BOX>  (729) 
N

>  <AVAILABILITY_TYPE>  (729) 
Prescription-only

>  <WITHDRAWN_YEAR>  (729) 
nan

>  <WITHDRAWN_COUNTRY>  (729) 
nan

>  <WITHDRAWN_REASON>  (729) 
nan

>  <CANONICAL_SMILES>  (729) 
CCCc1c2OC(=CC(=O)c2cc3C(=O)C=C(N(CC)c13)C(=O)O)C(=O)O

>  <name>  (729) 
Nedocromil 

>  <MW>  (729) 
371.345

>  <logP>  (729) 
2.4767

$$$$
CHEMBL1491
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 15 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 14 28  1  0
 16  6  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (730) 
418414

>  <SYNONYMS>  (730) 
Amlodipine (BAN, INN); Amlodipine Besilate (JAN); Amlodipine Besylate (FDA, USAN); Amlodipine Maleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (730) 
4

>  <RESEARCH_CODES>  (730) 
UK-4834026; UK-48340-26; UK-4834011; UK-48340-11

>  <APPLICANTS>  (730) 
Novartis Pharmaceuticals Corp; Dr Reddys Laboratories Inc; Daiichi Sankyo Inc; Boehringer Ingelheim Pharmaceuticals Inc; Synthon Pharmaceuticals Inc

>  <USAN_STEM>  (730) 
-dipine

>  <USAN_STEM_DEFINITION>  (730) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (730) 
-dipine

>  <USAN_YEAR>  (730) 
1986.0

>  <FIRST_APPROVAL>  (730) 
1992.0

>  <ATC_CODE>  (730) 
C08CA01

>  <ATC_CODE_DESCRIPTION>  (730) 
C08CA01 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (730) 
Anti-Anginal; Antihypertensive

>  <SC_PATENT_NO>  (730) 
US-5559111-A

>  <DRUG_TYPE>  (730) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (730) 
Y

>  <FIRST_IN_CLASS>  (730) 
N

>  <CHIRALITY>  (730) 
Racemic Mixture

>  <PRODRUG>  (730) 
N

>  <ORAL>  (730) 
Y

>  <PARENTERAL>  (730) 
N

>  <TOPICAL>  (730) 
N

>  <BLACK_BOX>  (730) 
Y

>  <AVAILABILITY_TYPE>  (730) 
Prescription-only

>  <WITHDRAWN_YEAR>  (730) 
nan

>  <WITHDRAWN_COUNTRY>  (730) 
nan

>  <WITHDRAWN_REASON>  (730) 
nan

>  <CANONICAL_SMILES>  (730) 
CCOC(=O)C1=C(COCCN)NC(=C(C1c2ccccc2Cl)C(=O)OC)C

>  <name>  (730) 
Amlodipine 

>  <MW>  (730) 
408.882

>  <logP>  (730) 
2.2663

$$$$
CHEMBL862
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (731) 
66029

>  <SYNONYMS>  (731) 
Guanfacine (BAN, INN); Guanfacine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (731) 
4

>  <RESEARCH_CODES>  (731) 
BS-100-141

>  <APPLICANTS>  (731) 
Shire Development Inc; Promius Pharma Llc

>  <USAN_STEM>  (731) 
guan-

>  <USAN_STEM_DEFINITION>  (731) 
antihypertensives (guanidine derivatives)

>  <USAN_STEM_SUBSTEM>  (731) 
guan-

>  <USAN_YEAR>  (731) 
1979.0

>  <FIRST_APPROVAL>  (731) 
1986.0

>  <ATC_CODE>  (731) 
C02AC02

>  <ATC_CODE_DESCRIPTION>  (731) 
C02AC02 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Centrally Acting:Imidazoline receptor agonists]

>  <INDICATION_CLASS>  (731) 
Antihypertensive

>  <SC_PATENT_NO>  (731) 
US-5854290-A

>  <DRUG_TYPE>  (731) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (731) 
Y

>  <FIRST_IN_CLASS>  (731) 
N

>  <CHIRALITY>  (731) 
Achiral Molecule

>  <PRODRUG>  (731) 
N

>  <ORAL>  (731) 
Y

>  <PARENTERAL>  (731) 
N

>  <TOPICAL>  (731) 
N

>  <BLACK_BOX>  (731) 
N

>  <AVAILABILITY_TYPE>  (731) 
Prescription-only

>  <WITHDRAWN_YEAR>  (731) 
nan

>  <WITHDRAWN_COUNTRY>  (731) 
nan

>  <WITHDRAWN_REASON>  (731) 
nan

>  <CANONICAL_SMILES>  (731) 
NC(=N)NC(=O)Cc1c(Cl)cccc1Cl

>  <name>  (731) 
Guanfacine 

>  <MW>  (731) 
246.097

>  <logP>  (731) 
1.54557

$$$$
CHEMBL2110990
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  5 10  1  0
 10 11  2  0
 10 12  2  0
 10 13  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (732) 
1383430

>  <SYNONYMS>  (732) 
Sulfogaiacol (INN, DCF); Potassium Guaiacolsulfonate (JAN, USP)

>  <DEVELOPMENT_PHASE>  (732) 
4

>  <RESEARCH_CODES>  (732) 
nan

>  <APPLICANTS>  (732) 
nan

>  <USAN_STEM>  (732) 
-fo-

>  <USAN_STEM_DEFINITION>  (732) 
phosphoro-derivatives

>  <USAN_STEM_SUBSTEM>  (732) 
-fo-

>  <USAN_YEAR>  (732) 
nan

>  <FIRST_APPROVAL>  (732) 
nan

>  <ATC_CODE>  (732) 
R05CA09

>  <ATC_CODE_DESCRIPTION>  (732) 
R05CA09 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Expectorants]

>  <INDICATION_CLASS>  (732) 
Expectorant

>  <SC_PATENT_NO>  (732) 
nan

>  <DRUG_TYPE>  (732) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (732) 
Y

>  <FIRST_IN_CLASS>  (732) 
N

>  <CHIRALITY>  (732) 
Achiral Molecule

>  <PRODRUG>  (732) 
N

>  <ORAL>  (732) 
N

>  <PARENTERAL>  (732) 
N

>  <TOPICAL>  (732) 
N

>  <BLACK_BOX>  (732) 
N

>  <AVAILABILITY_TYPE>  (732) 
Unknown

>  <WITHDRAWN_YEAR>  (732) 
nan

>  <WITHDRAWN_COUNTRY>  (732) 
nan

>  <WITHDRAWN_REASON>  (732) 
nan

>  <CANONICAL_SMILES>  (732) 
COc1cc(ccc1O)S(=O)(=O)O

>  <name>  (732) 
Sulfogaiacol 

>  <MW>  (732) 
204.203

>  <logP>  (732) 
0.6475

$$$$
CHEMBL1201328
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 23 27  1  0
 27 28  1  0
 16 29  1  0
 29 30  2  0
 30  5  1  0
 29  8  1  0
 15 10  1  0
 28 20  1  0
M  END
>  <PARENT_MOLREGNO>  (733) 
675279

>  <SYNONYMS>  (733) 
Carfenazine (INN); Carphenazine Maleate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (733) 
4

>  <RESEARCH_CODES>  (733) 
WY-2445

>  <APPLICANTS>  (733) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (733) 
nan

>  <USAN_STEM_DEFINITION>  (733) 
nan

>  <USAN_STEM_SUBSTEM>  (733) 
nan

>  <USAN_YEAR>  (733) 
1962.0

>  <FIRST_APPROVAL>  (733) 
1982.0

>  <ATC_CODE>  (733) 
nan

>  <ATC_CODE_DESCRIPTION>  (733) 
nan

>  <INDICATION_CLASS>  (733) 
Antipsychotic

>  <SC_PATENT_NO>  (733) 
nan

>  <DRUG_TYPE>  (733) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (733) 
Y

>  <FIRST_IN_CLASS>  (733) 
N

>  <CHIRALITY>  (733) 
Achiral Molecule

>  <PRODRUG>  (733) 
N

>  <ORAL>  (733) 
Y

>  <PARENTERAL>  (733) 
N

>  <TOPICAL>  (733) 
N

>  <BLACK_BOX>  (733) 
N

>  <AVAILABILITY_TYPE>  (733) 
Discontinued

>  <WITHDRAWN_YEAR>  (733) 
nan

>  <WITHDRAWN_COUNTRY>  (733) 
nan

>  <WITHDRAWN_REASON>  (733) 
nan

>  <CANONICAL_SMILES>  (733) 
CCC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1

>  <name>  (733) 
Carfenazine 

>  <MW>  (733) 
425.598

>  <logP>  (733) 
3.882

$$$$
CHEMBL3137301
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  9 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 16 11  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (734) 
1626732

>  <SYNONYMS>  (734) 
Sacubitril (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (734) 
4

>  <RESEARCH_CODES>  (734) 
AHU377

>  <APPLICANTS>  (734) 
Novartis Pharmaceuticals Corp; Novartis Pharma Ag

>  <USAN_STEM>  (734) 
-tril

>  <USAN_STEM_DEFINITION>  (734) 
endopeptidase inhibitors

>  <USAN_STEM_SUBSTEM>  (734) 
-tril

>  <USAN_YEAR>  (734) 
2014.0

>  <FIRST_APPROVAL>  (734) 
2015.0

>  <ATC_CODE>  (734) 
nan

>  <ATC_CODE_DESCRIPTION>  (734) 
nan

>  <INDICATION_CLASS>  (734) 
nan

>  <SC_PATENT_NO>  (734) 
US-7468390-B2

>  <DRUG_TYPE>  (734) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (734) 
Y

>  <FIRST_IN_CLASS>  (734) 
Y

>  <CHIRALITY>  (734) 
Single Stereoisomer

>  <PRODRUG>  (734) 
N

>  <ORAL>  (734) 
Y

>  <PARENTERAL>  (734) 
N

>  <TOPICAL>  (734) 
N

>  <BLACK_BOX>  (734) 
Y

>  <AVAILABILITY_TYPE>  (734) 
Prescription-only

>  <WITHDRAWN_YEAR>  (734) 
nan

>  <WITHDRAWN_COUNTRY>  (734) 
nan

>  <WITHDRAWN_REASON>  (734) 
nan

>  <CANONICAL_SMILES>  (734) 
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)O

>  <name>  (734) 
Sacubitril 

>  <MW>  (734) 
411.498

>  <logP>  (734) 
3.835

$$$$
CHEMBL1162
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  3  0
 16  2  1  0
 19  2  1  0
 15  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (735) 
187962

>  <SYNONYMS>  (735) 
Norethindrone (FDA, USP); Norethisterone (BAN, DCF, INN, JAN)

>  <DEVELOPMENT_PHASE>  (735) 
4

>  <RESEARCH_CODES>  (735) 
nan

>  <APPLICANTS>  (735) 
Ortho Mcneil Pharmaceutical Inc; Ortho Mcneil Janssen Pharmaceuticals Inc; Janssen Pharmaceuticals Inc; Gd Searle Llc; Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (735) 
nan

>  <USAN_STEM_DEFINITION>  (735) 
nan

>  <USAN_STEM_SUBSTEM>  (735) 
nan

>  <USAN_YEAR>  (735) 
nan

>  <FIRST_APPROVAL>  (735) 
1962.0

>  <ATC_CODE>  (735) 
G03DC02; G03AC01

>  <ATC_CODE_DESCRIPTION>  (735) 
G03DC02 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Estren derivatives]; G03AC01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Hormonal Contraceptives For Systemic Use:Progestogens]

>  <INDICATION_CLASS>  (735) 
Progestin

>  <SC_PATENT_NO>  (735) 
US-6667050-B1

>  <DRUG_TYPE>  (735) 
Natural Product-derived

>  <RULE_OF_FIVE>  (735) 
Y

>  <FIRST_IN_CLASS>  (735) 
N

>  <CHIRALITY>  (735) 
Single Stereoisomer

>  <PRODRUG>  (735) 
N

>  <ORAL>  (735) 
Y

>  <PARENTERAL>  (735) 
N

>  <TOPICAL>  (735) 
N

>  <BLACK_BOX>  (735) 
Y

>  <AVAILABILITY_TYPE>  (735) 
Prescription-only

>  <WITHDRAWN_YEAR>  (735) 
nan

>  <WITHDRAWN_COUNTRY>  (735) 
nan

>  <WITHDRAWN_REASON>  (735) 
nan

>  <CANONICAL_SMILES>  (735) 
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

>  <name>  (735) 
Norethindrone 

>  <MW>  (735) 
298.426

>  <logP>  (735) 
3.4925

$$$$
CHEMBL273575
     RDKit          

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18  2  1  0
 10  5  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (736) 
16225

>  <SYNONYMS>  (736) 
Nomifensine (BAN, INN); Nomifensine Maleate (USAN)

>  <DEVELOPMENT_PHASE>  (736) 
4

>  <RESEARCH_CODES>  (736) 
HOE-984

>  <APPLICANTS>  (736) 
Hoechst-Roussel

>  <USAN_STEM>  (736) 
nan

>  <USAN_STEM_DEFINITION>  (736) 
nan

>  <USAN_STEM_SUBSTEM>  (736) 
nan

>  <USAN_YEAR>  (736) 
1975.0

>  <FIRST_APPROVAL>  (736) 
1984.0

>  <ATC_CODE>  (736) 
N06AX04

>  <ATC_CODE_DESCRIPTION>  (736) 
N06AX04 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (736) 
Antidepressant

>  <SC_PATENT_NO>  (736) 
nan

>  <DRUG_TYPE>  (736) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (736) 
Y

>  <FIRST_IN_CLASS>  (736) 
N

>  <CHIRALITY>  (736) 
Racemic Mixture

>  <PRODRUG>  (736) 
N

>  <ORAL>  (736) 
N

>  <PARENTERAL>  (736) 
N

>  <TOPICAL>  (736) 
N

>  <BLACK_BOX>  (736) 
N

>  <AVAILABILITY_TYPE>  (736) 
Withdrawn

>  <WITHDRAWN_YEAR>  (736) 
1986.0

>  <WITHDRAWN_COUNTRY>  (736) 
United States; United Kingdom; United States; Spain; Germany; France

>  <WITHDRAWN_REASON>  (736) 
Serious hypersensitive reactions; Hemolytic Anemia; Hepatotoxicity

>  <CANONICAL_SMILES>  (736) 
CN1CC(c2ccccc2)c3cccc(N)c3C1

>  <name>  (736) 
Nomifensine 

>  <MW>  (736) 
238.334

>  <logP>  (736) 
2.8461

$$$$
CHEMBL1201308
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (737) 
675259

>  <SYNONYMS>  (737) 
Iofetamine (123I) (INN); Iofetamine Hydrochloride (123I) (USAN, FDA); N-Isopropyl-p-Iodoamphetamine (123I) HCl (JAN)

>  <DEVELOPMENT_PHASE>  (737) 
4

>  <RESEARCH_CODES>  (737) 
123I Labeled IMP; 123I-M123

>  <APPLICANTS>  (737) 
Imp Inc

>  <USAN_STEM>  (737) 
-fetamin(e); io-

>  <USAN_STEM_DEFINITION>  (737) 
amfetamine derivatives; iodine-containing contrast media

>  <USAN_STEM_SUBSTEM>  (737) 
-fetamin(e); io-

>  <USAN_YEAR>  (737) 
1984.0

>  <FIRST_APPROVAL>  (737) 
1987.0

>  <ATC_CODE>  (737) 
V09AB01

>  <ATC_CODE_DESCRIPTION>  (737) 
V09AB01 [Various:Diagnostic Radiopharmaceuticals:Central Nervous System:Iodine (123I) compounds]

>  <INDICATION_CLASS>  (737) 
Diagnostic Aid; Radioactive Agent

>  <SC_PATENT_NO>  (737) 
nan

>  <DRUG_TYPE>  (737) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (737) 
Y

>  <FIRST_IN_CLASS>  (737) 
N

>  <CHIRALITY>  (737) 
Racemic Mixture

>  <PRODRUG>  (737) 
N

>  <ORAL>  (737) 
N

>  <PARENTERAL>  (737) 
Y

>  <TOPICAL>  (737) 
N

>  <BLACK_BOX>  (737) 
N

>  <AVAILABILITY_TYPE>  (737) 
Discontinued

>  <WITHDRAWN_YEAR>  (737) 
nan

>  <WITHDRAWN_COUNTRY>  (737) 
nan

>  <WITHDRAWN_REASON>  (737) 
nan

>  <CANONICAL_SMILES>  (737) 
CC(C)NC(C)Cc1ccc(I)cc1

>  <name>  (737) 
Iofetamine 

>  <MW>  (737) 
303.187

>  <logP>  (737) 
3.2202

$$$$
CHEMBL651
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
  5 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  5 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (738) 
27576

>  <SYNONYMS>  (738) 
Methadone (BAN, INN); Methadone HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (738) 
4

>  <RESEARCH_CODES>  (738) 
nan

>  <APPLICANTS>  (738) 
Sandoz Inc; Roxane Laboratories Inc; Mylan Institutional Llc; Mallinckrodt Chemical Inc

>  <USAN_STEM>  (738) 
nan

>  <USAN_STEM_DEFINITION>  (738) 
nan

>  <USAN_STEM_SUBSTEM>  (738) 
nan

>  <USAN_YEAR>  (738) 
nan

>  <FIRST_APPROVAL>  (738) 
1947.0

>  <ATC_CODE>  (738) 
N07BC02; N02AC52

>  <ATC_CODE_DESCRIPTION>  (738) 
N07BC02 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in opioid dependence]; N02AC52 [Nervous System:Analgesics:Opioids:Diphenylpropylamine derivatives]

>  <INDICATION_CLASS>  (738) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (738) 
nan

>  <DRUG_TYPE>  (738) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (738) 
Y

>  <FIRST_IN_CLASS>  (738) 
N

>  <CHIRALITY>  (738) 
Racemic Mixture

>  <PRODRUG>  (738) 
N

>  <ORAL>  (738) 
Y

>  <PARENTERAL>  (738) 
Y

>  <TOPICAL>  (738) 
N

>  <BLACK_BOX>  (738) 
Y

>  <AVAILABILITY_TYPE>  (738) 
Prescription-only

>  <WITHDRAWN_YEAR>  (738) 
nan

>  <WITHDRAWN_COUNTRY>  (738) 
nan

>  <WITHDRAWN_REASON>  (738) 
nan

>  <CANONICAL_SMILES>  (738) 
CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2

>  <name>  (738) 
Methadone 

>  <MW>  (738) 
309.453

>  <logP>  (738) 
4.292

$$$$
CHEMBL521
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13 15  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (739) 
11674

>  <SYNONYMS>  (739) 
Ibuprofen (BAN, FDA, INN, JAN, USAN, USP); Ibuprofen Lysine (FDA, USAN); Ibuprofen Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (739) 
4

>  <RESEARCH_CODES>  (739) 
U-18573

>  <APPLICANTS>  (739) 
Banner Pharmacaps Inc; Alterna Tchp Llc; Abbvie Inc; Abbott Laboratories Pharmaceutical Products Div; Lundbeck Llc

>  <USAN_STEM>  (739) 
-profen

>  <USAN_STEM_DEFINITION>  (739) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (739) 
-profen

>  <USAN_YEAR>  (739) 
1968.0

>  <FIRST_APPROVAL>  (739) 
1974.0

>  <ATC_CODE>  (739) 
R02AX02; M01AE51; C01EB16; G02CC01; M01AE01; M02AA13

>  <ATC_CODE_DESCRIPTION>  (739) 
R02AX02 [Respiratory System:Throat Preparations:Throat Preparations:Other throat preparations]; M01AE51 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]; C01EB16 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]; G02CC01 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Other Gynecologicals:Antiinflammatory products for vaginal administration]; M01AE01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]; M02AA13 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]

>  <INDICATION_CLASS>  (739) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (739) 
US-6211246-B1

>  <DRUG_TYPE>  (739) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (739) 
Y

>  <FIRST_IN_CLASS>  (739) 
N

>  <CHIRALITY>  (739) 
Racemic Mixture

>  <PRODRUG>  (739) 
N

>  <ORAL>  (739) 
Y

>  <PARENTERAL>  (739) 
Y

>  <TOPICAL>  (739) 
N

>  <BLACK_BOX>  (739) 
Y

>  <AVAILABILITY_TYPE>  (739) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (739) 
nan

>  <WITHDRAWN_COUNTRY>  (739) 
nan

>  <WITHDRAWN_REASON>  (739) 
nan

>  <CANONICAL_SMILES>  (739) 
CC(C)Cc1ccc(cc1)C(C)C(=O)O

>  <name>  (739) 
Ibuprofen 

>  <MW>  (739) 
206.285

>  <logP>  (739) 
3.0732

$$$$
CHEMBL1201
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 18 29  1  0
 29 30  2  0
 30  7  1  0
 29 10  1  0
 17 12  1  0
 28 22  1  0
M  END
>  <PARENT_MOLREGNO>  (740) 
209829

>  <SYNONYMS>  (740) 
Thiothixene (FDA, USAN, USP); Tiotixene (BAN, DCF, INN, JAN); Thiothixene HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (740) 
4

>  <RESEARCH_CODES>  (740) 
P-4657B; CP-122521; CP-12252-1

>  <APPLICANTS>  (740) 
Pfizer Inc.

>  <USAN_STEM>  (740) 
nan

>  <USAN_STEM_DEFINITION>  (740) 
nan

>  <USAN_STEM_SUBSTEM>  (740) 
nan

>  <USAN_YEAR>  (740) 
1965.0

>  <FIRST_APPROVAL>  (740) 
1967.0

>  <ATC_CODE>  (740) 
N05AF04

>  <ATC_CODE_DESCRIPTION>  (740) 
N05AF04 [Nervous System:Psycholeptics:Antipsychotics:Thioxanthene derivatives]

>  <INDICATION_CLASS>  (740) 
Antipsychotic

>  <SC_PATENT_NO>  (740) 
nan

>  <DRUG_TYPE>  (740) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (740) 
Y

>  <FIRST_IN_CLASS>  (740) 
N

>  <CHIRALITY>  (740) 
Achiral Molecule

>  <PRODRUG>  (740) 
N

>  <ORAL>  (740) 
Y

>  <PARENTERAL>  (740) 
Y

>  <TOPICAL>  (740) 
N

>  <BLACK_BOX>  (740) 
Y

>  <AVAILABILITY_TYPE>  (740) 
Prescription-only

>  <WITHDRAWN_YEAR>  (740) 
nan

>  <WITHDRAWN_COUNTRY>  (740) 
nan

>  <WITHDRAWN_REASON>  (740) 
nan

>  <CANONICAL_SMILES>  (740) 
CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C\CCN4CCN(C)CC4)\c2c1

>  <name>  (740) 
Thiothixene 

>  <MW>  (740) 
443.638

>  <logP>  (740) 
3.4707

$$$$
CHEMBL1697856
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  7 15  1  0
 15 16  2  0
 16  4  1  0
M  END
>  <PARENT_MOLREGNO>  (741) 
1078605

>  <SYNONYMS>  (741) 
Bucetin (BAN, INN, JAN, MI)

>  <DEVELOPMENT_PHASE>  (741) 
4

>  <RESEARCH_CODES>  (741) 
nan

>  <APPLICANTS>  (741) 
nan

>  <USAN_STEM>  (741) 
nan

>  <USAN_STEM_DEFINITION>  (741) 
nan

>  <USAN_STEM_SUBSTEM>  (741) 
nan

>  <USAN_YEAR>  (741) 
nan

>  <FIRST_APPROVAL>  (741) 
nan

>  <ATC_CODE>  (741) 
N02BE04; N02BE54; N02BE74

>  <ATC_CODE_DESCRIPTION>  (741) 
N02BE04 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]; N02BE54 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]; N02BE74 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Anilides]

>  <INDICATION_CLASS>  (741) 
nan

>  <SC_PATENT_NO>  (741) 
nan

>  <DRUG_TYPE>  (741) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (741) 
Y

>  <FIRST_IN_CLASS>  (741) 
N

>  <CHIRALITY>  (741) 
Racemic Mixture

>  <PRODRUG>  (741) 
N

>  <ORAL>  (741) 
N

>  <PARENTERAL>  (741) 
N

>  <TOPICAL>  (741) 
N

>  <BLACK_BOX>  (741) 
N

>  <AVAILABILITY_TYPE>  (741) 
Withdrawn

>  <WITHDRAWN_YEAR>  (741) 
1986.0

>  <WITHDRAWN_COUNTRY>  (741) 
Germany

>  <WITHDRAWN_REASON>  (741) 
Renal

>  <CANONICAL_SMILES>  (741) 
CCOc1ccc(NC(=O)CC(C)O)cc1

>  <name>  (741) 
Bucetin 

>  <MW>  (741) 
223.272

>  <logP>  (741) 
1.7947

$$$$
CHEMBL1224
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 20 26  2  0
  7  2  1  0
 15 11  1  0
 26 16  1  0
M  END
>  <PARENT_MOLREGNO>  (742) 
226880

>  <SYNONYMS>  (742) 
Acrivastine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (742) 
4

>  <RESEARCH_CODES>  (742) 
BW-825C

>  <APPLICANTS>  (742) 
Ucb Inc

>  <USAN_STEM>  (742) 
-astine

>  <USAN_STEM_DEFINITION>  (742) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (742) 
-astine

>  <USAN_YEAR>  (742) 
1985.0

>  <FIRST_APPROVAL>  (742) 
1994.0

>  <ATC_CODE>  (742) 
R06AX18

>  <ATC_CODE_DESCRIPTION>  (742) 
R06AX18 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (742) 
Antihistaminic

>  <SC_PATENT_NO>  (742) 
nan

>  <DRUG_TYPE>  (742) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (742) 
Y

>  <FIRST_IN_CLASS>  (742) 
N

>  <CHIRALITY>  (742) 
Achiral Molecule

>  <PRODRUG>  (742) 
N

>  <ORAL>  (742) 
Y

>  <PARENTERAL>  (742) 
N

>  <TOPICAL>  (742) 
N

>  <BLACK_BOX>  (742) 
N

>  <AVAILABILITY_TYPE>  (742) 
Prescription-only

>  <WITHDRAWN_YEAR>  (742) 
nan

>  <WITHDRAWN_COUNTRY>  (742) 
nan

>  <WITHDRAWN_REASON>  (742) 
nan

>  <CANONICAL_SMILES>  (742) 
Cc1ccc(cc1)\C(=C/CN2CCCC2)\c3cccc(\C=C\C(=O)O)n3

>  <name>  (742) 
Acrivastine 

>  <MW>  (742) 
348.446

>  <logP>  (742) 
4.01532

$$$$
CHEMBL1088
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 21 24  1  0
 24 25  1  0
 24 26  1  0
  7  2  1  0
 23 10  1  0
 16 11  1  0
 23 18  1  0
M  CHG  2  24   1  26  -1
M  END
>  <PARENT_MOLREGNO>  (743) 
148004

>  <SYNONYMS>  (743) 
Mesoridazine (BAN, INN, USAN); Mesoridazine besylate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (743) 
4

>  <RESEARCH_CODES>  (743) 
NC-123; TPS-23

>  <APPLICANTS>  (743) 
Novartis Pharmaceuticals Corp; Novartis

>  <USAN_STEM>  (743) 
nan

>  <USAN_STEM_DEFINITION>  (743) 
nan

>  <USAN_STEM_SUBSTEM>  (743) 
nan

>  <USAN_YEAR>  (743) 
1965.0

>  <FIRST_APPROVAL>  (743) 
1970.0

>  <ATC_CODE>  (743) 
N05AC03

>  <ATC_CODE_DESCRIPTION>  (743) 
N05AC03 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperidine structure]

>  <INDICATION_CLASS>  (743) 
Antipsychotic

>  <SC_PATENT_NO>  (743) 
nan

>  <DRUG_TYPE>  (743) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (743) 
Y

>  <FIRST_IN_CLASS>  (743) 
N

>  <CHIRALITY>  (743) 
Racemic Mixture

>  <PRODRUG>  (743) 
N

>  <ORAL>  (743) 
Y

>  <PARENTERAL>  (743) 
Y

>  <TOPICAL>  (743) 
N

>  <BLACK_BOX>  (743) 
Y

>  <AVAILABILITY_TYPE>  (743) 
Discontinued

>  <WITHDRAWN_YEAR>  (743) 
nan

>  <WITHDRAWN_COUNTRY>  (743) 
nan

>  <WITHDRAWN_REASON>  (743) 
nan

>  <CANONICAL_SMILES>  (743) 
CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-]

>  <name>  (743) 
Mesoridazine 

>  <MW>  (743) 
386.586

>  <logP>  (743) 
4.9011

$$$$
CHEMBL524004
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 12 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
  8  2  1  0
 19 14  1  0
 25 20  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (744) 
469580

>  <SYNONYMS>  (744) 
Mepenzolate bromide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (744) 
4

>  <RESEARCH_CODES>  (744) 
nan

>  <APPLICANTS>  (744) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (744) 
nan

>  <USAN_STEM_DEFINITION>  (744) 
nan

>  <USAN_STEM_SUBSTEM>  (744) 
nan

>  <USAN_YEAR>  (744) 
nan

>  <FIRST_APPROVAL>  (744) 
1956.0

>  <ATC_CODE>  (744) 
A03AB12

>  <ATC_CODE_DESCRIPTION>  (744) 
A03AB12 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (744) 
Anticholinergic

>  <SC_PATENT_NO>  (744) 
nan

>  <DRUG_TYPE>  (744) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (744) 
Y

>  <FIRST_IN_CLASS>  (744) 
N

>  <CHIRALITY>  (744) 
Racemic Mixture

>  <PRODRUG>  (744) 
N

>  <ORAL>  (744) 
Y

>  <PARENTERAL>  (744) 
N

>  <TOPICAL>  (744) 
N

>  <BLACK_BOX>  (744) 
N

>  <AVAILABILITY_TYPE>  (744) 
Prescription-only

>  <WITHDRAWN_YEAR>  (744) 
nan

>  <WITHDRAWN_COUNTRY>  (744) 
nan

>  <WITHDRAWN_REASON>  (744) 
nan

>  <CANONICAL_SMILES>  (744) 
C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3

>  <name>  (744) 
Mepenzolate bromide 

>  <MW>  (744) 
340.443

>  <logP>  (744) 
2.7045

$$$$
CHEMBL628
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  5 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 16  2  1  0
 19 15  1  0
M  END
>  <PARENT_MOLREGNO>  (745) 
27029

>  <SYNONYMS>  (745) 
Oxpentifylline (BAN); Pentoxifylline (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (745) 
4

>  <RESEARCH_CODES>  (745) 
BL-191

>  <APPLICANTS>  (745) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (745) 
-fylline; -tox-

>  <USAN_STEM_DEFINITION>  (745) 
theophylline derivatives; toxins

>  <USAN_STEM_SUBSTEM>  (745) 
-fylline; -tox-

>  <USAN_YEAR>  (745) 
1976.0

>  <FIRST_APPROVAL>  (745) 
1984.0

>  <ATC_CODE>  (745) 
C04AD03

>  <ATC_CODE_DESCRIPTION>  (745) 
C04AD03 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Purine derivatives]

>  <INDICATION_CLASS>  (745) 
Vasodilator

>  <SC_PATENT_NO>  (745) 
nan

>  <DRUG_TYPE>  (745) 
Natural Product-derived

>  <RULE_OF_FIVE>  (745) 
Y

>  <FIRST_IN_CLASS>  (745) 
N

>  <CHIRALITY>  (745) 
Achiral Molecule

>  <PRODRUG>  (745) 
N

>  <ORAL>  (745) 
Y

>  <PARENTERAL>  (745) 
N

>  <TOPICAL>  (745) 
N

>  <BLACK_BOX>  (745) 
N

>  <AVAILABILITY_TYPE>  (745) 
Prescription-only

>  <WITHDRAWN_YEAR>  (745) 
nan

>  <WITHDRAWN_COUNTRY>  (745) 
nan

>  <WITHDRAWN_REASON>  (745) 
nan

>  <CANONICAL_SMILES>  (745) 
CN1C(=O)N(CCCCC(=O)C)C(=O)c2c1ncn2C

>  <name>  (745) 
Oxpentifylline 

>  <MW>  (745) 
278.312

>  <logP>  (745) 
0.193

$$$$
CHEMBL446143
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
M  END
>  <PARENT_MOLREGNO>  (746) 
84680

>  <SYNONYMS>  (746) 
Ornithine (INN, MI)

>  <DEVELOPMENT_PHASE>  (746) 
4

>  <RESEARCH_CODES>  (746) 
nan

>  <APPLICANTS>  (746) 
nan

>  <USAN_STEM>  (746) 
nan

>  <USAN_STEM_DEFINITION>  (746) 
nan

>  <USAN_STEM_SUBSTEM>  (746) 
nan

>  <USAN_YEAR>  (746) 
nan

>  <FIRST_APPROVAL>  (746) 
nan

>  <ATC_CODE>  (746) 
A05BA06

>  <ATC_CODE_DESCRIPTION>  (746) 
A05BA06 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Liver Therapy, Lipotropics:Liver therapy]

>  <INDICATION_CLASS>  (746) 
nan

>  <SC_PATENT_NO>  (746) 
nan

>  <DRUG_TYPE>  (746) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (746) 
Y

>  <FIRST_IN_CLASS>  (746) 
N

>  <CHIRALITY>  (746) 
Single Stereoisomer

>  <PRODRUG>  (746) 
N

>  <ORAL>  (746) 
N

>  <PARENTERAL>  (746) 
N

>  <TOPICAL>  (746) 
N

>  <BLACK_BOX>  (746) 
N

>  <AVAILABILITY_TYPE>  (746) 
Unknown

>  <WITHDRAWN_YEAR>  (746) 
nan

>  <WITHDRAWN_COUNTRY>  (746) 
nan

>  <WITHDRAWN_REASON>  (746) 
nan

>  <CANONICAL_SMILES>  (746) 
NCCC[C@H](N)C(=O)O

>  <name>  (746) 
Ornithine 

>  <MW>  (746) 
132.163

>  <logP>  (746) 
-0.8628

$$$$
CHEMBL818
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (747) 
56402

>  <SYNONYMS>  (747) 
Iobenguane Sulfate (131I) (USAN, FDA); Iobenguane Sulfate (123I) (USAN, FDA); Iobenguane (123I) (INN, USP); Iobenguane (131I) (INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (747) 
4

>  <RESEARCH_CODES>  (747) 
nan

>  <APPLICANTS>  (747) 
Pharmalucence Inc; Ge Healthcare; Cl Pharma Ag, Austria

>  <USAN_STEM>  (747) 
io-

>  <USAN_STEM_DEFINITION>  (747) 
iodine-containing contrast media

>  <USAN_STEM_SUBSTEM>  (747) 
io-

>  <USAN_YEAR>  (747) 
1994.0

>  <FIRST_APPROVAL>  (747) 
1994.0

>  <ATC_CODE>  (747) 
V09IX01; V10XA02; V09IX02

>  <ATC_CODE_DESCRIPTION>  (747) 
V09IX01 [Various:Diagnostic Radiopharmaceuticals:Tumour Detection:Other diagnostic radiopharmaceuticals for tumour detection]; V10XA02 [Various:Therapeutic Radiopharmaceuticals:Other Therapeutic Radiopharmaceuticals:Iodine (131I) compounds]; V09IX02 [Various:Diagnostic Radiopharmaceuticals:Tumour Detection:Other diagnostic radiopharmaceuticals for tumour detection]

>  <INDICATION_CLASS>  (747) 
Diagnostic Aid; Radioactive Agent; Diagnostic Aid (radioactive, adrenomedullary disorders and neuroendocrine tumors)

>  <SC_PATENT_NO>  (747) 
nan

>  <DRUG_TYPE>  (747) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (747) 
Y

>  <FIRST_IN_CLASS>  (747) 
N

>  <CHIRALITY>  (747) 
Achiral Molecule

>  <PRODRUG>  (747) 
N

>  <ORAL>  (747) 
N

>  <PARENTERAL>  (747) 
Y

>  <TOPICAL>  (747) 
N

>  <BLACK_BOX>  (747) 
N

>  <AVAILABILITY_TYPE>  (747) 
Prescription-only

>  <WITHDRAWN_YEAR>  (747) 
nan

>  <WITHDRAWN_COUNTRY>  (747) 
nan

>  <WITHDRAWN_REASON>  (747) 
nan

>  <CANONICAL_SMILES>  (747) 
NC(=N)NCc1cccc(I)c1

>  <name>  (747) 
Iobenguane Sulfate 

>  <MW>  (747) 
275.093

>  <logP>  (747) 
1.27427

$$$$
CHEMBL1201265
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
  8 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  2  0
 34  2  1  0
 26  4  1  0
 21  5  1  0
 34 27  1  0
M  END
>  <PARENT_MOLREGNO>  (748) 
675216

>  <SYNONYMS>  (748) 
Methylprednisolone Hemisuccinate (USP); Methylprednisolone Sodium Succinate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (748) 
4

>  <RESEARCH_CODES>  (748) 
nan

>  <APPLICANTS>  (748) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (748) 
-pred-

>  <USAN_STEM_DEFINITION>  (748) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (748) 
-pred-

>  <USAN_YEAR>  (748) 
nan

>  <FIRST_APPROVAL>  (748) 
1959.0

>  <ATC_CODE>  (748) 
D07AA01; D10AA02; H02AB04

>  <ATC_CODE_DESCRIPTION>  (748) 
D07AA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; D10AA02 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; H02AB04 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]

>  <INDICATION_CLASS>  (748) 
Adrenocortical Steroid; Glucocorticoid

>  <SC_PATENT_NO>  (748) 
nan

>  <DRUG_TYPE>  (748) 
Natural Product-derived

>  <RULE_OF_FIVE>  (748) 
Y

>  <FIRST_IN_CLASS>  (748) 
N

>  <CHIRALITY>  (748) 
Single Stereoisomer

>  <PRODRUG>  (748) 
Y

>  <ORAL>  (748) 
N

>  <PARENTERAL>  (748) 
Y

>  <TOPICAL>  (748) 
N

>  <BLACK_BOX>  (748) 
Y

>  <AVAILABILITY_TYPE>  (748) 
Prescription-only

>  <WITHDRAWN_YEAR>  (748) 
nan

>  <WITHDRAWN_COUNTRY>  (748) 
nan

>  <WITHDRAWN_REASON>  (748) 
nan

>  <CANONICAL_SMILES>  (748) 
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14

>  <name>  (748) 
Methylprednisolone Hemisuccinate 

>  <MW>  (748) 
474.55

>  <logP>  (748) 
2.2193

$$$$
CHEMBL1046
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
M  END
>  <PARENT_MOLREGNO>  (749) 
127755

>  <SYNONYMS>  (749) 
Aminocaproic Acid (BAN, FDA, INN, USAN, USP); epsilon-Aminocaproic Acid (JAN)

>  <DEVELOPMENT_PHASE>  (749) 
4

>  <RESEARCH_CODES>  (749) 
177 J.D; CL-10304; CY-116; EACA

>  <APPLICANTS>  (749) 
Clover Pharmaceuticals Corp; Baxter Healthcare Corp Anesthesia And Critical Care

>  <USAN_STEM>  (749) 
nan

>  <USAN_STEM_DEFINITION>  (749) 
nan

>  <USAN_STEM_SUBSTEM>  (749) 
nan

>  <USAN_YEAR>  (749) 
1963.0

>  <FIRST_APPROVAL>  (749) 
1964.0

>  <ATC_CODE>  (749) 
B02AA01

>  <ATC_CODE_DESCRIPTION>  (749) 
B02AA01 [Blood And Blood Forming Organs:Antihemorrhagics:Antifibrinolytics:Amino acids]

>  <INDICATION_CLASS>  (749) 
Hemostatic

>  <SC_PATENT_NO>  (749) 
nan

>  <DRUG_TYPE>  (749) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (749) 
Y

>  <FIRST_IN_CLASS>  (749) 
N

>  <CHIRALITY>  (749) 
Achiral Molecule

>  <PRODRUG>  (749) 
N

>  <ORAL>  (749) 
Y

>  <PARENTERAL>  (749) 
Y

>  <TOPICAL>  (749) 
N

>  <BLACK_BOX>  (749) 
N

>  <AVAILABILITY_TYPE>  (749) 
Prescription-only

>  <WITHDRAWN_YEAR>  (749) 
nan

>  <WITHDRAWN_COUNTRY>  (749) 
nan

>  <WITHDRAWN_REASON>  (749) 
nan

>  <CANONICAL_SMILES>  (749) 
NCCCCCC(=O)O

>  <name>  (749) 
Aminocaproic Acid 

>  <MW>  (749) 
131.175

>  <logP>  (749) 
0.5901

$$$$
CHEMBL527
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
  3 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 12  2  1  0
 11  6  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (750) 
11968

>  <SYNONYMS>  (750) 
Piroxicam (BAN, FDA, INN, JAN, USAN, USP); Piroxicam Olamine (USAN)

>  <DEVELOPMENT_PHASE>  (750) 
4

>  <RESEARCH_CODES>  (750) 
CP-16171; CP-16171-85

>  <APPLICANTS>  (750) 
Pfizer Laboratories Div Pfizer Inc; Pfizer Inc.

>  <USAN_STEM>  (750) 
-icam

>  <USAN_STEM_DEFINITION>  (750) 
anti-inflammatory agents (isoxicam type)

>  <USAN_STEM_SUBSTEM>  (750) 
-icam

>  <USAN_YEAR>  (750) 
1974.0

>  <FIRST_APPROVAL>  (750) 
1982.0

>  <ATC_CODE>  (750) 
M02AA07; S01BC06; M01AC01

>  <ATC_CODE_DESCRIPTION>  (750) 
M02AA07 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; S01BC06 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]; M01AC01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Oxicams]

>  <INDICATION_CLASS>  (750) 
Anti-Inflammatory; Analgesic

>  <SC_PATENT_NO>  (750) 
nan

>  <DRUG_TYPE>  (750) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (750) 
Y

>  <FIRST_IN_CLASS>  (750) 
N

>  <CHIRALITY>  (750) 
Achiral Molecule

>  <PRODRUG>  (750) 
N

>  <ORAL>  (750) 
Y

>  <PARENTERAL>  (750) 
N

>  <TOPICAL>  (750) 
N

>  <BLACK_BOX>  (750) 
Y

>  <AVAILABILITY_TYPE>  (750) 
Prescription-only

>  <WITHDRAWN_YEAR>  (750) 
nan

>  <WITHDRAWN_COUNTRY>  (750) 
nan

>  <WITHDRAWN_REASON>  (750) 
nan

>  <CANONICAL_SMILES>  (750) 
CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3

>  <name>  (750) 
Piroxicam 

>  <MW>  (750) 
331.353

>  <logP>  (750) 
1.581

$$$$
CHEMBL885
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  6 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
  8  2  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (751) 
74911

>  <SYNONYMS>  (751) 
Emtricitabine (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (751) 
4

>  <RESEARCH_CODES>  (751) 
(-)-FTC; 524W91; BW-524W91; FTC-(-)

>  <APPLICANTS>  (751) 
Gilead Sciences Inc

>  <USAN_STEM>  (751) 
-citabine

>  <USAN_STEM_DEFINITION>  (751) 
nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

>  <USAN_STEM_SUBSTEM>  (751) 
-citabine

>  <USAN_YEAR>  (751) 
1998.0

>  <FIRST_APPROVAL>  (751) 
2003.0

>  <ATC_CODE>  (751) 
J05AF09

>  <ATC_CODE_DESCRIPTION>  (751) 
J05AF09 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (751) 
nan

>  <SC_PATENT_NO>  (751) 
US-5814639-A

>  <DRUG_TYPE>  (751) 
Natural Product-derived

>  <RULE_OF_FIVE>  (751) 
Y

>  <FIRST_IN_CLASS>  (751) 
N

>  <CHIRALITY>  (751) 
Single Stereoisomer

>  <PRODRUG>  (751) 
Y

>  <ORAL>  (751) 
Y

>  <PARENTERAL>  (751) 
N

>  <TOPICAL>  (751) 
N

>  <BLACK_BOX>  (751) 
Y

>  <AVAILABILITY_TYPE>  (751) 
Prescription-only

>  <WITHDRAWN_YEAR>  (751) 
nan

>  <WITHDRAWN_COUNTRY>  (751) 
nan

>  <WITHDRAWN_REASON>  (751) 
nan

>  <CANONICAL_SMILES>  (751) 
NC1=NC(=O)N(C=C1F)[C@@H]2CS[C@H](CO)O2

>  <name>  (751) 
Emtricitabine 

>  <MW>  (751) 
247.251

>  <logP>  (751) 
-0.455

$$$$
CHEMBL93047
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 10 11  2  0
 10  3  1  0
M  END
>  <PARENT_MOLREGNO>  (752) 
150846

>  <SYNONYMS>  (752) 
Ethadione

>  <DEVELOPMENT_PHASE>  (752) 
4

>  <RESEARCH_CODES>  (752) 
nan

>  <APPLICANTS>  (752) 
nan

>  <USAN_STEM>  (752) 
nan

>  <USAN_STEM_DEFINITION>  (752) 
nan

>  <USAN_STEM_SUBSTEM>  (752) 
nan

>  <USAN_YEAR>  (752) 
nan

>  <FIRST_APPROVAL>  (752) 
nan

>  <ATC_CODE>  (752) 
N03AC03

>  <ATC_CODE_DESCRIPTION>  (752) 
N03AC03 [Nervous System:Antiepileptics:Antiepileptics:Oxazolidine derivatives]

>  <INDICATION_CLASS>  (752) 
nan

>  <SC_PATENT_NO>  (752) 
nan

>  <DRUG_TYPE>  (752) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (752) 
Y

>  <FIRST_IN_CLASS>  (752) 
N

>  <CHIRALITY>  (752) 
Achiral Molecule

>  <PRODRUG>  (752) 
N

>  <ORAL>  (752) 
N

>  <PARENTERAL>  (752) 
N

>  <TOPICAL>  (752) 
N

>  <BLACK_BOX>  (752) 
N

>  <AVAILABILITY_TYPE>  (752) 
Unknown

>  <WITHDRAWN_YEAR>  (752) 
nan

>  <WITHDRAWN_COUNTRY>  (752) 
nan

>  <WITHDRAWN_REASON>  (752) 
nan

>  <CANONICAL_SMILES>  (752) 
CCN1C(=O)OC(C)(C)C1=O

>  <name>  (752) 
Ethadione

>  <MW>  (752) 
157.169

>  <logP>  (752) 
0.7637

$$$$
CHEMBL32
     RDKit          

 29 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  4 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 22 26  1  0
 20 27  1  0
 27 28  2  0
 27 29  1  0
 26  3  1  0
 13  5  1  0
 12  7  1  0
 26 17  2  0
 25 23  1  0
M  END
>  <PARENT_MOLREGNO>  (753) 
1788

>  <SYNONYMS>  (753) 
Moxifloxacin (BAN, INN); Moxifloxacin HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (753) 
4

>  <RESEARCH_CODES>  (753) 
BAY-128039; BAY-12-8039

>  <APPLICANTS>  (753) 
Bayer Healthcare Pharmaceuticals Inc; Alcon Pharmaceuticals Ltd

>  <USAN_STEM>  (753) 
-oxacin

>  <USAN_STEM_DEFINITION>  (753) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (753) 
-oxacin

>  <USAN_YEAR>  (753) 
1998.0

>  <FIRST_APPROVAL>  (753) 
1999.0

>  <ATC_CODE>  (753) 
J01MA14; S01AE07

>  <ATC_CODE_DESCRIPTION>  (753) 
J01MA14 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE07 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]

>  <INDICATION_CLASS>  (753) 
nan

>  <SC_PATENT_NO>  (753) 
US-5849752-A

>  <DRUG_TYPE>  (753) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (753) 
Y

>  <FIRST_IN_CLASS>  (753) 
N

>  <CHIRALITY>  (753) 
Single Stereoisomer

>  <PRODRUG>  (753) 
N

>  <ORAL>  (753) 
Y

>  <PARENTERAL>  (753) 
Y

>  <TOPICAL>  (753) 
Y

>  <BLACK_BOX>  (753) 
Y

>  <AVAILABILITY_TYPE>  (753) 
Prescription-only

>  <WITHDRAWN_YEAR>  (753) 
nan

>  <WITHDRAWN_COUNTRY>  (753) 
nan

>  <WITHDRAWN_REASON>  (753) 
nan

>  <CANONICAL_SMILES>  (753) 
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O

>  <name>  (753) 
Moxifloxacin 

>  <MW>  (753) 
401.438

>  <logP>  (753) 
2.3705

$$$$
CHEMBL1148
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 16 11  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (754) 
180329

>  <SYNONYMS>  (754) 
Torasemide (BAN, INN); Torsemide (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (754) 
4

>  <RESEARCH_CODES>  (754) 
AC-4464; AC4464; BM-02015

>  <APPLICANTS>  (754) 
Meda Pharmaceuticals Inc; Hoffmann La Roche Inc

>  <USAN_STEM>  (754) 
-semide

>  <USAN_STEM_DEFINITION>  (754) 
diuretics (furosemide type)

>  <USAN_STEM_SUBSTEM>  (754) 
-semide

>  <USAN_YEAR>  (754) 
1989.0

>  <FIRST_APPROVAL>  (754) 
1993.0

>  <ATC_CODE>  (754) 
C03CA04

>  <ATC_CODE_DESCRIPTION>  (754) 
C03CA04 [Cardiovascular System:Diuretics:High-Ceiling Diuretics:Sulfonamides, plain]

>  <INDICATION_CLASS>  (754) 
Diuretic

>  <SC_PATENT_NO>  (754) 
nan

>  <DRUG_TYPE>  (754) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (754) 
Y

>  <FIRST_IN_CLASS>  (754) 
N

>  <CHIRALITY>  (754) 
Achiral Molecule

>  <PRODRUG>  (754) 
N

>  <ORAL>  (754) 
Y

>  <PARENTERAL>  (754) 
Y

>  <TOPICAL>  (754) 
N

>  <BLACK_BOX>  (754) 
N

>  <AVAILABILITY_TYPE>  (754) 
Prescription-only

>  <WITHDRAWN_YEAR>  (754) 
nan

>  <WITHDRAWN_COUNTRY>  (754) 
nan

>  <WITHDRAWN_REASON>  (754) 
nan

>  <CANONICAL_SMILES>  (754) 
CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc2cccc(C)c2

>  <name>  (754) 
Torasemide 

>  <MW>  (754) 
348.428

>  <logP>  (754) 
2.52992

$$$$
CHEMBL502135
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9  2  1  0
M  END
>  <PARENT_MOLREGNO>  (755) 
513206

>  <SYNONYMS>  (755) 
Xylose (FDA, USP)

>  <DEVELOPMENT_PHASE>  (755) 
4

>  <RESEARCH_CODES>  (755) 
nan

>  <APPLICANTS>  (755) 
Savage Laboratories Inc Div Altana Inc; Lyne Laboratories Inc

>  <USAN_STEM>  (755) 
nan

>  <USAN_STEM_DEFINITION>  (755) 
nan

>  <USAN_STEM_SUBSTEM>  (755) 
nan

>  <USAN_YEAR>  (755) 
nan

>  <FIRST_APPROVAL>  (755) 
nan

>  <ATC_CODE>  (755) 
nan

>  <ATC_CODE_DESCRIPTION>  (755) 
nan

>  <INDICATION_CLASS>  (755) 
Diagnostic Aid (intestinal function determination)

>  <SC_PATENT_NO>  (755) 
nan

>  <DRUG_TYPE>  (755) 
Natural Product-derived

>  <RULE_OF_FIVE>  (755) 
Y

>  <FIRST_IN_CLASS>  (755) 
N

>  <CHIRALITY>  (755) 
Racemic Mixture

>  <PRODRUG>  (755) 
N

>  <ORAL>  (755) 
Y

>  <PARENTERAL>  (755) 
N

>  <TOPICAL>  (755) 
N

>  <BLACK_BOX>  (755) 
N

>  <AVAILABILITY_TYPE>  (755) 
Discontinued

>  <WITHDRAWN_YEAR>  (755) 
nan

>  <WITHDRAWN_COUNTRY>  (755) 
nan

>  <WITHDRAWN_REASON>  (755) 
nan

>  <CANONICAL_SMILES>  (755) 
O[C@@H]1COC(O)[C@H](O)[C@H]1O

>  <name>  (755) 
Xylose 

>  <MW>  (755) 
150.13

>  <logP>  (755) 
-2.5823

$$$$
CHEMBL1077
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 11  2  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (756) 
140107

>  <SYNONYMS>  (756) 
Bromfenac (INN); Bromfenac sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (756) 
4

>  <RESEARCH_CODES>  (756) 
AHR-10282B

>  <APPLICANTS>  (756) 
Ista Pharmaceuticals Inc

>  <USAN_STEM>  (756) 
-ac

>  <USAN_STEM_DEFINITION>  (756) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (756) 
-ac

>  <USAN_YEAR>  (756) 
1986.0

>  <FIRST_APPROVAL>  (756) 
1997.0

>  <ATC_CODE>  (756) 
S01BC11

>  <ATC_CODE_DESCRIPTION>  (756) 
S01BC11 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]

>  <INDICATION_CLASS>  (756) 
Analgesic

>  <SC_PATENT_NO>  (756) 
US-8129431-B2

>  <DRUG_TYPE>  (756) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (756) 
Y

>  <FIRST_IN_CLASS>  (756) 
N

>  <CHIRALITY>  (756) 
Achiral Molecule

>  <PRODRUG>  (756) 
N

>  <ORAL>  (756) 
N

>  <PARENTERAL>  (756) 
N

>  <TOPICAL>  (756) 
Y

>  <BLACK_BOX>  (756) 
N

>  <AVAILABILITY_TYPE>  (756) 
Prescription-only

>  <WITHDRAWN_YEAR>  (756) 
1998.0

>  <WITHDRAWN_COUNTRY>  (756) 
Saudi Arabia; United States

>  <WITHDRAWN_REASON>  (756) 
Severe hepatitis and liver failure (some requiring transplantation); Hepatic Failure; Off-Label Abuse

>  <CANONICAL_SMILES>  (756) 
Nc1c(CC(=O)O)cccc1C(=O)c2ccc(Br)cc2

>  <name>  (756) 
Bromfenac 

>  <MW>  (756) 
334.169

>  <logP>  (756) 
2.8894

$$$$
CHEMBL848
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 11  2  1  0
 11  6  2  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (757) 
63649

>  <SYNONYMS>  (757) 
Lenalidomide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (757) 
4

>  <RESEARCH_CODES>  (757) 
CC-5013; CDC-501

>  <APPLICANTS>  (757) 
Celgene Corp

>  <USAN_STEM>  (757) 
-domide

>  <USAN_STEM_DEFINITION>  (757) 
thalidomide derivatives

>  <USAN_STEM_SUBSTEM>  (757) 
-domide

>  <USAN_YEAR>  (757) 
2004.0

>  <FIRST_APPROVAL>  (757) 
2005.0

>  <ATC_CODE>  (757) 
L04AX04

>  <ATC_CODE_DESCRIPTION>  (757) 
L04AX04 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Other immunosuppressants]

>  <INDICATION_CLASS>  (757) 
nan

>  <SC_PATENT_NO>  (757) 
US-5635517-A

>  <DRUG_TYPE>  (757) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (757) 
Y

>  <FIRST_IN_CLASS>  (757) 
N

>  <CHIRALITY>  (757) 
Racemic Mixture

>  <PRODRUG>  (757) 
N

>  <ORAL>  (757) 
Y

>  <PARENTERAL>  (757) 
N

>  <TOPICAL>  (757) 
N

>  <BLACK_BOX>  (757) 
Y

>  <AVAILABILITY_TYPE>  (757) 
Prescription-only

>  <WITHDRAWN_YEAR>  (757) 
nan

>  <WITHDRAWN_COUNTRY>  (757) 
nan

>  <WITHDRAWN_REASON>  (757) 
nan

>  <CANONICAL_SMILES>  (757) 
Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O

>  <name>  (757) 
Lenalidomide 

>  <MW>  (757) 
259.265

>  <logP>  (757) 
0.0298

$$$$
CHEMBL450
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13  3  1  0
M  END
>  <PARENT_MOLREGNO>  (758) 
2408

>  <SYNONYMS>  (758) 
Metharbital (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (758) 
4

>  <RESEARCH_CODES>  (758) 
nan

>  <APPLICANTS>  (758) 
Abbvie Inc

>  <USAN_STEM>  (758) 
nan

>  <USAN_STEM_DEFINITION>  (758) 
nan

>  <USAN_STEM_SUBSTEM>  (758) 
nan

>  <USAN_YEAR>  (758) 
nan

>  <FIRST_APPROVAL>  (758) 
1982.0

>  <ATC_CODE>  (758) 
N03AA30

>  <ATC_CODE_DESCRIPTION>  (758) 
N03AA30 [Nervous System:Antiepileptics:Antiepileptics:Barbiturates and derivatives]

>  <INDICATION_CLASS>  (758) 
nan

>  <SC_PATENT_NO>  (758) 
nan

>  <DRUG_TYPE>  (758) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (758) 
Y

>  <FIRST_IN_CLASS>  (758) 
N

>  <CHIRALITY>  (758) 
Achiral Molecule

>  <PRODRUG>  (758) 
N

>  <ORAL>  (758) 
Y

>  <PARENTERAL>  (758) 
N

>  <TOPICAL>  (758) 
N

>  <BLACK_BOX>  (758) 
N

>  <AVAILABILITY_TYPE>  (758) 
Discontinued

>  <WITHDRAWN_YEAR>  (758) 
nan

>  <WITHDRAWN_COUNTRY>  (758) 
nan

>  <WITHDRAWN_REASON>  (758) 
nan

>  <CANONICAL_SMILES>  (758) 
CCC1(CC)C(=O)NC(=O)N(C)C1=O

>  <name>  (758) 
Metharbital 

>  <MW>  (758) 
198.222

>  <logP>  (758) 
0.501

$$$$
CHEMBL1187846
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  7  2  1  0
 10  3  1  0
 10  8  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (759) 
661796

>  <SYNONYMS>  (759) 
Scopolamine (FDA); Hyoscine (BAN); Scopolamine Hydrobromide (JAN, USP)

>  <DEVELOPMENT_PHASE>  (759) 
4

>  <RESEARCH_CODES>  (759) 
nan

>  <APPLICANTS>  (759) 
Parke-Davis; Novartis Consumer Health Inc; Ciba-Geigy; Alcon; Wallace

>  <USAN_STEM>  (759) 
nan

>  <USAN_STEM_DEFINITION>  (759) 
nan

>  <USAN_STEM_SUBSTEM>  (759) 
nan

>  <USAN_YEAR>  (759) 
nan

>  <FIRST_APPROVAL>  (759) 
1979.0

>  <ATC_CODE>  (759) 
S01FA02; N05CM05; A04AD01; A04AD51

>  <ATC_CODE_DESCRIPTION>  (759) 
S01FA02 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]; N05CM05 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]; A04AD01 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Other antiemetics]; A04AD51 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Other antiemetics]

>  <INDICATION_CLASS>  (759) 
Anticholinergic

>  <SC_PATENT_NO>  (759) 
nan

>  <DRUG_TYPE>  (759) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (759) 
Y

>  <FIRST_IN_CLASS>  (759) 
N

>  <CHIRALITY>  (759) 
Single Stereoisomer

>  <PRODRUG>  (759) 
N

>  <ORAL>  (759) 
N

>  <PARENTERAL>  (759) 
N

>  <TOPICAL>  (759) 
Y

>  <BLACK_BOX>  (759) 
N

>  <AVAILABILITY_TYPE>  (759) 
Prescription-only

>  <WITHDRAWN_YEAR>  (759) 
nan

>  <WITHDRAWN_COUNTRY>  (759) 
nan

>  <WITHDRAWN_REASON>  (759) 
nan

>  <CANONICAL_SMILES>  (759) 
CN1[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@@H]23)OC(=O)[C@H](CO)c4ccccc4

>  <name>  (759) 
Scopolamine 

>  <MW>  (759) 
303.358

>  <logP>  (759) 
0.9181

$$$$
CHEMBL3707371
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  2 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 21 22  1  0
 22 23  1  0
 17  4  1  0
 10  5  1  0
 17 12  1  0
M  CHG  1  18   1
M  END
>  <PARENT_MOLREGNO>  (760) 
2039342

>  <SYNONYMS>  (760) 
Hydroxyethylpromethazine

>  <DEVELOPMENT_PHASE>  (760) 
4

>  <RESEARCH_CODES>  (760) 
nan

>  <APPLICANTS>  (760) 
nan

>  <USAN_STEM>  (760) 
nan

>  <USAN_STEM_DEFINITION>  (760) 
nan

>  <USAN_STEM_SUBSTEM>  (760) 
nan

>  <USAN_YEAR>  (760) 
nan

>  <FIRST_APPROVAL>  (760) 
nan

>  <ATC_CODE>  (760) 
R06AD05; R06AD55

>  <ATC_CODE_DESCRIPTION>  (760) 
R06AD05 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]; R06AD55 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]

>  <INDICATION_CLASS>  (760) 
nan

>  <SC_PATENT_NO>  (760) 
nan

>  <DRUG_TYPE>  (760) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (760) 
Y

>  <FIRST_IN_CLASS>  (760) 
N

>  <CHIRALITY>  (760) 
Racemic Mixture

>  <PRODRUG>  (760) 
N

>  <ORAL>  (760) 
N

>  <PARENTERAL>  (760) 
N

>  <TOPICAL>  (760) 
N

>  <BLACK_BOX>  (760) 
N

>  <AVAILABILITY_TYPE>  (760) 
Unknown

>  <WITHDRAWN_YEAR>  (760) 
nan

>  <WITHDRAWN_COUNTRY>  (760) 
nan

>  <WITHDRAWN_REASON>  (760) 
nan

>  <CANONICAL_SMILES>  (760) 
CC(CN1c2ccccc2Sc3ccccc13)[N+](C)(C)CCO

>  <name>  (760) 
Hydroxyethylpromethazine

>  <MW>  (760) 
329.489

>  <logP>  (760) 
3.7465

$$$$
CHEMBL242338
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  9 19  1  0
 19 20  1  0
 11  5  1  0
 19  6  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (761) 
392076

>  <SYNONYMS>  (761) 
Iodine (124i) 2beta-Carbomethoxy-3beta-(4 Iodophenyl)-Tropane

>  <DEVELOPMENT_PHASE>  (761) 
4

>  <RESEARCH_CODES>  (761) 
nan

>  <APPLICANTS>  (761) 
nan

>  <USAN_STEM>  (761) 
io-

>  <USAN_STEM_DEFINITION>  (761) 
iodine-containing contrast media

>  <USAN_STEM_SUBSTEM>  (761) 
io-

>  <USAN_YEAR>  (761) 
nan

>  <FIRST_APPROVAL>  (761) 
nan

>  <ATC_CODE>  (761) 
V09AX03

>  <ATC_CODE_DESCRIPTION>  (761) 
V09AX03 [Various:Diagnostic Radiopharmaceuticals:Central Nervous System:Other central nervous system diagnostic radiopharmaceuticals]

>  <INDICATION_CLASS>  (761) 
nan

>  <SC_PATENT_NO>  (761) 
nan

>  <DRUG_TYPE>  (761) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (761) 
Y

>  <FIRST_IN_CLASS>  (761) 
N

>  <CHIRALITY>  (761) 
Single Stereoisomer

>  <PRODRUG>  (761) 
N

>  <ORAL>  (761) 
N

>  <PARENTERAL>  (761) 
N

>  <TOPICAL>  (761) 
N

>  <BLACK_BOX>  (761) 
N

>  <AVAILABILITY_TYPE>  (761) 
Unknown

>  <WITHDRAWN_YEAR>  (761) 
nan

>  <WITHDRAWN_COUNTRY>  (761) 
nan

>  <WITHDRAWN_REASON>  (761) 
nan

>  <CANONICAL_SMILES>  (761) 
COC(=O)[C@@H]1[C@@H]2CC[C@H](C[C@@H]1c3ccc(I)cc3)N2C

>  <name>  (761) 
Iodine 

>  <MW>  (761) 
385.245

>  <logP>  (761) 
3.0305

$$$$
CHEMBL447
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 16  6  1  0
M  END
>  <PARENT_MOLREGNO>  (762) 
2326

>  <SYNONYMS>  (762) 
Secobarbital (INN, USP); Secobarbital Sodium (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (762) 
4

>  <RESEARCH_CODES>  (762) 
nan

>  <APPLICANTS>  (762) 
Wallace; Lilly; Eli Lilly And Co

>  <USAN_STEM>  (762) 
-barb-

>  <USAN_STEM_DEFINITION>  (762) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (762) 
-barb-

>  <USAN_YEAR>  (762) 
nan

>  <FIRST_APPROVAL>  (762) 
1950.0

>  <ATC_CODE>  (762) 
N05CA06

>  <ATC_CODE_DESCRIPTION>  (762) 
N05CA06 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (762) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (762) 
nan

>  <DRUG_TYPE>  (762) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (762) 
Y

>  <FIRST_IN_CLASS>  (762) 
N

>  <CHIRALITY>  (762) 
Racemic Mixture

>  <PRODRUG>  (762) 
N

>  <ORAL>  (762) 
Y

>  <PARENTERAL>  (762) 
Y

>  <TOPICAL>  (762) 
Y

>  <BLACK_BOX>  (762) 
N

>  <AVAILABILITY_TYPE>  (762) 
Prescription-only

>  <WITHDRAWN_YEAR>  (762) 
1980.0

>  <WITHDRAWN_COUNTRY>  (762) 
France; Norway

>  <WITHDRAWN_REASON>  (762) 
Self-poisoning

>  <CANONICAL_SMILES>  (762) 
CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O

>  <name>  (762) 
Secobarbital 

>  <MW>  (762) 
238.287

>  <logP>  (762) 
1.3511

$$$$
CHEMBL1584
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 22 26  1  0
 26 27  1  0
 15 28  1  0
 28 29  2  0
 29  4  1  0
 28  7  1  0
 14  9  1  0
 27 19  1  0
M  END
>  <PARENT_MOLREGNO>  (763) 
453721

>  <SYNONYMS>  (763) 
Piperacetazine (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (763) 
4

>  <RESEARCH_CODES>  (763) 
PC-1421

>  <APPLICANTS>  (763) 
Dow Pharmaceutical Corp Sub Dow Chemical Co

>  <USAN_STEM>  (763) 
nan

>  <USAN_STEM_DEFINITION>  (763) 
nan

>  <USAN_STEM_SUBSTEM>  (763) 
nan

>  <USAN_YEAR>  (763) 
1962.0

>  <FIRST_APPROVAL>  (763) 
1969.0

>  <ATC_CODE>  (763) 
nan

>  <ATC_CODE_DESCRIPTION>  (763) 
nan

>  <INDICATION_CLASS>  (763) 
Antipsychotic

>  <SC_PATENT_NO>  (763) 
nan

>  <DRUG_TYPE>  (763) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (763) 
Y

>  <FIRST_IN_CLASS>  (763) 
N

>  <CHIRALITY>  (763) 
Achiral Molecule

>  <PRODRUG>  (763) 
Y

>  <ORAL>  (763) 
Y

>  <PARENTERAL>  (763) 
N

>  <TOPICAL>  (763) 
N

>  <BLACK_BOX>  (763) 
N

>  <AVAILABILITY_TYPE>  (763) 
Discontinued

>  <WITHDRAWN_YEAR>  (763) 
nan

>  <WITHDRAWN_COUNTRY>  (763) 
nan

>  <WITHDRAWN_REASON>  (763) 
nan

>  <CANONICAL_SMILES>  (763) 
CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CCO)CC4)c2c1

>  <name>  (763) 
Piperacetazine 

>  <MW>  (763) 
410.583

>  <logP>  (763) 
4.9764

$$$$
CHEMBL14376
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 26 27  1  0
 27 28  2  0
  5 29  1  0
 29 30  2  0
 29 31  1  0
  8  3  1  0
 18 13  1  0
 28 19  1  0
 28 22  1  0
M  END
>  <PARENT_MOLREGNO>  (764) 
13949

>  <SYNONYMS>  (764) 
Iloperidone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (764) 
4

>  <RESEARCH_CODES>  (764) 
HP-873

>  <APPLICANTS>  (764) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (764) 
-peridone

>  <USAN_STEM_DEFINITION>  (764) 
antipsychotics (risperidone type)

>  <USAN_STEM_SUBSTEM>  (764) 
-peridone

>  <USAN_YEAR>  (764) 
1993.0

>  <FIRST_APPROVAL>  (764) 
2009.0

>  <ATC_CODE>  (764) 
N05AX14

>  <ATC_CODE_DESCRIPTION>  (764) 
N05AX14 [Nervous System:Psycholeptics:Antipsychotics:Other antipsychotics]

>  <INDICATION_CLASS>  (764) 
Antipsychotic

>  <SC_PATENT_NO>  (764) 
US-RE39198-E1

>  <DRUG_TYPE>  (764) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (764) 
Y

>  <FIRST_IN_CLASS>  (764) 
N

>  <CHIRALITY>  (764) 
Achiral Molecule

>  <PRODRUG>  (764) 
N

>  <ORAL>  (764) 
Y

>  <PARENTERAL>  (764) 
N

>  <TOPICAL>  (764) 
N

>  <BLACK_BOX>  (764) 
Y

>  <AVAILABILITY_TYPE>  (764) 
Prescription-only

>  <WITHDRAWN_YEAR>  (764) 
nan

>  <WITHDRAWN_COUNTRY>  (764) 
nan

>  <WITHDRAWN_REASON>  (764) 
nan

>  <CANONICAL_SMILES>  (764) 
COc1cc(ccc1OCCCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)C

>  <name>  (764) 
Iloperidone 

>  <MW>  (764) 
426.488

>  <logP>  (764) 
4.8266

$$$$
CHEMBL1408759
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15  4  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (765) 
832643

>  <SYNONYMS>  (765) 
Guaiazulene

>  <DEVELOPMENT_PHASE>  (765) 
4

>  <RESEARCH_CODES>  (765) 
nan

>  <APPLICANTS>  (765) 
nan

>  <USAN_STEM>  (765) 
nan

>  <USAN_STEM_DEFINITION>  (765) 
nan

>  <USAN_STEM_SUBSTEM>  (765) 
nan

>  <USAN_YEAR>  (765) 
nan

>  <FIRST_APPROVAL>  (765) 
nan

>  <ATC_CODE>  (765) 
S01XA01

>  <ATC_CODE_DESCRIPTION>  (765) 
S01XA01 [Sensory Organs:Ophthalmologicals:Other Ophthalmologicals:Other ophthalmologicals]

>  <INDICATION_CLASS>  (765) 
nan

>  <SC_PATENT_NO>  (765) 
nan

>  <DRUG_TYPE>  (765) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (765) 
Y

>  <FIRST_IN_CLASS>  (765) 
N

>  <CHIRALITY>  (765) 
Achiral Molecule

>  <PRODRUG>  (765) 
N

>  <ORAL>  (765) 
N

>  <PARENTERAL>  (765) 
N

>  <TOPICAL>  (765) 
N

>  <BLACK_BOX>  (765) 
N

>  <AVAILABILITY_TYPE>  (765) 
Unknown

>  <WITHDRAWN_YEAR>  (765) 
nan

>  <WITHDRAWN_COUNTRY>  (765) 
nan

>  <WITHDRAWN_REASON>  (765) 
nan

>  <CANONICAL_SMILES>  (765) 
CC(C)c1ccc(C)c2ccc(C)c2c1

>  <name>  (765) 
Guaiazulene

>  <MW>  (765) 
198.309

>  <logP>  (765) 
4.53164

$$$$
CHEMBL22242
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  1  0
  7  3  1  0
 20 12  1  0
M  END
>  <PARENT_MOLREGNO>  (766) 
27616

>  <SYNONYMS>  (766) 
Remoxipride (BAN, INN, USAN); Remoxipride HCl (USAN)

>  <DEVELOPMENT_PHASE>  (766) 
4

>  <RESEARCH_CODES>  (766) 
A-33547; FLA-731; A-33547.HCL.H20; FLA-731(-)

>  <APPLICANTS>  (766) 
Ab Astra, Sweden

>  <USAN_STEM>  (766) 
-pride

>  <USAN_STEM_DEFINITION>  (766) 
sulpiride derivatives

>  <USAN_STEM_SUBSTEM>  (766) 
-pride

>  <USAN_YEAR>  (766) 
1985.0

>  <FIRST_APPROVAL>  (766) 
1990.0

>  <ATC_CODE>  (766) 
N05AL04

>  <ATC_CODE_DESCRIPTION>  (766) 
N05AL04 [Nervous System:Psycholeptics:Antipsychotics:Benzamides]

>  <INDICATION_CLASS>  (766) 
Antipsychotic

>  <SC_PATENT_NO>  (766) 
nan

>  <DRUG_TYPE>  (766) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (766) 
Y

>  <FIRST_IN_CLASS>  (766) 
N

>  <CHIRALITY>  (766) 
Single Stereoisomer

>  <PRODRUG>  (766) 
N

>  <ORAL>  (766) 
N

>  <PARENTERAL>  (766) 
N

>  <TOPICAL>  (766) 
N

>  <BLACK_BOX>  (766) 
N

>  <AVAILABILITY_TYPE>  (766) 
Withdrawn

>  <WITHDRAWN_YEAR>  (766) 
1993.0

>  <WITHDRAWN_COUNTRY>  (766) 
United Kingdom; United Kingdom

>  <WITHDRAWN_REASON>  (766) 
Aplastic anemia; Aplastic anemia

>  <CANONICAL_SMILES>  (766) 
CCN1CCC[C@H]1CNC(=O)c2c(OC)ccc(Br)c2OC

>  <name>  (766) 
Remoxipride 

>  <MW>  (766) 
371.275

>  <logP>  (766) 
2.6804

$$$$
CHEMBL1098659
     RDKit          

  1  0  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
M  END
>  <PARENT_MOLREGNO>  (767) 
627419

>  <SYNONYMS>  (767) 
Purified Water (FDA); Sterile Water For Injection (FDA); Sterile Water For Irrigation (FDA); Water (USP); Deuterium Oxide (USAN); Water O 15 (USAN, USP); Tritiated Water (USAN)

>  <DEVELOPMENT_PHASE>  (767) 
4

>  <RESEARCH_CODES>  (767) 
nan

>  <APPLICANTS>  (767) 
Bristol-Myers Squibb; Baxter Healthcare Corp; B Braun Medical Inc; Abbott; Miles Laboratories Inc

>  <USAN_STEM>  (767) 
nan

>  <USAN_STEM_DEFINITION>  (767) 
nan

>  <USAN_STEM_SUBSTEM>  (767) 
nan

>  <USAN_YEAR>  (767) 
1963.0

>  <FIRST_APPROVAL>  (767) 
2011.0

>  <ATC_CODE>  (767) 
nan

>  <ATC_CODE_DESCRIPTION>  (767) 
nan

>  <INDICATION_CLASS>  (767) 
Radioactive Agent; Diagnostic Aid (radioactive, vascular disorders)

>  <SC_PATENT_NO>  (767) 
nan

>  <DRUG_TYPE>  (767) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (767) 
Y

>  <FIRST_IN_CLASS>  (767) 
N

>  <CHIRALITY>  (767) 
Achiral Molecule

>  <PRODRUG>  (767) 
N

>  <ORAL>  (767) 
N

>  <PARENTERAL>  (767) 
N

>  <TOPICAL>  (767) 
Y

>  <BLACK_BOX>  (767) 
N

>  <AVAILABILITY_TYPE>  (767) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (767) 
nan

>  <WITHDRAWN_COUNTRY>  (767) 
nan

>  <WITHDRAWN_REASON>  (767) 
nan

>  <CANONICAL_SMILES>  (767) 
O

>  <name>  (767) 
Purified Water 

>  <MW>  (767) 
18.015

>  <logP>  (767) 
-0.8247

$$$$
CHEMBL406393
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 27  8  1  0
 27 11  1  0
 23 12  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (768) 
442077

>  <SYNONYMS>  (768) 
Deoxycholic Acid (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (768) 
4

>  <RESEARCH_CODES>  (768) 
ATX-101

>  <APPLICANTS>  (768) 
Kythera Biopharmaceuticals, Inc.; Kythera Biopharmaceuticals Inc

>  <USAN_STEM>  (768) 
nan

>  <USAN_STEM_DEFINITION>  (768) 
nan

>  <USAN_STEM_SUBSTEM>  (768) 
nan

>  <USAN_YEAR>  (768) 
2013.0

>  <FIRST_APPROVAL>  (768) 
2015.0

>  <ATC_CODE>  (768) 
nan

>  <ATC_CODE_DESCRIPTION>  (768) 
nan

>  <INDICATION_CLASS>  (768) 
nan

>  <SC_PATENT_NO>  (768) 
US-7622130-B2

>  <DRUG_TYPE>  (768) 
Natural Product-derived

>  <RULE_OF_FIVE>  (768) 
Y

>  <FIRST_IN_CLASS>  (768) 
N

>  <CHIRALITY>  (768) 
Single Stereoisomer

>  <PRODRUG>  (768) 
N

>  <ORAL>  (768) 
N

>  <PARENTERAL>  (768) 
Y

>  <TOPICAL>  (768) 
N

>  <BLACK_BOX>  (768) 
N

>  <AVAILABILITY_TYPE>  (768) 
Prescription-only

>  <WITHDRAWN_YEAR>  (768) 
nan

>  <WITHDRAWN_COUNTRY>  (768) 
nan

>  <WITHDRAWN_REASON>  (768) 
nan

>  <CANONICAL_SMILES>  (768) 
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

>  <name>  (768) 
Deoxycholic Acid 

>  <MW>  (768) 
392.58

>  <logP>  (768) 
4.4779

$$$$
CHEMBL1201747
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 16 19  2  0
 19 20  1  0
 20 21  2  0
  5 22  1  0
 22 23  1  0
 23  2  1  0
 21  6  1  0
 12  7  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (769) 
675698

>  <SYNONYMS>  (769) 
Alcaftadine (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (769) 
4

>  <RESEARCH_CODES>  (769) 
R-89674

>  <APPLICANTS>  (769) 
Allergan Inc

>  <USAN_STEM>  (769) 
-(a)tadine

>  <USAN_STEM_DEFINITION>  (769) 
tricyclic histaminic-H1 receptor antagonists, loratadine derivatives

>  <USAN_STEM_SUBSTEM>  (769) 
-(a)tadine

>  <USAN_YEAR>  (769) 
2006.0

>  <FIRST_APPROVAL>  (769) 
2010.0

>  <ATC_CODE>  (769) 
S01GX11

>  <ATC_CODE_DESCRIPTION>  (769) 
S01GX11 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]

>  <INDICATION_CLASS>  (769) 
nan

>  <SC_PATENT_NO>  (769) 
US-5468743-A

>  <DRUG_TYPE>  (769) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (769) 
Y

>  <FIRST_IN_CLASS>  (769) 
N

>  <CHIRALITY>  (769) 
Achiral Molecule

>  <PRODRUG>  (769) 
N

>  <ORAL>  (769) 
N

>  <PARENTERAL>  (769) 
N

>  <TOPICAL>  (769) 
Y

>  <BLACK_BOX>  (769) 
N

>  <AVAILABILITY_TYPE>  (769) 
Prescription-only

>  <WITHDRAWN_YEAR>  (769) 
nan

>  <WITHDRAWN_COUNTRY>  (769) 
nan

>  <WITHDRAWN_REASON>  (769) 
nan

>  <CANONICAL_SMILES>  (769) 
CN1CCC(=C2c3ccccc3CCn4c(C=O)cnc24)CC1

>  <name>  (769) 
Alcaftadine 

>  <MW>  (769) 
307.397

>  <logP>  (769) 
2.7792

$$$$
CHEMBL1201010
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 29  8  1  0
 29 12  1  0
 24 13  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (770) 
674961

>  <SYNONYMS>  (770) 
Fludrocortisone (BAN, INN); Fludrocortisone Acetate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (770) 
4

>  <RESEARCH_CODES>  (770) 
nan

>  <APPLICANTS>  (770) 
King Pharmaceuticals Inc

>  <USAN_STEM>  (770) 
-cort-

>  <USAN_STEM_DEFINITION>  (770) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (770) 
-cort-

>  <USAN_YEAR>  (770) 
nan

>  <FIRST_APPROVAL>  (770) 
1955.0

>  <ATC_CODE>  (770) 
H02AA02

>  <ATC_CODE_DESCRIPTION>  (770) 
H02AA02 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Mineralocorticoids]

>  <INDICATION_CLASS>  (770) 
Adrenocortical Steroid (salt-regulating)

>  <SC_PATENT_NO>  (770) 
nan

>  <DRUG_TYPE>  (770) 
Natural Product-derived

>  <RULE_OF_FIVE>  (770) 
Y

>  <FIRST_IN_CLASS>  (770) 
N

>  <CHIRALITY>  (770) 
Single Stereoisomer

>  <PRODRUG>  (770) 
Y

>  <ORAL>  (770) 
Y

>  <PARENTERAL>  (770) 
N

>  <TOPICAL>  (770) 
N

>  <BLACK_BOX>  (770) 
N

>  <AVAILABILITY_TYPE>  (770) 
Prescription-only

>  <WITHDRAWN_YEAR>  (770) 
nan

>  <WITHDRAWN_COUNTRY>  (770) 
nan

>  <WITHDRAWN_REASON>  (770) 
nan

>  <CANONICAL_SMILES>  (770) 
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C

>  <name>  (770) 
Fludrocortisone 

>  <MW>  (770) 
422.493

>  <logP>  (770) 
2.4445

$$$$
CHEMBL654
     RDKit          

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  7  2  1  0
 20  5  1  0
 13  8  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (771) 
27610

>  <SYNONYMS>  (771) 
Mirtazapine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (771) 
4

>  <RESEARCH_CODES>  (771) 
ORG-3770

>  <APPLICANTS>  (771) 
Organon Usa Inc

>  <USAN_STEM>  (771) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (771) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (771) 
-pin(e)

>  <USAN_YEAR>  (771) 
1989.0

>  <FIRST_APPROVAL>  (771) 
1996.0

>  <ATC_CODE>  (771) 
N06AX11

>  <ATC_CODE_DESCRIPTION>  (771) 
N06AX11 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (771) 
Antidepressant

>  <SC_PATENT_NO>  (771) 
nan

>  <DRUG_TYPE>  (771) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (771) 
Y

>  <FIRST_IN_CLASS>  (771) 
N

>  <CHIRALITY>  (771) 
Racemic Mixture

>  <PRODRUG>  (771) 
N

>  <ORAL>  (771) 
Y

>  <PARENTERAL>  (771) 
N

>  <TOPICAL>  (771) 
N

>  <BLACK_BOX>  (771) 
Y

>  <AVAILABILITY_TYPE>  (771) 
Prescription-only

>  <WITHDRAWN_YEAR>  (771) 
nan

>  <WITHDRAWN_COUNTRY>  (771) 
nan

>  <WITHDRAWN_REASON>  (771) 
nan

>  <CANONICAL_SMILES>  (771) 
CN1CCN2C(C1)c3ccccc3Cc4cccnc24

>  <name>  (771) 
Mirtazapine 

>  <MW>  (771) 
265.36

>  <logP>  (771) 
2.4789

$$$$
CHEMBL1195
     RDKit          

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  1  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (772) 
208978

>  <SYNONYMS>  (772) 
Propoxycaine (INN); Propoxycaine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (772) 
4

>  <RESEARCH_CODES>  (772) 
nan

>  <APPLICANTS>  (772) 
Eastman Kodak Co

>  <USAN_STEM>  (772) 
-caine

>  <USAN_STEM_DEFINITION>  (772) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (772) 
-caine

>  <USAN_YEAR>  (772) 
nan

>  <FIRST_APPROVAL>  (772) 
1982.0

>  <ATC_CODE>  (772) 
nan

>  <ATC_CODE_DESCRIPTION>  (772) 
nan

>  <INDICATION_CLASS>  (772) 
Anesthetic (local)

>  <SC_PATENT_NO>  (772) 
nan

>  <DRUG_TYPE>  (772) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (772) 
Y

>  <FIRST_IN_CLASS>  (772) 
N

>  <CHIRALITY>  (772) 
Achiral Molecule

>  <PRODRUG>  (772) 
N

>  <ORAL>  (772) 
N

>  <PARENTERAL>  (772) 
Y

>  <TOPICAL>  (772) 
N

>  <BLACK_BOX>  (772) 
N

>  <AVAILABILITY_TYPE>  (772) 
Discontinued

>  <WITHDRAWN_YEAR>  (772) 
nan

>  <WITHDRAWN_COUNTRY>  (772) 
nan

>  <WITHDRAWN_REASON>  (772) 
nan

>  <CANONICAL_SMILES>  (772) 
CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC

>  <name>  (772) 
Propoxycaine 

>  <MW>  (772) 
294.395

>  <logP>  (772) 
2.5562

$$$$
CHEMBL1615438
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  4 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  3  0
 20 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
  7  2  1  0
 16 11  1  0
 22 17  1  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (773) 
1038389

>  <SYNONYMS>  (773) 
Levocabastine (BAN, INN); Levocabastine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (773) 
4

>  <RESEARCH_CODES>  (773) 
R-50547

>  <APPLICANTS>  (773) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (773) 
-astine

>  <USAN_STEM_DEFINITION>  (773) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (773) 
-astine

>  <USAN_YEAR>  (773) 
1985.0

>  <FIRST_APPROVAL>  (773) 
1993.0

>  <ATC_CODE>  (773) 
S01GX02; R01AC02

>  <ATC_CODE_DESCRIPTION>  (773) 
S01GX02 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]; R01AC02 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Antiallergic agents, excl. corticosteroids]

>  <INDICATION_CLASS>  (773) 
Antihistaminic

>  <SC_PATENT_NO>  (773) 
nan

>  <DRUG_TYPE>  (773) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (773) 
Y

>  <FIRST_IN_CLASS>  (773) 
N

>  <CHIRALITY>  (773) 
Single Stereoisomer

>  <PRODRUG>  (773) 
N

>  <ORAL>  (773) 
N

>  <PARENTERAL>  (773) 
N

>  <TOPICAL>  (773) 
Y

>  <BLACK_BOX>  (773) 
N

>  <AVAILABILITY_TYPE>  (773) 
Discontinued

>  <WITHDRAWN_YEAR>  (773) 
nan

>  <WITHDRAWN_COUNTRY>  (773) 
nan

>  <WITHDRAWN_REASON>  (773) 
nan

>  <CANONICAL_SMILES>  (773) 
C[C@@H]1CN(CC[C@]1(C(=O)O)c2ccccc2)[C@@H]3CC[C@@](CC3)(C#N)c4ccc(F)cc4

>  <name>  (773) 
Levocabastine 

>  <MW>  (773) 
420.528

>  <logP>  (773) 
4.89408

$$$$
CHEMBL827
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  5 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 11  6  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (774) 
57397

>  <SYNONYMS>  (774) 
Dexmethylphenidate (INN); Dexmethylphenidate HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (774) 
4

>  <RESEARCH_CODES>  (774) 
nan

>  <APPLICANTS>  (774) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (774) 
nan

>  <USAN_STEM_DEFINITION>  (774) 
nan

>  <USAN_STEM_SUBSTEM>  (774) 
nan

>  <USAN_YEAR>  (774) 
2002.0

>  <FIRST_APPROVAL>  (774) 
2001.0

>  <ATC_CODE>  (774) 
N06BA11

>  <ATC_CODE_DESCRIPTION>  (774) 
N06BA11 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (774) 
nan

>  <SC_PATENT_NO>  (774) 
US-5837284-A

>  <DRUG_TYPE>  (774) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (774) 
Y

>  <FIRST_IN_CLASS>  (774) 
N

>  <CHIRALITY>  (774) 
Single Stereoisomer

>  <PRODRUG>  (774) 
N

>  <ORAL>  (774) 
Y

>  <PARENTERAL>  (774) 
N

>  <TOPICAL>  (774) 
N

>  <BLACK_BOX>  (774) 
Y

>  <AVAILABILITY_TYPE>  (774) 
Prescription-only

>  <WITHDRAWN_YEAR>  (774) 
nan

>  <WITHDRAWN_COUNTRY>  (774) 
nan

>  <WITHDRAWN_REASON>  (774) 
nan

>  <CANONICAL_SMILES>  (774) 
COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2

>  <name>  (774) 
Dexmethylphenidate 

>  <MW>  (774) 
233.311

>  <logP>  (774) 
2.0853

$$$$
CHEMBL1201314
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 15  1  0
 25 18  2  0
M  END
>  <PARENT_MOLREGNO>  (775) 
675265

>  <SYNONYMS>  (775) 
Valganciclovir (BAN, INN); Valganciclovir HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (775) 
4

>  <RESEARCH_CODES>  (775) 
Ro-1079070/194; RS-079070-194

>  <APPLICANTS>  (775) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (775) 
-vir

>  <USAN_STEM_DEFINITION>  (775) 
antivirals: antivirals (acyclovir type)

>  <USAN_STEM_SUBSTEM>  (775) 
-vir (-ciclovir)

>  <USAN_YEAR>  (775) 
1997.0

>  <FIRST_APPROVAL>  (775) 
2001.0

>  <ATC_CODE>  (775) 
J05AB14

>  <ATC_CODE_DESCRIPTION>  (775) 
J05AB14 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (775) 
Antiviral

>  <SC_PATENT_NO>  (775) 
US-6083953-A

>  <DRUG_TYPE>  (775) 
Natural Product-derived

>  <RULE_OF_FIVE>  (775) 
Y

>  <FIRST_IN_CLASS>  (775) 
N

>  <CHIRALITY>  (775) 
Racemic Mixture

>  <PRODRUG>  (775) 
Y

>  <ORAL>  (775) 
Y

>  <PARENTERAL>  (775) 
N

>  <TOPICAL>  (775) 
N

>  <BLACK_BOX>  (775) 
Y

>  <AVAILABILITY_TYPE>  (775) 
Prescription-only

>  <WITHDRAWN_YEAR>  (775) 
nan

>  <WITHDRAWN_COUNTRY>  (775) 
nan

>  <WITHDRAWN_REASON>  (775) 
nan

>  <CANONICAL_SMILES>  (775) 
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2C(=O)N=C(N)Nc12

>  <name>  (775) 
Valganciclovir 

>  <MW>  (775) 
354.367

>  <logP>  (775) 
-1.4367

$$$$
CHEMBL1004
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 14  9  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (776) 
111498

>  <SYNONYMS>  (776) 
Doxylamine (BAN, INN); Doxylamine Succinate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (776) 
4

>  <RESEARCH_CODES>  (776) 
nan

>  <APPLICANTS>  (776) 
Sanofi Aventis Us Llc; Pfizer Laboratories Div Pfizer Inc; Chattem Inc

>  <USAN_STEM>  (776) 
nan

>  <USAN_STEM_DEFINITION>  (776) 
nan

>  <USAN_STEM_SUBSTEM>  (776) 
nan

>  <USAN_YEAR>  (776) 
nan

>  <FIRST_APPROVAL>  (776) 
1948.0

>  <ATC_CODE>  (776) 
R06AA09; R06AA59

>  <ATC_CODE_DESCRIPTION>  (776) 
R06AA09 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]; R06AA59 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]

>  <INDICATION_CLASS>  (776) 
Antihistaminic

>  <SC_PATENT_NO>  (776) 
US-6340695-B1

>  <DRUG_TYPE>  (776) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (776) 
Y

>  <FIRST_IN_CLASS>  (776) 
N

>  <CHIRALITY>  (776) 
Racemic Mixture

>  <PRODRUG>  (776) 
N

>  <ORAL>  (776) 
Y

>  <PARENTERAL>  (776) 
N

>  <TOPICAL>  (776) 
N

>  <BLACK_BOX>  (776) 
N

>  <AVAILABILITY_TYPE>  (776) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (776) 
nan

>  <WITHDRAWN_COUNTRY>  (776) 
nan

>  <WITHDRAWN_REASON>  (776) 
nan

>  <CANONICAL_SMILES>  (776) 
CN(C)CCOC(C)(c1ccccc1)c2ccccn2

>  <name>  (776) 
Doxylamine 

>  <MW>  (776) 
270.376

>  <logP>  (776) 
2.9233

$$$$
CHEMBL632
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (777) 
27152

>  <SYNONYMS>  (777) 
Betamethasone (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (777) 
4

>  <RESEARCH_CODES>  (777) 
SCH-4831

>  <APPLICANTS>  (777) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (777) 
nan

>  <USAN_STEM_DEFINITION>  (777) 
nan

>  <USAN_STEM_SUBSTEM>  (777) 
nan

>  <USAN_YEAR>  (777) 
1962.0

>  <FIRST_APPROVAL>  (777) 
1961.0

>  <ATC_CODE>  (777) 
S01CB04; H02AB01; A07EA04; D07AC01; D07XC01; S01BA06; R03BA04; S03BA03; C05AA05; R01AD06; S02BA07

>  <ATC_CODE_DESCRIPTION>  (777) 
S01CB04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; H02AB01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; A07EA04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; D07AC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; D07XC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, potent, other combinations]; S01BA06 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; R03BA04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; S03BA03 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; C05AA05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R01AD06 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S02BA07 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (777) 
Glucocorticoid

>  <SC_PATENT_NO>  (777) 
nan

>  <DRUG_TYPE>  (777) 
Natural Product-derived

>  <RULE_OF_FIVE>  (777) 
Y

>  <FIRST_IN_CLASS>  (777) 
N

>  <CHIRALITY>  (777) 
Single Stereoisomer

>  <PRODRUG>  (777) 
N

>  <ORAL>  (777) 
Y

>  <PARENTERAL>  (777) 
N

>  <TOPICAL>  (777) 
Y

>  <BLACK_BOX>  (777) 
N

>  <AVAILABILITY_TYPE>  (777) 
Discontinued

>  <WITHDRAWN_YEAR>  (777) 
nan

>  <WITHDRAWN_COUNTRY>  (777) 
nan

>  <WITHDRAWN_REASON>  (777) 
nan

>  <CANONICAL_SMILES>  (777) 
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

>  <name>  (777) 
Betamethasone 

>  <MW>  (777) 
392.467

>  <logP>  (777) 
1.8957

$$$$
CHEMBL323348
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (778) 
165740

>  <SYNONYMS>  (778) 
Dimethyl Phthalate (MI, USP)

>  <DEVELOPMENT_PHASE>  (778) 
4

>  <RESEARCH_CODES>  (778) 
nan

>  <APPLICANTS>  (778) 
nan

>  <USAN_STEM>  (778) 
nan

>  <USAN_STEM_DEFINITION>  (778) 
nan

>  <USAN_STEM_SUBSTEM>  (778) 
nan

>  <USAN_YEAR>  (778) 
nan

>  <FIRST_APPROVAL>  (778) 
nan

>  <ATC_CODE>  (778) 
P03BX02

>  <ATC_CODE_DESCRIPTION>  (778) 
P03BX02 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Insecticides And Repellents:Other insecticides and repellents]

>  <INDICATION_CLASS>  (778) 
nan

>  <SC_PATENT_NO>  (778) 
nan

>  <DRUG_TYPE>  (778) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (778) 
Y

>  <FIRST_IN_CLASS>  (778) 
N

>  <CHIRALITY>  (778) 
Achiral Molecule

>  <PRODRUG>  (778) 
N

>  <ORAL>  (778) 
N

>  <PARENTERAL>  (778) 
N

>  <TOPICAL>  (778) 
N

>  <BLACK_BOX>  (778) 
N

>  <AVAILABILITY_TYPE>  (778) 
Unknown

>  <WITHDRAWN_YEAR>  (778) 
nan

>  <WITHDRAWN_COUNTRY>  (778) 
nan

>  <WITHDRAWN_REASON>  (778) 
nan

>  <CANONICAL_SMILES>  (778) 
COC(=O)c1ccccc1C(=O)OC

>  <name>  (778) 
Dimethyl Phthalate 

>  <MW>  (778) 
194.186

>  <logP>  (778) 
1.2598

$$$$
CHEMBL615
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  6 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 21  2  1  0
 20  5  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (779) 
24806

>  <SYNONYMS>  (779) 
Penicillin V (FDA, USAN, USP); Phenoxymethylpenicillin (BAN, INN); Penicillin V Potassium (FDA, USAN, USP); Phenoxymethylpenicillin Potassium (JAN); Bicillin V2 (JAN); Penicillin V Benzathine (USAN, USP)

>  <DEVELOPMENT_PHASE>  (779) 
4

>  <RESEARCH_CODES>  (779) 
nan

>  <APPLICANTS>  (779) 
Aurobindo Pharma Ltd; Apothecon Sub Bristol Myers Squibb Co; Apothecon Inc Div Bristol Myers Squibb; American Antibiotics Llc; Eli Lilly And Co

>  <USAN_STEM>  (779) 
-cillin

>  <USAN_STEM_DEFINITION>  (779) 
penicillins

>  <USAN_STEM_SUBSTEM>  (779) 
-cillin

>  <USAN_YEAR>  (779) 
1975.0

>  <FIRST_APPROVAL>  (779) 
1958.0

>  <ATC_CODE>  (779) 
J01CE02; J01CE10

>  <ATC_CODE_DESCRIPTION>  (779) 
J01CE02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]; J01CE10 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]

>  <INDICATION_CLASS>  (779) 
Antibacterial

>  <SC_PATENT_NO>  (779) 
nan

>  <DRUG_TYPE>  (779) 
Natural Product-derived

>  <RULE_OF_FIVE>  (779) 
Y

>  <FIRST_IN_CLASS>  (779) 
N

>  <CHIRALITY>  (779) 
Single Stereoisomer

>  <PRODRUG>  (779) 
N

>  <ORAL>  (779) 
Y

>  <PARENTERAL>  (779) 
N

>  <TOPICAL>  (779) 
N

>  <BLACK_BOX>  (779) 
N

>  <AVAILABILITY_TYPE>  (779) 
Prescription-only

>  <WITHDRAWN_YEAR>  (779) 
nan

>  <WITHDRAWN_COUNTRY>  (779) 
nan

>  <WITHDRAWN_REASON>  (779) 
nan

>  <CANONICAL_SMILES>  (779) 
CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O

>  <name>  (779) 
Penicillin V 

>  <MW>  (779) 
350.396

>  <logP>  (779) 
0.6971

$$$$
CHEMBL1200538
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (780) 
674489

>  <SYNONYMS>  (780) 
Betamethasone Acetate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (780) 
4

>  <RESEARCH_CODES>  (780) 
nan

>  <APPLICANTS>  (780) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (780) 
nan

>  <USAN_STEM_DEFINITION>  (780) 
nan

>  <USAN_STEM_SUBSTEM>  (780) 
nan

>  <USAN_YEAR>  (780) 
nan

>  <FIRST_APPROVAL>  (780) 
1965.0

>  <ATC_CODE>  (780) 
S01CB04; H02AB01; A07EA04; D07AC01; D07XC01; S01BA06; R03BA04; S03BA03; C05AA05; R01AD06; S02BA07

>  <ATC_CODE_DESCRIPTION>  (780) 
S01CB04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; H02AB01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; A07EA04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; D07AC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; D07XC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, potent, other combinations]; S01BA06 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; R03BA04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; S03BA03 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; C05AA05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R01AD06 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S02BA07 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (780) 
Glucocorticoid

>  <SC_PATENT_NO>  (780) 
nan

>  <DRUG_TYPE>  (780) 
Natural Product-derived

>  <RULE_OF_FIVE>  (780) 
Y

>  <FIRST_IN_CLASS>  (780) 
N

>  <CHIRALITY>  (780) 
Single Stereoisomer

>  <PRODRUG>  (780) 
Y

>  <ORAL>  (780) 
N

>  <PARENTERAL>  (780) 
Y

>  <TOPICAL>  (780) 
N

>  <BLACK_BOX>  (780) 
N

>  <AVAILABILITY_TYPE>  (780) 
Prescription-only

>  <WITHDRAWN_YEAR>  (780) 
nan

>  <WITHDRAWN_COUNTRY>  (780) 
nan

>  <WITHDRAWN_REASON>  (780) 
nan

>  <CANONICAL_SMILES>  (780) 
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C

>  <name>  (780) 
Betamethasone Acetate 

>  <MW>  (780) 
434.504

>  <logP>  (780) 
2.4665

$$$$
CHEMBL131
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
  7 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 18  2  1  0
 21  2  1  0
 16  6  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (781) 
27370

>  <SYNONYMS>  (781) 
Prednisolone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (781) 
4

>  <RESEARCH_CODES>  (781) 
nan

>  <APPLICANTS>  (781) 
Schering Corp Sub Schering Plough Corp; Pharmacia And Upjohn Co; Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (781) 
pred-

>  <USAN_STEM_DEFINITION>  (781) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (781) 
pred-

>  <USAN_YEAR>  (781) 
nan

>  <FIRST_APPROVAL>  (781) 
1955.0

>  <ATC_CODE>  (781) 
A01AC54; C05AA04; R01AD52; A07EA01; S01BA04; S02BA03; D07AA03; H02AB06; D07XA02; R01AD02; S01CB02; S03BA02

>  <ATC_CODE_DESCRIPTION>  (781) 
A01AC54 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; C05AA04 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R01AD52 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; A07EA01 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; S01BA04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA03 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; D07AA03 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; H02AB06 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07XA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; R01AD02 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S01CB02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; S03BA02 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (781) 
Glucocorticoid

>  <SC_PATENT_NO>  (781) 
nan

>  <DRUG_TYPE>  (781) 
Natural Product-derived

>  <RULE_OF_FIVE>  (781) 
Y

>  <FIRST_IN_CLASS>  (781) 
N

>  <CHIRALITY>  (781) 
Single Stereoisomer

>  <PRODRUG>  (781) 
N

>  <ORAL>  (781) 
Y

>  <PARENTERAL>  (781) 
N

>  <TOPICAL>  (781) 
Y

>  <BLACK_BOX>  (781) 
N

>  <AVAILABILITY_TYPE>  (781) 
Prescription-only

>  <WITHDRAWN_YEAR>  (781) 
nan

>  <WITHDRAWN_COUNTRY>  (781) 
nan

>  <WITHDRAWN_REASON>  (781) 
nan

>  <CANONICAL_SMILES>  (781) 
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO

>  <name>  (781) 
Prednisolone 

>  <MW>  (781) 
360.45

>  <logP>  (781) 
1.5576

$$$$
CHEMBL237500
     RDKit          

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 13 26  1  0
 26 27  2  0
 26 28  1  0
  6 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  1  0
 28  5  1  0
 28  8  2  0
 25 15  1  0
 24 19  1  0
 35 29  1  0
M  END
>  <PARENT_MOLREGNO>  (782) 
399873

>  <SYNONYMS>  (782) 
Linagliptin (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (782) 
4

>  <RESEARCH_CODES>  (782) 
BI-1356-BS; BI-1356; BS-1356-BS

>  <APPLICANTS>  (782) 
Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (782) 
-gliptin

>  <USAN_STEM_DEFINITION>  (782) 
dipeptidyl aminopeptidase-IV inhibitors

>  <USAN_STEM_SUBSTEM>  (782) 
-gliptin

>  <USAN_YEAR>  (782) 
2009.0

>  <FIRST_APPROVAL>  (782) 
2011.0

>  <ATC_CODE>  (782) 
A10BH05

>  <ATC_CODE_DESCRIPTION>  (782) 
A10BH05 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Dipeptidyl peptidase 4 (DPP-4) inhibitors]

>  <INDICATION_CLASS>  (782) 
nan

>  <SC_PATENT_NO>  (782) 
US-6303661-B1

>  <DRUG_TYPE>  (782) 
Natural Product-derived

>  <RULE_OF_FIVE>  (782) 
Y

>  <FIRST_IN_CLASS>  (782) 
N

>  <CHIRALITY>  (782) 
Single Stereoisomer

>  <PRODRUG>  (782) 
N

>  <ORAL>  (782) 
Y

>  <PARENTERAL>  (782) 
N

>  <TOPICAL>  (782) 
N

>  <BLACK_BOX>  (782) 
N

>  <AVAILABILITY_TYPE>  (782) 
Prescription-only

>  <WITHDRAWN_YEAR>  (782) 
nan

>  <WITHDRAWN_COUNTRY>  (782) 
nan

>  <WITHDRAWN_REASON>  (782) 
nan

>  <CANONICAL_SMILES>  (782) 
CC#CCn1c(nc2N(C)C(=O)N(Cc3nc(C)c4ccccc4n3)C(=O)c12)N5CCC[C@@H](N)C5

>  <name>  (782) 
Linagliptin 

>  <MW>  (782) 
472.553

>  <logP>  (782) 
1.14742

$$$$
CHEMBL869
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 11  7  2  0
M  CHG  2  12   1  14  -1
M  END
>  <PARENT_MOLREGNO>  (783) 
70239

>  <SYNONYMS>  (783) 
Nitrofural (DCF, INN); Nitrofurazone (BAN, FDA, USP)

>  <DEVELOPMENT_PHASE>  (783) 
4

>  <RESEARCH_CODES>  (783) 
nan

>  <APPLICANTS>  (783) 
Shire Development Inc; Sherwood Medical Co

>  <USAN_STEM>  (783) 
nan

>  <USAN_STEM_DEFINITION>  (783) 
nan

>  <USAN_STEM_SUBSTEM>  (783) 
nan

>  <USAN_YEAR>  (783) 
nan

>  <FIRST_APPROVAL>  (783) 
1945.0

>  <ATC_CODE>  (783) 
D09AA03; B05CA03; S01AX04; D08AF01; P01CC02; S02AA02

>  <ATC_CODE_DESCRIPTION>  (783) 
D09AA03 [Dermatologicals:Medicated Dressings:Medicated Dressings:Medicated dressings with antiinfectives]; B05CA03 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:Irrigating Solutions:Antiinfectives]; S01AX04 [Sensory Organs:Ophthalmologicals:Antiinfectives:Other antiinfectives]; D08AF01 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Nitrofuran derivatives]; P01CC02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Leishmaniasis And Trypanosomiasis:Nitrofuran derivatives]; S02AA02 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]

>  <INDICATION_CLASS>  (783) 
Anti-Infective, Topical

>  <SC_PATENT_NO>  (783) 
nan

>  <DRUG_TYPE>  (783) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (783) 
Y

>  <FIRST_IN_CLASS>  (783) 
N

>  <CHIRALITY>  (783) 
Achiral Molecule

>  <PRODRUG>  (783) 
Y

>  <ORAL>  (783) 
N

>  <PARENTERAL>  (783) 
N

>  <TOPICAL>  (783) 
Y

>  <BLACK_BOX>  (783) 
N

>  <AVAILABILITY_TYPE>  (783) 
Withdrawn

>  <WITHDRAWN_YEAR>  (783) 
nan

>  <WITHDRAWN_COUNTRY>  (783) 
United States

>  <WITHDRAWN_REASON>  (783) 
nan

>  <CANONICAL_SMILES>  (783) 
OC(=N)N\N=C\c1oc(cc1)[N+](=O)[O-]

>  <name>  (783) 
Nitrofural 

>  <MW>  (783) 
198.138

>  <logP>  (783) 
0.60407

$$$$
CHEMBL170
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 10 23  1  0
 23 24  2  0
 24  3  1  0
 23  6  1  0
 18 13  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (784) 
255947

>  <SYNONYMS>  (784) 
Quinine (BAN, MI, NF); Quinine HCl (JAN, MI, NF); Quinine Glycerophosphate (NF); Quinine Phosphate (NF); Quinine Ascorbate (USAN); Quinine Bisulfate (MI, NF); Quinine Dihydrochloride (MI, NF); Quinine Salicylate (MI, NF); Quinine Hydrobromide (MI, NF); Quinine Sulfate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (784) 
4

>  <RESEARCH_CODES>  (784) 
nan

>  <APPLICANTS>  (784) 
Mutual Pharmaceutical Co Inc

>  <USAN_STEM>  (784) 
nan

>  <USAN_STEM_DEFINITION>  (784) 
nan

>  <USAN_STEM_SUBSTEM>  (784) 
nan

>  <USAN_YEAR>  (784) 
1980.0

>  <FIRST_APPROVAL>  (784) 
2005.0

>  <ATC_CODE>  (784) 
M09AA72; P01BC01

>  <ATC_CODE_DESCRIPTION>  (784) 
M09AA72 [Musculo-Skeletal System:Other Drugs For Disorders Of The Musculo-Skeletal System:Other Drugs For Disorders Of The Musculo-Skeletal System:Quinine and derivatives]; P01BC01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Methanolquinolines]

>  <INDICATION_CLASS>  (784) 
Deterrent (smoking); Antimalarial

>  <SC_PATENT_NO>  (784) 
nan

>  <DRUG_TYPE>  (784) 
Natural Product-derived

>  <RULE_OF_FIVE>  (784) 
Y

>  <FIRST_IN_CLASS>  (784) 
N

>  <CHIRALITY>  (784) 
Single Stereoisomer

>  <PRODRUG>  (784) 
N

>  <ORAL>  (784) 
Y

>  <PARENTERAL>  (784) 
N

>  <TOPICAL>  (784) 
N

>  <BLACK_BOX>  (784) 
Y

>  <AVAILABILITY_TYPE>  (784) 
Prescription-only

>  <WITHDRAWN_YEAR>  (784) 
nan

>  <WITHDRAWN_COUNTRY>  (784) 
nan

>  <WITHDRAWN_REASON>  (784) 
nan

>  <CANONICAL_SMILES>  (784) 
COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1

>  <name>  (784) 
Quinine 

>  <MW>  (784) 
324.424

>  <logP>  (784) 
3.1732

$$$$
CHEMBL565
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (785) 
16415

>  <SYNONYMS>  (785) 
Clofibrate (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (785) 
4

>  <RESEARCH_CODES>  (785) 
AY-61123; ICI-28257

>  <APPLICANTS>  (785) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (785) 
-fibrate

>  <USAN_STEM_DEFINITION>  (785) 
antihyperlipidemics (clofibrate type)

>  <USAN_STEM_SUBSTEM>  (785) 
-fibrate

>  <USAN_YEAR>  (785) 
1963.0

>  <FIRST_APPROVAL>  (785) 
1967.0

>  <ATC_CODE>  (785) 
C10AB01

>  <ATC_CODE_DESCRIPTION>  (785) 
C10AB01 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:Fibrates]

>  <INDICATION_CLASS>  (785) 
Antihyperlipidemic

>  <SC_PATENT_NO>  (785) 
nan

>  <DRUG_TYPE>  (785) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (785) 
Y

>  <FIRST_IN_CLASS>  (785) 
N

>  <CHIRALITY>  (785) 
Achiral Molecule

>  <PRODRUG>  (785) 
Y

>  <ORAL>  (785) 
Y

>  <PARENTERAL>  (785) 
N

>  <TOPICAL>  (785) 
N

>  <BLACK_BOX>  (785) 
N

>  <AVAILABILITY_TYPE>  (785) 
Discontinued

>  <WITHDRAWN_YEAR>  (785) 
nan

>  <WITHDRAWN_COUNTRY>  (785) 
nan

>  <WITHDRAWN_REASON>  (785) 
nan

>  <CANONICAL_SMILES>  (785) 
CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1

>  <name>  (785) 
Clofibrate 

>  <MW>  (785) 
242.702

>  <logP>  (785) 
3.0605

$$$$
CHEMBL16080
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
M  END
>  <PARENT_MOLREGNO>  (786) 
16727

>  <SYNONYMS>  (786) 
Trichloroethane

>  <DEVELOPMENT_PHASE>  (786) 
4

>  <RESEARCH_CODES>  (786) 
nan

>  <APPLICANTS>  (786) 
nan

>  <USAN_STEM>  (786) 
nan

>  <USAN_STEM_DEFINITION>  (786) 
nan

>  <USAN_STEM_SUBSTEM>  (786) 
nan

>  <USAN_YEAR>  (786) 
nan

>  <FIRST_APPROVAL>  (786) 
nan

>  <ATC_CODE>  (786) 
nan

>  <ATC_CODE_DESCRIPTION>  (786) 
nan

>  <INDICATION_CLASS>  (786) 
nan

>  <SC_PATENT_NO>  (786) 
nan

>  <DRUG_TYPE>  (786) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (786) 
Y

>  <FIRST_IN_CLASS>  (786) 
N

>  <CHIRALITY>  (786) 
Achiral Molecule

>  <PRODRUG>  (786) 
N

>  <ORAL>  (786) 
N

>  <PARENTERAL>  (786) 
N

>  <TOPICAL>  (786) 
N

>  <BLACK_BOX>  (786) 
N

>  <AVAILABILITY_TYPE>  (786) 
Withdrawn

>  <WITHDRAWN_YEAR>  (786) 
nan

>  <WITHDRAWN_COUNTRY>  (786) 
United States

>  <WITHDRAWN_REASON>  (786) 
nan

>  <CANONICAL_SMILES>  (786) 
CC(Cl)(Cl)Cl

>  <name>  (786) 
Trichloroethane

>  <MW>  (786) 
133.405

>  <logP>  (786) 
2.3765

$$$$
CHEMBL1102
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  9  3  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (787) 
151300

>  <SYNONYMS>  (787) 
Glutethimide (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (787) 
4

>  <RESEARCH_CODES>  (787) 
nan

>  <APPLICANTS>  (787) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (787) 
nan

>  <USAN_STEM_DEFINITION>  (787) 
nan

>  <USAN_STEM_SUBSTEM>  (787) 
nan

>  <USAN_YEAR>  (787) 
nan

>  <FIRST_APPROVAL>  (787) 
1976.0

>  <ATC_CODE>  (787) 
N05CE01

>  <ATC_CODE_DESCRIPTION>  (787) 
N05CE01 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Piperidinedione derivatives]

>  <INDICATION_CLASS>  (787) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (787) 
nan

>  <DRUG_TYPE>  (787) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (787) 
Y

>  <FIRST_IN_CLASS>  (787) 
N

>  <CHIRALITY>  (787) 
Racemic Mixture

>  <PRODRUG>  (787) 
N

>  <ORAL>  (787) 
Y

>  <PARENTERAL>  (787) 
N

>  <TOPICAL>  (787) 
N

>  <BLACK_BOX>  (787) 
N

>  <AVAILABILITY_TYPE>  (787) 
Discontinued

>  <WITHDRAWN_YEAR>  (787) 
nan

>  <WITHDRAWN_COUNTRY>  (787) 
nan

>  <WITHDRAWN_REASON>  (787) 
nan

>  <CANONICAL_SMILES>  (787) 
CCC1(CCC(=O)NC1=O)c2ccccc2

>  <name>  (787) 
Glutethimide 

>  <MW>  (787) 
217.268

>  <logP>  (787) 
1.771

$$$$
CHEMBL991
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
  4 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15  2  1  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (788) 
107119

>  <SYNONYMS>  (788) 
Stavudine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (788) 
4

>  <RESEARCH_CODES>  (788) 
BMY-27857

>  <APPLICANTS>  (788) 
Bristol Myers Squibb Co Pharmaceutical Research Institute; Bristol Myers Squibb Co

>  <USAN_STEM>  (788) 
-vudine

>  <USAN_STEM_DEFINITION>  (788) 
antineoplastics,antivirals (zidovudine group) (exception: edoxudine)

>  <USAN_STEM_SUBSTEM>  (788) 
-vudine

>  <USAN_YEAR>  (788) 
1991.0

>  <FIRST_APPROVAL>  (788) 
1994.0

>  <ATC_CODE>  (788) 
J05AF04

>  <ATC_CODE_DESCRIPTION>  (788) 
J05AF04 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (788) 
Antiviral

>  <SC_PATENT_NO>  (788) 
US-7135465-B2

>  <DRUG_TYPE>  (788) 
Natural Product-derived

>  <RULE_OF_FIVE>  (788) 
Y

>  <FIRST_IN_CLASS>  (788) 
N

>  <CHIRALITY>  (788) 
Single Stereoisomer

>  <PRODRUG>  (788) 
N

>  <ORAL>  (788) 
Y

>  <PARENTERAL>  (788) 
N

>  <TOPICAL>  (788) 
N

>  <BLACK_BOX>  (788) 
Y

>  <AVAILABILITY_TYPE>  (788) 
Prescription-only

>  <WITHDRAWN_YEAR>  (788) 
nan

>  <WITHDRAWN_COUNTRY>  (788) 
nan

>  <WITHDRAWN_REASON>  (788) 
nan

>  <CANONICAL_SMILES>  (788) 
CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O

>  <name>  (788) 
Stavudine 

>  <MW>  (788) 
224.216

>  <logP>  (788) 
-0.70908

$$$$
CHEMBL13280
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 17 21  1  0
 21 22  2  0
 21 23  1  0
 20  2  1  0
 13  8  1  0
 20 15  1  0
M  CHG  2  21   1  23  -1
M  END
>  <PARENT_MOLREGNO>  (789) 
11715

>  <SYNONYMS>  (789) 
Flunitrazepam (BAN, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (789) 
4

>  <RESEARCH_CODES>  (789) 
Ro-54200

>  <APPLICANTS>  (789) 
Roche, Puerto Rico

>  <USAN_STEM>  (789) 
-azepam

>  <USAN_STEM_DEFINITION>  (789) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (789) 
-azepam

>  <USAN_YEAR>  (789) 
1976.0

>  <FIRST_APPROVAL>  (789) 
nan

>  <ATC_CODE>  (789) 
N05CD03

>  <ATC_CODE_DESCRIPTION>  (789) 
N05CD03 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (789) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (789) 
nan

>  <DRUG_TYPE>  (789) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (789) 
Y

>  <FIRST_IN_CLASS>  (789) 
N

>  <CHIRALITY>  (789) 
Achiral Molecule

>  <PRODRUG>  (789) 
N

>  <ORAL>  (789) 
N

>  <PARENTERAL>  (789) 
N

>  <TOPICAL>  (789) 
N

>  <BLACK_BOX>  (789) 
N

>  <AVAILABILITY_TYPE>  (789) 
Withdrawn

>  <WITHDRAWN_YEAR>  (789) 
1996.0

>  <WITHDRAWN_COUNTRY>  (789) 
France; unapproved in United States

>  <WITHDRAWN_REASON>  (789) 
Abuse

>  <CANONICAL_SMILES>  (789) 
CN1C(=O)CN=C(c2ccccc2F)c3cc(ccc13)[N+](=O)[O-]

>  <name>  (789) 
Flunitrazepam 

>  <MW>  (789) 
313.288

>  <logP>  (789) 
2.5477

$$$$
CHEMBL93
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16  8  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (790) 
9217

>  <SYNONYMS>  (790) 
Zileuton (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (790) 
4

>  <RESEARCH_CODES>  (790) 
A-64077; ABBOTT-64077

>  <APPLICANTS>  (790) 
Cornerstone Therapeutics Inc

>  <USAN_STEM>  (790) 
-leuton

>  <USAN_STEM_DEFINITION>  (790) 
5-lipoxgenase inhibitors

>  <USAN_STEM_SUBSTEM>  (790) 
-leuton

>  <USAN_YEAR>  (790) 
1990.0

>  <FIRST_APPROVAL>  (790) 
1996.0

>  <ATC_CODE>  (790) 
nan

>  <ATC_CODE_DESCRIPTION>  (790) 
nan

>  <INDICATION_CLASS>  (790) 
Inhibitor (5-lipoxygenase)

>  <SC_PATENT_NO>  (790) 
nan

>  <DRUG_TYPE>  (790) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (790) 
Y

>  <FIRST_IN_CLASS>  (790) 
N

>  <CHIRALITY>  (790) 
Racemic Mixture

>  <PRODRUG>  (790) 
N

>  <ORAL>  (790) 
Y

>  <PARENTERAL>  (790) 
N

>  <TOPICAL>  (790) 
N

>  <BLACK_BOX>  (790) 
N

>  <AVAILABILITY_TYPE>  (790) 
Prescription-only

>  <WITHDRAWN_YEAR>  (790) 
nan

>  <WITHDRAWN_COUNTRY>  (790) 
nan

>  <WITHDRAWN_REASON>  (790) 
nan

>  <CANONICAL_SMILES>  (790) 
CC(N(O)C(=O)N)c1cc2ccccc2s1

>  <name>  (790) 
Zileuton 

>  <MW>  (790) 
236.296

>  <logP>  (790) 
2.7322

$$$$
CHEMBL33986
     RDKit          

 24 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  8 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 16 23  1  0
 23 24  2  0
 24  2  1  0
 23  5  1  0
 21  7  1  0
 13 10  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (791) 
45838

>  <SYNONYMS>  (791) 
Butorphanol (BAN, INN, USAN); Butorphanol Tartrate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (791) 
4

>  <RESEARCH_CODES>  (791) 
LEVO-BC-2627; LEVO-BC-2627 Tartrate

>  <APPLICANTS>  (791) 
Bristol-Myers Squibb; Bristol Myers Squibb Co Pharmaceutical Research Institute; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (791) 
nan

>  <USAN_STEM_DEFINITION>  (791) 
nan

>  <USAN_STEM_SUBSTEM>  (791) 
nan

>  <USAN_YEAR>  (791) 
1974.0

>  <FIRST_APPROVAL>  (791) 
1978.0

>  <ATC_CODE>  (791) 
N02AF01

>  <ATC_CODE_DESCRIPTION>  (791) 
N02AF01 [Nervous System:Analgesics:Opioids:Morphinan derivatives]

>  <INDICATION_CLASS>  (791) 
Analgesic; Antitussive

>  <SC_PATENT_NO>  (791) 
nan

>  <DRUG_TYPE>  (791) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (791) 
Y

>  <FIRST_IN_CLASS>  (791) 
N

>  <CHIRALITY>  (791) 
Single Stereoisomer

>  <PRODRUG>  (791) 
N

>  <ORAL>  (791) 
N

>  <PARENTERAL>  (791) 
Y

>  <TOPICAL>  (791) 
Y

>  <BLACK_BOX>  (791) 
Y

>  <AVAILABILITY_TYPE>  (791) 
Prescription-only

>  <WITHDRAWN_YEAR>  (791) 
nan

>  <WITHDRAWN_COUNTRY>  (791) 
nan

>  <WITHDRAWN_REASON>  (791) 
nan

>  <CANONICAL_SMILES>  (791) 
Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1

>  <name>  (791) 
Butorphanol 

>  <MW>  (791) 
327.468

>  <logP>  (791) 
3.3656

$$$$
CHEMBL544
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9  3  1  0
M  END
>  <PARENT_MOLREGNO>  (792) 
13474

>  <SYNONYMS>  (792) 
Mequinol (DCF, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (792) 
4

>  <RESEARCH_CODES>  (792) 
BMS-181158

>  <APPLICANTS>  (792) 
Aqua Pharmaceuticals Llc

>  <USAN_STEM>  (792) 
nan

>  <USAN_STEM_DEFINITION>  (792) 
nan

>  <USAN_STEM_SUBSTEM>  (792) 
nan

>  <USAN_YEAR>  (792) 
1999.0

>  <FIRST_APPROVAL>  (792) 
1999.0

>  <ATC_CODE>  (792) 
D11AX06

>  <ATC_CODE_DESCRIPTION>  (792) 
D11AX06 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (792) 
nan

>  <SC_PATENT_NO>  (792) 
US-6353029-B1

>  <DRUG_TYPE>  (792) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (792) 
Y

>  <FIRST_IN_CLASS>  (792) 
N

>  <CHIRALITY>  (792) 
Achiral Molecule

>  <PRODRUG>  (792) 
N

>  <ORAL>  (792) 
N

>  <PARENTERAL>  (792) 
N

>  <TOPICAL>  (792) 
Y

>  <BLACK_BOX>  (792) 
N

>  <AVAILABILITY_TYPE>  (792) 
Discontinued

>  <WITHDRAWN_YEAR>  (792) 
nan

>  <WITHDRAWN_COUNTRY>  (792) 
nan

>  <WITHDRAWN_REASON>  (792) 
nan

>  <CANONICAL_SMILES>  (792) 
COc1ccc(O)cc1

>  <name>  (792) 
Mequinol 

>  <MW>  (792) 
124.139

>  <logP>  (792) 
1.4008

$$$$
CHEMBL656
     RDKit          

 23 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 14 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 16  3  1  0
 17  6  1  0
 22  8  1  0
 17 13  1  0
 22 13  1  0
M  END
>  <PARENT_MOLREGNO>  (793) 
27624

>  <SYNONYMS>  (793) 
Oxycodone (BAN, INN, USAN); Oxycodone HCl (FDA, JAN, USAN, USP); Oxycodone terephthalate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (793) 
4

>  <RESEARCH_CODES>  (793) 
nan

>  <APPLICANTS>  (793) 
Lehigh Valley Technologies Inc; King Pharmaceuticals Research Development Inc; Forest Laboratories Inc; Endo Pharmaceuticals Inc; Purdue Frederick

>  <USAN_STEM>  (793) 
nan

>  <USAN_STEM_DEFINITION>  (793) 
nan

>  <USAN_STEM_SUBSTEM>  (793) 
nan

>  <USAN_YEAR>  (793) 
1963.0

>  <FIRST_APPROVAL>  (793) 
1950.0

>  <ATC_CODE>  (793) 
N02AA05; N02AA55

>  <ATC_CODE_DESCRIPTION>  (793) 
N02AA05 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]; N02AA55 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]

>  <INDICATION_CLASS>  (793) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (793) 
US-6277384-B1

>  <DRUG_TYPE>  (793) 
Natural Product-derived

>  <RULE_OF_FIVE>  (793) 
Y

>  <FIRST_IN_CLASS>  (793) 
N

>  <CHIRALITY>  (793) 
Single Stereoisomer

>  <PRODRUG>  (793) 
Y

>  <ORAL>  (793) 
Y

>  <PARENTERAL>  (793) 
N

>  <TOPICAL>  (793) 
N

>  <BLACK_BOX>  (793) 
Y

>  <AVAILABILITY_TYPE>  (793) 
Prescription-only

>  <WITHDRAWN_YEAR>  (793) 
nan

>  <WITHDRAWN_COUNTRY>  (793) 
United States

>  <WITHDRAWN_REASON>  (793) 
nan

>  <CANONICAL_SMILES>  (793) 
COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O

>  <name>  (793) 
Oxycodone 

>  <MW>  (793) 
315.369

>  <logP>  (793) 
1.0482

$$$$
CHEMBL1200733
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
M  END
>  <PARENT_MOLREGNO>  (794) 
674684

>  <SYNONYMS>  (794) 
Desflurane (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (794) 
4

>  <RESEARCH_CODES>  (794) 
I-653

>  <APPLICANTS>  (794) 
Baxter Healthcare Corp

>  <USAN_STEM>  (794) 
-flurane

>  <USAN_STEM_DEFINITION>  (794) 
general inhalation anesthetics (halogenated alkane derivatives)

>  <USAN_STEM_SUBSTEM>  (794) 
-flurane

>  <USAN_YEAR>  (794) 
1990.0

>  <FIRST_APPROVAL>  (794) 
1992.0

>  <ATC_CODE>  (794) 
N01AB07

>  <ATC_CODE_DESCRIPTION>  (794) 
N01AB07 [Nervous System:Anesthetics:Anesthetics, General:Halogenated hydrocarbons]

>  <INDICATION_CLASS>  (794) 
Anesthetic

>  <SC_PATENT_NO>  (794) 
nan

>  <DRUG_TYPE>  (794) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (794) 
Y

>  <FIRST_IN_CLASS>  (794) 
N

>  <CHIRALITY>  (794) 
Racemic Mixture

>  <PRODRUG>  (794) 
N

>  <ORAL>  (794) 
N

>  <PARENTERAL>  (794) 
N

>  <TOPICAL>  (794) 
Y

>  <BLACK_BOX>  (794) 
N

>  <AVAILABILITY_TYPE>  (794) 
Prescription-only

>  <WITHDRAWN_YEAR>  (794) 
nan

>  <WITHDRAWN_COUNTRY>  (794) 
nan

>  <WITHDRAWN_REASON>  (794) 
nan

>  <CANONICAL_SMILES>  (794) 
FC(F)OC(F)C(F)(F)F

>  <name>  (794) 
Desflurane 

>  <MW>  (794) 
168.036

>  <logP>  (794) 
2.0835

$$$$
CHEMBL750
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  6  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (795) 
39857

>  <SYNONYMS>  (795) 
Zonisamide (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (795) 
4

>  <RESEARCH_CODES>  (795) 
AD-810; CI-912; PD-110843

>  <APPLICANTS>  (795) 
Eisai Inc

>  <USAN_STEM>  (795) 
nan

>  <USAN_STEM_DEFINITION>  (795) 
nan

>  <USAN_STEM_SUBSTEM>  (795) 
nan

>  <USAN_YEAR>  (795) 
1985.0

>  <FIRST_APPROVAL>  (795) 
2000.0

>  <ATC_CODE>  (795) 
N03AX15

>  <ATC_CODE_DESCRIPTION>  (795) 
N03AX15 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (795) 
Anticonvulsant

>  <SC_PATENT_NO>  (795) 
nan

>  <DRUG_TYPE>  (795) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (795) 
Y

>  <FIRST_IN_CLASS>  (795) 
N

>  <CHIRALITY>  (795) 
Achiral Molecule

>  <PRODRUG>  (795) 
N

>  <ORAL>  (795) 
Y

>  <PARENTERAL>  (795) 
N

>  <TOPICAL>  (795) 
N

>  <BLACK_BOX>  (795) 
N

>  <AVAILABILITY_TYPE>  (795) 
Prescription-only

>  <WITHDRAWN_YEAR>  (795) 
nan

>  <WITHDRAWN_COUNTRY>  (795) 
nan

>  <WITHDRAWN_REASON>  (795) 
nan

>  <CANONICAL_SMILES>  (795) 
OS(=N)(=O)Cc1noc2ccccc12

>  <name>  (795) 
Zonisamide 

>  <MW>  (795) 
212.23

>  <logP>  (795) 
1.84757

$$$$
CHEMBL967
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21  2  1  0
 14  9  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (796) 
95909

>  <SYNONYMS>  (796) 
Temazepam (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (796) 
4

>  <RESEARCH_CODES>  (796) 
WY-3917

>  <APPLICANTS>  (796) 
Mallinckrodt Inc

>  <USAN_STEM>  (796) 
-azepam

>  <USAN_STEM_DEFINITION>  (796) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (796) 
-azepam

>  <USAN_YEAR>  (796) 
1969.0

>  <FIRST_APPROVAL>  (796) 
1981.0

>  <ATC_CODE>  (796) 
N05CD07

>  <ATC_CODE_DESCRIPTION>  (796) 
N05CD07 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (796) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (796) 
nan

>  <DRUG_TYPE>  (796) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (796) 
Y

>  <FIRST_IN_CLASS>  (796) 
N

>  <CHIRALITY>  (796) 
Racemic Mixture

>  <PRODRUG>  (796) 
N

>  <ORAL>  (796) 
Y

>  <PARENTERAL>  (796) 
N

>  <TOPICAL>  (796) 
N

>  <BLACK_BOX>  (796) 
Y

>  <AVAILABILITY_TYPE>  (796) 
Prescription-only

>  <WITHDRAWN_YEAR>  (796) 
nan

>  <WITHDRAWN_COUNTRY>  (796) 
nan

>  <WITHDRAWN_REASON>  (796) 
nan

>  <CANONICAL_SMILES>  (796) 
CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13

>  <name>  (796) 
Temazepam 

>  <MW>  (796) 
300.745

>  <logP>  (796) 
2.4722

$$$$
CHEMBL1697733
     RDKit          

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
M  CHG  2   9  -1  11   1
M  END
>  <PARENT_MOLREGNO>  (797) 
1078496

>  <SYNONYMS>  (797) 
Acetylcarnitine

>  <DEVELOPMENT_PHASE>  (797) 
4

>  <RESEARCH_CODES>  (797) 
nan

>  <APPLICANTS>  (797) 
nan

>  <USAN_STEM>  (797) 
nan

>  <USAN_STEM_DEFINITION>  (797) 
nan

>  <USAN_STEM_SUBSTEM>  (797) 
nan

>  <USAN_YEAR>  (797) 
nan

>  <FIRST_APPROVAL>  (797) 
nan

>  <ATC_CODE>  (797) 
N06BX12

>  <ATC_CODE_DESCRIPTION>  (797) 
N06BX12 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Other psychostimulants and nootropics]

>  <INDICATION_CLASS>  (797) 
nan

>  <SC_PATENT_NO>  (797) 
nan

>  <DRUG_TYPE>  (797) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (797) 
Y

>  <FIRST_IN_CLASS>  (797) 
N

>  <CHIRALITY>  (797) 
Single Stereoisomer

>  <PRODRUG>  (797) 
N

>  <ORAL>  (797) 
N

>  <PARENTERAL>  (797) 
N

>  <TOPICAL>  (797) 
N

>  <BLACK_BOX>  (797) 
N

>  <AVAILABILITY_TYPE>  (797) 
Unknown

>  <WITHDRAWN_YEAR>  (797) 
nan

>  <WITHDRAWN_COUNTRY>  (797) 
nan

>  <WITHDRAWN_REASON>  (797) 
nan

>  <CANONICAL_SMILES>  (797) 
CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C

>  <name>  (797) 
Acetylcarnitine

>  <MW>  (797) 
203.238

>  <logP>  (797) 
-1.2357

$$$$
CHEMBL1404
     RDKit          

 31 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 17 30  1  0
 30 31  1  0
  8  3  1  0
 31 14  1  0
 28 22  1  0
M  END
>  <PARENT_MOLREGNO>  (798) 
341382

>  <SYNONYMS>  (798) 
Ranolazine (FDA, INN, USAN); Ranolazine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (798) 
4

>  <RESEARCH_CODES>  (798) 
CVT-303; RS-43285-003; RS-43285

>  <APPLICANTS>  (798) 
Syntex; Gilead Sciences Inc

>  <USAN_STEM>  (798) 
nan

>  <USAN_STEM_DEFINITION>  (798) 
nan

>  <USAN_STEM_SUBSTEM>  (798) 
nan

>  <USAN_YEAR>  (798) 
1988.0

>  <FIRST_APPROVAL>  (798) 
2006.0

>  <ATC_CODE>  (798) 
C01EB18

>  <ATC_CODE_DESCRIPTION>  (798) 
C01EB18 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (798) 
Anti-Anginal

>  <SC_PATENT_NO>  (798) 
US-6303607-B1

>  <DRUG_TYPE>  (798) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (798) 
Y

>  <FIRST_IN_CLASS>  (798) 
N

>  <CHIRALITY>  (798) 
Racemic Mixture

>  <PRODRUG>  (798) 
N

>  <ORAL>  (798) 
Y

>  <PARENTERAL>  (798) 
N

>  <TOPICAL>  (798) 
N

>  <BLACK_BOX>  (798) 
N

>  <AVAILABILITY_TYPE>  (798) 
Prescription-only

>  <WITHDRAWN_YEAR>  (798) 
nan

>  <WITHDRAWN_COUNTRY>  (798) 
nan

>  <WITHDRAWN_REASON>  (798) 
nan

>  <CANONICAL_SMILES>  (798) 
COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2

>  <name>  (798) 
Ranolazine 

>  <MW>  (798) 
427.545

>  <logP>  (798) 
2.30804

$$$$
CHEMBL1201131
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 21 13  1  0
 19 15  2  0
M  END
>  <PARENT_MOLREGNO>  (799) 
675082

>  <SYNONYMS>  (799) 
Piperonyl Butoxide (BAN, FDA)

>  <DEVELOPMENT_PHASE>  (799) 
4

>  <RESEARCH_CODES>  (799) 
nan

>  <APPLICANTS>  (799) 
Bayer Healthcare Consumer Care

>  <USAN_STEM>  (799) 
nan

>  <USAN_STEM_DEFINITION>  (799) 
nan

>  <USAN_STEM_SUBSTEM>  (799) 
nan

>  <USAN_YEAR>  (799) 
nan

>  <FIRST_APPROVAL>  (799) 
2000.0

>  <ATC_CODE>  (799) 
nan

>  <ATC_CODE_DESCRIPTION>  (799) 
nan

>  <INDICATION_CLASS>  (799) 
nan

>  <SC_PATENT_NO>  (799) 
nan

>  <DRUG_TYPE>  (799) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (799) 
Y

>  <FIRST_IN_CLASS>  (799) 
N

>  <CHIRALITY>  (799) 
Achiral Molecule

>  <PRODRUG>  (799) 
N

>  <ORAL>  (799) 
N

>  <PARENTERAL>  (799) 
N

>  <TOPICAL>  (799) 
Y

>  <BLACK_BOX>  (799) 
N

>  <AVAILABILITY_TYPE>  (799) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (799) 
nan

>  <WITHDRAWN_COUNTRY>  (799) 
nan

>  <WITHDRAWN_REASON>  (799) 
nan

>  <CANONICAL_SMILES>  (799) 
CCCCOCCOCCOCc1cc2OCOc2cc1CCC

>  <name>  (799) 
Piperonyl Butoxide 

>  <MW>  (799) 
338.444

>  <logP>  (799) 
3.7177

$$$$
CHEMBL1681
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (800) 
513301

>  <SYNONYMS>  (800) 
Sodium Iodohippurate (123I) (USAN, USP, FDA); Sodium o-Iodo-(123I)-Hippurate (JAN); Iodohippurate Sodium I-131 (USAN, USP, FDA); Sodium Iodohippurate (131I) (INN); Sodium Iodohippurate (131I) Injection (JAN); Iodohippurate Sodium (123I) (USAN)

>  <DEVELOPMENT_PHASE>  (800) 
4

>  <RESEARCH_CODES>  (800) 
nan

>  <APPLICANTS>  (800) 
Ge Healthcare; Bristol-Myers Squibb; Bracco Diagnostics Inc; Abbott; Mallinckrodt Medical Inc

>  <USAN_STEM>  (800) 
io-

>  <USAN_STEM_DEFINITION>  (800) 
iodine-containing contrast media

>  <USAN_STEM_SUBSTEM>  (800) 
io-

>  <USAN_YEAR>  (800) 
1963.0

>  <FIRST_APPROVAL>  (800) 
1984.0

>  <ATC_CODE>  (800) 
V09CX01; V09CX02

>  <ATC_CODE_DESCRIPTION>  (800) 
V09CX01 [Various:Diagnostic Radiopharmaceuticals:Renal System:Other renal system diagnostic radiopharmaceuticals]; V09CX02 [Various:Diagnostic Radiopharmaceuticals:Renal System:Other renal system diagnostic radiopharmaceuticals]

>  <INDICATION_CLASS>  (800) 
Diagnostic Aid (renal function determination); Radioactive Agent

>  <SC_PATENT_NO>  (800) 
nan

>  <DRUG_TYPE>  (800) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (800) 
Y

>  <FIRST_IN_CLASS>  (800) 
N

>  <CHIRALITY>  (800) 
Achiral Molecule

>  <PRODRUG>  (800) 
N

>  <ORAL>  (800) 
N

>  <PARENTERAL>  (800) 
Y

>  <TOPICAL>  (800) 
N

>  <BLACK_BOX>  (800) 
N

>  <AVAILABILITY_TYPE>  (800) 
Discontinued

>  <WITHDRAWN_YEAR>  (800) 
nan

>  <WITHDRAWN_COUNTRY>  (800) 
nan

>  <WITHDRAWN_REASON>  (800) 
nan

>  <CANONICAL_SMILES>  (800) 
OC(=O)CNC(=O)c1ccccc1I

>  <name>  (800) 
Sodium Iodohippurate 

>  <MW>  (800) 
305.071

>  <logP>  (800) 
1.1056

$$$$
CHEMBL612
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (801) 
23199

>  <SYNONYMS>  (801) 
Dexamfetamine (BAN, INN); Dexamphetamine (DCF); Dextroamphetamine (USAN); Dextroamphetamine resin complex (FDA); Dextroamphetamine sulfate (FDA, USP); Dextroamphetamine Saccharate (FDA); Dextroamphetamine Adipate (FDA); Dextroamphetamine Phosphate (USP)

>  <DEVELOPMENT_PHASE>  (801) 
4

>  <RESEARCH_CODES>  (801) 
nan

>  <APPLICANTS>  (801) 
Teva Womens Health Inc; Teva Pharmaceuticals Usa Inc; Shire Development Inc; Amedra Pharmaceuticals Llc; Ucb Inc

>  <USAN_STEM>  (801) 
nan

>  <USAN_STEM_DEFINITION>  (801) 
nan

>  <USAN_STEM_SUBSTEM>  (801) 
nan

>  <USAN_YEAR>  (801) 
1964.0

>  <FIRST_APPROVAL>  (801) 
1955.0

>  <ATC_CODE>  (801) 
N06BA02

>  <ATC_CODE_DESCRIPTION>  (801) 
N06BA02 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Centrally acting sympathomimetics]

>  <INDICATION_CLASS>  (801) 
Stimulant (central)

>  <SC_PATENT_NO>  (801) 
US-6322819-B1

>  <DRUG_TYPE>  (801) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (801) 
Y

>  <FIRST_IN_CLASS>  (801) 
N

>  <CHIRALITY>  (801) 
Single Stereoisomer

>  <PRODRUG>  (801) 
N

>  <ORAL>  (801) 
Y

>  <PARENTERAL>  (801) 
N

>  <TOPICAL>  (801) 
N

>  <BLACK_BOX>  (801) 
Y

>  <AVAILABILITY_TYPE>  (801) 
Prescription-only

>  <WITHDRAWN_YEAR>  (801) 
nan

>  <WITHDRAWN_COUNTRY>  (801) 
nan

>  <WITHDRAWN_REASON>  (801) 
nan

>  <CANONICAL_SMILES>  (801) 
C[C@H](N)Cc1ccccc1

>  <name>  (801) 
Dexamfetamine 

>  <MW>  (801) 
135.21

>  <logP>  (801) 
1.5763

$$$$
CHEMBL625
     RDKit          

 14 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
  9  1  1  0
  8  4  1  0
 14 10  1  0
M  END
>  <PARENT_MOLREGNO>  (802) 
26590

>  <SYNONYMS>  (802) 
Thiabendazole (FDA, USAN, USP); Tiabendazole (BAN, INN, JAN)

>  <DEVELOPMENT_PHASE>  (802) 
4

>  <RESEARCH_CODES>  (802) 
MK-360

>  <APPLICANTS>  (802) 
Merck And Co Inc

>  <USAN_STEM>  (802) 
-bendazole

>  <USAN_STEM_DEFINITION>  (802) 
anthelmintics (tibendazole type)

>  <USAN_STEM_SUBSTEM>  (802) 
-bendazole

>  <USAN_YEAR>  (802) 
1962.0

>  <FIRST_APPROVAL>  (802) 
1967.0

>  <ATC_CODE>  (802) 
P02CA02; D01AC06

>  <ATC_CODE_DESCRIPTION>  (802) 
P02CA02 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Benzimidazole derivatives]; D01AC06 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Imidazole and triazole derivatives]

>  <INDICATION_CLASS>  (802) 
Anthelmintic

>  <SC_PATENT_NO>  (802) 
nan

>  <DRUG_TYPE>  (802) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (802) 
Y

>  <FIRST_IN_CLASS>  (802) 
N

>  <CHIRALITY>  (802) 
Achiral Molecule

>  <PRODRUG>  (802) 
N

>  <ORAL>  (802) 
Y

>  <PARENTERAL>  (802) 
N

>  <TOPICAL>  (802) 
N

>  <BLACK_BOX>  (802) 
N

>  <AVAILABILITY_TYPE>  (802) 
Discontinued

>  <WITHDRAWN_YEAR>  (802) 
nan

>  <WITHDRAWN_COUNTRY>  (802) 
nan

>  <WITHDRAWN_REASON>  (802) 
nan

>  <CANONICAL_SMILES>  (802) 
c1ccc2[nH]c(nc2c1)c3cscn3

>  <name>  (802) 
Thiabendazole 

>  <MW>  (802) 
201.254

>  <logP>  (802) 
2.6864

$$$$
CHEMBL487253
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  3 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 17 21  1  0
 21 22  1  0
 22 23  1  0
 16  2  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (803) 
453911

>  <SYNONYMS>  (803) 
Bendamustine (INN); Bendamustine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (803) 
4

>  <RESEARCH_CODES>  (803) 
SDX-105

>  <APPLICANTS>  (803) 
Cephalon Inc

>  <USAN_STEM>  (803) 
-mustine

>  <USAN_STEM_DEFINITION>  (803) 
antineoplastics (chloroethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (803) 
-mustine

>  <USAN_YEAR>  (803) 
2004.0

>  <FIRST_APPROVAL>  (803) 
2008.0

>  <ATC_CODE>  (803) 
L01AA09

>  <ATC_CODE_DESCRIPTION>  (803) 
L01AA09 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrogen mustard analogues]

>  <INDICATION_CLASS>  (803) 
nan

>  <SC_PATENT_NO>  (803) 
US-8344006-B2

>  <DRUG_TYPE>  (803) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (803) 
Y

>  <FIRST_IN_CLASS>  (803) 
N

>  <CHIRALITY>  (803) 
Achiral Molecule

>  <PRODRUG>  (803) 
N

>  <ORAL>  (803) 
N

>  <PARENTERAL>  (803) 
Y

>  <TOPICAL>  (803) 
N

>  <BLACK_BOX>  (803) 
N

>  <AVAILABILITY_TYPE>  (803) 
Prescription-only

>  <WITHDRAWN_YEAR>  (803) 
nan

>  <WITHDRAWN_COUNTRY>  (803) 
nan

>  <WITHDRAWN_REASON>  (803) 
nan

>  <CANONICAL_SMILES>  (803) 
Cn1c(CCCC(=O)O)nc2cc(ccc12)N(CCCl)CCCl

>  <name>  (803) 
Bendamustine 

>  <MW>  (803) 
358.269

>  <logP>  (803) 
3.2646

$$$$
CHEMBL29
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  6 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 20  2  1  0
 19  5  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (804) 
1615

>  <SYNONYMS>  (804) 
Benzylpenicillin (BAN, INN, MI); Benzylpenicillin Potassium (BAN, JAN); Penicillin G potassium (FDA, USP); Benzylpenicillin Sodium (BAN); Penicillin g sodium (FDA, USP); Benzathine Benzylpenicillin (BAN, INN); Benzathine Penicillin (BAN); Benzylpenicillin Benzathine (JAN); Penicillin G Benzathine (FDA, USP); Benethamine Penicillin (BAN, INN); Penicillin Calcium (USP)

>  <DEVELOPMENT_PHASE>  (804) 
4

>  <RESEARCH_CODES>  (804) 
nan

>  <APPLICANTS>  (804) 
King Pharmaceuticals Inc; John D Copanos And Co Inc; Bristol Myers Squibb Spa; Baxter Healthcare Corp; Pharmacia And Upjohn Co

>  <USAN_STEM>  (804) 
-cillin

>  <USAN_STEM_DEFINITION>  (804) 
penicillins

>  <USAN_STEM_SUBSTEM>  (804) 
-cillin

>  <USAN_YEAR>  (804) 
nan

>  <FIRST_APPROVAL>  (804) 
1947.0

>  <ATC_CODE>  (804) 
J01CE01; S01AA14; J01CE08

>  <ATC_CODE_DESCRIPTION>  (804) 
J01CE01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]; S01AA14 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]; J01CE08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]

>  <INDICATION_CLASS>  (804) 
Antibacterial

>  <SC_PATENT_NO>  (804) 
nan

>  <DRUG_TYPE>  (804) 
Natural Product-derived

>  <RULE_OF_FIVE>  (804) 
Y

>  <FIRST_IN_CLASS>  (804) 
N

>  <CHIRALITY>  (804) 
Single Stereoisomer

>  <PRODRUG>  (804) 
N

>  <ORAL>  (804) 
Y

>  <PARENTERAL>  (804) 
Y

>  <TOPICAL>  (804) 
N

>  <BLACK_BOX>  (804) 
Y

>  <AVAILABILITY_TYPE>  (804) 
Prescription-only

>  <WITHDRAWN_YEAR>  (804) 
nan

>  <WITHDRAWN_COUNTRY>  (804) 
nan

>  <WITHDRAWN_REASON>  (804) 
nan

>  <CANONICAL_SMILES>  (804) 
CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O

>  <name>  (804) 
Benzylpenicillin 

>  <MW>  (804) 
334.397

>  <logP>  (804) 
0.8608

$$$$
CHEMBL1741134
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  2  0
 18 21  1  0
 16 22  1  0
 22 23  2  0
 12 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 11  6  1  0
 23 13  1  0
 29 24  1  0
M  END
>  <PARENT_MOLREGNO>  (805) 
1120185

>  <SYNONYMS>  (805) 
Sodium Picosulfate (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (805) 
4

>  <RESEARCH_CODES>  (805) 
DA-1773; LA-391

>  <APPLICANTS>  (805) 
Ferring Pharmaceuticals As

>  <USAN_STEM>  (805) 
nan

>  <USAN_STEM_DEFINITION>  (805) 
nan

>  <USAN_STEM_SUBSTEM>  (805) 
nan

>  <USAN_YEAR>  (805) 
2012.0

>  <FIRST_APPROVAL>  (805) 
2012.0

>  <ATC_CODE>  (805) 
A06AB08; A06AB58

>  <ATC_CODE_DESCRIPTION>  (805) 
A06AB08 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]; A06AB58 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]

>  <INDICATION_CLASS>  (805) 
nan

>  <SC_PATENT_NO>  (805) 
US-8450338-B2

>  <DRUG_TYPE>  (805) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (805) 
Y

>  <FIRST_IN_CLASS>  (805) 
N

>  <CHIRALITY>  (805) 
Achiral Molecule

>  <PRODRUG>  (805) 
N

>  <ORAL>  (805) 
Y

>  <PARENTERAL>  (805) 
N

>  <TOPICAL>  (805) 
N

>  <BLACK_BOX>  (805) 
N

>  <AVAILABILITY_TYPE>  (805) 
Prescription-only

>  <WITHDRAWN_YEAR>  (805) 
nan

>  <WITHDRAWN_COUNTRY>  (805) 
nan

>  <WITHDRAWN_REASON>  (805) 
nan

>  <CANONICAL_SMILES>  (805) 
OS(=O)(=O)Oc1ccc(cc1)C(c2ccc(OS(=O)(=O)O)cc2)c3ccccn3

>  <name>  (805) 
Sodium Picosulfate 

>  <MW>  (805) 
437.451

>  <logP>  (805) 
2.625

$$$$
CHEMBL1574
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (806) 
453532

>  <SYNONYMS>  (806) 
Phentermine (BAN, INN, USAN); Phentermine resin complex (FDA); Phentermine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (806) 
4

>  <RESEARCH_CODES>  (806) 
nan

>  <APPLICANTS>  (806) 
Ucb Inc; Sandoz Consumer Health Care Group Div Sandoz Pharmaceuticals Corp; GlaxoSmithKline; Citius Pharmaceuticals Llc; Vivus Inc

>  <USAN_STEM>  (806) 
nan

>  <USAN_STEM_DEFINITION>  (806) 
nan

>  <USAN_STEM_SUBSTEM>  (806) 
nan

>  <USAN_YEAR>  (806) 
1962.0

>  <FIRST_APPROVAL>  (806) 
1959.0

>  <ATC_CODE>  (806) 
A08AA01

>  <ATC_CODE_DESCRIPTION>  (806) 
A08AA01 [Alimentary Tract And Metabolism:Antiobesity Preparations, Excl. Diet Products:Antiobesity Preparations, Excl. Diet Products:Centrally acting antiobesity products]

>  <INDICATION_CLASS>  (806) 
Anorexic; Appetite Suppressant (systemic)

>  <SC_PATENT_NO>  (806) 
US-6071537-A

>  <DRUG_TYPE>  (806) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (806) 
Y

>  <FIRST_IN_CLASS>  (806) 
N

>  <CHIRALITY>  (806) 
Achiral Molecule

>  <PRODRUG>  (806) 
N

>  <ORAL>  (806) 
Y

>  <PARENTERAL>  (806) 
N

>  <TOPICAL>  (806) 
N

>  <BLACK_BOX>  (806) 
N

>  <AVAILABILITY_TYPE>  (806) 
Prescription-only

>  <WITHDRAWN_YEAR>  (806) 
nan

>  <WITHDRAWN_COUNTRY>  (806) 
nan

>  <WITHDRAWN_REASON>  (806) 
nan

>  <CANONICAL_SMILES>  (806) 
CC(C)(N)Cc1ccccc1

>  <name>  (806) 
Phentermine 

>  <MW>  (806) 
149.237

>  <logP>  (806) 
1.9664

$$$$
CHEMBL1200430
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23  5  1  0
 22  8  1  0
 19  9  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (807) 
674381

>  <SYNONYMS>  (807) 
Estradiol Acetate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (807) 
4

>  <RESEARCH_CODES>  (807) 
Estradiol-3-Acetate

>  <APPLICANTS>  (807) 
Warner Chilcott Ireland Ltd; Warner Chilcott Co Llc

>  <USAN_STEM>  (807) 
estr-

>  <USAN_STEM_DEFINITION>  (807) 
estrogens

>  <USAN_STEM_SUBSTEM>  (807) 
estr-

>  <USAN_YEAR>  (807) 
2002.0

>  <FIRST_APPROVAL>  (807) 
2003.0

>  <ATC_CODE>  (807) 
G03CA03; G03CA53

>  <ATC_CODE_DESCRIPTION>  (807) 
G03CA03 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Natural and semisynthetic estrogens, plain]; G03CA53 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Estrogens:Natural and semisynthetic estrogens, plain]

>  <INDICATION_CLASS>  (807) 
nan

>  <SC_PATENT_NO>  (807) 
US-5855906-A

>  <DRUG_TYPE>  (807) 
Natural Product-derived

>  <RULE_OF_FIVE>  (807) 
Y

>  <FIRST_IN_CLASS>  (807) 
N

>  <CHIRALITY>  (807) 
Single Stereoisomer

>  <PRODRUG>  (807) 
Y

>  <ORAL>  (807) 
Y

>  <PARENTERAL>  (807) 
N

>  <TOPICAL>  (807) 
Y

>  <BLACK_BOX>  (807) 
Y

>  <AVAILABILITY_TYPE>  (807) 
Prescription-only

>  <WITHDRAWN_YEAR>  (807) 
nan

>  <WITHDRAWN_COUNTRY>  (807) 
nan

>  <WITHDRAWN_REASON>  (807) 
nan

>  <CANONICAL_SMILES>  (807) 
CC(=O)Oc1ccc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2c1

>  <name>  (807) 
Estradiol Acetate 

>  <MW>  (807) 
314.425

>  <logP>  (807) 
3.8289

$$$$
CHEMBL1502
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 15 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
  7 24  2  0
 24 25  1  0
 25 26  1  0
 24  3  1  0
 23 11  1  0
 22 13  1  0
M  CHG  2   9   1  10  -1
M  END
>  <PARENT_MOLREGNO>  (808) 
419598

>  <SYNONYMS>  (808) 
Pantoprazole (BAN, INN, USAN); Pantoprazole Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (808) 
4

>  <RESEARCH_CODES>  (808) 
BY-1023; SK&F-96022; SK-96022

>  <APPLICANTS>  (808) 
Wyeth Pharmaceuticals Inc; SmithKline Beecham

>  <USAN_STEM>  (808) 
-prazole

>  <USAN_STEM_DEFINITION>  (808) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (808) 
-prazole

>  <USAN_YEAR>  (808) 
1991.0

>  <FIRST_APPROVAL>  (808) 
2000.0

>  <ATC_CODE>  (808) 
A02BC02

>  <ATC_CODE_DESCRIPTION>  (808) 
A02BC02 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (808) 
Anti-Ulcerative

>  <SC_PATENT_NO>  (808) 
US-5997903-A

>  <DRUG_TYPE>  (808) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (808) 
Y

>  <FIRST_IN_CLASS>  (808) 
N

>  <CHIRALITY>  (808) 
Racemic Mixture

>  <PRODRUG>  (808) 
N

>  <ORAL>  (808) 
Y

>  <PARENTERAL>  (808) 
Y

>  <TOPICAL>  (808) 
N

>  <BLACK_BOX>  (808) 
N

>  <AVAILABILITY_TYPE>  (808) 
Prescription-only

>  <WITHDRAWN_YEAR>  (808) 
nan

>  <WITHDRAWN_COUNTRY>  (808) 
nan

>  <WITHDRAWN_REASON>  (808) 
nan

>  <CANONICAL_SMILES>  (808) 
COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC

>  <name>  (808) 
Pantoprazole 

>  <MW>  (808) 
383.376

>  <logP>  (808) 
2.8843

$$$$
CHEMBL1599
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 12 24  1  0
 24 25  2  0
  7 26  1  0
 26 27  2  0
 26 28  1  0
 11  6  1  0
 24  8  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (809) 
454446

>  <SYNONYMS>  (809) 
Cefapirin (INN, BAN); Cephapirin Sodium (FDA, USAN, USP); Sodium Cefapirin (JAN); Cephapirin Benzathine (USP)

>  <DEVELOPMENT_PHASE>  (809) 
4

>  <RESEARCH_CODES>  (809) 
BL-P-1322

>  <APPLICANTS>  (809) 
Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (809) 
nan

>  <USAN_STEM_DEFINITION>  (809) 
nan

>  <USAN_STEM_SUBSTEM>  (809) 
nan

>  <USAN_YEAR>  (809) 
1970.0

>  <FIRST_APPROVAL>  (809) 
1974.0

>  <ATC_CODE>  (809) 
J01DB08

>  <ATC_CODE_DESCRIPTION>  (809) 
J01DB08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:First-generation cephalosporins]

>  <INDICATION_CLASS>  (809) 
Antibacterial

>  <SC_PATENT_NO>  (809) 
nan

>  <DRUG_TYPE>  (809) 
Natural Product-derived

>  <RULE_OF_FIVE>  (809) 
Y

>  <FIRST_IN_CLASS>  (809) 
N

>  <CHIRALITY>  (809) 
Single Stereoisomer

>  <PRODRUG>  (809) 
N

>  <ORAL>  (809) 
N

>  <PARENTERAL>  (809) 
Y

>  <TOPICAL>  (809) 
N

>  <BLACK_BOX>  (809) 
N

>  <AVAILABILITY_TYPE>  (809) 
Discontinued

>  <WITHDRAWN_YEAR>  (809) 
nan

>  <WITHDRAWN_COUNTRY>  (809) 
nan

>  <WITHDRAWN_REASON>  (809) 
nan

>  <CANONICAL_SMILES>  (809) 
CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc3ccncc3)C2=O)C(=O)O

>  <name>  (809) 
Cefapirin 

>  <MW>  (809) 
423.472

>  <logP>  (809) 
0.4754

$$$$
CHEMBL1201345
     RDKit          

 19 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 10 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  2  0
 16 19  1  0
M  END
>  <PARENT_MOLREGNO>  (810) 
675296

>  <SYNONYMS>  (810) 
Sodium Tetradecyl Sulfate (FDA, INN, MI)

>  <DEVELOPMENT_PHASE>  (810) 
4

>  <RESEARCH_CODES>  (810) 
nan

>  <APPLICANTS>  (810) 
Elkins Sinn Div Ah Robins Co Inc

>  <USAN_STEM>  (810) 
nan

>  <USAN_STEM_DEFINITION>  (810) 
nan

>  <USAN_STEM_SUBSTEM>  (810) 
nan

>  <USAN_YEAR>  (810) 
nan

>  <FIRST_APPROVAL>  (810) 
1946.0

>  <ATC_CODE>  (810) 
C05BB04

>  <ATC_CODE_DESCRIPTION>  (810) 
C05BB04 [Cardiovascular System:Vasoprotectives:Antivaricose Therapy:Sclerosing agents for local injection]

>  <INDICATION_CLASS>  (810) 
nan

>  <SC_PATENT_NO>  (810) 
nan

>  <DRUG_TYPE>  (810) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (810) 
Y

>  <FIRST_IN_CLASS>  (810) 
N

>  <CHIRALITY>  (810) 
Racemic Mixture

>  <PRODRUG>  (810) 
N

>  <ORAL>  (810) 
N

>  <PARENTERAL>  (810) 
Y

>  <TOPICAL>  (810) 
N

>  <BLACK_BOX>  (810) 
N

>  <AVAILABILITY_TYPE>  (810) 
Prescription-only

>  <WITHDRAWN_YEAR>  (810) 
nan

>  <WITHDRAWN_COUNTRY>  (810) 
nan

>  <WITHDRAWN_REASON>  (810) 
nan

>  <CANONICAL_SMILES>  (810) 
CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O

>  <name>  (810) 
Sodium Tetradecyl Sulfate 

>  <MW>  (810) 
294.457

>  <logP>  (810) 
4.2171

$$$$
CHEMBL1641
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 21 24  1  0
 15 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
  8  2  1  0
 30  2  1  0
 30 11  1  0
 25 12  1  0
M  END
>  <PARENT_MOLREGNO>  (811) 
483808

>  <SYNONYMS>  (811) 
Hydrocortisone Sodium Phosphate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (811) 
4

>  <RESEARCH_CODES>  (811) 
nan

>  <APPLICANTS>  (811) 
Merck And Co Inc

>  <USAN_STEM>  (811) 
-cort-

>  <USAN_STEM_DEFINITION>  (811) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (811) 
-cort-

>  <USAN_YEAR>  (811) 
nan

>  <FIRST_APPROVAL>  (811) 
1960.0

>  <ATC_CODE>  (811) 
D07AA02; S01CB03; D07XA01; C05AA01; A07EA02; A01AC03; H02AB09; S01BA02; S02BA01

>  <ATC_CODE_DESCRIPTION>  (811) 
D07AA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; S01CB03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; D07XA01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; C05AA01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA02 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; A01AC03 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; H02AB09 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA01 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (811) 
Glucocorticoid

>  <SC_PATENT_NO>  (811) 
nan

>  <DRUG_TYPE>  (811) 
Natural Product-derived

>  <RULE_OF_FIVE>  (811) 
Y

>  <FIRST_IN_CLASS>  (811) 
N

>  <CHIRALITY>  (811) 
Single Stereoisomer

>  <PRODRUG>  (811) 
Y

>  <ORAL>  (811) 
N

>  <PARENTERAL>  (811) 
Y

>  <TOPICAL>  (811) 
N

>  <BLACK_BOX>  (811) 
N

>  <AVAILABILITY_TYPE>  (811) 
Discontinued

>  <WITHDRAWN_YEAR>  (811) 
nan

>  <WITHDRAWN_COUNTRY>  (811) 
nan

>  <WITHDRAWN_REASON>  (811) 
nan

>  <CANONICAL_SMILES>  (811) 
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COP(=O)(O)O)[C@@]4(C)C[C@H](O)[C@H]23

>  <name>  (811) 
Hydrocortisone Sodium Phosphate 

>  <MW>  (811) 
442.445

>  <logP>  (811) 
1.8986

$$$$
CHEMBL1201281
     RDKit          

 27 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  3 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
  2 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 24 19  1  0
M  CHG  2  25   1  27  -1
M  END
>  <PARENT_MOLREGNO>  (812) 
675232

>  <SYNONYMS>  (812) 
Chloramphenicol Sodium Succinate (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (812) 
4

>  <RESEARCH_CODES>  (812) 
nan

>  <APPLICANTS>  (812) 
Parkedale Pharmaceuticals Inc

>  <USAN_STEM>  (812) 
nan

>  <USAN_STEM_DEFINITION>  (812) 
nan

>  <USAN_STEM_SUBSTEM>  (812) 
nan

>  <USAN_YEAR>  (812) 
nan

>  <FIRST_APPROVAL>  (812) 
1959.0

>  <ATC_CODE>  (812) 
J01BA01; S02AA01; S03AA08; D10AF03; G01AA05; D06AX02; S01AA01

>  <ATC_CODE_DESCRIPTION>  (812) 
J01BA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Amphenicols:Amphenicols]; S02AA01 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]; S03AA08 [Sensory Organs:Ophthalmological And Otological Preparations:Antiinfectives:Antiinfectives]; D10AF03 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Antiinfectives for treatment of acne]; G01AA05 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Antibiotics]; D06AX02 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Antibiotics For Topical Use:Other antibiotics for topical use]; S01AA01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]

>  <INDICATION_CLASS>  (812) 
Antibacterial; Antirickettsial

>  <SC_PATENT_NO>  (812) 
nan

>  <DRUG_TYPE>  (812) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (812) 
Y

>  <FIRST_IN_CLASS>  (812) 
N

>  <CHIRALITY>  (812) 
Single Stereoisomer

>  <PRODRUG>  (812) 
Y

>  <ORAL>  (812) 
N

>  <PARENTERAL>  (812) 
Y

>  <TOPICAL>  (812) 
N

>  <BLACK_BOX>  (812) 
Y

>  <AVAILABILITY_TYPE>  (812) 
Prescription-only

>  <WITHDRAWN_YEAR>  (812) 
nan

>  <WITHDRAWN_COUNTRY>  (812) 
nan

>  <WITHDRAWN_REASON>  (812) 
nan

>  <CANONICAL_SMILES>  (812) 
O[C@@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+](=O)[O-]

>  <name>  (812) 
Chloramphenicol Sodium Succinate 

>  <MW>  (812) 
423.205

>  <logP>  (812) 
1.3247

$$$$
CHEMBL25
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (813) 
1280

>  <SYNONYMS>  (813) 
Aspirin (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (813) 
4

>  <RESEARCH_CODES>  (813) 
nan

>  <APPLICANTS>  (813) 
Boehringer Ingelheim Pharmaceuticals Inc; Bayer Healthcare Llc; Ah Robins Co; Aaipharma Llc; Bristol Myers Squibb Co

>  <USAN_STEM>  (813) 
nan

>  <USAN_STEM_DEFINITION>  (813) 
nan

>  <USAN_STEM_SUBSTEM>  (813) 
nan

>  <USAN_YEAR>  (813) 
nan

>  <FIRST_APPROVAL>  (813) 
1950.0

>  <ATC_CODE>  (813) 
A01AD05; B01AC06; N02BA51; N02BA01; N02BA71

>  <ATC_CODE_DESCRIPTION>  (813) 
A01AD05 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Other agents for local oral treatment]; B01AC06 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]; N02BA51 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Salicylic acid and derivatives]; N02BA01 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Salicylic acid and derivatives]; N02BA71 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Salicylic acid and derivatives]

>  <INDICATION_CLASS>  (813) 
Analgesic; Antipyretic; Antirheumatic

>  <SC_PATENT_NO>  (813) 
US-5972916-A

>  <DRUG_TYPE>  (813) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (813) 
Y

>  <FIRST_IN_CLASS>  (813) 
N

>  <CHIRALITY>  (813) 
Single Stereoisomer

>  <PRODRUG>  (813) 
N

>  <ORAL>  (813) 
Y

>  <PARENTERAL>  (813) 
N

>  <TOPICAL>  (813) 
N

>  <BLACK_BOX>  (813) 
N

>  <AVAILABILITY_TYPE>  (813) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (813) 
nan

>  <WITHDRAWN_COUNTRY>  (813) 
nan

>  <WITHDRAWN_REASON>  (813) 
nan

>  <CANONICAL_SMILES>  (813) 
CC(=O)Oc1ccccc1C(=O)O

>  <name>  (813) 
Aspirin 

>  <MW>  (813) 
180.159

>  <logP>  (813) 
1.3101

$$$$
CHEMBL1727
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  8 20  1  0
 20 21  2  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
  7  2  1  0
 20  4  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (814) 
555972

>  <SYNONYMS>  (814) 
Cefalexin (INN, BAN, JAN); Cephalexin (USAN, USP, FDA); Cephalexin HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (814) 
4

>  <RESEARCH_CODES>  (814) 
66873; LY-061188

>  <APPLICANTS>  (814) 
Shionogi Inc; Eli Lilly And Co

>  <USAN_STEM>  (814) 
nan

>  <USAN_STEM_DEFINITION>  (814) 
nan

>  <USAN_STEM_SUBSTEM>  (814) 
nan

>  <USAN_YEAR>  (814) 
1967.0

>  <FIRST_APPROVAL>  (814) 
1971.0

>  <ATC_CODE>  (814) 
J01DB01

>  <ATC_CODE_DESCRIPTION>  (814) 
J01DB01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:First-generation cephalosporins]

>  <INDICATION_CLASS>  (814) 
Antibacterial

>  <SC_PATENT_NO>  (814) 
nan

>  <DRUG_TYPE>  (814) 
Natural Product-derived

>  <RULE_OF_FIVE>  (814) 
Y

>  <FIRST_IN_CLASS>  (814) 
N

>  <CHIRALITY>  (814) 
Single Stereoisomer

>  <PRODRUG>  (814) 
N

>  <ORAL>  (814) 
Y

>  <PARENTERAL>  (814) 
N

>  <TOPICAL>  (814) 
N

>  <BLACK_BOX>  (814) 
Y

>  <AVAILABILITY_TYPE>  (814) 
Prescription-only

>  <WITHDRAWN_YEAR>  (814) 
nan

>  <WITHDRAWN_COUNTRY>  (814) 
nan

>  <WITHDRAWN_REASON>  (814) 
nan

>  <CANONICAL_SMILES>  (814) 
CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)C(=O)O

>  <name>  (814) 
Cefalexin 

>  <MW>  (814) 
347.396

>  <logP>  (814) 
0.4449

$$$$
CHEMBL1321
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (815) 
266225

>  <SYNONYMS>  (815) 
Procarbazine (BAN, INN); Procarbazine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (815) 
4

>  <RESEARCH_CODES>  (815) 
Ro-4646711; Ro-46467/1

>  <APPLICANTS>  (815) 
Sigma Tau Pharmaceuticals Inc

>  <USAN_STEM>  (815) 
nan

>  <USAN_STEM_DEFINITION>  (815) 
nan

>  <USAN_STEM_SUBSTEM>  (815) 
nan

>  <USAN_YEAR>  (815) 
1967.0

>  <FIRST_APPROVAL>  (815) 
1969.0

>  <ATC_CODE>  (815) 
L01XB01

>  <ATC_CODE_DESCRIPTION>  (815) 
L01XB01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Methylhydrazines]

>  <INDICATION_CLASS>  (815) 
Antineoplastic

>  <SC_PATENT_NO>  (815) 
nan

>  <DRUG_TYPE>  (815) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (815) 
Y

>  <FIRST_IN_CLASS>  (815) 
N

>  <CHIRALITY>  (815) 
Achiral Molecule

>  <PRODRUG>  (815) 
Y

>  <ORAL>  (815) 
Y

>  <PARENTERAL>  (815) 
N

>  <TOPICAL>  (815) 
N

>  <BLACK_BOX>  (815) 
Y

>  <AVAILABILITY_TYPE>  (815) 
Prescription-only

>  <WITHDRAWN_YEAR>  (815) 
nan

>  <WITHDRAWN_COUNTRY>  (815) 
nan

>  <WITHDRAWN_REASON>  (815) 
nan

>  <CANONICAL_SMILES>  (815) 
CNNCc1ccc(cc1)C(=O)NC(C)C

>  <name>  (815) 
Procarbazine 

>  <MW>  (815) 
221.304

>  <logP>  (815) 
1.0488

$$$$
CHEMBL139
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 10  5  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (816) 
29890

>  <SYNONYMS>  (816) 
Diclofenac (BAN, FDA, INN, USAN); Diclofenac Epolamine (FDA); Diclofenac Potassium (FDA, USAN); Diclofenac Sodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (816) 
4

>  <RESEARCH_CODES>  (816) 
CGP-45840B; GP-45840

>  <APPLICANTS>  (816) 
Gd Searle Llc; Fougera Pharmaceuticals Inc; Novartis Consumer Health Inc; Falcon Pharmaceuticals Ltd; Depomed Inc

>  <USAN_STEM>  (816) 
-ac

>  <USAN_STEM_DEFINITION>  (816) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (816) 
-ac

>  <USAN_YEAR>  (816) 
1973.0

>  <FIRST_APPROVAL>  (816) 
1988.0

>  <ATC_CODE>  (816) 
D11AX18; S01BC03; M01AB05; M02AA15; M01AB55

>  <ATC_CODE_DESCRIPTION>  (816) 
D11AX18 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]; S01BC03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]; M01AB05 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]; M02AA15 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; M01AB55 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (816) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (816) 
US-5607690-A

>  <DRUG_TYPE>  (816) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (816) 
Y

>  <FIRST_IN_CLASS>  (816) 
N

>  <CHIRALITY>  (816) 
Achiral Molecule

>  <PRODRUG>  (816) 
N

>  <ORAL>  (816) 
Y

>  <PARENTERAL>  (816) 
Y

>  <TOPICAL>  (816) 
Y

>  <BLACK_BOX>  (816) 
Y

>  <AVAILABILITY_TYPE>  (816) 
Prescription-only

>  <WITHDRAWN_YEAR>  (816) 
nan

>  <WITHDRAWN_COUNTRY>  (816) 
nan

>  <WITHDRAWN_REASON>  (816) 
nan

>  <CANONICAL_SMILES>  (816) 
OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl

>  <name>  (816) 
Diclofenac 

>  <MW>  (816) 
296.153

>  <logP>  (816) 
4.3641

$$$$
CHEMBL639
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 11 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
  8  2  1  0
 26  9  1  0
 19 13  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (817) 
27309

>  <SYNONYMS>  (817) 
Azelastine (BAN, INN); Azelastine HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (817) 
4

>  <RESEARCH_CODES>  (817) 
A-5610; E-0659; W-2979M

>  <APPLICANTS>  (817) 
Meda Pharmaceuticals Meda Pharmaceuticals Inc; Meda Pharmaceuticals Inc; Meda Pharmaceuticals

>  <USAN_STEM>  (817) 
-astine

>  <USAN_STEM_DEFINITION>  (817) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (817) 
-astine

>  <USAN_YEAR>  (817) 
1984.0

>  <FIRST_APPROVAL>  (817) 
1996.0

>  <ATC_CODE>  (817) 
S01GX07; R06AX19; R01AC03

>  <ATC_CODE_DESCRIPTION>  (817) 
S01GX07 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Other antiallergics]; R06AX19 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]; R01AC03 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Antiallergic agents, excl. corticosteroids]

>  <INDICATION_CLASS>  (817) 
Anti-Allergic; Anti-Asthmatic

>  <SC_PATENT_NO>  (817) 
US-8071073-B2

>  <DRUG_TYPE>  (817) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (817) 
Y

>  <FIRST_IN_CLASS>  (817) 
N

>  <CHIRALITY>  (817) 
Racemic Mixture

>  <PRODRUG>  (817) 
N

>  <ORAL>  (817) 
N

>  <PARENTERAL>  (817) 
N

>  <TOPICAL>  (817) 
Y

>  <BLACK_BOX>  (817) 
N

>  <AVAILABILITY_TYPE>  (817) 
Prescription-only

>  <WITHDRAWN_YEAR>  (817) 
nan

>  <WITHDRAWN_COUNTRY>  (817) 
nan

>  <WITHDRAWN_REASON>  (817) 
nan

>  <CANONICAL_SMILES>  (817) 
CN1CCCC(CC1)N2N=C(Cc3ccc(Cl)cc3)c4ccccc4C2=O

>  <name>  (817) 
Azelastine 

>  <MW>  (817) 
381.907

>  <logP>  (817) 
4.2975

$$$$
CHEMBL776
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  8  1  0
M  END
>  <PARENT_MOLREGNO>  (818) 
44647

>  <SYNONYMS>  (818) 
Metaproterenol Sulfate (FDA, USAN, USP); Orciprenaline Sulfate (JAN)

>  <DEVELOPMENT_PHASE>  (818) 
4

>  <RESEARCH_CODES>  (818) 
TH-152

>  <APPLICANTS>  (818) 
Boehringer Ingelheim Pharmaceuticals Inc; Boehringer Ingelheim

>  <USAN_STEM>  (818) 
nan

>  <USAN_STEM_DEFINITION>  (818) 
nan

>  <USAN_STEM_SUBSTEM>  (818) 
nan

>  <USAN_YEAR>  (818) 
1964.0

>  <FIRST_APPROVAL>  (818) 
1973.0

>  <ATC_CODE>  (818) 
R03CB03; R03AB03

>  <ATC_CODE_DESCRIPTION>  (818) 
R03CB03 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Non-selective beta-adrenoreceptor agonists]; R03AB03 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Non-selective beta-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (818) 
Bronchodilator

>  <SC_PATENT_NO>  (818) 
nan

>  <DRUG_TYPE>  (818) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (818) 
Y

>  <FIRST_IN_CLASS>  (818) 
N

>  <CHIRALITY>  (818) 
Racemic Mixture

>  <PRODRUG>  (818) 
N

>  <ORAL>  (818) 
Y

>  <PARENTERAL>  (818) 
N

>  <TOPICAL>  (818) 
Y

>  <BLACK_BOX>  (818) 
N

>  <AVAILABILITY_TYPE>  (818) 
Prescription-only

>  <WITHDRAWN_YEAR>  (818) 
nan

>  <WITHDRAWN_COUNTRY>  (818) 
nan

>  <WITHDRAWN_REASON>  (818) 
nan

>  <CANONICAL_SMILES>  (818) 
CC(C)NCC(O)c1cc(O)cc(O)c1

>  <name>  (818) 
Metaproterenol Sulfate 

>  <MW>  (818) 
211.261

>  <logP>  (818) 
1.1292

$$$$
CHEMBL1201287
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (819) 
675238

>  <SYNONYMS>  (819) 
Dexbrompheniramine (BAN, INN); Dexbrompheniramine Maleate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (819) 
4

>  <RESEARCH_CODES>  (819) 
nan

>  <APPLICANTS>  (819) 
Schering Plough Healthcare Products Inc; Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (819) 
nan

>  <USAN_STEM_DEFINITION>  (819) 
nan

>  <USAN_STEM_SUBSTEM>  (819) 
nan

>  <USAN_YEAR>  (819) 
nan

>  <FIRST_APPROVAL>  (819) 
1963.0

>  <ATC_CODE>  (819) 
R06AB56; R06AB06

>  <ATC_CODE_DESCRIPTION>  (819) 
R06AB56 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]; R06AB06 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]

>  <INDICATION_CLASS>  (819) 
Antihistaminic

>  <SC_PATENT_NO>  (819) 
nan

>  <DRUG_TYPE>  (819) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (819) 
Y

>  <FIRST_IN_CLASS>  (819) 
N

>  <CHIRALITY>  (819) 
Single Stereoisomer

>  <PRODRUG>  (819) 
N

>  <ORAL>  (819) 
Y

>  <PARENTERAL>  (819) 
N

>  <TOPICAL>  (819) 
N

>  <BLACK_BOX>  (819) 
N

>  <AVAILABILITY_TYPE>  (819) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (819) 
nan

>  <WITHDRAWN_COUNTRY>  (819) 
nan

>  <WITHDRAWN_REASON>  (819) 
nan

>  <CANONICAL_SMILES>  (819) 
CN(C)CC[C@@H](c1ccc(Br)cc1)c2ccccn2

>  <name>  (819) 
Dexbrompheniramine 

>  <MW>  (819) 
319.246

>  <logP>  (819) 
3.9277

$$$$
CHEMBL657
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  8  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (820) 
27629

>  <SYNONYMS>  (820) 
Diphenhydramine (BAN, INN, JAN); Diphenhydramine HCl (BAN, FDA, JAN, USP); Diphenhydramine Citrate (FDA, USP); Diphenhydramine Laurylsulfate (JAN); Diphenhydramine Tannate (JAN)

>  <DEVELOPMENT_PHASE>  (820) 
4

>  <RESEARCH_CODES>  (820) 
nan

>  <APPLICANTS>  (820) 
Pfizer Inc.; Parke Davis Div Warner Lambert Co; Mcneil Consumer Healthcare

>  <USAN_STEM>  (820) 
nan

>  <USAN_STEM_DEFINITION>  (820) 
nan

>  <USAN_STEM_SUBSTEM>  (820) 
nan

>  <USAN_YEAR>  (820) 
nan

>  <FIRST_APPROVAL>  (820) 
1946.0

>  <ATC_CODE>  (820) 
R06AA02; D04AA32; R06AA52

>  <ATC_CODE_DESCRIPTION>  (820) 
R06AA02 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]; D04AA32 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]; R06AA52 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]

>  <INDICATION_CLASS>  (820) 
Antihistaminic

>  <SC_PATENT_NO>  (820) 
US-8263647-B2

>  <DRUG_TYPE>  (820) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (820) 
Y

>  <FIRST_IN_CLASS>  (820) 
N

>  <CHIRALITY>  (820) 
Achiral Molecule

>  <PRODRUG>  (820) 
N

>  <ORAL>  (820) 
Y

>  <PARENTERAL>  (820) 
Y

>  <TOPICAL>  (820) 
N

>  <BLACK_BOX>  (820) 
N

>  <AVAILABILITY_TYPE>  (820) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (820) 
nan

>  <WITHDRAWN_COUNTRY>  (820) 
nan

>  <WITHDRAWN_REASON>  (820) 
nan

>  <CANONICAL_SMILES>  (820) 
CN(C)CCOC(c1ccccc1)c2ccccc2

>  <name>  (820) 
Diphenhydramine 

>  <MW>  (820) 
255.361

>  <logP>  (820) 
3.3542

$$$$
CHEMBL669
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  7  1  0
 13  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (821) 
28119

>  <SYNONYMS>  (821) 
Cyclobenzaprine (INN); Cyclobenzaprine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (821) 
4

>  <RESEARCH_CODES>  (821) 
MK-130; MK-130 [As The Base]

>  <APPLICANTS>  (821) 
Janssen Research And Development Llc; Ivax International Gmbh

>  <USAN_STEM>  (821) 
nan

>  <USAN_STEM_DEFINITION>  (821) 
nan

>  <USAN_STEM_SUBSTEM>  (821) 
nan

>  <USAN_YEAR>  (821) 
1977.0

>  <FIRST_APPROVAL>  (821) 
1977.0

>  <ATC_CODE>  (821) 
M03BX08

>  <ATC_CODE_DESCRIPTION>  (821) 
M03BX08 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Other centrally acting agents]

>  <INDICATION_CLASS>  (821) 
Relaxant (muscle)

>  <SC_PATENT_NO>  (821) 
US-7387793-B2

>  <DRUG_TYPE>  (821) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (821) 
Y

>  <FIRST_IN_CLASS>  (821) 
N

>  <CHIRALITY>  (821) 
Achiral Molecule

>  <PRODRUG>  (821) 
N

>  <ORAL>  (821) 
Y

>  <PARENTERAL>  (821) 
N

>  <TOPICAL>  (821) 
N

>  <BLACK_BOX>  (821) 
N

>  <AVAILABILITY_TYPE>  (821) 
Prescription-only

>  <WITHDRAWN_YEAR>  (821) 
nan

>  <WITHDRAWN_COUNTRY>  (821) 
nan

>  <WITHDRAWN_REASON>  (821) 
nan

>  <CANONICAL_SMILES>  (821) 
CN(C)CCC=C1c2ccccc2C=Cc3ccccc13

>  <name>  (821) 
Cyclobenzaprine 

>  <MW>  (821) 
275.395

>  <logP>  (821) 
4.5538

$$$$
CHEMBL1595
     RDKit          

 22 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 16  3  1  0
 17  6  1  0
 21  8  1  0
 18  9  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (822) 
454306

>  <SYNONYMS>  (822) 
Dihydrocodeine (BAN, INN); Dihydrocodeine Bitartrate (FDA, USP); Dihydrocodeine Phosphate (JAN)

>  <DEVELOPMENT_PHASE>  (822) 
4

>  <RESEARCH_CODES>  (822) 
DF-118

>  <APPLICANTS>  (822) 
Caraco Pharmaceutical Laboratories Ltd

>  <USAN_STEM>  (822) 
nan

>  <USAN_STEM_DEFINITION>  (822) 
nan

>  <USAN_STEM_SUBSTEM>  (822) 
nan

>  <USAN_YEAR>  (822) 
nan

>  <FIRST_APPROVAL>  (822) 
1983.0

>  <ATC_CODE>  (822) 
N02AA58; N02AA08

>  <ATC_CODE_DESCRIPTION>  (822) 
N02AA58 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]; N02AA08 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]

>  <INDICATION_CLASS>  (822) 
Analgesic

>  <SC_PATENT_NO>  (822) 
nan

>  <DRUG_TYPE>  (822) 
Natural Product-derived

>  <RULE_OF_FIVE>  (822) 
Y

>  <FIRST_IN_CLASS>  (822) 
N

>  <CHIRALITY>  (822) 
Single Stereoisomer

>  <PRODRUG>  (822) 
N

>  <ORAL>  (822) 
Y

>  <PARENTERAL>  (822) 
N

>  <TOPICAL>  (822) 
N

>  <BLACK_BOX>  (822) 
N

>  <AVAILABILITY_TYPE>  (822) 
Prescription-only

>  <WITHDRAWN_YEAR>  (822) 
nan

>  <WITHDRAWN_COUNTRY>  (822) 
nan

>  <WITHDRAWN_REASON>  (822) 
nan

>  <CANONICAL_SMILES>  (822) 
COc1ccc2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C

>  <name>  (822) 
Dihydrocodeine 

>  <MW>  (822) 
301.386

>  <logP>  (822) 
1.7251

$$$$
CHEMBL361497
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
  8 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 24  2  1  0
 25  5  1  0
 25 18  1  0
 27 20  1  0
M  END
>  <PARENT_MOLREGNO>  (823) 
316347

>  <SYNONYMS>  (823) 
Artesunate (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (823) 
4

>  <RESEARCH_CODES>  (823) 
nan

>  <APPLICANTS>  (823) 
nan

>  <USAN_STEM>  (823) 
arte-

>  <USAN_STEM_DEFINITION>  (823) 
antimalarials (artemisin dervatives)

>  <USAN_STEM_SUBSTEM>  (823) 
arte-

>  <USAN_YEAR>  (823) 
2002.0

>  <FIRST_APPROVAL>  (823) 
nan

>  <ATC_CODE>  (823) 
P01BE03

>  <ATC_CODE_DESCRIPTION>  (823) 
P01BE03 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Artemisinin and derivatives, plain]

>  <INDICATION_CLASS>  (823) 
nan

>  <SC_PATENT_NO>  (823) 
nan

>  <DRUG_TYPE>  (823) 
Natural Product-derived

>  <RULE_OF_FIVE>  (823) 
Y

>  <FIRST_IN_CLASS>  (823) 
N

>  <CHIRALITY>  (823) 
Single Stereoisomer

>  <PRODRUG>  (823) 
Y

>  <ORAL>  (823) 
N

>  <PARENTERAL>  (823) 
Y

>  <TOPICAL>  (823) 
N

>  <BLACK_BOX>  (823) 
N

>  <AVAILABILITY_TYPE>  (823) 
Discontinued

>  <WITHDRAWN_YEAR>  (823) 
nan

>  <WITHDRAWN_COUNTRY>  (823) 
nan

>  <WITHDRAWN_REASON>  (823) 
nan

>  <CANONICAL_SMILES>  (823) 
C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4

>  <name>  (823) 
Artesunate 

>  <MW>  (823) 
384.425

>  <logP>  (823) 
2.6024

$$$$
CHEMBL1657
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  3  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
 24 25  2  0
 11  6  1  0
 25 14  1  0
 24 17  1  0
M  END
>  <PARENT_MOLREGNO>  (824) 
495572

>  <SYNONYMS>  (824) 
Tazarotene (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (824) 
4

>  <RESEARCH_CODES>  (824) 
AGN-190168

>  <APPLICANTS>  (824) 
Stiefel Laboratories Inc; Allergan Inc

>  <USAN_STEM>  (824) 
-arotene

>  <USAN_STEM_DEFINITION>  (824) 
arotinoid derivatives

>  <USAN_STEM_SUBSTEM>  (824) 
-arotene

>  <USAN_YEAR>  (824) 
1994.0

>  <FIRST_APPROVAL>  (824) 
1997.0

>  <ATC_CODE>  (824) 
D05AX05

>  <ATC_CODE_DESCRIPTION>  (824) 
D05AX05 [Dermatologicals:Antipsoriatics:Antipsoriatics For Topical Use:Other antipsoriatics for topical use]

>  <INDICATION_CLASS>  (824) 
Keratolytic

>  <SC_PATENT_NO>  (824) 
US-8808716-B2

>  <DRUG_TYPE>  (824) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (824) 
Y

>  <FIRST_IN_CLASS>  (824) 
N

>  <CHIRALITY>  (824) 
Achiral Molecule

>  <PRODRUG>  (824) 
Y

>  <ORAL>  (824) 
N

>  <PARENTERAL>  (824) 
N

>  <TOPICAL>  (824) 
Y

>  <BLACK_BOX>  (824) 
N

>  <AVAILABILITY_TYPE>  (824) 
Prescription-only

>  <WITHDRAWN_YEAR>  (824) 
nan

>  <WITHDRAWN_COUNTRY>  (824) 
nan

>  <WITHDRAWN_REASON>  (824) 
nan

>  <CANONICAL_SMILES>  (824) 
CCOC(=O)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2

>  <name>  (824) 
Tazarotene 

>  <MW>  (824) 
351.471

>  <logP>  (824) 
4.4315

$$$$
CHEMBL1169
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  1  0
  9 11  2  0
 11  2  1  0
M  END
>  <PARENT_MOLREGNO>  (825) 
190484

>  <SYNONYMS>  (825) 
Aminosalicylic acid (FDA, USP); Aminosalicylate Potassium (USP); Potassium Aminosalicylate (FDA); Aminosalicylate sodium (FDA, USP); Aminosalicylate Calcium (USP); Calcium Para-Aminosalicylate (JAN)

>  <DEVELOPMENT_PHASE>  (825) 
4

>  <RESEARCH_CODES>  (825) 
nan

>  <APPLICANTS>  (825) 
Panray Corp Sub Ormont Drug And Chemical Co Inc; Glenwood Inc; Consolidated Midland Corp; Bristol Myers Squibb Co

>  <USAN_STEM>  (825) 
-sal-

>  <USAN_STEM_DEFINITION>  (825) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (825) 
-sal-

>  <USAN_YEAR>  (825) 
nan

>  <FIRST_APPROVAL>  (825) 
1950.0

>  <ATC_CODE>  (825) 
J04AA01; J04AA02; J04AA03

>  <ATC_CODE_DESCRIPTION>  (825) 
J04AA01 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Aminosalicylic acid and derivatives]; J04AA02 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Aminosalicylic acid and derivatives]; J04AA03 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Aminosalicylic acid and derivatives]

>  <INDICATION_CLASS>  (825) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (825) 
nan

>  <DRUG_TYPE>  (825) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (825) 
Y

>  <FIRST_IN_CLASS>  (825) 
N

>  <CHIRALITY>  (825) 
Achiral Molecule

>  <PRODRUG>  (825) 
N

>  <ORAL>  (825) 
Y

>  <PARENTERAL>  (825) 
N

>  <TOPICAL>  (825) 
N

>  <BLACK_BOX>  (825) 
N

>  <AVAILABILITY_TYPE>  (825) 
Prescription-only

>  <WITHDRAWN_YEAR>  (825) 
nan

>  <WITHDRAWN_COUNTRY>  (825) 
nan

>  <WITHDRAWN_REASON>  (825) 
nan

>  <CANONICAL_SMILES>  (825) 
Nc1ccc(C(=O)O)c(O)c1

>  <name>  (825) 
Aminosalicylic acid 

>  <MW>  (825) 
153.137

>  <logP>  (825) 
0.6726

$$$$
CHEMBL635
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
  7 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 18  2  1  0
 21  2  1  0
 16  6  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (826) 
27229

>  <SYNONYMS>  (826) 
Prednisone (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (826) 
4

>  <RESEARCH_CODES>  (826) 
nan

>  <APPLICANTS>  (826) 
Roxane Laboratories Inc; Pharmacia And Upjohn Co; Parke Davis Div Warner Lambert Co; Horizon Pharma Inc; Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (826) 
pred-

>  <USAN_STEM_DEFINITION>  (826) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (826) 
pred-

>  <USAN_YEAR>  (826) 
nan

>  <FIRST_APPROVAL>  (826) 
1955.0

>  <ATC_CODE>  (826) 
A07EA03; H02AB07

>  <ATC_CODE_DESCRIPTION>  (826) 
A07EA03 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; H02AB07 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]

>  <INDICATION_CLASS>  (826) 
Glucocorticoid

>  <SC_PATENT_NO>  (826) 
US-6488960-B1

>  <DRUG_TYPE>  (826) 
Natural Product-derived

>  <RULE_OF_FIVE>  (826) 
Y

>  <FIRST_IN_CLASS>  (826) 
N

>  <CHIRALITY>  (826) 
Single Stereoisomer

>  <PRODRUG>  (826) 
N

>  <ORAL>  (826) 
Y

>  <PARENTERAL>  (826) 
N

>  <TOPICAL>  (826) 
N

>  <BLACK_BOX>  (826) 
N

>  <AVAILABILITY_TYPE>  (826) 
Prescription-only

>  <WITHDRAWN_YEAR>  (826) 
nan

>  <WITHDRAWN_COUNTRY>  (826) 
nan

>  <WITHDRAWN_REASON>  (826) 
nan

>  <CANONICAL_SMILES>  (826) 
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO

>  <name>  (826) 
Prednisone 

>  <MW>  (826) 
358.434

>  <logP>  (826) 
1.7658

$$$$
CHEMBL761
     RDKit          

 16 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  6  2  1  0
 16  7  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (827) 
42468

>  <SYNONYMS>  (827) 
Naphazoline (BAN, INN); Naphazoline HCl (FDA, JAN, USP); Naphazoline Nitrate (JAN)

>  <DEVELOPMENT_PHASE>  (827) 
4

>  <RESEARCH_CODES>  (827) 
nan

>  <APPLICANTS>  (827) 
Novartis Pharmaceuticals Corp; Johnson And Johnson Group Consumer Companies; Bausch And Lomb Inc; Alcon Laboratories Inc

>  <USAN_STEM>  (827) 
-azoline

>  <USAN_STEM_DEFINITION>  (827) 
antihistamines/local vasoconstrictors (antazoline type)

>  <USAN_STEM_SUBSTEM>  (827) 
-azoline

>  <USAN_YEAR>  (827) 
nan

>  <FIRST_APPROVAL>  (827) 
1971.0

>  <ATC_CODE>  (827) 
R01AA08; R01AB02; S01GA01; S01GA51

>  <ATC_CODE_DESCRIPTION>  (827) 
R01AA08 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, plain]; R01AB02 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, combinations excl. corticosteroids]; S01GA01 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]; S01GA51 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]

>  <INDICATION_CLASS>  (827) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (827) 
nan

>  <DRUG_TYPE>  (827) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (827) 
Y

>  <FIRST_IN_CLASS>  (827) 
N

>  <CHIRALITY>  (827) 
Achiral Molecule

>  <PRODRUG>  (827) 
N

>  <ORAL>  (827) 
N

>  <PARENTERAL>  (827) 
N

>  <TOPICAL>  (827) 
Y

>  <BLACK_BOX>  (827) 
N

>  <AVAILABILITY_TYPE>  (827) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (827) 
nan

>  <WITHDRAWN_COUNTRY>  (827) 
nan

>  <WITHDRAWN_REASON>  (827) 
nan

>  <CANONICAL_SMILES>  (827) 
C(C1=NCCN1)c2cccc3ccccc23

>  <name>  (827) 
Naphazoline 

>  <MW>  (827) 
210.28

>  <logP>  (827) 
2.384

$$$$
CHEMBL714
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  2  0
 17  9  1  0
M  END
>  <PARENT_MOLREGNO>  (828) 
34094

>  <SYNONYMS>  (828) 
Albuterol (FDA, USAN, USP); Salbutamol (BAN, DCF, INN); Albuterol Sulfate (FDA, USAN, USP); Salbutamol Sulfate (JAN)

>  <DEVELOPMENT_PHASE>  (828) 
4

>  <RESEARCH_CODES>  (828) 
SCH-13949W Sulfate; SCH-13949W

>  <APPLICANTS>  (828) 
GlaxoSmithKline; Dey Lp; Boehringer Ingelheim Pharmaceuticals Inc; 3m Pharmaceuticals Inc; Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (828) 
-terol

>  <USAN_STEM_DEFINITION>  (828) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (828) 
-terol

>  <USAN_YEAR>  (828) 
1971.0

>  <FIRST_APPROVAL>  (828) 
1981.0

>  <ATC_CODE>  (828) 
R03AC02; R03CC02

>  <ATC_CODE_DESCRIPTION>  (828) 
R03AC02 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]; R03CC02 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (828) 
Bronchodilator

>  <SC_PATENT_NO>  (828) 
US-5775321-A

>  <DRUG_TYPE>  (828) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (828) 
Y

>  <FIRST_IN_CLASS>  (828) 
N

>  <CHIRALITY>  (828) 
Racemic Mixture

>  <PRODRUG>  (828) 
N

>  <ORAL>  (828) 
Y

>  <PARENTERAL>  (828) 
N

>  <TOPICAL>  (828) 
Y

>  <BLACK_BOX>  (828) 
Y

>  <AVAILABILITY_TYPE>  (828) 
Prescription-only

>  <WITHDRAWN_YEAR>  (828) 
nan

>  <WITHDRAWN_COUNTRY>  (828) 
nan

>  <WITHDRAWN_REASON>  (828) 
nan

>  <CANONICAL_SMILES>  (828) 
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1

>  <name>  (828) 
Albuterol 

>  <MW>  (828) 
239.315

>  <logP>  (828) 
1.306

$$$$
CHEMBL419
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  2  0
  9 11  2  0
  9 12  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (829) 
1148

>  <SYNONYMS>  (829) 
Mafenide (BAN, INN, USAN); Mafenide Acetate (FDA, JAN, USP); Mafenide HCl (MI)

>  <DEVELOPMENT_PHASE>  (829) 
4

>  <RESEARCH_CODES>  (829) 
nan

>  <APPLICANTS>  (829) 
Sterling Winthrop; Mylan Institutional Llc

>  <USAN_STEM>  (829) 
nan

>  <USAN_STEM_DEFINITION>  (829) 
nan

>  <USAN_STEM_SUBSTEM>  (829) 
nan

>  <USAN_YEAR>  (829) 
1967.0

>  <FIRST_APPROVAL>  (829) 
1969.0

>  <ATC_CODE>  (829) 
D06BA03

>  <ATC_CODE_DESCRIPTION>  (829) 
D06BA03 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]

>  <INDICATION_CLASS>  (829) 
Anti-Infective, Topical; Antibacterial

>  <SC_PATENT_NO>  (829) 
nan

>  <DRUG_TYPE>  (829) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (829) 
Y

>  <FIRST_IN_CLASS>  (829) 
N

>  <CHIRALITY>  (829) 
Achiral Molecule

>  <PRODRUG>  (829) 
N

>  <ORAL>  (829) 
N

>  <PARENTERAL>  (829) 
N

>  <TOPICAL>  (829) 
Y

>  <BLACK_BOX>  (829) 
N

>  <AVAILABILITY_TYPE>  (829) 
Prescription-only

>  <WITHDRAWN_YEAR>  (829) 
nan

>  <WITHDRAWN_COUNTRY>  (829) 
nan

>  <WITHDRAWN_REASON>  (829) 
nan

>  <CANONICAL_SMILES>  (829) 
NCc1ccc(cc1)S(=O)(=O)N

>  <name>  (829) 
Mafenide 

>  <MW>  (829) 
186.236

>  <logP>  (829) 
-0.2073

$$$$
CHEMBL1492
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  9 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  7  2  1  0
 15 10  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (830) 
418482

>  <SYNONYMS>  (830) 
Diphenylpyraline (BAN, INN); Diphenylpyraline HCl (FDA, JAN, MI, USP); Diphenylpyraline Teoclate (JAN)

>  <DEVELOPMENT_PHASE>  (830) 
4

>  <RESEARCH_CODES>  (830) 
nan

>  <APPLICANTS>  (830) 
GlaxoSmithKline

>  <USAN_STEM>  (830) 
nan

>  <USAN_STEM_DEFINITION>  (830) 
nan

>  <USAN_STEM_SUBSTEM>  (830) 
nan

>  <USAN_YEAR>  (830) 
nan

>  <FIRST_APPROVAL>  (830) 
1982.0

>  <ATC_CODE>  (830) 
R06AA57; R06AA07

>  <ATC_CODE_DESCRIPTION>  (830) 
R06AA57 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]; R06AA07 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]

>  <INDICATION_CLASS>  (830) 
nan

>  <SC_PATENT_NO>  (830) 
nan

>  <DRUG_TYPE>  (830) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (830) 
Y

>  <FIRST_IN_CLASS>  (830) 
N

>  <CHIRALITY>  (830) 
Achiral Molecule

>  <PRODRUG>  (830) 
N

>  <ORAL>  (830) 
Y

>  <PARENTERAL>  (830) 
N

>  <TOPICAL>  (830) 
N

>  <BLACK_BOX>  (830) 
N

>  <AVAILABILITY_TYPE>  (830) 
Discontinued

>  <WITHDRAWN_YEAR>  (830) 
nan

>  <WITHDRAWN_COUNTRY>  (830) 
nan

>  <WITHDRAWN_REASON>  (830) 
nan

>  <CANONICAL_SMILES>  (830) 
CN1CCC(CC1)OC(c2ccccc2)c3ccccc3

>  <name>  (830) 
Diphenylpyraline 

>  <MW>  (830) 
281.399

>  <logP>  (830) 
3.8868

$$$$
CHEMBL1402684
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 11 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 24 29  1  0
 29 30  2  0
 10  5  1  0
 20 11  1  0
 20 15  1  0
 30 21  1  0
M  END
>  <PARENT_MOLREGNO>  (831) 
826568

>  <SYNONYMS>  (831) 
Oxyphenisatin Acetate (USAN); Oxyphenisatine (BAN, INN)

>  <DEVELOPMENT_PHASE>  (831) 
4

>  <RESEARCH_CODES>  (831) 
nan

>  <APPLICANTS>  (831) 
Sterling Winthrop; Parke-Davis

>  <USAN_STEM>  (831) 
nan

>  <USAN_STEM_DEFINITION>  (831) 
nan

>  <USAN_STEM_SUBSTEM>  (831) 
nan

>  <USAN_YEAR>  (831) 
1962.0

>  <FIRST_APPROVAL>  (831) 
nan

>  <ATC_CODE>  (831) 
A06AB01

>  <ATC_CODE_DESCRIPTION>  (831) 
A06AB01 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]

>  <INDICATION_CLASS>  (831) 
Laxative

>  <SC_PATENT_NO>  (831) 
nan

>  <DRUG_TYPE>  (831) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (831) 
Y

>  <FIRST_IN_CLASS>  (831) 
N

>  <CHIRALITY>  (831) 
Achiral Molecule

>  <PRODRUG>  (831) 
N

>  <ORAL>  (831) 
N

>  <PARENTERAL>  (831) 
N

>  <TOPICAL>  (831) 
N

>  <BLACK_BOX>  (831) 
N

>  <AVAILABILITY_TYPE>  (831) 
Withdrawn

>  <WITHDRAWN_YEAR>  (831) 
1971.0

>  <WITHDRAWN_COUNTRY>  (831) 
Australia; Germany; France; United Kingdom; United States

>  <WITHDRAWN_REASON>  (831) 
Hepatic toxicity

>  <CANONICAL_SMILES>  (831) 
CC(=O)Oc1ccc(cc1)C2(C(=O)Nc3ccccc23)c4ccc(OC(=O)C)cc4

>  <name>  (831) 
Oxyphenisatin Acetate 

>  <MW>  (831) 
401.418

>  <logP>  (831) 
3.8237

$$$$
CHEMBL159226
     RDKit          

 20 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  6 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 14  4  1  0
M  END
>  <PARENT_MOLREGNO>  (832) 
265957

>  <SYNONYMS>  (832) 
Moxisylyte (DCF, INN, MI); Moxisylyte HCl (JAN); Thymoxamine (BAN)

>  <DEVELOPMENT_PHASE>  (832) 
4

>  <RESEARCH_CODES>  (832) 
nan

>  <APPLICANTS>  (832) 
nan

>  <USAN_STEM>  (832) 
nan

>  <USAN_STEM_DEFINITION>  (832) 
nan

>  <USAN_STEM_SUBSTEM>  (832) 
nan

>  <USAN_YEAR>  (832) 
nan

>  <FIRST_APPROVAL>  (832) 
nan

>  <ATC_CODE>  (832) 
G04BE06; C04AX10

>  <ATC_CODE_DESCRIPTION>  (832) 
G04BE06 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]; C04AX10 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Other peripheral vasodilators]

>  <INDICATION_CLASS>  (832) 
nan

>  <SC_PATENT_NO>  (832) 
nan

>  <DRUG_TYPE>  (832) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (832) 
Y

>  <FIRST_IN_CLASS>  (832) 
N

>  <CHIRALITY>  (832) 
Achiral Molecule

>  <PRODRUG>  (832) 
N

>  <ORAL>  (832) 
N

>  <PARENTERAL>  (832) 
N

>  <TOPICAL>  (832) 
N

>  <BLACK_BOX>  (832) 
N

>  <AVAILABILITY_TYPE>  (832) 
Withdrawn

>  <WITHDRAWN_YEAR>  (832) 
1993.0

>  <WITHDRAWN_COUNTRY>  (832) 
France

>  <WITHDRAWN_REASON>  (832) 
Necrotic Hepatitis

>  <CANONICAL_SMILES>  (832) 
CC(C)c1cc(OC(=O)C)c(C)cc1OCCN(C)C

>  <name>  (832) 
Moxisylyte 

>  <MW>  (832) 
279.38

>  <logP>  (832) 
2.98412

$$$$
CHEMBL648
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  7  2  1  0
 14  9  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (833) 
27546

>  <SYNONYMS>  (833) 
Cyclizine (BAN, DCF, INN, USP); Cyclizine HCl (BAN, USP); Cyclizine Lactate (BAN, FDA, USP)

>  <DEVELOPMENT_PHASE>  (833) 
4

>  <RESEARCH_CODES>  (833) 
nan

>  <APPLICANTS>  (833) 
GlaxoSmithKline

>  <USAN_STEM>  (833) 
nan

>  <USAN_STEM_DEFINITION>  (833) 
nan

>  <USAN_STEM_SUBSTEM>  (833) 
nan

>  <USAN_YEAR>  (833) 
nan

>  <FIRST_APPROVAL>  (833) 
1982.0

>  <ATC_CODE>  (833) 
R06AE03; R06AE53

>  <ATC_CODE_DESCRIPTION>  (833) 
R06AE03 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Piperazine derivatives]; R06AE53 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Piperazine derivatives]

>  <INDICATION_CLASS>  (833) 
Anti-Emetic; Antihistaminic; Antinauseant

>  <SC_PATENT_NO>  (833) 
nan

>  <DRUG_TYPE>  (833) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (833) 
Y

>  <FIRST_IN_CLASS>  (833) 
N

>  <CHIRALITY>  (833) 
Achiral Molecule

>  <PRODRUG>  (833) 
N

>  <ORAL>  (833) 
N

>  <PARENTERAL>  (833) 
Y

>  <TOPICAL>  (833) 
N

>  <BLACK_BOX>  (833) 
N

>  <AVAILABILITY_TYPE>  (833) 
Discontinued

>  <WITHDRAWN_YEAR>  (833) 
nan

>  <WITHDRAWN_COUNTRY>  (833) 
nan

>  <WITHDRAWN_REASON>  (833) 
nan

>  <CANONICAL_SMILES>  (833) 
CN1CCN(CC1)C(c2ccccc2)c3ccccc3

>  <name>  (833) 
Cyclizine 

>  <MW>  (833) 
266.388

>  <logP>  (833) 
3.0234

$$$$
CHEMBL403
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  2  0
 10 12  2  0
  4 13  1  0
 13 14  2  0
 13 15  1  0
 10  2  1  0
  8  5  1  0
M  END
>  <PARENT_MOLREGNO>  (834) 
194

>  <SYNONYMS>  (834) 
Sulbactam (BAN, INN); Sulbactam Sodium (FDA, JAN, USAN, USP); Sulbactam Benzathine (USAN)

>  <DEVELOPMENT_PHASE>  (834) 
4

>  <RESEARCH_CODES>  (834) 
CP-45899; CP-458992; CP-45899-2; CP-45899-99

>  <APPLICANTS>  (834) 
Pfizer Inc.

>  <USAN_STEM>  (834) 
-bactam

>  <USAN_STEM_DEFINITION>  (834) 
beta-lactamase inhibitors

>  <USAN_STEM_SUBSTEM>  (834) 
-bactam

>  <USAN_YEAR>  (834) 
1980.0

>  <FIRST_APPROVAL>  (834) 
1986.0

>  <ATC_CODE>  (834) 
J01CG01

>  <ATC_CODE_DESCRIPTION>  (834) 
J01CG01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase inhibitors]

>  <INDICATION_CLASS>  (834) 
Inhibitor (beta-lactamase); Synergist (penicillin/cephalosporin)

>  <SC_PATENT_NO>  (834) 
nan

>  <DRUG_TYPE>  (834) 
Natural Product-derived

>  <RULE_OF_FIVE>  (834) 
Y

>  <FIRST_IN_CLASS>  (834) 
N

>  <CHIRALITY>  (834) 
Single Stereoisomer

>  <PRODRUG>  (834) 
N

>  <ORAL>  (834) 
N

>  <PARENTERAL>  (834) 
Y

>  <TOPICAL>  (834) 
N

>  <BLACK_BOX>  (834) 
N

>  <AVAILABILITY_TYPE>  (834) 
Prescription-only

>  <WITHDRAWN_YEAR>  (834) 
nan

>  <WITHDRAWN_COUNTRY>  (834) 
nan

>  <WITHDRAWN_REASON>  (834) 
nan

>  <CANONICAL_SMILES>  (834) 
CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(=O)O

>  <name>  (834) 
Sulbactam 

>  <MW>  (834) 
233.245

>  <logP>  (834) 
-0.795

$$$$
CHEMBL267936
     RDKit          

 12 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
 10  3  1  0
  9  5  1  0
M  END
>  <PARENT_MOLREGNO>  (835) 
880

>  <SYNONYMS>  (835) 
Mecamylamine (BAN, INN); Mecamylamine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (835) 
4

>  <RESEARCH_CODES>  (835) 
nan

>  <APPLICANTS>  (835) 
Targacept Inc

>  <USAN_STEM>  (835) 
nan

>  <USAN_STEM_DEFINITION>  (835) 
nan

>  <USAN_STEM_SUBSTEM>  (835) 
nan

>  <USAN_YEAR>  (835) 
nan

>  <FIRST_APPROVAL>  (835) 
1956.0

>  <ATC_CODE>  (835) 
C02BB01

>  <ATC_CODE_DESCRIPTION>  (835) 
C02BB01 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Ganglion-Blocking:Secondary and tertiary amines]

>  <INDICATION_CLASS>  (835) 
Antihypertensive

>  <SC_PATENT_NO>  (835) 
nan

>  <DRUG_TYPE>  (835) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (835) 
Y

>  <FIRST_IN_CLASS>  (835) 
N

>  <CHIRALITY>  (835) 
Racemic Mixture

>  <PRODRUG>  (835) 
N

>  <ORAL>  (835) 
Y

>  <PARENTERAL>  (835) 
N

>  <TOPICAL>  (835) 
N

>  <BLACK_BOX>  (835) 
N

>  <AVAILABILITY_TYPE>  (835) 
Prescription-only

>  <WITHDRAWN_YEAR>  (835) 
nan

>  <WITHDRAWN_COUNTRY>  (835) 
nan

>  <WITHDRAWN_REASON>  (835) 
nan

>  <CANONICAL_SMILES>  (835) 
CNC1(C)C2CCC(C2)C1(C)C

>  <name>  (835) 
Mecamylamine 

>  <MW>  (835) 
167.296

>  <logP>  (835) 
2.4206

$$$$
CHEMBL762
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  4 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
  9  2  1  0
 15 11  1  0
M  END
>  <PARENT_MOLREGNO>  (836) 
42520

>  <SYNONYMS>  (836) 
Oxymetazoline (BAN, INN); Oxymetazoline HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (836) 
4

>  <RESEARCH_CODES>  (836) 
SCH-9384

>  <APPLICANTS>  (836) 
Schering Plough Healthcare Products Inc; Johnson And Johnson Group Consumer Companies

>  <USAN_STEM>  (836) 
-azoline

>  <USAN_STEM_DEFINITION>  (836) 
antihistamines/local vasoconstrictors (antazoline type)

>  <USAN_STEM_SUBSTEM>  (836) 
-azoline

>  <USAN_YEAR>  (836) 
1963.0

>  <FIRST_APPROVAL>  (836) 
1986.0

>  <ATC_CODE>  (836) 
R01AA05; R01AB07; S01GA04

>  <ATC_CODE_DESCRIPTION>  (836) 
R01AA05 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, plain]; R01AB07 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Sympathomimetics, combinations excl. corticosteroids]; S01GA04 [Sensory Organs:Ophthalmologicals:Decongestants And Antiallergics:Sympathomimetics used as decongestants]

>  <INDICATION_CLASS>  (836) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (836) 
nan

>  <DRUG_TYPE>  (836) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (836) 
Y

>  <FIRST_IN_CLASS>  (836) 
N

>  <CHIRALITY>  (836) 
Achiral Molecule

>  <PRODRUG>  (836) 
N

>  <ORAL>  (836) 
N

>  <PARENTERAL>  (836) 
N

>  <TOPICAL>  (836) 
Y

>  <BLACK_BOX>  (836) 
N

>  <AVAILABILITY_TYPE>  (836) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (836) 
nan

>  <WITHDRAWN_COUNTRY>  (836) 
nan

>  <WITHDRAWN_REASON>  (836) 
nan

>  <CANONICAL_SMILES>  (836) 
Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C

>  <name>  (836) 
Oxymetazoline 

>  <MW>  (836) 
260.381

>  <logP>  (836) 
2.85074

$$$$
CHEMBL1000
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 14 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 13  8  1  0
 20 15  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (837) 
111185

>  <SYNONYMS>  (837) 
Cetirizine (BAN, INN); Cetirizine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (837) 
4

>  <RESEARCH_CODES>  (837) 
P-071

>  <APPLICANTS>  (837) 
Mcneil Consumer Products Co Div Mcneilab Inc; Mcneil Consumer Healthcare Div Mcneil Ppc Inc; Mcneil Consumer Healthcare; Banner Pharmacaps Inc

>  <USAN_STEM>  (837) 
nan

>  <USAN_STEM_DEFINITION>  (837) 
nan

>  <USAN_STEM_SUBSTEM>  (837) 
nan

>  <USAN_YEAR>  (837) 
1985.0

>  <FIRST_APPROVAL>  (837) 
1995.0

>  <ATC_CODE>  (837) 
R06AE07

>  <ATC_CODE_DESCRIPTION>  (837) 
R06AE07 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Piperazine derivatives]

>  <INDICATION_CLASS>  (837) 
Antihistaminic

>  <SC_PATENT_NO>  (837) 
US-6455533-B1

>  <DRUG_TYPE>  (837) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (837) 
Y

>  <FIRST_IN_CLASS>  (837) 
N

>  <CHIRALITY>  (837) 
Racemic Mixture

>  <PRODRUG>  (837) 
N

>  <ORAL>  (837) 
Y

>  <PARENTERAL>  (837) 
N

>  <TOPICAL>  (837) 
N

>  <BLACK_BOX>  (837) 
N

>  <AVAILABILITY_TYPE>  (837) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (837) 
nan

>  <WITHDRAWN_COUNTRY>  (837) 
nan

>  <WITHDRAWN_REASON>  (837) 
nan

>  <CANONICAL_SMILES>  (837) 
OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3

>  <name>  (837) 
Cetirizine 

>  <MW>  (837) 
388.895

>  <logP>  (837) 
3.1482

$$$$
CHEMBL1198
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
  9 20  1  0
 20 21  2  0
 21  6  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (838) 
209224

>  <SYNONYMS>  (838) 
Pramocaine (INN, BAN); Pramoxine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (838) 
4

>  <RESEARCH_CODES>  (838) 
nan

>  <APPLICANTS>  (838) 
Meda Pharmaceuticals Inc; Ferndale Laboratories Inc; Boca Pharmacal Inc

>  <USAN_STEM>  (838) 
nan

>  <USAN_STEM_DEFINITION>  (838) 
nan

>  <USAN_STEM_SUBSTEM>  (838) 
nan

>  <USAN_YEAR>  (838) 
nan

>  <FIRST_APPROVAL>  (838) 
1976.0

>  <ATC_CODE>  (838) 
D04AB07; C05AD07

>  <ATC_CODE_DESCRIPTION>  (838) 
D04AB07 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; C05AD07 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]

>  <INDICATION_CLASS>  (838) 
Anesthetic (topical)

>  <SC_PATENT_NO>  (838) 
nan

>  <DRUG_TYPE>  (838) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (838) 
Y

>  <FIRST_IN_CLASS>  (838) 
N

>  <CHIRALITY>  (838) 
Achiral Molecule

>  <PRODRUG>  (838) 
N

>  <ORAL>  (838) 
N

>  <PARENTERAL>  (838) 
N

>  <TOPICAL>  (838) 
Y

>  <BLACK_BOX>  (838) 
N

>  <AVAILABILITY_TYPE>  (838) 
Prescription-only

>  <WITHDRAWN_YEAR>  (838) 
nan

>  <WITHDRAWN_COUNTRY>  (838) 
nan

>  <WITHDRAWN_REASON>  (838) 
nan

>  <CANONICAL_SMILES>  (838) 
CCCCOc1ccc(OCCCN2CCOCC2)cc1

>  <name>  (838) 
Pramocaine 

>  <MW>  (838) 
293.407

>  <logP>  (838) 
2.9666

$$$$
CHEMBL1201256
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 20 27  1  0
 27 28  2  0
 10  3  1  0
 28 17  1  0
M  END
>  <PARENT_MOLREGNO>  (839) 
675207

>  <SYNONYMS>  (839) 
Trimethobenzamide (INN); Trimethobenzamide HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (839) 
4

>  <RESEARCH_CODES>  (839) 
nan

>  <APPLICANTS>  (839) 
King Pharmaceuticals Inc; Jhp Pharmaceuticals Llc

>  <USAN_STEM>  (839) 
nan

>  <USAN_STEM_DEFINITION>  (839) 
nan

>  <USAN_STEM_SUBSTEM>  (839) 
nan

>  <USAN_YEAR>  (839) 
nan

>  <FIRST_APPROVAL>  (839) 
1974.0

>  <ATC_CODE>  (839) 
R06AA10

>  <ATC_CODE_DESCRIPTION>  (839) 
R06AA10 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]

>  <INDICATION_CLASS>  (839) 
Anti-Emetic

>  <SC_PATENT_NO>  (839) 
nan

>  <DRUG_TYPE>  (839) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (839) 
Y

>  <FIRST_IN_CLASS>  (839) 
N

>  <CHIRALITY>  (839) 
Achiral Molecule

>  <PRODRUG>  (839) 
N

>  <ORAL>  (839) 
Y

>  <PARENTERAL>  (839) 
Y

>  <TOPICAL>  (839) 
N

>  <BLACK_BOX>  (839) 
N

>  <AVAILABILITY_TYPE>  (839) 
Prescription-only

>  <WITHDRAWN_YEAR>  (839) 
nan

>  <WITHDRAWN_COUNTRY>  (839) 
nan

>  <WITHDRAWN_REASON>  (839) 
nan

>  <CANONICAL_SMILES>  (839) 
COc1cc(cc(OC)c1OC)C(=O)NCc2ccc(OCCN(C)C)cc2

>  <name>  (839) 
Trimethobenzamide 

>  <MW>  (839) 
388.464

>  <logP>  (839) 
2.5828

$$$$
CHEMBL1201117
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (840) 
675068

>  <SYNONYMS>  (840) 
Methocarbamol (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (840) 
4

>  <RESEARCH_CODES>  (840) 
nan

>  <APPLICANTS>  (840) 
Baxter Healthcare Corp Anesthesia Critical Care; Ah Robins Co; Actient Pharmaceuticals Llc

>  <USAN_STEM>  (840) 
nan

>  <USAN_STEM_DEFINITION>  (840) 
nan

>  <USAN_STEM_SUBSTEM>  (840) 
nan

>  <USAN_YEAR>  (840) 
nan

>  <FIRST_APPROVAL>  (840) 
1957.0

>  <ATC_CODE>  (840) 
M03BA53; M03BA03; M03BA73

>  <ATC_CODE_DESCRIPTION>  (840) 
M03BA53 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Carbamic acid esters]; M03BA03 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Carbamic acid esters]; M03BA73 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Carbamic acid esters]

>  <INDICATION_CLASS>  (840) 
Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (840) 
nan

>  <DRUG_TYPE>  (840) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (840) 
Y

>  <FIRST_IN_CLASS>  (840) 
N

>  <CHIRALITY>  (840) 
Racemic Mixture

>  <PRODRUG>  (840) 
N

>  <ORAL>  (840) 
Y

>  <PARENTERAL>  (840) 
Y

>  <TOPICAL>  (840) 
N

>  <BLACK_BOX>  (840) 
N

>  <AVAILABILITY_TYPE>  (840) 
Prescription-only

>  <WITHDRAWN_YEAR>  (840) 
nan

>  <WITHDRAWN_COUNTRY>  (840) 
nan

>  <WITHDRAWN_REASON>  (840) 
nan

>  <CANONICAL_SMILES>  (840) 
COc1ccccc1OCC(O)COC(=O)N

>  <name>  (840) 
Methocarbamol 

>  <MW>  (840) 
241.243

>  <logP>  (840) 
0.5302

$$$$
CHEMBL457299
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
M  END
>  <PARENT_MOLREGNO>  (841) 
466350

>  <SYNONYMS>  (841) 
Ethylene Glycol

>  <DEVELOPMENT_PHASE>  (841) 
4

>  <RESEARCH_CODES>  (841) 
nan

>  <APPLICANTS>  (841) 
nan

>  <USAN_STEM>  (841) 
nan

>  <USAN_STEM_DEFINITION>  (841) 
nan

>  <USAN_STEM_SUBSTEM>  (841) 
nan

>  <USAN_YEAR>  (841) 
nan

>  <FIRST_APPROVAL>  (841) 
nan

>  <ATC_CODE>  (841) 
A06AD15; A06AD65

>  <ATC_CODE_DESCRIPTION>  (841) 
A06AD15 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Osmotically acting laxatives]; A06AD65 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Osmotically acting laxatives]

>  <INDICATION_CLASS>  (841) 
nan

>  <SC_PATENT_NO>  (841) 
nan

>  <DRUG_TYPE>  (841) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (841) 
Y

>  <FIRST_IN_CLASS>  (841) 
N

>  <CHIRALITY>  (841) 
Achiral Molecule

>  <PRODRUG>  (841) 
N

>  <ORAL>  (841) 
N

>  <PARENTERAL>  (841) 
N

>  <TOPICAL>  (841) 
N

>  <BLACK_BOX>  (841) 
N

>  <AVAILABILITY_TYPE>  (841) 
Unknown

>  <WITHDRAWN_YEAR>  (841) 
nan

>  <WITHDRAWN_COUNTRY>  (841) 
nan

>  <WITHDRAWN_REASON>  (841) 
nan

>  <CANONICAL_SMILES>  (841) 
OCCO

>  <name>  (841) 
Ethylene Glycol

>  <MW>  (841) 
62.068

>  <logP>  (841) 
-1.029

$$$$
CHEMBL1201753
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
  9 25  1  0
 25 26  1  0
 26 27  1  0
  2 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 17  8  1  0
 16 11  1  0
 24 18  1  0
 27 25  1  0
M  END
>  <PARENT_MOLREGNO>  (842) 
675704

>  <SYNONYMS>  (842) 
Pitavastatin (INN); Pitavastatin Calcium (FDA)

>  <DEVELOPMENT_PHASE>  (842) 
4

>  <RESEARCH_CODES>  (842) 
nan

>  <APPLICANTS>  (842) 
Kowa Co Ltd

>  <USAN_STEM>  (842) 
-stat-

>  <USAN_STEM_DEFINITION>  (842) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (842) 
-stat- (-vastatin)

>  <USAN_YEAR>  (842) 
nan

>  <FIRST_APPROVAL>  (842) 
2009.0

>  <ATC_CODE>  (842) 
C10AA08

>  <ATC_CODE_DESCRIPTION>  (842) 
C10AA08 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (842) 
nan

>  <SC_PATENT_NO>  (842) 
US-5854259-A

>  <DRUG_TYPE>  (842) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (842) 
Y

>  <FIRST_IN_CLASS>  (842) 
N

>  <CHIRALITY>  (842) 
Single Stereoisomer

>  <PRODRUG>  (842) 
N

>  <ORAL>  (842) 
Y

>  <PARENTERAL>  (842) 
N

>  <TOPICAL>  (842) 
N

>  <BLACK_BOX>  (842) 
N

>  <AVAILABILITY_TYPE>  (842) 
Prescription-only

>  <WITHDRAWN_YEAR>  (842) 
nan

>  <WITHDRAWN_COUNTRY>  (842) 
nan

>  <WITHDRAWN_REASON>  (842) 
nan

>  <CANONICAL_SMILES>  (842) 
O[C@H](C[C@H](O)\C=C\c1c(nc2ccccc2c1c3ccc(F)cc3)C4CC4)CC(=O)O

>  <name>  (842) 
Pitavastatin 

>  <MW>  (842) 
421.468

>  <logP>  (842) 
4.5181

$$$$
CHEMBL807
     RDKit          

 13 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
  8  2  1  0
 13  2  1  0
 12  4  1  0
M  END
>  <PARENT_MOLREGNO>  (843) 
52523

>  <SYNONYMS>  (843) 
Memantine (BAN, INN, MI); Memantine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (843) 
4

>  <RESEARCH_CODES>  (843) 
nan

>  <APPLICANTS>  (843) 
Forest Laboratories Inc

>  <USAN_STEM>  (843) 
-mantine

>  <USAN_STEM_DEFINITION>  (843) 
antivirals/antiparkinsonians (adamantane derivatives)

>  <USAN_STEM_SUBSTEM>  (843) 
-mantine

>  <USAN_YEAR>  (843) 
2003.0

>  <FIRST_APPROVAL>  (843) 
2003.0

>  <ATC_CODE>  (843) 
N06DX01

>  <ATC_CODE_DESCRIPTION>  (843) 
N06DX01 [Nervous System:Psychoanaleptics:Anti-Dementia Drugs:Other anti-dementia drugs]

>  <INDICATION_CLASS>  (843) 
nan

>  <SC_PATENT_NO>  (843) 
US-8039009-B2

>  <DRUG_TYPE>  (843) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (843) 
Y

>  <FIRST_IN_CLASS>  (843) 
N

>  <CHIRALITY>  (843) 
Racemic Mixture

>  <PRODRUG>  (843) 
N

>  <ORAL>  (843) 
Y

>  <PARENTERAL>  (843) 
N

>  <TOPICAL>  (843) 
N

>  <BLACK_BOX>  (843) 
N

>  <AVAILABILITY_TYPE>  (843) 
Prescription-only

>  <WITHDRAWN_YEAR>  (843) 
nan

>  <WITHDRAWN_COUNTRY>  (843) 
nan

>  <WITHDRAWN_REASON>  (843) 
nan

>  <CANONICAL_SMILES>  (843) 
CC12CC3CC(C)(C1)CC(N)(C3)C2

>  <name>  (843) 
Memantine 

>  <MW>  (843) 
179.307

>  <logP>  (843) 
2.6941

$$$$
CHEMBL826
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 17  3  1  0
 17 11  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (844) 
57175

>  <SYNONYMS>  (844) 
Enoxacin (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (844) 
4

>  <RESEARCH_CODES>  (844) 
AT-2266; CI-919; PD-107779

>  <APPLICANTS>  (844) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (844) 
-oxacin

>  <USAN_STEM_DEFINITION>  (844) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (844) 
-oxacin

>  <USAN_YEAR>  (844) 
1984.0

>  <FIRST_APPROVAL>  (844) 
1991.0

>  <ATC_CODE>  (844) 
J01MA04

>  <ATC_CODE_DESCRIPTION>  (844) 
J01MA04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]

>  <INDICATION_CLASS>  (844) 
Antibacterial

>  <SC_PATENT_NO>  (844) 
nan

>  <DRUG_TYPE>  (844) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (844) 
Y

>  <FIRST_IN_CLASS>  (844) 
N

>  <CHIRALITY>  (844) 
Achiral Molecule

>  <PRODRUG>  (844) 
N

>  <ORAL>  (844) 
Y

>  <PARENTERAL>  (844) 
N

>  <TOPICAL>  (844) 
N

>  <BLACK_BOX>  (844) 
N

>  <AVAILABILITY_TYPE>  (844) 
Discontinued

>  <WITHDRAWN_YEAR>  (844) 
nan

>  <WITHDRAWN_COUNTRY>  (844) 
nan

>  <WITHDRAWN_REASON>  (844) 
nan

>  <CANONICAL_SMILES>  (844) 
CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3

>  <name>  (844) 
Enoxacin 

>  <MW>  (844) 
320.324

>  <logP>  (844) 
0.6633

$$$$
CHEMBL1201116
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 10 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  6 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 24  2  1  0
 23  5  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (845) 
675067

>  <SYNONYMS>  (845) 
Hetacillin (BAN, FDA, INN, USAN, USP); Hetacillin Potassium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (845) 
4

>  <RESEARCH_CODES>  (845) 
BL-P-804; BRL-804

>  <APPLICANTS>  (845) 
Bristol Laboratories Inc Div Bristol Myers Co

>  <USAN_STEM>  (845) 
-cillin

>  <USAN_STEM_DEFINITION>  (845) 
penicillins

>  <USAN_STEM_SUBSTEM>  (845) 
-cillin

>  <USAN_YEAR>  (845) 
1965.0

>  <FIRST_APPROVAL>  (845) 
1982.0

>  <ATC_CODE>  (845) 
J01CA18

>  <ATC_CODE_DESCRIPTION>  (845) 
J01CA18 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (845) 
Antibacterial

>  <SC_PATENT_NO>  (845) 
nan

>  <DRUG_TYPE>  (845) 
Natural Product-derived

>  <RULE_OF_FIVE>  (845) 
Y

>  <FIRST_IN_CLASS>  (845) 
N

>  <CHIRALITY>  (845) 
Single Stereoisomer

>  <PRODRUG>  (845) 
Y

>  <ORAL>  (845) 
Y

>  <PARENTERAL>  (845) 
N

>  <TOPICAL>  (845) 
N

>  <BLACK_BOX>  (845) 
N

>  <AVAILABILITY_TYPE>  (845) 
Discontinued

>  <WITHDRAWN_YEAR>  (845) 
nan

>  <WITHDRAWN_COUNTRY>  (845) 
nan

>  <WITHDRAWN_REASON>  (845) 
nan

>  <CANONICAL_SMILES>  (845) 
CC1(C)S[C@@H]2[C@H](N3C(=O)[C@H](NC3(C)C)c4ccccc4)C(=O)N2[C@H]1C(=O)O

>  <name>  (845) 
Hetacillin 

>  <MW>  (845) 
389.477

>  <logP>  (845) 
1.4111

$$$$
CHEMBL1201329
     RDKit          

 26 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 19  2  1  0
 10  5  1  0
 18 11  1  0
 17 13  1  0
 26 21  1  0
M  CHG  1  13   1
M  END
>  <PARENT_MOLREGNO>  (846) 
675280

>  <SYNONYMS>  (846) 
Trimetaphan Camsilate (BAN, DCF, INN, JAN); Trimethaphan camsylate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (846) 
4

>  <RESEARCH_CODES>  (846) 
nan

>  <APPLICANTS>  (846) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (846) 
nan

>  <USAN_STEM_DEFINITION>  (846) 
nan

>  <USAN_STEM_SUBSTEM>  (846) 
nan

>  <USAN_YEAR>  (846) 
nan

>  <FIRST_APPROVAL>  (846) 
1982.0

>  <ATC_CODE>  (846) 
C02BA01

>  <ATC_CODE_DESCRIPTION>  (846) 
C02BA01 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Ganglion-Blocking:Sulfonium derivatives]

>  <INDICATION_CLASS>  (846) 
Antihypertensive

>  <SC_PATENT_NO>  (846) 
nan

>  <DRUG_TYPE>  (846) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (846) 
Y

>  <FIRST_IN_CLASS>  (846) 
N

>  <CHIRALITY>  (846) 
Racemic Mixture

>  <PRODRUG>  (846) 
N

>  <ORAL>  (846) 
N

>  <PARENTERAL>  (846) 
Y

>  <TOPICAL>  (846) 
N

>  <BLACK_BOX>  (846) 
N

>  <AVAILABILITY_TYPE>  (846) 
Discontinued

>  <WITHDRAWN_YEAR>  (846) 
nan

>  <WITHDRAWN_COUNTRY>  (846) 
nan

>  <WITHDRAWN_REASON>  (846) 
nan

>  <CANONICAL_SMILES>  (846) 
O=C1N(Cc2ccccc2)C3C[S+]4CCCC4C3N1Cc5ccccc5

>  <name>  (846) 
Trimetaphan Camsilate 

>  <MW>  (846) 
365.522

>  <logP>  (846) 
3.6559

$$$$
CHEMBL605846
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
  6 27  1  0
 27 28  2  0
 28  3  1  0
 26 15  1  0
 26 20  2  0
M  END
>  <PARENT_MOLREGNO>  (847) 
603199

>  <SYNONYMS>  (847) 
Olodaterol (INN, USAN); Olodaterol HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (847) 
4

>  <RESEARCH_CODES>  (847) 
BI-1744; BI-1744-CL

>  <APPLICANTS>  (847) 
Boehringer Ingelheim Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals

>  <USAN_STEM>  (847) 
-terol

>  <USAN_STEM_DEFINITION>  (847) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (847) 
-terol

>  <USAN_YEAR>  (847) 
2011.0

>  <FIRST_APPROVAL>  (847) 
2014.0

>  <ATC_CODE>  (847) 
R03AC19

>  <ATC_CODE_DESCRIPTION>  (847) 
R03AC19 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (847) 
nan

>  <SC_PATENT_NO>  (847) 
US-5964416-A

>  <DRUG_TYPE>  (847) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (847) 
Y

>  <FIRST_IN_CLASS>  (847) 
N

>  <CHIRALITY>  (847) 
Single Stereoisomer

>  <PRODRUG>  (847) 
N

>  <ORAL>  (847) 
N

>  <PARENTERAL>  (847) 
N

>  <TOPICAL>  (847) 
Y

>  <BLACK_BOX>  (847) 
Y

>  <AVAILABILITY_TYPE>  (847) 
Prescription-only

>  <WITHDRAWN_YEAR>  (847) 
nan

>  <WITHDRAWN_COUNTRY>  (847) 
nan

>  <WITHDRAWN_REASON>  (847) 
nan

>  <CANONICAL_SMILES>  (847) 
COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3NC(=O)COc23)cc1

>  <name>  (847) 
Olodaterol 

>  <MW>  (847) 
386.448

>  <logP>  (847) 
2.376

$$$$
CHEMBL1449
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 10 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
  6 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 22  2  1  0
 21  5  1  0
 18 14  2  0
M  END
>  <PARENT_MOLREGNO>  (848) 
378225

>  <SYNONYMS>  (848) 
Ticarcillin (BAN, INN); Ticarcillin Disodium (FDA, USAN, USP); Ticarcillin Sodium (JAN); Ticarcillin Monosodium (USP)

>  <DEVELOPMENT_PHASE>  (848) 
4

>  <RESEARCH_CODES>  (848) 
BRL-2288

>  <APPLICANTS>  (848) 
GlaxoSmithKline

>  <USAN_STEM>  (848) 
-cillin

>  <USAN_STEM_DEFINITION>  (848) 
penicillins

>  <USAN_STEM_SUBSTEM>  (848) 
-cillin

>  <USAN_YEAR>  (848) 
1973.0

>  <FIRST_APPROVAL>  (848) 
1976.0

>  <ATC_CODE>  (848) 
J01CA13

>  <ATC_CODE_DESCRIPTION>  (848) 
J01CA13 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (848) 
Antibacterial

>  <SC_PATENT_NO>  (848) 
nan

>  <DRUG_TYPE>  (848) 
Natural Product-derived

>  <RULE_OF_FIVE>  (848) 
Y

>  <FIRST_IN_CLASS>  (848) 
N

>  <CHIRALITY>  (848) 
Single Stereoisomer

>  <PRODRUG>  (848) 
N

>  <ORAL>  (848) 
N

>  <PARENTERAL>  (848) 
Y

>  <TOPICAL>  (848) 
N

>  <BLACK_BOX>  (848) 
N

>  <AVAILABILITY_TYPE>  (848) 
Prescription-only

>  <WITHDRAWN_YEAR>  (848) 
nan

>  <WITHDRAWN_COUNTRY>  (848) 
nan

>  <WITHDRAWN_REASON>  (848) 
nan

>  <CANONICAL_SMILES>  (848) 
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O

>  <name>  (848) 
Ticarcillin 

>  <MW>  (848) 
384.435

>  <logP>  (848) 
0.548

$$$$
CHEMBL46
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
  6  2  1  0
 13  8  1  0
 21 11  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (849) 
3183

>  <SYNONYMS>  (849) 
Ondansetron (BAN, FDA, INN, USP); Ondansetron HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (849) 
4

>  <RESEARCH_CODES>  (849) 
GR-38032; GR-38032F

>  <APPLICANTS>  (849) 
Vestiq Pharmaceuticals Inc; GlaxoSmithKline; Baxter Healthcare Corp

>  <USAN_STEM>  (849) 
-setron

>  <USAN_STEM_DEFINITION>  (849) 
serotonin 5-HT3 antagonists

>  <USAN_STEM_SUBSTEM>  (849) 
-setron

>  <USAN_YEAR>  (849) 
1989.0

>  <FIRST_APPROVAL>  (849) 
1991.0

>  <ATC_CODE>  (849) 
A04AA01

>  <ATC_CODE_DESCRIPTION>  (849) 
A04AA01 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Serotonin (5HT3) antagonists]

>  <INDICATION_CLASS>  (849) 
Anti-Anxiety Agent; Anti-Emetic; Antischizophrenic

>  <SC_PATENT_NO>  (849) 
US-5854270-A

>  <DRUG_TYPE>  (849) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (849) 
Y

>  <FIRST_IN_CLASS>  (849) 
N

>  <CHIRALITY>  (849) 
Racemic Mixture

>  <PRODRUG>  (849) 
N

>  <ORAL>  (849) 
Y

>  <PARENTERAL>  (849) 
Y

>  <TOPICAL>  (849) 
N

>  <BLACK_BOX>  (849) 
N

>  <AVAILABILITY_TYPE>  (849) 
Prescription-only

>  <WITHDRAWN_YEAR>  (849) 
nan

>  <WITHDRAWN_COUNTRY>  (849) 
nan

>  <WITHDRAWN_REASON>  (849) 
nan

>  <CANONICAL_SMILES>  (849) 
Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C

>  <name>  (849) 
Ondansetron 

>  <MW>  (849) 
293.37

>  <logP>  (849) 
3.12852

$$$$
CHEMBL708
     RDKit          

 28 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 11  2  1  0
  9  4  2  0
 19 14  1  0
 28 20  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (850) 
33664

>  <SYNONYMS>  (850) 
Ziprasidone (BAN, INN); Ziprasidone HCl (FDA, USAN); Ziprasidone Mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (850) 
4

>  <RESEARCH_CODES>  (850) 
CP-88059; CP-880591; CP-88059-1; CP-8805927; CP-88059-27

>  <APPLICANTS>  (850) 
Pfizer Inc.

>  <USAN_STEM>  (850) 
-sidone

>  <USAN_STEM_DEFINITION>  (850) 
antipsychotic with binding activity on serotonin (5HT2A) and dopamine (D2) receptors

>  <USAN_STEM_SUBSTEM>  (850) 
-sidone

>  <USAN_YEAR>  (850) 
1994.0

>  <FIRST_APPROVAL>  (850) 
2001.0

>  <ATC_CODE>  (850) 
N05AE04

>  <ATC_CODE_DESCRIPTION>  (850) 
N05AE04 [Nervous System:Psycholeptics:Antipsychotics:Indole derivatives]

>  <INDICATION_CLASS>  (850) 
Antipsychotic

>  <SC_PATENT_NO>  (850) 
US-6110918-A

>  <DRUG_TYPE>  (850) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (850) 
Y

>  <FIRST_IN_CLASS>  (850) 
N

>  <CHIRALITY>  (850) 
Achiral Molecule

>  <PRODRUG>  (850) 
N

>  <ORAL>  (850) 
Y

>  <PARENTERAL>  (850) 
Y

>  <TOPICAL>  (850) 
N

>  <BLACK_BOX>  (850) 
Y

>  <AVAILABILITY_TYPE>  (850) 
Prescription-only

>  <WITHDRAWN_YEAR>  (850) 
nan

>  <WITHDRAWN_COUNTRY>  (850) 
nan

>  <WITHDRAWN_REASON>  (850) 
nan

>  <CANONICAL_SMILES>  (850) 
Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45

>  <name>  (850) 
Ziprasidone 

>  <MW>  (850) 
412.946

>  <logP>  (850) 
3.809

$$$$
CHEMBL192
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 17 24  1  0
 24 25  2  0
 24 26  2  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 14  4  1  0
 14  8  2  0
 20 15  1  0
 33 27  1  0
M  END
>  <PARENT_MOLREGNO>  (851) 
410802

>  <SYNONYMS>  (851) 
Sildenafil (BAN, INN); Sildenafil Citrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (851) 
4

>  <RESEARCH_CODES>  (851) 
UK-92480; UK-9248010; UK-92480-10

>  <APPLICANTS>  (851) 
Pfizer Ireland Pharmaceuticals; Pfizer Inc.

>  <USAN_STEM>  (851) 
-afil

>  <USAN_STEM_DEFINITION>  (851) 
PDE5 inhibitors

>  <USAN_STEM_SUBSTEM>  (851) 
-afil

>  <USAN_YEAR>  (851) 
1997.0

>  <FIRST_APPROVAL>  (851) 
1998.0

>  <ATC_CODE>  (851) 
G04BE03

>  <ATC_CODE_DESCRIPTION>  (851) 
G04BE03 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]

>  <INDICATION_CLASS>  (851) 
Impotence Therapy

>  <SC_PATENT_NO>  (851) 
US-6469012-B1

>  <DRUG_TYPE>  (851) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (851) 
Y

>  <FIRST_IN_CLASS>  (851) 
N

>  <CHIRALITY>  (851) 
Achiral Molecule

>  <PRODRUG>  (851) 
N

>  <ORAL>  (851) 
Y

>  <PARENTERAL>  (851) 
Y

>  <TOPICAL>  (851) 
N

>  <BLACK_BOX>  (851) 
Y

>  <AVAILABILITY_TYPE>  (851) 
Prescription-only

>  <WITHDRAWN_YEAR>  (851) 
nan

>  <WITHDRAWN_COUNTRY>  (851) 
nan

>  <WITHDRAWN_REASON>  (851) 
nan

>  <CANONICAL_SMILES>  (851) 
CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4

>  <name>  (851) 
Sildenafil 

>  <MW>  (851) 
474.587

>  <logP>  (851) 
1.6109

$$$$
CHEMBL1201198
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12  2  1  0
 12  6  1  0
 17 13  1  0
M  END
>  <PARENT_MOLREGNO>  (852) 
675149

>  <SYNONYMS>  (852) 
Pemirolast (INN); Pemirolast Potassium (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (852) 
4

>  <RESEARCH_CODES>  (852) 
BMY-26517

>  <APPLICANTS>  (852) 
Santen Inc

>  <USAN_STEM>  (852) 
-ast

>  <USAN_STEM_DEFINITION>  (852) 
antiasthmatics/antiallergics (not acting primarily as antihistamines,leukotriene biosynthesis inhibitors)

>  <USAN_STEM_SUBSTEM>  (852) 
-ast

>  <USAN_YEAR>  (852) 
1989.0

>  <FIRST_APPROVAL>  (852) 
1999.0

>  <ATC_CODE>  (852) 
nan

>  <ATC_CODE_DESCRIPTION>  (852) 
nan

>  <INDICATION_CLASS>  (852) 
Anti-Allergic; Inhibitor (mediator release)

>  <SC_PATENT_NO>  (852) 
nan

>  <DRUG_TYPE>  (852) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (852) 
Y

>  <FIRST_IN_CLASS>  (852) 
N

>  <CHIRALITY>  (852) 
Achiral Molecule

>  <PRODRUG>  (852) 
N

>  <ORAL>  (852) 
N

>  <PARENTERAL>  (852) 
N

>  <TOPICAL>  (852) 
Y

>  <BLACK_BOX>  (852) 
N

>  <AVAILABILITY_TYPE>  (852) 
Prescription-only

>  <WITHDRAWN_YEAR>  (852) 
nan

>  <WITHDRAWN_COUNTRY>  (852) 
nan

>  <WITHDRAWN_REASON>  (852) 
nan

>  <CANONICAL_SMILES>  (852) 
CC1=CC=CN2C(=O)C(=CN=C12)c3nnn[nH]3

>  <name>  (852) 
Pemirolast 

>  <MW>  (852) 
228.215

>  <logP>  (852) 
0.18302

$$$$
CHEMBL1342
     RDKit          

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
M  END
>  <PARENT_MOLREGNO>  (853) 
286065

>  <SYNONYMS>  (853) 
Sodium Oxybate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (853) 
4

>  <RESEARCH_CODES>  (853) 
WY-3478

>  <APPLICANTS>  (853) 
Jazz Pharmaceuticals Inc

>  <USAN_STEM>  (853) 
nan

>  <USAN_STEM_DEFINITION>  (853) 
nan

>  <USAN_STEM_SUBSTEM>  (853) 
nan

>  <USAN_YEAR>  (853) 
1966.0

>  <FIRST_APPROVAL>  (853) 
2002.0

>  <ATC_CODE>  (853) 
N07XX04; N01AX11

>  <ATC_CODE_DESCRIPTION>  (853) 
N07XX04 [Nervous System:Other Nervous System Drugs:Other Nervous System Drugs:Other nervous system drugs]; N01AX11 [Nervous System:Anesthetics:Anesthetics, General:Other general anesthetics]

>  <INDICATION_CLASS>  (853) 
Anesthesia, Adjunct To

>  <SC_PATENT_NO>  (853) 
US-6780889-B2

>  <DRUG_TYPE>  (853) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (853) 
Y

>  <FIRST_IN_CLASS>  (853) 
N

>  <CHIRALITY>  (853) 
Achiral Molecule

>  <PRODRUG>  (853) 
N

>  <ORAL>  (853) 
Y

>  <PARENTERAL>  (853) 
N

>  <TOPICAL>  (853) 
N

>  <BLACK_BOX>  (853) 
Y

>  <AVAILABILITY_TYPE>  (853) 
Prescription-only

>  <WITHDRAWN_YEAR>  (853) 
nan

>  <WITHDRAWN_COUNTRY>  (853) 
nan

>  <WITHDRAWN_REASON>  (853) 
nan

>  <CANONICAL_SMILES>  (853) 
OCCCC(=O)O

>  <name>  (853) 
Sodium Oxybate 

>  <MW>  (853) 
104.105

>  <logP>  (853) 
-0.1565

$$$$
CHEMBL16694
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  3 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 14  4  1  0
 13  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (854) 
17471

>  <SYNONYMS>  (854) 
Phenprocoumon (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (854) 
4

>  <RESEARCH_CODES>  (854) 
nan

>  <APPLICANTS>  (854) 
Organon Usa Inc

>  <USAN_STEM>  (854) 
nan

>  <USAN_STEM_DEFINITION>  (854) 
nan

>  <USAN_STEM_SUBSTEM>  (854) 
nan

>  <USAN_YEAR>  (854) 
1961.0

>  <FIRST_APPROVAL>  (854) 
1957.0

>  <ATC_CODE>  (854) 
B01AA04

>  <ATC_CODE_DESCRIPTION>  (854) 
B01AA04 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Vitamin K antagonists]

>  <INDICATION_CLASS>  (854) 
Anticoagulant

>  <SC_PATENT_NO>  (854) 
nan

>  <DRUG_TYPE>  (854) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (854) 
Y

>  <FIRST_IN_CLASS>  (854) 
N

>  <CHIRALITY>  (854) 
Racemic Mixture

>  <PRODRUG>  (854) 
N

>  <ORAL>  (854) 
Y

>  <PARENTERAL>  (854) 
N

>  <TOPICAL>  (854) 
N

>  <BLACK_BOX>  (854) 
N

>  <AVAILABILITY_TYPE>  (854) 
Discontinued

>  <WITHDRAWN_YEAR>  (854) 
nan

>  <WITHDRAWN_COUNTRY>  (854) 
nan

>  <WITHDRAWN_REASON>  (854) 
nan

>  <CANONICAL_SMILES>  (854) 
CCC(C1=C(O)Oc2ccccc2C1=O)c3ccccc3

>  <name>  (854) 
Phenprocoumon 

>  <MW>  (854) 
280.323

>  <logP>  (854) 
4.0405

$$$$
CHEMBL1431
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
M  END
>  <PARENT_MOLREGNO>  (855) 
369464

>  <SYNONYMS>  (855) 
Metformin (BAN, INN, USAN); Metformin HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (855) 
4

>  <RESEARCH_CODES>  (855) 
LA-6023

>  <APPLICANTS>  (855) 
Bristol Myers Squibb Co; Bristol Myers Squibb; Boehringer Ingelheim Pharmaceuticals Inc; Andrx Labs Llc; Bristol Myers Squibb Co Pharmaceutical Research Institute

>  <USAN_STEM>  (855) 
-formin

>  <USAN_STEM_DEFINITION>  (855) 
hypoglycemics (phenformin type)

>  <USAN_STEM_SUBSTEM>  (855) 
-formin

>  <USAN_YEAR>  (855) 
1969.0

>  <FIRST_APPROVAL>  (855) 
1995.0

>  <ATC_CODE>  (855) 
A10BA02

>  <ATC_CODE_DESCRIPTION>  (855) 
A10BA02 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Biguanides]

>  <INDICATION_CLASS>  (855) 
Antidiabetic

>  <SC_PATENT_NO>  (855) 
US-5965584-A

>  <DRUG_TYPE>  (855) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (855) 
Y

>  <FIRST_IN_CLASS>  (855) 
N

>  <CHIRALITY>  (855) 
Achiral Molecule

>  <PRODRUG>  (855) 
N

>  <ORAL>  (855) 
Y

>  <PARENTERAL>  (855) 
N

>  <TOPICAL>  (855) 
N

>  <BLACK_BOX>  (855) 
Y

>  <AVAILABILITY_TYPE>  (855) 
Prescription-only

>  <WITHDRAWN_YEAR>  (855) 
nan

>  <WITHDRAWN_COUNTRY>  (855) 
nan

>  <WITHDRAWN_REASON>  (855) 
nan

>  <CANONICAL_SMILES>  (855) 
CN(C)C(=N)NC(=N)N

>  <name>  (855) 
Metformin 

>  <MW>  (855) 
129.167

>  <logP>  (855) 
-1.03416

$$$$
CHEMBL815
     RDKit          

 25 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (856) 
55033

>  <SYNONYMS>  (856) 
Dinoprost (BAN, INN, JAN, USAN); Dinoprost Trometamol (BAN); Dinoprost Tromethamine (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (856) 
4

>  <RESEARCH_CODES>  (856) 
U-14583; PGF2ALPHA-THAM; U-14583E

>  <APPLICANTS>  (856) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (856) 
-prost

>  <USAN_STEM_DEFINITION>  (856) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (856) 
-prost

>  <USAN_YEAR>  (856) 
1971.0

>  <FIRST_APPROVAL>  (856) 
1982.0

>  <ATC_CODE>  (856) 
G02AD01

>  <ATC_CODE_DESCRIPTION>  (856) 
G02AD01 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Uterotonics:Prostaglandins]

>  <INDICATION_CLASS>  (856) 
Oxytocic; Prostaglandin

>  <SC_PATENT_NO>  (856) 
nan

>  <DRUG_TYPE>  (856) 
Natural Product-derived

>  <RULE_OF_FIVE>  (856) 
Y

>  <FIRST_IN_CLASS>  (856) 
N

>  <CHIRALITY>  (856) 
Single Stereoisomer

>  <PRODRUG>  (856) 
N

>  <ORAL>  (856) 
N

>  <PARENTERAL>  (856) 
Y

>  <TOPICAL>  (856) 
N

>  <BLACK_BOX>  (856) 
N

>  <AVAILABILITY_TYPE>  (856) 
Discontinued

>  <WITHDRAWN_YEAR>  (856) 
nan

>  <WITHDRAWN_COUNTRY>  (856) 
nan

>  <WITHDRAWN_REASON>  (856) 
nan

>  <CANONICAL_SMILES>  (856) 
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)O

>  <name>  (856) 
Dinoprost 

>  <MW>  (856) 
354.487

>  <logP>  (856) 
3.0429

$$$$
CHEMBL1200627
     RDKit          

  5  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  2  1  0
M  END
>  <PARENT_MOLREGNO>  (857) 
674578

>  <SYNONYMS>  (857) 
Propiolactone (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (857) 
4

>  <RESEARCH_CODES>  (857) 
nan

>  <APPLICANTS>  (857) 
Forest Laboratories Inc

>  <USAN_STEM>  (857) 
nan

>  <USAN_STEM_DEFINITION>  (857) 
nan

>  <USAN_STEM_SUBSTEM>  (857) 
nan

>  <USAN_YEAR>  (857) 
1964.0

>  <FIRST_APPROVAL>  (857) 
nan

>  <ATC_CODE>  (857) 
nan

>  <ATC_CODE_DESCRIPTION>  (857) 
nan

>  <INDICATION_CLASS>  (857) 
Disinfectant

>  <SC_PATENT_NO>  (857) 
nan

>  <DRUG_TYPE>  (857) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (857) 
Y

>  <FIRST_IN_CLASS>  (857) 
N

>  <CHIRALITY>  (857) 
Achiral Molecule

>  <PRODRUG>  (857) 
N

>  <ORAL>  (857) 
N

>  <PARENTERAL>  (857) 
N

>  <TOPICAL>  (857) 
N

>  <BLACK_BOX>  (857) 
N

>  <AVAILABILITY_TYPE>  (857) 
Discontinued

>  <WITHDRAWN_YEAR>  (857) 
nan

>  <WITHDRAWN_COUNTRY>  (857) 
nan

>  <WITHDRAWN_REASON>  (857) 
nan

>  <CANONICAL_SMILES>  (857) 
O=C1CCO1

>  <name>  (857) 
Propiolactone 

>  <MW>  (857) 
72.063

>  <logP>  (857) 
-0.0667

$$$$
CHEMBL810
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  6 12  1  0
 12 13  2  0
 12 14  1  0
 10  2  1  0
  9  5  1  0
M  END
>  <PARENT_MOLREGNO>  (858) 
53686

>  <SYNONYMS>  (858) 
Temozolomide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (858) 
4

>  <RESEARCH_CODES>  (858) 
CCRG-81045; M&B-39831; M-39831; SCH-52365

>  <APPLICANTS>  (858) 
Merck Sharp And Dohme Corp

>  <USAN_STEM>  (858) 
nan

>  <USAN_STEM_DEFINITION>  (858) 
nan

>  <USAN_STEM_SUBSTEM>  (858) 
nan

>  <USAN_YEAR>  (858) 
1999.0

>  <FIRST_APPROVAL>  (858) 
1999.0

>  <ATC_CODE>  (858) 
L01AX03

>  <ATC_CODE_DESCRIPTION>  (858) 
L01AX03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Other alkylating agents]

>  <INDICATION_CLASS>  (858) 
nan

>  <SC_PATENT_NO>  (858) 
US-6987108-B2

>  <DRUG_TYPE>  (858) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (858) 
Y

>  <FIRST_IN_CLASS>  (858) 
N

>  <CHIRALITY>  (858) 
Achiral Molecule

>  <PRODRUG>  (858) 
Y

>  <ORAL>  (858) 
Y

>  <PARENTERAL>  (858) 
Y

>  <TOPICAL>  (858) 
N

>  <BLACK_BOX>  (858) 
Y

>  <AVAILABILITY_TYPE>  (858) 
Prescription-only

>  <WITHDRAWN_YEAR>  (858) 
nan

>  <WITHDRAWN_COUNTRY>  (858) 
nan

>  <WITHDRAWN_REASON>  (858) 
nan

>  <CANONICAL_SMILES>  (858) 
CN1N=Nc2c(ncn2C1=O)C(=O)N

>  <name>  (858) 
Temozolomide 

>  <MW>  (858) 
194.154

>  <logP>  (858) 
-2.0781

$$$$
CHEMBL134342
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
M  END
>  <PARENT_MOLREGNO>  (859) 
224463

>  <SYNONYMS>  (859) 
Lipoic Acid

>  <DEVELOPMENT_PHASE>  (859) 
4

>  <RESEARCH_CODES>  (859) 
nan

>  <APPLICANTS>  (859) 
nan

>  <USAN_STEM>  (859) 
nan

>  <USAN_STEM_DEFINITION>  (859) 
nan

>  <USAN_STEM_SUBSTEM>  (859) 
nan

>  <USAN_YEAR>  (859) 
nan

>  <FIRST_APPROVAL>  (859) 
nan

>  <ATC_CODE>  (859) 
A16AX01

>  <ATC_CODE_DESCRIPTION>  (859) 
A16AX01 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Various alimentary tract and metabolism products]

>  <INDICATION_CLASS>  (859) 
nan

>  <SC_PATENT_NO>  (859) 
nan

>  <DRUG_TYPE>  (859) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (859) 
Y

>  <FIRST_IN_CLASS>  (859) 
N

>  <CHIRALITY>  (859) 
Single Stereoisomer

>  <PRODRUG>  (859) 
N

>  <ORAL>  (859) 
N

>  <PARENTERAL>  (859) 
N

>  <TOPICAL>  (859) 
N

>  <BLACK_BOX>  (859) 
N

>  <AVAILABILITY_TYPE>  (859) 
Unknown

>  <WITHDRAWN_YEAR>  (859) 
nan

>  <WITHDRAWN_COUNTRY>  (859) 
nan

>  <WITHDRAWN_REASON>  (859) 
nan

>  <CANONICAL_SMILES>  (859) 
OC(=O)CCCC[C@@H]1CCSS1

>  <name>  (859) 
Lipoic Acid

>  <MW>  (859) 
206.332

>  <logP>  (859) 
2.7851

$$$$
CHEMBL549
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 12 16  1  0
 16 17  3  0
  7 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 15  7  1  0
 15 10  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (860) 
14367

>  <SYNONYMS>  (860) 
Citalopram (BAN, INN, MI); Citalopram Hydrobromide (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (860) 
4

>  <RESEARCH_CODES>  (860) 
LU-10171B

>  <APPLICANTS>  (860) 
Forest Laboratories Inc; Biovail Laboratories International Srl

>  <USAN_STEM>  (860) 
nan

>  <USAN_STEM_DEFINITION>  (860) 
nan

>  <USAN_STEM_SUBSTEM>  (860) 
nan

>  <USAN_YEAR>  (860) 
1998.0

>  <FIRST_APPROVAL>  (860) 
1998.0

>  <ATC_CODE>  (860) 
N06AB04

>  <ATC_CODE_DESCRIPTION>  (860) 
N06AB04 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (860) 
nan

>  <SC_PATENT_NO>  (860) 
nan

>  <DRUG_TYPE>  (860) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (860) 
Y

>  <FIRST_IN_CLASS>  (860) 
N

>  <CHIRALITY>  (860) 
Racemic Mixture

>  <PRODRUG>  (860) 
N

>  <ORAL>  (860) 
Y

>  <PARENTERAL>  (860) 
N

>  <TOPICAL>  (860) 
N

>  <BLACK_BOX>  (860) 
Y

>  <AVAILABILITY_TYPE>  (860) 
Prescription-only

>  <WITHDRAWN_YEAR>  (860) 
nan

>  <WITHDRAWN_COUNTRY>  (860) 
nan

>  <WITHDRAWN_REASON>  (860) 
nan

>  <CANONICAL_SMILES>  (860) 
CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3

>  <name>  (860) 
Citalopram 

>  <MW>  (860) 
324.399

>  <logP>  (860) 
3.81298

$$$$
CHEMBL695
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  2  0
  9  2  1  0
M  END
>  <PARENT_MOLREGNO>  (861) 
31804

>  <SYNONYMS>  (861) 
Trimethadione (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (861) 
4

>  <RESEARCH_CODES>  (861) 
nan

>  <APPLICANTS>  (861) 
Abbvie Inc

>  <USAN_STEM>  (861) 
nan

>  <USAN_STEM_DEFINITION>  (861) 
nan

>  <USAN_STEM_SUBSTEM>  (861) 
nan

>  <USAN_YEAR>  (861) 
nan

>  <FIRST_APPROVAL>  (861) 
1946.0

>  <ATC_CODE>  (861) 
N03AC02

>  <ATC_CODE_DESCRIPTION>  (861) 
N03AC02 [Nervous System:Antiepileptics:Antiepileptics:Oxazolidine derivatives]

>  <INDICATION_CLASS>  (861) 
Anticonvulsant

>  <SC_PATENT_NO>  (861) 
nan

>  <DRUG_TYPE>  (861) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (861) 
Y

>  <FIRST_IN_CLASS>  (861) 
N

>  <CHIRALITY>  (861) 
Achiral Molecule

>  <PRODRUG>  (861) 
Y

>  <ORAL>  (861) 
Y

>  <PARENTERAL>  (861) 
N

>  <TOPICAL>  (861) 
N

>  <BLACK_BOX>  (861) 
N

>  <AVAILABILITY_TYPE>  (861) 
Prescription-only

>  <WITHDRAWN_YEAR>  (861) 
nan

>  <WITHDRAWN_COUNTRY>  (861) 
nan

>  <WITHDRAWN_REASON>  (861) 
nan

>  <CANONICAL_SMILES>  (861) 
CN1C(=O)OC(C)(C)C1=O

>  <name>  (861) 
Trimethadione 

>  <MW>  (861) 
143.142

>  <logP>  (861) 
0.3736

$$$$
CHEMBL1547
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  2  0
 14 15  1  0
  5 16  1  0
 16 17  1  0
 16 18  2  0
 18  2  1  0
 14  7  1  0
M  CHG  1   7   1
M  END
>  <PARENT_MOLREGNO>  (862) 
437211

>  <SYNONYMS>  (862) 
Thiamine (BAN, FDA, INN); Thiamine HCl (FDA, JAN, USP); Thiamine Mononitrate (USP); Thiamine Nitrate (JAN)

>  <DEVELOPMENT_PHASE>  (862) 
4

>  <RESEARCH_CODES>  (862) 
nan

>  <APPLICANTS>  (862) 
Hoffmann La Roche Inc; Basf; Astrazeneca Lp; Abraxis Pharmaceutical Products; Johnson & Johnson-Merck Consumer

>  <USAN_STEM>  (862) 
nan

>  <USAN_STEM_DEFINITION>  (862) 
nan

>  <USAN_STEM_SUBSTEM>  (862) 
nan

>  <USAN_YEAR>  (862) 
nan

>  <FIRST_APPROVAL>  (862) 
1985.0

>  <ATC_CODE>  (862) 
A11DA01

>  <ATC_CODE_DESCRIPTION>  (862) 
A11DA01 [Alimentary Tract And Metabolism:Vitamins:Vitamin B1, Plain And In Combination With Vitamin B6 And B12:Vitamin B1, plain]

>  <INDICATION_CLASS>  (862) 
Vitamin (enzyme co-factor)

>  <SC_PATENT_NO>  (862) 
nan

>  <DRUG_TYPE>  (862) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (862) 
Y

>  <FIRST_IN_CLASS>  (862) 
N

>  <CHIRALITY>  (862) 
Achiral Molecule

>  <PRODRUG>  (862) 
N

>  <ORAL>  (862) 
N

>  <PARENTERAL>  (862) 
Y

>  <TOPICAL>  (862) 
N

>  <BLACK_BOX>  (862) 
N

>  <AVAILABILITY_TYPE>  (862) 
Prescription-only

>  <WITHDRAWN_YEAR>  (862) 
nan

>  <WITHDRAWN_COUNTRY>  (862) 
nan

>  <WITHDRAWN_REASON>  (862) 
nan

>  <CANONICAL_SMILES>  (862) 
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1

>  <name>  (862) 
Thiamine 

>  <MW>  (862) 
265.362

>  <logP>  (862) 
0.60774

$$$$
CHEMBL550
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
  4 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14  3  1  0
 10  6  1  0
M  END
>  <PARENT_MOLREGNO>  (863) 
14406

>  <SYNONYMS>  (863) 
Pilocarpine (BAN, FDA, JAN, USP); Pilocarpine Nitrate (USP); Pilocarpine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (863) 
4

>  <RESEARCH_CODES>  (863) 
nan

>  <APPLICANTS>  (863) 
Allergan; Alcon Research Ltd; Alcon Laboratories Inc; Akorn Inc; Eisai Inc

>  <USAN_STEM>  (863) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (863) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (863) 
-pin(e)

>  <USAN_YEAR>  (863) 
nan

>  <FIRST_APPROVAL>  (863) 
1974.0

>  <ATC_CODE>  (863) 
S01EB01; N07AX01; S01EB51

>  <ATC_CODE_DESCRIPTION>  (863) 
S01EB01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]; N07AX01 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Other parasympathomimetics]; S01EB51 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]

>  <INDICATION_CLASS>  (863) 
Antiglaucoma Agent; Cholinergic (ophthalmic)

>  <SC_PATENT_NO>  (863) 
nan

>  <DRUG_TYPE>  (863) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (863) 
Y

>  <FIRST_IN_CLASS>  (863) 
N

>  <CHIRALITY>  (863) 
Single Stereoisomer

>  <PRODRUG>  (863) 
N

>  <ORAL>  (863) 
Y

>  <PARENTERAL>  (863) 
N

>  <TOPICAL>  (863) 
Y

>  <BLACK_BOX>  (863) 
N

>  <AVAILABILITY_TYPE>  (863) 
Prescription-only

>  <WITHDRAWN_YEAR>  (863) 
nan

>  <WITHDRAWN_COUNTRY>  (863) 
nan

>  <WITHDRAWN_REASON>  (863) 
nan

>  <CANONICAL_SMILES>  (863) 
CC[C@H]1[C@@H](Cc2cncn2C)COC1=O

>  <name>  (863) 
Pilocarpine 

>  <MW>  (863) 
208.261

>  <logP>  (863) 
1.1618

$$$$
CHEMBL1093
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 15 10  2  0
M  END
>  <PARENT_MOLREGNO>  (864) 
150423

>  <SYNONYMS>  (864) 
Articaine (BAN, INN); Articaine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (864) 
4

>  <RESEARCH_CODES>  (864) 
HOE-045; 40045

>  <APPLICANTS>  (864) 
Pierrel S.P.A.; Deproco Inc

>  <USAN_STEM>  (864) 
-caine

>  <USAN_STEM_DEFINITION>  (864) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (864) 
-caine

>  <USAN_YEAR>  (864) 
1998.0

>  <FIRST_APPROVAL>  (864) 
2000.0

>  <ATC_CODE>  (864) 
N01BB08; N01BB58

>  <ATC_CODE_DESCRIPTION>  (864) 
N01BB08 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB58 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (864) 
nan

>  <SC_PATENT_NO>  (864) 
nan

>  <DRUG_TYPE>  (864) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (864) 
Y

>  <FIRST_IN_CLASS>  (864) 
N

>  <CHIRALITY>  (864) 
Racemic Mixture

>  <PRODRUG>  (864) 
N

>  <ORAL>  (864) 
N

>  <PARENTERAL>  (864) 
Y

>  <TOPICAL>  (864) 
N

>  <BLACK_BOX>  (864) 
N

>  <AVAILABILITY_TYPE>  (864) 
Prescription-only

>  <WITHDRAWN_YEAR>  (864) 
nan

>  <WITHDRAWN_COUNTRY>  (864) 
nan

>  <WITHDRAWN_REASON>  (864) 
nan

>  <CANONICAL_SMILES>  (864) 
CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC

>  <name>  (864) 
Articaine 

>  <MW>  (864) 
284.381

>  <logP>  (864) 
2.16972

$$$$
CHEMBL1201262
     RDKit          

 25 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
  9 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
 17 25  2  0
 25  6  1  0
M  END
>  <PARENT_MOLREGNO>  (865) 
675213

>  <SYNONYMS>  (865) 
Dipivefrin (USAN); Dipivefrine (BAN, INN); Dipivefrin HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (865) 
4

>  <RESEARCH_CODES>  (865) 
nan

>  <APPLICANTS>  (865) 
Allergan Pharmaceutical

>  <USAN_STEM>  (865) 
nan

>  <USAN_STEM_DEFINITION>  (865) 
nan

>  <USAN_STEM_SUBSTEM>  (865) 
nan

>  <USAN_YEAR>  (865) 
1978.0

>  <FIRST_APPROVAL>  (865) 
1980.0

>  <ATC_CODE>  (865) 
S01EA02

>  <ATC_CODE_DESCRIPTION>  (865) 
S01EA02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Sympathomimetics in glaucoma therapy]

>  <INDICATION_CLASS>  (865) 
Adrenergic (ophthalmic); Antiglaucoma Agent

>  <SC_PATENT_NO>  (865) 
nan

>  <DRUG_TYPE>  (865) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (865) 
Y

>  <FIRST_IN_CLASS>  (865) 
N

>  <CHIRALITY>  (865) 
Racemic Mixture

>  <PRODRUG>  (865) 
Y

>  <ORAL>  (865) 
N

>  <PARENTERAL>  (865) 
N

>  <TOPICAL>  (865) 
Y

>  <BLACK_BOX>  (865) 
N

>  <AVAILABILITY_TYPE>  (865) 
Prescription-only

>  <WITHDRAWN_YEAR>  (865) 
nan

>  <WITHDRAWN_COUNTRY>  (865) 
nan

>  <WITHDRAWN_REASON>  (865) 
nan

>  <CANONICAL_SMILES>  (865) 
CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1

>  <name>  (865) 
Dipivefrin 

>  <MW>  (865) 
351.443

>  <logP>  (865) 
2.8424

$$$$
CHEMBL1484
     RDKit          

 35 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 10 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
  9 35  1  0
 11  5  1  0
 17 12  1  0
 34 29  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (866) 
407549

>  <SYNONYMS>  (866) 
Nicardipine (BAN, INN); Nicardipine HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (866) 
4

>  <RESEARCH_CODES>  (866) 
RS-69216; RS-69216-XX-07-0; YC-93

>  <APPLICANTS>  (866) 
Sun Pharma Global Inc; Exela Pharma Sciences; Ekr Therapeutics Inc

>  <USAN_STEM>  (866) 
-dipine

>  <USAN_STEM_DEFINITION>  (866) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (866) 
-dipine

>  <USAN_YEAR>  (866) 
1979.0

>  <FIRST_APPROVAL>  (866) 
1988.0

>  <ATC_CODE>  (866) 
C08CA04

>  <ATC_CODE_DESCRIPTION>  (866) 
C08CA04 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (866) 
Vasodilator

>  <SC_PATENT_NO>  (866) 
US-7612102-B2

>  <DRUG_TYPE>  (866) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (866) 
Y

>  <FIRST_IN_CLASS>  (866) 
N

>  <CHIRALITY>  (866) 
Racemic Mixture

>  <PRODRUG>  (866) 
N

>  <ORAL>  (866) 
Y

>  <PARENTERAL>  (866) 
Y

>  <TOPICAL>  (866) 
N

>  <BLACK_BOX>  (866) 
N

>  <AVAILABILITY_TYPE>  (866) 
Prescription-only

>  <WITHDRAWN_YEAR>  (866) 
nan

>  <WITHDRAWN_COUNTRY>  (866) 
nan

>  <WITHDRAWN_REASON>  (866) 
nan

>  <CANONICAL_SMILES>  (866) 
COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C

>  <name>  (866) 
Nicardipine 

>  <MW>  (866) 
479.533

>  <logP>  (866) 
3.6778

$$$$
CHEMBL965
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (867) 
94790

>  <SYNONYMS>  (867) 
Carbachol (BAN, FDA, INN, JAN, USP); Carbacholine Chloride (DCF)

>  <DEVELOPMENT_PHASE>  (867) 
4

>  <RESEARCH_CODES>  (867) 
nan

>  <APPLICANTS>  (867) 
Alcon Laboratories Inc

>  <USAN_STEM>  (867) 
nan

>  <USAN_STEM_DEFINITION>  (867) 
nan

>  <USAN_STEM_SUBSTEM>  (867) 
nan

>  <USAN_YEAR>  (867) 
nan

>  <FIRST_APPROVAL>  (867) 
1972.0

>  <ATC_CODE>  (867) 
N07AB01; S01EB02

>  <ATC_CODE_DESCRIPTION>  (867) 
N07AB01 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Choline esters]; S01EB02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]

>  <INDICATION_CLASS>  (867) 
Cholinergic (ophthalmic)

>  <SC_PATENT_NO>  (867) 
nan

>  <DRUG_TYPE>  (867) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (867) 
Y

>  <FIRST_IN_CLASS>  (867) 
N

>  <CHIRALITY>  (867) 
Achiral Molecule

>  <PRODRUG>  (867) 
N

>  <ORAL>  (867) 
N

>  <PARENTERAL>  (867) 
Y

>  <TOPICAL>  (867) 
N

>  <BLACK_BOX>  (867) 
N

>  <AVAILABILITY_TYPE>  (867) 
Prescription-only

>  <WITHDRAWN_YEAR>  (867) 
nan

>  <WITHDRAWN_COUNTRY>  (867) 
nan

>  <WITHDRAWN_REASON>  (867) 
nan

>  <CANONICAL_SMILES>  (867) 
C[N+](C)(C)CCOC(=O)N

>  <name>  (867) 
Carbachol 

>  <MW>  (867) 
147.198

>  <logP>  (867) 
-0.2121

$$$$
CHEMBL462547
     RDKit          

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
M  END
>  <PARENT_MOLREGNO>  (868) 
452538

>  <SYNONYMS>  (868) 
Urethan (NF); Urethane (DCF, INN)

>  <DEVELOPMENT_PHASE>  (868) 
4

>  <RESEARCH_CODES>  (868) 
nan

>  <APPLICANTS>  (868) 
nan

>  <USAN_STEM>  (868) 
nan

>  <USAN_STEM_DEFINITION>  (868) 
nan

>  <USAN_STEM_SUBSTEM>  (868) 
nan

>  <USAN_YEAR>  (868) 
nan

>  <FIRST_APPROVAL>  (868) 
nan

>  <ATC_CODE>  (868) 
nan

>  <ATC_CODE_DESCRIPTION>  (868) 
nan

>  <INDICATION_CLASS>  (868) 
nan

>  <SC_PATENT_NO>  (868) 
nan

>  <DRUG_TYPE>  (868) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (868) 
Y

>  <FIRST_IN_CLASS>  (868) 
N

>  <CHIRALITY>  (868) 
Achiral Molecule

>  <PRODRUG>  (868) 
N

>  <ORAL>  (868) 
N

>  <PARENTERAL>  (868) 
N

>  <TOPICAL>  (868) 
N

>  <BLACK_BOX>  (868) 
N

>  <AVAILABILITY_TYPE>  (868) 
Withdrawn

>  <WITHDRAWN_YEAR>  (868) 
nan

>  <WITHDRAWN_COUNTRY>  (868) 
United States

>  <WITHDRAWN_REASON>  (868) 
nan

>  <CANONICAL_SMILES>  (868) 
CCOC(=O)N

>  <name>  (868) 
Urethan 

>  <MW>  (868) 
89.094

>  <logP>  (868) 
0.1016

$$$$
CHEMBL1489662
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  2 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  9  4  1  0
 15 10  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (869) 
913546

>  <SYNONYMS>  (869) 
Difenpiramide

>  <DEVELOPMENT_PHASE>  (869) 
4

>  <RESEARCH_CODES>  (869) 
nan

>  <APPLICANTS>  (869) 
nan

>  <USAN_STEM>  (869) 
nan

>  <USAN_STEM_DEFINITION>  (869) 
nan

>  <USAN_STEM_SUBSTEM>  (869) 
nan

>  <USAN_YEAR>  (869) 
nan

>  <FIRST_APPROVAL>  (869) 
nan

>  <ATC_CODE>  (869) 
M01AB12

>  <ATC_CODE_DESCRIPTION>  (869) 
M01AB12 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (869) 
nan

>  <SC_PATENT_NO>  (869) 
nan

>  <DRUG_TYPE>  (869) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (869) 
Y

>  <FIRST_IN_CLASS>  (869) 
N

>  <CHIRALITY>  (869) 
Achiral Molecule

>  <PRODRUG>  (869) 
N

>  <ORAL>  (869) 
N

>  <PARENTERAL>  (869) 
N

>  <TOPICAL>  (869) 
N

>  <BLACK_BOX>  (869) 
N

>  <AVAILABILITY_TYPE>  (869) 
Unknown

>  <WITHDRAWN_YEAR>  (869) 
nan

>  <WITHDRAWN_COUNTRY>  (869) 
nan

>  <WITHDRAWN_REASON>  (869) 
nan

>  <CANONICAL_SMILES>  (869) 
O=C(Cc1ccc(cc1)c2ccccc2)Nc3ccccn3

>  <name>  (869) 
Difenpiramide

>  <MW>  (869) 
288.35

>  <logP>  (869) 
3.9298

$$$$
CHEMBL1200598
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 12 15  1  0
 10 16  1  0
 16 17  2  0
  3 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 23 26  1  0
 21 27  1  0
 27 28  2  0
 17  7  1  0
 28 18  1  0
M  END
>  <PARENT_MOLREGNO>  (870) 
674549

>  <SYNONYMS>  (870) 
Diethylstilbestrol Diphosphate (FDA, USP); Fosfestrol (BAN, INN, JAN)

>  <DEVELOPMENT_PHASE>  (870) 
4

>  <RESEARCH_CODES>  (870) 
nan

>  <APPLICANTS>  (870) 
Bayer Pharmaceuticals Corp

>  <USAN_STEM>  (870) 
-estr-

>  <USAN_STEM_DEFINITION>  (870) 
estrogens

>  <USAN_STEM_SUBSTEM>  (870) 
-estr-

>  <USAN_YEAR>  (870) 
nan

>  <FIRST_APPROVAL>  (870) 
1982.0

>  <ATC_CODE>  (870) 
L02AA04

>  <ATC_CODE_DESCRIPTION>  (870) 
L02AA04 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormones And Related Agents:Estrogens]

>  <INDICATION_CLASS>  (870) 
Estrogen

>  <SC_PATENT_NO>  (870) 
nan

>  <DRUG_TYPE>  (870) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (870) 
Y

>  <FIRST_IN_CLASS>  (870) 
N

>  <CHIRALITY>  (870) 
Achiral Molecule

>  <PRODRUG>  (870) 
Y

>  <ORAL>  (870) 
Y

>  <PARENTERAL>  (870) 
Y

>  <TOPICAL>  (870) 
N

>  <BLACK_BOX>  (870) 
N

>  <AVAILABILITY_TYPE>  (870) 
Discontinued

>  <WITHDRAWN_YEAR>  (870) 
nan

>  <WITHDRAWN_COUNTRY>  (870) 
nan

>  <WITHDRAWN_REASON>  (870) 
nan

>  <CANONICAL_SMILES>  (870) 
CC\C(=C(\CC)/c1ccc(OP(=O)(O)O)cc1)\c2ccc(OP(=O)(O)O)cc2

>  <name>  (870) 
Diethylstilbestrol Diphosphate 

>  <MW>  (870) 
428.314

>  <logP>  (870) 
4.3604

$$$$
CHEMBL1457
     RDKit          

 22 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 16  3  1  0
 17  6  1  0
 21  8  1  0
 18  9  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (871) 
388373

>  <SYNONYMS>  (871) 
Hydrocodone (BAN, INN); Hydrocodone Polistirex (FDA, USAN); Hydrocodone bitartrate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (871) 
4

>  <RESEARCH_CODES>  (871) 
nan

>  <APPLICANTS>  (871) 
Ucb Inc; Endo Pharmaceuticals Inc; Cypress Pharmaceutical Inc; Abbvie Inc

>  <USAN_STEM>  (871) 
nan

>  <USAN_STEM_DEFINITION>  (871) 
nan

>  <USAN_STEM_SUBSTEM>  (871) 
nan

>  <USAN_YEAR>  (871) 
1963.0

>  <FIRST_APPROVAL>  (871) 
1943.0

>  <ATC_CODE>  (871) 
R05DA03

>  <ATC_CODE_DESCRIPTION>  (871) 
R05DA03 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Opium alkaloids and derivatives]

>  <INDICATION_CLASS>  (871) 
Antitussive

>  <SC_PATENT_NO>  (871) 
US-6228398-B1

>  <DRUG_TYPE>  (871) 
Polymer

>  <RULE_OF_FIVE>  (871) 
Y

>  <FIRST_IN_CLASS>  (871) 
N

>  <CHIRALITY>  (871) 
Single Stereoisomer

>  <PRODRUG>  (871) 
N

>  <ORAL>  (871) 
Y

>  <PARENTERAL>  (871) 
N

>  <TOPICAL>  (871) 
N

>  <BLACK_BOX>  (871) 
Y

>  <AVAILABILITY_TYPE>  (871) 
Prescription-only

>  <WITHDRAWN_YEAR>  (871) 
nan

>  <WITHDRAWN_COUNTRY>  (871) 
nan

>  <WITHDRAWN_REASON>  (871) 
nan

>  <CANONICAL_SMILES>  (871) 
COc1ccc2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5Oc1c2[C@]45CCN3C

>  <name>  (871) 
Hydrocodone 

>  <MW>  (871) 
299.37

>  <logP>  (871) 
1.9333

$$$$
CHEMBL1200661
     RDKit          

 30 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (872) 
674612

>  <SYNONYMS>  (872) 
Unoprostone Isopropyl (FDA)

>  <DEVELOPMENT_PHASE>  (872) 
4

>  <RESEARCH_CODES>  (872) 
nan

>  <APPLICANTS>  (872) 
Sucampo Pharmaceuticals Inc

>  <USAN_STEM>  (872) 
-prost-

>  <USAN_STEM_DEFINITION>  (872) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (872) 
-prost-

>  <USAN_YEAR>  (872) 
nan

>  <FIRST_APPROVAL>  (872) 
2000.0

>  <ATC_CODE>  (872) 
S01EE02

>  <ATC_CODE_DESCRIPTION>  (872) 
S01EE02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Prostaglandin analogues1)]

>  <INDICATION_CLASS>  (872) 
nan

>  <SC_PATENT_NO>  (872) 
US-6458836-B1

>  <DRUG_TYPE>  (872) 
Natural Product-derived

>  <RULE_OF_FIVE>  (872) 
Y

>  <FIRST_IN_CLASS>  (872) 
N

>  <CHIRALITY>  (872) 
Single Stereoisomer

>  <PRODRUG>  (872) 
Y

>  <ORAL>  (872) 
N

>  <PARENTERAL>  (872) 
N

>  <TOPICAL>  (872) 
Y

>  <BLACK_BOX>  (872) 
N

>  <AVAILABILITY_TYPE>  (872) 
Prescription-only

>  <WITHDRAWN_YEAR>  (872) 
nan

>  <WITHDRAWN_COUNTRY>  (872) 
nan

>  <WITHDRAWN_REASON>  (872) 
nan

>  <CANONICAL_SMILES>  (872) 
CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OC(C)C

>  <name>  (872) 
Unoprostone Isopropyl 

>  <MW>  (872) 
424.622

>  <logP>  (872) 
5.1223

$$$$
CHEMBL582
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
M  END
>  <PARENT_MOLREGNO>  (873) 
17025

>  <SYNONYMS>  (873) 
Isopropanol (JAN); Isopropyl alcohol (FDA, USP)

>  <DEVELOPMENT_PHASE>  (873) 
4

>  <RESEARCH_CODES>  (873) 
nan

>  <APPLICANTS>  (873) 
Professional Disposables Inc; Carefusion 213 Llc; 3m Health Care Inc

>  <USAN_STEM>  (873) 
nan

>  <USAN_STEM_DEFINITION>  (873) 
nan

>  <USAN_STEM_SUBSTEM>  (873) 
nan

>  <USAN_YEAR>  (873) 
nan

>  <FIRST_APPROVAL>  (873) 
2000.0

>  <ATC_CODE>  (873) 
D08AX05

>  <ATC_CODE_DESCRIPTION>  (873) 
D08AX05 [Dermatologicals:Antiseptics And Disinfectants:Antiseptics And Disinfectants:Other antiseptics and disinfectants]

>  <INDICATION_CLASS>  (873) 
Anti-Infective, Topical; Pharmaceutic Aid (solvent)

>  <SC_PATENT_NO>  (873) 
US-5538353-A

>  <DRUG_TYPE>  (873) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (873) 
Y

>  <FIRST_IN_CLASS>  (873) 
N

>  <CHIRALITY>  (873) 
Achiral Molecule

>  <PRODRUG>  (873) 
N

>  <ORAL>  (873) 
N

>  <PARENTERAL>  (873) 
N

>  <TOPICAL>  (873) 
Y

>  <BLACK_BOX>  (873) 
N

>  <AVAILABILITY_TYPE>  (873) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (873) 
nan

>  <WITHDRAWN_COUNTRY>  (873) 
nan

>  <WITHDRAWN_REASON>  (873) 
nan

>  <CANONICAL_SMILES>  (873) 
CC(C)O

>  <name>  (873) 
Isopropanol 

>  <MW>  (873) 
60.096

>  <logP>  (873) 
0.3871

$$$$
CHEMBL649
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 11  1  0
 22 15  2  0
M  END
>  <PARENT_MOLREGNO>  (874) 
27570

>  <SYNONYMS>  (874) 
Nadolol (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (874) 
4

>  <RESEARCH_CODES>  (874) 
SQ-11725

>  <APPLICANTS>  (874) 
King Pharmaceuticals Inc

>  <USAN_STEM>  (874) 
-olol

>  <USAN_STEM_DEFINITION>  (874) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (874) 
-olol

>  <USAN_YEAR>  (874) 
1976.0

>  <FIRST_APPROVAL>  (874) 
1979.0

>  <ATC_CODE>  (874) 
C07AA12

>  <ATC_CODE_DESCRIPTION>  (874) 
C07AA12 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (874) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (874) 
nan

>  <DRUG_TYPE>  (874) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (874) 
Y

>  <FIRST_IN_CLASS>  (874) 
N

>  <CHIRALITY>  (874) 
Racemic Mixture

>  <PRODRUG>  (874) 
N

>  <ORAL>  (874) 
Y

>  <PARENTERAL>  (874) 
N

>  <TOPICAL>  (874) 
N

>  <BLACK_BOX>  (874) 
Y

>  <AVAILABILITY_TYPE>  (874) 
Prescription-only

>  <WITHDRAWN_YEAR>  (874) 
nan

>  <WITHDRAWN_COUNTRY>  (874) 
nan

>  <WITHDRAWN_REASON>  (874) 
nan

>  <CANONICAL_SMILES>  (874) 
CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12

>  <name>  (874) 
Nadolol 

>  <MW>  (874) 
309.406

>  <logP>  (874) 
0.6348

$$$$
CHEMBL1201039
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 13 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  2  0
 10  5  1  0
 24  7  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (875) 
674990

>  <SYNONYMS>  (875) 
Benzthiazide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (875) 
4

>  <RESEARCH_CODES>  (875) 
nan

>  <APPLICANTS>  (875) 
Solvay Pharmaceuticals; Pfizer Laboratories Div Pfizer Inc; Ah Robins Inc

>  <USAN_STEM>  (875) 
-thiazide

>  <USAN_STEM_DEFINITION>  (875) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (875) 
-thiazide

>  <USAN_YEAR>  (875) 
nan

>  <FIRST_APPROVAL>  (875) 
1960.0

>  <ATC_CODE>  (875) 
nan

>  <ATC_CODE_DESCRIPTION>  (875) 
nan

>  <INDICATION_CLASS>  (875) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (875) 
nan

>  <DRUG_TYPE>  (875) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (875) 
Y

>  <FIRST_IN_CLASS>  (875) 
N

>  <CHIRALITY>  (875) 
Achiral Molecule

>  <PRODRUG>  (875) 
N

>  <ORAL>  (875) 
Y

>  <PARENTERAL>  (875) 
N

>  <TOPICAL>  (875) 
N

>  <BLACK_BOX>  (875) 
N

>  <AVAILABILITY_TYPE>  (875) 
Discontinued

>  <WITHDRAWN_YEAR>  (875) 
nan

>  <WITHDRAWN_COUNTRY>  (875) 
nan

>  <WITHDRAWN_REASON>  (875) 
nan

>  <CANONICAL_SMILES>  (875) 
NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc3ccccc3)NS2(=O)=O

>  <name>  (875) 
Benzthiazide 

>  <MW>  (875) 
431.948

>  <logP>  (875) 
2.2427

$$$$
CHEMBL997
     RDKit          

 19 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 12 15  1  0
 10 16  1  0
 16 17  2  0
 16 18  1  0
 16 19  1  0
M  END
>  <PARENT_MOLREGNO>  (876) 
110435

>  <SYNONYMS>  (876) 
Ibandronic Acid (BAN, INN); Ibandronate Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (876) 
4

>  <RESEARCH_CODES>  (876) 
BM 21.0955; BM-21.0955

>  <APPLICANTS>  (876) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (876) 
-andr-

>  <USAN_STEM_DEFINITION>  (876) 
androgens

>  <USAN_STEM_SUBSTEM>  (876) 
-andr-

>  <USAN_YEAR>  (876) 
1997.0

>  <FIRST_APPROVAL>  (876) 
2003.0

>  <ATC_CODE>  (876) 
M05BA06

>  <ATC_CODE_DESCRIPTION>  (876) 
M05BA06 [Musculo-Skeletal System:Drugs For Treatment Of Bone Diseases:Drugs Affecting Bone Structure And Mineralization:Bisphosphonates]

>  <INDICATION_CLASS>  (876) 
Antihypercalcemic; Bone Resorption Inhibitor

>  <SC_PATENT_NO>  (876) 
US-6143326-A

>  <DRUG_TYPE>  (876) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (876) 
Y

>  <FIRST_IN_CLASS>  (876) 
N

>  <CHIRALITY>  (876) 
Achiral Molecule

>  <PRODRUG>  (876) 
N

>  <ORAL>  (876) 
Y

>  <PARENTERAL>  (876) 
Y

>  <TOPICAL>  (876) 
N

>  <BLACK_BOX>  (876) 
N

>  <AVAILABILITY_TYPE>  (876) 
Prescription-only

>  <WITHDRAWN_YEAR>  (876) 
nan

>  <WITHDRAWN_COUNTRY>  (876) 
nan

>  <WITHDRAWN_REASON>  (876) 
nan

>  <CANONICAL_SMILES>  (876) 
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O

>  <name>  (876) 
Ibandronic Acid 

>  <MW>  (876) 
319.231

>  <logP>  (876) 
0.5

$$$$
CHEMBL1165
     RDKit          

 36 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  2  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 14  9  1  0
 33 20  1  0
 31 22  1  0
M  END
>  <PARENT_MOLREGNO>  (877) 
188707

>  <SYNONYMS>  (877) 
Moexipril (BAN, INN); Moexipril HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (877) 
4

>  <RESEARCH_CODES>  (877) 
CI-925; RS-10085-197; SPM-925

>  <APPLICANTS>  (877) 
Ucb Inc

>  <USAN_STEM>  (877) 
-pril

>  <USAN_STEM_DEFINITION>  (877) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (877) 
-pril

>  <USAN_YEAR>  (877) 
1995.0

>  <FIRST_APPROVAL>  (877) 
1995.0

>  <ATC_CODE>  (877) 
C09AA13

>  <ATC_CODE_DESCRIPTION>  (877) 
C09AA13 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (877) 
Antihypertensive; Enzyme Inhibitor (angiotensin-converting)

>  <SC_PATENT_NO>  (877) 
nan

>  <DRUG_TYPE>  (877) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (877) 
Y

>  <FIRST_IN_CLASS>  (877) 
N

>  <CHIRALITY>  (877) 
Single Stereoisomer

>  <PRODRUG>  (877) 
Y

>  <ORAL>  (877) 
Y

>  <PARENTERAL>  (877) 
N

>  <TOPICAL>  (877) 
N

>  <BLACK_BOX>  (877) 
Y

>  <AVAILABILITY_TYPE>  (877) 
Prescription-only

>  <WITHDRAWN_YEAR>  (877) 
nan

>  <WITHDRAWN_COUNTRY>  (877) 
nan

>  <WITHDRAWN_REASON>  (877) 
nan

>  <CANONICAL_SMILES>  (877) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O

>  <name>  (877) 
Moexipril 

>  <MW>  (877) 
498.576

>  <logP>  (877) 
2.5843

$$$$
CHEMBL1469
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (878) 
397873

>  <SYNONYMS>  (878) 
Sodium phenylbutyrate (BAN, FDA, USAN)

>  <DEVELOPMENT_PHASE>  (878) 
4

>  <RESEARCH_CODES>  (878) 
nan

>  <APPLICANTS>  (878) 
Medicis Pharmaceutical Corp

>  <USAN_STEM>  (878) 
nan

>  <USAN_STEM_DEFINITION>  (878) 
nan

>  <USAN_STEM_SUBSTEM>  (878) 
nan

>  <USAN_YEAR>  (878) 
1995.0

>  <FIRST_APPROVAL>  (878) 
1996.0

>  <ATC_CODE>  (878) 
A16AX03

>  <ATC_CODE_DESCRIPTION>  (878) 
A16AX03 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Various alimentary tract and metabolism products]

>  <INDICATION_CLASS>  (878) 
Antihyperammonemic

>  <SC_PATENT_NO>  (878) 
nan

>  <DRUG_TYPE>  (878) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (878) 
Y

>  <FIRST_IN_CLASS>  (878) 
N

>  <CHIRALITY>  (878) 
Achiral Molecule

>  <PRODRUG>  (878) 
Y

>  <ORAL>  (878) 
Y

>  <PARENTERAL>  (878) 
N

>  <TOPICAL>  (878) 
N

>  <BLACK_BOX>  (878) 
N

>  <AVAILABILITY_TYPE>  (878) 
Prescription-only

>  <WITHDRAWN_YEAR>  (878) 
nan

>  <WITHDRAWN_COUNTRY>  (878) 
nan

>  <WITHDRAWN_REASON>  (878) 
nan

>  <CANONICAL_SMILES>  (878) 
OC(=O)CCCc1ccccc1

>  <name>  (878) 
Sodium phenylbutyrate 

>  <MW>  (878) 
164.204

>  <logP>  (878) 
2.0939

$$$$
CHEMBL2107825
     RDKit          

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 10 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 26 17  1  0
 26 20  1  0
 33 28  1  0
M  END
>  <PARENT_MOLREGNO>  (879) 
1380095

>  <SYNONYMS>  (879) 
Tenofovir Alafenamide (USAN); Tenofovir alafenamide fumarate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (879) 
4

>  <RESEARCH_CODES>  (879) 
GS-7340; GS-734003

>  <APPLICANTS>  (879) 
Gilead Sciences, Inc.; Gilead Sciences Inc

>  <USAN_STEM>  (879) 
-vir

>  <USAN_STEM_DEFINITION>  (879) 
antivirals

>  <USAN_STEM_SUBSTEM>  (879) 
-vir

>  <USAN_YEAR>  (879) 
2012.0

>  <FIRST_APPROVAL>  (879) 
2015.0

>  <ATC_CODE>  (879) 
nan

>  <ATC_CODE_DESCRIPTION>  (879) 
nan

>  <INDICATION_CLASS>  (879) 
nan

>  <SC_PATENT_NO>  (879) 
US-5814639-A

>  <DRUG_TYPE>  (879) 
Natural Product-derived

>  <RULE_OF_FIVE>  (879) 
Y

>  <FIRST_IN_CLASS>  (879) 
N

>  <CHIRALITY>  (879) 
Single Stereoisomer

>  <PRODRUG>  (879) 
Y

>  <ORAL>  (879) 
Y

>  <PARENTERAL>  (879) 
N

>  <TOPICAL>  (879) 
N

>  <BLACK_BOX>  (879) 
Y

>  <AVAILABILITY_TYPE>  (879) 
Prescription-only

>  <WITHDRAWN_YEAR>  (879) 
nan

>  <WITHDRAWN_COUNTRY>  (879) 
nan

>  <WITHDRAWN_REASON>  (879) 
nan

>  <CANONICAL_SMILES>  (879) 
CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)Oc3ccccc3

>  <name>  (879) 
Tenofovir Alafenamide 

>  <MW>  (879) 
476.474

>  <logP>  (879) 
2.9729

$$$$
CHEMBL235668
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15  2  1  0
  9  5  1  0
M  END
>  <PARENT_MOLREGNO>  (880) 
399292

>  <SYNONYMS>  (880) 
Tipiracil (INN, USAN, FDA); Tipiracil hydrochloride (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (880) 
4

>  <RESEARCH_CODES>  (880) 
MA-1; TPI (freebase); TAS-1-462

>  <APPLICANTS>  (880) 
Taiho Pharmaceutical Co., Ltd.; Taiho Oncology Inc

>  <USAN_STEM>  (880) 
-racil

>  <USAN_STEM_DEFINITION>  (880) 
uracil type antineoplastics

>  <USAN_STEM_SUBSTEM>  (880) 
-racil

>  <USAN_YEAR>  (880) 
2013.0

>  <FIRST_APPROVAL>  (880) 
2015.0

>  <ATC_CODE>  (880) 
nan

>  <ATC_CODE_DESCRIPTION>  (880) 
nan

>  <INDICATION_CLASS>  (880) 
nan

>  <SC_PATENT_NO>  (880) 
US-5744475-A

>  <DRUG_TYPE>  (880) 
Natural Product-derived

>  <RULE_OF_FIVE>  (880) 
Y

>  <FIRST_IN_CLASS>  (880) 
N

>  <CHIRALITY>  (880) 
Achiral Molecule

>  <PRODRUG>  (880) 
N

>  <ORAL>  (880) 
Y

>  <PARENTERAL>  (880) 
N

>  <TOPICAL>  (880) 
N

>  <BLACK_BOX>  (880) 
N

>  <AVAILABILITY_TYPE>  (880) 
Prescription-only

>  <WITHDRAWN_YEAR>  (880) 
nan

>  <WITHDRAWN_COUNTRY>  (880) 
nan

>  <WITHDRAWN_REASON>  (880) 
nan

>  <CANONICAL_SMILES>  (880) 
ClC1=C(CN2CCCC2=N)NC(=O)NC1=O

>  <name>  (880) 
Tipiracil 

>  <MW>  (880) 
242.666

>  <logP>  (880) 
0.28967

$$$$
CHEMBL614
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (881) 
23522

>  <SYNONYMS>  (881) 
Pyrazinamide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (881) 
4

>  <RESEARCH_CODES>  (881) 
nan

>  <APPLICANTS>  (881) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (881) 
nan

>  <USAN_STEM_DEFINITION>  (881) 
nan

>  <USAN_STEM_SUBSTEM>  (881) 
nan

>  <USAN_YEAR>  (881) 
nan

>  <FIRST_APPROVAL>  (881) 
1971.0

>  <ATC_CODE>  (881) 
J04AK01

>  <ATC_CODE_DESCRIPTION>  (881) 
J04AK01 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Other drugs for treatment of tuberculosis]

>  <INDICATION_CLASS>  (881) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (881) 
nan

>  <DRUG_TYPE>  (881) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (881) 
Y

>  <FIRST_IN_CLASS>  (881) 
N

>  <CHIRALITY>  (881) 
Achiral Molecule

>  <PRODRUG>  (881) 
Y

>  <ORAL>  (881) 
Y

>  <PARENTERAL>  (881) 
N

>  <TOPICAL>  (881) 
N

>  <BLACK_BOX>  (881) 
N

>  <AVAILABILITY_TYPE>  (881) 
Prescription-only

>  <WITHDRAWN_YEAR>  (881) 
nan

>  <WITHDRAWN_COUNTRY>  (881) 
nan

>  <WITHDRAWN_REASON>  (881) 
nan

>  <CANONICAL_SMILES>  (881) 
NC(=O)c1cnccn1

>  <name>  (881) 
Pyrazinamide 

>  <MW>  (881) 
123.115

>  <logP>  (881) 
-0.4245

$$$$
CHEMBL550348
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 12 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
  9  4  1  0
 14 10  1  0
 20 15  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (882) 
564990

>  <SYNONYMS>  (882) 
Deferasirox (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (882) 
4

>  <RESEARCH_CODES>  (882) 
ICL670A

>  <APPLICANTS>  (882) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (882) 
nan

>  <USAN_STEM_DEFINITION>  (882) 
nan

>  <USAN_STEM_SUBSTEM>  (882) 
nan

>  <USAN_YEAR>  (882) 
2004.0

>  <FIRST_APPROVAL>  (882) 
2005.0

>  <ATC_CODE>  (882) 
V03AC03

>  <ATC_CODE_DESCRIPTION>  (882) 
V03AC03 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Iron chelating agents]

>  <INDICATION_CLASS>  (882) 
nan

>  <SC_PATENT_NO>  (882) 
US-6465504-B1

>  <DRUG_TYPE>  (882) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (882) 
Y

>  <FIRST_IN_CLASS>  (882) 
N

>  <CHIRALITY>  (882) 
Achiral Molecule

>  <PRODRUG>  (882) 
N

>  <ORAL>  (882) 
Y

>  <PARENTERAL>  (882) 
N

>  <TOPICAL>  (882) 
N

>  <BLACK_BOX>  (882) 
Y

>  <AVAILABILITY_TYPE>  (882) 
Prescription-only

>  <WITHDRAWN_YEAR>  (882) 
nan

>  <WITHDRAWN_COUNTRY>  (882) 
nan

>  <WITHDRAWN_REASON>  (882) 
nan

>  <CANONICAL_SMILES>  (882) 
OC(=O)c1ccc(cc1)n2nc(nc2c3ccccc3O)c4ccccc4O

>  <name>  (882) 
Deferasirox 

>  <MW>  (882) 
373.368

>  <logP>  (882) 
3.7107

$$$$
CHEMBL301267
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 18  4  1  0
 20  6  1  0
 22  8  1  0
 20 12  1  0
M  END
>  <PARENT_MOLREGNO>  (883) 
88317

>  <SYNONYMS>  (883) 
Artemotil (INN)

>  <DEVELOPMENT_PHASE>  (883) 
4

>  <RESEARCH_CODES>  (883) 
nan

>  <APPLICANTS>  (883) 
nan

>  <USAN_STEM>  (883) 
arte-

>  <USAN_STEM_DEFINITION>  (883) 
antimalarials (artemisin dervatives)

>  <USAN_STEM_SUBSTEM>  (883) 
arte-

>  <USAN_YEAR>  (883) 
nan

>  <FIRST_APPROVAL>  (883) 
nan

>  <ATC_CODE>  (883) 
P01BE04

>  <ATC_CODE_DESCRIPTION>  (883) 
P01BE04 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Artemisinin and derivatives, plain]

>  <INDICATION_CLASS>  (883) 
nan

>  <SC_PATENT_NO>  (883) 
nan

>  <DRUG_TYPE>  (883) 
Natural Product-derived

>  <RULE_OF_FIVE>  (883) 
Y

>  <FIRST_IN_CLASS>  (883) 
N

>  <CHIRALITY>  (883) 
Single Stereoisomer

>  <PRODRUG>  (883) 
Y

>  <ORAL>  (883) 
N

>  <PARENTERAL>  (883) 
Y

>  <TOPICAL>  (883) 
N

>  <BLACK_BOX>  (883) 
N

>  <AVAILABILITY_TYPE>  (883) 
Discontinued

>  <WITHDRAWN_YEAR>  (883) 
nan

>  <WITHDRAWN_COUNTRY>  (883) 
nan

>  <WITHDRAWN_REASON>  (883) 
nan

>  <CANONICAL_SMILES>  (883) 
CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3

>  <name>  (883) 
Artemotil 

>  <MW>  (883) 
312.406

>  <logP>  (883) 
3.2309

$$$$
CHEMBL1094
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  6 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (884) 
150451

>  <SYNONYMS>  (884) 
Felbamate (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (884) 
4

>  <RESEARCH_CODES>  (884) 
W-554

>  <APPLICANTS>  (884) 
Meda Pharmaceuticals Inc

>  <USAN_STEM>  (884) 
-bamate

>  <USAN_STEM_DEFINITION>  (884) 
tranquilizers/antiepileptics (propanediol and pentanediol groups

>  <USAN_STEM_SUBSTEM>  (884) 
-bamate

>  <USAN_YEAR>  (884) 
1992.0

>  <FIRST_APPROVAL>  (884) 
1993.0

>  <ATC_CODE>  (884) 
N03AX10

>  <ATC_CODE_DESCRIPTION>  (884) 
N03AX10 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (884) 
Anti-Epileptic

>  <SC_PATENT_NO>  (884) 
nan

>  <DRUG_TYPE>  (884) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (884) 
Y

>  <FIRST_IN_CLASS>  (884) 
N

>  <CHIRALITY>  (884) 
Achiral Molecule

>  <PRODRUG>  (884) 
N

>  <ORAL>  (884) 
Y

>  <PARENTERAL>  (884) 
N

>  <TOPICAL>  (884) 
N

>  <BLACK_BOX>  (884) 
Y

>  <AVAILABILITY_TYPE>  (884) 
Prescription-only

>  <WITHDRAWN_YEAR>  (884) 
nan

>  <WITHDRAWN_COUNTRY>  (884) 
nan

>  <WITHDRAWN_REASON>  (884) 
nan

>  <CANONICAL_SMILES>  (884) 
NC(=O)OCC(COC(=O)N)c1ccccc1

>  <name>  (884) 
Felbamate 

>  <MW>  (884) 
238.243

>  <logP>  (884) 
0.9608

$$$$
CHEMBL473
     RDKit          

 29 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
  9 15  1  0
 15 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  2  0
 24 27  1  0
 22 28  1  0
 28 29  2  0
 16  6  1  0
 29 19  1  0
M  END
>  <PARENT_MOLREGNO>  (885) 
5638

>  <SYNONYMS>  (885) 
Dofetilide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (885) 
4

>  <RESEARCH_CODES>  (885) 
UK-68798

>  <APPLICANTS>  (885) 
Pfizer Pharmaceuticals Production Corp Ltd

>  <USAN_STEM>  (885) 
-ilide

>  <USAN_STEM_DEFINITION>  (885) 
class III antiarrhythmic agents

>  <USAN_STEM_SUBSTEM>  (885) 
-ilide

>  <USAN_YEAR>  (885) 
1993.0

>  <FIRST_APPROVAL>  (885) 
1999.0

>  <ATC_CODE>  (885) 
C01BD04

>  <ATC_CODE_DESCRIPTION>  (885) 
C01BD04 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class III]

>  <INDICATION_CLASS>  (885) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (885) 
US-6124363-A

>  <DRUG_TYPE>  (885) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (885) 
Y

>  <FIRST_IN_CLASS>  (885) 
N

>  <CHIRALITY>  (885) 
Achiral Molecule

>  <PRODRUG>  (885) 
N

>  <ORAL>  (885) 
Y

>  <PARENTERAL>  (885) 
N

>  <TOPICAL>  (885) 
N

>  <BLACK_BOX>  (885) 
Y

>  <AVAILABILITY_TYPE>  (885) 
Prescription-only

>  <WITHDRAWN_YEAR>  (885) 
nan

>  <WITHDRAWN_COUNTRY>  (885) 
nan

>  <WITHDRAWN_REASON>  (885) 
nan

>  <CANONICAL_SMILES>  (885) 
CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2

>  <name>  (885) 
Dofetilide 

>  <MW>  (885) 
441.575

>  <logP>  (885) 
1.9829

$$$$
CHEMBL1029
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13  5  1  0
M  END
>  <PARENT_MOLREGNO>  (886) 
122901

>  <SYNONYMS>  (886) 
Miglustat (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (886) 
4

>  <RESEARCH_CODES>  (886) 
OGT-918

>  <APPLICANTS>  (886) 
Actelion Pharmaceuticals Ltd

>  <USAN_STEM>  (886) 
-stat

>  <USAN_STEM_DEFINITION>  (886) 
enzyme inhibitors: glucosyltransferase inhibitors

>  <USAN_STEM_SUBSTEM>  (886) 
-stat (-glustat)

>  <USAN_YEAR>  (886) 
2003.0

>  <FIRST_APPROVAL>  (886) 
2003.0

>  <ATC_CODE>  (886) 
A16AX06

>  <ATC_CODE_DESCRIPTION>  (886) 
A16AX06 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Various alimentary tract and metabolism products]

>  <INDICATION_CLASS>  (886) 
nan

>  <SC_PATENT_NO>  (886) 
nan

>  <DRUG_TYPE>  (886) 
Natural Product-derived

>  <RULE_OF_FIVE>  (886) 
Y

>  <FIRST_IN_CLASS>  (886) 
Y

>  <CHIRALITY>  (886) 
Single Stereoisomer

>  <PRODRUG>  (886) 
N

>  <ORAL>  (886) 
Y

>  <PARENTERAL>  (886) 
N

>  <TOPICAL>  (886) 
N

>  <BLACK_BOX>  (886) 
N

>  <AVAILABILITY_TYPE>  (886) 
Prescription-only

>  <WITHDRAWN_YEAR>  (886) 
nan

>  <WITHDRAWN_COUNTRY>  (886) 
nan

>  <WITHDRAWN_REASON>  (886) 
nan

>  <CANONICAL_SMILES>  (886) 
CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO

>  <name>  (886) 
Miglustat 

>  <MW>  (886) 
219.281

>  <logP>  (886) 
-1.4543

$$$$
CHEMBL718
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
  2 13  1  0
 13 14  2  0
 13 15  1  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (887) 
34757

>  <SYNONYMS>  (887) 
Methyldopa (Racemic)

>  <DEVELOPMENT_PHASE>  (887) 
4

>  <RESEARCH_CODES>  (887) 
nan

>  <APPLICANTS>  (887) 
nan

>  <USAN_STEM>  (887) 
-dopa

>  <USAN_STEM_DEFINITION>  (887) 
dopamine receptor agonists

>  <USAN_STEM_SUBSTEM>  (887) 
-dopa

>  <USAN_YEAR>  (887) 
nan

>  <FIRST_APPROVAL>  (887) 
nan

>  <ATC_CODE>  (887) 
C02AB02

>  <ATC_CODE_DESCRIPTION>  (887) 
C02AB02 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Centrally Acting:Methyldopa]

>  <INDICATION_CLASS>  (887) 
nan

>  <SC_PATENT_NO>  (887) 
nan

>  <DRUG_TYPE>  (887) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (887) 
Y

>  <FIRST_IN_CLASS>  (887) 
N

>  <CHIRALITY>  (887) 
Racemic Mixture

>  <PRODRUG>  (887) 
N

>  <ORAL>  (887) 
N

>  <PARENTERAL>  (887) 
N

>  <TOPICAL>  (887) 
N

>  <BLACK_BOX>  (887) 
N

>  <AVAILABILITY_TYPE>  (887) 
Unknown

>  <WITHDRAWN_YEAR>  (887) 
nan

>  <WITHDRAWN_COUNTRY>  (887) 
nan

>  <WITHDRAWN_REASON>  (887) 
nan

>  <CANONICAL_SMILES>  (887) 
CC(N)(Cc1ccc(O)c(O)c1)C(=O)O

>  <name>  (887) 
Methyldopa 

>  <MW>  (887) 
211.217

>  <logP>  (887) 
0.4423

$$$$
CHEMBL505851
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
  3 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 10  3  1  0
 19 12  1  0
 18 14  1  0
M  END
>  <PARENT_MOLREGNO>  (888) 
488075

>  <SYNONYMS>  (888) 
Reposal

>  <DEVELOPMENT_PHASE>  (888) 
4

>  <RESEARCH_CODES>  (888) 
nan

>  <APPLICANTS>  (888) 
nan

>  <USAN_STEM>  (888) 
-sal

>  <USAN_STEM_DEFINITION>  (888) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (888) 
-sal

>  <USAN_YEAR>  (888) 
nan

>  <FIRST_APPROVAL>  (888) 
nan

>  <ATC_CODE>  (888) 
N05CA12

>  <ATC_CODE_DESCRIPTION>  (888) 
N05CA12 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (888) 
nan

>  <SC_PATENT_NO>  (888) 
nan

>  <DRUG_TYPE>  (888) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (888) 
Y

>  <FIRST_IN_CLASS>  (888) 
N

>  <CHIRALITY>  (888) 
Racemic Mixture

>  <PRODRUG>  (888) 
N

>  <ORAL>  (888) 
N

>  <PARENTERAL>  (888) 
N

>  <TOPICAL>  (888) 
N

>  <BLACK_BOX>  (888) 
N

>  <AVAILABILITY_TYPE>  (888) 
Unknown

>  <WITHDRAWN_YEAR>  (888) 
nan

>  <WITHDRAWN_COUNTRY>  (888) 
nan

>  <WITHDRAWN_REASON>  (888) 
nan

>  <CANONICAL_SMILES>  (888) 
CCC1(C(=O)NC(=O)NC1=O)C2=CC3CCC(C3)C2

>  <name>  (888) 
Reposal

>  <MW>  (888) 
262.309

>  <logP>  (888) 
1.4952

$$$$
CHEMBL231779
     RDKit          

 34 38  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 18 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
  8  3  1  0
 21  9  1  0
 21 15  2  0
 27 22  1  0
 33 28  1  0
M  END
>  <PARENT_MOLREGNO>  (889) 
397524

>  <SYNONYMS>  (889) 
Apixaban (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (889) 
4

>  <RESEARCH_CODES>  (889) 
BMS-562247; BMS-562247-01

>  <APPLICANTS>  (889) 
Bristol Myers Squibb Co Pharmaceutical Research Institute

>  <USAN_STEM>  (889) 
-xaban

>  <USAN_STEM_DEFINITION>  (889) 
antithrombotic: blood coagulation factor XA inhibitors

>  <USAN_STEM_SUBSTEM>  (889) 
-xaban

>  <USAN_YEAR>  (889) 
2005.0

>  <FIRST_APPROVAL>  (889) 
2012.0

>  <ATC_CODE>  (889) 
B01AF02

>  <ATC_CODE_DESCRIPTION>  (889) 
B01AF02 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Direct factor Xa inhibitors]

>  <INDICATION_CLASS>  (889) 
nan

>  <SC_PATENT_NO>  (889) 
US-6413980-B1

>  <DRUG_TYPE>  (889) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (889) 
Y

>  <FIRST_IN_CLASS>  (889) 
N

>  <CHIRALITY>  (889) 
Achiral Molecule

>  <PRODRUG>  (889) 
N

>  <ORAL>  (889) 
Y

>  <PARENTERAL>  (889) 
N

>  <TOPICAL>  (889) 
N

>  <BLACK_BOX>  (889) 
Y

>  <AVAILABILITY_TYPE>  (889) 
Prescription-only

>  <WITHDRAWN_YEAR>  (889) 
nan

>  <WITHDRAWN_COUNTRY>  (889) 
nan

>  <WITHDRAWN_REASON>  (889) 
nan

>  <CANONICAL_SMILES>  (889) 
COc1ccc(cc1)n2nc(C(=O)N)c3CCN(C(=O)c23)c4ccc(cc4)N5CCCCC5=O

>  <name>  (889) 
Apixaban 

>  <MW>  (889) 
459.506

>  <logP>  (889) 
2.6996

$$$$
CHEMBL409153
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 11 14  1  0
 14 15  3  0
  2 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 16 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
  7  3  1  0
 13  8  1  0
 23 19  1  0
 30 24  1  0
M  END
>  <PARENT_MOLREGNO>  (890) 
433556

>  <SYNONYMS>  (890) 
Isavuconazole

>  <DEVELOPMENT_PHASE>  (890) 
4

>  <RESEARCH_CODES>  (890) 
nan

>  <APPLICANTS>  (890) 
nan

>  <USAN_STEM>  (890) 
-conazole

>  <USAN_STEM_DEFINITION>  (890) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (890) 
-conazole

>  <USAN_YEAR>  (890) 
nan

>  <FIRST_APPROVAL>  (890) 
nan

>  <ATC_CODE>  (890) 
J02AC05

>  <ATC_CODE_DESCRIPTION>  (890) 
J02AC05 [Antiinfectives For Systemic Use:Antimycotics For Systemic Use:Antimycotics For Systemic Use:Triazole derivatives]

>  <INDICATION_CLASS>  (890) 
nan

>  <SC_PATENT_NO>  (890) 
nan

>  <DRUG_TYPE>  (890) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (890) 
Y

>  <FIRST_IN_CLASS>  (890) 
N

>  <CHIRALITY>  (890) 
Single Stereoisomer

>  <PRODRUG>  (890) 
N

>  <ORAL>  (890) 
N

>  <PARENTERAL>  (890) 
N

>  <TOPICAL>  (890) 
N

>  <BLACK_BOX>  (890) 
N

>  <AVAILABILITY_TYPE>  (890) 
Unknown

>  <WITHDRAWN_YEAR>  (890) 
nan

>  <WITHDRAWN_COUNTRY>  (890) 
nan

>  <WITHDRAWN_REASON>  (890) 
nan

>  <CANONICAL_SMILES>  (890) 
C[C@@H](c1nc(cs1)c2ccc(cc2)C#N)[C@](O)(Cn3cncn3)c4cc(F)ccc4F

>  <name>  (890) 
Isavuconazole

>  <MW>  (890) 
437.475

>  <logP>  (890) 
4.24298

$$$$
CHEMBL1537
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 10 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
  6 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 29  2  1  0
 28  5  1  0
 18 14  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (891) 
430506

>  <SYNONYMS>  (891) 
Azlocillin (BAN, INN, USAN); Azlocillin Sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (891) 
4

>  <RESEARCH_CODES>  (891) 
nan

>  <APPLICANTS>  (891) 
Bayer Pharmaceuticals Corp; Bayer

>  <USAN_STEM>  (891) 
-cillin

>  <USAN_STEM_DEFINITION>  (891) 
penicillins

>  <USAN_STEM_SUBSTEM>  (891) 
-cillin

>  <USAN_YEAR>  (891) 
1976.0

>  <FIRST_APPROVAL>  (891) 
1982.0

>  <ATC_CODE>  (891) 
J01CA09

>  <ATC_CODE_DESCRIPTION>  (891) 
J01CA09 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (891) 
Antibacterial

>  <SC_PATENT_NO>  (891) 
nan

>  <DRUG_TYPE>  (891) 
Natural Product-derived

>  <RULE_OF_FIVE>  (891) 
Y

>  <FIRST_IN_CLASS>  (891) 
N

>  <CHIRALITY>  (891) 
Single Stereoisomer

>  <PRODRUG>  (891) 
N

>  <ORAL>  (891) 
N

>  <PARENTERAL>  (891) 
Y

>  <TOPICAL>  (891) 
N

>  <BLACK_BOX>  (891) 
N

>  <AVAILABILITY_TYPE>  (891) 
Discontinued

>  <WITHDRAWN_YEAR>  (891) 
nan

>  <WITHDRAWN_COUNTRY>  (891) 
nan

>  <WITHDRAWN_REASON>  (891) 
nan

>  <CANONICAL_SMILES>  (891) 
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c4ccccc4)C(=O)N2[C@H]1C(=O)O

>  <name>  (891) 
Azlocillin 

>  <MW>  (891) 
461.5

>  <logP>  (891) 
0.0942

$$$$
CHEMBL595
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 13 22  1  0
 22 23  2  0
  6 24  1  0
 24 25  2  0
 25  3  1  0
 23 10  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (892) 
19737

>  <SYNONYMS>  (892) 
Pioglitazone (BAN, INN); Pioglitazone HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (892) 
4

>  <RESEARCH_CODES>  (892) 
U-72107A

>  <APPLICANTS>  (892) 
Takeda Pharmaceuticals Usa Inc

>  <USAN_STEM>  (892) 
-glitazone

>  <USAN_STEM_DEFINITION>  (892) 
PPST agonists (thiazolidene derivatives)

>  <USAN_STEM_SUBSTEM>  (892) 
-glitazone

>  <USAN_YEAR>  (892) 
1989.0

>  <FIRST_APPROVAL>  (892) 
1999.0

>  <ATC_CODE>  (892) 
A10BG03

>  <ATC_CODE_DESCRIPTION>  (892) 
A10BG03 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Thiazolidinediones]

>  <INDICATION_CLASS>  (892) 
Antidiabetic

>  <SC_PATENT_NO>  (892) 
US-5965584-A

>  <DRUG_TYPE>  (892) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (892) 
Y

>  <FIRST_IN_CLASS>  (892) 
N

>  <CHIRALITY>  (892) 
Racemic Mixture

>  <PRODRUG>  (892) 
N

>  <ORAL>  (892) 
Y

>  <PARENTERAL>  (892) 
N

>  <TOPICAL>  (892) 
N

>  <BLACK_BOX>  (892) 
Y

>  <AVAILABILITY_TYPE>  (892) 
Prescription-only

>  <WITHDRAWN_YEAR>  (892) 
nan

>  <WITHDRAWN_COUNTRY>  (892) 
nan

>  <WITHDRAWN_REASON>  (892) 
nan

>  <CANONICAL_SMILES>  (892) 
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1

>  <name>  (892) 
Pioglitazone 

>  <MW>  (892) 
356.447

>  <logP>  (892) 
3.1596

$$$$
CHEMBL170988
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (893) 
282509

>  <SYNONYMS>  (893) 
Phenformin (BAN, INN); Phenformin HCl (MI, USP)

>  <DEVELOPMENT_PHASE>  (893) 
4

>  <RESEARCH_CODES>  (893) 
nan

>  <APPLICANTS>  (893) 
Ciba-Geigy

>  <USAN_STEM>  (893) 
-formin

>  <USAN_STEM_DEFINITION>  (893) 
hypoglycemics (phenformin type)

>  <USAN_STEM_SUBSTEM>  (893) 
-formin

>  <USAN_YEAR>  (893) 
nan

>  <FIRST_APPROVAL>  (893) 
nan

>  <ATC_CODE>  (893) 
A10BA01

>  <ATC_CODE_DESCRIPTION>  (893) 
A10BA01 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Biguanides]

>  <INDICATION_CLASS>  (893) 
nan

>  <SC_PATENT_NO>  (893) 
nan

>  <DRUG_TYPE>  (893) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (893) 
Y

>  <FIRST_IN_CLASS>  (893) 
N

>  <CHIRALITY>  (893) 
Achiral Molecule

>  <PRODRUG>  (893) 
N

>  <ORAL>  (893) 
N

>  <PARENTERAL>  (893) 
N

>  <TOPICAL>  (893) 
N

>  <BLACK_BOX>  (893) 
N

>  <AVAILABILITY_TYPE>  (893) 
Withdrawn

>  <WITHDRAWN_YEAR>  (893) 
1977.0

>  <WITHDRAWN_COUNTRY>  (893) 
United States; Germany; France

>  <WITHDRAWN_REASON>  (893) 
Severe Metabolic Acidosis

>  <CANONICAL_SMILES>  (893) 
NC(=N)NC(=N)NCCc1ccccc1

>  <name>  (893) 
Phenformin 

>  <MW>  (893) 
205.265

>  <logP>  (893) 
0.23654

$$$$
CHEMBL797
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  7  2  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (894) 
49869

>  <SYNONYMS>  (894) 
Phensuximide (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (894) 
4

>  <RESEARCH_CODES>  (894) 
nan

>  <APPLICANTS>  (894) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (894) 
nan

>  <USAN_STEM_DEFINITION>  (894) 
nan

>  <USAN_STEM_SUBSTEM>  (894) 
nan

>  <USAN_YEAR>  (894) 
nan

>  <FIRST_APPROVAL>  (894) 
1982.0

>  <ATC_CODE>  (894) 
N03AD02

>  <ATC_CODE_DESCRIPTION>  (894) 
N03AD02 [Nervous System:Antiepileptics:Antiepileptics:Succinimide derivatives]

>  <INDICATION_CLASS>  (894) 
Anticonvulsant

>  <SC_PATENT_NO>  (894) 
nan

>  <DRUG_TYPE>  (894) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (894) 
Y

>  <FIRST_IN_CLASS>  (894) 
N

>  <CHIRALITY>  (894) 
Racemic Mixture

>  <PRODRUG>  (894) 
N

>  <ORAL>  (894) 
Y

>  <PARENTERAL>  (894) 
N

>  <TOPICAL>  (894) 
N

>  <BLACK_BOX>  (894) 
N

>  <AVAILABILITY_TYPE>  (894) 
Discontinued

>  <WITHDRAWN_YEAR>  (894) 
nan

>  <WITHDRAWN_COUNTRY>  (894) 
nan

>  <WITHDRAWN_REASON>  (894) 
nan

>  <CANONICAL_SMILES>  (894) 
CN1C(=O)CC(C1=O)c2ccccc2

>  <name>  (894) 
Phensuximide 

>  <MW>  (894) 
189.214

>  <logP>  (894) 
1.1589

$$$$
CHEMBL1199080
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12  7  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (895) 
673030

>  <SYNONYMS>  (895) 
Bretylium Tosilate (BAN, INN); Bretylium Tosylate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (895) 
4

>  <RESEARCH_CODES>  (895) 
ASL-603

>  <APPLICANTS>  (895) 
Hospira Inc; Baxter Healthcare Corp; B Braun Medical Inc; Abbott Laboratories Pharmaceutical Products Div; Hospira Worldwide, Inc

>  <USAN_STEM>  (895) 
-ium

>  <USAN_STEM_DEFINITION>  (895) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (895) 
-ium

>  <USAN_YEAR>  (895) 
1976.0

>  <FIRST_APPROVAL>  (895) 
1986.0

>  <ATC_CODE>  (895) 
C01BD02

>  <ATC_CODE_DESCRIPTION>  (895) 
C01BD02 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class III]

>  <INDICATION_CLASS>  (895) 
Anti-Adrenergic; Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (895) 
nan

>  <DRUG_TYPE>  (895) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (895) 
Y

>  <FIRST_IN_CLASS>  (895) 
N

>  <CHIRALITY>  (895) 
Achiral Molecule

>  <PRODRUG>  (895) 
N

>  <ORAL>  (895) 
N

>  <PARENTERAL>  (895) 
Y

>  <TOPICAL>  (895) 
N

>  <BLACK_BOX>  (895) 
N

>  <AVAILABILITY_TYPE>  (895) 
Prescription-only

>  <WITHDRAWN_YEAR>  (895) 
nan

>  <WITHDRAWN_COUNTRY>  (895) 
nan

>  <WITHDRAWN_REASON>  (895) 
nan

>  <CANONICAL_SMILES>  (895) 
CC[N+](C)(C)Cc1ccccc1Br

>  <name>  (895) 
Bretylium Tosilate 

>  <MW>  (895) 
243.168

>  <logP>  (895) 
3.0454

$$$$
CHEMBL1201354
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 17 12  1  0
 23 18  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (896) 
675305

>  <SYNONYMS>  (896) 
Tridihexethyl Chloride (BAN, FDA, USP); Tridihexethyl Iodide (INN, MI)

>  <DEVELOPMENT_PHASE>  (896) 
4

>  <RESEARCH_CODES>  (896) 
nan

>  <APPLICANTS>  (896) 
Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (896) 
nan

>  <USAN_STEM_DEFINITION>  (896) 
nan

>  <USAN_STEM_SUBSTEM>  (896) 
nan

>  <USAN_YEAR>  (896) 
nan

>  <FIRST_APPROVAL>  (896) 
1954.0

>  <ATC_CODE>  (896) 
A03AB08

>  <ATC_CODE_DESCRIPTION>  (896) 
A03AB08 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (896) 
nan

>  <SC_PATENT_NO>  (896) 
nan

>  <DRUG_TYPE>  (896) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (896) 
Y

>  <FIRST_IN_CLASS>  (896) 
N

>  <CHIRALITY>  (896) 
Racemic Mixture

>  <PRODRUG>  (896) 
N

>  <ORAL>  (896) 
Y

>  <PARENTERAL>  (896) 
Y

>  <TOPICAL>  (896) 
N

>  <BLACK_BOX>  (896) 
N

>  <AVAILABILITY_TYPE>  (896) 
Discontinued

>  <WITHDRAWN_YEAR>  (896) 
nan

>  <WITHDRAWN_COUNTRY>  (896) 
nan

>  <WITHDRAWN_REASON>  (896) 
nan

>  <CANONICAL_SMILES>  (896) 
CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c2ccccc2

>  <name>  (896) 
Tridihexethyl Chloride 

>  <MW>  (896) 
318.525

>  <logP>  (896) 
4.7211

$$$$
CHEMBL1112
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 10 27  1  0
 27 28  1  0
  6 29  2  0
 29 30  1  0
 29  2  1  0
 28  7  1  0
 26 16  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (897) 
155006

>  <SYNONYMS>  (897) 
Aripiprazole (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (897) 
4

>  <RESEARCH_CODES>  (897) 
OPC-14597; OPC-31

>  <APPLICANTS>  (897) 
Otsuka Pharmaceutical Development And Commercialization Inc; Otsuka Pharmaceutical Co Ltd

>  <USAN_STEM>  (897) 
-prazole

>  <USAN_STEM_DEFINITION>  (897) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (897) 
-prazole

>  <USAN_YEAR>  (897) 
1997.0

>  <FIRST_APPROVAL>  (897) 
2002.0

>  <ATC_CODE>  (897) 
N05AX12

>  <ATC_CODE_DESCRIPTION>  (897) 
N05AX12 [Nervous System:Psycholeptics:Antipsychotics:Other antipsychotics]

>  <INDICATION_CLASS>  (897) 
Antipsychotic; Antischizophrenic

>  <SC_PATENT_NO>  (897) 
US-6977257-B2

>  <DRUG_TYPE>  (897) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (897) 
Y

>  <FIRST_IN_CLASS>  (897) 
N

>  <CHIRALITY>  (897) 
Achiral Molecule

>  <PRODRUG>  (897) 
N

>  <ORAL>  (897) 
Y

>  <PARENTERAL>  (897) 
Y

>  <TOPICAL>  (897) 
N

>  <BLACK_BOX>  (897) 
Y

>  <AVAILABILITY_TYPE>  (897) 
Prescription-only

>  <WITHDRAWN_YEAR>  (897) 
nan

>  <WITHDRAWN_COUNTRY>  (897) 
nan

>  <WITHDRAWN_REASON>  (897) 
nan

>  <CANONICAL_SMILES>  (897) 
Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl

>  <name>  (897) 
Aripiprazole 

>  <MW>  (897) 
448.394

>  <logP>  (897) 
4.8593

$$$$
CHEMBL2107381
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
  9 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
  8 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 14  6  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (898) 
1379651

>  <SYNONYMS>  (898) 
Uridine Triacetate (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (898) 
4

>  <RESEARCH_CODES>  (898) 
nan

>  <APPLICANTS>  (898) 
Wellstat Therapeutics Corp

>  <USAN_STEM>  (898) 
-uridine

>  <USAN_STEM_DEFINITION>  (898) 
antivirals,antineoplastics (uridine derivatives)

>  <USAN_STEM_SUBSTEM>  (898) 
-uridine

>  <USAN_YEAR>  (898) 
2009.0

>  <FIRST_APPROVAL>  (898) 
2015.0

>  <ATC_CODE>  (898) 
nan

>  <ATC_CODE_DESCRIPTION>  (898) 
nan

>  <INDICATION_CLASS>  (898) 
nan

>  <SC_PATENT_NO>  (898) 
US-5968914-A

>  <DRUG_TYPE>  (898) 
Natural Product-derived

>  <RULE_OF_FIVE>  (898) 
Y

>  <FIRST_IN_CLASS>  (898) 
N

>  <CHIRALITY>  (898) 
Single Stereoisomer

>  <PRODRUG>  (898) 
N

>  <ORAL>  (898) 
Y

>  <PARENTERAL>  (898) 
N

>  <TOPICAL>  (898) 
N

>  <BLACK_BOX>  (898) 
N

>  <AVAILABILITY_TYPE>  (898) 
Prescription-only

>  <WITHDRAWN_YEAR>  (898) 
nan

>  <WITHDRAWN_COUNTRY>  (898) 
nan

>  <WITHDRAWN_REASON>  (898) 
nan

>  <CANONICAL_SMILES>  (898) 
CC(=O)OC[C@H]1O[C@H]([C@H](OC(=O)C)[C@@H]1OC(=O)C)N2C=CC(=O)NC2=O

>  <name>  (898) 
Uridine Triacetate 

>  <MW>  (898) 
370.314

>  <logP>  (898) 
-1.1395

$$$$
CHEMBL1200604
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 10  5  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (899) 
674555

>  <SYNONYMS>  (899) 
Tropicamide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (899) 
4

>  <RESEARCH_CODES>  (899) 
nan

>  <APPLICANTS>  (899) 
Alcon Laboratories Inc; Akorn Inc

>  <USAN_STEM>  (899) 
trop-

>  <USAN_STEM_DEFINITION>  (899) 
atropine derivatives

>  <USAN_STEM_SUBSTEM>  (899) 
trop-

>  <USAN_YEAR>  (899) 
1962.0

>  <FIRST_APPROVAL>  (899) 
1960.0

>  <ATC_CODE>  (899) 
S01FA06; S01FA56

>  <ATC_CODE_DESCRIPTION>  (899) 
S01FA06 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]; S01FA56 [Sensory Organs:Ophthalmologicals:Mydriatics And Cycloplegics:Anticholinergics]

>  <INDICATION_CLASS>  (899) 
Anticholinergic

>  <SC_PATENT_NO>  (899) 
nan

>  <DRUG_TYPE>  (899) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (899) 
Y

>  <FIRST_IN_CLASS>  (899) 
N

>  <CHIRALITY>  (899) 
Racemic Mixture

>  <PRODRUG>  (899) 
N

>  <ORAL>  (899) 
N

>  <PARENTERAL>  (899) 
N

>  <TOPICAL>  (899) 
Y

>  <BLACK_BOX>  (899) 
N

>  <AVAILABILITY_TYPE>  (899) 
Prescription-only

>  <WITHDRAWN_YEAR>  (899) 
nan

>  <WITHDRAWN_COUNTRY>  (899) 
nan

>  <WITHDRAWN_REASON>  (899) 
nan

>  <CANONICAL_SMILES>  (899) 
CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2

>  <name>  (899) 
Tropicamide 

>  <MW>  (899) 
284.359

>  <logP>  (899) 
2.2062

$$$$
CHEMBL2106915
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 10 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 22  3  1  0
 20  5  2  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (900) 
1379185

>  <SYNONYMS>  (900) 
Methopholine (USAN); Metofoline (BAN, INN)

>  <DEVELOPMENT_PHASE>  (900) 
4

>  <RESEARCH_CODES>  (900) 
ARC I-K-1; NIH-7672; Ro-417781

>  <APPLICANTS>  (900) 
Hoffmann-Laroche

>  <USAN_STEM>  (900) 
nan

>  <USAN_STEM_DEFINITION>  (900) 
nan

>  <USAN_STEM_SUBSTEM>  (900) 
nan

>  <USAN_YEAR>  (900) 
1963.0

>  <FIRST_APPROVAL>  (900) 
nan

>  <ATC_CODE>  (900) 
nan

>  <ATC_CODE_DESCRIPTION>  (900) 
nan

>  <INDICATION_CLASS>  (900) 
Analgesic

>  <SC_PATENT_NO>  (900) 
nan

>  <DRUG_TYPE>  (900) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (900) 
Y

>  <FIRST_IN_CLASS>  (900) 
N

>  <CHIRALITY>  (900) 
Racemic Mixture

>  <PRODRUG>  (900) 
N

>  <ORAL>  (900) 
N

>  <PARENTERAL>  (900) 
N

>  <TOPICAL>  (900) 
N

>  <BLACK_BOX>  (900) 
N

>  <AVAILABILITY_TYPE>  (900) 
Withdrawn

>  <WITHDRAWN_YEAR>  (900) 
1965.0

>  <WITHDRAWN_COUNTRY>  (900) 
United States

>  <WITHDRAWN_REASON>  (900) 
Unspecific Experimental Toxicity

>  <CANONICAL_SMILES>  (900) 
COc1cc2CCN(C)C(CCc3ccc(Cl)cc3)c2cc1OC

>  <name>  (900) 
Methopholine 

>  <MW>  (900) 
345.87

>  <logP>  (900) 
4.519

$$$$
CHEMBL1201260
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (901) 
675211

>  <SYNONYMS>  (901) 
Betanidine (INN); Betanidine Sulfate (JAN); Bethanidine Sulfate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (901) 
4

>  <RESEARCH_CODES>  (901) 
BW-467-C-60

>  <APPLICANTS>  (901) 
Ah Robins Co

>  <USAN_STEM>  (901) 
nan

>  <USAN_STEM_DEFINITION>  (901) 
nan

>  <USAN_STEM_SUBSTEM>  (901) 
nan

>  <USAN_YEAR>  (901) 
1962.0

>  <FIRST_APPROVAL>  (901) 
1982.0

>  <ATC_CODE>  (901) 
C02CC01

>  <ATC_CODE_DESCRIPTION>  (901) 
C02CC01 [Cardiovascular System:Antihypertensives:Antiadrenergic Agents, Peripherally Acting:Guanidine derivatives]

>  <INDICATION_CLASS>  (901) 
Antihypertensive

>  <SC_PATENT_NO>  (901) 
nan

>  <DRUG_TYPE>  (901) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (901) 
Y

>  <FIRST_IN_CLASS>  (901) 
N

>  <CHIRALITY>  (901) 
Achiral Molecule

>  <PRODRUG>  (901) 
N

>  <ORAL>  (901) 
Y

>  <PARENTERAL>  (901) 
N

>  <TOPICAL>  (901) 
N

>  <BLACK_BOX>  (901) 
N

>  <AVAILABILITY_TYPE>  (901) 
Discontinued

>  <WITHDRAWN_YEAR>  (901) 
nan

>  <WITHDRAWN_COUNTRY>  (901) 
nan

>  <WITHDRAWN_REASON>  (901) 
nan

>  <CANONICAL_SMILES>  (901) 
CN\C(=N/C)\NCc1ccccc1

>  <name>  (901) 
Betanidine 

>  <MW>  (901) 
177.251

>  <logP>  (901) 
0.9814

$$$$
CHEMBL2105720
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 15 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 11  6  1  0
 24 12  1  0
 18 16  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (902) 
1377990

>  <SYNONYMS>  (902) 
Lesinurad (INN, USAN); Lesinurad Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (902) 
4

>  <RESEARCH_CODES>  (902) 
RDEA594; RDEA594 Sodium

>  <APPLICANTS>  (902) 
Ardea Biosciences Inc; Ardea Biosciences

>  <USAN_STEM>  (902) 
-urad

>  <USAN_STEM_DEFINITION>  (902) 
urate transporter inhibitors

>  <USAN_STEM_SUBSTEM>  (902) 
-urad

>  <USAN_YEAR>  (902) 
2010.0

>  <FIRST_APPROVAL>  (902) 
2015.0

>  <ATC_CODE>  (902) 
M04AB05

>  <ATC_CODE_DESCRIPTION>  (902) 
M04AB05 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations increasing uric acid excretion]

>  <INDICATION_CLASS>  (902) 
nan

>  <SC_PATENT_NO>  (902) 
US-8003681-B2

>  <DRUG_TYPE>  (902) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (902) 
Y

>  <FIRST_IN_CLASS>  (902) 
N

>  <CHIRALITY>  (902) 
Achiral Molecule

>  <PRODRUG>  (902) 
N

>  <ORAL>  (902) 
Y

>  <PARENTERAL>  (902) 
N

>  <TOPICAL>  (902) 
N

>  <BLACK_BOX>  (902) 
Y

>  <AVAILABILITY_TYPE>  (902) 
Prescription-only

>  <WITHDRAWN_YEAR>  (902) 
nan

>  <WITHDRAWN_COUNTRY>  (902) 
nan

>  <WITHDRAWN_REASON>  (902) 
nan

>  <CANONICAL_SMILES>  (902) 
OC(=O)CSc1nnc(Br)n1c2ccc(C3CC3)c4ccccc24

>  <name>  (902) 
Lesinurad 

>  <MW>  (902) 
404.289

>  <logP>  (902) 
4.2371

$$$$
CHEMBL747
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 10  2  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (903) 
39570

>  <SYNONYMS>  (903) 
Cycloguanil Embonate (BAN, INN); Cycloguanil Pamoate (USAN)

>  <DEVELOPMENT_PHASE>  (903) 
4

>  <RESEARCH_CODES>  (903) 
CI-501; CN-14329-23A; PAM-MR-807-23A; TCMDC-125837

>  <APPLICANTS>  (903) 
Parke-Davis

>  <USAN_STEM>  (903) 
-nil

>  <USAN_STEM_DEFINITION>  (903) 
benzodiazepine receptor antagonists/agonists

>  <USAN_STEM_SUBSTEM>  (903) 
-nil

>  <USAN_YEAR>  (903) 
1964.0

>  <FIRST_APPROVAL>  (903) 
nan

>  <ATC_CODE>  (903) 
P01BB02

>  <ATC_CODE_DESCRIPTION>  (903) 
P01BB02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Biguanides]

>  <INDICATION_CLASS>  (903) 
Antimalarial

>  <SC_PATENT_NO>  (903) 
nan

>  <DRUG_TYPE>  (903) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (903) 
Y

>  <FIRST_IN_CLASS>  (903) 
N

>  <CHIRALITY>  (903) 
Achiral Molecule

>  <PRODRUG>  (903) 
N

>  <ORAL>  (903) 
Y

>  <PARENTERAL>  (903) 
N

>  <TOPICAL>  (903) 
N

>  <BLACK_BOX>  (903) 
N

>  <AVAILABILITY_TYPE>  (903) 
Discontinued

>  <WITHDRAWN_YEAR>  (903) 
nan

>  <WITHDRAWN_COUNTRY>  (903) 
nan

>  <WITHDRAWN_REASON>  (903) 
nan

>  <CANONICAL_SMILES>  (903) 
CC1(C)N=C(N)N=C(N)N1c2ccc(Cl)cc2

>  <name>  (903) 
Cycloguanil Embonate 

>  <MW>  (903) 
251.721

>  <logP>  (903) 
1.5255

$$$$
CHEMBL1430
     RDKit          

  9  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
M  END
>  <PARENT_MOLREGNO>  (904) 
369179

>  <SYNONYMS>  (904) 
Penicillamine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (904) 
4

>  <RESEARCH_CODES>  (904) 
nan

>  <APPLICANTS>  (904) 
Meda Pharmaceuticals Inc; Aton Pharma Inc

>  <USAN_STEM>  (904) 
nan

>  <USAN_STEM_DEFINITION>  (904) 
nan

>  <USAN_STEM_SUBSTEM>  (904) 
nan

>  <USAN_YEAR>  (904) 
1963.0

>  <FIRST_APPROVAL>  (904) 
1970.0

>  <ATC_CODE>  (904) 
M01CC01

>  <ATC_CODE_DESCRIPTION>  (904) 
M01CC01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Specific Antirheumatic Agents:Penicillamine and similar agents]

>  <INDICATION_CLASS>  (904) 
Chelating Agent

>  <SC_PATENT_NO>  (904) 
nan

>  <DRUG_TYPE>  (904) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (904) 
Y

>  <FIRST_IN_CLASS>  (904) 
N

>  <CHIRALITY>  (904) 
Single Stereoisomer

>  <PRODRUG>  (904) 
N

>  <ORAL>  (904) 
Y

>  <PARENTERAL>  (904) 
N

>  <TOPICAL>  (904) 
N

>  <BLACK_BOX>  (904) 
Y

>  <AVAILABILITY_TYPE>  (904) 
Prescription-only

>  <WITHDRAWN_YEAR>  (904) 
nan

>  <WITHDRAWN_COUNTRY>  (904) 
nan

>  <WITHDRAWN_REASON>  (904) 
nan

>  <CANONICAL_SMILES>  (904) 
CC(C)(S)[C@@H](N)C(=O)O

>  <name>  (904) 
Penicillamine 

>  <MW>  (904) 
149.215

>  <logP>  (904) 
0.1067

$$$$
CHEMBL311498
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
 13  2  1  0
 11  4  1  0
 21 14  1  0
M  END
>  <PARENT_MOLREGNO>  (905) 
128555

>  <SYNONYMS>  (905) 
Cianidanol (INN, JAN)

>  <DEVELOPMENT_PHASE>  (905) 
4

>  <RESEARCH_CODES>  (905) 
nan

>  <APPLICANTS>  (905) 
nan

>  <USAN_STEM>  (905) 
nan

>  <USAN_STEM_DEFINITION>  (905) 
nan

>  <USAN_STEM_SUBSTEM>  (905) 
nan

>  <USAN_YEAR>  (905) 
nan

>  <FIRST_APPROVAL>  (905) 
1977.0

>  <ATC_CODE>  (905) 
nan

>  <ATC_CODE_DESCRIPTION>  (905) 
nan

>  <INDICATION_CLASS>  (905) 
nan

>  <SC_PATENT_NO>  (905) 
nan

>  <DRUG_TYPE>  (905) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (905) 
Y

>  <FIRST_IN_CLASS>  (905) 
N

>  <CHIRALITY>  (905) 
Single Stereoisomer

>  <PRODRUG>  (905) 
N

>  <ORAL>  (905) 
N

>  <PARENTERAL>  (905) 
N

>  <TOPICAL>  (905) 
N

>  <BLACK_BOX>  (905) 
N

>  <AVAILABILITY_TYPE>  (905) 
Withdrawn

>  <WITHDRAWN_YEAR>  (905) 
1985.0

>  <WITHDRAWN_COUNTRY>  (905) 
Spain; Germany; France; Switzerland

>  <WITHDRAWN_REASON>  (905) 
Hemolytic Anemia

>  <CANONICAL_SMILES>  (905) 
O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)c(O)c3

>  <name>  (905) 
Cianidanol 

>  <MW>  (905) 
290.271

>  <logP>  (905) 
1.5461

$$$$
CHEMBL59
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
 11  4  1  0
M  END
>  <PARENT_MOLREGNO>  (906) 
4584

>  <SYNONYMS>  (906) 
Dopamine (BAN, INN); Dopamine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (906) 
4

>  <RESEARCH_CODES>  (906) 
ASL-279

>  <APPLICANTS>  (906) 
Baxter Healthcare Corp Anesthesia And Critical Care; Baxter Healthcare Corp; B Braun Medical Inc; Astrazeneca Lp; Hospira Inc

>  <USAN_STEM>  (906) 
-pamine

>  <USAN_STEM_DEFINITION>  (906) 
dopaminergics (butopamine type)

>  <USAN_STEM_SUBSTEM>  (906) 
-pamine

>  <USAN_YEAR>  (906) 
1969.0

>  <FIRST_APPROVAL>  (906) 
1974.0

>  <ATC_CODE>  (906) 
C01CA04

>  <ATC_CODE_DESCRIPTION>  (906) 
C01CA04 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (906) 
Adrenergic

>  <SC_PATENT_NO>  (906) 
nan

>  <DRUG_TYPE>  (906) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (906) 
Y

>  <FIRST_IN_CLASS>  (906) 
N

>  <CHIRALITY>  (906) 
Achiral Molecule

>  <PRODRUG>  (906) 
N

>  <ORAL>  (906) 
N

>  <PARENTERAL>  (906) 
Y

>  <TOPICAL>  (906) 
N

>  <BLACK_BOX>  (906) 
Y

>  <AVAILABILITY_TYPE>  (906) 
Prescription-only

>  <WITHDRAWN_YEAR>  (906) 
nan

>  <WITHDRAWN_COUNTRY>  (906) 
nan

>  <WITHDRAWN_REASON>  (906) 
nan

>  <CANONICAL_SMILES>  (906) 
NCCc1ccc(O)c(O)c1

>  <name>  (906) 
Dopamine 

>  <MW>  (906) 
153.181

>  <logP>  (906) 
0.599

$$$$
CHEMBL1689063
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
  9  4  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (907) 
1077322

>  <SYNONYMS>  (907) 
Avibactam (INN, USAN); Avibactam Sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (907) 
4

>  <RESEARCH_CODES>  (907) 
nan

>  <APPLICANTS>  (907) 
Forest Research Institute, Inc.; Cerexa Inc

>  <USAN_STEM>  (907) 
-bactam

>  <USAN_STEM_DEFINITION>  (907) 
beta-lactamase inhibitors

>  <USAN_STEM_SUBSTEM>  (907) 
-bactam

>  <USAN_YEAR>  (907) 
2012.0

>  <FIRST_APPROVAL>  (907) 
2015.0

>  <ATC_CODE>  (907) 
nan

>  <ATC_CODE_DESCRIPTION>  (907) 
nan

>  <INDICATION_CLASS>  (907) 
nan

>  <SC_PATENT_NO>  (907) 
US-7112592-B2

>  <DRUG_TYPE>  (907) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (907) 
Y

>  <FIRST_IN_CLASS>  (907) 
N

>  <CHIRALITY>  (907) 
Single Stereoisomer

>  <PRODRUG>  (907) 
N

>  <ORAL>  (907) 
N

>  <PARENTERAL>  (907) 
Y

>  <TOPICAL>  (907) 
N

>  <BLACK_BOX>  (907) 
N

>  <AVAILABILITY_TYPE>  (907) 
Prescription-only

>  <WITHDRAWN_YEAR>  (907) 
nan

>  <WITHDRAWN_COUNTRY>  (907) 
nan

>  <WITHDRAWN_REASON>  (907) 
nan

>  <CANONICAL_SMILES>  (907) 
NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O

>  <name>  (907) 
Avibactam 

>  <MW>  (907) 
265.247

>  <logP>  (907) 
-1.5253

$$$$
CHEMBL182
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
  9 17  1  0
 17 18  2  0
 18  2  1  0
 17  6  1  0
M  END
>  <PARENT_MOLREGNO>  (908) 
365284

>  <SYNONYMS>  (908) 
Ganciclovir (BAN, FDA, INN, JAN, USAN, USP); Ganciclovir sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (908) 
4

>  <RESEARCH_CODES>  (908) 
BW-759U; RS-21592; RS-21592 Sodium

>  <APPLICANTS>  (908) 
Roche Palo Alto Llc; Bausch And Lomb Inc

>  <USAN_STEM>  (908) 
-vir

>  <USAN_STEM_DEFINITION>  (908) 
antivirals: antivirals (acyclovir type)

>  <USAN_STEM_SUBSTEM>  (908) 
-vir (-ciclovir)

>  <USAN_YEAR>  (908) 
1987.0

>  <FIRST_APPROVAL>  (908) 
1989.0

>  <ATC_CODE>  (908) 
J05AB06; S01AD09

>  <ATC_CODE_DESCRIPTION>  (908) 
J05AB06 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD09 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]

>  <INDICATION_CLASS>  (908) 
Antiviral

>  <SC_PATENT_NO>  (908) 
nan

>  <DRUG_TYPE>  (908) 
Natural Product-derived

>  <RULE_OF_FIVE>  (908) 
Y

>  <FIRST_IN_CLASS>  (908) 
N

>  <CHIRALITY>  (908) 
Achiral Molecule

>  <PRODRUG>  (908) 
Y

>  <ORAL>  (908) 
Y

>  <PARENTERAL>  (908) 
Y

>  <TOPICAL>  (908) 
Y

>  <BLACK_BOX>  (908) 
Y

>  <AVAILABILITY_TYPE>  (908) 
Prescription-only

>  <WITHDRAWN_YEAR>  (908) 
nan

>  <WITHDRAWN_COUNTRY>  (908) 
nan

>  <WITHDRAWN_REASON>  (908) 
nan

>  <CANONICAL_SMILES>  (908) 
Nc1nc(O)c2ncn(COC(CO)CO)c2n1

>  <name>  (908) 
Ganciclovir 

>  <MW>  (908) 
255.234

>  <logP>  (908) 
-1.5586

$$$$
CHEMBL1237021
     RDKit          

 35 41  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 12  2  1  0
  9  3  1  0
  8  4  1  0
 19 14  1  0
 26 21  1  0
 35 27  1  0
 35 30  1  0
M  END
>  <PARENT_MOLREGNO>  (909) 
699372

>  <SYNONYMS>  (909) 
Lurasidone (INN); Lurasidone HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (909) 
4

>  <RESEARCH_CODES>  (909) 
SM-13496

>  <APPLICANTS>  (909) 
Sunovion Pharmaceuticals Inc

>  <USAN_STEM>  (909) 
-sidone

>  <USAN_STEM_DEFINITION>  (909) 
antipsychotic with binding activity on serotonin (5HT2A) and dopamine (D2) receptors

>  <USAN_STEM_SUBSTEM>  (909) 
-sidone

>  <USAN_YEAR>  (909) 
2005.0

>  <FIRST_APPROVAL>  (909) 
2010.0

>  <ATC_CODE>  (909) 
N05AE05

>  <ATC_CODE_DESCRIPTION>  (909) 
N05AE05 [Nervous System:Psycholeptics:Antipsychotics:Indole derivatives]

>  <INDICATION_CLASS>  (909) 
nan

>  <SC_PATENT_NO>  (909) 
US-5532372-A

>  <DRUG_TYPE>  (909) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (909) 
Y

>  <FIRST_IN_CLASS>  (909) 
N

>  <CHIRALITY>  (909) 
Single Stereoisomer

>  <PRODRUG>  (909) 
N

>  <ORAL>  (909) 
Y

>  <PARENTERAL>  (909) 
N

>  <TOPICAL>  (909) 
N

>  <BLACK_BOX>  (909) 
Y

>  <AVAILABILITY_TYPE>  (909) 
Prescription-only

>  <WITHDRAWN_YEAR>  (909) 
nan

>  <WITHDRAWN_COUNTRY>  (909) 
nan

>  <WITHDRAWN_REASON>  (909) 
nan

>  <CANONICAL_SMILES>  (909) 
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc7ccccc67

>  <name>  (909) 
Lurasidone 

>  <MW>  (909) 
492.689

>  <logP>  (909) 
4.2558

$$$$
CHEMBL593
     RDKit          

 32 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  2  0
 25 28  1  0
 23 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 10  5  1  0
 16 11  1  0
 32 19  1  0
 31 21  1  0
M  END
>  <PARENT_MOLREGNO>  (910) 
19573

>  <SYNONYMS>  (910) 
Delavirdine (INN); Delavirdine mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (910) 
4

>  <RESEARCH_CODES>  (910) 
U-90152; U-90152S; U-90152T

>  <APPLICANTS>  (910) 
Viiv Healthcare Co

>  <USAN_STEM>  (910) 
-vir-

>  <USAN_STEM_DEFINITION>  (910) 
antivirals

>  <USAN_STEM_SUBSTEM>  (910) 
-vir-

>  <USAN_YEAR>  (910) 
1994.0

>  <FIRST_APPROVAL>  (910) 
1997.0

>  <ATC_CODE>  (910) 
J05AG02

>  <ATC_CODE_DESCRIPTION>  (910) 
J05AG02 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Non-nucleoside reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (910) 
Antiviral

>  <SC_PATENT_NO>  (910) 
US-6177101-B1

>  <DRUG_TYPE>  (910) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (910) 
Y

>  <FIRST_IN_CLASS>  (910) 
N

>  <CHIRALITY>  (910) 
Achiral Molecule

>  <PRODRUG>  (910) 
N

>  <ORAL>  (910) 
Y

>  <PARENTERAL>  (910) 
N

>  <TOPICAL>  (910) 
N

>  <BLACK_BOX>  (910) 
N

>  <AVAILABILITY_TYPE>  (910) 
Prescription-only

>  <WITHDRAWN_YEAR>  (910) 
nan

>  <WITHDRAWN_COUNTRY>  (910) 
nan

>  <WITHDRAWN_REASON>  (910) 
nan

>  <CANONICAL_SMILES>  (910) 
CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(NS(=O)(=O)C)ccc4[nH]3

>  <name>  (910) 
Delavirdine 

>  <MW>  (910) 
456.572

>  <logP>  (910) 
2.7171

$$$$
CHEMBL275661
     RDKit          

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  2  1  0
M  END
>  <PARENT_MOLREGNO>  (911) 
21436

>  <SYNONYMS>  (911) 
Succinimide

>  <DEVELOPMENT_PHASE>  (911) 
4

>  <RESEARCH_CODES>  (911) 
nan

>  <APPLICANTS>  (911) 
nan

>  <USAN_STEM>  (911) 
nan

>  <USAN_STEM_DEFINITION>  (911) 
nan

>  <USAN_STEM_SUBSTEM>  (911) 
nan

>  <USAN_YEAR>  (911) 
nan

>  <FIRST_APPROVAL>  (911) 
nan

>  <ATC_CODE>  (911) 
G04BX10

>  <ATC_CODE_DESCRIPTION>  (911) 
G04BX10 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Other urologicals]

>  <INDICATION_CLASS>  (911) 
nan

>  <SC_PATENT_NO>  (911) 
nan

>  <DRUG_TYPE>  (911) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (911) 
Y

>  <FIRST_IN_CLASS>  (911) 
N

>  <CHIRALITY>  (911) 
Achiral Molecule

>  <PRODRUG>  (911) 
N

>  <ORAL>  (911) 
N

>  <PARENTERAL>  (911) 
N

>  <TOPICAL>  (911) 
N

>  <BLACK_BOX>  (911) 
N

>  <AVAILABILITY_TYPE>  (911) 
Unknown

>  <WITHDRAWN_YEAR>  (911) 
nan

>  <WITHDRAWN_COUNTRY>  (911) 
nan

>  <WITHDRAWN_REASON>  (911) 
nan

>  <CANONICAL_SMILES>  (911) 
O=C1CCC(=O)N1

>  <name>  (911) 
Succinimide

>  <MW>  (911) 
99.089

>  <logP>  (911) 
-0.577

$$$$
CHEMBL1534
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 14 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26  2  1  0
 24  4  2  0
 13  6  1  0
M  END
>  <PARENT_MOLREGNO>  (912) 
429204

>  <SYNONYMS>  (912) 
Riboflavin (BAN, FDA, INN, USP); Riboflavin Tetrabutyrate (JAN)

>  <DEVELOPMENT_PHASE>  (912) 
4

>  <RESEARCH_CODES>  (912) 
nan

>  <APPLICANTS>  (912) 
Sandoz Canada Inc; Hospira Inc

>  <USAN_STEM>  (912) 
nan

>  <USAN_STEM_DEFINITION>  (912) 
nan

>  <USAN_STEM_SUBSTEM>  (912) 
nan

>  <USAN_YEAR>  (912) 
nan

>  <FIRST_APPROVAL>  (912) 
1993.0

>  <ATC_CODE>  (912) 
A11HA04

>  <ATC_CODE_DESCRIPTION>  (912) 
A11HA04 [Alimentary Tract And Metabolism:Vitamins:Other Plain Vitamin Preparations:Other plain vitamin preparations]

>  <INDICATION_CLASS>  (912) 
Vitamin (enzyme co-factor)

>  <SC_PATENT_NO>  (912) 
nan

>  <DRUG_TYPE>  (912) 
Natural Product-derived

>  <RULE_OF_FIVE>  (912) 
Y

>  <FIRST_IN_CLASS>  (912) 
N

>  <CHIRALITY>  (912) 
Single Stereoisomer

>  <PRODRUG>  (912) 
N

>  <ORAL>  (912) 
N

>  <PARENTERAL>  (912) 
Y

>  <TOPICAL>  (912) 
N

>  <BLACK_BOX>  (912) 
N

>  <AVAILABILITY_TYPE>  (912) 
Prescription-only

>  <WITHDRAWN_YEAR>  (912) 
nan

>  <WITHDRAWN_COUNTRY>  (912) 
nan

>  <WITHDRAWN_REASON>  (912) 
nan

>  <CANONICAL_SMILES>  (912) 
Cc1cc2N=C3C(=O)NC(=O)N=C3N(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C

>  <name>  (912) 
Riboflavin 

>  <MW>  (912) 
376.369

>  <logP>  (912) 
-1.72356

$$$$
CHEMBL960
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
  6  2  2  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (913) 
93895

>  <SYNONYMS>  (913) 
Leflunomide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (913) 
4

>  <RESEARCH_CODES>  (913) 
HWA-486; SU-101; Sulol

>  <APPLICANTS>  (913) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (913) 
nan

>  <USAN_STEM_DEFINITION>  (913) 
nan

>  <USAN_STEM_SUBSTEM>  (913) 
nan

>  <USAN_YEAR>  (913) 
1998.0

>  <FIRST_APPROVAL>  (913) 
1998.0

>  <ATC_CODE>  (913) 
L04AA13

>  <ATC_CODE_DESCRIPTION>  (913) 
L04AA13 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants]

>  <INDICATION_CLASS>  (913) 
nan

>  <SC_PATENT_NO>  (913) 
nan

>  <DRUG_TYPE>  (913) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (913) 
Y

>  <FIRST_IN_CLASS>  (913) 
N

>  <CHIRALITY>  (913) 
Achiral Molecule

>  <PRODRUG>  (913) 
Y

>  <ORAL>  (913) 
Y

>  <PARENTERAL>  (913) 
N

>  <TOPICAL>  (913) 
N

>  <BLACK_BOX>  (913) 
Y

>  <AVAILABILITY_TYPE>  (913) 
Prescription-only

>  <WITHDRAWN_YEAR>  (913) 
nan

>  <WITHDRAWN_COUNTRY>  (913) 
nan

>  <WITHDRAWN_REASON>  (913) 
nan

>  <CANONICAL_SMILES>  (913) 
Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F

>  <name>  (913) 
Leflunomide 

>  <MW>  (913) 
270.21

>  <logP>  (913) 
3.25412

$$$$
CHEMBL1213456
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 12 16  1  0
 10 17  1  0
 17 18  2  0
 17 19  1  0
  4 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 16  3  1  0
 16  7  2  0
 15 13  1  0
 27 20  1  0
M  END
>  <PARENT_MOLREGNO>  (914) 
685299

>  <SYNONYMS>  (914) 
Nemonoxacin

>  <DEVELOPMENT_PHASE>  (914) 
4

>  <RESEARCH_CODES>  (914) 
TG-873870

>  <APPLICANTS>  (914) 
nan

>  <USAN_STEM>  (914) 
-oxacin

>  <USAN_STEM_DEFINITION>  (914) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (914) 
-oxacin

>  <USAN_YEAR>  (914) 
nan

>  <FIRST_APPROVAL>  (914) 
nan

>  <ATC_CODE>  (914) 
J01MB08

>  <ATC_CODE_DESCRIPTION>  (914) 
J01MB08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Other quinolones]

>  <INDICATION_CLASS>  (914) 
nan

>  <SC_PATENT_NO>  (914) 
nan

>  <DRUG_TYPE>  (914) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (914) 
Y

>  <FIRST_IN_CLASS>  (914) 
N

>  <CHIRALITY>  (914) 
Single Stereoisomer

>  <PRODRUG>  (914) 
N

>  <ORAL>  (914) 
N

>  <PARENTERAL>  (914) 
N

>  <TOPICAL>  (914) 
N

>  <BLACK_BOX>  (914) 
N

>  <AVAILABILITY_TYPE>  (914) 
Unknown

>  <WITHDRAWN_YEAR>  (914) 
nan

>  <WITHDRAWN_COUNTRY>  (914) 
nan

>  <WITHDRAWN_REASON>  (914) 
nan

>  <CANONICAL_SMILES>  (914) 
COc1c(ccc2C(=O)C(=CN(C3CC3)c12)C(=O)O)N4C[C@@H](C)C[C@H](N)C4

>  <name>  (914) 
Nemonoxacin

>  <MW>  (914) 
371.437

>  <logP>  (914) 
2.2167

$$$$
CHEMBL1513
     RDKit          

 32 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  7 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 14  5  1  0
 11  7  1  0
 21 16  1  0
 27 22  1  0
 32 28  2  0
M  END
>  <PARENT_MOLREGNO>  (915) 
421066

>  <SYNONYMS>  (915) 
Irbesartan (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (915) 
4

>  <RESEARCH_CODES>  (915) 
BMS-186295; SR-47436

>  <APPLICANTS>  (915) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (915) 
-sartan

>  <USAN_STEM_DEFINITION>  (915) 
angiotensin II receptor antagonists

>  <USAN_STEM_SUBSTEM>  (915) 
-sartan

>  <USAN_YEAR>  (915) 
1996.0

>  <FIRST_APPROVAL>  (915) 
1997.0

>  <ATC_CODE>  (915) 
C09CA04

>  <ATC_CODE_DESCRIPTION>  (915) 
C09CA04 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Angiotensin Ii Antagonists, Plain:Angiotensin II antagonists, plain]

>  <INDICATION_CLASS>  (915) 
Antihypertensive (angiotensin II receptor antagonist)

>  <SC_PATENT_NO>  (915) 
US-5994348-A

>  <DRUG_TYPE>  (915) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (915) 
Y

>  <FIRST_IN_CLASS>  (915) 
N

>  <CHIRALITY>  (915) 
Achiral Molecule

>  <PRODRUG>  (915) 
N

>  <ORAL>  (915) 
Y

>  <PARENTERAL>  (915) 
N

>  <TOPICAL>  (915) 
N

>  <BLACK_BOX>  (915) 
Y

>  <AVAILABILITY_TYPE>  (915) 
Prescription-only

>  <WITHDRAWN_YEAR>  (915) 
nan

>  <WITHDRAWN_COUNTRY>  (915) 
nan

>  <WITHDRAWN_REASON>  (915) 
nan

>  <CANONICAL_SMILES>  (915) 
CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5

>  <name>  (915) 
Irbesartan 

>  <MW>  (915) 
428.54

>  <logP>  (915) 
4.7774

$$$$
CHEMBL1757
     RDKit          

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  5  8  1  0
  4  2  1  0
M  END
>  <PARENT_MOLREGNO>  (916) 
581859

>  <SYNONYMS>  (916) 
Fosfomycin (BAN, INN, USAN); Fosfomycin Calcium (JAN); Fosfomycin Sodium (JAN); Fosfomycin Tromethamine (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (916) 
4

>  <RESEARCH_CODES>  (916) 
Z-1282

>  <APPLICANTS>  (916) 
Zambon Spa Italy; Merck

>  <USAN_STEM>  (916) 
fos-; -mycin

>  <USAN_STEM_DEFINITION>  (916) 
phosphoro-derivatives; antibiotics (Streptomyces strains)

>  <USAN_STEM_SUBSTEM>  (916) 
fos-; -mycin

>  <USAN_YEAR>  (916) 
1970.0

>  <FIRST_APPROVAL>  (916) 
1996.0

>  <ATC_CODE>  (916) 
J01XX01

>  <ATC_CODE_DESCRIPTION>  (916) 
J01XX01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Other antibacterials]

>  <INDICATION_CLASS>  (916) 
Antibacterial

>  <SC_PATENT_NO>  (916) 
nan

>  <DRUG_TYPE>  (916) 
Natural Product-derived

>  <RULE_OF_FIVE>  (916) 
Y

>  <FIRST_IN_CLASS>  (916) 
N

>  <CHIRALITY>  (916) 
Single Stereoisomer

>  <PRODRUG>  (916) 
N

>  <ORAL>  (916) 
Y

>  <PARENTERAL>  (916) 
N

>  <TOPICAL>  (916) 
N

>  <BLACK_BOX>  (916) 
N

>  <AVAILABILITY_TYPE>  (916) 
Prescription-only

>  <WITHDRAWN_YEAR>  (916) 
nan

>  <WITHDRAWN_COUNTRY>  (916) 
nan

>  <WITHDRAWN_REASON>  (916) 
nan

>  <CANONICAL_SMILES>  (916) 
C[C@@H]1O[C@@H]1P(=O)(O)O

>  <name>  (916) 
Fosfomycin 

>  <MW>  (916) 
138.059

>  <logP>  (916) 
-0.0911

$$$$
CHEMBL820
     RDKit          

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
M  END
>  <PARENT_MOLREGNO>  (917) 
56644

>  <SYNONYMS>  (917) 
Busulfan (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (917) 
4

>  <RESEARCH_CODES>  (917) 
nan

>  <APPLICANTS>  (917) 
Otsuka Pharmaceutical Co Ltd; Aspen Global Inc

>  <USAN_STEM>  (917) 
-sulfan

>  <USAN_STEM_DEFINITION>  (917) 
antineoplastics, alkylating agents (methanesulfonate derivatives)

>  <USAN_STEM_SUBSTEM>  (917) 
-sulfan

>  <USAN_YEAR>  (917) 
nan

>  <FIRST_APPROVAL>  (917) 
1954.0

>  <ATC_CODE>  (917) 
L01AB01

>  <ATC_CODE_DESCRIPTION>  (917) 
L01AB01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Alkyl sulfonates]

>  <INDICATION_CLASS>  (917) 
nan

>  <SC_PATENT_NO>  (917) 
nan

>  <DRUG_TYPE>  (917) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (917) 
Y

>  <FIRST_IN_CLASS>  (917) 
N

>  <CHIRALITY>  (917) 
Achiral Molecule

>  <PRODRUG>  (917) 
N

>  <ORAL>  (917) 
Y

>  <PARENTERAL>  (917) 
Y

>  <TOPICAL>  (917) 
N

>  <BLACK_BOX>  (917) 
Y

>  <AVAILABILITY_TYPE>  (917) 
Prescription-only

>  <WITHDRAWN_YEAR>  (917) 
nan

>  <WITHDRAWN_COUNTRY>  (917) 
nan

>  <WITHDRAWN_REASON>  (917) 
nan

>  <CANONICAL_SMILES>  (917) 
CS(=O)(=O)OCCCCOS(=O)(=O)C

>  <name>  (917) 
Busulfan 

>  <MW>  (917) 
246.306

>  <logP>  (917) 
-0.281

$$$$
CHEMBL666
     RDKit          

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  4  7  1  0
M  END
>  <PARENT_MOLREGNO>  (918) 
27780

>  <SYNONYMS>  (918) 
Foscarnet Sodium (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (918) 
4

>  <RESEARCH_CODES>  (918) 
EHB-776

>  <APPLICANTS>  (918) 
Clinigen Healthcare Ltd

>  <USAN_STEM>  (918) 
fos-

>  <USAN_STEM_DEFINITION>  (918) 
phosphoro-derivatives

>  <USAN_STEM_SUBSTEM>  (918) 
fos-

>  <USAN_YEAR>  (918) 
1985.0

>  <FIRST_APPROVAL>  (918) 
1991.0

>  <ATC_CODE>  (918) 
J05AD01

>  <ATC_CODE_DESCRIPTION>  (918) 
J05AD01 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Phosphonic acid derivatives]

>  <INDICATION_CLASS>  (918) 
Antiviral

>  <SC_PATENT_NO>  (918) 
nan

>  <DRUG_TYPE>  (918) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (918) 
Y

>  <FIRST_IN_CLASS>  (918) 
N

>  <CHIRALITY>  (918) 
Achiral Molecule

>  <PRODRUG>  (918) 
N

>  <ORAL>  (918) 
N

>  <PARENTERAL>  (918) 
Y

>  <TOPICAL>  (918) 
N

>  <BLACK_BOX>  (918) 
Y

>  <AVAILABILITY_TYPE>  (918) 
Prescription-only

>  <WITHDRAWN_YEAR>  (918) 
nan

>  <WITHDRAWN_COUNTRY>  (918) 
nan

>  <WITHDRAWN_REASON>  (918) 
nan

>  <CANONICAL_SMILES>  (918) 
OC(=O)P(=O)(O)O

>  <name>  (918) 
Foscarnet Sodium 

>  <MW>  (918) 
126.004

>  <logP>  (918) 
-0.1579

$$$$
CHEMBL564
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  7  1  0
 13  8  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (919) 
16391

>  <SYNONYMS>  (919) 
Promazine (BAN, INN); Promazine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (919) 
4

>  <RESEARCH_CODES>  (919) 
nan

>  <APPLICANTS>  (919) 
Wyeth Ayerst Laboratories; Baxter Healthcare Corp Anesthesia Critical Care

>  <USAN_STEM>  (919) 
nan

>  <USAN_STEM_DEFINITION>  (919) 
nan

>  <USAN_STEM_SUBSTEM>  (919) 
nan

>  <USAN_YEAR>  (919) 
nan

>  <FIRST_APPROVAL>  (919) 
1956.0

>  <ATC_CODE>  (919) 
N05AA03

>  <ATC_CODE_DESCRIPTION>  (919) 
N05AA03 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with aliphatic side-chain]

>  <INDICATION_CLASS>  (919) 
Antipsychotic

>  <SC_PATENT_NO>  (919) 
nan

>  <DRUG_TYPE>  (919) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (919) 
Y

>  <FIRST_IN_CLASS>  (919) 
N

>  <CHIRALITY>  (919) 
Achiral Molecule

>  <PRODRUG>  (919) 
N

>  <ORAL>  (919) 
Y

>  <PARENTERAL>  (919) 
Y

>  <TOPICAL>  (919) 
N

>  <BLACK_BOX>  (919) 
N

>  <AVAILABILITY_TYPE>  (919) 
Discontinued

>  <WITHDRAWN_YEAR>  (919) 
nan

>  <WITHDRAWN_COUNTRY>  (919) 
nan

>  <WITHDRAWN_REASON>  (919) 
nan

>  <CANONICAL_SMILES>  (919) 
CN(C)CCCN1c2ccccc2Sc3ccccc13

>  <name>  (919) 
Promazine 

>  <MW>  (919) 
284.428

>  <logP>  (919) 
4.241

$$$$
CHEMBL1750
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
  8  2  1  0
 11  7  1  0
 19 12  1  0
M  END
>  <PARENT_MOLREGNO>  (920) 
581569

>  <SYNONYMS>  (920) 
Clofarabine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (920) 
4

>  <RESEARCH_CODES>  (920) 
nan

>  <APPLICANTS>  (920) 
Genzyme Corp

>  <USAN_STEM>  (920) 
-arabine

>  <USAN_STEM_DEFINITION>  (920) 
antineoplastics (arabinofuranosyl derivatives)

>  <USAN_STEM_SUBSTEM>  (920) 
-arabine

>  <USAN_YEAR>  (920) 
2003.0

>  <FIRST_APPROVAL>  (920) 
2004.0

>  <ATC_CODE>  (920) 
L01BB06

>  <ATC_CODE_DESCRIPTION>  (920) 
L01BB06 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Purine analogues]

>  <INDICATION_CLASS>  (920) 
nan

>  <SC_PATENT_NO>  (920) 
US-5661136-A

>  <DRUG_TYPE>  (920) 
Natural Product-derived

>  <RULE_OF_FIVE>  (920) 
Y

>  <FIRST_IN_CLASS>  (920) 
N

>  <CHIRALITY>  (920) 
Single Stereoisomer

>  <PRODRUG>  (920) 
Y

>  <ORAL>  (920) 
N

>  <PARENTERAL>  (920) 
Y

>  <TOPICAL>  (920) 
N

>  <BLACK_BOX>  (920) 
N

>  <AVAILABILITY_TYPE>  (920) 
Prescription-only

>  <WITHDRAWN_YEAR>  (920) 
nan

>  <WITHDRAWN_COUNTRY>  (920) 
nan

>  <WITHDRAWN_REASON>  (920) 
nan

>  <CANONICAL_SMILES>  (920) 
Nc1nc(Cl)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F

>  <name>  (920) 
Clofarabine 

>  <MW>  (920) 
303.681

>  <logP>  (920) 
-0.3494

$$$$
CHEMBL76370
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  2  0
 22 12  1  0
 22 15  1  0
M  END
>  <PARENT_MOLREGNO>  (921) 
122247

>  <SYNONYMS>  (921) 
Tegaserod (BAN, INN, USAN); Tegaserod Maleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (921) 
4

>  <RESEARCH_CODES>  (921) 
SDZ-HTF-919; HTF-919

>  <APPLICANTS>  (921) 
Novartis Pharmaceuticals Corp; Novartis

>  <USAN_STEM>  (921) 
-serod

>  <USAN_STEM_DEFINITION>  (921) 
serotonin receptor antagonists and partial agonists

>  <USAN_STEM_SUBSTEM>  (921) 
-serod

>  <USAN_YEAR>  (921) 
1999.0

>  <FIRST_APPROVAL>  (921) 
2002.0

>  <ATC_CODE>  (921) 
A06AX06

>  <ATC_CODE_DESCRIPTION>  (921) 
A06AX06 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Other drugs for constipation]

>  <INDICATION_CLASS>  (921) 
nan

>  <SC_PATENT_NO>  (921) 
nan

>  <DRUG_TYPE>  (921) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (921) 
Y

>  <FIRST_IN_CLASS>  (921) 
N

>  <CHIRALITY>  (921) 
Achiral Molecule

>  <PRODRUG>  (921) 
N

>  <ORAL>  (921) 
Y

>  <PARENTERAL>  (921) 
N

>  <TOPICAL>  (921) 
N

>  <BLACK_BOX>  (921) 
N

>  <AVAILABILITY_TYPE>  (921) 
Withdrawn

>  <WITHDRAWN_YEAR>  (921) 
2007.0

>  <WITHDRAWN_COUNTRY>  (921) 
United States

>  <WITHDRAWN_REASON>  (921) 
Risk for heart attack, stroke, and unstable angina

>  <CANONICAL_SMILES>  (921) 
CCCCCNC(=N)N\N=C\c1c[nH]c2ccc(OC)cc12

>  <name>  (921) 
Tegaserod 

>  <MW>  (921) 
301.394

>  <logP>  (921) 
2.81457

$$$$
CHEMBL561
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 15 23  1  0
 23 24  1  0
 23 25  2  0
 25  3  1  0
 25 11  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (922) 
16278

>  <SYNONYMS>  (922) 
Lomefloxacin (BAN, INN, USAN); Lomefloxacin HCl (FDA, JAN, USAN); Lomefloxacin Mesylate (USAN)

>  <DEVELOPMENT_PHASE>  (922) 
4

>  <RESEARCH_CODES>  (922) 
SC-47111A; NY-198; SC-47111; SC-47111B

>  <APPLICANTS>  (922) 
Pharmacia Corp

>  <USAN_STEM>  (922) 
-oxacin

>  <USAN_STEM_DEFINITION>  (922) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (922) 
-oxacin

>  <USAN_YEAR>  (922) 
1988.0

>  <FIRST_APPROVAL>  (922) 
1992.0

>  <ATC_CODE>  (922) 
J01MA07; S01AE04

>  <ATC_CODE_DESCRIPTION>  (922) 
J01MA07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE04 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]

>  <INDICATION_CLASS>  (922) 
Antibacterial

>  <SC_PATENT_NO>  (922) 
nan

>  <DRUG_TYPE>  (922) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (922) 
Y

>  <FIRST_IN_CLASS>  (922) 
N

>  <CHIRALITY>  (922) 
Racemic Mixture

>  <PRODRUG>  (922) 
N

>  <ORAL>  (922) 
Y

>  <PARENTERAL>  (922) 
N

>  <TOPICAL>  (922) 
N

>  <BLACK_BOX>  (922) 
N

>  <AVAILABILITY_TYPE>  (922) 
Discontinued

>  <WITHDRAWN_YEAR>  (922) 
nan

>  <WITHDRAWN_COUNTRY>  (922) 
nan

>  <WITHDRAWN_REASON>  (922) 
nan

>  <CANONICAL_SMILES>  (922) 
CCN1C=C(C(=O)O)C(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12

>  <name>  (922) 
Lomefloxacin 

>  <MW>  (922) 
351.353

>  <logP>  (922) 
1.7959

$$$$
CHEMBL1336
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 12 28  1  0
 28 29  2  0
  7 30  2  0
 30 31  1  0
 31 32  2  0
 32  5  1  0
 29  9  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (923) 
276734

>  <SYNONYMS>  (923) 
Sorafenib (INN, USAN); Sorafenib Tosylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (923) 
4

>  <RESEARCH_CODES>  (923) 
BAY-43-9006; BAY-54-9085

>  <APPLICANTS>  (923) 
Bayer Healthcare Pharmaceuticals Inc; Bayer Healthcare Ag

>  <USAN_STEM>  (923) 
-rafenib

>  <USAN_STEM_DEFINITION>  (923) 
raf kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (923) 
-rafenib

>  <USAN_YEAR>  (923) 
2007.0

>  <FIRST_APPROVAL>  (923) 
2005.0

>  <ATC_CODE>  (923) 
L01XE05

>  <ATC_CODE_DESCRIPTION>  (923) 
L01XE05 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (923) 
nan

>  <SC_PATENT_NO>  (923) 
US-7235576-B1

>  <DRUG_TYPE>  (923) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (923) 
Y

>  <FIRST_IN_CLASS>  (923) 
N

>  <CHIRALITY>  (923) 
Achiral Molecule

>  <PRODRUG>  (923) 
N

>  <ORAL>  (923) 
Y

>  <PARENTERAL>  (923) 
N

>  <TOPICAL>  (923) 
N

>  <BLACK_BOX>  (923) 
N

>  <AVAILABILITY_TYPE>  (923) 
Prescription-only

>  <WITHDRAWN_YEAR>  (923) 
nan

>  <WITHDRAWN_COUNTRY>  (923) 
nan

>  <WITHDRAWN_REASON>  (923) 
nan

>  <CANONICAL_SMILES>  (923) 
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1

>  <name>  (923) 
Sorafenib 

>  <MW>  (923) 
464.831

>  <logP>  (923) 
5.5497

$$$$
CHEMBL1200607
     RDKit          

 20 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
M  END
>  <PARENT_MOLREGNO>  (924) 
674558

>  <SYNONYMS>  (924) 
Perflexane (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (924) 
4

>  <RESEARCH_CODES>  (924) 
AF-0150; AF0150

>  <APPLICANTS>  (924) 
Imcor Pharmaceuticals Co

>  <USAN_STEM>  (924) 
nan

>  <USAN_STEM_DEFINITION>  (924) 
nan

>  <USAN_STEM_SUBSTEM>  (924) 
nan

>  <USAN_YEAR>  (924) 
1999.0

>  <FIRST_APPROVAL>  (924) 
2002.0

>  <ATC_CODE>  (924) 
nan

>  <ATC_CODE_DESCRIPTION>  (924) 
nan

>  <INDICATION_CLASS>  (924) 
nan

>  <SC_PATENT_NO>  (924) 
US-5798091-A

>  <DRUG_TYPE>  (924) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (924) 
Y

>  <FIRST_IN_CLASS>  (924) 
N

>  <CHIRALITY>  (924) 
Achiral Molecule

>  <PRODRUG>  (924) 
N

>  <ORAL>  (924) 
N

>  <PARENTERAL>  (924) 
Y

>  <TOPICAL>  (924) 
N

>  <BLACK_BOX>  (924) 
N

>  <AVAILABILITY_TYPE>  (924) 
Discontinued

>  <WITHDRAWN_YEAR>  (924) 
nan

>  <WITHDRAWN_COUNTRY>  (924) 
nan

>  <WITHDRAWN_REASON>  (924) 
nan

>  <CANONICAL_SMILES>  (924) 
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

>  <name>  (924) 
Perflexane 

>  <MW>  (924) 
338.038

>  <logP>  (924) 
4.6522

$$$$
CHEMBL5
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17  3  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (925) 
147

>  <SYNONYMS>  (925) 
Nalidixic Acid (BAN, FDA, INN, JAN, USAN, USP); Nalidixate Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (925) 
4

>  <RESEARCH_CODES>  (925) 
WIN-18320; WIN-183203

>  <APPLICANTS>  (925) 
Sterling Winthrop; Sanofi Aventis Us Llc

>  <USAN_STEM>  (925) 
nan

>  <USAN_STEM_DEFINITION>  (925) 
nan

>  <USAN_STEM_SUBSTEM>  (925) 
nan

>  <USAN_YEAR>  (925) 
1962.0

>  <FIRST_APPROVAL>  (925) 
1964.0

>  <ATC_CODE>  (925) 
J01MB02

>  <ATC_CODE_DESCRIPTION>  (925) 
J01MB02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Other quinolones]

>  <INDICATION_CLASS>  (925) 
Antibacterial

>  <SC_PATENT_NO>  (925) 
nan

>  <DRUG_TYPE>  (925) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (925) 
Y

>  <FIRST_IN_CLASS>  (925) 
N

>  <CHIRALITY>  (925) 
Achiral Molecule

>  <PRODRUG>  (925) 
N

>  <ORAL>  (925) 
Y

>  <PARENTERAL>  (925) 
N

>  <TOPICAL>  (925) 
N

>  <BLACK_BOX>  (925) 
N

>  <AVAILABILITY_TYPE>  (925) 
Discontinued

>  <WITHDRAWN_YEAR>  (925) 
nan

>  <WITHDRAWN_COUNTRY>  (925) 
nan

>  <WITHDRAWN_REASON>  (925) 
nan

>  <CANONICAL_SMILES>  (925) 
CCN1C=C(C(=O)O)C(=O)c2ccc(C)nc12

>  <name>  (925) 
Nalidixic Acid 

>  <MW>  (925) 
232.239

>  <logP>  (925) 
1.42302

$$$$
CHEMBL44618
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
M  END
>  <PARENT_MOLREGNO>  (926) 
67839

>  <SYNONYMS>  (926) 
Chloroform (NF)

>  <DEVELOPMENT_PHASE>  (926) 
4

>  <RESEARCH_CODES>  (926) 
nan

>  <APPLICANTS>  (926) 
nan

>  <USAN_STEM>  (926) 
nan

>  <USAN_STEM_DEFINITION>  (926) 
nan

>  <USAN_STEM_SUBSTEM>  (926) 
nan

>  <USAN_YEAR>  (926) 
nan

>  <FIRST_APPROVAL>  (926) 
nan

>  <ATC_CODE>  (926) 
N01AB02

>  <ATC_CODE_DESCRIPTION>  (926) 
N01AB02 [Nervous System:Anesthetics:Anesthetics, General:Halogenated hydrocarbons]

>  <INDICATION_CLASS>  (926) 
nan

>  <SC_PATENT_NO>  (926) 
nan

>  <DRUG_TYPE>  (926) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (926) 
Y

>  <FIRST_IN_CLASS>  (926) 
N

>  <CHIRALITY>  (926) 
Achiral Molecule

>  <PRODRUG>  (926) 
N

>  <ORAL>  (926) 
N

>  <PARENTERAL>  (926) 
N

>  <TOPICAL>  (926) 
N

>  <BLACK_BOX>  (926) 
N

>  <AVAILABILITY_TYPE>  (926) 
Withdrawn

>  <WITHDRAWN_YEAR>  (926) 
nan

>  <WITHDRAWN_COUNTRY>  (926) 
United States

>  <WITHDRAWN_REASON>  (926) 
nan

>  <CANONICAL_SMILES>  (926) 
ClC(Cl)Cl

>  <name>  (926) 
Chloroform 

>  <MW>  (926) 
119.378

>  <logP>  (926) 
1.9864

$$$$
CHEMBL11
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  7  1  0
 13  8  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (927) 
605

>  <SYNONYMS>  (927) 
Imipramine (BAN, INN); Imipramine Pamoate (FDA); Imipramine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (927) 
4

>  <RESEARCH_CODES>  (927) 
nan

>  <APPLICANTS>  (927) 
Sanofi Aventis Us Llc; Novartis Pharmaceuticals Corp; Mallinckrodt Inc; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (927) 
-pramine

>  <USAN_STEM_DEFINITION>  (927) 
antidepressants (imipramine type)

>  <USAN_STEM_SUBSTEM>  (927) 
-pramine

>  <USAN_YEAR>  (927) 
nan

>  <FIRST_APPROVAL>  (927) 
1959.0

>  <ATC_CODE>  (927) 
N06AA02

>  <ATC_CODE_DESCRIPTION>  (927) 
N06AA02 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (927) 
Antidepressant

>  <SC_PATENT_NO>  (927) 
nan

>  <DRUG_TYPE>  (927) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (927) 
Y

>  <FIRST_IN_CLASS>  (927) 
N

>  <CHIRALITY>  (927) 
Achiral Molecule

>  <PRODRUG>  (927) 
N

>  <ORAL>  (927) 
Y

>  <PARENTERAL>  (927) 
Y

>  <TOPICAL>  (927) 
N

>  <BLACK_BOX>  (927) 
Y

>  <AVAILABILITY_TYPE>  (927) 
Prescription-only

>  <WITHDRAWN_YEAR>  (927) 
nan

>  <WITHDRAWN_COUNTRY>  (927) 
nan

>  <WITHDRAWN_REASON>  (927) 
nan

>  <CANONICAL_SMILES>  (927) 
CN(C)CCCN1c2ccccc2CCc3ccccc13

>  <name>  (927) 
Imipramine 

>  <MW>  (927) 
280.415

>  <logP>  (927) 
3.875

$$$$
CHEMBL1762
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (928) 
583520

>  <SYNONYMS>  (928) 
Tocainide (BAN, INN, USAN); Tocainide HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (928) 
4

>  <RESEARCH_CODES>  (928) 
W-36095

>  <APPLICANTS>  (928) 
Astrazeneca Pharmaceuticals Lp

>  <USAN_STEM>  (928) 
nan

>  <USAN_STEM_DEFINITION>  (928) 
nan

>  <USAN_STEM_SUBSTEM>  (928) 
nan

>  <USAN_YEAR>  (928) 
1976.0

>  <FIRST_APPROVAL>  (928) 
1984.0

>  <ATC_CODE>  (928) 
C01BB03

>  <ATC_CODE_DESCRIPTION>  (928) 
C01BB03 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ib]

>  <INDICATION_CLASS>  (928) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (928) 
nan

>  <DRUG_TYPE>  (928) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (928) 
Y

>  <FIRST_IN_CLASS>  (928) 
N

>  <CHIRALITY>  (928) 
Racemic Mixture

>  <PRODRUG>  (928) 
N

>  <ORAL>  (928) 
Y

>  <PARENTERAL>  (928) 
N

>  <TOPICAL>  (928) 
N

>  <BLACK_BOX>  (928) 
Y

>  <AVAILABILITY_TYPE>  (928) 
Discontinued

>  <WITHDRAWN_YEAR>  (928) 
nan

>  <WITHDRAWN_COUNTRY>  (928) 
nan

>  <WITHDRAWN_REASON>  (928) 
nan

>  <CANONICAL_SMILES>  (928) 
CC(N)C(=O)Nc1c(C)cccc1C

>  <name>  (928) 
Tocainide 

>  <MW>  (928) 
192.262

>  <logP>  (928) 
1.58914

$$$$
CHEMBL645
     RDKit          

 23 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 13 22  1  0
 22 23  2  0
 23 10  1  0
M  END
>  <PARENT_MOLREGNO>  (929) 
27417

>  <SYNONYMS>  (929) 
Bisoprolol (BAN, INN, USAN); Bisoprolol Fumarate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (929) 
4

>  <RESEARCH_CODES>  (929) 
CL-297939; EMD-33512; EMD-33-512

>  <APPLICANTS>  (929) 
Teva Womens Health Inc

>  <USAN_STEM>  (929) 
-olol

>  <USAN_STEM_DEFINITION>  (929) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (929) 
-olol

>  <USAN_YEAR>  (929) 
1987.0

>  <FIRST_APPROVAL>  (929) 
1992.0

>  <ATC_CODE>  (929) 
C07AB57; C07AB07

>  <ATC_CODE_DESCRIPTION>  (929) 
C07AB57 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]; C07AB07 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]

>  <INDICATION_CLASS>  (929) 
Antihypertensive (beta-blocker)

>  <SC_PATENT_NO>  (929) 
nan

>  <DRUG_TYPE>  (929) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (929) 
Y

>  <FIRST_IN_CLASS>  (929) 
N

>  <CHIRALITY>  (929) 
Racemic Mixture

>  <PRODRUG>  (929) 
N

>  <ORAL>  (929) 
Y

>  <PARENTERAL>  (929) 
N

>  <TOPICAL>  (929) 
N

>  <BLACK_BOX>  (929) 
N

>  <AVAILABILITY_TYPE>  (929) 
Prescription-only

>  <WITHDRAWN_YEAR>  (929) 
nan

>  <WITHDRAWN_COUNTRY>  (929) 
nan

>  <WITHDRAWN_REASON>  (929) 
nan

>  <CANONICAL_SMILES>  (929) 
CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1

>  <name>  (929) 
Bisoprolol 

>  <MW>  (929) 
325.449

>  <logP>  (929) 
2.3659

$$$$
CHEMBL22
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
  5 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19 20  1  0
 20 21  1  0
 19  3  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (930) 
1216

>  <SYNONYMS>  (930) 
Trimethoprim (BAN, FDA, INN, JAN, USAN, USP); Trimethoprim HCl (FDA); Trimethoprim Sulfate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (930) 
4

>  <RESEARCH_CODES>  (930) 
BW-5672; BW-56-72; TCMDC-125538; BW-72U

>  <APPLICANTS>  (930) 
Heather Drug Co Inc; Fsc Laboratories Inc; Allergan Inc; Able Laboratories Inc; Monarch Pharmaceuticals Inc

>  <USAN_STEM>  (930) 
-prim

>  <USAN_STEM_DEFINITION>  (930) 
antibacterials (trimethoprim type)

>  <USAN_STEM_SUBSTEM>  (930) 
-prim

>  <USAN_YEAR>  (930) 
1964.0

>  <FIRST_APPROVAL>  (930) 
1973.0

>  <ATC_CODE>  (930) 
J01EA01

>  <ATC_CODE_DESCRIPTION>  (930) 
J01EA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Trimethoprim and derivatives]

>  <INDICATION_CLASS>  (930) 
Antibacterial

>  <SC_PATENT_NO>  (930) 
US-5763449-A

>  <DRUG_TYPE>  (930) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (930) 
Y

>  <FIRST_IN_CLASS>  (930) 
N

>  <CHIRALITY>  (930) 
Achiral Molecule

>  <PRODRUG>  (930) 
N

>  <ORAL>  (930) 
Y

>  <PARENTERAL>  (930) 
Y

>  <TOPICAL>  (930) 
Y

>  <BLACK_BOX>  (930) 
N

>  <AVAILABILITY_TYPE>  (930) 
Prescription-only

>  <WITHDRAWN_YEAR>  (930) 
nan

>  <WITHDRAWN_COUNTRY>  (930) 
nan

>  <WITHDRAWN_REASON>  (930) 
nan

>  <CANONICAL_SMILES>  (930) 
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC

>  <name>  (930) 
Trimethoprim 

>  <MW>  (930) 
290.323

>  <logP>  (930) 
1.2576

$$$$
CHEMBL836
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 25 27  2  0
 25 28  1  0
  9  4  1  0
 24 17  1  0
M  END
>  <PARENT_MOLREGNO>  (931) 
61181

>  <SYNONYMS>  (931) 
Tamsulosin (BAN, INN); Tamsulosin HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (931) 
4

>  <RESEARCH_CODES>  (931) 
LY-253351; R-(-)-YM-12617; YM-12617-1; YM-617

>  <APPLICANTS>  (931) 
GlaxoSmithKline; Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (931) 
nan

>  <USAN_STEM_DEFINITION>  (931) 
nan

>  <USAN_STEM_SUBSTEM>  (931) 
nan

>  <USAN_YEAR>  (931) 
1993.0

>  <FIRST_APPROVAL>  (931) 
1997.0

>  <ATC_CODE>  (931) 
G04CA02

>  <ATC_CODE_DESCRIPTION>  (931) 
G04CA02 [Genito Urinary System And Sex Hormones:Urologicals:Drugs Used In Benign Prostatic Hypertrophy:Alpha-adrenoreceptor antagonists]

>  <INDICATION_CLASS>  (931) 
Benign Prostatic Hyperplasia Therapy Agent

>  <SC_PATENT_NO>  (931) 
US-5565467-A

>  <DRUG_TYPE>  (931) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (931) 
Y

>  <FIRST_IN_CLASS>  (931) 
N

>  <CHIRALITY>  (931) 
Single Stereoisomer

>  <PRODRUG>  (931) 
N

>  <ORAL>  (931) 
Y

>  <PARENTERAL>  (931) 
N

>  <TOPICAL>  (931) 
N

>  <BLACK_BOX>  (931) 
N

>  <AVAILABILITY_TYPE>  (931) 
Prescription-only

>  <WITHDRAWN_YEAR>  (931) 
nan

>  <WITHDRAWN_COUNTRY>  (931) 
nan

>  <WITHDRAWN_REASON>  (931) 
nan

>  <CANONICAL_SMILES>  (931) 
CCOc1ccccc1OCCN[C@H](C)Cc2ccc(OC)c(c2)S(=O)(=O)N

>  <name>  (931) 
Tamsulosin 

>  <MW>  (931) 
408.52

>  <logP>  (931) 
2.3409

$$$$
CHEMBL1514
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  8 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 20 15  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (932) 
421070

>  <SYNONYMS>  (932) 
Levacetylmethadol (INN); Levomethadyl Acetate (USAN); Levomethadyl Acetate HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (932) 
4

>  <RESEARCH_CODES>  (932) 
LAAM; MK-790

>  <APPLICANTS>  (932) 
Roxane Laboratories Inc

>  <USAN_STEM>  (932) 
nan

>  <USAN_STEM_DEFINITION>  (932) 
nan

>  <USAN_STEM_SUBSTEM>  (932) 
nan

>  <USAN_YEAR>  (932) 
1972.0

>  <FIRST_APPROVAL>  (932) 
1993.0

>  <ATC_CODE>  (932) 
N07BC03

>  <ATC_CODE_DESCRIPTION>  (932) 
N07BC03 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in opioid dependence]

>  <INDICATION_CLASS>  (932) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (932) 
nan

>  <DRUG_TYPE>  (932) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (932) 
Y

>  <FIRST_IN_CLASS>  (932) 
N

>  <CHIRALITY>  (932) 
Single Stereoisomer

>  <PRODRUG>  (932) 
Y

>  <ORAL>  (932) 
Y

>  <PARENTERAL>  (932) 
N

>  <TOPICAL>  (932) 
N

>  <BLACK_BOX>  (932) 
N

>  <AVAILABILITY_TYPE>  (932) 
Withdrawn

>  <WITHDRAWN_YEAR>  (932) 
2001.0

>  <WITHDRAWN_COUNTRY>  (932) 
European Union; United States

>  <WITHDRAWN_REASON>  (932) 
Life-threatening ventricular arrhythmias (especially torsade de pointes)

>  <CANONICAL_SMILES>  (932) 
CC[C@H](OC(=O)C)C(C[C@H](C)N(C)C)(c1ccccc1)c2ccccc2

>  <name>  (932) 
Levacetylmethadol 

>  <MW>  (932) 
353.506

>  <logP>  (932) 
4.6546

$$$$
CHEMBL1194666
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (933) 
668616

>  <SYNONYMS>  (933) 
Amfepramone (INN, DCF); Diethylpropion (BAN); Diethylpropion HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (933) 
4

>  <RESEARCH_CODES>  (933) 
nan

>  <APPLICANTS>  (933) 
Watson Pharmaceuticals; Sanofi Aventis Us Llc; 3m Pharmaceuticals Inc

>  <USAN_STEM>  (933) 
nan

>  <USAN_STEM_DEFINITION>  (933) 
nan

>  <USAN_STEM_SUBSTEM>  (933) 
nan

>  <USAN_YEAR>  (933) 
nan

>  <FIRST_APPROVAL>  (933) 
1959.0

>  <ATC_CODE>  (933) 
A08AA03

>  <ATC_CODE_DESCRIPTION>  (933) 
A08AA03 [Alimentary Tract And Metabolism:Antiobesity Preparations, Excl. Diet Products:Antiobesity Preparations, Excl. Diet Products:Centrally acting antiobesity products]

>  <INDICATION_CLASS>  (933) 
Anorexic

>  <SC_PATENT_NO>  (933) 
nan

>  <DRUG_TYPE>  (933) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (933) 
Y

>  <FIRST_IN_CLASS>  (933) 
N

>  <CHIRALITY>  (933) 
Racemic Mixture

>  <PRODRUG>  (933) 
N

>  <ORAL>  (933) 
Y

>  <PARENTERAL>  (933) 
N

>  <TOPICAL>  (933) 
N

>  <BLACK_BOX>  (933) 
N

>  <AVAILABILITY_TYPE>  (933) 
Prescription-only

>  <WITHDRAWN_YEAR>  (933) 
nan

>  <WITHDRAWN_COUNTRY>  (933) 
nan

>  <WITHDRAWN_REASON>  (933) 
nan

>  <CANONICAL_SMILES>  (933) 
CCN(CC)C(C)C(=O)c1ccccc1

>  <name>  (933) 
Amfepramone 

>  <MW>  (933) 
205.301

>  <logP>  (933) 
2.5996

$$$$
CHEMBL506
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  5 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19  3  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (934) 
10389

>  <SYNONYMS>  (934) 
Primaquine (BAN, INN); Primaquine Phosphate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (934) 
4

>  <RESEARCH_CODES>  (934) 
nan

>  <APPLICANTS>  (934) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (934) 
nan

>  <USAN_STEM_DEFINITION>  (934) 
nan

>  <USAN_STEM_SUBSTEM>  (934) 
nan

>  <USAN_YEAR>  (934) 
nan

>  <FIRST_APPROVAL>  (934) 
1952.0

>  <ATC_CODE>  (934) 
P01BA03

>  <ATC_CODE_DESCRIPTION>  (934) 
P01BA03 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Aminoquinolines]

>  <INDICATION_CLASS>  (934) 
Antimalarial

>  <SC_PATENT_NO>  (934) 
nan

>  <DRUG_TYPE>  (934) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (934) 
Y

>  <FIRST_IN_CLASS>  (934) 
N

>  <CHIRALITY>  (934) 
Racemic Mixture

>  <PRODRUG>  (934) 
N

>  <ORAL>  (934) 
Y

>  <PARENTERAL>  (934) 
N

>  <TOPICAL>  (934) 
N

>  <BLACK_BOX>  (934) 
Y

>  <AVAILABILITY_TYPE>  (934) 
Prescription-only

>  <WITHDRAWN_YEAR>  (934) 
nan

>  <WITHDRAWN_COUNTRY>  (934) 
nan

>  <WITHDRAWN_REASON>  (934) 
nan

>  <CANONICAL_SMILES>  (934) 
COc1cc(NC(C)CCCN)c2ncccc2c1

>  <name>  (934) 
Primaquine 

>  <MW>  (934) 
259.353

>  <logP>  (934) 
2.7827

$$$$
CHEMBL1201325
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  6 22  1  0
 22 23  1  0
 23  2  1  0
 15 10  1  0
 21 16  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (935) 
675276

>  <SYNONYMS>  (935) 
Hexocyclium Methylsulfate (FDA, MI); Hexocyclium Metilsulfate (BAN, INN)

>  <DEVELOPMENT_PHASE>  (935) 
4

>  <RESEARCH_CODES>  (935) 
nan

>  <APPLICANTS>  (935) 
Abbvie Inc

>  <USAN_STEM>  (935) 
-ium

>  <USAN_STEM_DEFINITION>  (935) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (935) 
-ium

>  <USAN_YEAR>  (935) 
nan

>  <FIRST_APPROVAL>  (935) 
1982.0

>  <ATC_CODE>  (935) 
A03AB10

>  <ATC_CODE_DESCRIPTION>  (935) 
A03AB10 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (935) 
nan

>  <SC_PATENT_NO>  (935) 
nan

>  <DRUG_TYPE>  (935) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (935) 
Y

>  <FIRST_IN_CLASS>  (935) 
N

>  <CHIRALITY>  (935) 
Racemic Mixture

>  <PRODRUG>  (935) 
N

>  <ORAL>  (935) 
Y

>  <PARENTERAL>  (935) 
N

>  <TOPICAL>  (935) 
N

>  <BLACK_BOX>  (935) 
N

>  <AVAILABILITY_TYPE>  (935) 
Discontinued

>  <WITHDRAWN_YEAR>  (935) 
nan

>  <WITHDRAWN_COUNTRY>  (935) 
nan

>  <WITHDRAWN_REASON>  (935) 
nan

>  <CANONICAL_SMILES>  (935) 
C[N+]1(C)CCN(CC(O)(C2CCCCC2)c3ccccc3)CC1

>  <name>  (935) 
Hexocyclium Methylsulfate 

>  <MW>  (935) 
317.497

>  <logP>  (935) 
2.8465

$$$$
CHEMBL517
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  4 23  1  0
 23 24  1  0
 23 25  1  0
 16 11  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (936) 
11143

>  <SYNONYMS>  (936) 
Disopyramide (BAN, INN, JAN, USAN); Disopyramide Phosphate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (936) 
4

>  <RESEARCH_CODES>  (936) 
SC-7031; SC-13957

>  <APPLICANTS>  (936) 
Gd Searle Llc

>  <USAN_STEM>  (936) 
nan

>  <USAN_STEM_DEFINITION>  (936) 
nan

>  <USAN_STEM_SUBSTEM>  (936) 
nan

>  <USAN_YEAR>  (936) 
1970.0

>  <FIRST_APPROVAL>  (936) 
1977.0

>  <ATC_CODE>  (936) 
C01BA03

>  <ATC_CODE_DESCRIPTION>  (936) 
C01BA03 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ia]

>  <INDICATION_CLASS>  (936) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (936) 
nan

>  <DRUG_TYPE>  (936) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (936) 
Y

>  <FIRST_IN_CLASS>  (936) 
N

>  <CHIRALITY>  (936) 
Racemic Mixture

>  <PRODRUG>  (936) 
N

>  <ORAL>  (936) 
Y

>  <PARENTERAL>  (936) 
N

>  <TOPICAL>  (936) 
N

>  <BLACK_BOX>  (936) 
Y

>  <AVAILABILITY_TYPE>  (936) 
Prescription-only

>  <WITHDRAWN_YEAR>  (936) 
nan

>  <WITHDRAWN_COUNTRY>  (936) 
nan

>  <WITHDRAWN_REASON>  (936) 
nan

>  <CANONICAL_SMILES>  (936) 
CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C

>  <name>  (936) 
Disopyramide 

>  <MW>  (936) 
339.483

>  <logP>  (936) 
3.3619

$$$$
CHEMBL1303
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  4 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 11  7  1  0
 22 12  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (937) 
258371

>  <SYNONYMS>  (937) 
Rotigotine (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (937) 
4

>  <RESEARCH_CODES>  (937) 
SPM-962

>  <APPLICANTS>  (937) 
Ucb Inc

>  <USAN_STEM>  (937) 
nan

>  <USAN_STEM_DEFINITION>  (937) 
nan

>  <USAN_STEM_SUBSTEM>  (937) 
nan

>  <USAN_YEAR>  (937) 
2004.0

>  <FIRST_APPROVAL>  (937) 
2007.0

>  <ATC_CODE>  (937) 
N04BC09

>  <ATC_CODE_DESCRIPTION>  (937) 
N04BC09 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopamine agonists]

>  <INDICATION_CLASS>  (937) 
nan

>  <SC_PATENT_NO>  (937) 
US-6699498-B1

>  <DRUG_TYPE>  (937) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (937) 
Y

>  <FIRST_IN_CLASS>  (937) 
N

>  <CHIRALITY>  (937) 
Single Stereoisomer

>  <PRODRUG>  (937) 
N

>  <ORAL>  (937) 
N

>  <PARENTERAL>  (937) 
N

>  <TOPICAL>  (937) 
Y

>  <BLACK_BOX>  (937) 
Y

>  <AVAILABILITY_TYPE>  (937) 
Prescription-only

>  <WITHDRAWN_YEAR>  (937) 
nan

>  <WITHDRAWN_COUNTRY>  (937) 
nan

>  <WITHDRAWN_REASON>  (937) 
nan

>  <CANONICAL_SMILES>  (937) 
CCCN(CCc1cccs1)[C@H]2CCc3c(O)cccc3C2

>  <name>  (937) 
Rotigotine 

>  <MW>  (937) 
315.482

>  <logP>  (937) 
4.2657

$$$$
CHEMBL1200790
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 12  3  1  0
M  END
>  <PARENT_MOLREGNO>  (938) 
674741

>  <SYNONYMS>  (938) 
Methyprylon (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (938) 
4

>  <RESEARCH_CODES>  (938) 
nan

>  <APPLICANTS>  (938) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (938) 
nan

>  <USAN_STEM_DEFINITION>  (938) 
nan

>  <USAN_STEM_SUBSTEM>  (938) 
nan

>  <USAN_YEAR>  (938) 
nan

>  <FIRST_APPROVAL>  (938) 
1982.0

>  <ATC_CODE>  (938) 
N05CE02

>  <ATC_CODE_DESCRIPTION>  (938) 
N05CE02 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Piperidinedione derivatives]

>  <INDICATION_CLASS>  (938) 
nan

>  <SC_PATENT_NO>  (938) 
nan

>  <DRUG_TYPE>  (938) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (938) 
Y

>  <FIRST_IN_CLASS>  (938) 
N

>  <CHIRALITY>  (938) 
Racemic Mixture

>  <PRODRUG>  (938) 
N

>  <ORAL>  (938) 
Y

>  <PARENTERAL>  (938) 
N

>  <TOPICAL>  (938) 
N

>  <BLACK_BOX>  (938) 
N

>  <AVAILABILITY_TYPE>  (938) 
Discontinued

>  <WITHDRAWN_YEAR>  (938) 
nan

>  <WITHDRAWN_COUNTRY>  (938) 
nan

>  <WITHDRAWN_REASON>  (938) 
nan

>  <CANONICAL_SMILES>  (938) 
CCC1(CC)C(=O)NCC(C)C1=O

>  <name>  (938) 
Methyprylon 

>  <MW>  (938) 
183.251

>  <logP>  (938) 
1.1278

$$$$
CHEMBL276520
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  1 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 11  3  1  0
 11  6  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (939) 
16580

>  <SYNONYMS>  (939) 
Indalpine (BAN, INN, MI)

>  <DEVELOPMENT_PHASE>  (939) 
4

>  <RESEARCH_CODES>  (939) 
LM-5008

>  <APPLICANTS>  (939) 
nan

>  <USAN_STEM>  (939) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (939) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (939) 
-pin(e)

>  <USAN_YEAR>  (939) 
nan

>  <FIRST_APPROVAL>  (939) 
nan

>  <ATC_CODE>  (939) 
nan

>  <ATC_CODE_DESCRIPTION>  (939) 
nan

>  <INDICATION_CLASS>  (939) 
nan

>  <SC_PATENT_NO>  (939) 
nan

>  <DRUG_TYPE>  (939) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (939) 
Y

>  <FIRST_IN_CLASS>  (939) 
N

>  <CHIRALITY>  (939) 
Achiral Molecule

>  <PRODRUG>  (939) 
N

>  <ORAL>  (939) 
N

>  <PARENTERAL>  (939) 
N

>  <TOPICAL>  (939) 
N

>  <BLACK_BOX>  (939) 
N

>  <AVAILABILITY_TYPE>  (939) 
Withdrawn

>  <WITHDRAWN_YEAR>  (939) 
1985.0

>  <WITHDRAWN_COUNTRY>  (939) 
France

>  <WITHDRAWN_REASON>  (939) 
Agranulocytosis

>  <CANONICAL_SMILES>  (939) 
C(Cc1c[nH]c2ccccc12)C3CCNCC3

>  <name>  (939) 
Indalpine 

>  <MW>  (939) 
228.339

>  <logP>  (939) 
3.1001

$$$$
CHEMBL1200862
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
  2 12  1  0
 12 13  2  0
 12 14  1  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (940) 
674813

>  <SYNONYMS>  (940) 
Metirosine (BAN, INN); Metyrosine (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (940) 
4

>  <RESEARCH_CODES>  (940) 
L-588357-0; MK-781

>  <APPLICANTS>  (940) 
Biovail Technologies Ltd

>  <USAN_STEM>  (940) 
nan

>  <USAN_STEM_DEFINITION>  (940) 
nan

>  <USAN_STEM_SUBSTEM>  (940) 
nan

>  <USAN_YEAR>  (940) 
1976.0

>  <FIRST_APPROVAL>  (940) 
1979.0

>  <ATC_CODE>  (940) 
C02KB01

>  <ATC_CODE_DESCRIPTION>  (940) 
C02KB01 [Cardiovascular System:Antihypertensives:Other Antihypertensives:Tyrosine hydroxylase inhibitors]

>  <INDICATION_CLASS>  (940) 
Antihypertensive

>  <SC_PATENT_NO>  (940) 
nan

>  <DRUG_TYPE>  (940) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (940) 
Y

>  <FIRST_IN_CLASS>  (940) 
N

>  <CHIRALITY>  (940) 
Single Stereoisomer

>  <PRODRUG>  (940) 
N

>  <ORAL>  (940) 
Y

>  <PARENTERAL>  (940) 
N

>  <TOPICAL>  (940) 
N

>  <BLACK_BOX>  (940) 
N

>  <AVAILABILITY_TYPE>  (940) 
Prescription-only

>  <WITHDRAWN_YEAR>  (940) 
nan

>  <WITHDRAWN_COUNTRY>  (940) 
nan

>  <WITHDRAWN_REASON>  (940) 
nan

>  <CANONICAL_SMILES>  (940) 
C[C@](N)(Cc1ccc(O)cc1)C(=O)O

>  <name>  (940) 
Metirosine 

>  <MW>  (940) 
195.218

>  <logP>  (940) 
0.7367

$$$$
CHEMBL119
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
  5 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  2  0
 25 26  1  0
 26 27  1  0
 25  3  1  0
 19  8  1  0
 18 11  1  0
M  END
>  <PARENT_MOLREGNO>  (941) 
19101

>  <SYNONYMS>  (941) 
Trimetrexate (BAN, INN, USAN); Trimetrexate Glucuronate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (941) 
4

>  <RESEARCH_CODES>  (941) 
CI-898

>  <APPLICANTS>  (941) 
U. S. Bioscience; Parke-Davis; Medimmune Oncology Inc

>  <USAN_STEM>  (941) 
-trexate

>  <USAN_STEM_DEFINITION>  (941) 
antimetabolites (folic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (941) 
-trexate

>  <USAN_YEAR>  (941) 
1981.0

>  <FIRST_APPROVAL>  (941) 
1993.0

>  <ATC_CODE>  (941) 
P01AX07

>  <ATC_CODE_DESCRIPTION>  (941) 
P01AX07 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Other agents against amoebiasis and other protozoal diseases]

>  <INDICATION_CLASS>  (941) 
Antineoplastic

>  <SC_PATENT_NO>  (941) 
US-6017922-A

>  <DRUG_TYPE>  (941) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (941) 
Y

>  <FIRST_IN_CLASS>  (941) 
N

>  <CHIRALITY>  (941) 
Achiral Molecule

>  <PRODRUG>  (941) 
N

>  <ORAL>  (941) 
N

>  <PARENTERAL>  (941) 
Y

>  <TOPICAL>  (941) 
N

>  <BLACK_BOX>  (941) 
N

>  <AVAILABILITY_TYPE>  (941) 
Discontinued

>  <WITHDRAWN_YEAR>  (941) 
nan

>  <WITHDRAWN_COUNTRY>  (941) 
nan

>  <WITHDRAWN_REASON>  (941) 
nan

>  <CANONICAL_SMILES>  (941) 
COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC

>  <name>  (941) 
Trimetrexate 

>  <MW>  (941) 
369.425

>  <logP>  (941) 
2.74052

$$$$
CHEMBL1164729
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  3  0
  9 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 20 22  1  0
 11  6  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (942) 
647206

>  <SYNONYMS>  (942) 
Febuxostat (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (942) 
4

>  <RESEARCH_CODES>  (942) 
TMX-67

>  <APPLICANTS>  (942) 
Takeda Pharmaceuticals Usa Inc

>  <USAN_STEM>  (942) 
-stat

>  <USAN_STEM_DEFINITION>  (942) 
enzyme inhibitors: xanthine oxydase and xanthine

>  <USAN_STEM_SUBSTEM>  (942) 
-stat (-xostat)

>  <USAN_YEAR>  (942) 
2002.0

>  <FIRST_APPROVAL>  (942) 
2009.0

>  <ATC_CODE>  (942) 
M04AA03

>  <ATC_CODE_DESCRIPTION>  (942) 
M04AA03 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations inhibiting uric acid production]

>  <INDICATION_CLASS>  (942) 
nan

>  <SC_PATENT_NO>  (942) 
US-5614520-A

>  <DRUG_TYPE>  (942) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (942) 
Y

>  <FIRST_IN_CLASS>  (942) 
N

>  <CHIRALITY>  (942) 
Achiral Molecule

>  <PRODRUG>  (942) 
N

>  <ORAL>  (942) 
Y

>  <PARENTERAL>  (942) 
N

>  <TOPICAL>  (942) 
N

>  <BLACK_BOX>  (942) 
N

>  <AVAILABILITY_TYPE>  (942) 
Prescription-only

>  <WITHDRAWN_YEAR>  (942) 
nan

>  <WITHDRAWN_COUNTRY>  (942) 
nan

>  <WITHDRAWN_REASON>  (942) 
nan

>  <CANONICAL_SMILES>  (942) 
CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O

>  <name>  (942) 
Febuxostat 

>  <MW>  (942) 
316.382

>  <logP>  (942) 
3.7232

$$$$
CHEMBL1570
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 12 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 18 24  1  0
 24 25  2  0
 11  6  1  0
 25 15  1  0
M  END
>  <PARENT_MOLREGNO>  (943) 
453043

>  <SYNONYMS>  (943) 
Aldesulfone Sodium (DCF, INN); Sulfoxone Sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (943) 
4

>  <RESEARCH_CODES>  (943) 
nan

>  <APPLICANTS>  (943) 
Abbvie Inc

>  <USAN_STEM>  (943) 
nan

>  <USAN_STEM_DEFINITION>  (943) 
nan

>  <USAN_STEM_SUBSTEM>  (943) 
nan

>  <USAN_YEAR>  (943) 
nan

>  <FIRST_APPROVAL>  (943) 
1982.0

>  <ATC_CODE>  (943) 
J04BA03

>  <ATC_CODE_DESCRIPTION>  (943) 
J04BA03 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Lepra:Drugs for treatment of lepra]

>  <INDICATION_CLASS>  (943) 
nan

>  <SC_PATENT_NO>  (943) 
nan

>  <DRUG_TYPE>  (943) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (943) 
Y

>  <FIRST_IN_CLASS>  (943) 
N

>  <CHIRALITY>  (943) 
Racemic Mixture

>  <PRODRUG>  (943) 
N

>  <ORAL>  (943) 
Y

>  <PARENTERAL>  (943) 
N

>  <TOPICAL>  (943) 
N

>  <BLACK_BOX>  (943) 
N

>  <AVAILABILITY_TYPE>  (943) 
Discontinued

>  <WITHDRAWN_YEAR>  (943) 
nan

>  <WITHDRAWN_COUNTRY>  (943) 
nan

>  <WITHDRAWN_REASON>  (943) 
nan

>  <CANONICAL_SMILES>  (943) 
OS(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(NCS(=O)O)cc2

>  <name>  (943) 
Aldesulfone Sodium 

>  <MW>  (943) 
404.491

>  <logP>  (943) 
1.7016

$$$$
CHEMBL1159
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  3  0
  4  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  2 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (944) 
187515

>  <SYNONYMS>  (944) 
Pinacidil (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (944) 
4

>  <RESEARCH_CODES>  (944) 
nan

>  <APPLICANTS>  (944) 
Leo Pharmaceutical Products Ltd

>  <USAN_STEM>  (944) 
-dil

>  <USAN_STEM_DEFINITION>  (944) 
vasodilators (undefined group)

>  <USAN_STEM_SUBSTEM>  (944) 
-dil

>  <USAN_YEAR>  (944) 
1984.0

>  <FIRST_APPROVAL>  (944) 
1989.0

>  <ATC_CODE>  (944) 
C02DG01

>  <ATC_CODE_DESCRIPTION>  (944) 
C02DG01 [Cardiovascular System:Antihypertensives:Arteriolar Smooth Muscle, Agents Acting On:Guanidine derivatives]

>  <INDICATION_CLASS>  (944) 
Antihypertensive

>  <SC_PATENT_NO>  (944) 
nan

>  <DRUG_TYPE>  (944) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (944) 
Y

>  <FIRST_IN_CLASS>  (944) 
N

>  <CHIRALITY>  (944) 
Racemic Mixture

>  <PRODRUG>  (944) 
N

>  <ORAL>  (944) 
Y

>  <PARENTERAL>  (944) 
N

>  <TOPICAL>  (944) 
N

>  <BLACK_BOX>  (944) 
N

>  <AVAILABILITY_TYPE>  (944) 
Discontinued

>  <WITHDRAWN_YEAR>  (944) 
nan

>  <WITHDRAWN_COUNTRY>  (944) 
nan

>  <WITHDRAWN_REASON>  (944) 
nan

>  <CANONICAL_SMILES>  (944) 
CC(N\C(=N/C#N)\Nc1ccncc1)C(C)(C)C

>  <name>  (944) 
Pinacidil 

>  <MW>  (944) 
245.33

>  <logP>  (944) 
2.35478

$$$$
CHEMBL1873475
     RDKit          

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
  8 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 24 32  1  0
 32 33  2  0
  7  2  1  0
 10  6  1  0
 16 11  1  0
 33 21  1  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (945) 
1214046

>  <SYNONYMS>  (945) 
Ibrutinib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (945) 
4

>  <RESEARCH_CODES>  (945) 
CRA-032765; PCI-32765; PCI-32765-00

>  <APPLICANTS>  (945) 
Pharmacyclics Inc

>  <USAN_STEM>  (945) 
-tinib; -tinib

>  <USAN_STEM_DEFINITION>  (945) 
tyrosine kinase inhibitors: Bruton's (Btk) inhibitors; tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (945) 
-tinib (-brutinib); -tinib

>  <USAN_YEAR>  (945) 
2011.0

>  <FIRST_APPROVAL>  (945) 
2013.0

>  <ATC_CODE>  (945) 
L01XE27

>  <ATC_CODE_DESCRIPTION>  (945) 
L01XE27 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (945) 
nan

>  <SC_PATENT_NO>  (945) 
US-7514444-B2

>  <DRUG_TYPE>  (945) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (945) 
Y

>  <FIRST_IN_CLASS>  (945) 
Y

>  <CHIRALITY>  (945) 
Single Stereoisomer

>  <PRODRUG>  (945) 
N

>  <ORAL>  (945) 
Y

>  <PARENTERAL>  (945) 
N

>  <TOPICAL>  (945) 
N

>  <BLACK_BOX>  (945) 
N

>  <AVAILABILITY_TYPE>  (945) 
Prescription-only

>  <WITHDRAWN_YEAR>  (945) 
nan

>  <WITHDRAWN_COUNTRY>  (945) 
nan

>  <WITHDRAWN_REASON>  (945) 
nan

>  <CANONICAL_SMILES>  (945) 
Nc1ncnc2c1c(nn2[C@@H]3CCCN(C3)C(=O)C=C)c4ccc(Oc5ccccc5)cc4

>  <name>  (945) 
Ibrutinib 

>  <MW>  (945) 
440.507

>  <logP>  (945) 
4.2173

$$$$
CHEMBL3707214
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  7  2  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (946) 
2039185

>  <SYNONYMS>  (946) 
Morpholine Salicylate

>  <DEVELOPMENT_PHASE>  (946) 
4

>  <RESEARCH_CODES>  (946) 
nan

>  <APPLICANTS>  (946) 
nan

>  <USAN_STEM>  (946) 
nan

>  <USAN_STEM_DEFINITION>  (946) 
nan

>  <USAN_STEM_SUBSTEM>  (946) 
nan

>  <USAN_YEAR>  (946) 
nan

>  <FIRST_APPROVAL>  (946) 
nan

>  <ATC_CODE>  (946) 
N02BA08

>  <ATC_CODE_DESCRIPTION>  (946) 
N02BA08 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Salicylic acid and derivatives]

>  <INDICATION_CLASS>  (946) 
nan

>  <SC_PATENT_NO>  (946) 
nan

>  <DRUG_TYPE>  (946) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (946) 
Y

>  <FIRST_IN_CLASS>  (946) 
N

>  <CHIRALITY>  (946) 
Achiral Molecule

>  <PRODRUG>  (946) 
N

>  <ORAL>  (946) 
N

>  <PARENTERAL>  (946) 
N

>  <TOPICAL>  (946) 
N

>  <BLACK_BOX>  (946) 
N

>  <AVAILABILITY_TYPE>  (946) 
Unknown

>  <WITHDRAWN_YEAR>  (946) 
nan

>  <WITHDRAWN_COUNTRY>  (946) 
nan

>  <WITHDRAWN_REASON>  (946) 
nan

>  <CANONICAL_SMILES>  (946) 
Oc1ccccc1C(=O)ON2CCOCC2

>  <name>  (946) 
Morpholine Salicylate

>  <MW>  (946) 
223.228

>  <logP>  (946) 
0.7962

$$$$
CHEMBL1232132
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
  2 13  1  0
 13 14  2  0
 13 15  1  0
 12  4  1  0
M  END
>  <PARENT_MOLREGNO>  (947) 
694482

>  <SYNONYMS>  (947) 
3,5 Dibromotyrosine

>  <DEVELOPMENT_PHASE>  (947) 
4

>  <RESEARCH_CODES>  (947) 
nan

>  <APPLICANTS>  (947) 
nan

>  <USAN_STEM>  (947) 
nan

>  <USAN_STEM_DEFINITION>  (947) 
nan

>  <USAN_STEM_SUBSTEM>  (947) 
nan

>  <USAN_YEAR>  (947) 
nan

>  <FIRST_APPROVAL>  (947) 
nan

>  <ATC_CODE>  (947) 
H03BX02

>  <ATC_CODE_DESCRIPTION>  (947) 
H03BX02 [Systemic Hormonal Preparations, Excl. :Thyroid Therapy:Antithyroid Preparations:Other antithyroid preparations]

>  <INDICATION_CLASS>  (947) 
nan

>  <SC_PATENT_NO>  (947) 
nan

>  <DRUG_TYPE>  (947) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (947) 
Y

>  <FIRST_IN_CLASS>  (947) 
N

>  <CHIRALITY>  (947) 
Single Stereoisomer

>  <PRODRUG>  (947) 
N

>  <ORAL>  (947) 
N

>  <PARENTERAL>  (947) 
N

>  <TOPICAL>  (947) 
N

>  <BLACK_BOX>  (947) 
N

>  <AVAILABILITY_TYPE>  (947) 
Unknown

>  <WITHDRAWN_YEAR>  (947) 
nan

>  <WITHDRAWN_COUNTRY>  (947) 
nan

>  <WITHDRAWN_REASON>  (947) 
nan

>  <CANONICAL_SMILES>  (947) 
N[C@@H](Cc1cc(Br)c(O)c(Br)c1)C(=O)O

>  <name>  (947) 
3,5 Dibromotyrosine

>  <MW>  (947) 
338.983

>  <logP>  (947) 
1.8716

$$$$
CHEMBL449
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14  5  1  0
M  END
>  <PARENT_MOLREGNO>  (948) 
2393

>  <SYNONYMS>  (948) 
Butabarbital (USP); Secbutabarbital (BAN, INN); Butabarbital Sodium (FDA, USP); Secbutabarbital Sodium (INN)

>  <DEVELOPMENT_PHASE>  (948) 
4

>  <RESEARCH_CODES>  (948) 
nan

>  <APPLICANTS>  (948) 
Parke-Davis; Meda Pharmaceuticals Inc

>  <USAN_STEM>  (948) 
-barb-

>  <USAN_STEM_DEFINITION>  (948) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (948) 
-barb-

>  <USAN_YEAR>  (948) 
nan

>  <FIRST_APPROVAL>  (948) 
1939.0

>  <ATC_CODE>  (948) 
nan

>  <ATC_CODE_DESCRIPTION>  (948) 
nan

>  <INDICATION_CLASS>  (948) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (948) 
nan

>  <DRUG_TYPE>  (948) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (948) 
Y

>  <FIRST_IN_CLASS>  (948) 
N

>  <CHIRALITY>  (948) 
Racemic Mixture

>  <PRODRUG>  (948) 
N

>  <ORAL>  (948) 
Y

>  <PARENTERAL>  (948) 
N

>  <TOPICAL>  (948) 
N

>  <BLACK_BOX>  (948) 
N

>  <AVAILABILITY_TYPE>  (948) 
Prescription-only

>  <WITHDRAWN_YEAR>  (948) 
nan

>  <WITHDRAWN_COUNTRY>  (948) 
nan

>  <WITHDRAWN_REASON>  (948) 
nan

>  <CANONICAL_SMILES>  (948) 
CCC(C)C1(CC)C(=O)NC(=O)NC1=O

>  <name>  (948) 
Butabarbital 

>  <MW>  (948) 
212.249

>  <logP>  (948) 
0.7949

$$$$
CHEMBL847
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 14 18  1  0
 18 19  2  0
 18 20  1  0
 17  6  1  0
 16  9  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (949) 
63445

>  <SYNONYMS>  (949) 
Oxamniquine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (949) 
4

>  <RESEARCH_CODES>  (949) 
UK-4271

>  <APPLICANTS>  (949) 
Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (949) 
nan

>  <USAN_STEM_DEFINITION>  (949) 
nan

>  <USAN_STEM_SUBSTEM>  (949) 
nan

>  <USAN_YEAR>  (949) 
1975.0

>  <FIRST_APPROVAL>  (949) 
1980.0

>  <ATC_CODE>  (949) 
P02BA02

>  <ATC_CODE_DESCRIPTION>  (949) 
P02BA02 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antitrematodals:Quinoline derivatives and related substances]

>  <INDICATION_CLASS>  (949) 
Antischistosomal

>  <SC_PATENT_NO>  (949) 
nan

>  <DRUG_TYPE>  (949) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (949) 
Y

>  <FIRST_IN_CLASS>  (949) 
N

>  <CHIRALITY>  (949) 
Racemic Mixture

>  <PRODRUG>  (949) 
N

>  <ORAL>  (949) 
Y

>  <PARENTERAL>  (949) 
N

>  <TOPICAL>  (949) 
N

>  <BLACK_BOX>  (949) 
N

>  <AVAILABILITY_TYPE>  (949) 
Discontinued

>  <WITHDRAWN_YEAR>  (949) 
nan

>  <WITHDRAWN_COUNTRY>  (949) 
nan

>  <WITHDRAWN_REASON>  (949) 
nan

>  <CANONICAL_SMILES>  (949) 
CC(C)NCC1CCc2cc(CO)c(cc2N1)[N+](=O)[O-]

>  <name>  (949) 
Oxamniquine 

>  <MW>  (949) 
279.34

>  <logP>  (949) 
1.8118

$$$$
CHEMBL1160819
     RDKit          

  1  0  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
M  END
>  <PARENT_MOLREGNO>  (950) 
642358

>  <SYNONYMS>  (950) 
Ammonia Solution, Strong (NF); Ammonia Water (JAN); Ammonia (13N) (USAN, USP, FDA)

>  <DEVELOPMENT_PHASE>  (950) 
4

>  <RESEARCH_CODES>  (950) 
nan

>  <APPLICANTS>  (950) 
Feinstein Institute Medical Research

>  <USAN_STEM>  (950) 
nan

>  <USAN_STEM_DEFINITION>  (950) 
nan

>  <USAN_STEM_SUBSTEM>  (950) 
nan

>  <USAN_YEAR>  (950) 
1990.0

>  <FIRST_APPROVAL>  (950) 
2007.0

>  <ATC_CODE>  (950) 
nan

>  <ATC_CODE_DESCRIPTION>  (950) 
nan

>  <INDICATION_CLASS>  (950) 
Pharmaceutic Aid (solvent and source of ammonia); Diagnostic Aid (cardiac imaging); Diagnostic Aid (liver imaging); Radioactive Agent

>  <SC_PATENT_NO>  (950) 
nan

>  <DRUG_TYPE>  (950) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (950) 
Y

>  <FIRST_IN_CLASS>  (950) 
N

>  <CHIRALITY>  (950) 
Achiral Molecule

>  <PRODRUG>  (950) 
N

>  <ORAL>  (950) 
N

>  <PARENTERAL>  (950) 
Y

>  <TOPICAL>  (950) 
N

>  <BLACK_BOX>  (950) 
N

>  <AVAILABILITY_TYPE>  (950) 
Prescription-only

>  <WITHDRAWN_YEAR>  (950) 
nan

>  <WITHDRAWN_COUNTRY>  (950) 
nan

>  <WITHDRAWN_REASON>  (950) 
nan

>  <CANONICAL_SMILES>  (950) 
N

>  <name>  (950) 
Ammonia Solution, Strong 

>  <MW>  (950) 
17.031

>  <logP>  (950) 
0.162

$$$$
CHEMBL127516
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (951) 
209964

>  <SYNONYMS>  (951) 
Butamben (USAN, USP); Butamben Picrate (USAN)

>  <DEVELOPMENT_PHASE>  (951) 
4

>  <RESEARCH_CODES>  (951) 
ABBOTT-34842

>  <APPLICANTS>  (951) 
Abbott

>  <USAN_STEM>  (951) 
nan

>  <USAN_STEM_DEFINITION>  (951) 
nan

>  <USAN_STEM_SUBSTEM>  (951) 
nan

>  <USAN_YEAR>  (951) 
1975.0

>  <FIRST_APPROVAL>  (951) 
nan

>  <ATC_CODE>  (951) 
nan

>  <ATC_CODE_DESCRIPTION>  (951) 
nan

>  <INDICATION_CLASS>  (951) 
Anesthetic (topical)

>  <SC_PATENT_NO>  (951) 
nan

>  <DRUG_TYPE>  (951) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (951) 
Y

>  <FIRST_IN_CLASS>  (951) 
N

>  <CHIRALITY>  (951) 
Achiral Molecule

>  <PRODRUG>  (951) 
N

>  <ORAL>  (951) 
N

>  <PARENTERAL>  (951) 
N

>  <TOPICAL>  (951) 
N

>  <BLACK_BOX>  (951) 
N

>  <AVAILABILITY_TYPE>  (951) 
Withdrawn

>  <WITHDRAWN_YEAR>  (951) 
1964.0

>  <WITHDRAWN_COUNTRY>  (951) 
United States; United States

>  <WITHDRAWN_REASON>  (951) 
Dermatologic Toxicity; Psychiatric Reaction; Dermatologic Toxicity; Psychiatric Reaction

>  <CANONICAL_SMILES>  (951) 
CCCCOC(=O)c1ccc(N)cc1

>  <name>  (951) 
Butamben 

>  <MW>  (951) 
193.246

>  <logP>  (951) 
2.2257

$$$$
CHEMBL1801800
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  9  2  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (952) 
1162878

>  <SYNONYMS>  (952) 
Metabromsalan (INN, USAN)

>  <DEVELOPMENT_PHASE>  (952) 
4

>  <RESEARCH_CODES>  (952) 
nan

>  <APPLICANTS>  (952) 
nan

>  <USAN_STEM>  (952) 
-sal-

>  <USAN_STEM_DEFINITION>  (952) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (952) 
-sal-

>  <USAN_YEAR>  (952) 
1966.0

>  <FIRST_APPROVAL>  (952) 
nan

>  <ATC_CODE>  (952) 
nan

>  <ATC_CODE_DESCRIPTION>  (952) 
nan

>  <INDICATION_CLASS>  (952) 
Disinfectant

>  <SC_PATENT_NO>  (952) 
nan

>  <DRUG_TYPE>  (952) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (952) 
Y

>  <FIRST_IN_CLASS>  (952) 
N

>  <CHIRALITY>  (952) 
Achiral Molecule

>  <PRODRUG>  (952) 
N

>  <ORAL>  (952) 
N

>  <PARENTERAL>  (952) 
N

>  <TOPICAL>  (952) 
N

>  <BLACK_BOX>  (952) 
N

>  <AVAILABILITY_TYPE>  (952) 
Withdrawn

>  <WITHDRAWN_YEAR>  (952) 
nan

>  <WITHDRAWN_COUNTRY>  (952) 
United States

>  <WITHDRAWN_REASON>  (952) 
nan

>  <CANONICAL_SMILES>  (952) 
Oc1c(Br)cc(Br)cc1C(=O)Nc2ccccc2

>  <name>  (952) 
Metabromsalan 

>  <MW>  (952) 
371.028

>  <logP>  (952) 
4.1695

$$$$
CHEMBL1201273
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  2 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  2  0
 12  4  1  0
 11  7  1  0
 24 17  1  0
M  END
>  <PARENT_MOLREGNO>  (953) 
675224

>  <SYNONYMS>  (953) 
Protokylol (BAN, INN); Protokylol HCl (FDA, MI)

>  <DEVELOPMENT_PHASE>  (953) 
4

>  <RESEARCH_CODES>  (953) 
nan

>  <APPLICANTS>  (953) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (953) 
nan

>  <USAN_STEM_DEFINITION>  (953) 
nan

>  <USAN_STEM_SUBSTEM>  (953) 
nan

>  <USAN_YEAR>  (953) 
nan

>  <FIRST_APPROVAL>  (953) 
1982.0

>  <ATC_CODE>  (953) 
nan

>  <ATC_CODE_DESCRIPTION>  (953) 
nan

>  <INDICATION_CLASS>  (953) 
nan

>  <SC_PATENT_NO>  (953) 
nan

>  <DRUG_TYPE>  (953) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (953) 
Y

>  <FIRST_IN_CLASS>  (953) 
N

>  <CHIRALITY>  (953) 
Racemic Mixture

>  <PRODRUG>  (953) 
N

>  <ORAL>  (953) 
Y

>  <PARENTERAL>  (953) 
N

>  <TOPICAL>  (953) 
N

>  <BLACK_BOX>  (953) 
N

>  <AVAILABILITY_TYPE>  (953) 
Discontinued

>  <WITHDRAWN_YEAR>  (953) 
nan

>  <WITHDRAWN_COUNTRY>  (953) 
nan

>  <WITHDRAWN_REASON>  (953) 
nan

>  <CANONICAL_SMILES>  (953) 
CC(Cc1ccc2OCOc2c1)NCC(O)c3ccc(O)c(O)c3

>  <name>  (953) 
Protokylol 

>  <MW>  (953) 
331.368

>  <logP>  (953) 
2.0807

$$$$
CHEMBL1201227
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 10  5  1  0
 15 11  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (954) 
675178

>  <SYNONYMS>  (954) 
Cycrimine (BAN, INN); Cycrimine HCl (FDA, MI, USP)

>  <DEVELOPMENT_PHASE>  (954) 
4

>  <RESEARCH_CODES>  (954) 
nan

>  <APPLICANTS>  (954) 
Eli Lilly And Co

>  <USAN_STEM>  (954) 
nan

>  <USAN_STEM_DEFINITION>  (954) 
nan

>  <USAN_STEM_SUBSTEM>  (954) 
nan

>  <USAN_YEAR>  (954) 
nan

>  <FIRST_APPROVAL>  (954) 
1982.0

>  <ATC_CODE>  (954) 
nan

>  <ATC_CODE_DESCRIPTION>  (954) 
nan

>  <INDICATION_CLASS>  (954) 
nan

>  <SC_PATENT_NO>  (954) 
nan

>  <DRUG_TYPE>  (954) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (954) 
Y

>  <FIRST_IN_CLASS>  (954) 
N

>  <CHIRALITY>  (954) 
Racemic Mixture

>  <PRODRUG>  (954) 
N

>  <ORAL>  (954) 
Y

>  <PARENTERAL>  (954) 
N

>  <TOPICAL>  (954) 
N

>  <BLACK_BOX>  (954) 
N

>  <AVAILABILITY_TYPE>  (954) 
Discontinued

>  <WITHDRAWN_YEAR>  (954) 
nan

>  <WITHDRAWN_COUNTRY>  (954) 
nan

>  <WITHDRAWN_REASON>  (954) 
nan

>  <CANONICAL_SMILES>  (954) 
OC(CCN1CCCCC1)(C2CCCC2)c3ccccc3

>  <name>  (954) 
Cycrimine 

>  <MW>  (954) 
287.447

>  <logP>  (954) 
3.9404

$$$$
CHEMBL1213252
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  6 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21  4  1  0
 12  7  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (955) 
685093

>  <SYNONYMS>  (955) 
Clorazepic Acid (BAN); Clorazepate Dipotassium (FDA, JAN, USAN, USP); Dipotassium Clorazepate (INN); Clorazepate Monopotassium (USAN)

>  <DEVELOPMENT_PHASE>  (955) 
4

>  <RESEARCH_CODES>  (955) 
4306 CB; ABBOTT-35616; 4311 CB; ABBOTT-39083

>  <APPLICANTS>  (955) 
Lundbeck Llc; Clin-Midy, France; Abbott

>  <USAN_STEM>  (955) 
nan

>  <USAN_STEM_DEFINITION>  (955) 
nan

>  <USAN_STEM_SUBSTEM>  (955) 
nan

>  <USAN_YEAR>  (955) 
1969.0

>  <FIRST_APPROVAL>  (955) 
1972.0

>  <ATC_CODE>  (955) 
N05BA05

>  <ATC_CODE_DESCRIPTION>  (955) 
N05BA05 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (955) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (955) 
nan

>  <DRUG_TYPE>  (955) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (955) 
Y

>  <FIRST_IN_CLASS>  (955) 
N

>  <CHIRALITY>  (955) 
Racemic Mixture

>  <PRODRUG>  (955) 
Y

>  <ORAL>  (955) 
Y

>  <PARENTERAL>  (955) 
N

>  <TOPICAL>  (955) 
N

>  <BLACK_BOX>  (955) 
N

>  <AVAILABILITY_TYPE>  (955) 
Prescription-only

>  <WITHDRAWN_YEAR>  (955) 
nan

>  <WITHDRAWN_COUNTRY>  (955) 
nan

>  <WITHDRAWN_REASON>  (955) 
nan

>  <CANONICAL_SMILES>  (955) 
OC(=O)C1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O

>  <name>  (955) 
Clorazepic Acid 

>  <MW>  (955) 
314.728

>  <logP>  (955) 
2.5827

$$$$
CHEMBL1083659
     RDKit          

 32 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  5 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31 32  1  0
  8  2  1  0
 17 11  1  0
 22 18  1  0
 32 23  2  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (956) 
630322

>  <SYNONYMS>  (956) 
Suvorexant (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (956) 
4

>  <RESEARCH_CODES>  (956) 
MK-4305

>  <APPLICANTS>  (956) 
Merck Sharp And Dohme Corp

>  <USAN_STEM>  (956) 
nan

>  <USAN_STEM_DEFINITION>  (956) 
nan

>  <USAN_STEM_SUBSTEM>  (956) 
nan

>  <USAN_YEAR>  (956) 
2010.0

>  <FIRST_APPROVAL>  (956) 
2014.0

>  <ATC_CODE>  (956) 
nan

>  <ATC_CODE_DESCRIPTION>  (956) 
nan

>  <INDICATION_CLASS>  (956) 
nan

>  <SC_PATENT_NO>  (956) 
US-7951797-B2

>  <DRUG_TYPE>  (956) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (956) 
Y

>  <FIRST_IN_CLASS>  (956) 
Y

>  <CHIRALITY>  (956) 
Single Stereoisomer

>  <PRODRUG>  (956) 
N

>  <ORAL>  (956) 
Y

>  <PARENTERAL>  (956) 
N

>  <TOPICAL>  (956) 
N

>  <BLACK_BOX>  (956) 
N

>  <AVAILABILITY_TYPE>  (956) 
Prescription-only

>  <WITHDRAWN_YEAR>  (956) 
nan

>  <WITHDRAWN_COUNTRY>  (956) 
nan

>  <WITHDRAWN_REASON>  (956) 
nan

>  <CANONICAL_SMILES>  (956) 
C[C@@H]1CCN(CCN1C(=O)c2cc(C)ccc2n3nccn3)c4oc5ccc(Cl)cc5n4

>  <name>  (956) 
Suvorexant 

>  <MW>  (956) 
450.93

>  <logP>  (956) 
4.11132

$$$$
CHEMBL456
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 10 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 18  7  1  0
M  END
>  <PARENT_MOLREGNO>  (957) 
2654

>  <SYNONYMS>  (957) 
Etacrynic Acid (DCF, INN, JAN); Ethacrynic acid (BAN, FDA, USAN, USP); Ethacrynate Sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (957) 
4

>  <RESEARCH_CODES>  (957) 
MK-595

>  <APPLICANTS>  (957) 
Aton Pharma Inc

>  <USAN_STEM>  (957) 
nan

>  <USAN_STEM_DEFINITION>  (957) 
nan

>  <USAN_STEM_SUBSTEM>  (957) 
nan

>  <USAN_YEAR>  (957) 
1963.0

>  <FIRST_APPROVAL>  (957) 
1967.0

>  <ATC_CODE>  (957) 
C03CC01

>  <ATC_CODE_DESCRIPTION>  (957) 
C03CC01 [Cardiovascular System:Diuretics:High-Ceiling Diuretics:Aryloxyacetic acid derivatives]

>  <INDICATION_CLASS>  (957) 
Diuretic

>  <SC_PATENT_NO>  (957) 
nan

>  <DRUG_TYPE>  (957) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (957) 
Y

>  <FIRST_IN_CLASS>  (957) 
N

>  <CHIRALITY>  (957) 
Achiral Molecule

>  <PRODRUG>  (957) 
N

>  <ORAL>  (957) 
Y

>  <PARENTERAL>  (957) 
Y

>  <TOPICAL>  (957) 
N

>  <BLACK_BOX>  (957) 
N

>  <AVAILABILITY_TYPE>  (957) 
Prescription-only

>  <WITHDRAWN_YEAR>  (957) 
nan

>  <WITHDRAWN_COUNTRY>  (957) 
nan

>  <WITHDRAWN_REASON>  (957) 
nan

>  <CANONICAL_SMILES>  (957) 
CCC(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl

>  <name>  (957) 
Etacrynic Acid 

>  <MW>  (957) 
303.141

>  <logP>  (957) 
3.6057

$$$$
CHEMBL968
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 25 26  1  0
 26 27  2  0
 27  8  1  0
 19 14  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (958) 
95929

>  <SYNONYMS>  (958) 
Flurazepam (BAN, INN, JAN); Flurazepam HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (958) 
4

>  <RESEARCH_CODES>  (958) 
Ro-56901; Ro-5-6901

>  <APPLICANTS>  (958) 
Valeant Pharmaceuticals International

>  <USAN_STEM>  (958) 
-azepam

>  <USAN_STEM_DEFINITION>  (958) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (958) 
-azepam

>  <USAN_YEAR>  (958) 
1968.0

>  <FIRST_APPROVAL>  (958) 
1970.0

>  <ATC_CODE>  (958) 
N05CD01

>  <ATC_CODE_DESCRIPTION>  (958) 
N05CD01 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (958) 
Anticonvulsant; Relaxant (muscle); Sedative-Hypnotic

>  <SC_PATENT_NO>  (958) 
nan

>  <DRUG_TYPE>  (958) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (958) 
Y

>  <FIRST_IN_CLASS>  (958) 
N

>  <CHIRALITY>  (958) 
Achiral Molecule

>  <PRODRUG>  (958) 
N

>  <ORAL>  (958) 
Y

>  <PARENTERAL>  (958) 
N

>  <TOPICAL>  (958) 
N

>  <BLACK_BOX>  (958) 
N

>  <AVAILABILITY_TYPE>  (958) 
Prescription-only

>  <WITHDRAWN_YEAR>  (958) 
nan

>  <WITHDRAWN_COUNTRY>  (958) 
nan

>  <WITHDRAWN_REASON>  (958) 
nan

>  <CANONICAL_SMILES>  (958) 
CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c3cc(Cl)ccc13

>  <name>  (958) 
Flurazepam 

>  <MW>  (958) 
387.886

>  <logP>  (958) 
4.0049

$$$$
CHEMBL39736
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
M  END
>  <PARENT_MOLREGNO>  (959) 
56090

>  <SYNONYMS>  (959) 
Buformin (INN, USAN); Buformin HCl (JAN)

>  <DEVELOPMENT_PHASE>  (959) 
4

>  <RESEARCH_CODES>  (959) 
W 37

>  <APPLICANTS>  (959) 
nan

>  <USAN_STEM>  (959) 
-formin

>  <USAN_STEM_DEFINITION>  (959) 
hypoglycemics (phenformin type)

>  <USAN_STEM_SUBSTEM>  (959) 
-formin

>  <USAN_YEAR>  (959) 
1965.0

>  <FIRST_APPROVAL>  (959) 
nan

>  <ATC_CODE>  (959) 
A10BA03

>  <ATC_CODE_DESCRIPTION>  (959) 
A10BA03 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Biguanides]

>  <INDICATION_CLASS>  (959) 
Antidiabetic

>  <SC_PATENT_NO>  (959) 
nan

>  <DRUG_TYPE>  (959) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (959) 
Y

>  <FIRST_IN_CLASS>  (959) 
N

>  <CHIRALITY>  (959) 
Achiral Molecule

>  <PRODRUG>  (959) 
N

>  <ORAL>  (959) 
N

>  <PARENTERAL>  (959) 
N

>  <TOPICAL>  (959) 
N

>  <BLACK_BOX>  (959) 
N

>  <AVAILABILITY_TYPE>  (959) 
Withdrawn

>  <WITHDRAWN_YEAR>  (959) 
1978.0

>  <WITHDRAWN_COUNTRY>  (959) 
Germany

>  <WITHDRAWN_REASON>  (959) 
Metabolic toxicity

>  <CANONICAL_SMILES>  (959) 
CCCC\N=C(\N)/N=C(N)N

>  <name>  (959) 
Buformin 

>  <MW>  (959) 
157.221

>  <logP>  (959) 
-0.6254

$$$$
CHEMBL717
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 13 18  1  0
 18 19  2  0
 18 20  1  0
  5 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 28  2  1  0
 10  4  1  0
 13  8  1  0
 28 21  1  0
M  END
>  <PARENT_MOLREGNO>  (960) 
34608

>  <SYNONYMS>  (960) 
Medroxyprogesterone (BAN, INN); Medroxyprogesterone acetate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (960) 
4

>  <RESEARCH_CODES>  (960) 
nan

>  <APPLICANTS>  (960) 
Wyeth Pharmaceuticals Inc; Pharmacia And Upjohn Sub Pfizer Inc; Pharmacia And Upjohn Co

>  <USAN_STEM>  (960) 
-gest-

>  <USAN_STEM_DEFINITION>  (960) 
progestins

>  <USAN_STEM_SUBSTEM>  (960) 
-gest-

>  <USAN_YEAR>  (960) 
nan

>  <FIRST_APPROVAL>  (960) 
1959.0

>  <ATC_CODE>  (960) 
G03AC06; G03DA02; L02AB02

>  <ATC_CODE_DESCRIPTION>  (960) 
G03AC06 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Hormonal Contraceptives For Systemic Use:Progestogens]; G03DA02 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Progestogens:Pregnen (4) derivatives]; L02AB02 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormones And Related Agents:Progestogens]

>  <INDICATION_CLASS>  (960) 
Progestin

>  <SC_PATENT_NO>  (960) 
US-6495534-B2

>  <DRUG_TYPE>  (960) 
Natural Product-derived

>  <RULE_OF_FIVE>  (960) 
Y

>  <FIRST_IN_CLASS>  (960) 
N

>  <CHIRALITY>  (960) 
Single Stereoisomer

>  <PRODRUG>  (960) 
N

>  <ORAL>  (960) 
Y

>  <PARENTERAL>  (960) 
Y

>  <TOPICAL>  (960) 
N

>  <BLACK_BOX>  (960) 
Y

>  <AVAILABILITY_TYPE>  (960) 
Prescription-only

>  <WITHDRAWN_YEAR>  (960) 
nan

>  <WITHDRAWN_COUNTRY>  (960) 
nan

>  <WITHDRAWN_REASON>  (960) 
nan

>  <CANONICAL_SMILES>  (960) 
C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(=O)C)C(=O)C)[C@@]4(C)CCC(=O)C=C14

>  <name>  (960) 
Medroxyprogesterone 

>  <MW>  (960) 
386.532

>  <logP>  (960) 
4.6552

$$$$
CHEMBL1286
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  3 10  1  0
 10 11  2  0
 10 12  1  0
  8  4  1  0
M  END
>  <PARENT_MOLREGNO>  (961) 
252155

>  <SYNONYMS>  (961) 
Levetiracetam (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (961) 
4

>  <RESEARCH_CODES>  (961) 
UCB-22059; UCB-L059

>  <APPLICANTS>  (961) 
Ucb Inc; Hq Speciality Pharma Llc

>  <USAN_STEM>  (961) 
-racetam

>  <USAN_STEM_DEFINITION>  (961) 
nootropes (piracetam type)

>  <USAN_STEM_SUBSTEM>  (961) 
-racetam

>  <USAN_YEAR>  (961) 
1999.0

>  <FIRST_APPROVAL>  (961) 
1999.0

>  <ATC_CODE>  (961) 
N03AX14

>  <ATC_CODE_DESCRIPTION>  (961) 
N03AX14 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (961) 
nan

>  <SC_PATENT_NO>  (961) 
US-6471992-B1

>  <DRUG_TYPE>  (961) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (961) 
Y

>  <FIRST_IN_CLASS>  (961) 
N

>  <CHIRALITY>  (961) 
Single Stereoisomer

>  <PRODRUG>  (961) 
N

>  <ORAL>  (961) 
Y

>  <PARENTERAL>  (961) 
Y

>  <TOPICAL>  (961) 
N

>  <BLACK_BOX>  (961) 
Y

>  <AVAILABILITY_TYPE>  (961) 
Prescription-only

>  <WITHDRAWN_YEAR>  (961) 
nan

>  <WITHDRAWN_COUNTRY>  (961) 
nan

>  <WITHDRAWN_REASON>  (961) 
nan

>  <CANONICAL_SMILES>  (961) 
CC[C@H](N1CCCC1=O)C(=O)N

>  <name>  (961) 
Levetiracetam 

>  <MW>  (961) 
170.212

>  <logP>  (961) 
-0.1273

$$$$
CHEMBL185
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8  2  1  0
M  END
>  <PARENT_MOLREGNO>  (962) 
368538

>  <SYNONYMS>  (962) 
Fluorouracil (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (962) 
4

>  <RESEARCH_CODES>  (962) 
5-FU; Ro-29757

>  <APPLICANTS>  (962) 
Valeant International Bermuda; Pharmacia And Upjohn Co; Elorac Inc; Aqua Pharmaceuticals Llc; Valeant Pharmaceuticals International

>  <USAN_STEM>  (962) 
-uracil

>  <USAN_STEM_DEFINITION>  (962) 
uracil derivatives used as thyroid antagonists and as antineoplastics

>  <USAN_STEM_SUBSTEM>  (962) 
-uracil

>  <USAN_YEAR>  (962) 
1962.0

>  <FIRST_APPROVAL>  (962) 
1962.0

>  <ATC_CODE>  (962) 
L01BC52; L01BC02

>  <ATC_CODE_DESCRIPTION>  (962) 
L01BC52 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]; L01BC02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (962) 
Antineoplastic

>  <SC_PATENT_NO>  (962) 
US-6670335-B2

>  <DRUG_TYPE>  (962) 
Natural Product-derived

>  <RULE_OF_FIVE>  (962) 
Y

>  <FIRST_IN_CLASS>  (962) 
N

>  <CHIRALITY>  (962) 
Achiral Molecule

>  <PRODRUG>  (962) 
N

>  <ORAL>  (962) 
N

>  <PARENTERAL>  (962) 
Y

>  <TOPICAL>  (962) 
Y

>  <BLACK_BOX>  (962) 
Y

>  <AVAILABILITY_TYPE>  (962) 
Prescription-only

>  <WITHDRAWN_YEAR>  (962) 
nan

>  <WITHDRAWN_COUNTRY>  (962) 
nan

>  <WITHDRAWN_REASON>  (962) 
nan

>  <CANONICAL_SMILES>  (962) 
FC1=CNC(=O)NC1=O

>  <name>  (962) 
Fluorouracil 

>  <MW>  (962) 
130.078

>  <logP>  (962) 
-0.7977

$$$$
CHEMBL463
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
  7  2  1  0
M  END
>  <PARENT_MOLREGNO>  (963) 
4011

>  <SYNONYMS>  (963) 
Aminohippuric Acid (USP); Aminohippurate Sodium (FDA, USP); p-Aminohippurate Sodium (JAN)

>  <DEVELOPMENT_PHASE>  (963) 
4

>  <RESEARCH_CODES>  (963) 
nan

>  <APPLICANTS>  (963) 
Merck And Co Inc

>  <USAN_STEM>  (963) 
nan

>  <USAN_STEM_DEFINITION>  (963) 
nan

>  <USAN_STEM_SUBSTEM>  (963) 
nan

>  <USAN_YEAR>  (963) 
nan

>  <FIRST_APPROVAL>  (963) 
nan

>  <ATC_CODE>  (963) 
V04CH30

>  <ATC_CODE_DESCRIPTION>  (963) 
V04CH30 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for renal function and ureteral injuries]

>  <INDICATION_CLASS>  (963) 
Diagnostic Aid (renal function determination)

>  <SC_PATENT_NO>  (963) 
nan

>  <DRUG_TYPE>  (963) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (963) 
Y

>  <FIRST_IN_CLASS>  (963) 
N

>  <CHIRALITY>  (963) 
Achiral Molecule

>  <PRODRUG>  (963) 
N

>  <ORAL>  (963) 
N

>  <PARENTERAL>  (963) 
Y

>  <TOPICAL>  (963) 
N

>  <BLACK_BOX>  (963) 
N

>  <AVAILABILITY_TYPE>  (963) 
Prescription-only

>  <WITHDRAWN_YEAR>  (963) 
nan

>  <WITHDRAWN_COUNTRY>  (963) 
nan

>  <WITHDRAWN_REASON>  (963) 
nan

>  <CANONICAL_SMILES>  (963) 
Nc1ccc(cc1)C(=O)NCC(=O)O

>  <name>  (963) 
Aminohippuric Acid 

>  <MW>  (963) 
194.19

>  <logP>  (963) 
0.0832

$$$$
CHEMBL548
     RDKit          

 25 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (964) 
14125

>  <SYNONYMS>  (964) 
Dinoprostone (BAN, FDA, INN, JAN, USAN, USP); Dinoprostone beta-Cyclodextrin Clathrate (JAN)

>  <DEVELOPMENT_PHASE>  (964) 
4

>  <RESEARCH_CODES>  (964) 
U-12062

>  <APPLICANTS>  (964) 
Pharmacia And Upjohn Co; Ferring Controlled Therapeutics Ltd

>  <USAN_STEM>  (964) 
-prost-

>  <USAN_STEM_DEFINITION>  (964) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (964) 
-prost-

>  <USAN_YEAR>  (964) 
1971.0

>  <FIRST_APPROVAL>  (964) 
1977.0

>  <ATC_CODE>  (964) 
G02AD02

>  <ATC_CODE_DESCRIPTION>  (964) 
G02AD02 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Uterotonics:Prostaglandins]

>  <INDICATION_CLASS>  (964) 
Oxytocic; Prostaglandin

>  <SC_PATENT_NO>  (964) 
nan

>  <DRUG_TYPE>  (964) 
Natural Product-derived

>  <RULE_OF_FIVE>  (964) 
Y

>  <FIRST_IN_CLASS>  (964) 
N

>  <CHIRALITY>  (964) 
Single Stereoisomer

>  <PRODRUG>  (964) 
N

>  <ORAL>  (964) 
N

>  <PARENTERAL>  (964) 
Y

>  <TOPICAL>  (964) 
Y

>  <BLACK_BOX>  (964) 
N

>  <AVAILABILITY_TYPE>  (964) 
Prescription-only

>  <WITHDRAWN_YEAR>  (964) 
nan

>  <WITHDRAWN_COUNTRY>  (964) 
nan

>  <WITHDRAWN_REASON>  (964) 
nan

>  <CANONICAL_SMILES>  (964) 
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(=O)O

>  <name>  (964) 
Dinoprostone 

>  <MW>  (964) 
352.471

>  <logP>  (964) 
3.2511

$$$$
CHEMBL575
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 20 24  1  0
 24 25  2  0
 24 26  1  0
 10  3  1  0
 22 14  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (965) 
16716

>  <SYNONYMS>  (965) 
Methicillin (BAN); Meticillin (INN); Methicillin sodium (FDA, USAN, USP); Meticillin Sodium (JAN)

>  <DEVELOPMENT_PHASE>  (965) 
4

>  <RESEARCH_CODES>  (965) 
BRL-1241; SQ-16123; X-1497

>  <APPLICANTS>  (965) 
Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (965) 
-cillin

>  <USAN_STEM_DEFINITION>  (965) 
penicillins

>  <USAN_STEM_SUBSTEM>  (965) 
-cillin

>  <USAN_YEAR>  (965) 
1962.0

>  <FIRST_APPROVAL>  (965) 
1982.0

>  <ATC_CODE>  (965) 
J01CF03

>  <ATC_CODE_DESCRIPTION>  (965) 
J01CF03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]

>  <INDICATION_CLASS>  (965) 
Antibacterial

>  <SC_PATENT_NO>  (965) 
nan

>  <DRUG_TYPE>  (965) 
Natural Product-derived

>  <RULE_OF_FIVE>  (965) 
Y

>  <FIRST_IN_CLASS>  (965) 
N

>  <CHIRALITY>  (965) 
Single Stereoisomer

>  <PRODRUG>  (965) 
N

>  <ORAL>  (965) 
N

>  <PARENTERAL>  (965) 
Y

>  <TOPICAL>  (965) 
N

>  <BLACK_BOX>  (965) 
N

>  <AVAILABILITY_TYPE>  (965) 
Discontinued

>  <WITHDRAWN_YEAR>  (965) 
nan

>  <WITHDRAWN_COUNTRY>  (965) 
nan

>  <WITHDRAWN_REASON>  (965) 
nan

>  <CANONICAL_SMILES>  (965) 
COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O

>  <name>  (965) 
Methicillin 

>  <MW>  (965) 
380.422

>  <logP>  (965) 
0.9491

$$$$
CHEMBL1490
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  2 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 10  5  1  0
 16 11  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (966) 
418411

>  <SYNONYMS>  (966) 
Trihexyphenidyl (BAN, INN); Benzhexol (BAN); Trihexyphenidyl HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (966) 
4

>  <RESEARCH_CODES>  (966) 
nan

>  <APPLICANTS>  (966) 
Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (966) 
nan

>  <USAN_STEM_DEFINITION>  (966) 
nan

>  <USAN_STEM_SUBSTEM>  (966) 
nan

>  <USAN_YEAR>  (966) 
nan

>  <FIRST_APPROVAL>  (966) 
1949.0

>  <ATC_CODE>  (966) 
N04AA01

>  <ATC_CODE_DESCRIPTION>  (966) 
N04AA01 [Nervous System:Anti-Parkinson Drugs:Anticholinergic Agents:Tertiary amines]

>  <INDICATION_CLASS>  (966) 
Anticholinergic; Antiparkinsonian

>  <SC_PATENT_NO>  (966) 
nan

>  <DRUG_TYPE>  (966) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (966) 
Y

>  <FIRST_IN_CLASS>  (966) 
N

>  <CHIRALITY>  (966) 
Racemic Mixture

>  <PRODRUG>  (966) 
N

>  <ORAL>  (966) 
Y

>  <PARENTERAL>  (966) 
N

>  <TOPICAL>  (966) 
N

>  <BLACK_BOX>  (966) 
N

>  <AVAILABILITY_TYPE>  (966) 
Prescription-only

>  <WITHDRAWN_YEAR>  (966) 
nan

>  <WITHDRAWN_COUNTRY>  (966) 
nan

>  <WITHDRAWN_REASON>  (966) 
nan

>  <CANONICAL_SMILES>  (966) 
OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3

>  <name>  (966) 
Trihexyphenidyl 

>  <MW>  (966) 
301.474

>  <logP>  (966) 
4.3305

$$$$
CHEMBL452
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 13 21  1  0
 21 22  2  0
 22  4  1  0
 21  7  1  0
 19 14  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (967) 
2465

>  <SYNONYMS>  (967) 
Clonazepam (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (967) 
4

>  <RESEARCH_CODES>  (967) 
Ro-54023; Ro-5-4023

>  <APPLICANTS>  (967) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (967) 
-azepam

>  <USAN_STEM_DEFINITION>  (967) 
antianxiety agents (diazepam type)

>  <USAN_STEM_SUBSTEM>  (967) 
-azepam

>  <USAN_YEAR>  (967) 
1969.0

>  <FIRST_APPROVAL>  (967) 
1975.0

>  <ATC_CODE>  (967) 
N03AE01

>  <ATC_CODE_DESCRIPTION>  (967) 
N03AE01 [Nervous System:Antiepileptics:Antiepileptics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (967) 
Anticonvulsant

>  <SC_PATENT_NO>  (967) 
nan

>  <DRUG_TYPE>  (967) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (967) 
Y

>  <FIRST_IN_CLASS>  (967) 
N

>  <CHIRALITY>  (967) 
Achiral Molecule

>  <PRODRUG>  (967) 
N

>  <ORAL>  (967) 
Y

>  <PARENTERAL>  (967) 
N

>  <TOPICAL>  (967) 
N

>  <BLACK_BOX>  (967) 
N

>  <AVAILABILITY_TYPE>  (967) 
Prescription-only

>  <WITHDRAWN_YEAR>  (967) 
nan

>  <WITHDRAWN_COUNTRY>  (967) 
nan

>  <WITHDRAWN_REASON>  (967) 
nan

>  <CANONICAL_SMILES>  (967) 
[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1

>  <name>  (967) 
Clonazepam 

>  <MW>  (967) 
315.716

>  <logP>  (967) 
3.0377

$$$$
CHEMBL1371
     RDKit          

 11 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11  2  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (968) 
315123

>  <SYNONYMS>  (968) 
Chlorzoxazone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (968) 
4

>  <RESEARCH_CODES>  (968) 
nan

>  <APPLICANTS>  (968) 
Ortho Mcneil Pharmaceutical Inc; Janssen Research And Development Llc

>  <USAN_STEM>  (968) 
nan

>  <USAN_STEM_DEFINITION>  (968) 
nan

>  <USAN_STEM_SUBSTEM>  (968) 
nan

>  <USAN_YEAR>  (968) 
nan

>  <FIRST_APPROVAL>  (968) 
1958.0

>  <ATC_CODE>  (968) 
M03BB73; M03BB03; M03BB53

>  <ATC_CODE_DESCRIPTION>  (968) 
M03BB73 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Oxazol, thiazine, and triazine derivatives]; M03BB03 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Oxazol, thiazine, and triazine derivatives]; M03BB53 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Oxazol, thiazine, and triazine derivatives]

>  <INDICATION_CLASS>  (968) 
Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (968) 
nan

>  <DRUG_TYPE>  (968) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (968) 
Y

>  <FIRST_IN_CLASS>  (968) 
N

>  <CHIRALITY>  (968) 
Achiral Molecule

>  <PRODRUG>  (968) 
N

>  <ORAL>  (968) 
Y

>  <PARENTERAL>  (968) 
N

>  <TOPICAL>  (968) 
N

>  <BLACK_BOX>  (968) 
N

>  <AVAILABILITY_TYPE>  (968) 
Prescription-only

>  <WITHDRAWN_YEAR>  (968) 
nan

>  <WITHDRAWN_COUNTRY>  (968) 
nan

>  <WITHDRAWN_REASON>  (968) 
nan

>  <CANONICAL_SMILES>  (968) 
Clc1ccc2OC(=O)Nc2c1

>  <name>  (968) 
Chlorzoxazone 

>  <MW>  (968) 
169.567

>  <logP>  (968) 
1.7745

$$$$
CHEMBL712
     RDKit          

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  8  3  1  0
 18  9  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (969) 
33809

>  <SYNONYMS>  (969) 
Anisindione (BAN, FDA, INN, MI, NF)

>  <DEVELOPMENT_PHASE>  (969) 
4

>  <RESEARCH_CODES>  (969) 
nan

>  <APPLICANTS>  (969) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (969) 
nan

>  <USAN_STEM_DEFINITION>  (969) 
nan

>  <USAN_STEM_SUBSTEM>  (969) 
nan

>  <USAN_YEAR>  (969) 
nan

>  <FIRST_APPROVAL>  (969) 
1957.0

>  <ATC_CODE>  (969) 
nan

>  <ATC_CODE_DESCRIPTION>  (969) 
nan

>  <INDICATION_CLASS>  (969) 
nan

>  <SC_PATENT_NO>  (969) 
nan

>  <DRUG_TYPE>  (969) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (969) 
Y

>  <FIRST_IN_CLASS>  (969) 
N

>  <CHIRALITY>  (969) 
Achiral Molecule

>  <PRODRUG>  (969) 
N

>  <ORAL>  (969) 
Y

>  <PARENTERAL>  (969) 
N

>  <TOPICAL>  (969) 
N

>  <BLACK_BOX>  (969) 
N

>  <AVAILABILITY_TYPE>  (969) 
Discontinued

>  <WITHDRAWN_YEAR>  (969) 
nan

>  <WITHDRAWN_COUNTRY>  (969) 
nan

>  <WITHDRAWN_REASON>  (969) 
nan

>  <CANONICAL_SMILES>  (969) 
COc1ccc(cc1)C2C(=O)c3ccccc3C2=O

>  <name>  (969) 
Anisindione 

>  <MW>  (969) 
252.269

>  <logP>  (969) 
2.858

$$$$
CHEMBL1378
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 15 26  1  0
 26 27  2  0
 27  4  1  0
 26  7  1  0
 14  9  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (970) 
320810

>  <SYNONYMS>  (970) 
Thiethylperazine (BAN, INN, USAN); Thiethylperazine Malate (FDA, USP); Thietylperazine Malate (JAN); Thiethylperazine Maleate (FDA, USAN, USP); Thietylperazine Maleate (JAN)

>  <DEVELOPMENT_PHASE>  (970) 
4

>  <RESEARCH_CODES>  (970) 
GS-95

>  <APPLICANTS>  (970) 
Novartis Pharmaceuticals Corp; Novartis

>  <USAN_STEM>  (970) 
nan

>  <USAN_STEM_DEFINITION>  (970) 
nan

>  <USAN_STEM_SUBSTEM>  (970) 
nan

>  <USAN_YEAR>  (970) 
1962.0

>  <FIRST_APPROVAL>  (970) 
1961.0

>  <ATC_CODE>  (970) 
R06AD03

>  <ATC_CODE_DESCRIPTION>  (970) 
R06AD03 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]

>  <INDICATION_CLASS>  (970) 
Anti-Emetic

>  <SC_PATENT_NO>  (970) 
nan

>  <DRUG_TYPE>  (970) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (970) 
Y

>  <FIRST_IN_CLASS>  (970) 
N

>  <CHIRALITY>  (970) 
Achiral Molecule

>  <PRODRUG>  (970) 
N

>  <ORAL>  (970) 
Y

>  <PARENTERAL>  (970) 
Y

>  <TOPICAL>  (970) 
Y

>  <BLACK_BOX>  (970) 
N

>  <AVAILABILITY_TYPE>  (970) 
Discontinued

>  <WITHDRAWN_YEAR>  (970) 
nan

>  <WITHDRAWN_COUNTRY>  (970) 
nan

>  <WITHDRAWN_REASON>  (970) 
nan

>  <CANONICAL_SMILES>  (970) 
CCSc1ccc2Sc3ccccc3N(CCCN4CCN(C)CC4)c2c1

>  <name>  (970) 
Thiethylperazine 

>  <MW>  (970) 
399.629

>  <logP>  (970) 
5.0388

$$$$
CHEMBL1387
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  3  0
 16  2  1  0
 19  2  1  0
 10  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (971) 
328153

>  <SYNONYMS>  (971) 
Norethynodrel (FDA, USAN, USP); Noretynodrel (BAN, DCF, INN)

>  <DEVELOPMENT_PHASE>  (971) 
4

>  <RESEARCH_CODES>  (971) 
SC-4642

>  <APPLICANTS>  (971) 
Gd Searle Llc

>  <USAN_STEM>  (971) 
nan

>  <USAN_STEM_DEFINITION>  (971) 
nan

>  <USAN_STEM_SUBSTEM>  (971) 
nan

>  <USAN_YEAR>  (971) 
1962.0

>  <FIRST_APPROVAL>  (971) 
1961.0

>  <ATC_CODE>  (971) 
nan

>  <ATC_CODE_DESCRIPTION>  (971) 
nan

>  <INDICATION_CLASS>  (971) 
Progestin

>  <SC_PATENT_NO>  (971) 
nan

>  <DRUG_TYPE>  (971) 
Natural Product-derived

>  <RULE_OF_FIVE>  (971) 
Y

>  <FIRST_IN_CLASS>  (971) 
N

>  <CHIRALITY>  (971) 
Single Stereoisomer

>  <PRODRUG>  (971) 
N

>  <ORAL>  (971) 
Y

>  <PARENTERAL>  (971) 
N

>  <TOPICAL>  (971) 
N

>  <BLACK_BOX>  (971) 
N

>  <AVAILABILITY_TYPE>  (971) 
Discontinued

>  <WITHDRAWN_YEAR>  (971) 
nan

>  <WITHDRAWN_COUNTRY>  (971) 
nan

>  <WITHDRAWN_REASON>  (971) 
nan

>  <CANONICAL_SMILES>  (971) 
C[C@]12CC[C@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@@H]1CC[C@@]2(O)C#C

>  <name>  (971) 
Norethynodrel 

>  <MW>  (971) 
298.426

>  <logP>  (971) 
3.6366

$$$$
CHEMBL1201073
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (972) 
675024

>  <SYNONYMS>  (972) 
Succimer (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (972) 
4

>  <RESEARCH_CODES>  (972) 
DIM-SA; DMSA

>  <APPLICANTS>  (972) 
Lundbeck Llc

>  <USAN_STEM>  (972) 
nan

>  <USAN_STEM_DEFINITION>  (972) 
nan

>  <USAN_STEM_SUBSTEM>  (972) 
nan

>  <USAN_YEAR>  (972) 
1978.0

>  <FIRST_APPROVAL>  (972) 
1991.0

>  <ATC_CODE>  (972) 
nan

>  <ATC_CODE_DESCRIPTION>  (972) 
nan

>  <INDICATION_CLASS>  (972) 
Diagnostic Aid

>  <SC_PATENT_NO>  (972) 
nan

>  <DRUG_TYPE>  (972) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (972) 
Y

>  <FIRST_IN_CLASS>  (972) 
N

>  <CHIRALITY>  (972) 
Single Stereoisomer

>  <PRODRUG>  (972) 
N

>  <ORAL>  (972) 
Y

>  <PARENTERAL>  (972) 
N

>  <TOPICAL>  (972) 
N

>  <BLACK_BOX>  (972) 
N

>  <AVAILABILITY_TYPE>  (972) 
Prescription-only

>  <WITHDRAWN_YEAR>  (972) 
nan

>  <WITHDRAWN_COUNTRY>  (972) 
nan

>  <WITHDRAWN_REASON>  (972) 
nan

>  <CANONICAL_SMILES>  (972) 
OC(=O)[C@H](S)[C@H](S)C(=O)O

>  <name>  (972) 
Succimer 

>  <MW>  (972) 
182.222

>  <logP>  (972) 
-0.2476

$$$$
CHEMBL1291
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 14 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
 21 10  1  0
M  END
>  <PARENT_MOLREGNO>  (973) 
255221

>  <SYNONYMS>  (973) 
Metipranolol (BAN, INN, USAN); Metipranolol HCl (FDA)

>  <DEVELOPMENT_PHASE>  (973) 
4

>  <RESEARCH_CODES>  (973) 
BM-01004; VUAB-6453; VUAB6453 (SPOFA)

>  <APPLICANTS>  (973) 
Bausch And Lomb Pharmaceuticals Inc; Bausch & Lomb Pharmaceuticals

>  <USAN_STEM>  (973) 
-olol

>  <USAN_STEM_DEFINITION>  (973) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (973) 
-olol

>  <USAN_YEAR>  (973) 
1990.0

>  <FIRST_APPROVAL>  (973) 
1989.0

>  <ATC_CODE>  (973) 
S01ED04; S01ED54

>  <ATC_CODE_DESCRIPTION>  (973) 
S01ED04 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; S01ED54 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]

>  <INDICATION_CLASS>  (973) 
Antihypertensive (beta-blocker, ophthalmic)

>  <SC_PATENT_NO>  (973) 
nan

>  <DRUG_TYPE>  (973) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (973) 
Y

>  <FIRST_IN_CLASS>  (973) 
N

>  <CHIRALITY>  (973) 
Racemic Mixture

>  <PRODRUG>  (973) 
Y

>  <ORAL>  (973) 
N

>  <PARENTERAL>  (973) 
N

>  <TOPICAL>  (973) 
Y

>  <BLACK_BOX>  (973) 
N

>  <AVAILABILITY_TYPE>  (973) 
Prescription-only

>  <WITHDRAWN_YEAR>  (973) 
1990.0

>  <WITHDRAWN_COUNTRY>  (973) 
United Kingdom

>  <WITHDRAWN_REASON>  (973) 
Uveitis

>  <CANONICAL_SMILES>  (973) 
CC(C)NCC(O)COc1cc(C)c(OC(=O)C)c(C)c1C

>  <name>  (973) 
Metipranolol 

>  <MW>  (973) 
309.406

>  <logP>  (973) 
2.27486

$$$$
CHEMBL1100
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10  3  1  0
M  END
>  <PARENT_MOLREGNO>  (974) 
150989

>  <SYNONYMS>  (974) 
Paramethadione (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (974) 
4

>  <RESEARCH_CODES>  (974) 
nan

>  <APPLICANTS>  (974) 
Abbvie Inc

>  <USAN_STEM>  (974) 
nan

>  <USAN_STEM_DEFINITION>  (974) 
nan

>  <USAN_STEM_SUBSTEM>  (974) 
nan

>  <USAN_YEAR>  (974) 
nan

>  <FIRST_APPROVAL>  (974) 
1949.0

>  <ATC_CODE>  (974) 
N03AC01

>  <ATC_CODE_DESCRIPTION>  (974) 
N03AC01 [Nervous System:Antiepileptics:Antiepileptics:Oxazolidine derivatives]

>  <INDICATION_CLASS>  (974) 
nan

>  <SC_PATENT_NO>  (974) 
nan

>  <DRUG_TYPE>  (974) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (974) 
Y

>  <FIRST_IN_CLASS>  (974) 
N

>  <CHIRALITY>  (974) 
Racemic Mixture

>  <PRODRUG>  (974) 
N

>  <ORAL>  (974) 
Y

>  <PARENTERAL>  (974) 
N

>  <TOPICAL>  (974) 
N

>  <BLACK_BOX>  (974) 
N

>  <AVAILABILITY_TYPE>  (974) 
Discontinued

>  <WITHDRAWN_YEAR>  (974) 
nan

>  <WITHDRAWN_COUNTRY>  (974) 
nan

>  <WITHDRAWN_REASON>  (974) 
nan

>  <CANONICAL_SMILES>  (974) 
CCC1(C)OC(=O)N(C)C1=O

>  <name>  (974) 
Paramethadione 

>  <MW>  (974) 
157.169

>  <logP>  (974) 
0.7637

$$$$
CHEMBL829
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  8  1  0
 14  9  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (975) 
57833

>  <SYNONYMS>  (975) 
Alimemazine (INN, BAN); Alimemazine Tartrate (JAN); Trimeprazine Tartrate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (975) 
4

>  <RESEARCH_CODES>  (975) 
nan

>  <APPLICANTS>  (975) 
Allergan Herbert Skin Care Div Allergan Inc

>  <USAN_STEM>  (975) 
nan

>  <USAN_STEM_DEFINITION>  (975) 
nan

>  <USAN_STEM_SUBSTEM>  (975) 
nan

>  <USAN_YEAR>  (975) 
nan

>  <FIRST_APPROVAL>  (975) 
1982.0

>  <ATC_CODE>  (975) 
R06AD01

>  <ATC_CODE_DESCRIPTION>  (975) 
R06AD01 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]

>  <INDICATION_CLASS>  (975) 
Antipruritic

>  <SC_PATENT_NO>  (975) 
nan

>  <DRUG_TYPE>  (975) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (975) 
Y

>  <FIRST_IN_CLASS>  (975) 
N

>  <CHIRALITY>  (975) 
Racemic Mixture

>  <PRODRUG>  (975) 
N

>  <ORAL>  (975) 
Y

>  <PARENTERAL>  (975) 
N

>  <TOPICAL>  (975) 
N

>  <BLACK_BOX>  (975) 
N

>  <AVAILABILITY_TYPE>  (975) 
Discontinued

>  <WITHDRAWN_YEAR>  (975) 
nan

>  <WITHDRAWN_COUNTRY>  (975) 
nan

>  <WITHDRAWN_REASON>  (975) 
nan

>  <CANONICAL_SMILES>  (975) 
CC(CN(C)C)CN1c2ccccc2Sc3ccccc13

>  <name>  (975) 
Alimemazine 

>  <MW>  (975) 
298.455

>  <logP>  (975) 
4.487

$$$$
CHEMBL3707234
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  4 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  2 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 11  6  1  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (976) 
2039205

>  <SYNONYMS>  (976) 
Nicofetamide

>  <DEVELOPMENT_PHASE>  (976) 
4

>  <RESEARCH_CODES>  (976) 
nan

>  <APPLICANTS>  (976) 
nan

>  <USAN_STEM>  (976) 
nan

>  <USAN_STEM_DEFINITION>  (976) 
nan

>  <USAN_STEM_SUBSTEM>  (976) 
nan

>  <USAN_YEAR>  (976) 
nan

>  <FIRST_APPROVAL>  (976) 
nan

>  <ATC_CODE>  (976) 
A03AC04

>  <ATC_CODE_DESCRIPTION>  (976) 
A03AC04 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic antispasmodics, amides with tertiary amines]

>  <INDICATION_CLASS>  (976) 
nan

>  <SC_PATENT_NO>  (976) 
nan

>  <DRUG_TYPE>  (976) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (976) 
Y

>  <FIRST_IN_CLASS>  (976) 
N

>  <CHIRALITY>  (976) 
Racemic Mixture

>  <PRODRUG>  (976) 
N

>  <ORAL>  (976) 
N

>  <PARENTERAL>  (976) 
N

>  <TOPICAL>  (976) 
N

>  <BLACK_BOX>  (976) 
N

>  <AVAILABILITY_TYPE>  (976) 
Unknown

>  <WITHDRAWN_YEAR>  (976) 
nan

>  <WITHDRAWN_COUNTRY>  (976) 
nan

>  <WITHDRAWN_REASON>  (976) 
nan

>  <CANONICAL_SMILES>  (976) 
O=C(NC(Cc1ccccc1)c2ccccc2)c3cccnc3

>  <name>  (976) 
Nicofetamide

>  <MW>  (976) 
302.377

>  <logP>  (976) 
3.7954

$$$$
CHEMBL54
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
  5 18  1  0
 18 19  1  0
  2 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 19  2  1  0
 17 11  1  0
 26 20  1  0
M  END
>  <PARENT_MOLREGNO>  (977) 
3859

>  <SYNONYMS>  (977) 
Haloperidol (BAN, FDA, INN, JAN, USAN, USP); Haloperidol Lactate (FDA)

>  <DEVELOPMENT_PHASE>  (977) 
4

>  <RESEARCH_CODES>  (977) 
MCN-JR-1625; R-1625

>  <APPLICANTS>  (977) 
Ortho Mcneil Pharmaceutical Inc; Ortho Mcneil Pharmaceutical; Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (977) 
-peridol

>  <USAN_STEM_DEFINITION>  (977) 
antipsychotics (haloperidol type)

>  <USAN_STEM_SUBSTEM>  (977) 
-peridol

>  <USAN_YEAR>  (977) 
1965.0

>  <FIRST_APPROVAL>  (977) 
1967.0

>  <ATC_CODE>  (977) 
N05AD01

>  <ATC_CODE_DESCRIPTION>  (977) 
N05AD01 [Nervous System:Psycholeptics:Antipsychotics:Butyrophenone derivatives]

>  <INDICATION_CLASS>  (977) 
Antidyskinetic (in gilles de la tourette's disease); Antipsychotic

>  <SC_PATENT_NO>  (977) 
nan

>  <DRUG_TYPE>  (977) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (977) 
Y

>  <FIRST_IN_CLASS>  (977) 
N

>  <CHIRALITY>  (977) 
Achiral Molecule

>  <PRODRUG>  (977) 
N

>  <ORAL>  (977) 
Y

>  <PARENTERAL>  (977) 
Y

>  <TOPICAL>  (977) 
N

>  <BLACK_BOX>  (977) 
Y

>  <AVAILABILITY_TYPE>  (977) 
Prescription-only

>  <WITHDRAWN_YEAR>  (977) 
nan

>  <WITHDRAWN_COUNTRY>  (977) 
nan

>  <WITHDRAWN_REASON>  (977) 
nan

>  <CANONICAL_SMILES>  (977) 
OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3

>  <name>  (977) 
Haloperidol 

>  <MW>  (977) 
375.871

>  <logP>  (977) 
4.4256

$$$$
CHEMBL404
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  2  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 11 15  1  0
 15 16  2  0
 15 17  2  0
  9 18  1  0
 18 19  2  0
 18 20  1  0
 15  2  1  0
  8  4  1  0
 13 10  1  0
M  END
>  <PARENT_MOLREGNO>  (978) 
207

>  <SYNONYMS>  (978) 
Tazobactam (BAN, INN, USAN); Tazobactam sodium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (978) 
4

>  <RESEARCH_CODES>  (978) 
CL-298741; YTR-830H; CL-307579

>  <APPLICANTS>  (978) 
Wyeth Pharmaceuticals Inc; Taiho, Japan

>  <USAN_STEM>  (978) 
-bactam

>  <USAN_STEM_DEFINITION>  (978) 
beta-lactamase inhibitors

>  <USAN_STEM_SUBSTEM>  (978) 
-bactam

>  <USAN_YEAR>  (978) 
1989.0

>  <FIRST_APPROVAL>  (978) 
1993.0

>  <ATC_CODE>  (978) 
J01CG02

>  <ATC_CODE_DESCRIPTION>  (978) 
J01CG02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase inhibitors]

>  <INDICATION_CLASS>  (978) 
Inhibitor (beta-lactamase)

>  <SC_PATENT_NO>  (978) 
US-6207661-B1

>  <DRUG_TYPE>  (978) 
Natural Product-derived

>  <RULE_OF_FIVE>  (978) 
Y

>  <FIRST_IN_CLASS>  (978) 
N

>  <CHIRALITY>  (978) 
Single Stereoisomer

>  <PRODRUG>  (978) 
N

>  <ORAL>  (978) 
N

>  <PARENTERAL>  (978) 
Y

>  <TOPICAL>  (978) 
N

>  <BLACK_BOX>  (978) 
N

>  <AVAILABILITY_TYPE>  (978) 
Prescription-only

>  <WITHDRAWN_YEAR>  (978) 
nan

>  <WITHDRAWN_COUNTRY>  (978) 
nan

>  <WITHDRAWN_REASON>  (978) 
nan

>  <CANONICAL_SMILES>  (978) 
C[C@]1(Cn2ccnn2)[C@@H](N3[C@@H](CC3=O)S1(=O)=O)C(=O)O

>  <name>  (978) 
Tazobactam 

>  <MW>  (978) 
300.296

>  <logP>  (978) 
-1.5232

$$$$
CHEMBL1201317
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
M  END
>  <PARENT_MOLREGNO>  (979) 
675268

>  <SYNONYMS>  (979) 
Triclofos (BAN, INN); Triclofos Sodium (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (979) 
4

>  <RESEARCH_CODES>  (979) 
SCH-10159

>  <APPLICANTS>  (979) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (979) 
nan

>  <USAN_STEM_DEFINITION>  (979) 
nan

>  <USAN_STEM_SUBSTEM>  (979) 
nan

>  <USAN_YEAR>  (979) 
1963.0

>  <FIRST_APPROVAL>  (979) 
1982.0

>  <ATC_CODE>  (979) 
N05CM07

>  <ATC_CODE_DESCRIPTION>  (979) 
N05CM07 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]

>  <INDICATION_CLASS>  (979) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (979) 
nan

>  <DRUG_TYPE>  (979) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (979) 
Y

>  <FIRST_IN_CLASS>  (979) 
N

>  <CHIRALITY>  (979) 
Achiral Molecule

>  <PRODRUG>  (979) 
Y

>  <ORAL>  (979) 
Y

>  <PARENTERAL>  (979) 
N

>  <TOPICAL>  (979) 
N

>  <BLACK_BOX>  (979) 
N

>  <AVAILABILITY_TYPE>  (979) 
Discontinued

>  <WITHDRAWN_YEAR>  (979) 
nan

>  <WITHDRAWN_COUNTRY>  (979) 
nan

>  <WITHDRAWN_REASON>  (979) 
nan

>  <CANONICAL_SMILES>  (979) 
OP(=O)(O)OCC(Cl)(Cl)Cl

>  <name>  (979) 
Triclofos 

>  <MW>  (979) 
229.383

>  <logP>  (979) 
1.4659

$$$$
CHEMBL1237119
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 19 10  1  0
 19 14  1  0
 23 16  1  0
M  END
>  <PARENT_MOLREGNO>  (980) 
699470

>  <SYNONYMS>  (980) 
Treprostinil (INN, USAN); Tresprostinil (FDA); Treprostinil Diolamine (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (980) 
4

>  <RESEARCH_CODES>  (980) 
15AU81; LRX-15; UT-15

>  <APPLICANTS>  (980) 
United Therapeutics Corp; United Therapeutics

>  <USAN_STEM>  (980) 
-nil; -prost-

>  <USAN_STEM_DEFINITION>  (980) 
benzodiazepine receptor antagonists/agonists; prostaglandins

>  <USAN_STEM_SUBSTEM>  (980) 
-nil; -prost-

>  <USAN_YEAR>  (980) 
2002.0

>  <FIRST_APPROVAL>  (980) 
2002.0

>  <ATC_CODE>  (980) 
B01AC21

>  <ATC_CODE_DESCRIPTION>  (980) 
B01AC21 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (980) 
nan

>  <SC_PATENT_NO>  (980) 
US-6521212-B1

>  <DRUG_TYPE>  (980) 
Natural Product-derived

>  <RULE_OF_FIVE>  (980) 
Y

>  <FIRST_IN_CLASS>  (980) 
N

>  <CHIRALITY>  (980) 
Single Stereoisomer

>  <PRODRUG>  (980) 
N

>  <ORAL>  (980) 
Y

>  <PARENTERAL>  (980) 
Y

>  <TOPICAL>  (980) 
Y

>  <BLACK_BOX>  (980) 
N

>  <AVAILABILITY_TYPE>  (980) 
Prescription-only

>  <WITHDRAWN_YEAR>  (980) 
nan

>  <WITHDRAWN_COUNTRY>  (980) 
nan

>  <WITHDRAWN_REASON>  (980) 
nan

>  <CANONICAL_SMILES>  (980) 
CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@@H]2Cc3c(C[C@H]12)cccc3OCC(=O)O

>  <name>  (980) 
Treprostinil 

>  <MW>  (980) 
390.52

>  <logP>  (980) 
3.5832

$$$$
CHEMBL126
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 15 22  1  0
 22 23  1  0
 22 24  2  0
 11  6  1  0
 24 12  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (981) 
26280

>  <SYNONYMS>  (981) 
Linezolid (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (981) 
4

>  <RESEARCH_CODES>  (981) 
U-100766

>  <APPLICANTS>  (981) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (981) 
-zolid

>  <USAN_STEM_DEFINITION>  (981) 
oxazolidinone antibacterials

>  <USAN_STEM_SUBSTEM>  (981) 
-zolid

>  <USAN_YEAR>  (981) 
1997.0

>  <FIRST_APPROVAL>  (981) 
2000.0

>  <ATC_CODE>  (981) 
J01XX08

>  <ATC_CODE_DESCRIPTION>  (981) 
J01XX08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Other antibacterials]

>  <INDICATION_CLASS>  (981) 
Antibacterial

>  <SC_PATENT_NO>  (981) 
US-6514529-B2

>  <DRUG_TYPE>  (981) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (981) 
Y

>  <FIRST_IN_CLASS>  (981) 
N

>  <CHIRALITY>  (981) 
Single Stereoisomer

>  <PRODRUG>  (981) 
N

>  <ORAL>  (981) 
Y

>  <PARENTERAL>  (981) 
Y

>  <TOPICAL>  (981) 
N

>  <BLACK_BOX>  (981) 
N

>  <AVAILABILITY_TYPE>  (981) 
Prescription-only

>  <WITHDRAWN_YEAR>  (981) 
nan

>  <WITHDRAWN_COUNTRY>  (981) 
nan

>  <WITHDRAWN_REASON>  (981) 
nan

>  <CANONICAL_SMILES>  (981) 
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCOCC3)c(F)c2

>  <name>  (981) 
Linezolid 

>  <MW>  (981) 
337.351

>  <logP>  (981) 
1.1236

$$$$
CHEMBL289469
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  7  2  1  0
 10  3  1  0
 23 14  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (982) 
54547

>  <SYNONYMS>  (982) 
Granisetron (BAN, FDA, INN, USAN); Granisetron HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (982) 
4

>  <RESEARCH_CODES>  (982) 
BRL-43694; LY-278584; BRL-43694A

>  <APPLICANTS>  (982) 
Prostrakan Inc; Hoffmann La Roche Inc

>  <USAN_STEM>  (982) 
-setron

>  <USAN_STEM_DEFINITION>  (982) 
serotonin 5-HT3 antagonists

>  <USAN_STEM_SUBSTEM>  (982) 
-setron

>  <USAN_YEAR>  (982) 
1991.0

>  <FIRST_APPROVAL>  (982) 
1993.0

>  <ATC_CODE>  (982) 
A04AA02

>  <ATC_CODE_DESCRIPTION>  (982) 
A04AA02 [Alimentary Tract And Metabolism:Antiemetics And Antinauseants:Antiemetics And Antinauseants:Serotonin (5HT3) antagonists]

>  <INDICATION_CLASS>  (982) 
Anti-Emetic

>  <SC_PATENT_NO>  (982) 
US-5952340-A

>  <DRUG_TYPE>  (982) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (982) 
Y

>  <FIRST_IN_CLASS>  (982) 
N

>  <CHIRALITY>  (982) 
Single Stereoisomer

>  <PRODRUG>  (982) 
N

>  <ORAL>  (982) 
Y

>  <PARENTERAL>  (982) 
Y

>  <TOPICAL>  (982) 
Y

>  <BLACK_BOX>  (982) 
N

>  <AVAILABILITY_TYPE>  (982) 
Prescription-only

>  <WITHDRAWN_YEAR>  (982) 
nan

>  <WITHDRAWN_COUNTRY>  (982) 
nan

>  <WITHDRAWN_REASON>  (982) 
nan

>  <CANONICAL_SMILES>  (982) 
CN1C2CCCC1CC(C2)NC(=O)c3nn(C)c4ccccc34

>  <name>  (982) 
Granisetron 

>  <MW>  (982) 
312.417

>  <logP>  (982) 
2.3184

$$$$
CHEMBL36
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 10  3  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (983) 
2080

>  <SYNONYMS>  (983) 
Pyrimethamine (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (983) 
4

>  <RESEARCH_CODES>  (983) 
GNF-Pf-5586; TCMDC-123831; TCMDC-125860

>  <APPLICANTS>  (983) 
Hoffmann La Roche Inc; Corepharma Llc

>  <USAN_STEM>  (983) 
nan

>  <USAN_STEM_DEFINITION>  (983) 
nan

>  <USAN_STEM_SUBSTEM>  (983) 
nan

>  <USAN_YEAR>  (983) 
nan

>  <FIRST_APPROVAL>  (983) 
1953.0

>  <ATC_CODE>  (983) 
P01BD01; P01BD51

>  <ATC_CODE_DESCRIPTION>  (983) 
P01BD01 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Diaminopyrimidines]; P01BD51 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Antimalarials:Diaminopyrimidines]

>  <INDICATION_CLASS>  (983) 
Antimalarial

>  <SC_PATENT_NO>  (983) 
nan

>  <DRUG_TYPE>  (983) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (983) 
Y

>  <FIRST_IN_CLASS>  (983) 
N

>  <CHIRALITY>  (983) 
Achiral Molecule

>  <PRODRUG>  (983) 
N

>  <ORAL>  (983) 
Y

>  <PARENTERAL>  (983) 
N

>  <TOPICAL>  (983) 
N

>  <BLACK_BOX>  (983) 
N

>  <AVAILABILITY_TYPE>  (983) 
Prescription-only

>  <WITHDRAWN_YEAR>  (983) 
nan

>  <WITHDRAWN_COUNTRY>  (983) 
nan

>  <WITHDRAWN_REASON>  (983) 
nan

>  <CANONICAL_SMILES>  (983) 
CCc1nc(N)nc(N)c1c2ccc(Cl)cc2

>  <name>  (983) 
Pyrimethamine 

>  <MW>  (983) 
248.717

>  <logP>  (983) 
2.5238

$$$$
CHEMBL509
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
  7 18  2  0
 18 19  1  0
 18  2  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (984) 
10531

>  <SYNONYMS>  (984) 
Meclofenamic Acid (BAN, INN, USAN); Meclofenamate sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (984) 
4

>  <RESEARCH_CODES>  (984) 
CI-583; INF-4668; CL-583; CL-583.NA SALT

>  <APPLICANTS>  (984) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (984) 
nan

>  <USAN_STEM_DEFINITION>  (984) 
nan

>  <USAN_STEM_SUBSTEM>  (984) 
nan

>  <USAN_YEAR>  (984) 
1976.0

>  <FIRST_APPROVAL>  (984) 
1980.0

>  <ATC_CODE>  (984) 
M01AG04; M02AA18

>  <ATC_CODE_DESCRIPTION>  (984) 
M01AG04 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Fenamates]; M02AA18 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]

>  <INDICATION_CLASS>  (984) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (984) 
nan

>  <DRUG_TYPE>  (984) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (984) 
Y

>  <FIRST_IN_CLASS>  (984) 
N

>  <CHIRALITY>  (984) 
Achiral Molecule

>  <PRODRUG>  (984) 
N

>  <ORAL>  (984) 
Y

>  <PARENTERAL>  (984) 
N

>  <TOPICAL>  (984) 
N

>  <BLACK_BOX>  (984) 
N

>  <AVAILABILITY_TYPE>  (984) 
Prescription-only

>  <WITHDRAWN_YEAR>  (984) 
nan

>  <WITHDRAWN_COUNTRY>  (984) 
nan

>  <WITHDRAWN_REASON>  (984) 
nan

>  <CANONICAL_SMILES>  (984) 
Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl

>  <name>  (984) 
Meclofenamic Acid 

>  <MW>  (984) 
296.153

>  <logP>  (984) 
4.74362

$$$$
CHEMBL1200922
     RDKit          

 16 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  5 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
M  END
>  <PARENT_MOLREGNO>  (985) 
674873

>  <SYNONYMS>  (985) 
Mebutamate (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (985) 
4

>  <RESEARCH_CODES>  (985) 
W-583

>  <APPLICANTS>  (985) 
Medpointe Pharmaceuticals Medpointe Healthcare Inc

>  <USAN_STEM>  (985) 
nan

>  <USAN_STEM_DEFINITION>  (985) 
nan

>  <USAN_STEM_SUBSTEM>  (985) 
nan

>  <USAN_YEAR>  (985) 
1961.0

>  <FIRST_APPROVAL>  (985) 
1982.0

>  <ATC_CODE>  (985) 
N05BC04

>  <ATC_CODE_DESCRIPTION>  (985) 
N05BC04 [Nervous System:Psycholeptics:Anxiolytics:Carbamates]

>  <INDICATION_CLASS>  (985) 
Antihypertensive

>  <SC_PATENT_NO>  (985) 
nan

>  <DRUG_TYPE>  (985) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (985) 
Y

>  <FIRST_IN_CLASS>  (985) 
N

>  <CHIRALITY>  (985) 
Racemic Mixture

>  <PRODRUG>  (985) 
N

>  <ORAL>  (985) 
Y

>  <PARENTERAL>  (985) 
N

>  <TOPICAL>  (985) 
N

>  <BLACK_BOX>  (985) 
N

>  <AVAILABILITY_TYPE>  (985) 
Discontinued

>  <WITHDRAWN_YEAR>  (985) 
nan

>  <WITHDRAWN_COUNTRY>  (985) 
nan

>  <WITHDRAWN_REASON>  (985) 
nan

>  <CANONICAL_SMILES>  (985) 
CCC(C)C(C)(COC(=O)N)COC(=O)N

>  <name>  (985) 
Mebutamate 

>  <MW>  (985) 
232.28

>  <logP>  (985) 
1.2294

$$$$
CHEMBL1200829
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11  3  1  0
M  END
>  <PARENT_MOLREGNO>  (986) 
674780

>  <SYNONYMS>  (986) 
Gluconolactone (FDA, USP)

>  <DEVELOPMENT_PHASE>  (986) 
4

>  <RESEARCH_CODES>  (986) 
nan

>  <APPLICANTS>  (986) 
United Guardian Inc

>  <USAN_STEM>  (986) 
nan

>  <USAN_STEM_DEFINITION>  (986) 
nan

>  <USAN_STEM_SUBSTEM>  (986) 
nan

>  <USAN_YEAR>  (986) 
nan

>  <FIRST_APPROVAL>  (986) 
1990.0

>  <ATC_CODE>  (986) 
nan

>  <ATC_CODE_DESCRIPTION>  (986) 
nan

>  <INDICATION_CLASS>  (986) 
Chelating Agent

>  <SC_PATENT_NO>  (986) 
nan

>  <DRUG_TYPE>  (986) 
Natural Product-derived

>  <RULE_OF_FIVE>  (986) 
Y

>  <FIRST_IN_CLASS>  (986) 
N

>  <CHIRALITY>  (986) 
Single Stereoisomer

>  <PRODRUG>  (986) 
N

>  <ORAL>  (986) 
N

>  <PARENTERAL>  (986) 
N

>  <TOPICAL>  (986) 
N

>  <BLACK_BOX>  (986) 
N

>  <AVAILABILITY_TYPE>  (986) 
Prescription-only

>  <WITHDRAWN_YEAR>  (986) 
nan

>  <WITHDRAWN_COUNTRY>  (986) 
nan

>  <WITHDRAWN_REASON>  (986) 
nan

>  <CANONICAL_SMILES>  (986) 
OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O

>  <name>  (986) 
Gluconolactone 

>  <MW>  (986) 
178.14

>  <logP>  (986) 
-3.0132

$$$$
CHEMBL7413
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  3  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  7 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18  7  1  0
M  END
>  <PARENT_MOLREGNO>  (987) 
2216

>  <SYNONYMS>  (987) 
Methohexital (BAN, INN, USP); Methohexital sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (987) 
4

>  <RESEARCH_CODES>  (987) 
nan

>  <APPLICANTS>  (987) 
Jhp Pharmaceuticals Llc

>  <USAN_STEM>  (987) 
nan

>  <USAN_STEM_DEFINITION>  (987) 
nan

>  <USAN_STEM_SUBSTEM>  (987) 
nan

>  <USAN_YEAR>  (987) 
nan

>  <FIRST_APPROVAL>  (987) 
1960.0

>  <ATC_CODE>  (987) 
N01AF01; N05CA15

>  <ATC_CODE_DESCRIPTION>  (987) 
N01AF01 [Nervous System:Anesthetics:Anesthetics, General:Barbiturates, plain]; N05CA15 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (987) 
Anesthetic (intravenous)

>  <SC_PATENT_NO>  (987) 
nan

>  <DRUG_TYPE>  (987) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (987) 
Y

>  <FIRST_IN_CLASS>  (987) 
N

>  <CHIRALITY>  (987) 
Racemic Mixture

>  <PRODRUG>  (987) 
N

>  <ORAL>  (987) 
N

>  <PARENTERAL>  (987) 
Y

>  <TOPICAL>  (987) 
N

>  <BLACK_BOX>  (987) 
Y

>  <AVAILABILITY_TYPE>  (987) 
Prescription-only

>  <WITHDRAWN_YEAR>  (987) 
nan

>  <WITHDRAWN_COUNTRY>  (987) 
nan

>  <WITHDRAWN_REASON>  (987) 
nan

>  <CANONICAL_SMILES>  (987) 
CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O

>  <name>  (987) 
Methohexital 

>  <MW>  (987) 
262.309

>  <logP>  (987) 
1.3066

$$$$
CHEMBL35
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  7 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 11 19  1  0
 19 20  2  0
 20 21  1  0
 20  5  1  0
 18 14  2  0
M  END
>  <PARENT_MOLREGNO>  (988) 
2046

>  <SYNONYMS>  (988) 
Furosemide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (988) 
4

>  <RESEARCH_CODES>  (988) 
LB-502

>  <APPLICANTS>  (988) 
Hikma Maple Ltd; Fresenius Kabi Usa Llc; Dava Pharmaceuticals Inc; Abraxis Pharmaceutical Products; Hospira Inc

>  <USAN_STEM>  (988) 
-semide

>  <USAN_STEM_DEFINITION>  (988) 
diuretics (furosemide type)

>  <USAN_STEM_SUBSTEM>  (988) 
-semide

>  <USAN_YEAR>  (988) 
1964.0

>  <FIRST_APPROVAL>  (988) 
1966.0

>  <ATC_CODE>  (988) 
C03CA01

>  <ATC_CODE_DESCRIPTION>  (988) 
C03CA01 [Cardiovascular System:Diuretics:High-Ceiling Diuretics:Sulfonamides, plain]

>  <INDICATION_CLASS>  (988) 
Diuretic

>  <SC_PATENT_NO>  (988) 
nan

>  <DRUG_TYPE>  (988) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (988) 
Y

>  <FIRST_IN_CLASS>  (988) 
N

>  <CHIRALITY>  (988) 
Achiral Molecule

>  <PRODRUG>  (988) 
N

>  <ORAL>  (988) 
Y

>  <PARENTERAL>  (988) 
Y

>  <TOPICAL>  (988) 
N

>  <BLACK_BOX>  (988) 
Y

>  <AVAILABILITY_TYPE>  (988) 
Prescription-only

>  <WITHDRAWN_YEAR>  (988) 
nan

>  <WITHDRAWN_COUNTRY>  (988) 
nan

>  <WITHDRAWN_REASON>  (988) 
nan

>  <CANONICAL_SMILES>  (988) 
NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl

>  <name>  (988) 
Furosemide 

>  <MW>  (988) 
330.749

>  <logP>  (988) 
1.8907

$$$$
CHEMBL742
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
  8  3  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (989) 
38833

>  <SYNONYMS>  (989) 
Ketamine (BAN, INN); Ketamine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (989) 
4

>  <RESEARCH_CODES>  (989) 
CI-581; CL-369; CN-52372-2

>  <APPLICANTS>  (989) 
Jhp Pharmaceuticals Llc

>  <USAN_STEM>  (989) 
nan

>  <USAN_STEM_DEFINITION>  (989) 
nan

>  <USAN_STEM_SUBSTEM>  (989) 
nan

>  <USAN_YEAR>  (989) 
1966.0

>  <FIRST_APPROVAL>  (989) 
1970.0

>  <ATC_CODE>  (989) 
N01AX03

>  <ATC_CODE_DESCRIPTION>  (989) 
N01AX03 [Nervous System:Anesthetics:Anesthetics, General:Other general anesthetics]

>  <INDICATION_CLASS>  (989) 
Anesthetic

>  <SC_PATENT_NO>  (989) 
nan

>  <DRUG_TYPE>  (989) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (989) 
Y

>  <FIRST_IN_CLASS>  (989) 
N

>  <CHIRALITY>  (989) 
Racemic Mixture

>  <PRODRUG>  (989) 
N

>  <ORAL>  (989) 
N

>  <PARENTERAL>  (989) 
Y

>  <TOPICAL>  (989) 
N

>  <BLACK_BOX>  (989) 
Y

>  <AVAILABILITY_TYPE>  (989) 
Prescription-only

>  <WITHDRAWN_YEAR>  (989) 
nan

>  <WITHDRAWN_COUNTRY>  (989) 
nan

>  <WITHDRAWN_REASON>  (989) 
nan

>  <CANONICAL_SMILES>  (989) 
CNC1(CCCCC1=O)c2ccccc2Cl

>  <name>  (989) 
Ketamine 

>  <MW>  (989) 
237.73

>  <logP>  (989) 
2.8978

$$$$
CHEMBL617
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 12 22  1  0
 22 23  2  0
  7 24  1  0
 24 25  2  0
 24 26  1  0
 11  6  1  0
 22  8  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (990) 
24991

>  <SYNONYMS>  (990) 
Cefalotin (INN, BAN); Cefalotin Sodium (JAN); Cephalothin sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (990) 
4

>  <RESEARCH_CODES>  (990) 
38253

>  <APPLICANTS>  (990) 
Eli Lilly And Co

>  <USAN_STEM>  (990) 
nan

>  <USAN_STEM_DEFINITION>  (990) 
nan

>  <USAN_STEM_SUBSTEM>  (990) 
nan

>  <USAN_YEAR>  (990) 
1965.0

>  <FIRST_APPROVAL>  (990) 
1974.0

>  <ATC_CODE>  (990) 
J01DB03

>  <ATC_CODE_DESCRIPTION>  (990) 
J01DB03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:First-generation cephalosporins]

>  <INDICATION_CLASS>  (990) 
Antibacterial

>  <SC_PATENT_NO>  (990) 
nan

>  <DRUG_TYPE>  (990) 
Natural Product-derived

>  <RULE_OF_FIVE>  (990) 
Y

>  <FIRST_IN_CLASS>  (990) 
N

>  <CHIRALITY>  (990) 
Single Stereoisomer

>  <PRODRUG>  (990) 
N

>  <ORAL>  (990) 
N

>  <PARENTERAL>  (990) 
Y

>  <TOPICAL>  (990) 
N

>  <BLACK_BOX>  (990) 
N

>  <AVAILABILITY_TYPE>  (990) 
Discontinued

>  <WITHDRAWN_YEAR>  (990) 
nan

>  <WITHDRAWN_COUNTRY>  (990) 
nan

>  <WITHDRAWN_REASON>  (990) 
nan

>  <CANONICAL_SMILES>  (990) 
CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc3cccs3)C2=O)C(=O)O

>  <name>  (990) 
Cefalotin 

>  <MW>  (990) 
396.446

>  <logP>  (990) 
0.5923

$$$$
CHEMBL395110
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  6 22  1  0
 22  2  1  0
 21  8  1  0
 14  9  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (991) 
396101

>  <SYNONYMS>  (991) 
Pecazine (INN, BAN)

>  <DEVELOPMENT_PHASE>  (991) 
4

>  <RESEARCH_CODES>  (991) 
nan

>  <APPLICANTS>  (991) 
nan

>  <USAN_STEM>  (991) 
nan

>  <USAN_STEM_DEFINITION>  (991) 
nan

>  <USAN_STEM_SUBSTEM>  (991) 
nan

>  <USAN_YEAR>  (991) 
nan

>  <FIRST_APPROVAL>  (991) 
nan

>  <ATC_CODE>  (991) 
nan

>  <ATC_CODE_DESCRIPTION>  (991) 
nan

>  <INDICATION_CLASS>  (991) 
nan

>  <SC_PATENT_NO>  (991) 
nan

>  <DRUG_TYPE>  (991) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (991) 
Y

>  <FIRST_IN_CLASS>  (991) 
N

>  <CHIRALITY>  (991) 
Racemic Mixture

>  <PRODRUG>  (991) 
N

>  <ORAL>  (991) 
N

>  <PARENTERAL>  (991) 
N

>  <TOPICAL>  (991) 
N

>  <BLACK_BOX>  (991) 
N

>  <AVAILABILITY_TYPE>  (991) 
Withdrawn

>  <WITHDRAWN_YEAR>  (991) 
nan

>  <WITHDRAWN_COUNTRY>  (991) 
United States

>  <WITHDRAWN_REASON>  (991) 
nan

>  <CANONICAL_SMILES>  (991) 
CN1CCCC(CN2c3ccccc3Sc4ccccc24)C1

>  <name>  (991) 
Pecazine 

>  <MW>  (991) 
310.466

>  <logP>  (991) 
4.6311

$$$$
CHEMBL1201233
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
M  END
>  <PARENT_MOLREGNO>  (992) 
675184

>  <SYNONYMS>  (992) 
Methyldopate (BAN); Methyldopate HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (992) 
4

>  <RESEARCH_CODES>  (992) 
nan

>  <APPLICANTS>  (992) 
Merck And Co Inc

>  <USAN_STEM>  (992) 
nan

>  <USAN_STEM_DEFINITION>  (992) 
nan

>  <USAN_STEM_SUBSTEM>  (992) 
nan

>  <USAN_YEAR>  (992) 
1963.0

>  <FIRST_APPROVAL>  (992) 
1962.0

>  <ATC_CODE>  (992) 
nan

>  <ATC_CODE_DESCRIPTION>  (992) 
nan

>  <INDICATION_CLASS>  (992) 
Antihypertensive

>  <SC_PATENT_NO>  (992) 
nan

>  <DRUG_TYPE>  (992) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (992) 
Y

>  <FIRST_IN_CLASS>  (992) 
N

>  <CHIRALITY>  (992) 
Single Stereoisomer

>  <PRODRUG>  (992) 
Y

>  <ORAL>  (992) 
N

>  <PARENTERAL>  (992) 
Y

>  <TOPICAL>  (992) 
N

>  <BLACK_BOX>  (992) 
N

>  <AVAILABILITY_TYPE>  (992) 
Prescription-only

>  <WITHDRAWN_YEAR>  (992) 
nan

>  <WITHDRAWN_COUNTRY>  (992) 
nan

>  <WITHDRAWN_REASON>  (992) 
nan

>  <CANONICAL_SMILES>  (992) 
CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1

>  <name>  (992) 
Methyldopate 

>  <MW>  (992) 
239.271

>  <logP>  (992) 
0.9208

$$$$
CHEMBL589
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 10  1  0
 19 14  2  0
M  END
>  <PARENT_MOLREGNO>  (993) 
19316

>  <SYNONYMS>  (993) 
Ropinirole (BAN, INN, USAN); Ropinirole HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (993) 
4

>  <RESEARCH_CODES>  (993) 
SK&F-101468; SK&F-101468A; SK&F-101468-A

>  <APPLICANTS>  (993) 
SmithKline Beecham Corp Dba GlaxoSmithKline; SmithKline Beecham; GlaxoSmithKline

>  <USAN_STEM>  (993) 
nan

>  <USAN_STEM_DEFINITION>  (993) 
nan

>  <USAN_STEM_SUBSTEM>  (993) 
nan

>  <USAN_YEAR>  (993) 
1993.0

>  <FIRST_APPROVAL>  (993) 
1997.0

>  <ATC_CODE>  (993) 
N04BC04

>  <ATC_CODE_DESCRIPTION>  (993) 
N04BC04 [Nervous System:Anti-Parkinson Drugs:Dopaminergic Agents:Dopamine agonists]

>  <INDICATION_CLASS>  (993) 
Antiparkinsonian (D2 receptor agonist)

>  <SC_PATENT_NO>  (993) 
US-7927624-B2

>  <DRUG_TYPE>  (993) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (993) 
Y

>  <FIRST_IN_CLASS>  (993) 
N

>  <CHIRALITY>  (993) 
Achiral Molecule

>  <PRODRUG>  (993) 
N

>  <ORAL>  (993) 
Y

>  <PARENTERAL>  (993) 
N

>  <TOPICAL>  (993) 
N

>  <BLACK_BOX>  (993) 
Y

>  <AVAILABILITY_TYPE>  (993) 
Prescription-only

>  <WITHDRAWN_YEAR>  (993) 
nan

>  <WITHDRAWN_COUNTRY>  (993) 
nan

>  <WITHDRAWN_REASON>  (993) 
nan

>  <CANONICAL_SMILES>  (993) 
CCCN(CCC)CCc1cccc2NC(=O)Cc12

>  <name>  (993) 
Ropinirole 

>  <MW>  (993) 
260.381

>  <logP>  (993) 
2.8457

$$$$
CHEMBL1422
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  2 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 11  6  1  0
 14  9  1  0
 27 20  1  0
M  END
>  <PARENT_MOLREGNO>  (994) 
363589

>  <SYNONYMS>  (994) 
Sitagliptin (INN); Sitagliptin Phosphate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (994) 
4

>  <RESEARCH_CODES>  (994) 
MK-0431

>  <APPLICANTS>  (994) 
Merck Sharp And Dohme Corp

>  <USAN_STEM>  (994) 
-gliptin

>  <USAN_STEM_DEFINITION>  (994) 
dipeptidyl aminopeptidase-IV inhibitors

>  <USAN_STEM_SUBSTEM>  (994) 
-gliptin

>  <USAN_YEAR>  (994) 
2005.0

>  <FIRST_APPROVAL>  (994) 
2006.0

>  <ATC_CODE>  (994) 
A10BH01

>  <ATC_CODE_DESCRIPTION>  (994) 
A10BH01 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Dipeptidyl peptidase 4 (DPP-4) inhibitors]

>  <INDICATION_CLASS>  (994) 
nan

>  <SC_PATENT_NO>  (994) 
US-6303661-B1

>  <DRUG_TYPE>  (994) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (994) 
Y

>  <FIRST_IN_CLASS>  (994) 
N

>  <CHIRALITY>  (994) 
Single Stereoisomer

>  <PRODRUG>  (994) 
N

>  <ORAL>  (994) 
Y

>  <PARENTERAL>  (994) 
N

>  <TOPICAL>  (994) 
N

>  <BLACK_BOX>  (994) 
N

>  <AVAILABILITY_TYPE>  (994) 
Prescription-only

>  <WITHDRAWN_YEAR>  (994) 
nan

>  <WITHDRAWN_COUNTRY>  (994) 
nan

>  <WITHDRAWN_REASON>  (994) 
nan

>  <CANONICAL_SMILES>  (994) 
N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F

>  <name>  (994) 
Sitagliptin 

>  <MW>  (994) 
407.318

>  <logP>  (994) 
2.0165

$$$$
CHEMBL1201758
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 14 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 12  7  1  0
 21 15  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (995) 
675709

>  <SYNONYMS>  (995) 
Bepotastine (INN, USAN); Bepotastine Besilate (FDA); Bepotastine Besylate (USAN)

>  <DEVELOPMENT_PHASE>  (995) 
4

>  <RESEARCH_CODES>  (995) 
TAU-284

>  <APPLICANTS>  (995) 
Ube Industries For Ista Pharmaceuticals; Ista Pharmaceuticals

>  <USAN_STEM>  (995) 
-astine

>  <USAN_STEM_DEFINITION>  (995) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (995) 
-astine

>  <USAN_YEAR>  (995) 
2009.0

>  <FIRST_APPROVAL>  (995) 
2009.0

>  <ATC_CODE>  (995) 
nan

>  <ATC_CODE_DESCRIPTION>  (995) 
nan

>  <INDICATION_CLASS>  (995) 
nan

>  <SC_PATENT_NO>  (995) 
US-6780877-B2

>  <DRUG_TYPE>  (995) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (995) 
Y

>  <FIRST_IN_CLASS>  (995) 
N

>  <CHIRALITY>  (995) 
Single Stereoisomer

>  <PRODRUG>  (995) 
N

>  <ORAL>  (995) 
N

>  <PARENTERAL>  (995) 
N

>  <TOPICAL>  (995) 
Y

>  <BLACK_BOX>  (995) 
N

>  <AVAILABILITY_TYPE>  (995) 
Prescription-only

>  <WITHDRAWN_YEAR>  (995) 
nan

>  <WITHDRAWN_COUNTRY>  (995) 
nan

>  <WITHDRAWN_REASON>  (995) 
nan

>  <CANONICAL_SMILES>  (995) 
OC(=O)CCCN1CCC(CC1)O[C@@H](c2ccc(Cl)cc2)c3ccccn3

>  <name>  (995) 
Bepotastine 

>  <MW>  (995) 
388.895

>  <logP>  (995) 
4.1702

$$$$
CHEMBL24
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 13 18  1  0
 18 19  2  0
 19 10  1  0
M  END
>  <PARENT_MOLREGNO>  (996) 
1279

>  <SYNONYMS>  (996) 
Atenolol (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (996) 
4

>  <RESEARCH_CODES>  (996) 
ICI-66082

>  <APPLICANTS>  (996) 
Astrazeneca Pharmaceuticals Lp; Astrazeneca Lp

>  <USAN_STEM>  (996) 
-olol

>  <USAN_STEM_DEFINITION>  (996) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (996) 
-olol

>  <USAN_YEAR>  (996) 
1976.0

>  <FIRST_APPROVAL>  (996) 
1981.0

>  <ATC_CODE>  (996) 
C07AB03

>  <ATC_CODE_DESCRIPTION>  (996) 
C07AB03 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]

>  <INDICATION_CLASS>  (996) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (996) 
nan

>  <DRUG_TYPE>  (996) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (996) 
Y

>  <FIRST_IN_CLASS>  (996) 
N

>  <CHIRALITY>  (996) 
Racemic Mixture

>  <PRODRUG>  (996) 
N

>  <ORAL>  (996) 
Y

>  <PARENTERAL>  (996) 
Y

>  <TOPICAL>  (996) 
N

>  <BLACK_BOX>  (996) 
Y

>  <AVAILABILITY_TYPE>  (996) 
Prescription-only

>  <WITHDRAWN_YEAR>  (996) 
nan

>  <WITHDRAWN_COUNTRY>  (996) 
nan

>  <WITHDRAWN_REASON>  (996) 
nan

>  <CANONICAL_SMILES>  (996) 
CC(C)NCC(O)COc1ccc(CC(=O)N)cc1

>  <name>  (996) 
Atenolol 

>  <MW>  (996) 
266.341

>  <logP>  (996) 
0.4521

$$$$
CHEMBL878
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
  8 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 13  2  1  0
 10  4  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (997) 
73548

>  <SYNONYMS>  (997) 
Metolazone (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (997) 
4

>  <RESEARCH_CODES>  (997) 
SR-720-22

>  <APPLICANTS>  (997) 
Ucb Inc; Gd Searle Llc

>  <USAN_STEM>  (997) 
nan

>  <USAN_STEM_DEFINITION>  (997) 
nan

>  <USAN_STEM_SUBSTEM>  (997) 
nan

>  <USAN_YEAR>  (997) 
1968.0

>  <FIRST_APPROVAL>  (997) 
1973.0

>  <ATC_CODE>  (997) 
C03BA08

>  <ATC_CODE_DESCRIPTION>  (997) 
C03BA08 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Excl. Thiazides:Sulfonamides, plain]

>  <INDICATION_CLASS>  (997) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (997) 
nan

>  <DRUG_TYPE>  (997) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (997) 
Y

>  <FIRST_IN_CLASS>  (997) 
N

>  <CHIRALITY>  (997) 
Racemic Mixture

>  <PRODRUG>  (997) 
N

>  <ORAL>  (997) 
Y

>  <PARENTERAL>  (997) 
N

>  <TOPICAL>  (997) 
N

>  <BLACK_BOX>  (997) 
N

>  <AVAILABILITY_TYPE>  (997) 
Prescription-only

>  <WITHDRAWN_YEAR>  (997) 
nan

>  <WITHDRAWN_COUNTRY>  (997) 
nan

>  <WITHDRAWN_REASON>  (997) 
nan

>  <CANONICAL_SMILES>  (997) 
CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N

>  <name>  (997) 
Metolazone 

>  <MW>  (997) 
365.842

>  <logP>  (997) 
2.71412

$$$$
CHEMBL1604
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
  8 20  1  0
 20 21  2  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
  7  2  1  0
 20  4  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (998) 
454576

>  <SYNONYMS>  (998) 
Cefradine (BAN, INN, JAN); Cephradine (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (998) 
4

>  <RESEARCH_CODES>  (998) 
SK&F-D39304; SK-D-39304; SQ-11436; SQ-22022 [Dihydrate]; SQ-22022

>  <APPLICANTS>  (998) 
Ersana Inc Sub Er Squibb And Sons; Bristol Myers Squibb Co

>  <USAN_STEM>  (998) 
nan

>  <USAN_STEM_DEFINITION>  (998) 
nan

>  <USAN_STEM_SUBSTEM>  (998) 
nan

>  <USAN_YEAR>  (998) 
1971.0

>  <FIRST_APPROVAL>  (998) 
1974.0

>  <ATC_CODE>  (998) 
J01DB09

>  <ATC_CODE_DESCRIPTION>  (998) 
J01DB09 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:First-generation cephalosporins]

>  <INDICATION_CLASS>  (998) 
Antibacterial

>  <SC_PATENT_NO>  (998) 
nan

>  <DRUG_TYPE>  (998) 
Natural Product-derived

>  <RULE_OF_FIVE>  (998) 
Y

>  <FIRST_IN_CLASS>  (998) 
N

>  <CHIRALITY>  (998) 
Single Stereoisomer

>  <PRODRUG>  (998) 
N

>  <ORAL>  (998) 
Y

>  <PARENTERAL>  (998) 
Y

>  <TOPICAL>  (998) 
N

>  <BLACK_BOX>  (998) 
N

>  <AVAILABILITY_TYPE>  (998) 
Discontinued

>  <WITHDRAWN_YEAR>  (998) 
nan

>  <WITHDRAWN_COUNTRY>  (998) 
nan

>  <WITHDRAWN_REASON>  (998) 
nan

>  <CANONICAL_SMILES>  (998) 
CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(=O)O

>  <name>  (998) 
Cefradine 

>  <MW>  (998) 
349.412

>  <logP>  (998) 
0.3486

$$$$
CHEMBL148
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
  7 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 10  4  1  0
  9  5  1  0
M  END
>  <PARENT_MOLREGNO>  (999) 
43934

>  <SYNONYMS>  (999) 
Imipenem (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (999) 
4

>  <RESEARCH_CODES>  (999) 
MK-0787

>  <APPLICANTS>  (999) 
Merck And Co Inc

>  <USAN_STEM>  (999) 
-penem

>  <USAN_STEM_DEFINITION>  (999) 
antibacterial antibiotics, carbapenem derivatives

>  <USAN_STEM_SUBSTEM>  (999) 
-penem

>  <USAN_YEAR>  (999) 
1983.0

>  <FIRST_APPROVAL>  (999) 
1985.0

>  <ATC_CODE>  (999) 
nan

>  <ATC_CODE_DESCRIPTION>  (999) 
nan

>  <INDICATION_CLASS>  (999) 
Antibacterial

>  <SC_PATENT_NO>  (999) 
nan

>  <DRUG_TYPE>  (999) 
Natural Product-derived

>  <RULE_OF_FIVE>  (999) 
Y

>  <FIRST_IN_CLASS>  (999) 
N

>  <CHIRALITY>  (999) 
Single Stereoisomer

>  <PRODRUG>  (999) 
N

>  <ORAL>  (999) 
N

>  <PARENTERAL>  (999) 
Y

>  <TOPICAL>  (999) 
N

>  <BLACK_BOX>  (999) 
N

>  <AVAILABILITY_TYPE>  (999) 
Prescription-only

>  <WITHDRAWN_YEAR>  (999) 
nan

>  <WITHDRAWN_COUNTRY>  (999) 
nan

>  <WITHDRAWN_REASON>  (999) 
nan

>  <CANONICAL_SMILES>  (999) 
C[C@@H](O)[C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCNC=N

>  <name>  (999) 
Imipenem 

>  <MW>  (999) 
299.352

>  <logP>  (999) 
-0.17603

$$$$
CHEMBL894
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1000) 
77128

>  <SYNONYMS>  (1000) 
Bupropion (BAN, INN); Bupropion Hydrobromide (FDA, USAN); Bupropion HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1000) 
4

>  <RESEARCH_CODES>  (1000) 
BW-323

>  <APPLICANTS>  (1000) 
Valeant International Srl; Valeant International Barbados Srl; GlaxoSmithKline; Edgemont Pharmaceuticals Llc

>  <USAN_STEM>  (1000) 
nan

>  <USAN_STEM_DEFINITION>  (1000) 
nan

>  <USAN_STEM_SUBSTEM>  (1000) 
nan

>  <USAN_YEAR>  (1000) 
1974.0

>  <FIRST_APPROVAL>  (1000) 
1985.0

>  <ATC_CODE>  (1000) 
N06AX12

>  <ATC_CODE_DESCRIPTION>  (1000) 
N06AX12 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (1000) 
Antidepressant

>  <SC_PATENT_NO>  (1000) 
US-6096341-A

>  <DRUG_TYPE>  (1000) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1000) 
Y

>  <FIRST_IN_CLASS>  (1000) 
N

>  <CHIRALITY>  (1000) 
Racemic Mixture

>  <PRODRUG>  (1000) 
N

>  <ORAL>  (1000) 
Y

>  <PARENTERAL>  (1000) 
N

>  <TOPICAL>  (1000) 
N

>  <BLACK_BOX>  (1000) 
Y

>  <AVAILABILITY_TYPE>  (1000) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1000) 
nan

>  <WITHDRAWN_COUNTRY>  (1000) 
nan

>  <WITHDRAWN_REASON>  (1000) 
nan

>  <CANONICAL_SMILES>  (1000) 
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1

>  <name>  (1000) 
Bupropion 

>  <MW>  (1000) 
239.746

>  <logP>  (1000) 
3.2993

$$$$
CHEMBL640
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1001) 
27341

>  <SYNONYMS>  (1001) 
Procainamide (BAN, INN); Procainamide HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1001) 
4

>  <RESEARCH_CODES>  (1001) 
nan

>  <APPLICANTS>  (1001) 
King Pharmaceuticals Inc; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (1001) 
nan

>  <USAN_STEM_DEFINITION>  (1001) 
nan

>  <USAN_STEM_SUBSTEM>  (1001) 
nan

>  <USAN_YEAR>  (1001) 
nan

>  <FIRST_APPROVAL>  (1001) 
1950.0

>  <ATC_CODE>  (1001) 
C01BA02

>  <ATC_CODE_DESCRIPTION>  (1001) 
C01BA02 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ia]

>  <INDICATION_CLASS>  (1001) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (1001) 
nan

>  <DRUG_TYPE>  (1001) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1001) 
Y

>  <FIRST_IN_CLASS>  (1001) 
N

>  <CHIRALITY>  (1001) 
Achiral Molecule

>  <PRODRUG>  (1001) 
N

>  <ORAL>  (1001) 
Y

>  <PARENTERAL>  (1001) 
Y

>  <TOPICAL>  (1001) 
N

>  <BLACK_BOX>  (1001) 
Y

>  <AVAILABILITY_TYPE>  (1001) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1001) 
nan

>  <WITHDRAWN_COUNTRY>  (1001) 
nan

>  <WITHDRAWN_REASON>  (1001) 
nan

>  <CANONICAL_SMILES>  (1001) 
CCN(CC)CCNC(=O)c1ccc(N)cc1

>  <name>  (1001) 
Procainamide 

>  <MW>  (1001) 
235.331

>  <logP>  (1001) 
1.3404

$$$$
CHEMBL404108
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  5 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 15 20  2  0
 20  2  1  0
 13  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1002) 
424824

>  <SYNONYMS>  (1002) 
Lumiracoxib (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1002) 
4

>  <RESEARCH_CODES>  (1002) 
COX-189

>  <APPLICANTS>  (1002) 
Novartis

>  <USAN_STEM>  (1002) 
-coxib

>  <USAN_STEM_DEFINITION>  (1002) 
cyclooxygenase-2 inhibitors

>  <USAN_STEM_SUBSTEM>  (1002) 
-coxib

>  <USAN_YEAR>  (1002) 
2002.0

>  <FIRST_APPROVAL>  (1002) 
nan

>  <ATC_CODE>  (1002) 
M01AH06

>  <ATC_CODE_DESCRIPTION>  (1002) 
M01AH06 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Coxibs]

>  <INDICATION_CLASS>  (1002) 
nan

>  <SC_PATENT_NO>  (1002) 
nan

>  <DRUG_TYPE>  (1002) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1002) 
Y

>  <FIRST_IN_CLASS>  (1002) 
N

>  <CHIRALITY>  (1002) 
Achiral Molecule

>  <PRODRUG>  (1002) 
N

>  <ORAL>  (1002) 
N

>  <PARENTERAL>  (1002) 
N

>  <TOPICAL>  (1002) 
N

>  <BLACK_BOX>  (1002) 
N

>  <AVAILABILITY_TYPE>  (1002) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1002) 
2007.0

>  <WITHDRAWN_COUNTRY>  (1002) 
European Union

>  <WITHDRAWN_REASON>  (1002) 
Liver injury

>  <CANONICAL_SMILES>  (1002) 
Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1

>  <name>  (1002) 
Lumiracoxib 

>  <MW>  (1002) 
293.725

>  <logP>  (1002) 
4.15822

$$$$
CHEMBL514
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1003) 
10898

>  <SYNONYMS>  (1003) 
Lomustine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1003) 
4

>  <RESEARCH_CODES>  (1003) 
CCNU

>  <APPLICANTS>  (1003) 
Bristol Myers Squibb Co

>  <USAN_STEM>  (1003) 
-mustine

>  <USAN_STEM_DEFINITION>  (1003) 
antineoplastics (chloroethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (1003) 
-mustine

>  <USAN_YEAR>  (1003) 
1972.0

>  <FIRST_APPROVAL>  (1003) 
1976.0

>  <ATC_CODE>  (1003) 
L01AD02

>  <ATC_CODE_DESCRIPTION>  (1003) 
L01AD02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrosoureas]

>  <INDICATION_CLASS>  (1003) 
Antineoplastic

>  <SC_PATENT_NO>  (1003) 
nan

>  <DRUG_TYPE>  (1003) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1003) 
Y

>  <FIRST_IN_CLASS>  (1003) 
N

>  <CHIRALITY>  (1003) 
Achiral Molecule

>  <PRODRUG>  (1003) 
N

>  <ORAL>  (1003) 
Y

>  <PARENTERAL>  (1003) 
N

>  <TOPICAL>  (1003) 
N

>  <BLACK_BOX>  (1003) 
Y

>  <AVAILABILITY_TYPE>  (1003) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1003) 
nan

>  <WITHDRAWN_COUNTRY>  (1003) 
nan

>  <WITHDRAWN_REASON>  (1003) 
nan

>  <CANONICAL_SMILES>  (1003) 
ClCCN(N=O)C(=O)NC1CCCCC1

>  <name>  (1003) 
Lomustine 

>  <MW>  (1003) 
233.699

>  <logP>  (1003) 
2.2509

$$$$
CHEMBL492
     RDKit          

 20 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1004) 
6883

>  <SYNONYMS>  (1004) 
Etidocaine (BAN, INN, USAN); Etidocaine HCl (FDA)

>  <DEVELOPMENT_PHASE>  (1004) 
4

>  <RESEARCH_CODES>  (1004) 
W-19053

>  <APPLICANTS>  (1004) 
Dentsply Pharmaceutical; Astrazeneca Lp; Astra

>  <USAN_STEM>  (1004) 
-caine

>  <USAN_STEM_DEFINITION>  (1004) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (1004) 
-caine

>  <USAN_YEAR>  (1004) 
1973.0

>  <FIRST_APPROVAL>  (1004) 
1976.0

>  <ATC_CODE>  (1004) 
N01BB07; N01BB57

>  <ATC_CODE_DESCRIPTION>  (1004) 
N01BB07 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB57 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (1004) 
Anesthetic (local)

>  <SC_PATENT_NO>  (1004) 
nan

>  <DRUG_TYPE>  (1004) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1004) 
Y

>  <FIRST_IN_CLASS>  (1004) 
N

>  <CHIRALITY>  (1004) 
Racemic Mixture

>  <PRODRUG>  (1004) 
N

>  <ORAL>  (1004) 
N

>  <PARENTERAL>  (1004) 
Y

>  <TOPICAL>  (1004) 
N

>  <BLACK_BOX>  (1004) 
N

>  <AVAILABILITY_TYPE>  (1004) 
Discontinued

>  <WITHDRAWN_YEAR>  (1004) 
nan

>  <WITHDRAWN_COUNTRY>  (1004) 
nan

>  <WITHDRAWN_REASON>  (1004) 
nan

>  <CANONICAL_SMILES>  (1004) 
CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C

>  <name>  (1004) 
Etidocaine 

>  <MW>  (1004) 
276.424

>  <logP>  (1004) 
3.75244

$$$$
CHEMBL1186579
     RDKit          

 26 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 17 26  2  0
 19  2  1  0
  6  4  1  0
 20  9  1  0
 26  9  1  0
 24 10  1  0
 26 12  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (1005) 
660529

>  <SYNONYMS>  (1005) 
Methylnaltrexone bromide (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1005) 
4

>  <RESEARCH_CODES>  (1005) 
MRZ-2663BR

>  <APPLICANTS>  (1005) 
Salix Pharmaceuticals Inc

>  <USAN_STEM>  (1005) 
nan

>  <USAN_STEM_DEFINITION>  (1005) 
nan

>  <USAN_STEM_SUBSTEM>  (1005) 
nan

>  <USAN_YEAR>  (1005) 
2006.0

>  <FIRST_APPROVAL>  (1005) 
2008.0

>  <ATC_CODE>  (1005) 
A06AH01

>  <ATC_CODE_DESCRIPTION>  (1005) 
A06AH01 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Peripheral opioid receptor antagonists]

>  <INDICATION_CLASS>  (1005) 
nan

>  <SC_PATENT_NO>  (1005) 
US-6559158-B1

>  <DRUG_TYPE>  (1005) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1005) 
Y

>  <FIRST_IN_CLASS>  (1005) 
N

>  <CHIRALITY>  (1005) 
Racemic Mixture

>  <PRODRUG>  (1005) 
N

>  <ORAL>  (1005) 
N

>  <PARENTERAL>  (1005) 
Y

>  <TOPICAL>  (1005) 
N

>  <BLACK_BOX>  (1005) 
N

>  <AVAILABILITY_TYPE>  (1005) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1005) 
nan

>  <WITHDRAWN_COUNTRY>  (1005) 
nan

>  <WITHDRAWN_REASON>  (1005) 
nan

>  <CANONICAL_SMILES>  (1005) 
C[N+]1(CC2CC2)CC[C@]34[C@H]5Oc6c(O)ccc(C[C@@H]1[C@]3(O)CCC5=O)c46

>  <name>  (1005) 
Methylnaltrexone bromide 

>  <MW>  (1005) 
356.442

>  <logP>  (1005) 
1.67

$$$$
CHEMBL260538
     RDKit          

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 17 22  1  0
 22 23  2  0
 22 24  1  0
 14 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
  9  4  1  0
 35 10  1  0
 17 12  1  0
 35 25  1  0
 34 28  1  0
M  END
>  <PARENT_MOLREGNO>  (1006) 
431376

>  <SYNONYMS>  (1006) 
Ulipristal acetate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1006) 
4

>  <RESEARCH_CODES>  (1006) 
CDB-2914; VA2914

>  <APPLICANTS>  (1006) 
Laboratoire Hra Pharma

>  <USAN_STEM>  (1006) 
nan

>  <USAN_STEM_DEFINITION>  (1006) 
nan

>  <USAN_STEM_SUBSTEM>  (1006) 
nan

>  <USAN_YEAR>  (1006) 
2009.0

>  <FIRST_APPROVAL>  (1006) 
2010.0

>  <ATC_CODE>  (1006) 
nan

>  <ATC_CODE_DESCRIPTION>  (1006) 
nan

>  <INDICATION_CLASS>  (1006) 
nan

>  <SC_PATENT_NO>  (1006) 
US-8426392-B2

>  <DRUG_TYPE>  (1006) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1006) 
Y

>  <FIRST_IN_CLASS>  (1006) 
N

>  <CHIRALITY>  (1006) 
Single Stereoisomer

>  <PRODRUG>  (1006) 
N

>  <ORAL>  (1006) 
Y

>  <PARENTERAL>  (1006) 
N

>  <TOPICAL>  (1006) 
N

>  <BLACK_BOX>  (1006) 
N

>  <AVAILABILITY_TYPE>  (1006) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1006) 
nan

>  <WITHDRAWN_COUNTRY>  (1006) 
nan

>  <WITHDRAWN_REASON>  (1006) 
nan

>  <CANONICAL_SMILES>  (1006) 
CN(C)c1ccc(cc1)[C@H]2C[C@@]3(C)[C@@H](CC[C@]3(OC(=O)C)C(=O)C)[C@@H]4CCC5=CC(=O)CCC5=C24

>  <name>  (1006) 
Ulipristal acetate 

>  <MW>  (1006) 
475.629

>  <logP>  (1006) 
5.543

$$$$
CHEMBL1909283
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1007) 
1249053

>  <SYNONYMS>  (1007) 
Mebanazine (BAN, INN)

>  <DEVELOPMENT_PHASE>  (1007) 
4

>  <RESEARCH_CODES>  (1007) 
nan

>  <APPLICANTS>  (1007) 
nan

>  <USAN_STEM>  (1007) 
nan

>  <USAN_STEM_DEFINITION>  (1007) 
nan

>  <USAN_STEM_SUBSTEM>  (1007) 
nan

>  <USAN_YEAR>  (1007) 
nan

>  <FIRST_APPROVAL>  (1007) 
nan

>  <ATC_CODE>  (1007) 
nan

>  <ATC_CODE_DESCRIPTION>  (1007) 
nan

>  <INDICATION_CLASS>  (1007) 
nan

>  <SC_PATENT_NO>  (1007) 
nan

>  <DRUG_TYPE>  (1007) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1007) 
Y

>  <FIRST_IN_CLASS>  (1007) 
N

>  <CHIRALITY>  (1007) 
Racemic Mixture

>  <PRODRUG>  (1007) 
N

>  <ORAL>  (1007) 
N

>  <PARENTERAL>  (1007) 
N

>  <TOPICAL>  (1007) 
N

>  <BLACK_BOX>  (1007) 
N

>  <AVAILABILITY_TYPE>  (1007) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1007) 
1975.0

>  <WITHDRAWN_COUNTRY>  (1007) 
United Kingdom

>  <WITHDRAWN_REASON>  (1007) 
Hepatotoxicity; Drug Interaction

>  <CANONICAL_SMILES>  (1007) 
CC(NN)c1ccccc1

>  <name>  (1007) 
Mebanazine 

>  <MW>  (1007) 
136.198

>  <logP>  (1007) 
1.2109

$$$$
CHEMBL976
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 12 21  1  0
 21 22  2  0
 21 23  1  0
  8  3  1  0
 23  9  1  0
 20 11  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1008) 
99024

>  <SYNONYMS>  (1008) 
Praziquantel (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1008) 
4

>  <RESEARCH_CODES>  (1008) 
EMBAY-8440

>  <APPLICANTS>  (1008) 
Bayer Pharma Ag

>  <USAN_STEM>  (1008) 
-antel

>  <USAN_STEM_DEFINITION>  (1008) 
anthelmintics: 2-deoxoparaherquamide A derivatives

>  <USAN_STEM_SUBSTEM>  (1008) 
-antel (-quantel)

>  <USAN_YEAR>  (1008) 
1978.0

>  <FIRST_APPROVAL>  (1008) 
1982.0

>  <ATC_CODE>  (1008) 
P02BA01

>  <ATC_CODE_DESCRIPTION>  (1008) 
P02BA01 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antitrematodals:Quinoline derivatives and related substances]

>  <INDICATION_CLASS>  (1008) 
Anthelmintic (veterinary)

>  <SC_PATENT_NO>  (1008) 
nan

>  <DRUG_TYPE>  (1008) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1008) 
Y

>  <FIRST_IN_CLASS>  (1008) 
N

>  <CHIRALITY>  (1008) 
Racemic Mixture

>  <PRODRUG>  (1008) 
N

>  <ORAL>  (1008) 
Y

>  <PARENTERAL>  (1008) 
N

>  <TOPICAL>  (1008) 
N

>  <BLACK_BOX>  (1008) 
N

>  <AVAILABILITY_TYPE>  (1008) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1008) 
nan

>  <WITHDRAWN_COUNTRY>  (1008) 
nan

>  <WITHDRAWN_REASON>  (1008) 
nan

>  <CANONICAL_SMILES>  (1008) 
O=C(C1CCCCC1)N2CC3N(CCc4ccccc34)C(=O)C2

>  <name>  (1008) 
Praziquantel 

>  <MW>  (1008) 
312.413

>  <logP>  (1008) 
2.5349

$$$$
CHEMBL865
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  5 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 12  2  2  0
 11  6  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1009) 
67010

>  <SYNONYMS>  (1009) 
Valdecoxib (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1009) 
4

>  <RESEARCH_CODES>  (1009) 
SC-65872

>  <APPLICANTS>  (1009) 
Gd Searle Llc

>  <USAN_STEM>  (1009) 
-coxib

>  <USAN_STEM_DEFINITION>  (1009) 
cyclooxygenase-2 inhibitors

>  <USAN_STEM_SUBSTEM>  (1009) 
-coxib

>  <USAN_YEAR>  (1009) 
1998.0

>  <FIRST_APPROVAL>  (1009) 
2001.0

>  <ATC_CODE>  (1009) 
M01AH03

>  <ATC_CODE_DESCRIPTION>  (1009) 
M01AH03 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Coxibs]

>  <INDICATION_CLASS>  (1009) 
nan

>  <SC_PATENT_NO>  (1009) 
nan

>  <DRUG_TYPE>  (1009) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1009) 
Y

>  <FIRST_IN_CLASS>  (1009) 
N

>  <CHIRALITY>  (1009) 
Achiral Molecule

>  <PRODRUG>  (1009) 
N

>  <ORAL>  (1009) 
Y

>  <PARENTERAL>  (1009) 
N

>  <TOPICAL>  (1009) 
N

>  <BLACK_BOX>  (1009) 
Y

>  <AVAILABILITY_TYPE>  (1009) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1009) 
2004.0

>  <WITHDRAWN_COUNTRY>  (1009) 
United States

>  <WITHDRAWN_REASON>  (1009) 
Risk for heart attack and stroke

>  <CANONICAL_SMILES>  (1009) 
Cc1onc(c2ccccc2)c1c3ccc(cc3)S(=O)(=O)N

>  <name>  (1009) 
Valdecoxib 

>  <MW>  (1009) 
314.366

>  <logP>  (1009) 
2.96442

$$$$
CHEMBL146095
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 24 25  1  0
 25 26  2  0
 14  9  1  0
 26 16  1  0
 26 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1010) 
244737

>  <SYNONYMS>  (1010) 
Glafenine (DCF, INN, JAN, MI)

>  <DEVELOPMENT_PHASE>  (1010) 
4

>  <RESEARCH_CODES>  (1010) 
R-1707

>  <APPLICANTS>  (1010) 
nan

>  <USAN_STEM>  (1010) 
-fenine

>  <USAN_STEM_DEFINITION>  (1010) 
analgesics (fenamic acid subgroup)

>  <USAN_STEM_SUBSTEM>  (1010) 
-fenine

>  <USAN_YEAR>  (1010) 
nan

>  <FIRST_APPROVAL>  (1010) 
nan

>  <ATC_CODE>  (1010) 
N02BG03

>  <ATC_CODE_DESCRIPTION>  (1010) 
N02BG03 [Nervous System:Analgesics:Other Analgesics And Antipyretics:Other analgesics and antipyretics]

>  <INDICATION_CLASS>  (1010) 
nan

>  <SC_PATENT_NO>  (1010) 
nan

>  <DRUG_TYPE>  (1010) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1010) 
Y

>  <FIRST_IN_CLASS>  (1010) 
N

>  <CHIRALITY>  (1010) 
Racemic Mixture

>  <PRODRUG>  (1010) 
N

>  <ORAL>  (1010) 
N

>  <PARENTERAL>  (1010) 
N

>  <TOPICAL>  (1010) 
N

>  <BLACK_BOX>  (1010) 
N

>  <AVAILABILITY_TYPE>  (1010) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1010) 
1984.0

>  <WITHDRAWN_COUNTRY>  (1010) 
Germany; France

>  <WITHDRAWN_REASON>  (1010) 
Anaphylaxis

>  <CANONICAL_SMILES>  (1010) 
OCC(O)COC(=O)c1ccccc1Nc2ccnc3cc(Cl)ccc23

>  <name>  (1010) 
Glafenine 

>  <MW>  (1010) 
372.808

>  <logP>  (1010) 
3.1418

$$$$
CHEMBL1200596
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1011) 
674547

>  <SYNONYMS>  (1011) 
Chloroxine (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1011) 
4

>  <RESEARCH_CODES>  (1011) 
nan

>  <APPLICANTS>  (1011) 
Westwood Squibb Pharmaceuticals Inc

>  <USAN_STEM>  (1011) 
nan

>  <USAN_STEM_DEFINITION>  (1011) 
nan

>  <USAN_STEM_SUBSTEM>  (1011) 
nan

>  <USAN_YEAR>  (1011) 
1977.0

>  <FIRST_APPROVAL>  (1011) 
1976.0

>  <ATC_CODE>  (1011) 
nan

>  <ATC_CODE_DESCRIPTION>  (1011) 
nan

>  <INDICATION_CLASS>  (1011) 
Antiseborrheic

>  <SC_PATENT_NO>  (1011) 
nan

>  <DRUG_TYPE>  (1011) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1011) 
Y

>  <FIRST_IN_CLASS>  (1011) 
N

>  <CHIRALITY>  (1011) 
Achiral Molecule

>  <PRODRUG>  (1011) 
N

>  <ORAL>  (1011) 
N

>  <PARENTERAL>  (1011) 
N

>  <TOPICAL>  (1011) 
Y

>  <BLACK_BOX>  (1011) 
N

>  <AVAILABILITY_TYPE>  (1011) 
Discontinued

>  <WITHDRAWN_YEAR>  (1011) 
nan

>  <WITHDRAWN_COUNTRY>  (1011) 
nan

>  <WITHDRAWN_REASON>  (1011) 
nan

>  <CANONICAL_SMILES>  (1011) 
Oc1c(Cl)cc(Cl)c2cccnc12

>  <name>  (1011) 
Chloroxine 

>  <MW>  (1011) 
214.051

>  <logP>  (1011) 
3.2472

$$$$
CHEMBL1411979
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  6 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12  8  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1012) 
835863

>  <SYNONYMS>  (1012) 
Methapyrilene (BAN, INN); Methapyrilene HCl (MI, USP); Methapyrilene Fumarate (MI, USP)

>  <DEVELOPMENT_PHASE>  (1012) 
4

>  <RESEARCH_CODES>  (1012) 
nan

>  <APPLICANTS>  (1012) 
Lilly; Abbott

>  <USAN_STEM>  (1012) 
nan

>  <USAN_STEM_DEFINITION>  (1012) 
nan

>  <USAN_STEM_SUBSTEM>  (1012) 
nan

>  <USAN_YEAR>  (1012) 
nan

>  <FIRST_APPROVAL>  (1012) 
nan

>  <ATC_CODE>  (1012) 
R06AC05

>  <ATC_CODE_DESCRIPTION>  (1012) 
R06AC05 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted ethylene diamines]

>  <INDICATION_CLASS>  (1012) 
nan

>  <SC_PATENT_NO>  (1012) 
nan

>  <DRUG_TYPE>  (1012) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1012) 
Y

>  <FIRST_IN_CLASS>  (1012) 
N

>  <CHIRALITY>  (1012) 
Achiral Molecule

>  <PRODRUG>  (1012) 
N

>  <ORAL>  (1012) 
N

>  <PARENTERAL>  (1012) 
N

>  <TOPICAL>  (1012) 
N

>  <BLACK_BOX>  (1012) 
N

>  <AVAILABILITY_TYPE>  (1012) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1012) 
1979.0

>  <WITHDRAWN_COUNTRY>  (1012) 
United Kingdom; United States; Germany; United Kingdom; United States; Germany

>  <WITHDRAWN_REASON>  (1012) 
Animal carcinogenicity (rodents); Animal carcinogenicity (rodents)

>  <CANONICAL_SMILES>  (1012) 
CN(C)CCN(Cc1cccs1)c2ccccn2

>  <name>  (1012) 
Methapyrilene 

>  <MW>  (1012) 
261.394

>  <logP>  (1012) 
2.7113

$$$$
CHEMBL1201323
     RDKit          

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  4  2  0
M  END
>  <PARENT_MOLREGNO>  (1013) 
675274

>  <SYNONYMS>  (1013) 
Betazole (INN); Ametazole (BAN); Betazole HCl (FDA, JAN, MI, USP)

>  <DEVELOPMENT_PHASE>  (1013) 
4

>  <RESEARCH_CODES>  (1013) 
nan

>  <APPLICANTS>  (1013) 
Eli Lilly And Co

>  <USAN_STEM>  (1013) 
nan

>  <USAN_STEM_DEFINITION>  (1013) 
nan

>  <USAN_STEM_SUBSTEM>  (1013) 
nan

>  <USAN_YEAR>  (1013) 
nan

>  <FIRST_APPROVAL>  (1013) 
1982.0

>  <ATC_CODE>  (1013) 
V04CG02

>  <ATC_CODE_DESCRIPTION>  (1013) 
V04CG02 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for gastric secretion]

>  <INDICATION_CLASS>  (1013) 
nan

>  <SC_PATENT_NO>  (1013) 
nan

>  <DRUG_TYPE>  (1013) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1013) 
Y

>  <FIRST_IN_CLASS>  (1013) 
N

>  <CHIRALITY>  (1013) 
Achiral Molecule

>  <PRODRUG>  (1013) 
N

>  <ORAL>  (1013) 
N

>  <PARENTERAL>  (1013) 
Y

>  <TOPICAL>  (1013) 
N

>  <BLACK_BOX>  (1013) 
N

>  <AVAILABILITY_TYPE>  (1013) 
Discontinued

>  <WITHDRAWN_YEAR>  (1013) 
nan

>  <WITHDRAWN_COUNTRY>  (1013) 
nan

>  <WITHDRAWN_REASON>  (1013) 
nan

>  <CANONICAL_SMILES>  (1013) 
NCCc1cc[nH]n1

>  <name>  (1013) 
Betazole 

>  <MW>  (1013) 
111.148

>  <logP>  (1013) 
-0.0891

$$$$
CHEMBL1546
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1014) 
436204

>  <SYNONYMS>  (1014) 
Hydroxyamfetamine (INN, BAN); Hydroxyamphetamine Hydrobromide (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1014) 
4

>  <RESEARCH_CODES>  (1014) 
nan

>  <APPLICANTS>  (1014) 
Pharmics Inc; Akorn Inc

>  <USAN_STEM>  (1014) 
nan

>  <USAN_STEM_DEFINITION>  (1014) 
nan

>  <USAN_STEM_SUBSTEM>  (1014) 
nan

>  <USAN_YEAR>  (1014) 
nan

>  <FIRST_APPROVAL>  (1014) 
1969.0

>  <ATC_CODE>  (1014) 
nan

>  <ATC_CODE_DESCRIPTION>  (1014) 
nan

>  <INDICATION_CLASS>  (1014) 
Adrenergic (ophthalmic)

>  <SC_PATENT_NO>  (1014) 
nan

>  <DRUG_TYPE>  (1014) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1014) 
Y

>  <FIRST_IN_CLASS>  (1014) 
N

>  <CHIRALITY>  (1014) 
Racemic Mixture

>  <PRODRUG>  (1014) 
N

>  <ORAL>  (1014) 
N

>  <PARENTERAL>  (1014) 
N

>  <TOPICAL>  (1014) 
Y

>  <BLACK_BOX>  (1014) 
N

>  <AVAILABILITY_TYPE>  (1014) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1014) 
nan

>  <WITHDRAWN_COUNTRY>  (1014) 
nan

>  <WITHDRAWN_REASON>  (1014) 
nan

>  <CANONICAL_SMILES>  (1014) 
CC(N)Cc1ccc(O)cc1

>  <name>  (1014) 
Hydroxyamfetamine 

>  <MW>  (1014) 
151.209

>  <logP>  (1014) 
1.2819

$$$$
CHEMBL259209
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 10  8  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1015) 
427379

>  <SYNONYMS>  (1015) 
Milnacipran (BAN, INN); Milnacipran HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1015) 
4

>  <RESEARCH_CODES>  (1015) 
nan

>  <APPLICANTS>  (1015) 
Cypress Bioscience Inc

>  <USAN_STEM>  (1015) 
nan

>  <USAN_STEM_DEFINITION>  (1015) 
nan

>  <USAN_STEM_SUBSTEM>  (1015) 
nan

>  <USAN_YEAR>  (1015) 
2007.0

>  <FIRST_APPROVAL>  (1015) 
2009.0

>  <ATC_CODE>  (1015) 
N06AX17

>  <ATC_CODE_DESCRIPTION>  (1015) 
N06AX17 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (1015) 
nan

>  <SC_PATENT_NO>  (1015) 
US-6602911-B2

>  <DRUG_TYPE>  (1015) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1015) 
Y

>  <FIRST_IN_CLASS>  (1015) 
N

>  <CHIRALITY>  (1015) 
Racemic Mixture

>  <PRODRUG>  (1015) 
N

>  <ORAL>  (1015) 
Y

>  <PARENTERAL>  (1015) 
N

>  <TOPICAL>  (1015) 
N

>  <BLACK_BOX>  (1015) 
Y

>  <AVAILABILITY_TYPE>  (1015) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1015) 
nan

>  <WITHDRAWN_COUNTRY>  (1015) 
nan

>  <WITHDRAWN_REASON>  (1015) 
nan

>  <CANONICAL_SMILES>  (1015) 
CCN(CC)C(=O)C1(CC1CN)c2ccccc2

>  <name>  (1015) 
Milnacipran 

>  <MW>  (1015) 
246.354

>  <logP>  (1015) 
1.7714

$$$$
CHEMBL61593
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  2  0
 10 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
  8 22  1  0
 22 23  2  0
 23 24  1  0
 23  5  1  0
 12  7  1  0
 19 15  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1016) 
92458

>  <SYNONYMS>  (1016) 
Cyclothiazide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1016) 
4

>  <RESEARCH_CODES>  (1016) 
35483

>  <APPLICANTS>  (1016) 
Pharmacia And Upjohn Co; Eli Lilly And Co

>  <USAN_STEM>  (1016) 
-thiazide

>  <USAN_STEM_DEFINITION>  (1016) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (1016) 
-thiazide

>  <USAN_YEAR>  (1016) 
1963.0

>  <FIRST_APPROVAL>  (1016) 
1982.0

>  <ATC_CODE>  (1016) 
C03AA09

>  <ATC_CODE_DESCRIPTION>  (1016) 
C03AA09 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (1016) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (1016) 
nan

>  <DRUG_TYPE>  (1016) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1016) 
Y

>  <FIRST_IN_CLASS>  (1016) 
N

>  <CHIRALITY>  (1016) 
Racemic Mixture

>  <PRODRUG>  (1016) 
N

>  <ORAL>  (1016) 
Y

>  <PARENTERAL>  (1016) 
N

>  <TOPICAL>  (1016) 
N

>  <BLACK_BOX>  (1016) 
N

>  <AVAILABILITY_TYPE>  (1016) 
Discontinued

>  <WITHDRAWN_YEAR>  (1016) 
nan

>  <WITHDRAWN_COUNTRY>  (1016) 
nan

>  <WITHDRAWN_REASON>  (1016) 
nan

>  <CANONICAL_SMILES>  (1016) 
NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C3CC4CC3C=C4)cc1Cl

>  <name>  (1016) 
Cyclothiazide 

>  <MW>  (1016) 
389.886

>  <logP>  (1016) 
1.2295

$$$$
CHEMBL3275586
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  7 14  1  0
 14 15  1  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 15  4  1  0
 30 17  1  0
 23 18  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (1017) 
1753620

>  <SYNONYMS>  (1017) 
Dixyrazine

>  <DEVELOPMENT_PHASE>  (1017) 
4

>  <RESEARCH_CODES>  (1017) 
nan

>  <APPLICANTS>  (1017) 
nan

>  <USAN_STEM>  (1017) 
nan

>  <USAN_STEM_DEFINITION>  (1017) 
nan

>  <USAN_STEM_SUBSTEM>  (1017) 
nan

>  <USAN_YEAR>  (1017) 
nan

>  <FIRST_APPROVAL>  (1017) 
nan

>  <ATC_CODE>  (1017) 
N05AB01

>  <ATC_CODE_DESCRIPTION>  (1017) 
N05AB01 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (1017) 
nan

>  <SC_PATENT_NO>  (1017) 
nan

>  <DRUG_TYPE>  (1017) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1017) 
Y

>  <FIRST_IN_CLASS>  (1017) 
N

>  <CHIRALITY>  (1017) 
Racemic Mixture

>  <PRODRUG>  (1017) 
N

>  <ORAL>  (1017) 
N

>  <PARENTERAL>  (1017) 
N

>  <TOPICAL>  (1017) 
N

>  <BLACK_BOX>  (1017) 
N

>  <AVAILABILITY_TYPE>  (1017) 
Unknown

>  <WITHDRAWN_YEAR>  (1017) 
nan

>  <WITHDRAWN_COUNTRY>  (1017) 
nan

>  <WITHDRAWN_REASON>  (1017) 
nan

>  <CANONICAL_SMILES>  (1017) 
CC(CN1CCN(CCOCCO)CC1)CN2c3ccccc3Sc4ccccc24

>  <name>  (1017) 
Dixyrazine

>  <MW>  (1017) 
427.614

>  <logP>  (1017) 
3.5519

$$$$
CHEMBL3707231
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
  8 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 20  2  1  0
 24  2  1  0
 18  6  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1018) 
2039202

>  <SYNONYMS>  (1018) 
Fluclorolone

>  <DEVELOPMENT_PHASE>  (1018) 
4

>  <RESEARCH_CODES>  (1018) 
nan

>  <APPLICANTS>  (1018) 
nan

>  <USAN_STEM>  (1018) 
-olone

>  <USAN_STEM_DEFINITION>  (1018) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (1018) 
-olone

>  <USAN_YEAR>  (1018) 
nan

>  <FIRST_APPROVAL>  (1018) 
nan

>  <ATC_CODE>  (1018) 
D07AC02

>  <ATC_CODE_DESCRIPTION>  (1018) 
D07AC02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]

>  <INDICATION_CLASS>  (1018) 
nan

>  <SC_PATENT_NO>  (1018) 
nan

>  <DRUG_TYPE>  (1018) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1018) 
Y

>  <FIRST_IN_CLASS>  (1018) 
N

>  <CHIRALITY>  (1018) 
Single Stereoisomer

>  <PRODRUG>  (1018) 
N

>  <ORAL>  (1018) 
N

>  <PARENTERAL>  (1018) 
N

>  <TOPICAL>  (1018) 
N

>  <BLACK_BOX>  (1018) 
N

>  <AVAILABILITY_TYPE>  (1018) 
Unknown

>  <WITHDRAWN_YEAR>  (1018) 
nan

>  <WITHDRAWN_COUNTRY>  (1018) 
nan

>  <WITHDRAWN_REASON>  (1018) 
nan

>  <CANONICAL_SMILES>  (1018) 
C[C@]12C[C@H](Cl)[C@@]3(Cl)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO

>  <name>  (1018) 
Fluclorolone

>  <MW>  (1018) 
447.33

>  <logP>  (1018) 
2.0843

$$$$
CHEMBL681
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 10  6  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1019) 
29090

>  <SYNONYMS>  (1019) 
Etomidate (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1019) 
4

>  <RESEARCH_CODES>  (1019) 
nan

>  <APPLICANTS>  (1019) 
Hospira Inc

>  <USAN_STEM>  (1019) 
nan

>  <USAN_STEM_DEFINITION>  (1019) 
nan

>  <USAN_STEM_SUBSTEM>  (1019) 
nan

>  <USAN_YEAR>  (1019) 
1975.0

>  <FIRST_APPROVAL>  (1019) 
1982.0

>  <ATC_CODE>  (1019) 
N01AX07

>  <ATC_CODE_DESCRIPTION>  (1019) 
N01AX07 [Nervous System:Anesthetics:Anesthetics, General:Other general anesthetics]

>  <INDICATION_CLASS>  (1019) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (1019) 
nan

>  <DRUG_TYPE>  (1019) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1019) 
Y

>  <FIRST_IN_CLASS>  (1019) 
N

>  <CHIRALITY>  (1019) 
Single Stereoisomer

>  <PRODRUG>  (1019) 
N

>  <ORAL>  (1019) 
N

>  <PARENTERAL>  (1019) 
Y

>  <TOPICAL>  (1019) 
N

>  <BLACK_BOX>  (1019) 
N

>  <AVAILABILITY_TYPE>  (1019) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1019) 
nan

>  <WITHDRAWN_COUNTRY>  (1019) 
nan

>  <WITHDRAWN_REASON>  (1019) 
nan

>  <CANONICAL_SMILES>  (1019) 
CCOC(=O)c1cncn1[C@H](C)c2ccccc2

>  <name>  (1019) 
Etomidate 

>  <MW>  (1019) 
244.294

>  <logP>  (1019) 
2.6691

$$$$
CHEMBL1201320
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  2  0
 23 24  1  0
 11  3  1  0
 10  6  1  0
 23 15  1  0
M  CHG  2  12   1  13  -1
M  END
>  <PARENT_MOLREGNO>  (1020) 
675271

>  <SYNONYMS>  (1020) 
Esomeprazole (BAN, INN); Esomeprazole Sodium (FDA, USAN); Esomeprazole Potassium (USAN); Esomeprazole Strontium (FDA, USAN); Esomeprazole Magnesium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1020) 
4

>  <RESEARCH_CODES>  (1020) 
H199/18 Sodium; Fm0F67; H199/18 Magnesium Trihydrate

>  <APPLICANTS>  (1020) 
Teva Parenteral Medicines; Ltd.; Hanmi Fine Chemical Co.; Astrazeneca Lp

>  <USAN_STEM>  (1020) 
-prazole

>  <USAN_STEM_DEFINITION>  (1020) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (1020) 
-prazole

>  <USAN_YEAR>  (1020) 
1999.0

>  <FIRST_APPROVAL>  (1020) 
2001.0

>  <ATC_CODE>  (1020) 
A02BC05

>  <ATC_CODE_DESCRIPTION>  (1020) 
A02BC05 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (1020) 
nan

>  <SC_PATENT_NO>  (1020) 
US-5714504-A

>  <DRUG_TYPE>  (1020) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1020) 
Y

>  <FIRST_IN_CLASS>  (1020) 
N

>  <CHIRALITY>  (1020) 
Single Stereoisomer

>  <PRODRUG>  (1020) 
Y

>  <ORAL>  (1020) 
Y

>  <PARENTERAL>  (1020) 
Y

>  <TOPICAL>  (1020) 
N

>  <BLACK_BOX>  (1020) 
N

>  <AVAILABILITY_TYPE>  (1020) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1020) 
nan

>  <WITHDRAWN_COUNTRY>  (1020) 
nan

>  <WITHDRAWN_REASON>  (1020) 
nan

>  <CANONICAL_SMILES>  (1020) 
COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C

>  <name>  (1020) 
Esomeprazole 

>  <MW>  (1020) 
345.424

>  <logP>  (1020) 
2.89974

$$$$
CHEMBL1201776
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1021) 
675727

>  <SYNONYMS>  (1021) 
Tapentadol (INN, USAN); Tapentadol HCl (FDA)

>  <DEVELOPMENT_PHASE>  (1021) 
4

>  <RESEARCH_CODES>  (1021) 
BN-200; CG-5503

>  <APPLICANTS>  (1021) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (1021) 
-adol

>  <USAN_STEM_DEFINITION>  (1021) 
analgesics (mixed opiate receptor agonists/antagonists)

>  <USAN_STEM_SUBSTEM>  (1021) 
-adol

>  <USAN_YEAR>  (1021) 
2005.0

>  <FIRST_APPROVAL>  (1021) 
2008.0

>  <ATC_CODE>  (1021) 
N02AX06

>  <ATC_CODE_DESCRIPTION>  (1021) 
N02AX06 [Nervous System:Analgesics:Opioids:Other opioids]

>  <INDICATION_CLASS>  (1021) 
nan

>  <SC_PATENT_NO>  (1021) 
US-6071970-A

>  <DRUG_TYPE>  (1021) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1021) 
Y

>  <FIRST_IN_CLASS>  (1021) 
N

>  <CHIRALITY>  (1021) 
Single Stereoisomer

>  <PRODRUG>  (1021) 
N

>  <ORAL>  (1021) 
Y

>  <PARENTERAL>  (1021) 
N

>  <TOPICAL>  (1021) 
N

>  <BLACK_BOX>  (1021) 
Y

>  <AVAILABILITY_TYPE>  (1021) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1021) 
nan

>  <WITHDRAWN_COUNTRY>  (1021) 
nan

>  <WITHDRAWN_REASON>  (1021) 
nan

>  <CANONICAL_SMILES>  (1021) 
CC[C@H]([C@@H](C)CN(C)C)c1cccc(O)c1

>  <name>  (1021) 
Tapentadol 

>  <MW>  (1021) 
221.344

>  <logP>  (1021) 
3.0835

$$$$
CHEMBL1909289
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
  4 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 11  6  1  0
 22 17  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1022) 
1249059

>  <SYNONYMS>  (1022) 
Xenazoic Acid (INN, MI)

>  <DEVELOPMENT_PHASE>  (1022) 
4

>  <RESEARCH_CODES>  (1022) 
CV-58903; SKF-8318

>  <APPLICANTS>  (1022) 
nan

>  <USAN_STEM>  (1022) 
nan

>  <USAN_STEM_DEFINITION>  (1022) 
nan

>  <USAN_STEM_SUBSTEM>  (1022) 
nan

>  <USAN_YEAR>  (1022) 
nan

>  <FIRST_APPROVAL>  (1022) 
nan

>  <ATC_CODE>  (1022) 
nan

>  <ATC_CODE_DESCRIPTION>  (1022) 
nan

>  <INDICATION_CLASS>  (1022) 
nan

>  <SC_PATENT_NO>  (1022) 
nan

>  <DRUG_TYPE>  (1022) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1022) 
Y

>  <FIRST_IN_CLASS>  (1022) 
N

>  <CHIRALITY>  (1022) 
Racemic Mixture

>  <PRODRUG>  (1022) 
N

>  <ORAL>  (1022) 
N

>  <PARENTERAL>  (1022) 
N

>  <TOPICAL>  (1022) 
N

>  <BLACK_BOX>  (1022) 
N

>  <AVAILABILITY_TYPE>  (1022) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1022) 
1965.0

>  <WITHDRAWN_COUNTRY>  (1022) 
Francia

>  <WITHDRAWN_REASON>  (1022) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (1022) 
CCOC(Nc1ccc(cc1)C(=O)O)C(=O)c2ccc(cc2)c3ccccc3

>  <name>  (1022) 
Xenazoic Acid 

>  <MW>  (1022) 
375.424

>  <logP>  (1022) 
4.7092

$$$$
CHEMBL509282
     RDKit          

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1023) 
454376

>  <SYNONYMS>  (1023) 
Sedormid

>  <DEVELOPMENT_PHASE>  (1023) 
4

>  <RESEARCH_CODES>  (1023) 
nan

>  <APPLICANTS>  (1023) 
nan

>  <USAN_STEM>  (1023) 
nan

>  <USAN_STEM_DEFINITION>  (1023) 
nan

>  <USAN_STEM_SUBSTEM>  (1023) 
nan

>  <USAN_YEAR>  (1023) 
nan

>  <FIRST_APPROVAL>  (1023) 
nan

>  <ATC_CODE>  (1023) 
N05CM12

>  <ATC_CODE_DESCRIPTION>  (1023) 
N05CM12 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Other hypnotics and sedatives]

>  <INDICATION_CLASS>  (1023) 
nan

>  <SC_PATENT_NO>  (1023) 
nan

>  <DRUG_TYPE>  (1023) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1023) 
Y

>  <FIRST_IN_CLASS>  (1023) 
N

>  <CHIRALITY>  (1023) 
Racemic Mixture

>  <PRODRUG>  (1023) 
N

>  <ORAL>  (1023) 
N

>  <PARENTERAL>  (1023) 
N

>  <TOPICAL>  (1023) 
N

>  <BLACK_BOX>  (1023) 
N

>  <AVAILABILITY_TYPE>  (1023) 
Unknown

>  <WITHDRAWN_YEAR>  (1023) 
nan

>  <WITHDRAWN_COUNTRY>  (1023) 
nan

>  <WITHDRAWN_REASON>  (1023) 
nan

>  <CANONICAL_SMILES>  (1023) 
CC(C)C(CC=C)C(=O)NC(=O)N

>  <name>  (1023) 
Sedormid

>  <MW>  (1023) 
184.239

>  <logP>  (1023) 
1.0296

$$$$
CHEMBL1589
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 10 12  2  0
 10 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
  9  4  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1024) 
454070

>  <SYNONYMS>  (1024) 
Acetohexamide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1024) 
4

>  <RESEARCH_CODES>  (1024) 
33006

>  <APPLICANTS>  (1024) 
Eli Lilly Industries Inc

>  <USAN_STEM>  (1024) 
nan

>  <USAN_STEM_DEFINITION>  (1024) 
nan

>  <USAN_STEM_SUBSTEM>  (1024) 
nan

>  <USAN_YEAR>  (1024) 
1962.0

>  <FIRST_APPROVAL>  (1024) 
1964.0

>  <ATC_CODE>  (1024) 
A10BB31

>  <ATC_CODE_DESCRIPTION>  (1024) 
A10BB31 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (1024) 
Antidiabetic

>  <SC_PATENT_NO>  (1024) 
nan

>  <DRUG_TYPE>  (1024) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1024) 
Y

>  <FIRST_IN_CLASS>  (1024) 
N

>  <CHIRALITY>  (1024) 
Achiral Molecule

>  <PRODRUG>  (1024) 
N

>  <ORAL>  (1024) 
Y

>  <PARENTERAL>  (1024) 
N

>  <TOPICAL>  (1024) 
N

>  <BLACK_BOX>  (1024) 
N

>  <AVAILABILITY_TYPE>  (1024) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1024) 
nan

>  <WITHDRAWN_COUNTRY>  (1024) 
nan

>  <WITHDRAWN_REASON>  (1024) 
nan

>  <CANONICAL_SMILES>  (1024) 
CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2

>  <name>  (1024) 
Acetohexamide 

>  <MW>  (1024) 
324.402

>  <logP>  (1024) 
2.2098

$$$$
CHEMBL1697766
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  5 23  1  0
 23 24  1  0
 24  2  1  0
 22  9  1  0
 15 10  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1025) 
1078530

>  <SYNONYMS>  (1025) 
Perazine

>  <DEVELOPMENT_PHASE>  (1025) 
4

>  <RESEARCH_CODES>  (1025) 
nan

>  <APPLICANTS>  (1025) 
nan

>  <USAN_STEM>  (1025) 
nan

>  <USAN_STEM_DEFINITION>  (1025) 
nan

>  <USAN_STEM_SUBSTEM>  (1025) 
nan

>  <USAN_YEAR>  (1025) 
nan

>  <FIRST_APPROVAL>  (1025) 
nan

>  <ATC_CODE>  (1025) 
N05AB10

>  <ATC_CODE_DESCRIPTION>  (1025) 
N05AB10 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (1025) 
nan

>  <SC_PATENT_NO>  (1025) 
nan

>  <DRUG_TYPE>  (1025) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1025) 
Y

>  <FIRST_IN_CLASS>  (1025) 
N

>  <CHIRALITY>  (1025) 
Achiral Molecule

>  <PRODRUG>  (1025) 
N

>  <ORAL>  (1025) 
N

>  <PARENTERAL>  (1025) 
N

>  <TOPICAL>  (1025) 
N

>  <BLACK_BOX>  (1025) 
N

>  <AVAILABILITY_TYPE>  (1025) 
Unknown

>  <WITHDRAWN_YEAR>  (1025) 
nan

>  <WITHDRAWN_COUNTRY>  (1025) 
nan

>  <WITHDRAWN_REASON>  (1025) 
nan

>  <CANONICAL_SMILES>  (1025) 
CN1CCN(CCCN2c3ccccc3Sc4ccccc24)CC1

>  <name>  (1025) 
Perazine

>  <MW>  (1025) 
339.508

>  <logP>  (1025) 
3.9268

$$$$
CHEMBL1520
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 17 24  1  0
 24 25  2  0
 24 26  2  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 33 34  1  0
 14  4  1  0
 14  8  1  0
 20 15  1  0
 34 27  1  0
M  END
>  <PARENT_MOLREGNO>  (1026) 
421326

>  <SYNONYMS>  (1026) 
Vardenafil (BAN, INN); Vardenafil HCl (FDA); Vardenafil Dihydrochloride (USAN)

>  <DEVELOPMENT_PHASE>  (1026) 
4

>  <RESEARCH_CODES>  (1026) 
nan

>  <APPLICANTS>  (1026) 
Bayer Healthcare Pharmaceuticals Inc; Bayer

>  <USAN_STEM>  (1026) 
-afil

>  <USAN_STEM_DEFINITION>  (1026) 
PDE5 inhibitors

>  <USAN_STEM_SUBSTEM>  (1026) 
-afil

>  <USAN_YEAR>  (1026) 
2001.0

>  <FIRST_APPROVAL>  (1026) 
2003.0

>  <ATC_CODE>  (1026) 
G04BE09

>  <ATC_CODE_DESCRIPTION>  (1026) 
G04BE09 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]

>  <INDICATION_CLASS>  (1026) 
nan

>  <SC_PATENT_NO>  (1026) 
US-6362178-B1

>  <DRUG_TYPE>  (1026) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1026) 
Y

>  <FIRST_IN_CLASS>  (1026) 
N

>  <CHIRALITY>  (1026) 
Achiral Molecule

>  <PRODRUG>  (1026) 
N

>  <ORAL>  (1026) 
Y

>  <PARENTERAL>  (1026) 
N

>  <TOPICAL>  (1026) 
N

>  <BLACK_BOX>  (1026) 
N

>  <AVAILABILITY_TYPE>  (1026) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1026) 
nan

>  <WITHDRAWN_COUNTRY>  (1026) 
nan

>  <WITHDRAWN_REASON>  (1026) 
nan

>  <CANONICAL_SMILES>  (1026) 
CCCc1nc(C)c2C(=O)N=C(Nn12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4

>  <name>  (1026) 
Vardenafil 

>  <MW>  (1026) 
488.614

>  <logP>  (1026) 
2.07042

$$$$
CHEMBL221959
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  5 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  3  0
  7  2  1  0
 18 10  1  0
 18 14  2  0
M  END
>  <PARENT_MOLREGNO>  (1027) 
367860

>  <SYNONYMS>  (1027) 
Tofacitinib (INN, USAN); Tofacitinib Citrate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1027) 
4

>  <RESEARCH_CODES>  (1027) 
CP-690; CP-690550; CP-690550-10

>  <APPLICANTS>  (1027) 
Pfizer Inc.

>  <USAN_STEM>  (1027) 
-tinib

>  <USAN_STEM_DEFINITION>  (1027) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (1027) 
-tinib

>  <USAN_YEAR>  (1027) 
2010.0

>  <FIRST_APPROVAL>  (1027) 
2012.0

>  <ATC_CODE>  (1027) 
L04AA29

>  <ATC_CODE_DESCRIPTION>  (1027) 
L04AA29 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants]

>  <INDICATION_CLASS>  (1027) 
nan

>  <SC_PATENT_NO>  (1027) 
US-6956041-B2; US-6956027-B2

>  <DRUG_TYPE>  (1027) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1027) 
Y

>  <FIRST_IN_CLASS>  (1027) 
N

>  <CHIRALITY>  (1027) 
Single Stereoisomer

>  <PRODRUG>  (1027) 
N

>  <ORAL>  (1027) 
Y

>  <PARENTERAL>  (1027) 
N

>  <TOPICAL>  (1027) 
N

>  <BLACK_BOX>  (1027) 
Y

>  <AVAILABILITY_TYPE>  (1027) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1027) 
nan

>  <WITHDRAWN_COUNTRY>  (1027) 
nan

>  <WITHDRAWN_REASON>  (1027) 
nan

>  <CANONICAL_SMILES>  (1027) 
C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#N

>  <name>  (1027) 
Tofacitinib 

>  <MW>  (1027) 
312.377

>  <logP>  (1027) 
1.54478

$$$$
CHEMBL924
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  2  9  1  0
  9 10  2  0
  9 11  1  0
  9 12  1  0
  2 13  1  0
 13 14  2  0
 13 15  1  0
 13 16  1  0
  8  4  1  0
M  END
>  <PARENT_MOLREGNO>  (1028) 
83838

>  <SYNONYMS>  (1028) 
Zoledronic acid (BAN, FDA, INN, USAN); Zoledronate Disodium (USAN); Zoledronate Trisodium (USAN)

>  <DEVELOPMENT_PHASE>  (1028) 
4

>  <RESEARCH_CODES>  (1028) 
CGP-42446; CGP-42446A; CGP-42446B

>  <APPLICANTS>  (1028) 
Novartis Pharmaceuticals Corp; Ciba-Geigy

>  <USAN_STEM>  (1028) 
nan

>  <USAN_STEM_DEFINITION>  (1028) 
nan

>  <USAN_STEM_SUBSTEM>  (1028) 
nan

>  <USAN_YEAR>  (1028) 
1996.0

>  <FIRST_APPROVAL>  (1028) 
2001.0

>  <ATC_CODE>  (1028) 
M05BA08

>  <ATC_CODE_DESCRIPTION>  (1028) 
M05BA08 [Musculo-Skeletal System:Drugs For Treatment Of Bone Diseases:Drugs Affecting Bone Structure And Mineralization:Bisphosphonates]

>  <INDICATION_CLASS>  (1028) 
Osteoporosis Therapy Adjunct; Bone Resorption Inhibitor

>  <SC_PATENT_NO>  (1028) 
US-7932241-B2

>  <DRUG_TYPE>  (1028) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1028) 
Y

>  <FIRST_IN_CLASS>  (1028) 
N

>  <CHIRALITY>  (1028) 
Achiral Molecule

>  <PRODRUG>  (1028) 
N

>  <ORAL>  (1028) 
N

>  <PARENTERAL>  (1028) 
Y

>  <TOPICAL>  (1028) 
N

>  <BLACK_BOX>  (1028) 
N

>  <AVAILABILITY_TYPE>  (1028) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1028) 
nan

>  <WITHDRAWN_COUNTRY>  (1028) 
nan

>  <WITHDRAWN_REASON>  (1028) 
nan

>  <CANONICAL_SMILES>  (1028) 
OC(Cn1ccnc1)(P(=O)(O)O)P(=O)(O)O

>  <name>  (1028) 
Zoledronic acid 

>  <MW>  (1028) 
272.09

>  <logP>  (1028) 
-1.1154

$$$$
CHEMBL1201112
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
  9  3  1  0
 12  8  1  0
 20 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1029) 
675063

>  <SYNONYMS>  (1029) 
Nelarabine (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1029) 
4

>  <RESEARCH_CODES>  (1029) 
506U

>  <APPLICANTS>  (1029) 
SmithKline Beecham Corp Dba GlaxoSmithKline

>  <USAN_STEM>  (1029) 
-arabine

>  <USAN_STEM_DEFINITION>  (1029) 
antineoplastics (arabinofuranosyl derivatives)

>  <USAN_STEM_SUBSTEM>  (1029) 
-arabine

>  <USAN_YEAR>  (1029) 
1997.0

>  <FIRST_APPROVAL>  (1029) 
2005.0

>  <ATC_CODE>  (1029) 
L01BB07

>  <ATC_CODE_DESCRIPTION>  (1029) 
L01BB07 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Purine analogues]

>  <INDICATION_CLASS>  (1029) 
Antineoplastic

>  <SC_PATENT_NO>  (1029) 
US-5424295-A

>  <DRUG_TYPE>  (1029) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1029) 
Y

>  <FIRST_IN_CLASS>  (1029) 
N

>  <CHIRALITY>  (1029) 
Single Stereoisomer

>  <PRODRUG>  (1029) 
Y

>  <ORAL>  (1029) 
N

>  <PARENTERAL>  (1029) 
Y

>  <TOPICAL>  (1029) 
N

>  <BLACK_BOX>  (1029) 
Y

>  <AVAILABILITY_TYPE>  (1029) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1029) 
nan

>  <WITHDRAWN_COUNTRY>  (1029) 
nan

>  <WITHDRAWN_REASON>  (1029) 
nan

>  <CANONICAL_SMILES>  (1029) 
COc1nc(N)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O

>  <name>  (1029) 
Nelarabine 

>  <MW>  (1029) 
297.271

>  <logP>  (1029) 
-1.9714

$$$$
CHEMBL41355
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 10 20  1  0
 20 21  2  0
 21 22  1  0
 21  7  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1030) 
61945

>  <SYNONYMS>  (1030) 
Ezogabine (FDA, USAN); Retigabine (INN, USAN)

>  <DEVELOPMENT_PHASE>  (1030) 
4

>  <RESEARCH_CODES>  (1030) 
AWD-21360; D-23129; GKE-841; GW582892X; WAY-143841

>  <APPLICANTS>  (1030) 
GlaxoSmithKline

>  <USAN_STEM>  (1030) 
-gab-

>  <USAN_STEM_DEFINITION>  (1030) 
gabamimetics

>  <USAN_STEM_SUBSTEM>  (1030) 
-gab-

>  <USAN_YEAR>  (1030) 
2006.0

>  <FIRST_APPROVAL>  (1030) 
2011.0

>  <ATC_CODE>  (1030) 
N03AX21

>  <ATC_CODE_DESCRIPTION>  (1030) 
N03AX21 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (1030) 
nan

>  <SC_PATENT_NO>  (1030) 
nan

>  <DRUG_TYPE>  (1030) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1030) 
Y

>  <FIRST_IN_CLASS>  (1030) 
N

>  <CHIRALITY>  (1030) 
Achiral Molecule

>  <PRODRUG>  (1030) 
N

>  <ORAL>  (1030) 
Y

>  <PARENTERAL>  (1030) 
N

>  <TOPICAL>  (1030) 
N

>  <BLACK_BOX>  (1030) 
N

>  <AVAILABILITY_TYPE>  (1030) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1030) 
nan

>  <WITHDRAWN_COUNTRY>  (1030) 
nan

>  <WITHDRAWN_REASON>  (1030) 
nan

>  <CANONICAL_SMILES>  (1030) 
CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N

>  <name>  (1030) 
Ezogabine 

>  <MW>  (1030) 
303.337

>  <logP>  (1030) 
3.5884

$$$$
CHEMBL697
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  8  2  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1031) 
31857

>  <SYNONYMS>  (1031) 
Mesuximide (BAN, INN); Methsuximide (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1031) 
4

>  <RESEARCH_CODES>  (1031) 
nan

>  <APPLICANTS>  (1031) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (1031) 
nan

>  <USAN_STEM_DEFINITION>  (1031) 
nan

>  <USAN_STEM_SUBSTEM>  (1031) 
nan

>  <USAN_YEAR>  (1031) 
nan

>  <FIRST_APPROVAL>  (1031) 
1957.0

>  <ATC_CODE>  (1031) 
N03AD03

>  <ATC_CODE_DESCRIPTION>  (1031) 
N03AD03 [Nervous System:Antiepileptics:Antiepileptics:Succinimide derivatives]

>  <INDICATION_CLASS>  (1031) 
Anticonvulsant

>  <SC_PATENT_NO>  (1031) 
nan

>  <DRUG_TYPE>  (1031) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1031) 
Y

>  <FIRST_IN_CLASS>  (1031) 
N

>  <CHIRALITY>  (1031) 
Racemic Mixture

>  <PRODRUG>  (1031) 
N

>  <ORAL>  (1031) 
Y

>  <PARENTERAL>  (1031) 
N

>  <TOPICAL>  (1031) 
N

>  <BLACK_BOX>  (1031) 
N

>  <AVAILABILITY_TYPE>  (1031) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1031) 
nan

>  <WITHDRAWN_COUNTRY>  (1031) 
nan

>  <WITHDRAWN_REASON>  (1031) 
nan

>  <CANONICAL_SMILES>  (1031) 
CN1C(=O)CC(C)(C1=O)c2ccccc2

>  <name>  (1031) 
Mesuximide 

>  <MW>  (1031) 
203.241

>  <logP>  (1031) 
1.333

$$$$
CHEMBL1104
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  6  1  0
M  CHG  1   3   1
M  END
>  <PARENT_MOLREGNO>  (1032) 
151408

>  <SYNONYMS>  (1032) 
Edrophonium Chloride (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1032) 
4

>  <RESEARCH_CODES>  (1032) 
nan

>  <APPLICANTS>  (1032) 
Valeant Pharmaceuticals International; Mylan Institutional Llc

>  <USAN_STEM>  (1032) 
-ium

>  <USAN_STEM_DEFINITION>  (1032) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (1032) 
-ium

>  <USAN_YEAR>  (1032) 
nan

>  <FIRST_APPROVAL>  (1032) 
1951.0

>  <ATC_CODE>  (1032) 
nan

>  <ATC_CODE_DESCRIPTION>  (1032) 
nan

>  <INDICATION_CLASS>  (1032) 
Antidote (to curare principles); Diagnostic Aid (myasthenia gravis)

>  <SC_PATENT_NO>  (1032) 
nan

>  <DRUG_TYPE>  (1032) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1032) 
Y

>  <FIRST_IN_CLASS>  (1032) 
N

>  <CHIRALITY>  (1032) 
Achiral Molecule

>  <PRODRUG>  (1032) 
N

>  <ORAL>  (1032) 
N

>  <PARENTERAL>  (1032) 
Y

>  <TOPICAL>  (1032) 
N

>  <BLACK_BOX>  (1032) 
N

>  <AVAILABILITY_TYPE>  (1032) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1032) 
nan

>  <WITHDRAWN_COUNTRY>  (1032) 
nan

>  <WITHDRAWN_REASON>  (1032) 
nan

>  <CANONICAL_SMILES>  (1032) 
CC[N+](C)(C)c1cccc(O)c1

>  <name>  (1032) 
Edrophonium Chloride 

>  <MW>  (1032) 
166.244

>  <logP>  (1032) 
1.979

$$$$
CHEMBL855
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
  7  2  1  0
 15 11  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1033) 
65539

>  <SYNONYMS>  (1033) 
Triprolidine (BAN, INN); Triprolidine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1033) 
4

>  <RESEARCH_CODES>  (1033) 
nan

>  <APPLICANTS>  (1033) 
GlaxoSmithKline

>  <USAN_STEM>  (1033) 
nan

>  <USAN_STEM_DEFINITION>  (1033) 
nan

>  <USAN_STEM_SUBSTEM>  (1033) 
nan

>  <USAN_YEAR>  (1033) 
nan

>  <FIRST_APPROVAL>  (1033) 
1983.0

>  <ATC_CODE>  (1033) 
R06AX07

>  <ATC_CODE_DESCRIPTION>  (1033) 
R06AX07 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (1033) 
Antihistaminic

>  <SC_PATENT_NO>  (1033) 
nan

>  <DRUG_TYPE>  (1033) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1033) 
Y

>  <FIRST_IN_CLASS>  (1033) 
N

>  <CHIRALITY>  (1033) 
Achiral Molecule

>  <PRODRUG>  (1033) 
N

>  <ORAL>  (1033) 
Y

>  <PARENTERAL>  (1033) 
N

>  <TOPICAL>  (1033) 
N

>  <BLACK_BOX>  (1033) 
N

>  <AVAILABILITY_TYPE>  (1033) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1033) 
nan

>  <WITHDRAWN_COUNTRY>  (1033) 
nan

>  <WITHDRAWN_REASON>  (1033) 
nan

>  <CANONICAL_SMILES>  (1033) 
Cc1ccc(cc1)\C(=C/CN2CCCC2)\c3ccccn3

>  <name>  (1033) 
Triprolidine 

>  <MW>  (1033) 
278.399

>  <logP>  (1033) 
3.91752

$$$$
CHEMBL1197
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 10  5  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1034) 
209162

>  <SYNONYMS>  (1034) 
Hexylcaine (INN); Hexylcaine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1034) 
4

>  <RESEARCH_CODES>  (1034) 
nan

>  <APPLICANTS>  (1034) 
Merck And Co Inc

>  <USAN_STEM>  (1034) 
-caine

>  <USAN_STEM_DEFINITION>  (1034) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (1034) 
-caine

>  <USAN_YEAR>  (1034) 
nan

>  <FIRST_APPROVAL>  (1034) 
1982.0

>  <ATC_CODE>  (1034) 
nan

>  <ATC_CODE_DESCRIPTION>  (1034) 
nan

>  <INDICATION_CLASS>  (1034) 
nan

>  <SC_PATENT_NO>  (1034) 
nan

>  <DRUG_TYPE>  (1034) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1034) 
Y

>  <FIRST_IN_CLASS>  (1034) 
N

>  <CHIRALITY>  (1034) 
Racemic Mixture

>  <PRODRUG>  (1034) 
N

>  <ORAL>  (1034) 
N

>  <PARENTERAL>  (1034) 
N

>  <TOPICAL>  (1034) 
Y

>  <BLACK_BOX>  (1034) 
N

>  <AVAILABILITY_TYPE>  (1034) 
Discontinued

>  <WITHDRAWN_YEAR>  (1034) 
nan

>  <WITHDRAWN_COUNTRY>  (1034) 
nan

>  <WITHDRAWN_REASON>  (1034) 
nan

>  <CANONICAL_SMILES>  (1034) 
CC(CNC1CCCCC1)OC(=O)c2ccccc2

>  <name>  (1034) 
Hexylcaine 

>  <MW>  (1034) 
261.365

>  <logP>  (1034) 
3.1542

$$$$
CHEMBL1909072
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
  7 26  1  0
 26 27  1  0
 27  4  1  0
 25 11  1  0
 17 12  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (1035) 
1248996

>  <SYNONYMS>  (1035) 
Pipamazine (BAN, INN, MI)

>  <DEVELOPMENT_PHASE>  (1035) 
4

>  <RESEARCH_CODES>  (1035) 
nan

>  <APPLICANTS>  (1035) 
nan

>  <USAN_STEM>  (1035) 
nan

>  <USAN_STEM_DEFINITION>  (1035) 
nan

>  <USAN_STEM_SUBSTEM>  (1035) 
nan

>  <USAN_YEAR>  (1035) 
nan

>  <FIRST_APPROVAL>  (1035) 
nan

>  <ATC_CODE>  (1035) 
nan

>  <ATC_CODE_DESCRIPTION>  (1035) 
nan

>  <INDICATION_CLASS>  (1035) 
nan

>  <SC_PATENT_NO>  (1035) 
nan

>  <DRUG_TYPE>  (1035) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1035) 
Y

>  <FIRST_IN_CLASS>  (1035) 
N

>  <CHIRALITY>  (1035) 
Achiral Molecule

>  <PRODRUG>  (1035) 
N

>  <ORAL>  (1035) 
N

>  <PARENTERAL>  (1035) 
N

>  <TOPICAL>  (1035) 
N

>  <BLACK_BOX>  (1035) 
N

>  <AVAILABILITY_TYPE>  (1035) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1035) 
nan

>  <WITHDRAWN_COUNTRY>  (1035) 
United States

>  <WITHDRAWN_REASON>  (1035) 
nan

>  <CANONICAL_SMILES>  (1035) 
NC(=O)C1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1

>  <name>  (1035) 
Pipamazine 

>  <MW>  (1035) 
401.963

>  <logP>  (1035) 
4.5301

$$$$
CHEMBL2107834
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 11 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 17 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 13  7  1  0
 31 15  1  0
 24 19  1  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (1036) 
1380104

>  <SYNONYMS>  (1036) 
Riociguat (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1036) 
4

>  <RESEARCH_CODES>  (1036) 
nan

>  <APPLICANTS>  (1036) 
Bayer Healthcare Pharms; Bayer Healthcare Pharmaceuticals Inc

>  <USAN_STEM>  (1036) 
-ciguat

>  <USAN_STEM_DEFINITION>  (1036) 
guanaline cyclase activator

>  <USAN_STEM_SUBSTEM>  (1036) 
-ciguat

>  <USAN_YEAR>  (1036) 
2012.0

>  <FIRST_APPROVAL>  (1036) 
2013.0

>  <ATC_CODE>  (1036) 
C02KX05

>  <ATC_CODE_DESCRIPTION>  (1036) 
C02KX05 [Cardiovascular System:Antihypertensives:Other Antihypertensives:Other antihypertensives]

>  <INDICATION_CLASS>  (1036) 
nan

>  <SC_PATENT_NO>  (1036) 
US-6743798-B1

>  <DRUG_TYPE>  (1036) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1036) 
Y

>  <FIRST_IN_CLASS>  (1036) 
Y

>  <CHIRALITY>  (1036) 
Achiral Molecule

>  <PRODRUG>  (1036) 
N

>  <ORAL>  (1036) 
Y

>  <PARENTERAL>  (1036) 
N

>  <TOPICAL>  (1036) 
N

>  <BLACK_BOX>  (1036) 
Y

>  <AVAILABILITY_TYPE>  (1036) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1036) 
nan

>  <WITHDRAWN_COUNTRY>  (1036) 
nan

>  <WITHDRAWN_REASON>  (1036) 
nan

>  <CANONICAL_SMILES>  (1036) 
COC(=O)N(C)c1c(N)nc(nc1N)c2nn(Cc3ccccc3F)c4ncccc24

>  <name>  (1036) 
Riociguat 

>  <MW>  (1036) 
422.424

>  <logP>  (1036) 
2.4427

$$$$
CHEMBL2105669
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 16 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 25 28  1  0
 22 29  1  0
 29 30  1  0
 30 31  2  0
  6  2  1  0
 12  7  1  0
 18 13  1  0
 30 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1037) 
1377939

>  <SYNONYMS>  (1037) 
Tedizolid Phosphate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1037) 
4

>  <RESEARCH_CODES>  (1037) 
TR-701-FA

>  <APPLICANTS>  (1037) 
Cubist Pharmaceuticals Inc

>  <USAN_STEM>  (1037) 
-zolid

>  <USAN_STEM_DEFINITION>  (1037) 
oxazolidinone antibacterials

>  <USAN_STEM_SUBSTEM>  (1037) 
-zolid

>  <USAN_YEAR>  (1037) 
2009.0

>  <FIRST_APPROVAL>  (1037) 
2014.0

>  <ATC_CODE>  (1037) 
nan

>  <ATC_CODE_DESCRIPTION>  (1037) 
nan

>  <INDICATION_CLASS>  (1037) 
nan

>  <SC_PATENT_NO>  (1037) 
US-7816379-B2

>  <DRUG_TYPE>  (1037) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1037) 
Y

>  <FIRST_IN_CLASS>  (1037) 
N

>  <CHIRALITY>  (1037) 
Single Stereoisomer

>  <PRODRUG>  (1037) 
N

>  <ORAL>  (1037) 
Y

>  <PARENTERAL>  (1037) 
Y

>  <TOPICAL>  (1037) 
N

>  <BLACK_BOX>  (1037) 
N

>  <AVAILABILITY_TYPE>  (1037) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1037) 
nan

>  <WITHDRAWN_COUNTRY>  (1037) 
nan

>  <WITHDRAWN_REASON>  (1037) 
nan

>  <CANONICAL_SMILES>  (1037) 
Cn1nnc(n1)c2ccc(cn2)c3ccc(cc3F)N4C[C@H](COP(=O)(O)O)OC4=O

>  <name>  (1037) 
Tedizolid Phosphate 

>  <MW>  (1037) 
450.323

>  <logP>  (1037) 
1.5127

$$$$
CHEMBL1615350
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21  7  1  0
 13  8  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1038) 
1038336

>  <SYNONYMS>  (1038) 
Clomacran (BAN, INN); Clomacran Phosphate (USAN)

>  <DEVELOPMENT_PHASE>  (1038) 
4

>  <RESEARCH_CODES>  (1038) 
SKF-14336-D; SK&F-14336

>  <APPLICANTS>  (1038) 
SmithKline Beecham

>  <USAN_STEM>  (1038) 
nan

>  <USAN_STEM_DEFINITION>  (1038) 
nan

>  <USAN_STEM_SUBSTEM>  (1038) 
nan

>  <USAN_YEAR>  (1038) 
1968.0

>  <FIRST_APPROVAL>  (1038) 
nan

>  <ATC_CODE>  (1038) 
nan

>  <ATC_CODE_DESCRIPTION>  (1038) 
nan

>  <INDICATION_CLASS>  (1038) 
Antipsychotic

>  <SC_PATENT_NO>  (1038) 
nan

>  <DRUG_TYPE>  (1038) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1038) 
Y

>  <FIRST_IN_CLASS>  (1038) 
N

>  <CHIRALITY>  (1038) 
Racemic Mixture

>  <PRODRUG>  (1038) 
N

>  <ORAL>  (1038) 
N

>  <PARENTERAL>  (1038) 
N

>  <TOPICAL>  (1038) 
N

>  <BLACK_BOX>  (1038) 
N

>  <AVAILABILITY_TYPE>  (1038) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1038) 
1982.0

>  <WITHDRAWN_COUNTRY>  (1038) 
United Kingdom

>  <WITHDRAWN_REASON>  (1038) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (1038) 
CN(C)CCCC1c2ccccc2Nc3ccc(Cl)cc13

>  <name>  (1038) 
Clomacran 

>  <MW>  (1038) 
300.833

>  <logP>  (1038) 
4.8707

$$$$
CHEMBL1201048
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25  6  1  0
 25  9  1  0
 22 10  1  0
 20 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1039) 
674999

>  <SYNONYMS>  (1039) 
Dromostanolone Propionate (FDA, USAN, USP); Drostanolone (BAN, INN); Drostanolone Propionate (JAN)

>  <DEVELOPMENT_PHASE>  (1039) 
4

>  <RESEARCH_CODES>  (1039) 
32379

>  <APPLICANTS>  (1039) 
Eli Lilly And Co

>  <USAN_STEM>  (1039) 
-olone

>  <USAN_STEM_DEFINITION>  (1039) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (1039) 
-olone

>  <USAN_YEAR>  (1039) 
1963.0

>  <FIRST_APPROVAL>  (1039) 
1982.0

>  <ATC_CODE>  (1039) 
nan

>  <ATC_CODE_DESCRIPTION>  (1039) 
nan

>  <INDICATION_CLASS>  (1039) 
Antineoplastic

>  <SC_PATENT_NO>  (1039) 
nan

>  <DRUG_TYPE>  (1039) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1039) 
Y

>  <FIRST_IN_CLASS>  (1039) 
N

>  <CHIRALITY>  (1039) 
Single Stereoisomer

>  <PRODRUG>  (1039) 
Y

>  <ORAL>  (1039) 
N

>  <PARENTERAL>  (1039) 
Y

>  <TOPICAL>  (1039) 
N

>  <BLACK_BOX>  (1039) 
N

>  <AVAILABILITY_TYPE>  (1039) 
Discontinued

>  <WITHDRAWN_YEAR>  (1039) 
nan

>  <WITHDRAWN_COUNTRY>  (1039) 
nan

>  <WITHDRAWN_REASON>  (1039) 
nan

>  <CANONICAL_SMILES>  (1039) 
CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C

>  <name>  (1039) 
Dromostanolone Propionate 

>  <MW>  (1039) 
360.538

>  <logP>  (1039) 
5.166

$$$$
CHEMBL1201754
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
  6 16  1  0
 16 17  2  0
 17  4  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1040) 
675705

>  <SYNONYMS>  (1040) 
Rufinamide (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1040) 
4

>  <RESEARCH_CODES>  (1040) 
60231/4; CGP-33101; E2080; RUF-331

>  <APPLICANTS>  (1040) 
Eisai Inc

>  <USAN_STEM>  (1040) 
nan

>  <USAN_STEM_DEFINITION>  (1040) 
nan

>  <USAN_STEM_SUBSTEM>  (1040) 
nan

>  <USAN_YEAR>  (1040) 
2000.0

>  <FIRST_APPROVAL>  (1040) 
2008.0

>  <ATC_CODE>  (1040) 
N03AF03

>  <ATC_CODE_DESCRIPTION>  (1040) 
N03AF03 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives]

>  <INDICATION_CLASS>  (1040) 
nan

>  <SC_PATENT_NO>  (1040) 
US-6740669-B1

>  <DRUG_TYPE>  (1040) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1040) 
Y

>  <FIRST_IN_CLASS>  (1040) 
N

>  <CHIRALITY>  (1040) 
Achiral Molecule

>  <PRODRUG>  (1040) 
N

>  <ORAL>  (1040) 
Y

>  <PARENTERAL>  (1040) 
N

>  <TOPICAL>  (1040) 
N

>  <BLACK_BOX>  (1040) 
N

>  <AVAILABILITY_TYPE>  (1040) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1040) 
nan

>  <WITHDRAWN_COUNTRY>  (1040) 
nan

>  <WITHDRAWN_REASON>  (1040) 
nan

>  <CANONICAL_SMILES>  (1040) 
NC(=O)c1cn(Cc2c(F)cccc2F)nn1

>  <name>  (1040) 
Rufinamide 

>  <MW>  (1040) 
238.197

>  <logP>  (1040) 
0.7035

$$$$
CHEMBL1200368
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 11 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
  7 29  1  0
 29 30  2  0
 30  4  1  0
 19 13  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1041) 
674319

>  <SYNONYMS>  (1041) 
Bentiromide (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1041) 
4

>  <RESEARCH_CODES>  (1041) 
Btpaba Pft; E-2663

>  <APPLICANTS>  (1041) 
Savage Laboratories Inc Div Altana Inc

>  <USAN_STEM>  (1041) 
nan

>  <USAN_STEM_DEFINITION>  (1041) 
nan

>  <USAN_STEM_SUBSTEM>  (1041) 
nan

>  <USAN_YEAR>  (1041) 
1979.0

>  <FIRST_APPROVAL>  (1041) 
1983.0

>  <ATC_CODE>  (1041) 
V04CK03

>  <ATC_CODE_DESCRIPTION>  (1041) 
V04CK03 [Various:Diagnostic Agents:Other Diagnostic Agents:Tests for pancreatic function]

>  <INDICATION_CLASS>  (1041) 
Diagnostic Aid (pancreas function determination)

>  <SC_PATENT_NO>  (1041) 
nan

>  <DRUG_TYPE>  (1041) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1041) 
Y

>  <FIRST_IN_CLASS>  (1041) 
N

>  <CHIRALITY>  (1041) 
Single Stereoisomer

>  <PRODRUG>  (1041) 
N

>  <ORAL>  (1041) 
Y

>  <PARENTERAL>  (1041) 
N

>  <TOPICAL>  (1041) 
N

>  <BLACK_BOX>  (1041) 
N

>  <AVAILABILITY_TYPE>  (1041) 
Discontinued

>  <WITHDRAWN_YEAR>  (1041) 
nan

>  <WITHDRAWN_COUNTRY>  (1041) 
nan

>  <WITHDRAWN_REASON>  (1041) 
nan

>  <CANONICAL_SMILES>  (1041) 
OC(=O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c3ccccc3)cc1

>  <name>  (1041) 
Bentiromide 

>  <MW>  (1041) 
404.422

>  <logP>  (1041) 
3.0702

$$$$
CHEMBL1909286
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1042) 
1249056

>  <SYNONYMS>  (1042) 
Fenoxypropazine (BAN, INN); Phenoxypropazine (MI)

>  <DEVELOPMENT_PHASE>  (1042) 
4

>  <RESEARCH_CODES>  (1042) 
nan

>  <APPLICANTS>  (1042) 
nan

>  <USAN_STEM>  (1042) 
nan

>  <USAN_STEM_DEFINITION>  (1042) 
nan

>  <USAN_STEM_SUBSTEM>  (1042) 
nan

>  <USAN_YEAR>  (1042) 
nan

>  <FIRST_APPROVAL>  (1042) 
nan

>  <ATC_CODE>  (1042) 
nan

>  <ATC_CODE_DESCRIPTION>  (1042) 
nan

>  <INDICATION_CLASS>  (1042) 
nan

>  <SC_PATENT_NO>  (1042) 
nan

>  <DRUG_TYPE>  (1042) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1042) 
Y

>  <FIRST_IN_CLASS>  (1042) 
N

>  <CHIRALITY>  (1042) 
Racemic Mixture

>  <PRODRUG>  (1042) 
N

>  <ORAL>  (1042) 
N

>  <PARENTERAL>  (1042) 
N

>  <TOPICAL>  (1042) 
N

>  <BLACK_BOX>  (1042) 
N

>  <AVAILABILITY_TYPE>  (1042) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1042) 
1966.0

>  <WITHDRAWN_COUNTRY>  (1042) 
United Kingdom

>  <WITHDRAWN_REASON>  (1042) 
Hepatotoxicity; Drug Interaction

>  <CANONICAL_SMILES>  (1042) 
CC(COc1ccccc1)NN

>  <name>  (1042) 
Fenoxypropazine 

>  <MW>  (1042) 
166.224

>  <logP>  (1042) 
0.9172

$$$$
CHEMBL930
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1043) 
85305

>  <SYNONYMS>  (1043) 
Glutamine (FDA, INN, USAN, USP); L-Glutamine (JAN); Levoglutamide (DCF)

>  <DEVELOPMENT_PHASE>  (1043) 
4

>  <RESEARCH_CODES>  (1043) 
nan

>  <APPLICANTS>  (1043) 
Emmaus Medical Inc

>  <USAN_STEM>  (1043) 
nan

>  <USAN_STEM_DEFINITION>  (1043) 
nan

>  <USAN_STEM_SUBSTEM>  (1043) 
nan

>  <USAN_YEAR>  (1043) 
2002.0

>  <FIRST_APPROVAL>  (1043) 
2004.0

>  <ATC_CODE>  (1043) 
A16AA03

>  <ATC_CODE_DESCRIPTION>  (1043) 
A16AA03 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Amino acids and derivatives]

>  <INDICATION_CLASS>  (1043) 
nan

>  <SC_PATENT_NO>  (1043) 
nan

>  <DRUG_TYPE>  (1043) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1043) 
Y

>  <FIRST_IN_CLASS>  (1043) 
N

>  <CHIRALITY>  (1043) 
Single Stereoisomer

>  <PRODRUG>  (1043) 
N

>  <ORAL>  (1043) 
Y

>  <PARENTERAL>  (1043) 
N

>  <TOPICAL>  (1043) 
N

>  <BLACK_BOX>  (1043) 
N

>  <AVAILABILITY_TYPE>  (1043) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1043) 
nan

>  <WITHDRAWN_COUNTRY>  (1043) 
nan

>  <WITHDRAWN_REASON>  (1043) 
nan

>  <CANONICAL_SMILES>  (1043) 
N[C@@H](CCC(=O)N)C(=O)O

>  <name>  (1043) 
Glutamine 

>  <MW>  (1043) 
146.146

>  <logP>  (1043) 
-1.3362

$$$$
CHEMBL1201319
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1044) 
675270

>  <SYNONYMS>  (1044) 
Metaraminol (BAN, INN); Metaraminol Bitartrate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1044) 
4

>  <RESEARCH_CODES>  (1044) 
nan

>  <APPLICANTS>  (1044) 
Merck And Co Inc

>  <USAN_STEM>  (1044) 
nan

>  <USAN_STEM_DEFINITION>  (1044) 
nan

>  <USAN_STEM_SUBSTEM>  (1044) 
nan

>  <USAN_YEAR>  (1044) 
nan

>  <FIRST_APPROVAL>  (1044) 
1954.0

>  <ATC_CODE>  (1044) 
C01CA09

>  <ATC_CODE_DESCRIPTION>  (1044) 
C01CA09 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (1044) 
Adrenergic

>  <SC_PATENT_NO>  (1044) 
nan

>  <DRUG_TYPE>  (1044) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1044) 
Y

>  <FIRST_IN_CLASS>  (1044) 
N

>  <CHIRALITY>  (1044) 
Single Stereoisomer

>  <PRODRUG>  (1044) 
N

>  <ORAL>  (1044) 
N

>  <PARENTERAL>  (1044) 
Y

>  <TOPICAL>  (1044) 
N

>  <BLACK_BOX>  (1044) 
N

>  <AVAILABILITY_TYPE>  (1044) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1044) 
nan

>  <WITHDRAWN_COUNTRY>  (1044) 
nan

>  <WITHDRAWN_REASON>  (1044) 
nan

>  <CANONICAL_SMILES>  (1044) 
C[C@H](N)[C@H](O)c1cccc(O)c1

>  <name>  (1044) 
Metaraminol 

>  <MW>  (1044) 
167.208

>  <logP>  (1044) 
0.7728

$$$$
CHEMBL168815
     RDKit          

 13 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  6  2  1  0
 11  4  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1045) 
279727

>  <SYNONYMS>  (1045) 
Cevimeline (INN); Cevimeline HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1045) 
4

>  <RESEARCH_CODES>  (1045) 
AF102B; FKS-508; SND-5008; SNI-2011; SNK-508

>  <APPLICANTS>  (1045) 
Daiichi Sankyo Co Ltd

>  <USAN_STEM>  (1045) 
-meline

>  <USAN_STEM_DEFINITION>  (1045) 
cholinergic agonists (arecoline derivatives used in treatment of Alzheimer disease)

>  <USAN_STEM_SUBSTEM>  (1045) 
-meline

>  <USAN_YEAR>  (1045) 
1997.0

>  <FIRST_APPROVAL>  (1045) 
2000.0

>  <ATC_CODE>  (1045) 
N07AX03

>  <ATC_CODE_DESCRIPTION>  (1045) 
N07AX03 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Other parasympathomimetics]

>  <INDICATION_CLASS>  (1045) 
Alzheimer's Disease Treatment (adjunct)

>  <SC_PATENT_NO>  (1045) 
nan

>  <DRUG_TYPE>  (1045) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1045) 
Y

>  <FIRST_IN_CLASS>  (1045) 
N

>  <CHIRALITY>  (1045) 
Racemic Mixture

>  <PRODRUG>  (1045) 
N

>  <ORAL>  (1045) 
Y

>  <PARENTERAL>  (1045) 
N

>  <TOPICAL>  (1045) 
N

>  <BLACK_BOX>  (1045) 
N

>  <AVAILABILITY_TYPE>  (1045) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1045) 
nan

>  <WITHDRAWN_COUNTRY>  (1045) 
nan

>  <WITHDRAWN_REASON>  (1045) 
nan

>  <CANONICAL_SMILES>  (1045) 
CC1OC2(CS1)CN3CCC2CC3

>  <name>  (1045) 
Cevimeline 

>  <MW>  (1045) 
199.319

>  <logP>  (1045) 
1.5602

$$$$
CHEMBL412873
     RDKit          

 17 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8 16  1  0
 16 17  1  0
 17  1  1  0
 16  4  1  0
 15  6  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1046) 
11265

>  <SYNONYMS>  (1046) 
Sparteine (INN); Sparteine Sulfate (JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1046) 
4

>  <RESEARCH_CODES>  (1046) 
nan

>  <APPLICANTS>  (1046) 
nan

>  <USAN_STEM>  (1046) 
nan

>  <USAN_STEM_DEFINITION>  (1046) 
nan

>  <USAN_STEM_SUBSTEM>  (1046) 
nan

>  <USAN_YEAR>  (1046) 
1962.0

>  <FIRST_APPROVAL>  (1046) 
nan

>  <ATC_CODE>  (1046) 
C01BA04

>  <ATC_CODE_DESCRIPTION>  (1046) 
C01BA04 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ia]

>  <INDICATION_CLASS>  (1046) 
Oxytocic

>  <SC_PATENT_NO>  (1046) 
nan

>  <DRUG_TYPE>  (1046) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1046) 
Y

>  <FIRST_IN_CLASS>  (1046) 
N

>  <CHIRALITY>  (1046) 
Single Stereoisomer

>  <PRODRUG>  (1046) 
N

>  <ORAL>  (1046) 
N

>  <PARENTERAL>  (1046) 
N

>  <TOPICAL>  (1046) 
N

>  <BLACK_BOX>  (1046) 
N

>  <AVAILABILITY_TYPE>  (1046) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1046) 
nan

>  <WITHDRAWN_COUNTRY>  (1046) 
United States

>  <WITHDRAWN_REASON>  (1046) 
nan

>  <CANONICAL_SMILES>  (1046) 
C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1

>  <name>  (1046) 
Sparteine 

>  <MW>  (1046) 
234.387

>  <logP>  (1046) 
2.3451

$$$$
CHEMBL1551365
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
M  END
>  <PARENT_MOLREGNO>  (1047) 
975249

>  <SYNONYMS>  (1047) 
Ethyl Nitrite [Spirit] (MI, NF)

>  <DEVELOPMENT_PHASE>  (1047) 
4

>  <RESEARCH_CODES>  (1047) 
nan

>  <APPLICANTS>  (1047) 
nan

>  <USAN_STEM>  (1047) 
nan

>  <USAN_STEM_DEFINITION>  (1047) 
nan

>  <USAN_STEM_SUBSTEM>  (1047) 
nan

>  <USAN_YEAR>  (1047) 
nan

>  <FIRST_APPROVAL>  (1047) 
nan

>  <ATC_CODE>  (1047) 
nan

>  <ATC_CODE_DESCRIPTION>  (1047) 
nan

>  <INDICATION_CLASS>  (1047) 
nan

>  <SC_PATENT_NO>  (1047) 
nan

>  <DRUG_TYPE>  (1047) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1047) 
Y

>  <FIRST_IN_CLASS>  (1047) 
N

>  <CHIRALITY>  (1047) 
Achiral Molecule

>  <PRODRUG>  (1047) 
N

>  <ORAL>  (1047) 
N

>  <PARENTERAL>  (1047) 
N

>  <TOPICAL>  (1047) 
N

>  <BLACK_BOX>  (1047) 
N

>  <AVAILABILITY_TYPE>  (1047) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1047) 
nan

>  <WITHDRAWN_COUNTRY>  (1047) 
United States

>  <WITHDRAWN_REASON>  (1047) 
nan

>  <CANONICAL_SMILES>  (1047) 
CCON=O

>  <name>  (1047) 
Ethyl Nitrite [Spirit] 

>  <MW>  (1047) 
75.067

>  <logP>  (1047) 
0.7043

$$$$
CHEMBL638
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  2 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
  8  3  1  0
 17 13  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1048) 
27308

>  <SYNONYMS>  (1048) 
Voriconazole (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1048) 
4

>  <RESEARCH_CODES>  (1048) 
UK-109496

>  <APPLICANTS>  (1048) 
Pfizer Inc.

>  <USAN_STEM>  (1048) 
-conazole

>  <USAN_STEM_DEFINITION>  (1048) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (1048) 
-conazole

>  <USAN_YEAR>  (1048) 
1999.0

>  <FIRST_APPROVAL>  (1048) 
2002.0

>  <ATC_CODE>  (1048) 
J02AC03

>  <ATC_CODE_DESCRIPTION>  (1048) 
J02AC03 [Antiinfectives For Systemic Use:Antimycotics For Systemic Use:Antimycotics For Systemic Use:Triazole derivatives]

>  <INDICATION_CLASS>  (1048) 
nan

>  <SC_PATENT_NO>  (1048) 
US-5567817-A

>  <DRUG_TYPE>  (1048) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1048) 
Y

>  <FIRST_IN_CLASS>  (1048) 
N

>  <CHIRALITY>  (1048) 
Single Stereoisomer

>  <PRODRUG>  (1048) 
N

>  <ORAL>  (1048) 
Y

>  <PARENTERAL>  (1048) 
Y

>  <TOPICAL>  (1048) 
N

>  <BLACK_BOX>  (1048) 
N

>  <AVAILABILITY_TYPE>  (1048) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1048) 
nan

>  <WITHDRAWN_COUNTRY>  (1048) 
nan

>  <WITHDRAWN_REASON>  (1048) 
nan

>  <CANONICAL_SMILES>  (1048) 
C[C@@H](c1ncncc1F)[C@](O)(Cn2cncn2)c3ccc(F)cc3F

>  <name>  (1048) 
Voriconazole 

>  <MW>  (1048) 
349.316

>  <logP>  (1048) 
2.1769

$$$$
CHEMBL1489
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
  8  2  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1049) 
418401

>  <SYNONYMS>  (1049) 
Azacitidine (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1049) 
4

>  <RESEARCH_CODES>  (1049) 
U-18496

>  <APPLICANTS>  (1049) 
Celgene Corp

>  <USAN_STEM>  (1049) 
nan

>  <USAN_STEM_DEFINITION>  (1049) 
nan

>  <USAN_STEM_SUBSTEM>  (1049) 
nan

>  <USAN_YEAR>  (1049) 
1978.0

>  <FIRST_APPROVAL>  (1049) 
2004.0

>  <ATC_CODE>  (1049) 
L01BC07

>  <ATC_CODE_DESCRIPTION>  (1049) 
L01BC07 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (1049) 
Antineoplastic

>  <SC_PATENT_NO>  (1049) 
nan

>  <DRUG_TYPE>  (1049) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1049) 
Y

>  <FIRST_IN_CLASS>  (1049) 
N

>  <CHIRALITY>  (1049) 
Single Stereoisomer

>  <PRODRUG>  (1049) 
Y

>  <ORAL>  (1049) 
N

>  <PARENTERAL>  (1049) 
Y

>  <TOPICAL>  (1049) 
N

>  <BLACK_BOX>  (1049) 
N

>  <AVAILABILITY_TYPE>  (1049) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1049) 
nan

>  <WITHDRAWN_COUNTRY>  (1049) 
nan

>  <WITHDRAWN_REASON>  (1049) 
nan

>  <CANONICAL_SMILES>  (1049) 
NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O

>  <name>  (1049) 
Azacitidine 

>  <MW>  (1049) 
244.207

>  <logP>  (1049) 
-3.168

$$$$
CHEMBL1006
     RDKit          

 12 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  9 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1050) 
112480

>  <SYNONYMS>  (1050) 
Amifostine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1050) 
4

>  <RESEARCH_CODES>  (1050) 
WR-2721

>  <APPLICANTS>  (1050) 
Medimmune

>  <USAN_STEM>  (1050) 
nan

>  <USAN_STEM_DEFINITION>  (1050) 
nan

>  <USAN_STEM_SUBSTEM>  (1050) 
nan

>  <USAN_YEAR>  (1050) 
1991.0

>  <FIRST_APPROVAL>  (1050) 
1995.0

>  <ATC_CODE>  (1050) 
V03AF05

>  <ATC_CODE_DESCRIPTION>  (1050) 
V03AF05 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Detoxifying agents for antineoplastic treatment]

>  <INDICATION_CLASS>  (1050) 
Protectant (topical); Radioprotector

>  <SC_PATENT_NO>  (1050) 
US-5994409-A

>  <DRUG_TYPE>  (1050) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1050) 
Y

>  <FIRST_IN_CLASS>  (1050) 
N

>  <CHIRALITY>  (1050) 
Achiral Molecule

>  <PRODRUG>  (1050) 
Y

>  <ORAL>  (1050) 
N

>  <PARENTERAL>  (1050) 
Y

>  <TOPICAL>  (1050) 
N

>  <BLACK_BOX>  (1050) 
N

>  <AVAILABILITY_TYPE>  (1050) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1050) 
nan

>  <WITHDRAWN_COUNTRY>  (1050) 
nan

>  <WITHDRAWN_REASON>  (1050) 
nan

>  <CANONICAL_SMILES>  (1050) 
NCCCNCCSP(=O)(O)O

>  <name>  (1050) 
Amifostine 

>  <MW>  (1050) 
214.227

>  <logP>  (1050) 
-0.2493

$$$$
CHEMBL1644
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
  8 21  1  0
 21 22  2  0
  3 23  1  0
 23 24  2  0
 23 25  1  0
  7  2  1  0
 21  4  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1051) 
485902

>  <SYNONYMS>  (1051) 
Cefadroxil (BAN, INN, JAN, USAN, USP); Cefadroxil/Cefadroxil Hemihydrate (FDA)

>  <DEVELOPMENT_PHASE>  (1051) 
4

>  <RESEARCH_CODES>  (1051) 
BL-S578; MJF-11567-3

>  <APPLICANTS>  (1051) 
Warner Chilcott Inc

>  <USAN_STEM>  (1051) 
cef-

>  <USAN_STEM_DEFINITION>  (1051) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (1051) 
cef-

>  <USAN_YEAR>  (1051) 
1974.0

>  <FIRST_APPROVAL>  (1051) 
1978.0

>  <ATC_CODE>  (1051) 
J01DB05

>  <ATC_CODE_DESCRIPTION>  (1051) 
J01DB05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:First-generation cephalosporins]

>  <INDICATION_CLASS>  (1051) 
Antibacterial

>  <SC_PATENT_NO>  (1051) 
nan

>  <DRUG_TYPE>  (1051) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1051) 
Y

>  <FIRST_IN_CLASS>  (1051) 
N

>  <CHIRALITY>  (1051) 
Single Stereoisomer

>  <PRODRUG>  (1051) 
N

>  <ORAL>  (1051) 
Y

>  <PARENTERAL>  (1051) 
N

>  <TOPICAL>  (1051) 
N

>  <BLACK_BOX>  (1051) 
Y

>  <AVAILABILITY_TYPE>  (1051) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1051) 
nan

>  <WITHDRAWN_COUNTRY>  (1051) 
nan

>  <WITHDRAWN_REASON>  (1051) 
nan

>  <CANONICAL_SMILES>  (1051) 
CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O

>  <name>  (1051) 
Cefadroxil 

>  <MW>  (1051) 
363.395

>  <logP>  (1051) 
0.1505

$$$$
CHEMBL2216870
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
  3 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 13  5  1  0
 13  9  2  0
 25 14  1  0
 22 16  1  0
 31 26  1  0
M  END
>  <PARENT_MOLREGNO>  (1052) 
1448219

>  <SYNONYMS>  (1052) 
Idelalisib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1052) 
4

>  <RESEARCH_CODES>  (1052) 
CAL-101; GS-1101

>  <APPLICANTS>  (1052) 
Gilead Sciences Inc

>  <USAN_STEM>  (1052) 
-lisib

>  <USAN_STEM_DEFINITION>  (1052) 
phosphatidylinositol 3-kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (1052) 
-lisib

>  <USAN_YEAR>  (1052) 
2013.0

>  <FIRST_APPROVAL>  (1052) 
2014.0

>  <ATC_CODE>  (1052) 
L01XX47

>  <ATC_CODE_DESCRIPTION>  (1052) 
L01XX47 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (1052) 
nan

>  <SC_PATENT_NO>  (1052) 
US-6800620-B2

>  <DRUG_TYPE>  (1052) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1052) 
Y

>  <FIRST_IN_CLASS>  (1052) 
Y

>  <CHIRALITY>  (1052) 
Single Stereoisomer

>  <PRODRUG>  (1052) 
N

>  <ORAL>  (1052) 
Y

>  <PARENTERAL>  (1052) 
N

>  <TOPICAL>  (1052) 
N

>  <BLACK_BOX>  (1052) 
Y

>  <AVAILABILITY_TYPE>  (1052) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1052) 
nan

>  <WITHDRAWN_COUNTRY>  (1052) 
nan

>  <WITHDRAWN_REASON>  (1052) 
nan

>  <CANONICAL_SMILES>  (1052) 
CC[C@H](Nc1ncnc2[nH]cnc12)C3=Nc4cccc(F)c4C(=O)N3c5ccccc5

>  <name>  (1052) 
Idelalisib 

>  <MW>  (1052) 
415.432

>  <logP>  (1052) 
3.7543

$$$$
CHEMBL1257
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1053) 
238429

>  <SYNONYMS>  (1053) 
Enflurane (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1053) 
4

>  <RESEARCH_CODES>  (1053) 
Anesthetic Compound No. 347

>  <APPLICANTS>  (1053) 
Baxter Healthcare Corp

>  <USAN_STEM>  (1053) 
-flurane

>  <USAN_STEM_DEFINITION>  (1053) 
general inhalation anesthetics (halogenated alkane derivatives)

>  <USAN_STEM_SUBSTEM>  (1053) 
-flurane

>  <USAN_YEAR>  (1053) 
1970.0

>  <FIRST_APPROVAL>  (1053) 
1972.0

>  <ATC_CODE>  (1053) 
N01AB04

>  <ATC_CODE_DESCRIPTION>  (1053) 
N01AB04 [Nervous System:Anesthetics:Anesthetics, General:Halogenated hydrocarbons]

>  <INDICATION_CLASS>  (1053) 
Anesthetic (inhalation)

>  <SC_PATENT_NO>  (1053) 
nan

>  <DRUG_TYPE>  (1053) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1053) 
Y

>  <FIRST_IN_CLASS>  (1053) 
N

>  <CHIRALITY>  (1053) 
Racemic Mixture

>  <PRODRUG>  (1053) 
N

>  <ORAL>  (1053) 
N

>  <PARENTERAL>  (1053) 
N

>  <TOPICAL>  (1053) 
Y

>  <BLACK_BOX>  (1053) 
N

>  <AVAILABILITY_TYPE>  (1053) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1053) 
nan

>  <WITHDRAWN_COUNTRY>  (1053) 
nan

>  <WITHDRAWN_REASON>  (1053) 
nan

>  <CANONICAL_SMILES>  (1053) 
FC(F)OC(F)(F)C(F)Cl

>  <name>  (1053) 
Enflurane 

>  <MW>  (1053) 
184.491

>  <logP>  (1053) 
2.3528

$$$$
CHEMBL1503
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  2  0
 23 24  1  0
 11  3  1  0
 10  6  1  0
 23 15  1  0
M  CHG  2  12   1  13  -1
M  END
>  <PARENT_MOLREGNO>  (1054) 
419601

>  <SYNONYMS>  (1054) 
Omeprazole (BAN, FDA, INN, JAN, USAN, USP); Omeprazole magnesium (FDA, USAN); Omeprazole Sodium (USAN)

>  <DEVELOPMENT_PHASE>  (1054) 
4

>  <RESEARCH_CODES>  (1054) 
H 168/68; H-168/68; H 168/68 Magnesium; H 168/68 Sodium

>  <APPLICANTS>  (1054) 
Gastroentero Logic Llc; Dexcel Pharma Technologies Ltd; Astrazeneca Lp; Astra Pharmaceutical Production Ab, Sweden; Santarus Inc

>  <USAN_STEM>  (1054) 
-prazole

>  <USAN_STEM_DEFINITION>  (1054) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (1054) 
-prazole

>  <USAN_YEAR>  (1054) 
1986.0

>  <FIRST_APPROVAL>  (1054) 
1989.0

>  <ATC_CODE>  (1054) 
A02BC01

>  <ATC_CODE_DESCRIPTION>  (1054) 
A02BC01 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (1054) 
Depressant (gastric acid secretory); Antisecretory (gastric)

>  <SC_PATENT_NO>  (1054) 
US-5817338-A

>  <DRUG_TYPE>  (1054) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1054) 
Y

>  <FIRST_IN_CLASS>  (1054) 
N

>  <CHIRALITY>  (1054) 
Racemic Mixture

>  <PRODRUG>  (1054) 
Y

>  <ORAL>  (1054) 
Y

>  <PARENTERAL>  (1054) 
N

>  <TOPICAL>  (1054) 
N

>  <BLACK_BOX>  (1054) 
Y

>  <AVAILABILITY_TYPE>  (1054) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1054) 
nan

>  <WITHDRAWN_COUNTRY>  (1054) 
nan

>  <WITHDRAWN_REASON>  (1054) 
nan

>  <CANONICAL_SMILES>  (1054) 
COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C

>  <name>  (1054) 
Omeprazole 

>  <MW>  (1054) 
345.424

>  <logP>  (1054) 
2.89974

$$$$
CHEMBL1149
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  CHG  2   2   1  11  -1
M  END
>  <PARENT_MOLREGNO>  (1055) 
181939

>  <SYNONYMS>  (1055) 
Levocarnitine (BAN, FDA, INN, USAN, USP); Levocarnitine Chloride (INN, JAN)

>  <DEVELOPMENT_PHASE>  (1055) 
4

>  <RESEARCH_CODES>  (1055) 
nan

>  <APPLICANTS>  (1055) 
Sigma Tau Pharmaceuticals Inc

>  <USAN_STEM>  (1055) 
nan

>  <USAN_STEM_DEFINITION>  (1055) 
nan

>  <USAN_STEM_SUBSTEM>  (1055) 
nan

>  <USAN_YEAR>  (1055) 
1987.0

>  <FIRST_APPROVAL>  (1055) 
1985.0

>  <ATC_CODE>  (1055) 
A16AA01

>  <ATC_CODE_DESCRIPTION>  (1055) 
A16AA01 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Amino acids and derivatives]

>  <INDICATION_CLASS>  (1055) 
Replenisher (carnitine)

>  <SC_PATENT_NO>  (1055) 
US-6335369-B1

>  <DRUG_TYPE>  (1055) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1055) 
Y

>  <FIRST_IN_CLASS>  (1055) 
N

>  <CHIRALITY>  (1055) 
Single Stereoisomer

>  <PRODRUG>  (1055) 
N

>  <ORAL>  (1055) 
Y

>  <PARENTERAL>  (1055) 
Y

>  <TOPICAL>  (1055) 
N

>  <BLACK_BOX>  (1055) 
N

>  <AVAILABILITY_TYPE>  (1055) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1055) 
nan

>  <WITHDRAWN_COUNTRY>  (1055) 
nan

>  <WITHDRAWN_REASON>  (1055) 
nan

>  <CANONICAL_SMILES>  (1055) 
C[N+](C)(C)C[C@H](O)CC(=O)[O-]

>  <name>  (1055) 
Levocarnitine 

>  <MW>  (1055) 
161.201

>  <logP>  (1055) 
-1.8065

$$$$
CHEMBL537
     RDKit          

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1056) 
13329

>  <SYNONYMS>  (1056) 
Hydroquinone (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1056) 
4

>  <RESEARCH_CODES>  (1056) 
nan

>  <APPLICANTS>  (1056) 
Galderma Laboratories Lp

>  <USAN_STEM>  (1056) 
nan

>  <USAN_STEM_DEFINITION>  (1056) 
nan

>  <USAN_STEM_SUBSTEM>  (1056) 
nan

>  <USAN_YEAR>  (1056) 
nan

>  <FIRST_APPROVAL>  (1056) 
2002.0

>  <ATC_CODE>  (1056) 
D11AX11

>  <ATC_CODE_DESCRIPTION>  (1056) 
D11AX11 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (1056) 
Depigmentor

>  <SC_PATENT_NO>  (1056) 
US-7915243-B2

>  <DRUG_TYPE>  (1056) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1056) 
Y

>  <FIRST_IN_CLASS>  (1056) 
N

>  <CHIRALITY>  (1056) 
Achiral Molecule

>  <PRODRUG>  (1056) 
N

>  <ORAL>  (1056) 
N

>  <PARENTERAL>  (1056) 
N

>  <TOPICAL>  (1056) 
Y

>  <BLACK_BOX>  (1056) 
N

>  <AVAILABILITY_TYPE>  (1056) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1056) 
nan

>  <WITHDRAWN_COUNTRY>  (1056) 
nan

>  <WITHDRAWN_REASON>  (1056) 
nan

>  <CANONICAL_SMILES>  (1056) 
Oc1ccc(O)cc1

>  <name>  (1056) 
Hydroquinone 

>  <MW>  (1056) 
110.112

>  <logP>  (1056) 
1.0978

$$$$
CHEMBL1200845
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 27  2  1  0
 26  5  1  0
 24  7  1  0
 19  8  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1057) 
674796

>  <SYNONYMS>  (1057) 
Halcinonide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1057) 
4

>  <RESEARCH_CODES>  (1057) 
SO-18566; SQ-18566

>  <APPLICANTS>  (1057) 
Westwood Squibb Pharmaceuticals Inc; Ranbaxy Laboratories Inc; Bristol Myers Squibb

>  <USAN_STEM>  (1057) 
-onide

>  <USAN_STEM_DEFINITION>  (1057) 
topical steroids (acetal derivatives)

>  <USAN_STEM_SUBSTEM>  (1057) 
-onide

>  <USAN_YEAR>  (1057) 
1973.0

>  <FIRST_APPROVAL>  (1057) 
1974.0

>  <ATC_CODE>  (1057) 
D07AD02

>  <ATC_CODE_DESCRIPTION>  (1057) 
D07AD02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, very potent (group IV)]

>  <INDICATION_CLASS>  (1057) 
Anti-Inflammatory (topical)

>  <SC_PATENT_NO>  (1057) 
nan

>  <DRUG_TYPE>  (1057) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1057) 
Y

>  <FIRST_IN_CLASS>  (1057) 
N

>  <CHIRALITY>  (1057) 
Single Stereoisomer

>  <PRODRUG>  (1057) 
N

>  <ORAL>  (1057) 
N

>  <PARENTERAL>  (1057) 
N

>  <TOPICAL>  (1057) 
Y

>  <BLACK_BOX>  (1057) 
N

>  <AVAILABILITY_TYPE>  (1057) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1057) 
nan

>  <WITHDRAWN_COUNTRY>  (1057) 
nan

>  <WITHDRAWN_REASON>  (1057) 
nan

>  <CANONICAL_SMILES>  (1057) 
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl

>  <name>  (1057) 
Halcinonide 

>  <MW>  (1057) 
454.966

>  <logP>  (1057) 
3.8893

$$$$
CHEMBL659
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20  3  1  0
 21  6  1  0
 18 12  1  0
 21 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1058) 
27639

>  <SYNONYMS>  (1058) 
Galantamine (BAN, INN, MI, USAN); Galantamine hydrobromide (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1058) 
4

>  <RESEARCH_CODES>  (1058) 
nan

>  <APPLICANTS>  (1058) 
Janssen Pharmaceuticals Inc; Janssen Pharmaceutica, Belgium

>  <USAN_STEM>  (1058) 
nan

>  <USAN_STEM_DEFINITION>  (1058) 
nan

>  <USAN_STEM_SUBSTEM>  (1058) 
nan

>  <USAN_YEAR>  (1058) 
2000.0

>  <FIRST_APPROVAL>  (1058) 
2001.0

>  <ATC_CODE>  (1058) 
N06DA04

>  <ATC_CODE_DESCRIPTION>  (1058) 
N06DA04 [Nervous System:Psychoanaleptics:Anti-Dementia Drugs:Anticholinesterases]

>  <INDICATION_CLASS>  (1058) 
nan

>  <SC_PATENT_NO>  (1058) 
US-6099863-A

>  <DRUG_TYPE>  (1058) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1058) 
Y

>  <FIRST_IN_CLASS>  (1058) 
N

>  <CHIRALITY>  (1058) 
Single Stereoisomer

>  <PRODRUG>  (1058) 
N

>  <ORAL>  (1058) 
Y

>  <PARENTERAL>  (1058) 
N

>  <TOPICAL>  (1058) 
N

>  <BLACK_BOX>  (1058) 
N

>  <AVAILABILITY_TYPE>  (1058) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1058) 
nan

>  <WITHDRAWN_COUNTRY>  (1058) 
nan

>  <WITHDRAWN_REASON>  (1058) 
nan

>  <CANONICAL_SMILES>  (1058) 
COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24

>  <name>  (1058) 
Galantamine 

>  <MW>  (1058) 
287.359

>  <logP>  (1058) 
1.8503

$$$$
CHEMBL1201146
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  5 24  1  0
 24 25  3  0
 22  5  1  0
 22  8  1  0
 19  9  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1059) 
675097

>  <SYNONYMS>  (1059) 
Norethindrone acetate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1059) 
4

>  <RESEARCH_CODES>  (1059) 
nan

>  <APPLICANTS>  (1059) 
Novo Nordisk Inc; Novartis Pharmaceuticals Corp; Duramed Research Inc; Abbvie Endocrine Inc; Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (1059) 
nan

>  <USAN_STEM_DEFINITION>  (1059) 
nan

>  <USAN_STEM_SUBSTEM>  (1059) 
nan

>  <USAN_YEAR>  (1059) 
nan

>  <FIRST_APPROVAL>  (1059) 
1973.0

>  <ATC_CODE>  (1059) 
nan

>  <ATC_CODE_DESCRIPTION>  (1059) 
nan

>  <INDICATION_CLASS>  (1059) 
Progestin

>  <SC_PATENT_NO>  (1059) 
US-6036976-A

>  <DRUG_TYPE>  (1059) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1059) 
Y

>  <FIRST_IN_CLASS>  (1059) 
N

>  <CHIRALITY>  (1059) 
Single Stereoisomer

>  <PRODRUG>  (1059) 
Y

>  <ORAL>  (1059) 
Y

>  <PARENTERAL>  (1059) 
Y

>  <TOPICAL>  (1059) 
Y

>  <BLACK_BOX>  (1059) 
N

>  <AVAILABILITY_TYPE>  (1059) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1059) 
nan

>  <WITHDRAWN_COUNTRY>  (1059) 
nan

>  <WITHDRAWN_REASON>  (1059) 
nan

>  <CANONICAL_SMILES>  (1059) 
CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C

>  <name>  (1059) 
Norethindrone acetate 

>  <MW>  (1059) 
340.463

>  <logP>  (1059) 
4.0633

$$$$
CHEMBL33
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
  6 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 20 24  1  0
 24 25  2  0
 24 26  1  0
 22  2  1  0
 23  5  2  0
 13  7  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1060) 
1795

>  <SYNONYMS>  (1060) 
Levofloxacin (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1060) 
4

>  <RESEARCH_CODES>  (1060) 
DR-3355; RWJ-25213

>  <APPLICANTS>  (1060) 
Santen Inc; Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (1060) 
-oxacin

>  <USAN_STEM_DEFINITION>  (1060) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (1060) 
-oxacin

>  <USAN_YEAR>  (1060) 
1996.0

>  <FIRST_APPROVAL>  (1060) 
1996.0

>  <ATC_CODE>  (1060) 
J01MA12; S01AE05

>  <ATC_CODE_DESCRIPTION>  (1060) 
J01MA12 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE05 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]

>  <INDICATION_CLASS>  (1060) 
Antibacterial

>  <SC_PATENT_NO>  (1060) 
US-6806256-B2

>  <DRUG_TYPE>  (1060) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1060) 
Y

>  <FIRST_IN_CLASS>  (1060) 
N

>  <CHIRALITY>  (1060) 
Single Stereoisomer

>  <PRODRUG>  (1060) 
N

>  <ORAL>  (1060) 
Y

>  <PARENTERAL>  (1060) 
Y

>  <TOPICAL>  (1060) 
Y

>  <BLACK_BOX>  (1060) 
Y

>  <AVAILABILITY_TYPE>  (1060) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1060) 
nan

>  <WITHDRAWN_COUNTRY>  (1060) 
nan

>  <WITHDRAWN_REASON>  (1060) 
nan

>  <CANONICAL_SMILES>  (1060) 
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O

>  <name>  (1060) 
Levofloxacin 

>  <MW>  (1060) 
361.373

>  <logP>  (1060) 
1.544

$$$$
CHEMBL1615209
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 11 24  2  0
 24 25  1  0
 24  7  1  0
 23 15  1  0
 22 17  1  0
M  CHG  2  13   1  14  -1
M  END
>  <PARENT_MOLREGNO>  (1061) 
1038220

>  <SYNONYMS>  (1061) 
Dexrabeprazole

>  <DEVELOPMENT_PHASE>  (1061) 
4

>  <RESEARCH_CODES>  (1061) 
nan

>  <APPLICANTS>  (1061) 
nan

>  <USAN_STEM>  (1061) 
-prazole

>  <USAN_STEM_DEFINITION>  (1061) 
antiulcer agents (benzimidazole derivatives)

>  <USAN_STEM_SUBSTEM>  (1061) 
-prazole

>  <USAN_YEAR>  (1061) 
nan

>  <FIRST_APPROVAL>  (1061) 
nan

>  <ATC_CODE>  (1061) 
A02BC07

>  <ATC_CODE_DESCRIPTION>  (1061) 
A02BC07 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):Proton pump inhibitors]

>  <INDICATION_CLASS>  (1061) 
nan

>  <SC_PATENT_NO>  (1061) 
nan

>  <DRUG_TYPE>  (1061) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1061) 
Y

>  <FIRST_IN_CLASS>  (1061) 
N

>  <CHIRALITY>  (1061) 
Achiral Molecule

>  <PRODRUG>  (1061) 
N

>  <ORAL>  (1061) 
N

>  <PARENTERAL>  (1061) 
N

>  <TOPICAL>  (1061) 
N

>  <BLACK_BOX>  (1061) 
N

>  <AVAILABILITY_TYPE>  (1061) 
Unknown

>  <WITHDRAWN_YEAR>  (1061) 
nan

>  <WITHDRAWN_COUNTRY>  (1061) 
nan

>  <WITHDRAWN_REASON>  (1061) 
nan

>  <CANONICAL_SMILES>  (1061) 
COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C

>  <name>  (1061) 
Dexrabeprazole

>  <MW>  (1061) 
359.451

>  <logP>  (1061) 
2.98942

$$$$
CHEMBL21
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
  7  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1062) 
1159

>  <SYNONYMS>  (1062) 
Sulfanilamide (DCF, FDA, INN, MI, NF)

>  <DEVELOPMENT_PHASE>  (1062) 
4

>  <RESEARCH_CODES>  (1062) 
nan

>  <APPLICANTS>  (1062) 
Meda Pharmaceuticals Inc

>  <USAN_STEM>  (1062) 
sulfa-

>  <USAN_STEM_DEFINITION>  (1062) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (1062) 
sulfa-

>  <USAN_YEAR>  (1062) 
nan

>  <FIRST_APPROVAL>  (1062) 
1985.0

>  <ATC_CODE>  (1062) 
J01EB06; D06BA05

>  <ATC_CODE_DESCRIPTION>  (1062) 
J01EB06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]; D06BA05 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]

>  <INDICATION_CLASS>  (1062) 
nan

>  <SC_PATENT_NO>  (1062) 
nan

>  <DRUG_TYPE>  (1062) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1062) 
Y

>  <FIRST_IN_CLASS>  (1062) 
N

>  <CHIRALITY>  (1062) 
Achiral Molecule

>  <PRODRUG>  (1062) 
N

>  <ORAL>  (1062) 
N

>  <PARENTERAL>  (1062) 
N

>  <TOPICAL>  (1062) 
Y

>  <BLACK_BOX>  (1062) 
N

>  <AVAILABILITY_TYPE>  (1062) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1062) 
nan

>  <WITHDRAWN_COUNTRY>  (1062) 
nan

>  <WITHDRAWN_REASON>  (1062) 
nan

>  <CANONICAL_SMILES>  (1062) 
Nc1ccc(cc1)S(=O)(=O)N

>  <name>  (1062) 
Sulfanilamide 

>  <MW>  (1062) 
172.209

>  <logP>  (1062) 
-0.0838

$$$$
CHEMBL471737
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  2  0
 22 23  1  0
 23 24  1  0
 22 25  1  0
 25 26  2  0
  8 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  1  0
 32  3  1  0
 30  5  2  0
 26 15  1  0
 26 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1063) 
448872

>  <SYNONYMS>  (1063) 
Ivabradine (INN, USAN); Ivabradine hydrochloride (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1063) 
4

>  <RESEARCH_CODES>  (1063) 
AMG-998; S-16257

>  <APPLICANTS>  (1063) 
Amgen Inc.; Amgen Inc

>  <USAN_STEM>  (1063) 
nan

>  <USAN_STEM_DEFINITION>  (1063) 
nan

>  <USAN_STEM_SUBSTEM>  (1063) 
nan

>  <USAN_YEAR>  (1063) 
2014.0

>  <FIRST_APPROVAL>  (1063) 
2015.0

>  <ATC_CODE>  (1063) 
C01EB17

>  <ATC_CODE_DESCRIPTION>  (1063) 
C01EB17 [Cardiovascular System:Cardiac Therapy:Other Cardiac Preparations:Other cardiac preparations]

>  <INDICATION_CLASS>  (1063) 
nan

>  <SC_PATENT_NO>  (1063) 
US-7361650-B2; US-7361649-B2

>  <DRUG_TYPE>  (1063) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1063) 
Y

>  <FIRST_IN_CLASS>  (1063) 
Y

>  <CHIRALITY>  (1063) 
Single Stereoisomer

>  <PRODRUG>  (1063) 
N

>  <ORAL>  (1063) 
Y

>  <PARENTERAL>  (1063) 
N

>  <TOPICAL>  (1063) 
N

>  <BLACK_BOX>  (1063) 
N

>  <AVAILABILITY_TYPE>  (1063) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1063) 
nan

>  <WITHDRAWN_COUNTRY>  (1063) 
nan

>  <WITHDRAWN_REASON>  (1063) 
nan

>  <CANONICAL_SMILES>  (1063) 
COc1cc2CCN(CCCN(C)C[C@H]3Cc4cc(OC)c(OC)cc34)C(=O)Cc2cc1OC

>  <name>  (1063) 
Ivabradine 

>  <MW>  (1063) 
468.594

>  <logP>  (1063) 
3.31

$$$$
CHEMBL1201263
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 33 13  1  0
 33 17  1  0
 29 18  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (1064) 
675214

>  <SYNONYMS>  (1064) 
Hydrocortamate (INN); Hydrocortamate HCl (FDA, MI)

>  <DEVELOPMENT_PHASE>  (1064) 
4

>  <RESEARCH_CODES>  (1064) 
nan

>  <APPLICANTS>  (1064) 
Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (1064) 
-cort-

>  <USAN_STEM_DEFINITION>  (1064) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (1064) 
-cort-

>  <USAN_YEAR>  (1064) 
nan

>  <FIRST_APPROVAL>  (1064) 
1956.0

>  <ATC_CODE>  (1064) 
nan

>  <ATC_CODE_DESCRIPTION>  (1064) 
nan

>  <INDICATION_CLASS>  (1064) 
nan

>  <SC_PATENT_NO>  (1064) 
nan

>  <DRUG_TYPE>  (1064) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1064) 
Y

>  <FIRST_IN_CLASS>  (1064) 
N

>  <CHIRALITY>  (1064) 
Single Stereoisomer

>  <PRODRUG>  (1064) 
Y

>  <ORAL>  (1064) 
N

>  <PARENTERAL>  (1064) 
N

>  <TOPICAL>  (1064) 
Y

>  <BLACK_BOX>  (1064) 
N

>  <AVAILABILITY_TYPE>  (1064) 
Discontinued

>  <WITHDRAWN_YEAR>  (1064) 
nan

>  <WITHDRAWN_COUNTRY>  (1064) 
nan

>  <WITHDRAWN_REASON>  (1064) 
nan

>  <CANONICAL_SMILES>  (1064) 
CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

>  <name>  (1064) 
Hydrocortamate 

>  <MW>  (1064) 
475.626

>  <logP>  (1064) 
2.6743

$$$$
CHEMBL73234
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 14 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 18 14  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (1065) 
117805

>  <SYNONYMS>  (1065) 
Pentoxyverine (INN, BAN, DCF); Carbetapentane Citrate (MI, NF); Pentoxyverine Citrate (JAN)

>  <DEVELOPMENT_PHASE>  (1065) 
4

>  <RESEARCH_CODES>  (1065) 
nan

>  <APPLICANTS>  (1065) 
Pfizer Inc.

>  <USAN_STEM>  (1065) 
nan

>  <USAN_STEM_DEFINITION>  (1065) 
nan

>  <USAN_STEM_SUBSTEM>  (1065) 
nan

>  <USAN_YEAR>  (1065) 
nan

>  <FIRST_APPROVAL>  (1065) 
nan

>  <ATC_CODE>  (1065) 
R05DB05

>  <ATC_CODE_DESCRIPTION>  (1065) 
R05DB05 [Respiratory System:Cough And Cold Preparations:Cough Suppressants, Excl. Combinations With Expectorants:Other cough suppressants]

>  <INDICATION_CLASS>  (1065) 
nan

>  <SC_PATENT_NO>  (1065) 
nan

>  <DRUG_TYPE>  (1065) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1065) 
Y

>  <FIRST_IN_CLASS>  (1065) 
N

>  <CHIRALITY>  (1065) 
Achiral Molecule

>  <PRODRUG>  (1065) 
N

>  <ORAL>  (1065) 
N

>  <PARENTERAL>  (1065) 
N

>  <TOPICAL>  (1065) 
N

>  <BLACK_BOX>  (1065) 
N

>  <AVAILABILITY_TYPE>  (1065) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1065) 
nan

>  <WITHDRAWN_COUNTRY>  (1065) 
United States

>  <WITHDRAWN_REASON>  (1065) 
nan

>  <CANONICAL_SMILES>  (1065) 
CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2

>  <name>  (1065) 
Pentoxyverine 

>  <MW>  (1065) 
333.472

>  <logP>  (1065) 
3.4

$$$$
CHEMBL1742471
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  2  0
 15 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
  7 25  2  0
 25 26  1  0
 26  5  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1066) 
1121342

>  <SYNONYMS>  (1066) 
Ebrotidine (INN)

>  <DEVELOPMENT_PHASE>  (1066) 
4

>  <RESEARCH_CODES>  (1066) 
nan

>  <APPLICANTS>  (1066) 
nan

>  <USAN_STEM>  (1066) 
-tidine

>  <USAN_STEM_DEFINITION>  (1066) 
H2-receptor antagonists (cimetidine type)

>  <USAN_STEM_SUBSTEM>  (1066) 
-tidine

>  <USAN_YEAR>  (1066) 
nan

>  <FIRST_APPROVAL>  (1066) 
nan

>  <ATC_CODE>  (1066) 
nan

>  <ATC_CODE_DESCRIPTION>  (1066) 
nan

>  <INDICATION_CLASS>  (1066) 
nan

>  <SC_PATENT_NO>  (1066) 
nan

>  <DRUG_TYPE>  (1066) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1066) 
Y

>  <FIRST_IN_CLASS>  (1066) 
N

>  <CHIRALITY>  (1066) 
Achiral Molecule

>  <PRODRUG>  (1066) 
N

>  <ORAL>  (1066) 
N

>  <PARENTERAL>  (1066) 
N

>  <TOPICAL>  (1066) 
N

>  <BLACK_BOX>  (1066) 
N

>  <AVAILABILITY_TYPE>  (1066) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1066) 
1998.0

>  <WITHDRAWN_COUNTRY>  (1066) 
Spain

>  <WITHDRAWN_REASON>  (1066) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (1066) 
NC(=N)Nc1nc(CSCCN\C=N\S(=O)(=O)c2ccc(Br)cc2)cs1

>  <name>  (1066) 
Ebrotidine 

>  <MW>  (1066) 
477.435

>  <logP>  (1066) 
2.45097

$$$$
CHEMBL1242
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  5 14  1  0
 14 15  1  0
 14 16  2  0
 16  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1067) 
231062

>  <SYNONYMS>  (1067) 
Phenazopyridine (BAN, INN); Phenazopyridine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1067) 
4

>  <RESEARCH_CODES>  (1067) 
NC-150; W-1655

>  <APPLICANTS>  (1067) 
Hoffmann La Roche Inc; Able Laboratories Inc

>  <USAN_STEM>  (1067) 
nan

>  <USAN_STEM_DEFINITION>  (1067) 
nan

>  <USAN_STEM_SUBSTEM>  (1067) 
nan

>  <USAN_YEAR>  (1067) 
1961.0

>  <FIRST_APPROVAL>  (1067) 
1987.0

>  <ATC_CODE>  (1067) 
G04BX06

>  <ATC_CODE_DESCRIPTION>  (1067) 
G04BX06 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Other urologicals]

>  <INDICATION_CLASS>  (1067) 
Analgesic (urinary tract)

>  <SC_PATENT_NO>  (1067) 
nan

>  <DRUG_TYPE>  (1067) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1067) 
Y

>  <FIRST_IN_CLASS>  (1067) 
N

>  <CHIRALITY>  (1067) 
Achiral Molecule

>  <PRODRUG>  (1067) 
N

>  <ORAL>  (1067) 
Y

>  <PARENTERAL>  (1067) 
N

>  <TOPICAL>  (1067) 
N

>  <BLACK_BOX>  (1067) 
N

>  <AVAILABILITY_TYPE>  (1067) 
Discontinued

>  <WITHDRAWN_YEAR>  (1067) 
nan

>  <WITHDRAWN_COUNTRY>  (1067) 
nan

>  <WITHDRAWN_REASON>  (1067) 
nan

>  <CANONICAL_SMILES>  (1067) 
Nc1ccc(N=Nc2ccccc2)c(N)n1

>  <name>  (1067) 
Phenazopyridine 

>  <MW>  (1067) 
213.244

>  <logP>  (1067) 
2.6614

$$$$
CHEMBL1290
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 16 11  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1068) 
254975

>  <SYNONYMS>  (1068) 
Penbutolol (BAN, INN); Penbutolol Sulfate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1068) 
4

>  <RESEARCH_CODES>  (1068) 
HOE-39-893d; HOE-893d

>  <APPLICANTS>  (1068) 
Actient Pharmaceuticals Llc

>  <USAN_STEM>  (1068) 
-olol

>  <USAN_STEM_DEFINITION>  (1068) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (1068) 
-olol

>  <USAN_YEAR>  (1068) 
1977.0

>  <FIRST_APPROVAL>  (1068) 
1987.0

>  <ATC_CODE>  (1068) 
C07AA23

>  <ATC_CODE_DESCRIPTION>  (1068) 
C07AA23 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (1068) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (1068) 
nan

>  <DRUG_TYPE>  (1068) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1068) 
Y

>  <FIRST_IN_CLASS>  (1068) 
N

>  <CHIRALITY>  (1068) 
Single Stereoisomer

>  <PRODRUG>  (1068) 
N

>  <ORAL>  (1068) 
Y

>  <PARENTERAL>  (1068) 
N

>  <TOPICAL>  (1068) 
N

>  <BLACK_BOX>  (1068) 
N

>  <AVAILABILITY_TYPE>  (1068) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1068) 
nan

>  <WITHDRAWN_COUNTRY>  (1068) 
nan

>  <WITHDRAWN_REASON>  (1068) 
nan

>  <CANONICAL_SMILES>  (1068) 
CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2

>  <name>  (1068) 
Penbutolol 

>  <MW>  (1068) 
291.435

>  <logP>  (1068) 
3.472

$$$$
CHEMBL459265
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  3
 15 16  1  0
 15 17  1  0
 14 18  1  0
 18 19  2  0
 10 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 23 26  1  0
 26 27  1  0
 26 28  1  0
  9  4  1  0
 19 11  1  0
 25 20  1  0
M  CHG  1  15   1
M  END
>  <PARENT_MOLREGNO>  (1069) 
504234

>  <SYNONYMS>  (1069) 
Gentian Violet (FDA, USP); Methylrosanilinium Chloride (INN, JAN)

>  <DEVELOPMENT_PHASE>  (1069) 
4

>  <RESEARCH_CODES>  (1069) 
GNF-Pf-880

>  <APPLICANTS>  (1069) 
Savage Laboratories Inc Div Altana Inc; Key Pharmaceuticals Inc Sub Schering Plough Corp

>  <USAN_STEM>  (1069) 
nan

>  <USAN_STEM_DEFINITION>  (1069) 
nan

>  <USAN_STEM_SUBSTEM>  (1069) 
nan

>  <USAN_YEAR>  (1069) 
nan

>  <FIRST_APPROVAL>  (1069) 
1982.0

>  <ATC_CODE>  (1069) 
nan

>  <ATC_CODE_DESCRIPTION>  (1069) 
nan

>  <INDICATION_CLASS>  (1069) 
Anti-Infective, Topical

>  <SC_PATENT_NO>  (1069) 
nan

>  <DRUG_TYPE>  (1069) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1069) 
Y

>  <FIRST_IN_CLASS>  (1069) 
N

>  <CHIRALITY>  (1069) 
Achiral Molecule

>  <PRODRUG>  (1069) 
N

>  <ORAL>  (1069) 
N

>  <PARENTERAL>  (1069) 
N

>  <TOPICAL>  (1069) 
Y

>  <BLACK_BOX>  (1069) 
N

>  <AVAILABILITY_TYPE>  (1069) 
Discontinued

>  <WITHDRAWN_YEAR>  (1069) 
nan

>  <WITHDRAWN_COUNTRY>  (1069) 
nan

>  <WITHDRAWN_REASON>  (1069) 
nan

>  <CANONICAL_SMILES>  (1069) 
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C

>  <name>  (1069) 
Gentian Violet 

>  <MW>  (1069) 
372.536

>  <logP>  (1069) 
4.4596

$$$$
CHEMBL942
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 15 20  1  0
 20 21  2  0
 11 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 10  5  1  0
 21 12  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (1070) 
88841

>  <SYNONYMS>  (1070) 
Bisacodyl (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1070) 
4

>  <RESEARCH_CODES>  (1070) 
nan

>  <APPLICANTS>  (1070) 
Braintree Laboratories Inc

>  <USAN_STEM>  (1070) 
nan

>  <USAN_STEM_DEFINITION>  (1070) 
nan

>  <USAN_STEM_SUBSTEM>  (1070) 
nan

>  <USAN_YEAR>  (1070) 
nan

>  <FIRST_APPROVAL>  (1070) 
2004.0

>  <ATC_CODE>  (1070) 
A06AB02; A06AB52; A06AG02

>  <ATC_CODE_DESCRIPTION>  (1070) 
A06AB02 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]; A06AB52 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Contact laxatives]; A06AG02 [Alimentary Tract And Metabolism:Drugs For Constipation:Drugs For Constipation:Enemas]

>  <INDICATION_CLASS>  (1070) 
Laxative

>  <SC_PATENT_NO>  (1070) 
US-7291324-B2

>  <DRUG_TYPE>  (1070) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1070) 
Y

>  <FIRST_IN_CLASS>  (1070) 
N

>  <CHIRALITY>  (1070) 
Achiral Molecule

>  <PRODRUG>  (1070) 
N

>  <ORAL>  (1070) 
Y

>  <PARENTERAL>  (1070) 
N

>  <TOPICAL>  (1070) 
N

>  <BLACK_BOX>  (1070) 
N

>  <AVAILABILITY_TYPE>  (1070) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1070) 
nan

>  <WITHDRAWN_COUNTRY>  (1070) 
nan

>  <WITHDRAWN_REASON>  (1070) 
nan

>  <CANONICAL_SMILES>  (1070) 
CC(=O)Oc1ccc(cc1)C(c2ccc(OC(=O)C)cc2)c3ccccn3

>  <name>  (1070) 
Bisacodyl 

>  <MW>  (1070) 
361.397

>  <logP>  (1070) 
4.1124

$$$$
CHEMBL1508
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 12 16  1  0
 16 17  3  0
  7 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 15  7  1  0
 15 10  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1071) 
421007

>  <SYNONYMS>  (1071) 
Escitalopram (BAN, INN); Escitalopram Oxalate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1071) 
4

>  <RESEARCH_CODES>  (1071) 
LU-260540

>  <APPLICANTS>  (1071) 
Forest Laboratories Inc

>  <USAN_STEM>  (1071) 
nan

>  <USAN_STEM_DEFINITION>  (1071) 
nan

>  <USAN_STEM_SUBSTEM>  (1071) 
nan

>  <USAN_YEAR>  (1071) 
2000.0

>  <FIRST_APPROVAL>  (1071) 
2002.0

>  <ATC_CODE>  (1071) 
N06AB10

>  <ATC_CODE_DESCRIPTION>  (1071) 
N06AB10 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (1071) 
nan

>  <SC_PATENT_NO>  (1071) 
US-6916941-B2

>  <DRUG_TYPE>  (1071) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1071) 
Y

>  <FIRST_IN_CLASS>  (1071) 
N

>  <CHIRALITY>  (1071) 
Single Stereoisomer

>  <PRODRUG>  (1071) 
N

>  <ORAL>  (1071) 
Y

>  <PARENTERAL>  (1071) 
N

>  <TOPICAL>  (1071) 
N

>  <BLACK_BOX>  (1071) 
Y

>  <AVAILABILITY_TYPE>  (1071) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1071) 
nan

>  <WITHDRAWN_COUNTRY>  (1071) 
nan

>  <WITHDRAWN_REASON>  (1071) 
nan

>  <CANONICAL_SMILES>  (1071) 
CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3

>  <name>  (1071) 
Escitalopram 

>  <MW>  (1071) 
324.399

>  <logP>  (1071) 
3.81298

$$$$
CHEMBL852
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  1  0
 14 15  1  0
 15 16  1  0
  2 17  1  0
 17 18  2  0
 17 19  1  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (1072) 
65415

>  <SYNONYMS>  (1072) 
Melphalan (BAN, FDA, INN, JAN, USAN, USP); Melphalan HCl (FDA)

>  <DEVELOPMENT_PHASE>  (1072) 
4

>  <RESEARCH_CODES>  (1072) 
CB-3025

>  <APPLICANTS>  (1072) 
GlaxoSmithKline

>  <USAN_STEM>  (1072) 
nan

>  <USAN_STEM_DEFINITION>  (1072) 
nan

>  <USAN_STEM_SUBSTEM>  (1072) 
nan

>  <USAN_YEAR>  (1072) 
1963.0

>  <FIRST_APPROVAL>  (1072) 
1964.0

>  <ATC_CODE>  (1072) 
L01AA03

>  <ATC_CODE_DESCRIPTION>  (1072) 
L01AA03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrogen mustard analogues]

>  <INDICATION_CLASS>  (1072) 
Antineoplastic

>  <SC_PATENT_NO>  (1072) 
US-8410077-B2

>  <DRUG_TYPE>  (1072) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1072) 
Y

>  <FIRST_IN_CLASS>  (1072) 
N

>  <CHIRALITY>  (1072) 
Single Stereoisomer

>  <PRODRUG>  (1072) 
N

>  <ORAL>  (1072) 
Y

>  <PARENTERAL>  (1072) 
Y

>  <TOPICAL>  (1072) 
N

>  <BLACK_BOX>  (1072) 
Y

>  <AVAILABILITY_TYPE>  (1072) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1072) 
nan

>  <WITHDRAWN_COUNTRY>  (1072) 
nan

>  <WITHDRAWN_REASON>  (1072) 
nan

>  <CANONICAL_SMILES>  (1072) 
N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O

>  <name>  (1072) 
Melphalan 

>  <MW>  (1072) 
305.205

>  <logP>  (1072) 
1.925

$$$$
CHEMBL515
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1073) 
11002

>  <SYNONYMS>  (1073) 
Chlorambucil (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1073) 
4

>  <RESEARCH_CODES>  (1073) 
nan

>  <APPLICANTS>  (1073) 
Aspen Global Inc

>  <USAN_STEM>  (1073) 
nan

>  <USAN_STEM_DEFINITION>  (1073) 
nan

>  <USAN_STEM_SUBSTEM>  (1073) 
nan

>  <USAN_YEAR>  (1073) 
nan

>  <FIRST_APPROVAL>  (1073) 
1957.0

>  <ATC_CODE>  (1073) 
L01AA02

>  <ATC_CODE_DESCRIPTION>  (1073) 
L01AA02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrogen mustard analogues]

>  <INDICATION_CLASS>  (1073) 
Antineoplastic

>  <SC_PATENT_NO>  (1073) 
nan

>  <DRUG_TYPE>  (1073) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1073) 
Y

>  <FIRST_IN_CLASS>  (1073) 
N

>  <CHIRALITY>  (1073) 
Achiral Molecule

>  <PRODRUG>  (1073) 
N

>  <ORAL>  (1073) 
Y

>  <PARENTERAL>  (1073) 
N

>  <TOPICAL>  (1073) 
N

>  <BLACK_BOX>  (1073) 
Y

>  <AVAILABILITY_TYPE>  (1073) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1073) 
nan

>  <WITHDRAWN_COUNTRY>  (1073) 
nan

>  <WITHDRAWN_REASON>  (1073) 
nan

>  <CANONICAL_SMILES>  (1073) 
OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl

>  <name>  (1073) 
Chlorambucil 

>  <MW>  (1073) 
304.217

>  <logP>  (1073) 
3.3779

$$$$
CHEMBL1095777
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
  7 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 11  3  1  0
  9  5  2  0
 29 18  1  0
 29 23  2  0
M  END
>  <PARENT_MOLREGNO>  (1074) 
625589

>  <SYNONYMS>  (1074) 
Indacaterol (INN, USAN); Indacaterol Maleate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1074) 
4

>  <RESEARCH_CODES>  (1074) 
QAB149; QABI49; QAB149-AFA

>  <APPLICANTS>  (1074) 
Novartis Pharmaceuticals Corp; Novartis Pharma Ag

>  <USAN_STEM>  (1074) 
-terol

>  <USAN_STEM_DEFINITION>  (1074) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (1074) 
-terol

>  <USAN_YEAR>  (1074) 
2008.0

>  <FIRST_APPROVAL>  (1074) 
2011.0

>  <ATC_CODE>  (1074) 
R03AC18

>  <ATC_CODE_DESCRIPTION>  (1074) 
R03AC18 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (1074) 
nan

>  <SC_PATENT_NO>  (1074) 
US-6521260-B1

>  <DRUG_TYPE>  (1074) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1074) 
Y

>  <FIRST_IN_CLASS>  (1074) 
N

>  <CHIRALITY>  (1074) 
Single Stereoisomer

>  <PRODRUG>  (1074) 
N

>  <ORAL>  (1074) 
N

>  <PARENTERAL>  (1074) 
N

>  <TOPICAL>  (1074) 
Y

>  <BLACK_BOX>  (1074) 
Y

>  <AVAILABILITY_TYPE>  (1074) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1074) 
nan

>  <WITHDRAWN_COUNTRY>  (1074) 
nan

>  <WITHDRAWN_REASON>  (1074) 
nan

>  <CANONICAL_SMILES>  (1074) 
CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c3ccc(O)c4NC(=O)C=Cc34

>  <name>  (1074) 
Indacaterol 

>  <MW>  (1074) 
392.499

>  <logP>  (1074) 
3.1489

$$$$
CHEMBL440
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  6 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 13 17  1  0
 15  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1075) 
2132

>  <SYNONYMS>  (1075) 
Thiamylal (USP); Thiamylal Sodium (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1075) 
4

>  <RESEARCH_CODES>  (1075) 
nan

>  <APPLICANTS>  (1075) 
Parkedale Pharmaceuticals Inc

>  <USAN_STEM>  (1075) 
nan

>  <USAN_STEM_DEFINITION>  (1075) 
nan

>  <USAN_STEM_SUBSTEM>  (1075) 
nan

>  <USAN_YEAR>  (1075) 
nan

>  <FIRST_APPROVAL>  (1075) 
1982.0

>  <ATC_CODE>  (1075) 
nan

>  <ATC_CODE_DESCRIPTION>  (1075) 
nan

>  <INDICATION_CLASS>  (1075) 
Anesthetic (intravenous)

>  <SC_PATENT_NO>  (1075) 
nan

>  <DRUG_TYPE>  (1075) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1075) 
Y

>  <FIRST_IN_CLASS>  (1075) 
N

>  <CHIRALITY>  (1075) 
Racemic Mixture

>  <PRODRUG>  (1075) 
N

>  <ORAL>  (1075) 
N

>  <PARENTERAL>  (1075) 
Y

>  <TOPICAL>  (1075) 
N

>  <BLACK_BOX>  (1075) 
N

>  <AVAILABILITY_TYPE>  (1075) 
Discontinued

>  <WITHDRAWN_YEAR>  (1075) 
nan

>  <WITHDRAWN_COUNTRY>  (1075) 
nan

>  <WITHDRAWN_REASON>  (1075) 
nan

>  <CANONICAL_SMILES>  (1075) 
CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S

>  <name>  (1075) 
Thiamylal 

>  <MW>  (1075) 
254.355

>  <logP>  (1075) 
1.9273

$$$$
CHEMBL842
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  2  0
 10  5  1  0
 15  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1076) 
62615

>  <SYNONYMS>  (1076) 
Chlorothiazide (BAN, FDA, INN, USP); Chlorothiazide Sodium (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1076) 
4

>  <RESEARCH_CODES>  (1076) 
nan

>  <APPLICANTS>  (1076) 
Salix Pharmaceuticals Inc; Oak Pharmaceuticals Inc Sub Akorn Inc; Merck And Co Inc

>  <USAN_STEM>  (1076) 
-thiazide

>  <USAN_STEM_DEFINITION>  (1076) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (1076) 
-thiazide

>  <USAN_YEAR>  (1076) 
1964.0

>  <FIRST_APPROVAL>  (1076) 
1958.0

>  <ATC_CODE>  (1076) 
C03AA04; C03AH01

>  <ATC_CODE_DESCRIPTION>  (1076) 
C03AA04 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]; C03AH01 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, combinations with psycholeptics and/or analgesics]

>  <INDICATION_CLASS>  (1076) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (1076) 
nan

>  <DRUG_TYPE>  (1076) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1076) 
Y

>  <FIRST_IN_CLASS>  (1076) 
N

>  <CHIRALITY>  (1076) 
Achiral Molecule

>  <PRODRUG>  (1076) 
N

>  <ORAL>  (1076) 
Y

>  <PARENTERAL>  (1076) 
Y

>  <TOPICAL>  (1076) 
N

>  <BLACK_BOX>  (1076) 
N

>  <AVAILABILITY_TYPE>  (1076) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1076) 
nan

>  <WITHDRAWN_COUNTRY>  (1076) 
nan

>  <WITHDRAWN_REASON>  (1076) 
nan

>  <CANONICAL_SMILES>  (1076) 
NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O

>  <name>  (1076) 
Chlorothiazide 

>  <MW>  (1076) 
295.729

>  <logP>  (1076) 
-0.0609

$$$$
CHEMBL1271
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  2 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17  2  1  0
 13  8  1  0
M  CHG  2   2   1   8   1
M  END
>  <PARENT_MOLREGNO>  (1077) 
247401

>  <SYNONYMS>  (1077) 
Pentolinium Tartrate (FDA, MI, NF); Pentolonium Tartrate (BAN, INN)

>  <DEVELOPMENT_PHASE>  (1077) 
4

>  <RESEARCH_CODES>  (1077) 
nan

>  <APPLICANTS>  (1077) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (1077) 
-ium

>  <USAN_STEM_DEFINITION>  (1077) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (1077) 
-ium

>  <USAN_YEAR>  (1077) 
nan

>  <FIRST_APPROVAL>  (1077) 
1982.0

>  <ATC_CODE>  (1077) 
nan

>  <ATC_CODE_DESCRIPTION>  (1077) 
nan

>  <INDICATION_CLASS>  (1077) 
nan

>  <SC_PATENT_NO>  (1077) 
nan

>  <DRUG_TYPE>  (1077) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1077) 
Y

>  <FIRST_IN_CLASS>  (1077) 
N

>  <CHIRALITY>  (1077) 
Achiral Molecule

>  <PRODRUG>  (1077) 
N

>  <ORAL>  (1077) 
N

>  <PARENTERAL>  (1077) 
Y

>  <TOPICAL>  (1077) 
N

>  <BLACK_BOX>  (1077) 
N

>  <AVAILABILITY_TYPE>  (1077) 
Discontinued

>  <WITHDRAWN_YEAR>  (1077) 
nan

>  <WITHDRAWN_COUNTRY>  (1077) 
nan

>  <WITHDRAWN_REASON>  (1077) 
nan

>  <CANONICAL_SMILES>  (1077) 
C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1

>  <name>  (1077) 
Pentolinium Tartrate 

>  <MW>  (1077) 
240.435

>  <logP>  (1077) 
2.6375

$$$$
CHEMBL1428
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 21 23  1  0
 13 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 12 30  1  0
 14  8  1  0
 20 15  1  0
M  CHG  2  21   1  23  -1
M  END
>  <PARENT_MOLREGNO>  (1078) 
365248

>  <SYNONYMS>  (1078) 
Nimodipine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1078) 
4

>  <RESEARCH_CODES>  (1078) 
BAY-E-9736

>  <APPLICANTS>  (1078) 
Bayer Pharmaceuticals Corp

>  <USAN_STEM>  (1078) 
-dipine

>  <USAN_STEM_DEFINITION>  (1078) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (1078) 
-dipine

>  <USAN_YEAR>  (1078) 
1979.0

>  <FIRST_APPROVAL>  (1078) 
1988.0

>  <ATC_CODE>  (1078) 
C08CA06

>  <ATC_CODE_DESCRIPTION>  (1078) 
C08CA06 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (1078) 
Vasodilator

>  <SC_PATENT_NO>  (1078) 
nan

>  <DRUG_TYPE>  (1078) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1078) 
Y

>  <FIRST_IN_CLASS>  (1078) 
N

>  <CHIRALITY>  (1078) 
Racemic Mixture

>  <PRODRUG>  (1078) 
N

>  <ORAL>  (1078) 
Y

>  <PARENTERAL>  (1078) 
N

>  <TOPICAL>  (1078) 
N

>  <BLACK_BOX>  (1078) 
Y

>  <AVAILABILITY_TYPE>  (1078) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1078) 
nan

>  <WITHDRAWN_COUNTRY>  (1078) 
nan

>  <WITHDRAWN_REASON>  (1078) 
nan

>  <CANONICAL_SMILES>  (1078) 
COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C

>  <name>  (1078) 
Nimodipine 

>  <MW>  (1078) 
418.446

>  <logP>  (1078) 
2.9708

$$$$
CHEMBL88
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1079) 
8417

>  <SYNONYMS>  (1079) 
Cyclophosphamide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1079) 
4

>  <RESEARCH_CODES>  (1079) 
nan

>  <APPLICANTS>  (1079) 
Baxter Healthcare Corp

>  <USAN_STEM>  (1079) 
nan

>  <USAN_STEM_DEFINITION>  (1079) 
nan

>  <USAN_STEM_SUBSTEM>  (1079) 
nan

>  <USAN_YEAR>  (1079) 
nan

>  <FIRST_APPROVAL>  (1079) 
1959.0

>  <ATC_CODE>  (1079) 
L01AA01

>  <ATC_CODE_DESCRIPTION>  (1079) 
L01AA01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Alkylating Agents:Nitrogen mustard analogues]

>  <INDICATION_CLASS>  (1079) 
Antineoplastic; Immunosuppressant

>  <SC_PATENT_NO>  (1079) 
nan

>  <DRUG_TYPE>  (1079) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1079) 
Y

>  <FIRST_IN_CLASS>  (1079) 
N

>  <CHIRALITY>  (1079) 
Racemic Mixture

>  <PRODRUG>  (1079) 
Y

>  <ORAL>  (1079) 
Y

>  <PARENTERAL>  (1079) 
Y

>  <TOPICAL>  (1079) 
N

>  <BLACK_BOX>  (1079) 
N

>  <AVAILABILITY_TYPE>  (1079) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1079) 
nan

>  <WITHDRAWN_COUNTRY>  (1079) 
nan

>  <WITHDRAWN_REASON>  (1079) 
nan

>  <CANONICAL_SMILES>  (1079) 
ClCCN(CCCl)P1(=O)NCCCO1

>  <name>  (1079) 
Cyclophosphamide 

>  <MW>  (1079) 
261.089

>  <logP>  (1079) 
1.884

$$$$
CHEMBL821
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
M  END
>  <PARENT_MOLREGNO>  (1080) 
56752

>  <SYNONYMS>  (1080) 
Guanidine HCl (FDA)

>  <DEVELOPMENT_PHASE>  (1080) 
4

>  <RESEARCH_CODES>  (1080) 
nan

>  <APPLICANTS>  (1080) 
Merck Sharp And Dohme Corp

>  <USAN_STEM>  (1080) 
guan-

>  <USAN_STEM_DEFINITION>  (1080) 
antihypertensives (guanidine derivatives)

>  <USAN_STEM_SUBSTEM>  (1080) 
guan-

>  <USAN_YEAR>  (1080) 
nan

>  <FIRST_APPROVAL>  (1080) 
1939.0

>  <ATC_CODE>  (1080) 
nan

>  <ATC_CODE_DESCRIPTION>  (1080) 
nan

>  <INDICATION_CLASS>  (1080) 
nan

>  <SC_PATENT_NO>  (1080) 
nan

>  <DRUG_TYPE>  (1080) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1080) 
Y

>  <FIRST_IN_CLASS>  (1080) 
N

>  <CHIRALITY>  (1080) 
Achiral Molecule

>  <PRODRUG>  (1080) 
N

>  <ORAL>  (1080) 
Y

>  <PARENTERAL>  (1080) 
N

>  <TOPICAL>  (1080) 
N

>  <BLACK_BOX>  (1080) 
N

>  <AVAILABILITY_TYPE>  (1080) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1080) 
nan

>  <WITHDRAWN_COUNTRY>  (1080) 
nan

>  <WITHDRAWN_REASON>  (1080) 
nan

>  <CANONICAL_SMILES>  (1080) 
NC(=N)N

>  <name>  (1080) 
Guanidine HCl 

>  <MW>  (1080) 
59.072

>  <logP>  (1080) 
-1.16143

$$$$
CHEMBL1201784
     RDKit          

 15 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1081) 
675735

>  <SYNONYMS>  (1081) 
Hexaminolevulinate HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1081) 
4

>  <RESEARCH_CODES>  (1081) 
P-1026

>  <APPLICANTS>  (1081) 
Photocure Asa

>  <USAN_STEM>  (1081) 
nan

>  <USAN_STEM_DEFINITION>  (1081) 
nan

>  <USAN_STEM_SUBSTEM>  (1081) 
nan

>  <USAN_YEAR>  (1081) 
2003.0

>  <FIRST_APPROVAL>  (1081) 
2010.0

>  <ATC_CODE>  (1081) 
nan

>  <ATC_CODE_DESCRIPTION>  (1081) 
nan

>  <INDICATION_CLASS>  (1081) 
nan

>  <SC_PATENT_NO>  (1081) 
US-6034267-A

>  <DRUG_TYPE>  (1081) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1081) 
Y

>  <FIRST_IN_CLASS>  (1081) 
N

>  <CHIRALITY>  (1081) 
Achiral Molecule

>  <PRODRUG>  (1081) 
N

>  <ORAL>  (1081) 
N

>  <PARENTERAL>  (1081) 
Y

>  <TOPICAL>  (1081) 
N

>  <BLACK_BOX>  (1081) 
N

>  <AVAILABILITY_TYPE>  (1081) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1081) 
nan

>  <WITHDRAWN_COUNTRY>  (1081) 
nan

>  <WITHDRAWN_REASON>  (1081) 
nan

>  <CANONICAL_SMILES>  (1081) 
CCCCCCOC(=O)CCC(=O)CN

>  <name>  (1081) 
Hexaminolevulinate HCl 

>  <MW>  (1081) 
215.293

>  <logP>  (1081) 
1.4179

$$$$
CHEMBL1200709
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1082) 
674660

>  <SYNONYMS>  (1082) 
Crotamiton (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1082) 
4

>  <RESEARCH_CODES>  (1082) 
nan

>  <APPLICANTS>  (1082) 
Ranbaxy Laboratories Inc

>  <USAN_STEM>  (1082) 
nan

>  <USAN_STEM_DEFINITION>  (1082) 
nan

>  <USAN_STEM_SUBSTEM>  (1082) 
nan

>  <USAN_YEAR>  (1082) 
nan

>  <FIRST_APPROVAL>  (1082) 
1949.0

>  <ATC_CODE>  (1082) 
nan

>  <ATC_CODE_DESCRIPTION>  (1082) 
nan

>  <INDICATION_CLASS>  (1082) 
Scabicide

>  <SC_PATENT_NO>  (1082) 
nan

>  <DRUG_TYPE>  (1082) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1082) 
Y

>  <FIRST_IN_CLASS>  (1082) 
N

>  <CHIRALITY>  (1082) 
Achiral Molecule

>  <PRODRUG>  (1082) 
N

>  <ORAL>  (1082) 
N

>  <PARENTERAL>  (1082) 
N

>  <TOPICAL>  (1082) 
Y

>  <BLACK_BOX>  (1082) 
N

>  <AVAILABILITY_TYPE>  (1082) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1082) 
nan

>  <WITHDRAWN_COUNTRY>  (1082) 
nan

>  <WITHDRAWN_REASON>  (1082) 
nan

>  <CANONICAL_SMILES>  (1082) 
CCN(C(=O)\C=C\C)c1ccccc1C

>  <name>  (1082) 
Crotamiton 

>  <MW>  (1082) 
203.285

>  <logP>  (1082) 
2.92402

$$$$
CHEMBL448
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1083) 
2327

>  <SYNONYMS>  (1083) 
Pentobarbital (BAN, FDA, INN, USP); Pentobarbital Calcium (JAN); Pentobarbital Sodium (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1083) 
4

>  <RESEARCH_CODES>  (1083) 
nan

>  <APPLICANTS>  (1083) 
Halsey Drug Co Inc; Everylife; Elkins Sinn Div Ah Robins Co Inc; Anabolic Inc; Oak Pharmaceuticals Inc

>  <USAN_STEM>  (1083) 
-barb-

>  <USAN_STEM_DEFINITION>  (1083) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (1083) 
-barb-

>  <USAN_YEAR>  (1083) 
nan

>  <FIRST_APPROVAL>  (1083) 
1973.0

>  <ATC_CODE>  (1083) 
N05CA01

>  <ATC_CODE_DESCRIPTION>  (1083) 
N05CA01 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (1083) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (1083) 
nan

>  <DRUG_TYPE>  (1083) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1083) 
Y

>  <FIRST_IN_CLASS>  (1083) 
N

>  <CHIRALITY>  (1083) 
Racemic Mixture

>  <PRODRUG>  (1083) 
N

>  <ORAL>  (1083) 
Y

>  <PARENTERAL>  (1083) 
Y

>  <TOPICAL>  (1083) 
Y

>  <BLACK_BOX>  (1083) 
N

>  <AVAILABILITY_TYPE>  (1083) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1083) 
1980.0

>  <WITHDRAWN_COUNTRY>  (1083) 
Norway; Norway

>  <WITHDRAWN_REASON>  (1083) 
Self-Poisonings; Self-Poisonings

>  <CANONICAL_SMILES>  (1083) 
CCCC(C)C1(CC)C(=O)NC(=O)NC1=O

>  <name>  (1083) 
Pentobarbital 

>  <MW>  (1083) 
226.276

>  <logP>  (1083) 
1.185

$$$$
CHEMBL521686
     RDKit          

 32 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  5 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 19  2  1  0
 17  7  1  0
 17 12  1  0
 27 22  1  0
 32 30  1  0
M  END
>  <PARENT_MOLREGNO>  (1084) 
469866

>  <SYNONYMS>  (1084) 
Olaparib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1084) 
4

>  <RESEARCH_CODES>  (1084) 
AZD-2281; AZD2281

>  <APPLICANTS>  (1084) 
Astrazeneca Pharmaceuticals Lp; Astrazeneca

>  <USAN_STEM>  (1084) 
-parib

>  <USAN_STEM_DEFINITION>  (1084) 
poly-ADP-ribose polymerase inhibitors

>  <USAN_STEM_SUBSTEM>  (1084) 
-parib

>  <USAN_YEAR>  (1084) 
2013.0

>  <FIRST_APPROVAL>  (1084) 
2014.0

>  <ATC_CODE>  (1084) 
L01XX46

>  <ATC_CODE_DESCRIPTION>  (1084) 
L01XX46 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (1084) 
nan

>  <SC_PATENT_NO>  (1084) 
US-7151102-B2

>  <DRUG_TYPE>  (1084) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1084) 
Y

>  <FIRST_IN_CLASS>  (1084) 
N

>  <CHIRALITY>  (1084) 
Achiral Molecule

>  <PRODRUG>  (1084) 
N

>  <ORAL>  (1084) 
Y

>  <PARENTERAL>  (1084) 
N

>  <TOPICAL>  (1084) 
N

>  <BLACK_BOX>  (1084) 
N

>  <AVAILABILITY_TYPE>  (1084) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1084) 
nan

>  <WITHDRAWN_COUNTRY>  (1084) 
nan

>  <WITHDRAWN_REASON>  (1084) 
nan

>  <CANONICAL_SMILES>  (1084) 
Fc1ccc(CC2=NNC(=O)c3ccccc23)cc1C(=O)N4CCN(CC4)C(=O)C5CC5

>  <name>  (1084) 
Olaparib 

>  <MW>  (1084) 
434.471

>  <logP>  (1084) 
2.3474

$$$$
CHEMBL340978
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 11 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 14  6  1  0
 13  9  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1085) 
219327

>  <SYNONYMS>  (1085) 
Benoxaprofen (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1085) 
4

>  <RESEARCH_CODES>  (1085) 
Compound 90459

>  <APPLICANTS>  (1085) 
Lilly

>  <USAN_STEM>  (1085) 
-profen

>  <USAN_STEM_DEFINITION>  (1085) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (1085) 
-profen

>  <USAN_YEAR>  (1085) 
1976.0

>  <FIRST_APPROVAL>  (1085) 
1982.0

>  <ATC_CODE>  (1085) 
M01AE06

>  <ATC_CODE_DESCRIPTION>  (1085) 
M01AE06 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (1085) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (1085) 
nan

>  <DRUG_TYPE>  (1085) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1085) 
Y

>  <FIRST_IN_CLASS>  (1085) 
N

>  <CHIRALITY>  (1085) 
Racemic Mixture

>  <PRODRUG>  (1085) 
N

>  <ORAL>  (1085) 
N

>  <PARENTERAL>  (1085) 
N

>  <TOPICAL>  (1085) 
N

>  <BLACK_BOX>  (1085) 
N

>  <AVAILABILITY_TYPE>  (1085) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1085) 
1982.0

>  <WITHDRAWN_COUNTRY>  (1085) 
United States; United Kingdom; United States; Spain; Germany

>  <WITHDRAWN_REASON>  (1085) 
Liver and kidney failure; Gastrointestinal bleeding; Ulcers; Liver necrosis; Photosensitivity; Animal carcinogenicity

>  <CANONICAL_SMILES>  (1085) 
CC(C(=O)O)c1ccc2oc(nc2c1)c3ccc(Cl)cc3

>  <name>  (1085) 
Benoxaprofen 

>  <MW>  (1085) 
301.729

>  <logP>  (1085) 
4.3363

$$$$
CHEMBL454
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1086) 
2524

>  <SYNONYMS>  (1086) 
Butalbital (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1086) 
4

>  <RESEARCH_CODES>  (1086) 
nan

>  <APPLICANTS>  (1086) 
Watson Laboratories Inc

>  <USAN_STEM>  (1086) 
nan

>  <USAN_STEM_DEFINITION>  (1086) 
nan

>  <USAN_STEM_SUBSTEM>  (1086) 
nan

>  <USAN_YEAR>  (1086) 
1966.0

>  <FIRST_APPROVAL>  (1086) 
1983.0

>  <ATC_CODE>  (1086) 
nan

>  <ATC_CODE_DESCRIPTION>  (1086) 
nan

>  <INDICATION_CLASS>  (1086) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (1086) 
nan

>  <DRUG_TYPE>  (1086) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1086) 
Y

>  <FIRST_IN_CLASS>  (1086) 
N

>  <CHIRALITY>  (1086) 
Achiral Molecule

>  <PRODRUG>  (1086) 
N

>  <ORAL>  (1086) 
Y

>  <PARENTERAL>  (1086) 
N

>  <TOPICAL>  (1086) 
N

>  <BLACK_BOX>  (1086) 
N

>  <AVAILABILITY_TYPE>  (1086) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1086) 
nan

>  <WITHDRAWN_COUNTRY>  (1086) 
nan

>  <WITHDRAWN_REASON>  (1086) 
nan

>  <CANONICAL_SMILES>  (1086) 
CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O

>  <name>  (1086) 
Butalbital 

>  <MW>  (1086) 
224.26

>  <logP>  (1086) 
0.961

$$$$
CHEMBL1726
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 10 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
  9 28  1  0
 11  5  1  0
 17 12  1  0
M  CHG  2  18   1  20  -1
M  END
>  <PARENT_MOLREGNO>  (1087) 
554892

>  <SYNONYMS>  (1087) 
Nisoldipine (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1087) 
4

>  <RESEARCH_CODES>  (1087) 
BAY-K-5552

>  <APPLICANTS>  (1087) 
Shionogi Inc

>  <USAN_STEM>  (1087) 
-dipine

>  <USAN_STEM_DEFINITION>  (1087) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (1087) 
-dipine

>  <USAN_YEAR>  (1087) 
1981.0

>  <FIRST_APPROVAL>  (1087) 
1995.0

>  <ATC_CODE>  (1087) 
C08CA07

>  <ATC_CODE_DESCRIPTION>  (1087) 
C08CA07 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (1087) 
Vasodilator (coronary)

>  <SC_PATENT_NO>  (1087) 
nan

>  <DRUG_TYPE>  (1087) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1087) 
Y

>  <FIRST_IN_CLASS>  (1087) 
N

>  <CHIRALITY>  (1087) 
Racemic Mixture

>  <PRODRUG>  (1087) 
N

>  <ORAL>  (1087) 
Y

>  <PARENTERAL>  (1087) 
N

>  <TOPICAL>  (1087) 
N

>  <BLACK_BOX>  (1087) 
N

>  <AVAILABILITY_TYPE>  (1087) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1087) 
nan

>  <WITHDRAWN_COUNTRY>  (1087) 
nan

>  <WITHDRAWN_REASON>  (1087) 
nan

>  <CANONICAL_SMILES>  (1087) 
COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OCC(C)C)C

>  <name>  (1087) 
Nisoldipine 

>  <MW>  (1087) 
388.42

>  <logP>  (1087) 
3.2018

$$$$
CHEMBL37744
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1088) 
54070

>  <SYNONYMS>  (1088) 
Zimeldine (BAN, INN); Zimeldine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (1088) 
4

>  <RESEARCH_CODES>  (1088) 
H 102/09 HCl

>  <APPLICANTS>  (1088) 
Astra Pharmaceutical Production Ab, Sweden

>  <USAN_STEM>  (1088) 
nan

>  <USAN_STEM_DEFINITION>  (1088) 
nan

>  <USAN_STEM_SUBSTEM>  (1088) 
nan

>  <USAN_YEAR>  (1088) 
1977.0

>  <FIRST_APPROVAL>  (1088) 
nan

>  <ATC_CODE>  (1088) 
N06AB02

>  <ATC_CODE_DESCRIPTION>  (1088) 
N06AB02 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (1088) 
Antidepressant

>  <SC_PATENT_NO>  (1088) 
nan

>  <DRUG_TYPE>  (1088) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1088) 
Y

>  <FIRST_IN_CLASS>  (1088) 
N

>  <CHIRALITY>  (1088) 
Achiral Molecule

>  <PRODRUG>  (1088) 
N

>  <ORAL>  (1088) 
N

>  <PARENTERAL>  (1088) 
N

>  <TOPICAL>  (1088) 
N

>  <BLACK_BOX>  (1088) 
N

>  <AVAILABILITY_TYPE>  (1088) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1088) 
1983.0

>  <WITHDRAWN_COUNTRY>  (1088) 
United Kingdom, Germany

>  <WITHDRAWN_REASON>  (1088) 
Guillan-Barre Syndrome, hepatotoxicity

>  <CANONICAL_SMILES>  (1088) 
CN(C)C\C=C(\c1ccc(Br)cc1)/c2cccnc2

>  <name>  (1088) 
Zimeldine 

>  <MW>  (1088) 
317.23

>  <logP>  (1088) 
3.8374

$$$$
CHEMBL832
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  8 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 10  5  1  0
 17 12  1  0
 23 18  1  0
 29 24  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (1089) 
60232

>  <SYNONYMS>  (1089) 
Sulfinpyrazone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1089) 
4

>  <RESEARCH_CODES>  (1089) 
nan

>  <APPLICANTS>  (1089) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (1089) 
nan

>  <USAN_STEM_DEFINITION>  (1089) 
nan

>  <USAN_STEM_SUBSTEM>  (1089) 
nan

>  <USAN_YEAR>  (1089) 
nan

>  <FIRST_APPROVAL>  (1089) 
1959.0

>  <ATC_CODE>  (1089) 
M04AB02

>  <ATC_CODE_DESCRIPTION>  (1089) 
M04AB02 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations increasing uric acid excretion]

>  <INDICATION_CLASS>  (1089) 
Uricosuric

>  <SC_PATENT_NO>  (1089) 
nan

>  <DRUG_TYPE>  (1089) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1089) 
Y

>  <FIRST_IN_CLASS>  (1089) 
N

>  <CHIRALITY>  (1089) 
Racemic Mixture

>  <PRODRUG>  (1089) 
N

>  <ORAL>  (1089) 
Y

>  <PARENTERAL>  (1089) 
N

>  <TOPICAL>  (1089) 
N

>  <BLACK_BOX>  (1089) 
N

>  <AVAILABILITY_TYPE>  (1089) 
Discontinued

>  <WITHDRAWN_YEAR>  (1089) 
nan

>  <WITHDRAWN_COUNTRY>  (1089) 
nan

>  <WITHDRAWN_REASON>  (1089) 
nan

>  <CANONICAL_SMILES>  (1089) 
[O-][S+](CCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)c4ccccc4

>  <name>  (1089) 
Sulfinpyrazone 

>  <MW>  (1089) 
404.491

>  <logP>  (1089) 
3.7955

$$$$
CHEMBL1201340
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  6 20  1  0
 20 21  1  0
 21  2  1  0
 13  8  1  0
 19 14  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (1090) 
675291

>  <SYNONYMS>  (1090) 
Diphemanil Methylsulfate (FDA, USP); Diphemanil Metilsulfate (BAN, INN)

>  <DEVELOPMENT_PHASE>  (1090) 
4

>  <RESEARCH_CODES>  (1090) 
nan

>  <APPLICANTS>  (1090) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (1090) 
-nil

>  <USAN_STEM_DEFINITION>  (1090) 
benzodiazepine receptor antagonists/agonists

>  <USAN_STEM_SUBSTEM>  (1090) 
-nil

>  <USAN_YEAR>  (1090) 
nan

>  <FIRST_APPROVAL>  (1090) 
1982.0

>  <ATC_CODE>  (1090) 
A03AB15

>  <ATC_CODE_DESCRIPTION>  (1090) 
A03AB15 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (1090) 
nan

>  <SC_PATENT_NO>  (1090) 
nan

>  <DRUG_TYPE>  (1090) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1090) 
Y

>  <FIRST_IN_CLASS>  (1090) 
N

>  <CHIRALITY>  (1090) 
Achiral Molecule

>  <PRODRUG>  (1090) 
N

>  <ORAL>  (1090) 
Y

>  <PARENTERAL>  (1090) 
N

>  <TOPICAL>  (1090) 
N

>  <BLACK_BOX>  (1090) 
N

>  <AVAILABILITY_TYPE>  (1090) 
Discontinued

>  <WITHDRAWN_YEAR>  (1090) 
nan

>  <WITHDRAWN_COUNTRY>  (1090) 
nan

>  <WITHDRAWN_REASON>  (1090) 
nan

>  <CANONICAL_SMILES>  (1090) 
C[N+]1(C)CCC(=C(c2ccccc2)c3ccccc3)CC1

>  <name>  (1090) 
Diphemanil Methylsulfate 

>  <MW>  (1090) 
278.419

>  <logP>  (1090) 
4.3587

$$$$
CHEMBL95
     RDKit          

 15 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  2  1  0
  8  3  1  0
 15 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1091) 
9333

>  <SYNONYMS>  (1091) 
Tacrine (BAN, INN); Tacrine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1091) 
4

>  <RESEARCH_CODES>  (1091) 
CI-970

>  <APPLICANTS>  (1091) 
Shionogi Inc

>  <USAN_STEM>  (1091) 
-crine

>  <USAN_STEM_DEFINITION>  (1091) 
acridine derivatives

>  <USAN_STEM_SUBSTEM>  (1091) 
-crine

>  <USAN_YEAR>  (1091) 
1988.0

>  <FIRST_APPROVAL>  (1091) 
1993.0

>  <ATC_CODE>  (1091) 
N06DA01

>  <ATC_CODE_DESCRIPTION>  (1091) 
N06DA01 [Nervous System:Psychoanaleptics:Anti-Dementia Drugs:Anticholinesterases]

>  <INDICATION_CLASS>  (1091) 
Cognition Adjuvant; Dementia Symptoms Treatment Adjunct

>  <SC_PATENT_NO>  (1091) 
nan

>  <DRUG_TYPE>  (1091) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1091) 
Y

>  <FIRST_IN_CLASS>  (1091) 
N

>  <CHIRALITY>  (1091) 
Achiral Molecule

>  <PRODRUG>  (1091) 
N

>  <ORAL>  (1091) 
Y

>  <PARENTERAL>  (1091) 
N

>  <TOPICAL>  (1091) 
N

>  <BLACK_BOX>  (1091) 
N

>  <AVAILABILITY_TYPE>  (1091) 
Discontinued

>  <WITHDRAWN_YEAR>  (1091) 
nan

>  <WITHDRAWN_COUNTRY>  (1091) 
nan

>  <WITHDRAWN_REASON>  (1091) 
nan

>  <CANONICAL_SMILES>  (1091) 
Nc1c2CCCCc2nc3ccccc13

>  <name>  (1091) 
Tacrine 

>  <MW>  (1091) 
198.269

>  <logP>  (1091) 
2.6958

$$$$
CHEMBL1201191
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 14 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 13  8  1  0
 20 15  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (1092) 
675142

>  <SYNONYMS>  (1092) 
Levocetirizine (BAN, INN, USAN); Levocetirizine Dihydrochloride (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1092) 
4

>  <RESEARCH_CODES>  (1092) 
UCB-28556

>  <APPLICANTS>  (1092) 
Ucb S.A.; Ucb Inc

>  <USAN_STEM>  (1092) 
nan

>  <USAN_STEM_DEFINITION>  (1092) 
nan

>  <USAN_STEM_SUBSTEM>  (1092) 
nan

>  <USAN_YEAR>  (1092) 
2007.0

>  <FIRST_APPROVAL>  (1092) 
2007.0

>  <ATC_CODE>  (1092) 
R06AE09

>  <ATC_CODE_DESCRIPTION>  (1092) 
R06AE09 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Piperazine derivatives]

>  <INDICATION_CLASS>  (1092) 
nan

>  <SC_PATENT_NO>  (1092) 
nan

>  <DRUG_TYPE>  (1092) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1092) 
Y

>  <FIRST_IN_CLASS>  (1092) 
N

>  <CHIRALITY>  (1092) 
Single Stereoisomer

>  <PRODRUG>  (1092) 
N

>  <ORAL>  (1092) 
Y

>  <PARENTERAL>  (1092) 
N

>  <TOPICAL>  (1092) 
N

>  <BLACK_BOX>  (1092) 
Y

>  <AVAILABILITY_TYPE>  (1092) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1092) 
nan

>  <WITHDRAWN_COUNTRY>  (1092) 
nan

>  <WITHDRAWN_REASON>  (1092) 
nan

>  <CANONICAL_SMILES>  (1092) 
OC(=O)COCCN1CCN(CC1)[C@H](c2ccccc2)c3ccc(Cl)cc3

>  <name>  (1092) 
Levocetirizine 

>  <MW>  (1092) 
388.895

>  <logP>  (1092) 
3.1482

$$$$
CHEMBL896
     RDKit          

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 12  7  1  0
 19 14  1  0
 26 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1093) 
77459

>  <SYNONYMS>  (1093) 
Hydroxyzine (BAN, INN); Hydroxyzine Pamoate (FDA, JAN, USP); Hydroxyzine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1093) 
4

>  <RESEARCH_CODES>  (1093) 
nan

>  <APPLICANTS>  (1093) 
Roerig Div Pfizer Inc; Pfizer Laboratories Div Pfizer Inc; Pfizer Inc.

>  <USAN_STEM>  (1093) 
nan

>  <USAN_STEM_DEFINITION>  (1093) 
nan

>  <USAN_STEM_SUBSTEM>  (1093) 
nan

>  <USAN_YEAR>  (1093) 
nan

>  <FIRST_APPROVAL>  (1093) 
1956.0

>  <ATC_CODE>  (1093) 
N05BB01; N05BB51

>  <ATC_CODE_DESCRIPTION>  (1093) 
N05BB01 [Nervous System:Psycholeptics:Anxiolytics:Diphenylmethane derivatives]; N05BB51 [Nervous System:Psycholeptics:Anxiolytics:Diphenylmethane derivatives]

>  <INDICATION_CLASS>  (1093) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (1093) 
nan

>  <DRUG_TYPE>  (1093) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1093) 
Y

>  <FIRST_IN_CLASS>  (1093) 
N

>  <CHIRALITY>  (1093) 
Racemic Mixture

>  <PRODRUG>  (1093) 
N

>  <ORAL>  (1093) 
Y

>  <PARENTERAL>  (1093) 
Y

>  <TOPICAL>  (1093) 
N

>  <BLACK_BOX>  (1093) 
N

>  <AVAILABILITY_TYPE>  (1093) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1093) 
nan

>  <WITHDRAWN_COUNTRY>  (1093) 
nan

>  <WITHDRAWN_REASON>  (1093) 
nan

>  <CANONICAL_SMILES>  (1093) 
OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3

>  <name>  (1093) 
Hydroxyzine 

>  <MW>  (1093) 
374.912

>  <logP>  (1093) 
3.0559

$$$$
CHEMBL3707363
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  2 17  1  0
 17 18  1  0
 17 19  1  0
 10  5  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1094) 
2039334

>  <SYNONYMS>  (1094) 
Trimethyldiphenylpropylamine

>  <DEVELOPMENT_PHASE>  (1094) 
4

>  <RESEARCH_CODES>  (1094) 
nan

>  <APPLICANTS>  (1094) 
nan

>  <USAN_STEM>  (1094) 
nan

>  <USAN_STEM_DEFINITION>  (1094) 
nan

>  <USAN_STEM_SUBSTEM>  (1094) 
nan

>  <USAN_YEAR>  (1094) 
nan

>  <FIRST_APPROVAL>  (1094) 
nan

>  <ATC_CODE>  (1094) 
A03AX30

>  <ATC_CODE_DESCRIPTION>  (1094) 
A03AX30 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Other drugs for functional gastrointestinal disorders]

>  <INDICATION_CLASS>  (1094) 
nan

>  <SC_PATENT_NO>  (1094) 
nan

>  <DRUG_TYPE>  (1094) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1094) 
Y

>  <FIRST_IN_CLASS>  (1094) 
N

>  <CHIRALITY>  (1094) 
Racemic Mixture

>  <PRODRUG>  (1094) 
N

>  <ORAL>  (1094) 
N

>  <PARENTERAL>  (1094) 
N

>  <TOPICAL>  (1094) 
N

>  <BLACK_BOX>  (1094) 
N

>  <AVAILABILITY_TYPE>  (1094) 
Unknown

>  <WITHDRAWN_YEAR>  (1094) 
nan

>  <WITHDRAWN_COUNTRY>  (1094) 
nan

>  <WITHDRAWN_REASON>  (1094) 
nan

>  <CANONICAL_SMILES>  (1094) 
CC(CC(c1ccccc1)c2ccccc2)N(C)C

>  <name>  (1094) 
Trimethyldiphenylpropylamine

>  <MW>  (1094) 
253.389

>  <logP>  (1094) 
4.1587

$$$$
CHEMBL1200908
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
  6 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 28  6  1  0
 28 10  1  0
 23 11  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1095) 
674859

>  <SYNONYMS>  (1095) 
Halobetasol Propionate (FDA, USAN); Ulobetasol (INN)

>  <DEVELOPMENT_PHASE>  (1095) 
4

>  <RESEARCH_CODES>  (1095) 
BMY-30056; CGP-14458

>  <APPLICANTS>  (1095) 
Ranbaxy Laboratories Inc

>  <USAN_STEM>  (1095) 
nan

>  <USAN_STEM_DEFINITION>  (1095) 
nan

>  <USAN_STEM_SUBSTEM>  (1095) 
nan

>  <USAN_YEAR>  (1095) 
1990.0

>  <FIRST_APPROVAL>  (1095) 
1990.0

>  <ATC_CODE>  (1095) 
D07AC21

>  <ATC_CODE_DESCRIPTION>  (1095) 
D07AC21 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]

>  <INDICATION_CLASS>  (1095) 
Anti-Inflammatory (topical)

>  <SC_PATENT_NO>  (1095) 
US-8962028-B2

>  <DRUG_TYPE>  (1095) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1095) 
Y

>  <FIRST_IN_CLASS>  (1095) 
N

>  <CHIRALITY>  (1095) 
Single Stereoisomer

>  <PRODRUG>  (1095) 
Y

>  <ORAL>  (1095) 
N

>  <PARENTERAL>  (1095) 
N

>  <TOPICAL>  (1095) 
Y

>  <BLACK_BOX>  (1095) 
N

>  <AVAILABILITY_TYPE>  (1095) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1095) 
nan

>  <WITHDRAWN_COUNTRY>  (1095) 
nan

>  <WITHDRAWN_REASON>  (1095) 
nan

>  <CANONICAL_SMILES>  (1095) 
CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl

>  <name>  (1095) 
Halobetasol Propionate 

>  <MW>  (1095) 
484.967

>  <logP>  (1095) 
4.0511

$$$$
CHEMBL1388
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  5 14  1  0
 14 15  2  0
 15  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1096) 
328158

>  <SYNONYMS>  (1096) 
Monobenzone (FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1096) 
4

>  <RESEARCH_CODES>  (1096) 
nan

>  <APPLICANTS>  (1096) 
Valeant Pharmaceuticals International

>  <USAN_STEM>  (1096) 
nan

>  <USAN_STEM_DEFINITION>  (1096) 
nan

>  <USAN_STEM_SUBSTEM>  (1096) 
nan

>  <USAN_YEAR>  (1096) 
nan

>  <FIRST_APPROVAL>  (1096) 
1952.0

>  <ATC_CODE>  (1096) 
D11AX13

>  <ATC_CODE_DESCRIPTION>  (1096) 
D11AX13 [Dermatologicals:Other Dermatological Preparations:Other Dermatological Preparations:Other dermatologicals]

>  <INDICATION_CLASS>  (1096) 
Depigmentor

>  <SC_PATENT_NO>  (1096) 
nan

>  <DRUG_TYPE>  (1096) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1096) 
Y

>  <FIRST_IN_CLASS>  (1096) 
N

>  <CHIRALITY>  (1096) 
Achiral Molecule

>  <PRODRUG>  (1096) 
N

>  <ORAL>  (1096) 
N

>  <PARENTERAL>  (1096) 
N

>  <TOPICAL>  (1096) 
Y

>  <BLACK_BOX>  (1096) 
N

>  <AVAILABILITY_TYPE>  (1096) 
Discontinued

>  <WITHDRAWN_YEAR>  (1096) 
nan

>  <WITHDRAWN_COUNTRY>  (1096) 
nan

>  <WITHDRAWN_REASON>  (1096) 
nan

>  <CANONICAL_SMILES>  (1096) 
Oc1ccc(OCc2ccccc2)cc1

>  <name>  (1096) 
Monobenzone 

>  <MW>  (1096) 
200.237

>  <logP>  (1096) 
2.9712

$$$$
CHEMBL436
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
  7 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 12  3  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1097) 
2084

>  <SYNONYMS>  (1097) 
Tolrestat (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1097) 
4

>  <RESEARCH_CODES>  (1097) 
AY-27773

>  <APPLICANTS>  (1097) 
Wyeth-Ayerst Laboratories

>  <USAN_STEM>  (1097) 
-stat

>  <USAN_STEM_DEFINITION>  (1097) 
enzyme inhibitors: aldose-reductase inhibitors

>  <USAN_STEM_SUBSTEM>  (1097) 
-stat (-restat)

>  <USAN_YEAR>  (1097) 
1984.0

>  <FIRST_APPROVAL>  (1097) 
nan

>  <ATC_CODE>  (1097) 
A10XA01

>  <ATC_CODE_DESCRIPTION>  (1097) 
A10XA01 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Other Drugs Used In Diabetes:Aldose reductase inhibitors]

>  <INDICATION_CLASS>  (1097) 
Inhibitor (aldose reductase)

>  <SC_PATENT_NO>  (1097) 
nan

>  <DRUG_TYPE>  (1097) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1097) 
Y

>  <FIRST_IN_CLASS>  (1097) 
N

>  <CHIRALITY>  (1097) 
Achiral Molecule

>  <PRODRUG>  (1097) 
N

>  <ORAL>  (1097) 
N

>  <PARENTERAL>  (1097) 
N

>  <TOPICAL>  (1097) 
N

>  <BLACK_BOX>  (1097) 
N

>  <AVAILABILITY_TYPE>  (1097) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1097) 
1996.0

>  <WITHDRAWN_COUNTRY>  (1097) 
Canada; Italy; Argentina

>  <WITHDRAWN_REASON>  (1097) 
Hepatic necrosis

>  <CANONICAL_SMILES>  (1097) 
COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(=O)O

>  <name>  (1097) 
Tolrestat 

>  <MW>  (1097) 
357.353

>  <logP>  (1097) 
3.5591

$$$$
CHEMBL799
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  7 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27  2  1  0
 26  5  1  0
 17 13  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1098) 
50440

>  <SYNONYMS>  (1098) 
Cilostazol (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1098) 
4

>  <RESEARCH_CODES>  (1098) 
OPC-13013; OPC-21

>  <APPLICANTS>  (1098) 
Otsuka Pharmaceutical Co Ltd

>  <USAN_STEM>  (1098) 
nan

>  <USAN_STEM_DEFINITION>  (1098) 
nan

>  <USAN_STEM_SUBSTEM>  (1098) 
nan

>  <USAN_YEAR>  (1098) 
1997.0

>  <FIRST_APPROVAL>  (1098) 
1999.0

>  <ATC_CODE>  (1098) 
B01AC23

>  <ATC_CODE_DESCRIPTION>  (1098) 
B01AC23 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (1098) 
Antithrombotic; Inhibitor (platelet); Vasodilator

>  <SC_PATENT_NO>  (1098) 
nan

>  <DRUG_TYPE>  (1098) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1098) 
Y

>  <FIRST_IN_CLASS>  (1098) 
N

>  <CHIRALITY>  (1098) 
Achiral Molecule

>  <PRODRUG>  (1098) 
N

>  <ORAL>  (1098) 
Y

>  <PARENTERAL>  (1098) 
N

>  <TOPICAL>  (1098) 
N

>  <BLACK_BOX>  (1098) 
Y

>  <AVAILABILITY_TYPE>  (1098) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1098) 
nan

>  <WITHDRAWN_COUNTRY>  (1098) 
nan

>  <WITHDRAWN_REASON>  (1098) 
nan

>  <CANONICAL_SMILES>  (1098) 
O=C1CCc2cc(OCCCCc3nnnn3C4CCCCC4)ccc2N1

>  <name>  (1098) 
Cilostazol 

>  <MW>  (1098) 
369.469

>  <logP>  (1098) 
3.4647

$$$$
CHEMBL1201242
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  8  1  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1099) 
675193

>  <SYNONYMS>  (1099) 
Indecainide (INN); Indecainide HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1099) 
4

>  <RESEARCH_CODES>  (1099) 
LY-135837

>  <APPLICANTS>  (1099) 
Eli Lilly And Co

>  <USAN_STEM>  (1099) 
nan

>  <USAN_STEM_DEFINITION>  (1099) 
nan

>  <USAN_STEM_SUBSTEM>  (1099) 
nan

>  <USAN_YEAR>  (1099) 
1983.0

>  <FIRST_APPROVAL>  (1099) 
1989.0

>  <ATC_CODE>  (1099) 
nan

>  <ATC_CODE_DESCRIPTION>  (1099) 
nan

>  <INDICATION_CLASS>  (1099) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (1099) 
nan

>  <DRUG_TYPE>  (1099) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1099) 
Y

>  <FIRST_IN_CLASS>  (1099) 
N

>  <CHIRALITY>  (1099) 
Achiral Molecule

>  <PRODRUG>  (1099) 
N

>  <ORAL>  (1099) 
Y

>  <PARENTERAL>  (1099) 
N

>  <TOPICAL>  (1099) 
N

>  <BLACK_BOX>  (1099) 
N

>  <AVAILABILITY_TYPE>  (1099) 
Discontinued

>  <WITHDRAWN_YEAR>  (1099) 
nan

>  <WITHDRAWN_COUNTRY>  (1099) 
nan

>  <WITHDRAWN_REASON>  (1099) 
nan

>  <CANONICAL_SMILES>  (1099) 
CC(C)NCCCC1(C(=O)N)c2ccccc2c3ccccc13

>  <name>  (1099) 
Indecainide 

>  <MW>  (1099) 
308.425

>  <logP>  (1099) 
3.2166

$$$$
CHEMBL607710
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1100) 
604618

>  <SYNONYMS>  (1100) 
Chlorphenesin (BAN, INN); Chlorphenesin Carbamate (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1100) 
4

>  <RESEARCH_CODES>  (1100) 
U-19646

>  <APPLICANTS>  (1100) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (1100) 
nan

>  <USAN_STEM_DEFINITION>  (1100) 
nan

>  <USAN_STEM_SUBSTEM>  (1100) 
nan

>  <USAN_YEAR>  (1100) 
1963.0

>  <FIRST_APPROVAL>  (1100) 
1965.0

>  <ATC_CODE>  (1100) 
D01AE07

>  <ATC_CODE_DESCRIPTION>  (1100) 
D01AE07 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (1100) 
Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (1100) 
nan

>  <DRUG_TYPE>  (1100) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1100) 
Y

>  <FIRST_IN_CLASS>  (1100) 
N

>  <CHIRALITY>  (1100) 
Racemic Mixture

>  <PRODRUG>  (1100) 
N

>  <ORAL>  (1100) 
Y

>  <PARENTERAL>  (1100) 
N

>  <TOPICAL>  (1100) 
N

>  <BLACK_BOX>  (1100) 
N

>  <AVAILABILITY_TYPE>  (1100) 
Discontinued

>  <WITHDRAWN_YEAR>  (1100) 
nan

>  <WITHDRAWN_COUNTRY>  (1100) 
nan

>  <WITHDRAWN_REASON>  (1100) 
nan

>  <CANONICAL_SMILES>  (1100) 
NC(=O)OCC(O)COc1ccc(Cl)cc1

>  <name>  (1100) 
Chlorphenesin 

>  <MW>  (1100) 
245.662

>  <logP>  (1100) 
1.175

$$$$
CHEMBL567
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
  7 26  1  0
 26 27  1  0
 27  4  1  0
 25 11  1  0
 17 12  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (1101) 
16505

>  <SYNONYMS>  (1101) 
Perphenazine (BAN, FDA, INN, JAN, USP); Perphenazine Fendizoate (JAN); Perphenazine Maleate (JAN)

>  <DEVELOPMENT_PHASE>  (1101) 
4

>  <RESEARCH_CODES>  (1101) 
nan

>  <APPLICANTS>  (1101) 
Schering Corp Sub Schering Plough Corp; New River Pharmaceuticals Inc

>  <USAN_STEM>  (1101) 
nan

>  <USAN_STEM_DEFINITION>  (1101) 
nan

>  <USAN_STEM_SUBSTEM>  (1101) 
nan

>  <USAN_YEAR>  (1101) 
nan

>  <FIRST_APPROVAL>  (1101) 
1957.0

>  <ATC_CODE>  (1101) 
N05AB03

>  <ATC_CODE_DESCRIPTION>  (1101) 
N05AB03 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (1101) 
Antipsychotic

>  <SC_PATENT_NO>  (1101) 
nan

>  <DRUG_TYPE>  (1101) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1101) 
Y

>  <FIRST_IN_CLASS>  (1101) 
N

>  <CHIRALITY>  (1101) 
Achiral Molecule

>  <PRODRUG>  (1101) 
N

>  <ORAL>  (1101) 
Y

>  <PARENTERAL>  (1101) 
Y

>  <TOPICAL>  (1101) 
N

>  <BLACK_BOX>  (1101) 
Y

>  <AVAILABILITY_TYPE>  (1101) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1101) 
nan

>  <WITHDRAWN_COUNTRY>  (1101) 
nan

>  <WITHDRAWN_REASON>  (1101) 
nan

>  <CANONICAL_SMILES>  (1101) 
OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1

>  <name>  (1101) 
Perphenazine 

>  <MW>  (1101) 
403.979

>  <logP>  (1101) 
3.9427

$$$$
CHEMBL2111135
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  2 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 17  4  1  0
 10  5  1  0
 17 12  1  0
M  CHG  1  18   1
M  END
>  <PARENT_MOLREGNO>  (1102) 
1383575

>  <SYNONYMS>  (1102) 
Thiazinamium Chloride (USAN); Thiazinamium Metilsulfate (INN, MI)

>  <DEVELOPMENT_PHASE>  (1102) 
4

>  <RESEARCH_CODES>  (1102) 
WY-460E

>  <APPLICANTS>  (1102) 
nan

>  <USAN_STEM>  (1102) 
-ium

>  <USAN_STEM_DEFINITION>  (1102) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (1102) 
-ium

>  <USAN_YEAR>  (1102) 
1978.0

>  <FIRST_APPROVAL>  (1102) 
nan

>  <ATC_CODE>  (1102) 
R06AD06

>  <ATC_CODE_DESCRIPTION>  (1102) 
R06AD06 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]

>  <INDICATION_CLASS>  (1102) 
Anti-Allergic

>  <SC_PATENT_NO>  (1102) 
nan

>  <DRUG_TYPE>  (1102) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1102) 
Y

>  <FIRST_IN_CLASS>  (1102) 
N

>  <CHIRALITY>  (1102) 
Racemic Mixture

>  <PRODRUG>  (1102) 
N

>  <ORAL>  (1102) 
N

>  <PARENTERAL>  (1102) 
N

>  <TOPICAL>  (1102) 
N

>  <BLACK_BOX>  (1102) 
N

>  <AVAILABILITY_TYPE>  (1102) 
Unknown

>  <WITHDRAWN_YEAR>  (1102) 
nan

>  <WITHDRAWN_COUNTRY>  (1102) 
nan

>  <WITHDRAWN_REASON>  (1102) 
nan

>  <CANONICAL_SMILES>  (1102) 
CC(CN1c2ccccc2Sc3ccccc13)[N+](C)(C)C

>  <name>  (1102) 
Thiazinamium Chloride 

>  <MW>  (1102) 
299.463

>  <logP>  (1102) 
4.384

$$$$
CHEMBL981
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
  2 20  1  0
 20 21  2  0
 20 22  1  0
 10  5  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1103) 
100310

>  <SYNONYMS>  (1103) 
Fenofibric acid (FDA); Choline fenofibrate (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1103) 
4

>  <RESEARCH_CODES>  (1103) 
ABT-335

>  <APPLICANTS>  (1103) 
Ar Holding Co Inc; Abbvie Inc

>  <USAN_STEM>  (1103) 
nan

>  <USAN_STEM_DEFINITION>  (1103) 
nan

>  <USAN_STEM_SUBSTEM>  (1103) 
nan

>  <USAN_YEAR>  (1103) 
2006.0

>  <FIRST_APPROVAL>  (1103) 
2008.0

>  <ATC_CODE>  (1103) 
C10AB11

>  <ATC_CODE_DESCRIPTION>  (1103) 
C10AB11 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:Fibrates]

>  <INDICATION_CLASS>  (1103) 
nan

>  <SC_PATENT_NO>  (1103) 
US-7259186-B2

>  <DRUG_TYPE>  (1103) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1103) 
Y

>  <FIRST_IN_CLASS>  (1103) 
N

>  <CHIRALITY>  (1103) 
Achiral Molecule

>  <PRODRUG>  (1103) 
N

>  <ORAL>  (1103) 
Y

>  <PARENTERAL>  (1103) 
N

>  <TOPICAL>  (1103) 
N

>  <BLACK_BOX>  (1103) 
N

>  <AVAILABILITY_TYPE>  (1103) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1103) 
nan

>  <WITHDRAWN_COUNTRY>  (1103) 
nan

>  <WITHDRAWN_REASON>  (1103) 
nan

>  <CANONICAL_SMILES>  (1103) 
CC(C)(Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2)C(=O)O

>  <name>  (1103) 
Fenofibric acid 

>  <MW>  (1103) 
318.756

>  <logP>  (1103) 
3.813

$$$$
CHEMBL530
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  6 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 19  2  1  0
 18  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1104) 
12465

>  <SYNONYMS>  (1104) 
Amdinocillin (FDA, USAN, USP); Mecillinam (BAN, INN)

>  <DEVELOPMENT_PHASE>  (1104) 
4

>  <RESEARCH_CODES>  (1104) 
Ro-109070

>  <APPLICANTS>  (1104) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (1104) 
-cillin

>  <USAN_STEM_DEFINITION>  (1104) 
penicillins

>  <USAN_STEM_SUBSTEM>  (1104) 
-cillin

>  <USAN_YEAR>  (1104) 
1981.0

>  <FIRST_APPROVAL>  (1104) 
1984.0

>  <ATC_CODE>  (1104) 
J01CA11

>  <ATC_CODE_DESCRIPTION>  (1104) 
J01CA11 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (1104) 
Antibacterial

>  <SC_PATENT_NO>  (1104) 
nan

>  <DRUG_TYPE>  (1104) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1104) 
Y

>  <FIRST_IN_CLASS>  (1104) 
N

>  <CHIRALITY>  (1104) 
Single Stereoisomer

>  <PRODRUG>  (1104) 
N

>  <ORAL>  (1104) 
N

>  <PARENTERAL>  (1104) 
Y

>  <TOPICAL>  (1104) 
N

>  <BLACK_BOX>  (1104) 
N

>  <AVAILABILITY_TYPE>  (1104) 
Discontinued

>  <WITHDRAWN_YEAR>  (1104) 
nan

>  <WITHDRAWN_COUNTRY>  (1104) 
nan

>  <WITHDRAWN_REASON>  (1104) 
nan

>  <CANONICAL_SMILES>  (1104) 
CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(=O)O

>  <name>  (1104) 
Amdinocillin 

>  <MW>  (1104) 
325.434

>  <logP>  (1104) 
1.4062

$$$$
CHEMBL87992
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 13 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  5  1  0
 12  7  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1105) 
139940

>  <SYNONYMS>  (1105) 
Eslicarbazepine Acetate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1105) 
4

>  <RESEARCH_CODES>  (1105) 
BIA-2-093; SEP-0002093

>  <APPLICANTS>  (1105) 
Sunovion Pharmaceuticals Inc

>  <USAN_STEM>  (1105) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (1105) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (1105) 
-pin(e)

>  <USAN_YEAR>  (1105) 
2008.0

>  <FIRST_APPROVAL>  (1105) 
2009.0

>  <ATC_CODE>  (1105) 
N03AF04

>  <ATC_CODE_DESCRIPTION>  (1105) 
N03AF04 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives]

>  <INDICATION_CLASS>  (1105) 
nan

>  <SC_PATENT_NO>  (1105) 
US-5753646-A

>  <DRUG_TYPE>  (1105) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1105) 
Y

>  <FIRST_IN_CLASS>  (1105) 
N

>  <CHIRALITY>  (1105) 
Single Stereoisomer

>  <PRODRUG>  (1105) 
Y

>  <ORAL>  (1105) 
Y

>  <PARENTERAL>  (1105) 
N

>  <TOPICAL>  (1105) 
N

>  <BLACK_BOX>  (1105) 
N

>  <AVAILABILITY_TYPE>  (1105) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1105) 
nan

>  <WITHDRAWN_COUNTRY>  (1105) 
nan

>  <WITHDRAWN_REASON>  (1105) 
nan

>  <CANONICAL_SMILES>  (1105) 
CC(=O)O[C@H]1Cc2ccccc2N(C(=O)N)c3ccccc13

>  <name>  (1105) 
Eslicarbazepine Acetate 

>  <MW>  (1105) 
296.326

>  <logP>  (1105) 
3.0637

$$$$
CHEMBL592105
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  7 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 10 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 24 27  1  0
 27 28  1  0
 27 29  1  0
  9  4  1  0
 17 12  1  0
 26 21  1  0
M  END
>  <PARENT_MOLREGNO>  (1106) 
588923

>  <SYNONYMS>  (1106) 
Methylrosaniline

>  <DEVELOPMENT_PHASE>  (1106) 
4

>  <RESEARCH_CODES>  (1106) 
MMV665941; SJ000140980

>  <APPLICANTS>  (1106) 
nan

>  <USAN_STEM>  (1106) 
nan

>  <USAN_STEM_DEFINITION>  (1106) 
nan

>  <USAN_STEM_SUBSTEM>  (1106) 
nan

>  <USAN_YEAR>  (1106) 
nan

>  <FIRST_APPROVAL>  (1106) 
nan

>  <ATC_CODE>  (1106) 
G01AX09; D01AE02

>  <ATC_CODE_DESCRIPTION>  (1106) 
G01AX09 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Other antiinfectives and antiseptics]; D01AE02 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (1106) 
nan

>  <SC_PATENT_NO>  (1106) 
nan

>  <DRUG_TYPE>  (1106) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1106) 
Y

>  <FIRST_IN_CLASS>  (1106) 
N

>  <CHIRALITY>  (1106) 
Achiral Molecule

>  <PRODRUG>  (1106) 
N

>  <ORAL>  (1106) 
N

>  <PARENTERAL>  (1106) 
N

>  <TOPICAL>  (1106) 
N

>  <BLACK_BOX>  (1106) 
N

>  <AVAILABILITY_TYPE>  (1106) 
Unknown

>  <WITHDRAWN_YEAR>  (1106) 
nan

>  <WITHDRAWN_COUNTRY>  (1106) 
nan

>  <WITHDRAWN_REASON>  (1106) 
nan

>  <CANONICAL_SMILES>  (1106) 
CN(C)c1ccc(cc1)C(O)(c2ccc(cc2)N(C)C)c3ccc(cc3)N(C)C

>  <name>  (1106) 
Methylrosaniline

>  <MW>  (1106) 
389.543

>  <logP>  (1106) 
4.1688

$$$$
CHEMBL278819
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  4 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
  7  2  1  0
 16 11  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1107) 
33583

>  <SYNONYMS>  (1107) 
Minaprine (BAN, INN, USAN); Minaprine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (1107) 
4

>  <RESEARCH_CODES>  (1107) 
AGR-1240; CB-30038; 30038CB

>  <APPLICANTS>  (1107) 
Sanofi; Clin-Midy, France

>  <USAN_STEM>  (1107) 
nan

>  <USAN_STEM_DEFINITION>  (1107) 
nan

>  <USAN_STEM_SUBSTEM>  (1107) 
nan

>  <USAN_YEAR>  (1107) 
1986.0

>  <FIRST_APPROVAL>  (1107) 
nan

>  <ATC_CODE>  (1107) 
N06AX07

>  <ATC_CODE_DESCRIPTION>  (1107) 
N06AX07 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants]

>  <INDICATION_CLASS>  (1107) 
Antidepressant; Psychotropic

>  <SC_PATENT_NO>  (1107) 
nan

>  <DRUG_TYPE>  (1107) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1107) 
Y

>  <FIRST_IN_CLASS>  (1107) 
N

>  <CHIRALITY>  (1107) 
Achiral Molecule

>  <PRODRUG>  (1107) 
N

>  <ORAL>  (1107) 
N

>  <PARENTERAL>  (1107) 
N

>  <TOPICAL>  (1107) 
N

>  <BLACK_BOX>  (1107) 
N

>  <AVAILABILITY_TYPE>  (1107) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1107) 
1996.0

>  <WITHDRAWN_COUNTRY>  (1107) 
France; France

>  <WITHDRAWN_REASON>  (1107) 
Convulsions; Convulsions

>  <CANONICAL_SMILES>  (1107) 
Cc1cc(nnc1NCCN2CCOCC2)c3ccccc3

>  <name>  (1107) 
Minaprine 

>  <MW>  (1107) 
298.39

>  <logP>  (1107) 
2.19612

$$$$
CHEMBL1237122
     RDKit          

 26 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1108) 
699473

>  <SYNONYMS>  (1108) 
Carboprost (BAN, INN, USAN); Carboprost Trometanol (BAN); Carboprost Tromethamine (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1108) 
4

>  <RESEARCH_CODES>  (1108) 
U-32921; U-32921E

>  <APPLICANTS>  (1108) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (1108) 
-prost

>  <USAN_STEM_DEFINITION>  (1108) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (1108) 
-prost

>  <USAN_YEAR>  (1108) 
1976.0

>  <FIRST_APPROVAL>  (1108) 
1979.0

>  <ATC_CODE>  (1108) 
G02AD04

>  <ATC_CODE_DESCRIPTION>  (1108) 
G02AD04 [Genito Urinary System And Sex Hormones:Other Gynecologicals:Uterotonics:Prostaglandins]

>  <INDICATION_CLASS>  (1108) 
Oxytocic

>  <SC_PATENT_NO>  (1108) 
nan

>  <DRUG_TYPE>  (1108) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1108) 
Y

>  <FIRST_IN_CLASS>  (1108) 
N

>  <CHIRALITY>  (1108) 
Single Stereoisomer

>  <PRODRUG>  (1108) 
N

>  <ORAL>  (1108) 
N

>  <PARENTERAL>  (1108) 
Y

>  <TOPICAL>  (1108) 
N

>  <BLACK_BOX>  (1108) 
Y

>  <AVAILABILITY_TYPE>  (1108) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1108) 
nan

>  <WITHDRAWN_COUNTRY>  (1108) 
nan

>  <WITHDRAWN_REASON>  (1108) 
nan

>  <CANONICAL_SMILES>  (1108) 
CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)O

>  <name>  (1108) 
Carboprost 

>  <MW>  (1108) 
368.514

>  <logP>  (1108) 
3.433

$$$$
CHEMBL2028019
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 25 26  1  0
 10 27  1  0
 27 28  1  0
 28  7  1  0
 18 13  1  0
 25 19  1  0
M  END
>  <PARENT_MOLREGNO>  (1109) 
1340277

>  <SYNONYMS>  (1109) 
Cariprazine (INN, USAN, FDA); Cariprazine hydrochloride (FDA); Cariprazine HCl (USAN)

>  <DEVELOPMENT_PHASE>  (1109) 
4

>  <RESEARCH_CODES>  (1109) 
RGH-188; RGH-188 HCl

>  <APPLICANTS>  (1109) 
Forest Research Institute Inc; Forest Laboratories

>  <USAN_STEM>  (1109) 
nan

>  <USAN_STEM_DEFINITION>  (1109) 
nan

>  <USAN_STEM_SUBSTEM>  (1109) 
nan

>  <USAN_YEAR>  (1109) 
2011.0

>  <FIRST_APPROVAL>  (1109) 
2015.0

>  <ATC_CODE>  (1109) 
N05AX15

>  <ATC_CODE_DESCRIPTION>  (1109) 
N05AX15 [Nervous System:Psycholeptics:Antipsychotics:Other antipsychotics]

>  <INDICATION_CLASS>  (1109) 
nan

>  <SC_PATENT_NO>  (1109) 
US-7737142-B2

>  <DRUG_TYPE>  (1109) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1109) 
Y

>  <FIRST_IN_CLASS>  (1109) 
N

>  <CHIRALITY>  (1109) 
Single Stereoisomer

>  <PRODRUG>  (1109) 
N

>  <ORAL>  (1109) 
Y

>  <PARENTERAL>  (1109) 
N

>  <TOPICAL>  (1109) 
N

>  <BLACK_BOX>  (1109) 
Y

>  <AVAILABILITY_TYPE>  (1109) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1109) 
nan

>  <WITHDRAWN_COUNTRY>  (1109) 
nan

>  <WITHDRAWN_REASON>  (1109) 
nan

>  <CANONICAL_SMILES>  (1109) 
CN(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1

>  <name>  (1109) 
Cariprazine 

>  <MW>  (1109) 
427.42

>  <logP>  (1109) 
4.3355

$$$$
CHEMBL429
     RDKit          

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 10  5  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1110) 
1785

>  <SYNONYMS>  (1110) 
Labetalol (BAN, INN); Labetalol HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1110) 
4

>  <RESEARCH_CODES>  (1110) 
AH-5158A; SCH-15719W

>  <APPLICANTS>  (1110) 
Schering Corp Sub Schering Plough Corp; Prometheus Laboratories Inc; GlaxoSmithKline

>  <USAN_STEM>  (1110) 
-alol

>  <USAN_STEM_DEFINITION>  (1110) 
combined alpha and beta receptors

>  <USAN_STEM_SUBSTEM>  (1110) 
-alol

>  <USAN_YEAR>  (1110) 
1976.0

>  <FIRST_APPROVAL>  (1110) 
1984.0

>  <ATC_CODE>  (1110) 
C07AG01

>  <ATC_CODE_DESCRIPTION>  (1110) 
C07AG01 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Alpha and beta blocking agents]

>  <INDICATION_CLASS>  (1110) 
Anti-Adrenergic (alpha-receptor); Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (1110) 
nan

>  <DRUG_TYPE>  (1110) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1110) 
Y

>  <FIRST_IN_CLASS>  (1110) 
N

>  <CHIRALITY>  (1110) 
Racemic Mixture

>  <PRODRUG>  (1110) 
N

>  <ORAL>  (1110) 
Y

>  <PARENTERAL>  (1110) 
Y

>  <TOPICAL>  (1110) 
N

>  <BLACK_BOX>  (1110) 
N

>  <AVAILABILITY_TYPE>  (1110) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1110) 
nan

>  <WITHDRAWN_COUNTRY>  (1110) 
nan

>  <WITHDRAWN_REASON>  (1110) 
nan

>  <CANONICAL_SMILES>  (1110) 
CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N

>  <name>  (1110) 
Labetalol 

>  <MW>  (1110) 
328.412

>  <logP>  (1110) 
2.1354

$$$$
CHEMBL108545
     RDKit          

 11 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1111) 
178495

>  <SYNONYMS>  (1111) 
Methyl Salicylate (FDA, JAN, NF)

>  <DEVELOPMENT_PHASE>  (1111) 
4

>  <RESEARCH_CODES>  (1111) 
nan

>  <APPLICANTS>  (1111) 
Hisamitsu Pharmaceutical Co Inc

>  <USAN_STEM>  (1111) 
nan

>  <USAN_STEM_DEFINITION>  (1111) 
nan

>  <USAN_STEM_SUBSTEM>  (1111) 
nan

>  <USAN_YEAR>  (1111) 
nan

>  <FIRST_APPROVAL>  (1111) 
2008.0

>  <ATC_CODE>  (1111) 
nan

>  <ATC_CODE_DESCRIPTION>  (1111) 
nan

>  <INDICATION_CLASS>  (1111) 
Pharmaceutic Aid (flavor)

>  <SC_PATENT_NO>  (1111) 
US-8809615-B2

>  <DRUG_TYPE>  (1111) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1111) 
Y

>  <FIRST_IN_CLASS>  (1111) 
N

>  <CHIRALITY>  (1111) 
Achiral Molecule

>  <PRODRUG>  (1111) 
N

>  <ORAL>  (1111) 
N

>  <PARENTERAL>  (1111) 
N

>  <TOPICAL>  (1111) 
Y

>  <BLACK_BOX>  (1111) 
N

>  <AVAILABILITY_TYPE>  (1111) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1111) 
nan

>  <WITHDRAWN_COUNTRY>  (1111) 
nan

>  <WITHDRAWN_REASON>  (1111) 
nan

>  <CANONICAL_SMILES>  (1111) 
COC(=O)c1ccccc1O

>  <name>  (1111) 
Methyl Salicylate 

>  <MW>  (1111) 
152.149

>  <logP>  (1111) 
1.1788

$$$$
CHEMBL701
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1112) 
32869

>  <SYNONYMS>  (1112) 
Baclofen (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1112) 
4

>  <RESEARCH_CODES>  (1112) 
BA-34647

>  <APPLICANTS>  (1112) 
Ucb Inc; Novartis Pharmaceuticals Corp; Medtronic Inc; Cns Therapeutics Inc

>  <USAN_STEM>  (1112) 
nan

>  <USAN_STEM_DEFINITION>  (1112) 
nan

>  <USAN_STEM_SUBSTEM>  (1112) 
nan

>  <USAN_YEAR>  (1112) 
1971.0

>  <FIRST_APPROVAL>  (1112) 
1977.0

>  <ATC_CODE>  (1112) 
M03BX01

>  <ATC_CODE_DESCRIPTION>  (1112) 
M03BX01 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Other centrally acting agents]

>  <INDICATION_CLASS>  (1112) 
Relaxant (muscle)

>  <SC_PATENT_NO>  (1112) 
US-6024981-A

>  <DRUG_TYPE>  (1112) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1112) 
Y

>  <FIRST_IN_CLASS>  (1112) 
N

>  <CHIRALITY>  (1112) 
Racemic Mixture

>  <PRODRUG>  (1112) 
N

>  <ORAL>  (1112) 
Y

>  <PARENTERAL>  (1112) 
Y

>  <TOPICAL>  (1112) 
N

>  <BLACK_BOX>  (1112) 
Y

>  <AVAILABILITY_TYPE>  (1112) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1112) 
nan

>  <WITHDRAWN_COUNTRY>  (1112) 
nan

>  <WITHDRAWN_REASON>  (1112) 
nan

>  <CANONICAL_SMILES>  (1112) 
NCC(CC(=O)O)c1ccc(Cl)cc1

>  <name>  (1112) 
Baclofen 

>  <MW>  (1112) 
213.664

>  <logP>  (1112) 
1.857

$$$$
CHEMBL602
     RDKit          

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
M  END
>  <PARENT_MOLREGNO>  (1113) 
21036

>  <SYNONYMS>  (1113) 
Cysteamine (USAN); Mercaptamine (BAN, DCF, INN); Cysteamine HCl (FDA, USAN); Cysteamine Bitartrate (FDA)

>  <DEVELOPMENT_PHASE>  (1113) 
4

>  <RESEARCH_CODES>  (1113) 
L-1573; CI-9148

>  <APPLICANTS>  (1113) 
Sigma Tau Pharmaceuticals Inc; Mylan Pharmaceuticals Inc

>  <USAN_STEM>  (1113) 
nan

>  <USAN_STEM_DEFINITION>  (1113) 
nan

>  <USAN_STEM_SUBSTEM>  (1113) 
nan

>  <USAN_YEAR>  (1113) 
1990.0

>  <FIRST_APPROVAL>  (1113) 
1994.0

>  <ATC_CODE>  (1113) 
A16AA04; S01XA21

>  <ATC_CODE_DESCRIPTION>  (1113) 
A16AA04 [Alimentary Tract And Metabolism:Other Alimentary Tract And Metabolism Products:Other Alimentary Tract And Metabolism Products:Amino acids and derivatives]; S01XA21 [Sensory Organs:Ophthalmologicals:Other Ophthalmologicals:Other ophthalmologicals]

>  <INDICATION_CLASS>  (1113) 
Anti-Urolithic (cystine calculi)

>  <SC_PATENT_NO>  (1113) 
US-8026284-B2

>  <DRUG_TYPE>  (1113) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1113) 
Y

>  <FIRST_IN_CLASS>  (1113) 
N

>  <CHIRALITY>  (1113) 
Achiral Molecule

>  <PRODRUG>  (1113) 
N

>  <ORAL>  (1113) 
Y

>  <PARENTERAL>  (1113) 
N

>  <TOPICAL>  (1113) 
Y

>  <BLACK_BOX>  (1113) 
N

>  <AVAILABILITY_TYPE>  (1113) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1113) 
nan

>  <WITHDRAWN_COUNTRY>  (1113) 
nan

>  <WITHDRAWN_REASON>  (1113) 
nan

>  <CANONICAL_SMILES>  (1113) 
NCCS

>  <name>  (1113) 
Cysteamine 

>  <MW>  (1113) 
77.152

>  <logP>  (1113) 
-0.1251

$$$$
CHEMBL1729
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  5 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 19  3  1  0
 16 10  1  0
 30 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1114) 
557741

>  <SYNONYMS>  (1114) 
Cisapride (BAN, INN, JAN, USAN); Cisapride Monohydrate (FDA)

>  <DEVELOPMENT_PHASE>  (1114) 
4

>  <RESEARCH_CODES>  (1114) 
R-51619

>  <APPLICANTS>  (1114) 
Janssen Pharmaceuticals Inc; Janssen Pharmaceutica Products Lp

>  <USAN_STEM>  (1114) 
-pride

>  <USAN_STEM_DEFINITION>  (1114) 
sulpiride derivatives

>  <USAN_STEM_SUBSTEM>  (1114) 
-pride

>  <USAN_YEAR>  (1114) 
1983.0

>  <FIRST_APPROVAL>  (1114) 
1993.0

>  <ATC_CODE>  (1114) 
A03FA02

>  <ATC_CODE_DESCRIPTION>  (1114) 
A03FA02 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Propulsives:Propulsives]

>  <INDICATION_CLASS>  (1114) 
Stimulant (peristaltic)

>  <SC_PATENT_NO>  (1114) 
nan

>  <DRUG_TYPE>  (1114) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1114) 
Y

>  <FIRST_IN_CLASS>  (1114) 
N

>  <CHIRALITY>  (1114) 
Racemic Mixture

>  <PRODRUG>  (1114) 
N

>  <ORAL>  (1114) 
Y

>  <PARENTERAL>  (1114) 
N

>  <TOPICAL>  (1114) 
N

>  <BLACK_BOX>  (1114) 
N

>  <AVAILABILITY_TYPE>  (1114) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1114) 
2000.0

>  <WITHDRAWN_COUNTRY>  (1114) 
United States

>  <WITHDRAWN_REASON>  (1114) 
Fatal arrhythmia

>  <CANONICAL_SMILES>  (1114) 
COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c3cc(Cl)c(N)cc3OC

>  <name>  (1114) 
Cisapride 

>  <MW>  (1114) 
465.953

>  <logP>  (1114) 
3.3581

$$$$
CHEMBL773
     RDKit          

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1115) 
44010

>  <SYNONYMS>  (1115) 
Aminoacetic Acid (JAN); Glycine (FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1115) 
4

>  <RESEARCH_CODES>  (1115) 
nan

>  <APPLICANTS>  (1115) 
Hospira Inc; Baxter Healthcare Corp; B Braun Medical Inc

>  <USAN_STEM>  (1115) 
nan

>  <USAN_STEM_DEFINITION>  (1115) 
nan

>  <USAN_STEM_SUBSTEM>  (1115) 
nan

>  <USAN_YEAR>  (1115) 
nan

>  <FIRST_APPROVAL>  (1115) 
nan

>  <ATC_CODE>  (1115) 
B05CX03; A02AB07

>  <ATC_CODE_DESCRIPTION>  (1115) 
B05CX03 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:Irrigating Solutions:Other irrigating solutions]; A02AB07 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Antacids:Aluminium compounds]

>  <INDICATION_CLASS>  (1115) 
nan

>  <SC_PATENT_NO>  (1115) 
nan

>  <DRUG_TYPE>  (1115) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1115) 
Y

>  <FIRST_IN_CLASS>  (1115) 
N

>  <CHIRALITY>  (1115) 
Achiral Molecule

>  <PRODRUG>  (1115) 
N

>  <ORAL>  (1115) 
N

>  <PARENTERAL>  (1115) 
N

>  <TOPICAL>  (1115) 
N

>  <BLACK_BOX>  (1115) 
N

>  <AVAILABILITY_TYPE>  (1115) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1115) 
nan

>  <WITHDRAWN_COUNTRY>  (1115) 
nan

>  <WITHDRAWN_REASON>  (1115) 
nan

>  <CANONICAL_SMILES>  (1115) 
NCC(=O)O

>  <name>  (1115) 
Aminoacetic Acid 

>  <MW>  (1115) 
75.067

>  <logP>  (1115) 
-0.9703

$$$$
CHEMBL70418
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21  2  1  0
 14  9  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1116) 
111390

>  <SYNONYMS>  (1116) 
Clobazam (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1116) 
4

>  <RESEARCH_CODES>  (1116) 
H-4723; HR-376; LM-2717

>  <APPLICANTS>  (1116) 
Lundbeck Llc

>  <USAN_STEM>  (1116) 
nan

>  <USAN_STEM_DEFINITION>  (1116) 
nan

>  <USAN_STEM_SUBSTEM>  (1116) 
nan

>  <USAN_YEAR>  (1116) 
1975.0

>  <FIRST_APPROVAL>  (1116) 
2005.0

>  <ATC_CODE>  (1116) 
N05BA09

>  <ATC_CODE_DESCRIPTION>  (1116) 
N05BA09 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (1116) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (1116) 
nan

>  <DRUG_TYPE>  (1116) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1116) 
Y

>  <FIRST_IN_CLASS>  (1116) 
N

>  <CHIRALITY>  (1116) 
Achiral Molecule

>  <PRODRUG>  (1116) 
N

>  <ORAL>  (1116) 
Y

>  <PARENTERAL>  (1116) 
N

>  <TOPICAL>  (1116) 
N

>  <BLACK_BOX>  (1116) 
N

>  <AVAILABILITY_TYPE>  (1116) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1116) 
nan

>  <WITHDRAWN_COUNTRY>  (1116) 
nan

>  <WITHDRAWN_REASON>  (1116) 
nan

>  <CANONICAL_SMILES>  (1116) 
CN1C(=O)CC(=O)N(c2ccccc2)c3cc(Cl)ccc13

>  <name>  (1116) 
Clobazam 

>  <MW>  (1116) 
300.745

>  <logP>  (1116) 
3.3712

$$$$
CHEMBL107
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  2  0
 11 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
  9  3  1  0
 25  6  1  0
 25 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1117) 
14440

>  <SYNONYMS>  (1117) 
Colchicine (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1117) 
4

>  <RESEARCH_CODES>  (1117) 
nan

>  <APPLICANTS>  (1117) 
Takeda Pharmaceuticals Usa Inc; Merck And Co Inc

>  <USAN_STEM>  (1117) 
nan

>  <USAN_STEM_DEFINITION>  (1117) 
nan

>  <USAN_STEM_SUBSTEM>  (1117) 
nan

>  <USAN_YEAR>  (1117) 
nan

>  <FIRST_APPROVAL>  (1117) 
1961.0

>  <ATC_CODE>  (1117) 
M04AC01

>  <ATC_CODE_DESCRIPTION>  (1117) 
M04AC01 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations with no effect on uric acid metabolism]

>  <INDICATION_CLASS>  (1117) 
Suppressant (gout)

>  <SC_PATENT_NO>  (1117) 
US-7601758-B1

>  <DRUG_TYPE>  (1117) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1117) 
Y

>  <FIRST_IN_CLASS>  (1117) 
N

>  <CHIRALITY>  (1117) 
Single Stereoisomer

>  <PRODRUG>  (1117) 
N

>  <ORAL>  (1117) 
Y

>  <PARENTERAL>  (1117) 
N

>  <TOPICAL>  (1117) 
N

>  <BLACK_BOX>  (1117) 
N

>  <AVAILABILITY_TYPE>  (1117) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1117) 
nan

>  <WITHDRAWN_COUNTRY>  (1117) 
nan

>  <WITHDRAWN_REASON>  (1117) 
nan

>  <CANONICAL_SMILES>  (1117) 
COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C

>  <name>  (1117) 
Colchicine 

>  <MW>  (1117) 
399.443

>  <logP>  (1117) 
2.8716

$$$$
CHEMBL473417
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
  8 25  1  0
 25 26  1  0
 25 27  2  0
 27  5  1  0
 18 12  1  0
 24 19  1  0
M  END
>  <PARENT_MOLREGNO>  (1118) 
460092

>  <SYNONYMS>  (1118) 
Vismodegib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1118) 
4

>  <RESEARCH_CODES>  (1118) 
nan

>  <APPLICANTS>  (1118) 
Genentech Inc

>  <USAN_STEM>  (1118) 
nan

>  <USAN_STEM_DEFINITION>  (1118) 
nan

>  <USAN_STEM_SUBSTEM>  (1118) 
nan

>  <USAN_YEAR>  (1118) 
2009.0

>  <FIRST_APPROVAL>  (1118) 
2012.0

>  <ATC_CODE>  (1118) 
L01XX43

>  <ATC_CODE_DESCRIPTION>  (1118) 
L01XX43 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Other antineoplastic agents]

>  <INDICATION_CLASS>  (1118) 
nan

>  <SC_PATENT_NO>  (1118) 
US-7888364-B2

>  <DRUG_TYPE>  (1118) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1118) 
Y

>  <FIRST_IN_CLASS>  (1118) 
Y

>  <CHIRALITY>  (1118) 
Achiral Molecule

>  <PRODRUG>  (1118) 
N

>  <ORAL>  (1118) 
Y

>  <PARENTERAL>  (1118) 
N

>  <TOPICAL>  (1118) 
N

>  <BLACK_BOX>  (1118) 
Y

>  <AVAILABILITY_TYPE>  (1118) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1118) 
nan

>  <WITHDRAWN_COUNTRY>  (1118) 
nan

>  <WITHDRAWN_REASON>  (1118) 
nan

>  <CANONICAL_SMILES>  (1118) 
CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(c2)c3ccccn3)c(Cl)c1

>  <name>  (1118) 
Vismodegib 

>  <MW>  (1118) 
421.305

>  <logP>  (1118) 
4.7112

$$$$
CHEMBL1496
     RDKit          

 33 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
  8 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
  6 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 30 32  2  0
 30 33  1  0
 16  4  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1119) 
418845

>  <SYNONYMS>  (1119) 
Rosuvastatin (BAN, INN); Rosuvastatin Calcium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1119) 
4

>  <RESEARCH_CODES>  (1119) 
S-4522; ZD-4522; ZD-4522 (Calcium salt)

>  <APPLICANTS>  (1119) 
Ipr Pharmaceuticals Inc

>  <USAN_STEM>  (1119) 
-stat-

>  <USAN_STEM_DEFINITION>  (1119) 
enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

>  <USAN_STEM_SUBSTEM>  (1119) 
-stat- (-vastatin)

>  <USAN_YEAR>  (1119) 
2000.0

>  <FIRST_APPROVAL>  (1119) 
2003.0

>  <ATC_CODE>  (1119) 
C10AA07

>  <ATC_CODE_DESCRIPTION>  (1119) 
C10AA07 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:HMG CoA reductase inhibitors]

>  <INDICATION_CLASS>  (1119) 
nan

>  <SC_PATENT_NO>  (1119) 
US-RE37314-E1

>  <DRUG_TYPE>  (1119) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1119) 
Y

>  <FIRST_IN_CLASS>  (1119) 
N

>  <CHIRALITY>  (1119) 
Single Stereoisomer

>  <PRODRUG>  (1119) 
N

>  <ORAL>  (1119) 
Y

>  <PARENTERAL>  (1119) 
N

>  <TOPICAL>  (1119) 
N

>  <BLACK_BOX>  (1119) 
N

>  <AVAILABILITY_TYPE>  (1119) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1119) 
nan

>  <WITHDRAWN_COUNTRY>  (1119) 
nan

>  <WITHDRAWN_REASON>  (1119) 
nan

>  <CANONICAL_SMILES>  (1119) 
CC(C)c1nc(nc(c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(=O)(=O)C

>  <name>  (1119) 
Rosuvastatin 

>  <MW>  (1119) 
481.546

>  <logP>  (1119) 
2.4017

$$$$
CHEMBL1908919
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 12 23  1  0
 23 24  2  0
  6 25  1  0
 25 26  2  0
 26  3  1  0
 24  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1120) 
1248838

>  <SYNONYMS>  (1120) 
Florbetapir F 18 (USAN, FDA)

>  <DEVELOPMENT_PHASE>  (1120) 
4

>  <RESEARCH_CODES>  (1120) 
18F-AV-45

>  <APPLICANTS>  (1120) 
Avid Radiopharmaceuticals Inc

>  <USAN_STEM>  (1120) 
nan

>  <USAN_STEM_DEFINITION>  (1120) 
nan

>  <USAN_STEM_SUBSTEM>  (1120) 
nan

>  <USAN_YEAR>  (1120) 
2009.0

>  <FIRST_APPROVAL>  (1120) 
2012.0

>  <ATC_CODE>  (1120) 
V09AX05

>  <ATC_CODE_DESCRIPTION>  (1120) 
V09AX05 [Various:Diagnostic Radiopharmaceuticals:Central Nervous System:Other central nervous system diagnostic radiopharmaceuticals]

>  <INDICATION_CLASS>  (1120) 
nan

>  <SC_PATENT_NO>  (1120) 
US-7687052-B2

>  <DRUG_TYPE>  (1120) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1120) 
Y

>  <FIRST_IN_CLASS>  (1120) 
N

>  <CHIRALITY>  (1120) 
Achiral Molecule

>  <PRODRUG>  (1120) 
N

>  <ORAL>  (1120) 
N

>  <PARENTERAL>  (1120) 
Y

>  <TOPICAL>  (1120) 
N

>  <BLACK_BOX>  (1120) 
N

>  <AVAILABILITY_TYPE>  (1120) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1120) 
nan

>  <WITHDRAWN_COUNTRY>  (1120) 
nan

>  <WITHDRAWN_REASON>  (1120) 
nan

>  <CANONICAL_SMILES>  (1120) 
CNc1ccc(\C=C\c2ccc(OCCOCCOCCF)nc2)cc1

>  <name>  (1120) 
Florbetapir F 18 

>  <MW>  (1120) 
360.429

>  <logP>  (1120) 
3.6752

$$$$
CHEMBL753
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  2 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 10  5  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1121) 
41434

>  <SYNONYMS>  (1121) 
Phenoxybenzamine (BAN, INN); Phenoxybenzamine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1121) 
4

>  <RESEARCH_CODES>  (1121) 
nan

>  <APPLICANTS>  (1121) 
Wellspring Pharmaceutical Corp

>  <USAN_STEM>  (1121) 
nan

>  <USAN_STEM_DEFINITION>  (1121) 
nan

>  <USAN_STEM_SUBSTEM>  (1121) 
nan

>  <USAN_YEAR>  (1121) 
nan

>  <FIRST_APPROVAL>  (1121) 
1953.0

>  <ATC_CODE>  (1121) 
C04AX02

>  <ATC_CODE_DESCRIPTION>  (1121) 
C04AX02 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Other peripheral vasodilators]

>  <INDICATION_CLASS>  (1121) 
Antihypertensive

>  <SC_PATENT_NO>  (1121) 
nan

>  <DRUG_TYPE>  (1121) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1121) 
Y

>  <FIRST_IN_CLASS>  (1121) 
N

>  <CHIRALITY>  (1121) 
Racemic Mixture

>  <PRODRUG>  (1121) 
N

>  <ORAL>  (1121) 
Y

>  <PARENTERAL>  (1121) 
N

>  <TOPICAL>  (1121) 
N

>  <BLACK_BOX>  (1121) 
N

>  <AVAILABILITY_TYPE>  (1121) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1121) 
nan

>  <WITHDRAWN_COUNTRY>  (1121) 
nan

>  <WITHDRAWN_REASON>  (1121) 
nan

>  <CANONICAL_SMILES>  (1121) 
CC(COc1ccccc1)N(CCCl)Cc2ccccc2

>  <name>  (1121) 
Phenoxybenzamine 

>  <MW>  (1121) 
303.833

>  <logP>  (1121) 
4.1949

$$$$
CHEMBL1201208
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7  2  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1122) 
675159

>  <SYNONYMS>  (1122) 
Phenmetrazine (BAN, INN); Phenmetrazine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1122) 
4

>  <RESEARCH_CODES>  (1122) 
nan

>  <APPLICANTS>  (1122) 
Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (1122) 
nan

>  <USAN_STEM_DEFINITION>  (1122) 
nan

>  <USAN_STEM_SUBSTEM>  (1122) 
nan

>  <USAN_YEAR>  (1122) 
nan

>  <FIRST_APPROVAL>  (1122) 
1982.0

>  <ATC_CODE>  (1122) 
nan

>  <ATC_CODE_DESCRIPTION>  (1122) 
nan

>  <INDICATION_CLASS>  (1122) 
Anorexic

>  <SC_PATENT_NO>  (1122) 
nan

>  <DRUG_TYPE>  (1122) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1122) 
Y

>  <FIRST_IN_CLASS>  (1122) 
N

>  <CHIRALITY>  (1122) 
Racemic Mixture

>  <PRODRUG>  (1122) 
N

>  <ORAL>  (1122) 
Y

>  <PARENTERAL>  (1122) 
N

>  <TOPICAL>  (1122) 
N

>  <BLACK_BOX>  (1122) 
N

>  <AVAILABILITY_TYPE>  (1122) 
Discontinued

>  <WITHDRAWN_YEAR>  (1122) 
nan

>  <WITHDRAWN_COUNTRY>  (1122) 
nan

>  <WITHDRAWN_REASON>  (1122) 
nan

>  <CANONICAL_SMILES>  (1122) 
CC1NCCOC1c2ccccc2

>  <name>  (1122) 
Phenmetrazine 

>  <MW>  (1122) 
177.247

>  <logP>  (1122) 
1.736

$$$$
CHEMBL1515
     RDKit          

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1123) 
421089

>  <SYNONYMS>  (1123) 
Methimazole (FDA, USP); Thiamazole (BAN, DCF, INN, JAN)

>  <DEVELOPMENT_PHASE>  (1123) 
4

>  <RESEARCH_CODES>  (1123) 
nan

>  <APPLICANTS>  (1123) 
King Pharmaceuticals Inc

>  <USAN_STEM>  (1123) 
nan

>  <USAN_STEM_DEFINITION>  (1123) 
nan

>  <USAN_STEM_SUBSTEM>  (1123) 
nan

>  <USAN_YEAR>  (1123) 
nan

>  <FIRST_APPROVAL>  (1123) 
1950.0

>  <ATC_CODE>  (1123) 
H03BB52; H03BB02

>  <ATC_CODE_DESCRIPTION>  (1123) 
H03BB52 [Systemic Hormonal Preparations, Excl. :Thyroid Therapy:Antithyroid Preparations:Sulfur-containing imidazole derivatives]; H03BB02 [Systemic Hormonal Preparations, Excl. :Thyroid Therapy:Antithyroid Preparations:Sulfur-containing imidazole derivatives]

>  <INDICATION_CLASS>  (1123) 
Thyroid Inhibitor

>  <SC_PATENT_NO>  (1123) 
nan

>  <DRUG_TYPE>  (1123) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1123) 
Y

>  <FIRST_IN_CLASS>  (1123) 
N

>  <CHIRALITY>  (1123) 
Achiral Molecule

>  <PRODRUG>  (1123) 
N

>  <ORAL>  (1123) 
Y

>  <PARENTERAL>  (1123) 
N

>  <TOPICAL>  (1123) 
N

>  <BLACK_BOX>  (1123) 
N

>  <AVAILABILITY_TYPE>  (1123) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1123) 
nan

>  <WITHDRAWN_COUNTRY>  (1123) 
nan

>  <WITHDRAWN_REASON>  (1123) 
nan

>  <CANONICAL_SMILES>  (1123) 
CN1C=CNC1=S

>  <name>  (1123) 
Methimazole 

>  <MW>  (1123) 
114.173

>  <logP>  (1123) 
1.08269

$$$$
CHEMBL471
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 11 17  1  0
 17 18  2  0
 18  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1124) 
5528

>  <SYNONYMS>  (1124) 
Sotalol (BAN, INN); Sotalol HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1124) 
4

>  <RESEARCH_CODES>  (1124) 
MJ-1999

>  <APPLICANTS>  (1124) 
Bayer Healthcare Pharmaceuticals Inc; Academic Pharmaceuticals Inc

>  <USAN_STEM>  (1124) 
-alol

>  <USAN_STEM_DEFINITION>  (1124) 
combined alpha and beta receptors

>  <USAN_STEM_SUBSTEM>  (1124) 
-alol

>  <USAN_YEAR>  (1124) 
1967.0

>  <FIRST_APPROVAL>  (1124) 
1992.0

>  <ATC_CODE>  (1124) 
C07AA07; C07AA57

>  <ATC_CODE_DESCRIPTION>  (1124) 
C07AA07 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]; C07AA57 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]

>  <INDICATION_CLASS>  (1124) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (1124) 
nan

>  <DRUG_TYPE>  (1124) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1124) 
Y

>  <FIRST_IN_CLASS>  (1124) 
N

>  <CHIRALITY>  (1124) 
Racemic Mixture

>  <PRODRUG>  (1124) 
N

>  <ORAL>  (1124) 
Y

>  <PARENTERAL>  (1124) 
Y

>  <TOPICAL>  (1124) 
N

>  <BLACK_BOX>  (1124) 
Y

>  <AVAILABILITY_TYPE>  (1124) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1124) 
nan

>  <WITHDRAWN_COUNTRY>  (1124) 
nan

>  <WITHDRAWN_REASON>  (1124) 
nan

>  <CANONICAL_SMILES>  (1124) 
CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1

>  <name>  (1124) 
Sotalol 

>  <MW>  (1124) 
272.37

>  <logP>  (1124) 
1.0895

$$$$
CHEMBL386630
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  6 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 17  2  1  0
 20  2  1  0
 15  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1125) 
364520

>  <SYNONYMS>  (1125) 
Testosterone (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1125) 
4

>  <RESEARCH_CODES>  (1125) 
nan

>  <APPLICANTS>  (1125) 
Auxilium Pharmaceuticals Inc; Alza Corp; Actient Pharmaceuticals Llc; Abbvie Inc; Eli Lilly And Co

>  <USAN_STEM>  (1125) 
-ster-

>  <USAN_STEM_DEFINITION>  (1125) 
steroids (androgens, anabolics)

>  <USAN_STEM_SUBSTEM>  (1125) 
-ster-

>  <USAN_YEAR>  (1125) 
nan

>  <FIRST_APPROVAL>  (1125) 
1972.0

>  <ATC_CODE>  (1125) 
G03BA03

>  <ATC_CODE_DESCRIPTION>  (1125) 
G03BA03 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Androgens:3-oxoandrosten (4) derivatives]

>  <INDICATION_CLASS>  (1125) 
Androgen

>  <SC_PATENT_NO>  (1125) 
US-5840327-A

>  <DRUG_TYPE>  (1125) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1125) 
Y

>  <FIRST_IN_CLASS>  (1125) 
N

>  <CHIRALITY>  (1125) 
Single Stereoisomer

>  <PRODRUG>  (1125) 
N

>  <ORAL>  (1125) 
N

>  <PARENTERAL>  (1125) 
Y

>  <TOPICAL>  (1125) 
Y

>  <BLACK_BOX>  (1125) 
Y

>  <AVAILABILITY_TYPE>  (1125) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1125) 
nan

>  <WITHDRAWN_COUNTRY>  (1125) 
nan

>  <WITHDRAWN_REASON>  (1125) 
nan

>  <CANONICAL_SMILES>  (1125) 
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O

>  <name>  (1125) 
Testosterone 

>  <MW>  (1125) 
288.431

>  <logP>  (1125) 
3.8792

$$$$
CHEMBL44884
     RDKit          

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1126) 
67617

>  <SYNONYMS>  (1126) 
Ethambutol (BAN, INN); Ethambutol HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1126) 
4

>  <RESEARCH_CODES>  (1126) 
CL-40881

>  <APPLICANTS>  (1126) 
Sti Pharma Llc

>  <USAN_STEM>  (1126) 
nan

>  <USAN_STEM_DEFINITION>  (1126) 
nan

>  <USAN_STEM_SUBSTEM>  (1126) 
nan

>  <USAN_YEAR>  (1126) 
1963.0

>  <FIRST_APPROVAL>  (1126) 
1967.0

>  <ATC_CODE>  (1126) 
J04AK02

>  <ATC_CODE_DESCRIPTION>  (1126) 
J04AK02 [Antiinfectives For Systemic Use:Antimycobacterials:Drugs For Treatment Of Tuberculosis:Other drugs for treatment of tuberculosis]

>  <INDICATION_CLASS>  (1126) 
Antibacterial (tuberculostatic)

>  <SC_PATENT_NO>  (1126) 
nan

>  <DRUG_TYPE>  (1126) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1126) 
Y

>  <FIRST_IN_CLASS>  (1126) 
N

>  <CHIRALITY>  (1126) 
Single Stereoisomer

>  <PRODRUG>  (1126) 
N

>  <ORAL>  (1126) 
Y

>  <PARENTERAL>  (1126) 
N

>  <TOPICAL>  (1126) 
N

>  <BLACK_BOX>  (1126) 
N

>  <AVAILABILITY_TYPE>  (1126) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1126) 
nan

>  <WITHDRAWN_COUNTRY>  (1126) 
nan

>  <WITHDRAWN_REASON>  (1126) 
nan

>  <CANONICAL_SMILES>  (1126) 
CC[C@@H](CO)NCCN[C@@H](CC)CO

>  <name>  (1126) 
Ethambutol 

>  <MW>  (1126) 
204.314

>  <logP>  (1126) 
-0.2926

$$$$
CHEMBL1583
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 14 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 19 31  1  0
 31 32  2  0
 16 12  1  0
 31 13  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (1127) 
453719

>  <SYNONYMS>  (1127) 
Bacampicillin (BAN, INN); Bacampicillin HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1127) 
4

>  <RESEARCH_CODES>  (1127) 
nan

>  <APPLICANTS>  (1127) 
Pfizer Laboratories Div Pfizer Inc

>  <USAN_STEM>  (1127) 
-cillin

>  <USAN_STEM_DEFINITION>  (1127) 
penicillins

>  <USAN_STEM_SUBSTEM>  (1127) 
-cillin

>  <USAN_YEAR>  (1127) 
1977.0

>  <FIRST_APPROVAL>  (1127) 
1980.0

>  <ATC_CODE>  (1127) 
J01CA06

>  <ATC_CODE_DESCRIPTION>  (1127) 
J01CA06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]

>  <INDICATION_CLASS>  (1127) 
Antibacterial

>  <SC_PATENT_NO>  (1127) 
nan

>  <DRUG_TYPE>  (1127) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1127) 
Y

>  <FIRST_IN_CLASS>  (1127) 
N

>  <CHIRALITY>  (1127) 
Racemic Mixture

>  <PRODRUG>  (1127) 
Y

>  <ORAL>  (1127) 
Y

>  <PARENTERAL>  (1127) 
N

>  <TOPICAL>  (1127) 
N

>  <BLACK_BOX>  (1127) 
N

>  <AVAILABILITY_TYPE>  (1127) 
Discontinued

>  <WITHDRAWN_YEAR>  (1127) 
nan

>  <WITHDRAWN_COUNTRY>  (1127) 
nan

>  <WITHDRAWN_REASON>  (1127) 
nan

>  <CANONICAL_SMILES>  (1127) 
CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O

>  <name>  (1127) 
Bacampicillin 

>  <MW>  (1127) 
465.528

>  <logP>  (1127) 
1.2958

$$$$
CHEMBL1289
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  3  0
 10 11  1  0
  6 12  1  0
 12 13  2  0
 13 14  1  0
 13  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1128) 
253862

>  <SYNONYMS>  (1128) 
Haloprogin (FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1128) 
4

>  <RESEARCH_CODES>  (1128) 
M-1028

>  <APPLICANTS>  (1128) 
Westwood Squibb Pharmaceuticals Inc

>  <USAN_STEM>  (1128) 
nan

>  <USAN_STEM_DEFINITION>  (1128) 
nan

>  <USAN_STEM_SUBSTEM>  (1128) 
nan

>  <USAN_YEAR>  (1128) 
1967.0

>  <FIRST_APPROVAL>  (1128) 
1982.0

>  <ATC_CODE>  (1128) 
D01AE11

>  <ATC_CODE_DESCRIPTION>  (1128) 
D01AE11 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (1128) 
Antibacterial

>  <SC_PATENT_NO>  (1128) 
nan

>  <DRUG_TYPE>  (1128) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1128) 
Y

>  <FIRST_IN_CLASS>  (1128) 
N

>  <CHIRALITY>  (1128) 
Achiral Molecule

>  <PRODRUG>  (1128) 
N

>  <ORAL>  (1128) 
N

>  <PARENTERAL>  (1128) 
N

>  <TOPICAL>  (1128) 
Y

>  <BLACK_BOX>  (1128) 
N

>  <AVAILABILITY_TYPE>  (1128) 
Discontinued

>  <WITHDRAWN_YEAR>  (1128) 
nan

>  <WITHDRAWN_COUNTRY>  (1128) 
nan

>  <WITHDRAWN_REASON>  (1128) 
nan

>  <CANONICAL_SMILES>  (1128) 
Clc1cc(Cl)c(OCC#CI)cc1Cl

>  <name>  (1128) 
Haloprogin 

>  <MW>  (1128) 
361.393

>  <logP>  (1128) 
4.4215

$$$$
CHEMBL1200356
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  6 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 20  2  1  0
 19  5  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1129) 
674307

>  <SYNONYMS>  (1129) 
Ciclacillin (BAN, INN, JAN); Cyclacillin (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1129) 
4

>  <RESEARCH_CODES>  (1129) 
WY-4508

>  <APPLICANTS>  (1129) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (1129) 
-cillin

>  <USAN_STEM_DEFINITION>  (1129) 
penicillins

>  <USAN_STEM_SUBSTEM>  (1129) 
-cillin

>  <USAN_YEAR>  (1129) 
1969.0

>  <FIRST_APPROVAL>  (1129) 
1979.0

>  <ATC_CODE>  (1129) 
nan

>  <ATC_CODE_DESCRIPTION>  (1129) 
nan

>  <INDICATION_CLASS>  (1129) 
Antibacterial

>  <SC_PATENT_NO>  (1129) 
nan

>  <DRUG_TYPE>  (1129) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1129) 
Y

>  <FIRST_IN_CLASS>  (1129) 
N

>  <CHIRALITY>  (1129) 
Single Stereoisomer

>  <PRODRUG>  (1129) 
N

>  <ORAL>  (1129) 
Y

>  <PARENTERAL>  (1129) 
N

>  <TOPICAL>  (1129) 
N

>  <BLACK_BOX>  (1129) 
N

>  <AVAILABILITY_TYPE>  (1129) 
Discontinued

>  <WITHDRAWN_YEAR>  (1129) 
nan

>  <WITHDRAWN_COUNTRY>  (1129) 
nan

>  <WITHDRAWN_REASON>  (1129) 
nan

>  <CANONICAL_SMILES>  (1129) 
CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O

>  <name>  (1129) 
Ciclacillin 

>  <MW>  (1129) 
341.433

>  <logP>  (1129) 
0.2797

$$$$
CHEMBL254316
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
  6 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
  5 32  1  0
  8  2  1  0
 20 15  2  0
 31 25  1  0
M  END
>  <PARENT_MOLREGNO>  (1130) 
422253

>  <SYNONYMS>  (1130) 
Raltegravir (INN, USAN); Raltegravir Potassium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1130) 
4

>  <RESEARCH_CODES>  (1130) 
MK-0518

>  <APPLICANTS>  (1130) 
Merck Sharp And Dohme Corp; Merck & Co

>  <USAN_STEM>  (1130) 
-vir

>  <USAN_STEM_DEFINITION>  (1130) 
antivirals: integrase inhibitors

>  <USAN_STEM_SUBSTEM>  (1130) 
-vir (-tegravir)

>  <USAN_YEAR>  (1130) 
2007.0

>  <FIRST_APPROVAL>  (1130) 
2007.0

>  <ATC_CODE>  (1130) 
J05AX08

>  <ATC_CODE_DESCRIPTION>  (1130) 
J05AX08 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals]

>  <INDICATION_CLASS>  (1130) 
nan

>  <SC_PATENT_NO>  (1130) 
US-7169780-B2

>  <DRUG_TYPE>  (1130) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1130) 
Y

>  <FIRST_IN_CLASS>  (1130) 
Y

>  <CHIRALITY>  (1130) 
Achiral Molecule

>  <PRODRUG>  (1130) 
N

>  <ORAL>  (1130) 
Y

>  <PARENTERAL>  (1130) 
N

>  <TOPICAL>  (1130) 
N

>  <BLACK_BOX>  (1130) 
N

>  <AVAILABILITY_TYPE>  (1130) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1130) 
nan

>  <WITHDRAWN_COUNTRY>  (1130) 
nan

>  <WITHDRAWN_REASON>  (1130) 
nan

>  <CANONICAL_SMILES>  (1130) 
CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)c2oc(C)nn2)C(=O)NCc3ccc(F)cc3)O

>  <name>  (1130) 
Raltegravir 

>  <MW>  (1130) 
444.423

>  <logP>  (1130) 
0.91152

$$$$
CHEMBL1788388
     RDKit          

 16 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1131) 
1152052

>  <SYNONYMS>  (1131) 
Dibutylsuccinate

>  <DEVELOPMENT_PHASE>  (1131) 
4

>  <RESEARCH_CODES>  (1131) 
nan

>  <APPLICANTS>  (1131) 
nan

>  <USAN_STEM>  (1131) 
nan

>  <USAN_STEM_DEFINITION>  (1131) 
nan

>  <USAN_STEM_SUBSTEM>  (1131) 
nan

>  <USAN_YEAR>  (1131) 
nan

>  <FIRST_APPROVAL>  (1131) 
nan

>  <ATC_CODE>  (1131) 
P03BX04

>  <ATC_CODE_DESCRIPTION>  (1131) 
P03BX04 [Antiparasitic Products, Insecticides And Repellents:Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents:Insecticides And Repellents:Other insecticides and repellents]

>  <INDICATION_CLASS>  (1131) 
nan

>  <SC_PATENT_NO>  (1131) 
nan

>  <DRUG_TYPE>  (1131) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1131) 
Y

>  <FIRST_IN_CLASS>  (1131) 
N

>  <CHIRALITY>  (1131) 
Achiral Molecule

>  <PRODRUG>  (1131) 
N

>  <ORAL>  (1131) 
N

>  <PARENTERAL>  (1131) 
N

>  <TOPICAL>  (1131) 
N

>  <BLACK_BOX>  (1131) 
N

>  <AVAILABILITY_TYPE>  (1131) 
Unknown

>  <WITHDRAWN_YEAR>  (1131) 
nan

>  <WITHDRAWN_COUNTRY>  (1131) 
nan

>  <WITHDRAWN_REASON>  (1131) 
nan

>  <CANONICAL_SMILES>  (1131) 
CCCCOC(=O)CCC(=O)OCCCC

>  <name>  (1131) 
Dibutylsuccinate

>  <MW>  (1131) 
230.304

>  <logP>  (1131) 
2.4532

$$$$
CHEMBL453
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  5 17  2  0
 17 18  1  0
 17  2  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1132) 
2484

>  <SYNONYMS>  (1132) 
Sulfafurazole (BAN, INN); Sulfisoxazole (FDA, JAN, USP); Sulfisoxazole Diolamine (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1132) 
4

>  <RESEARCH_CODES>  (1132) 
NU-445

>  <APPLICANTS>  (1132) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (1132) 
nan

>  <USAN_STEM_DEFINITION>  (1132) 
nan

>  <USAN_STEM_SUBSTEM>  (1132) 
nan

>  <USAN_YEAR>  (1132) 
1966.0

>  <FIRST_APPROVAL>  (1132) 
1971.0

>  <ATC_CODE>  (1132) 
S01AB02; J01EB05

>  <ATC_CODE_DESCRIPTION>  (1132) 
S01AB02 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; J01EB05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]

>  <INDICATION_CLASS>  (1132) 
Antibacterial

>  <SC_PATENT_NO>  (1132) 
nan

>  <DRUG_TYPE>  (1132) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1132) 
Y

>  <FIRST_IN_CLASS>  (1132) 
N

>  <CHIRALITY>  (1132) 
Achiral Molecule

>  <PRODRUG>  (1132) 
N

>  <ORAL>  (1132) 
Y

>  <PARENTERAL>  (1132) 
Y

>  <TOPICAL>  (1132) 
Y

>  <BLACK_BOX>  (1132) 
N

>  <AVAILABILITY_TYPE>  (1132) 
Discontinued

>  <WITHDRAWN_YEAR>  (1132) 
nan

>  <WITHDRAWN_COUNTRY>  (1132) 
nan

>  <WITHDRAWN_REASON>  (1132) 
nan

>  <CANONICAL_SMILES>  (1132) 
Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C

>  <name>  (1132) 
Sulfafurazole 

>  <MW>  (1132) 
267.31

>  <logP>  (1132) 
1.67444

$$$$
CHEMBL1421
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
  4 22  2  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 28 32  1  0
 32 33  1  0
 24  2  1  0
 10  6  1  0
 20 14  1  0
 33 25  1  0
M  END
>  <PARENT_MOLREGNO>  (1133) 
361469

>  <SYNONYMS>  (1133) 
Dasatinib (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1133) 
4

>  <RESEARCH_CODES>  (1133) 
BMS-354825; BMS-354825-03

>  <APPLICANTS>  (1133) 
Bristol Myers Squibb Co

>  <USAN_STEM>  (1133) 
-tinib

>  <USAN_STEM_DEFINITION>  (1133) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (1133) 
-tinib

>  <USAN_YEAR>  (1133) 
2005.0

>  <FIRST_APPROVAL>  (1133) 
2006.0

>  <ATC_CODE>  (1133) 
L01XE06

>  <ATC_CODE_DESCRIPTION>  (1133) 
L01XE06 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (1133) 
nan

>  <SC_PATENT_NO>  (1133) 
US-6596746-B1

>  <DRUG_TYPE>  (1133) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1133) 
Y

>  <FIRST_IN_CLASS>  (1133) 
Y

>  <CHIRALITY>  (1133) 
Achiral Molecule

>  <PRODRUG>  (1133) 
N

>  <ORAL>  (1133) 
Y

>  <PARENTERAL>  (1133) 
N

>  <TOPICAL>  (1133) 
N

>  <BLACK_BOX>  (1133) 
N

>  <AVAILABILITY_TYPE>  (1133) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1133) 
nan

>  <WITHDRAWN_COUNTRY>  (1133) 
nan

>  <WITHDRAWN_REASON>  (1133) 
nan

>  <CANONICAL_SMILES>  (1133) 
Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4

>  <name>  (1133) 
Dasatinib 

>  <MW>  (1133) 
488.017

>  <logP>  (1133) 
3.31354

$$$$
CHEMBL1200861
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1134) 
674812

>  <SYNONYMS>  (1134) 
Tartaric Acid (FDA, JAN, NF)

>  <DEVELOPMENT_PHASE>  (1134) 
4

>  <RESEARCH_CODES>  (1134) 
nan

>  <APPLICANTS>  (1134) 
Mallinckrodt Inc

>  <USAN_STEM>  (1134) 
nan

>  <USAN_STEM_DEFINITION>  (1134) 
nan

>  <USAN_STEM_SUBSTEM>  (1134) 
nan

>  <USAN_YEAR>  (1134) 
nan

>  <FIRST_APPROVAL>  (1134) 
1985.0

>  <ATC_CODE>  (1134) 
nan

>  <ATC_CODE_DESCRIPTION>  (1134) 
nan

>  <INDICATION_CLASS>  (1134) 
Pharmaceutic Aid (buffering agent)

>  <SC_PATENT_NO>  (1134) 
nan

>  <DRUG_TYPE>  (1134) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1134) 
Y

>  <FIRST_IN_CLASS>  (1134) 
N

>  <CHIRALITY>  (1134) 
Single Stereoisomer

>  <PRODRUG>  (1134) 
N

>  <ORAL>  (1134) 
Y

>  <PARENTERAL>  (1134) 
N

>  <TOPICAL>  (1134) 
N

>  <BLACK_BOX>  (1134) 
N

>  <AVAILABILITY_TYPE>  (1134) 
Discontinued

>  <WITHDRAWN_YEAR>  (1134) 
nan

>  <WITHDRAWN_COUNTRY>  (1134) 
nan

>  <WITHDRAWN_REASON>  (1134) 
nan

>  <CANONICAL_SMILES>  (1134) 
O[C@@H]([C@H](O)C(=O)O)C(=O)O

>  <name>  (1134) 
Tartaric Acid 

>  <MW>  (1134) 
150.086

>  <logP>  (1134) 
-2.1226

$$$$
CHEMBL893
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 16 20  1  0
 20 21  2  0
 20 22  1  0
  5 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
  6  2  2  0
 18 10  1  0
 17 11  1  0
 29 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1135) 
77085

>  <SYNONYMS>  (1135) 
Dicloxacillin (BAN, INN, USAN); Dicloxacillin Sodium (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1135) 
4

>  <RESEARCH_CODES>  (1135) 
BRL-1702; R-13423; P-1011

>  <APPLICANTS>  (1135) 
Wyeth Ayerst Laboratories; Apothecon Inc Div Bristol Myers Squibb

>  <USAN_STEM>  (1135) 
-cillin

>  <USAN_STEM_DEFINITION>  (1135) 
penicillins

>  <USAN_STEM_SUBSTEM>  (1135) 
-cillin

>  <USAN_YEAR>  (1135) 
1965.0

>  <FIRST_APPROVAL>  (1135) 
1968.0

>  <ATC_CODE>  (1135) 
J01CF01

>  <ATC_CODE_DESCRIPTION>  (1135) 
J01CF01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]

>  <INDICATION_CLASS>  (1135) 
Antibacterial

>  <SC_PATENT_NO>  (1135) 
nan

>  <DRUG_TYPE>  (1135) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1135) 
Y

>  <FIRST_IN_CLASS>  (1135) 
N

>  <CHIRALITY>  (1135) 
Single Stereoisomer

>  <PRODRUG>  (1135) 
N

>  <ORAL>  (1135) 
Y

>  <PARENTERAL>  (1135) 
N

>  <TOPICAL>  (1135) 
N

>  <BLACK_BOX>  (1135) 
N

>  <AVAILABILITY_TYPE>  (1135) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1135) 
nan

>  <WITHDRAWN_COUNTRY>  (1135) 
nan

>  <WITHDRAWN_REASON>  (1135) 
nan

>  <CANONICAL_SMILES>  (1135) 
Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(Cl)cccc4Cl

>  <name>  (1135) 
Dicloxacillin 

>  <MW>  (1135) 
470.334

>  <logP>  (1135) 
3.20212

$$$$
CHEMBL488
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
  9  3  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1136) 
6317

>  <SYNONYMS>  (1136) 
Aminoglutethimide (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1136) 
4

>  <RESEARCH_CODES>  (1136) 
nan

>  <APPLICANTS>  (1136) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (1136) 
nan

>  <USAN_STEM_DEFINITION>  (1136) 
nan

>  <USAN_STEM_SUBSTEM>  (1136) 
nan

>  <USAN_YEAR>  (1136) 
nan

>  <FIRST_APPROVAL>  (1136) 
1980.0

>  <ATC_CODE>  (1136) 
L02BG01

>  <ATC_CODE_DESCRIPTION>  (1136) 
L02BG01 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Aromatase inhibitors]

>  <INDICATION_CLASS>  (1136) 
Adrenocortical Suppressant; Antineoplastic

>  <SC_PATENT_NO>  (1136) 
nan

>  <DRUG_TYPE>  (1136) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1136) 
Y

>  <FIRST_IN_CLASS>  (1136) 
N

>  <CHIRALITY>  (1136) 
Racemic Mixture

>  <PRODRUG>  (1136) 
N

>  <ORAL>  (1136) 
Y

>  <PARENTERAL>  (1136) 
N

>  <TOPICAL>  (1136) 
N

>  <BLACK_BOX>  (1136) 
N

>  <AVAILABILITY_TYPE>  (1136) 
Discontinued

>  <WITHDRAWN_YEAR>  (1136) 
nan

>  <WITHDRAWN_COUNTRY>  (1136) 
nan

>  <WITHDRAWN_REASON>  (1136) 
nan

>  <CANONICAL_SMILES>  (1136) 
CCC1(CCC(=O)NC1=O)c2ccc(N)cc2

>  <name>  (1136) 
Aminoglutethimide 

>  <MW>  (1136) 
232.283

>  <logP>  (1136) 
1.3532

$$$$
CHEMBL3301800
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 10 23  1  0
 23 24  2  0
  5 25  1  0
 25 26  2  0
 25 27  1  0
  9  4  1  0
 23  6  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1137) 
1763771

>  <SYNONYMS>  (1137) 
Cefprozil (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1137) 
4

>  <RESEARCH_CODES>  (1137) 
BMY-28100-03-800

>  <APPLICANTS>  (1137) 
Corden Pharma Latina Spa

>  <USAN_STEM>  (1137) 
cef-

>  <USAN_STEM_DEFINITION>  (1137) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (1137) 
cef-

>  <USAN_YEAR>  (1137) 
1990.0

>  <FIRST_APPROVAL>  (1137) 
1991.0

>  <ATC_CODE>  (1137) 
J01DC10

>  <ATC_CODE_DESCRIPTION>  (1137) 
J01DC10 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Second-generation cephalosporins]

>  <INDICATION_CLASS>  (1137) 
Antibacterial

>  <SC_PATENT_NO>  (1137) 
nan

>  <DRUG_TYPE>  (1137) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1137) 
Y

>  <FIRST_IN_CLASS>  (1137) 
N

>  <CHIRALITY>  (1137) 
Single Stereoisomer

>  <PRODRUG>  (1137) 
N

>  <ORAL>  (1137) 
Y

>  <PARENTERAL>  (1137) 
N

>  <TOPICAL>  (1137) 
N

>  <BLACK_BOX>  (1137) 
N

>  <AVAILABILITY_TYPE>  (1137) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1137) 
nan

>  <WITHDRAWN_COUNTRY>  (1137) 
nan

>  <WITHDRAWN_REASON>  (1137) 
nan

>  <CANONICAL_SMILES>  (1137) 
CC=CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O

>  <name>  (1137) 
Cefprozil 

>  <MW>  (1137) 
389.433

>  <logP>  (1137) 
0.7067

$$$$
CHEMBL3707301
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 13 22  1  0
 22 23  2  0
  9 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  2  0
  8  3  1  0
 22  9  1  0
 21 16  1  0
 31 24  1  0
M  END
>  <PARENT_MOLREGNO>  (1138) 
2039272

>  <SYNONYMS>  (1138) 
Idanpramine

>  <DEVELOPMENT_PHASE>  (1138) 
4

>  <RESEARCH_CODES>  (1138) 
nan

>  <APPLICANTS>  (1138) 
nan

>  <USAN_STEM>  (1138) 
-pramine

>  <USAN_STEM_DEFINITION>  (1138) 
antidepressants (imipramine type)

>  <USAN_STEM_SUBSTEM>  (1138) 
-pramine

>  <USAN_YEAR>  (1138) 
nan

>  <FIRST_APPROVAL>  (1138) 
nan

>  <ATC_CODE>  (1138) 
A03AX06

>  <ATC_CODE_DESCRIPTION>  (1138) 
A03AX06 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Other drugs for functional gastrointestinal disorders]

>  <INDICATION_CLASS>  (1138) 
nan

>  <SC_PATENT_NO>  (1138) 
nan

>  <DRUG_TYPE>  (1138) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1138) 
Y

>  <FIRST_IN_CLASS>  (1138) 
N

>  <CHIRALITY>  (1138) 
Achiral Molecule

>  <PRODRUG>  (1138) 
N

>  <ORAL>  (1138) 
N

>  <PARENTERAL>  (1138) 
N

>  <TOPICAL>  (1138) 
N

>  <BLACK_BOX>  (1138) 
N

>  <AVAILABILITY_TYPE>  (1138) 
Unknown

>  <WITHDRAWN_YEAR>  (1138) 
nan

>  <WITHDRAWN_COUNTRY>  (1138) 
nan

>  <WITHDRAWN_REASON>  (1138) 
nan

>  <CANONICAL_SMILES>  (1138) 
COc1ccc(cc1)C2(NC(=O)N(CCN3CCCCC3)C2=O)c4ccc(OC)cc4

>  <name>  (1138) 
Idanpramine

>  <MW>  (1138) 
423.513

>  <logP>  (1138) 
2.9851

$$$$
CHEMBL1525826
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  2  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
  8  3  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1139) 
949710

>  <SYNONYMS>  (1139) 
Sulfalene (INN, USAN); Sulfamethopyrazine (JAN); Sulfametopyrazine (BAN, DCF)

>  <DEVELOPMENT_PHASE>  (1139) 
4

>  <RESEARCH_CODES>  (1139) 
nan

>  <APPLICANTS>  (1139) 
Farmitalia, Societa Farmaceutici Italia, Italy; Abbott

>  <USAN_STEM>  (1139) 
sulfa-

>  <USAN_STEM_DEFINITION>  (1139) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (1139) 
sulfa-

>  <USAN_YEAR>  (1139) 
1965.0

>  <FIRST_APPROVAL>  (1139) 
nan

>  <ATC_CODE>  (1139) 
J01ED02

>  <ATC_CODE_DESCRIPTION>  (1139) 
J01ED02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]

>  <INDICATION_CLASS>  (1139) 
Antibacterial

>  <SC_PATENT_NO>  (1139) 
nan

>  <DRUG_TYPE>  (1139) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1139) 
Y

>  <FIRST_IN_CLASS>  (1139) 
N

>  <CHIRALITY>  (1139) 
Achiral Molecule

>  <PRODRUG>  (1139) 
N

>  <ORAL>  (1139) 
Y

>  <PARENTERAL>  (1139) 
N

>  <TOPICAL>  (1139) 
N

>  <BLACK_BOX>  (1139) 
N

>  <AVAILABILITY_TYPE>  (1139) 
Discontinued

>  <WITHDRAWN_YEAR>  (1139) 
nan

>  <WITHDRAWN_COUNTRY>  (1139) 
nan

>  <WITHDRAWN_REASON>  (1139) 
nan

>  <CANONICAL_SMILES>  (1139) 
COc1nccnc1NS(=O)(=O)c2ccc(N)cc2

>  <name>  (1139) 
Sulfalene 

>  <MW>  (1139) 
280.309

>  <logP>  (1139) 
0.8682

$$$$
CHEMBL141
     RDKit          

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
  8  2  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1140) 
33986

>  <SYNONYMS>  (1140) 
Lamivudine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1140) 
4

>  <RESEARCH_CODES>  (1140) 
GR-109714X

>  <APPLICANTS>  (1140) 
Viiv Healthcare Co; GlaxoSmithKline

>  <USAN_STEM>  (1140) 
-vudine

>  <USAN_STEM_DEFINITION>  (1140) 
antineoplastics,antivirals (zidovudine group) (exception: edoxudine)

>  <USAN_STEM_SUBSTEM>  (1140) 
-vudine

>  <USAN_YEAR>  (1140) 
1992.0

>  <FIRST_APPROVAL>  (1140) 
1995.0

>  <ATC_CODE>  (1140) 
J05AF05

>  <ATC_CODE_DESCRIPTION>  (1140) 
J05AF05 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (1140) 
Antiviral

>  <SC_PATENT_NO>  (1140) 
US-5905082-A

>  <DRUG_TYPE>  (1140) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1140) 
Y

>  <FIRST_IN_CLASS>  (1140) 
N

>  <CHIRALITY>  (1140) 
Single Stereoisomer

>  <PRODRUG>  (1140) 
N

>  <ORAL>  (1140) 
Y

>  <PARENTERAL>  (1140) 
N

>  <TOPICAL>  (1140) 
N

>  <BLACK_BOX>  (1140) 
Y

>  <AVAILABILITY_TYPE>  (1140) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1140) 
nan

>  <WITHDRAWN_COUNTRY>  (1140) 
nan

>  <WITHDRAWN_REASON>  (1140) 
nan

>  <CANONICAL_SMILES>  (1140) 
NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2

>  <name>  (1140) 
Lamivudine 

>  <MW>  (1140) 
229.261

>  <logP>  (1140) 
-0.5941

$$$$
CHEMBL3545985
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  2 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  9  4  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1141) 
1927831

>  <SYNONYMS>  (1141) 
Benzfetamine (INN); Benzphetamine HCl (FDA, MI, NF)

>  <DEVELOPMENT_PHASE>  (1141) 
4

>  <RESEARCH_CODES>  (1141) 
nan

>  <APPLICANTS>  (1141) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (1141) 
nan

>  <USAN_STEM_DEFINITION>  (1141) 
nan

>  <USAN_STEM_SUBSTEM>  (1141) 
nan

>  <USAN_YEAR>  (1141) 
nan

>  <FIRST_APPROVAL>  (1141) 
1960.0

>  <ATC_CODE>  (1141) 
nan

>  <ATC_CODE_DESCRIPTION>  (1141) 
nan

>  <INDICATION_CLASS>  (1141) 
nan

>  <SC_PATENT_NO>  (1141) 
nan

>  <DRUG_TYPE>  (1141) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1141) 
Y

>  <FIRST_IN_CLASS>  (1141) 
N

>  <CHIRALITY>  (1141) 
Single Stereoisomer

>  <PRODRUG>  (1141) 
N

>  <ORAL>  (1141) 
Y

>  <PARENTERAL>  (1141) 
N

>  <TOPICAL>  (1141) 
N

>  <BLACK_BOX>  (1141) 
N

>  <AVAILABILITY_TYPE>  (1141) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1141) 
nan

>  <WITHDRAWN_COUNTRY>  (1141) 
nan

>  <WITHDRAWN_REASON>  (1141) 
nan

>  <CANONICAL_SMILES>  (1141) 
C[C@@H](Cc1ccccc1)N(C)Cc2ccccc2

>  <name>  (1141) 
Benzfetamine 

>  <MW>  (1141) 
239.362

>  <logP>  (1141) 
3.7496

$$$$
CHEMBL673
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  3  0
  2  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1142) 
28477

>  <SYNONYMS>  (1142) 
Pargyline (BAN, INN); Pargyline HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1142) 
4

>  <RESEARCH_CODES>  (1142) 
A-19120; MO-911

>  <APPLICANTS>  (1142) 
Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (1142) 
nan

>  <USAN_STEM_DEFINITION>  (1142) 
nan

>  <USAN_STEM_SUBSTEM>  (1142) 
nan

>  <USAN_YEAR>  (1142) 
1962.0

>  <FIRST_APPROVAL>  (1142) 
1982.0

>  <ATC_CODE>  (1142) 
C02KC01

>  <ATC_CODE_DESCRIPTION>  (1142) 
C02KC01 [Cardiovascular System:Antihypertensives:Other Antihypertensives:MAO inhibitors]

>  <INDICATION_CLASS>  (1142) 
Antihypertensive

>  <SC_PATENT_NO>  (1142) 
nan

>  <DRUG_TYPE>  (1142) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1142) 
Y

>  <FIRST_IN_CLASS>  (1142) 
N

>  <CHIRALITY>  (1142) 
Achiral Molecule

>  <PRODRUG>  (1142) 
N

>  <ORAL>  (1142) 
Y

>  <PARENTERAL>  (1142) 
N

>  <TOPICAL>  (1142) 
N

>  <BLACK_BOX>  (1142) 
N

>  <AVAILABILITY_TYPE>  (1142) 
Discontinued

>  <WITHDRAWN_YEAR>  (1142) 
nan

>  <WITHDRAWN_COUNTRY>  (1142) 
nan

>  <WITHDRAWN_REASON>  (1142) 
nan

>  <CANONICAL_SMILES>  (1142) 
CN(CC#C)Cc1ccccc1

>  <name>  (1142) 
Pargyline 

>  <MW>  (1142) 
159.232

>  <logP>  (1142) 
1.7516

$$$$
CHEMBL528
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
  4 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 15  8  1  0
 14  9  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1143) 
12105

>  <SYNONYMS>  (1143) 
Ceftizoxime (BAN, INN); Ceftizoxime Sodium (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1143) 
4

>  <RESEARCH_CODES>  (1143) 
FK-749; FR-13749; SK&F-88373Z; SK&F-88373-Z

>  <APPLICANTS>  (1143) 
Astellas Pharma Us Inc

>  <USAN_STEM>  (1143) 
cef-

>  <USAN_STEM_DEFINITION>  (1143) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (1143) 
cef-

>  <USAN_YEAR>  (1143) 
1980.0

>  <FIRST_APPROVAL>  (1143) 
1983.0

>  <ATC_CODE>  (1143) 
J01DD07

>  <ATC_CODE_DESCRIPTION>  (1143) 
J01DD07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Third-generation cephalosporins]

>  <INDICATION_CLASS>  (1143) 
Antibacterial

>  <SC_PATENT_NO>  (1143) 
nan

>  <DRUG_TYPE>  (1143) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1143) 
Y

>  <FIRST_IN_CLASS>  (1143) 
N

>  <CHIRALITY>  (1143) 
Single Stereoisomer

>  <PRODRUG>  (1143) 
N

>  <ORAL>  (1143) 
N

>  <PARENTERAL>  (1143) 
Y

>  <TOPICAL>  (1143) 
N

>  <BLACK_BOX>  (1143) 
N

>  <AVAILABILITY_TYPE>  (1143) 
Discontinued

>  <WITHDRAWN_YEAR>  (1143) 
nan

>  <WITHDRAWN_COUNTRY>  (1143) 
nan

>  <WITHDRAWN_REASON>  (1143) 
nan

>  <CANONICAL_SMILES>  (1143) 
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(=O)O)\c3csc(N)n3

>  <name>  (1143) 
Ceftizoxime 

>  <MW>  (1143) 
383.411

>  <logP>  (1143) 
-0.5558

$$$$
CHEMBL1237
     RDKit          

 29 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  8 17  1  0
 17 18  2  0
 17 19  1  0
  6 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 16 11  1  0
 26 22  1  0
M  END
>  <PARENT_MOLREGNO>  (1144) 
230659

>  <SYNONYMS>  (1144) 
Lisinopril (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1144) 
4

>  <RESEARCH_CODES>  (1144) 
MK-521

>  <APPLICANTS>  (1144) 
Merck Research Laboratories Div Merck Co Inc; Astrazeneca Uk Ltd

>  <USAN_STEM>  (1144) 
-pril

>  <USAN_STEM_DEFINITION>  (1144) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (1144) 
-pril

>  <USAN_YEAR>  (1144) 
1984.0

>  <FIRST_APPROVAL>  (1144) 
1987.0

>  <ATC_CODE>  (1144) 
C09AA03

>  <ATC_CODE_DESCRIPTION>  (1144) 
C09AA03 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (1144) 
Antihypertensive

>  <SC_PATENT_NO>  (1144) 
nan

>  <DRUG_TYPE>  (1144) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1144) 
Y

>  <FIRST_IN_CLASS>  (1144) 
N

>  <CHIRALITY>  (1144) 
Single Stereoisomer

>  <PRODRUG>  (1144) 
N

>  <ORAL>  (1144) 
Y

>  <PARENTERAL>  (1144) 
N

>  <TOPICAL>  (1144) 
N

>  <BLACK_BOX>  (1144) 
Y

>  <AVAILABILITY_TYPE>  (1144) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1144) 
nan

>  <WITHDRAWN_COUNTRY>  (1144) 
nan

>  <WITHDRAWN_REASON>  (1144) 
nan

>  <CANONICAL_SMILES>  (1144) 
NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O

>  <name>  (1144) 
Lisinopril 

>  <MW>  (1144) 
405.495

>  <logP>  (1144) 
1.2352

$$$$
CHEMBL1874750
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 13 22  1  0
 22 23  1  0
  5 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  2  0
 28 29  1  0
 29 30  1  0
 28  3  1  0
 23 10  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1145) 
1215321

>  <SYNONYMS>  (1145) 
Cinepazide (BAN, DCF, INN, MI); Cinepazide Maleate (JAN)

>  <DEVELOPMENT_PHASE>  (1145) 
4

>  <RESEARCH_CODES>  (1145) 
MD-67350 [As Maleate]

>  <APPLICANTS>  (1145) 
nan

>  <USAN_STEM>  (1145) 
nan

>  <USAN_STEM_DEFINITION>  (1145) 
nan

>  <USAN_STEM_SUBSTEM>  (1145) 
nan

>  <USAN_YEAR>  (1145) 
nan

>  <FIRST_APPROVAL>  (1145) 
1980.0

>  <ATC_CODE>  (1145) 
C04AX27

>  <ATC_CODE_DESCRIPTION>  (1145) 
C04AX27 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Other peripheral vasodilators]

>  <INDICATION_CLASS>  (1145) 
nan

>  <SC_PATENT_NO>  (1145) 
nan

>  <DRUG_TYPE>  (1145) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1145) 
Y

>  <FIRST_IN_CLASS>  (1145) 
N

>  <CHIRALITY>  (1145) 
Achiral Molecule

>  <PRODRUG>  (1145) 
N

>  <ORAL>  (1145) 
N

>  <PARENTERAL>  (1145) 
N

>  <TOPICAL>  (1145) 
N

>  <BLACK_BOX>  (1145) 
N

>  <AVAILABILITY_TYPE>  (1145) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1145) 
1987.0

>  <WITHDRAWN_COUNTRY>  (1145) 
Spain

>  <WITHDRAWN_REASON>  (1145) 
Agranulocytosis

>  <CANONICAL_SMILES>  (1145) 
COc1cc(\C=C\C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC

>  <name>  (1145) 
Cinepazide 

>  <MW>  (1145) 
417.506

>  <logP>  (1145) 
1.4922

$$$$
CHEMBL218490
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 16 18  2  0
 16 19  1  0
 15  4  1  0
 15 11  2  0
M  END
>  <PARENT_MOLREGNO>  (1146) 
366274

>  <SYNONYMS>  (1146) 
Dorzolamide (BAN, INN); Dorzolamide HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1146) 
4

>  <RESEARCH_CODES>  (1146) 
MK-507

>  <APPLICANTS>  (1146) 
Merck Sharp And Dohme Corp; Merck Research Laboratories Div Merck Co Inc

>  <USAN_STEM>  (1146) 
-zolamide

>  <USAN_STEM_DEFINITION>  (1146) 
carbonic anhydrase inhibitors

>  <USAN_STEM_SUBSTEM>  (1146) 
-zolamide

>  <USAN_YEAR>  (1146) 
1992.0

>  <FIRST_APPROVAL>  (1146) 
1994.0

>  <ATC_CODE>  (1146) 
S01EC03

>  <ATC_CODE_DESCRIPTION>  (1146) 
S01EC03 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Carbonic anhydrase inhibitors]

>  <INDICATION_CLASS>  (1146) 
Carbonic Anhydrase Inhibitor

>  <SC_PATENT_NO>  (1146) 
nan

>  <DRUG_TYPE>  (1146) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1146) 
Y

>  <FIRST_IN_CLASS>  (1146) 
N

>  <CHIRALITY>  (1146) 
Single Stereoisomer

>  <PRODRUG>  (1146) 
N

>  <ORAL>  (1146) 
N

>  <PARENTERAL>  (1146) 
N

>  <TOPICAL>  (1146) 
Y

>  <BLACK_BOX>  (1146) 
N

>  <AVAILABILITY_TYPE>  (1146) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1146) 
nan

>  <WITHDRAWN_COUNTRY>  (1146) 
nan

>  <WITHDRAWN_REASON>  (1146) 
nan

>  <CANONICAL_SMILES>  (1146) 
CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(=O)(=O)N

>  <name>  (1146) 
Dorzolamide 

>  <MW>  (1146) 
324.449

>  <logP>  (1146) 
0.612

$$$$
CHEMBL459048
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
  9 11  1  0
  9 12  1  0
  7  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1147) 
463381

>  <SYNONYMS>  (1147) 
Sobrerol

>  <DEVELOPMENT_PHASE>  (1147) 
4

>  <RESEARCH_CODES>  (1147) 
nan

>  <APPLICANTS>  (1147) 
nan

>  <USAN_STEM>  (1147) 
nan

>  <USAN_STEM_DEFINITION>  (1147) 
nan

>  <USAN_STEM_SUBSTEM>  (1147) 
nan

>  <USAN_YEAR>  (1147) 
nan

>  <FIRST_APPROVAL>  (1147) 
nan

>  <ATC_CODE>  (1147) 
R05CB07

>  <ATC_CODE_DESCRIPTION>  (1147) 
R05CB07 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Mucolytics]

>  <INDICATION_CLASS>  (1147) 
nan

>  <SC_PATENT_NO>  (1147) 
nan

>  <DRUG_TYPE>  (1147) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1147) 
Y

>  <FIRST_IN_CLASS>  (1147) 
N

>  <CHIRALITY>  (1147) 
Single Stereoisomer

>  <PRODRUG>  (1147) 
N

>  <ORAL>  (1147) 
N

>  <PARENTERAL>  (1147) 
N

>  <TOPICAL>  (1147) 
N

>  <BLACK_BOX>  (1147) 
N

>  <AVAILABILITY_TYPE>  (1147) 
Unknown

>  <WITHDRAWN_YEAR>  (1147) 
nan

>  <WITHDRAWN_COUNTRY>  (1147) 
nan

>  <WITHDRAWN_REASON>  (1147) 
nan

>  <CANONICAL_SMILES>  (1147) 
CC1=CC[C@@H](C[C@@H]1O)C(C)(C)O

>  <name>  (1147) 
Sobrerol

>  <MW>  (1147) 
170.252

>  <logP>  (1147) 
1.4745

$$$$
CHEMBL11978
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1148) 
9951

>  <SYNONYMS>  (1148) 
Nicotinyl Methylamide

>  <DEVELOPMENT_PHASE>  (1148) 
4

>  <RESEARCH_CODES>  (1148) 
nan

>  <APPLICANTS>  (1148) 
nan

>  <USAN_STEM>  (1148) 
nan

>  <USAN_STEM_DEFINITION>  (1148) 
nan

>  <USAN_STEM_SUBSTEM>  (1148) 
nan

>  <USAN_YEAR>  (1148) 
nan

>  <FIRST_APPROVAL>  (1148) 
nan

>  <ATC_CODE>  (1148) 
A05AB01

>  <ATC_CODE_DESCRIPTION>  (1148) 
A05AB01 [Alimentary Tract And Metabolism:Bile And Liver Therapy:Bile Therapy:Preparations for biliary tract therapy]

>  <INDICATION_CLASS>  (1148) 
nan

>  <SC_PATENT_NO>  (1148) 
nan

>  <DRUG_TYPE>  (1148) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1148) 
Y

>  <FIRST_IN_CLASS>  (1148) 
N

>  <CHIRALITY>  (1148) 
Achiral Molecule

>  <PRODRUG>  (1148) 
N

>  <ORAL>  (1148) 
N

>  <PARENTERAL>  (1148) 
N

>  <TOPICAL>  (1148) 
N

>  <BLACK_BOX>  (1148) 
N

>  <AVAILABILITY_TYPE>  (1148) 
Unknown

>  <WITHDRAWN_YEAR>  (1148) 
nan

>  <WITHDRAWN_COUNTRY>  (1148) 
nan

>  <WITHDRAWN_REASON>  (1148) 
nan

>  <CANONICAL_SMILES>  (1148) 
CNC(=O)c1cccnc1

>  <name>  (1148) 
Nicotinyl Methylamide

>  <MW>  (1148) 
136.154

>  <logP>  (1148) 
0.4412

$$$$
CHEMBL315818
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1149) 
137495

>  <SYNONYMS>  (1149) 
Phenibut

>  <DEVELOPMENT_PHASE>  (1149) 
4

>  <RESEARCH_CODES>  (1149) 
nan

>  <APPLICANTS>  (1149) 
nan

>  <USAN_STEM>  (1149) 
nan

>  <USAN_STEM_DEFINITION>  (1149) 
nan

>  <USAN_STEM_SUBSTEM>  (1149) 
nan

>  <USAN_YEAR>  (1149) 
nan

>  <FIRST_APPROVAL>  (1149) 
nan

>  <ATC_CODE>  (1149) 
N06BX22

>  <ATC_CODE_DESCRIPTION>  (1149) 
N06BX22 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Other psychostimulants and nootropics]

>  <INDICATION_CLASS>  (1149) 
nan

>  <SC_PATENT_NO>  (1149) 
nan

>  <DRUG_TYPE>  (1149) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1149) 
Y

>  <FIRST_IN_CLASS>  (1149) 
N

>  <CHIRALITY>  (1149) 
Racemic Mixture

>  <PRODRUG>  (1149) 
N

>  <ORAL>  (1149) 
N

>  <PARENTERAL>  (1149) 
N

>  <TOPICAL>  (1149) 
N

>  <BLACK_BOX>  (1149) 
N

>  <AVAILABILITY_TYPE>  (1149) 
Unknown

>  <WITHDRAWN_YEAR>  (1149) 
nan

>  <WITHDRAWN_COUNTRY>  (1149) 
nan

>  <WITHDRAWN_REASON>  (1149) 
nan

>  <CANONICAL_SMILES>  (1149) 
NCC(CC(=O)O)c1ccccc1

>  <name>  (1149) 
Phenibut

>  <MW>  (1149) 
179.219

>  <logP>  (1149) 
1.2036

$$$$
CHEMBL19
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  4 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
  6  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1150) 
1124

>  <SYNONYMS>  (1150) 
Methazolamide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1150) 
4

>  <RESEARCH_CODES>  (1150) 
nan

>  <APPLICANTS>  (1150) 
Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (1150) 
-zolamide

>  <USAN_STEM_DEFINITION>  (1150) 
carbonic anhydrase inhibitors

>  <USAN_STEM_SUBSTEM>  (1150) 
-zolamide

>  <USAN_YEAR>  (1150) 
nan

>  <FIRST_APPROVAL>  (1150) 
1959.0

>  <ATC_CODE>  (1150) 
S01EC05

>  <ATC_CODE_DESCRIPTION>  (1150) 
S01EC05 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Carbonic anhydrase inhibitors]

>  <INDICATION_CLASS>  (1150) 
Carbonic Anhydrase Inhibitor

>  <SC_PATENT_NO>  (1150) 
nan

>  <DRUG_TYPE>  (1150) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1150) 
Y

>  <FIRST_IN_CLASS>  (1150) 
N

>  <CHIRALITY>  (1150) 
Achiral Molecule

>  <PRODRUG>  (1150) 
N

>  <ORAL>  (1150) 
Y

>  <PARENTERAL>  (1150) 
N

>  <TOPICAL>  (1150) 
N

>  <BLACK_BOX>  (1150) 
N

>  <AVAILABILITY_TYPE>  (1150) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1150) 
nan

>  <WITHDRAWN_COUNTRY>  (1150) 
nan

>  <WITHDRAWN_REASON>  (1150) 
nan

>  <CANONICAL_SMILES>  (1150) 
CN1N=C(S/C/1=N/C(=O)C)S(=O)(=O)N

>  <name>  (1150) 
Methazolamide 

>  <MW>  (1150) 
236.278

>  <logP>  (1150) 
-1.4238

$$$$
CHEMBL1256786
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 19 23  2  0
  6 24  1  0
 24 25  2  0
 25  3  1  0
 23 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1151) 
705778

>  <SYNONYMS>  (1151) 
Formoterol (BAN, INN); Formoterol Fumarate (FDA, JAN, USAN); Formoterol Fumarate Dihydrate (FDA)

>  <DEVELOPMENT_PHASE>  (1151) 
4

>  <RESEARCH_CODES>  (1151) 
BD-40A; CGP-25827A; YM-08316

>  <APPLICANTS>  (1151) 
Novartis Pharmaceuticals Corp; Mylan Specialty Lp; Merck Sharp And Dohme Corp; Astrazeneca Lp

>  <USAN_STEM>  (1151) 
-terol

>  <USAN_STEM_DEFINITION>  (1151) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (1151) 
-terol

>  <USAN_YEAR>  (1151) 
1997.0

>  <FIRST_APPROVAL>  (1151) 
2001.0

>  <ATC_CODE>  (1151) 
R03AC13

>  <ATC_CODE_DESCRIPTION>  (1151) 
R03AC13 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (1151) 
Bronchodilator

>  <SC_PATENT_NO>  (1151) 
US-6068832-A

>  <DRUG_TYPE>  (1151) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1151) 
Y

>  <FIRST_IN_CLASS>  (1151) 
N

>  <CHIRALITY>  (1151) 
Racemic Mixture

>  <PRODRUG>  (1151) 
N

>  <ORAL>  (1151) 
N

>  <PARENTERAL>  (1151) 
N

>  <TOPICAL>  (1151) 
Y

>  <BLACK_BOX>  (1151) 
Y

>  <AVAILABILITY_TYPE>  (1151) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1151) 
nan

>  <WITHDRAWN_COUNTRY>  (1151) 
nan

>  <WITHDRAWN_REASON>  (1151) 
nan

>  <CANONICAL_SMILES>  (1151) 
COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1

>  <name>  (1151) 
Formoterol 

>  <MW>  (1151) 
344.411

>  <logP>  (1151) 
2.2233

$$$$
CHEMBL1393
     RDKit          

 29 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 20 29  1  0
 29  5  1  0
 13  7  1  0
 29 15  1  0
 23 18  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1152) 
328201

>  <SYNONYMS>  (1152) 
Spironolactone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1152) 
4

>  <RESEARCH_CODES>  (1152) 
nan

>  <APPLICANTS>  (1152) 
Gd Searle Llc

>  <USAN_STEM>  (1152) 
nan

>  <USAN_STEM_DEFINITION>  (1152) 
nan

>  <USAN_STEM_SUBSTEM>  (1152) 
nan

>  <USAN_YEAR>  (1152) 
nan

>  <FIRST_APPROVAL>  (1152) 
1960.0

>  <ATC_CODE>  (1152) 
C03DA01

>  <ATC_CODE_DESCRIPTION>  (1152) 
C03DA01 [Cardiovascular System:Diuretics:Potassium-Sparing Agents:Aldosterone antagonists]

>  <INDICATION_CLASS>  (1152) 
Aldosterone Antagonist; Diuretic

>  <SC_PATENT_NO>  (1152) 
nan

>  <DRUG_TYPE>  (1152) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1152) 
Y

>  <FIRST_IN_CLASS>  (1152) 
N

>  <CHIRALITY>  (1152) 
Single Stereoisomer

>  <PRODRUG>  (1152) 
N

>  <ORAL>  (1152) 
Y

>  <PARENTERAL>  (1152) 
N

>  <TOPICAL>  (1152) 
N

>  <BLACK_BOX>  (1152) 
Y

>  <AVAILABILITY_TYPE>  (1152) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1152) 
nan

>  <WITHDRAWN_COUNTRY>  (1152) 
nan

>  <WITHDRAWN_REASON>  (1152) 
nan

>  <CANONICAL_SMILES>  (1152) 
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13

>  <name>  (1152) 
Spironolactone 

>  <MW>  (1152) 
416.583

>  <logP>  (1152) 
4.8523

$$$$
CHEMBL429910
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 11 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
  7 27  1  0
 27 28  2  0
 28  4  1  0
 14  9  1  0
 25 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1153) 
441579

>  <SYNONYMS>  (1153) 
Dapagliflozin (FDA, INN); Dapagliflozin propanediol (FDA); Dapagliflozin Propylene Glycol (USAN)

>  <DEVELOPMENT_PHASE>  (1153) 
4

>  <RESEARCH_CODES>  (1153) 
BMS-512148; BMS-512148-05

>  <APPLICANTS>  (1153) 
Bristol-Myers Squibb; Astrazeneca Ab

>  <USAN_STEM>  (1153) 
-gliflozin

>  <USAN_STEM_DEFINITION>  (1153) 
phlorozin derivatives, phenolic glycosides

>  <USAN_STEM_SUBSTEM>  (1153) 
-gliflozin

>  <USAN_YEAR>  (1153) 
2007.0

>  <FIRST_APPROVAL>  (1153) 
2014.0

>  <ATC_CODE>  (1153) 
A10BX09

>  <ATC_CODE_DESCRIPTION>  (1153) 
A10BX09 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Other blood glucose lowering drugs, excl. insulins]

>  <INDICATION_CLASS>  (1153) 
nan

>  <SC_PATENT_NO>  (1153) 
US-6414126-B1

>  <DRUG_TYPE>  (1153) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1153) 
Y

>  <FIRST_IN_CLASS>  (1153) 
N

>  <CHIRALITY>  (1153) 
Single Stereoisomer

>  <PRODRUG>  (1153) 
N

>  <ORAL>  (1153) 
Y

>  <PARENTERAL>  (1153) 
N

>  <TOPICAL>  (1153) 
N

>  <BLACK_BOX>  (1153) 
N

>  <AVAILABILITY_TYPE>  (1153) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1153) 
nan

>  <WITHDRAWN_COUNTRY>  (1153) 
nan

>  <WITHDRAWN_REASON>  (1153) 
nan

>  <CANONICAL_SMILES>  (1153) 
CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc1

>  <name>  (1153) 
Dapagliflozin 

>  <MW>  (1153) 
408.878

>  <logP>  (1153) 
1.8444

$$$$
CHEMBL1187833
     RDKit          

 32 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  2  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 18 29  1  0
 29 30  1  0
 18 31  1  0
 31 32  1  0
  8  3  1  0
 14  9  1  0
 30 15  1  0
 32 15  1  0
 28 23  1  0
M  CHG  1  18   1
M  END
>  <PARENT_MOLREGNO>  (1154) 
661783

>  <SYNONYMS>  (1154) 
Umeclidinium (USAN); Umeclidinium Bromide (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1154) 
4

>  <RESEARCH_CODES>  (1154) 
GSK573719; GSK573719A

>  <APPLICANTS>  (1154) 
GlaxoSmithKline; Glaxo Grp Ltd; Glaxo Group Ltd England Dba GlaxoSmithKline

>  <USAN_STEM>  (1154) 
-clidinium; -ium

>  <USAN_STEM_DEFINITION>  (1154) 
muscarinic receptor antagonists; quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (1154) 
-clidinium; -ium

>  <USAN_YEAR>  (1154) 
2011.0

>  <FIRST_APPROVAL>  (1154) 
2013.0

>  <ATC_CODE>  (1154) 
R03BB07

>  <ATC_CODE_DESCRIPTION>  (1154) 
R03BB07 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Anticholinergics]

>  <INDICATION_CLASS>  (1154) 
nan

>  <SC_PATENT_NO>  (1154) 
US-5873360-A

>  <DRUG_TYPE>  (1154) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1154) 
Y

>  <FIRST_IN_CLASS>  (1154) 
N

>  <CHIRALITY>  (1154) 
Achiral Molecule

>  <PRODRUG>  (1154) 
N

>  <ORAL>  (1154) 
N

>  <PARENTERAL>  (1154) 
N

>  <TOPICAL>  (1154) 
Y

>  <BLACK_BOX>  (1154) 
Y

>  <AVAILABILITY_TYPE>  (1154) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1154) 
nan

>  <WITHDRAWN_COUNTRY>  (1154) 
nan

>  <WITHDRAWN_REASON>  (1154) 
nan

>  <CANONICAL_SMILES>  (1154) 
OC(c1ccccc1)(c2ccccc2)C34CC[N+](CCOCc5ccccc5)(CC3)CC4

>  <name>  (1154) 
Umeclidinium 

>  <MW>  (1154) 
428.596

>  <logP>  (1154) 
5.14

$$$$
CHEMBL578
     RDKit          

 27 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 14  9  1  0
 24 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1155) 
16847

>  <SYNONYMS>  (1155) 
Enalapril (BAN, INN); Enalapril Maleate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1155) 
4

>  <RESEARCH_CODES>  (1155) 
nan

>  <APPLICANTS>  (1155) 
Valeant International Barbados Srl; Biovail Laboratories Inc; Astrazeneca Pharmaceuticals Lp

>  <USAN_STEM>  (1155) 
-pril

>  <USAN_STEM_DEFINITION>  (1155) 
antihypertensives (ACE inhibitors)

>  <USAN_STEM_SUBSTEM>  (1155) 
-pril

>  <USAN_YEAR>  (1155) 
1981.0

>  <FIRST_APPROVAL>  (1155) 
1985.0

>  <ATC_CODE>  (1155) 
C09AA02

>  <ATC_CODE_DESCRIPTION>  (1155) 
C09AA02 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Ace Inhibitors, Plain:ACE inhibitors, plain]

>  <INDICATION_CLASS>  (1155) 
Antihypertensive

>  <SC_PATENT_NO>  (1155) 
US-8568747-B1

>  <DRUG_TYPE>  (1155) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1155) 
Y

>  <FIRST_IN_CLASS>  (1155) 
N

>  <CHIRALITY>  (1155) 
Single Stereoisomer

>  <PRODRUG>  (1155) 
Y

>  <ORAL>  (1155) 
Y

>  <PARENTERAL>  (1155) 
N

>  <TOPICAL>  (1155) 
N

>  <BLACK_BOX>  (1155) 
Y

>  <AVAILABILITY_TYPE>  (1155) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1155) 
nan

>  <WITHDRAWN_COUNTRY>  (1155) 
nan

>  <WITHDRAWN_REASON>  (1155) 
nan

>  <CANONICAL_SMILES>  (1155) 
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O

>  <name>  (1155) 
Enalapril 

>  <MW>  (1155) 
376.453

>  <logP>  (1155) 
1.6046

$$$$
CHEMBL1488
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1156) 
418344

>  <SYNONYMS>  (1156) 
Uracil mustard (FDA, USAN, USP); Uramustine (BAN, INN)

>  <DEVELOPMENT_PHASE>  (1156) 
4

>  <RESEARCH_CODES>  (1156) 
U-8344

>  <APPLICANTS>  (1156) 
Shire Development Inc

>  <USAN_STEM>  (1156) 
-racil

>  <USAN_STEM_DEFINITION>  (1156) 
uracil type antineoplastics

>  <USAN_STEM_SUBSTEM>  (1156) 
-racil

>  <USAN_YEAR>  (1156) 
1962.0

>  <FIRST_APPROVAL>  (1156) 
1962.0

>  <ATC_CODE>  (1156) 
nan

>  <ATC_CODE_DESCRIPTION>  (1156) 
nan

>  <INDICATION_CLASS>  (1156) 
Antineoplastic

>  <SC_PATENT_NO>  (1156) 
nan

>  <DRUG_TYPE>  (1156) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1156) 
Y

>  <FIRST_IN_CLASS>  (1156) 
N

>  <CHIRALITY>  (1156) 
Achiral Molecule

>  <PRODRUG>  (1156) 
N

>  <ORAL>  (1156) 
Y

>  <PARENTERAL>  (1156) 
N

>  <TOPICAL>  (1156) 
N

>  <BLACK_BOX>  (1156) 
N

>  <AVAILABILITY_TYPE>  (1156) 
Discontinued

>  <WITHDRAWN_YEAR>  (1156) 
nan

>  <WITHDRAWN_COUNTRY>  (1156) 
nan

>  <WITHDRAWN_REASON>  (1156) 
nan

>  <CANONICAL_SMILES>  (1156) 
ClCCN(CCCl)C1=CNC(=O)NC1=O

>  <name>  (1156) 
Uracil mustard 

>  <MW>  (1156) 
252.101

>  <logP>  (1156) 
0.3472

$$$$
CHEMBL1002
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  2  0
 17  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1157) 
111482

>  <SYNONYMS>  (1157) 
Levosalbutamol (INN); Levalbuterol HCl (FDA, USAN); Levalbuterol Tartrate (FDA, USAN); Levalbuterol Sulfate (USAN)

>  <DEVELOPMENT_PHASE>  (1157) 
4

>  <RESEARCH_CODES>  (1157) 
nan

>  <APPLICANTS>  (1157) 
Sunovion Pharmaceuticals Inc; Sepracor

>  <USAN_STEM>  (1157) 
-sal-

>  <USAN_STEM_DEFINITION>  (1157) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (1157) 
-sal-

>  <USAN_YEAR>  (1157) 
1997.0

>  <FIRST_APPROVAL>  (1157) 
1999.0

>  <ATC_CODE>  (1157) 
nan

>  <ATC_CODE_DESCRIPTION>  (1157) 
nan

>  <INDICATION_CLASS>  (1157) 
Asthma Prophylactic; Bronchodilator

>  <SC_PATENT_NO>  (1157) 
US-5836299-A

>  <DRUG_TYPE>  (1157) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1157) 
Y

>  <FIRST_IN_CLASS>  (1157) 
N

>  <CHIRALITY>  (1157) 
Single Stereoisomer

>  <PRODRUG>  (1157) 
N

>  <ORAL>  (1157) 
N

>  <PARENTERAL>  (1157) 
N

>  <TOPICAL>  (1157) 
Y

>  <BLACK_BOX>  (1157) 
N

>  <AVAILABILITY_TYPE>  (1157) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1157) 
nan

>  <WITHDRAWN_COUNTRY>  (1157) 
nan

>  <WITHDRAWN_REASON>  (1157) 
nan

>  <CANONICAL_SMILES>  (1157) 
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1

>  <name>  (1157) 
Levosalbutamol 

>  <MW>  (1157) 
239.315

>  <logP>  (1157) 
1.306

$$$$
CHEMBL715
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
  7  2  1  0
 22  8  1  0
 15 10  1  0
 22 17  2  0
M  END
>  <PARENT_MOLREGNO>  (1158) 
34197

>  <SYNONYMS>  (1158) 
Olanzapine (BAN, FDA, INN, USAN); Olanzapine Pamoate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1158) 
4

>  <RESEARCH_CODES>  (1158) 
LY-170053

>  <APPLICANTS>  (1158) 
Eli Lilly Co; Eli Lilly And Co

>  <USAN_STEM>  (1158) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (1158) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (1158) 
-pin(e)

>  <USAN_YEAR>  (1158) 
1992.0

>  <FIRST_APPROVAL>  (1158) 
1996.0

>  <ATC_CODE>  (1158) 
N05AH03

>  <ATC_CODE_DESCRIPTION>  (1158) 
N05AH03 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]

>  <INDICATION_CLASS>  (1158) 
Antipsychotic

>  <SC_PATENT_NO>  (1158) 
US-5945416-A

>  <DRUG_TYPE>  (1158) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1158) 
Y

>  <FIRST_IN_CLASS>  (1158) 
N

>  <CHIRALITY>  (1158) 
Achiral Molecule

>  <PRODRUG>  (1158) 
N

>  <ORAL>  (1158) 
Y

>  <PARENTERAL>  (1158) 
Y

>  <TOPICAL>  (1158) 
N

>  <BLACK_BOX>  (1158) 
Y

>  <AVAILABILITY_TYPE>  (1158) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1158) 
nan

>  <WITHDRAWN_COUNTRY>  (1158) 
nan

>  <WITHDRAWN_REASON>  (1158) 
nan

>  <CANONICAL_SMILES>  (1158) 
CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24

>  <name>  (1158) 
Olanzapine 

>  <MW>  (1158) 
312.442

>  <logP>  (1158) 
3.43922

$$$$
CHEMBL122
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 12 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 10  5  1  0
 16 11  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1159) 
21697

>  <SYNONYMS>  (1159) 
Rofecoxib (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1159) 
4

>  <RESEARCH_CODES>  (1159) 
MK-0966; MK-966

>  <APPLICANTS>  (1159) 
Merck Research Laboratories Div Merck Co Inc

>  <USAN_STEM>  (1159) 
-coxib

>  <USAN_STEM_DEFINITION>  (1159) 
cyclooxygenase-2 inhibitors

>  <USAN_STEM_SUBSTEM>  (1159) 
-coxib

>  <USAN_YEAR>  (1159) 
1998.0

>  <FIRST_APPROVAL>  (1159) 
1999.0

>  <ATC_CODE>  (1159) 
M01AH02

>  <ATC_CODE_DESCRIPTION>  (1159) 
M01AH02 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Coxibs]

>  <INDICATION_CLASS>  (1159) 
nan

>  <SC_PATENT_NO>  (1159) 
US-5691374-A

>  <DRUG_TYPE>  (1159) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1159) 
Y

>  <FIRST_IN_CLASS>  (1159) 
N

>  <CHIRALITY>  (1159) 
Achiral Molecule

>  <PRODRUG>  (1159) 
N

>  <ORAL>  (1159) 
Y

>  <PARENTERAL>  (1159) 
N

>  <TOPICAL>  (1159) 
N

>  <BLACK_BOX>  (1159) 
N

>  <AVAILABILITY_TYPE>  (1159) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1159) 
2004.0

>  <WITHDRAWN_COUNTRY>  (1159) 
United States

>  <WITHDRAWN_REASON>  (1159) 
Risk for heart attack and stroke

>  <CANONICAL_SMILES>  (1159) 
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3

>  <name>  (1159) 
Rofecoxib 

>  <MW>  (1159) 
314.362

>  <logP>  (1159) 
2.5577

$$$$
CHEMBL1059
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1160) 
136161

>  <SYNONYMS>  (1160) 
Pregabalin (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1160) 
4

>  <RESEARCH_CODES>  (1160) 
CI-1008; PD-144723

>  <APPLICANTS>  (1160) 
Pf Prism Cv

>  <USAN_STEM>  (1160) 
-gab-

>  <USAN_STEM_DEFINITION>  (1160) 
gabamimetics

>  <USAN_STEM_SUBSTEM>  (1160) 
-gab-

>  <USAN_YEAR>  (1160) 
1997.0

>  <FIRST_APPROVAL>  (1160) 
2004.0

>  <ATC_CODE>  (1160) 
N03AX16

>  <ATC_CODE_DESCRIPTION>  (1160) 
N03AX16 [Nervous System:Antiepileptics:Antiepileptics:Other antiepileptics]

>  <INDICATION_CLASS>  (1160) 
Anticonvulsant

>  <SC_PATENT_NO>  (1160) 
US-6001876-A

>  <DRUG_TYPE>  (1160) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1160) 
Y

>  <FIRST_IN_CLASS>  (1160) 
N

>  <CHIRALITY>  (1160) 
Single Stereoisomer

>  <PRODRUG>  (1160) 
N

>  <ORAL>  (1160) 
Y

>  <PARENTERAL>  (1160) 
N

>  <TOPICAL>  (1160) 
N

>  <BLACK_BOX>  (1160) 
N

>  <AVAILABILITY_TYPE>  (1160) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1160) 
nan

>  <WITHDRAWN_COUNTRY>  (1160) 
nan

>  <WITHDRAWN_REASON>  (1160) 
nan

>  <CANONICAL_SMILES>  (1160) 
CC(C)C[C@H](CN)CC(=O)O

>  <name>  (1160) 
Pregabalin 

>  <MW>  (1160) 
159.229

>  <logP>  (1160) 
1.0821

$$$$
CHEMBL1200342
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 23  2  1  0
 21  4  1  0
 17  5  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1161) 
674293

>  <SYNONYMS>  (1161) 
Paramethasone (BAN, INN); Paramethasone Acetate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1161) 
4

>  <RESEARCH_CODES>  (1161) 
nan

>  <APPLICANTS>  (1161) 
Eli Lilly And Co

>  <USAN_STEM>  (1161) 
nan

>  <USAN_STEM_DEFINITION>  (1161) 
nan

>  <USAN_STEM_SUBSTEM>  (1161) 
nan

>  <USAN_YEAR>  (1161) 
1962.0

>  <FIRST_APPROVAL>  (1161) 
1982.0

>  <ATC_CODE>  (1161) 
H02AB05

>  <ATC_CODE_DESCRIPTION>  (1161) 
H02AB05 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]

>  <INDICATION_CLASS>  (1161) 
Glucocorticoid

>  <SC_PATENT_NO>  (1161) 
nan

>  <DRUG_TYPE>  (1161) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1161) 
Y

>  <FIRST_IN_CLASS>  (1161) 
N

>  <CHIRALITY>  (1161) 
Single Stereoisomer

>  <PRODRUG>  (1161) 
Y

>  <ORAL>  (1161) 
Y

>  <PARENTERAL>  (1161) 
N

>  <TOPICAL>  (1161) 
N

>  <BLACK_BOX>  (1161) 
N

>  <AVAILABILITY_TYPE>  (1161) 
Discontinued

>  <WITHDRAWN_YEAR>  (1161) 
nan

>  <WITHDRAWN_COUNTRY>  (1161) 
nan

>  <WITHDRAWN_REASON>  (1161) 
nan

>  <CANONICAL_SMILES>  (1161) 
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C

>  <name>  (1161) 
Paramethasone 

>  <MW>  (1161) 
434.504

>  <logP>  (1161) 
2.3224

$$$$
CHEMBL418995
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 11  1  0
 17 12  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1162) 
176014

>  <SYNONYMS>  (1162) 
Amineptine (INN, MI)

>  <DEVELOPMENT_PHASE>  (1162) 
4

>  <RESEARCH_CODES>  (1162) 
nan

>  <APPLICANTS>  (1162) 
nan

>  <USAN_STEM>  (1162) 
nan

>  <USAN_STEM_DEFINITION>  (1162) 
nan

>  <USAN_STEM_SUBSTEM>  (1162) 
nan

>  <USAN_YEAR>  (1162) 
nan

>  <FIRST_APPROVAL>  (1162) 
nan

>  <ATC_CODE>  (1162) 
N06AA19

>  <ATC_CODE_DESCRIPTION>  (1162) 
N06AA19 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (1162) 
nan

>  <SC_PATENT_NO>  (1162) 
nan

>  <DRUG_TYPE>  (1162) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1162) 
Y

>  <FIRST_IN_CLASS>  (1162) 
N

>  <CHIRALITY>  (1162) 
Achiral Molecule

>  <PRODRUG>  (1162) 
N

>  <ORAL>  (1162) 
N

>  <PARENTERAL>  (1162) 
N

>  <TOPICAL>  (1162) 
N

>  <BLACK_BOX>  (1162) 
N

>  <AVAILABILITY_TYPE>  (1162) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1162) 
1999.0

>  <WITHDRAWN_COUNTRY>  (1162) 
France; Thailand

>  <WITHDRAWN_REASON>  (1162) 
Abuse; Dependence; Severe Acne

>  <CANONICAL_SMILES>  (1162) 
OC(=O)CCCCCCNC1c2ccccc2CCc3ccccc13

>  <name>  (1162) 
Amineptine 

>  <MW>  (1162) 
337.463

>  <logP>  (1162) 
4.4993

$$$$
CHEMBL1764
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 14 22  1  0
 22 23  2  0
 23  3  1  0
 22  6  1  0
 13  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1163) 
583530

>  <SYNONYMS>  (1163) 
Levomepromazine (BAN, DCF, FDA, INN, USAN); Methotrimeprazine (USP); Levomepromazine Maleate (JAN, USAN); Levomepromazine HCl (JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1163) 
4

>  <RESEARCH_CODES>  (1163) 
CL-36467; CL-39743; RP-7044; SK&F-5116; XP03

>  <APPLICANTS>  (1163) 
Orgasynth; Lan; Immunex Corp; Aventis

>  <USAN_STEM>  (1163) 
nan

>  <USAN_STEM_DEFINITION>  (1163) 
nan

>  <USAN_STEM_SUBSTEM>  (1163) 
nan

>  <USAN_YEAR>  (1163) 
2003.0

>  <FIRST_APPROVAL>  (1163) 
1982.0

>  <ATC_CODE>  (1163) 
N05AA02

>  <ATC_CODE_DESCRIPTION>  (1163) 
N05AA02 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with aliphatic side-chain]

>  <INDICATION_CLASS>  (1163) 
Analgesic

>  <SC_PATENT_NO>  (1163) 
nan

>  <DRUG_TYPE>  (1163) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1163) 
Y

>  <FIRST_IN_CLASS>  (1163) 
N

>  <CHIRALITY>  (1163) 
Single Stereoisomer

>  <PRODRUG>  (1163) 
N

>  <ORAL>  (1163) 
N

>  <PARENTERAL>  (1163) 
Y

>  <TOPICAL>  (1163) 
N

>  <BLACK_BOX>  (1163) 
N

>  <AVAILABILITY_TYPE>  (1163) 
Discontinued

>  <WITHDRAWN_YEAR>  (1163) 
nan

>  <WITHDRAWN_COUNTRY>  (1163) 
nan

>  <WITHDRAWN_REASON>  (1163) 
nan

>  <CANONICAL_SMILES>  (1163) 
COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1

>  <name>  (1163) 
Levomepromazine 

>  <MW>  (1163) 
328.481

>  <logP>  (1163) 
4.4956

$$$$
CHEMBL422
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 20 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
  5 27  1  0
 27 28  1  0
 28  2  1  0
 22  9  1  0
 15 10  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1164) 
1325

>  <SYNONYMS>  (1164) 
Trifluoperazine (BAN, INN); Trifluoperazine HCl (FDA, JAN, USP); Trifluoperazine Maleate (JAN)

>  <DEVELOPMENT_PHASE>  (1164) 
4

>  <RESEARCH_CODES>  (1164) 
nan

>  <APPLICANTS>  (1164) 
GlaxoSmithKline

>  <USAN_STEM>  (1164) 
nan

>  <USAN_STEM_DEFINITION>  (1164) 
nan

>  <USAN_STEM_SUBSTEM>  (1164) 
nan

>  <USAN_YEAR>  (1164) 
nan

>  <FIRST_APPROVAL>  (1164) 
1959.0

>  <ATC_CODE>  (1164) 
N05AB06

>  <ATC_CODE_DESCRIPTION>  (1164) 
N05AB06 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with piperazine structure]

>  <INDICATION_CLASS>  (1164) 
Antipsychotic; Sedative-Hypnotic

>  <SC_PATENT_NO>  (1164) 
nan

>  <DRUG_TYPE>  (1164) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1164) 
Y

>  <FIRST_IN_CLASS>  (1164) 
N

>  <CHIRALITY>  (1164) 
Achiral Molecule

>  <PRODRUG>  (1164) 
N

>  <ORAL>  (1164) 
Y

>  <PARENTERAL>  (1164) 
Y

>  <TOPICAL>  (1164) 
N

>  <BLACK_BOX>  (1164) 
Y

>  <AVAILABILITY_TYPE>  (1164) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1164) 
nan

>  <WITHDRAWN_COUNTRY>  (1164) 
nan

>  <WITHDRAWN_REASON>  (1164) 
nan

>  <CANONICAL_SMILES>  (1164) 
CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1

>  <name>  (1164) 
Trifluoperazine 

>  <MW>  (1164) 
407.505

>  <logP>  (1164) 
4.9456

$$$$
CHEMBL1180725
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
  4 25  1  0
 25 26  1  0
 25 27  1  0
 24 11  1  0
 17 12  1  0
 24 19  1  0
M  CHG  1   4   1
M  END
>  <PARENT_MOLREGNO>  (1165) 
654675

>  <SYNONYMS>  (1165) 
Propantheline bromide (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1165) 
4

>  <RESEARCH_CODES>  (1165) 
nan

>  <APPLICANTS>  (1165) 
Shire Development Inc; Gd Searle Llc

>  <USAN_STEM>  (1165) 
nan

>  <USAN_STEM_DEFINITION>  (1165) 
nan

>  <USAN_STEM_SUBSTEM>  (1165) 
nan

>  <USAN_YEAR>  (1165) 
nan

>  <FIRST_APPROVAL>  (1165) 
1953.0

>  <ATC_CODE>  (1165) 
A03AB05

>  <ATC_CODE_DESCRIPTION>  (1165) 
A03AB05 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]

>  <INDICATION_CLASS>  (1165) 
Anticholinergic

>  <SC_PATENT_NO>  (1165) 
nan

>  <DRUG_TYPE>  (1165) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1165) 
Y

>  <FIRST_IN_CLASS>  (1165) 
N

>  <CHIRALITY>  (1165) 
Achiral Molecule

>  <PRODRUG>  (1165) 
N

>  <ORAL>  (1165) 
Y

>  <PARENTERAL>  (1165) 
Y

>  <TOPICAL>  (1165) 
N

>  <BLACK_BOX>  (1165) 
N

>  <AVAILABILITY_TYPE>  (1165) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1165) 
nan

>  <WITHDRAWN_COUNTRY>  (1165) 
nan

>  <WITHDRAWN_REASON>  (1165) 
nan

>  <CANONICAL_SMILES>  (1165) 
CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C

>  <name>  (1165) 
Propantheline bromide 

>  <MW>  (1165) 
368.497

>  <logP>  (1165) 
4.7308

$$$$
CHEMBL558
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1166) 
15958

>  <SYNONYMS>  (1166) 
Mexiletine (BAN, INN); Mexiletine HCl (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1166) 
4

>  <RESEARCH_CODES>  (1166) 
KO-1173 CL; KO-1173-Cl

>  <APPLICANTS>  (1166) 
Boehringer Ingelheim

>  <USAN_STEM>  (1166) 
nan

>  <USAN_STEM_DEFINITION>  (1166) 
nan

>  <USAN_STEM_SUBSTEM>  (1166) 
nan

>  <USAN_YEAR>  (1166) 
1986.0

>  <FIRST_APPROVAL>  (1166) 
1985.0

>  <ATC_CODE>  (1166) 
C01BB02

>  <ATC_CODE_DESCRIPTION>  (1166) 
C01BB02 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ib]

>  <INDICATION_CLASS>  (1166) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (1166) 
nan

>  <DRUG_TYPE>  (1166) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1166) 
Y

>  <FIRST_IN_CLASS>  (1166) 
N

>  <CHIRALITY>  (1166) 
Racemic Mixture

>  <PRODRUG>  (1166) 
N

>  <ORAL>  (1166) 
Y

>  <PARENTERAL>  (1166) 
N

>  <TOPICAL>  (1166) 
N

>  <BLACK_BOX>  (1166) 
Y

>  <AVAILABILITY_TYPE>  (1166) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1166) 
nan

>  <WITHDRAWN_COUNTRY>  (1166) 
nan

>  <WITHDRAWN_REASON>  (1166) 
nan

>  <CANONICAL_SMILES>  (1166) 
CC(N)COc1c(C)cccc1C

>  <name>  (1166) 
Mexiletine 

>  <MW>  (1166) 
179.263

>  <logP>  (1166) 
2.02944

$$$$
CHEMBL1863513
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 17 26  1  0
 26 27  2  0
 16 28  1  0
 28 29  1  0
 28 30  1  0
  9 31  1  0
 24  8  1  0
 24 11  1  0
 26 11  1  0
 28 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1167) 
1204084

>  <SYNONYMS>  (1167) 
Ingenol Mebutate (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1167) 
4

>  <RESEARCH_CODES>  (1167) 
PEP-005

>  <APPLICANTS>  (1167) 
Leo Pharma As

>  <USAN_STEM>  (1167) 
nan

>  <USAN_STEM_DEFINITION>  (1167) 
nan

>  <USAN_STEM_SUBSTEM>  (1167) 
nan

>  <USAN_YEAR>  (1167) 
2008.0

>  <FIRST_APPROVAL>  (1167) 
2010.0

>  <ATC_CODE>  (1167) 
D06BX02

>  <ATC_CODE_DESCRIPTION>  (1167) 
D06BX02 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Other chemotherapeutics]

>  <INDICATION_CLASS>  (1167) 
nan

>  <SC_PATENT_NO>  (1167) 
US-6432452-B1

>  <DRUG_TYPE>  (1167) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1167) 
Y

>  <FIRST_IN_CLASS>  (1167) 
N

>  <CHIRALITY>  (1167) 
Single Stereoisomer

>  <PRODRUG>  (1167) 
N

>  <ORAL>  (1167) 
N

>  <PARENTERAL>  (1167) 
N

>  <TOPICAL>  (1167) 
Y

>  <BLACK_BOX>  (1167) 
N

>  <AVAILABILITY_TYPE>  (1167) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1167) 
nan

>  <WITHDRAWN_COUNTRY>  (1167) 
nan

>  <WITHDRAWN_REASON>  (1167) 
nan

>  <CANONICAL_SMILES>  (1167) 
C\C=C(\C)/C(=O)O[C@H]1C(=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C)C

>  <name>  (1167) 
Ingenol Mebutate 

>  <MW>  (1167) 
430.541

>  <logP>  (1167) 
2.3323

$$$$
CHEMBL1909288
     RDKit          

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 11 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 27 32  1  0
 32 33  2  0
 10  5  1  0
 23 11  1  0
 23 18  1  0
 33 24  1  0
M  END
>  <PARENT_MOLREGNO>  (1168) 
1249058

>  <SYNONYMS>  (1168) 
Triacetyldiphenolisatin

>  <DEVELOPMENT_PHASE>  (1168) 
4

>  <RESEARCH_CODES>  (1168) 
nan

>  <APPLICANTS>  (1168) 
nan

>  <USAN_STEM>  (1168) 
nan

>  <USAN_STEM_DEFINITION>  (1168) 
nan

>  <USAN_STEM_SUBSTEM>  (1168) 
nan

>  <USAN_YEAR>  (1168) 
nan

>  <FIRST_APPROVAL>  (1168) 
nan

>  <ATC_CODE>  (1168) 
nan

>  <ATC_CODE_DESCRIPTION>  (1168) 
nan

>  <INDICATION_CLASS>  (1168) 
nan

>  <SC_PATENT_NO>  (1168) 
nan

>  <DRUG_TYPE>  (1168) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1168) 
Y

>  <FIRST_IN_CLASS>  (1168) 
N

>  <CHIRALITY>  (1168) 
Achiral Molecule

>  <PRODRUG>  (1168) 
N

>  <ORAL>  (1168) 
N

>  <PARENTERAL>  (1168) 
N

>  <TOPICAL>  (1168) 
N

>  <BLACK_BOX>  (1168) 
N

>  <AVAILABILITY_TYPE>  (1168) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1168) 
1971.0

>  <WITHDRAWN_COUNTRY>  (1168) 
Australia

>  <WITHDRAWN_REASON>  (1168) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (1168) 
CC(=O)Oc1ccc(cc1)C2(C(=O)N(C(=O)C)c3ccccc23)c4ccc(OC(=O)C)cc4

>  <name>  (1168) 
Triacetyldiphenolisatin

>  <MW>  (1168) 
443.455

>  <logP>  (1168) 
3.7647

$$$$
CHEMBL1094966
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  2  0
 17  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1169) 
624172

>  <SYNONYMS>  (1169) 
Pirbuterol (BAN, INN); Pirbuterol Acetate (FDA, USAN); Pirbuterol HCl (JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1169) 
4

>  <RESEARCH_CODES>  (1169) 
CP-2431414; CP-24314-14; CP-24314-1

>  <APPLICANTS>  (1169) 
Pfizer Inc.; Medicis Pharmaceutical Corp

>  <USAN_STEM>  (1169) 
-terol

>  <USAN_STEM_DEFINITION>  (1169) 
bronchodilators (phenethylamine derivatives)

>  <USAN_STEM_SUBSTEM>  (1169) 
-terol

>  <USAN_YEAR>  (1169) 
1973.0

>  <FIRST_APPROVAL>  (1169) 
1986.0

>  <ATC_CODE>  (1169) 
R03AC08; R03CC07

>  <ATC_CODE_DESCRIPTION>  (1169) 
R03AC08 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]; R03CC07 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (1169) 
Bronchodilator

>  <SC_PATENT_NO>  (1169) 
nan

>  <DRUG_TYPE>  (1169) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1169) 
Y

>  <FIRST_IN_CLASS>  (1169) 
N

>  <CHIRALITY>  (1169) 
Racemic Mixture

>  <PRODRUG>  (1169) 
N

>  <ORAL>  (1169) 
N

>  <PARENTERAL>  (1169) 
N

>  <TOPICAL>  (1169) 
Y

>  <BLACK_BOX>  (1169) 
N

>  <AVAILABILITY_TYPE>  (1169) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1169) 
nan

>  <WITHDRAWN_COUNTRY>  (1169) 
nan

>  <WITHDRAWN_REASON>  (1169) 
nan

>  <CANONICAL_SMILES>  (1169) 
CC(C)(C)NCC(O)c1ccc(O)c(CO)n1

>  <name>  (1169) 
Pirbuterol 

>  <MW>  (1169) 
240.303

>  <logP>  (1169) 
0.701

$$$$
CHEMBL916
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 14 26  1  0
 26 27  2  0
  9 28  1  0
 28 29  2  0
 28 30  1  0
 27 11  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1170) 
82721

>  <SYNONYMS>  (1170) 
Tirofiban (BAN, INN); Tirofiban HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1170) 
4

>  <RESEARCH_CODES>  (1170) 
L-700462; MK-383

>  <APPLICANTS>  (1170) 
Medicure International Inc

>  <USAN_STEM>  (1170) 
-fiban

>  <USAN_STEM_DEFINITION>  (1170) 
fibrinogen receptor antagonists (glycoprotein IIb/IIIa receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (1170) 
-fiban

>  <USAN_YEAR>  (1170) 
1994.0

>  <FIRST_APPROVAL>  (1170) 
1998.0

>  <ATC_CODE>  (1170) 
B01AC17

>  <ATC_CODE_DESCRIPTION>  (1170) 
B01AC17 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (1170) 
Treatment of Unstable Angina

>  <SC_PATENT_NO>  (1170) 
US-5733919-A

>  <DRUG_TYPE>  (1170) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1170) 
Y

>  <FIRST_IN_CLASS>  (1170) 
N

>  <CHIRALITY>  (1170) 
Single Stereoisomer

>  <PRODRUG>  (1170) 
N

>  <ORAL>  (1170) 
N

>  <PARENTERAL>  (1170) 
Y

>  <TOPICAL>  (1170) 
N

>  <BLACK_BOX>  (1170) 
N

>  <AVAILABILITY_TYPE>  (1170) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1170) 
nan

>  <WITHDRAWN_COUNTRY>  (1170) 
nan

>  <WITHDRAWN_REASON>  (1170) 
nan

>  <CANONICAL_SMILES>  (1170) 
CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O

>  <name>  (1170) 
Tirofiban 

>  <MW>  (1170) 
440.606

>  <logP>  (1170) 
2.9505

$$$$
CHEMBL511
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
  8 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
  6 20  1  0
 20 21  2  0
 21  3  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1171) 
10661

>  <SYNONYMS>  (1171) 
Mepyramine (INN, BAN); Pyrilamine Maleate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1171) 
4

>  <RESEARCH_CODES>  (1171) 
nan

>  <APPLICANTS>  (1171) 
Allergan Pharmaceutical

>  <USAN_STEM>  (1171) 
nan

>  <USAN_STEM_DEFINITION>  (1171) 
nan

>  <USAN_STEM_SUBSTEM>  (1171) 
nan

>  <USAN_YEAR>  (1171) 
nan

>  <FIRST_APPROVAL>  (1171) 
1973.0

>  <ATC_CODE>  (1171) 
D04AA02; R06AC01

>  <ATC_CODE_DESCRIPTION>  (1171) 
D04AA02 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]; R06AC01 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted ethylene diamines]

>  <INDICATION_CLASS>  (1171) 
Antihistaminic

>  <SC_PATENT_NO>  (1171) 
nan

>  <DRUG_TYPE>  (1171) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1171) 
Y

>  <FIRST_IN_CLASS>  (1171) 
N

>  <CHIRALITY>  (1171) 
Achiral Molecule

>  <PRODRUG>  (1171) 
N

>  <ORAL>  (1171) 
Y

>  <PARENTERAL>  (1171) 
N

>  <TOPICAL>  (1171) 
Y

>  <BLACK_BOX>  (1171) 
N

>  <AVAILABILITY_TYPE>  (1171) 
Discontinued

>  <WITHDRAWN_YEAR>  (1171) 
nan

>  <WITHDRAWN_COUNTRY>  (1171) 
nan

>  <WITHDRAWN_REASON>  (1171) 
nan

>  <CANONICAL_SMILES>  (1171) 
COc1ccc(CN(CCN(C)C)c2ccccn2)cc1

>  <name>  (1171) 
Mepyramine 

>  <MW>  (1171) 
285.391

>  <logP>  (1171) 
2.6584

$$$$
CHEMBL978
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  CHG  1   4   1
M  END
>  <PARENT_MOLREGNO>  (1172) 
99320

>  <SYNONYMS>  (1172) 
Methacholine Chloride (BAN, FDA, INN, USP); Methacholine Bromide (NF)

>  <DEVELOPMENT_PHASE>  (1172) 
4

>  <RESEARCH_CODES>  (1172) 
nan

>  <APPLICANTS>  (1172) 
Methapharm Inc

>  <USAN_STEM>  (1172) 
nan

>  <USAN_STEM_DEFINITION>  (1172) 
nan

>  <USAN_STEM_SUBSTEM>  (1172) 
nan

>  <USAN_YEAR>  (1172) 
nan

>  <FIRST_APPROVAL>  (1172) 
1986.0

>  <ATC_CODE>  (1172) 
nan

>  <ATC_CODE_DESCRIPTION>  (1172) 
nan

>  <INDICATION_CLASS>  (1172) 
Cholinergic

>  <SC_PATENT_NO>  (1172) 
nan

>  <DRUG_TYPE>  (1172) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1172) 
Y

>  <FIRST_IN_CLASS>  (1172) 
N

>  <CHIRALITY>  (1172) 
Racemic Mixture

>  <PRODRUG>  (1172) 
N

>  <ORAL>  (1172) 
N

>  <PARENTERAL>  (1172) 
N

>  <TOPICAL>  (1172) 
Y

>  <BLACK_BOX>  (1172) 
N

>  <AVAILABILITY_TYPE>  (1172) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1172) 
nan

>  <WITHDRAWN_COUNTRY>  (1172) 
nan

>  <WITHDRAWN_REASON>  (1172) 
nan

>  <CANONICAL_SMILES>  (1172) 
CC(C[N+](C)(C)C)OC(=O)C

>  <name>  (1172) 
Methacholine Chloride 

>  <MW>  (1172) 
160.237

>  <logP>  (1172) 
0.6442

$$$$
CHEMBL101
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  8 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 10  5  1  0
 17 12  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1173) 
12417

>  <SYNONYMS>  (1173) 
Phenylbutazone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1173) 
4

>  <RESEARCH_CODES>  (1173) 
nan

>  <APPLICANTS>  (1173) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (1173) 
-butazone

>  <USAN_STEM_DEFINITION>  (1173) 
anti-inflammatory analgesics (phenylbutazone type)

>  <USAN_STEM_SUBSTEM>  (1173) 
-butazone

>  <USAN_YEAR>  (1173) 
nan

>  <FIRST_APPROVAL>  (1173) 
1980.0

>  <ATC_CODE>  (1173) 
M02AA01; M01AA01

>  <ATC_CODE_DESCRIPTION>  (1173) 
M02AA01 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; M01AA01 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Butylpyrazolidines]

>  <INDICATION_CLASS>  (1173) 
Antirheumatic

>  <SC_PATENT_NO>  (1173) 
nan

>  <DRUG_TYPE>  (1173) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1173) 
Y

>  <FIRST_IN_CLASS>  (1173) 
N

>  <CHIRALITY>  (1173) 
Achiral Molecule

>  <PRODRUG>  (1173) 
N

>  <ORAL>  (1173) 
Y

>  <PARENTERAL>  (1173) 
N

>  <TOPICAL>  (1173) 
N

>  <BLACK_BOX>  (1173) 
N

>  <AVAILABILITY_TYPE>  (1173) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1173) 
1985.0

>  <WITHDRAWN_COUNTRY>  (1173) 
Germany

>  <WITHDRAWN_REASON>  (1173) 
Off-Label Abuse; Hematologic Toxicity

>  <CANONICAL_SMILES>  (1173) 
CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3

>  <name>  (1173) 
Phenylbutazone 

>  <MW>  (1173) 
308.381

>  <logP>  (1173) 
3.7878

$$$$
CHEMBL1201274
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 13 21  1  0
 21 22  2  0
 22 10  1  0
 20 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1174) 
675225

>  <SYNONYMS>  (1174) 
Levobetaxolol (INN); Levobetaxolol HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1174) 
4

>  <RESEARCH_CODES>  (1174) 
AL-1577A

>  <APPLICANTS>  (1174) 
Alcon Pharmaceuticals Ltd

>  <USAN_STEM>  (1174) 
-olol

>  <USAN_STEM_DEFINITION>  (1174) 
beta-blockers (propranolol type)

>  <USAN_STEM_SUBSTEM>  (1174) 
-olol

>  <USAN_YEAR>  (1174) 
1989.0

>  <FIRST_APPROVAL>  (1174) 
2000.0

>  <ATC_CODE>  (1174) 
nan

>  <ATC_CODE_DESCRIPTION>  (1174) 
nan

>  <INDICATION_CLASS>  (1174) 
Anti-Adrenergic (beta-receptor)

>  <SC_PATENT_NO>  (1174) 
nan

>  <DRUG_TYPE>  (1174) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1174) 
Y

>  <FIRST_IN_CLASS>  (1174) 
N

>  <CHIRALITY>  (1174) 
Single Stereoisomer

>  <PRODRUG>  (1174) 
N

>  <ORAL>  (1174) 
N

>  <PARENTERAL>  (1174) 
N

>  <TOPICAL>  (1174) 
Y

>  <BLACK_BOX>  (1174) 
N

>  <AVAILABILITY_TYPE>  (1174) 
Discontinued

>  <WITHDRAWN_YEAR>  (1174) 
nan

>  <WITHDRAWN_COUNTRY>  (1174) 
nan

>  <WITHDRAWN_REASON>  (1174) 
nan

>  <CANONICAL_SMILES>  (1174) 
CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1

>  <name>  (1174) 
Levobetaxolol 

>  <MW>  (1174) 
307.434

>  <logP>  (1174) 
2.3934

$$$$
CHEMBL2107333
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1175) 
1379603

>  <SYNONYMS>  (1175) 
Dimethyl Fumarate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1175) 
4

>  <RESEARCH_CODES>  (1175) 
AZL-0211089

>  <APPLICANTS>  (1175) 
Biogen Idec Inc

>  <USAN_STEM>  (1175) 
nan

>  <USAN_STEM_DEFINITION>  (1175) 
nan

>  <USAN_STEM_SUBSTEM>  (1175) 
nan

>  <USAN_YEAR>  (1175) 
2005.0

>  <FIRST_APPROVAL>  (1175) 
2013.0

>  <ATC_CODE>  (1175) 
N07XX09

>  <ATC_CODE_DESCRIPTION>  (1175) 
N07XX09 [Nervous System:Other Nervous System Drugs:Other Nervous System Drugs:Other nervous system drugs]

>  <INDICATION_CLASS>  (1175) 
nan

>  <SC_PATENT_NO>  (1175) 
US-6509376-B1

>  <DRUG_TYPE>  (1175) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1175) 
Y

>  <FIRST_IN_CLASS>  (1175) 
N

>  <CHIRALITY>  (1175) 
Achiral Molecule

>  <PRODRUG>  (1175) 
N

>  <ORAL>  (1175) 
Y

>  <PARENTERAL>  (1175) 
N

>  <TOPICAL>  (1175) 
N

>  <BLACK_BOX>  (1175) 
N

>  <AVAILABILITY_TYPE>  (1175) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1175) 
nan

>  <WITHDRAWN_COUNTRY>  (1175) 
nan

>  <WITHDRAWN_REASON>  (1175) 
nan

>  <CANONICAL_SMILES>  (1175) 
COC(=O)\C=C\C(=O)OC

>  <name>  (1175) 
Dimethyl Fumarate 

>  <MW>  (1175) 
144.126

>  <logP>  (1175) 
-0.1114

$$$$
CHEMBL1200963
     RDKit          

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 18 12  1  0
 30 25  1  0
M  END
>  <PARENT_MOLREGNO>  (1176) 
674914

>  <SYNONYMS>  (1176) 
Bimatoprost (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1176) 
4

>  <RESEARCH_CODES>  (1176) 
AGN-192024

>  <APPLICANTS>  (1176) 
Allergan Inc

>  <USAN_STEM>  (1176) 
-prost

>  <USAN_STEM_DEFINITION>  (1176) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (1176) 
-prost

>  <USAN_YEAR>  (1176) 
2001.0

>  <FIRST_APPROVAL>  (1176) 
2001.0

>  <ATC_CODE>  (1176) 
S01EE03

>  <ATC_CODE_DESCRIPTION>  (1176) 
S01EE03 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Prostaglandin analogues1)]

>  <INDICATION_CLASS>  (1176) 
nan

>  <SC_PATENT_NO>  (1176) 
US-7351404-B2

>  <DRUG_TYPE>  (1176) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1176) 
Y

>  <FIRST_IN_CLASS>  (1176) 
N

>  <CHIRALITY>  (1176) 
Single Stereoisomer

>  <PRODRUG>  (1176) 
N

>  <ORAL>  (1176) 
N

>  <PARENTERAL>  (1176) 
N

>  <TOPICAL>  (1176) 
Y

>  <BLACK_BOX>  (1176) 
N

>  <AVAILABILITY_TYPE>  (1176) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1176) 
nan

>  <WITHDRAWN_COUNTRY>  (1176) 
nan

>  <WITHDRAWN_REASON>  (1176) 
nan

>  <CANONICAL_SMILES>  (1176) 
CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCc2ccccc2

>  <name>  (1176) 
Bimatoprost 

>  <MW>  (1176) 
415.574

>  <logP>  (1176) 
3.1469

$$$$
CHEMBL1663
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1177) 
498105

>  <SYNONYMS>  (1177) 
Perflutren (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1177) 
4

>  <RESEARCH_CODES>  (1177) 
DMP-115; FS-069; FS069; MRX-115

>  <APPLICANTS>  (1177) 
Lantheus Medical Imaging Inc

>  <USAN_STEM>  (1177) 
perflu-

>  <USAN_STEM_DEFINITION>  (1177) 
blood substitutes and/or diagnostics (perfluorochemicals)

>  <USAN_STEM_SUBSTEM>  (1177) 
perflu-

>  <USAN_YEAR>  (1177) 
1999.0

>  <FIRST_APPROVAL>  (1177) 
2001.0

>  <ATC_CODE>  (1177) 
nan

>  <ATC_CODE_DESCRIPTION>  (1177) 
nan

>  <INDICATION_CLASS>  (1177) 
nan

>  <SC_PATENT_NO>  (1177) 
US-6033645-A

>  <DRUG_TYPE>  (1177) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1177) 
Y

>  <FIRST_IN_CLASS>  (1177) 
N

>  <CHIRALITY>  (1177) 
Achiral Molecule

>  <PRODRUG>  (1177) 
N

>  <ORAL>  (1177) 
N

>  <PARENTERAL>  (1177) 
Y

>  <TOPICAL>  (1177) 
N

>  <BLACK_BOX>  (1177) 
Y

>  <AVAILABILITY_TYPE>  (1177) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1177) 
nan

>  <WITHDRAWN_COUNTRY>  (1177) 
nan

>  <WITHDRAWN_REASON>  (1177) 
nan

>  <CANONICAL_SMILES>  (1177) 
FC(F)(F)C(F)(F)C(F)(F)F

>  <name>  (1177) 
Perflutren 

>  <MW>  (1177) 
188.017

>  <logP>  (1177) 
2.7463

$$$$
CHEMBL18
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
 13 14  2  0
 13 15  2  0
 13 16  1  0
 12  4  1  0
 11  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1178) 
1096

>  <SYNONYMS>  (1178) 
Ethoxzolamide (FDA, MI, USP)

>  <DEVELOPMENT_PHASE>  (1178) 
4

>  <RESEARCH_CODES>  (1178) 
nan

>  <APPLICANTS>  (1178) 
Pharmacia And Upjohn Co; Allergan Pharmaceutical

>  <USAN_STEM>  (1178) 
-zolamide

>  <USAN_STEM_DEFINITION>  (1178) 
carbonic anhydrase inhibitors

>  <USAN_STEM_SUBSTEM>  (1178) 
-zolamide

>  <USAN_YEAR>  (1178) 
nan

>  <FIRST_APPROVAL>  (1178) 
1982.0

>  <ATC_CODE>  (1178) 
nan

>  <ATC_CODE_DESCRIPTION>  (1178) 
nan

>  <INDICATION_CLASS>  (1178) 
nan

>  <SC_PATENT_NO>  (1178) 
nan

>  <DRUG_TYPE>  (1178) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1178) 
Y

>  <FIRST_IN_CLASS>  (1178) 
N

>  <CHIRALITY>  (1178) 
Achiral Molecule

>  <PRODRUG>  (1178) 
N

>  <ORAL>  (1178) 
Y

>  <PARENTERAL>  (1178) 
N

>  <TOPICAL>  (1178) 
N

>  <BLACK_BOX>  (1178) 
N

>  <AVAILABILITY_TYPE>  (1178) 
Discontinued

>  <WITHDRAWN_YEAR>  (1178) 
nan

>  <WITHDRAWN_COUNTRY>  (1178) 
nan

>  <WITHDRAWN_REASON>  (1178) 
nan

>  <CANONICAL_SMILES>  (1178) 
CCOc1ccc2nc(sc2c1)S(=O)(=O)N

>  <name>  (1178) 
Ethoxzolamide 

>  <MW>  (1178) 
258.324

>  <logP>  (1178) 
1.3424

$$$$
CHEMBL3184437
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
  9  3  1  0
M  END
>  <PARENT_MOLREGNO>  (1179) 
1673728

>  <SYNONYMS>  (1179) 
Dichlorobenzyl Alcohol

>  <DEVELOPMENT_PHASE>  (1179) 
4

>  <RESEARCH_CODES>  (1179) 
nan

>  <APPLICANTS>  (1179) 
nan

>  <USAN_STEM>  (1179) 
nan

>  <USAN_STEM_DEFINITION>  (1179) 
nan

>  <USAN_STEM_SUBSTEM>  (1179) 
nan

>  <USAN_YEAR>  (1179) 
nan

>  <FIRST_APPROVAL>  (1179) 
nan

>  <ATC_CODE>  (1179) 
R02AA03

>  <ATC_CODE_DESCRIPTION>  (1179) 
R02AA03 [Respiratory System:Throat Preparations:Throat Preparations:Antiseptics]

>  <INDICATION_CLASS>  (1179) 
nan

>  <SC_PATENT_NO>  (1179) 
nan

>  <DRUG_TYPE>  (1179) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1179) 
Y

>  <FIRST_IN_CLASS>  (1179) 
N

>  <CHIRALITY>  (1179) 
Achiral Molecule

>  <PRODRUG>  (1179) 
N

>  <ORAL>  (1179) 
N

>  <PARENTERAL>  (1179) 
N

>  <TOPICAL>  (1179) 
N

>  <BLACK_BOX>  (1179) 
N

>  <AVAILABILITY_TYPE>  (1179) 
Unknown

>  <WITHDRAWN_YEAR>  (1179) 
nan

>  <WITHDRAWN_COUNTRY>  (1179) 
nan

>  <WITHDRAWN_REASON>  (1179) 
nan

>  <CANONICAL_SMILES>  (1179) 
OCc1ccc(Cl)cc1Cl

>  <name>  (1179) 
Dichlorobenzyl Alcohol

>  <MW>  (1179) 
177.03

>  <logP>  (1179) 
2.4857

$$$$
CHEMBL153192
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  8  2  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1180) 
255047

>  <SYNONYMS>  (1180) 
Bromosalicychloranilidine

>  <DEVELOPMENT_PHASE>  (1180) 
4

>  <RESEARCH_CODES>  (1180) 
nan

>  <APPLICANTS>  (1180) 
nan

>  <USAN_STEM>  (1180) 
-sal-

>  <USAN_STEM_DEFINITION>  (1180) 
anti-inflammatory agents (salicylic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (1180) 
-sal-

>  <USAN_YEAR>  (1180) 
nan

>  <FIRST_APPROVAL>  (1180) 
nan

>  <ATC_CODE>  (1180) 
D01AE01

>  <ATC_CODE_DESCRIPTION>  (1180) 
D01AE01 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Other antifungals for topical use]

>  <INDICATION_CLASS>  (1180) 
nan

>  <SC_PATENT_NO>  (1180) 
nan

>  <DRUG_TYPE>  (1180) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1180) 
Y

>  <FIRST_IN_CLASS>  (1180) 
N

>  <CHIRALITY>  (1180) 
Achiral Molecule

>  <PRODRUG>  (1180) 
N

>  <ORAL>  (1180) 
N

>  <PARENTERAL>  (1180) 
N

>  <TOPICAL>  (1180) 
N

>  <BLACK_BOX>  (1180) 
N

>  <AVAILABILITY_TYPE>  (1180) 
Unknown

>  <WITHDRAWN_YEAR>  (1180) 
nan

>  <WITHDRAWN_COUNTRY>  (1180) 
nan

>  <WITHDRAWN_REASON>  (1180) 
nan

>  <CANONICAL_SMILES>  (1180) 
Oc1ccc(Br)cc1C(=O)Nc2ccc(Cl)cc2

>  <name>  (1180) 
Bromosalicychloranilidine

>  <MW>  (1180) 
326.577

>  <logP>  (1180) 
4.0604

$$$$
CHEMBL267894
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  3  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 12 16  1  0
 14  3  1  0
M  END
>  <PARENT_MOLREGNO>  (1181) 
2366

>  <SYNONYMS>  (1181) 
Amobarbital (BAN, INN, JAN, USP); Amobarbital Sodium (USP); Amobarbital Sodium For Injection (JAN)

>  <DEVELOPMENT_PHASE>  (1181) 
4

>  <RESEARCH_CODES>  (1181) 
nan

>  <APPLICANTS>  (1181) 
SmithKline Beecham; Marion Merrell Dow; Lilly

>  <USAN_STEM>  (1181) 
-barb-

>  <USAN_STEM_DEFINITION>  (1181) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (1181) 
-barb-

>  <USAN_YEAR>  (1181) 
nan

>  <FIRST_APPROVAL>  (1181) 
nan

>  <ATC_CODE>  (1181) 
N05CA02

>  <ATC_CODE_DESCRIPTION>  (1181) 
N05CA02 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (1181) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (1181) 
nan

>  <DRUG_TYPE>  (1181) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1181) 
Y

>  <FIRST_IN_CLASS>  (1181) 
N

>  <CHIRALITY>  (1181) 
Achiral Molecule

>  <PRODRUG>  (1181) 
N

>  <ORAL>  (1181) 
N

>  <PARENTERAL>  (1181) 
N

>  <TOPICAL>  (1181) 
N

>  <BLACK_BOX>  (1181) 
N

>  <AVAILABILITY_TYPE>  (1181) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1181) 
1980.0

>  <WITHDRAWN_COUNTRY>  (1181) 
Norway; Norway

>  <WITHDRAWN_REASON>  (1181) 
Self-Poisonings; Self-Poisonings

>  <CANONICAL_SMILES>  (1181) 
CCC1(CCC(C)C)C(=O)NC(=NC1=O)O

>  <name>  (1181) 
Amobarbital 

>  <MW>  (1181) 
226.276

>  <logP>  (1181) 
1.3894

$$$$
CHEMBL268164
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
  3 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 10  3  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1182) 
2198

>  <SYNONYMS>  (1182) 
Cyclobarbital (BAN, INN, MI, NF); Cyclobarbital Calcium (BAN, NF)

>  <DEVELOPMENT_PHASE>  (1182) 
4

>  <RESEARCH_CODES>  (1182) 
nan

>  <APPLICANTS>  (1182) 
Sterling Winthrop

>  <USAN_STEM>  (1182) 
-barb-

>  <USAN_STEM_DEFINITION>  (1182) 
barbituric acid derivatives

>  <USAN_STEM_SUBSTEM>  (1182) 
-barb-

>  <USAN_YEAR>  (1182) 
nan

>  <FIRST_APPROVAL>  (1182) 
nan

>  <ATC_CODE>  (1182) 
N05CA10

>  <ATC_CODE_DESCRIPTION>  (1182) 
N05CA10 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Barbiturates, plain]

>  <INDICATION_CLASS>  (1182) 
nan

>  <SC_PATENT_NO>  (1182) 
nan

>  <DRUG_TYPE>  (1182) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1182) 
Y

>  <FIRST_IN_CLASS>  (1182) 
N

>  <CHIRALITY>  (1182) 
Achiral Molecule

>  <PRODRUG>  (1182) 
N

>  <ORAL>  (1182) 
N

>  <PARENTERAL>  (1182) 
N

>  <TOPICAL>  (1182) 
N

>  <BLACK_BOX>  (1182) 
N

>  <AVAILABILITY_TYPE>  (1182) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1182) 
1980.0

>  <WITHDRAWN_COUNTRY>  (1182) 
Norway; Norway

>  <WITHDRAWN_REASON>  (1182) 
Self-poisonings; Self-poisonings

>  <CANONICAL_SMILES>  (1182) 
CCC1(C(=O)NC(=O)NC1=O)C2=CCCCC2

>  <name>  (1182) 
Cyclobarbital 

>  <MW>  (1182) 
236.271

>  <logP>  (1182) 
1.2492

$$$$
CHEMBL2103877
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  2 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
  9  3  1  0
 17 13  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1183) 
1376147

>  <SYNONYMS>  (1183) 
Efinaconazole (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1183) 
4

>  <RESEARCH_CODES>  (1183) 
KP-103

>  <APPLICANTS>  (1183) 
Dow Pharmaceutical Sciences

>  <USAN_STEM>  (1183) 
-conazole

>  <USAN_STEM_DEFINITION>  (1183) 
systemic antifungals (miconazole type)

>  <USAN_STEM_SUBSTEM>  (1183) 
-conazole

>  <USAN_YEAR>  (1183) 
2011.0

>  <FIRST_APPROVAL>  (1183) 
2014.0

>  <ATC_CODE>  (1183) 
D01AC19

>  <ATC_CODE_DESCRIPTION>  (1183) 
D01AC19 [Dermatologicals:Antifungals For Dermatological Use:Antifungals For Topical Use:Imidazole and triazole derivatives]

>  <INDICATION_CLASS>  (1183) 
nan

>  <SC_PATENT_NO>  (1183) 
US-7214506-B2

>  <DRUG_TYPE>  (1183) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1183) 
Y

>  <FIRST_IN_CLASS>  (1183) 
N

>  <CHIRALITY>  (1183) 
Single Stereoisomer

>  <PRODRUG>  (1183) 
N

>  <ORAL>  (1183) 
N

>  <PARENTERAL>  (1183) 
N

>  <TOPICAL>  (1183) 
Y

>  <BLACK_BOX>  (1183) 
N

>  <AVAILABILITY_TYPE>  (1183) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1183) 
nan

>  <WITHDRAWN_COUNTRY>  (1183) 
nan

>  <WITHDRAWN_REASON>  (1183) 
nan

>  <CANONICAL_SMILES>  (1183) 
C[C@@H](N1CCC(=C)CC1)[C@](O)(Cn2cncn2)c3ccc(F)cc3F

>  <name>  (1183) 
Efinaconazole 

>  <MW>  (1183) 
348.397

>  <logP>  (1183) 
2.4846

$$$$
CHEMBL1075
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 18 29  1  0
 29 30  2  0
 30  7  1  0
 29 10  1  0
 17 12  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1184) 
139866

>  <SYNONYMS>  (1184) 
Moracizine (BAN, INN); Moricizine (USAN); Moricizine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1184) 
4

>  <RESEARCH_CODES>  (1184) 
EN-313

>  <APPLICANTS>  (1184) 
Shire Development Inc; Roberts Pharmaceutical

>  <USAN_STEM>  (1184) 
nan

>  <USAN_STEM_DEFINITION>  (1184) 
nan

>  <USAN_STEM_SUBSTEM>  (1184) 
nan

>  <USAN_YEAR>  (1184) 
1981.0

>  <FIRST_APPROVAL>  (1184) 
1990.0

>  <ATC_CODE>  (1184) 
C01BG01

>  <ATC_CODE_DESCRIPTION>  (1184) 
C01BG01 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Other antiarrhythmics, class I and III]

>  <INDICATION_CLASS>  (1184) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (1184) 
nan

>  <DRUG_TYPE>  (1184) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1184) 
Y

>  <FIRST_IN_CLASS>  (1184) 
N

>  <CHIRALITY>  (1184) 
Achiral Molecule

>  <PRODRUG>  (1184) 
N

>  <ORAL>  (1184) 
Y

>  <PARENTERAL>  (1184) 
N

>  <TOPICAL>  (1184) 
N

>  <BLACK_BOX>  (1184) 
Y

>  <AVAILABILITY_TYPE>  (1184) 
Discontinued

>  <WITHDRAWN_YEAR>  (1184) 
nan

>  <WITHDRAWN_COUNTRY>  (1184) 
nan

>  <WITHDRAWN_REASON>  (1184) 
nan

>  <CANONICAL_SMILES>  (1184) 
CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN4CCOCC4)c2c1

>  <name>  (1184) 
Moracizine 

>  <MW>  (1184) 
427.526

>  <logP>  (1184) 
4.1066

$$$$
CHEMBL1025
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1185) 
119717

>  <SYNONYMS>  (1185) 
Dyflos (BAN); Isoflurophate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1185) 
4

>  <RESEARCH_CODES>  (1185) 
nan

>  <APPLICANTS>  (1185) 
Merck And Co Inc

>  <USAN_STEM>  (1185) 
nan

>  <USAN_STEM_DEFINITION>  (1185) 
nan

>  <USAN_STEM_SUBSTEM>  (1185) 
nan

>  <USAN_YEAR>  (1185) 
nan

>  <FIRST_APPROVAL>  (1185) 
1957.0

>  <ATC_CODE>  (1185) 
S01EB07

>  <ATC_CODE_DESCRIPTION>  (1185) 
S01EB07 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]

>  <INDICATION_CLASS>  (1185) 
Cholinergic (ophthalmic)

>  <SC_PATENT_NO>  (1185) 
nan

>  <DRUG_TYPE>  (1185) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1185) 
Y

>  <FIRST_IN_CLASS>  (1185) 
N

>  <CHIRALITY>  (1185) 
Achiral Molecule

>  <PRODRUG>  (1185) 
N

>  <ORAL>  (1185) 
N

>  <PARENTERAL>  (1185) 
N

>  <TOPICAL>  (1185) 
Y

>  <BLACK_BOX>  (1185) 
N

>  <AVAILABILITY_TYPE>  (1185) 
Discontinued

>  <WITHDRAWN_YEAR>  (1185) 
nan

>  <WITHDRAWN_COUNTRY>  (1185) 
nan

>  <WITHDRAWN_REASON>  (1185) 
nan

>  <CANONICAL_SMILES>  (1185) 
CC(C)OP(=O)(F)OC(C)C

>  <name>  (1185) 
Dyflos 

>  <MW>  (1185) 
184.147

>  <logP>  (1185) 
2.914

$$$$
CHEMBL491571
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
  8 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  2  0
 23 26  1  0
 20 27  1  0
 11  4  1  0
 10  5  1  0
 27 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1186) 
460466

>  <SYNONYMS>  (1186) 
Doripenem (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1186) 
4

>  <RESEARCH_CODES>  (1186) 
S-4661

>  <APPLICANTS>  (1186) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (1186) 
-penem

>  <USAN_STEM_DEFINITION>  (1186) 
antibacterial antibiotics, carbapenem derivatives

>  <USAN_STEM_SUBSTEM>  (1186) 
-penem

>  <USAN_YEAR>  (1186) 
2005.0

>  <FIRST_APPROVAL>  (1186) 
2007.0

>  <ATC_CODE>  (1186) 
J01DH04

>  <ATC_CODE_DESCRIPTION>  (1186) 
J01DH04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Carbapenems]

>  <INDICATION_CLASS>  (1186) 
nan

>  <SC_PATENT_NO>  (1186) 
US-8247402-B2

>  <DRUG_TYPE>  (1186) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1186) 
Y

>  <FIRST_IN_CLASS>  (1186) 
N

>  <CHIRALITY>  (1186) 
Single Stereoisomer

>  <PRODRUG>  (1186) 
N

>  <ORAL>  (1186) 
N

>  <PARENTERAL>  (1186) 
Y

>  <TOPICAL>  (1186) 
N

>  <BLACK_BOX>  (1186) 
N

>  <AVAILABILITY_TYPE>  (1186) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1186) 
nan

>  <WITHDRAWN_COUNTRY>  (1186) 
nan

>  <WITHDRAWN_REASON>  (1186) 
nan

>  <CANONICAL_SMILES>  (1186) 
C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@H](CNS(=O)(=O)N)C3

>  <name>  (1186) 
Doripenem 

>  <MW>  (1186) 
420.513

>  <logP>  (1186) 
-1.6031

$$$$
CHEMBL809
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  2  0
  6 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  3  1  0
 14  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1187) 
53616

>  <SYNONYMS>  (1187) 
Sertraline (BAN, INN); Sertraline HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1187) 
4

>  <RESEARCH_CODES>  (1187) 
CP-519741; CP-51974-1

>  <APPLICANTS>  (1187) 
Pfizer Pharmaceuticals Inc

>  <USAN_STEM>  (1187) 
-traline

>  <USAN_STEM_DEFINITION>  (1187) 
selective serotonin reuptake inhibitors (SSRI)

>  <USAN_STEM_SUBSTEM>  (1187) 
-traline

>  <USAN_YEAR>  (1187) 
1983.0

>  <FIRST_APPROVAL>  (1187) 
1991.0

>  <ATC_CODE>  (1187) 
N06AB06

>  <ATC_CODE_DESCRIPTION>  (1187) 
N06AB06 [Nervous System:Psychoanaleptics:Antidepressants:Selective serotonin reuptake inhibitors]

>  <INDICATION_CLASS>  (1187) 
Antidepressant

>  <SC_PATENT_NO>  (1187) 
US-6727283-B2

>  <DRUG_TYPE>  (1187) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1187) 
Y

>  <FIRST_IN_CLASS>  (1187) 
N

>  <CHIRALITY>  (1187) 
Single Stereoisomer

>  <PRODRUG>  (1187) 
N

>  <ORAL>  (1187) 
Y

>  <PARENTERAL>  (1187) 
N

>  <TOPICAL>  (1187) 
N

>  <BLACK_BOX>  (1187) 
Y

>  <AVAILABILITY_TYPE>  (1187) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1187) 
nan

>  <WITHDRAWN_COUNTRY>  (1187) 
nan

>  <WITHDRAWN_REASON>  (1187) 
nan

>  <CANONICAL_SMILES>  (1187) 
CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13

>  <name>  (1187) 
Sertraline 

>  <MW>  (1187) 
306.236

>  <logP>  (1187) 
5.1796

$$$$
CHEMBL2110569
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
  9 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 11  5  1  0
 19  6  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1188) 
1383009

>  <SYNONYMS>  (1188) 
Ioflupane (123I) (BAN, INN, USAN, FDA)

>  <DEVELOPMENT_PHASE>  (1188) 
4

>  <RESEARCH_CODES>  (1188) 
V09AB03

>  <APPLICANTS>  (1188) 
Ge Healthcare Inc

>  <USAN_STEM>  (1188) 
io-

>  <USAN_STEM_DEFINITION>  (1188) 
iodine-containing contrast media

>  <USAN_STEM_SUBSTEM>  (1188) 
io-

>  <USAN_YEAR>  (1188) 
2009.0

>  <FIRST_APPROVAL>  (1188) 
2011.0

>  <ATC_CODE>  (1188) 
V09AB03

>  <ATC_CODE_DESCRIPTION>  (1188) 
V09AB03 [Various:Diagnostic Radiopharmaceuticals:Central Nervous System:Iodine (123I) compounds]

>  <INDICATION_CLASS>  (1188) 
nan

>  <SC_PATENT_NO>  (1188) 
nan

>  <DRUG_TYPE>  (1188) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1188) 
Y

>  <FIRST_IN_CLASS>  (1188) 
N

>  <CHIRALITY>  (1188) 
Single Stereoisomer

>  <PRODRUG>  (1188) 
N

>  <ORAL>  (1188) 
N

>  <PARENTERAL>  (1188) 
Y

>  <TOPICAL>  (1188) 
N

>  <BLACK_BOX>  (1188) 
N

>  <AVAILABILITY_TYPE>  (1188) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1188) 
nan

>  <WITHDRAWN_COUNTRY>  (1188) 
nan

>  <WITHDRAWN_REASON>  (1188) 
nan

>  <CANONICAL_SMILES>  (1188) 
COC(=O)[C@@H]1C2CCC(C[C@@H]1c3ccc(I)cc3)N2CCCF

>  <name>  (1188) 
Ioflupane 

>  <MW>  (1188) 
431.289

>  <logP>  (1188) 
3.7603

$$$$
CHEMBL45
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
  9 16  1  0
 16 17  2  0
 17  3  1  0
 16  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1189) 
3012

>  <SYNONYMS>  (1189) 
Melatonin

>  <DEVELOPMENT_PHASE>  (1189) 
4

>  <RESEARCH_CODES>  (1189) 
nan

>  <APPLICANTS>  (1189) 
nan

>  <USAN_STEM>  (1189) 
nan

>  <USAN_STEM_DEFINITION>  (1189) 
nan

>  <USAN_STEM_SUBSTEM>  (1189) 
nan

>  <USAN_YEAR>  (1189) 
nan

>  <FIRST_APPROVAL>  (1189) 
nan

>  <ATC_CODE>  (1189) 
N05CH01

>  <ATC_CODE_DESCRIPTION>  (1189) 
N05CH01 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Melatonin receptor agonists]

>  <INDICATION_CLASS>  (1189) 
nan

>  <SC_PATENT_NO>  (1189) 
nan

>  <DRUG_TYPE>  (1189) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1189) 
Y

>  <FIRST_IN_CLASS>  (1189) 
N

>  <CHIRALITY>  (1189) 
Achiral Molecule

>  <PRODRUG>  (1189) 
N

>  <ORAL>  (1189) 
N

>  <PARENTERAL>  (1189) 
N

>  <TOPICAL>  (1189) 
N

>  <BLACK_BOX>  (1189) 
N

>  <AVAILABILITY_TYPE>  (1189) 
Unknown

>  <WITHDRAWN_YEAR>  (1189) 
nan

>  <WITHDRAWN_COUNTRY>  (1189) 
nan

>  <WITHDRAWN_REASON>  (1189) 
nan

>  <CANONICAL_SMILES>  (1189) 
COc1ccc2[nH]cc(CCNC(=O)C)c2c1

>  <name>  (1189) 
Melatonin

>  <MW>  (1189) 
232.283

>  <logP>  (1189) 
1.8551

$$$$
CHEMBL1605
     RDKit          

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  7 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 21 25  1  0
 25 26  2  0
 25 27  1  0
  6  2  1  0
 23 16  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1190) 
454578

>  <SYNONYMS>  (1190) 
Ceftibuten (BAN, INN, USAN); Ceftibuten Dihydrate (FDA)

>  <DEVELOPMENT_PHASE>  (1190) 
4

>  <RESEARCH_CODES>  (1190) 
7432-S; SCH-39720

>  <APPLICANTS>  (1190) 
Pernix Therapeutics Llc

>  <USAN_STEM>  (1190) 
cef-

>  <USAN_STEM_DEFINITION>  (1190) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (1190) 
cef-

>  <USAN_YEAR>  (1190) 
1989.0

>  <FIRST_APPROVAL>  (1190) 
1995.0

>  <ATC_CODE>  (1190) 
J01DD14

>  <ATC_CODE_DESCRIPTION>  (1190) 
J01DD14 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Third-generation cephalosporins]

>  <INDICATION_CLASS>  (1190) 
Antibacterial

>  <SC_PATENT_NO>  (1190) 
nan

>  <DRUG_TYPE>  (1190) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1190) 
Y

>  <FIRST_IN_CLASS>  (1190) 
N

>  <CHIRALITY>  (1190) 
Single Stereoisomer

>  <PRODRUG>  (1190) 
N

>  <ORAL>  (1190) 
Y

>  <PARENTERAL>  (1190) 
N

>  <TOPICAL>  (1190) 
N

>  <BLACK_BOX>  (1190) 
N

>  <AVAILABILITY_TYPE>  (1190) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1190) 
nan

>  <WITHDRAWN_COUNTRY>  (1190) 
nan

>  <WITHDRAWN_REASON>  (1190) 
nan

>  <CANONICAL_SMILES>  (1190) 
Nc1nc(cs1)\C(=C\CC(=O)O)\C(=O)N[C@H]2[C@H]3SCC=C(N3C2=O)C(=O)O

>  <name>  (1190) 
Ceftibuten 

>  <MW>  (1190) 
410.433

>  <logP>  (1190) 
-0.0482

$$$$
CHEMBL1200374
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
  6 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 18  2  1  0
 21  2  1  0
 16  5  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1191) 
674325

>  <SYNONYMS>  (1191) 
Exemestane (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1191) 
4

>  <RESEARCH_CODES>  (1191) 
FCE-24304; PNU-155971

>  <APPLICANTS>  (1191) 
Pharmacia And Upjohn Co

>  <USAN_STEM>  (1191) 
-mestane

>  <USAN_STEM_DEFINITION>  (1191) 
antineoplastics (aromatase inhibitors)

>  <USAN_STEM_SUBSTEM>  (1191) 
-mestane

>  <USAN_YEAR>  (1191) 
1999.0

>  <FIRST_APPROVAL>  (1191) 
1999.0

>  <ATC_CODE>  (1191) 
L02BG06

>  <ATC_CODE_DESCRIPTION>  (1191) 
L02BG06 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Aromatase inhibitors]

>  <INDICATION_CLASS>  (1191) 
nan

>  <SC_PATENT_NO>  (1191) 
nan

>  <DRUG_TYPE>  (1191) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1191) 
Y

>  <FIRST_IN_CLASS>  (1191) 
N

>  <CHIRALITY>  (1191) 
Single Stereoisomer

>  <PRODRUG>  (1191) 
N

>  <ORAL>  (1191) 
Y

>  <PARENTERAL>  (1191) 
N

>  <TOPICAL>  (1191) 
N

>  <BLACK_BOX>  (1191) 
N

>  <AVAILABILITY_TYPE>  (1191) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1191) 
nan

>  <WITHDRAWN_COUNTRY>  (1191) 
nan

>  <WITHDRAWN_REASON>  (1191) 
nan

>  <CANONICAL_SMILES>  (1191) 
C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O

>  <name>  (1191) 
Exemestane 

>  <MW>  (1191) 
296.41

>  <logP>  (1191) 
4.0295

$$$$
CHEMBL71
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21  7  1  0
 13  8  1  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1192) 
6216

>  <SYNONYMS>  (1192) 
Chlorpromazine (BAN, FDA, INN, USP); Chlorpromazine Hibenzate (JAN); Chlorpromazine Phenolphthalinate (JAN); Chlorpromazine Tannate (JAN); Chlorpromazine HCl (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1192) 
4

>  <RESEARCH_CODES>  (1192) 
nan

>  <APPLICANTS>  (1192) 
GlaxoSmithKline

>  <USAN_STEM>  (1192) 
nan

>  <USAN_STEM_DEFINITION>  (1192) 
nan

>  <USAN_STEM_SUBSTEM>  (1192) 
nan

>  <USAN_YEAR>  (1192) 
nan

>  <FIRST_APPROVAL>  (1192) 
1957.0

>  <ATC_CODE>  (1192) 
N05AA01

>  <ATC_CODE_DESCRIPTION>  (1192) 
N05AA01 [Nervous System:Psycholeptics:Antipsychotics:Phenothiazines with aliphatic side-chain]

>  <INDICATION_CLASS>  (1192) 
Anti-Emetic; Antipsychotic

>  <SC_PATENT_NO>  (1192) 
nan

>  <DRUG_TYPE>  (1192) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1192) 
Y

>  <FIRST_IN_CLASS>  (1192) 
N

>  <CHIRALITY>  (1192) 
Achiral Molecule

>  <PRODRUG>  (1192) 
N

>  <ORAL>  (1192) 
Y

>  <PARENTERAL>  (1192) 
Y

>  <TOPICAL>  (1192) 
Y

>  <BLACK_BOX>  (1192) 
Y

>  <AVAILABILITY_TYPE>  (1192) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1192) 
nan

>  <WITHDRAWN_COUNTRY>  (1192) 
nan

>  <WITHDRAWN_REASON>  (1192) 
nan

>  <CANONICAL_SMILES>  (1192) 
CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13

>  <name>  (1192) 
Chlorpromazine 

>  <MW>  (1192) 
318.873

>  <logP>  (1192) 
4.8944

$$$$
CHEMBL833
     RDKit          

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
  7  2  1  0
 17  9  1  0
 16 12  2  0
M  END
>  <PARENT_MOLREGNO>  (1193) 
60319

>  <SYNONYMS>  (1193) 
Ticlopidine (BAN, INN); Ticlopidine HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1193) 
4

>  <RESEARCH_CODES>  (1193) 
4-C-32; 53-32C

>  <APPLICANTS>  (1193) 
Roche Palo Alto Llc

>  <USAN_STEM>  (1193) 
nan

>  <USAN_STEM_DEFINITION>  (1193) 
nan

>  <USAN_STEM_SUBSTEM>  (1193) 
nan

>  <USAN_YEAR>  (1193) 
1978.0

>  <FIRST_APPROVAL>  (1193) 
1991.0

>  <ATC_CODE>  (1193) 
B01AC05

>  <ATC_CODE_DESCRIPTION>  (1193) 
B01AC05 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (1193) 
Inhibitor (platelet)

>  <SC_PATENT_NO>  (1193) 
nan

>  <DRUG_TYPE>  (1193) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1193) 
Y

>  <FIRST_IN_CLASS>  (1193) 
N

>  <CHIRALITY>  (1193) 
Achiral Molecule

>  <PRODRUG>  (1193) 
Y

>  <ORAL>  (1193) 
Y

>  <PARENTERAL>  (1193) 
N

>  <TOPICAL>  (1193) 
N

>  <BLACK_BOX>  (1193) 
Y

>  <AVAILABILITY_TYPE>  (1193) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1193) 
nan

>  <WITHDRAWN_COUNTRY>  (1193) 
nan

>  <WITHDRAWN_REASON>  (1193) 
nan

>  <CANONICAL_SMILES>  (1193) 
Clc1ccccc1CN2CCc3sccc3C2

>  <name>  (1193) 
Ticlopidine 

>  <MW>  (1193) 
263.793

>  <logP>  (1193) 
3.9598

$$$$
CHEMBL4
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
  6 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 20 24  1  0
 24 25  2  0
 24 26  1  0
 22  2  1  0
 23  5  2  0
 13  7  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1194) 
146

>  <SYNONYMS>  (1194) 
Ofloxacin (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1194) 
4

>  <RESEARCH_CODES>  (1194) 
DL-8280; HOE-280

>  <APPLICANTS>  (1194) 
Ortho Mcneil Pharmaceutical Inc; Janssen Pharmaceuticals Inc; Daiichi Pharmaceutical Corp; Allergan Inc

>  <USAN_STEM>  (1194) 
-oxacin

>  <USAN_STEM_DEFINITION>  (1194) 
antibacterials (quinolone derivatives)

>  <USAN_STEM_SUBSTEM>  (1194) 
-oxacin

>  <USAN_YEAR>  (1194) 
1984.0

>  <FIRST_APPROVAL>  (1194) 
1990.0

>  <ATC_CODE>  (1194) 
S01AE01; J01MA01; S02AA16

>  <ATC_CODE_DESCRIPTION>  (1194) 
S01AE01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]; J01MA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S02AA16 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives]

>  <INDICATION_CLASS>  (1194) 
Antibacterial

>  <SC_PATENT_NO>  (1194) 
nan

>  <DRUG_TYPE>  (1194) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1194) 
Y

>  <FIRST_IN_CLASS>  (1194) 
N

>  <CHIRALITY>  (1194) 
Racemic Mixture

>  <PRODRUG>  (1194) 
N

>  <ORAL>  (1194) 
Y

>  <PARENTERAL>  (1194) 
Y

>  <TOPICAL>  (1194) 
Y

>  <BLACK_BOX>  (1194) 
Y

>  <AVAILABILITY_TYPE>  (1194) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1194) 
nan

>  <WITHDRAWN_COUNTRY>  (1194) 
nan

>  <WITHDRAWN_REASON>  (1194) 
nan

>  <CANONICAL_SMILES>  (1194) 
CC1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O

>  <name>  (1194) 
Ofloxacin 

>  <MW>  (1194) 
361.373

>  <logP>  (1194) 
1.544

$$$$
CHEMBL1201168
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  6  2  2  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1195) 
675119

>  <SYNONYMS>  (1195) 
Isocarboxazid (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1195) 
4

>  <RESEARCH_CODES>  (1195) 
nan

>  <APPLICANTS>  (1195) 
Validus Pharmaceuticals Inc

>  <USAN_STEM>  (1195) 
nan

>  <USAN_STEM_DEFINITION>  (1195) 
nan

>  <USAN_STEM_SUBSTEM>  (1195) 
nan

>  <USAN_YEAR>  (1195) 
nan

>  <FIRST_APPROVAL>  (1195) 
1959.0

>  <ATC_CODE>  (1195) 
N06AF01

>  <ATC_CODE_DESCRIPTION>  (1195) 
N06AF01 [Nervous System:Psychoanaleptics:Antidepressants:Monoamine oxidase inhibitors, non-selective]

>  <INDICATION_CLASS>  (1195) 
Antidepressant

>  <SC_PATENT_NO>  (1195) 
nan

>  <DRUG_TYPE>  (1195) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1195) 
Y

>  <FIRST_IN_CLASS>  (1195) 
N

>  <CHIRALITY>  (1195) 
Achiral Molecule

>  <PRODRUG>  (1195) 
N

>  <ORAL>  (1195) 
Y

>  <PARENTERAL>  (1195) 
N

>  <TOPICAL>  (1195) 
N

>  <BLACK_BOX>  (1195) 
Y

>  <AVAILABILITY_TYPE>  (1195) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1195) 
nan

>  <WITHDRAWN_COUNTRY>  (1195) 
nan

>  <WITHDRAWN_REASON>  (1195) 
nan

>  <CANONICAL_SMILES>  (1195) 
Cc1onc(c1)C(=O)NNCc2ccccc2

>  <name>  (1195) 
Isocarboxazid 

>  <MW>  (1195) 
231.255

>  <logP>  (1195) 
1.41762

$$$$
CHEMBL1087
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  7  2  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1196) 
147981

>  <SYNONYMS>  (1196) 
Mepivacaine (BAN, INN); Mepivacaine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1196) 
4

>  <RESEARCH_CODES>  (1196) 
nan

>  <APPLICANTS>  (1196) 
Hospira Inc; Eastman Kodak Co

>  <USAN_STEM>  (1196) 
-caine

>  <USAN_STEM_DEFINITION>  (1196) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (1196) 
-caine

>  <USAN_YEAR>  (1196) 
nan

>  <FIRST_APPROVAL>  (1196) 
1960.0

>  <ATC_CODE>  (1196) 
N01BB03; N01BB53

>  <ATC_CODE_DESCRIPTION>  (1196) 
N01BB03 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB53 [Nervous System:Anesthetics:Anesthetics, Local:Amides]

>  <INDICATION_CLASS>  (1196) 
Anesthetic (local)

>  <SC_PATENT_NO>  (1196) 
nan

>  <DRUG_TYPE>  (1196) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1196) 
Y

>  <FIRST_IN_CLASS>  (1196) 
N

>  <CHIRALITY>  (1196) 
Racemic Mixture

>  <PRODRUG>  (1196) 
N

>  <ORAL>  (1196) 
N

>  <PARENTERAL>  (1196) 
Y

>  <TOPICAL>  (1196) 
N

>  <BLACK_BOX>  (1196) 
N

>  <AVAILABILITY_TYPE>  (1196) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1196) 
nan

>  <WITHDRAWN_COUNTRY>  (1196) 
nan

>  <WITHDRAWN_REASON>  (1196) 
nan

>  <CANONICAL_SMILES>  (1196) 
CN1CCCCC1C(=O)Nc2c(C)cccc2C

>  <name>  (1196) 
Mepivacaine 

>  <MW>  (1196) 
246.354

>  <logP>  (1196) 
2.72624

$$$$
CHEMBL1201293
     RDKit          

 11 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1197) 
675244

>  <SYNONYMS>  (1197) 
Acamprosate (BAN, INN); Acamprosate Calcium (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1197) 
4

>  <RESEARCH_CODES>  (1197) 
nan

>  <APPLICANTS>  (1197) 
Forest Laboratories Inc

>  <USAN_STEM>  (1197) 
nan

>  <USAN_STEM_DEFINITION>  (1197) 
nan

>  <USAN_STEM_SUBSTEM>  (1197) 
nan

>  <USAN_YEAR>  (1197) 
2002.0

>  <FIRST_APPROVAL>  (1197) 
2004.0

>  <ATC_CODE>  (1197) 
N07BB03

>  <ATC_CODE_DESCRIPTION>  (1197) 
N07BB03 [Nervous System:Other Nervous System Drugs:Drugs Used In Addictive Disorders:Drugs used in alcohol dependence]

>  <INDICATION_CLASS>  (1197) 
nan

>  <SC_PATENT_NO>  (1197) 
nan

>  <DRUG_TYPE>  (1197) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1197) 
Y

>  <FIRST_IN_CLASS>  (1197) 
N

>  <CHIRALITY>  (1197) 
Achiral Molecule

>  <PRODRUG>  (1197) 
N

>  <ORAL>  (1197) 
Y

>  <PARENTERAL>  (1197) 
N

>  <TOPICAL>  (1197) 
N

>  <BLACK_BOX>  (1197) 
N

>  <AVAILABILITY_TYPE>  (1197) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1197) 
nan

>  <WITHDRAWN_COUNTRY>  (1197) 
nan

>  <WITHDRAWN_REASON>  (1197) 
nan

>  <CANONICAL_SMILES>  (1197) 
CC(=O)NCCCS(=O)(=O)O

>  <name>  (1197) 
Acamprosate 

>  <MW>  (1197) 
181.213

>  <logP>  (1197) 
-0.5996

$$$$
CHEMBL677
     RDKit          

 13 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1198) 
28939

>  <SYNONYMS>  (1198) 
Corbadrine (DCF, INN); Levonordefrin (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1198) 
4

>  <RESEARCH_CODES>  (1198) 
nan

>  <APPLICANTS>  (1198) 
Eastman Kodak Co

>  <USAN_STEM>  (1198) 
nan

>  <USAN_STEM_DEFINITION>  (1198) 
nan

>  <USAN_STEM_SUBSTEM>  (1198) 
nan

>  <USAN_YEAR>  (1198) 
nan

>  <FIRST_APPROVAL>  (1198) 
1960.0

>  <ATC_CODE>  (1198) 
nan

>  <ATC_CODE_DESCRIPTION>  (1198) 
nan

>  <INDICATION_CLASS>  (1198) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (1198) 
nan

>  <DRUG_TYPE>  (1198) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1198) 
Y

>  <FIRST_IN_CLASS>  (1198) 
N

>  <CHIRALITY>  (1198) 
Single Stereoisomer

>  <PRODRUG>  (1198) 
N

>  <ORAL>  (1198) 
N

>  <PARENTERAL>  (1198) 
Y

>  <TOPICAL>  (1198) 
N

>  <BLACK_BOX>  (1198) 
N

>  <AVAILABILITY_TYPE>  (1198) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1198) 
nan

>  <WITHDRAWN_COUNTRY>  (1198) 
nan

>  <WITHDRAWN_REASON>  (1198) 
nan

>  <CANONICAL_SMILES>  (1198) 
C[C@H](N)[C@H](O)c1ccc(O)c(O)c1

>  <name>  (1198) 
Corbadrine 

>  <MW>  (1198) 
183.207

>  <logP>  (1198) 
0.4784

$$$$
CHEMBL1697686
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1199) 
1078456

>  <SYNONYMS>  (1199) 
Cloforex (INN, MI)

>  <DEVELOPMENT_PHASE>  (1199) 
4

>  <RESEARCH_CODES>  (1199) 
D-237

>  <APPLICANTS>  (1199) 
nan

>  <USAN_STEM>  (1199) 
-orex

>  <USAN_STEM_DEFINITION>  (1199) 
anorexiants

>  <USAN_STEM_SUBSTEM>  (1199) 
-orex

>  <USAN_YEAR>  (1199) 
nan

>  <FIRST_APPROVAL>  (1199) 
nan

>  <ATC_CODE>  (1199) 
nan

>  <ATC_CODE_DESCRIPTION>  (1199) 
nan

>  <INDICATION_CLASS>  (1199) 
nan

>  <SC_PATENT_NO>  (1199) 
nan

>  <DRUG_TYPE>  (1199) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1199) 
Y

>  <FIRST_IN_CLASS>  (1199) 
N

>  <CHIRALITY>  (1199) 
Achiral Molecule

>  <PRODRUG>  (1199) 
N

>  <ORAL>  (1199) 
N

>  <PARENTERAL>  (1199) 
N

>  <TOPICAL>  (1199) 
N

>  <BLACK_BOX>  (1199) 
N

>  <AVAILABILITY_TYPE>  (1199) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1199) 
1969.0

>  <WITHDRAWN_COUNTRY>  (1199) 
Germany

>  <WITHDRAWN_REASON>  (1199) 
Cardiovascular

>  <CANONICAL_SMILES>  (1199) 
CCOC(=O)NC(C)(C)Cc1ccc(Cl)cc1

>  <name>  (1199) 
Cloforex 

>  <MW>  (1199) 
255.745

>  <logP>  (1199) 
3.4072

$$$$
CHEMBL494
     RDKit          

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 17 25  1  0
 25 26  1  0
 26 11  1  0
 26 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1200) 
7494

>  <SYNONYMS>  (1200) 
Iloprost (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1200) 
4

>  <RESEARCH_CODES>  (1200) 
ZK-00036374

>  <APPLICANTS>  (1200) 
Actelion Pharmaceuticals Ltd

>  <USAN_STEM>  (1200) 
-prost

>  <USAN_STEM_DEFINITION>  (1200) 
prostaglandins

>  <USAN_STEM_SUBSTEM>  (1200) 
-prost

>  <USAN_YEAR>  (1200) 
2004.0

>  <FIRST_APPROVAL>  (1200) 
2004.0

>  <ATC_CODE>  (1200) 
B01AC11

>  <ATC_CODE_DESCRIPTION>  (1200) 
B01AC11 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Platelet aggregation inhibitors excl. heparin]

>  <INDICATION_CLASS>  (1200) 
nan

>  <SC_PATENT_NO>  (1200) 
nan

>  <DRUG_TYPE>  (1200) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1200) 
Y

>  <FIRST_IN_CLASS>  (1200) 
N

>  <CHIRALITY>  (1200) 
Racemic Mixture

>  <PRODRUG>  (1200) 
N

>  <ORAL>  (1200) 
N

>  <PARENTERAL>  (1200) 
N

>  <TOPICAL>  (1200) 
Y

>  <BLACK_BOX>  (1200) 
N

>  <AVAILABILITY_TYPE>  (1200) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1200) 
nan

>  <WITHDRAWN_COUNTRY>  (1200) 
nan

>  <WITHDRAWN_REASON>  (1200) 
nan

>  <CANONICAL_SMILES>  (1200) 
CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(=C/CCCC(=O)O)\C[C@H]12

>  <name>  (1200) 
Iloprost 

>  <MW>  (1200) 
360.494

>  <logP>  (1200) 
3.5413

$$$$
CHEMBL1200910
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
  4 12  1  0
 12 13  2  0
 12 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 10  5  2  0
 21 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1201) 
674861

>  <SYNONYMS>  (1201) 
Acetylsulfisoxazole (JAN); Sulfisoxazole Acetyl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1201) 
4

>  <RESEARCH_CODES>  (1201) 
nan

>  <APPLICANTS>  (1201) 
Ross Laboratories Div Abbott Laboratories Inc; Hoffmann La Roche Inc; Eli Lilly And Co

>  <USAN_STEM>  (1201) 
nan

>  <USAN_STEM_DEFINITION>  (1201) 
nan

>  <USAN_STEM_SUBSTEM>  (1201) 
nan

>  <USAN_YEAR>  (1201) 
nan

>  <FIRST_APPROVAL>  (1201) 
1953.0

>  <ATC_CODE>  (1201) 
nan

>  <ATC_CODE_DESCRIPTION>  (1201) 
nan

>  <INDICATION_CLASS>  (1201) 
Antibacterial

>  <SC_PATENT_NO>  (1201) 
nan

>  <DRUG_TYPE>  (1201) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1201) 
Y

>  <FIRST_IN_CLASS>  (1201) 
N

>  <CHIRALITY>  (1201) 
Achiral Molecule

>  <PRODRUG>  (1201) 
Y

>  <ORAL>  (1201) 
Y

>  <PARENTERAL>  (1201) 
N

>  <TOPICAL>  (1201) 
N

>  <BLACK_BOX>  (1201) 
N

>  <AVAILABILITY_TYPE>  (1201) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1201) 
nan

>  <WITHDRAWN_COUNTRY>  (1201) 
nan

>  <WITHDRAWN_REASON>  (1201) 
nan

>  <CANONICAL_SMILES>  (1201) 
CC(=O)N(c1onc(C)c1C)S(=O)(=O)c2ccc(N)cc2

>  <name>  (1201) 
Acetylsulfisoxazole 

>  <MW>  (1201) 
309.347

>  <logP>  (1201) 
1.61544

$$$$
CHEMBL1201173
     RDKit          

 25 28  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
  8 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25  2  1  0
 17  4  1  0
 12  5  1  0
 25 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1202) 
675124

>  <SYNONYMS>  (1202) 
Medrysone (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1202) 
4

>  <RESEARCH_CODES>  (1202) 
U-8471

>  <APPLICANTS>  (1202) 
Allergan Pharmaceutical

>  <USAN_STEM>  (1202) 
nan

>  <USAN_STEM_DEFINITION>  (1202) 
nan

>  <USAN_STEM_SUBSTEM>  (1202) 
nan

>  <USAN_YEAR>  (1202) 
1965.0

>  <FIRST_APPROVAL>  (1202) 
1969.0

>  <ATC_CODE>  (1202) 
S01BA08

>  <ATC_CODE_DESCRIPTION>  (1202) 
S01BA08 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]

>  <INDICATION_CLASS>  (1202) 
Glucocorticoid

>  <SC_PATENT_NO>  (1202) 
nan

>  <DRUG_TYPE>  (1202) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1202) 
Y

>  <FIRST_IN_CLASS>  (1202) 
N

>  <CHIRALITY>  (1202) 
Single Stereoisomer

>  <PRODRUG>  (1202) 
N

>  <ORAL>  (1202) 
N

>  <PARENTERAL>  (1202) 
N

>  <TOPICAL>  (1202) 
Y

>  <BLACK_BOX>  (1202) 
N

>  <AVAILABILITY_TYPE>  (1202) 
Discontinued

>  <WITHDRAWN_YEAR>  (1202) 
nan

>  <WITHDRAWN_COUNTRY>  (1202) 
nan

>  <WITHDRAWN_REASON>  (1202) 
nan

>  <CANONICAL_SMILES>  (1202) 
C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(=O)C)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)CCC(=O)C=C14

>  <name>  (1202) 
Medrysone 

>  <MW>  (1202) 
344.495

>  <logP>  (1202) 
3.9403

$$$$
CHEMBL1201245
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 13  8  1  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1203) 
675196

>  <SYNONYMS>  (1203) 
Bromazine (INN, BAN, DCF); Bromodiphenhydramine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1203) 
4

>  <RESEARCH_CODES>  (1203) 
nan

>  <APPLICANTS>  (1203) 
Parke Davis Div Warner Lambert Co; Forest Laboratories Inc

>  <USAN_STEM>  (1203) 
nan

>  <USAN_STEM_DEFINITION>  (1203) 
nan

>  <USAN_STEM_SUBSTEM>  (1203) 
nan

>  <USAN_YEAR>  (1203) 
nan

>  <FIRST_APPROVAL>  (1203) 
1954.0

>  <ATC_CODE>  (1203) 
R06AA01

>  <ATC_CODE_DESCRIPTION>  (1203) 
R06AA01 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]

>  <INDICATION_CLASS>  (1203) 
Antihistaminic

>  <SC_PATENT_NO>  (1203) 
nan

>  <DRUG_TYPE>  (1203) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1203) 
Y

>  <FIRST_IN_CLASS>  (1203) 
N

>  <CHIRALITY>  (1203) 
Racemic Mixture

>  <PRODRUG>  (1203) 
N

>  <ORAL>  (1203) 
Y

>  <PARENTERAL>  (1203) 
N

>  <TOPICAL>  (1203) 
N

>  <BLACK_BOX>  (1203) 
N

>  <AVAILABILITY_TYPE>  (1203) 
Discontinued

>  <WITHDRAWN_YEAR>  (1203) 
nan

>  <WITHDRAWN_COUNTRY>  (1203) 
nan

>  <WITHDRAWN_REASON>  (1203) 
nan

>  <CANONICAL_SMILES>  (1203) 
CN(C)CCOC(c1ccccc1)c2ccc(Br)cc2

>  <name>  (1203) 
Bromazine 

>  <MW>  (1203) 
334.257

>  <logP>  (1203) 
4.1167

$$$$
CHEMBL652
     RDKit          

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 10 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 18  7  1  0
 28 23  1  0
M  END
>  <PARENT_MOLREGNO>  (1204) 
27588

>  <SYNONYMS>  (1204) 
Flecainide (BAN, INN); Flecainide Acetate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1204) 
4

>  <RESEARCH_CODES>  (1204) 
nan

>  <APPLICANTS>  (1204) 
Medicis Pharmaceutical Corp

>  <USAN_STEM>  (1204) 
nan

>  <USAN_STEM_DEFINITION>  (1204) 
nan

>  <USAN_STEM_SUBSTEM>  (1204) 
nan

>  <USAN_YEAR>  (1204) 
1977.0

>  <FIRST_APPROVAL>  (1204) 
1985.0

>  <ATC_CODE>  (1204) 
C01BC04

>  <ATC_CODE_DESCRIPTION>  (1204) 
C01BC04 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ic]

>  <INDICATION_CLASS>  (1204) 
Cardiac Depressant (anti-arrhythmic)

>  <SC_PATENT_NO>  (1204) 
nan

>  <DRUG_TYPE>  (1204) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1204) 
Y

>  <FIRST_IN_CLASS>  (1204) 
N

>  <CHIRALITY>  (1204) 
Racemic Mixture

>  <PRODRUG>  (1204) 
N

>  <ORAL>  (1204) 
Y

>  <PARENTERAL>  (1204) 
N

>  <TOPICAL>  (1204) 
N

>  <BLACK_BOX>  (1204) 
Y

>  <AVAILABILITY_TYPE>  (1204) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1204) 
nan

>  <WITHDRAWN_COUNTRY>  (1204) 
nan

>  <WITHDRAWN_REASON>  (1204) 
nan

>  <CANONICAL_SMILES>  (1204) 
FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2

>  <name>  (1204) 
Flecainide 

>  <MW>  (1204) 
414.346

>  <logP>  (1204) 
3.4407

$$$$
CHEMBL1201234
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1205) 
675185

>  <SYNONYMS>  (1205) 
Mephentermine (BAN, INN); Mephentermine Sulfate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1205) 
4

>  <RESEARCH_CODES>  (1205) 
nan

>  <APPLICANTS>  (1205) 
Baxter Healthcare Corp Anesthesia Critical Care

>  <USAN_STEM>  (1205) 
nan

>  <USAN_STEM_DEFINITION>  (1205) 
nan

>  <USAN_STEM_SUBSTEM>  (1205) 
nan

>  <USAN_YEAR>  (1205) 
nan

>  <FIRST_APPROVAL>  (1205) 
1951.0

>  <ATC_CODE>  (1205) 
C01CA11

>  <ATC_CODE_DESCRIPTION>  (1205) 
C01CA11 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (1205) 
Adrenergic (vasoconstrictor)

>  <SC_PATENT_NO>  (1205) 
nan

>  <DRUG_TYPE>  (1205) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1205) 
Y

>  <FIRST_IN_CLASS>  (1205) 
N

>  <CHIRALITY>  (1205) 
Achiral Molecule

>  <PRODRUG>  (1205) 
N

>  <ORAL>  (1205) 
N

>  <PARENTERAL>  (1205) 
Y

>  <TOPICAL>  (1205) 
N

>  <BLACK_BOX>  (1205) 
N

>  <AVAILABILITY_TYPE>  (1205) 
Discontinued

>  <WITHDRAWN_YEAR>  (1205) 
nan

>  <WITHDRAWN_COUNTRY>  (1205) 
nan

>  <WITHDRAWN_REASON>  (1205) 
nan

>  <CANONICAL_SMILES>  (1205) 
CNC(C)(C)Cc1ccccc1

>  <name>  (1205) 
Mephentermine 

>  <MW>  (1205) 
163.264

>  <logP>  (1205) 
2.2271

$$$$
CHEMBL577
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  4 13  1  0
 13 14  2  0
 13 15  1  0
  2 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 12  7  1  0
 22 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1206) 
16759

>  <SYNONYMS>  (1206) 
Enalaprilat (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1206) 
4

>  <RESEARCH_CODES>  (1206) 
MK-421; MK-422

>  <APPLICANTS>  (1206) 
Biovail Laboratories International Srl

>  <USAN_STEM>  (1206) 
-prilat

>  <USAN_STEM_DEFINITION>  (1206) 
antihypertensives (ACE inhibitors) (diacid analogs of the -pril entity)

>  <USAN_STEM_SUBSTEM>  (1206) 
-prilat

>  <USAN_YEAR>  (1206) 
1984.0

>  <FIRST_APPROVAL>  (1206) 
1988.0

>  <ATC_CODE>  (1206) 
nan

>  <ATC_CODE_DESCRIPTION>  (1206) 
nan

>  <INDICATION_CLASS>  (1206) 
Antihypertensive

>  <SC_PATENT_NO>  (1206) 
nan

>  <DRUG_TYPE>  (1206) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1206) 
Y

>  <FIRST_IN_CLASS>  (1206) 
N

>  <CHIRALITY>  (1206) 
Single Stereoisomer

>  <PRODRUG>  (1206) 
N

>  <ORAL>  (1206) 
N

>  <PARENTERAL>  (1206) 
Y

>  <TOPICAL>  (1206) 
N

>  <BLACK_BOX>  (1206) 
Y

>  <AVAILABILITY_TYPE>  (1206) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1206) 
nan

>  <WITHDRAWN_COUNTRY>  (1206) 
nan

>  <WITHDRAWN_REASON>  (1206) 
nan

>  <CANONICAL_SMILES>  (1206) 
C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O

>  <name>  (1206) 
Enalaprilat 

>  <MW>  (1206) 
348.399

>  <logP>  (1206) 
1.1261

$$$$
CHEMBL1289601
     RDKit          

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 14 22  1  0
 22 23  1  0
 22 24  2  0
  9 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 27  3  1  0
 25  5  1  0
 24 11  1  0
 21 19  1  0
M  END
>  <PARENT_MOLREGNO>  (1207) 
716009

>  <SYNONYMS>  (1207) 
Lenvatinib (INN, USAN); Lenvatinib Mesylate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1207) 
4

>  <RESEARCH_CODES>  (1207) 
ER-203492-00; E7080

>  <APPLICANTS>  (1207) 
Eisai Inc; Eisai

>  <USAN_STEM>  (1207) 
-tinib

>  <USAN_STEM_DEFINITION>  (1207) 
tyrosine kinase inhibitors

>  <USAN_STEM_SUBSTEM>  (1207) 
-tinib

>  <USAN_YEAR>  (1207) 
2010.0

>  <FIRST_APPROVAL>  (1207) 
2015.0

>  <ATC_CODE>  (1207) 
L01XE29

>  <ATC_CODE_DESCRIPTION>  (1207) 
L01XE29 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (1207) 
nan

>  <SC_PATENT_NO>  (1207) 
US-7253286-B2

>  <DRUG_TYPE>  (1207) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1207) 
Y

>  <FIRST_IN_CLASS>  (1207) 
N

>  <CHIRALITY>  (1207) 
Achiral Molecule

>  <PRODRUG>  (1207) 
N

>  <ORAL>  (1207) 
Y

>  <PARENTERAL>  (1207) 
N

>  <TOPICAL>  (1207) 
N

>  <BLACK_BOX>  (1207) 
N

>  <AVAILABILITY_TYPE>  (1207) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1207) 
nan

>  <WITHDRAWN_COUNTRY>  (1207) 
nan

>  <WITHDRAWN_REASON>  (1207) 
nan

>  <CANONICAL_SMILES>  (1207) 
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(=O)N

>  <name>  (1207) 
Lenvatinib 

>  <MW>  (1207) 
426.86

>  <logP>  (1207) 
4.0719

$$$$
CHEMBL2104489
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 13 18  1  0
 18 19  2  0
 18 20  1  0
  5 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27  2  1  0
 10  4  1  0
 13  8  1  0
 27 21  1  0
M  END
>  <PARENT_MOLREGNO>  (1208) 
1376759

>  <SYNONYMS>  (1208) 
Anagestone (INN); Anagestone Acetate (USAN)

>  <DEVELOPMENT_PHASE>  (1208) 
4

>  <RESEARCH_CODES>  (1208) 
nan

>  <APPLICANTS>  (1208) 
Ortho Pharmaceutical

>  <USAN_STEM>  (1208) 
-gest-

>  <USAN_STEM_DEFINITION>  (1208) 
progestins

>  <USAN_STEM_SUBSTEM>  (1208) 
-gest-

>  <USAN_YEAR>  (1208) 
1965.0

>  <FIRST_APPROVAL>  (1208) 
nan

>  <ATC_CODE>  (1208) 
nan

>  <ATC_CODE_DESCRIPTION>  (1208) 
nan

>  <INDICATION_CLASS>  (1208) 
Progestin

>  <SC_PATENT_NO>  (1208) 
nan

>  <DRUG_TYPE>  (1208) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1208) 
Y

>  <FIRST_IN_CLASS>  (1208) 
N

>  <CHIRALITY>  (1208) 
Racemic Mixture

>  <PRODRUG>  (1208) 
N

>  <ORAL>  (1208) 
N

>  <PARENTERAL>  (1208) 
N

>  <TOPICAL>  (1208) 
N

>  <BLACK_BOX>  (1208) 
N

>  <AVAILABILITY_TYPE>  (1208) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1208) 
1969.0

>  <WITHDRAWN_COUNTRY>  (1208) 
Germany

>  <WITHDRAWN_REASON>  (1208) 
Animal Carcinogenicity

>  <CANONICAL_SMILES>  (1208) 
C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)C2CC[C@]3(OC(=O)C)C(=O)C)[C@@]4(C)CCCC=C14

>  <name>  (1208) 
Anagestone 

>  <MW>  (1208) 
372.549

>  <logP>  (1208) 
5.4762

$$$$
CHEMBL1425
     RDKit          

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  2  1  0
 10  6  2  0
M  END
>  <PARENT_MOLREGNO>  (1209) 
364693

>  <SYNONYMS>  (1209) 
Mercaptopurine (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1209) 
4

>  <RESEARCH_CODES>  (1209) 
nan

>  <APPLICANTS>  (1209) 
Teva Pharmaceuticals Usa Inc

>  <USAN_STEM>  (1209) 
nan

>  <USAN_STEM_DEFINITION>  (1209) 
nan

>  <USAN_STEM_SUBSTEM>  (1209) 
nan

>  <USAN_YEAR>  (1209) 
nan

>  <FIRST_APPROVAL>  (1209) 
1953.0

>  <ATC_CODE>  (1209) 
L01BB02

>  <ATC_CODE_DESCRIPTION>  (1209) 
L01BB02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Purine analogues]

>  <INDICATION_CLASS>  (1209) 
Antineoplastic

>  <SC_PATENT_NO>  (1209) 
nan

>  <DRUG_TYPE>  (1209) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1209) 
Y

>  <FIRST_IN_CLASS>  (1209) 
N

>  <CHIRALITY>  (1209) 
Achiral Molecule

>  <PRODRUG>  (1209) 
Y

>  <ORAL>  (1209) 
Y

>  <PARENTERAL>  (1209) 
N

>  <TOPICAL>  (1209) 
N

>  <BLACK_BOX>  (1209) 
Y

>  <AVAILABILITY_TYPE>  (1209) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1209) 
nan

>  <WITHDRAWN_COUNTRY>  (1209) 
nan

>  <WITHDRAWN_REASON>  (1209) 
nan

>  <CANONICAL_SMILES>  (1209) 
Sc1ncnc2nc[nH]c12

>  <name>  (1209) 
Mercaptopurine 

>  <MW>  (1209) 
152.182

>  <logP>  (1209) 
0.6416

$$$$
CHEMBL1152
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28  8  1  0
 28 12  1  0
 24 13  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1210) 
182546

>  <SYNONYMS>  (1210) 
Prednisolone acetate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1210) 
4

>  <RESEARCH_CODES>  (1210) 
nan

>  <APPLICANTS>  (1210) 
Schering Corp Sub Schering Plough Corp; Pfizer Laboratories Div Pfizer Inc; Allergan Pharmaceutical; Alcon Laboratories Inc; Taro Pharmaceuticals Usa Inc

>  <USAN_STEM>  (1210) 
pred-

>  <USAN_STEM_DEFINITION>  (1210) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (1210) 
pred-

>  <USAN_YEAR>  (1210) 
nan

>  <FIRST_APPROVAL>  (1210) 
1955.0

>  <ATC_CODE>  (1210) 
C05AA04; A07EA01; S01BA04; S02BA03; D07AA03; H02AB06; D07XA02; R01AD02; S01CB02; S03BA02

>  <ATC_CODE_DESCRIPTION>  (1210) 
C05AA04 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A07EA01 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; S01BA04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA03 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; D07AA03 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, weak (group I)]; H02AB06 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07XA02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, weak, other combinations]; R01AD02 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S01CB02 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; S03BA02 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (1210) 
Glucocorticoid

>  <SC_PATENT_NO>  (1210) 
US-5881926-A

>  <DRUG_TYPE>  (1210) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1210) 
Y

>  <FIRST_IN_CLASS>  (1210) 
N

>  <CHIRALITY>  (1210) 
Single Stereoisomer

>  <PRODRUG>  (1210) 
Y

>  <ORAL>  (1210) 
Y

>  <PARENTERAL>  (1210) 
Y

>  <TOPICAL>  (1210) 
Y

>  <BLACK_BOX>  (1210) 
N

>  <AVAILABILITY_TYPE>  (1210) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1210) 
nan

>  <WITHDRAWN_COUNTRY>  (1210) 
nan

>  <WITHDRAWN_REASON>  (1210) 
nan

>  <CANONICAL_SMILES>  (1210) 
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

>  <name>  (1210) 
Prednisolone acetate 

>  <MW>  (1210) 
402.487

>  <logP>  (1210) 
2.1284

$$$$
CHEMBL384467
     RDKit          

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 23  2  1  0
 21  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1211) 
365281

>  <SYNONYMS>  (1211) 
Dexamethasone (BAN, FDA, INN, JAN, USP); Dexamethasone Metasulfobenzoate Sodium (JAN); Dexamethasone Palmitate (JAN); Dexamethasone Valerate (JAN)

>  <DEVELOPMENT_PHASE>  (1211) 
4

>  <RESEARCH_CODES>  (1211) 
nan

>  <APPLICANTS>  (1211) 
Falcon Pharmaceuticals Ltd; Allergan Inc; Alcon Pharmaceuticals Ltd; Alcon Laboratories Inc; Merck And Co Inc

>  <USAN_STEM>  (1211) 
nan

>  <USAN_STEM_DEFINITION>  (1211) 
nan

>  <USAN_STEM_SUBSTEM>  (1211) 
nan

>  <USAN_YEAR>  (1211) 
nan

>  <FIRST_APPROVAL>  (1211) 
1958.0

>  <ATC_CODE>  (1211) 
D07XB05; R01AD03; D10AA03; H02AB02; C05AA09; A01AC02; S01BA01; S03BA01; S02BA06; D07AB19; S01CB01; R01AD53

>  <ATC_CODE_DESCRIPTION>  (1211) 
D07XB05 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD03 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; D10AA03 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; H02AB02 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; C05AA09 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; A01AC02 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S03BA01 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; S02BA06 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; D07AB19 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]; S01CB01 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; R01AD53 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]

>  <INDICATION_CLASS>  (1211) 
Glucocorticoid

>  <SC_PATENT_NO>  (1211) 
US-6284804-B1

>  <DRUG_TYPE>  (1211) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1211) 
Y

>  <FIRST_IN_CLASS>  (1211) 
N

>  <CHIRALITY>  (1211) 
Single Stereoisomer

>  <PRODRUG>  (1211) 
N

>  <ORAL>  (1211) 
Y

>  <PARENTERAL>  (1211) 
Y

>  <TOPICAL>  (1211) 
Y

>  <BLACK_BOX>  (1211) 
N

>  <AVAILABILITY_TYPE>  (1211) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1211) 
nan

>  <WITHDRAWN_COUNTRY>  (1211) 
nan

>  <WITHDRAWN_REASON>  (1211) 
nan

>  <CANONICAL_SMILES>  (1211) 
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

>  <name>  (1211) 
Dexamethasone 

>  <MW>  (1211) 
392.467

>  <logP>  (1211) 
1.8957

$$$$
CHEMBL15870
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  9 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 11  6  1  0
 20 12  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1212) 
16599

>  <SYNONYMS>  (1212) 
Indoprofen (BAN, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1212) 
4

>  <RESEARCH_CODES>  (1212) 
K-4277

>  <APPLICANTS>  (1212) 
Farmitalia Carlo Erba S.P.A., Italy

>  <USAN_STEM>  (1212) 
-profen

>  <USAN_STEM_DEFINITION>  (1212) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (1212) 
-profen

>  <USAN_YEAR>  (1212) 
1976.0

>  <FIRST_APPROVAL>  (1212) 
1979.0

>  <ATC_CODE>  (1212) 
M01AE10

>  <ATC_CODE_DESCRIPTION>  (1212) 
M01AE10 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (1212) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (1212) 
nan

>  <DRUG_TYPE>  (1212) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1212) 
Y

>  <FIRST_IN_CLASS>  (1212) 
N

>  <CHIRALITY>  (1212) 
Racemic Mixture

>  <PRODRUG>  (1212) 
N

>  <ORAL>  (1212) 
N

>  <PARENTERAL>  (1212) 
N

>  <TOPICAL>  (1212) 
N

>  <BLACK_BOX>  (1212) 
N

>  <AVAILABILITY_TYPE>  (1212) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1212) 
1983.0

>  <WITHDRAWN_COUNTRY>  (1212) 
United Kingdom; Spain; Germany

>  <WITHDRAWN_REASON>  (1212) 
Animal Carcinogenicity (rodent); Gastrointestinal Toxicity

>  <CANONICAL_SMILES>  (1212) 
CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O

>  <name>  (1212) 
Indoprofen 

>  <MW>  (1212) 
281.311

>  <logP>  (1212) 
3.0351

$$$$
CHEMBL1370
     RDKit          

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 27  4  1  0
 26  6  1  0
 24  8  1  0
 20  9  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1213) 
313314

>  <SYNONYMS>  (1213) 
Budesonide (BAN, FDA, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1213) 
4

>  <RESEARCH_CODES>  (1213) 
S-1320

>  <APPLICANTS>  (1213) 
Santarus Inc; Astrazeneca Pharmaceuticals Lp; Astrazeneca Lp

>  <USAN_STEM>  (1213) 
-onide

>  <USAN_STEM_DEFINITION>  (1213) 
topical steroids (acetal derivatives)

>  <USAN_STEM_SUBSTEM>  (1213) 
-onide

>  <USAN_YEAR>  (1213) 
1979.0

>  <FIRST_APPROVAL>  (1213) 
1994.0

>  <ATC_CODE>  (1213) 
A07EA06; R03BA02; D07AC09; R01AD05

>  <ATC_CODE_DESCRIPTION>  (1213) 
A07EA06 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; R03BA02 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; D07AC09 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; R01AD05 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]

>  <INDICATION_CLASS>  (1213) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (1213) 
US-5914122-A

>  <DRUG_TYPE>  (1213) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1213) 
Y

>  <FIRST_IN_CLASS>  (1213) 
N

>  <CHIRALITY>  (1213) 
Racemic Mixture

>  <PRODRUG>  (1213) 
N

>  <ORAL>  (1213) 
Y

>  <PARENTERAL>  (1213) 
N

>  <TOPICAL>  (1213) 
Y

>  <BLACK_BOX>  (1213) 
Y

>  <AVAILABILITY_TYPE>  (1213) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1213) 
nan

>  <WITHDRAWN_COUNTRY>  (1213) 
nan

>  <WITHDRAWN_REASON>  (1213) 
nan

>  <CANONICAL_SMILES>  (1213) 
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

>  <name>  (1213) 
Budesonide 

>  <MW>  (1213) 
430.541

>  <logP>  (1213) 
2.7168

$$$$
CHEMBL1200959
     RDKit          

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  5 21  1  0
 21  2  1  0
 20  7  1  0
 13  8  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1214) 
674910

>  <SYNONYMS>  (1214) 
Methdilazine (BAN, FDA, INN, USP); Methdilazine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1214) 
4

>  <RESEARCH_CODES>  (1214) 
nan

>  <APPLICANTS>  (1214) 
Westwood Squibb Pharmaceuticals Inc

>  <USAN_STEM>  (1214) 
nan

>  <USAN_STEM_DEFINITION>  (1214) 
nan

>  <USAN_STEM_SUBSTEM>  (1214) 
nan

>  <USAN_YEAR>  (1214) 
nan

>  <FIRST_APPROVAL>  (1214) 
1982.0

>  <ATC_CODE>  (1214) 
R06AD04

>  <ATC_CODE_DESCRIPTION>  (1214) 
R06AD04 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives]

>  <INDICATION_CLASS>  (1214) 
Antipruritic

>  <SC_PATENT_NO>  (1214) 
nan

>  <DRUG_TYPE>  (1214) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1214) 
Y

>  <FIRST_IN_CLASS>  (1214) 
N

>  <CHIRALITY>  (1214) 
Racemic Mixture

>  <PRODRUG>  (1214) 
N

>  <ORAL>  (1214) 
Y

>  <PARENTERAL>  (1214) 
N

>  <TOPICAL>  (1214) 
N

>  <BLACK_BOX>  (1214) 
N

>  <AVAILABILITY_TYPE>  (1214) 
Discontinued

>  <WITHDRAWN_YEAR>  (1214) 
nan

>  <WITHDRAWN_COUNTRY>  (1214) 
nan

>  <WITHDRAWN_REASON>  (1214) 
nan

>  <CANONICAL_SMILES>  (1214) 
CN1CCC(CN2c3ccccc3Sc4ccccc24)C1

>  <name>  (1214) 
Methdilazine 

>  <MW>  (1214) 
296.439

>  <logP>  (1214) 
4.241

$$$$
CHEMBL811
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13  7  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1215) 
54051

>  <SYNONYMS>  (1215) 
Brompheniramine (BAN, INN); Brompheniramine Maleate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1215) 
4

>  <RESEARCH_CODES>  (1215) 
nan

>  <APPLICANTS>  (1215) 
Wyeth Consumer Healthcare; Wyeth Ayerst Laboratories; Alza Corp; Ah Robins Co

>  <USAN_STEM>  (1215) 
nan

>  <USAN_STEM_DEFINITION>  (1215) 
nan

>  <USAN_STEM_SUBSTEM>  (1215) 
nan

>  <USAN_YEAR>  (1215) 
nan

>  <FIRST_APPROVAL>  (1215) 
1957.0

>  <ATC_CODE>  (1215) 
R06AB01; R06AB51

>  <ATC_CODE_DESCRIPTION>  (1215) 
R06AB01 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]; R06AB51 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Substituted alkylamines]

>  <INDICATION_CLASS>  (1215) 
Antihistaminic

>  <SC_PATENT_NO>  (1215) 
nan

>  <DRUG_TYPE>  (1215) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1215) 
Y

>  <FIRST_IN_CLASS>  (1215) 
N

>  <CHIRALITY>  (1215) 
Racemic Mixture

>  <PRODRUG>  (1215) 
N

>  <ORAL>  (1215) 
Y

>  <PARENTERAL>  (1215) 
Y

>  <TOPICAL>  (1215) 
N

>  <BLACK_BOX>  (1215) 
N

>  <AVAILABILITY_TYPE>  (1215) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1215) 
nan

>  <WITHDRAWN_COUNTRY>  (1215) 
nan

>  <WITHDRAWN_REASON>  (1215) 
nan

>  <CANONICAL_SMILES>  (1215) 
CN(C)CCC(c1ccc(Br)cc1)c2ccccn2

>  <name>  (1215) 
Brompheniramine 

>  <MW>  (1215) 
319.246

>  <logP>  (1215) 
3.9277

$$$$
CHEMBL1220
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 13  8  1  0
M  CHG  2  14   1  16  -1
M  END
>  <PARENT_MOLREGNO>  (1216) 
222633

>  <SYNONYMS>  (1216) 
Tinidazole (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1216) 
4

>  <RESEARCH_CODES>  (1216) 
CP-12574

>  <APPLICANTS>  (1216) 
Mission Pharmacal Co

>  <USAN_STEM>  (1216) 
-nidazole

>  <USAN_STEM_DEFINITION>  (1216) 
antiprotozoal substances (metronidazole type)

>  <USAN_STEM_SUBSTEM>  (1216) 
-nidazole

>  <USAN_YEAR>  (1216) 
1970.0

>  <FIRST_APPROVAL>  (1216) 
2004.0

>  <ATC_CODE>  (1216) 
J01XD02; P01AB02

>  <ATC_CODE_DESCRIPTION>  (1216) 
J01XD02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Antibacterials:Imidazole derivatives]; P01AB02 [Antiparasitic Products, Insecticides And Repellents:Antiprotozoals:Agents Against Amoebiasis And Other Protozoal Diseases:Nitroimidazole derivatives]

>  <INDICATION_CLASS>  (1216) 
Antiprotozoal

>  <SC_PATENT_NO>  (1216) 
nan

>  <DRUG_TYPE>  (1216) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1216) 
Y

>  <FIRST_IN_CLASS>  (1216) 
N

>  <CHIRALITY>  (1216) 
Achiral Molecule

>  <PRODRUG>  (1216) 
Y

>  <ORAL>  (1216) 
Y

>  <PARENTERAL>  (1216) 
N

>  <TOPICAL>  (1216) 
N

>  <BLACK_BOX>  (1216) 
Y

>  <AVAILABILITY_TYPE>  (1216) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1216) 
nan

>  <WITHDRAWN_COUNTRY>  (1216) 
nan

>  <WITHDRAWN_REASON>  (1216) 
nan

>  <CANONICAL_SMILES>  (1216) 
CCS(=O)(=O)CCn1c(C)ncc1[N+](=O)[O-]

>  <name>  (1216) 
Tinidazole 

>  <MW>  (1216) 
247.276

>  <logP>  (1216) 
0.53442

$$$$
CHEMBL23838
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 13 16  1  0
 16 17  2  0
 16 18  1  0
 15 10  1  0
M  CHG  2  16   1  18  -1
M  END
>  <PARENT_MOLREGNO>  (1217) 
30435

>  <SYNONYMS>  (1217) 
Paraoxon

>  <DEVELOPMENT_PHASE>  (1217) 
4

>  <RESEARCH_CODES>  (1217) 
nan

>  <APPLICANTS>  (1217) 
nan

>  <USAN_STEM>  (1217) 
nan

>  <USAN_STEM_DEFINITION>  (1217) 
nan

>  <USAN_STEM_SUBSTEM>  (1217) 
nan

>  <USAN_YEAR>  (1217) 
nan

>  <FIRST_APPROVAL>  (1217) 
nan

>  <ATC_CODE>  (1217) 
S01EB10

>  <ATC_CODE_DESCRIPTION>  (1217) 
S01EB10 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]

>  <INDICATION_CLASS>  (1217) 
nan

>  <SC_PATENT_NO>  (1217) 
nan

>  <DRUG_TYPE>  (1217) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1217) 
Y

>  <FIRST_IN_CLASS>  (1217) 
N

>  <CHIRALITY>  (1217) 
Achiral Molecule

>  <PRODRUG>  (1217) 
N

>  <ORAL>  (1217) 
N

>  <PARENTERAL>  (1217) 
N

>  <TOPICAL>  (1217) 
N

>  <BLACK_BOX>  (1217) 
N

>  <AVAILABILITY_TYPE>  (1217) 
Unknown

>  <WITHDRAWN_YEAR>  (1217) 
nan

>  <WITHDRAWN_COUNTRY>  (1217) 
nan

>  <WITHDRAWN_REASON>  (1217) 
nan

>  <CANONICAL_SMILES>  (1217) 
CCOP(=O)(OCC)Oc1ccc(cc1)[N+](=O)[O-]

>  <name>  (1217) 
Paraoxon

>  <MW>  (1217) 
275.197

>  <logP>  (1217) 
3.1547

$$$$
CHEMBL1113
     RDKit          

 22 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 14 21  1  0
 21 22  2  0
 22  2  1  0
 21  5  1  0
 12  7  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1218) 
155045

>  <SYNONYMS>  (1218) 
Amoxapine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1218) 
4

>  <RESEARCH_CODES>  (1218) 
CL-67772

>  <APPLICANTS>  (1218) 
Lederle Laboratories Div American Cyanamid Co

>  <USAN_STEM>  (1218) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (1218) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (1218) 
-pin(e)

>  <USAN_YEAR>  (1218) 
1971.0

>  <FIRST_APPROVAL>  (1218) 
1980.0

>  <ATC_CODE>  (1218) 
N06AA17

>  <ATC_CODE_DESCRIPTION>  (1218) 
N06AA17 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors]

>  <INDICATION_CLASS>  (1218) 
Antidepressant

>  <SC_PATENT_NO>  (1218) 
nan

>  <DRUG_TYPE>  (1218) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1218) 
Y

>  <FIRST_IN_CLASS>  (1218) 
N

>  <CHIRALITY>  (1218) 
Achiral Molecule

>  <PRODRUG>  (1218) 
N

>  <ORAL>  (1218) 
Y

>  <PARENTERAL>  (1218) 
N

>  <TOPICAL>  (1218) 
N

>  <BLACK_BOX>  (1218) 
Y

>  <AVAILABILITY_TYPE>  (1218) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1218) 
nan

>  <WITHDRAWN_COUNTRY>  (1218) 
nan

>  <WITHDRAWN_REASON>  (1218) 
nan

>  <CANONICAL_SMILES>  (1218) 
Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1

>  <name>  (1218) 
Amoxapine 

>  <MW>  (1218) 
313.788

>  <logP>  (1218) 
3.4292

$$$$
CHEMBL813
     RDKit          

 30 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 10 17  1  0
 17 18  2  0
 17 19  1  0
  8 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 25 28  1  0
 28 29  2  0
 28 30  1  0
 20  5  1  0
 16 12  1  0
 27 22  1  0
M  END
>  <PARENT_MOLREGNO>  (1219) 
54211

>  <SYNONYMS>  (1219) 
Eprosartan (BAN, INN, USAN); Eprosartan Mesylate (BAN, FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1219) 
4

>  <RESEARCH_CODES>  (1219) 
SK&F-108566; SK-108566; SK&F-108566J; SK&F-108566-J

>  <APPLICANTS>  (1219) 
SmithKline Beecham; Abbvie Inc

>  <USAN_STEM>  (1219) 
-sartan

>  <USAN_STEM_DEFINITION>  (1219) 
angiotensin II receptor antagonists

>  <USAN_STEM_SUBSTEM>  (1219) 
-sartan

>  <USAN_YEAR>  (1219) 
1994.0

>  <FIRST_APPROVAL>  (1219) 
1997.0

>  <ATC_CODE>  (1219) 
C09CA02

>  <ATC_CODE_DESCRIPTION>  (1219) 
C09CA02 [Cardiovascular System:Agents Acting On The Renin-Angiotensin System:Angiotensin Ii Antagonists, Plain:Angiotensin II antagonists, plain]

>  <INDICATION_CLASS>  (1219) 
Antihypertensive

>  <SC_PATENT_NO>  (1219) 
nan

>  <DRUG_TYPE>  (1219) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1219) 
Y

>  <FIRST_IN_CLASS>  (1219) 
N

>  <CHIRALITY>  (1219) 
Achiral Molecule

>  <PRODRUG>  (1219) 
N

>  <ORAL>  (1219) 
Y

>  <PARENTERAL>  (1219) 
N

>  <TOPICAL>  (1219) 
N

>  <BLACK_BOX>  (1219) 
Y

>  <AVAILABILITY_TYPE>  (1219) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1219) 
nan

>  <WITHDRAWN_COUNTRY>  (1219) 
nan

>  <WITHDRAWN_REASON>  (1219) 
nan

>  <CANONICAL_SMILES>  (1219) 
CCCCc1ncc(\C=C(/Cc2cccs2)\C(=O)O)n1Cc3ccc(cc3)C(=O)O

>  <name>  (1219) 
Eprosartan 

>  <MW>  (1219) 
424.522

>  <logP>  (1219) 
4.7444

$$$$
CHEMBL1650
     RDKit          

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28  8  1  0
 28 12  1  0
 24 13  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1220) 
487711

>  <SYNONYMS>  (1220) 
Cortisone (BAN, INN); Cortisone acetate (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1220) 
4

>  <RESEARCH_CODES>  (1220) 
nan

>  <APPLICANTS>  (1220) 
Pharmacia And Upjohn Co; Panray Corp Sub Ormont Drug And Chemical Co Inc; Merck And Co Inc; Impax Laboratories Inc

>  <USAN_STEM>  (1220) 
-cort-

>  <USAN_STEM_DEFINITION>  (1220) 
cortisone derivatives

>  <USAN_STEM_SUBSTEM>  (1220) 
-cort-

>  <USAN_YEAR>  (1220) 
nan

>  <FIRST_APPROVAL>  (1220) 
1950.0

>  <ATC_CODE>  (1220) 
S01BA03; H02AB10

>  <ATC_CODE_DESCRIPTION>  (1220) 
S01BA03 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; H02AB10 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]

>  <INDICATION_CLASS>  (1220) 
Glucocorticoid

>  <SC_PATENT_NO>  (1220) 
nan

>  <DRUG_TYPE>  (1220) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1220) 
Y

>  <FIRST_IN_CLASS>  (1220) 
N

>  <CHIRALITY>  (1220) 
Single Stereoisomer

>  <PRODRUG>  (1220) 
N

>  <ORAL>  (1220) 
Y

>  <PARENTERAL>  (1220) 
Y

>  <TOPICAL>  (1220) 
N

>  <BLACK_BOX>  (1220) 
N

>  <AVAILABILITY_TYPE>  (1220) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1220) 
nan

>  <WITHDRAWN_COUNTRY>  (1220) 
nan

>  <WITHDRAWN_REASON>  (1220) 
nan

>  <CANONICAL_SMILES>  (1220) 
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C

>  <name>  (1220) 
Cortisone 

>  <MW>  (1220) 
402.487

>  <logP>  (1220) 
2.5606

$$$$
CHEMBL1521
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  3  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 18 22  1  0
 22 23  3  0
 12  7  1  0
 21 13  1  0
 21 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1221) 
421332

>  <SYNONYMS>  (1221) 
Zaleplon (BAN, FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1221) 
4

>  <RESEARCH_CODES>  (1221) 
CL-284846; L-846; L846; LJC 10846; LJC-10846; ZAL-846

>  <APPLICANTS>  (1221) 
King Pharmaceuticals Research And Development Inc Sub King Pharmaceuticals Inc

>  <USAN_STEM>  (1221) 
-plon

>  <USAN_STEM_DEFINITION>  (1221) 
non-benzodiazepine anxiolytics, sedatives, hypnotics

>  <USAN_STEM_SUBSTEM>  (1221) 
-plon

>  <USAN_YEAR>  (1221) 
1994.0

>  <FIRST_APPROVAL>  (1221) 
1999.0

>  <ATC_CODE>  (1221) 
N05CF03

>  <ATC_CODE_DESCRIPTION>  (1221) 
N05CF03 [Nervous System:Psycholeptics:Hypnotics And Sedatives:Benzodiazepine related drugs]

>  <INDICATION_CLASS>  (1221) 
Sedative-Hypnotic

>  <SC_PATENT_NO>  (1221) 
nan

>  <DRUG_TYPE>  (1221) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1221) 
Y

>  <FIRST_IN_CLASS>  (1221) 
N

>  <CHIRALITY>  (1221) 
Achiral Molecule

>  <PRODRUG>  (1221) 
N

>  <ORAL>  (1221) 
Y

>  <PARENTERAL>  (1221) 
N

>  <TOPICAL>  (1221) 
N

>  <BLACK_BOX>  (1221) 
Y

>  <AVAILABILITY_TYPE>  (1221) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1221) 
nan

>  <WITHDRAWN_COUNTRY>  (1221) 
nan

>  <WITHDRAWN_REASON>  (1221) 
nan

>  <CANONICAL_SMILES>  (1221) 
CCN(C(=O)C)c1cccc(c1)c2ccnc3c(cnn23)C#N

>  <name>  (1221) 
Zaleplon 

>  <MW>  (1221) 
305.341

>  <logP>  (1221) 
2.64078

$$$$
CHEMBL1445
     RDKit          

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 23  2  1  0
 23  6  1  0
 18  7  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1222) 
377718

>  <SYNONYMS>  (1222) 
Fluoxymesterone (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1222) 
4

>  <RESEARCH_CODES>  (1222) 
nan

>  <APPLICANTS>  (1222) 
Pharmacia And Upjohn Co; Bristol Myers Squibb

>  <USAN_STEM>  (1222) 
-ster-

>  <USAN_STEM_DEFINITION>  (1222) 
steroids (androgens, anabolics)

>  <USAN_STEM_SUBSTEM>  (1222) 
-ster-

>  <USAN_YEAR>  (1222) 
nan

>  <FIRST_APPROVAL>  (1222) 
1956.0

>  <ATC_CODE>  (1222) 
G03BA01

>  <ATC_CODE_DESCRIPTION>  (1222) 
G03BA01 [Genito Urinary System And Sex Hormones:Sex Hormones And Modulators Of The Genital System:Androgens:3-oxoandrosten (4) derivatives]

>  <INDICATION_CLASS>  (1222) 
Androgen

>  <SC_PATENT_NO>  (1222) 
nan

>  <DRUG_TYPE>  (1222) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1222) 
Y

>  <FIRST_IN_CLASS>  (1222) 
N

>  <CHIRALITY>  (1222) 
Single Stereoisomer

>  <PRODRUG>  (1222) 
N

>  <ORAL>  (1222) 
Y

>  <PARENTERAL>  (1222) 
N

>  <TOPICAL>  (1222) 
N

>  <BLACK_BOX>  (1222) 
N

>  <AVAILABILITY_TYPE>  (1222) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1222) 
nan

>  <WITHDRAWN_COUNTRY>  (1222) 
nan

>  <WITHDRAWN_REASON>  (1222) 
nan

>  <CANONICAL_SMILES>  (1222) 
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C

>  <name>  (1222) 
Fluoxymesterone 

>  <MW>  (1222) 
336.447

>  <logP>  (1222) 
3.3322

$$$$
CHEMBL563
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 12  6  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1223) 
16308

>  <SYNONYMS>  (1223) 
Flurbiprofen (BAN, FDA, INN, JAN, USAN, USP); Flurbiprofen sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1223) 
4

>  <RESEARCH_CODES>  (1223) 
BTS 18322; BTS-18322; U-27182

>  <APPLICANTS>  (1223) 
Pharmacia And Upjohn Co; Allergan Pharmaceutical

>  <USAN_STEM>  (1223) 
-profen

>  <USAN_STEM_DEFINITION>  (1223) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (1223) 
-profen

>  <USAN_YEAR>  (1223) 
1976.0

>  <FIRST_APPROVAL>  (1223) 
1986.0

>  <ATC_CODE>  (1223) 
M01AE09; S01BC04; R02AX01; M02AA19

>  <ATC_CODE_DESCRIPTION>  (1223) 
M01AE09 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]; S01BC04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]; R02AX01 [Respiratory System:Throat Preparations:Throat Preparations:Other throat preparations]; M02AA19 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]

>  <INDICATION_CLASS>  (1223) 
Analgesic; Anti-Inflammatory; Inhibitor (prostaglandin synthesis)

>  <SC_PATENT_NO>  (1223) 
nan

>  <DRUG_TYPE>  (1223) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1223) 
Y

>  <FIRST_IN_CLASS>  (1223) 
N

>  <CHIRALITY>  (1223) 
Racemic Mixture

>  <PRODRUG>  (1223) 
N

>  <ORAL>  (1223) 
Y

>  <PARENTERAL>  (1223) 
N

>  <TOPICAL>  (1223) 
Y

>  <BLACK_BOX>  (1223) 
Y

>  <AVAILABILITY_TYPE>  (1223) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1223) 
nan

>  <WITHDRAWN_COUNTRY>  (1223) 
nan

>  <WITHDRAWN_REASON>  (1223) 
nan

>  <CANONICAL_SMILES>  (1223) 
CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2

>  <name>  (1223) 
Flurbiprofen 

>  <MW>  (1223) 
244.265

>  <logP>  (1223) 
3.6808

$$$$
CHEMBL1082407
     RDKit          

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  8 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 15 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  3  0
 24 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  1  0
 29 31  1  0
 29 32  1  0
 10  5  1  0
 18 12  1  0
 28 21  1  0
M  END
>  <PARENT_MOLREGNO>  (1224) 
630886

>  <SYNONYMS>  (1224) 
Enzalutamide (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1224) 
4

>  <RESEARCH_CODES>  (1224) 
MDV-3100

>  <APPLICANTS>  (1224) 
Astellas Pharma Us Inc

>  <USAN_STEM>  (1224) 
-lutamide

>  <USAN_STEM_DEFINITION>  (1224) 
non-steroid antiandrogens

>  <USAN_STEM_SUBSTEM>  (1224) 
-lutamide

>  <USAN_YEAR>  (1224) 
nan

>  <FIRST_APPROVAL>  (1224) 
2012.0

>  <ATC_CODE>  (1224) 
L02BB04

>  <ATC_CODE_DESCRIPTION>  (1224) 
L02BB04 [Antineoplastic And Immunomodulating Agents:Endocrine Therapy:Hormone Antagonists And Related Agents:Anti-androgens]

>  <INDICATION_CLASS>  (1224) 
nan

>  <SC_PATENT_NO>  (1224) 
US-7709517-B2

>  <DRUG_TYPE>  (1224) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1224) 
Y

>  <FIRST_IN_CLASS>  (1224) 
N

>  <CHIRALITY>  (1224) 
Achiral Molecule

>  <PRODRUG>  (1224) 
N

>  <ORAL>  (1224) 
Y

>  <PARENTERAL>  (1224) 
N

>  <TOPICAL>  (1224) 
N

>  <BLACK_BOX>  (1224) 
N

>  <AVAILABILITY_TYPE>  (1224) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1224) 
nan

>  <WITHDRAWN_COUNTRY>  (1224) 
nan

>  <WITHDRAWN_REASON>  (1224) 
nan

>  <CANONICAL_SMILES>  (1224) 
CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C2(C)C)c3ccc(C#N)c(c3)C(F)(F)F

>  <name>  (1224) 
Enzalutamide 

>  <MW>  (1224) 
464.444

>  <logP>  (1224) 
3.99248

$$$$
CHEMBL980
     RDKit          

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
  8  3  1  0
M  END
>  <PARENT_MOLREGNO>  (1225) 
100157

>  <SYNONYMS>  (1225) 
Guaifenesin (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1225) 
4

>  <RESEARCH_CODES>  (1225) 
nan

>  <APPLICANTS>  (1225) 
Reckitt Benckiser Llc

>  <USAN_STEM>  (1225) 
nan

>  <USAN_STEM_DEFINITION>  (1225) 
nan

>  <USAN_STEM_SUBSTEM>  (1225) 
nan

>  <USAN_YEAR>  (1225) 
1975.0

>  <FIRST_APPROVAL>  (1225) 
2002.0

>  <ATC_CODE>  (1225) 
R05CA03

>  <ATC_CODE_DESCRIPTION>  (1225) 
R05CA03 [Respiratory System:Cough And Cold Preparations:Expectorants, Excl. Combinations With Cough Suppressants:Expectorants]

>  <INDICATION_CLASS>  (1225) 
Expectorant

>  <SC_PATENT_NO>  (1225) 
US-6372252-B1

>  <DRUG_TYPE>  (1225) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1225) 
Y

>  <FIRST_IN_CLASS>  (1225) 
N

>  <CHIRALITY>  (1225) 
Racemic Mixture

>  <PRODRUG>  (1225) 
N

>  <ORAL>  (1225) 
Y

>  <PARENTERAL>  (1225) 
N

>  <TOPICAL>  (1225) 
N

>  <BLACK_BOX>  (1225) 
N

>  <AVAILABILITY_TYPE>  (1225) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1225) 
nan

>  <WITHDRAWN_COUNTRY>  (1225) 
nan

>  <WITHDRAWN_REASON>  (1225) 
nan

>  <CANONICAL_SMILES>  (1225) 
COc1ccccc1OCC(O)CO

>  <name>  (1225) 
Guaifenesin 

>  <MW>  (1225) 
198.218

>  <logP>  (1225) 
0.4272

$$$$
CHEMBL1480
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 11 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 10 25  1  0
 12  6  1  0
 19 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1226) 
405365

>  <SYNONYMS>  (1226) 
Felodipine (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1226) 
4

>  <RESEARCH_CODES>  (1226) 
H 154/82; H-154/82

>  <APPLICANTS>  (1226) 
Astrazeneca Pharmaceuticals Lp

>  <USAN_STEM>  (1226) 
-dipine

>  <USAN_STEM_DEFINITION>  (1226) 
phenylpyridine vasodilators (nifedipine type)

>  <USAN_STEM_SUBSTEM>  (1226) 
-dipine

>  <USAN_YEAR>  (1226) 
1985.0

>  <FIRST_APPROVAL>  (1226) 
1991.0

>  <ATC_CODE>  (1226) 
C08CA02

>  <ATC_CODE_DESCRIPTION>  (1226) 
C08CA02 [Cardiovascular System:Calcium Channel Blockers:Selective Calcium Channel Blockers With Mainly Vascular Effects:Dihydropyridine derivatives]

>  <INDICATION_CLASS>  (1226) 
Vasodilator

>  <SC_PATENT_NO>  (1226) 
nan

>  <DRUG_TYPE>  (1226) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1226) 
Y

>  <FIRST_IN_CLASS>  (1226) 
N

>  <CHIRALITY>  (1226) 
Racemic Mixture

>  <PRODRUG>  (1226) 
N

>  <ORAL>  (1226) 
Y

>  <PARENTERAL>  (1226) 
N

>  <TOPICAL>  (1226) 
N

>  <BLACK_BOX>  (1226) 
N

>  <AVAILABILITY_TYPE>  (1226) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1226) 
nan

>  <WITHDRAWN_COUNTRY>  (1226) 
nan

>  <WITHDRAWN_REASON>  (1226) 
nan

>  <CANONICAL_SMILES>  (1226) 
CCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C

>  <name>  (1226) 
Felodipine 

>  <MW>  (1226) 
384.259

>  <logP>  (1226) 
3.9643

$$$$
CHEMBL696
     RDKit          

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9  3  1  0
M  END
>  <PARENT_MOLREGNO>  (1227) 
31811

>  <SYNONYMS>  (1227) 
Ethosuximide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1227) 
4

>  <RESEARCH_CODES>  (1227) 
CI-366; CN-10395; PM-671

>  <APPLICANTS>  (1227) 
Parke Davis Div Warner Lambert Co

>  <USAN_STEM>  (1227) 
nan

>  <USAN_STEM_DEFINITION>  (1227) 
nan

>  <USAN_STEM_SUBSTEM>  (1227) 
nan

>  <USAN_YEAR>  (1227) 
1962.0

>  <FIRST_APPROVAL>  (1227) 
1960.0

>  <ATC_CODE>  (1227) 
N03AD01; N03AD51

>  <ATC_CODE_DESCRIPTION>  (1227) 
N03AD01 [Nervous System:Antiepileptics:Antiepileptics:Succinimide derivatives]; N03AD51 [Nervous System:Antiepileptics:Antiepileptics:Succinimide derivatives]

>  <INDICATION_CLASS>  (1227) 
Anticonvulsant

>  <SC_PATENT_NO>  (1227) 
nan

>  <DRUG_TYPE>  (1227) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1227) 
Y

>  <FIRST_IN_CLASS>  (1227) 
N

>  <CHIRALITY>  (1227) 
Racemic Mixture

>  <PRODRUG>  (1227) 
N

>  <ORAL>  (1227) 
Y

>  <PARENTERAL>  (1227) 
N

>  <TOPICAL>  (1227) 
N

>  <BLACK_BOX>  (1227) 
N

>  <AVAILABILITY_TYPE>  (1227) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1227) 
nan

>  <WITHDRAWN_COUNTRY>  (1227) 
nan

>  <WITHDRAWN_REASON>  (1227) 
nan

>  <CANONICAL_SMILES>  (1227) 
CCC1(C)CC(=O)NC1=O

>  <name>  (1227) 
Ethosuximide 

>  <MW>  (1227) 
141.17

>  <logP>  (1227) 
0.4492

$$$$
CHEMBL596
     RDKit          

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  9 18  1  0
 18 19  1  0
  5 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 19  6  1  0
 17 12  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1228) 
19915

>  <SYNONYMS>  (1228) 
Fentanyl (BAN, FDA, INN, USAN); Fentanyl citrate (FDA, JAN, USAN, USP); Fentanyl HCl (FDA)

>  <DEVELOPMENT_PHASE>  (1228) 
4

>  <RESEARCH_CODES>  (1228) 
MCN-JR-4263-49; R-4263

>  <APPLICANTS>  (1228) 
Baxter Healthcare Corp Anesthesia And Critical Care; Archimedes Development Ltd; Akorn Manufacturing Inc; Akorn Inc; Incline Therapeutics Inc

>  <USAN_STEM>  (1228) 
nan

>  <USAN_STEM_DEFINITION>  (1228) 
nan

>  <USAN_STEM_SUBSTEM>  (1228) 
nan

>  <USAN_YEAR>  (1228) 
1963.0

>  <FIRST_APPROVAL>  (1228) 
1968.0

>  <ATC_CODE>  (1228) 
N01AH01; N01AH51; N02AB03

>  <ATC_CODE_DESCRIPTION>  (1228) 
N01AH01 [Nervous System:Anesthetics:Anesthetics, General:Opioid anesthetics]; N01AH51 [Nervous System:Anesthetics:Anesthetics, General:Opioid anesthetics]; N02AB03 [Nervous System:Analgesics:Opioids:Phenylpiperidine derivatives]

>  <INDICATION_CLASS>  (1228) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (1228) 
US-5697896-A

>  <DRUG_TYPE>  (1228) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1228) 
Y

>  <FIRST_IN_CLASS>  (1228) 
N

>  <CHIRALITY>  (1228) 
Achiral Molecule

>  <PRODRUG>  (1228) 
N

>  <ORAL>  (1228) 
Y

>  <PARENTERAL>  (1228) 
Y

>  <TOPICAL>  (1228) 
Y

>  <BLACK_BOX>  (1228) 
Y

>  <AVAILABILITY_TYPE>  (1228) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1228) 
nan

>  <WITHDRAWN_COUNTRY>  (1228) 
nan

>  <WITHDRAWN_REASON>  (1228) 
nan

>  <CANONICAL_SMILES>  (1228) 
CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccccc3

>  <name>  (1228) 
Fentanyl 

>  <MW>  (1228) 
336.479

>  <logP>  (1228) 
4.1367

$$$$
CHEMBL437
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
  7  2  1  0
 16 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1229) 
2095

>  <SYNONYMS>  (1229) 
Sulfathiazole (BAN, INN, USP); Sulfathiazole (Triple Sulfa) (FDA); Sulfathiazole Sodium (MI, NF)

>  <DEVELOPMENT_PHASE>  (1229) 
4

>  <RESEARCH_CODES>  (1229) 
nan

>  <APPLICANTS>  (1229) 
Ortho Mcneil Pharmaceutical Inc

>  <USAN_STEM>  (1229) 
sulfa-

>  <USAN_STEM_DEFINITION>  (1229) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (1229) 
sulfa-

>  <USAN_YEAR>  (1229) 
nan

>  <FIRST_APPROVAL>  (1229) 
1945.0

>  <ATC_CODE>  (1229) 
J01EB07; D06BA02

>  <ATC_CODE_DESCRIPTION>  (1229) 
J01EB07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]; D06BA02 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]

>  <INDICATION_CLASS>  (1229) 
Antibacterial

>  <SC_PATENT_NO>  (1229) 
nan

>  <DRUG_TYPE>  (1229) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1229) 
Y

>  <FIRST_IN_CLASS>  (1229) 
N

>  <CHIRALITY>  (1229) 
Achiral Molecule

>  <PRODRUG>  (1229) 
N

>  <ORAL>  (1229) 
N

>  <PARENTERAL>  (1229) 
N

>  <TOPICAL>  (1229) 
Y

>  <BLACK_BOX>  (1229) 
N

>  <AVAILABILITY_TYPE>  (1229) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1229) 
nan

>  <WITHDRAWN_COUNTRY>  (1229) 
United States; United States

>  <WITHDRAWN_REASON>  (1229) 
nan

>  <CANONICAL_SMILES>  (1229) 
Nc1ccc(cc1)S(=O)(=O)Nc2nccs2

>  <name>  (1229) 
Sulfathiazole 

>  <MW>  (1229) 
255.324

>  <logP>  (1229) 
1.5261

$$$$
CHEMBL989
     RDKit          

 32 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 28  2  1  0
 27  5  1  0
 25  7  1  0
 20  8  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1230) 
105252

>  <SYNONYMS>  (1230) 
Fluocinolone (BAN); Fluocinolone Acetonide (FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1230) 
4

>  <RESEARCH_CODES>  (1230) 
nan

>  <APPLICANTS>  (1230) 
Medimetriks Pharmaceuticals Inc; Hill Dermaceuticals Inc; Galderma Laboratories Lp; Bausch And Lomb Inc

>  <USAN_STEM>  (1230) 
-olone

>  <USAN_STEM_DEFINITION>  (1230) 
steroids (not prednisolone derivatives)

>  <USAN_STEM_SUBSTEM>  (1230) 
-olone

>  <USAN_YEAR>  (1230) 
1962.0

>  <FIRST_APPROVAL>  (1230) 
1963.0

>  <ATC_CODE>  (1230) 
D07AC04; S01BA15; S02BA08; C05AA10

>  <ATC_CODE_DESCRIPTION>  (1230) 
D07AC04 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; S01BA15 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA08 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; C05AA10 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]

>  <INDICATION_CLASS>  (1230) 
Glucocorticoid

>  <SC_PATENT_NO>  (1230) 
US-6217895-B1

>  <DRUG_TYPE>  (1230) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1230) 
Y

>  <FIRST_IN_CLASS>  (1230) 
N

>  <CHIRALITY>  (1230) 
Single Stereoisomer

>  <PRODRUG>  (1230) 
N

>  <ORAL>  (1230) 
N

>  <PARENTERAL>  (1230) 
Y

>  <TOPICAL>  (1230) 
Y

>  <BLACK_BOX>  (1230) 
N

>  <AVAILABILITY_TYPE>  (1230) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1230) 
nan

>  <WITHDRAWN_COUNTRY>  (1230) 
nan

>  <WITHDRAWN_REASON>  (1230) 
nan

>  <CANONICAL_SMILES>  (1230) 
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

>  <name>  (1230) 
Fluocinolone 

>  <MW>  (1230) 
452.494

>  <logP>  (1230) 
2.3668

$$$$
CHEMBL1089221
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  6  1  0
 15 10  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1231) 
621308

>  <SYNONYMS>  (1231) 
Bendazac (BAN, INN, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1231) 
4

>  <RESEARCH_CODES>  (1231) 
AF-1934

>  <APPLICANTS>  (1231) 
Angelini Francesco, Italy

>  <USAN_STEM>  (1231) 
-ac

>  <USAN_STEM_DEFINITION>  (1231) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (1231) 
-ac

>  <USAN_YEAR>  (1231) 
1969.0

>  <FIRST_APPROVAL>  (1231) 
1984.0

>  <ATC_CODE>  (1231) 
M02AA11; S01BC07

>  <ATC_CODE_DESCRIPTION>  (1231) 
M02AA11 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Antiinflammatory preparations, non-steroids for topical use]; S01BC07 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Antiinflammatory agents, non-steroids]

>  <INDICATION_CLASS>  (1231) 
Anti-Inflammatory

>  <SC_PATENT_NO>  (1231) 
nan

>  <DRUG_TYPE>  (1231) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1231) 
Y

>  <FIRST_IN_CLASS>  (1231) 
N

>  <CHIRALITY>  (1231) 
Achiral Molecule

>  <PRODRUG>  (1231) 
N

>  <ORAL>  (1231) 
N

>  <PARENTERAL>  (1231) 
N

>  <TOPICAL>  (1231) 
N

>  <BLACK_BOX>  (1231) 
N

>  <AVAILABILITY_TYPE>  (1231) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1231) 
1993.0

>  <WITHDRAWN_COUNTRY>  (1231) 
Spain

>  <WITHDRAWN_REASON>  (1231) 
Hepatotoxicity

>  <CANONICAL_SMILES>  (1231) 
OC(=O)COc1nn(Cc2ccccc2)c3ccccc13

>  <name>  (1231) 
Bendazac 

>  <MW>  (1231) 
282.299

>  <logP>  (1231) 
2.548

$$$$
CHEMBL1200979
     RDKit          

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1232) 
674930

>  <SYNONYMS>  (1232) 
Dexpanthenol (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1232) 
4

>  <RESEARCH_CODES>  (1232) 
nan

>  <APPLICANTS>  (1232) 
Hospira Inc; Hoffmann La Roche Inc; Astrazeneca Lp; Abraxis Pharmaceutical Products; Sandoz Canada Inc

>  <USAN_STEM>  (1232) 
nan

>  <USAN_STEM_DEFINITION>  (1232) 
nan

>  <USAN_STEM_SUBSTEM>  (1232) 
nan

>  <USAN_YEAR>  (1232) 
1970.0

>  <FIRST_APPROVAL>  (1232) 
1985.0

>  <ATC_CODE>  (1232) 
D03AX03; S01XA12; A11HA30

>  <ATC_CODE_DESCRIPTION>  (1232) 
D03AX03 [Dermatologicals:Preparations For Treatment Of Wounds And Ulcers:Cicatrizants:Other cicatrizants]; S01XA12 [Sensory Organs:Ophthalmologicals:Other Ophthalmologicals:Other ophthalmologicals]; A11HA30 [Alimentary Tract And Metabolism:Vitamins:Other Plain Vitamin Preparations:Other plain vitamin preparations]

>  <INDICATION_CLASS>  (1232) 
Cholinergic

>  <SC_PATENT_NO>  (1232) 
nan

>  <DRUG_TYPE>  (1232) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1232) 
Y

>  <FIRST_IN_CLASS>  (1232) 
N

>  <CHIRALITY>  (1232) 
Single Stereoisomer

>  <PRODRUG>  (1232) 
N

>  <ORAL>  (1232) 
N

>  <PARENTERAL>  (1232) 
Y

>  <TOPICAL>  (1232) 
N

>  <BLACK_BOX>  (1232) 
N

>  <AVAILABILITY_TYPE>  (1232) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1232) 
nan

>  <WITHDRAWN_COUNTRY>  (1232) 
nan

>  <WITHDRAWN_REASON>  (1232) 
nan

>  <CANONICAL_SMILES>  (1232) 
CC(C)(CO)[C@@H](O)C(=O)NCCCO

>  <name>  (1232) 
Dexpanthenol 

>  <MW>  (1232) 
205.254

>  <logP>  (1232) 
-1.1356

$$$$
CHEMBL1103
     RDKit          

 16 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
  6 15  2  0
 15 16  1  0
 16  4  2  0
 13  9  1  0
M  CHG  2   1  -1   2   1
M  END
>  <PARENT_MOLREGNO>  (1233) 
151310

>  <SYNONYMS>  (1233) 
Furazolidone (BAN, FDA, INN, USP)

>  <DEVELOPMENT_PHASE>  (1233) 
4

>  <RESEARCH_CODES>  (1233) 
nan

>  <APPLICANTS>  (1233) 
Shire Development Inc

>  <USAN_STEM>  (1233) 
nan

>  <USAN_STEM_DEFINITION>  (1233) 
nan

>  <USAN_STEM_SUBSTEM>  (1233) 
nan

>  <USAN_YEAR>  (1233) 
nan

>  <FIRST_APPROVAL>  (1233) 
1958.0

>  <ATC_CODE>  (1233) 
G01AX06

>  <ATC_CODE_DESCRIPTION>  (1233) 
G01AX06 [Genito Urinary System And Sex Hormones:Gynecological Antiinfectives And Antiseptics:Antiinfectives And Antiseptics, Excl. Combinations:Other antiinfectives and antiseptics]

>  <INDICATION_CLASS>  (1233) 
Anti-Infective, Topical; Antiprotozoal (trichomonas, topical)

>  <SC_PATENT_NO>  (1233) 
nan

>  <DRUG_TYPE>  (1233) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1233) 
Y

>  <FIRST_IN_CLASS>  (1233) 
N

>  <CHIRALITY>  (1233) 
Achiral Molecule

>  <PRODRUG>  (1233) 
N

>  <ORAL>  (1233) 
Y

>  <PARENTERAL>  (1233) 
N

>  <TOPICAL>  (1233) 
N

>  <BLACK_BOX>  (1233) 
N

>  <AVAILABILITY_TYPE>  (1233) 
Discontinued

>  <WITHDRAWN_YEAR>  (1233) 
nan

>  <WITHDRAWN_COUNTRY>  (1233) 
nan

>  <WITHDRAWN_REASON>  (1233) 
nan

>  <CANONICAL_SMILES>  (1233) 
[O-][N+](=O)c1oc(\C=N\N2CCOC2=O)cc1

>  <name>  (1233) 
Furazolidone 

>  <MW>  (1233) 
225.16

>  <logP>  (1233) 
0.9739

$$$$
CHEMBL1297
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10 18  2  0
 18  6  1  0
 17 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1234) 
255534

>  <SYNONYMS>  (1234) 
Fenoprofen (BAN, INN, USAN); Fenoprofen Calcium (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1234) 
4

>  <RESEARCH_CODES>  (1234) 
53858; 69323

>  <APPLICANTS>  (1234) 
Xspire Llc; Lilly; Dista Products Co Div Eli Lilly And Co

>  <USAN_STEM>  (1234) 
-profen

>  <USAN_STEM_DEFINITION>  (1234) 
anti-inflammatory/analgesic agents (ibuprofen type)

>  <USAN_STEM_SUBSTEM>  (1234) 
-profen

>  <USAN_YEAR>  (1234) 
1971.0

>  <FIRST_APPROVAL>  (1234) 
1976.0

>  <ATC_CODE>  (1234) 
M01AE04

>  <ATC_CODE_DESCRIPTION>  (1234) 
M01AE04 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Propionic acid derivatives]

>  <INDICATION_CLASS>  (1234) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (1234) 
nan

>  <DRUG_TYPE>  (1234) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1234) 
Y

>  <FIRST_IN_CLASS>  (1234) 
N

>  <CHIRALITY>  (1234) 
Racemic Mixture

>  <PRODRUG>  (1234) 
N

>  <ORAL>  (1234) 
Y

>  <PARENTERAL>  (1234) 
N

>  <TOPICAL>  (1234) 
N

>  <BLACK_BOX>  (1234) 
Y

>  <AVAILABILITY_TYPE>  (1234) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1234) 
nan

>  <WITHDRAWN_COUNTRY>  (1234) 
nan

>  <WITHDRAWN_REASON>  (1234) 
nan

>  <CANONICAL_SMILES>  (1234) 
CC(C(=O)O)c1cccc(Oc2ccccc2)c1

>  <name>  (1234) 
Fenoprofen 

>  <MW>  (1234) 
242.274

>  <logP>  (1234) 
3.667

$$$$
CHEMBL1481
     RDKit          

 34 36  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
  7 33  1  0
 33 34  2  0
 33  3  1  0
 18 13  1  0
 32 26  1  0
M  END
>  <PARENT_MOLREGNO>  (1235) 
405366

>  <SYNONYMS>  (1235) 
Glimepiride (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1235) 
4

>  <RESEARCH_CODES>  (1235) 
HOE-490

>  <APPLICANTS>  (1235) 
Takeda Pharmaceuticals Usa Inc; Sb Pharmco Puerto Rico Inc; Sanofi Aventis Us Llc

>  <USAN_STEM>  (1235) 
gli-

>  <USAN_STEM_DEFINITION>  (1235) 
antihyperglycemics

>  <USAN_STEM_SUBSTEM>  (1235) 
gli-

>  <USAN_YEAR>  (1235) 
1992.0

>  <FIRST_APPROVAL>  (1235) 
1995.0

>  <ATC_CODE>  (1235) 
A10BB12

>  <ATC_CODE_DESCRIPTION>  (1235) 
A10BB12 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Sulfonylureas]

>  <INDICATION_CLASS>  (1235) 
Hypoglycemic

>  <SC_PATENT_NO>  (1235) 
US-6150383-A

>  <DRUG_TYPE>  (1235) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1235) 
Y

>  <FIRST_IN_CLASS>  (1235) 
N

>  <CHIRALITY>  (1235) 
Single Stereoisomer

>  <PRODRUG>  (1235) 
N

>  <ORAL>  (1235) 
Y

>  <PARENTERAL>  (1235) 
N

>  <TOPICAL>  (1235) 
N

>  <BLACK_BOX>  (1235) 
N

>  <AVAILABILITY_TYPE>  (1235) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1235) 
nan

>  <WITHDRAWN_COUNTRY>  (1235) 
nan

>  <WITHDRAWN_REASON>  (1235) 
nan

>  <CANONICAL_SMILES>  (1235) 
CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O

>  <name>  (1235) 
Glimepiride 

>  <MW>  (1235) 
490.626

>  <logP>  (1235) 
3.074

$$$$
CHEMBL788
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
  7  3  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1236) 
47675

>  <SYNONYMS>  (1236) 
Idoxuridine (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1236) 
4

>  <RESEARCH_CODES>  (1236) 
5IUDR; Allergan 211; SK&F-14287

>  <APPLICANTS>  (1236) 
GlaxoSmithKline; Allergan Pharmaceutical; Alcon Laboratories Inc

>  <USAN_STEM>  (1236) 
-uridine

>  <USAN_STEM_DEFINITION>  (1236) 
antivirals,antineoplastics (uridine derivatives)

>  <USAN_STEM_SUBSTEM>  (1236) 
-uridine

>  <USAN_YEAR>  (1236) 
1962.0

>  <FIRST_APPROVAL>  (1236) 
1963.0

>  <ATC_CODE>  (1236) 
J05AB02; S01AD01; D06BB01

>  <ATC_CODE_DESCRIPTION>  (1236) 
J05AB02 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]; D06BB01 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]

>  <INDICATION_CLASS>  (1236) 
Antiviral (ophthalmic)

>  <SC_PATENT_NO>  (1236) 
nan

>  <DRUG_TYPE>  (1236) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1236) 
Y

>  <FIRST_IN_CLASS>  (1236) 
N

>  <CHIRALITY>  (1236) 
Single Stereoisomer

>  <PRODRUG>  (1236) 
N

>  <ORAL>  (1236) 
N

>  <PARENTERAL>  (1236) 
N

>  <TOPICAL>  (1236) 
Y

>  <BLACK_BOX>  (1236) 
N

>  <AVAILABILITY_TYPE>  (1236) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1236) 
nan

>  <WITHDRAWN_COUNTRY>  (1236) 
nan

>  <WITHDRAWN_REASON>  (1236) 
nan

>  <CANONICAL_SMILES>  (1236) 
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(I)C(=O)NC2=O

>  <name>  (1236) 
Idoxuridine 

>  <MW>  (1236) 
354.1

>  <logP>  (1236) 
-1.2181

$$$$
CHEMBL1161681
     RDKit          

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
M  END
>  <PARENT_MOLREGNO>  (1237) 
643220

>  <SYNONYMS>  (1237) 
Sodium nitrite (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1237) 
4

>  <RESEARCH_CODES>  (1237) 
nan

>  <APPLICANTS>  (1237) 
Hope Pharmaceuticals

>  <USAN_STEM>  (1237) 
nan

>  <USAN_STEM_DEFINITION>  (1237) 
nan

>  <USAN_STEM_SUBSTEM>  (1237) 
nan

>  <USAN_YEAR>  (1237) 
nan

>  <FIRST_APPROVAL>  (1237) 
2011.0

>  <ATC_CODE>  (1237) 
V03AB08

>  <ATC_CODE_DESCRIPTION>  (1237) 
V03AB08 [Various:All Other Therapeutic Products:All Other Therapeutic Products:Antidotes]

>  <INDICATION_CLASS>  (1237) 
Antidote (to cyanide poisoning)

>  <SC_PATENT_NO>  (1237) 
US-8496973-B2

>  <DRUG_TYPE>  (1237) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1237) 
Y

>  <FIRST_IN_CLASS>  (1237) 
N

>  <CHIRALITY>  (1237) 
Achiral Molecule

>  <PRODRUG>  (1237) 
N

>  <ORAL>  (1237) 
N

>  <PARENTERAL>  (1237) 
Y

>  <TOPICAL>  (1237) 
N

>  <BLACK_BOX>  (1237) 
Y

>  <AVAILABILITY_TYPE>  (1237) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1237) 
nan

>  <WITHDRAWN_COUNTRY>  (1237) 
nan

>  <WITHDRAWN_REASON>  (1237) 
nan

>  <CANONICAL_SMILES>  (1237) 
ON=O

>  <name>  (1237) 
Sodium nitrite 

>  <MW>  (1237) 
47.013

>  <logP>  (1237) 
0.142

$$$$
CHEMBL709
     RDKit          

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 13  3  1  0
 11  5  1  0
 28 24  1  0
M  END
>  <PARENT_MOLREGNO>  (1238) 
33667

>  <SYNONYMS>  (1238) 
Alfuzosin (BAN, INN); Alfuzosin HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1238) 
4

>  <RESEARCH_CODES>  (1238) 
SL-7749910; SL-77499-10

>  <APPLICANTS>  (1238) 
Sanofi Aventis Us Llc

>  <USAN_STEM>  (1238) 
nan

>  <USAN_STEM_DEFINITION>  (1238) 
nan

>  <USAN_STEM_SUBSTEM>  (1238) 
nan

>  <USAN_YEAR>  (1238) 
1984.0

>  <FIRST_APPROVAL>  (1238) 
2003.0

>  <ATC_CODE>  (1238) 
G04CA01

>  <ATC_CODE_DESCRIPTION>  (1238) 
G04CA01 [Genito Urinary System And Sex Hormones:Urologicals:Drugs Used In Benign Prostatic Hypertrophy:Alpha-adrenoreceptor antagonists]

>  <INDICATION_CLASS>  (1238) 
Antihypertensive (alpha-blocker)

>  <SC_PATENT_NO>  (1238) 
US-6149940-A

>  <DRUG_TYPE>  (1238) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1238) 
Y

>  <FIRST_IN_CLASS>  (1238) 
N

>  <CHIRALITY>  (1238) 
Racemic Mixture

>  <PRODRUG>  (1238) 
N

>  <ORAL>  (1238) 
Y

>  <PARENTERAL>  (1238) 
N

>  <TOPICAL>  (1238) 
N

>  <BLACK_BOX>  (1238) 
N

>  <AVAILABILITY_TYPE>  (1238) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1238) 
nan

>  <WITHDRAWN_COUNTRY>  (1238) 
nan

>  <WITHDRAWN_REASON>  (1238) 
nan

>  <CANONICAL_SMILES>  (1238) 
COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3

>  <name>  (1238) 
Alfuzosin 

>  <MW>  (1238) 
389.456

>  <logP>  (1238) 
1.3507

$$$$
CHEMBL1179047
     RDKit          

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 17 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1239) 
652997

>  <SYNONYMS>  (1239) 
Chloroprocaine (INN); Chloroprocaine HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1239) 
4

>  <RESEARCH_CODES>  (1239) 
nan

>  <APPLICANTS>  (1239) 
Fresenius Kabi Usa Llc

>  <USAN_STEM>  (1239) 
-caine

>  <USAN_STEM_DEFINITION>  (1239) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (1239) 
-caine

>  <USAN_YEAR>  (1239) 
nan

>  <FIRST_APPROVAL>  (1239) 
1955.0

>  <ATC_CODE>  (1239) 
N01BA04

>  <ATC_CODE_DESCRIPTION>  (1239) 
N01BA04 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]

>  <INDICATION_CLASS>  (1239) 
Anesthetic (local)

>  <SC_PATENT_NO>  (1239) 
nan

>  <DRUG_TYPE>  (1239) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1239) 
Y

>  <FIRST_IN_CLASS>  (1239) 
N

>  <CHIRALITY>  (1239) 
Achiral Molecule

>  <PRODRUG>  (1239) 
N

>  <ORAL>  (1239) 
N

>  <PARENTERAL>  (1239) 
Y

>  <TOPICAL>  (1239) 
N

>  <BLACK_BOX>  (1239) 
N

>  <AVAILABILITY_TYPE>  (1239) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1239) 
nan

>  <WITHDRAWN_COUNTRY>  (1239) 
nan

>  <WITHDRAWN_REASON>  (1239) 
nan

>  <CANONICAL_SMILES>  (1239) 
CCN(CC)CCOC(=O)c1ccc(N)cc1Cl

>  <name>  (1239) 
Chloroprocaine 

>  <MW>  (1239) 
270.76

>  <logP>  (1239) 
2.4208

$$$$
CHEMBL1201251
     RDKit          

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  2  0
 15  9  1  0
 23 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1240) 
675202

>  <SYNONYMS>  (1240) 
Arbutamine (BAN, INN); Arbutamine HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1240) 
4

>  <RESEARCH_CODES>  (1240) 
GP-2-121-3

>  <APPLICANTS>  (1240) 
Gensia Automedics Inc

>  <USAN_STEM>  (1240) 
nan

>  <USAN_STEM_DEFINITION>  (1240) 
nan

>  <USAN_STEM_SUBSTEM>  (1240) 
nan

>  <USAN_YEAR>  (1240) 
1992.0

>  <FIRST_APPROVAL>  (1240) 
1997.0

>  <ATC_CODE>  (1240) 
C01CA22

>  <ATC_CODE_DESCRIPTION>  (1240) 
C01CA22 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (1240) 
Stimulant (cardiac)

>  <SC_PATENT_NO>  (1240) 
nan

>  <DRUG_TYPE>  (1240) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1240) 
Y

>  <FIRST_IN_CLASS>  (1240) 
N

>  <CHIRALITY>  (1240) 
Single Stereoisomer

>  <PRODRUG>  (1240) 
N

>  <ORAL>  (1240) 
N

>  <PARENTERAL>  (1240) 
Y

>  <TOPICAL>  (1240) 
N

>  <BLACK_BOX>  (1240) 
N

>  <AVAILABILITY_TYPE>  (1240) 
Discontinued

>  <WITHDRAWN_YEAR>  (1240) 
nan

>  <WITHDRAWN_COUNTRY>  (1240) 
nan

>  <WITHDRAWN_REASON>  (1240) 
nan

>  <CANONICAL_SMILES>  (1240) 
O[C@@H](CNCCCCc1ccc(O)cc1)c2ccc(O)c(O)c2

>  <name>  (1240) 
Arbutamine 

>  <MW>  (1240) 
317.385

>  <logP>  (1240) 
2.4493

$$$$
CHEMBL620
     RDKit          

 26 29  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
  7  2  1  0
  9  2  1  0
 20 15  1  0
 26 21  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (1241) 
26351

>  <SYNONYMS>  (1241) 
Clidinium Bromide (BAN, FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1241) 
4

>  <RESEARCH_CODES>  (1241) 
Ro-23773

>  <APPLICANTS>  (1241) 
Hoffmann La Roche Inc

>  <USAN_STEM>  (1241) 
-ium

>  <USAN_STEM_DEFINITION>  (1241) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (1241) 
-ium

>  <USAN_YEAR>  (1241) 
1961.0

>  <FIRST_APPROVAL>  (1241) 
1982.0

>  <ATC_CODE>  (1241) 
A03CA02

>  <ATC_CODE_DESCRIPTION>  (1241) 
A03CA02 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Antispasmodics In Combination With Psycholeptics:Synthetic anticholinergic agents in combination with psycholeptics]

>  <INDICATION_CLASS>  (1241) 
Anticholinergic

>  <SC_PATENT_NO>  (1241) 
nan

>  <DRUG_TYPE>  (1241) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1241) 
Y

>  <FIRST_IN_CLASS>  (1241) 
N

>  <CHIRALITY>  (1241) 
Racemic Mixture

>  <PRODRUG>  (1241) 
N

>  <ORAL>  (1241) 
Y

>  <PARENTERAL>  (1241) 
N

>  <TOPICAL>  (1241) 
N

>  <BLACK_BOX>  (1241) 
N

>  <AVAILABILITY_TYPE>  (1241) 
Discontinued

>  <WITHDRAWN_YEAR>  (1241) 
nan

>  <WITHDRAWN_COUNTRY>  (1241) 
nan

>  <WITHDRAWN_REASON>  (1241) 
nan

>  <CANONICAL_SMILES>  (1241) 
C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c3ccccc3)c4ccccc4

>  <name>  (1241) 
Clidinium Bromide 

>  <MW>  (1241) 
352.454

>  <logP>  (1241) 
2.7045

$$$$
CHEMBL477772
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
  2 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 27 29  2  0
 27 30  1  0
 18 31  2  0
 13  3  2  0
 12  6  1  0
 31 14  1  0
 26 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1242) 
489525

>  <SYNONYMS>  (1242) 
Pazopanib (INN); Pazopanib HCl (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1242) 
4

>  <RESEARCH_CODES>  (1242) 
GW786034; GW786034B

>  <APPLICANTS>  (1242) 
GlaxoSmithKline

>  <USAN_STEM>  (1242) 
-anib

>  <USAN_STEM_DEFINITION>  (1242) 
angiogenesis inhibitors

>  <USAN_STEM_SUBSTEM>  (1242) 
-anib

>  <USAN_YEAR>  (1242) 
2005.0

>  <FIRST_APPROVAL>  (1242) 
2009.0

>  <ATC_CODE>  (1242) 
L01XE11

>  <ATC_CODE_DESCRIPTION>  (1242) 
L01XE11 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors]

>  <INDICATION_CLASS>  (1242) 
nan

>  <SC_PATENT_NO>  (1242) 
US-7105530-B2

>  <DRUG_TYPE>  (1242) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1242) 
Y

>  <FIRST_IN_CLASS>  (1242) 
N

>  <CHIRALITY>  (1242) 
Achiral Molecule

>  <PRODRUG>  (1242) 
N

>  <ORAL>  (1242) 
Y

>  <PARENTERAL>  (1242) 
N

>  <TOPICAL>  (1242) 
N

>  <BLACK_BOX>  (1242) 
Y

>  <AVAILABILITY_TYPE>  (1242) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1242) 
nan

>  <WITHDRAWN_COUNTRY>  (1242) 
nan

>  <WITHDRAWN_REASON>  (1242) 
nan

>  <CANONICAL_SMILES>  (1242) 
CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3

>  <name>  (1242) 
Pazopanib 

>  <MW>  (1242) 
437.529

>  <logP>  (1242) 
3.13904

$$$$
CHEMBL2103827
     RDKit          

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
  2 13  1  0
 13 14  2  0
 13 15  1  0
 12  5  1  0
M  END
>  <PARENT_MOLREGNO>  (1243) 
1376097

>  <SYNONYMS>  (1243) 
Droxidopa (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1243) 
4

>  <RESEARCH_CODES>  (1243) 
DOPS; L-DOPS

>  <APPLICANTS>  (1243) 
Chelsea Therapeutics Inc

>  <USAN_STEM>  (1243) 
-dopa

>  <USAN_STEM_DEFINITION>  (1243) 
dopamine receptor agonists

>  <USAN_STEM_SUBSTEM>  (1243) 
-dopa

>  <USAN_YEAR>  (1243) 
2008.0

>  <FIRST_APPROVAL>  (1243) 
2014.0

>  <ATC_CODE>  (1243) 
C01CA27

>  <ATC_CODE_DESCRIPTION>  (1243) 
C01CA27 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (1243) 
nan

>  <SC_PATENT_NO>  (1243) 
nan

>  <DRUG_TYPE>  (1243) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1243) 
Y

>  <FIRST_IN_CLASS>  (1243) 
N

>  <CHIRALITY>  (1243) 
Single Stereoisomer

>  <PRODRUG>  (1243) 
N

>  <ORAL>  (1243) 
Y

>  <PARENTERAL>  (1243) 
N

>  <TOPICAL>  (1243) 
N

>  <BLACK_BOX>  (1243) 
N

>  <AVAILABILITY_TYPE>  (1243) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1243) 
nan

>  <WITHDRAWN_COUNTRY>  (1243) 
nan

>  <WITHDRAWN_REASON>  (1243) 
nan

>  <CANONICAL_SMILES>  (1243) 
N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(=O)O

>  <name>  (1243) 
Droxidopa 

>  <MW>  (1243) 
213.189

>  <logP>  (1243) 
-0.4569

$$$$
CHEMBL1364
     RDKit          

 12 12  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  2  0
 11 12  1  0
 11  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1244) 
308201

>  <SYNONYMS>  (1244) 
Pyridoxine (BAN, FDA, INN); Pyridoxine HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1244) 
4

>  <RESEARCH_CODES>  (1244) 
nan

>  <APPLICANTS>  (1244) 
Hospira Inc; Hoffmann La Roche Inc; Astrazeneca Lp; Abraxis Pharmaceutical Products; Sandoz Canada Inc

>  <USAN_STEM>  (1244) 
nan

>  <USAN_STEM_DEFINITION>  (1244) 
nan

>  <USAN_STEM_SUBSTEM>  (1244) 
nan

>  <USAN_YEAR>  (1244) 
nan

>  <FIRST_APPROVAL>  (1244) 
1985.0

>  <ATC_CODE>  (1244) 
A11HA02

>  <ATC_CODE_DESCRIPTION>  (1244) 
A11HA02 [Alimentary Tract And Metabolism:Vitamins:Other Plain Vitamin Preparations:Other plain vitamin preparations]

>  <INDICATION_CLASS>  (1244) 
Vitamin (enzyme co-factor)

>  <SC_PATENT_NO>  (1244) 
US-6340695-B1

>  <DRUG_TYPE>  (1244) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1244) 
Y

>  <FIRST_IN_CLASS>  (1244) 
N

>  <CHIRALITY>  (1244) 
Achiral Molecule

>  <PRODRUG>  (1244) 
N

>  <ORAL>  (1244) 
Y

>  <PARENTERAL>  (1244) 
Y

>  <TOPICAL>  (1244) 
N

>  <BLACK_BOX>  (1244) 
N

>  <AVAILABILITY_TYPE>  (1244) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1244) 
nan

>  <WITHDRAWN_COUNTRY>  (1244) 
nan

>  <WITHDRAWN_REASON>  (1244) 
nan

>  <CANONICAL_SMILES>  (1244) 
Cc1ncc(CO)c(CO)c1O

>  <name>  (1244) 
Pyridoxine 

>  <MW>  (1244) 
169.18

>  <logP>  (1244) 
0.08022

$$$$
CHEMBL1464
     RDKit          

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
  5 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 16  6  1  0
 14  9  1  0
 23 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1245) 
394165

>  <SYNONYMS>  (1245) 
Warfarin (BAN, INN); Warfarin Potassium (FDA, JAN, MI, USP); Warfarin sodium (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1245) 
4

>  <RESEARCH_CODES>  (1245) 
nan

>  <APPLICANTS>  (1245) 
Pharmaceutical Research Assoc Inc; Bristol Myers Squibb Pharma Co; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (1245) 
-farin

>  <USAN_STEM_DEFINITION>  (1245) 
warfarin analogs

>  <USAN_STEM_SUBSTEM>  (1245) 
-farin

>  <USAN_YEAR>  (1245) 
nan

>  <FIRST_APPROVAL>  (1245) 
1954.0

>  <ATC_CODE>  (1245) 
B01AA03

>  <ATC_CODE_DESCRIPTION>  (1245) 
B01AA03 [Blood And Blood Forming Organs:Antithrombotic Agents:Antithrombotic Agents:Vitamin K antagonists]

>  <INDICATION_CLASS>  (1245) 
Anticoagulant

>  <SC_PATENT_NO>  (1245) 
nan

>  <DRUG_TYPE>  (1245) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1245) 
Y

>  <FIRST_IN_CLASS>  (1245) 
N

>  <CHIRALITY>  (1245) 
Racemic Mixture

>  <PRODRUG>  (1245) 
N

>  <ORAL>  (1245) 
Y

>  <PARENTERAL>  (1245) 
Y

>  <TOPICAL>  (1245) 
N

>  <BLACK_BOX>  (1245) 
Y

>  <AVAILABILITY_TYPE>  (1245) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1245) 
nan

>  <WITHDRAWN_COUNTRY>  (1245) 
nan

>  <WITHDRAWN_REASON>  (1245) 
nan

>  <CANONICAL_SMILES>  (1245) 
CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3

>  <name>  (1245) 
Warfarin 

>  <MW>  (1245) 
308.333

>  <logP>  (1245) 
3.6096

$$$$
CHEMBL19490
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  4  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 11  2  2  0
 20 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1246) 
23001

>  <SYNONYMS>  (1246) 
Zomepirac (BAN, INN); Zomepirac Sodium (USAN, USP)

>  <DEVELOPMENT_PHASE>  (1246) 
4

>  <RESEARCH_CODES>  (1246) 
MCN-2783-21-98

>  <APPLICANTS>  (1246) 
Ortho-Mcneil

>  <USAN_STEM>  (1246) 
-ac

>  <USAN_STEM_DEFINITION>  (1246) 
anti-inflammatory agents (acetic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (1246) 
-ac

>  <USAN_YEAR>  (1246) 
1978.0

>  <FIRST_APPROVAL>  (1246) 
1980.0

>  <ATC_CODE>  (1246) 
M01AB04

>  <ATC_CODE_DESCRIPTION>  (1246) 
M01AB04 [Musculo-Skeletal System:Antiinflammatory And Antirheumatic Products:Antiinflammatory And Antirheumatic Products, Non-Steroids:Acetic acid derivatives and related substances]

>  <INDICATION_CLASS>  (1246) 
Analgesic; Anti-Inflammatory

>  <SC_PATENT_NO>  (1246) 
nan

>  <DRUG_TYPE>  (1246) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1246) 
Y

>  <FIRST_IN_CLASS>  (1246) 
N

>  <CHIRALITY>  (1246) 
Achiral Molecule

>  <PRODRUG>  (1246) 
N

>  <ORAL>  (1246) 
N

>  <PARENTERAL>  (1246) 
N

>  <TOPICAL>  (1246) 
N

>  <BLACK_BOX>  (1246) 
N

>  <AVAILABILITY_TYPE>  (1246) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1246) 
1983.0

>  <WITHDRAWN_COUNTRY>  (1246) 
United States; United Kingdom; United States; Spain; Germany 

>  <WITHDRAWN_REASON>  (1246) 
Anaphylactic reactions and non_fatal allergic reactions

>  <CANONICAL_SMILES>  (1246) 
Cc1cc(CC(=O)O)n(C)c1C(=O)c2ccc(Cl)cc2

>  <name>  (1246) 
Zomepirac 

>  <MW>  (1246) 
291.734

>  <logP>  (1246) 
2.84502

$$$$
CHEMBL573
     RDKit          

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
>  <PARENT_MOLREGNO>  (1247) 
16656

>  <SYNONYMS>  (1247) 
Niacin (FDA, USP); Nicotinic Acid (INN, JAN)

>  <DEVELOPMENT_PHASE>  (1247) 
4

>  <RESEARCH_CODES>  (1247) 
nan

>  <APPLICANTS>  (1247) 
Medpointe Pharmaceuticals Medpointe Healthcare Inc; Abbvie Inc

>  <USAN_STEM>  (1247) 
nan

>  <USAN_STEM_DEFINITION>  (1247) 
nan

>  <USAN_STEM_SUBSTEM>  (1247) 
nan

>  <USAN_YEAR>  (1247) 
nan

>  <FIRST_APPROVAL>  (1247) 
nan

>  <ATC_CODE>  (1247) 
C10AD52; C04AC01; C10AD02

>  <ATC_CODE_DESCRIPTION>  (1247) 
C10AD52 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:Nicotinic acid and derivatives]; C04AC01 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Nicotinic acid and derivatives]; C10AD02 [Cardiovascular System:Lipid Modifying Agents:Lipid Modifying Agents, Plain:Nicotinic acid and derivatives]

>  <INDICATION_CLASS>  (1247) 
Antihyperlipidemic; Vitamin (enzyme co-factor)

>  <SC_PATENT_NO>  (1247) 
US-6080428-A

>  <DRUG_TYPE>  (1247) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1247) 
Y

>  <FIRST_IN_CLASS>  (1247) 
N

>  <CHIRALITY>  (1247) 
Achiral Molecule

>  <PRODRUG>  (1247) 
N

>  <ORAL>  (1247) 
Y

>  <PARENTERAL>  (1247) 
N

>  <TOPICAL>  (1247) 
N

>  <BLACK_BOX>  (1247) 
N

>  <AVAILABILITY_TYPE>  (1247) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1247) 
nan

>  <WITHDRAWN_COUNTRY>  (1247) 
nan

>  <WITHDRAWN_REASON>  (1247) 
nan

>  <CANONICAL_SMILES>  (1247) 
OC(=O)c1cccnc1

>  <name>  (1247) 
Niacin 

>  <MW>  (1247) 
123.111

>  <logP>  (1247) 
0.7798

$$$$
CHEMBL831
     RDKit          

 23 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
  7  2  1  0
 23  8  1  0
 15 10  1  0
 23 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1248) 
59519

>  <SYNONYMS>  (1248) 
Loxapine (BAN, FDA, INN, USAN); Loxapine HCl (FDA); Loxapine Succinate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1248) 
4

>  <RESEARCH_CODES>  (1248) 
CL-62362; SUM 3170; SUM-3170; CL-71563

>  <APPLICANTS>  (1248) 
Watson Laboratories Inc; Alexza Pharmaceuticals Inc

>  <USAN_STEM>  (1248) 
-pin(e)

>  <USAN_STEM_DEFINITION>  (1248) 
tricyclic compounds

>  <USAN_STEM_SUBSTEM>  (1248) 
-pin(e)

>  <USAN_YEAR>  (1248) 
1969.0

>  <FIRST_APPROVAL>  (1248) 
1975.0

>  <ATC_CODE>  (1248) 
N05AH01

>  <ATC_CODE_DESCRIPTION>  (1248) 
N05AH01 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]

>  <INDICATION_CLASS>  (1248) 
Tranquilizer (minor)

>  <SC_PATENT_NO>  (1248) 
US-6716416-B2

>  <DRUG_TYPE>  (1248) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1248) 
Y

>  <FIRST_IN_CLASS>  (1248) 
N

>  <CHIRALITY>  (1248) 
Achiral Molecule

>  <PRODRUG>  (1248) 
N

>  <ORAL>  (1248) 
Y

>  <PARENTERAL>  (1248) 
Y

>  <TOPICAL>  (1248) 
Y

>  <BLACK_BOX>  (1248) 
Y

>  <AVAILABILITY_TYPE>  (1248) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1248) 
nan

>  <WITHDRAWN_COUNTRY>  (1248) 
nan

>  <WITHDRAWN_REASON>  (1248) 
nan

>  <CANONICAL_SMILES>  (1248) 
CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24

>  <name>  (1248) 
Loxapine 

>  <MW>  (1248) 
327.815

>  <logP>  (1248) 
3.7714

$$$$
CHEMBL888
     RDKit          

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
  8  2  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1249) 
75901

>  <SYNONYMS>  (1249) 
Gemcitabine (BAN, INN, USAN); Gemcitabine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1249) 
4

>  <RESEARCH_CODES>  (1249) 
LY-188011

>  <APPLICANTS>  (1249) 
Lilly; Hospira Inc; Eli Lilly And Co

>  <USAN_STEM>  (1249) 
-citabine

>  <USAN_STEM_DEFINITION>  (1249) 
nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

>  <USAN_STEM_SUBSTEM>  (1249) 
-citabine

>  <USAN_YEAR>  (1249) 
1989.0

>  <FIRST_APPROVAL>  (1249) 
1996.0

>  <ATC_CODE>  (1249) 
L01BC05

>  <ATC_CODE_DESCRIPTION>  (1249) 
L01BC05 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Antimetabolites:Pyrimidine analogues]

>  <INDICATION_CLASS>  (1249) 
Antineoplastic

>  <SC_PATENT_NO>  (1249) 
nan

>  <DRUG_TYPE>  (1249) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1249) 
Y

>  <FIRST_IN_CLASS>  (1249) 
N

>  <CHIRALITY>  (1249) 
Single Stereoisomer

>  <PRODRUG>  (1249) 
Y

>  <ORAL>  (1249) 
N

>  <PARENTERAL>  (1249) 
Y

>  <TOPICAL>  (1249) 
N

>  <BLACK_BOX>  (1249) 
N

>  <AVAILABILITY_TYPE>  (1249) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1249) 
nan

>  <WITHDRAWN_COUNTRY>  (1249) 
nan

>  <WITHDRAWN_REASON>  (1249) 
nan

>  <CANONICAL_SMILES>  (1249) 
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F

>  <name>  (1249) 
Gemcitabine 

>  <MW>  (1249) 
263.2

>  <logP>  (1249) 
-1.2886

$$$$
CHEMBL770
     RDKit          

 12 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  6  2  1  0
 12  7  1  0
M  END
>  <PARENT_MOLREGNO>  (1250) 
43448

>  <SYNONYMS>  (1250) 
Tolazoline (BAN, INN); Tolazoline HCl (FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1250) 
4

>  <RESEARCH_CODES>  (1250) 
TCMDC-125842

>  <APPLICANTS>  (1250) 
Novartis Pharmaceuticals Corp

>  <USAN_STEM>  (1250) 
-azoline

>  <USAN_STEM_DEFINITION>  (1250) 
antihistamines/local vasoconstrictors (antazoline type)

>  <USAN_STEM_SUBSTEM>  (1250) 
-azoline

>  <USAN_YEAR>  (1250) 
nan

>  <FIRST_APPROVAL>  (1250) 
1985.0

>  <ATC_CODE>  (1250) 
M02AX02; C04AB02

>  <ATC_CODE_DESCRIPTION>  (1250) 
M02AX02 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Other topical products for joint and muscular pain]; C04AB02 [Cardiovascular System:Peripheral Vasodilators:Peripheral Vasodilators:Imidazoline derivatives]

>  <INDICATION_CLASS>  (1250) 
Vasodilator (peripheral)

>  <SC_PATENT_NO>  (1250) 
nan

>  <DRUG_TYPE>  (1250) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1250) 
Y

>  <FIRST_IN_CLASS>  (1250) 
N

>  <CHIRALITY>  (1250) 
Achiral Molecule

>  <PRODRUG>  (1250) 
N

>  <ORAL>  (1250) 
N

>  <PARENTERAL>  (1250) 
Y

>  <TOPICAL>  (1250) 
N

>  <BLACK_BOX>  (1250) 
N

>  <AVAILABILITY_TYPE>  (1250) 
Discontinued

>  <WITHDRAWN_YEAR>  (1250) 
nan

>  <WITHDRAWN_COUNTRY>  (1250) 
nan

>  <WITHDRAWN_REASON>  (1250) 
nan

>  <CANONICAL_SMILES>  (1250) 
C(C1=NCCN1)c2ccccc2

>  <name>  (1250) 
Tolazoline 

>  <MW>  (1250) 
160.22

>  <logP>  (1250) 
1.2308

$$$$
CHEMBL398707
     RDKit          

 21 25  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  2  0
 20  2  1  0
 11  5  1  0
 21  5  1  0
 20  6  1  0
 21 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1251) 
419580

>  <SYNONYMS>  (1251) 
Hydromorphone (BAN, INN); Hydromorphone HCl (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1251) 
4

>  <RESEARCH_CODES>  (1251) 
nan

>  <APPLICANTS>  (1251) 
Purdue Pharmaceutical Products Lp; Purdue Pharma Lp; Mallinckrodt Inc; Hospira Inc

>  <USAN_STEM>  (1251) 
nan

>  <USAN_STEM_DEFINITION>  (1251) 
nan

>  <USAN_STEM_SUBSTEM>  (1251) 
nan

>  <USAN_YEAR>  (1251) 
nan

>  <FIRST_APPROVAL>  (1251) 
1984.0

>  <ATC_CODE>  (1251) 
N02AA03

>  <ATC_CODE_DESCRIPTION>  (1251) 
N02AA03 [Nervous System:Analgesics:Opioids:Natural opium alkaloids]

>  <INDICATION_CLASS>  (1251) 
Analgesic (narcotic)

>  <SC_PATENT_NO>  (1251) 
US-6589960-B2

>  <DRUG_TYPE>  (1251) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1251) 
Y

>  <FIRST_IN_CLASS>  (1251) 
N

>  <CHIRALITY>  (1251) 
Single Stereoisomer

>  <PRODRUG>  (1251) 
N

>  <ORAL>  (1251) 
Y

>  <PARENTERAL>  (1251) 
Y

>  <TOPICAL>  (1251) 
N

>  <BLACK_BOX>  (1251) 
Y

>  <AVAILABILITY_TYPE>  (1251) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1251) 
nan

>  <WITHDRAWN_COUNTRY>  (1251) 
nan

>  <WITHDRAWN_REASON>  (1251) 
nan

>  <CANONICAL_SMILES>  (1251) 
CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2Oc5c(O)ccc(C[C@@H]14)c35

>  <name>  (1251) 
Hydromorphone 

>  <MW>  (1251) 
285.343

>  <logP>  (1251) 
1.6303

$$$$
CHEMBL588
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
  7  2  1  0
 21  8  1  0
 21 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1252) 
19278

>  <SYNONYMS>  (1252) 
Fenoldopam (BAN, INN); Fenoldopam mesylate (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1252) 
4

>  <RESEARCH_CODES>  (1252) 
SK&F-82526; SK-82526; SK&F-82526J; SK-82526-J

>  <APPLICANTS>  (1252) 
Hospira Inc

>  <USAN_STEM>  (1252) 
nan

>  <USAN_STEM_DEFINITION>  (1252) 
nan

>  <USAN_STEM_SUBSTEM>  (1252) 
nan

>  <USAN_YEAR>  (1252) 
1984.0

>  <FIRST_APPROVAL>  (1252) 
1997.0

>  <ATC_CODE>  (1252) 
C01CA19

>  <ATC_CODE_DESCRIPTION>  (1252) 
C01CA19 [Cardiovascular System:Cardiac Therapy:Cardiac Stimulants Excl. Cardiac Glycosides:Adrenergic and dopaminergic agents]

>  <INDICATION_CLASS>  (1252) 
Antihypertensive; Dopamine Agonist

>  <SC_PATENT_NO>  (1252) 
nan

>  <DRUG_TYPE>  (1252) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1252) 
Y

>  <FIRST_IN_CLASS>  (1252) 
N

>  <CHIRALITY>  (1252) 
Racemic Mixture

>  <PRODRUG>  (1252) 
N

>  <ORAL>  (1252) 
N

>  <PARENTERAL>  (1252) 
Y

>  <TOPICAL>  (1252) 
N

>  <BLACK_BOX>  (1252) 
N

>  <AVAILABILITY_TYPE>  (1252) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1252) 
nan

>  <WITHDRAWN_COUNTRY>  (1252) 
nan

>  <WITHDRAWN_REASON>  (1252) 
nan

>  <CANONICAL_SMILES>  (1252) 
Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23

>  <name>  (1252) 
Fenoldopam 

>  <MW>  (1252) 
305.761

>  <logP>  (1252) 
2.7344

$$$$
CHEMBL190
     RDKit          

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12  2  1  0
 11  7  2  0
M  END
>  <PARENT_MOLREGNO>  (1253) 
381693

>  <SYNONYMS>  (1253) 
Theophylline (BAN, FDA, JAN, USP); Aminophylline (BAN, FDA, INN, JAN, USP); Choline Theophyllinate (BAN, INN); Choline Theophylline (JAN); Oxtriphylline (FDA, USP); Ambuphylline (USAN); Bufylline (BAN); Theophylline Olamine (USP)

>  <DEVELOPMENT_PHASE>  (1253) 
4

>  <RESEARCH_CODES>  (1253) 
nan

>  <APPLICANTS>  (1253) 
Fisons Corp; Eli Lilly And Co; Baxter Healthcare Corp; B Braun Medical Inc; Hospira Inc

>  <USAN_STEM>  (1253) 
nan

>  <USAN_STEM_DEFINITION>  (1253) 
nan

>  <USAN_STEM_SUBSTEM>  (1253) 
nan

>  <USAN_YEAR>  (1253) 
1964.0

>  <FIRST_APPROVAL>  (1253) 
1940.0

>  <ATC_CODE>  (1253) 
R03DA54; R03DA05; R03DA55; R03DA74; R03DA04; R03DA02; R03DA10

>  <ATC_CODE_DESCRIPTION>  (1253) 
R03DA54 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA05 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA55 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA74 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA02 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]; R03DA10 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Xanthines]

>  <INDICATION_CLASS>  (1253) 
Bronchodilator; Relaxant (smooth muscle); Diuretic

>  <SC_PATENT_NO>  (1253) 
nan

>  <DRUG_TYPE>  (1253) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1253) 
Y

>  <FIRST_IN_CLASS>  (1253) 
N

>  <CHIRALITY>  (1253) 
Achiral Molecule

>  <PRODRUG>  (1253) 
N

>  <ORAL>  (1253) 
Y

>  <PARENTERAL>  (1253) 
Y

>  <TOPICAL>  (1253) 
Y

>  <BLACK_BOX>  (1253) 
N

>  <AVAILABILITY_TYPE>  (1253) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1253) 
nan

>  <WITHDRAWN_COUNTRY>  (1253) 
nan

>  <WITHDRAWN_REASON>  (1253) 
nan

>  <CANONICAL_SMILES>  (1253) 
CN1C(=O)N(C)c2nc[nH]c2C1=O

>  <name>  (1253) 
Theophylline 

>  <MW>  (1253) 
180.167

>  <logP>  (1253) 
-1.0397

$$$$
CHEMBL1587
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
  3 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
 16 22  1  0
 22 23  2  0
 22 24  2  0
 22 25  1  0
 19  2  1  0
 18 12  1  0
M  END
>  <PARENT_MOLREGNO>  (1254) 
453832

>  <SYNONYMS>  (1254) 
Polythiazide (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1254) 
4

>  <RESEARCH_CODES>  (1254) 
P-2525

>  <APPLICANTS>  (1254) 
Pfizer Laboratories Div Pfizer Inc; Pfizer Inc.

>  <USAN_STEM>  (1254) 
-thiazide

>  <USAN_STEM_DEFINITION>  (1254) 
diuretics (thiazide derivatives)

>  <USAN_STEM_SUBSTEM>  (1254) 
-thiazide

>  <USAN_YEAR>  (1254) 
1961.0

>  <FIRST_APPROVAL>  (1254) 
1961.0

>  <ATC_CODE>  (1254) 
C03AA05

>  <ATC_CODE_DESCRIPTION>  (1254) 
C03AA05 [Cardiovascular System:Diuretics:Low-Ceiling Diuretics, Thiazides:Thiazides, plain]

>  <INDICATION_CLASS>  (1254) 
Antihypertensive; Diuretic

>  <SC_PATENT_NO>  (1254) 
nan

>  <DRUG_TYPE>  (1254) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1254) 
Y

>  <FIRST_IN_CLASS>  (1254) 
N

>  <CHIRALITY>  (1254) 
Racemic Mixture

>  <PRODRUG>  (1254) 
N

>  <ORAL>  (1254) 
Y

>  <PARENTERAL>  (1254) 
N

>  <TOPICAL>  (1254) 
N

>  <BLACK_BOX>  (1254) 
N

>  <AVAILABILITY_TYPE>  (1254) 
Discontinued

>  <WITHDRAWN_YEAR>  (1254) 
nan

>  <WITHDRAWN_COUNTRY>  (1254) 
nan

>  <WITHDRAWN_REASON>  (1254) 
nan

>  <CANONICAL_SMILES>  (1254) 
CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(cc2S1(=O)=O)S(=O)(=O)N

>  <name>  (1254) 
Polythiazide 

>  <MW>  (1254) 
439.89

>  <logP>  (1254) 
1.655

$$$$
CHEMBL1497
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
  8 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 29  8  1  0
 29 12  1  0
 24 13  1  0
 22 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1255) 
419410

>  <SYNONYMS>  (1255) 
Betamethasone valerate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1255) 
4

>  <RESEARCH_CODES>  (1255) 
nan

>  <APPLICANTS>  (1255) 
Schering Corp; Savage Laboratories Inc Div Altana Inc; Pharmaderm Div Altana Inc; E Fougera Div Altana Inc; Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (1255) 
nan

>  <USAN_STEM_DEFINITION>  (1255) 
nan

>  <USAN_STEM_SUBSTEM>  (1255) 
nan

>  <USAN_YEAR>  (1255) 
1969.0

>  <FIRST_APPROVAL>  (1255) 
1967.0

>  <ATC_CODE>  (1255) 
S01CB04; H02AB01; A07EA04; D07AC01; D07XC01; S01BA06; R03BA04; S03BA03; C05AA05; R01AD06; S02BA07

>  <ATC_CODE_DESCRIPTION>  (1255) 
S01CB04 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; H02AB01 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; A07EA04 [Alimentary Tract And Metabolism:Antidiarrheals, Intestinal Antiinflammatory/Antiinfective :Intestinal Antiinflammatory Agents:Corticosteroids acting locally]; D07AC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; D07XC01 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, potent, other combinations]; S01BA06 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; R03BA04 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; S03BA03 [Sensory Organs:Ophthalmological And Otological Preparations:Corticosteroids:Corticosteroids]; C05AA05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R01AD06 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; S02BA07 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]

>  <INDICATION_CLASS>  (1255) 
Glucocorticoid

>  <SC_PATENT_NO>  (1255) 
US-6126920-A

>  <DRUG_TYPE>  (1255) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1255) 
Y

>  <FIRST_IN_CLASS>  (1255) 
N

>  <CHIRALITY>  (1255) 
Single Stereoisomer

>  <PRODRUG>  (1255) 
Y

>  <ORAL>  (1255) 
N

>  <PARENTERAL>  (1255) 
N

>  <TOPICAL>  (1255) 
Y

>  <BLACK_BOX>  (1255) 
Y

>  <AVAILABILITY_TYPE>  (1255) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1255) 
nan

>  <WITHDRAWN_COUNTRY>  (1255) 
nan

>  <WITHDRAWN_REASON>  (1255) 
nan

>  <CANONICAL_SMILES>  (1255) 
CCCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO

>  <name>  (1255) 
Betamethasone valerate 

>  <MW>  (1255) 
476.585

>  <logP>  (1255) 
3.6368

$$$$
CHEMBL1760
     RDKit          

 16 16  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1256) 
583322

>  <SYNONYMS>  (1256) 
Terbutaline (BAN, INN); Terbutaline Sulfate (FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1256) 
4

>  <RESEARCH_CODES>  (1256) 
KWD-2019

>  <APPLICANTS>  (1256) 
Sanofi Aventis Us Llc; Novartis Pharmaceuticals Corp; Lehigh Valley Technologies Inc; Aaipharma Llc

>  <USAN_STEM>  (1256) 
nan

>  <USAN_STEM_DEFINITION>  (1256) 
nan

>  <USAN_STEM_SUBSTEM>  (1256) 
nan

>  <USAN_YEAR>  (1256) 
1970.0

>  <FIRST_APPROVAL>  (1256) 
1974.0

>  <ATC_CODE>  (1256) 
R03AC03; R03CC03; R03CC53

>  <ATC_CODE_DESCRIPTION>  (1256) 
R03AC03 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics, Inhalants:Selective beta-2-adrenoreceptor agonists]; R03CC03 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Selective beta-2-adrenoreceptor agonists]; R03CC53 [Respiratory System:Drugs For Obstructive Airway Diseases:Adrenergics For Systemic Use:Selective beta-2-adrenoreceptor agonists]

>  <INDICATION_CLASS>  (1256) 
Bronchodilator

>  <SC_PATENT_NO>  (1256) 
nan

>  <DRUG_TYPE>  (1256) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1256) 
Y

>  <FIRST_IN_CLASS>  (1256) 
N

>  <CHIRALITY>  (1256) 
Racemic Mixture

>  <PRODRUG>  (1256) 
N

>  <ORAL>  (1256) 
Y

>  <PARENTERAL>  (1256) 
Y

>  <TOPICAL>  (1256) 
Y

>  <BLACK_BOX>  (1256) 
Y

>  <AVAILABILITY_TYPE>  (1256) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1256) 
nan

>  <WITHDRAWN_COUNTRY>  (1256) 
nan

>  <WITHDRAWN_REASON>  (1256) 
nan

>  <CANONICAL_SMILES>  (1256) 
CC(C)(C)NCC(O)c1cc(O)cc(O)c1

>  <name>  (1256) 
Terbutaline 

>  <MW>  (1256) 
225.288

>  <logP>  (1256) 
1.5193

$$$$
CHEMBL451
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 12 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 15  3  1  0
 11  5  1  0
 21 16  1  0
M  CHG  2  13   1  14  -1
M  END
>  <PARENT_MOLREGNO>  (1257) 
2431

>  <SYNONYMS>  (1257) 
Chlordiazepoxide (BAN, FDA, INN, JAN, USP); Chlordiazepoxide HCl (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1257) 
4

>  <RESEARCH_CODES>  (1257) 
Ro-50690; Ro-5-0690

>  <APPLICANTS>  (1257) 
Valeant Pharmaceuticals International; Hoffmann La Roche Inc

>  <USAN_STEM>  (1257) 
nan

>  <USAN_STEM_DEFINITION>  (1257) 
nan

>  <USAN_STEM_SUBSTEM>  (1257) 
nan

>  <USAN_YEAR>  (1257) 
1963.0

>  <FIRST_APPROVAL>  (1257) 
1960.0

>  <ATC_CODE>  (1257) 
N05BA02

>  <ATC_CODE_DESCRIPTION>  (1257) 
N05BA02 [Nervous System:Psycholeptics:Anxiolytics:Benzodiazepine derivatives]

>  <INDICATION_CLASS>  (1257) 
Sedative-Hypnotic; Tranquilizer (minor)

>  <SC_PATENT_NO>  (1257) 
nan

>  <DRUG_TYPE>  (1257) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1257) 
Y

>  <FIRST_IN_CLASS>  (1257) 
Y

>  <CHIRALITY>  (1257) 
Achiral Molecule

>  <PRODRUG>  (1257) 
N

>  <ORAL>  (1257) 
Y

>  <PARENTERAL>  (1257) 
Y

>  <TOPICAL>  (1257) 
N

>  <BLACK_BOX>  (1257) 
N

>  <AVAILABILITY_TYPE>  (1257) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1257) 
nan

>  <WITHDRAWN_COUNTRY>  (1257) 
nan

>  <WITHDRAWN_REASON>  (1257) 
nan

>  <CANONICAL_SMILES>  (1257) 
CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3

>  <name>  (1257) 
Chlordiazepoxide 

>  <MW>  (1257) 
299.761

>  <logP>  (1257) 
2.9507

$$$$
CHEMBL900
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 13  8  1  0
 19 14  1  0
M  END
>  <PARENT_MOLREGNO>  (1258) 
77779

>  <SYNONYMS>  (1258) 
Orphenadrine (BAN, INN); Orphenadrine HCl (FDA); Orphenadrine Citrate (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1258) 
4

>  <RESEARCH_CODES>  (1258) 
nan

>  <APPLICANTS>  (1258) 
Medicis Pharmaceutical Corp; 3m Pharmaceuticals Inc

>  <USAN_STEM>  (1258) 
nan

>  <USAN_STEM_DEFINITION>  (1258) 
nan

>  <USAN_STEM_SUBSTEM>  (1258) 
nan

>  <USAN_YEAR>  (1258) 
nan

>  <FIRST_APPROVAL>  (1258) 
1957.0

>  <ATC_CODE>  (1258) 
M03BC51; N04AB02; M03BC01

>  <ATC_CODE_DESCRIPTION>  (1258) 
M03BC51 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Ethers, chemically close to antihistamines]; N04AB02 [Nervous System:Anti-Parkinson Drugs:Anticholinergic Agents:Ethers chemically close to antihistamines]; M03BC01 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Centrally Acting Agents:Ethers, chemically close to antihistamines]

>  <INDICATION_CLASS>  (1258) 
Antihistaminic; Relaxant (skeletal muscle)

>  <SC_PATENT_NO>  (1258) 
nan

>  <DRUG_TYPE>  (1258) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1258) 
Y

>  <FIRST_IN_CLASS>  (1258) 
N

>  <CHIRALITY>  (1258) 
Racemic Mixture

>  <PRODRUG>  (1258) 
N

>  <ORAL>  (1258) 
Y

>  <PARENTERAL>  (1258) 
Y

>  <TOPICAL>  (1258) 
N

>  <BLACK_BOX>  (1258) 
N

>  <AVAILABILITY_TYPE>  (1258) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1258) 
nan

>  <WITHDRAWN_COUNTRY>  (1258) 
nan

>  <WITHDRAWN_REASON>  (1258) 
nan

>  <CANONICAL_SMILES>  (1258) 
CN(C)CCOC(c1ccccc1)c2ccccc2C

>  <name>  (1258) 
Orphenadrine 

>  <MW>  (1258) 
269.388

>  <logP>  (1258) 
3.66262

$$$$
CHEMBL1213351
     RDKit          

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  6 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
  6 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 13  8  1  0
 25 20  1  0
M  END
>  <PARENT_MOLREGNO>  (1259) 
685193

>  <SYNONYMS>  (1259) 
Dextropropoxyphene (INN, BAN, DCF); Propoxyphene napsylate (FDA, USAN, USP); Propoxyphene HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1259) 
4

>  <RESEARCH_CODES>  (1259) 
nan

>  <APPLICANTS>  (1259) 
Xanodyne Pharmaceutics Inc; Aaipharma Llc

>  <USAN_STEM>  (1259) 
nan

>  <USAN_STEM_DEFINITION>  (1259) 
nan

>  <USAN_STEM_SUBSTEM>  (1259) 
nan

>  <USAN_YEAR>  (1259) 
1964.0

>  <FIRST_APPROVAL>  (1259) 
1957.0

>  <ATC_CODE>  (1259) 
N02AC04

>  <ATC_CODE_DESCRIPTION>  (1259) 
N02AC04 [Nervous System:Analgesics:Opioids:Diphenylpropylamine derivatives]

>  <INDICATION_CLASS>  (1259) 
Analgesic

>  <SC_PATENT_NO>  (1259) 
nan

>  <DRUG_TYPE>  (1259) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1259) 
Y

>  <FIRST_IN_CLASS>  (1259) 
N

>  <CHIRALITY>  (1259) 
Single Stereoisomer

>  <PRODRUG>  (1259) 
N

>  <ORAL>  (1259) 
Y

>  <PARENTERAL>  (1259) 
N

>  <TOPICAL>  (1259) 
N

>  <BLACK_BOX>  (1259) 
Y

>  <AVAILABILITY_TYPE>  (1259) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1259) 
2014.0

>  <WITHDRAWN_COUNTRY>  (1259) 
United States; United States

>  <WITHDRAWN_REASON>  (1259) 
Serious toxicity to the heart; Serious toxicity to the heart

>  <CANONICAL_SMILES>  (1259) 
CCC(=O)O[C@@](Cc1ccccc1)([C@H](C)CN(C)C)c2ccccc2

>  <name>  (1259) 
Dextropropoxyphene 

>  <MW>  (1259) 
339.479

>  <logP>  (1259) 
4.2755

$$$$
CHEMBL685
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 11 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 14  6  1  0
 13  8  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1260) 
29637

>  <SYNONYMS>  (1260) 
Mebendazole (BAN, FDA, INN, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1260) 
4

>  <RESEARCH_CODES>  (1260) 
R-17635

>  <APPLICANTS>  (1260) 
Janssen Pharmaceuticals Inc

>  <USAN_STEM>  (1260) 
-bendazole

>  <USAN_STEM_DEFINITION>  (1260) 
anthelmintics (tibendazole type)

>  <USAN_STEM_SUBSTEM>  (1260) 
-bendazole

>  <USAN_YEAR>  (1260) 
1971.0

>  <FIRST_APPROVAL>  (1260) 
1974.0

>  <ATC_CODE>  (1260) 
P02CA51; P02CA01

>  <ATC_CODE_DESCRIPTION>  (1260) 
P02CA51 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Benzimidazole derivatives]; P02CA01 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Benzimidazole derivatives]

>  <INDICATION_CLASS>  (1260) 
Anthelmintic

>  <SC_PATENT_NO>  (1260) 
nan

>  <DRUG_TYPE>  (1260) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1260) 
Y

>  <FIRST_IN_CLASS>  (1260) 
N

>  <CHIRALITY>  (1260) 
Achiral Molecule

>  <PRODRUG>  (1260) 
N

>  <ORAL>  (1260) 
Y

>  <PARENTERAL>  (1260) 
N

>  <TOPICAL>  (1260) 
N

>  <BLACK_BOX>  (1260) 
N

>  <AVAILABILITY_TYPE>  (1260) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1260) 
nan

>  <WITHDRAWN_COUNTRY>  (1260) 
nan

>  <WITHDRAWN_REASON>  (1260) 
nan

>  <CANONICAL_SMILES>  (1260) 
COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c3ccccc3

>  <name>  (1260) 
Mebendazole 

>  <MW>  (1260) 
295.298

>  <logP>  (1260) 
2.9722

$$$$
CHEMBL294199
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
  5 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21  3  1  0
M  END
>  <PARENT_MOLREGNO>  (1261) 
91783

>  <SYNONYMS>  (1261) 
Capsaicin (FDA, USP)

>  <DEVELOPMENT_PHASE>  (1261) 
4

>  <RESEARCH_CODES>  (1261) 
nan

>  <APPLICANTS>  (1261) 
Neurogesx Inc

>  <USAN_STEM>  (1261) 
nan

>  <USAN_STEM_DEFINITION>  (1261) 
nan

>  <USAN_STEM_SUBSTEM>  (1261) 
nan

>  <USAN_YEAR>  (1261) 
nan

>  <FIRST_APPROVAL>  (1261) 
2009.0

>  <ATC_CODE>  (1261) 
M02AB01; N01BX04

>  <ATC_CODE_DESCRIPTION>  (1261) 
M02AB01 [Musculo-Skeletal System:Topical Products For Joint And Muscular Pain:Topical Products For Joint And Muscular Pain:Capsaicin and similar agents]; N01BX04 [Nervous System:Anesthetics:Anesthetics, Local:Other local anesthetics]

>  <INDICATION_CLASS>  (1261) 
Analgesic (topical); Antineuralgic, Specific Pain Syndromes, Topical

>  <SC_PATENT_NO>  (1261) 
US-6239180-B1

>  <DRUG_TYPE>  (1261) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1261) 
Y

>  <FIRST_IN_CLASS>  (1261) 
N

>  <CHIRALITY>  (1261) 
Achiral Molecule

>  <PRODRUG>  (1261) 
N

>  <ORAL>  (1261) 
N

>  <PARENTERAL>  (1261) 
N

>  <TOPICAL>  (1261) 
Y

>  <BLACK_BOX>  (1261) 
N

>  <AVAILABILITY_TYPE>  (1261) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1261) 
nan

>  <WITHDRAWN_COUNTRY>  (1261) 
nan

>  <WITHDRAWN_REASON>  (1261) 
nan

>  <CANONICAL_SMILES>  (1261) 
COc1cc(CNC(=O)CCCC\C=C\C(C)C)ccc1O

>  <name>  (1261) 
Capsaicin 

>  <MW>  (1261) 
305.418

>  <logP>  (1261) 
3.7896

$$$$
CHEMBL363295
     RDKit          

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 10  5  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1262) 
308699

>  <SYNONYMS>  (1262) 
Terodiline (BAN, INN, JAN); Terodiline HCl (USAN)

>  <DEVELOPMENT_PHASE>  (1262) 
4

>  <RESEARCH_CODES>  (1262) 
nan

>  <APPLICANTS>  (1262) 
Marion Merrell Dow

>  <USAN_STEM>  (1262) 
-dil-

>  <USAN_STEM_DEFINITION>  (1262) 
vasodilators (undefined group)

>  <USAN_STEM_SUBSTEM>  (1262) 
-dil-

>  <USAN_YEAR>  (1262) 
1966.0

>  <FIRST_APPROVAL>  (1262) 
1986.0

>  <ATC_CODE>  (1262) 
G04BD05

>  <ATC_CODE_DESCRIPTION>  (1262) 
G04BD05 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (1262) 
Vasodilator (coronary)

>  <SC_PATENT_NO>  (1262) 
nan

>  <DRUG_TYPE>  (1262) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1262) 
Y

>  <FIRST_IN_CLASS>  (1262) 
N

>  <CHIRALITY>  (1262) 
Racemic Mixture

>  <PRODRUG>  (1262) 
N

>  <ORAL>  (1262) 
N

>  <PARENTERAL>  (1262) 
N

>  <TOPICAL>  (1262) 
N

>  <BLACK_BOX>  (1262) 
N

>  <AVAILABILITY_TYPE>  (1262) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1262) 
1991.0

>  <WITHDRAWN_COUNTRY>  (1262) 
Germany; Spain; United Kingdom

>  <WITHDRAWN_REASON>  (1262) 
Ventricular Tachycardia and Arrhythmia

>  <CANONICAL_SMILES>  (1262) 
CC(CC(c1ccccc1)c2ccccc2)NC(C)(C)C

>  <name>  (1262) 
Terodiline 

>  <MW>  (1262) 
281.443

>  <logP>  (1262) 
4.9852

$$$$
CHEMBL1888176
     RDKit          

 29 33  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
  2 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 12  6  1  0
 13  8  1  0
 17 13  1  0
 23 18  1  0
 29 24  1  0
M  CHG  1  13   1
M  END
>  <PARENT_MOLREGNO>  (1263) 
1228747

>  <SYNONYMS>  (1263) 
Trospium Chloride (BAN, FDA, INN, JAN, MI, USAN)

>  <DEVELOPMENT_PHASE>  (1263) 
4

>  <RESEARCH_CODES>  (1263) 
IP631

>  <APPLICANTS>  (1263) 
Allergan Inc

>  <USAN_STEM>  (1263) 
-ium

>  <USAN_STEM_DEFINITION>  (1263) 
quaternary ammonium derivatives

>  <USAN_STEM_SUBSTEM>  (1263) 
-ium

>  <USAN_YEAR>  (1263) 
2001.0

>  <FIRST_APPROVAL>  (1263) 
2004.0

>  <ATC_CODE>  (1263) 
G04BD09

>  <ATC_CODE_DESCRIPTION>  (1263) 
G04BD09 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence]

>  <INDICATION_CLASS>  (1263) 
nan

>  <SC_PATENT_NO>  (1263) 
US-7410978-B2

>  <DRUG_TYPE>  (1263) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1263) 
Y

>  <FIRST_IN_CLASS>  (1263) 
N

>  <CHIRALITY>  (1263) 
Racemic Mixture

>  <PRODRUG>  (1263) 
N

>  <ORAL>  (1263) 
Y

>  <PARENTERAL>  (1263) 
N

>  <TOPICAL>  (1263) 
N

>  <BLACK_BOX>  (1263) 
N

>  <AVAILABILITY_TYPE>  (1263) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1263) 
nan

>  <WITHDRAWN_COUNTRY>  (1263) 
nan

>  <WITHDRAWN_REASON>  (1263) 
nan

>  <CANONICAL_SMILES>  (1263) 
OC(C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]23CCCC3)(c4ccccc4)c5ccccc5

>  <name>  (1263) 
Trospium Chloride 

>  <MW>  (1263) 
392.519

>  <logP>  (1263) 
3.7697

$$$$
CHEMBL3707390
     RDKit          

 14 15  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  4 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13  2  1  0
  9  3  1  0
M  END
>  <PARENT_MOLREGNO>  (1264) 
2039361

>  <SYNONYMS>  (1264) 
Mebicar

>  <DEVELOPMENT_PHASE>  (1264) 
4

>  <RESEARCH_CODES>  (1264) 
nan

>  <APPLICANTS>  (1264) 
nan

>  <USAN_STEM>  (1264) 
nan

>  <USAN_STEM_DEFINITION>  (1264) 
nan

>  <USAN_STEM_SUBSTEM>  (1264) 
nan

>  <USAN_YEAR>  (1264) 
nan

>  <FIRST_APPROVAL>  (1264) 
nan

>  <ATC_CODE>  (1264) 
N06BX21

>  <ATC_CODE_DESCRIPTION>  (1264) 
N06BX21 [Nervous System:Psychoanaleptics:Psychostimulants, Agents Used For Adhd And Nootropics:Other psychostimulants and nootropics]

>  <INDICATION_CLASS>  (1264) 
nan

>  <SC_PATENT_NO>  (1264) 
nan

>  <DRUG_TYPE>  (1264) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1264) 
Y

>  <FIRST_IN_CLASS>  (1264) 
N

>  <CHIRALITY>  (1264) 
Achiral Molecule

>  <PRODRUG>  (1264) 
N

>  <ORAL>  (1264) 
N

>  <PARENTERAL>  (1264) 
N

>  <TOPICAL>  (1264) 
N

>  <BLACK_BOX>  (1264) 
N

>  <AVAILABILITY_TYPE>  (1264) 
Unknown

>  <WITHDRAWN_YEAR>  (1264) 
nan

>  <WITHDRAWN_COUNTRY>  (1264) 
nan

>  <WITHDRAWN_REASON>  (1264) 
nan

>  <CANONICAL_SMILES>  (1264) 
CN1C2C(N(C)C(=O)N2C)N(C)C1=O

>  <name>  (1264) 
Mebicar

>  <MW>  (1264) 
198.226

>  <logP>  (1264) 
-0.367

$$$$
CHEMBL128
     RDKit          

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 13 19  1  0
 19 20  2  0
 20  7  1  0
 19 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1265) 
27111

>  <SYNONYMS>  (1265) 
Sumatriptan (BAN, FDA, INN, USP); Sumatriptan Succinate (FDA, USAN)

>  <DEVELOPMENT_PHASE>  (1265) 
4

>  <RESEARCH_CODES>  (1265) 
GR-43175C

>  <APPLICANTS>  (1265) 
SmithKline Beecham Corp Dba GlaxoSmithKline; Nupathe Inc; Meridian Medical Technologies Inc Sub King Pharmaceuticals Inc; GlaxoSmithKline; Zogenix Inc

>  <USAN_STEM>  (1265) 
-triptan

>  <USAN_STEM_DEFINITION>  (1265) 
antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

>  <USAN_STEM_SUBSTEM>  (1265) 
-triptan

>  <USAN_YEAR>  (1265) 
1989.0

>  <FIRST_APPROVAL>  (1265) 
1992.0

>  <ATC_CODE>  (1265) 
N02CC01

>  <ATC_CODE_DESCRIPTION>  (1265) 
N02CC01 [Nervous System:Analgesics:Antimigraine Preparations:Selective serotonin (5HT1) agonists]

>  <INDICATION_CLASS>  (1265) 
Antimigraine

>  <SC_PATENT_NO>  (1265) 
US-5872145-A

>  <DRUG_TYPE>  (1265) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1265) 
Y

>  <FIRST_IN_CLASS>  (1265) 
N

>  <CHIRALITY>  (1265) 
Achiral Molecule

>  <PRODRUG>  (1265) 
N

>  <ORAL>  (1265) 
Y

>  <PARENTERAL>  (1265) 
Y

>  <TOPICAL>  (1265) 
Y

>  <BLACK_BOX>  (1265) 
N

>  <AVAILABILITY_TYPE>  (1265) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1265) 
nan

>  <WITHDRAWN_COUNTRY>  (1265) 
nan

>  <WITHDRAWN_REASON>  (1265) 
nan

>  <CANONICAL_SMILES>  (1265) 
CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1

>  <name>  (1265) 
Sumatriptan 

>  <MW>  (1265) 
295.408

>  <logP>  (1265) 
1.3212

$$$$
CHEMBL1626
     RDKit          

 24 26  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
  6  2  1  0
 17 12  1  0
 24 18  1  0
M  END
>  <PARENT_MOLREGNO>  (1266) 
469763

>  <SYNONYMS>  (1266) 
Clemastine (BAN, INN, USAN); Clemastine Fumarate (BAN, FDA, JAN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1266) 
4

>  <RESEARCH_CODES>  (1266) 
HS-592

>  <APPLICANTS>  (1266) 
Novartis Pharmaceuticals Corp; Novartis Consumer Health Inc; Novartis

>  <USAN_STEM>  (1266) 
-astine

>  <USAN_STEM_DEFINITION>  (1266) 
antihistaminics (histamine-H1 receptor antagonists)

>  <USAN_STEM_SUBSTEM>  (1266) 
-astine

>  <USAN_YEAR>  (1266) 
1969.0

>  <FIRST_APPROVAL>  (1266) 
1977.0

>  <ATC_CODE>  (1266) 
R06AA04; R06AA54; D04AA14

>  <ATC_CODE_DESCRIPTION>  (1266) 
R06AA04 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]; R06AA54 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Aminoalkyl ethers]; D04AA14 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]

>  <INDICATION_CLASS>  (1266) 
Antihistaminic

>  <SC_PATENT_NO>  (1266) 
nan

>  <DRUG_TYPE>  (1266) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1266) 
Y

>  <FIRST_IN_CLASS>  (1266) 
N

>  <CHIRALITY>  (1266) 
Single Stereoisomer

>  <PRODRUG>  (1266) 
N

>  <ORAL>  (1266) 
Y

>  <PARENTERAL>  (1266) 
N

>  <TOPICAL>  (1266) 
N

>  <BLACK_BOX>  (1266) 
N

>  <AVAILABILITY_TYPE>  (1266) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1266) 
nan

>  <WITHDRAWN_COUNTRY>  (1266) 
nan

>  <WITHDRAWN_REASON>  (1266) 
nan

>  <CANONICAL_SMILES>  (1266) 
CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3

>  <name>  (1266) 
Clemastine 

>  <MW>  (1266) 
343.898

>  <logP>  (1266) 
5.1044

$$$$
CHEMBL713
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
  5 18  1  0
 18 19  2  0
 18 20  1  0
 20  2  1  0
  8  4  1  0
 16  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1267) 
33889

>  <SYNONYMS>  (1267) 
Entecavir (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1267) 
4

>  <RESEARCH_CODES>  (1267) 
BMS-200475-01; SQ-34676

>  <APPLICANTS>  (1267) 
Bristol Myers Squibb

>  <USAN_STEM>  (1267) 
-vir

>  <USAN_STEM_DEFINITION>  (1267) 
antivirals: carbocyclic nucleosides

>  <USAN_STEM_SUBSTEM>  (1267) 
-vir (-cavir)

>  <USAN_YEAR>  (1267) 
1999.0

>  <FIRST_APPROVAL>  (1267) 
2005.0

>  <ATC_CODE>  (1267) 
J05AF10

>  <ATC_CODE_DESCRIPTION>  (1267) 
J05AF10 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors]

>  <INDICATION_CLASS>  (1267) 
nan

>  <SC_PATENT_NO>  (1267) 
nan

>  <DRUG_TYPE>  (1267) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1267) 
Y

>  <FIRST_IN_CLASS>  (1267) 
N

>  <CHIRALITY>  (1267) 
Single Stereoisomer

>  <PRODRUG>  (1267) 
Y

>  <ORAL>  (1267) 
Y

>  <PARENTERAL>  (1267) 
N

>  <TOPICAL>  (1267) 
N

>  <BLACK_BOX>  (1267) 
Y

>  <AVAILABILITY_TYPE>  (1267) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1267) 
nan

>  <WITHDRAWN_COUNTRY>  (1267) 
nan

>  <WITHDRAWN_REASON>  (1267) 
nan

>  <CANONICAL_SMILES>  (1267) 
NC1=Nc2c(ncn2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1

>  <name>  (1267) 
Entecavir 

>  <MW>  (1267) 
277.284

>  <logP>  (1267) 
-0.8278

$$$$
CHEMBL30
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  3 15  1  0
 15 16  1  0
 16 17  3  0
 13  9  2  0
M  END
>  <PARENT_MOLREGNO>  (1268) 
1620

>  <SYNONYMS>  (1268) 
Cimetidine (BAN, FDA, INN, JAN, USAN, USP); Cimetidine HCl (FDA, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1268) 
4

>  <RESEARCH_CODES>  (1268) 
nan

>  <APPLICANTS>  (1268) 
GlaxoSmithKline

>  <USAN_STEM>  (1268) 
-tidine

>  <USAN_STEM_DEFINITION>  (1268) 
H2-receptor antagonists (cimetidine type)

>  <USAN_STEM_SUBSTEM>  (1268) 
-tidine

>  <USAN_YEAR>  (1268) 
1975.0

>  <FIRST_APPROVAL>  (1268) 
1977.0

>  <ATC_CODE>  (1268) 
A02BA51; A02BA01

>  <ATC_CODE_DESCRIPTION>  (1268) 
A02BA51 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):H2-receptor antagonists]; A02BA01 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord):H2-receptor antagonists]

>  <INDICATION_CLASS>  (1268) 
Antagonist (to histamine-H2 receptors)

>  <SC_PATENT_NO>  (1268) 
nan

>  <DRUG_TYPE>  (1268) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1268) 
Y

>  <FIRST_IN_CLASS>  (1268) 
N

>  <CHIRALITY>  (1268) 
Achiral Molecule

>  <PRODRUG>  (1268) 
N

>  <ORAL>  (1268) 
Y

>  <PARENTERAL>  (1268) 
Y

>  <TOPICAL>  (1268) 
N

>  <BLACK_BOX>  (1268) 
N

>  <AVAILABILITY_TYPE>  (1268) 
Over-The-Counter

>  <WITHDRAWN_YEAR>  (1268) 
nan

>  <WITHDRAWN_COUNTRY>  (1268) 
nan

>  <WITHDRAWN_REASON>  (1268) 
nan

>  <CANONICAL_SMILES>  (1268) 
CN\C(=N/CCSCc1nc[nH]c1C)\NC#N

>  <name>  (1268) 
Cimetidine 

>  <MW>  (1268) 
252.347

>  <logP>  (1268) 
0.5974

$$$$
CHEMBL1191
     RDKit          

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
  5 17  1  0
 17  2  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1269) 
204115

>  <SYNONYMS>  (1269) 
Sulfamethizole (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1269) 
4

>  <RESEARCH_CODES>  (1269) 
nan

>  <APPLICANTS>  (1269) 
Wyeth Ayerst Laboratories

>  <USAN_STEM>  (1269) 
sulfa-

>  <USAN_STEM_DEFINITION>  (1269) 
antimicrobials (sulfonamides derivatives)

>  <USAN_STEM_SUBSTEM>  (1269) 
sulfa-

>  <USAN_YEAR>  (1269) 
nan

>  <FIRST_APPROVAL>  (1269) 
1953.0

>  <ATC_CODE>  (1269) 
D06BA04; S01AB01; J01EB02; B05CA04

>  <ATC_CODE_DESCRIPTION>  (1269) 
D06BA04 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]; S01AB01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; J01EB02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]; B05CA04 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:Irrigating Solutions:Antiinfectives]

>  <INDICATION_CLASS>  (1269) 
Antibacterial

>  <SC_PATENT_NO>  (1269) 
nan

>  <DRUG_TYPE>  (1269) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1269) 
Y

>  <FIRST_IN_CLASS>  (1269) 
N

>  <CHIRALITY>  (1269) 
Achiral Molecule

>  <PRODRUG>  (1269) 
N

>  <ORAL>  (1269) 
Y

>  <PARENTERAL>  (1269) 
N

>  <TOPICAL>  (1269) 
N

>  <BLACK_BOX>  (1269) 
N

>  <AVAILABILITY_TYPE>  (1269) 
Discontinued

>  <WITHDRAWN_YEAR>  (1269) 
nan

>  <WITHDRAWN_COUNTRY>  (1269) 
nan

>  <WITHDRAWN_REASON>  (1269) 
nan

>  <CANONICAL_SMILES>  (1269) 
Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1

>  <name>  (1269) 
Sulfamethizole 

>  <MW>  (1269) 
270.339

>  <logP>  (1269) 
1.22952

$$$$
CHEMBL1096
     RDKit          

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 13 20  1  0
 20 21  2  0
 20 22  1  0
 19  4  1  0
 18  7  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1270) 
150549

>  <SYNONYMS>  (1270) 
Amlexanox (BAN, FDA, INN, JAN, MI, USAN)

>  <DEVELOPMENT_PHASE>  (1270) 
4

>  <RESEARCH_CODES>  (1270) 
AA-673; CHX-3673

>  <APPLICANTS>  (1270) 
Uluru Inc

>  <USAN_STEM>  (1270) 
-xanox

>  <USAN_STEM_DEFINITION>  (1270) 
antiallergic respiratory tract drugs (xanoxic acid derivatives)

>  <USAN_STEM_SUBSTEM>  (1270) 
-xanox

>  <USAN_YEAR>  (1270) 
1995.0

>  <FIRST_APPROVAL>  (1270) 
1996.0

>  <ATC_CODE>  (1270) 
R03DX01; A01AD07

>  <ATC_CODE_DESCRIPTION>  (1270) 
R03DX01 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Systemic Drugs For Obstructive Airway Diseases:Other systemic drugs for obstructive airway diseases]; A01AD07 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Other agents for local oral treatment]

>  <INDICATION_CLASS>  (1270) 
Anti-Allergic

>  <SC_PATENT_NO>  (1270) 
nan

>  <DRUG_TYPE>  (1270) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1270) 
Y

>  <FIRST_IN_CLASS>  (1270) 
N

>  <CHIRALITY>  (1270) 
Achiral Molecule

>  <PRODRUG>  (1270) 
N

>  <ORAL>  (1270) 
N

>  <PARENTERAL>  (1270) 
N

>  <TOPICAL>  (1270) 
Y

>  <BLACK_BOX>  (1270) 
N

>  <AVAILABILITY_TYPE>  (1270) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1270) 
nan

>  <WITHDRAWN_COUNTRY>  (1270) 
nan

>  <WITHDRAWN_REASON>  (1270) 
nan

>  <CANONICAL_SMILES>  (1270) 
CC(C)c1ccc2Oc3nc(N)c(cc3C(=O)c2c1)C(=O)O

>  <name>  (1270) 
Amlexanox 

>  <MW>  (1270) 
298.298

>  <logP>  (1270) 
2.745

$$$$
CHEMBL79
     RDKit          

 17 17  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 10  1  0
M  END
>  <PARENT_MOLREGNO>  (1271) 
6723

>  <SYNONYMS>  (1271) 
Lidocaine (FDA, INN, JAN, USP); Lignocaine (BAN); Lidocaine HCl (FDA, JAN, USP); Lignocaine HCl (BAN)

>  <DEVELOPMENT_PHASE>  (1271) 
4

>  <RESEARCH_CODES>  (1271) 
nan

>  <APPLICANTS>  (1271) 
Amphastar Pharmaceuticals Inc; Akorn Inc; Noven Pharmaceuticals Inc; Abraxis Pharmaceutical Products; Abbott Laboratories Pharmaceutical Products Div

>  <USAN_STEM>  (1271) 
-caine

>  <USAN_STEM_DEFINITION>  (1271) 
local anesthetics

>  <USAN_STEM_SUBSTEM>  (1271) 
-caine

>  <USAN_YEAR>  (1271) 
nan

>  <FIRST_APPROVAL>  (1271) 
1948.0

>  <ATC_CODE>  (1271) 
S01HA07; N01BB02; C01BB01; N01BB52; R02AD02; C05AD01; D04AB01; S02DA01

>  <ATC_CODE_DESCRIPTION>  (1271) 
S01HA07 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]; N01BB02 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; C01BB01 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ib]; N01BB52 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; R02AD02 [Respiratory System:Throat Preparations:Throat Preparations:Anesthetics, local]; C05AD01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; D04AB01 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; S02DA01 [Sensory Organs:Otologicals:Other Otologicals:Analgesics and anesthetics]

>  <INDICATION_CLASS>  (1271) 
Anesthetic (topical); Anesthetic (local)

>  <SC_PATENT_NO>  (1271) 
US-5658583-A

>  <DRUG_TYPE>  (1271) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1271) 
Y

>  <FIRST_IN_CLASS>  (1271) 
N

>  <CHIRALITY>  (1271) 
Achiral Molecule

>  <PRODRUG>  (1271) 
N

>  <ORAL>  (1271) 
Y

>  <PARENTERAL>  (1271) 
Y

>  <TOPICAL>  (1271) 
Y

>  <BLACK_BOX>  (1271) 
Y

>  <AVAILABILITY_TYPE>  (1271) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1271) 
nan

>  <WITHDRAWN_COUNTRY>  (1271) 
nan

>  <WITHDRAWN_REASON>  (1271) 
nan

>  <CANONICAL_SMILES>  (1271) 
CCN(CC)CC(=O)Nc1c(C)cccc1C

>  <name>  (1271) 
Lidocaine 

>  <MW>  (1271) 
234.343

>  <logP>  (1271) 
2.58374

$$$$
CHEMBL284348
     RDKit          

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
M  END
>  <PARENT_MOLREGNO>  (1272) 
31289

>  <SYNONYMS>  (1272) 
Dalfampridine (FDA, USAN); Fampridine (INN)

>  <DEVELOPMENT_PHASE>  (1272) 
4

>  <RESEARCH_CODES>  (1272) 
EL-970

>  <APPLICANTS>  (1272) 
Acorda Therapeutics Inc

>  <USAN_STEM>  (1272) 
nan

>  <USAN_STEM_DEFINITION>  (1272) 
nan

>  <USAN_STEM_SUBSTEM>  (1272) 
nan

>  <USAN_YEAR>  (1272) 
1994.0

>  <FIRST_APPROVAL>  (1272) 
2010.0

>  <ATC_CODE>  (1272) 
N07XX07

>  <ATC_CODE_DESCRIPTION>  (1272) 
N07XX07 [Nervous System:Other Nervous System Drugs:Other Nervous System Drugs:Other nervous system drugs]

>  <INDICATION_CLASS>  (1272) 
Multiple Sclerosis Symptomatic Treatment

>  <SC_PATENT_NO>  (1272) 
US-5540938-A

>  <DRUG_TYPE>  (1272) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1272) 
Y

>  <FIRST_IN_CLASS>  (1272) 
N

>  <CHIRALITY>  (1272) 
Achiral Molecule

>  <PRODRUG>  (1272) 
N

>  <ORAL>  (1272) 
Y

>  <PARENTERAL>  (1272) 
N

>  <TOPICAL>  (1272) 
N

>  <BLACK_BOX>  (1272) 
N

>  <AVAILABILITY_TYPE>  (1272) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1272) 
nan

>  <WITHDRAWN_COUNTRY>  (1272) 
nan

>  <WITHDRAWN_REASON>  (1272) 
nan

>  <CANONICAL_SMILES>  (1272) 
Nc1ccncc1

>  <name>  (1272) 
Dalfampridine 

>  <MW>  (1272) 
94.117

>  <logP>  (1272) 
0.6638

$$$$
CHEMBL1201148
     RDKit          

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 22  2  1  0
 20  4  1  0
 16  5  1  0
 14  8  1  0
M  END
>  <PARENT_MOLREGNO>  (1273) 
675099

>  <SYNONYMS>  (1273) 
Meprednisone (FDA, INN, USAN, USP)

>  <DEVELOPMENT_PHASE>  (1273) 
4

>  <RESEARCH_CODES>  (1273) 
SCH-4358

>  <APPLICANTS>  (1273) 
Schering Corp Sub Schering Plough Corp

>  <USAN_STEM>  (1273) 
-pred-

>  <USAN_STEM_DEFINITION>  (1273) 
prednisone and prednisolone derivatives

>  <USAN_STEM_SUBSTEM>  (1273) 
-pred-

>  <USAN_YEAR>  (1273) 
1965.0

>  <FIRST_APPROVAL>  (1273) 
1982.0

>  <ATC_CODE>  (1273) 
H02AB15

>  <ATC_CODE_DESCRIPTION>  (1273) 
H02AB15 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]

>  <INDICATION_CLASS>  (1273) 
nan

>  <SC_PATENT_NO>  (1273) 
nan

>  <DRUG_TYPE>  (1273) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1273) 
Y

>  <FIRST_IN_CLASS>  (1273) 
N

>  <CHIRALITY>  (1273) 
Single Stereoisomer

>  <PRODRUG>  (1273) 
N

>  <ORAL>  (1273) 
Y

>  <PARENTERAL>  (1273) 
N

>  <TOPICAL>  (1273) 
N

>  <BLACK_BOX>  (1273) 
N

>  <AVAILABILITY_TYPE>  (1273) 
Discontinued

>  <WITHDRAWN_YEAR>  (1273) 
nan

>  <WITHDRAWN_COUNTRY>  (1273) 
nan

>  <WITHDRAWN_REASON>  (1273) 
nan

>  <CANONICAL_SMILES>  (1273) 
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO

>  <name>  (1273) 
Meprednisone 

>  <MW>  (1273) 
372.461

>  <logP>  (1273) 
2.0118

$$$$
CHEMBL1256841
     RDKit          

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 14  9  1  0
 22 17  1  0
M  END
>  <PARENT_MOLREGNO>  (1274) 
705834

>  <SYNONYMS>  (1274) 
Nialamide (BAN, INN, MI, NF)

>  <DEVELOPMENT_PHASE>  (1274) 
4

>  <RESEARCH_CODES>  (1274) 
nan

>  <APPLICANTS>  (1274) 
nan

>  <USAN_STEM>  (1274) 
nan

>  <USAN_STEM_DEFINITION>  (1274) 
nan

>  <USAN_STEM_SUBSTEM>  (1274) 
nan

>  <USAN_YEAR>  (1274) 
nan

>  <FIRST_APPROVAL>  (1274) 
nan

>  <ATC_CODE>  (1274) 
N06AF02

>  <ATC_CODE_DESCRIPTION>  (1274) 
N06AF02 [Nervous System:Psychoanaleptics:Antidepressants:Monoamine oxidase inhibitors, non-selective]

>  <INDICATION_CLASS>  (1274) 
nan

>  <SC_PATENT_NO>  (1274) 
nan

>  <DRUG_TYPE>  (1274) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1274) 
Y

>  <FIRST_IN_CLASS>  (1274) 
N

>  <CHIRALITY>  (1274) 
Achiral Molecule

>  <PRODRUG>  (1274) 
N

>  <ORAL>  (1274) 
N

>  <PARENTERAL>  (1274) 
N

>  <TOPICAL>  (1274) 
N

>  <BLACK_BOX>  (1274) 
N

>  <AVAILABILITY_TYPE>  (1274) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1274) 
1974.0

>  <WITHDRAWN_COUNTRY>  (1274) 
United Kingdom; United States

>  <WITHDRAWN_REASON>  (1274) 
Hepatotoxicity; Drug Interaction

>  <CANONICAL_SMILES>  (1274) 
O=C(CCNNC(=O)c1ccncc1)NCc2ccccc2

>  <name>  (1274) 
Nialamide 

>  <MW>  (1274) 
298.346

>  <logP>  (1274) 
1.0225

$$$$
CHEMBL1200
     RDKit          

 22 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  8 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  1  0
 11  6  1  0
M  END
>  <PARENT_MOLREGNO>  (1275) 
209594

>  <SYNONYMS>  (1275) 
Oxybuprocaine (INN, BAN); Benoxinate HCl (FDA, USP); Oxybuprocaine HCl (JAN)

>  <DEVELOPMENT_PHASE>  (1275) 
4

>  <RESEARCH_CODES>  (1275) 
nan

>  <APPLICANTS>  (1275) 
Sola Barnes Hind

>  <USAN_STEM>  (1275) 
nan

>  <USAN_STEM_DEFINITION>  (1275) 
nan

>  <USAN_STEM_SUBSTEM>  (1275) 
nan

>  <USAN_YEAR>  (1275) 
nan

>  <FIRST_APPROVAL>  (1275) 
1982.0

>  <ATC_CODE>  (1275) 
D04AB03; S01HA02

>  <ATC_CODE_DESCRIPTION>  (1275) 
D04AB03 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; S01HA02 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]

>  <INDICATION_CLASS>  (1275) 
Anesthetic (topical)

>  <SC_PATENT_NO>  (1275) 
nan

>  <DRUG_TYPE>  (1275) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1275) 
Y

>  <FIRST_IN_CLASS>  (1275) 
N

>  <CHIRALITY>  (1275) 
Achiral Molecule

>  <PRODRUG>  (1275) 
N

>  <ORAL>  (1275) 
N

>  <PARENTERAL>  (1275) 
N

>  <TOPICAL>  (1275) 
Y

>  <BLACK_BOX>  (1275) 
N

>  <AVAILABILITY_TYPE>  (1275) 
Discontinued

>  <WITHDRAWN_YEAR>  (1275) 
nan

>  <WITHDRAWN_COUNTRY>  (1275) 
nan

>  <WITHDRAWN_REASON>  (1275) 
nan

>  <CANONICAL_SMILES>  (1275) 
CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC

>  <name>  (1275) 
Oxybuprocaine 

>  <MW>  (1275) 
308.422

>  <logP>  (1275) 
2.9463

$$$$
CHEMBL1963681
     RDKit          

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 11 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  6 32  1  0
 32 33  2  0
 33 34  1  0
 33  3  1  0
 14  9  1  0
 24 19  1  0
 29 25  1  0
M  END
>  <PARENT_MOLREGNO>  (1276) 
1285392

>  <SYNONYMS>  (1276) 
Avanafil (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1276) 
4

>  <RESEARCH_CODES>  (1276) 
TA-1790

>  <APPLICANTS>  (1276) 
Vivus Inc

>  <USAN_STEM>  (1276) 
-afil

>  <USAN_STEM_DEFINITION>  (1276) 
PDE5 inhibitors

>  <USAN_STEM_SUBSTEM>  (1276) 
-afil

>  <USAN_YEAR>  (1276) 
2000.0

>  <FIRST_APPROVAL>  (1276) 
2011.0

>  <ATC_CODE>  (1276) 
G04BE10

>  <ATC_CODE_DESCRIPTION>  (1276) 
G04BE10 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs used in erectile dysfunction]

>  <INDICATION_CLASS>  (1276) 
nan

>  <SC_PATENT_NO>  (1276) 
US-6656935-B2

>  <DRUG_TYPE>  (1276) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1276) 
Y

>  <FIRST_IN_CLASS>  (1276) 
N

>  <CHIRALITY>  (1276) 
Single Stereoisomer

>  <PRODRUG>  (1276) 
N

>  <ORAL>  (1276) 
Y

>  <PARENTERAL>  (1276) 
N

>  <TOPICAL>  (1276) 
N

>  <BLACK_BOX>  (1276) 
N

>  <AVAILABILITY_TYPE>  (1276) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1276) 
nan

>  <WITHDRAWN_COUNTRY>  (1276) 
nan

>  <WITHDRAWN_REASON>  (1276) 
nan

>  <CANONICAL_SMILES>  (1276) 
COc1ccc(CNc2nc(ncc2C(=O)NCc3ncccn3)N4CCC[C@H]4CO)cc1Cl

>  <name>  (1276) 
Avanafil 

>  <MW>  (1276) 
483.96

>  <logP>  (1276) 
2.4318

$$$$
CHEMBL1436
     RDKit          

 29 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 12 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
  4 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 15  8  1  0
 14  9  1  0
 29 25  2  0
M  END
>  <PARENT_MOLREGNO>  (1277) 
371655

>  <SYNONYMS>  (1277) 
Cefuroxime (BAN, INN, USAN, FDA); Cefuroxime Sodium (BAN, FDA, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1277) 
4

>  <RESEARCH_CODES>  (1277) 
640/359

>  <APPLICANTS>  (1277) 
Glaxo, England; Covis Pharma Sarl; B Braun Medical Inc

>  <USAN_STEM>  (1277) 
cef-

>  <USAN_STEM_DEFINITION>  (1277) 
cephalosporins

>  <USAN_STEM_SUBSTEM>  (1277) 
cef-

>  <USAN_YEAR>  (1277) 
1984.0

>  <FIRST_APPROVAL>  (1277) 
1983.0

>  <ATC_CODE>  (1277) 
J01DC02; S01AA27; J01RA03

>  <ATC_CODE_DESCRIPTION>  (1277) 
J01DC02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Other Beta-Lactam Antibacterials:Second-generation cephalosporins]; S01AA27 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]; J01RA03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Combinations Of Antibacterials:Combinations of antibacterials]

>  <INDICATION_CLASS>  (1277) 
Antibacterial

>  <SC_PATENT_NO>  (1277) 
nan

>  <DRUG_TYPE>  (1277) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1277) 
Y

>  <FIRST_IN_CLASS>  (1277) 
N

>  <CHIRALITY>  (1277) 
Single Stereoisomer

>  <PRODRUG>  (1277) 
N

>  <ORAL>  (1277) 
N

>  <PARENTERAL>  (1277) 
Y

>  <TOPICAL>  (1277) 
N

>  <BLACK_BOX>  (1277) 
N

>  <AVAILABILITY_TYPE>  (1277) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1277) 
nan

>  <WITHDRAWN_COUNTRY>  (1277) 
nan

>  <WITHDRAWN_REASON>  (1277) 
nan

>  <CANONICAL_SMILES>  (1277) 
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)N)\c3occc3

>  <name>  (1277) 
Cefuroxime 

>  <MW>  (1277) 
424.391

>  <logP>  (1277) 
-0.536

$$$$
CHEMBL2107830
     RDKit          

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
  5 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 22 29  1  0
 29 30  2  0
 17 31  2  0
 10  3  1  0
 31 12  1  0
 30 19  1  0
 28 24  1  0
M  END
>  <PARENT_MOLREGNO>  (1278) 
1380100

>  <SYNONYMS>  (1278) 
Empagliflozin (FDA, INN, USAN)

>  <DEVELOPMENT_PHASE>  (1278) 
4

>  <RESEARCH_CODES>  (1278) 
nan

>  <APPLICANTS>  (1278) 
Boehringer Ingelheim Pharmaceuticals Inc

>  <USAN_STEM>  (1278) 
-gliflozin

>  <USAN_STEM_DEFINITION>  (1278) 
phlorozin derivatives, phenolic glycosides

>  <USAN_STEM_SUBSTEM>  (1278) 
-gliflozin

>  <USAN_YEAR>  (1278) 
2012.0

>  <FIRST_APPROVAL>  (1278) 
2014.0

>  <ATC_CODE>  (1278) 
A10BX12

>  <ATC_CODE_DESCRIPTION>  (1278) 
A10BX12 [Alimentary Tract And Metabolism:Drugs Used In Diabetes:Blood Glucose Lowering Drugs, Excl. Insulins:Other blood glucose lowering drugs, excl. insulins]

>  <INDICATION_CLASS>  (1278) 
nan

>  <SC_PATENT_NO>  (1278) 
US-6303661-B1

>  <DRUG_TYPE>  (1278) 
Natural Product-derived

>  <RULE_OF_FIVE>  (1278) 
Y

>  <FIRST_IN_CLASS>  (1278) 
N

>  <CHIRALITY>  (1278) 
Single Stereoisomer

>  <PRODRUG>  (1278) 
N

>  <ORAL>  (1278) 
Y

>  <PARENTERAL>  (1278) 
N

>  <TOPICAL>  (1278) 
N

>  <BLACK_BOX>  (1278) 
N

>  <AVAILABILITY_TYPE>  (1278) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1278) 
nan

>  <WITHDRAWN_COUNTRY>  (1278) 
nan

>  <WITHDRAWN_REASON>  (1278) 
nan

>  <CANONICAL_SMILES>  (1278) 
OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2

>  <name>  (1278) 
Empagliflozin 

>  <MW>  (1278) 
450.915

>  <logP>  (1278) 
1.6134

$$$$
CHEMBL2105458
     RDKit          

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
  7  2  1  0
 14 10  1  0
 20 15  1  0
M  END
>  <PARENT_MOLREGNO>  (1279) 
1377728

>  <SYNONYMS>  (1279) 
Thenalidine (BAN, INN, MI)

>  <DEVELOPMENT_PHASE>  (1279) 
4

>  <RESEARCH_CODES>  (1279) 
nan

>  <APPLICANTS>  (1279) 
nan

>  <USAN_STEM>  (1279) 
nan

>  <USAN_STEM_DEFINITION>  (1279) 
nan

>  <USAN_STEM_SUBSTEM>  (1279) 
nan

>  <USAN_YEAR>  (1279) 
nan

>  <FIRST_APPROVAL>  (1279) 
nan

>  <ATC_CODE>  (1279) 
R06AX53; D04AA03; R06AX03

>  <ATC_CODE_DESCRIPTION>  (1279) 
R06AX53 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]; D04AA03 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antihistamines for topical use]; R06AX03 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Other antihistamines for systemic use]

>  <INDICATION_CLASS>  (1279) 
nan

>  <SC_PATENT_NO>  (1279) 
nan

>  <DRUG_TYPE>  (1279) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1279) 
Y

>  <FIRST_IN_CLASS>  (1279) 
N

>  <CHIRALITY>  (1279) 
Achiral Molecule

>  <PRODRUG>  (1279) 
N

>  <ORAL>  (1279) 
N

>  <PARENTERAL>  (1279) 
N

>  <TOPICAL>  (1279) 
N

>  <BLACK_BOX>  (1279) 
N

>  <AVAILABILITY_TYPE>  (1279) 
Withdrawn

>  <WITHDRAWN_YEAR>  (1279) 
1960.0

>  <WITHDRAWN_COUNTRY>  (1279) 
United States

>  <WITHDRAWN_REASON>  (1279) 
Agranulocytosis

>  <CANONICAL_SMILES>  (1279) 
CN1CCC(CC1)N(Cc2cccs2)c3ccccc3

>  <name>  (1279) 
Thenalidine 

>  <MW>  (1279) 
286.444

>  <logP>  (1279) 
3.8489

$$$$
CHEMBL1237044
     RDKit          

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
  8  3  1  0
 15  9  1  0
M  END
>  <PARENT_MOLREGNO>  (1280) 
699395

>  <SYNONYMS>  (1280) 
Tramadol (BAN, INN); Tramadol HCl (FDA, JAN, USAN)

>  <DEVELOPMENT_PHASE>  (1280) 
4

>  <RESEARCH_CODES>  (1280) 
CG-315E; U-26225A

>  <APPLICANTS>  (1280) 
Shionogi Inc; Purdue Pharma Products Lp; Janssen Pharmaceuticals Inc; Cipher Pharmaceuticals Inc; Valeant International Barbados Srl

>  <USAN_STEM>  (1280) 
-adol

>  <USAN_STEM_DEFINITION>  (1280) 
analgesics (mixed opiate receptor agonists/antagonists)

>  <USAN_STEM_SUBSTEM>  (1280) 
-adol

>  <USAN_YEAR>  (1280) 
1969.0

>  <FIRST_APPROVAL>  (1280) 
1995.0

>  <ATC_CODE>  (1280) 
N02AX52; N02AX02

>  <ATC_CODE_DESCRIPTION>  (1280) 
N02AX52 [Nervous System:Analgesics:Opioids:Other opioids]; N02AX02 [Nervous System:Analgesics:Opioids:Other opioids]

>  <INDICATION_CLASS>  (1280) 
Analgesic

>  <SC_PATENT_NO>  (1280) 
US-6106861-A

>  <DRUG_TYPE>  (1280) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1280) 
Y

>  <FIRST_IN_CLASS>  (1280) 
N

>  <CHIRALITY>  (1280) 
Racemic Mixture

>  <PRODRUG>  (1280) 
N

>  <ORAL>  (1280) 
Y

>  <PARENTERAL>  (1280) 
N

>  <TOPICAL>  (1280) 
N

>  <BLACK_BOX>  (1280) 
N

>  <AVAILABILITY_TYPE>  (1280) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1280) 
nan

>  <WITHDRAWN_COUNTRY>  (1280) 
nan

>  <WITHDRAWN_REASON>  (1280) 
nan

>  <CANONICAL_SMILES>  (1280) 
COc1cccc(c1)C2(O)CCCCC2CN(C)C

>  <name>  (1280) 
Tramadol 

>  <MW>  (1280) 
263.381

>  <logP>  (1280) 
2.6346

$$$$
CHEMBL3707265
     RDKit          

 10  9  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
M  CHG  1   2   1
M  END
>  <PARENT_MOLREGNO>  (1281) 
2039236

>  <SYNONYMS>  (1281) 
Fluoroethylcholine (18f)

>  <DEVELOPMENT_PHASE>  (1281) 
4

>  <RESEARCH_CODES>  (1281) 
nan

>  <APPLICANTS>  (1281) 
nan

>  <USAN_STEM>  (1281) 
nan

>  <USAN_STEM_DEFINITION>  (1281) 
nan

>  <USAN_STEM_SUBSTEM>  (1281) 
nan

>  <USAN_YEAR>  (1281) 
nan

>  <FIRST_APPROVAL>  (1281) 
nan

>  <ATC_CODE>  (1281) 
V09IX08

>  <ATC_CODE_DESCRIPTION>  (1281) 
V09IX08 [Various:Diagnostic Radiopharmaceuticals:Tumour Detection:Other diagnostic radiopharmaceuticals for tumour detection]

>  <INDICATION_CLASS>  (1281) 
nan

>  <SC_PATENT_NO>  (1281) 
nan

>  <DRUG_TYPE>  (1281) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1281) 
Y

>  <FIRST_IN_CLASS>  (1281) 
N

>  <CHIRALITY>  (1281) 
Achiral Molecule

>  <PRODRUG>  (1281) 
N

>  <ORAL>  (1281) 
N

>  <PARENTERAL>  (1281) 
N

>  <TOPICAL>  (1281) 
N

>  <BLACK_BOX>  (1281) 
N

>  <AVAILABILITY_TYPE>  (1281) 
Unknown

>  <WITHDRAWN_YEAR>  (1281) 
nan

>  <WITHDRAWN_COUNTRY>  (1281) 
nan

>  <WITHDRAWN_REASON>  (1281) 
nan

>  <CANONICAL_SMILES>  (1281) 
C[N+](C)(C)CCOCCF

>  <name>  (1281) 
Fluoroethylcholine 

>  <MW>  (1281) 
150.217

>  <logP>  (1281) 
0.6787

$$$$
CHEMBL3707362
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  8  1  0
 14  9  1  0
 21 16  1  0
M  END
>  <PARENT_MOLREGNO>  (1282) 
2039333

>  <SYNONYMS>  (1282) 
Dimethylaminopropionylphenothiazine

>  <DEVELOPMENT_PHASE>  (1282) 
4

>  <RESEARCH_CODES>  (1282) 
nan

>  <APPLICANTS>  (1282) 
nan

>  <USAN_STEM>  (1282) 
nan

>  <USAN_STEM_DEFINITION>  (1282) 
nan

>  <USAN_STEM_SUBSTEM>  (1282) 
nan

>  <USAN_YEAR>  (1282) 
nan

>  <FIRST_APPROVAL>  (1282) 
nan

>  <ATC_CODE>  (1282) 
A03AC02

>  <ATC_CODE_DESCRIPTION>  (1282) 
A03AC02 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic antispasmodics, amides with tertiary amines]

>  <INDICATION_CLASS>  (1282) 
nan

>  <SC_PATENT_NO>  (1282) 
nan

>  <DRUG_TYPE>  (1282) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1282) 
Y

>  <FIRST_IN_CLASS>  (1282) 
N

>  <CHIRALITY>  (1282) 
Racemic Mixture

>  <PRODRUG>  (1282) 
N

>  <ORAL>  (1282) 
N

>  <PARENTERAL>  (1282) 
N

>  <TOPICAL>  (1282) 
N

>  <BLACK_BOX>  (1282) 
N

>  <AVAILABILITY_TYPE>  (1282) 
Unknown

>  <WITHDRAWN_YEAR>  (1282) 
nan

>  <WITHDRAWN_COUNTRY>  (1282) 
nan

>  <WITHDRAWN_REASON>  (1282) 
nan

>  <CANONICAL_SMILES>  (1282) 
CC(N(C)C)C(=O)N1c2ccccc2Sc3ccccc13

>  <name>  (1282) 
Dimethylaminopropionylphenothiazine

>  <MW>  (1282) 
298.411

>  <logP>  (1282) 
3.766

$$$$
CHEMBL3707307
     RDKit          

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  9 19  1  0
 19 20  1  0
 20 21  2  0
 21  4  1  0
 20  7  1  0
 18 13  1  0
M  END
>  <PARENT_MOLREGNO>  (1283) 
2039278

>  <SYNONYMS>  (1283) 
Fabomotizole

>  <DEVELOPMENT_PHASE>  (1283) 
4

>  <RESEARCH_CODES>  (1283) 
nan

>  <APPLICANTS>  (1283) 
nan

>  <USAN_STEM>  (1283) 
nan

>  <USAN_STEM_DEFINITION>  (1283) 
nan

>  <USAN_STEM_SUBSTEM>  (1283) 
nan

>  <USAN_YEAR>  (1283) 
nan

>  <FIRST_APPROVAL>  (1283) 
nan

>  <ATC_CODE>  (1283) 
N05BX04

>  <ATC_CODE_DESCRIPTION>  (1283) 
N05BX04 [Nervous System:Psycholeptics:Anxiolytics:Other anxiolytics]

>  <INDICATION_CLASS>  (1283) 
nan

>  <SC_PATENT_NO>  (1283) 
nan

>  <DRUG_TYPE>  (1283) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1283) 
Y

>  <FIRST_IN_CLASS>  (1283) 
N

>  <CHIRALITY>  (1283) 
Achiral Molecule

>  <PRODRUG>  (1283) 
N

>  <ORAL>  (1283) 
N

>  <PARENTERAL>  (1283) 
N

>  <TOPICAL>  (1283) 
N

>  <BLACK_BOX>  (1283) 
N

>  <AVAILABILITY_TYPE>  (1283) 
Unknown

>  <WITHDRAWN_YEAR>  (1283) 
nan

>  <WITHDRAWN_COUNTRY>  (1283) 
nan

>  <WITHDRAWN_REASON>  (1283) 
nan

>  <CANONICAL_SMILES>  (1283) 
CCOc1ccc2nc(SCCN3CCOCC3)[nH]c2c1

>  <name>  (1283) 
Fabomotizole

>  <MW>  (1283) 
307.419

>  <logP>  (1283) 
2.3859

$$$$
CHEMBL897
     RDKit          

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 16 11  1  0
M  END
>  <PARENT_MOLREGNO>  (1284) 
77474

>  <SYNONYMS>  (1284) 
Probenecid (BAN, FDA, INN, JAN, USP)

>  <DEVELOPMENT_PHASE>  (1284) 
4

>  <RESEARCH_CODES>  (1284) 
nan

>  <APPLICANTS>  (1284) 
Merck And Co Inc; Bristol Laboratories Inc Div Bristol Myers Co; Apothecon Sub Bristol Myers Squibb Co

>  <USAN_STEM>  (1284) 
nan

>  <USAN_STEM_DEFINITION>  (1284) 
nan

>  <USAN_STEM_SUBSTEM>  (1284) 
nan

>  <USAN_YEAR>  (1284) 
nan

>  <FIRST_APPROVAL>  (1284) 
1951.0

>  <ATC_CODE>  (1284) 
M04AB01

>  <ATC_CODE_DESCRIPTION>  (1284) 
M04AB01 [Musculo-Skeletal System:Antigout Preparations:Antigout Preparations:Preparations increasing uric acid excretion]

>  <INDICATION_CLASS>  (1284) 
Uricosuric

>  <SC_PATENT_NO>  (1284) 
nan

>  <DRUG_TYPE>  (1284) 
Synthetic Small Molecule

>  <RULE_OF_FIVE>  (1284) 
Y

>  <FIRST_IN_CLASS>  (1284) 
N

>  <CHIRALITY>  (1284) 
Achiral Molecule

>  <PRODRUG>  (1284) 
N

>  <ORAL>  (1284) 
Y

>  <PARENTERAL>  (1284) 
N

>  <TOPICAL>  (1284) 
N

>  <BLACK_BOX>  (1284) 
N

>  <AVAILABILITY_TYPE>  (1284) 
Prescription-only

>  <WITHDRAWN_YEAR>  (1284) 
nan

>  <WITHDRAWN_COUNTRY>  (1284) 
nan

>  <WITHDRAWN_REASON>  (1284) 
nan

>  <CANONICAL_SMILES>  (1284) 
CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O

>  <name>  (1284) 
Probenecid 

>  <MW>  (1284) 
285.365

>  <logP>  (1284) 
2.1955

$$$$
